Citrus Sinensis ID: 002887
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 870 | 2.2.26 [Sep-21-2011] | |||||||
| O65924 | 881 | Putative leucine-rich rep | no | no | 0.974 | 0.962 | 0.493 | 0.0 | |
| O64556 | 877 | Putative leucine-rich rep | no | no | 0.974 | 0.966 | 0.495 | 0.0 | |
| Q9FZB1 | 872 | Probable LRR receptor-lik | no | no | 0.945 | 0.943 | 0.476 | 0.0 | |
| C0LGD6 | 852 | Probable LRR receptor-lik | no | no | 0.941 | 0.961 | 0.487 | 0.0 | |
| C0LGG4 | 890 | Probable LRR receptor-lik | no | no | 0.945 | 0.924 | 0.470 | 0.0 | |
| C0LGG6 | 876 | Probable LRR receptor-lik | no | no | 0.964 | 0.957 | 0.461 | 0.0 | |
| O64483 | 876 | Senescence-induced recept | no | no | 0.971 | 0.964 | 0.466 | 0.0 | |
| Q9LIG2 | 899 | Receptor-like protein kin | no | no | 0.965 | 0.934 | 0.445 | 0.0 | |
| Q9SI06 | 892 | Putative leucine-rich rep | no | no | 0.970 | 0.946 | 0.459 | 0.0 | |
| Q9ZQR3 | 868 | Leucine-rich repeat recep | no | no | 0.936 | 0.938 | 0.449 | 0.0 |
| >sp|O65924|Y2921_ARATH Putative leucine-rich repeat receptor-like protein kinase At2g19210 OS=Arabidopsis thaliana GN=At2g19210 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 820 bits (2117), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/896 (49%), Positives = 574/896 (64%), Gaps = 48/896 (5%)
Query: 3 MLTTFIFA-FLCIVALTAVVHAQNQSGFISIDCGIPENENYADKVTGINYVSDAPYVDTA 61
L+ IFA F + L +V AQ+QSGF+SIDCGIPE+ +Y D+ T I YVSDA +V++
Sbjct: 6 FLSLIIFACFFAVFVL--LVRAQDQSGFVSIDCGIPEDSSYNDETTDIKYVSDAAFVESG 63
Query: 62 VSHSISPEYSKETVERQFSYLRSFPEGIRNCYTLRPPNGD-VKFLIRARFMYGNYDGLDK 120
HSI PE+ ++E+QF +RSFPEG RNCY ++PP G K+LIR RFMYGNYD L K
Sbjct: 64 TIHSIDPEFQTSSLEKQFQNVRSFPEGNRNCYDVKPPQGKGFKYLIRTRFMYGNYDNLGK 123
Query: 121 APSFDLMLGADAWDSVQLQDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRPL 180
AP FDL LG + WDSV + + +I+TKEIIH D++HVCLV+ + G PF+SALE+R L
Sbjct: 124 APDFDLYLGFNIWDSVTIDNATTIVTKEIIHTLRSDHVHVCLVDKNRGTPFLSALEIRLL 183
Query: 181 TNSIYPPTASDLYRPTPTGSMSLVLRWDVGT----PL----DIYDRIWWPDNFKNVERIS 232
++ Y TP S+ L RWD+G P+ D++DRIW P F +
Sbjct: 184 KSNTYE---------TPYDSLILFKRWDLGGLGALPVRYKDDVFDRIWIPLRFPKYTIFN 234
Query: 233 TSSNVNPATSL-FQPPVTVMQSAIIPANGSSSFWFSWESVSTVFKYYTCMYFSEFESEQA 291
S ++ + FQP VM +A P + S FSWE +KY+ M+F+E E
Sbjct: 235 ASLTIDSNNNEGFQPARFVMNTATSPEDLSQDIIFSWEPKDPTWKYFVYMHFAEV-VELP 293
Query: 292 ETRSREMNIYLNGRFWSEIP----PPQYLNTTTHRL-TATNAQQYVISIMQTKNSSLAPI 346
+RE + LN + EI P+YL T T + + + + QT S+L PI
Sbjct: 294 SNETREFKVLLNEK---EINMSSFSPRYLYTDTLFVQNPVSGPKLEFRLQQTPRSTLPPI 350
Query: 347 LNALEIYQEKEFLQLLTNQQDVDAIMKIKSKYEVKRDWQGDPCAPKVYMWQGINCSYDAN 406
+NA+E Y+ EFLQ T+QQDVDAIM+IKSKY VK+ W GDPCAP Y W+ INCSY N
Sbjct: 351 INAIETYRVNEFLQSPTDQQDVDAIMRIKSKYGVKKSWLGDPCAPVKYPWKDINCSYVDN 410
Query: 407 QSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG 466
+SPRIIS+NLSSSG+ G+I +LT + LDLS NSLTG +P+FL L +L LNL G
Sbjct: 411 ESPRIISVNLSSSGLTGEIDAAFSNLTLLHILDLSNNSLTGKIPDFLGNLHNLTELNLEG 470
Query: 467 NNLQGSLPSGLSEKVKNGSLSLSVDGNRNLCPSASC-----KKKSNKFIFPVLASVVSFC 521
N L G++P L E+ + L +DGN +LC SASC K K N +I P++ASVV
Sbjct: 471 NKLSGAIPVKLLERSNKKLILLRIDGNPDLCVSASCQISDEKTKKNVYIIPLVASVVGVL 530
Query: 522 ILLALLAIL----QNLRRRKQAGKKKGSLELENRKFSYFDVLKITNNFERVLGKGGFGTV 577
L+ +A+ + RR G + G L+ R + Y +V+K+TNNFERVLG+GGFG V
Sbjct: 531 GLVLAIALFLLYKKRHRRGGSGGVRAGPLDTTKRYYKYSEVVKVTNNFERVLGQGGFGKV 590
Query: 578 YHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637
YHG L+D QVAVK+LS SS QGYK+F+AEVELL+R HHKNLT L+GYC EG M LIYEF
Sbjct: 591 YHGVLNDDQVAVKILSESSAQGYKEFRAEVELLLRVHHKNLTALIGYCHEGKKMALIYEF 650
Query: 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK 697
MANG L +L +K+ L WE RLQI+ ++AQGLEYLHNGCKPPIV RDVK ANIL+NEK
Sbjct: 651 MANGTLGDYLSGEKSYVLSWEERLQISLDAAQGLEYLHNGCKPPIVQRDVKPANILINEK 710
Query: 698 FQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELI 757
QAK+ADFGLSR ++G +T V GT GYLDPEY+++ +L+EKSD+YSFGVVLLE++
Sbjct: 711 LQAKIADFGLSRSVALDGNNQDTTAVAGTIGYLDPEYHLTQKLSEKSDIYSFGVVLLEVV 770
Query: 758 TGQPVIQK---TPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIH 814
+GQPVI + T + I V ML+ GDI+ IVD +L FD + WK E+A+AC
Sbjct: 771 SGQPVIARSRTTAENIHITDRVDLMLSTGDIRGIVDPKLGERFDAGSAWKITEVAMACAS 830
Query: 815 TISTRRPTMNQVVIELNDCLAMEIARTKAHETAPDGTPDELMIDLNLHSDVFPLAR 870
+ S RPTM+ VV EL + ++ AR A T D M N S +FP AR
Sbjct: 831 SSSKNRPTMSHVVAELKESVSR--ARAGGGSGASSVT-DPAMT--NFDSGMFPQAR 881
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O64556|Y2923_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g19230 OS=Arabidopsis thaliana GN=At2g19230 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 792 bits (2045), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 438/884 (49%), Positives = 573/884 (64%), Gaps = 36/884 (4%)
Query: 8 IFAFLCIVALTAVVHAQNQSGFISIDCGIPENENYADKVTGINYVSDAPYVDTAVSHSIS 67
+ +F V + +V AQ+QSGF+SIDCGIPE+ +Y D+ T I Y+SDA +V++ HSI
Sbjct: 9 LVSFASFVVVLVLVCAQDQSGFVSIDCGIPEDSSYYDEKTDIKYISDAAFVESGTIHSID 68
Query: 68 PEYSKETVERQFSYLRSFPEGIRNCYTLRPPNGD-VKFLIRARFMYGNYDGLDKAPSFDL 126
++ K+ +E+QF +RSFPEG +NCY ++PP G K+LIR RFMYGNYD L KAP FDL
Sbjct: 69 SKFQKKNLEKQFQKVRSFPEGKKNCYDVQPPQGKGFKYLIRTRFMYGNYDNLGKAPDFDL 128
Query: 127 MLGADAWDSVQLQDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRPLTNSIYP 186
LG + WDSV L++ +I+TKEII+ D +HVCLV+ + G PF+S LELR L N+IY
Sbjct: 129 YLGVNLWDSVTLENSTTIVTKEIIYTLRSDKVHVCLVDKERGTPFLSVLELRLLKNNIYE 188
Query: 187 PTASDLYRPTPTGSMSLVLRWDVGT--------PLDIYDRIWWPDNFKNVERISTSSNVN 238
TASD S+ L RWD+G DI+DR W P F N ++TS ++
Sbjct: 189 -TASD--------SLMLYRRWDLGATGDLPARYKDDIFDRFWMPLMFPNFLILNTSLMID 239
Query: 239 PATS-LFQPPVTVMQSAIIPANGS-SSFWFSWESVSTVFKYYTCMYFSEFESEQAETRSR 296
P +S F PP VM +A+ P N S WE +K+Y ++F+E E + +R
Sbjct: 240 PTSSNGFLPPSVVMSTAVAPMNSSIEQIMVYWEPRDPNWKFYIYIHFAEVE-KLPSNETR 298
Query: 297 EMNIYLNGRF--WSEIPPPQYLNTTTHRLTATNAQQYVISIM-QTKNSSLAPILNALEIY 353
E +++LN + + P YL T T + + ++ ++ Q S+ PI+NA+E Y
Sbjct: 299 EFSVFLNKEQIDTTSVFRPSYLYTDTLYVQNPVSGPFLEFVLRQGVKSTRPPIMNAIETY 358
Query: 354 QEKEFLQLLTNQQDVDAIMKIKSKYEVKRDWQGDPCAPKVYMWQGINCSYDANQSPRIIS 413
+ EFL L T+Q DVDAIMKIK+KY+VK++W GDPCAP Y WQGINCSY AN PRIIS
Sbjct: 359 RTNEFLDLPTDQNDVDAIMKIKTKYKVKKNWLGDPCAPFGYPWQGINCSYTANNPPRIIS 418
Query: 414 INLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSL 473
+NLS SG+ G I P +LT ++ LDLS N LTG VP+FLA L L LNL N L G L
Sbjct: 419 VNLSFSGLTGQIDPVFITLTPLQKLDLSNNRLTGTVPDFLANLPDLTELNLEENKLTGIL 478
Query: 474 PSGLSEKVKNGSLSLSVDGNRNLCPSASCKKKS---NKFIFPVLASVVS-FCILLALLAI 529
P L E+ K+GSLSL V GN +LC S SC+ K ++I P +ASV F +LLAL++
Sbjct: 479 PEKLLERSKDGSLSLRVGGNPDLCVSDSCRNKKTERKEYIIPSVASVTGLFFLLLALISF 538
Query: 530 LQNLRRRKQAGKKKGSLELENRKFSYFDVLKITNNFERVLGKGGFGTVYHGYLDDKQVAV 589
Q +++Q K G L+ + R + Y ++++ITNNFERVLG+GGFG VY+G L +QVA+
Sbjct: 539 WQ--FKKRQQSVKTGPLDTK-RYYKYSEIVEITNNFERVLGQGGFGKVYYGVLRGEQVAI 595
Query: 590 KMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLE 649
KMLS SS QGYK+F+AEVELL+R HHKNL L+GYC EG M LIYE++ NG L +L
Sbjct: 596 KMLSKSSAQGYKEFRAEVELLLRVHHKNLIALIGYCHEGDQMALIYEYIGNGTLGDYLSG 655
Query: 650 DKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 709
+ L WE RLQI+ ++AQGLEYLHNGCKPPIVHRDVK NIL+NEK QAK+ADFGLSR
Sbjct: 656 KNSSILSWEERLQISLDAAQGLEYLHNGCKPPIVHRDVKPTNILINEKLQAKIADFGLSR 715
Query: 710 IFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVI--QKTP 767
F +EG + VST V GT GYLDPE+Y + +EKSDVYSFGVVLLE+ITGQPVI +T
Sbjct: 716 SFTLEGDSQVSTEVAGTIGYLDPEHYSMQQFSEKSDVYSFGVVLLEVITGQPVISRSRTE 775
Query: 768 QRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVV 827
+ I VS ML++GDIK+IVD +L F+ WK E+ALAC + R TM+QVV
Sbjct: 776 ENRHISDRVSLMLSKGDIKSIVDPKLGERFNAGLAWKITEVALACASESTKTRLTMSQVV 835
Query: 828 IELNDCLAMEIARTKAHETAPD-GTPDELMIDLNLHSDVFPLAR 870
EL + L ART P E+ + + + V P R
Sbjct: 836 AELKESLCR--ARTSGDSGDISFSEPTEMNVSMTVDPGVLPQPR 877
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 778 bits (2008), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/859 (47%), Positives = 565/859 (65%), Gaps = 36/859 (4%)
Query: 7 FIFAFLCIVALTAVVHAQNQSGFISIDCG-IPENENYADKVTGINYVSDAPYVDTAVSHS 65
F+ + + V AQ+Q GFIS+DCG +P+N Y +K T I Y SDA Y+D+ +
Sbjct: 7 FLLFLITAYVILESVQAQDQLGFISLDCGLVPKNATYTEKTTNITYKSDANYIDSGLVGR 66
Query: 66 ISPEYSKETVERQFSYLRSFPEGIRNCYTLRPPNGDVKFLIRARFMYGNYDGLDKAPSFD 125
IS EY K +++Q +RSFPEG RNCY ++LIRA F YGNYDGL + P FD
Sbjct: 67 ISAEY-KAQLQQQTWTVRSFPEGERNCYNFNL-TAKSRYLIRATFTYGNYDGLRQVPKFD 124
Query: 126 LMLGADAWDSVQLQDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRPLTNSIY 185
+ +G W SV+L + E+IH+ +D + +CLV T GIPFIS+LELRPL N+ Y
Sbjct: 125 IHIGPSKWTSVKLDGVGNGAVLEMIHVLTQDRLQICLVKTGKGIPFISSLELRPLNNNTY 184
Query: 186 PPTASDL-------YRPTPTGSMSLVLRWDVGTPLDIYDRIWWPDNFKNVERISTSSNVN 238
+ L + TPT +R+D DI+DR+W ++ IST V+
Sbjct: 185 LTQSGSLIGFARVFFSATPT-----FIRYDE----DIHDRVWVRQFGNGLKSISTDLLVD 235
Query: 239 PATSLFQPPVTVMQSAIIPANGSSSFWFSWESVSTVFKYYTCMYFSEFESEQAETRSREM 298
+ + P V ++A +P+N S F W + + Y M+F+E ++ + + RE
Sbjct: 236 TSNP-YDVPQAVAKTACVPSNASQPLIFDWTLDNITSQSYVYMHFAEIQTLK-DNDIREF 293
Query: 299 NIYLNG--RFWSEIPPPQYLNTT--THRLTATNAQQYVISIMQTKNSSLAPILNALEIYQ 354
NI NG +S + P ++ +T + ++ + +S +T NS+L P++N LEIY+
Sbjct: 294 NITYNGGQNVYSYLRPEKFEISTLFDSKPLSSPDGSFSLSFTKTGNSTLPPLINGLEIYK 353
Query: 355 EKEFLQLLTNQQDVDAIMKIKSKYEV--KRDWQGDPCAPKVYMWQGINCSYDANQSPRII 412
+ L+L T+Q +V A++ IK+ Y++ K WQGDPCAPK Y W+G+NCSY + PRII
Sbjct: 354 VLDLLELETDQDEVSAMINIKATYDLSKKVSWQGDPCAPKSYQWEGLNCSYPNSDQPRII 413
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN-NLQG 471
S+NL+ + + G I P I LT + LDLSKN L+G +PEF A+++ L+++NLSGN L
Sbjct: 414 SLNLAENKLTGTITPEISKLTQLIELDLSKNDLSGEIPEFFADMKLLKLINLSGNLGLNS 473
Query: 472 SLPSGLSEKVKNGSLSLSVDGNRNLCPSASCKKKSNKF-IFPVLASVVSFCILLALLAIL 530
++P + +++ + SL L + ++ + + + K KS K + P++ASV LL +LAI
Sbjct: 474 TIPDSIQQRLDSKSLILIL--SKTVTKTVTLKGKSKKVPMIPIVASVAGVFALLVILAIF 531
Query: 531 QNLRRRKQAGKKKG---SLELENRKFSYFDVLKITNNFERVLGKGGFGTVYHGYLDDKQV 587
+ RRK KG S+ + R+ +Y +VLK+TNNFERVLGKGGFGTVYHG L+D QV
Sbjct: 532 F-VVRRKNGESNKGTNPSIITKERRITYPEVLKMTNNFERVLGKGGFGTVYHGNLEDTQV 590
Query: 588 AVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHL 647
AVKMLS SS QGYK+F+AEVELL+R HH+NL LVGYCD+G N+ LIYE+MANG+L+ ++
Sbjct: 591 AVKMLSHSSAQGYKEFKAEVELLLRVHHRNLVGLVGYCDDGDNLALIYEYMANGDLKENM 650
Query: 648 LEDKA-DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFG 706
+ + L WE R+QIA E+AQGLEYLHNGC PP+VHRDVK+ NILLNE++ AKLADFG
Sbjct: 651 SGKRGGNVLTWENRMQIAVEAAQGLEYLHNGCTPPMVHRDVKTTNILLNERYGAKLADFG 710
Query: 707 LSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 766
LSR FPV+G +HVST V GTPGYLDPEYY +N L+EKSDVYSFGVVLLE++T QPV KT
Sbjct: 711 LSRSFPVDGESHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVTDKT 770
Query: 767 PQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQV 826
+RT I +WV SML +GDIK+I+D +L GD+DTN WK VE+ALAC++ S RRPTM V
Sbjct: 771 RERTHINEWVGSMLTKGDIKSILDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHV 830
Query: 827 VIELNDCLAMEIARTKAHE 845
V ELN+C+A+E AR + E
Sbjct: 831 VTELNECVALENARRQGRE 849
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGD6|Y1570_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g05700 OS=Arabidopsis thaliana GN=At1g05700 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 774 bits (1998), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/850 (48%), Positives = 550/850 (64%), Gaps = 31/850 (3%)
Query: 7 FIFAFLCIVALTAVVHAQNQSGFISIDCGIPENENYADKVTGINYVSDAPYVDTAVSHSI 66
I++ + L V AQ+QSGFISIDCGIP +Y D TGINYVSD+ +V+T VS SI
Sbjct: 9 LIYSAAFALCLVVSVLAQDQSGFISIDCGIPSGSSYKDDTTGINYVSDSSFVETGVSKSI 68
Query: 67 SPEYSKETVERQFSYLRSFPEGIRNCYTLRPPNGD-VKFLIRARFMYGNYDGLDKAPSFD 125
T +RQ LRSFPEG RNCYTL P G K+LIRA FMYGNYDG + +P FD
Sbjct: 69 -----PFTAQRQLQNLRSFPEGSRNCYTLIPIQGKGKKYLIRASFMYGNYDGENGSPEFD 123
Query: 126 LMLGADAWDSVQLQDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRPLTNSIY 185
L LG + WD+V L + SI++KE++++ + I VCL N G PFIS LELR L N
Sbjct: 124 LFLGGNIWDTVLLSNGSSIVSKEVVYLSQSENIFVCLGNKGKGTPFISTLELRFLGND-- 181
Query: 186 PPTASDLYRPTPTGSMSLVLRWDV----GTPL----DIYDRIWWPDNFKNVERISTSSNV 237
T D +P G++ RWD+ G+P+ D+YDRIW P NF I+TS V
Sbjct: 182 -NTTYD----SPNGALFFSRRWDLRSLMGSPVRYDDDVYDRIWIPRNFGYCREINTSLPV 236
Query: 238 NPATSLFQPPVTVMQSAIIPANGSSSFWFSWESVSTVFKYYTCMYFSEFESEQAE-TRSR 296
+ + VM +A+ P N + + E+ +Y+ M+F+E E + ++R
Sbjct: 237 TSDNNSYSLSSLVMSTAMTPINTTRPITMTLENSDPNVRYFVYMHFAEVEDLSLKPNQTR 296
Query: 297 EMNIYLNGRFWSEIPPPQYLNTTTHRLTATNAQQYVISIMQTKNSSLAPILNALEIYQEK 356
E +I +NG + P+YL T T L + + S+++T S+L PI+NALEIY
Sbjct: 297 EFDISINGVTVAAGFSPKYLQTNTFFLNPESQSKIAFSLVRTPKSTLPPIVNALEIYVAN 356
Query: 357 EFLQLLTNQQDVDAIMKIKSKYEVKRDWQGDPCAPKVYMWQGINCSYDANQSPRIISINL 416
F Q LTNQ+D DA+ +K+ Y+VK++W GDPC P Y+W+G+NCSYD+ PRI S+NL
Sbjct: 357 SFSQSLTNQEDGDAVTSLKTSYKVKKNWHGDPCLPNDYIWEGLNCSYDSLTPPRITSLNL 416
Query: 417 SSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSG 476
SSSG+ G I +LT I+ LDLS N LTG +PEFL++L+ LRVLNL N L GS+PS
Sbjct: 417 SSSGLTGHISSSFSNLTMIQELDLSNNGLTGDIPEFLSKLKFLRVLNLENNTLTGSVPSE 476
Query: 477 LSEKVKNGSLSLSVDGNRNLCPSASCKK-KSNKFIFPVLASVVSFCILLALLAILQNLRR 535
L E+ GS SL + N LC SC+K S K + P++AS + ILL L + +R
Sbjct: 477 LLERSNTGSFSLRLGENPGLCTEISCRKSNSKKLVIPLVASFAALFILLLLSGVFWRIRN 536
Query: 536 RKQ-----AGKKKGSLELENRK-FSYFDVLKITNNFERVLGKGGFGTVYHGYLDDKQVAV 589
R+ A + + EN+ F++ DV+K+TNNF +VLGKGGFGTVYHG+ D+ QVAV
Sbjct: 537 RRNKSVNSAPQTSPMAKSENKLLFTFADVIKMTNNFGQVLGKGGFGTVYHGFYDNLQVAV 596
Query: 590 KMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLE 649
K+LS +S QG+K+F++EVE+L+R HH NLT L+GY EG MGLIYEFMANGN+ HL
Sbjct: 597 KLLSETSAQGFKEFRSEVEVLVRVHHVNLTALIGYFHEGDQMGLIYEFMANGNMADHLAG 656
Query: 650 DKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 709
TL W +RLQIA ++AQGLEYLH GCKPPIVHRDVK++NILLNEK +AKLADFGLSR
Sbjct: 657 KYQHTLSWRQRLQIALDAAQGLEYLHCGCKPPIVHRDVKTSNILLNEKNRAKLADFGLSR 716
Query: 710 IFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT-PQ 768
F E +HVST V GTPGYLDP + +N L EKSD+YSFGVVLLE+ITG+ VI+++ +
Sbjct: 717 SFHTESRSHVSTLVAGTPGYLDPLCFETNGLNEKSDIYSFGVVLLEMITGKTVIKESQTK 776
Query: 769 RTLIGQWVSSML-ARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVV 827
R + WV S+L + D+ N++D ++ DFD N+VWK VE+AL+ + + RP M +V
Sbjct: 777 RVHVSDWVISILRSTNDVNNVIDSKMAKDFDVNSVWKVVELALSSVSQNVSDRPNMPHIV 836
Query: 828 IELNDCLAME 837
LN+CL E
Sbjct: 837 RGLNECLQRE 846
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 756 bits (1951), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/875 (47%), Positives = 562/875 (64%), Gaps = 52/875 (5%)
Query: 9 FAFLCIVALTAV--VHAQNQSGFISIDCG-IPENENYADKVTGINYVSDAPYVDTAVSHS 65
F L I+A T + V AQNQ+GFIS+DCG +P+ Y +K T I Y SD Y+D+ +
Sbjct: 7 FLHLLIIAFTVLRSVEAQNQAGFISLDCGLVPKETTYTEKSTNITYKSDVDYIDSGLVGK 66
Query: 66 ISPEYSKETVERQFSYLRSFPEGIRNCYTLRPPNGDVKFLIRARFMYGNYDGLDKAPSFD 125
I+ Y K ++Q +RSFP G RNCY + + K+LIR F+YGNYDGL++ PSFD
Sbjct: 67 INDAY-KTQFQQQVWAVRSFPVGQRNCYNVNL-TANNKYLIRGTFVYGNYDGLNQFPSFD 124
Query: 126 LMLGADAWDSVQLQDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRPLTNSIY 185
L +G + W SV++ + EIIH+ +D + VCLV T PFIS+LE+RPL N Y
Sbjct: 125 LHIGPNKWSSVKILGVTNTSMHEIIHVVPQDSLEVCLVKTGPTTPFISSLEVRPLNNESY 184
Query: 186 PPTASDL------YRPTPTGSMSLVLRWDVGTPLDIYDRIWWPDNFKNVERISTSSNVNP 239
+ L Y P+ + S +R+D DI+DR+W ++F + E + S+++
Sbjct: 185 LTQSGSLMLFARVYFPSSSSSF---IRYDE----DIHDRVW--NSFTDDETVWISTDLPI 235
Query: 240 ATS-LFQPPVTVMQSAIIPANGSSSFWFSWESVSTVFKYYTCMYFSEFESEQAETRSREM 298
TS + P +VM++A +P N S + W + Y M+F+E ++ A +RE
Sbjct: 236 DTSNSYDMPQSVMKTAAVPKNASEPWLLWWTLDENTAQSYVYMHFAEVQNLTAN-ETREF 294
Query: 299 NIYLNG--RFWSEIPPPQYLNTTTH--RLTATNAQQYVISIMQTKNSSLAPILNALEIYQ 354
NI NG R++S + PP +T R +++ + + T NS+L P+LNALEIY
Sbjct: 295 NITYNGGLRWFSYLRPPNLSISTIFNPRAVSSSNGIFNFTFAMTGNSTLPPLLNALEIYT 354
Query: 355 EKEFLQLLTNQQDVDAIMKIKSKYEVKR--DWQGDPCAPKVYMWQGINCSYDANQSPRII 412
+ LQL TN+ +V A+M IK Y + + WQGDPCAP++Y W+G+NCSY ++ RII
Sbjct: 355 VVDILQLETNKDEVSAMMNIKETYGLSKKISWQGDPCAPQLYRWEGLNCSYPDSEGSRII 414
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN-NLQ- 470
S+NL+ S + G I I LT + LDLS N L+G +P F AE++SL+++NLSGN NL
Sbjct: 415 SLNLNGSELTGSITSDISKLTLLTVLDLSNNDLSGDIPTFFAEMKSLKLINLSGNPNLNL 474
Query: 471 GSLPSGLSEKVKNGSLSLSVDGNRNLCPSASCKKKSNKFIFPVLASVVSFCILLALLAIL 530
++P L ++V + SL+L + N L P KK I +A V + ++LA+ ++
Sbjct: 475 TAIPDSLQQRVNSKSLTLILGENLTLTPKKESKKVPMVAIAASVAGVFALLVILAIFFVI 534
Query: 531 QNLRRRKQAGKKKG-------------------SLELENRKFSYFDVLKITNNFERVLGK 571
+ R+ +A K G S+ RK +Y +VLK+TNNFERVLGK
Sbjct: 535 K--RKNVKAHKSPGPPPLVTPGIVKSETRSSNPSIITRERKITYPEVLKMTNNFERVLGK 592
Query: 572 GGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANM 631
GGFGTVYHG LD +VAVKMLS SS QGYK+F+AEVELL+R HH++L LVGYCD+G N+
Sbjct: 593 GGFGTVYHGNLDGAEVAVKMLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDNL 652
Query: 632 GLIYEFMANGNLQAHLLEDKA-DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSA 690
LIYE+MANG+L+ ++ + + L WE R+QIA E+AQGLEYLHNGC+PP+VHRDVK+
Sbjct: 653 ALIYEYMANGDLRENMSGKRGGNVLTWENRMQIAVEAAQGLEYLHNGCRPPMVHRDVKTT 712
Query: 691 NILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFG 750
NILLNE+ AKLADFGLSR FP++G HVST V GTPGYLDPEYY +N L+EKSDVYSFG
Sbjct: 713 NILLNERCGAKLADFGLSRSFPIDGECHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFG 772
Query: 751 VVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIAL 810
VVLLE++T QPVI KT +R I WV ML +GDIK+IVD +L GD+DTN WK VE+AL
Sbjct: 773 VVLLEIVTNQPVIDKTRERPHINDWVGFMLTKGDIKSIVDPKLMGDYDTNGAWKIVELAL 832
Query: 811 ACIHTISTRRPTMNQVVIELNDCLAMEIARTKAHE 845
AC++ S RRPTM VV+ELNDC+A+E AR + E
Sbjct: 833 ACVNPSSNRRPTMAHVVMELNDCVALENARRQGSE 867
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG6|Y5189_ARATH Probable LRR receptor-like protein kinase At1g51890 OS=Arabidopsis thaliana GN=At1g51890 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 750 bits (1936), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/907 (46%), Positives = 569/907 (62%), Gaps = 68/907 (7%)
Query: 1 MIMLTTFIFAFLCIVALTAVVHAQNQSGFISIDCG-IPENENYADKVTGINYVSDAPYVD 59
M L+ IF F A+ +V AQ+QSGFIS+DCG +P Y +K T I Y SDA Y+D
Sbjct: 1 MRFLSFLIFVF----AVLGLVQAQDQSGFISLDCGLVPTEITYVEKSTNITYRSDATYID 56
Query: 60 TAVSHSISPEYSKETVERQFSYLRSFPEGIRNCYTLRPPNGDVKFLIRARFMYGNYDGLD 119
+ V I+ Y + ++Q LRSFPEG RNCY K+LIR F+YGNYDGL+
Sbjct: 57 SGVPGKINEVY-RTQFQQQIWALRSFPEGQRNCYNFSL-TAKRKYLIRGTFIYGNYDGLN 114
Query: 120 KAPSFDLMLGADAWDSVQLQDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRP 179
+ PSFDL +G + W SV + R+ E+IH+ +D++ +CLV T PFIS+LELRP
Sbjct: 115 QLPSFDLYIGPNKWTSVSIPGVRNGSVSEMIHVLRQDHLQICLVKTGETTPFISSLELRP 174
Query: 180 LTNSIYPPTASDL-------YRPTPTGSMSLVLRWDVGTPLDIYDRIWWP--DNFKNVER 230
L N+ Y + L + PTP LR+D D++DRIW P DN ++
Sbjct: 175 LNNNTYVTKSGSLIVVARLYFSPTPP-----FLRYDE----DVHDRIWIPFLDNKNSL-- 223
Query: 231 ISTSSNVNPATSLFQPPVTVMQSAIIPANGSSSFWFSWESVSTVFKYYTCMYFSEFESEQ 290
+ST +V+ ++ + P TV ++A +P N + +W + Y M+F+E E+ +
Sbjct: 224 LSTELSVD-TSNFYNVPQTVAKTAAVPLNATQPLKINWSLDDITSQSYIYMHFAEIENLE 282
Query: 291 AETRSREMNIYLNG--RFWSEIPPPQYLNTTTHRLTATNA--QQYVISIMQTKNSSLAPI 346
A +RE NI NG ++S PP++ TT + A ++ + + T NS+ P+
Sbjct: 283 A-NETREFNITYNGGENWFSYFRPPKFRITTVYNPAAVSSLDGNFNFTFSMTGNSTHPPL 341
Query: 347 LNALEIYQEKEFLQLLTNQQDVDAIMKIKSKYEVKR--DWQGDPCAPKVYMWQGINCSYD 404
+N LEIYQ E QL T Q +V A+M IK+ Y + + WQGDPCAP++Y W+G+NCSY
Sbjct: 342 INGLEIYQVLELPQLDTYQDEVSAMMNIKTIYGLSKRSSWQGDPCAPELYRWEGLNCSYP 401
Query: 405 ANQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNL 464
P+IIS+NLS S ++G I I LT + LDLS N L+G +P +++++L ++NL
Sbjct: 402 NFAPPQIISLNLSGSNLSGTITSDISKLTHLRELDLSNNDLSGDIPFVFSDMKNLTLINL 461
Query: 465 SGN-NLQGSLPSGLSEKVKNGSLSLSVDGNRNLCPSASCKKKSNKFIFPVLASVVSFCIL 523
SGN NL S+P L +++ N SL+L D + K +N + + ASV S +
Sbjct: 462 SGNKNLNRSVPETLQKRIDNKSLTLIRD--------ETGKNSTN--VVAIAASVASVFAV 511
Query: 524 LALLAILQNLRRRKQ-------------------AGKKKGSLELENRKFSYFDVLKITNN 564
L +LAI+ + R+KQ A S+ + RKF+Y +VLK+T N
Sbjct: 512 LVILAIVFVVIRKKQRTNEASGPRSFTTGTVKSDARSSSSSIITKERKFTYSEVLKMTKN 571
Query: 565 FERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGY 624
FERVLGKGGFGTVYHG LDD QVAVKMLS SS QGYK+F+AEVELL+R HH++L LVGY
Sbjct: 572 FERVLGKGGFGTVYHGNLDDTQVAVKMLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGY 631
Query: 625 CDEGANMGLIYEFMANGNLQAHLL-EDKADTLCWERRLQIASESAQGLEYLHNGCKPPIV 683
CD+G N+ LIYE+M G+L+ ++ + + L WE R+QIA E+AQGLEYLHNGC+PP+V
Sbjct: 632 CDDGDNLALIYEYMEKGDLRENMSGKHSVNVLSWETRMQIAVEAAQGLEYLHNGCRPPMV 691
Query: 684 HRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEK 743
HRDVK NILLNE+ QAKLADFGLSR FPV+G +HV T V GTPGYLDPEYY +N L+EK
Sbjct: 692 HRDVKPTNILLNERSQAKLADFGLSRSFPVDGESHVMTVVAGTPGYLDPEYYRTNWLSEK 751
Query: 744 SDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVW 803
SDVYSFGVVLLE++T QPV+ K +R I +WV ML GDIK+IVD +L D+DTN VW
Sbjct: 752 SDVYSFGVVLLEIVTNQPVMNKNRERPHINEWVMFMLTNGDIKSIVDPKLNEDYDTNGVW 811
Query: 804 KAVEIALACIHTISTRRPTMNQVVIELNDCLAMEIARTKAHETAPDGTPDELMIDLNLHS 863
K VE+ALAC++ S+RRPTM VV+ELN+CLA+EI R + + + + + S
Sbjct: 812 KVVELALACVNPSSSRRPTMPHVVMELNECLALEIERKQGSQAT--YIKESVEFSPSSAS 869
Query: 864 DVFPLAR 870
D PLAR
Sbjct: 870 DFSPLAR 876
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64483|SIRK_ARATH Senescence-induced receptor-like serine/threonine-protein kinase OS=Arabidopsis thaliana GN=SIRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 742 bits (1915), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/891 (46%), Positives = 557/891 (62%), Gaps = 46/891 (5%)
Query: 2 IMLTTFIFAFLCIVALTAVVHAQNQSGFISIDCGIPENENYADKVTGINYVSDAPYVDTA 61
I+ T+F F +VHAQ+QSGFISIDCGIP++ +Y D+ TGI YVSD+ +VD+
Sbjct: 10 ILFTSFALLFF-------LVHAQDQSGFISIDCGIPDDSSYNDETTGIKYVSDSAFVDSG 62
Query: 62 VSHSISPEYSKETVERQFSYLRSFPEGIRNCYTLRPPNGD-VKFLIRARFMYGNYDGLDK 120
+ I+ ++ +R +RSFP+ R+CY + P G K+LIR RFMYGNYD L +
Sbjct: 63 TTKRIAAQFQSSGFDRHLLNVRSFPQSKRSCYDVPTPRGKGFKYLIRTRFMYGNYDDLGR 122
Query: 121 APSFDLMLGADAWDSVQLQDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRPL 180
P FDL LG + WDSV+L D +I+ KEII +P D + VC+V+ ++G PF+S LE+R L
Sbjct: 123 VPEFDLYLGVNFWDSVKLDDATTILNKEIITIPLLDNVQVCVVDKNAGTPFLSVLEIRLL 182
Query: 181 TNSIYPPTASDLYRPTPTGSMSLVLRWDVGT--------PLDIYDRIWWPDNFKNVERI- 231
N+ Y TP +++L+ R D DIYDRIW P + +I
Sbjct: 183 LNTTYE---------TPYDALTLLRRLDYSKTGKLPSRYKDDIYDRIWTPRIVSSEYKIL 233
Query: 232 STSSNVNP-ATSLFQPPVTVMQSAIIPANGSSSFWFSWESVSTVFKYYTCMYFSEFESEQ 290
+TS V+ + +QP TVM +A N S S+ K+Y M+F+E E +
Sbjct: 234 NTSLTVDQFLNNGYQPASTVMSTAETARNESLYLTLSFRPPDPNAKFYVYMHFAEIEVLK 293
Query: 291 AETRSREMNIYLNGRFWSEIPPPQYLNTTTHRLTATNAQQYVI--SIMQTKNS-SLAPIL 347
+ ++RE +I+LN S +YL T T +T I S++Q L PI+
Sbjct: 294 S-NQTREFSIWLNEDVISPSFKLRYLLTDTF-VTPDPVSGITINFSLLQPPGEFVLPPII 351
Query: 348 NALEIYQEKEFLQLLTNQQDVDAIMKIKSKYEVKRDWQGDPCAPKVYMWQGINC-SYDAN 406
NALE+YQ EFLQ+ T+ QDVDA+ KIK+ Y VK++WQGDPC P Y W+GI+C D
Sbjct: 352 NALEVYQVNEFLQIPTHPQDVDAMRKIKATYRVKKNWQGDPCVPVDYSWEGIDCIQSDNT 411
Query: 407 QSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG 466
+PR++S+N+S S + G I P +LTSI LDLS N+LTG +P FLA L +L LN+ G
Sbjct: 412 TNPRVVSLNISFSELRGQIDPAFSNLTSIRKLDLSGNTLTGEIPAFLANLPNLTELNVEG 471
Query: 467 NNLQGSLPSGLSEKVKNGSLSLSVDGNRNLCPSASC---KKKSNKFIFPVLASVVSFCIL 523
N L G +P L E+ KNGSLSL N +LC S SC KKK+ L V +L
Sbjct: 472 NKLTGIVPQRLHERSKNGSLSLRFGRNPDLCLSDSCSNTKKKNKNGYIIPLVVVGIIVVL 531
Query: 524 LALLAILQNLRRRKQAG---KKKGSLELENRKFSYFDVLKITNNFERVLGKGGFGTVYHG 580
L LA+ + ++++Q G ++ G L+ R F Y +V+ ITNNFERV+GKGGFG VYHG
Sbjct: 532 LTALALFRRFKKKQQRGTLGERNGPLKTAKRYFKYSEVVNITNNFERVIGKGGFGKVYHG 591
Query: 581 YLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640
++ +QVAVK+LS S QGYK+F+AEV+LL+R HH NLT LVGYC+E +M LIYE+MAN
Sbjct: 592 VINGEQVAVKVLSEESAQGYKEFRAEVDLLMRVHHTNLTSLVGYCNEINHMVLIYEYMAN 651
Query: 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQA 700
NL +L ++ L WE RL+I+ ++AQGLEYLHNGCKPPIVHRDVK NILLNEK QA
Sbjct: 652 ENLGDYLAGKRSFILSWEERLKISLDAAQGLEYLHNGCKPPIVHRDVKPTNILLNEKLQA 711
Query: 701 KLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 760
K+ADFGLSR F VEG +ST V G+ GYLDPEYY + ++ EKSDVYS GVVLLE+ITGQ
Sbjct: 712 KMADFGLSRSFSVEGSGQISTVVAGSIGYLDPEYYSTRQMNEKSDVYSLGVVLLEVITGQ 771
Query: 761 PVIQKTP-QRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTR 819
P I + ++ I V S+LA GDI+ IVD RL+ +D + WK EIALAC S +
Sbjct: 772 PAIASSKTEKVHISDHVRSILANGDIRGIVDQRLRERYDVGSAWKMSEIALACTEHTSAQ 831
Query: 820 RPTMNQVVIELNDCLAMEIARTKAHETAPDGTPDELMIDLNLHSDVFPLAR 870
RPTM+QVV+EL + + E D T M+ +NL +++ P AR
Sbjct: 832 RPTMSQVVMELKQIVYGIVT---DQENYDDSTK---MLTVNLDTEMVPRAR 876
|
Involved in innate immune response of plants. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LIG2|RLK6_ARATH Receptor-like protein kinase At3g21340 OS=Arabidopsis thaliana GN=At3g21340 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 728 bits (1878), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/905 (44%), Positives = 565/905 (62%), Gaps = 65/905 (7%)
Query: 11 FLCIVALTAVVHAQNQSGFISIDCG-IPENENYADKVTGINYVSDAPYVDTAVSHSISPE 69
F+ AL +V AQ+Q GFIS+DCG +P Y D TG+ Y +D +V + + I
Sbjct: 15 FISFYALLHLVEAQDQKGFISLDCGSLPNEPPYNDPSTGLTYSTDDGFVQSGKTGRIQKA 74
Query: 70 YSKETVERQFSYLRSFPEGIRNCYTLRPPNGDVKFLIRARFMYGNYDGLDKAPSFDLMLG 129
+ + + LR FP+G RNCYTL D +LI+A F+YGNYDGL+ PSFDL LG
Sbjct: 75 F-ESIFSKPSLKLRYFPDGFRNCYTLNVTQ-DTNYLIKAVFVYGNYDGLNNPPSFDLYLG 132
Query: 130 ADAWDSVQLQDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRPLTNSIYPPTA 189
+ W +V + + +EIIH + VCLV T + P I+ LELRPL N+ Y
Sbjct: 133 PNLWVTVDMNGRTNGTIQEIIHKTISKSLQVCLVKTGTSSPMINTLELRPLKNNTYN--- 189
Query: 190 SDLYRPTPTGSMSLVLRW-------DVGTPLDIYDRIWWPD-NFKNVERISTSSNVNPAT 241
T +GS+ R+ ++ P D+ DR W+P + K ++T+ N+N +
Sbjct: 190 ------TQSGSLKYFFRYYFSGSGQNIRYPDDVNDRKWYPFFDAKEWTELTTNLNINSSN 243
Query: 242 SLFQPPVTVMQSAIIPANGSSSFWFSWESVSTVFKYYTCMYFSEFESEQAETRSREMNIY 301
+ PP VM SA P + ++ FSW S+ ++Y M+F+E ++ ++ +RE +
Sbjct: 244 G-YAPPEVVMASASTPISTFGTWNFSWLLPSSTTQFYVYMHFAEIQTLRS-LDTREFKVT 301
Query: 302 LNGRFWSEIPPPQYLNTTTHRLTATNAQQY-----VISIMQTKNSSLAPILNALEIYQEK 356
LNG+ E P+ L T T + + QQ ++ + +T S+L P++NALE++
Sbjct: 302 LNGKLAYERYSPKTLATET--IFYSTPQQCEDGTCLLELTKTPKSTLPPLMNALEVFTVI 359
Query: 357 EFLQLLTNQQDVDAIMKIKSKYEVKR-DWQGDPCAPKVYMWQGINCSYDANQSPRII-SI 414
+F Q+ TN DV AI I+S Y + + WQGDPC PK ++W+G+NC+ N +P I+ S+
Sbjct: 360 DFPQMETNPDDVAAIKSIQSTYGLSKISWQGDPCVPKQFLWEGLNCNNLDNSTPPIVTSL 419
Query: 415 NLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLP 474
NLSSS + G I I +LT ++ LDLS N+LTG +PEFLA+++SL V+NLSGNN GS+P
Sbjct: 420 NLSSSHLTGIIAQGIQNLTHLQELDLSNNNLTGGIPEFLADIKSLLVINLSGNNFNGSIP 479
Query: 475 SGLSEKVKNGSLSLSVDGNRNL-CPSASCKKKSNK-------FIFPVLASVVSFCILLAL 526
L +K L L ++GN NL CP C K+ + P++ASV +L +
Sbjct: 480 QILLQK---KGLKLILEGNANLICPDGLCVNKAGNGGAKKMNVVIPIVASVAFVVVLGSA 536
Query: 527 LAILQNLRRRKQAGKK-------------------KGSLELENRKFSYFDVLKITNNFER 567
LA +++K + + + ++ +NR+F+Y +V+ +TNNFER
Sbjct: 537 LAFFFIFKKKKTSNSQDLGPSSYTQVSEVRTIRSSESAIMTKNRRFTYSEVVTMTNNFER 596
Query: 568 VLGKGGFGTVYHGYLDD-KQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCD 626
VLGKGGFG VYHG +++ +QVAVKMLS SS QGYK+F+AEVELL+R HHKNL LVGYCD
Sbjct: 597 VLGKGGFGMVYHGTVNNTEQVAVKMLSHSSSQGYKEFKAEVELLLRVHHKNLVGLVGYCD 656
Query: 627 EGANMGLIYEFMANGNLQAHLLEDKADT-LCWERRLQIASESAQGLEYLHNGCKPPIVHR 685
EG N+ LIYE+MANG+L+ H+ + + L WE RL+I ESAQGLEYLHNGCKPP+VHR
Sbjct: 657 EGENLALIYEYMANGDLREHMSGKRGGSILNWETRLKIVVESAQGLEYLHNGCKPPMVHR 716
Query: 686 DVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSD 745
DVK+ NILLNE AKLADFGLSR FP+EG THVST V GTPGYLDPEYY +N L EKSD
Sbjct: 717 DVKTTNILLNEHLHAKLADFGLSRSFPIEGETHVSTVVAGTPGYLDPEYYRTNWLNEKSD 776
Query: 746 VYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKA 805
VYSFG+VLLE+IT Q VI ++ ++ I +WV ML +GDI+NI+D +L GD+D+ +VW+A
Sbjct: 777 VYSFGIVLLEIITNQLVINQSREKPHIAEWVGLMLTKGDIQNIMDPKLYGDYDSGSVWRA 836
Query: 806 VEIALACIHTISTRRPTMNQVVIELNDCLAMEIARTKAHETAPDGTPDELMIDLNLHSDV 865
VE+A++C++ S RRPTM+QVVIELN+CL+ E AR + + + + +N
Sbjct: 837 VELAMSCLNPSSARRPTMSQVVIELNECLSYENARGGTSQNM--NSESSIEVSMNFDIGA 894
Query: 866 FPLAR 870
P AR
Sbjct: 895 TPDAR 899
|
Probable receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SI06|Y5573_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g04300 OS=Arabidopsis thaliana GN=At2g04300 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 727 bits (1876), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/895 (45%), Positives = 559/895 (62%), Gaps = 51/895 (5%)
Query: 11 FLCIVALTAVVHAQNQSGFISIDCGIPENEN-YADKVTGINYVSDAPYVDTAVSHSISPE 69
F L VV A NQ GFIS+DCG+ NE Y D T + Y +D +V + + +I E
Sbjct: 14 FFITFGLLHVVEAGNQEGFISLDCGLSPNEPPYVDAATDLTYTTDNDFVQSGKTGTIDKE 73
Query: 70 YSKETVERQFSYLRSFPEGIRNCYTLRPPNGDVKFLIRARFMYGNYDGLDKAPSFDLMLG 129
+ T + LR FPEG+RNCYTL G +LIRA F+YGNYDGL+K FDL LG
Sbjct: 74 L-ESTYNKPILQLRYFPEGVRNCYTLNVTLG-TNYLIRASFVYGNYDGLNKELEFDLYLG 131
Query: 130 ADAWDSVQ--LQDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRPLTNSIYPP 187
+ W +V + + T+EIIH + VCL+ T IP I++LELRPL N Y
Sbjct: 132 PNLWANVNTAVYLMNGVTTEEIIHSTKSKVLQVCLIKTGESIPIINSLELRPLINDTYN- 190
Query: 188 TASDLYRPTPTGSMSLVLRWDVGT-------PLDIYDRIWWPDNFKNV-ERISTSSNVNP 239
T +GS+ + R T P D+ DR W+P ++ ++T+ NVN
Sbjct: 191 --------TQSGSLKYLFRNYFSTSRRIIRYPNDVNDRHWYPFFDEDAWTELTTNLNVNS 242
Query: 240 ATSLFQPPVTVMQSAIIPANGSSSFWFSWESVSTVFKYYTCMYFSEFESEQAETRSREMN 299
+ + PP VM SA P + ++ F F+W + + K+Y+ M+F++ ++ QA +RE +
Sbjct: 243 SNG-YDPPKFVMASASTPISKNAPFNFTWSLIPSTAKFYSYMHFADIQTLQAN-ETREFD 300
Query: 300 IYLNGRFWSEIPPPQYLNTTTHRLTA---TNAQQYVISIMQTKNSSLAPILNALEIYQEK 356
+ LNG E P+ T T Q +I +++T S+L P+ +ALE++
Sbjct: 301 MMLNGNLALERYRPKTFATGTIYFIKPQICEGGQCIIELLKTSKSTLPPLCSALEVFTVI 360
Query: 357 EFLQLLTNQQDVDAIMKIKSKYEV-KRDWQGDPCAPKVYMWQGINCSYDANQSPRIIS-I 414
+F +L TNQ DV AI I++ Y V K WQGDPC PK +MW G+NC+ +P I+ +
Sbjct: 361 DFPELETNQDDVIAIKNIQNTYGVSKTSWQGDPCVPKRFMWDGLNCNNSYISTPPTITFL 420
Query: 415 NLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLP 474
NLSSS + G I I +LT +++LDLS N+LTG VPEFLA L+SL V+NLSGNNL GS+P
Sbjct: 421 NLSSSHLTGIIASAIQNLTHLQNLDLSNNNLTGGVPEFLAGLKSLLVINLSGNNLSGSVP 480
Query: 475 SGLSEKVKNGSLSLSVDGNRNL-CPSASC----------KKKSNKFIFPVLASVVSFCIL 523
L +K L L+++GN L CP SC KK + +A VV
Sbjct: 481 QTLLQK---KGLKLNLEGNIYLNCPDGSCVSKDGNGGAKKKNVVVLVVVSIALVVVLGSA 537
Query: 524 LALLAILQNLRR-RKQAGKKKGSLE----LENRKFSYFDVLKITNNFERVLGKGGFGTVY 578
LAL + + + R + + SL+ +NR+F+Y +V+K+TNNFE++LGKGGFG VY
Sbjct: 538 LALFLVFRKRKTPRNEVSRTSRSLDPTITTKNRRFTYSEVVKMTNNFEKILGKGGFGMVY 597
Query: 579 HGYLDD-KQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637
HG ++D +QVAVKMLS SS QGYK+F+AEVELL+R HHKNL LVGYCDEG N+ LIYE+
Sbjct: 598 HGTVNDAEQVAVKMLSPSSSQGYKEFKAEVELLLRVHHKNLVGLVGYCDEGENLSLIYEY 657
Query: 638 MANGNLQAHLLEDKA-DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE 696
MA G+L+ H+L ++ L W+ RL+I +ESAQGLEYLHNGCKPP+VHRDVK+ NILL+E
Sbjct: 658 MAKGDLKEHMLGNQGVSILDWKTRLKIVAESAQGLEYLHNGCKPPMVHRDVKTTNILLDE 717
Query: 697 KFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEL 756
FQAKLADFGLSR FP+EG T V T V GTPGYLDPEYY +N L EKSDVYSFG+VLLE+
Sbjct: 718 HFQAKLADFGLSRSFPLEGETRVDTVVAGTPGYLDPEYYRTNWLNEKSDVYSFGIVLLEI 777
Query: 757 ITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTI 816
IT Q VI ++ ++ I +WV ML +GDIK+I+D + GD+D +VW+AVE+A++C++
Sbjct: 778 ITNQHVINQSREKPHIAEWVGVMLTKGDIKSIIDPKFSGDYDAGSVWRAVELAMSCVNPS 837
Query: 817 STRRPTMNQVVIELNDCLAMEIARTK-AHETAPDGTPDELMIDLNLHSDVFPLAR 870
ST RPTM+QVVIELN+CLA E +R + G+ + N ++ P AR
Sbjct: 838 STGRPTMSQVVIELNECLASENSRRGMSQNMESKGSIQYTEVSTNFGTEYTPEAR 892
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZQR3|Y2451_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14510 OS=Arabidopsis thaliana GN=At2g14510 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 718 bits (1854), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/846 (44%), Positives = 540/846 (63%), Gaps = 31/846 (3%)
Query: 7 FIFAFLCIVALTAVVHAQNQSGFISIDCGIPENENYADKVTGINYVSDAPYVDTAVSHSI 66
F+ ++ ++V +QNQ GFIS+DCG+P E+Y + + + ++SD ++ + +I
Sbjct: 7 FMLLACATFSIMSLVKSQNQQGFISLDCGLPSKESYIEPSSNLTFISDVNFIRGGKTGNI 66
Query: 67 SPEYSKETVERQFSYLRSFPEGIRNCYTLRPPNGDVKFLIRARFMYGNYDGLDKAPSFDL 126
+ + F LR FP+GIRNCY+L G K+LIR F YGNYDGL+ +P FDL
Sbjct: 67 QNNSRTNFIFKPFKVLRYFPDGIRNCYSLSVKQG-TKYLIRTLFYYGNYDGLNTSPRFDL 125
Query: 127 MLGADAWDSVQ--LQDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRPLTNSI 184
LG + W SV + D + +EI+H+ + + +CLV T + P ISA+ELRPL
Sbjct: 126 FLGPNIWTSVDVLIADVGDGVVEEIVHVTRSNILDICLVKTGTSTPMISAIELRPLRYDT 185
Query: 185 YPPTASDLYRPTPTGSMSLVLRW-------DVGTPLDIYDRIWWPDNFKNVERISTSSNV 237
Y TA TGS+ + + + P D+YDR+W P + +I+T+ NV
Sbjct: 186 Y--TAR-------TGSLKSMAHFYFTNSDEAIRYPEDVYDRVWMPYSQPEWTQINTTRNV 236
Query: 238 NPATSLFQPPVTVMQSAIIPANGSSSFWFSWESVSTVFKYYTCMYFSEFESEQAETRSRE 297
+ + + PP V+Q+A IP NGS F+W S+ + Y ++F+E + + +RE
Sbjct: 237 SGFSDGYNPPQGVIQTASIPTNGSEPLTFTWNLESSDDETYAYLFFAEIQQLKV-NETRE 295
Query: 298 MNIYLNGRFWSEIPPPQYLNTTTHRLTATNAQQYV--ISIMQTKNSSLAPILNALEIYQE 355
I NG + + P ++ T + V + + +T S+L P++NA+EI+
Sbjct: 296 FKILANGVDYIDYTPWKFEARTLSNPAPLKCEGGVCRVQLSKTPKSTLPPLMNAIEIFSV 355
Query: 356 KEFLQLLTNQQDVDAIMKIKSKYEVKR-DWQGDPCAPKVYMWQGINCSY-DANQSPRIIS 413
+F Q TN +V AI KI+S Y++ R WQGDPC PK + W G++C+ D + PRIIS
Sbjct: 356 IQFPQSDTNTDEVIAIKKIQSTYQLSRISWQGDPCVPKQFSWMGVSCNVIDISTPPRIIS 415
Query: 414 INLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSL 473
++LS SG+ G I P I +LT + LDLS N+LTG VPEFLA ++ L V++L GNNL+GS+
Sbjct: 416 LDLSLSGLTGVISPSIQNLTMLRELDLSNNNLTGEVPEFLATIKPLLVIHLRGNNLRGSV 475
Query: 474 PSGLSEKVKNGSLSLSVDGNRNLCPSASCKKKSNKFIFPVLASVVSFCILLALLAILQNL 533
P L ++ KN L L VD N + K + ++ ++AS+ + + +L ++
Sbjct: 476 PQALQDREKNDGLKLFVDPN----ITRRGKHQPKSWLVAIVASISCVAVTIIVLVLIFIF 531
Query: 534 RRRKQAGKK--KGSLELENRKFSYFDVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKM 591
RRRK + +K + SLE++NR+F Y +V ++TNNFE VLGKGGFG VYHG+L+++QVAVK+
Sbjct: 532 RRRKSSTRKVIRPSLEMKNRRFKYSEVKEMTNNFEVVLGKGGFGVVYHGFLNNEQVAVKV 591
Query: 592 LSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDK 651
LS SS QGYK+F+ EVELL+R HH NL LVGYCDEG ++ LIYEFM NGNL+ HL +
Sbjct: 592 LSQSSTQGYKEFKTEVELLLRVHHVNLVSLVGYCDEGIDLALIYEFMENGNLKEHLSGKR 651
Query: 652 ADT-LCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710
+ L W RL+IA ESA G+EYLH GC+PP+VHRDVKS NILL +F+AKLADFGLSR
Sbjct: 652 GGSVLNWSSRLKIAIESALGIEYLHIGCQPPMVHRDVKSTNILLGLRFEAKLADFGLSRS 711
Query: 711 FPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRT 770
F V HVST V GT GYLDPEYY+ N LTEKSDVYSFG+VLLE ITGQPVI+++ ++
Sbjct: 712 FLVGSQAHVSTNVAGTLGYLDPEYYLKNWLTEKSDVYSFGIVLLESITGQPVIEQSRDKS 771
Query: 771 LIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIEL 830
I +W SMLA GDI++I+D L D+D+++ WKA+E+A+ CI+ ST+RP M +V EL
Sbjct: 772 YIVEWAKSMLANGDIESIMDPNLHQDYDSSSSWKALELAMLCINPSSTQRPNMTRVAHEL 831
Query: 831 NDCLAM 836
N+CL +
Sbjct: 832 NECLEI 837
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 870 | ||||||
| 255549716 | 892 | Nodulation receptor kinase precursor, pu | 0.963 | 0.939 | 0.538 | 0.0 | |
| 255549706 | 886 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.986 | 0.968 | 0.524 | 0.0 | |
| 255549714 | 915 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.956 | 0.909 | 0.557 | 0.0 | |
| 255549700 | 884 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.993 | 0.977 | 0.524 | 0.0 | |
| 255549712 | 884 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.983 | 0.968 | 0.525 | 0.0 | |
| 255549708 | 883 | Nodulation receptor kinase precursor, pu | 0.975 | 0.961 | 0.501 | 0.0 | |
| 356522218 | 890 | PREDICTED: putative leucine-rich repeat | 0.983 | 0.961 | 0.494 | 0.0 | |
| 356556621 | 892 | PREDICTED: probable LRR receptor-like se | 0.975 | 0.951 | 0.502 | 0.0 | |
| 356556632 | 884 | PREDICTED: putative leucine-rich repeat | 0.958 | 0.943 | 0.514 | 0.0 | |
| 356547364 | 887 | PREDICTED: putative leucine-rich repeat | 0.973 | 0.954 | 0.506 | 0.0 |
| >gi|255549716|ref|XP_002515909.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223544814|gb|EEF46329.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 923 bits (2385), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/889 (53%), Positives = 614/889 (69%), Gaps = 51/889 (5%)
Query: 19 AVVHAQNQSGFISIDCGIPENENYADKVTGINYVSDAPYVDTAVSHSISPEYSKETVERQ 78
+VH Q+QSGFIS+DCG+P N Y D+ T +NY SDA ++DT +S S++P ++ + + RQ
Sbjct: 18 CMVHGQDQSGFISLDCGLPANTTYTDETTSLNYNSDASFIDTGISKSLAPGFTTDNLRRQ 77
Query: 79 FSYLRSFPEGIRNCYTLRPPNGDVKFLIRARFMYGNYDGLDKAPSFDLMLGADAWDSVQL 138
Y+RSFPEG RNCY L D ++LIRA FMYGNYDGL++ P FDL +G + W SV++
Sbjct: 78 LWYIRSFPEGDRNCYNLTLAK-DTEYLIRATFMYGNYDGLNQLPEFDLHIGPNKWVSVKI 136
Query: 139 QDPRSIITKEII-HMPNKDYIHVCLVNTDSGIPFISALELRPLTNSIYPPTASDLYRPTP 197
+ + +T+EII P YIHVCLV D+G PFISALE RPL N Y T
Sbjct: 137 LNASTSVTEEIIIGSPKSKYIHVCLVTKDTGTPFISALETRPLKNGTYV---------TE 187
Query: 198 TGSMSLVL--RWDVGT--------PLDIYDRIWWPDNFKNVERISTSSNVN-PATSLFQP 246
+GS+ L L R DVG+ P D+YDR W+P +FK IST+ V+ + FQP
Sbjct: 188 SGSLGLALFTREDVGSLNNRIVRYPNDVYDRRWFPYHFKRGTDISTTLTVDLDDHNDFQP 247
Query: 247 PVTVMQSAIIPANGSSSFWFSWESVSTVFKYYTCMYFSEFESEQAETRSREMNIYLNGRF 306
P VM+SA+I N SS F + + T +K Y M+F+E +A +SR+ NI LNG+
Sbjct: 248 PSIVMRSAVISINTSSPLEF-YINNDTTYKLYAYMHFAEIVKLEAN-QSRQFNISLNGKI 305
Query: 307 WSEIPPPQYLNTTT-HRLTATNAQQYVISIMQTKNSSLAPILNALEIYQEKEFLQLLTNQ 365
W P YL TTT + +A Y S+ + + S+L P+LNA+E+Y + LQ TNQ
Sbjct: 306 WYGPVTPTYLYTTTVYSTSAITDGMYEFSLSKVEGSALPPLLNAIELYYVVDLLQPETNQ 365
Query: 366 QDVDAIMKIKSKYEVKR-DWQGDPCAPKVYMWQGINCSYDANQSPRIISINLSSSGIAGD 424
+DV IM IKS Y + R +WQGDPCAP+ ++W+G++C Y+ SP IIS+NLSSSG+ G+
Sbjct: 366 RDVIGIMNIKSTYRISRTNWQGDPCAPEDFVWEGLSCKYNVTSSPVIISLNLSSSGLHGE 425
Query: 425 IVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNG 484
I P I +L S+E LDLS N+LT VP+FL++LQSL+ LNL+GN L G++P L ++ +G
Sbjct: 426 IAPDIANLKSLEILDLSNNNLTALVPDFLSQLQSLKFLNLTGNRLNGTIPDDLLKRADSG 485
Query: 485 SLSLSVDGNRNLCPSASCKKK-----SNKFIFPVLASVVSFCILLALLAILQNLRRRKQA 539
L+LSVDGN LC S SC KK + FI PV+ASV + +++ +L + L+RRKQ
Sbjct: 486 -LTLSVDGNPELCKSVSCNKKKKKKKNTDFIVPVVASVAALLVIIVVLTTIWYLKRRKQK 544
Query: 540 G-----------------KKKGSLELENRKFSYFDVLKITNNFERVLGKGGFGTVYHGYL 582
G K LEL R+F+Y DVLKITNNF VLG+GGFGTVYHGYL
Sbjct: 545 GTYLHKYILAGRTEAEAKKTHEPLELNKRQFTYSDVLKITNNFGSVLGRGGFGTVYHGYL 604
Query: 583 DDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642
DD +VAVKMLS SSVQGYK+F AEV LL+R HHKNLT LVGYCDEG NMGLIYE+MANGN
Sbjct: 605 DDVEVAVKMLSPSSVQGYKEFHAEVRLLLRVHHKNLTTLVGYCDEGNNMGLIYEYMANGN 664
Query: 643 LQAHLLE-DKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAK 701
L+ HL D L WE RLQIA E+AQGL+YLHNGCKPPIVHRDVK+ NILLN++FQAK
Sbjct: 665 LKHHLSGCDHPSILSWEGRLQIALEAAQGLDYLHNGCKPPIVHRDVKTTNILLNDRFQAK 724
Query: 702 LADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
LADFGLSR FPVE G+HVST V GTPGYLDP+YY++N LTEKSDVYS+GVVLLE+IT +P
Sbjct: 725 LADFGLSRTFPVEDGSHVSTVVAGTPGYLDPDYYVTNWLTEKSDVYSYGVVLLEIITSRP 784
Query: 762 VIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRP 821
VI +T +T + QWV +ML +GDIKNIVD RL+GDFD N+VWK E+A+AC+ T S RP
Sbjct: 785 VIARTRDKTHVSQWVKAMLDKGDIKNIVDPRLRGDFDNNSVWKVTELAMACLSTTSGERP 844
Query: 822 TMNQVVIELNDCLAMEIARTKAHETAPDGTPDELMIDLNLHSDVFPLAR 870
+M+QVV+ELNDCL E+AR + + + E +I L+LH+ V PLAR
Sbjct: 845 SMSQVVMELNDCLTTEMARAREGRSTQSSSSVE-VISLHLHTGVSPLAR 892
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549706|ref|XP_002515904.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544809|gb|EEF46324.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 922 bits (2383), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 469/895 (52%), Positives = 615/895 (68%), Gaps = 37/895 (4%)
Query: 2 IMLTTFIFAFLCIVALTAVVHAQNQSGFISIDCGIPENENYADKVTGINYVSDAPYVDTA 61
I+L F F ++AL +VH Q+QSGFIS+DCG+P N +Y+D T +N++SDA Y++
Sbjct: 3 IILFQFFSKFFGVLALIVLVHCQDQSGFISLDCGLPGNTSYSDATTTLNFISDASYIEIG 62
Query: 62 VSHSISPEYSKETVERQFSYLRSFPEGIRNCYTLRPPNGDVKFLIRARFMYGNYDGLDKA 121
+S S++PE+S ++ R Y+RSFP+G RNCY + D ++LIRA FMYGNYDG+++
Sbjct: 63 ISKSLAPEFSTNSIFRPLWYVRSFPQGSRNCYNVTLTK-DTEYLIRATFMYGNYDGINQR 121
Query: 122 PSFDLMLGADAWDSVQLQDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRPLT 181
PSFDL LG + W SVQ+ + + KEIIH P + YIHVCLVNT+SG PFISALELRPL
Sbjct: 122 PSFDLYLGPNKWVSVQILNGSIPVRKEIIHHPKRKYIHVCLVNTNSGTPFISALELRPLK 181
Query: 182 NSIYPPTASDLYRPTPTGSMSLVLRWDVGT--------PLDIYDRIWWPDNFKNVERIST 233
N Y + +GS++L R D+ + P D+YDR W P +F IST
Sbjct: 182 NGTYV---------SESGSLALFDRADISSITNQTVRYPDDVYDRRWSPFHFVEWTDIST 232
Query: 234 SSNVNPATS-LFQPPVTVMQSAIIPANGSSSFWFSWESVSTVFKYYTCMYFSEFESEQAE 292
+ ++ S +Q P TVM+SA P N SS + + K+Y +F+E A
Sbjct: 233 TETIDLGKSNSYQLPSTVMRSAGTPRNSSSPMEVTIAAEDPTLKFYAYFHFAEIVKLDAN 292
Query: 293 TRSREMNIYLNGRFWSEIPPPQYL-NTTTHRLTATNAQQYVISIMQTKNSSLAPILNALE 351
+SRE NI LNG W YL +TT A + Y I + S+L P+LNA+E
Sbjct: 293 -QSREFNITLNGDIWYGPITLHYLYSTTVSSGYAISGGTYDFQIFKVGGSTLPPLLNAVE 351
Query: 352 IYQEKEFLQLLTNQQDVDAIMKIKSKYEVKRDWQGDPCAPKVYMWQGINCSYDANQSPRI 411
+Y E LQL T Q+DV A++KIKS Y++ R+WQGDPCAP+ Y+W+G+ C+Y + SP I
Sbjct: 352 VYYIVELLQLETKQEDVYAMIKIKSTYKITRNWQGDPCAPQDYVWEGLKCNYSNSASPVI 411
Query: 412 ISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQG 471
IS++LSSSG+ GD+ P +L S+ESLDLS NSLTGPVP+FL++L+SL+VL+L+GN L G
Sbjct: 412 ISLDLSSSGLTGDVPPVFANLKSLESLDLSNNSLTGPVPDFLSQLKSLKVLDLTGNKLTG 471
Query: 472 SLPSGLSEKVKNGSLSLSVDGNRNLCPSASCKKKSNK------FIFPVLASVVSFCILLA 525
+P L ++ ++G L LS GN LC S SC + K F+ PV+AS+ + +++A
Sbjct: 472 IIPDDLFKRSQSGLLLLSFGGNPELCASVSCSNNNKKKKKNNNFVVPVVASIAALLVIVA 531
Query: 526 LLAILQNLRRRKQAGKKKGSL---------ELENRKFSYFDVLKITNNFERVLGKGGFGT 576
L I+ RRRKQ + E+ NR+F+Y +VLK+T NFE VLG+GGFGT
Sbjct: 532 ALTIICCCRRRKQQVARNEEADTKETYEPREMRNRRFTYSEVLKLTKNFESVLGRGGFGT 591
Query: 577 VYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYE 636
VY+GYL D +VAVK+LS+SSVQGYK+F+AEV+LL+R HHKNLT LVGYCDEG NM LIYE
Sbjct: 592 VYYGYLGDIEVAVKVLSTSSVQGYKEFEAEVKLLLRVHHKNLTTLVGYCDEGGNMILIYE 651
Query: 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE 696
+MANGNL+ HL + D L WE RL+IA E+AQGLEYLHNGCKPPIVHRDVK+ANILL++
Sbjct: 652 YMANGNLRQHLSGEHPDILSWEGRLKIALETAQGLEYLHNGCKPPIVHRDVKTANILLDD 711
Query: 697 KFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEL 756
KFQAKLADFGLSR+FP EGGTHVST V GTPGYLDPEYY+ N LTEKSDVYSFGVVLLE+
Sbjct: 712 KFQAKLADFGLSRMFPAEGGTHVSTIVAGTPGYLDPEYYVRNWLTEKSDVYSFGVVLLEI 771
Query: 757 ITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTI 816
IT + VI +T ++T + QWV ML RGDIKNIVD RL GDFDTNT WKA E+A+AC+
Sbjct: 772 ITSRSVISQTSEKTHVSQWVKPMLERGDIKNIVDSRLCGDFDTNTAWKAAELAMACVSAT 831
Query: 817 STRRPTMNQVVIELNDCLAMEIARTKAHETAPDGTPDELMIDLNLHSDVF-PLAR 870
ST RP+M+QVV+EL++CL E+ART+ + ++ +N+ S V P +R
Sbjct: 832 STERPSMSQVVMELSECLKTEMARTREGYCSAQSNSSAELMSVNVLSTVLSPRSR 886
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549714|ref|XP_002515908.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544813|gb|EEF46328.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 912 bits (2356), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 482/865 (55%), Positives = 602/865 (69%), Gaps = 33/865 (3%)
Query: 3 MLTTFIFAFLCIVALTAVVHAQNQSGFISIDCGIPENENYADKVTGINYVSDAPYVDTAV 62
ML + F L I+AL AVV AQ QSGFISIDCGI EN Y D T I+YVSDA ++DT
Sbjct: 32 MLKYYPFPLLSIIALLAVVQAQAQSGFISIDCGISENATYTDSTTSIDYVSDAAFIDTGK 91
Query: 63 SHSISPEYSKETVERQFSYLRSFPEGIRNCYTLRPPNGDVKFLIRARFMYGNYDGLDKAP 122
S SI+ EY++ + +Q +RSF EG+RNCY + G K+LIRA F+YGNYDG +KAP
Sbjct: 92 SKSIAAEYTRYNINQQLQNVRSFAEGVRNCYKIGLKKG-AKYLIRAEFLYGNYDGQNKAP 150
Query: 123 SFDLMLGADAWDSVQLQDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRPLTN 182
FDL LG+ W++V + IITKEIIH+ N YI VCLVNT SG PF+S LELRP+
Sbjct: 151 IFDLYLGSSKWETVDTINSTMIITKEIIHLINTSYIDVCLVNTGSGTPFMSKLELRPIRI 210
Query: 183 SIYPPTASDLYRPTPTGSMSLVLRWDVGTPL--------DIYDRIWWPDNFKNVERISTS 234
S Y T GS++ R DVG+ D+YDRIW P++F ISTS
Sbjct: 211 SAYS---------TSLGSLARFSRSDVGSTTNRTLRYADDVYDRIWTPNHFFKWAEISTS 261
Query: 235 SNVNP-ATSLFQPPVTVMQSAIIPANGSSSFWFSWESVSTVFKYYTCMYFSEFESEQAET 293
++ A + ++PP VM++A IPAN + S + T F++ M+F+E +A
Sbjct: 262 ETIDALAQNDYRPPSIVMRTAGIPANDNEPMTVSIDFEDTTFRFLVYMHFAEILKLEA-N 320
Query: 294 RSREMNIYLNGRFWSEIPPPQYLNTTT-HRLTATNAQQYVISIMQTKNSSLAPILNALEI 352
SR+ NI LNG W P YL TTT T + QY SI +T+NS+L P+LNA+EI
Sbjct: 321 ESRQFNISLNGEHWFGPLRPDYLYTTTVFSPTVLSGGQYEFSIYKTENSTLPPLLNAIEI 380
Query: 353 YQEKEFLQLLTNQQDVDAIMKIKSKYEVKRDWQGDPCAPKVYMWQGINCSYDANQSPRII 412
Y + Q +NQ+DVDAI IKS Y +KR+WQGDPCAP+ Y+W+G+NCSY N PRII
Sbjct: 381 YYILDLSQPQSNQEDVDAITNIKSSYGIKRNWQGDPCAPQAYLWEGLNCSYSGNVMPRII 440
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGS 472
S+NLSSSG+ G+I I SLTS+ESLDLS N LTG VP+FL++L SL VL L+GN L GS
Sbjct: 441 SLNLSSSGLTGEIPSSISSLTSLESLDLSNNYLTGSVPDFLSQLPSLNVLILTGNRLSGS 500
Query: 473 LPSGLSEKVKNGSLSLSVDGNRNLCPSASCK-KKSNKFIFPVLASVVSFCILL-ALLAIL 530
+P L EK + L LSV GN NLC +SCK +K N + PV+AS+ I++ AL AIL
Sbjct: 501 VPPSLVEKSEQNLLVLSVGGNANLCLKSSCKNEKKNNVVVPVVASIAGVLIIISALAAIL 560
Query: 531 QNLRRRKQAGKKK------GSLELENRKFSYFDVLKITNNFERVLGKGGFGTVYHGYLDD 584
+RRKQ + G LE + R+F+Y ++L ITNNFERVLGKGGFGTVYHGYLDD
Sbjct: 561 YTRKRRKQQEEDTKTSNIYGPLESKERQFTYSEILNITNNFERVLGKGGFGTVYHGYLDD 620
Query: 585 KQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQ 644
QVAVK+LS S QGYK+F AEV+LL+R HH+NLT LVG+C+EG MGLIYE+MANG+L+
Sbjct: 621 TQVAVKILSPLSAQGYKEFHAEVKLLLRVHHRNLTSLVGFCNEGTKMGLIYEYMANGDLE 680
Query: 645 AHLLEDK-ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLA 703
HLL + L WERRL IA E+A+GLEYLHNGCKPPIVHRD+K+ANILLN++FQA+LA
Sbjct: 681 -HLLSGRNRHVLKWERRLDIAVEAAKGLEYLHNGCKPPIVHRDIKTANILLNDQFQARLA 739
Query: 704 DFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVI 763
DFGLS+ FPVEGGTHVST V GTPGYLDPEY ++N LTEKSDVYSFGVVLL++ITG+PVI
Sbjct: 740 DFGLSKSFPVEGGTHVSTVVAGTPGYLDPEYSMTNWLTEKSDVYSFGVVLLKIITGRPVI 799
Query: 764 QKTPQRTL-IGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPT 822
+R++ I WVSS++A GDIK ++D L GDFD N+VWKAVE+A+AC S RPT
Sbjct: 800 AVIDERSIHISHWVSSLVANGDIKTVIDPCLGGDFDINSVWKAVEVAMACTSPTSAGRPT 859
Query: 823 MNQVVIELNDCLAMEIART-KAHET 846
MNQVV EL + LA E AR + H+T
Sbjct: 860 MNQVVRELIESLAEETARAEEGHKT 884
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549700|ref|XP_002515901.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544806|gb|EEF46321.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 895 bits (2314), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/883 (52%), Positives = 620/883 (70%), Gaps = 19/883 (2%)
Query: 3 MLTTFIFAFLCIVALTAVVHAQNQSGFISIDCGIPENENYADKVTGINYVSDAPYVDTAV 62
ML F+F F+ ++ LTAV +AQ+QSGFISIDCG+P N +Y D+ T +NY+SDA ++D +
Sbjct: 6 MLWDFLFRFIPVLFLTAV-YAQDQSGFISIDCGLPANSSYTDETTSLNYISDASFIDVGI 64
Query: 63 SHSISPEYSKETVERQFSYLRSFPEGIRNCYTLRPPNGDVKFLIRARFMYGNYDGLDKAP 122
+I+P+ + + +RQ +RSFPEG RNC+ + + K+LIRA F +G+YDG ++ P
Sbjct: 65 ITTITPKVTTNSTDRQQLSVRSFPEGDRNCFNVELAK-NTKYLIRAIFAHGDYDGSNELP 123
Query: 123 SFDLMLGADAWDSVQLQDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRPLTN 182
FDL LG + W +V++ + + KEIIH P +YIH+CLVNTDSG+PFISALELRPL N
Sbjct: 124 EFDLHLGPNKWVTVKILNASIPVIKEIIHTPTLNYIHICLVNTDSGMPFISALELRPLKN 183
Query: 183 SIYPPTASDLYRPTPTGSMSLVLRWDVGTPLDIYDRIWWPDNFKNVERISTSSNVNPATS 242
+ Y + L + T SL + V P D++DRIW PD+F +ST V+
Sbjct: 184 TTYVAQSGALVKSTRLDLGSLTNK-TVRYPDDVFDRIWTPDHFHKWTDLSTPDTVDAQNH 242
Query: 243 L-FQPPVTVMQSAIIPANGSSSFWFSWESVSTVFKYYTCMYFSEFESEQAETRSREMNIY 301
+ FQPP VM++A +P N S + F + T +Y M+F+E QA +SR NI
Sbjct: 243 IDFQPPSVVMRTANMPTNASENMEFYIDIDDTTSLFYVYMHFAEIVELQAN-QSRLFNIS 301
Query: 302 LNGRFWSEIPPPQYLNT-TTHRLTATNAQQYVISIMQTKNSSLAPILNALEIYQEKEFLQ 360
LNG W P +L++ T + + S+ + + S+L P+LNA+EIY + Q
Sbjct: 302 LNGTIWYGPVIPNHLSSGTVYSQFPIIGGNNMFSLFKIEGSTLPPLLNAIEIYFVVDLSQ 361
Query: 361 LLTNQQDVDAIMKIKSKYEVKRDWQGDPCAPKVYMWQGINCSYDANQSPRIISINLSSSG 420
T+Q DVDAIMKIKS Y + ++WQGDPCAP+ Y+W G+NCSY + P + S+NLSSSG
Sbjct: 362 SETDQDDVDAIMKIKSTYGITKNWQGDPCAPQAYVWHGLNCSYSDDDPPTVKSLNLSSSG 421
Query: 421 IAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEK 480
+ G+IV I +L S+E LDLS NSL+G +P+FL+ + SL+VLNL+GN L G++P+ L E+
Sbjct: 422 LRGEIVSEIANLRSLELLDLSNNSLSGSLPDFLSRMTSLKVLNLTGNKLTGTIPADLFER 481
Query: 481 VKNGSLSLSVDGNRNLCPSASCKKKSNKFIFPVLASVVSFCILLA-LLAILQNLRRRKQA 539
+ GSL LSV GN LCPS SC KK + PV+ASVV+F IL A L+ IL+ R QA
Sbjct: 482 SQQGSLLLSVSGNPELCPSVSCTKKKKSVVVPVVASVVAFFILAAALVVILRYFFVRSQA 541
Query: 540 GKKKGSLELEN----------RKFSYFDVLKITNNFERVLGKGGFGTVYHGYLDD-KQVA 588
+ + E R+FSY ++LKITNNF+++LGKGGFGTVYHG L+D QVA
Sbjct: 542 KTNEAKISYETNDEPLVESKKRQFSYSEILKITNNFDKILGKGGFGTVYHGTLNDGTQVA 601
Query: 589 VKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLL 648
VK+LS SS QGYK+FQAEV+LL+R HH+NLT LVGYC+EG N+GLIYE+MANGNL+ +L
Sbjct: 602 VKVLSLSSAQGYKEFQAEVKLLLRVHHRNLTTLVGYCNEGTNLGLIYEYMANGNLEDYLS 661
Query: 649 EDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 708
+ +TL WE RL+IA+E+AQGLEYLHNGCKP IVHRDVK+ NILLN+KFQAKLADFGLS
Sbjct: 662 DSCLNTLSWEIRLRIATEAAQGLEYLHNGCKPQIVHRDVKTTNILLNDKFQAKLADFGLS 721
Query: 709 RIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQ 768
RIFPV+G TH+ST V GTPGYLDPEYY++N LT+KSDV+SFGVVLLE+ITG+P I +T +
Sbjct: 722 RIFPVDGSTHISTVVAGTPGYLDPEYYVNNWLTDKSDVFSFGVVLLEIITGRPAIAQTRE 781
Query: 769 RTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828
RT I QWVSSML +GDI IVD RL GDF+ N+VWKA E+A+ C+ S RRPTMNQ V+
Sbjct: 782 RTHISQWVSSMLEKGDIHGIVDPRLNGDFEINSVWKAAELAMGCVSASSARRPTMNQAVV 841
Query: 829 ELNDCLAMEIARTKAHETAPDGTPDEL-MIDLNLHSDVFPLAR 870
ELNDCL +E+ RT+ +++ + + ++ +N+H++ PLAR
Sbjct: 842 ELNDCLNIEMGRTREGQSSQSFNSNSIELMTVNVHTEASPLAR 884
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549712|ref|XP_002515907.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544812|gb|EEF46327.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 888 bits (2295), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/889 (52%), Positives = 613/889 (68%), Gaps = 33/889 (3%)
Query: 4 LTTFIFAFLCIVALTAVVHAQNQSGFISIDCGIPENENYADKVTGINYVSDAPYVDTAVS 63
L+ F+F FL I+AL +VH Q+QSGFISIDCG+P N +Y D TG+NYVSDA ++DT +
Sbjct: 7 LSNFLFRFLPILALAILVHCQDQSGFISIDCGLPANSSYTDATTGLNYVSDAAFIDTGII 66
Query: 64 HSISPEYSKETVERQFSYLRSFPEGIRNCYTLRPPNGDVKFLIRARFMYGNYDGLDKAPS 123
++++P + +++RQ +RSFPEG RNCY + G K+LIRA F+Y NYDGL K P
Sbjct: 67 NNLAPGLNTSSIDRQQLSVRSFPEGDRNCYQVELTRG-TKYLIRAIFLYRNYDGLSKLPH 125
Query: 124 FDLMLGADAWDSVQLQDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRPLTNS 183
FDL LG + W +V++ + + EII+ P +YIHVCLVNT G PFISALELRPL N+
Sbjct: 126 FDLHLGPNKWITVKILNATIPVITEIIYTPILNYIHVCLVNTGLGTPFISALELRPLKNT 185
Query: 184 IYPPTASDLYRPTPTGSMSLVLRWDVGT--------PLDIYDRIWWPDNFKNVERISTSS 235
Y + G+++ R D G+ P D+YDRIW PD++ +ST
Sbjct: 186 TYEIRSE--------GALAKFARLDFGSVTNKTVRYPDDVYDRIWTPDHYYKWTDLSTPE 237
Query: 236 NVNPA-TSLFQPPVTVMQSAIIPANGSSSFWFSWESVSTVFKYYTCMYFSEFESEQAETR 294
++ + FQPP VM +A +P N S F ++ T ++Y M+F+E +A +
Sbjct: 238 TIDAQFHNDFQPPSIVMSTANVPTNASEDMQFFIDNEDTSLQFYFYMHFAEIVKLEAN-Q 296
Query: 295 SREMNIYLNGRFWSEIPPPQYLNTTT-HRLTATNAQQYVISIMQTKNSSLAPILNALEIY 353
SR+ NI LNG + P YL T++ + NA V S+ + S+L P+LNA+EIY
Sbjct: 297 SRQFNISLNGTIFFGPVIPDYLYTSSVYNGLPINAGSNVFSLFKIGGSTLPPLLNAIEIY 356
Query: 354 QEKEFLQLLTNQQDVDAIMKIKSKYEVKRDWQGDPCAPKVYMWQGINCSYDANQSPRIIS 413
+ Q T+Q DVDAI KIKS Y + R+WQGD CAP+ Y+WQG+NCSY N P+I S
Sbjct: 357 FFVDLSQSQTDQDDVDAITKIKSTYGITRNWQGDACAPQAYVWQGLNCSYSDNDPPKITS 416
Query: 414 INLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSL 473
+NLSSSG+ G+IV I +L S+E LDLS NSL+GPVP+FL+++ SL+VLNL+GN L G +
Sbjct: 417 LNLSSSGLTGEIVSDIANLKSLEFLDLSNNSLSGPVPDFLSQMPSLKVLNLTGNKLTGRI 476
Query: 474 PSGLSEKVKNGSLSLSVDGNRNLCPSASCKKKSNKFIFPVLASVVSFCILLALLAIL--- 530
P L E+ + GSL LSV GN LCPS SCKKK PV+ASV S IL A +A++
Sbjct: 477 PVDLFERTQKGSLLLSVSGNPELCPSVSCKKKEKSIAVPVVASVASVFILAAAVAVILRY 536
Query: 531 QNLRRRKQAGKKKGS------LELENRKFSYFDVLKITNNFERVLGKGGFGTVYHGYL-D 583
+ LR + G+ K S +EL+N++F+Y +VLKITNNFE+VLGKGGFGTVY+G L D
Sbjct: 537 RILRSVSETGETKLSHESNEPMELKNKQFTYSEVLKITNNFEKVLGKGGFGTVYYGTLAD 596
Query: 584 DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL 643
QVAVK+LS SSVQGYK+F AEV+LL+R HH+NLT LVG C EG NMGLIYE+MANGNL
Sbjct: 597 GTQVAVKILSQSSVQGYKEFLAEVKLLMRVHHRNLTTLVGCCIEGTNMGLIYEYMANGNL 656
Query: 644 QAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLA 703
+ +L +TL WE RL+IA E+ QGLEYLH GCK PIVHRDVK+ NILLN+KFQAK++
Sbjct: 657 EDYLSGSNLNTLSWEARLRIALEAGQGLEYLHGGCKLPIVHRDVKTTNILLNDKFQAKIS 716
Query: 704 DFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVI 763
DFGLSRIFP +GGTHVST V GTPGYLDPEYY++N LT+KSDVYSFGVVLLE+IT +PVI
Sbjct: 717 DFGLSRIFPADGGTHVSTIVAGTPGYLDPEYYVTNWLTDKSDVYSFGVVLLEIITCRPVI 776
Query: 764 --QKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRP 821
+ + + I QWVSSM+ GD+ +I D RL G+++ N+VWK VE+A+ C+ T S RRP
Sbjct: 777 AQNRNHENSHISQWVSSMIENGDVNSIADPRLNGEYEVNSVWKIVELAMECLSTTSARRP 836
Query: 822 TMNQVVIELNDCLAMEIARTKAHETAPDGTPDELMIDLNLHSDVFPLAR 870
TMNQVVIELN+CL E+ART+ ++ EL + +N+ ++ PLAR
Sbjct: 837 TMNQVVIELNECLKTEMARTREGQSTQSYYSIEL-VTVNVDTESSPLAR 884
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549708|ref|XP_002515905.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223544810|gb|EEF46325.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 873 bits (2256), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/904 (50%), Positives = 598/904 (66%), Gaps = 55/904 (6%)
Query: 1 MIMLTTFIFAFLCIVALTAVVHAQNQSGFISIDCGIPENENYADKVTGINYVSDAPYVDT 60
M++ F F FLCI+A+ +VH Q+QSGFIS+DCG+ N +Y D+ TG+ Y+SDA +++T
Sbjct: 1 MVLFCPFFFKFLCILAVRVLVHGQDQSGFISLDCGLQANSSYTDEKTGLKYISDAAFIET 60
Query: 61 AVSHSISPEYSKETVERQFSYLRSFPEGIRNCYTLRPPNGDVKFLIRARFMYGNYDGLDK 120
V+ SI+PE+ + +Q +RSFP+G RNCY + + ++LIRA F+Y NYDGL+K
Sbjct: 61 GVTKSIAPEFLG-SFNQQLRQVRSFPKGDRNCYKVELVK-NTRYLIRATFLYANYDGLNK 118
Query: 121 APSFDLMLGADAWDSVQLQDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRPL 180
P+FDL +G + W +VQ+ +P KEIIH P + I+VCLV T PFISALE+RPL
Sbjct: 119 LPAFDLHIGPNKWVNVQITNPLIYPIKEIIHAPTFNNIYVCLVRTGPWTPFISALEIRPL 178
Query: 181 TNSIYPPTASDLYRPTPTGSMSLVLRWDVGT--------PLDIYDRIWWPDNFKNVERIS 232
NS Y +GS+SL R DVG+ P D+YDR+W P +F IS
Sbjct: 179 HNSTYV---------AQSGSLSLFNRVDVGSLTNQTIRYPDDVYDRMWLPFHFDKGTDIS 229
Query: 233 TSSNVNPATSLFQPPVTVMQSAIIPANGSSSFWFSWESVSTVFKYYTCMYFSEFESEQAE 292
T N+ FQ P TVM SA +P N S + ++ F+ Y ++F+E +
Sbjct: 230 TKENITSGIDYFQLPSTVMNSATVPLNASEQIILNIDTQDNTFQAYVYIHFAEIVRLEPN 289
Query: 293 TRSREMNIYLNGR-FWSEIPPPQYLNTTTHRLTATNAQQYVISIMQTKNSSLAPILNALE 351
+SR NI LNG+ + + P TT + +A +++ S S+L P+LNALE
Sbjct: 290 -QSRRFNISLNGKILYGPVTPKHLEATTVYSQSAIPGGKFLFSFYGVGGSTLPPLLNALE 348
Query: 352 IYQEKEFLQLLTNQQDVDAIMKIKSKYEVKRDWQGDPCAPKVYMWQGINCSYDANQSPRI 411
+Y + L TNQ DV+AI KIKS Y + R+WQGDPC+P+ Y W G+NC+Y SP I
Sbjct: 349 LYSVVDLLHSETNQVDVNAITKIKSTYGITRNWQGDPCSPQDYKWDGLNCTYSNTASPVI 408
Query: 412 ISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQG 471
S++ SSSG+ G+I P I +L +E+LDLS NSLTGPVP+FL++L L+ LNL+GNNL G
Sbjct: 409 TSLDFSSSGLTGEIDPDISNLKWLETLDLSNNSLTGPVPDFLSQL-PLKSLNLAGNNLTG 467
Query: 472 SLPSGLSEKVKNGSLSLSVDGNRNLCPSASCKKKSNKFI-FPVLASVVSFCILLALLAI- 529
++P+ L + ++ L LSV GN LC S SC + K I PV+ SV + +++A AI
Sbjct: 468 TIPADLFNRWQSDLLFLSVSGNPQLCASVSCNSDNKKNITVPVIISVTALFVIIAGSAII 527
Query: 530 LQNLRRRKQAG---------------------KKKGSLELENRKFSYFDVLKITNNFERV 568
L L++RKQ G K+ LEL+ R+ YF++++ITNNF+R+
Sbjct: 528 LWRLKKRKQQGTVPNGFCWVMIWPVVGKMEAEAKREPLELQKRQLRYFEIVQITNNFQRI 587
Query: 569 LGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEG 628
LGKGGFGTVYHG+LDD +VAVKMLS SS QGYK+FQ EV+LL+R HH+NLT LVGYCDEG
Sbjct: 588 LGKGGFGTVYHGHLDDMEVAVKMLSPSSAQGYKEFQTEVKLLLRVHHRNLTSLVGYCDEG 647
Query: 629 ANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVK 688
M LIYE+MANGNL+ +L + + L WE RL+IA E+AQGLEYLHNGCKPPI+HRDVK
Sbjct: 648 NKMALIYEYMANGNLRDNLSDGNGNFLSWEERLRIALEAAQGLEYLHNGCKPPIIHRDVK 707
Query: 689 SANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYS 748
NILLN KFQAKLADFGLSRI PVEGG+HVST V GTPGYLDPEYY +N LTEKSDV+S
Sbjct: 708 PTNILLNNKFQAKLADFGLSRICPVEGGSHVSTIVAGTPGYLDPEYYATNWLTEKSDVFS 767
Query: 749 FGVVLLELITGQPVIQKT--PQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAV 806
FGVVLLE+IT PVI KT T + QW SSM+ +GDI++IVD RL DFD N++WK V
Sbjct: 768 FGVVLLEIITSGPVISKTRDGDTTHLSQWFSSMVEKGDIQSIVDPRLGDDFDINSLWKVV 827
Query: 807 EIALACIHTISTRRPTMNQVVIELNDCLAMEIARTKAHETAPDGTPDELMIDLNLHSDVF 866
E+A+AC+ S +RPTMNQVVIEL++CLA E +T+ + T LH+++
Sbjct: 828 ELAMACVSATSAQRPTMNQVVIELSECLATETVKTEGTSSQSYSTV--------LHTELT 879
Query: 867 PLAR 870
PLAR
Sbjct: 880 PLAR 883
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356522218|ref|XP_003529744.1| PREDICTED: putative leucine-rich repeat receptor-like protein kinase At2g19210-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 859 bits (2220), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 447/904 (49%), Positives = 594/904 (65%), Gaps = 48/904 (5%)
Query: 1 MIMLTTFIFAFLCIVALTAVVHAQNQSGFISIDCGIPENENYADKVTGINYVSDAPYVDT 60
M ML F++A ++ +V AQ+QSGF SIDCG+PE +Y +K TGI Y+SDA ++D
Sbjct: 1 MGMLLQFLYALFGVLTAVVLVQAQDQSGFTSIDCGLPEASSYNEKTTGIFYISDAKFIDA 60
Query: 61 AVSHSISPEYSKETVERQFSYLRSFPEGIRNCYTLRPPNGDVKFLIRARFMYGNYDGLDK 120
VS SISP K T +Q +Y+RSFP G RNCY + +G K+LIRA F YGNYDGL++
Sbjct: 61 GVSKSISPA-QKSTHLQQLAYVRSFPSGERNCYRINVTSG-TKYLIRATFFYGNYDGLNQ 118
Query: 121 APSFDLMLGADAWDSVQLQDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRPL 180
P FDL LGA+ WD+V + EIIH P+ DYI CLVNT G PFISA+ELR L
Sbjct: 119 PPQFDLHLGANIWDTVNFPNASLSEISEIIHTPSLDYIQPCLVNTGKGTPFISAIELRTL 178
Query: 181 TNSIYPPTASDLYRPTPTGSMSLVLRWDVGT--------PLDIYDRIWWPDNFKNVERIS 232
N+ Y +++ S++ R+D+G+ D+YDRIW P ++S
Sbjct: 179 NNAFYVTASAE--------SLAYYQRYDLGSITNLGYRYNYDVYDRIWVPHGLNQWTQLS 230
Query: 233 TSSNV-NPATSLFQPPVTVMQSAIIPANGSSSFWFSWESVSTVFKYYTCMYFSEFESEQA 291
++ ++ + + ++ P VM +A P N S+ F F W + K+Y M+FSE E A
Sbjct: 231 STLHLLDIFQNDYKLPEVVMSTAATPINASAPFQFYWGPDNVDDKFYIYMHFSEVEI-LA 289
Query: 292 ETRSREMNIYLNGRFWSEIPPPQYLNTTT--HRLTATNAQQYVISIMQTKNSSLAPILNA 349
E +R NI++NG+ + P YL T T + T A +Y+ S+ +T S+L PI+NA
Sbjct: 290 ENETRTFNIFMNGKLFYGPLTPGYLTTNTIYAKSALTGATRYLFSLAKTGTSTLPPIINA 349
Query: 350 LEIYQEKEFLQLLTNQQDVDAIMKIKSKYEVKRDWQGDPCAPKVYMWQGINCSYDANQSP 409
+EIY+ +F Q T Q DVDAI IK+ Y V R+WQGDPC P Y+W+G+NCSYD +P
Sbjct: 350 MEIYKVIDFPQSETEQDDVDAITNIKNAYGVDRNWQGDPCGPVAYIWEGLNCSYD--NTP 407
Query: 410 RIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNL 469
RI S+NLSSSG+ G I +I LT ++ LDLS NSL+G +P+FL +LQSL+VLNL NNL
Sbjct: 408 RITSLNLSSSGLTGQISSFISELTMLQYLDLSNNSLSGSLPDFLTQLQSLKVLNLVNNNL 467
Query: 470 QGSLPSGLSEKVKNGSLSLSVDGNRNLCPSASCKKKSNK--------------FIFPVLA 515
G +P GL E+ K GSLSLS+ N NLC S C ++SN + P
Sbjct: 468 TGPVPGGLVERSKEGSLSLSLGQNPNLCESDPCIQQSNNKQPDAANQNKNKNNIVIPAAT 527
Query: 516 SVVSFCILLALL--AILQNLRRRKQAGKKKGS-----LELENRKFSYFDVLKITNNFERV 568
SV +L+ ++ AI+ L++RK GK + + R++S+ +++KIT++F R+
Sbjct: 528 SVAGILVLVIIVVTAIICGLKKRKPQGKATNTPSGSQFASKQRQYSFNELVKITDDFTRI 587
Query: 569 LGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEG 628
LG+G FG VYHG +DD QVAVKMLS S+V+GY+QF AEV+LL+R HH+NLT LVGYC+E
Sbjct: 588 LGRGAFGKVYHGIIDDTQVAVKMLSPSAVRGYEQFLAEVKLLMRVHHRNLTSLVGYCNEE 647
Query: 629 ANMGLIYEFMANGNLQAHL--LEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRD 686
NMGLIYE+MANGNL L +A L WE RLQIA ++AQGLEYLHNGCKPPI+HRD
Sbjct: 648 NNMGLIYEYMANGNLDEILSGKSSRAKFLTWEDRLQIALDAAQGLEYLHNGCKPPIIHRD 707
Query: 687 VKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDV 746
VK ANILLNE FQAKLADFGLS+ FP +GG+++ST V GTPGYLDPEY IS+RLTEKSDV
Sbjct: 708 VKCANILLNENFQAKLADFGLSKSFPTDGGSYMSTVVAGTPGYLDPEYSISSRLTEKSDV 767
Query: 747 YSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAV 806
YSFGVVLLE++TG+P I KTP++T I QWV ML GDIKNI D RLQ DFDT++VW+ V
Sbjct: 768 YSFGVVLLEMVTGKPAIAKTPEKTHISQWVKFMLPNGDIKNIADSRLQEDFDTSSVWRVV 827
Query: 807 EIALACIHTISTRRPTMNQVVIELNDCLAMEIARTKAHETAPDGTPDELMIDLNLHSDVF 866
EI +A + +RP+M+ +V EL +CL E+AR + + EL + LN +++
Sbjct: 828 EIGMASVSISPVKRPSMSNIVNELKECLTTELARKYSGRDTENNDSIEL-VTLNFTTELG 886
Query: 867 PLAR 870
P AR
Sbjct: 887 PPAR 890
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356556621|ref|XP_003546622.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g51880-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 853 bits (2205), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 459/913 (50%), Positives = 597/913 (65%), Gaps = 64/913 (7%)
Query: 1 MIMLTTFIFAFLCIVALTAVVHAQNQSGFISIDCGIPENENYADKVTGINYVSDAPYVDT 60
M M +F+ FL + L ++ AQ+QSGFISI CG P N+ TG+NY SDA +++T
Sbjct: 1 MGMSRSFLVTFLGCLVLAVLIQAQDQSGFISIACGAPAGVNFTVPNTGLNYTSDANFINT 60
Query: 61 AVSHSISPEYSKETVERQFSYLRSFPEGIRNCYTLRPPNGDVKFLIRARFMYGNYDGLDK 120
VS +I PE + ++ ++ LRSFPEG RNCY + G K+LIRA F+YGNYDGL+
Sbjct: 61 GVSRTIVPELRDQFLQNVWN-LRSFPEGQRNCYKINITRGS-KYLIRASFLYGNYDGLNM 118
Query: 121 APSFDLMLGADAWDSVQLQDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRPL 180
P FDL+LGA+ W +V + + + EII++P+ DY+H+C+V+T G PFISA+ELR L
Sbjct: 119 LPKFDLLLGANRWLTVNINNASVSLDFEIIYVPSLDYVHICMVDTGHGTPFISAIELRTL 178
Query: 181 TNSIYPPTASDLYRPTPTGSMSLVLRWDVGTP------LDIYDRIW-------W-PDNFK 226
IY T GS+ R D+G+ D+YDR W W P NF
Sbjct: 179 RIDIYE---------TRFGSLETDFRVDLGSNRGYRYNYDVYDRYWSGADLDTWRPLNFP 229
Query: 227 NVERISTSSNVNPATSLFQPPVTVMQSAIIPANGSSSFWFSWESVSTVFKYYTCMYFSEF 286
I S V + ++PP VM +AI PAN S+ SW+ +Y ++F+E
Sbjct: 230 ----IDADSLVQ---NDYKPPAVVMSTAITPANVSAPLVISWKPDDPKDSFYVYLHFTEI 282
Query: 287 ESEQAETRSREMNIYLNGRFWSEIPPPQYLNTTT-HRLTATNAQQYVISIMQTKNSSLAP 345
+ A+ ++RE NI LNG W+E P+Y + T + + + ++ S + T+ S+L P
Sbjct: 283 QV-LAKNQTREFNITLNGNPWTENISPRYHSVNTIYSTSGISGEKINFSFVMTETSTLPP 341
Query: 346 ILNALEIYQEKEFLQLLTNQQDVDAIMKIKSKYEVKRDWQGDPCAPKVYMWQGINCSYDA 405
I+NA+EIY+ KEF Q T Q DVDAI IKS Y V RDWQGDPC+PK Y+W+G+NC+Y
Sbjct: 342 IINAIEIYRVKEFPQPDTYQGDVDAITTIKSVYGVTRDWQGDPCSPKDYLWEGLNCTYPV 401
Query: 406 NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLS 465
SPRII++NLSSSG++G I P I +LT +E LDLS NSL G VP+FL++LQ L++LNL
Sbjct: 402 VDSPRIITLNLSSSGLSGKIDPSILNLTMLEKLDLSNNSLDGEVPDFLSQLQHLKILNLE 461
Query: 466 GNNLQGSLPSGLSEKVKNGSLSLSVDGNRNLCPSASCKKKSN---------KFIFPVLAS 516
NNL GS+PS L EK K GSLSLSV N +LC S C +K + PV+AS
Sbjct: 462 NNNLSGSIPSTLVEKSKEGSLSLSVGQNPHLCESGQCNEKEKEKGEEEDKKNIVTPVVAS 521
Query: 517 VVSFCILL-ALLAILQNLRRR----------------KQAGKKKGSLELENRKFSYFDVL 559
ILL A+ AIL+ L+RR + G+ L+ + + +SY DVL
Sbjct: 522 AGGVVILLLAVAAILRTLKRRNSKASMVEKDQSPISPQYTGQDDSLLQSKKQIYSYSDVL 581
Query: 560 KITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLT 619
ITNNF ++GKGG GTVY GY+DD VAVKMLS SSV GY+QFQAEV+LL+R HHKNL
Sbjct: 582 NITNNFNTIVGKGGSGTVYLGYIDDTPVAVKMLSPSSVHGYQQFQAEVKLLMRVHHKNLI 641
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADT--LCWERRLQIASESAQGLEYLHNG 677
LVGYC+EG N LIYE+M NGNLQ H+ ++ T WE RL+IA ++A GLEYL NG
Sbjct: 642 SLVGYCNEGDNKALIYEYMNNGNLQEHITGKRSKTKFFTWEDRLRIAVDAASGLEYLQNG 701
Query: 678 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYIS 737
CKPPI+HRDVKS NILLNE FQAKL+DFGLS+I P +G THVST + GTPGYLDPEYYI+
Sbjct: 702 CKPPIIHRDVKSTNILLNEHFQAKLSDFGLSKIIPTDGSTHVSTVIAGTPGYLDPEYYIT 761
Query: 738 NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797
NRLTEKSDVYSFGVVLLE+IT +PVI K ++T I QWVSS++A+GDIK+IVD RL+GDF
Sbjct: 762 NRLTEKSDVYSFGVVLLEIITSKPVITKNQEKTHISQWVSSLVAKGDIKSIVDSRLEGDF 821
Query: 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAMEIARTKAHETAPDGTPDELMI 857
D N+VWKAVEIA AC+ RRP ++ +V EL + LAME+ARTK PD +
Sbjct: 822 DNNSVWKAVEIAAACVSPNPNRRPIISVIVTELKESLAMELARTKYG--GPDSRDSVKPV 879
Query: 858 DLNLHSDVFPLAR 870
+NL+++ P AR
Sbjct: 880 TMNLNTEFSPQAR 892
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356556632|ref|XP_003546627.1| PREDICTED: putative leucine-rich repeat receptor-like protein kinase At2g19210-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 851 bits (2199), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/880 (51%), Positives = 584/880 (66%), Gaps = 46/880 (5%)
Query: 21 VHAQNQSGFISIDCGIPENENYADKVTGINYVSDAPYVDTAVSHSISPEYSKETVERQFS 80
+ AQ+QSGFISIDCG P+ NY + TGINY SDA +++T VS I+ E K ++Q
Sbjct: 21 IQAQDQSGFISIDCGAPD-VNYTESTTGINYTSDANFINTGVSRIIASEL-KNGYQKQAW 78
Query: 81 YLRSFPEGIRNCYTLRPPNGDVKFLIRARFMYGNYDGLDKAPSFDLMLGADAWDSVQLQD 140
Y+RSFPEG+RNCY + G +LIRA F+YGNYDGL+ P FDL+LGA+ W +V + +
Sbjct: 79 YVRSFPEGVRNCYKINITRGST-YLIRASFLYGNYDGLNMLPQFDLLLGANRWATVTIYN 137
Query: 141 PRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRPLTNSIYPPTASDLYRPTPTGS 200
EIIH+P+ D + +CLVNT G PFISA+ELR L N Y T GS
Sbjct: 138 ASLDQFNEIIHVPSLDSVQLCLVNTGHGTPFISAVELRTLKNDTYV---------TRFGS 188
Query: 201 MSLVLRWDVGTP------LDIYDRIWWP-DNFKNVERISTSSNVNP-ATSLFQPPVTVMQ 252
+ RWD+G+ D+YDR W+ N + +++ S +V+ + S F+PP VM
Sbjct: 189 LETYNRWDLGSNQAYRYNYDVYDRAWFTYGNNNDWTQLNVSISVDSLSQSDFKPPAIVMS 248
Query: 253 SAIIPANGSSSFWFSWESVSTVFKYYTCMYFSEFESEQAETRSREMNIYLNGRFWSEIPP 312
+A+ P N S+ SWE YY M+F+E E + + ++RE NI NG+ W +
Sbjct: 249 TAVTPVNASAPLVISWEPQDQTELYYVYMHFTEVEVLE-KNQTREFNINQNGKPWYQNLS 307
Query: 313 PQYLNT-TTHRLTATNAQQYVISIMQTKNSSLAPILNALEIYQEKEFLQLLTNQQDVDAI 371
P+Y T + T+ ++ S+ T+NS+L PI+NA+EIY+ K+F Q T Q DVD I
Sbjct: 308 PRYQKADTIYSGIGTSGEKIKYSLEMTENSNLPPIINAIEIYRLKDFQQSDTYQGDVDVI 367
Query: 372 MKIKSKYEVKRDWQGDPCAPKVYMWQGINCSYDANQSPRIISINLSSSGIAGDIVPYIFS 431
IKS Y+V RDWQGDPC P Y+W G+NC+Y ANQSPRI ++NLSSSG+ G I P I
Sbjct: 368 TTIKSVYKVTRDWQGDPCGPVAYLWHGLNCTYAANQSPRITTLNLSSSGLLGKIDPSISK 427
Query: 432 LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSVD 491
L +E LDLS NSL G VP+FL++LQ L++LNL NNL GS+PS L EK K GSLSLSV
Sbjct: 428 LAMLEKLDLSNNSLNGEVPDFLSQLQHLKILNLEKNNLSGSIPSTLVEKSKEGSLSLSVG 487
Query: 492 GNRNLCPSASCKKKSNK-----FIFPVLASVVSFCILLALLA-ILQNLRRRKQAGKKKGS 545
N LC S C +K + + P++ASV ILL ++A IL L+RRK K +
Sbjct: 488 QNSFLCESDQCNEKQKEKKKNNIVTPLVASVSGVVILLVVMAAILWTLKRRKSKEKDQSQ 547
Query: 546 ------------LELENRKFSYFDVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLS 593
L+ + + +S+ DVLKITNNF LGKGGFGTVY G+++D VAVKMLS
Sbjct: 548 ISPQYTEQDDSLLQFKKQIYSFSDVLKITNNFNTTLGKGGFGTVYLGHINDTPVAVKMLS 607
Query: 594 SSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKAD 653
SSV GY+QFQAEV+LL+R HHKNLT LVGYC+EG + GLIYE+MANGNL HL
Sbjct: 608 PSSVHGYQQFQAEVKLLMRVHHKNLTSLVGYCNEGTSKGLIYEYMANGNLLEHLSGKHGK 667
Query: 654 T--LCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 711
T WE RL+IA ++A GLEYL NGCKPPI+HRDVKS NILLNE FQAKL+DFGLS++
Sbjct: 668 TKFFTWEERLRIAVDAALGLEYLQNGCKPPIIHRDVKSTNILLNELFQAKLSDFGLSKVI 727
Query: 712 PVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTL 771
P EG THVST V GTPGYLDPEY+I+NRLTEKSDVYSFGVVLLE+IT QPVI + +
Sbjct: 728 PTEGVTHVSTVVAGTPGYLDPEYFITNRLTEKSDVYSFGVVLLEIITSQPVIARNQENIH 787
Query: 772 IGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELN 831
I +WVSS++ +GDIK IVD RL+G +DTN+VWKAVEIA AC+ +RP + +V+EL
Sbjct: 788 ISEWVSSLIMKGDIKAIVDSRLEGAYDTNSVWKAVEIATACVSPNLNKRPITSVIVVELK 847
Query: 832 DCLAMEIARTKAHETAPDGTPDELM-IDLNLHSDVFPLAR 870
+ LAME+ARTK T T D + + +NL+++ P AR
Sbjct: 848 ESLAMELARTKNRGT---NTRDSVTSVTMNLNTEFIPQAR 884
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547364|ref|XP_003542083.1| PREDICTED: putative leucine-rich repeat receptor-like protein kinase At2g19210-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 846 bits (2186), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 455/898 (50%), Positives = 589/898 (65%), Gaps = 51/898 (5%)
Query: 3 MLTTFIFAFLCIVALTAVVHAQNQSGFISIDCGIPENENYADKVTGINYVSDAPYVDTAV 62
M TF FL + + AQ+QSGFISIDCG P + NY + TGINY SDA +V+T V
Sbjct: 11 MPMTFFVVFLGGL----LTQAQDQSGFISIDCGAPADINYTEPKTGINYTSDANFVNTGV 66
Query: 63 SHSISPEYSKETVERQFSYLRSFPEGIRNCYTLRPPNGDVKFLIRARFMYGNYDGLDKAP 122
S ++ E +RQ +RSFPEG RNCY + G +LIR F+YGNYDGL+KAP
Sbjct: 67 SGTVETEIISSGYQRQMMNVRSFPEGKRNCYKINITRGST-YLIRTNFLYGNYDGLNKAP 125
Query: 123 SFDLMLGADAWDSVQLQDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRPLTN 182
FD+ LGA+ W +V + + + EII++P+ DY+ +CLV+TD G PFISA+ELR L N
Sbjct: 126 QFDIHLGANRWYTVTISNASTPQANEIIYVPSLDYLQICLVDTDHGTPFISAIELRTLKN 185
Query: 183 SIYPPTASDLYRPTPTGSMSLVLRWDVGTP------LDIYDRIWW--PDNFKNVERISTS 234
Y T GS+ RWD+G+ D+YDR W+ DN K+ +++S S
Sbjct: 186 YTYV---------TQFGSLEYYNRWDLGSNNSYRYNHDVYDRFWYIYGDN-KDWKQLSAS 235
Query: 235 SNVNPATSL----FQPPVTVMQSAIIPANGSSSFWFSWESVSTVFKYYTCMYFSEFESEQ 290
PA SL ++PP ++ +A+ P N S+ SWE YY M+F+E +
Sbjct: 236 I---PADSLNQNDYKPPEIILSTAVTPVNASAPLVISWEPPDQTELYYVYMHFTEIQV-L 291
Query: 291 AETRSREMNIYLNGRFWSEIPPPQYLNTTT-HRLTATNAQQYVISIMQTKNSSLAPILNA 349
A+ ++RE NI NG+ W P Y N TT + T+ ++ S+ +TK+SSL PI+NA
Sbjct: 292 AKNQTREFNIAQNGKPWCPNMSPPYQNVTTIYSRLGTSGKKIEYSLEKTKDSSLPPIINA 351
Query: 350 LEIYQEKEFLQLLTNQQDVDAIMKIKSKYEVKRDWQGDPCAPKVYMWQGINCSYDANQSP 409
+EIY+ F Q T+Q DVDAI IKS Y + RDWQGDPC+P Y+W G+NC+Y N++P
Sbjct: 352 IEIYRVINFQQSDTHQGDVDAIATIKSVYGMTRDWQGDPCSPVAYLWNGLNCTYRGNENP 411
Query: 410 RIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNL 469
RI ++NLSSS ++G I P I LT +E LDLS N+L G VP+FL+ LQ L+++NL NNL
Sbjct: 412 RITTLNLSSSELSGMIDPSISYLTMLEKLDLSNNNLNGEVPDFLSRLQHLKIINLDNNNL 471
Query: 470 QGSLPSGLSEKVKNGSLSLSVDGNRNLCPSASC--KKKSNKFIFPVLASVVSFCILL-AL 526
GS+PS L +K K G LSLSV N LC S C KKK + P+LASV IL+ A+
Sbjct: 472 TGSIPSELVKKSKEGFLSLSVGQNLYLCESGQCNEKKKKKNIVTPLLASVSGVLILVVAV 531
Query: 527 LAILQNLRRRKQAGKKKGSL------------ELENRKFSYFDVLKITNNFERVLGKGGF 574
AI L++RK K + + + + + +S+ DVL+ITNNF ++GKGGF
Sbjct: 532 AAISWTLKKRKPKEKNQSEMSAQCTEQDDSLHQFKKQIYSHSDVLRITNNFNTIVGKGGF 591
Query: 575 GTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLI 634
GTVY GY+D VAVKMLS+SSV GY+QFQAEV+LL+R HH NLT LVGYC+EG N GLI
Sbjct: 592 GTVYLGYIDGTPVAVKMLSTSSVHGYQQFQAEVKLLMRVHHANLTSLVGYCNEGDNKGLI 651
Query: 635 YEFMANGNLQAHLLED--KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANI 692
YE+MANGNL HL K+ L WE RL+IA ++A GLEYL GCKPPI+HRDVKS NI
Sbjct: 652 YEYMANGNLHEHLSGKHIKSKFLTWEDRLRIAVDAALGLEYLQTGCKPPIIHRDVKSTNI 711
Query: 693 LLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVV 752
LL+EK QAKL+DFGLS+I P++GGTHVST V GTPGYLDPEYYISNRLT+KSD+Y FGVV
Sbjct: 712 LLDEKLQAKLSDFGLSKIIPIDGGTHVSTVVAGTPGYLDPEYYISNRLTQKSDIYGFGVV 771
Query: 753 LLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALAC 812
LLE+IT QPVI +RT I QWV S++ GDIK IVD RL+GDFD N+ WKAVEIA+AC
Sbjct: 772 LLEIITCQPVIAWNEERTHIIQWVRSLIGIGDIKGIVDSRLEGDFDINSAWKAVEIAMAC 831
Query: 813 IHTISTRRPTMNQVVIELNDCLAMEIARTKAHETAPDGTPDELMIDLNLHSDVFPLAR 870
+ + RP M +V EL + LA E+ARTK H +A D + +NL ++ PLAR
Sbjct: 832 VSLNPSERPIMRVIVTELKETLATELARTK-HNSA-DSINSIEPVTMNLDTEFTPLAR 887
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 870 | ||||||
| TAIR|locus:2017557 | 894 | IOS1 "IMPAIRED OOMYCETE SUSCEP | 0.368 | 0.359 | 0.604 | 1.3e-200 | |
| TAIR|locus:2126540 | 876 | AT4G29990 [Arabidopsis thalian | 0.979 | 0.972 | 0.470 | 1.8e-197 | |
| TAIR|locus:2047675 | 881 | AT2G19210 [Arabidopsis thalian | 0.982 | 0.970 | 0.466 | 7.8e-197 | |
| TAIR|locus:2195850 | 890 | AT1G51860 [Arabidopsis thalian | 0.371 | 0.362 | 0.600 | 1.4e-183 | |
| TAIR|locus:2059093 | 876 | FRK1 "FLG22-induced receptor-l | 0.983 | 0.977 | 0.450 | 3.7e-183 | |
| TAIR|locus:2055160 | 886 | AT2G14440 [Arabidopsis thalian | 0.495 | 0.486 | 0.483 | 3.9e-179 | |
| TAIR|locus:2017572 | 882 | AT1G51790 [Arabidopsis thalian | 0.956 | 0.943 | 0.438 | 8.1e-179 | |
| TAIR|locus:2195825 | 865 | AT1G51850 [Arabidopsis thalian | 0.367 | 0.369 | 0.583 | 1.2e-175 | |
| TAIR|locus:2824870 | 884 | AT1G51805 [Arabidopsis thalian | 0.367 | 0.361 | 0.577 | 2.5e-175 | |
| TAIR|locus:2055165 | 868 | AT2G14510 [Arabidopsis thalian | 0.977 | 0.979 | 0.415 | 1.3e-173 |
| TAIR|locus:2017557 IOS1 "IMPAIRED OOMYCETE SUSCEPTIBILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1009 (360.2 bits), Expect = 1.3e-200, Sum P(2) = 1.3e-200
Identities = 196/324 (60%), Positives = 243/324 (75%)
Query: 549 ENRKFSYFDVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVE 608
+NRK +Y DV+KITNNFERVLG+GGFG VY+G L+++ VAVKML+ S+ GYKQF+AEVE
Sbjct: 572 KNRKLTYIDVVKITNNFERVLGRGGFGVVYYGVLNNEPVAVKMLTESTALGYKQFKAEVE 631
Query: 609 LLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADT-LCWERRLQIASES 667
LL+R HHK+LT LVGYC+EG M LIYEFMANG+L+ HL + + L WE RL+IA+ES
Sbjct: 632 LLLRVHHKDLTCLVGYCEEGDKMSLIYEFMANGDLKEHLSGKRGPSILTWEGRLRIAAES 691
Query: 668 AQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPXXXXXXXXXXXXXXX 727
AQGLEYLHNGCKP IVHRD+K+ NILLNEKFQAKLADFGLSR FP
Sbjct: 692 AQGLEYLHNGCKPQIVHRDIKTTNILLNEKFQAKLADFGLSRSFPLGTETHVSTIVAGTP 751
Query: 728 XYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKN 787
YLDPEYY +N LTEKSDV+SFGVVLLEL+T QPVI +++ I +WV ML+RGDI +
Sbjct: 752 GYLDPEYYRTNWLTEKSDVFSFGVVLLELVTNQPVIDMKREKSHIAEWVGLMLSRGDINS 811
Query: 788 IVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAMEIARTKAHETA 847
IVD +LQGDFD NT+WK VE A+ C++ S+RRPTM QVV++L +CL ME+AR
Sbjct: 812 IVDPKLQGDFDPNTIWKVVETAMTCLNPSSSRRPTMTQVVMDLKECLNMEMARNMGSRMT 871
Query: 848 PDGTPDE-LMIDLNLHSDVFPLAR 870
D T D + + +N +++ P AR
Sbjct: 872 -DSTNDSSIELSMNFTTELNPGAR 894
|
|
| TAIR|locus:2126540 AT4G29990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1912 (678.1 bits), Expect = 1.8e-197, P = 1.8e-197
Identities = 415/882 (47%), Positives = 539/882 (61%)
Query: 8 IFAFLCIVALTAVVHAQNQSGFISIDCGIPENENYADKVTGINYVSDAPYVDTAVSHSIS 67
+ +++ I + +V AQ+QSGFISIDCGIP++ +Y D+ T + YVSD +V++ SHSI
Sbjct: 6 LLSWISITSCVCLVFAQDQSGFISIDCGIPDDSSYTDEKTNMKYVSDLGFVESGTSHSIV 65
Query: 68 PEYSKETVERQFSYLRSFPEGIRNCYTLRPPNGD-VKFLIRARFMYGNYDGLDKAPSFDL 126
+ ++ERQF +RSFPEG RNCY +RP G K+LIR RFMYGNYDG K P FDL
Sbjct: 66 SDLQTTSLERQFQNVRSFPEGKRNCYDIRPQQGKGFKYLIRTRFMYGNYDGFSKTPEFDL 125
Query: 127 MLGADAWDSVQLQDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRPLTNSIY- 185
+GA+ W+SV L + +I+TKEII+ P D+IHVCLV+ + G PF+S LE+R L N Y
Sbjct: 126 YIGANLWESVVLINETAIMTKEIIYTPPSDHIHVCLVDKNRGTPFLSVLEIRFLKNDTYD 185
Query: 186 -PPTASDLYRPTPTGSMS-LVLRWDVGTPLDIYDRIWWPDNFKNVERISTSSNVNPAT-S 242
P A L R G+ + L +R+ D YDRIW P + ++TS ++ +
Sbjct: 186 TPYEALMLGRRWDFGTATNLQIRYKD----DFYDRIWMPYKSPYQKTLNTSLTIDETNHN 241
Query: 243 LFQPPVTVMQSAIIPANGXXXXXXXXXXXXXXXKYYTCMYFSEFESEQAETRSREMNIYL 302
F+P VM+SAI P N K+Y M+F+E Q +RE +IY+
Sbjct: 242 GFRPASIVMRSAIAPGNESNPLKFNWAPDDPRSKFYIYMHFAEVRELQ-RNETREFDIYI 300
Query: 303 NGRFWSEIPPPQYLNTTTHR-LTATNAQQYVISIMQTKNSSLAPILNALEIYQEKEFLQL 361
N +E P YL T T + + I + +T S+L PI+NA+EIYQ EFLQL
Sbjct: 301 NDVILAENFRPFYLFTDTRSTVDPVGRKMNEIVLQRTGVSTLPPIINAIEIYQINEFLQL 360
Query: 362 LTNQQDVDAIMKIKSKYEVKRDWQGDPCAPKVYMWQGINCSY-DANQSPRIISINLSSSG 420
T+QQDVDA+ KIK KY VK++WQGDPC P W+G+ C + D N SP+ I++NLSSSG
Sbjct: 361 PTDQQDVDAMTKIKFKYRVKKNWQGDPCVPVDNSWEGLECLHSDNNTSPKSIALNLSSSG 420
Query: 421 IAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVXXXXXXXXXXXXXXXXXEK 480
+ G I P +LTSI LDLS NSLTG VP+FLA L +L EK
Sbjct: 421 LTGQIDPAFANLTSINKLDLSNNSLTGKVPDFLASLPNLTELNLEGNKLTGSIPAKLLEK 480
Query: 481 VKNGSLSLSVDGNRNLCPSASCK---KKSNKFIFPVLASVVSFCXXXXXXXXXQNLRRR- 536
K+GSLSL GN +LC S SC+ KK +I PV+AS+ + ++R
Sbjct: 481 SKDGSLSLRFGGNPDLCQSPSCQTTTKKKIGYIVPVVASLAGLLIVLTALALIWHFKKRS 540
Query: 537 -------KQAGKKKGSLELENRKFSYFDVLKITNNFERVLGKGGFGTVYHGYLDDKQVAV 589
K G G L+ R F Y +V+ ITNNFERVLGKGGFG VYHG+L+ QVAV
Sbjct: 541 RRGTISNKPLGVNTGPLDTAKRYFIYSEVVNITNNFERVLGKGGFGKVYHGFLNGDQVAV 600
Query: 590 KMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLE 649
K+LS S QGYK+F+AEVELL+R HH NLT L+GYC+E +M LIYE+MANGNL +L
Sbjct: 601 KILSEESTQGYKEFRAEVELLMRVHHTNLTSLIGYCNEDNHMALIYEYMANGNLGDYLSG 660
Query: 650 DKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 709
+ L WE RLQI+ ++AQGLEYLH GCKPPIVHRDVK ANILLNE QAK+ADFGLSR
Sbjct: 661 KSSLILSWEERLQISLDAAQGLEYLHYGCKPPIVHRDVKPANILLNENLQAKIADFGLSR 720
Query: 710 IFPXXXXXXXXXXXXXXXXYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQR 769
FP YLDPEYY + ++ EKSDVYSFGVVLLE+ITG+P I +
Sbjct: 721 SFPVEGSSQVSTVVAGTIGYLDPEYYATRQMNEKSDVYSFGVVLLEVITGKPAIWHSRTE 780
Query: 770 TL-IGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828
++ + V SMLA GDIK IVD RL F+ + WK E+ALAC S +RPTM+QVV+
Sbjct: 781 SVHLSDQVGSMLANGDIKGIVDQRLGDRFEVGSAWKITELALACASESSEQRPTMSQVVM 840
Query: 829 ELNDCLAMEIARTKAHETAPDGTPDELMIDLNLHSDVFPLAR 870
EL + + H+ P M+ +NL +++ P AR
Sbjct: 841 ELKQSIFGRVNNRSDHKD-----PVR-MVTMNLDTEMVPRAR 876
|
|
| TAIR|locus:2047675 AT2G19210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1906 (676.0 bits), Expect = 7.8e-197, P = 7.8e-197
Identities = 414/887 (46%), Positives = 542/887 (61%)
Query: 4 LTTFIFAFLCIVAL-TAVVHAQNQSGFISIDCGIPENENYADKVTGINYVSDAPYVDTAV 62
L+ IFA C A+ +V AQ+QSGF+SIDCGIPE+ +Y D+ T I YVSDA +V++
Sbjct: 7 LSLIIFA--CFFAVFVLLVRAQDQSGFVSIDCGIPEDSSYNDETTDIKYVSDAAFVESGT 64
Query: 63 SHSISPEYSKETVERQFSYLRSFPEGIRNCYTLRPPNGD-VKFLIRARFMYGNYDGLDKA 121
HSI PE+ ++E+QF +RSFPEG RNCY ++PP G K+LIR RFMYGNYD L KA
Sbjct: 65 IHSIDPEFQTSSLEKQFQNVRSFPEGNRNCYDVKPPQGKGFKYLIRTRFMYGNYDNLGKA 124
Query: 122 PSFDLMLGADAWDSVQLQDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRPLT 181
P FDL LG + WDSV + + +I+TKEIIH D++HVCLV+ + G PF+SALE+R L
Sbjct: 125 PDFDLYLGFNIWDSVTIDNATTIVTKEIIHTLRSDHVHVCLVDKNRGTPFLSALEIRLLK 184
Query: 182 NSIY--PPTASDLYRPTPTGSM-SLVLRWDVGTPLDIYDRIWWPDNFKNVERISTSSNVN 238
++ Y P + L++ G + +L +R+ D++DRIW P F + S ++
Sbjct: 185 SNTYETPYDSLILFKRWDLGGLGALPVRYKD----DVFDRIWIPLRFPKYTIFNASLTID 240
Query: 239 PATSL-FQPPVTVMQSAIIPANGXXXXXXXXXXXXXXXKYYTCMYFSEFESEQAETRSRE 297
+ FQP VM +A P + KY+ M+F+E E +RE
Sbjct: 241 SNNNEGFQPARFVMNTATSPEDLSQDIIFSWEPKDPTWKYFVYMHFAEVV-ELPSNETRE 299
Query: 298 MNIYLNGRFWSEIP-PPQYLNTTTHRL-TATNAQQYVISIMQTKNSSLAPILNALEIYQE 355
+ LN + + P+YL T T + + + + QT S+L PI+NA+E Y+
Sbjct: 300 FKVLLNEKEINMSSFSPRYLYTDTLFVQNPVSGPKLEFRLQQTPRSTLPPIINAIETYRV 359
Query: 356 KEFLQLLTNQQDVDAIMKIKSKYEVKRDWQGDPCAPKVYMWQGINCSYDANQSPRIISIN 415
EFLQ T+QQDVDAIM+IKSKY VK+ W GDPCAP Y W+ INCSY N+SPRIIS+N
Sbjct: 360 NEFLQSPTDQQDVDAIMRIKSKYGVKKSWLGDPCAPVKYPWKDINCSYVDNESPRIISVN 419
Query: 416 LSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVXXXXXXXXXXXXXX 475
LSSSG+ G+I +LT + LDLS NSLTG +P+FL L +L
Sbjct: 420 LSSSGLTGEIDAAFSNLTLLHILDLSNNSLTGKIPDFLGNLHNLTELNLEGNKLSGAIPV 479
Query: 476 XXXEKVKNGSLSLSVDGNRNLCPSASC-----KKKSNKFIFPVLASVVSFCXXXXXXXXX 530
E+ + L +DGN +LC SASC K K N +I P++ASVV
Sbjct: 480 KLLERSNKKLILLRIDGNPDLCVSASCQISDEKTKKNVYIIPLVASVVGVLGLVLAIALF 539
Query: 531 ----QNLRRRKQAGKKKGSLELENRKFSYFDVLKITNNFERVLGKGGFGTVYHGYLDDKQ 586
+ RR G + G L+ R + Y +V+K+TNNFERVLG+GGFG VYHG L+D Q
Sbjct: 540 LLYKKRHRRGGSGGVRAGPLDTTKRYYKYSEVVKVTNNFERVLGQGGFGKVYHGVLNDDQ 599
Query: 587 VAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAH 646
VAVK+LS SS QGYK+F+AEVELL+R HHKNLT L+GYC EG M LIYEFMANG L +
Sbjct: 600 VAVKILSESSAQGYKEFRAEVELLLRVHHKNLTALIGYCHEGKKMALIYEFMANGTLGDY 659
Query: 647 LLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFG 706
L +K+ L WE RLQI+ ++AQGLEYLHNGCKPPIV RDVK ANIL+NEK QAK+ADFG
Sbjct: 660 LSGEKSYVLSWEERLQISLDAAQGLEYLHNGCKPPIVQRDVKPANILINEKLQAKIADFG 719
Query: 707 LSRIFPXXXXXXXXXXXXXXXXYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK- 765
LSR YLDPEY+++ +L+EKSD+YSFGVVLLE+++GQPVI +
Sbjct: 720 LSRSVALDGNNQDTTAVAGTIGYLDPEYHLTQKLSEKSDIYSFGVVLLEVVSGQPVIARS 779
Query: 766 --TPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTM 823
T + I V ML+ GDI+ IVD +L FD + WK E+A+AC + S RPTM
Sbjct: 780 RTTAENIHITDRVDLMLSTGDIRGIVDPKLGERFDAGSAWKITEVAMACASSSSKNRPTM 839
Query: 824 NQVVIELNDCLAMEIARTKAHETAPDGTPDELMIDLNLHSDVFPLAR 870
+ VV EL + ++ AR A T D M N S +FP AR
Sbjct: 840 SHVVAELKESVSR--ARAGGGSGASSVT-DPAMT--NFDSGMFPQAR 881
|
|
| TAIR|locus:2195850 AT1G51860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 984 (351.4 bits), Expect = 1.4e-183, Sum P(2) = 1.4e-183
Identities = 197/328 (60%), Positives = 240/328 (73%)
Query: 545 SLELENRKFSYFDVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQ 604
S+ RK +Y +VLK+TNNFERVLGKGGFGTVYHG LD +VAVKMLS SS QGYK+F+
Sbjct: 566 SIITRERKITYPEVLKMTNNFERVLGKGGFGTVYHGNLDGAEVAVKMLSHSSAQGYKEFK 625
Query: 605 AEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKA-DTLCWERRLQI 663
AEVELL+R HH++L LVGYCD+G N+ LIYE+MANG+L+ ++ + + L WE R+QI
Sbjct: 626 AEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMSGKRGGNVLTWENRMQI 685
Query: 664 ASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPXXXXXXXXXXX 723
A E+AQGLEYLHNGC+PP+VHRDVK+ NILLNE+ AKLADFGLSR FP
Sbjct: 686 AVEAAQGLEYLHNGCRPPMVHRDVKTTNILLNERCGAKLADFGLSRSFPIDGECHVSTVV 745
Query: 724 XXXXXYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG 783
YLDPEYY +N L+EKSDVYSFGVVLLE++T QPVI KT +R I WV ML +G
Sbjct: 746 AGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVIDKTRERPHINDWVGFMLTKG 805
Query: 784 DIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAMEIARTKA 843
DIK+IVD +L GD+DTN WK VE+ALAC++ S RRPTM VV+ELNDC+A+E AR +
Sbjct: 806 DIKSIVDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVMELNDCVALENARRQG 865
Query: 844 HETAPD-GTPDELMIDLNLHSDVFPLAR 870
E G+ D L+ SD P AR
Sbjct: 866 SEEMYSMGSVD---YSLSSTSDFAPGAR 890
|
|
| TAIR|locus:2059093 FRK1 "FLG22-induced receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1777 (630.6 bits), Expect = 3.7e-183, P = 3.7e-183
Identities = 401/890 (45%), Positives = 533/890 (59%)
Query: 1 MIMLTTFI-FAFLCIVALTAVVHAQNQSGFISIDCGIPENENYADKVTGINYVSDAPYVD 59
M ML + F L +VHAQ+QSGFISIDCGIP++ +Y D+ TGI YVSD+ +VD
Sbjct: 1 MAMLKSLSSILFTSFALLFFLVHAQDQSGFISIDCGIPDDSSYNDETTGIKYVSDSAFVD 60
Query: 60 TAVSHSISPEYSKETVERQFSYLRSFPEGIRNCYTLRPPNGD-VKFLIRARFMYGNYDGL 118
+ + I+ ++ +R +RSFP+ R+CY + P G K+LIR RFMYGNYD L
Sbjct: 61 SGTTKRIAAQFQSSGFDRHLLNVRSFPQSKRSCYDVPTPRGKGFKYLIRTRFMYGNYDDL 120
Query: 119 DKAPSFDLMLGADAWDSVQLQDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELR 178
+ P FDL LG + WDSV+L D +I+ KEII +P D + VC+V+ ++G PF+S LE+R
Sbjct: 121 GRVPEFDLYLGVNFWDSVKLDDATTILNKEIITIPLLDNVQVCVVDKNAGTPFLSVLEIR 180
Query: 179 PLTNSIY--PPTASDLYRP---TPTGSMSLVLRWDVGTPLDIYDRIWWPDNFKNVERI-S 232
L N+ Y P A L R + TG + + D DIYDRIW P + +I +
Sbjct: 181 LLLNTTYETPYDALTLLRRLDYSKTGKLPSRYK-D-----DIYDRIWTPRIVSSEYKILN 234
Query: 233 TSSNVNP-ATSLFQPPVTVMQSAIIPANGXXXXXXXXXXXXXXXKYYTCMYFSEFESEQA 291
TS V+ + +QP TVM +A N K+Y M+F+E E ++
Sbjct: 235 TSLTVDQFLNNGYQPASTVMSTAETARNESLYLTLSFRPPDPNAKFYVYMHFAEIEVLKS 294
Query: 292 ETRSREMNIYLNGRFWSEIPPPQYLNTTTHRLTATNAQQYVI--SIMQTKNSS-LAPILN 348
++RE +I+LN S +YL T T +T I S++Q L PI+N
Sbjct: 295 N-QTREFSIWLNEDVISPSFKLRYLLTDTF-VTPDPVSGITINFSLLQPPGEFVLPPIIN 352
Query: 349 ALEIYQEKEFLQLLTNQQDVDAIMKIKSKYEVKRDWQGDPCAPKVYMWQGINC-SYDANQ 407
ALE+YQ EFLQ+ T+ QDVDA+ KIK+ Y VK++WQGDPC P Y W+GI+C D
Sbjct: 353 ALEVYQVNEFLQIPTHPQDVDAMRKIKATYRVKKNWQGDPCVPVDYSWEGIDCIQSDNTT 412
Query: 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVXXXXXX 467
+PR++S+N+S S + G I P +LTSI LDLS N+LTG +P FLA L +L
Sbjct: 413 NPRVVSLNISFSELRGQIDPAFSNLTSIRKLDLSGNTLTGEIPAFLANLPNLTELNVEGN 472
Query: 468 XXXXXXXXXXXEKVKNGSLSLSVDGNRNLCPSASCK--KKSNK--FIFP--VLASVVSFC 521
E+ KNGSLSL N +LC S SC KK NK +I P V+ +V
Sbjct: 473 KLTGIVPQRLHERSKNGSLSLRFGRNPDLCLSDSCSNTKKKNKNGYIIPLVVVGIIVVLL 532
Query: 522 XXXXXXXXXQNLRRRKQAGKKKGSLELENRKFSYFDVLKITNNFERVLGKGGFGTVYHGY 581
+ ++R G++ G L+ R F Y +V+ ITNNFERV+GKGGFG VYHG
Sbjct: 533 TALALFRRFKKKQQRGTLGERNGPLKTAKRYFKYSEVVNITNNFERVIGKGGFGKVYHGV 592
Query: 582 LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641
++ +QVAVK+LS S QGYK+F+AEV+LL+R HH NLT LVGYC+E +M LIYE+MAN
Sbjct: 593 INGEQVAVKVLSEESAQGYKEFRAEVDLLMRVHHTNLTSLVGYCNEINHMVLIYEYMANE 652
Query: 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAK 701
NL +L ++ L WE RL+I+ ++AQGLEYLHNGCKPPIVHRDVK NILLNEK QAK
Sbjct: 653 NLGDYLAGKRSFILSWEERLKISLDAAQGLEYLHNGCKPPIVHRDVKPTNILLNEKLQAK 712
Query: 702 LADFGLSRIFPXXXXXXXXXXXXXXXXYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
+ADFGLSR F YLDPEYY + ++ EKSDVYS GVVLLE+ITGQP
Sbjct: 713 MADFGLSRSFSVEGSGQISTVVAGSIGYLDPEYYSTRQMNEKSDVYSLGVVLLEVITGQP 772
Query: 762 VIQKTP-QRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRR 820
I + ++ I V S+LA GDI+ IVD RL+ +D + WK EIALAC S +R
Sbjct: 773 AIASSKTEKVHISDHVRSILANGDIRGIVDQRLRERYDVGSAWKMSEIALACTEHTSAQR 832
Query: 821 PTMNQVVIELNDCLAMEIARTKAHETAPDGTPDELMIDLNLHSDVFPLAR 870
PTM+QVV+EL + I + E D T M+ +NL +++ P AR
Sbjct: 833 PTMSQVVMELKQ-IVYGIVTDQ--ENYDDSTK---MLTVNLDTEMVPRAR 876
|
|
| TAIR|locus:2055160 AT2G14440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1009 (360.2 bits), Expect = 3.9e-179, Sum P(2) = 3.9e-179
Identities = 216/447 (48%), Positives = 281/447 (62%)
Query: 404 DANQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVXX 463
D + PRIIS++LSSSG+ G I P I +LT + LDLS N+LTG +P L L LR
Sbjct: 407 DISTPPRIISLDLSSSGLTGVITPSIQNLTMLRELDLSNNNLTGVIPPSLQNLTMLRELD 466
Query: 464 XXXXXXXXXXXXXXXEKVKNGSLSLSVDGNRNLCPSASCKKKSN-------------KFI 510
+ L + R P A +++N ++
Sbjct: 467 LSNNNLTGEVPEFLATIKPLLVIHLRGNNLRGSVPQALQDRENNDGLKLLRGKHQPKSWL 526
Query: 511 FPVLASVVSFCXXXXXXXXXQNLRRRKQAGKK--KGSLELENRKFSYFDVLKITNNFERV 568
++AS+ RRRK + +K + SLE++NR+F Y +V ++TNNFE V
Sbjct: 527 VAIVASISCVAVTIIVLVLIFIFRRRKSSTRKVIRPSLEMKNRRFKYSEVKEMTNNFEVV 586
Query: 569 LGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEG 628
LGKGGFG VYHG+L+++QVAVK+LS SS QGYK+F+ EVELL+R HH NL LVGYCD+G
Sbjct: 587 LGKGGFGVVYHGFLNNEQVAVKVLSQSSTQGYKEFKTEVELLLRVHHVNLVSLVGYCDKG 646
Query: 629 ANMGLIYEFMANGNLQAHLLEDKAD-TLCWERRLQIASESAQGLEYLHNGCKPPIVHRDV 687
++ LIYEFM NGNL+ HL + L W RL+IA ESA G+EYLH GCKPP+VHRDV
Sbjct: 647 NDLALIYEFMENGNLKEHLSGKRGGPVLNWPGRLKIAIESALGIEYLHIGCKPPMVHRDV 706
Query: 688 KSANILLNEKFQAKLADFGLSRIFPXXXXXXXXXXXXXXXXYLDPEYYISNRLTEKSDVY 747
KS NILL +F+AKLADFGLSR F YLDPEYY N LTEKSDVY
Sbjct: 707 KSTNILLGLRFEAKLADFGLSRSFLVGSQTHVSTNVAGTLGYLDPEYYQKNWLTEKSDVY 766
Query: 748 SFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVE 807
SFG+VLLE+ITGQPVI+++ ++ I +W SMLA GDI++I+D L D+DT++ WKA+E
Sbjct: 767 SFGIVLLEIITGQPVIEQSRDKSYIVEWAKSMLANGDIESIMDRNLHQDYDTSSSWKALE 826
Query: 808 IALACIHTISTRRPTMNQVVIELNDCL 834
+A+ CI+ ST RP M +V ELN+CL
Sbjct: 827 LAMLCINPSSTLRPNMTRVAHELNECL 853
|
|
| TAIR|locus:2017572 AT1G51790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1736 (616.2 bits), Expect = 8.1e-179, P = 8.1e-179
Identities = 381/869 (43%), Positives = 525/869 (60%)
Query: 11 FLCIVALTAVVHAQNQSGFISIDCGI-PENENYADKVTGINYVSDAPYVDTAVSHSISPE 69
F+C VAL + AQ+QSGFISIDCG+ PEN +Y + T I YVSD+ Y DT S+ ++PE
Sbjct: 11 FICCVALLNLAIAQDQSGFISIDCGLQPENSSYTETSTDIKYVSDSSYTDTGTSYFVAPE 70
Query: 70 YSKETVERQFSYLRSFPEGIRNCYTLRPPNGDVKFLIRARFMYGNYDGLDKAPSFDLMLG 129
+++ +++ +RSFPEGIRNCYT+ N K+LIRA FMYGNYD ++ P FDL LG
Sbjct: 71 -NRQNMKQSMWSVRSFPEGIRNCYTIAV-NSSTKYLIRADFMYGNYDSRNEIPGFDLHLG 128
Query: 130 ADAWDSVQLQDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRPLTNSIYPPTA 189
+ WD+V+L P ++KEII+ D I VCLVNT +G PFIS LELR L NS Y +
Sbjct: 129 PNKWDTVELVSPLQTVSKEIIYYVLTDTIQVCLVNTGNGTPFISVLELRQLPNSSYAAQS 188
Query: 190 SDL--YRPTPTGSMS-LVLRWDVGTPLDIYDRIWWP---DNFKNVERISTSSNVNPATSL 243
L ++ GS + L +R+ P D++DRIW+P + K + STS N +T
Sbjct: 189 ESLQLFQRLDFGSTTNLTVRY----PNDVFDRIWFPATPNGTKPLSDPSTSLTSN-STGN 243
Query: 244 FQPPVTVMQSAIIPANGXXXXXXXXXXXXXXXKYYTCMYFSEFESEQAET-RSREMNIYL 302
F+ P VM++ I+P N +++ +YF+E + + T +RE I L
Sbjct: 244 FRLPQVVMRTGIVPDNPRGFVDFGWIPDDPSLEFFFYLYFTELQQPNSGTVETREFVILL 303
Query: 303 NGRFWSEIPPPQYLNTTTHRLTATN---AQQYVISIMQTKNSSLAPILNALEIYQEKEFL 359
NG+ + E Y T L +N A+ + S+ QT++SSL P++NA+E Y +
Sbjct: 304 NGKSFGEPLSLNYFRTLA--LFTSNPLKAESFQFSLRQTQSSSLPPLINAMETYFVNKLP 361
Query: 360 QLLTNQQDVDAIMKIKSKYEVKRDWQGDPCAPKVYMWQGINCSYDANQSPRIISINLSSS 419
Q T+ D+ A+ IKS Y+VKR+W+GD C P+ Y W+G+NCS++ PR+I++NLSS+
Sbjct: 362 QSSTDPNDLSAMRNIKSAYKVKRNWEGDVCVPQAYTWEGLNCSFNGTNMPRVIALNLSSA 421
Query: 420 GIAGDIVPYIFSLTSIESLDLSKNSLTGP-VPEFLAELQSLRVXXXXXXXXXXXXXXXXX 478
G+ G+I I L+ ++ LDLS N+L+GP VP FLA+LQ LRV
Sbjct: 422 GLTGEITSDISRLSQLQILDLSNNNLSGPAVPAFLAQLQFLRVLHLANNQLSGPIPSSLI 481
Query: 479 EKVKNGSLSLSVDGNRNLCPSASCKK-KSNK---FIFPVLASVVSFCXXXXXXXXXQNL- 533
E++ + S + S+ + N C S + K NK F+ P++AS+ +
Sbjct: 482 ERLDSFSGNPSIC-SANACEEVSQNRSKKNKLPSFVIPLVASLAGLLLLFIISAAIFLIL 540
Query: 534 -RRRKQ--AGKKKG----SLELENRKFSYFDVLKITNNFERVLGKGGFGTVYHGYLDDKQ 586
R++KQ G + LE NRKF+Y +++ ITN F+R GK GFG Y G LD K+
Sbjct: 541 MRKKKQDYGGNETAVDAFDLEPSNRKFTYAEIVNITNGFDRDQGKVGFGRNYLGKLDGKE 600
Query: 587 VAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAH 646
V VK++SS S QGYKQ +AEV+ L R HHKNL ++GYC+EG M +IYE+MANGNL+ H
Sbjct: 601 VTVKLVSSLSSQGYKQLRAEVKHLFRIHHKNLITMLGYCNEGDKMAVIYEYMANGNLKQH 660
Query: 647 LLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFG 706
+ E+ WE RL IA + AQGLEYLH GCKPPI+HR+VK N+ L+E F AKL FG
Sbjct: 661 ISENSTTVFSWEDRLGIAVDVAQGLEYLHTGCKPPIIHRNVKCTNVFLDESFNAKLGGFG 720
Query: 707 LSRIFPXXXXXXXXXXXXXXXXYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 766
LSR F Y+DPEYY SN LTEKSDVYSFGVVLLE++T +P I K
Sbjct: 721 LSRAFDAAEGSHLNTAIAGTPGYVDPEYYTSNMLTEKSDVYSFGVVLLEIVTAKPAIIKN 780
Query: 767 PQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQV 826
+R I QWV S+L+R +I I+D L GD+D N+ +K VEIA+AC+ S RP M+QV
Sbjct: 781 EERMHISQWVESLLSRENIVEILDPSLCGDYDPNSAFKTVEIAVACVCRNSGDRPGMSQV 840
Query: 827 VIELNDCLAMEIARTKAHETAPDGTPDEL 855
V L + LA+E+ R K H P G+ D L
Sbjct: 841 VTALKESLAVEVERKK-H--LPVGSTDSL 866
|
|
| TAIR|locus:2195825 AT1G51850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 960 (343.0 bits), Expect = 1.2e-175, Sum P(3) = 1.2e-175
Identities = 189/324 (58%), Positives = 238/324 (73%)
Query: 549 ENRKFSYFDVLKITNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSSSSVQGYKQFQAEV 607
+NR+F+Y V +TNNF+R+LGKGGFG VYHG+++ +QVAVK+LS SS QGYK+F+AEV
Sbjct: 544 KNRRFTYSQVAIMTNNFQRILGKGGFGMVYHGFVNGTEQVAVKILSHSSSQGYKEFKAEV 603
Query: 608 ELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKAD-TLCWERRLQIASE 666
ELL+R HHKNL LVGYCDEG NM LIYE+MANG+L+ H+ + TL W RL+I E
Sbjct: 604 ELLLRVHHKNLVGLVGYCDEGENMALIYEYMANGDLKEHMSGTRNRFTLNWGTRLKIVVE 663
Query: 667 SAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPXXXXXXXXXXXXXX 726
SAQGLEYLHNGCKPP+VHRDVK+ NILLNE FQAKLADFGLSR FP
Sbjct: 664 SAQGLEYLHNGCKPPMVHRDVKTTNILLNEHFQAKLADFGLSRSFPIEGETHVSTVVAGT 723
Query: 727 XXYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIK 786
YLDPEYY +N LTEKSDVYSFG+VLLELIT +PVI K+ ++ I +WV ML +GDI
Sbjct: 724 PGYLDPEYYKTNWLTEKSDVYSFGIVLLELITNRPVIDKSREKPHIAEWVGVMLTKGDIN 783
Query: 787 NIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAMEIARTKAHET 846
+I+D L D+D+ +VWKAVE+A++C++ S RRPTM+QVVIELN+C+A E +R A
Sbjct: 784 SIMDPNLNEDYDSGSVWKAVELAMSCLNPSSARRPTMSQVVIELNECIASENSRGGASRD 843
Query: 847 APDGTPDELMIDLNLHSDVFPLAR 870
+ E + L +++ P AR
Sbjct: 844 MDSKSSIE--VSLTFDTELSPTAR 865
|
|
| TAIR|locus:2824870 AT1G51805 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 961 (343.3 bits), Expect = 2.5e-175, Sum P(2) = 2.5e-175
Identities = 187/324 (57%), Positives = 240/324 (74%)
Query: 549 ENRKFSYFDVLKITNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSSSSVQGYKQFQAEV 607
+N++F+Y V+ +TNNF+R+LGKGGFG VYHG+++ +QVAVK+LS SS QGYKQF+AEV
Sbjct: 563 KNKRFTYSQVVIMTNNFQRILGKGGFGIVYHGFVNGVEQVAVKILSHSSSQGYKQFKAEV 622
Query: 608 ELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKAD-TLCWERRLQIASE 666
ELL+R HHKNL LVGYCDEG NM LIYE+MANG+L+ H+ + L WE RL+I +
Sbjct: 623 ELLLRVHHKNLVGLVGYCDEGENMALIYEYMANGDLKEHMSGTRNRFILNWETRLKIVID 682
Query: 667 SAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPXXXXXXXXXXXXXX 726
SAQGLEYLHNGCKP +VHRDVK+ NILLNE F+AKLADFGLSR FP
Sbjct: 683 SAQGLEYLHNGCKPLMVHRDVKTTNILLNEHFEAKLADFGLSRSFPIGGETHVSTVVAGT 742
Query: 727 XXYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIK 786
YLDPEYY +NRLTEKSDVYSFG+VLLE+IT +PVI ++ ++ I +WV ML +GDI
Sbjct: 743 PGYLDPEYYKTNRLTEKSDVYSFGIVLLEMITNRPVIDQSREKPYISEWVGIMLTKGDII 802
Query: 787 NIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAMEIARTKAHET 846
+I+D L GD+D+ +VWKAVE+A++C++ STRRPTM+QV+I LN+CL E +R A
Sbjct: 803 SIMDPSLNGDYDSGSVWKAVELAMSCLNPSSTRRPTMSQVLIALNECLVSENSRGGASRD 862
Query: 847 APDGTPDELMIDLNLHSDVFPLAR 870
+ L + L +DV P+AR
Sbjct: 863 MD--SKSSLEVSLTFDTDVSPMAR 884
|
|
| TAIR|locus:2055165 AT2G14510 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1687 (598.9 bits), Expect = 1.3e-173, P = 1.3e-173
Identities = 364/876 (41%), Positives = 514/876 (58%)
Query: 7 FIFAFLCIVALTAVVHAQNQSGFISIDCGIPENENYADKVTGINYVSDAPYVDTAVSHSI 66
F+ ++ ++V +QNQ GFIS+DCG+P E+Y + + + ++SD ++ + +I
Sbjct: 7 FMLLACATFSIMSLVKSQNQQGFISLDCGLPSKESYIEPSSNLTFISDVNFIRGGKTGNI 66
Query: 67 SPEYSKETVERQFSYLRSFPEGIRNCYTLRPPNGDVKFLIRARFMYGNYDGLDKAPSFDL 126
+ + F LR FP+GIRNCY+L G K+LIR F YGNYDGL+ +P FDL
Sbjct: 67 QNNSRTNFIFKPFKVLRYFPDGIRNCYSLSVKQG-TKYLIRTLFYYGNYDGLNTSPRFDL 125
Query: 127 MLGADAWDSVQ--LQDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRPLTNSI 184
LG + W SV + D + +EI+H+ + + +CLV T + P ISA+ELRPL
Sbjct: 126 FLGPNIWTSVDVLIADVGDGVVEEIVHVTRSNILDICLVKTGTSTPMISAIELRPLRYDT 185
Query: 185 YPPTASDLYRPTP---TGSMSLVLRWDVGTPLDIYDRIWWPDNFKNVERISTSSNVNPAT 241
Y L T S + R+ P D+YDR+W P + +I+T+ NV+ +
Sbjct: 186 YTARTGSLKSMAHFYFTNSDEAI-RY----PEDVYDRVWMPYSQPEWTQINTTRNVSGFS 240
Query: 242 SLFQPPVTVMQSAIIPANGXXXXXXXXXXXXXXXKYYTCMYFSEFESEQAETRSREMNIY 301
+ PP V+Q+A IP NG + Y ++F+E + + +RE I
Sbjct: 241 DGYNPPQGVIQTASIPTNGSEPLTFTWNLESSDDETYAYLFFAEIQQLKVN-ETREFKIL 299
Query: 302 LNGRFWSEIPPPQYLNTTTHRLTATNAQQYV--ISIMQTKNSSLAPILNALEIYQEKEFL 359
NG + + P ++ T + V + + +T S+L P++NA+EI+ +F
Sbjct: 300 ANGVDYIDYTPWKFEARTLSNPAPLKCEGGVCRVQLSKTPKSTLPPLMNAIEIFSVIQFP 359
Query: 360 QLLTNQQDVDAIMKIKSKYEVKR-DWQGDPCAPKVYMWQGINCSY-DANQSPRIISINLS 417
Q TN +V AI KI+S Y++ R WQGDPC PK + W G++C+ D + PRIIS++LS
Sbjct: 360 QSDTNTDEVIAIKKIQSTYQLSRISWQGDPCVPKQFSWMGVSCNVIDISTPPRIISLDLS 419
Query: 418 SSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVXXXXXXXXXXXXXXXX 477
SG+ G I P I +LT + LDLS N+LTG VPEFLA ++ L V
Sbjct: 420 LSGLTGVISPSIQNLTMLRELDLSNNNLTGEVPEFLATIKPLLVIHLRGNNLRGSVPQAL 479
Query: 478 XEKVKNGSLSLSVDGNRNLCPSASCKKKSNKFIFPVLASVVSFCXXXXXXXXXQNLRRRK 537
++ KN L L VD N + K + ++ ++AS+ RRRK
Sbjct: 480 QDREKNDGLKLFVDPNI----TRRGKHQPKSWLVAIVASISCVAVTIIVLVLIFIFRRRK 535
Query: 538 QAGKK--KGSLELENRKFSYFDVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSSS 595
+ +K + SLE++NR+F Y +V ++TNNFE VLGKGGFG VYHG+L+++QVAVK+LS S
Sbjct: 536 SSTRKVIRPSLEMKNRRFKYSEVKEMTNNFEVVLGKGGFGVVYHGFLNNEQVAVKVLSQS 595
Query: 596 SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADT- 654
S QGYK+F+ EVELL+R HH NL LVGYCDEG ++ LIYEFM NGNL+ HL + +
Sbjct: 596 STQGYKEFKTEVELLLRVHHVNLVSLVGYCDEGIDLALIYEFMENGNLKEHLSGKRGGSV 655
Query: 655 LCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPXX 714
L W RL+IA ESA G+EYLH GC+PP+VHRDVKS NILL +F+AKLADFGLSR F
Sbjct: 656 LNWSSRLKIAIESALGIEYLHIGCQPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVG 715
Query: 715 XXXXXXXXXXXXXXYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQ 774
YLDPEYY+ N LTEKSDVYSFG+VLLE ITGQPVI+++ ++ I +
Sbjct: 716 SQAHVSTNVAGTLGYLDPEYYLKNWLTEKSDVYSFGIVLLESITGQPVIEQSRDKSYIVE 775
Query: 775 WVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834
W SMLA GDI++I+D L D+D+++ WKA+E+A+ CI+ ST+RP M +V ELN+CL
Sbjct: 776 WAKSMLANGDIESIMDPNLHQDYDSSSSWKALELAMLCINPSSTQRPNMTRVAHELNECL 835
Query: 835 AMEIARTKAHETAPDGTPDELMIDLNLHSDVFPLAR 870
EI + + L + SD+ P AR
Sbjct: 836 --EIYNLTKIRSQDQNSSKSLGHTVTFISDI-PSAR 868
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00034228001 | SubName- Full=Chromosome chr9 scaffold_7, whole genome shotgun sequence; (853 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 870 | |||
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 1e-108 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-35 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-33 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-33 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-27 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-26 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-26 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-26 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-25 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-23 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-20 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-20 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-19 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-16 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-14 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-13 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-13 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-13 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-11 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.002 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.002 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 335 bits (862), Expect = e-108
Identities = 145/345 (42%), Positives = 204/345 (59%), Gaps = 33/345 (9%)
Query: 32 IDCGIPENENYADKVTGINYVSDAPYVDTAVSHSISPEYSKETVERQFSYLRSFPEGIRN 91
IDCG+P NE+Y D TGI +VSDA ++DT S +IS E S + + + LRSFP+G RN
Sbjct: 1 IDCGLPSNESYTDPSTGITWVSDAGFIDTGKSGNISKENSSSFLSKPYKTLRSFPDGKRN 60
Query: 92 CYTLRP-PNGDVKFLIRARFMYGNYDGLDK---APSFDLMLGADAWDSVQLQ-DPRSIIT 146
CYTL P K+LIRA F+YGNYDGL+ PSFDL LG + W +V L D +
Sbjct: 61 CYTLPVTPGKGTKYLIRATFLYGNYDGLNSVSSPPSFDLYLGVNLWTTVNLSNDSGDSVV 120
Query: 147 KE-IIHMPNKDYIHVCLVNTDSGIPFISALELRPLTNSIYPPTASDLYRPTPTGSMSLVL 205
KE IIH+ D + VCLVNT +G PFISALELRPL +S+YP + + ++ LV
Sbjct: 121 KEYIIHVTKSDTLSVCLVNTGTGTPFISALELRPLPDSLYPSS-------GGSQALKLVA 173
Query: 206 RWDVGT-------PLDIYDRIWWPD-NFKNVERISTSSNVNPATS--LFQPPVTVMQSAI 255
R + G P D+YDRIW P + +ISTS +V+ +++ + PP V+Q+A+
Sbjct: 174 RLNFGGSEGTIRYPDDVYDRIWEPFFSSPGWSQISTSLSVDISSNNAPYIPPSAVLQTAV 233
Query: 256 IPANGSSSFWFSWESVSTVFKYYTCMYFSEFESEQAETRSREMNIYLNGRFWSEIPPPQY 315
P N S+ F+W+ V F+YY ++F+E +S + +RE +IY+NG+ P+Y
Sbjct: 234 TPTNASAPLNFTWDLVDPNFEYYVYLHFAEIQSLE----TREFDIYINGKTVYGDVSPKY 289
Query: 316 LNTTT---HRLTATNA---QQYVISIMQTKNSSLAPILNALEIYQ 354
L T T + N IS++ T S+L P+LNALEI++
Sbjct: 290 LGTDTGALYLDFPVNVSGGGLLNISLVPTSGSTLPPLLNALEIFK 334
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 2e-48
Identities = 66/201 (32%), Positives = 99/201 (49%), Gaps = 13/201 (6%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGY-KQFQAEVELLIRAHHKNLTIL 621
LG+G FG VY K VA+K++ ++ ++ E+++L + H N+ L
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH-NGCKP 680
++ + L+ E+ G+L L + + R + LEYLH G
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF--YLRQILSALEYLHSKG--- 117
Query: 681 PIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRL 740
IVHRD+K NILL+E KLADFGL+R TT VGTP Y+ PE +
Sbjct: 118 -IVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLLGKGY 173
Query: 741 TEKSDVYSFGVVLLELITGQP 761
+ D++S GV+L EL+TG+P
Sbjct: 174 GKAVDIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 2e-47
Identities = 77/278 (27%), Positives = 121/278 (43%), Gaps = 35/278 (12%)
Query: 565 FERVLGKGGFGTVYHGYLDDK------QVAVKML-SSSSVQGYKQFQAEVELLIRAHHKN 617
+ LG+G FG VY G L K +VAVK L +S Q ++F E ++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNG 677
+ L+G C E + ++ E+M G+L L L L A + A+G+EYL +
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLL-SYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 678 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPG---YLDPEY 734
+HRD+ + N L+ E K++DFGLSR + G ++ PE
Sbjct: 122 ---NFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPES 174
Query: 735 YISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHR 792
+ T KSDV+SFGV+L E+ T QP + + L +++ + N
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL--EYLKNGYRLPQPPNCPPEL 232
Query: 793 LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIEL 830
++ L C RPT +++V L
Sbjct: 233 -------------YDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 3e-47
Identities = 81/281 (28%), Positives = 129/281 (45%), Gaps = 40/281 (14%)
Query: 565 FERVLGKGGFGTVYHGYLDDK------QVAVKMLSSSSVQGYKQ-FQAEVELLIRAHHKN 617
+ LG+G FG VY G L +VAVK L + + ++ F E ++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNG 677
+ L+G C +G + ++ E+M G+L L + L + LQ+A + A+G+EYL +
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLL-DFLRKHGEKLTLKDLLQMALQIAKGMEYLESK 121
Query: 678 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLD-----P 732
VHRD+ + N L+ E K++DFGLSR G L P
Sbjct: 122 ---NFVHRDLAARNCLVTENLVVKISDFGLSRD-----IYEDDYYRKRGGGKLPIKWMAP 173
Query: 733 EYYISNRLTEKSDVYSFGVVLLELITG--QPVIQKTPQRTLIGQWVSSMLARGDIKNIVD 790
E + T KSDV+SFGV+L E+ T QP + + V +L G
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE------VLELLEDG------- 220
Query: 791 HRL-QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIEL 830
+RL + + + ++ E+ L C RPT +++V +L
Sbjct: 221 YRLPRPENCPDELY---ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 3e-47
Identities = 85/280 (30%), Positives = 135/280 (48%), Gaps = 35/280 (12%)
Query: 567 RVLGKGGFGTVYHGYLDDK-----QVAVKML-SSSSVQGYKQFQAEVELLIRAHHKNLTI 620
+ LG+G FG VY G L K +VAVK L +S + K F E ++ + H N+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 621 LVGYCDEGANMGLIYEFMANGNLQAHLLE-------DKADTLCWERRLQIASESAQGLEY 673
L+G C E + L+ E+M G+L +L + + TL + L A + A+G+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 674 LHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEGGTHVSTTVVGTPGYLDP 732
L VHRD+ + N L+ E K++DFGLSR ++ + + + ++ P
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 733 EYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDH 791
E T KSDV+SFGV+L E+ T G TP L + V L +G +
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGA-----TPYPGLSNEEVLEYLRKG-------Y 224
Query: 792 RL-QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIEL 830
RL + ++ + ++ E+ L+C RPT +++V L
Sbjct: 225 RLPKPEYCPDELY---ELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 77/278 (27%), Positives = 124/278 (44%), Gaps = 34/278 (12%)
Query: 565 FERVLGKGGFGTVYHGYLDDK------QVAVKML-SSSSVQGYKQFQAEVELLIRAHHKN 617
+ LG+G FG VY G L K +VAVK L +S Q ++F E ++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNG 677
+ L+G C E + ++ E+M G+L +L +++ L L A + A+G+EYL +
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122
Query: 678 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPG---YLDPEY 734
+HRD+ + N L+ E K++DFGLSR + V G ++ PE
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPES 175
Query: 735 YISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHR 792
+ T KSDV+SFGV+L E+ T +P + L +++ N
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVL--EYLKKGYRLPKPPNCPPEL 233
Query: 793 LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIEL 830
++ L C RPT +++V L
Sbjct: 234 -------------YKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 3e-46
Identities = 72/194 (37%), Positives = 111/194 (57%), Gaps = 13/194 (6%)
Query: 569 LGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQ-FQAEVELLIRAHHKNLTILVGYC 625
LG+GGFGTVY K+VA+K++ + E+E+L + +H N+ L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 626 DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH-NGCKPPIVH 684
++ ++ L+ E+ G+L+ LL++ L + L+I + +GLEYLH NG I+H
Sbjct: 61 EDENHLYLVMEYCEGGSLKD-LLKENEGKLSEDEILRILLQILEGLEYLHSNG----IIH 115
Query: 685 RDVKSANILLNEK-FQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNR-LTE 742
RD+K NILL+ + KLADFGLS++ + T+VGTP Y+ PE + +E
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 743 KSDVYSFGVVLLEL 756
KSD++S GV+L EL
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 4e-43
Identities = 75/203 (36%), Positives = 108/203 (53%), Gaps = 14/203 (6%)
Query: 565 FERVLGKGGFGTVYHGYLDD--KQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTI 620
R LG G FGTVY K VAVK+L S + + + E+ +L R H N+
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 621 LVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH-NGCK 679
L+ ++ ++ L+ E+ G+L +L L + +IA + +GLEYLH NG
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLHSNG-- 118
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNR 739
I+HRD+K NILL+E K+ADFGL++ + TT VGTP Y+ PE +
Sbjct: 119 --IIHRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMAPEVLLGGN 174
Query: 740 L-TEKSDVYSFGVVLLELITGQP 761
K DV+S GV+L EL+TG+P
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKP 197
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 6e-41
Identities = 68/211 (32%), Positives = 106/211 (50%), Gaps = 29/211 (13%)
Query: 567 RVLGKGGFGTVYHGYLDD--KQVAVK--MLSSSSVQGYKQFQAEVELLIRAHHKNLTILV 622
+LG+G FG+VY D + +AVK LS S + + + E+ +L H N+ V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI---V 62
Query: 623 GY----CDEGANMGLIY-EFMANGNLQAHLLEDKA---DTLCWERRL--QIASESAQGLE 672
Y DE N I+ E+++ G+L + LL+ + + R+ QI +GL
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKLPEPVI--RKYTRQIL----EGLA 115
Query: 673 YLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLD 731
YLH NG IVHRD+K ANIL++ KLADFG ++ + +V GTP ++
Sbjct: 116 YLHSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 732 PEYYISNRLTEKSDVYSFGVVLLELITGQPV 762
PE +D++S G ++E+ TG+P
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 8e-35
Identities = 73/215 (33%), Positives = 110/215 (51%), Gaps = 22/215 (10%)
Query: 567 RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVG- 623
+GKGGFG VY K+VA+K++ S + ++ E+++L + H N+ G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 624 -YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIA---SESAQGLEYLH-NGC 678
+ + + EF + G+L+ LL+ TL E QIA E +GLEYLH NG
Sbjct: 66 YLKKDELWIVM--EFCSGGSLKD-LLKSTNQTLT-ES--QIAYVCKELLKGLEYLHSNG- 118
Query: 679 KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISN 738
I+HRD+K+ANILL + KL DFGLS + T+VGTP ++ PE
Sbjct: 119 ---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPEVINGK 172
Query: 739 RLTEKSDVYSFGVVLLELITGQPVIQK-TPQRTLI 772
K+D++S G+ +EL G+P + P + L
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPYSELPPMKALF 207
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 8e-33
Identities = 133/559 (23%), Positives = 228/559 (40%), Gaps = 102/559 (18%)
Query: 9 FAFLCIVALTAVVHAQNQSG--FISIDCGIPENENYADKVTGINYVSDAPYVDTAVSHSI 66
L AL AV+ + + I CG N A T + D Y +++
Sbjct: 3 LWLLAASALLAVLASLASPEPFTMRISCGARVNVRTAP--TNTLWYKDFAYTGGIPANAT 60
Query: 67 SPEYSKETVERQFSYLRSFP--EGIRNCYTL-RPPNGDVKFLIRARFMYGNYDGLDKAPS 123
P + + LR FP +G NCY + R P G + +R F D P
Sbjct: 61 RPSF----IAPPLKTLRYFPLSDGPENCYNINRVPKG--HYSVRVFFGLVAEPNFDSEPL 114
Query: 124 FDLMLGADAWDSVQL---QDPRSIITKEIIHMPNKDYIHVCLVNTDSGIPFISALELRPL 180
FD+ + S++ + + ++ + + +C +T G P I ++E+ +
Sbjct: 115 FDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGS-ASICFHSTGHGDPAILSIEILQV 173
Query: 181 TNSIYPPTASDLYRPTPTGSMSLVLR-------------WDVGTPLDIY--DRIWWPD-N 224
+ Y P+ ++LR +D D + DR W
Sbjct: 174 DD--------KAYNFGPSWGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQT 225
Query: 225 FKNV--ERISTSSNVNPATSLFQP---PVTVMQSAIIPANGSSSFWFSWESVSTVFKYYT 279
F + + IST + + + P P ++ QSA++ + ++ V Y
Sbjct: 226 FGSGSDQAISTENVI--KKASNAPNFYPESLYQSALVSTDTQPDLSYTM-DVDPNRNYSV 282
Query: 280 CMYFSEFESEQAETRSREMNIYLNG----------RFWSEIPPPQYLNTTTHRLTATNAQ 329
++F+E ++ R ++ +NG + E LN T A + +
Sbjct: 283 WLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYTALVLNKTV----AVSGR 338
Query: 330 QYVISIMQTKNSSLAPILNALEIYQ----EKEFLQLLTNQQDVDAIMKIKSKYEV--KRD 383
I +Q K + A I+NA+E+++ E + T ++V A+ +KS + +
Sbjct: 339 TLTIV-LQPKKGTHA-IINAIEVFEIITAESK-----TLLEEVSALQTLKSSLGLPLRFG 391
Query: 384 WQGDPCAPKVYMWQGINCSYDANQSPRII-------------------------SINLSS 418
W GDPC P+ + W G +C +D+ + I SINLS
Sbjct: 392 WNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSG 451
Query: 419 SGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLS 478
+ I G+I P + S+TS+E LDLS NS G +PE L +L SLR+LNL+GN+L G +P+ L
Sbjct: 452 NSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
Query: 479 EKVKNGSLSLSVDGNRNLC 497
++ + + S + N LC
Sbjct: 512 GRLLHRA-SFNFTDNAGLC 529
|
Length = 623 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 27/220 (12%)
Query: 567 RVLGKGGFGTVY---HGYLDDKQVAVK--MLSSSSVQGYKQFQAEVELLIRAHHKNLTIL 621
+ +GKG FG VY D K +K LS+ S + + EV++L + +H N+
Sbjct: 6 KQIGKGSFGKVYLVRRKS-DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI--- 61
Query: 622 VGYCD---EGANMGLIYEFMANGNLQAHLLEDKAD------TLCWERRLQIASESAQGLE 672
+ Y + E + ++ E+ G+L + + K + + +Q+ L+
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL----ALK 117
Query: 673 YLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDP 732
YLH I+HRD+K NI L KL DFG+S++ ++ TVVGTP YL P
Sbjct: 118 YLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL--SSTVDLAKTVVGTPYYLSP 172
Query: 733 EYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLI 772
E + KSD++S G VL EL T + + L
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-31
Identities = 121/469 (25%), Positives = 204/469 (43%), Gaps = 74/469 (15%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
++ + LS + ++G+I + S + SLDLS N L+G +P +E+ L L+LS N
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ 558
Query: 469 LQGSLPSGL-----------SEKVKNGSL----------SLSVDGNRNLCPSAS------ 501
L G +P L S +GSL + +V GN +LC +
Sbjct: 559 LSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPP 618
Query: 502 CKK--KSNKFIFPVLASVVSFCILLALLAILQNLRRRKQAGKKK-----GSLELE----- 549
CK+ K+ + F + ++ +F +L + +R R K+ G+ EL+
Sbjct: 619 CKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSK 678
Query: 550 -NRKFSYFDVLKITNNFERVLGKGGFGTVYHG--YLDDKQVAVK------MLSSSSVQGY 600
++ + D+L E V+ +G G Y G + Q VK + SS +
Sbjct: 679 VSKSITINDILSSLKE-ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADM 737
Query: 601 KQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERR 660
+ Q H N+ L+G C LI+E++ NL L L WERR
Sbjct: 738 GKLQ----------HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-----NLSWERR 782
Query: 661 LQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720
+IA A+ L +LH C P +V ++ I+++ K + L L + + +S
Sbjct: 783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFIS 841
Query: 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ-PVIQKTPQRTLIGQWVSSM 779
+ Y+ PE + +TEKSD+Y FG++L+EL+TG+ P + I +W
Sbjct: 842 S------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYC 895
Query: 780 LARGDIKNIVDHRLQGD--FDTNTVWKAVEIALACIHTISTRRPTMNQV 826
+ + +D ++GD + N + + + +AL C T T RP N V
Sbjct: 896 YSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDV 944
|
Length = 968 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 568 VLGKGGFGTVYHGY--LDDKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVG 623
++G+G FG VY G VA+K +S + + K E++LL H N+ +G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI-ASESAQGLEYLHN-GCKPP 681
+ ++ +I E+ NG+L+ + K E + + + QGL YLH G
Sbjct: 67 SIETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLHEQG---- 119
Query: 682 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLT 741
++HRD+K+ANIL + KLADFG++ +VVGTP ++ PE + +
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGAS 177
Query: 742 EKSDVYSFGVVLLELITGQP 761
SD++S G ++EL+TG P
Sbjct: 178 TASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (302), Expect = 2e-29
Identities = 77/277 (27%), Positives = 127/277 (45%), Gaps = 19/277 (6%)
Query: 564 NFERVLGKGGFGTVYHGYLDDKQVAVKMLS---SSSVQGYKQFQAEVELLIR-AHHKNLT 619
R LG+G FG VY D K VA+K+L+ S + ++F E+++L H N+
Sbjct: 3 RILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHL-LEDKADTLCWERRLQIASESAQGLEYLHNGC 678
L + + ++ L+ E++ G+L+ L + L L I ++ LEYLH+
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121
Query: 679 KPPIVHRDVKSANILLNEK-FQAKLADFGLSRIFPVEGGT----HVSTTVVGTPGYLDPE 733
I+HRD+K NILL+ KL DFGL+++ P G T + +T VGTPGY+ PE
Sbjct: 122 ---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 734 YYISNRL---TEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVD 790
+ L + SD++S G+ L EL+TG P + + Q + +L +
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT--PSLA 236
Query: 791 HRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVV 827
L A ++ + R + + +
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 67/196 (34%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 566 ERVLGKGGFGTVYHG-YLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGY 624
ER LG G FG V+ G + + +VA+K+L S + + FQ EV+ L R HK+L L
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70
Query: 625 CDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVH 684
C G + +I E M G+L A L + L + +A + A+G+ YL + +H
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIH 127
Query: 685 RDVKSANILLNEKFQAKLADFGLSRIF--PVEGGTHVSTTVVGTPGYLDPEYYISNRLTE 742
RD+ + NIL+ E K+ADFGL+R+ V + T PE +
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTA----PEAASHGTFST 183
Query: 743 KSDVYSFGVVLLELIT 758
KSDV+SFG++L E+ T
Sbjct: 184 KSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 66/213 (30%), Positives = 112/213 (52%), Gaps = 18/213 (8%)
Query: 556 FDVLKITNNFERVLGKGGFGTVY---HGYLDDKQ---VAVKMLSSSSV-QGYKQFQAEVE 608
LK F + LG+G FG V + L D VAVK L+ S Q F+ E+E
Sbjct: 3 KRHLK----FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIE 58
Query: 609 LLIRAHHKNLTILVGYCDE--GANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASE 666
+L H+N+ G C++ G ++ LI E++ +G+L+ L+ D + +R L +S+
Sbjct: 59 ILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLR-DYLQRHRDQINLKRLLLFSSQ 117
Query: 667 SAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGT 726
+G++YL + +HRD+ + NIL+ + K++DFGL+++ P + + +
Sbjct: 118 ICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 727 PG-YLDPEYYISNRLTEKSDVYSFGVVLLELIT 758
P + PE +++ + SDV+SFGV L EL T
Sbjct: 175 PIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 563 NNFERV--LGKGGFGTVYHGY--LDDKQVAVK---MLSSSSVQGYKQFQAEVELLIRAHH 615
++ ERV LG+G G VY K A+K + + KQ E++ L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR--KQLLRELKTLRSCES 58
Query: 616 KNLTILVG-YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCW-ERRL-QIASESAQGLE 672
+ G + EG + ++ E+M G+L A LL E L IA + +GL+
Sbjct: 59 PYVVKCYGAFYKEGE-ISIVLEYMDGGSL-ADLL---KKVGKIPEPVLAYIARQILKGLD 113
Query: 673 YLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDP 732
YLH I+HRD+K +N+L+N K + K+ADFG+S++ +E T VGT Y+ P
Sbjct: 114 YLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCNTFVGTVTYMSP 169
Query: 733 EYYISNRLTEKSDVYSFGVVLLELITGQ 760
E + +D++S G+ LLE G+
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 32/207 (15%)
Query: 566 ERVLGKGGFGTVYHG-YLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGY 624
ER LG G FG V+ G + +VAVK L ++ + F E +++ + H L L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP-EAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 625 CDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVH 684
C E + ++ E+M+ G+L L + L + + +A++ A+G+ YL +H
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIH 126
Query: 685 RDVKSANILLNEKFQAKLADFGLSRI-------------FPVEGGTHVSTTVVGTPGYLD 731
RD+ + NIL+ E K+ADFGL+R+ FP++ +
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK--------------WTA 172
Query: 732 PEYYISNRLTEKSDVYSFGVVLLELIT 758
PE R T KSDV+SFG++L E++T
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 31/199 (15%)
Query: 569 LGKGGFGTVYHGYLDDKQVAVKMLS--SSSVQGYKQFQAEVELLIRAHHKNLTILVGYCD 626
+GKG FG V G ++VAVK L S++ Q F AE ++ H NL L+G
Sbjct: 14 IGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQ---AFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 627 EGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRD 686
+G + ++ E+MA G+L +L + ++L A + +G+EYL + VHRD
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRD 127
Query: 687 VKSANILLNEKFQAKLADFGLSRI---------FPVEGGTHVSTTVVGTPGYLDPEYYIS 737
+ + N+L++E AK++DFGL++ PV+ + PE
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------------WTAPEALRE 173
Query: 738 NRLTEKSDVYSFGVVLLEL 756
+ + KSDV+SFG++L E+
Sbjct: 174 KKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 78/248 (31%), Positives = 115/248 (46%), Gaps = 51/248 (20%)
Query: 565 FERVLGKGGFGTVYHGYL------DDK-QVAVKMLSSSSV-QGYKQFQAEVELLIRAHHK 616
+R LG+G FG V+ G +DK VAVK L ++ K F+ E ELL H+
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 617 NLTILVGYCDEGANMGLIYEFMANGN----LQAH------LLEDKADT--LCWERRLQIA 664
N+ G C EG +++E+M +G+ L++H L + L + LQIA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 665 SESAQGLEYL---HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR------IFPVEG 715
+ A G+ YL H VHRD+ + N L+ K+ DFG+SR + V G
Sbjct: 129 VQIASGMVYLASQH------FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGG 182
Query: 716 GTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQP--------VIQK 765
T + ++ PE + + T +SDV+SFGVVL E+ T QP VI+
Sbjct: 183 HTMLPIR------WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236
Query: 766 TPQRTLIG 773
Q L+
Sbjct: 237 ITQGRLLQ 244
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 73/274 (26%), Positives = 120/274 (43%), Gaps = 29/274 (10%)
Query: 565 FERVLGKGGFGTVYHGYLDDK-QVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVG 623
R LG G FG V+ G ++ VAVK L ++ K F AE +++ + H L L
Sbjct: 10 LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYA 68
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL--HNGCKPP 681
C + ++ E M G+L +L L + + +A++ A G+ YL N
Sbjct: 69 VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN----- 123
Query: 682 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP---GYLDPEYYISN 738
+HRD+ + N+L+ E K+ADFGL+R+ + G + PE + N
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVI----KEDIYEAREGAKFPIKWTAPEAALYN 179
Query: 739 RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798
R + KSDV+SFG++L E++T + P + V + +G +R+
Sbjct: 180 RFSIKSDVWSFGILLTEIVT----YGRMPYPGMTNAEVLQQVDQG-------YRMPC--P 226
Query: 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832
+ +I L C RPT + +L D
Sbjct: 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 67/210 (31%), Positives = 99/210 (47%), Gaps = 36/210 (17%)
Query: 569 LGKGGFGTVY---HGYLDDKQV-AVKMLSSSSVQGYKQFQ---AEVELLIRAHHKNLTIL 621
LGKG FG V D ++ A+K+L + K+ + E +L R +H + L
Sbjct: 1 LGKGSFGKVLLVRK--KDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 622 VGYC---DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQ------IASESAQGLE 672
+ E + L+ E+ G L +HL + E R A+E LE
Sbjct: 59 --HYAFQTEE-KLYLVLEYAPGGELFSHLSK--------EGRFSEERARFYAAEIVLALE 107
Query: 673 YLHN-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLD 731
YLH+ G I++RD+K NILL+ KL DFGL++ EG + T GTP YL
Sbjct: 108 YLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFCGTPEYLA 161
Query: 732 PEYYISNRLTEKSDVYSFGVVLLELITGQP 761
PE + + D +S GV+L E++TG+P
Sbjct: 162 PEVLLGKGYGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 65/193 (33%), Positives = 98/193 (50%), Gaps = 9/193 (4%)
Query: 569 LGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCD 626
LG G +G VY G VAVK L +++ ++F E ++ H NL L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 627 EGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRD 686
+I EFM GNL +L E + L +A++ + +EYL K +HRD
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 129
Query: 687 VKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYYISNRLTEKSD 745
+ + N L+ E K+ADFGLSR+ + G T+ + P + PE N+ + KSD
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 187
Query: 746 VYSFGVVLLELIT 758
V++FGV+L E+ T
Sbjct: 188 VWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 67/217 (30%), Positives = 105/217 (48%), Gaps = 30/217 (13%)
Query: 557 DVLKITNNFERVLGKGGFGTVYHGY--LDDKQVAVKM--LSSSSVQGYKQFQAEVELLIR 612
D ++ N E+ +G+G G VY K+VA+K L + + E+ ++
Sbjct: 16 DPRELYKNLEK-IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN---EILIMKD 71
Query: 613 AHHKNLTILVGYCD---EGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIAS---E 666
H N+ V Y D G + ++ E+M G+L ++ + E QIA E
Sbjct: 72 CKHPNI---VDYYDSYLVGDELWVVMEYMDGGSL-TDIITQNFVRMN-EP--QIAYVCRE 124
Query: 667 SAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS--TTVV 724
QGLEYLH+ ++HRD+KS NILL++ KLADFG F + S +VV
Sbjct: 125 VLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKEKSKRNSVV 177
Query: 725 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
GTP ++ PE K D++S G++ +E+ G+P
Sbjct: 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 45/229 (19%)
Query: 565 FERVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQGY-KQFQAEVE---LLIRAHHKNL 618
F +++G+G F TV +K+ A+K+L + K ++E L H +
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 619 TILVGYC---DEGANMGLIYEFMANGNLQAHLLE----DKADTLCWERRLQIASESAQGL 671
L Y DE N+ + E+ NG L ++ + D+ T A+E L
Sbjct: 65 IKL--YYTFQDE-ENLYFVLEYAPNGELLQYIRKYGSLDEKCTR------FYAAEILLAL 115
Query: 672 EYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF------------------P 712
EYLH G I+HRD+K NILL++ K+ DFG +++
Sbjct: 116 EYLHSKG----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 713 VEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
+E + VGT Y+ PE + SD+++ G ++ +++TG+P
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 29/216 (13%)
Query: 565 FERVLGKGGFGTVYHGYLDDKQ-------VAVKML-SSSSVQGYKQFQAEVELLIRAHHK 616
F LG+G FG VY G L VA+K L ++ + ++F+ E EL+ H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 617 NLTILVGYCDEGANMGLIYEFMANGNLQAHLL--------------EDKADTLCWERRLQ 662
N+ L+G C + +++E++A+G+L L+ E +L L
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 663 IASESAQGLEYL--HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720
IA + A G+EYL H+ VHRD+ + N L+ E K++DFGLSR V
Sbjct: 129 IAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEL 756
+ + ++ PE + + T +SD++SFGVVL E+
Sbjct: 184 SKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 70/207 (33%), Positives = 109/207 (52%), Gaps = 21/207 (10%)
Query: 565 FERVLGKGGFGTVYHGYLDDKQ------VAVKMLSSSSVQGYKQFQAEVELLIRAHHKNL 618
F + LGKG FG+V D Q VAVK L S+ + + F+ E+E+L H N+
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 619 TILVGYCDEGA--NMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN 676
G C N+ L+ E++ G+L+ +L + + + L + L AS+ +G+EYL
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYL-- 124
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPG-----YLD 731
G K VHRD+ + NIL+ + + K+ DFGL+++ P + + V PG +
Sbjct: 125 GSKR-YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYY----KVREPGESPIFWYA 179
Query: 732 PEYYISNRLTEKSDVYSFGVVLLELIT 758
PE ++ + SDV+SFGVVL EL T
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 83/277 (29%), Positives = 138/277 (49%), Gaps = 40/277 (14%)
Query: 567 RVLGKGGFGTVYHGYLDDK-----QVAVKMLSS-SSVQGYKQFQAEVELLIRAHHKNLTI 620
RV+GKG FG VYHG L D AVK L+ + ++ +QF E ++ H N+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 621 LVGYC--DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGC 678
L+G C EG+ + ++ +M +G+L+ + + + + + + A+G+EYL +
Sbjct: 61 LLGICLPSEGSPL-VVLPYMKHGDLR-NFIRSETHNPTVKDLIGFGLQVAKGMEYLAS-- 116
Query: 679 KPPIVHRDVKSANILLNEKFQAKLADFGLSR------IFPVEGGTHVSTTVVGTPGYLDP 732
VHRD+ + N +L+E F K+ADFGL+R + V T V ++
Sbjct: 117 -KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV----KWMAL 171
Query: 733 EYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDH 791
E + + T KSDV+SFGV+L EL+T G P P + ++ L +G
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVDSFDITVYLLQG-------R 219
Query: 792 RL-QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVV 827
RL Q ++ + ++ E+ L+C H RPT +++V
Sbjct: 220 RLLQPEYCPDPLY---EVMLSCWHPKPEMRPTFSELV 253
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 28/271 (10%)
Query: 568 VLGKGGFGTVYHGYLDDKQ-VAVKM--LSSSSV----QGYKQFQAEVELLIRAHHKNLTI 620
VLGKG +GTVY G + Q +AVK L +S+V + Y++ Q EV+LL H N+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 621 LVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKP 680
+G C + + + EF+ G++ + L ++ L + + G+ YLHN C
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVAYLHNNC-- 122
Query: 681 PIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG--GTH--VSTTVVGTPGYLDPEYYI 736
+VHRD+K N++L KL DFG +R G GTH + ++ GTP ++ PE
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 737 SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796
+ KSD++S G + E+ TG+P + + +++M G + ++ RL
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-------LAAMFYIGAHRGLMP-RLPDS 233
Query: 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVV 827
F A++ +C+ RP+ Q++
Sbjct: 234 FSAA----AIDFVTSCLTRDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 70/223 (31%), Positives = 99/223 (44%), Gaps = 33/223 (14%)
Query: 565 FERVLGKGGFGTVYHG-------YLDDKQVAVKMLSS-SSVQGYKQFQAEVELLIRAHHK 616
+ R +G+G FG V+ Y VAVKML +S FQ E L+ H
Sbjct: 9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 617 NLTILVGYCDEGANMGLIYEFMANGNLQAHL---------------------LEDKADTL 655
N+ L+G C G M L++E+MA G+L L +
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 656 CWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715
C E +L IA + A G+ YL + VHRD+ + N L+ E K+ADFGLSR
Sbjct: 129 CTE-QLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184
Query: 716 GTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 758
S ++ PE NR T +SDV+++GVVL E+ +
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 81/272 (29%), Positives = 125/272 (45%), Gaps = 31/272 (11%)
Query: 566 ERVLGKGGFGTVYHGYL-----DDKQVAVKML-SSSSVQGYKQFQAEVELLIRAHHKNLT 619
E+V+G G FG V G L + VA+K L + SS + F E ++ + H N+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCK 679
L G + + +I E+M NG+L L E+ + + + A G++YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG-TP-GYLDPEYYIS 737
VHRD+ + NIL+N K++DFGLSR T+ TT G P + PE
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY--TTKGGKIPIRWTAPEAIAY 182
Query: 738 NRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVD-HRLQG 795
+ T SDV+SFG+V+ E+++ G+ P + Q V IK + D +RL
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGE-----RPYWDMSNQDV--------IKAVEDGYRLPP 229
Query: 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVV 827
D + ++ L C RPT +Q+V
Sbjct: 230 PMDCPSA--LYQLMLDCWQKDRNERPTFSQIV 259
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 22/203 (10%)
Query: 567 RVLGKGGFGTVYHGYLDDK-QVAVKMLSSSSVQGYKQ-FQAEVELLIRAHHKNLTILVGY 624
+GKG FG VY G L +VAVK S+ K+ F E E+L + H N+ L+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 625 CDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVH 684
C + + ++ E + G+L L K + L ++ LQ++ ++A G+EYL + +H
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 685 RDVKSANILLNEKFQAKLADFGLSR-----IFPVEGGTH---VSTTVVGTPGYLDPEYYI 736
RD+ + N L+ E K++DFG+SR I+ V G + T PE
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTA--------PEALN 168
Query: 737 SNRLTEKSDVYSFGVVLLELITG 759
R T +SDV+S+G++L E +
Sbjct: 169 YGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 69/218 (31%), Positives = 105/218 (48%), Gaps = 25/218 (11%)
Query: 569 LGKGGFGTVY----HGYLDDKQ---VAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTIL 621
LG+G FG V+ H L ++ VAVK L +S + FQ E ELL H+++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 622 VGYCDEGANMGLIYEFMANGNLQ---------AHLLEDKADTLCWE----RRLQIASESA 668
G C EG + +++E+M +G+L A +L D + + L IAS+ A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 669 QGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPG 728
G+ YL VHRD+ + N L+ + K+ DFG+SR V +
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 729 YLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQ 764
++ PE + + T +SD++SFGVVL E+ T QP Q
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 18/219 (8%)
Query: 568 VLGKGGFGTVY--HGYLDDKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVG 623
+GKG FGTV D K + K + ++ + +Q +EV +L H N+ V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI---VR 63
Query: 624 YCDEGANMG-----LIYEFMANGNLQAHLLEDKADTLCWERR--LQIASESAQGLEYLHN 676
Y D + ++ E+ G+L + + K + E +I ++ L HN
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 677 GCKPP--IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEY 734
P ++HRD+K ANI L+ KL DFGL++I + + + T VGTP Y+ PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI--LGHDSSFAKTYVGTPYYMSPEQ 181
Query: 735 YISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIG 773
EKSD++S G ++ EL P Q L
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLAS 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 64/197 (32%), Positives = 104/197 (52%), Gaps = 9/197 (4%)
Query: 565 FERVLGKGGFGTVYHGYLDDK-QVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVG 623
F + LG G FG V+ G K VA+KM+ ++ F E +++++ H NL L G
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIV 683
C + + ++ E+MANG L +L E K L E L + S+ + +EYL + +
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNG---FI 122
Query: 684 HRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYYISNRLTE 742
HRD+ + N L+ E K++DFGL+R V + S+ P + PE + +R +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 743 KSDVYSFGVVLLELITG 759
KSDV+SFGV++ E+ +
Sbjct: 181 KSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 564 NFE--RVLGKGGFGTVYH-GYLDDKQV-------AVKMLSSSSVQGYKQFQAEVELLIRA 613
+FE RV+GKG FG V D K++ K + SV+ E +L
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLN---ERRILQEL 57
Query: 614 HHKNLTIL-VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI-ASESAQGL 671
+H L L + DE NM L+ + + G+L+ HL + + E +++ E L
Sbjct: 58 NHPFLVNLWYSFQDE-ENMYLVVDLLLGGDLRYHLSQKVKFS---EEQVKFWICEIVLAL 113
Query: 672 EYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLD 731
EYLH+ I+HRD+K NILL+E+ + DF ++ ++T+ GTPGY+
Sbjct: 114 EYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVT---PDTLTTSTSGTPGYMA 167
Query: 732 PEYYISNRLTEKSDVYSFGVVLLELITG 759
PE + D +S GV E + G
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRG 195
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 32/211 (15%)
Query: 567 RVLGKGGFGTVYHGY-LDD------KQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLT 619
+LG G FG+VY G LDD K+V++ + + KQ + E+ LL + H N+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQ---GLEYLHN 676
+G E N+ + E + G+L L K + I + Q GLEYLH+
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSL--AKLLKKYGSF---PEPVIRLYTRQILLGLEYLHD 120
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST-----TVVGTPGYLD 731
VHRD+K ANIL++ KLADFG+++ V + G+P ++
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYWMA 169
Query: 732 PEYYIS-NRLTEKSDVYSFGVVLLELITGQP 761
PE +D++S G +LE+ TG+P
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKP 200
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 31/209 (14%)
Query: 566 ERVLGKGGFGTVYHGYLDDKQ--VAVKM--LSSSSVQGYKQFQAEVELLIRAHHKNLTIL 621
+GKG FG VY VA+K+ L + + + Q E++ L + +T
Sbjct: 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYITKY 64
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLE---DKADTLCWERRLQIASESAQGLEYLHNGC 678
G +G+ + +I E+ G+ LL+ + + I E GLEYLH
Sbjct: 65 YGSFLKGSKLWIIMEYCGGGSC-LDLLKPGKLDETYIAF-----ILREVLLGLEYLHEEG 118
Query: 679 KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV------VGTPGYLDP 732
K +HRD+K+ANILL+E+ KLADFG+S +++T+ VGTP ++ P
Sbjct: 119 K---IHRDIKAANILLSEEGDVKLADFGVS--------GQLTSTMSKRNTFVGTPFWMAP 167
Query: 733 EYYISNRLTEKSDVYSFGVVLLELITGQP 761
E + EK+D++S G+ +EL G+P
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 57/192 (29%), Positives = 105/192 (54%), Gaps = 9/192 (4%)
Query: 569 LGKGGFGTVYHGY-LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDE 627
+G G FG V+ GY L+ ++VA+K + ++ + F E +++++ H L L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 628 GANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDV 687
+ + L++EFM +G L +L + E L + + +G+ YL + ++HRD+
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126
Query: 688 KSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYYISNRLTEKSDV 746
+ N L+ E K++DFG++R V + S+T P + PE + ++ + KSDV
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRF--VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 747 YSFGVVLLELIT 758
+SFGV++ E+ +
Sbjct: 185 WSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 27/211 (12%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQ---FQA--EVELLIRAHHKN 617
+ LG+G + VY + VA+K + + K F A E++LL H N
Sbjct: 4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPN 63
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDK------ADTLCWERRLQIASESAQGL 671
+ L+ +N+ L++EFM +L+ +++DK AD + L +GL
Sbjct: 64 IIGLLDVFGHKSNINLVFEFME-TDLEK-VIKDKSIVLTPADIKSY--MLMTL----RGL 115
Query: 672 EYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLD 731
EYLH+ I+HRD+K N+L+ KLADFGL+R F ++ VV T Y
Sbjct: 116 EYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRKMTHQVV-TRWYRA 170
Query: 732 PE-YYISNRLTEKSDVYSFGVVLLELITGQP 761
PE + + D++S G + EL+ P
Sbjct: 171 PELLFGARHYGVGVDMWSVGCIFAELLLRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 59/199 (29%), Positives = 107/199 (53%), Gaps = 16/199 (8%)
Query: 568 VLGKGGFGTVYHG-YLDDKQ-VAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYC 625
LG+G +G+VY + + Q VA+K++ ++ E+ +L + + G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 626 DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIAS---ESAQGLEYLHNGCKPPI 682
+ ++ ++ E+ G++ + +++ TL E +IA+ ++ +GLEYLH+
Sbjct: 68 FKNTDLWIVMEYCGAGSV-SDIMKITNKTLTEE---EIAAILYQTLKGLEYLHSN---KK 120
Query: 683 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTE 742
+HRD+K+ NILLNE+ QAKLADFG+S + TV+GTP ++ PE
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQ--LTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178
Query: 743 KSDVYSFGVVLLELITGQP 761
K+D++S G+ +E+ G+P
Sbjct: 179 KADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 63/196 (32%), Positives = 94/196 (47%), Gaps = 9/196 (4%)
Query: 567 RVLGKGGFG--TVYHGYLDDKQVAVKM--LSSSSVQGYKQFQAEVELLIRAHHKNLTILV 622
RVLGKG FG T+Y DD V K L+ S + + E+ +L H N+
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 623 GYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPI 682
+ + + + E+ G L ++ K E L + + Y+H K I
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGI 122
Query: 683 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTE 742
+HRD+K+ NI L + KL DFG+S+I E ++ TVVGTP Y+ PE +
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSE--YSMAETVVGTPYYMSPELCQGVKYNF 180
Query: 743 KSDVYSFGVVLLELIT 758
KSD+++ G VL EL+T
Sbjct: 181 KSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 55/220 (25%)
Query: 569 LGKGGFGTVYHG--YLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKN--------- 617
+G G +G VY + VA+K++ ++ Q E+ +L H N
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 618 ----LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIA---SESAQG 670
L I++ YC G ++ IY+ + L E QIA E+ +G
Sbjct: 71 RRDKLWIVMEYC-GGGSLQDIYQV-----TRGPLSEL-----------QIAYVCRETLKG 113
Query: 671 LEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV------V 724
L YLH K +HRD+K ANILL E KLADFG+S ++ T+ +
Sbjct: 114 LAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVS--------AQLTATIAKRKSFI 162
Query: 725 GTPGYLDPEYYISNRL---TEKSDVYSFGVVLLELITGQP 761
GTP ++ PE R K D+++ G+ +EL QP
Sbjct: 163 GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 78/281 (27%), Positives = 120/281 (42%), Gaps = 42/281 (14%)
Query: 569 LGKGGFGTVYHGYLDDK-----QVAVKMLS-SSSVQGYKQFQAEVELLIRAHHKNLTILV 622
LG G FG+V G K +VAVK L G K+F E ++ + H + L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 623 GYCDEGANMGLIYEFMANGNLQAHLLEDK----ADTLCWERRLQIASESAQGLEYLHNGC 678
G C +G + L+ E G L +L + + +D A + A G+ YL
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLE-SK 114
Query: 679 KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPE--YY 735
VHRD+ + N+LL + QAK++DFG+SR + +TT P + PE Y
Sbjct: 115 H--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 736 ISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL- 793
+ + KSDV+S+GV L E + G P + G V +ML G RL
Sbjct: 173 --GKFSSKSDVWSYGVTLWEAFSYGAK-----PYGEMKGAEVIAMLESG-------ERLP 218
Query: 794 QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834
+ + ++ I L+C RPT +++
Sbjct: 219 RPEECPQEIY---SIMLSCWKYRPEDRPTFSELESTFRRDP 256
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 6e-22
Identities = 68/226 (30%), Positives = 102/226 (45%), Gaps = 26/226 (11%)
Query: 565 FERVLGKGGFGTVYHGYL-------DDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKN 617
+R LG+G FG V+ D VAVK L ++ K FQ E ELL H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADT--------------LCWERRLQI 663
+ G C +G + +++E+M +G+L L D L + L I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 664 ASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV 723
AS+ A G+ YL VHRD+ + N L+ K+ DFG+SR V
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 724 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTP 767
+ ++ PE + + T +SDV+SFGV+L E+ T QP Q +
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 9e-22
Identities = 69/221 (31%), Positives = 112/221 (50%), Gaps = 16/221 (7%)
Query: 567 RVLGKGGFGTVYHGYLDDK-QVAVKMLS--SSSVQGYKQFQAEVELLIRAHHKNLTILVG 623
+ LG G FG V+ GY ++ +VAVK L + SVQ F E L+ H L L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYA 68
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIV 683
+ + +I E+MA G+L L D+ + + + +++ A+G+ Y+ + +
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYI 125
Query: 684 HRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYYISNRLTE 742
HRD+++AN+L++E K+ADFGL+R+ +E + + P + PE T
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAINFGSFTI 183
Query: 743 KSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG 783
KSDV+SFG++L E++T K P + V S L RG
Sbjct: 184 KSDVWSFGILLYEIVT----YGKIPYPGMSNSDVMSALQRG 220
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 15/211 (7%)
Query: 569 LGKGGFGTVYHGYL-DDKQV-AVKMLSSSSVQGYKQFQA--EVELLIRAHHKNLTILVGY 624
+GKG FG V+ DK+V A+K + S + ++ +A E +L + + + Y
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI---IRY 64
Query: 625 CD---EGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPP 681
+ + + ++ E+ NG+L L + L ++ + + GL +LH
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKK 121
Query: 682 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLT 741
I+HRD+KS N+ L+ K+ D G++++ + T+ + T+VGTP YL PE
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELCEDKPYN 179
Query: 742 EKSDVYSFGVVLLELITGQPVIQKTPQRTLI 772
EKSDV++ GVVL E TG+ Q LI
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFDANNQGALI 210
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 74/286 (25%), Positives = 129/286 (45%), Gaps = 33/286 (11%)
Query: 559 LKITNNFE----RVLGKGGFGTVYHGY-LDDKQ-----VAVKML-SSSSVQGYKQFQAEV 607
L+I E +VLG G FGTVY G + + + VA+K+L +S + K+ E
Sbjct: 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEA 60
Query: 608 ELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASES 667
++ H ++ L+G C + + LI + M G L ++ K D + + L +
Sbjct: 61 YVMASVDHPHVVRLLGIC-LSSQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQI 118
Query: 668 AQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP 727
A+G+ YL + +VHRD+ + N+L+ K+ DFGL+++ V P
Sbjct: 119 AKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV-DEKEYHAEGGKVP 174
Query: 728 -GYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIK 786
++ E + T KSDV+S+GV + EL+T P + + +L +G+
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMT----FGAKPYEGIPAVEIPDLLEKGE-- 228
Query: 787 NIVDHRL-QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELN 831
RL Q T V+ + + C + RPT +++ E +
Sbjct: 229 -----RLPQPPICTIDVYM---VLVKCWMIDAESRPTFKELINEFS 266
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 15/212 (7%)
Query: 569 LGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQA--EVELLIRAHHKNLTILVGY 624
+G+G +G VY L + VA+K + A E++LL +H N+ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 625 CDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVH 684
++ L++EFM + +L L++D+ L + QGL + H I+H
Sbjct: 67 FRHKGDLYLVFEFM-DTDL-YKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILH 121
Query: 685 RDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRL-TEK 743
RD+K N+L+N + KLADFGL+R F + T V T Y PE + ++ +
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPY--THYVVTRWYRAPELLLGDKGYSTP 179
Query: 744 SDVYSFGVVLLELITGQPVIQKTPQRTLIGQW 775
D++S G + EL++ +P+ P ++ I Q
Sbjct: 180 VDIWSVGCIFAELLSRRPLF---PGKSEIDQL 208
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 69/220 (31%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 565 FERVLGKGGFGTVYHGYL-------DDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKN 617
+R LG+G FG V+ D VAVK L +S K F E ELL H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADT-----------LCWERRLQIASE 666
+ G C EG + +++E+M +G+L L D L + L IA +
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 667 SAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGT 726
A G+ YL VHRD+ + N L+ E K+ DFG+SR V +
Sbjct: 129 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 727 PGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQ 764
++ PE + + T +SDV+S GVVL E+ T QP Q
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 36/214 (16%)
Query: 569 LGKGGFGTVY---HGYLDDKQVAVKMLSSSSVQGYKQFQ---AEVELLIRAHHKNLTILV 622
+ KG +G V+ D A+K++ + + Q E ++L +A + +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDI-YAIKVIKKADMIRKNQVDQVLTERDILSQAQS-PYVVKL 58
Query: 623 GYCDEGA-NMGLIYEFMANGNLQAHLL-------EDKADTLCWERRLQIASESAQGLEYL 674
Y +G N+ L+ E++ G+L A LL ED A R+ IA E LEYL
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDL-ASLLENVGSLDEDVA-------RIYIA-EIVLALEYL 109
Query: 675 H-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLS------RIFPVEGGTHVSTTVVGTP 727
H NG I+HRD+K NIL++ KL DFGLS R + +VGTP
Sbjct: 110 HSNG----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP 165
Query: 728 GYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
Y+ PE + ++ D +S G +L E + G P
Sbjct: 166 DYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIP 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 7e-21
Identities = 80/291 (27%), Positives = 140/291 (48%), Gaps = 41/291 (14%)
Query: 565 FERVLGKGGFGTVYHGYLDDK----QVAVK-MLSSSSVQGYKQFQAEVELLIR-AHHKNL 618
F+ V+G+G FG V + A+K M +S ++ F E+E+L + HH N+
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 619 TILVGYCDEGANMGLIYEFMANGNL-----QAHLLE---------DKADTLCWERRLQIA 664
L+G C+ + L E+ +GNL ++ +LE A TL ++ L A
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 665 SESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVV 724
++ A+G++YL + +HRD+ + NIL+ E + AK+ADFGLSR V +V T+
Sbjct: 131 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV----YVKKTMG 183
Query: 725 GTP-GYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG 783
P ++ E + T SDV+S+GV+L E+++ + TP + + L +G
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS----LGGTPYCGMTCAELYEKLPQG 239
Query: 784 DIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834
+RL+ + + + ++ C RP+ Q+++ LN L
Sbjct: 240 -------YRLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILVSLNRML 281
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 8e-21
Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 567 RVLGKGGFGTVY--HGYLDDKQVAVKMLSSSSVQGYKQF--QAEVELLIRAHHKNLTILV 622
RV+G+G FG V+ D K V +K + + ++ Q E ++L H N+ +
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI---I 62
Query: 623 GYCD---EGANMGLIYEFMANGNLQAHLLEDKADTLCWERR-LQIASESAQGLEYLHNGC 678
Y + E + ++ E+ G L A ++ + ++L E L + L ++H
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTL-AEYIQKRCNSLLDEDTILHFFVQILLALHHVHT-- 119
Query: 679 KPPIVHRDVKSANILLNE-KFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYIS 737
I+HRD+K+ NILL++ K K+ DFG+S+I + TVVGTP Y+ PE
Sbjct: 120 -KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCYISPELCEG 175
Query: 738 NRLTEKSDVYSFGVVLLELIT 758
+KSD+++ G VL EL +
Sbjct: 176 KPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 8e-21
Identities = 72/220 (32%), Positives = 113/220 (51%), Gaps = 30/220 (13%)
Query: 565 FERVLGKGGFGTVYHGYLDDK----QVAVKMLSS-SSVQGYKQFQAEVELLIR-AHHKNL 618
FE V+G+G FG V + A+KML +S ++ F E+E+L + HH N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 619 TILVGYCDEGANMGLIYEFMANGNL-----QAHLLED---------KADTLCWERRLQIA 664
L+G C+ + + E+ GNL ++ +LE A TL ++ LQ A
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 665 SESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVV 724
S+ A G++YL +HRD+ + N+L+ E +K+ADFGLSR V +V T+
Sbjct: 126 SDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGEEV----YVKKTMG 178
Query: 725 GTP-GYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 761
P ++ E + T KSDV+SFGV+L E+++ G P
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 9e-21
Identities = 61/195 (31%), Positives = 104/195 (53%), Gaps = 9/195 (4%)
Query: 566 ERVLGKGGFGTVYHGYLDD-KQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGY 624
+ LG G FG V+ GY + +VA+K L S+ + F AE L+ + H L L
Sbjct: 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP-EAFLAEANLMKQLQHPRLVRLYAV 69
Query: 625 CDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVH 684
+ + +I E+M NG+L L + L + + +A++ A+G+ ++ + +H
Sbjct: 70 VTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIH 125
Query: 685 RDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYYISNRLTEK 743
RD+++ANIL++E K+ADFGL+R+ +E + + P + PE T K
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 744 SDVYSFGVVLLELIT 758
SDV+SFG++L E++T
Sbjct: 184 SDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 9e-21
Identities = 68/240 (28%), Positives = 112/240 (46%), Gaps = 35/240 (14%)
Query: 565 FERVLGKGGFGTVYHGYL-----DDKQ-VAVKMLSS-SSVQGYKQFQAEVELLIRAHHKN 617
F LG+ FG +Y G+L D Q VA+K L ++ Q + +FQ E L+ HH N
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLL--EDKADTLCWERR-------------LQ 662
+ L+G + + +++E++ G+L L+ +D C L
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 663 IASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722
IA + A G+EYL + VH+D+ + NIL+ E+ K++D GLSR V
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEL----------ITGQPVIQKTPQRTLI 772
+ ++ PE + + + SD++SFGVVL E+ + Q VI+ +R L+
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLL 245
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 9e-21
Identities = 65/198 (32%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 567 RVLGKGGFGTVYHGYL--DDKQVAVK-MLSSSSVQGYKQFQAEVELLIRAHHKNLTILVG 623
LG G G V K +AVK + + KQ E+++L + + + G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRL-QIASESAQGLEYLHNGCKPPI 682
++ + E+M G+L L + ER L +IA +GL YLH K I
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHEKHK--I 122
Query: 683 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTE 742
+HRDVK +NIL+N + Q KL DFG+S + ++ T VGT Y+ PE N +
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSG----QLVNSLAKTFVGTSSYMAPERIQGNDYSV 178
Query: 743 KSDVYSFGVVLLELITGQ 760
KSD++S G+ L+EL TG+
Sbjct: 179 KSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 567 RVLGKGGFGTVYHGYLDD-------KQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLT 619
++LG+G FG VY Y D KQV S + + + E++LL H+ +
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHLLEDKA--DTLCWERRLQIASESAQGLEYLHNG 677
G + + + E+M G+++ L A +T+ + QI +G+EYLH+
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLHSN 123
Query: 678 CKPPIVHRDVKSANILLNEKFQAKLADFGLS-RIFPVEGGTHVSTTVVGTPGYLDPEYYI 736
IVHRD+K ANIL + KL DFG S R+ + +V GTP ++ PE
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 737 SNRLTEKSDVYSFGVVLLELITGQP 761
K+DV+S G ++E++T +P
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 564 NFERVLGKGGFGTVYHGYLDDKQ--VAVKMLSSSSVQGYKQFQAEVELLIR-------AH 614
V+G G VY VA+K + + Q V+ L + +
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLE------KCQTSVDELRKEVQAMSQCN 57
Query: 615 HKNLTILVGYCD--EGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIAS---ESAQ 669
H N ++ Y G + L+ +++ G+L +++ + + IA+ E +
Sbjct: 58 HPN--VVKYYTSFVVGDELWLVMPYLSGGSL-LDIMKSSYPRGGLDEAI-IATVLKEVLK 113
Query: 670 GLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT---HVSTTVVG 725
GLEYLH NG +HRD+K+ NILL E K+ADFG+S +GG V T VG
Sbjct: 114 GLEYLHSNG----QIHRDIKAGNILLGEDGSVKIADFGVSASL-ADGGDRTRKVRKTFVG 168
Query: 726 TPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTP 767
TP ++ PE K+D++SFG+ +EL TG K P
Sbjct: 169 TPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 72/266 (27%), Positives = 130/266 (48%), Gaps = 24/266 (9%)
Query: 565 FERVLGKGGFGTVYHG-YLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVG 623
F + LG G FG V+ G + +VA+K ++ ++ + F E +++++ H L L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIV 683
C + + ++ EFM NG L + L + L + L + + +G+EYL + +
Sbjct: 67 VCTQQKPLYIVTEFMENGCL-LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFI 122
Query: 684 HRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYYISNRLTE 742
HRD+ + N L++ K++DFG++R V + S++ P + PE + ++ +
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 743 KSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL-QGDFDTNT 801
KSDV+SFGV++ E+ T K P V M++RG RL + + T
Sbjct: 181 KSDVWSFGVLMWEVFTE----GKMPFEKKSNYEVVEMISRG-------FRLYRPKLASMT 229
Query: 802 VWKAVEIALACIHTISTRRPTMNQVV 827
V+ E+ +C H RPT +++
Sbjct: 230 VY---EVMYSCWHEKPEGRPTFAELL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 82/298 (27%), Positives = 141/298 (47%), Gaps = 51/298 (17%)
Query: 569 LGKGGFGTVYH----GYLDDK-----QVAVKMLSS-SSVQGYKQFQAEVELL-IRAHHKN 617
LG+G FG V G +K +VAVKML S ++ + +E+E++ + HKN
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKA--------------DTLCWERRLQI 663
+ L+G C + + +I E+ + GNL+ +L + + L ++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 664 ASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV 723
A + A+G+EYL +HRD+ + N+L+ E K+ADFGL+R H+
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 197
Query: 724 VGTPG-----YLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSS 778
T G ++ PE T +SDV+SFGV+L E+ T + +P + + +
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----LGGSPYPGVPVEELFK 253
Query: 779 MLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836
+L G HR+ D +N + + C H + ++RPT Q+V +L+ LA+
Sbjct: 254 LLKEG-------HRM--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 61/191 (31%), Positives = 101/191 (52%), Gaps = 11/191 (5%)
Query: 568 VLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDE 627
++G+G FG V G ++VAVK + + F E ++ + HHKNL L+G
Sbjct: 13 IIGEGEFGAVLQGEYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 628 GANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDV 687
+ ++ E M+ GNL L + + LQ + + A+G+EYL + +VHRD+
Sbjct: 71 NG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDL 126
Query: 688 KSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVY 747
+ NIL++E AK++DFGL+R+ + G S V + PE + + KSDV+
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSM--GVDNSKLPV---KWTAPEALKHKKFSSKSDVW 181
Query: 748 SFGVVLLELIT 758
S+GV+L E+ +
Sbjct: 182 SYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 43/221 (19%)
Query: 556 FDVLKITNNFERVLGKGGFGTVY--HGYLDDKQVAVKM--LSSSSVQGYKQFQAEVELLI 611
++++K +G+G FG +Y D + +K L+ V+ + + EV LL
Sbjct: 2 YEIIKK-------IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLA 54
Query: 612 RAHHKN-------------LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWE 658
+ H N L I++ YCD G + M N Q +L + L W
Sbjct: 55 KMKHPNIVTFFASFQENGRLFIVMEYCDGG-------DLMKRINRQRGVLFSEDQILSW- 106
Query: 659 RRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQ-AKLADFGLSRIFPVEGGT 717
+QI+ GL+++H+ I+HRD+KS NI L++ AKL DFG++R +
Sbjct: 107 -FVQIS----LGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSM 156
Query: 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 758
++ T VGTP YL PE + K+D++S G VL EL T
Sbjct: 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 69/266 (25%), Positives = 129/266 (48%), Gaps = 24/266 (9%)
Query: 565 FERVLGKGGFGTVYHGYLDDK-QVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVG 623
F + LG G FG V +G + VA+KM+ S+ +F E +++++ H+ L L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIV 683
C + + ++ E+M+NG L +L E + L++ + +G+ YL + +
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLES---KQFI 122
Query: 684 HRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYYISNRLTE 742
HRD+ + N L++++ K++DFGLSR V + S+ P + PE + ++ +
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLLYSKFSS 180
Query: 743 KSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL-QGDFDTNT 801
KSDV++FGV++ E+ + + K P +++G RL + +
Sbjct: 181 KSDVWAFGVLMWEVYS----LGKMPYERFNNSETVEKVSQG-------LRLYRPHLASEK 229
Query: 802 VWKAVEIALACIHTISTRRPTMNQVV 827
V+ I +C H + RPT Q++
Sbjct: 230 VY---AIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 30/212 (14%)
Query: 565 FERV--LGKGGFGTVYHGY--LDDKQVAVKM---------LSSSSVQGYKQFQAEVELLI 611
+E++ LG+G +G VY + VA+K + S++++ E+ LL
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-------EISLLK 53
Query: 612 RAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQ-IASESAQG 670
H N+ L+ + L++E+ +L+ +L DK ++ I + +G
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL--DKRPGPLSPNLIKSIMYQLLRG 110
Query: 671 LEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYL 730
L Y H+ I+HRD+K NIL+N KLADFGL+R F + T+ T V T Y
Sbjct: 111 LAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTLWYR 165
Query: 731 DPEYYISNRLTEKS-DVYSFGVVLLELITGQP 761
PE + ++ + D++S G + E+ITG+P
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 564 NFERVLGKGGFGTVYHGYLDDKQ--VAVKMLSSSSVQGYKQFQ---AEVELLIRAHHKNL 618
F + LG G FG V A+K+LS + + KQ + E +L H L
Sbjct: 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 619 TILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI------ASESAQGLE 672
L G + +N+ L+ E++ G L +HL K+ R A++ LE
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHL--RKS------GRFPEPVARFYAAQVVLALE 115
Query: 673 YLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDP 732
YLH+ IV+RD+K N+LL+ K+ DFG ++ V+G T+ T+ GTP YL P
Sbjct: 116 YLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTY---TLCGTPEYLAP 167
Query: 733 EYYISNRLTEKS-DVYSFGVVLLELITGQP 761
E I ++ K+ D ++ G+++ E++ G P
Sbjct: 168 E-IILSKGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 3e-20
Identities = 62/192 (32%), Positives = 103/192 (53%), Gaps = 11/192 (5%)
Query: 568 VLGKGGFGTVYHGYLDDKQ-VAVKMLSSSSVQGYK-QFQAEVELLIRAHHKNLTILVGYC 625
+LGKG FG V+ G L DK VAVK Q K +F +E +L + H N+ L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 626 DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN-GCKPPIVH 684
+ + ++ E + G+ + L K D L ++ ++ A ++A G+ YL + C +H
Sbjct: 62 TQRQPIYIVMELVPGGDFLS-FLRKKKDELKTKQLVKFALDAAAGMAYLESKNC----IH 116
Query: 685 RDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYYISNRLTEK 743
RD+ + N L+ E K++DFG+SR + G + S+ + P + PE R + +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 744 SDVYSFGVVLLE 755
SDV+S+G++L E
Sbjct: 175 SDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 4e-20
Identities = 68/229 (29%), Positives = 111/229 (48%), Gaps = 31/229 (13%)
Query: 569 LGKGGFGTVYHGYLDDKQ--VAVKMLSSSSVQG-YKQFQAEVELLIRAHHKNLTILVGYC 625
+GKG FG V+ G + Q VA+K++ + + Q E+ +L + +T G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 626 DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIAS---ESAQGLEYLHNGCKPPI 682
+G + +I E++ G+ L D QIA+ E +GL+YLH+ K
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGPFD------EFQIATMLKEILKGLDYLHSEKK--- 122
Query: 683 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS-TTVVGTPGYLDPEYYISNRLT 741
+HRD+K+AN+LL+E+ KLADFG++ T + T VGTP ++ PE +
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLT---DTQIKRNTFVGTPFWMAPEVIQQSAYD 179
Query: 742 EKSDVYSFGVVLLELITGQP------------VIQKTPQRTLIGQWVSS 778
K+D++S G+ +EL G+P +I K TL G++
Sbjct: 180 SKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKP 228
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 568 VLGKGGFGTVYHGYL-------DDKQVAVKMLSSSSVQGYKQ-FQAEVELLIRAHHKNLT 619
LG+G FG V+ + V VK L + + + F+ E+++ + HKN+
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHLL-------EDKADTLCWERRLQIASESAQGLE 672
L+G C E +I E+ G+L+ L + K L ++++ + ++ A G++
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 673 YLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEGGTHVSTTVVGTP-GYL 730
+L N VHRD+ + N L++ + + K++ LS+ ++ E + + P +L
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI---PLRWL 185
Query: 731 DPEYYISNRLTEKSDVYSFGVVLLELIT 758
PE + + KSDV+SFGV++ E+ T
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 48/219 (21%)
Query: 569 LGKGGFGTVYHGY-LDDKQV-AVKM--LSSSSVQGYKQFQAEVELLIRAHHKNLT----- 619
+G G FG VY LD ++ AVK + + + K+ E+++L H NL
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 620 --------ILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERR--LQIASESAQ 669
I + YC G + E + +G + D+ R LQ+
Sbjct: 68 EVHREKVYIFMEYCSGGT----LEELLEHGRI-----LDEHVI----RVYTLQLLE---- 110
Query: 670 GLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST---TVVG 725
GL YLH +G IVHRD+K ANI L+ KL DFG + T + ++ G
Sbjct: 111 GLAYLHSHG----IVHRDIKPANIFLDHNGVIKLGDFGCAVKL-KNNTTTMGEEVQSLAG 165
Query: 726 TPGYLDPEYYISNRLTEK---SDVYSFGVVLLELITGQP 761
TP Y+ PE + +D++S G V+LE+ TG+
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 1e-19
Identities = 83/298 (27%), Positives = 138/298 (46%), Gaps = 53/298 (17%)
Query: 569 LGKGGFGTVY--HGYLDDKQ-------VAVKMLS-SSSVQGYKQFQAEVELL-IRAHHKN 617
LG+G FG V Y DK VAVKML +++ + +E+EL+ + HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADT--------------LCWERRLQI 663
+ L+G C + + +I E+ A GNL+ L + L ++ +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 664 ASESAQGLEYLHNG-CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722
A + A+G+EYL + C +HRD+ + N+L+ E K+ADFGL+R G +
Sbjct: 140 AYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLAR-----GVHDIDYY 190
Query: 723 VVGTPG-----YLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVS 777
+ G ++ PE T +SDV+SFG+++ E+ T + +P + + +
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT----LGGSPYPGIPVEELF 246
Query: 778 SMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835
+L G HR+ D +N + + C H + T+RPT Q+V L+ LA
Sbjct: 247 KLLREG-------HRM--DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 53/230 (23%)
Query: 566 ERVLGKGGFGTVYHGYLD-------DKQVAVKMLS-SSSVQGYKQF--QAEVELLIRAHH 615
R LG+G FG VY G + +VA+K ++ ++S++ +F +A V HH
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNLQAHLLE--------DKADTLCWERRLQIASES 667
+ L+G G ++ E MA G+L+++L ++ +Q+A+E
Sbjct: 71 --VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 668 AQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR--------------IFPV 713
A G+ YL VHRD+ + N ++ E K+ DFG++R + PV
Sbjct: 129 ADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 714 EGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 761
++ PE T KSDV+SFGVVL E+ T QP
Sbjct: 186 R--------------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 13/217 (5%)
Query: 569 LGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDE 627
LG+G FG V+ G + +VA+K L ++ + F E +++ + H L L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 628 GANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDV 687
+ ++ EFM G+L L E L + + +A++ A G+ Y+ + +HRD+
Sbjct: 73 -EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDL 128
Query: 688 KSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYYISNRLTEKSDV 746
++ANIL+ + K+ADFGL+R+ +E + + P + PE + R T KSDV
Sbjct: 129 RAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 747 YSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG 783
+SFG++L EL+T + P ++ + V + RG
Sbjct: 187 WSFGILLTELVTK----GRVPYPGMVNREVLEQVERG 219
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 67/217 (30%), Positives = 112/217 (51%), Gaps = 30/217 (13%)
Query: 568 VLGKGGFGTVYHGYLDDK----QVAVKMLSS-SSVQGYKQFQAEVELLIR-AHHKNLTIL 621
V+G+G FG V + A+K + +S ++ F E+E+L + HH N+ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 622 VGYCDEGANMGLIYEFMANGNL-----QAHLLED---------KADTLCWERRLQIASES 667
+G C+ + L E+ +GNL ++ +LE A TL ++ L A++
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 668 AQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP 727
A+G++YL + +HRD+ + NIL+ E + AK+ADFGLSR V +V T+ P
Sbjct: 122 ARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV----YVKKTMGRLP 174
Query: 728 -GYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 761
++ E + T SDV+S+GV+L E+++ G P
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 569 LGKGGFGTVYHGYL-DDKQV-AVKMLSSSSVQGY-KQFQAEVELLIRAHHKNLTILVGYC 625
LG+G G+V L + + A+K +++ KQ E+E+ + G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 626 --DEGANMGLIYEFMANGNLQAHLLEDKADT-LCWERRL-QIASESAQGLEYLHNGCKPP 681
+ +++G+ E+ G+L + + K E+ L +IA +GL YLH+
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RK 125
Query: 682 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLT 741
I+HRD+K +NILL K Q KL DFG+S E ++ T GT Y+ PE +
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGVSG----ELVNSLAGTFTGTSFYMAPERIQGKPYS 181
Query: 742 EKSDVYSFGVVLLELITGQ-PVIQKTPQR 769
SDV+S G+ LLE+ + P +
Sbjct: 182 ITSDVWSLGLTLLEVAQNRFPFPPEGEPP 210
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 11/193 (5%)
Query: 565 FERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGY 624
+ +GKG FG V G +VAVK + + + + F AE ++ + H NL L+G
Sbjct: 10 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 67
Query: 625 -CDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIV 683
+E + ++ E+MA G+L +L L + L+ + + + +EYL V
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFV 124
Query: 684 HRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEK 743
HRD+ + N+L++E AK++DFGL++ E + T + + PE + + K
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVK-WTAPEALREKKFSTK 179
Query: 744 SDVYSFGVVLLEL 756
SDV+SFG++L E+
Sbjct: 180 SDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 23/200 (11%)
Query: 571 KGGFGTVYHGYLDDKQV-----AVKMLSSSSVQGYKQ---FQAE-VELLIRAHHKNLTIL 621
KG FG+VY L K+ A+K+L S + Q +AE ++I+ + L
Sbjct: 6 KGAFGSVY---LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPP 681
+ L+ E++ G+ + + W + Q +E G+E LH +
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEVVLGVEDLH---QRG 117
Query: 682 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLT 741
I+HRD+K N+L+++ KL DFGLSR + VGTP YL PE +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFVGTPDYLAPETILGVGDD 171
Query: 742 EKSDVYSFGVVLLELITGQP 761
+ SD +S G V+ E + G P
Sbjct: 172 KMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 3e-19
Identities = 81/295 (27%), Positives = 135/295 (45%), Gaps = 45/295 (15%)
Query: 569 LGKGGFGTVYH----GYLDDK-----QVAVKMLSSSSV-QGYKQFQAEVELL-IRAHHKN 617
LG+G FG V G DK VAVKML + + +E+E++ + HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKA--------------DTLCWERRLQI 663
+ L+G C + + ++ E+ + GNL+ +L + + L ++ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 664 ASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV 723
A + A+G+EYL +HRD+ + N+L+ E K+ADFGL+R V + T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR--DVHNIDYYKKTT 194
Query: 724 VG--TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLA 781
G ++ PE T +SDV+SFGV+L E+ T +P + + + +L
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG----SPYPGIPVEELFKLLK 250
Query: 782 RGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836
G HR+ D N + I C H + ++RPT Q+V +L+ L +
Sbjct: 251 EG-------HRM--DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 65/221 (29%), Positives = 113/221 (51%), Gaps = 13/221 (5%)
Query: 565 FERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVG 623
E LG+G FG V+ G + +VA+K L ++ + F E +++ + H+ L L
Sbjct: 10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 68
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIV 683
E + ++ E+M+ G+L L + L + + +A++ A G+ Y+ + V
Sbjct: 69 VVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 124
Query: 684 HRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYYISNRLTE 742
HRD+++ANIL+ E K+ADFGL+R+ +E + + P + PE + R T
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 743 KSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG 783
KSDV+SFG++L EL T + P ++ + V + RG
Sbjct: 183 KSDVWSFGILLTELTTK----GRVPYPGMVNREVLDQVERG 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 52/197 (26%), Positives = 86/197 (43%), Gaps = 11/197 (5%)
Query: 569 LGKGGFGTVYHGYLDD--KQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVG 623
LGKGGFG V + K A K L + +G + E ++L + + + L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIV 683
+ ++ L+ M G+L+ H+ R + A++ GLE+LH IV
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIV 117
Query: 684 HRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEK 743
+RD+K N+LL++ +++D GL+ GTPGY+ PE
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVLQGEVYDFS 174
Query: 744 SDVYSFGVVLLELITGQ 760
D ++ G L E+I G+
Sbjct: 175 VDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 562 TNNF--ERVLGKGGFGTVYHG--YLDDKQVAVKMLSSSSVQGYKQFQ---AEVELLIRAH 614
NF E+ +GKG F VY LD + VA+K + + K Q E++LL +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 615 HKNLTILVGYCDEGANMGLIYEFMANGNL---------QAHLLEDKADTLCWERRLQIAS 665
H N+ + E + ++ E G+L Q L+ ++ W+ +Q+ S
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERT---IWKYFVQLCS 117
Query: 666 ESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG 725
LE++H I+HRD+K AN+ + KL D GL R F + T + ++VG
Sbjct: 118 ----ALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVG 168
Query: 726 TPGYLDPEYYISNRLTEKSDVYSFGVVLLEL 756
TP Y+ PE N KSD++S G +L E+
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 60/196 (30%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 565 FERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVG 623
+ LG G FG V+ G + + +VAVK L ++ + F E +++ + H L L
Sbjct: 10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYA 68
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIV 683
E + ++ E+M+ G+L L + + L + +A++ A G+ Y+ + +
Sbjct: 69 VVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYI 124
Query: 684 HRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYYISNRLTE 742
HRD++SANIL+ + K+ADFGL+R+ +E + + P + PE + R T
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 743 KSDVYSFGVVLLELIT 758
KSDV+SFG++L EL+T
Sbjct: 183 KSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 4e-19
Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 566 ERVLGKGGFGTVYHGYL-----DDKQVAVKMLSSSSVQGYKQ-FQAEVELLIRAHHKNLT 619
++V+G G FG V+ G L + VA+K L + +Q F +E ++ + H N+
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCK 679
L G + +I E+M NG L +L + + ++ + + A G++YL +
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKYLSD--- 125
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYYISN 738
VHRD+ + NIL+N + K++DFGLSR+ + +T+ P + PE
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 739 RLTEKSDVYSFGVVLLELIT 758
+ T SDV+SFG+V+ E+++
Sbjct: 186 KFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 568 VLGKGGFGTVYHGY--LDDKQVAVKMLS-SSSVQGYKQFQAEVELLIRAHH---KNLTIL 621
++G+G +G VY G + VA+K+++ + Q EV LL + N+T
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPP 681
G +G + +I E+ G+++ + I E L+Y+H K
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYIS---VIIREVLVALKYIH---KVG 121
Query: 682 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLT 741
++HRD+K+ANIL+ KL DFG++ + + +T VGTP ++ PE +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 742 E-KSDVYSFGVVLLELITGQP 761
+ K+D++S G+ + E+ TG P
Sbjct: 180 DTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 66/222 (29%), Positives = 104/222 (46%), Gaps = 36/222 (16%)
Query: 567 RVLGKGGFGTVYHGYLDD--------KQVAVKML-SSSSVQGYKQFQAEVELLIRAHHKN 617
LG G FG VY G D +VAVK L ++ Q K+F E L+ +H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADT-----LCWERRLQIASESAQGLE 672
+ L+G C +I E M G+L ++L + + + L + L I + A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 673 YLHNGCKPPIVHRDVKSANILLNEKFQA-----KLADFGLSR------IFPVEGGTHVST 721
YL + +HRD+ + N L++EK K+ DFGL+R + EG +
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 761
++ PE + + T +SDV+SFGV++ E++T QP
Sbjct: 178 R------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 71/250 (28%), Positives = 107/250 (42%), Gaps = 44/250 (17%)
Query: 569 LGKGGFGTVY--HGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILV-GYC 625
LG G FG VY A K++ S + + F E+++L H N+ L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 626 DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRL---QIA---SESAQGLEYLHNGCK 679
E + ++ EF G L + +LE ER L QI + + L +LH+
Sbjct: 73 YEN-KLWILIEFCDGGALDSIMLE-------LERGLTEPQIRYVCRQMLEALNFLHSH-- 122
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEY----- 734
++HRD+K+ NILL KLADFG+S T +GTP ++ PE
Sbjct: 123 -KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTPYWMAPEVVACET 179
Query: 735 YISNRLTEKSDVYSFGVVLLELITGQP------------VIQKTPQRTLI--GQWVSSM- 779
+ N K+D++S G+ L+EL +P I K+ TL +W SS
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239
Query: 780 --LARGDIKN 787
L +K+
Sbjct: 240 DFLKSCLVKD 249
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 27/206 (13%)
Query: 569 LGKGGFGTVYH-GYLDDKQV-AVKMLSSSSVQGYKQFQA--EVELLIRAHHKNLTILVGY 624
LGKG +G+VY L D Q A+K + S+ ++ A E+ +L +H N+ + Y
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI---ISY 64
Query: 625 CD---EGANMGLIYEFMANGNLQAHLLEDKA------DTLCWERRLQIASESAQGLEYLH 675
+ +G + ++ E+ G+L + + K + W +Q+ +GL+ LH
Sbjct: 65 KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGLQALH 120
Query: 676 NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYY 735
I+HRD+KSANILL K+ D G+S++ +++ T +GTP Y+ PE +
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTPHYMAPEVW 173
Query: 736 ISNRLTEKSDVYSFGVVLLELITGQP 761
+ KSD++S G +L E+ T P
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAP 199
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 567 RVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQGYKQFQA--EVELLIRAHHKNLTILV 622
+G+G G V+ + VA+K ++ ++G QA E++ L H + L+
Sbjct: 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 623 GYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERR----LQIASESAQ---GLEYLH 675
G+ L+ E+M D ++ L E R Q+ S G+ Y+H
Sbjct: 66 DVFPHGSGFVLVMEYM---------PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 676 -NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPE- 733
NG I+HRD+K AN+L++ K+ADFGL+R+F E + + V T Y PE
Sbjct: 117 ANG----IMHRDLKPANLLISADGVLKIADFGLARLFS-EEEPRLYSHQVATRWYRAPEL 171
Query: 734 YYISNRLTEKSDVYSFGVVLLELITGQP 761
Y + + D+++ G + EL+ G P
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 73/282 (25%), Positives = 128/282 (45%), Gaps = 36/282 (12%)
Query: 568 VLGKGGFGTVYHGYLDD------KQVAVKMLS--SSSVQGYKQFQAEVELLIRAHHKNLT 619
+L +G FG +++G L D ++V VK + +S +Q E LL H+N+
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ-VTLLLQESCLLYGLSHQNIL 71
Query: 620 ILVGYCDEGANMGLI-YEFMANGNLQAHLL------EDKADTLCWERRLQIASESAQGLE 672
++ C E + Y +M GNL+ L + L ++ + +A + A G+
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 673 YLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEGGTHVSTTVVGTP-GYL 730
YLH K ++H+D+ + N +++E+ Q K+ D LSR +FP H P ++
Sbjct: 132 YLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFP--MDYHCLGDNENRPVKWM 186
Query: 731 DPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVD 790
E ++ + SDV+SFGV+L EL+T + +TP + +++ L G
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELMT----LGQTPYVEIDPFEMAAYLKDG------- 235
Query: 791 HRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832
+RL N + + C RP+ +Q+V L D
Sbjct: 236 YRLAQPI--NCPDELFAVMACCWALDPEERPSFSQLVQCLTD 275
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 565 FERVLGKGGFGTVY----HGYLDDK---QVAVKMLSSSSVQGYKQFQAEVELLIRAH--- 614
F + LG G FG V +G +VAVKML ++ ++ EL I +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS-ELKIMSHLGN 97
Query: 615 HKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL 674
H+N+ L+G C G + +I E+ G+L L + L E L + + A+G+ +L
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 675 HN-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI------FPVEGGTHVSTTVVGTP 727
+ C +HRD+ + N+LL K+ DFGL+R + V+G +
Sbjct: 158 ASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK----- 208
Query: 728 GYLDPEYYISNRLTEKSDVYSFGVVLLELIT 758
++ PE + T +SDV+S+G++L E+ +
Sbjct: 209 -WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 62/195 (31%), Positives = 100/195 (51%), Gaps = 12/195 (6%)
Query: 566 ERVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQGYK-QFQAEVELLIRAHHKNLTILV 622
ER+ G+G FG V+ G L D+ VAVK + K +F E +L + H N+ L+
Sbjct: 1 ERI-GRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 623 GYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPI 682
G C + + ++ E + G+ L + L + +Q+ +A G+EYL +
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLT-FLRTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 683 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST-TVVGTP-GYLDPEYYISNRL 740
+HRD+ + N L+ EK K++DFG+SR E G + ST + P + PE R
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 741 TEKSDVYSFGVVLLE 755
+ +SDV+SFG++L E
Sbjct: 174 SSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 79/292 (27%), Positives = 132/292 (45%), Gaps = 47/292 (16%)
Query: 567 RVLGKGGFGTVYHGYL--DDK---QVAVKML-----SSSSVQGYKQFQAEVELLIRAHHK 616
++LG+G FG+V G L DD +VAVK + + S ++ F +E + H
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEE---FLSEAACMKDFDHP 61
Query: 617 NLTILVGYCDEGANMG------LIYEFMANGNLQAHLL----EDKADTLCWERRLQIASE 666
N+ L+G C E +++ +I FM +G+L + LL + L + L+ +
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121
Query: 667 SAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEGGTHVSTTVVG 725
A G+EYL N +HRD+ + N +L E +ADFGLS+ I+ G + +
Sbjct: 122 IALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIY--SGDYYRQGRIAK 176
Query: 726 TP-GYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARG 783
P ++ E T KSDV++FGV + E+ T GQ TP + + L G
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ-----TPYPGVENHEIYDYLRHG 231
Query: 784 DIKNIVDHRLQGDFDT-NTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834
+RL+ D + ++ ++ +C RPT ++ L + L
Sbjct: 232 -------NRLKQPEDCLDELY---DLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 79/295 (26%), Positives = 134/295 (45%), Gaps = 45/295 (15%)
Query: 569 LGKGGFGTVYH----GYLDDK-----QVAVKMLSSSSVQ-GYKQFQAEVELL-IRAHHKN 617
LG+G FG V G DK VAVKML + + +E+E++ + HKN
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKA--------------DTLCWERRLQI 663
+ L+G C + + +I E+ + GNL+ +L + + + ++ +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 664 ASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV 723
+ A+G+EYL +HRD+ + N+L+ E K+ADFGL+R V + T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DVNNIDYYKKTT 197
Query: 724 VG--TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLA 781
G ++ PE T +SDV+SFGV++ E+ T + +P + + + +L
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKLLK 253
Query: 782 RGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836
G HR+ D N + + C H I + RPT Q+V +L+ L +
Sbjct: 254 EG-------HRM--DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 66/202 (32%), Positives = 109/202 (53%), Gaps = 14/202 (6%)
Query: 567 RVLGKGGFGTV----YHGYLDD--KQVAVKMLSSSSVQGY-KQFQAEVELLIRAHHKNLT 619
R LG+G FG V Y D+ +QVAVK L S + + E+E+L +H+N+
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 620 ILVGYCDEGANMG--LIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNG 677
G C E G LI EF+ +G+L+ +L +K + +++L+ A + +G++YL G
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYL--G 126
Query: 678 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGY-LDPEYYI 736
+ VHRD+ + N+L+ + Q K+ DFGL++ + + + +P + PE I
Sbjct: 127 SRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 737 SNRLTEKSDVYSFGVVLLELIT 758
++ SDV+SFGV L EL+T
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-18
Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 31/209 (14%)
Query: 567 RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQ---AEVELLIRAHHKNLTIL 621
R +G G FG VY ++ VA+K +S S Q +++Q EV L + H N
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 622 VGYCDEGANMGLIYEFM---ANGNLQAH---LLEDKADTLCWERRLQIASESAQGLEYLH 675
G L+ E+ A+ L+ H L E + +C + QGL YLH
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAIC--------HGALQGLAYLH 132
Query: 676 NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYY 735
+ + +HRD+K+ NILL E KLADFG + + + + VGTP ++ PE
Sbjct: 133 SHER---IHRDIKAGNILLTEPGTVKLADFGSASL------VSPANSFVGTPYWMAPEVI 183
Query: 736 IS---NRLTEKSDVYSFGVVLLELITGQP 761
++ + K DV+S G+ +EL +P
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 18/203 (8%)
Query: 565 FERVLGKGGFGTV--YHGYLDDKQVAVKMLS--SSSVQGYKQFQAEVELLIRAHHKNLTI 620
F RV+GKG +G V D KQ +K L+ ++S + K + E +LL + H N+
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI-- 61
Query: 621 LVGYCD--EGANMGLIYEFMA---NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH 675
V Y + EG + GL+Y M G+L L E K L + ++ + A L+YLH
Sbjct: 62 -VAYRESWEGED-GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119
Query: 676 NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYY 735
+ I+HRD+K+ N+ L K+ D G++R+ +E +++T++GTP Y+ PE +
Sbjct: 120 ---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPYYMSPELF 174
Query: 736 ISNRLTEKSDVYSFGVVLLELIT 758
+ KSDV++ G + E+ T
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 27/210 (12%)
Query: 567 RVLGKGGFGTVYHG---YLDDK----QVAVKML-SSSSVQGYKQFQAEVELLIRAHHKNL 618
R LG G FG VY G D QVAVK L S S Q F E ++ + +H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 619 TILVGYCDEGANMGLIYEFMANGNLQAHLLE-----DKADTLCWERRLQIASESAQGLEY 673
L+G E ++ E MA G+L++ L E ++ +L + L A + A+G +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 674 LHNGCKPPIVHRDVKSANILLNEKFQ---AKLADFGLSR-IFPVE---GGTHVSTTVVGT 726
L +HRD+ + N LL K AK+ADFG++R I+ G +
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 727 PGYLDPEYYISNRLTEKSDVYSFGVVLLEL 756
P PE ++ T K+DV+SFGV+L E+
Sbjct: 189 P----PEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 68/245 (27%), Positives = 104/245 (42%), Gaps = 44/245 (17%)
Query: 563 NNFERV--LGKGGFGTVYHGY-LDDKQV-AVKMLSSSSVQGYKQ---FQAEVELLIRAHH 615
++FE + +G+G FG V+ D QV A+K+L S + Q +AE ++L A
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWER-RLQIASESAQGLEYL 674
+ L + ++ L+ E+M G+L L+ + D E R IA E L+ +
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLI--RKDVFPEETARFYIA-ELVLALDSV 117
Query: 675 HN-GCKPPIVHRDVKSANILLNEKFQAKLADFGLS------------------------- 708
H G +HRD+K NIL++ KLADFGL
Sbjct: 118 HKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 709 --RIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ-PVIQK 765
R + + + VGTP Y+ PE + D +S GV+L E++ G P
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233
Query: 766 TPQRT 770
T Q T
Sbjct: 234 TLQET 238
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 4e-18
Identities = 82/287 (28%), Positives = 129/287 (44%), Gaps = 45/287 (15%)
Query: 567 RVLGKGGFGTVYHGYL--DD---KQVAVKML-----SSSSVQGYKQFQAEVELLIRAHHK 616
R+LGKG FG+V L +D ++VAVKML SSS ++ +F E + H
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE---EFLREAACMKEFDHP 61
Query: 617 NLTILVGYCDEGANMG------LIYEFMANGNLQAHLLE----DKADTLCWERRLQIASE 666
N+ L+G G +I FM +G+L LL ++ TL + ++ +
Sbjct: 62 NVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMID 121
Query: 667 SAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEGGTHVSTTVVG 725
A G+EYL + +HRD+ + N +LNE +ADFGLS+ I+ G +
Sbjct: 122 IASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIY--SGDYYRQGCASK 176
Query: 726 TP-GYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARG 783
P +L E N T SDV++FGV + E++T GQ TP + + + L +G
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ-----TPYAGVENSEIYNYLIKG 231
Query: 784 DIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIEL 830
+ RL+ D + E+ C RP+ + +L
Sbjct: 232 N-------RLKQPPD--CLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 62/216 (28%), Positives = 106/216 (49%), Gaps = 29/216 (13%)
Query: 565 FERV--LGKGGFGTVYHGY--LDDKQVAVK-MLSSSSVQGYKQFQA-EVELLIRAHHKNL 618
+E++ +G+G +G VY + VA+K + + +G+ E++LL + H N+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 619 TILVGYCDEGANMG--LIYEFMANGNLQAHLLEDKADTL------CWERRLQIASESAQG 670
L +++E+M + +L LL+ C+ ++L +G
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDH-DLTG-LLDSPEVKFTESQIKCYMKQL------LEG 112
Query: 671 LEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGY 729
L+YLH NG I+HRD+K +NIL+N KLADFGL+R + + V+ T Y
Sbjct: 113 LQYLHSNG----ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWY 167
Query: 730 LDPEYYI-SNRLTEKSDVYSFGVVLLELITGQPVIQ 764
PE + + R + D++S G +L EL G+P+ Q
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 5e-18
Identities = 77/296 (26%), Positives = 132/296 (44%), Gaps = 51/296 (17%)
Query: 569 LGKGGFGTVYHGYLDD-------KQVAVKML-SSSSVQGYKQFQAEVELLIR-AHHKNLT 619
LG+G FG V VAVKML ++ + +E+E++ HKN+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHL--------------LEDKADTLCWERRLQIAS 665
L+G C + + ++ E+ A+GNL+ L +TL + + A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 666 ESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV-----S 720
+ A+G+E+L + +HRD+ + N+L+ E K+ADFGL+R H
Sbjct: 140 QVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLAR------DIHHIDYYRK 190
Query: 721 TTVVGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSM 779
TT P ++ PE T +SDV+SFGV+L E+ T + +P + + + +
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT----LGGSPYPGIPVEELFKL 246
Query: 780 LARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835
L G +R+ + N + + C H + ++RPT Q+V +L+ L
Sbjct: 247 LKEG-------YRM--EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRMLT 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 58/197 (29%), Positives = 80/197 (40%), Gaps = 11/197 (5%)
Query: 569 LGKGGFGTVYHGYLDDK-----QVAVKMLSSSSVQGYKQ-FQAEVELLIRAHHKNLTILV 622
LG G FG V G VAVK L S + F E ++ H+NL L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 623 GYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPI 682
G M ++ E G+L L +D A + A G+ YL
Sbjct: 63 GVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRF 118
Query: 683 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYYISNRLT 741
+HRD+ + NILL + K+ DFGL R P +V + P + PE + +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178
Query: 742 EKSDVYSFGVVLLELIT 758
SDV+ FGV L E+ T
Sbjct: 179 HASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 9e-18
Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 562 TNNFER-VLGKGGFGTVYHGYLDDKQV--AVKMLSSSSVQGYKQFQAEVELLIRAHHKNL 618
N ER VLGKG +G VY QV A+K + + + E+ L H+N+
Sbjct: 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNI 67
Query: 619 TILVGYCDEGANMGLIYEFMANGNLQAHL------LEDKADTLCWERRLQIASESAQGLE 672
+G E + E + G+L A L L+D T+ + + QI +GL+
Sbjct: 68 VQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QIL----EGLK 122
Query: 673 YLHNGCKPPIVHRDVKSANILLNE-KFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLD 731
YLH+ IVHRD+K N+L+N K++DFG S+ + G + T GT Y+
Sbjct: 123 YLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK--RLAGINPCTETFTGTLQYMA 177
Query: 732 PEYYISNRLT---EKSDVYSFGVVLLELITGQP 761
PE I +D++S G ++E+ TG+P
Sbjct: 178 PE-VIDKGPRGYGAPADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 14/209 (6%)
Query: 557 DVLKITNNFERVLGKGGFGTVYHGYLDDKQ--VAVKMLSSSSVQG-YKQFQAEVELLIRA 613
D ++ ER+ GKG FG VY G + + VA+K++ + + Q E+ +L +
Sbjct: 1 DPEELFTKLERI-GKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 614 HHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEY 673
+T G +G + +I E++ G+ L K L I E +GL+Y
Sbjct: 60 DSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDY 116
Query: 674 LHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS-TTVVGTPGYLDP 732
LH+ K +HRD+K+AN+LL+E+ KLADFG++ T + T VGTP ++ P
Sbjct: 117 LHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT---DTQIKRNTFVGTPFWMAP 170
Query: 733 EYYISNRLTEKSDVYSFGVVLLELITGQP 761
E + K+D++S G+ +EL G+P
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 69/220 (31%), Positives = 114/220 (51%), Gaps = 32/220 (14%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEV---ELLIRAHHKNLT 619
FE++ G+G GTVY ++VA+K ++ +Q + E+ E+L+ +K+
Sbjct: 24 FEKI-GQGASGTVYTAIDVATGQEVAIKQMNLQ-----QQPKKELIINEILVMRENKHPN 77
Query: 620 ILVGYCDE---GANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIAS---ESAQGLEY 673
I V Y D G + ++ E++A G+L D C + QIA+ E Q LE+
Sbjct: 78 I-VNYLDSYLVGDELWVVMEYLAGGSLT-----DVVTETCMDEG-QIAAVCRECLQALEF 130
Query: 674 LHNGCKPPIVHRDVKSANILLNEKFQAKLADFGL-SRIFPVEGGTHVSTTVVGTPGYLDP 732
LH+ ++HRD+KS NILL KL DFG ++I P + +T+VGTP ++ P
Sbjct: 131 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAP 184
Query: 733 EYYISNRLTEKSDVYSFGVVLLELITGQ-PVIQKTPQRTL 771
E K D++S G++ +E++ G+ P + + P R L
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 59/196 (30%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 565 FERVLGKGGFGTVYHG-YLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVG 623
E+ LG G FG V+ Y +VAVK + S+ + F AE ++ H L L
Sbjct: 10 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHA 68
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIV 683
+ + +I EFMA G+L L D+ + + +++ A+G+ ++ + +
Sbjct: 69 VVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYI 124
Query: 684 HRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYYISNRLTE 742
HRD+++ANIL++ K+ADFGL+R+ +E + + P + PE T
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAINFGSFTI 182
Query: 743 KSDVYSFGVVLLELIT 758
KSDV+SFG++L+E++T
Sbjct: 183 KSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 72/226 (31%), Positives = 116/226 (51%), Gaps = 28/226 (12%)
Query: 557 DVLKITNNFERVLGKGGFGTVYHGYLD---DKQVAVKMLSSSSVQGYKQFQAEVELLIRA 613
D K FE++ G+G GTVY +D ++VA+K ++ Q K+ E+L+
Sbjct: 16 DPKKKYTRFEKI-GQGASGTVYTA-IDIATGQEVAIKQMNLQ--QQPKKELIINEILVMR 71
Query: 614 HHKNLTILVGYCDE---GANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIAS---ES 667
+KN I V Y D G + ++ E++A G+L + E D QIA+ E
Sbjct: 72 ENKNPNI-VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD------EGQIAAVCREC 124
Query: 668 AQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGL-SRIFPVEGGTHVSTTVVGT 726
Q L++LH+ ++HRD+KS NILL KL DFG ++I P + +T+VGT
Sbjct: 125 LQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGT 178
Query: 727 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ-PVIQKTPQRTL 771
P ++ PE K D++S G++ +E++ G+ P + + P R L
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 37/236 (15%)
Query: 567 RVLGKGGFGTVYHGYLDD-------KQVAVKMLSSSSVQG-YKQFQAEVELLIRAHHKNL 618
+ LG+G FG V VAVKML ++ + +E LL + +H ++
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 619 TILVGYCDEGANMGLIYEFMANGNLQAHLLE----------------------DKADTLC 656
L G C + + LI E+ G+L++ L E L
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 657 WERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716
+ A + ++G++YL + +VHRD+ + N+L+ E + K++DFGLSR E
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV-YEED 181
Query: 717 THVSTTVVGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTPQR 769
++V + P ++ E + T +SDV+SFGV+L E++T G P P+R
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 28/211 (13%)
Query: 568 VLGKGGFGTVYHGY--LDDKQVAVKM--LSSSSVQGYKQ-------FQAEVELLIRAHHK 616
++G G FG+VY G + +AVK L S S + E+ LL H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 617 NLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKA--DTLCWERRLQIASESAQGLEYL 674
N+ +G + ++ + E++ G++ A L A +TL QI +GL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNYL 122
Query: 675 HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPG------ 728
HN I+HRD+K ANIL++ K K++DFG+S+ +E + + T P
Sbjct: 123 HN---RGIIHRDIKGANILVDNKGGIKISDFGISK--KLEANSLSTKTNGARPSLQGSVF 177
Query: 729 YLDPEYYISNRLTEKSDVYSFGVVLLELITG 759
++ PE T K+D++S G +++E++TG
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 58/172 (33%), Positives = 90/172 (52%), Gaps = 18/172 (10%)
Query: 593 SSSSVQGYKQFQAEVELLIRAHHKNLTILVG----YCDEGANMGLIYEFMANGNLQAHLL 648
+ SSV+ KQ E++++ H +V + +E N+ + EFM G+L +
Sbjct: 42 AKSSVR--KQILRELQIM---HECRSPYIVSFYGAFLNEN-NICMCMEFMDCGSLDR--I 93
Query: 649 EDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 708
K + E +IA +GL YL+N I+HRD+K +NIL+N + Q KL DFG+S
Sbjct: 94 YKKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVS 151
Query: 709 RIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 760
E ++ T VGT Y+ PE + T KSDV+S G+ ++EL G+
Sbjct: 152 G----ELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 567 RVLGKGGFGT---VYHGYLDDKQVAVKML----SSSSVQGYKQFQAEVELLIRAHHKNLT 619
RV+G+G FG V H D++ A+K + SSS+V+ ++ E LL + H N+
Sbjct: 6 RVVGEGSFGRALLVQH-VNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIV 61
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCK 679
+ ++ ++ E+ G+L + + + LQ + G++++H +
Sbjct: 62 AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---E 118
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNR 739
++HRD+KS NI L + + KL DFG +R+ G + T VGTP Y+ PE + +
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMP 176
Query: 740 LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLI 772
KSD++S G +L EL T + Q + LI
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHPFQANSWKNLI 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 5e-17
Identities = 67/203 (33%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 567 RVLGKGGFGTV----YHGYLDD--KQVAVKMLSSS-SVQGYKQFQAEVELLIRAHHKNLT 619
RVLG+G FG V Y D + VAVK L Q ++ E+ +L +H+N+
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 620 ILVGYCDEGANMG--LIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNG 677
G C E G LI E++ G+L+ +L + K L + L A + +G+ YLH+
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMAYLHS- 125
Query: 678 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG-TPGY-LDPEYY 735
+HRD+ + N+LL+ K+ DFGL++ P EG + G +P + E
Sbjct: 126 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP-EGHEYYRVREDGDSPVFWYAVECL 182
Query: 736 ISNRLTEKSDVYSFGVVLLELIT 758
N+ + SDV+SFGV L EL+T
Sbjct: 183 KENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 5e-17
Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 567 RVLGKGGFGTVYHGY-------LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLT 619
++LG+G FG VY Y L KQV S + + + E++LL H+ +
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 620 ILVGYCDEGA--NMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNG 677
G + A + + E+M G+++ L A T R+ + +G+ YLH+
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKY--TRQILEGMSYLHSN 125
Query: 678 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV--EGGTHVSTTVVGTPGYLDPEYY 735
IVHRD+K ANIL + KL DFG S+ GT + +V GTP ++ PE
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR-SVTGTPYWMSPEVI 181
Query: 736 ISNRLTEKSDVYSFGVVLLELITGQP 761
K+DV+S G ++E++T +P
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 6e-17
Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 27/204 (13%)
Query: 569 LGKGGFGTVYHGYLDDKQ--VAVKMLSSSSVQG-YKQFQAEVELLIRAHHKNLTILVGYC 625
+GKG FG V+ G + Q VA+K++ + + Q E+ +L + +T G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 626 DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIAS---ESAQGLEYLHNGCKPPI 682
+ + +I E++ G+ L D QIA+ E +GL+YLH+ K
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLEPGPLD------ETQIATILREILKGLDYLHSEKK--- 122
Query: 683 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV-----VGTPGYLDPEYYIS 737
+HRD+K+AN+LL+E + KLADFG++ G T + VGTP ++ PE
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVA-------GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 738 NRLTEKSDVYSFGVVLLELITGQP 761
+ K+D++S G+ +EL G+P
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 66/207 (31%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 567 RVLGKGGFGTVYHGYLDD--KQVAVKML-----SSSSVQGYKQFQAEVELLIRAHHKNLT 619
++LG+G FG VY Y D +++AVK + S + + + E++LL H +
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 620 ILVGYC---DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN 676
G C E + + E+M G+++ L A T RR + QG+ YLH+
Sbjct: 68 QYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRY--TRQILQGVSYLHS 124
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLS-RIFPV-EGGTHVSTTVVGTPGYLDPEY 734
IVHRD+K ANIL + KL DFG S RI + GT + +V GTP ++ PE
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIK-SVTGTPYWMSPEV 180
Query: 735 YISNRLTEKSDVYSFGVVLLELITGQP 761
K+DV+S ++E++T +P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 29/213 (13%)
Query: 567 RVLGKGGFGTVYHGYLD-------DKQVAVKMLS-SSSVQGYKQFQAEVELLIRAHHKNL 618
R LG+G FG VY G + +VA+K ++ ++S++ +F E ++ + ++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 619 TILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTL--------CWERRLQIASESAQG 670
L+G +G +I E M G+L+++L + + ++ +Q+A E A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 671 LEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVE----GGTHVSTTVVG 725
+ YL N K VHRD+ + N ++ E F K+ DFG++R I+ + GG +
Sbjct: 132 MAYL-NANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV--- 185
Query: 726 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 758
++ PE T SDV+SFGVVL E+ T
Sbjct: 186 --RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 566 ERVLGKGGFGTVYHG--YLDDKQVAVKMLSSSSVQGYKQFQ---AEVELLIRAHHKNLTI 620
E+ +G+G F VY LD K VA+K + + K Q E++LL + +H N+
Sbjct: 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK 66
Query: 621 LVGYCDEGANMGLIYEFMANGNLQAHLLEDKA------DTLCWERRLQIASESAQGLEYL 674
+ E + ++ E G+L + K + W+ +Q+ S +E++
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS----AVEHM 122
Query: 675 HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEY 734
H+ ++HRD+K AN+ + KL D GL R F + T + ++VGTP Y+ PE
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPER 177
Query: 735 YISNRLTEKSDVYSFGVVLLEL 756
N KSD++S G +L E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 7e-17
Identities = 72/225 (32%), Positives = 114/225 (50%), Gaps = 26/225 (11%)
Query: 557 DVLKITNNFERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAH 614
D K FE++ G+G GTVY ++VA++ ++ Q K+ E+L+
Sbjct: 17 DPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRE 73
Query: 615 HKNLTILVGYCDE---GANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIAS---ESA 668
+KN I V Y D G + ++ E++A G+L + E D QIA+ E
Sbjct: 74 NKNPNI-VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD------EGQIAAVCRECL 126
Query: 669 QGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGL-SRIFPVEGGTHVSTTVVGTP 727
Q LE+LH+ ++HRD+KS NILL KL DFG ++I P + +T+VGTP
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTP 180
Query: 728 GYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ-PVIQKTPQRTL 771
++ PE K D++S G++ +E+I G+ P + + P R L
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 9e-17
Identities = 66/246 (26%), Positives = 112/246 (45%), Gaps = 42/246 (17%)
Query: 565 FERVLGKGGFGTVYHGYLDDKQ------------------VAVKMLSSSSVQGYKQ-FQA 605
F+ LG+G FG V+ + + Q VAVK+L + + + F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 606 EVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQ----AHLLEDKAD-------- 653
EV++L R N+ L+G C + + +I E+M NG+L +H L+DK +
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 654 -----TLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 708
+ + L +A + A G++YL + VHRD+ + N L+ E K+ADFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 709 RIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT---GQPVIQK 765
R + V ++ E + + T SDV++FGV L E++ QP +
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245
Query: 766 TPQRTL 771
T ++ +
Sbjct: 246 TDEQVI 251
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 47/231 (20%)
Query: 564 NFERVLGKGGFGTVY-------HGYLDDK-----------QVAVKML-SSSSVQGYKQFQ 604
NF LG+G FG V+ + + VAVK+L +S + F
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 605 AEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL----QAHLLEDKAD-----TL 655
EV++L R N+ L+G C + +I E+M NG+L Q H+ E +L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 656 CWERRLQIASESAQGLEYL--HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR---- 709
+ L +A++ A G+ YL N VHRD+ + N L+ + + K+ADFG+SR
Sbjct: 128 SFSTLLYMATQIASGMRYLESLN-----FVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 710 --IFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 758
+ V+G ++ E + + T KSDV++FGV L E++T
Sbjct: 183 SDYYRVQG------RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-16
Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 29/197 (14%)
Query: 586 QVAVKMLSSSSVQG---YKQFQAEVELLIRAHHKNLTILVGYCDEG-ANMGL---IYEFM 638
+VA+K+L + + + +F+ E L R +H N+ L+ D G A GL ++E++
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALL---DSGEAPPGLLFAVFEYV 61
Query: 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE-- 696
L+ L D A L ++ + L HN IVHRD+K NI++++
Sbjct: 62 PGRTLREVLAADGA--LPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTG 116
Query: 697 -KFQAKLADFGLSRIFPVEGGTH--------VSTTVVGTPGYLDPEYYISNRLTEKSDVY 747
+ AK+ DFG+ + P G +T V+GTP Y PE +T SD+Y
Sbjct: 117 VRPHAKVLDFGIGTLLP---GVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 748 SFGVVLLELITGQPVIQ 764
++G++ LE +TGQ V+Q
Sbjct: 174 AWGLIFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 31/213 (14%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVKMLS-SSSVQGYKQFQAEVELLIRAHHKNLTIL 621
++ +LG G GTVY Y L + +AVK++ +V+ KQ +E+E+L + +
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRL------QIASESAQGLEYLH 675
G + + EFM G+L + R++ +IA +GL YL
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVY------------RKIPEHVLGRIAVAVVKGLTYLW 112
Query: 676 NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYY 735
K I+HRDVK +N+L+N + Q KL DFG+S ++ T VGT Y+ PE
Sbjct: 113 -SLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPERI 165
Query: 736 ISNRLTEKSDVYSFGVVLLELITGQ---PVIQK 765
+ SDV+S G+ +EL G+ P IQK
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPYPQIQK 198
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 57/198 (28%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 569 LGKGGFGTVY--HGYLDDKQVAVKMLSSSSVQGYKQ---FQAEVELLIRAHHKNLTILVG 623
LG GGFG V ++ A+K + + Q +E E+L +H + L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIV 683
+ + ++ E+ G L +L D+ + R IA EYLHN I+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELW-TILRDRGLFDEYTARFYIAC-VVLAFEYLHN---RGII 115
Query: 684 HRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEK 743
+RD+K N+LL+ KL DFG ++ T T GTP Y+ PE ++
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW---TFCGTPEYVAPEIILNKGYDFS 172
Query: 744 SDVYSFGVVLLELITGQP 761
D +S G++L EL+TG+P
Sbjct: 173 VDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-16
Identities = 72/231 (31%), Positives = 108/231 (46%), Gaps = 35/231 (15%)
Query: 566 ERV--LGKGGFGTVY---HGYLDDKQVAVKML---SSSSVQGYKQFQAEVELLIRAHHKN 617
ERV +G G GTVY H + A+K++ +V+ +Q E+E+L +H N
Sbjct: 77 ERVNRIGSGAGGTVYKVIH-RPTGRLYALKVIYGNHEDTVR--RQICREIEILRDVNHPN 133
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRL-QIASESAQGLEYLHN 676
+ D + ++ EFM G+L+ + D E+ L +A + G+ YLH
Sbjct: 134 VVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD-------EQFLADVARQILSGIAYLH- 185
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYI 736
+ IVHRD+K +N+L+N K+ADFG+SRI S+ VGT Y+ PE I
Sbjct: 186 --RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPE-RI 240
Query: 737 SNRLTE------KSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLA 781
+ L D++S GV +LE G+ Q G W S M A
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ----GDWASLMCA 287
|
Length = 353 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 3e-16
Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 19/218 (8%)
Query: 568 VLGKGGFGTVYHG-YLDDKQVAVKMLSSSSVQGYKQFQAEVELLIR-AHHKNLTILVGYC 625
++G G +G VY G ++ Q+A + + ++ + E+ +L + +HH+N+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 626 DEGANMG------LIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCK 679
+ G L+ EF G++ + K +TL E I E +GL +LH +
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---Q 129
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNR 739
++HRD+K N+LL E + KL DFG+S G T +GTP ++ PE +
Sbjct: 130 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYWMAPEVIACDE 187
Query: 740 LTE-----KSDVYSFGVVLLELITGQ-PVIQKTPQRTL 771
+ KSD++S G+ +E+ G P+ P R L
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 225
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 5e-16
Identities = 52/199 (26%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 567 RVLGKGGFGTVYHGYL----DDKQVAVKMLSSSSVQGYKQFQAEVELLI---RAHHKNLT 619
++LG G FGTV+ G D ++ V + + G + FQ + ++ H +
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCK 679
L+G C GA++ L+ + G+L H+ + + D+L +R L + A+G+ YL
Sbjct: 73 RLLGIC-PGASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR- 129
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNR 739
+VHR++ + NILL ++ADFG++ + + + + ++ E + R
Sbjct: 130 --MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187
Query: 740 LTEKSDVYSFGVVLLELIT 758
T +SDV+S+GV + E+++
Sbjct: 188 YTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 64/264 (24%), Positives = 115/264 (43%), Gaps = 33/264 (12%)
Query: 577 VYHGYLDDKQVAVKMLSSSSVQGYK----QFQAEVELLIRAHHKNLTILVGY----CDEG 628
+Y G ++K+V ++ +G+K + E++ L R N+ + G+ D+
Sbjct: 36 IYKGIFNNKEVIIRTFKKFH-KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 629 ANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVK 688
+ LI E+ G L+ L DK L ++ +L +A + +GL L+ P ++++
Sbjct: 95 PRLSLILEYCTRGYLREVL--DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 689 SANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYY--ISNRLTEKSDV 746
S + L+ E ++ K+ GL +I +V+ V Y + I + T K D+
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDI 205
Query: 747 YSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAV 806
YS GVVL E+ TG K P L + + ++ I +L D K
Sbjct: 206 YSLGVVLWEIFTG-----KIPFENLTTKEIYDLI----INKNNSLKL--PLDCPLEIKC- 253
Query: 807 EIALACIHTISTRRPTMNQVVIEL 830
I AC S +RP + +++ L
Sbjct: 254 -IVEACTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 567 RVLGKGGFGTVYHGYLDD--KQVAVKML-----SSSSVQGYKQFQAEVELLIRAHHKNLT 619
++LG+G FG VY Y D +++AVK + S + + + E++LL H+ +
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 620 ILVGYCDEGA--NMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNG 677
G + + + E M G+++ L A T R+ + +G+ YLH+
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKY--TRQILEGVSYLHSN 125
Query: 678 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV--EGGTHVSTTVVGTPGYLDPEYY 735
IVHRD+K ANIL + KL DFG S+ GT + +V GTP ++ PE
Sbjct: 126 M---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK-SVTGTPYWMSPEVI 181
Query: 736 ISNRLTEKSDVYSFGVVLLELITGQP 761
K+D++S G ++E++T +P
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 63/219 (28%), Positives = 109/219 (49%), Gaps = 28/219 (12%)
Query: 569 LGKGGFGTVYHGYLDDKQV--AVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCD 626
LG G FG VY + A K++ + S + + + E+E+L +H + L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 627 EGANMGLIYEFMANGNLQAHLLE-DKADTLCWERRLQ-IASESAQGLEYLHNGCKPPIVH 684
+ ++ EF G + A +LE D+ T E ++Q I + + L+YLH+ I+H
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQYLHS---MKIIH 133
Query: 685 RDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST-----TVVGTPGYLDPEYYISNR 739
RD+K+ N+LL KLADFG+S +V T + +GTP ++ PE +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS-------AKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 740 LTE-----KSDVYSFGVVLLELITGQPVIQK-TPQRTLI 772
+ + K+D++S G+ L+E+ +P + P R L+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL 225
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 18/214 (8%)
Query: 569 LGKGGFGTVYHGYLDDKQV--AVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCD 626
LG G FG VY + V A K++ + S + + + E+++L H N+ L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 627 EGANMGLIYEFMANGNLQAHLLE-DKADTLCWERRLQIA-SESAQGLEYLHNGCKPPIVH 684
N+ ++ EF A G + A +LE ++ T E ++++ ++ + L YLH I+H
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 685 RDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTE-- 742
RD+K+ NIL KLADFG+S + +GTP ++ PE + +
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 743 ---KSDVYSFGVVLLELITGQPVIQK-TPQRTLI 772
K+DV+S G+ L+E+ +P + P R L+
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHELNPMRVLL 218
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 7e-16
Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 566 ERVLGKGGFGTVYHGYLD-----DKQVAVKMLSSSSVQGYKQ-FQAEVELLIRAHHKNLT 619
E+V+G G FG V G L + VA+K L + + ++ F +E ++ + H N+
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHLLE-DKADTLCWERRLQIASESAQGLEYLHNGC 678
L G + + ++ E+M NG+L A L + D T+ + + + A G++YL +
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI--QLVGMLRGIASGMKYLSD-- 124
Query: 679 KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYYIS 737
VHRD+ + NIL+N K++DFGLSR+ + +T P + PE
Sbjct: 125 -MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183
Query: 738 NRLTEKSDVYSFGVVLLELIT 758
+ T SDV+S+G+V+ E+++
Sbjct: 184 RKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 7e-16
Identities = 65/203 (32%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 567 RVLGKGGFGTVY--HGYLDDKQVAVKMLSSSSVQGYKQFQ---AEVELLIRAHHKNLTIL 621
R +G G FG VY ++ VA+K +S S Q +++Q EV+ L R H N
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPP 681
G L+ E+ + LLE L I + QGL YLH+
Sbjct: 91 KGCYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---N 145
Query: 682 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYIS---N 738
++HRD+K+ NILL E Q KLADFG + I + + VGTP ++ PE ++
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVILAMDEG 199
Query: 739 RLTEKSDVYSFGVVLLELITGQP 761
+ K DV+S G+ +EL +P
Sbjct: 200 QYDGKVDVWSLGITCIELAERKP 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 8e-16
Identities = 69/228 (30%), Positives = 114/228 (50%), Gaps = 32/228 (14%)
Query: 557 DVLKITNNFERVLGKGGFGTVYHG--YLDDKQVAVKMLSSSSVQGYKQFQAEV---ELLI 611
D K +E++ G+G GTV+ ++VA+K ++ KQ + E+ E+L+
Sbjct: 16 DPKKKYTRYEKI-GQGASGTVFTAIDVATGQEVAIKQINLQ-----KQPKKELIINEILV 69
Query: 612 RAHHKNLTILVGYCDE---GANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIAS--- 665
KN I V + D G + ++ E++A G+L + E D QIA+
Sbjct: 70 MKELKNPNI-VNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMD------EAQIAAVCR 122
Query: 666 ESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGL-SRIFPVEGGTHVSTTVV 724
E Q LE+LH ++HRD+KS N+LL KL DFG ++I P + +T+V
Sbjct: 123 ECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTMV 176
Query: 725 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ-PVIQKTPQRTL 771
GTP ++ PE K D++S G++ +E++ G+ P + + P R L
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 8e-16
Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 567 RVLGKGGFGTVY-----HGYLDDKQVAVKMLSSSSV----QGYKQFQAEVELLIRAHHKN 617
+VLGKGG+G V+ G K A+K+L +++ + +AE +L H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHL------LEDKADTLCWERRLQIASESAQGL 671
+ L+ G + LI E+++ G L HL +ED A C+ SE + L
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTA---CF-----YLSEISLAL 113
Query: 672 EYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLD 731
E+LH + I++RD+K NILL+ + KL DFGL + + GT V+ T GT Y+
Sbjct: 114 EHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGT-VTHTFCGTIEYMA 168
Query: 732 PEYYISNRLTEKSDVYSFGVVLLELITGQP 761
PE + + + D +S G ++ +++TG P
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTGAP 198
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 11/208 (5%)
Query: 567 RVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQ---GYKQFQAEVELLIRAHHKNLTIL 621
RVLGKGGFG V + K A K L ++ G E ++L + + + + L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPP 681
+ + L+ M G+L+ H+ R + A+E GLE LH +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QER 122
Query: 682 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLT 741
IV+RD+K NILL++ +++D GL+ P EG T VGT GY+ PE + R T
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQTIKGR--VGTVGYMAPEVVKNERYT 179
Query: 742 EKSDVYSFGVVLLELITGQPVIQKTPQR 769
D ++ G +L E+I GQ Q+ ++
Sbjct: 180 FSPDWWALGCLLYEMIAGQSPFQQRKKK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 63/201 (31%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 569 LGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQ---AEVELLIRAHHKNLTILVG 623
+G G FG VY ++ VAVK +S S Q +++Q EV+ L + H N G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIV 683
+ L+ E+ + LLE L I + QGL YLH+ +
Sbjct: 89 CYLKEHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM---I 143
Query: 684 HRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYIS---NRL 740
HRD+K+ NILL E Q KLADFG + + + + VGTP ++ PE ++ +
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASK------SSPANSFVGTPYWMAPEVILAMDEGQY 197
Query: 741 TEKSDVYSFGVVLLELITGQP 761
K DV+S G+ +EL +P
Sbjct: 198 DGKVDVWSLGITCIELAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 76/278 (27%), Positives = 125/278 (44%), Gaps = 32/278 (11%)
Query: 566 ERVLGKGGFGTVYHGYLD-----DKQVAVKMLSSS-SVQGYKQFQAEVELLIRAHHKNLT 619
E V+G G FG V G L + VA+K L S + + + F +E ++ + H N+
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHL-LEDKADTLCWERRLQIASESAQGLEYLHNGC 678
L G + + +I EFM NG L + L D T+ + + + A G++YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI--QLVGMLRGIAAGMKYL---S 123
Query: 679 KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP---GYLDPEYY 735
+ VHRD+ + NIL+N K++DFGLSR + T+ +G + PE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 736 ISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIV--DHRL 793
+ T SDV+S+G+V+ E+++ G+ ++ D+ N + D+RL
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMS-------------YGERPYWDMSNQDVINAIEQDYRL 230
Query: 794 QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELN 831
D T ++ L C RP Q+V L+
Sbjct: 231 PPPMDCPTALH--QLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 45/217 (20%)
Query: 564 NFERVLGKGGFGTV--YHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNL--- 618
NF ++ G+G G V +QVAVK + Q + EV ++ H N+
Sbjct: 23 NFVKI-GEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 619 --TILVGYCDEGANMGLIYEFMANGNL-----QAHLLEDKADTLCWERRLQIASESAQGL 671
+ LVG DE + ++ EF+ G L + E++ T+C L + + L
Sbjct: 82 YSSYLVG--DE---LWVVMEFLEGGALTDIVTHTRMNEEQIATVC----LAVL----KAL 128
Query: 672 EYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFG----LSRIFPVEGGTHVSTTVVGTP 727
+LH ++HRD+KS +ILL + KL+DFG +S+ P ++VGTP
Sbjct: 129 SFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR------KSLVGTP 179
Query: 728 GYLDPEYYISNRL---TEKSDVYSFGVVLLELITGQP 761
++ PE IS RL TE D++S G++++E++ G+P
Sbjct: 180 YWMAPE-VIS-RLPYGTE-VDIWSLGIMVIEMVDGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 28/212 (13%)
Query: 567 RVLGKGGFGTVYHGYLDDKQ---VAVKMLS----SSSVQG--YKQFQAEVELLIRAHHKN 617
+ LG G F + Y D K +AVK ++ +SS Q + + E+ L+ R +H +
Sbjct: 6 QQLGTGAFSSCY-QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLED-----KADTLCWERRLQIASESAQGLE 672
+ ++G E ++ L E+MA G++ +HLL +A + + +L +GL
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSV-SHLLSKYGAFKEAVIINYTEQL------LRGLS 117
Query: 673 YLHNGCKPPIVHRDVKSANILLNEKFQ-AKLADFGLSRIFP--VEGGTHVSTTVVGTPGY 729
YLH I+HRDVK AN+L++ Q ++ADFG + G ++GT +
Sbjct: 118 YLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 730 LDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
+ PE + DV+S G V++E+ T +P
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 66/220 (30%), Positives = 109/220 (49%), Gaps = 37/220 (16%)
Query: 564 NFERVLGKGGFGTVYHGYLDD-------KQVAVKMLS-SSSVQGYKQFQAEVELL--IRA 613
R LG+G FG VY G D +VAVK ++ S+S++ +F E ++
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68
Query: 614 HHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKAD----------TLCWERRLQI 663
HH + L+G +G ++ E MA+G+L+++L + + TL + +Q+
Sbjct: 69 HH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQM 124
Query: 664 ASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVE----GGTH 718
A+E A G+ YL N K VHRD+ + N ++ F K+ DFG++R I+ + GG
Sbjct: 125 AAEIADGMAYL-NAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG 181
Query: 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 758
+ ++ PE T SD++SFGVVL E+ +
Sbjct: 182 LLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 17/208 (8%)
Query: 563 NNFER--VLGKGGFGTVYHGYLDDKQ----VAVK-MLSSSSVQGYKQF-QAEVELLIRAH 614
N +E V+G+G +G V +K VA+K S + K+ EV++L +
Sbjct: 1 NKYEVLGVVGEGAYGVVLK--CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR 58
Query: 615 HKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL 674
H+N+ L + L++E++ L+ LLE L + + Q + Y
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 675 HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEY 734
H I+HRD+K NIL++E KL DFG +R T V T Y PE
Sbjct: 117 H---SHNIIHRDIKPENILVSESGVLKLCDFGFARALR-ARPASPLTDYVATRWYRAPEL 172
Query: 735 YISNRLTEKS-DVYSFGVVLLELITGQP 761
+ + K DV++ G ++ EL+ G+P
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 19/219 (8%)
Query: 567 RVLGKGGFGTVYHG-YLDDKQVAVKMLSSSSVQGYKQFQAEVELLIR-AHHKNLTILVGY 624
V+G G +G VY G ++ Q+A + + ++ + E+ +L + +HH+N+ G
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 625 CDEGANMG------LIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGC 678
+ + G L+ EF G++ + K + L + I E +GL +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH--- 138
Query: 679 KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISN 738
++HRD+K N+LL E + KL DFG+S G T +GTP ++ PE +
Sbjct: 139 AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYWMAPEVIACD 196
Query: 739 RLTE-----KSDVYSFGVVLLELITGQ-PVIQKTPQRTL 771
+ +SD++S G+ +E+ G P+ P R L
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 567 RVLGKGGFGTVYHGYLDDKQ--VAVKMLSSSSVQGYKQFQA---EVELLIRA-HHKNLTI 620
+VLGKG FG V L A+K L V + E +L A H LT
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 621 LVGYCDEGANMGLIY--EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGC 678
L +C L + E++ G+L H+ R A+E GL++LH
Sbjct: 61 L--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDE--ARARFYAAEIICGLQFLH--- 113
Query: 679 KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISN 738
K I++RD+K N+LL++ K+ADFG+ + G ++T GTP Y+ PE
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFCGTPDYIAPEILKGQ 171
Query: 739 RLTEKSDVYSFGVVLLELITGQ 760
+ E D +SFGV+L E++ GQ
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 26/209 (12%)
Query: 566 ERVLGKGGFGTVYHG--YLDDKQVAVKMLSSSSVQGYKQFQ---AEVELLIRAHHKNLTI 620
E+ +G+G F VY LD VA+K + + K E++LL + +H N+
Sbjct: 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 66
Query: 621 LVGYCDEGANMGLIYEFMANGNL---------QAHLLEDKADTLCWERRLQIASESAQGL 671
E + ++ E G+L Q L+ +K W+ +Q+ S L
Sbjct: 67 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKT---VWKYFVQLCS----AL 119
Query: 672 EYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLD 731
E++H+ ++HRD+K AN+ + KL D GL R F + T + ++VGTP Y+
Sbjct: 120 EHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMS 174
Query: 732 PEYYISNRLTEKSDVYSFGVVLLELITGQ 760
PE N KSD++S G +L E+ Q
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-15
Identities = 67/231 (29%), Positives = 107/231 (46%), Gaps = 26/231 (11%)
Query: 566 ERVLGKGGFGTVYHG--YLDDKQVAVKM--LSSSSVQGYKQFQAEVELL-------IRAH 614
RVLG G GTV D + AVK+ + S + QAEV L I
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 615 HKNLTILVGYCDEG-----ANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQ 669
H++ D + L+ ++ G+L+ + + +A T R + Q
Sbjct: 97 HEDFA----KKDPRNPENVLMIALVLDYANAGDLRQEI-KSRAKTNRTFREHEAGLLFIQ 151
Query: 670 GLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGY 729
L +H+ ++HRD+KSANILL KL DFG S+++ V T GTP Y
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211
Query: 730 LDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPV----IQKTPQRTLIGQW 775
+ PE + ++K+D++S GV+L EL+T +P +++ +TL G++
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY 262
|
Length = 496 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 15/216 (6%)
Query: 567 RVLGKGGFGTVYHG-YLDDK----QVAVKMLSSSSVQGYKQ-FQAEVELLIRAHHKNLTI 620
R +G+G FG VY G Y+ + VAVK + + ++ F E ++ + H ++
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 621 LVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKP 680
L+G E + ++ E G L+++L +K +L + + + + L YL +
Sbjct: 72 LIGVITENP-VWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLES---K 126
Query: 681 PIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYYISNR 739
VHRD+ + N+L++ KL DFGLSR +E ++ + P ++ PE R
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 740 LTEKSDVYSFGVVLLE-LITGQPVIQKTPQRTLIGQ 774
T SDV+ FGV + E L+ G Q +IG+
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR 220
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 39/224 (17%)
Query: 569 LGKGGFGTVYHGY--LDDKQVAVK-MLSSSSVQGYK-QFQAEVELLIRAHHKN----LTI 620
LG+G FG VY + VA+K +L + G+ E+++L + H N + +
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 621 LVGYCDEGAN-MGLIY---EFMAN------GNLQAHLLEDKADTLCWERRLQIASESAQG 670
V D+ G +Y +M + N L E + C+ LQ+ +G
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTE--SQIKCY--MLQLL----EG 127
Query: 671 LEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF---------PVEGGTHVST 721
+ YLH + I+HRD+K+ANIL++ + K+ADFGL+R + GGT T
Sbjct: 128 INYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184
Query: 722 TVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQ 764
+V T Y PE + R T D++ G V E+ T +P++Q
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ 228
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 52/194 (26%), Positives = 96/194 (49%), Gaps = 9/194 (4%)
Query: 569 LGKGGFGT--VYHGYLDDKQVAVKMLSSSSVQGYKQFQA--EVELLIRAHHKNLTILVGY 624
+G+G FG + D KQ +K ++ S + ++ ++ EV +L H N+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 625 CDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVH 684
+E N+ ++ ++ G+L + + ++ L + L+++H+ I+H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILH 124
Query: 685 RDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKS 744
RD+KS NI L + KL DFG++R+ + ++ T +GTP YL PE + KS
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEICENRPYNNKS 182
Query: 745 DVYSFGVVLLELIT 758
D+++ G VL E+ T
Sbjct: 183 DIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-15
Identities = 62/203 (30%), Positives = 92/203 (45%), Gaps = 19/203 (9%)
Query: 567 RVLGKGGFGTVYHG--YLDDKQVAVKMLSSSSVQGYKQFQ---AEVELLIRAHHKNLTIL 621
R +G G FG VY + + VA+K +S S Q +++Q EV L + H N
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPP 681
G L+ E+ + LLE L + + QGL YLH+
Sbjct: 81 RGCYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---N 135
Query: 682 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYIS---N 738
++HRDVK+ NILL+E KL DFG + I + VGTP ++ PE ++
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMAPEVILAMDEG 189
Query: 739 RLTEKSDVYSFGVVLLELITGQP 761
+ K DV+S G+ +EL +P
Sbjct: 190 QYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-15
Identities = 40/85 (47%), Positives = 54/85 (63%), Gaps = 5/85 (5%)
Query: 393 VYMWQGINCSYDANQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEF 452
V +WQGI C N S R++SI+LS I+G I IF L I++++LS N L+GP+P+
Sbjct: 57 VCLWQGITC----NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDD 112
Query: 453 LAEL-QSLRVLNLSGNNLQGSLPSG 476
+ SLR LNLS NN GS+P G
Sbjct: 113 IFTTSSSLRYLNLSNNNFTGSIPRG 137
|
Length = 968 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 58/235 (24%)
Query: 562 TNNFE--RVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQGYKQFQAEVELLIR-AHHK 616
T FE V+G+G +G VY + VA+K++ + ++ + E +L + ++H
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHP 63
Query: 617 NLT------ILVGYCDEGANMGLIYEFMANG---NLQAHLLEDKADTLCWERRL---QIA 664
N+ I + L+ E G +L L + +RL IA
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG-------KRLKEEWIA 116
Query: 665 ---SESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721
E+ +GL YLH ++HRD+K NILL + + KL DFG+S + +
Sbjct: 117 YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA--------QLDS 165
Query: 722 TV------VGTPGYLDPE---------YYISNRLTEKSDVYSFGVVLLELITGQP 761
T+ +GTP ++ PE R SDV+S G+ +EL G+P
Sbjct: 166 TLGRRNTFIGTPYWMAPEVIACDEQPDASYDAR----SDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 39/224 (17%)
Query: 569 LGKGGFGTVYHGY--LDDKQVAVKMLS----SSSVQGYKQFQAEV--------ELLI--R 612
LG+G +G V Y L K VA+K + S+ V +Q EL I
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 613 AHHKNLTILVG-YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQ-IASESAQG 670
H+N+ LV Y + + L+ + MA +L +++ K E +++ I + G
Sbjct: 77 IKHENIMGLVDVYVEGDF-INLVMDIMA-SDL-KKVVDRK--IRLTESQVKCILLQILNG 131
Query: 671 LEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR--IFPVEGGTHVS-------- 720
L LH K +HRD+ ANI +N K K+ADFGL+R +P T
Sbjct: 132 LNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 721 --TTVVGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQP 761
T+ V T Y PE + + + D++S G + EL+TG+P
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 8e-15
Identities = 67/208 (32%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 567 RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLT-- 619
+V+GKG FG V D K AVK+L ++ + K AE +L+ KN+
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLL----KNVKHP 56
Query: 620 ILVG--YCDEGAN-MGLIYEFMANGNLQAHLLEDKADTLCWERRLQI-ASESAQGLEYLH 675
LVG Y + A+ + + +++ G L HL +++ E R + A+E A L YLH
Sbjct: 57 FLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFP---EPRARFYAAEIASALGYLH 113
Query: 676 NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG--GTHVSTTVVGTPGYLDPE 733
+ I++RD+K NILL+ + L DFGL + EG + ++T GTP YL PE
Sbjct: 114 S---LNIIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEHSKTTSTFCGTPEYLAPE 166
Query: 734 YYISNRLTEKSDVYSFGVVLLELITGQP 761
D + G VL E++ G P
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 567 RVLGKGGFGTVYHGYLDDKQ--VAVKMLSSSSVQGYKQFQAEVE--------LLIRAHHK 616
+VLGKG FG V L K AVK L V +VE L + +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL----IDDDVECTMVEKRVLALAWENP 56
Query: 617 NLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN 676
LT L ++ + EF+ G+L H+ +DK + R A+E GL++LH+
Sbjct: 57 FLTHLYCTFQTKEHLFFVMEFLNGGDLMFHI-QDKGRFDLY-RATFYAAEIVCGLQFLHS 114
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSR--IFPVEGGTHVSTTVVGTPGYLDPEY 734
I++RD+K N++L+ K+ADFG+ + +F G + ++T GTP Y+ PE
Sbjct: 115 K---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF----GDNRASTFCGTPDYIAPEI 167
Query: 735 YISNRLTEKSDVYSFGVVLLELITGQ 760
+ T D +SFGV+L E++ GQ
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 63/219 (28%), Positives = 90/219 (41%), Gaps = 42/219 (19%)
Query: 564 NFERVLGKGGFGTV----YHGYLDDKQVAVKMLSSSSVQGYKQF---QAEVELLI----- 611
VLG+G FG V Y + A+K L K + EVE L+
Sbjct: 2 RCLAVLGRGHFGKVLLAEYKK--TGELYAIKALK-------KGDIIARDEVESLMCEKRI 52
Query: 612 -----RAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI-AS 665
H L L ++ + E+ A G+L H+ D E R A+
Sbjct: 53 FETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS----EPRAVFYAA 108
Query: 666 ESAQGLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST--T 722
GL+YLH N IV+RD+K N+LL+ + K+ADFGL + EG T
Sbjct: 109 CVVLGLQYLHENK----IVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTST 160
Query: 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
GTP +L PE T D + GV++ E++ G+
Sbjct: 161 FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 25/227 (11%)
Query: 569 LGKGGFGTVYHGYLD----DKQVAVKMLSSSSVQGY--KQFQAEVELLIRAHHKNLTILV 622
LG G FGTV G +K VAVK+L + + + E ++ + + + ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 623 GYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRL-QIASESAQGLEYL--HNGCK 679
G C E + L+ E G L L ++K T E+ + ++ + + G++YL N
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVT---EKNITELVHQVSMGMKYLEETN--- 115
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYYISN 738
VHRD+ + N+LL + AK++DFGLS+ + + + T P + PE
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 739 RLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGD 784
+ + KSDV+SFGV++ E + GQ P + + G V+ M+ G+
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQ-----KPYKGMKGNEVTQMIESGE 215
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 59/222 (26%), Positives = 109/222 (49%), Gaps = 17/222 (7%)
Query: 569 LGKGGFGTVYHGY--LDDKQ--VAVKMLSSSSVQGYK-QFQAEVELLIRAHHKNLTILVG 623
LG G FG V G + KQ VA+K+L + + + + + E E++ + + + ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIV 683
C E + L+ E MA+G L K D + +++ + + G++YL V
Sbjct: 63 VC-EAEALMLVME-MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117
Query: 684 HRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYYISNRLTE 742
HRD+ + N+LL + AK++DFGLS+ + + + + P + PE + +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 743 KSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARG 783
+SDV+S+G+ + E + GQ P + + G V S + +G
Sbjct: 178 RSDVWSYGITMWEAFSYGQ-----KPYKKMKGPEVMSFIEQG 214
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 20/224 (8%)
Query: 569 LGKGGFGTVYHGYL--DDKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVG 623
LGKGGFG V + K A K L+ + +GY+ E +L + H + + L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 624 YCDEGANMGLIYEFMANGNLQAHL--LEDKADTLCWERRLQIASESAQGLEYLHNGCKPP 681
++ L+ M G+L+ H+ ++++ R ++ GLE+LH +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117
Query: 682 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLT 741
I++RD+K N+LL+ +++D GL+ ++ G + GTPG++ PE
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175
Query: 742 EKSDVYSFGVVLLELIT--------GQPVIQKTPQRTLIGQWVS 777
D ++ GV L E+I G+ V K ++ ++ V+
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVT 219
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 60/200 (30%), Positives = 104/200 (52%), Gaps = 14/200 (7%)
Query: 567 RVLGKGGFGTVYHG-YLDDKQ-----VAVKML-SSSSVQGYKQFQAEVELLIRAHHKNLT 619
+VLG G FGTVY G ++ D + VA+K+L ++S + K+ E ++ +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCK 679
L+G C + + L+ + M G L ++ E+K D + + L + A+G+ YL +
Sbjct: 73 RLLGIC-LTSTVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLE---E 127
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV-EGGTHVSTTVVGTPGYLDPEYYISN 738
+VHRD+ + N+L+ K+ DFGL+R+ + E H V ++ E +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK-WMALESILHR 186
Query: 739 RLTEKSDVYSFGVVLLELIT 758
R T +SDV+S+GV + EL+T
Sbjct: 187 RFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 50/224 (22%)
Query: 564 NFERV--LGKGGFGTVYHG--YLDDKQVAVKM---------LSSSSVQGYKQFQAEVELL 610
FE++ +G+G +G VY + VA+K + SS++ E+ LL
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-------EITLL 60
Query: 611 IRAHHKN----LTILVGYCDEGANMGLIYEF----MAN--GNLQAHLLEDKADTLCWERR 660
+ H N ++VG ++ L+ E+ +A+ N+ E + L
Sbjct: 61 LNLRHPNIVELKEVVVG--KHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLM---- 114
Query: 661 LQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF--PVEGGTH 718
LQ+ +GL+YLH I+HRD+K +N+LL +K K+ADFGL+R + P
Sbjct: 115 LQLL----RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA---KP 164
Query: 719 VSTTVVGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQP 761
++ VV T Y PE + T D+++ G +L EL+ +P
Sbjct: 165 MTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 65/229 (28%), Positives = 105/229 (45%), Gaps = 28/229 (12%)
Query: 551 RKFSYFDVLKITNNFERVLGKGGFGTVYHG--YLDDKQVAVKMLSSSSVQGYKQFQA--E 606
R FD++ G+G +G VY + VA+K + + + A E
Sbjct: 4 RCVDKFDIIGQI-------GEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIRE 56
Query: 607 VELLIRAHHKNLTIL----------VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLC 656
+++L + +H+N+ L + + + L++E+M + +L LLE
Sbjct: 57 IKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMG-LLESGLVHFS 114
Query: 657 WERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716
+ + +GL Y H K +HRD+K +NILLN K Q KLADFGL+R++ E
Sbjct: 115 EDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
Query: 717 THVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQ 764
+ V+ T Y PE + R DV+S G +L EL T +P+ Q
Sbjct: 172 RPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 62/199 (31%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 567 RVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQ---GYKQFQAEVELLIRAHHKNLTIL 621
RVLGKGGFG V + K A K L ++ G E ++L + + + + L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPP 681
+ + L+ M G+L+ H+ ER L A+E GLE LH +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---REN 122
Query: 682 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLT 741
V+RD+K NILL++ +++D GL+ P EG VGT GY+ PE + R T
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIP-EG--ESIRGRVGTVGYMAPEVLNNQRYT 179
Query: 742 EKSDVYSFGVVLLELITGQ 760
D + G ++ E+I GQ
Sbjct: 180 LSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 61/238 (25%), Positives = 109/238 (45%), Gaps = 34/238 (14%)
Query: 565 FERVLGKGGFGTVY-------HGYLDDK-----------QVAVKMLSSSSVQGYKQ-FQA 605
F+ LG+G FG V+ ++D VAVKML + + + F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 606 EVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL---------QAHLLEDKADTLC 656
E++++ R N+ L+ C + +I E+M NG+L Q + T+
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 657 WERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716
+ + +A++ A G++YL + VHRD+ + N L+ + + K+ADFG+SR
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT---GQPVIQKTPQRTL 771
+ V ++ E + + T SDV++FGV L E++T QP Q + ++ +
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 567 RVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQ---GYKQFQAEVELLIRAHHKNLTIL 621
RVLGKGGFG V + K A K L ++ G E +L + + + +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR-FVVS 64
Query: 622 VGYCDEGAN-MGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKP 680
+ Y E + + L+ M G+L+ H+ +R + A+E GLE L +
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RE 121
Query: 681 PIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRL 740
IV+RD+K NILL+++ +++D GL+ P EG T VGT GY+ PE + +
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIP-EGETVRGR--VGTVGYMAPEVINNEKY 178
Query: 741 TEKSDVYSFGVVLLELITGQPVIQKTPQR 769
T D + G ++ E+I GQ +K +R
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQSPFRKRKER 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 58/204 (28%), Positives = 106/204 (51%), Gaps = 14/204 (6%)
Query: 567 RVLGKGGFGTVYHG-YLDDKQ-----VAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLT 619
+VLG G FGTVY G ++ + + VA+K+L+ ++ + +F E ++ H +L
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCK 679
L+G C + L+ + M +G L ++ E K D + + L + A+G+ YL +
Sbjct: 73 RLLGVC-LSPTIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLE---E 127
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNR 739
+VHRD+ + N+L+ K+ DFGL+R+ + + + ++ E +
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 187
Query: 740 LTEKSDVYSFGVVLLELIT--GQP 761
T +SDV+S+GV + EL+T G+P
Sbjct: 188 FTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 569 LGKGGFGTVYHG-------YLDDKQVAVKM----LSSSSVQGYKQFQAEVELLIRAH--- 614
+G G +GTVY ++ K V V+ L S+V+ EV LL R
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-------EVALLKRLEAFD 60
Query: 615 HKNLTILVGYC-----DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQ 669
H N+ L+ C D + L++E + + +L+ +L + L E + + +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 670 GLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGY 729
GL++LH C IVHRD+K NIL+ Q KLADFGL+RI+ + T VV T Y
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL---TPVVVTLWY 173
Query: 730 LDPEYYISNRLTEKSDVYSFGVVLLELITGQPV 762
PE + + D++S G + E+ +P+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 28/187 (14%)
Query: 585 KQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL- 643
+QVAVKM+ Q + EV ++ H+N+ + G + ++ EF+ G L
Sbjct: 47 RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106
Query: 644 ----QAHLLEDKADTLCWERRLQIASESA-QGLEYLHNGCKPPIVHRDVKSANILLNEKF 698
Q L E++ T+C ES Q L YLH+ ++HRD+KS +ILL
Sbjct: 107 DIVSQTRLNEEQIATVC---------ESVLQALCYLHS---QGVIHRDIKSDSILLTLDG 154
Query: 699 QAKLADFG----LSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLL 754
+ KL+DFG +S+ P ++VGTP ++ PE + D++S G++++
Sbjct: 155 RVKLSDFGFCAQISKDVPKR------KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVI 208
Query: 755 ELITGQP 761
E++ G+P
Sbjct: 209 EMVDGEP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-14
Identities = 62/200 (31%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRA-HHKNLTI 620
++LGKG FG V+ L ++ A+K L V + E +L A H LT
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 621 LVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKP 680
L N+ + E++ G+L H+ R A+E GL++LH+
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRATFYAAEIICGLQFLHS---K 115
Query: 681 PIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRL 740
IV+RD+K NILL+ K+ADFG+ + + G + T GTP Y+ PE + +
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCGTPDYIAPEILLGQKY 173
Query: 741 TEKSDVYSFGVVLLELITGQ 760
D +SFGV+L E++ GQ
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 63/198 (31%), Positives = 91/198 (45%), Gaps = 17/198 (8%)
Query: 569 LGKGGFGTVYHGYLDDKQVA---VKMLSSSSVQGYK-----QFQAEVELLIRAHHKNLTI 620
LGKG FGTVY D K VA +K+L V Q E +LL + H +
Sbjct: 8 LGKGSFGTVYL-VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 621 LVGYCDEGANMGLIYEFMANGNLQAHLLEDK--ADTLCWERRLQIASESAQGLEYLHNGC 678
E +I E+ +L L E K TL + + + G+ Y+H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH--- 123
Query: 679 KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISN 738
+ I+HRD+K+ NI L K+ DFG+SR+ + G ++TT GTP Y+ PE
Sbjct: 124 QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEALKHQ 180
Query: 739 RLTEKSDVYSFGVVLLEL 756
KSD++S G +L E+
Sbjct: 181 GYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-14
Identities = 60/225 (26%), Positives = 111/225 (49%), Gaps = 16/225 (7%)
Query: 567 RVLGKGGFGTVYHG-YLDDKQ-----VAVKML-SSSSVQGYKQFQAEVELLIRAHHKNLT 619
+VLG G FGTVY G ++ + + VA+K L ++S + K+ E ++ + ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCK 679
L+G C + LI + M G L ++ E K D + + L + A+G+ YL +
Sbjct: 73 RLLGICLTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---E 127
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNR 739
+VHRD+ + N+L+ K+ DFGL+++ + + + ++ E +
Sbjct: 128 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRI 187
Query: 740 LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGD 784
T +SDV+S+GV + EL+T P + +SS+L +G+
Sbjct: 188 YTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEKGE 228
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 9e-14
Identities = 69/241 (28%), Positives = 110/241 (45%), Gaps = 29/241 (12%)
Query: 556 FDVLKITNNFERV--LGKGGFGTVY---HGYLDDKQVAVKM-LSSSSVQGYKQFQA--EV 607
F + +E++ +G+G FG V+ H VA+K L + +G+ A E+
Sbjct: 5 FPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQI-VALKKVLMENEKEGFP-ITALREI 62
Query: 608 ELLIRAHHKNLTILVGYCDEGANMG--------LIYEFMANGNLQAHLLEDKADTLCWER 659
++L H+N+ L+ C A L++EF + +L A LL +K
Sbjct: 63 KILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DL-AGLLSNKNVKFTLSE 120
Query: 660 RLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF--PVEGGT 717
++ GL Y+H I+HRD+K+ANIL+ + KLADFGL+R F
Sbjct: 121 IKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177
Query: 718 HVSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQ---KTPQRTLIG 773
+ T V T Y PE + R D++ G ++ E+ T P++Q + Q TLI
Sbjct: 178 NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS 237
Query: 774 Q 774
Q
Sbjct: 238 Q 238
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-13
Identities = 66/249 (26%), Positives = 112/249 (44%), Gaps = 46/249 (18%)
Query: 563 NNFE--RVLGKGGFGTVYHGYLDDKQ--VAVKMLSSSSVQGYKQ---FQAEVELLIRAHH 615
++FE +V+G+G FG V D A+K+L + + +Q +AE ++L+ A
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH 675
+ + + N+ LI EF+ G++ L+ K DTL E +E+ ++ +H
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIH 118
Query: 676 NGCKPPIVHRDVKSANILLNEKFQAKLADFGLS-------RIFPVEGGTH---------- 718
+ +HRD+K N+LL+ K KL+DFGL R TH
Sbjct: 119 ---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 719 ----------------VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITG-QP 761
++ + VGTP Y+ PE ++ + D +S GV++ E++ G P
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 762 VIQKTPQRT 770
+TPQ T
Sbjct: 236 FCSETPQET 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 62/201 (30%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 567 RVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQGYKQFQA---EVELLIRAH-HKNLTI 620
RVLGKG FG V L + AVK+L + + E +L A H LT
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 621 LVGYCDEGAN-MGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCK 679
L C + + + + EF+ G+L H+ K+ R A+E L +LH+
Sbjct: 61 LY-CCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITSALMFLHD--- 114
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNR 739
I++RD+K N+LL+ + KLADFG+ + G T ++T GTP Y+ PE
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEILQEML 172
Query: 740 LTEKSDVYSFGVVLLELITGQ 760
D ++ GV+L E++ G
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGH 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 25/216 (11%)
Query: 564 NFERV--LGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQA-EVELLIRAHHKNL 618
NF+++ LG+G + TVY G + VA+K + + +G E+ L+ H+N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 619 TILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESA------QGLE 672
L + L++E+M + +L+ ++ DT L + + +G+
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYM-----DTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 673 YLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLD 731
+ H N ++HRD+K N+L+N++ + KLADFGL+R F + T S VV T Y
Sbjct: 115 FCHENR----VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVV-TLWYRA 168
Query: 732 PEYYISNRLTEKS-DVYSFGVVLLELITGQPVIQKT 766
P+ + +R S D++S G ++ E+ITG+P+ T
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 567 RVLGKGGFGTVYHGYLDDK----QVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTI 620
+ LG+G FG+V G L+ +VAVK + + + + F +E + H N+
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 621 LVGYCDEGA-NMG-----LIYEFMANGNLQAHLLE----DKADTLCWERRLQIASESAQG 670
L+G C + + G +I FM +G+L + LL D L + ++ ++ A G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 671 LEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GY 729
+EYL + +HRD+ + N +LNE +ADFGLS+ G + + P +
Sbjct: 125 MEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKI-YNGDYYRQGRIAKMPVKW 180
Query: 730 LDPEYYISNRLTEKSDVYSFGVVLLELIT-GQ 760
+ E T KSDV+SFGV + E+ T GQ
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQ 212
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 64/215 (29%), Positives = 92/215 (42%), Gaps = 30/215 (13%)
Query: 569 LGKGGFGTVY--HGYLDDKQVAVKMLSSSSVQGYKQFQ---AEVELLIRAHHKNL-TILV 622
LG G FG V + A+K L + KQ Q E +L+ H + ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 623 GYCDEGANMGLIYEFMANGNLQAHLLE------DKADTLCWERRLQIASESAQGLEYLHN 676
+ DE + + EF+ G L HL + D A E L EYLH+
Sbjct: 86 SFQDEN-RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL--------AFEYLHS 136
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYI 736
I++RD+K N+LL+ K K+ DFG ++ P + T+ GTP YL PE
Sbjct: 137 ---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQ 188
Query: 737 SNRLTEKSDVYSFGVVLLELITGQ-PVIQKTPQRT 770
S + D ++ GV+L E I G P TP R
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI 223
|
Length = 329 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 67/256 (26%), Positives = 107/256 (41%), Gaps = 57/256 (22%)
Query: 563 NNFE--RVLGKGGFGTV--YHGYLDDKQVAVKMLSSSSVQGYKQ---FQAEVELLIRAHH 615
++FE +V+G+G FG V A+K L S + +Q +AE ++L A
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD- 59
Query: 616 KNLTILVGYC---DEGANMGLIYEFMANGNLQAHLLEDKADTLCWER-RLQIASESAQGL 671
N ++ Y DE + LI E++ G++ L+ K DT E R IA E+ +
Sbjct: 60 -NPWVVKLYYSFQDE-NYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYIA-ETILAI 114
Query: 672 EYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLS-------------RIFPVEGGTH 718
+ +H K +HRD+K N+LL+ K KL+DFGL +
Sbjct: 115 DSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 719 VSTT-----------------------VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLE 755
+ VGTP Y+ PE ++ ++ D +S GV++ E
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231
Query: 756 LITG-QPVIQKTPQRT 770
++ G P PQ T
Sbjct: 232 MLVGYPPFCSDNPQET 247
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 65/264 (24%), Positives = 119/264 (45%), Gaps = 30/264 (11%)
Query: 606 EVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIAS 665
E+ +L + H+NL L+ + L++EF+ + L LE + L R +
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDD--LEKYPNGLDESRVRKYLF 107
Query: 666 ESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG 725
+ +G+E+ H+ I+HRD+K NIL+++ KL DFG +R + V T V
Sbjct: 108 QILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFART--LAAPGEVYTDYVA 162
Query: 726 TPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGD 784
T Y PE + + + D+++ G ++ E++TG+P+ P + I Q + G+
Sbjct: 163 TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF---PGDSDIDQLYHIIKCLGN 219
Query: 785 IKNIVDHRLQGDFDTNTVWKAVEIALAC-IHTISTRRPTMNQVVIEL-NDCLAMEIARTK 842
+ R Q F N ++ + + I + R P ++ +V++L CL ++
Sbjct: 220 LIP----RHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRID----- 270
Query: 843 AHETAPDGTPDELMIDLNLHSDVF 866
PD P + LH + F
Sbjct: 271 -----PDDRPSSSQL---LHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 21/219 (9%)
Query: 564 NFERV--LGKGGFGTVYHG--YLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLT 619
+FE + +G G +G VY + A+K++ + + Q E+ ++ H N+
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIA---SESAQGLEYLHN 676
G + + EF G+LQ D QIA E+ QGL YLH+
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQ-----DIYHVTGPLSESQIAYVSRETLQGLYYLHS 124
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYI 736
K +HRD+K ANILL + KLADFG+S + + +GTP ++ PE
Sbjct: 125 KGK---MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWMAPEVAA 179
Query: 737 SNR---LTEKSDVYSFGVVLLELITGQ-PVIQKTPQRTL 771
R + D+++ G+ +EL Q P+ P R L
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-13
Identities = 64/248 (25%), Positives = 111/248 (44%), Gaps = 46/248 (18%)
Query: 564 NFE--RVLGKGGFGTVYHGYLDDKQ--VAVKMLSSSSVQGYKQ---FQAEVELLIRAHHK 616
+FE +V+G+G FG V D A+K+L + + +Q +AE ++L+ A
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 617 NLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN 676
+ + + N+ LI EF+ G++ L+ K DTL E +E+ ++ +H
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYIAETVLAIDSIH- 118
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFG----------------LSRIFPVE------ 714
+ +HRD+K N+LL+ K KL+DFG L+ P +
Sbjct: 119 --QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 715 -----------GGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITG-QPV 762
++ + VGTP Y+ PE ++ + D +S GV++ E++ G P
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 763 IQKTPQRT 770
+TPQ T
Sbjct: 237 CSETPQET 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 567 RVLGKGGFGTV--YHGYLDDKQVAVKMLSSSSVQGYKQFQ---AEVELLIRAHHKNLTIL 621
++LGKG FG V K A+K+L + + E +L H LT L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPP 681
+ + E++ G L HL ++ +R +E L+YLH+G
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSG---K 115
Query: 682 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST--TVVGTPGYLDPEYYISNR 739
IV+RD+K N++L++ K+ DFGL + EG T +T T GTP YL PE N
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCK----EGITDAATMKTFCGTPEYLAPEVLEDND 171
Query: 740 LTEKSDVYSFGVVLLELITGQ 760
D + GVV+ E++ G+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 564 NFERV--LGKGGFGTVYHGYLDDKQV-----AVKMLSSSSVQGYKQFQ---AEVELLIRA 613
+ ER+ +G G FG V+ L ++ A+K+++ V KQ Q E +L
Sbjct: 2 DLERIKTVGTGTFGRVH---LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV 58
Query: 614 HHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEY 673
H + L + + ++ E++ G L ++L + L ASE LEY
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALEY 116
Query: 674 LHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPE 733
LH+ IV+RD+K NILL+++ KL DFG ++ + T T+ GTP YL PE
Sbjct: 117 LHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTW---TLCGTPEYLAPE 168
Query: 734 YYISNRLTEKSDVYSFGVVLLELITGQP 761
S + D ++ G+++ E++ G P
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 565 FERVLGKGGFGTVY----HGYLD---------DKQ---VAVKMLSSSSVQGYKQ-FQAEV 607
+ LG+G FG V+ G + D Q VAVKML + + + F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 608 ELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLE----------DKADTLCW 657
+++ R + N+ L+G C + +I E+M NG+L L + + ++
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 658 ERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717
L +A + A G++YL VHRD+ + N L+ + K+ADFG+SR
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 758
+ V ++ E + + T SDV++FGV L E+ T
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 569 LGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYK-QFQAEVELLIRAHHKNLTILVGYC 625
LG+G + TV+ G L + VA+K + +G EV LL H N+ L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 626 DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHR 685
+ L++E++ + +L+ L++ + + + +GL Y H K I+HR
Sbjct: 73 HTERCLTLVFEYLDS-DLK-QYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHR 127
Query: 686 DVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYI-SNRLTEKS 744
D+K N+L+NEK + KLADFGL+R V T+ + V T Y P+ + S +
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYSTPI 185
Query: 745 DVYSFGVVLLELITGQPV 762
D++ G +L E+ TG+P+
Sbjct: 186 DMWGVGCILYEMATGRPM 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELL-----IRAHHKNLT 619
+VLGKG FG V L D+ AVK+L + +VE + A
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ----DDDVECTMTEKRVLALAGKHP 56
Query: 620 ILVG-YC--DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN 676
L + + + E++ G+L H+ R A+E GL++LH
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLH- 113
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYI 736
+ I++RD+K N+LL+ + K+ADFG+ + + G T ++T GTP Y+ PE
Sbjct: 114 --ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILS 169
Query: 737 SNRLTEKSDVYSFGVVLLELITGQP 761
D ++ GV+L E++ GQ
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 3e-13
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 38/213 (17%)
Query: 567 RVLGKGGFGTVYHG-YLDDKQ-VAVKML--SSSSVQGYKQFQAEVELLIR-AHHKNLTIL 621
+ LG G FG+VY + + VA+K + S + + EV+ L + H N+ L
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR-EVKSLRKLNEHPNIVKL 63
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQ-IASESAQGLEYLH-NGCK 679
E + ++E+M GNL L++D+ E ++ I + QGL ++H +G
Sbjct: 64 KEVFRENDELYFVFEYM-EGNLY-QLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG-- 119
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS-----TTVVGTPGYLDPE- 733
HRD+K N+L++ K+ADFGL+R + T V T Y PE
Sbjct: 120 --FFHRDLKPENLLVSGPEVVKIADFGLAR--------EIRSRPPYTDYVSTRWYRAPEI 169
Query: 734 -----YYISNRLTEKSDVYSFGVVLLELITGQP 761
Y S D+++ G ++ EL T +P
Sbjct: 170 LLRSTSYSS-----PVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 61/216 (28%), Positives = 107/216 (49%), Gaps = 28/216 (12%)
Query: 567 RVLGKGGFGTVYHGYLD---DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNL----- 618
R LG G G V+ +D DK+VAVK + + Q K E++++ R H N+
Sbjct: 11 RPLGCGSNGLVFSA-VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69
Query: 619 TILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESA--------QG 670
+ D ++G + E + +Q ++ D A+ L + ++ E A +G
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVL---EQGPLSEEHARLFMYQLLRG 126
Query: 671 LEYLHNGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIFP--VEGGTHVSTTVVGTP 727
L+Y+H+ ++HRD+K AN+ +N E K+ DFGL+RI ++S +V T
Sbjct: 127 LKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-TK 182
Query: 728 GYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPV 762
Y P +S N T+ D+++ G + E++TG+P+
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPL 218
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 11/198 (5%)
Query: 569 LGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYK-QFQAEVELLIRAHHKNLTILVGYC 625
LG+G + TVY G L D VA+K + +G EV LL H N+ L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 626 DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHR 685
++ L++E++ + +L+ +L +D +++ + +GL Y H + ++HR
Sbjct: 74 HTEKSLTLVFEYL-DKDLKQYL-DDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHR 128
Query: 686 DVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYI-SNRLTEKS 744
D+K N+L+NE+ + KLADFGL+R + T+ + V T Y P+ + S + +
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYSTQI 186
Query: 745 DVYSFGVVLLELITGQPV 762
D++ G + E+ TG+P+
Sbjct: 187 DMWGVGCIFYEMSTGRPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 31/216 (14%)
Query: 564 NFE--RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQ---FQAEVELLIRAHHK 616
+FE +V+G+G FG V L DK A+K+L+ + + F+ E ++L+ ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 617 NLTILVGYCDEGANMGLIYEFMANGNL-------QAHLLEDKADTLCWERRLQIASESAQ 669
+T L + N+ L+ ++ G+L + L ED A E + IA +S
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAE--MVIAIDSVH 119
Query: 670 GLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGY 729
L Y VHRD+K NIL++ +LADFG S + +E GT S+ VGTP Y
Sbjct: 120 QLHY---------VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDY 169
Query: 730 LDPEYYIS-----NRLTEKSDVYSFGVVLLELITGQ 760
+ PE + + + D +S GV + E++ G+
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 5e-13
Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 18/182 (9%)
Query: 585 KQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL- 643
KQVAVK + Q + EV ++ HH+N+ + G + ++ EF+ G L
Sbjct: 48 KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107
Query: 644 ----QAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQ 699
+ E++ T+C + L YLHN ++HRD+KS +ILL +
Sbjct: 108 DIVTHTRMNEEQIATVCLS--------VLRALSYLHN---QGVIHRDIKSDSILLTSDGR 156
Query: 700 AKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITG 759
KL+DFG V ++VGTP ++ PE + D++S G++++E+I G
Sbjct: 157 IKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
Query: 760 QP 761
+P
Sbjct: 215 EP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 24/212 (11%)
Query: 564 NFE--RVLGKGGFGTVY-----HGYLDDKQVAVKMLSSSS-VQGYKQFQ---AEVELLIR 612
NFE RVLG G +G V+ G+ K A+K+L ++ VQ K + E ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 613 AHHKNLTILVGYC-DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGL 671
+ + Y + LI +++ G L HL + + T E R+ IA E L
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIA-EIVLAL 118
Query: 672 EYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLD 731
++LH + I++RD+K NILL+ + L DFGLS+ F + + + GT Y+
Sbjct: 119 DHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSFCGTIEYMA 174
Query: 732 PEYYISNRLT----EKSDVYSFGVVLLELITG 759
PE + + + D +S GV+ EL+TG
Sbjct: 175 PE--VIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 67/203 (33%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 567 RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSV---QGYKQFQAEVELLIR-AHHKNLTI 620
+V+GKG FG V LD K AVK+L V + K AE +L++ H L
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 621 LVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKP 680
L + + +F+ G L HL ++ + R A+E A L YLH+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHS---I 115
Query: 681 PIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG--GTHVSTTVVGTPGYLDPEYYISN 738
IV+RD+K NILL+ + L DFGL + EG + +TT GTP YL PE
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK----EGIAQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 739 RLTEKSDVYSFGVVLLELITGQP 761
D + G VL E++ G P
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 7e-13
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVE----LLIRAHHKNLTI 620
+VLGKG FG V L D+ A+K+L + + L + A H LT
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 621 LVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH-NGCK 679
L + + E++ G+L + ++ R A+E L +LH +G
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQI--QRSRKFDEPRSRFYAAEVTLALMFLHRHG-- 116
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNR 739
+++RD+K NILL+ + KLADFG+ + + G T +TT GTP Y+ PE
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEILQELE 172
Query: 740 LTEKSDVYSFGVVLLELITGQP 761
D ++ GV++ E++ GQP
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-13
Identities = 38/104 (36%), Positives = 60/104 (57%), Gaps = 3/104 (2%)
Query: 671 LEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYL 730
L+ +H+ ++HRD+KSANI L KL DFG S+ + V+++ GTP YL
Sbjct: 182 LDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238
Query: 731 DPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQ 774
PE + R ++K+D++S GV+L EL+T + QR ++ Q
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQ 282
|
Length = 478 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 9e-13
Identities = 66/220 (30%), Positives = 105/220 (47%), Gaps = 48/220 (21%)
Query: 569 LGKGGFGTVYHGYLDDKQ----VAVKMLSSSSVQGYKQFQA------------EVELLIR 612
LGKG +G V+ D++ VA+K K F A E+ L
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALK----------KIFDAFRNATDAQRTFREIMFLQE 62
Query: 613 -AHHKNLTIL--VGYCDEGANMGLIYEFMA---NGNLQAHLLEDKADTLCWERRLQIASE 666
H N+ L V + ++ L++E+M + ++A++LED +R I +
Sbjct: 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDV------HKRY-IMYQ 115
Query: 667 SAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH---VSTTV 723
+ L+Y+H+G ++HRD+K +NILLN + KLADFGL+R V T
Sbjct: 116 LLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY 172
Query: 724 VGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQPV 762
V T Y PE + S R T+ D++S G +L E++ G+P+
Sbjct: 173 VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 34/220 (15%)
Query: 558 VLKITNNFERV--LGKGGFGTVYHGY--LDDKQVAVK--MLSSSSVQGYKQFQAEVELLI 611
V +ITN + + +G G FG V L + VA+K M S+ K+ E++LL
Sbjct: 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLK 64
Query: 612 RAHHKNLTILVGYCD----EGANMGLIYEFMA---NGNLQAHLLEDKADTLCWERRLQ-I 663
H+N+ + D ++ + E + + L + LE + +Q
Sbjct: 65 HLRHENI---ISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQF--------IQYF 113
Query: 664 ASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV 723
+ +GL+Y+H+ +VHRD+K +NIL+NE K+ DFGL+RI T
Sbjct: 114 LYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGY 165
Query: 724 VGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPV 762
V T Y PE ++ + + D++S G + E++ G+P+
Sbjct: 166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 54/198 (27%), Positives = 101/198 (51%), Gaps = 11/198 (5%)
Query: 569 LGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYK-QFQAEVELLIRAHHKNLTILVGYC 625
LG+G + TV+ G L + VA+K + +G EV LL H N+ L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 626 DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHR 685
++ L++E++ + +L+ ++ +D + + + +GL Y H + ++HR
Sbjct: 74 HTDKSLTLVFEYL-DKDLKQYM-DDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHR 128
Query: 686 DVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYI-SNRLTEKS 744
D+K N+L+NE+ + KLADFGL+R V T+ + V T Y P+ + S+ + +
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYSTQI 186
Query: 745 DVYSFGVVLLELITGQPV 762
D++ G + E+ +G+P+
Sbjct: 187 DMWGVGCIFFEMASGRPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 60/224 (26%), Positives = 94/224 (41%), Gaps = 21/224 (9%)
Query: 569 LGKGGFGTVY--------HGYLDDKQVAVKMLS-----SSSVQGYKQFQAEVELLIRA-H 614
LG G FG VY L K++ V + + +EV ++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 615 HKNLTILVGYCDEGANMGLIYEFMANGNLQAHL--LEDKADTLCWERRLQIASESAQGLE 672
H N+ E + ++ + + L H L++K ER I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 673 YLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDP 732
YLH + IVHRD+ NI+L E + + DFGL++ + T+VVGT Y P
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSCP 182
Query: 733 EYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWV 776
E + EK+DV++FG +L ++ T QP T +L + V
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV 226
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 564 NFERVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQGYKQFQAE------VELLIRAHH 615
NF VLGKG FG V D+ A+K+L + Q + VE + A
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI-----IQDDDVECTMVEKRVLALP 57
Query: 616 KNLTILVGYCDEGANMGLIY---EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLE 672
L M +Y E++ G+L H+ + + A+E A GL
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGKFKEPHAVFYAAEIAIGLF 115
Query: 673 YLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDP 732
+LH I++RD+K N++L+ + K+ADFG+ + G T + T GTP Y+ P
Sbjct: 116 FLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTPDYIAP 170
Query: 733 EYYISNRLTEKS-DVYSFGVVLLELITGQP 761
E I+ + KS D ++FGV+L E++ GQP
Sbjct: 171 E-IIAYQPYGKSVDWWAFGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 567 RVLGKGGFGTVY--HGYLDDKQVAVKMLSSSSVQ---GYKQFQAEVELLIRAHHKNLTIL 621
RVLGKGGFG V K A K L ++ G E ++L + + + +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR-FVVS 64
Query: 622 VGYCDEGAN-MGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKP 680
+ Y E + + L+ M G+L+ H+ ER + A+E GLE LH +
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RE 121
Query: 681 PIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRL 740
IV+RD+K NILL++ +++D GL+ P EG T VGT GY+ PE + R
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIP-EGETIRGR--VGTVGYMAPEVVKNERY 178
Query: 741 TEKSDVYSFGVVLLELITGQPVIQK 765
T D + G ++ E+I G+ ++
Sbjct: 179 TFSPDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 37/92 (40%), Positives = 51/92 (55%), Gaps = 10/92 (10%)
Query: 670 GLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS--TTVVGTP 727
GL YL K I+HRDVK +NIL+N + + KL DFG+S G S + VGT
Sbjct: 111 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSMANSFVGTR 162
Query: 728 GYLDPEYYISNRLTEKSDVYSFGVVLLELITG 759
Y+ PE T +SD++S G+ L+E+ G
Sbjct: 163 SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 13/206 (6%)
Query: 562 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAE-VE---LLIRAHH 615
NF VLGKG FG V D+ A+K+L V + VE L ++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH 675
LT L + + E++ G+L H+ + + + A+E + GL +LH
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISVGLFFLH 118
Query: 676 NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYY 735
+ I++RD+K N++L+ + K+ADFG+ + V+G T + T GTP Y+ PE
Sbjct: 119 ---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTFCGTPDYIAPEII 173
Query: 736 ISNRLTEKSDVYSFGVVLLELITGQP 761
+ D +++GV+L E++ GQP
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 54/220 (24%), Positives = 107/220 (48%), Gaps = 27/220 (12%)
Query: 562 TNNFERVLGKGGFGTVYHGYL-------DDKQVAVKMLS-SSSVQGYKQFQAEVELLIRA 613
T F LG+ FG VY G+L + VA+K L + ++F+ E + R
Sbjct: 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL 65
Query: 614 HHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLL------------EDKA--DTLCWER 659
H N+ L+G + + +I+ + ++ +L L+ +DK TL
Sbjct: 66 QHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPAD 125
Query: 660 RLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEGGTH 718
+ I ++ A G+E+L + +VH+D+ + N+L+ +K K++D GL R ++ +
Sbjct: 126 FVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182
Query: 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 758
+ +++ ++ PE + + + SD++S+GVVL E+ +
Sbjct: 183 MGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 47/219 (21%)
Query: 569 LGKGGFGTVYHGYLDDK---QVAVKMLSSSSVQGYKQFQA---------EVELLIRAHHK 616
+G G +GTV LD + +VA+K L Y+ FQ+ E+ LL H+
Sbjct: 23 VGSGAYGTVCSA-LDRRTGAKVAIKKL-------YRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 617 NLTILVGY------CDEGANMGLIYEFMAN--GNLQAH--LLEDKADTLCWERRLQIASE 666
N+ L+ D + L+ FM G L H L ED+ L ++
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQ-------- 126
Query: 667 SAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGT 726
+GL+Y+H I+HRD+K N+ +NE + K+ DFGL+R E T V T
Sbjct: 127 MLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVT 178
Query: 727 PGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQ 764
Y PE ++ T+ D++S G ++ E++TG+P+ +
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 69/220 (31%), Positives = 114/220 (51%), Gaps = 29/220 (13%)
Query: 567 RVLGKGGFGTVY-----HGYLDDKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLT 619
+VLG+G FG V+ G + A+K+L ++ V+ + + E ++L +H +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 620 IL-VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI-ASESAQGLEYLHN- 676
L + EG + LI +F+ G+L L ++ T E ++ +E A L++LH+
Sbjct: 62 KLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFT---EEDVKFYLAELALALDHLHSL 117
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT--VVGTPGYLDPEY 734
G I++RD+K NILL+E+ KL DFGLS+ E H GT Y+ PE
Sbjct: 118 G----IIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVEYMAPE- 168
Query: 735 YISNRL--TEKSDVYSFGVVLLELITGQ-PVIQKTPQRTL 771
+ NR T+ +D +SFGV++ E++TG P K + T+
Sbjct: 169 -VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM 207
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 42/219 (19%)
Query: 569 LGKGGFGTV----YHGYLDDKQVAVKMLSS--SSVQGYKQFQAEVELLIR-AHHKNLTIL 621
LG+G +G V +++ VA+K +++ S K+ E++LL HKN+T L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 622 VGY--CDEGANMGL-IYEFMANGNL-----------QAHLLEDKADTLCWERRLQIASES 667
G L +YE + +L AH LC
Sbjct: 68 YDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILC----------- 116
Query: 668 AQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF---PVEGGTHVSTTVV 724
GL+Y+H+ ++HRD+K N+L+N + K+ DFGL+R F P E + T V
Sbjct: 117 --GLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYV 170
Query: 725 GTPGYLDPEYYISNRLTEKS-DVYSFGVVLLELITGQPV 762
T Y PE +S + K+ DV+S G +L EL+ +PV
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 63/203 (31%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 567 RVLGKGGFGTVY--HGYLDDKQVAVKMLSSSSV---QGYKQFQAEVELLIR-AHHKNLTI 620
+V+GKG FG V ++K AVK+L ++ + K +E +L++ H L
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 621 LVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCW-ERRLQI-ASESAQGLEYLHNGC 678
L + + +++ G L HL ++ C+ E R + A+E A L YLH+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHS-- 114
Query: 679 KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISN 738
IV+RD+K NILL+ + L DFGL + GT ++T GTP YL PE
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQ 171
Query: 739 RLTEKSDVYSFGVVLLELITGQP 761
D + G VL E++ G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 23/214 (10%)
Query: 569 LGKGGFGTVYHG--YLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCD 626
+G G +G VY + AVK++ + Q E+ ++ H N+ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 627 EGANMGLIYEFMANGNLQA--HLLEDKADTLCWERRLQIA---SESAQGLEYLHNGCKPP 681
+ + E+ G+LQ H+ ++ LQIA E+ QGL YLH+ K
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSE-------LQIAYVCRETLQGLAYLHSKGK-- 127
Query: 682 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNR-- 739
+HRD+K ANILL + KLADFG++ + + +GTP ++ PE +
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGTPYWMAPEVAAVEKNG 184
Query: 740 -LTEKSDVYSFGVVLLELITGQ-PVIQKTPQRTL 771
+ D+++ G+ +EL Q P+ P R L
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 569 LGKGGFGTVYHGY----LDDKQVAVKML-SSSSVQGYKQFQAEVELLIRAHHKNLTILVG 623
+G G FG V G + +V VK L +S++ F EV+ +H N+ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDK------ADTLCWERRLQIASESAQGLEYLHNG 677
C E L+ EF G+L+ +L ++ A +R +A E A GL +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR---MACEVASGLLWLH-- 117
Query: 678 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYY-- 735
+ +H D+ N L K+ D+GL+ E +L PE
Sbjct: 118 -QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 736 -----ISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTPQRTL 771
+ T+KS+++S GV + EL T QP + ++ L
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL 219
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 569 LGKGGFGTVYHGYLDD--KQVAVKMLSSSSVQGYKQFQ---AEVELLIRAHHKNLTILVG 623
+GKG FG VY D + A+K+LS + K+ E +L+R +VG
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 624 Y---CDEGANMGLIYEFMANGNLQAHLL------EDKADTLCWERRLQIASESAQGLEYL 674
+++ L+ ++M+ G L HL ED+A + IA E LE+L
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRA-------KFYIA-ELVLALEHL 112
Query: 675 HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEY 734
H K IV+RD+K NILL+ L DFGLS+ + T GT YL PE
Sbjct: 113 H---KYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEV 167
Query: 735 YISNR-LTEKSDVYSFGVVLLELITG 759
+ + T+ D +S GV++ E+ G
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 49/218 (22%)
Query: 568 VLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQA--EVELLIRAHHKNLTILVG 623
LG+G + TVY G L + VA+K + +G F A E LL H N+ L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHD 70
Query: 624 YCDEGANMGLIYEFM----------ANGNLQAH--------LLEDKADTLCWERRLQIAS 665
+ L++E++ G L H LL
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL----------------- 113
Query: 666 ESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG 725
+GL Y H + ++HRD+K N+L++E+ + KLADFGL+R V T+ S VV
Sbjct: 114 ---RGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY-SNEVV- 165
Query: 726 TPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQPV 762
T Y P+ + S + D++ G + E+ TG+P+
Sbjct: 166 TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 38/212 (17%)
Query: 568 VLGKGGFGTVYHGYLDD--KQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYC 625
++G+GGFG VY D K A+K L + K Q E L N I++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI---KMKQGETLAL------NERIMLSLV 51
Query: 626 DEGA---------------NMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI-ASESAQ 669
G + I + M G+L HL + + E+ ++ A+E
Sbjct: 52 STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFS---EKEMRFYATEIIL 108
Query: 670 GLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGY 729
GLE++HN +V+RD+K ANILL+E +++D GL+ F + H S VGT GY
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHAS---VGTHGY 161
Query: 730 LDPEYYISNRLTEKS-DVYSFGVVLLELITGQ 760
+ PE + S D +S G +L +L+ G
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 58/204 (28%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 564 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQA--EVELLIRAHHKNLT 619
N E+ LG+G + TVY G ++ + VA+K++S + +G F A E LL H N+
Sbjct: 9 NLEK-LGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIV 66
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCK 679
+L + ++E+M + +L ++++ + RL + +GL Y+H
Sbjct: 67 LLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIH---G 121
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYI-SN 738
I+HRD+K N+L++ + KLADFGL+R + T+ S V T Y P+ + +
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGAT 179
Query: 739 RLTEKSDVYSFGVVLLELITGQPV 762
+ D++ G + +E++ GQP
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 8e-12
Identities = 61/232 (26%), Positives = 91/232 (39%), Gaps = 49/232 (21%)
Query: 567 RVLGKGGFGTVYHGYLDD--KQVAVKMLSSSSVQG---YKQFQAEVELLIRAHHKNLTIL 621
++LGKG G V+ L K A+K+L + K+ E E+L H L L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI------ASESAQGLEYLH 675
+ L+ ++ G L LL+ + + L A+E LEYLH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELF-RLLQRQPG-----KCLSEEVARFYAAEVLLALEYLH 120
Query: 676 -NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV--------------- 719
G IV+RD+K NILL+E L+DF LS+ VE
Sbjct: 121 LLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 720 ------------STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITG 759
S + VGT Y+ PE + D ++ G++L E++ G
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 8e-12
Identities = 68/246 (27%), Positives = 114/246 (46%), Gaps = 31/246 (12%)
Query: 527 LAILQNLRRRKQAGKKKGSLELENR--KFSYFDVLKITNNFERVLGKGGFGTVYHGYLDD 584
+ L+NL+ K+ K S + R K Y D NF R LG G FG V +
Sbjct: 1 IQFLKNLQLHKK--KDSDSTKEPKRKNKMKYEDF-----NFIRTLGTGSFGRVILATYKN 53
Query: 585 KQ---VAVKMLSSSSVQGYKQFQ---AEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638
+ VA+K S + KQ +E ++L +H L G + + + L+ EF+
Sbjct: 54 EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFV 113
Query: 639 ANGNLQAHLLEDKA---DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLN 695
G L +K D C+ A++ EYL + IV+RD+K N+LL+
Sbjct: 114 IGGEFFTFLRRNKRFPNDVGCF-----YAAQIVLIFEYLQS---LNIVYRDLKPENLLLD 165
Query: 696 EKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLE 755
+ K+ DFG +++ V+ T+ T+ GTP Y+ PE ++ + +D ++ G+ + E
Sbjct: 166 KDGFIKMTDFGFAKV--VDTRTY---TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYE 220
Query: 756 LITGQP 761
++ G P
Sbjct: 221 ILVGCP 226
|
Length = 340 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 9e-12
Identities = 49/171 (28%), Positives = 88/171 (51%), Gaps = 28/171 (16%)
Query: 606 EVELLIRAHHKNLT----ILVGYCDEGANMGLIY---EFMANGNLQAHLLEDKADT-LCW 657
E+ +L++ H N+ ++VG +N+ IY E++ + +L++ L+E L
Sbjct: 54 EINILLKLQHPNIVTVKEVVVG-----SNLDKIYMVMEYVEH-DLKS-LMETMKQPFLQS 106
Query: 658 ERR---LQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714
E + LQ+ S G+ +LH I+HRD+K++N+LLN + K+ DFGL+R +
Sbjct: 107 EVKCLMLQLLS----GVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159
Query: 715 GGTHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQ 764
T +V T Y PE + + + D++S G + EL+T +P+
Sbjct: 160 --LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 9e-12
Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 566 ERVLGKGGFGTVYHGYLD--DKQ---VAVKML-SSSSVQGYKQFQAEVELLIRAHHKNLT 619
ER+LG G FG + G L K+ VA+ L + S + + F AE L + H N+
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCK 679
L G G M ++ E+M+NG L + L + + L + + + A G++YL +
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ-LVAGQLMGMLPGLASGMKYL---SE 125
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYL--DPEYYIS 737
VH+ + + +L+N K++ F R + + TT+ G L PE
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182
Query: 738 NRLTEKSDVYSFGVVLLELIT 758
+ + SDV+SFG+V+ E+++
Sbjct: 183 HHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 569 LGKGGFGTVYHG--YLDDKQVAVKMLS-SSSVQGYKQFQA-EVELL---IRAHHKN---- 617
+G+G +GTVY + VA+K + S +G E+ LL H N
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 618 LTILVGY-CDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN 676
L + G D + L++E + + +L +L + L E + + +G+++LH+
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS 125
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS-TTVVGTPGYLDPEYY 735
IVHRD+K NIL+ Q K+ADFGL+RI+ ++ T+VV T Y PE
Sbjct: 126 HR---IVHRDLKPQNILVTSDGQVKIADFGLARIY----SFEMALTSVVVTLWYRAPEVL 178
Query: 736 ISNRLTEKSDVYSFGVVLLELITGQP 761
+ + D++S G + EL +P
Sbjct: 179 LQSSYATPVDMWSVGCIFAELFRRRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 16/201 (7%)
Query: 567 RVLGKGGFGTVY--HGYLDDKQVAVKMLSSSSVQGYKQFQ---AEVELLIRAHHKNLTIL 621
++LGKG FG V K A+K+L + + E +L H LT L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPP 681
+ + E+ G L HL + +R +E L YLH+
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALGYLHSC---D 115
Query: 682 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST--TVVGTPGYLDPEYYISNR 739
+V+RD+K N++L++ K+ DFGL + EG + +T T GTP YL PE N
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 740 LTEKSDVYSFGVVLLELITGQ 760
D + GVV+ E++ G+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 564 NFE--RVLGKGGFGTVY-----HGYLDDKQVAVKMLSSSS-VQGYK---QFQAEVELLIR 612
NFE +VLG G +G V+ G+ K A+K+L ++ VQ K + E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 613 AHHKNLTILVGYC-DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIAS-ESAQG 670
+ + Y + LI +++ G L HL + + E+ +QI S E
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLA 117
Query: 671 LEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYL 730
LE+LH K I++RD+K NILL+ L DFGLS+ F E + + GT Y+
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-HEDEVERAYSFCGTIEYM 173
Query: 731 DPEYYISNRLTEKS--DVYSFGVVLLELITG 759
P+ D +S GV++ EL+TG
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 38/212 (17%)
Query: 568 VLGKGGFGTVYHGYLDD--KQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYC 625
++G+GGFG VY D K A+K L + K Q E L N I++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI---KMKQGETLAL------NERIMLSLV 51
Query: 626 DEGA---------------NMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI-ASESAQ 669
G + I + M G+L HL + + E ++ A+E
Sbjct: 52 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---EAEMRFYAAEIIL 108
Query: 670 GLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGY 729
GLE++HN +V+RD+K ANILL+E +++D GL+ F + H S VGT GY
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHAS---VGTHGY 161
Query: 730 LDPEYYISNRLTEKS-DVYSFGVVLLELITGQ 760
+ PE + S D +S G +L +L+ G
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 15/201 (7%)
Query: 567 RVLGKGGFGTVYHGYLDDKQV----AVKMLSSSSVQGYKQFQ---AEVELLIRAHHKNLT 619
++LGKG FG V + +K A+K+L + + E +L + H LT
Sbjct: 1 KLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCK 679
L + + E+ G L HL ++ +R +E L+YLH+ +
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHS--E 114
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNR 739
+V+RD+K N++L++ K+ DFGL + +G T T GTP YL PE N
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDND 172
Query: 740 LTEKSDVYSFGVVLLELITGQ 760
D + GVV+ E++ G+
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 21/201 (10%)
Query: 569 LGKGGFGTVYHGYLDDKQ-----VAVKMLSSSSVQGY---KQFQAEVELLIRAHHKNLTI 620
+G+GG+G V+ L K+ VA+K + S + + E ++L + L
Sbjct: 9 VGQGGYGQVF---LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVK 65
Query: 621 LVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKP 680
L+ + + L E++ G+ + LL + R +A E + ++ LH +
Sbjct: 66 LLYAFQDDEYLYLAMEYVPGGDFRT-LLNNLGVLSEDHARFYMA-EMFEAVDALH---EL 120
Query: 681 PIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRL 740
+HRD+K N L++ KL DFGLS+ G + +VVG+P Y+ PE
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEVLRGKGY 175
Query: 741 TEKSDVYSFGVVLLELITGQP 761
D +S G +L E + G P
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFP 196
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 2e-11
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 35/218 (16%)
Query: 564 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLS---SSSVQGYKQFQAEVELLIRAHHKNL 618
+ +G G +G V ++VA+K +S + K+ E++LL H+N+
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDA-KRILREIKLLRHLRHENI 61
Query: 619 T--ILVGYCDEGANMGLIY---EFMANGNLQA------HLLEDKADTLCWERRLQIASES 667
+ + + +Y E M +L L +D + QI
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLY----QILR-- 114
Query: 668 AQGLEYLH--NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEGGTHVSTTVV 724
GL+YLH N ++HRD+K +NIL+N K+ DFGL+R + P E T V
Sbjct: 115 --GLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167
Query: 725 GTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQP 761
T Y PE +S +R T+ D++S G + EL+T +P
Sbjct: 168 VTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAE-VE---LLIRAHHKN 617
NF VLGKG FG V D+ A+K+L V + VE L +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNG 677
LT L + + E++ G+L + + + A+E A GL +LH+
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQI--QQVGRFKEPHAVFYAAEIAIGLFFLHS- 119
Query: 678 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYIS 737
I++RD+K N++L+ + K+ADFG+ + +G T + T GTP Y+ PE
Sbjct: 120 --KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDYIAPEIIAY 175
Query: 738 NRLTEKSDVYSFGVVLLELITGQP 761
+ D ++FGV+L E++ GQ
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQA 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 569 LGKGGFGTVYHGYLDD--KQVAVKMLSSSSVQ---GYKQFQAEVELLIRAHHKNLTILVG 623
LGKGGFG V + + K A K L ++ G K E E+L + + + L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIV 683
+ ++ L+ M G+L+ H+ L ER + +++ G+ +LH+ IV
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIV 117
Query: 684 HRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEK 743
+RD+K N+LL+++ +L+D GL+ ++ G + T GT GY+ PE +
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTI-TQRAGTNGYMAPEILKEEPYSYP 174
Query: 744 SDVYSFGVVLLELITGQ 760
D ++ G + E++ G+
Sbjct: 175 VDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 59/201 (29%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 567 RVLGKGGFGTV--YHGYLDDKQVAVKMLSSSSVQGYKQFQ---AEVELLIRAHHKNLTIL 621
++LGKG FG V + A+K+L + + E +L H LT L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPP 681
+ + E+ G L HL ++ T ER +E LEYLH+
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFT--EERARFYGAEIVSALEYLHS---RD 115
Query: 682 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST--TVVGTPGYLDPEYYISNR 739
+V+RD+K N++L++ K+ DFGL + EG + +T T GTP YL PE N
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 740 LTEKSDVYSFGVVLLELITGQ 760
D + GVV+ E++ G+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 46/182 (25%), Positives = 83/182 (45%), Gaps = 18/182 (9%)
Query: 585 KQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL- 643
K VAVK + Q + EV ++ H+N+ + G + ++ EF+ G L
Sbjct: 46 KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105
Query: 644 ----QAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQ 699
+ E++ +C ++ AQG ++HRD+KS +ILL +
Sbjct: 106 DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG-----------VIHRDIKSDSILLTHDGR 154
Query: 700 AKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITG 759
KL+DFG V ++VGTP ++ PE + D++S G++++E++ G
Sbjct: 155 VKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
Query: 760 QP 761
+P
Sbjct: 213 EP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 36/94 (38%), Positives = 47/94 (50%), Gaps = 9/94 (9%)
Query: 671 LEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYL 730
L YL K ++HRDVK +NILL+ KL DFG+S V+ T G Y+
Sbjct: 127 LHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISG-RLVDSKAK--TRSAGCAAYM 181
Query: 731 DPEYYISNRLTEK----SDVYSFGVVLLELITGQ 760
PE K +DV+S G+ L+EL TGQ
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 10/159 (6%)
Query: 606 EVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIAS 665
E+ +L + H NL L+ + L++E+ + L + LE + +I
Sbjct: 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVL--NELEKNPRGVPEHLIKKIIW 107
Query: 666 ESAQGLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVV 724
++ Q + + H + C +HRDVK NIL+ ++ Q KL DFG +RI + G T V
Sbjct: 108 QTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYV 161
Query: 725 GTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPV 762
T Y PE + + + DV++ G V EL+TGQP+
Sbjct: 162 ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 567 RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQ---FQAEVELLIRAHHKNLTIL 621
+V+GKG FG V D AVK+L ++ K+ AE +L++ +
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 622 VGYCDEGA-NMGLIYEFMANGNLQAHLLEDKADTLCW-ERRLQI-ASESAQGLEYLHNGC 678
+ Y + A + + +++ G L HL ++ C+ E R + A+E A + YLH+
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRER----CFLEPRARFYAAEVASAIGYLHS-- 114
Query: 679 KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISN 738
I++RD+K NILL+ + L DFGL + T ++T GTP YL PE
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171
Query: 739 RLTEKSDVYSFGVVLLELITGQP 761
D + G VL E++ G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 71/231 (30%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 562 TNNFERV--LGKGGFGTVYH--GYLDDKQVAVKMLSSSSVQGYKQFQAEVELL-IRAHHK 616
T+ +E + +GKG +G VY D AVK+L S ++ +AE +L +H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHP 79
Query: 617 NLTILVGY---CDE--GANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQ-----IASE 666
N+ G D+ G + L+ E + NG L+ K +C +R + I
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLE-LCNGGSVTELV--KGLLICGQRLDEAMISYILYG 136
Query: 667 SAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGT 726
+ GL++LHN I+HRDVK NILL + KL DFG+S + T VGT
Sbjct: 137 ALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSA--QLTSTRLRRNTSVGT 191
Query: 727 PGYLDPEYYISNRLTEKS-----DVYSFGVVLLELITGQ-PVIQKTPQRTL 771
P ++ PE + + S DV+S G+ +EL G P+ P +TL
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL 242
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-11
Identities = 28/58 (48%), Positives = 40/58 (68%)
Query: 421 IAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLS 478
++G I P IFSL + SLDLS NSL+G +PE + +LQ+L +L+L NN G +P L+
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALT 329
|
Length = 968 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 66/232 (28%), Positives = 107/232 (46%), Gaps = 25/232 (10%)
Query: 554 SYFDVLKITNNFERVLGKGGFGTVYHGY--LDDKQVAVKMLSS--SSVQGYKQFQAEVEL 609
S F VLK N + +G G G V Y + D+ VA+K LS + K+ E+ L
Sbjct: 11 STFTVLKRYQNL-KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 610 LIRAHHKNLTILVGY------CDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI 663
+ +HKN+ L+ +E ++ L+ E M Q +E L ER +
Sbjct: 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME-----LDHERMSYL 124
Query: 664 ASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV 723
+ G+++LH+ I+HRD+K +NI++ K+ DFGL+R G + + T
Sbjct: 125 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPY 178
Query: 724 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQW 775
V T Y PE + E D++S G ++ E++ + + P R I QW
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF---PGRDYIDQW 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 34/213 (15%)
Query: 569 LGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQA--EVELLIRAHHKNLTILVGY 624
+G+G +G VY G + VA+K + S + A E+ LL H N+ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 625 CDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRL----------QIASESAQGLEYL 674
+ + + LI+EF++ +L+ +L D+L + + QI QG+ +
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYL-----DSLPKGQYMDAELVKSYLYQIL----QGILFC 117
Query: 675 HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF--PVEGGTHVSTTVVGTPGYLDP 732
H ++HRD+K N+L++ K KLADFGL+R F PV TH VV T Y P
Sbjct: 118 H---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH---EVV-TLWYRAP 170
Query: 733 EYYI-SNRLTEKSDVYSFGVVLLELITGQPVIQ 764
E + S R + D++S G + E+ T +P+
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 31/213 (14%)
Query: 565 FERV--LGKGGFGTVYHG--YLDDKQVAVKMLS---------SSSVQGYKQFQAEVELLI 611
+++V +G+G +G VY L + VA+K + S++++ E+ LL
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-------EISLLK 53
Query: 612 RAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGL 671
+H N+ L+ + L++EF+ + +L+ ++ L + QG+
Sbjct: 54 ELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 672 EYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF--PVEGGTHVSTTVVGTPGY 729
Y H+ ++HRD+K N+L++ + KLADFGL+R F PV TH VV T Y
Sbjct: 113 AYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWY 165
Query: 730 LDPEYYISNRLTEKS-DVYSFGVVLLELITGQP 761
PE + +R D++S G + E++ +P
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 48/136 (35%), Positives = 66/136 (48%), Gaps = 21/136 (15%)
Query: 660 RLQIASESAQGLEYLHN-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV----- 713
R+ A E+ LEYLHN G IVHRD+K N+L+ KL DFGLS+I +
Sbjct: 104 RMYFA-ETVLALEYLHNYG----IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158
Query: 714 --EGGTHVST------TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITG-QPVIQ 764
EG T V GTP Y+ PE + + D ++ G++L E + G P
Sbjct: 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
Query: 765 KTPQRTLIGQWVSSML 780
TP+ L GQ +S +
Sbjct: 219 DTPEE-LFGQVISDDI 233
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 67/221 (30%), Positives = 100/221 (45%), Gaps = 22/221 (9%)
Query: 569 LGKGGFGTVYHGY----LDDKQVAVKML-SSSSVQGYKQFQAEVELLIRAHHKNLTILVG 623
+G G FG V G QV VK L S+SVQ +F E + H NL +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 624 YCDEGANMGLIYEFMANGNLQAHL-LEDKADTLCWERRL--QIASESAQGLEYLHNGCKP 680
C E L+ EF G+L+ +L KA+ + + ++A E A GL +LH K
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119
Query: 681 PIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYYI--- 736
+H D+ N LL K+ D+GLS E +V+ + P ++ PE
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE-DYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 737 SNRL----TEKSDVYSFGVVLLEL--ITGQPVIQKTPQRTL 771
N L T++S+V+S GV + EL + QP + ++ L
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL 219
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 7e-11
Identities = 53/224 (23%), Positives = 100/224 (44%), Gaps = 28/224 (12%)
Query: 566 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKN---- 617
+G G +G V K+VA+K + + K+ E+++L H N
Sbjct: 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAI 69
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKAD-TLCWERRL--QIASESAQGLEYL 674
IL + ++ ++ + M + +L H++ T R Q+ +GL+Y+
Sbjct: 70 RDILRPPGADFKDVYVVMDLMES-DLH-HIIHSDQPLTEEHIRYFLYQLL----RGLKYI 123
Query: 675 HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI---FPVEGGTHVSTTVVGTPGYLD 731
H+ ++HRD+K +N+L+NE + ++ DFG++R P E + T V T Y
Sbjct: 124 HSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM-TEYVATRWYRA 179
Query: 732 PEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQ 774
PE +S T D++S G + E++ + + P + + Q
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF---PGKNYVHQ 220
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 51/209 (24%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 568 VLGKGGFGTVYHGYLDD--KQVAVKM--LSSSSVQGYKQFQ--------AEVELLIRAHH 615
++GKG +G VY + +AVK L ++ + Q +E+E L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRL--QIASESAQGLEY 673
N+ +G+ + + E++ G++ L +E +L + +GL Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSI-GSCLRTYGR---FEEQLVRFFTEQVLEGLAY 123
Query: 674 LHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPE 733
LH+ I+HRD+K+ N+L++ K++DFG+S+ + ++ G+ ++ PE
Sbjct: 124 LHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 734 YYISNR--LTEKSDVYSFGVVLLELITGQ 760
S + K D++S G V+LE+ G+
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 567 RVLGKGGFGTVYHGYLDDKQ----VAVKMLSSSSVQGYKQFQ-AEVELLIRAHHKNL-TI 620
+G+G +G V K VA+K +S Q + Q E+++L R H+N+ I
Sbjct: 11 SYIGEGAYGMVCSAT--HKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGI 68
Query: 621 L-VGYCDEGANMGLIY---EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN 676
L + + +Y E M + + ++ QI +GL+Y+H+
Sbjct: 69 LDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQIL----RGLKYIHS 124
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF-PVEGGTHVSTTVVGTPGYLDPEYY 735
++HRD+K +N+LLN K+ DFGL+RI P T T V T Y PE
Sbjct: 125 A---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181
Query: 736 ISNRLTEKS-DVYSFGVVLLELITGQPV 762
++++ K+ D++S G +L E+++ +P+
Sbjct: 182 LNSKGYTKAIDIWSVGCILAEMLSNRPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 35/214 (16%)
Query: 563 NNFERV--LGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIR-------- 612
++FER+ LG G G V V+ S + K E++ IR
Sbjct: 5 DDFERISELGAGNGGVVTK---------VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQ 55
Query: 613 -AHHKNLTILVG-----YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASE 666
H N +VG Y D + + E M G+L L E A + E +++
Sbjct: 56 VLHECNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIA 111
Query: 667 SAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGT 726
+GL YL K I+HRDVK +NIL+N + + KL DFG+S ++ + VGT
Sbjct: 112 VLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGT 165
Query: 727 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 760
Y+ PE + +SD++S G+ L+EL G+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 67/233 (28%), Positives = 106/233 (45%), Gaps = 27/233 (11%)
Query: 554 SYFDVLKITNNFERVLGKGGFGTVYHGY--LDDKQVAVKMLSS--SSVQGYKQFQAEVEL 609
S F VLK N + +G G G V Y + + VA+K LS +V K+ E+ L
Sbjct: 10 STFTVLKRYQNL-KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVL 68
Query: 610 LIRAHHKNLTILVGY------CDEGANMGLIYEFM-ANGNLQAHLLEDKADTLCWERRLQ 662
+ +HKN+ L+ +E ++ L+ E M AN + D ER
Sbjct: 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDH------ERMSY 122
Query: 663 IASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722
+ + G+++LH+ I+HRD+K +NI++ K+ DFGL+R G + + T
Sbjct: 123 LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTP 176
Query: 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQW 775
V T Y PE + E D++S G ++ E+I G + P I QW
Sbjct: 177 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLF---PGTDHIDQW 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 33/214 (15%)
Query: 564 NFERVLGKGGFGTV---YHGYLDDKQVAVKMLSS--SSVQGYKQFQAEVELLIRAHHKNL 618
+G G +G V + K VA+K LS S K+ E+ LL H+N+
Sbjct: 18 QNLSPVGSGAYGQVCSAFDTKTGRK-VAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76
Query: 619 TIL--VGYCDEGAN----MGLIYEFMA---NGNLQAHLLEDKADTLCWERRLQIASESAQ 669
L V + L+ M N ++ L D D + + + + +
Sbjct: 77 IGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSD--DHIQF-----LVYQILR 129
Query: 670 GLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGY 729
GL+Y+H+ I+HRD+K +NI +NE + K+ DFGL+R E T V T Y
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 181
Query: 730 LDPEYYISNRL--TEKSDVYSFGVVLLELITGQP 761
PE + N + + D++S G ++ EL+TG+
Sbjct: 182 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 6/96 (6%)
Query: 669 QGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPG 728
+GL++LH+ +VHRD+K NIL+ Q KLADFGL+RI+ + T+VV T
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLW 174
Query: 729 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQ 764
Y PE + + D++S G + E+ +P+ +
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 22/219 (10%)
Query: 569 LGKGGFGTVY--HGYLDDKQVAVKMLSSSSVQGYKQFQAEVELL-IRAHHKNLTILVGY- 624
+GKG +G V+ + + AVK+L ++ +AE +L + H N+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 625 ----CDEGANMGLIYEFMANGNLQ--AHLLEDKADTLCWERRLQIASESAQGLEYLHNGC 678
G + L+ E G++ + + + I E+ GL++LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 679 KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYY--- 735
+HRDVK NILL + KL DFG+S + T VGTP ++ PE
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSA--QLTSTRLRRNTSVGTPFWMAPEVIACE 199
Query: 736 --ISNRLTEKSDVYSFGVVLLELITGQPVIQKT-PQRTL 771
+ + + DV+S G+ +EL G P + P R L
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL 238
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 31/211 (14%)
Query: 564 NFERV--LGKGGFGTVYHG--YLDDKQVAVKMLS---------SSSVQGYKQFQAEVELL 610
NF++V +G+G +G VY L + VA+K + S++++ E+ LL
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-------EISLL 53
Query: 611 IRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQG 670
+H N+ L+ + L++EF+ + +L+ + + + QG
Sbjct: 54 KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQG 112
Query: 671 LEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF--PVEGGTHVSTTVVGTPG 728
L + H+ ++HRD+K N+L+N + KLADFGL+R F PV TH VV T
Sbjct: 113 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EVV-TLW 165
Query: 729 YLDPEYYISNRL-TEKSDVYSFGVVLLELIT 758
Y PE + + + D++S G + E++T
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 73/242 (30%), Positives = 109/242 (45%), Gaps = 34/242 (14%)
Query: 533 LRRRKQAGKKKGSLELENRKFSYFDVLKITNNFERVLGKGGFGTVY---HGYLDDKQV-A 588
L R ++A +K L + K FDV+K V+G+G FG V H KQV A
Sbjct: 25 LSRYEKAAEKITKLRM---KAEDFDVIK-------VIGRGAFGEVQLVRHK--SSKQVYA 72
Query: 589 VKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYC--DEGANMGLIYEFMANGNLQ 644
+K+LS + + F E E I AH + I+ + + + ++ E+M G+L
Sbjct: 73 MKLLSKFEMIKRSDSAFFWE-ERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDL- 130
Query: 645 AHLLEDKADTLCWERRLQIASESAQGLEYLHN-GCKPPIVHRDVKSANILLNEKFQAKLA 703
+L+ + W R +E L+ +H+ G +HRDVK N+LL++ KLA
Sbjct: 131 VNLMSNYDIPEKWARFY--TAEVVLALDAIHSMG----FIHRDVKPDNMLLDKSGHLKLA 184
Query: 704 DFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLT----EKSDVYSFGVVLLELITG 759
DFG G T VGTP Y+ PE S + D +S GV L E++ G
Sbjct: 185 DFGTCMKMDANGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
Query: 760 QP 761
Sbjct: 244 DT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-10
Identities = 65/232 (28%), Positives = 106/232 (45%), Gaps = 25/232 (10%)
Query: 554 SYFDVLKITNNFERVLGKGGFGTVYHGY--LDDKQVAVKMLSS--SSVQGYKQFQAEVEL 609
S F VLK N + +G G G V Y + ++ VA+K LS + K+ E+ L
Sbjct: 18 STFTVLKRYQNL-KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 610 LIRAHHKNLTILVGY------CDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI 663
+ +HKN+ L+ +E ++ ++ E M Q +E L ER +
Sbjct: 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-----LDHERMSYL 131
Query: 664 ASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV 723
+ G+++LH+ I+HRD+K +NI++ K+ DFGL+R G + + T
Sbjct: 132 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPY 185
Query: 724 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQW 775
V T Y PE + E D++S G ++ E+I G + P I QW
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF---PGTDHIDQW 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 569 LGKGGFGTVYHGYLDDKQ--VAVKMLSSSSVQGYKQFQ---AEVELLIRAHHKNLTILVG 623
+GKG FG V D Q A+K + + + + AE +L + + + L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 624 YCDEGANMGLIYEFMANGNLQAHLL-EDKADTLCWERRLQIASESAQGLEYLHNGCKPPI 682
+ L+ F+ G L HL E + D R A E LE LH K +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDL--SRARFYTA-ELLCALENLH---KFNV 114
Query: 683 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTE 742
++RD+K NILL+ + L DFGL ++ + + T GTP YL PE + + T+
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 743 KSDVYSFGVVLLELITGQP 761
D ++ GV+L E++TG P
Sbjct: 173 AVDWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 35/214 (16%)
Query: 563 NNFERV--LGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIR-------- 612
++FE++ LG G G V+ V S + K E++ IR
Sbjct: 5 DDFEKISELGAGNGGVVFK---------VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQ 55
Query: 613 -AHHKNLTILVG-----YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASE 666
H N +VG Y D + + E M G+L L KA + + +++
Sbjct: 56 VLHECNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIA 111
Query: 667 SAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGT 726
+GL YL K I+HRDVK +NIL+N + + KL DFG+S ++ + VGT
Sbjct: 112 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGT 165
Query: 727 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 760
Y+ PE + +SD++S G+ L+E+ G+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 66/232 (28%), Positives = 101/232 (43%), Gaps = 56/232 (24%)
Query: 556 FDVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQ------------- 602
F++LK V+G+G FG V VKM ++ V K
Sbjct: 3 FEILK-------VIGRGAFGEV---------AVVKMKNTGQVYAMKILNKWEMLKRAETA 46
Query: 603 -FQAEVELLIRAHHKNLTIL-VGYCDEGANMGLIYEFMANGNL-------QAHLLEDKAD 653
F+ E ++L+ + +T L + DE N+ L+ ++ G+L + L ED A
Sbjct: 47 CFREERDVLVNGDRRWITNLHYAFQDEN-NLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR 105
Query: 654 TLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713
E L I +S L Y VHRD+K N+LL++ +LADFG S + +
Sbjct: 106 FYLAEMVLAI--DSVHQLGY---------VHRDIKPDNVLLDKNGHIRLADFG-SCLRLL 153
Query: 714 EGGTHVSTTVVGTPGYLDPEYYIS-----NRLTEKSDVYSFGVVLLELITGQ 760
GT S VGTP Y+ PE + R + D +S GV + E++ G+
Sbjct: 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 564 NFE--RVLGKGGFGTVY-----HGYLDDKQVAVKMLSSSSV------QGYKQFQAEVELL 610
NFE +VLG G +G V+ G+ K A+K+L +++ + + + V
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 611 IRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIAS-ESAQ 669
+R +T+ + E A + LI ++++ G + HL + + E ++ S E
Sbjct: 61 VRQSPFLVTLHYAFQTE-AKLHLILDYVSGGEMFTHLYQRDNFS---EDEVRFYSGEIIL 116
Query: 670 GLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGY 729
LE+LH K IV+RD+K NILL+ + L DFGLS+ F E + + GT Y
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TYSFCGTIEY 172
Query: 730 LDPEYYISNRLTEKS-DVYSFGVVLLELITG 759
+ PE K+ D +S G+++ EL+TG
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 46/216 (21%)
Query: 569 LGKGGFGTVY---HGYLDDKQVAVKMLSSSSVQ-GYKQFQAEVELLIRAHHKNLTILVGY 624
+G+G FGTV H +AVK + S+ + K+ ++++++R+ + +V +
Sbjct: 12 IGRGAFGTVNKMLHKPSG-TIMAVKRIRSTVDEKEQKRLLMDLDVVMRS--SDCPYIVKF 68
Query: 625 ------------CDE--GANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQG 670
C E ++ Y++ L++ + E+ +IA + +
Sbjct: 69 YGALFREGDCWICMELMDISLDKFYKY-VYEVLKSVIPEEILG--------KIAVATVKA 119
Query: 671 LEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS----TTVVGT 726
L YL K I+HRDVK +NILL+ KL DFG+S G V T G
Sbjct: 120 LNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS-------GQLVDSIAKTRDAGC 170
Query: 727 PGYLDPEYYISNRLTE---KSDVYSFGVVLLELITG 759
Y+ PE + +SDV+S G+ L E+ TG
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 30/208 (14%)
Query: 569 LGKGGFGTVYHGYLDDKQVAVKM------LSSSSVQGYKQFQAEVELLIRAHHKNLTILV 622
LGKG +G+VY V + M L S + Q E+++L +A +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK---FNQIIMELDILHKAVSPYIVDFY 65
Query: 623 G-YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRL-QIASESAQGLEYL---HNG 677
G + EGA + + E+M G+L A E L +I +GL++L HN
Sbjct: 66 GAFFIEGA-VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN- 123
Query: 678 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYIS 737
I+HRDVK N+L+N Q KL DFG+S ++ T +G Y+ PE S
Sbjct: 124 ----IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS----LAKTNIGCQSYMAPERIKS 175
Query: 738 NRLTE------KSDVYSFGVVLLELITG 759
+ +SDV+S G+ +LE+ G
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 563 NNFERV--LGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQA--EVELLIRAHHK 616
+++E++ LG+G + TVY G ++ K VA+K++ +G F A E LL H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHA 63
Query: 617 NLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN 676
N+ +L + L++E++ Q ++ L E + +GL Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQ--YMDKHPGGLHPENVKLFLFQLLRGLSYIH- 120
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYI 736
+ I+HRD+K N+L+++ + KLADFGL+R V +H + V T Y P+ +
Sbjct: 121 --QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--SHTYSNEVVTLWYRPPDVLL 176
Query: 737 SNRLTEKS---DVYSFGVVLLELITG 759
+ TE S D++ G + +E+I G
Sbjct: 177 GS--TEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 41/107 (38%), Positives = 57/107 (53%), Gaps = 19/107 (17%)
Query: 662 QIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS- 720
+IA + LEYLH+ ++HRDVK +N+L+N Q KL DFG+S G V
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS-------GYLVDS 157
Query: 721 ---TTVVGTPGYLDPEYYISNRLTE-----KSDVYSFGVVLLELITG 759
T G Y+ PE I+ L + KSDV+S G+ ++EL TG
Sbjct: 158 VAKTIDAGCKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 53/223 (23%), Positives = 83/223 (37%), Gaps = 30/223 (13%)
Query: 565 FERVLGK----GGFGTVYHGYLDDKQVAVKM--LSSSSVQGYKQFQAEVELLIRAHHKNL 618
++GK + + VAVK L S S + K Q E+ + H N+
Sbjct: 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 619 TILVGYCDEGANMGLIYEFMANGN----LQAHLLEDKADTLCWERRLQIASESAQGLEYL 674
V + + ++ MA G+ L+ H E + I + L+Y+
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAI----AFILKDVLNALDYI 117
Query: 675 H-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGY---- 729
H G +HR VK+++ILL+ + L+ S ++ G V P
Sbjct: 118 HSKGF----IHRSVKASHILLSGDGKVVLSGLRYSVSM-IKHGKR-QRVVHDFPKSSVKN 171
Query: 730 ---LDPEYYISNRL--TEKSDVYSFGVVLLELITGQPVIQKTP 767
L PE N EKSD+YS G+ EL G + P
Sbjct: 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 48/215 (22%)
Query: 569 LGKGGFGTVYHGYLDDK---QVAVKMLSSSSVQGYKQFQAEV-------ELLIRAH--HK 616
+G G +G+V +D + +VA+K LS + FQ+E+ EL + H H+
Sbjct: 23 VGSGAYGSVCSA-IDKRTGEKVAIKKLS-------RPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 617 NLTILVGY------CDEGANMGLIYEFMANGNLQA----HLLEDKADTLCWERRLQIASE 666
N+ L+ DE + L+ +M +LQ L EDK L ++
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQ-------- 125
Query: 667 SAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGT 726
GL+Y+H I+HRD+K N+ +NE + K+ DFGL+R E T V T
Sbjct: 126 MLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVT 177
Query: 727 PGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQ 760
Y PE ++ + D++S G ++ E++TG+
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 5/97 (5%)
Query: 669 QGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPG 728
+GL+YLH+ I+HRD+K N+L+N K+ DFGL+R+ + H++ VV T
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQY 169
Query: 729 YLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQPVIQ 764
Y PE + S T D++S G + EL+ + + Q
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-09
Identities = 57/232 (24%), Positives = 96/232 (41%), Gaps = 53/232 (22%)
Query: 567 RVLGKGGFGTVYHGYLDDK----QVAVKMLS---SSSVQGYKQFQAEVELLIRAHHKNLT 619
R++GKGG G VY Y D +VA+K + S + K+F E ++ H +
Sbjct: 8 RLIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 620 ILVGYCDEGANMGLIYEFMA--NGNLQAHLLEDKADTLCWERR---------------LQ 662
+ C +G +Y M G LL+ W++ L
Sbjct: 66 PVYSICSDGD---PVYYTMPYIEGYTLKSLLKS-----VWQKESLSKELAEKTSVGAFLS 117
Query: 663 IASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI------------ 710
I + +EY+H+ ++HRD+K NILL + + D+G +
Sbjct: 118 IFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 711 FPVEGGTHVSTT----VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 758
+ S T +VGTP Y+ PE + +E +D+Y+ GV+L +++T
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 83/345 (24%), Positives = 128/345 (37%), Gaps = 96/345 (27%)
Query: 565 FERVLGKGGFGTVYHGYLDD-------KQVAVKMLSSSSVQG-YKQFQAEVELLIR-AHH 615
+ LG+G FG V + VAVKML + YK E+++LI HH
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHH 70
Query: 616 KN--------------LTILVGYCDEGANM-----GLIYEFMANGNLQAHLLEDKADTLC 656
N L ++V YC G N+ F N E K
Sbjct: 71 LNVVNLLGACTKPGGPLMVIVEYCKFG-NLSNYLRSKRECFSPYRNKSTRKREMKQKEGK 129
Query: 657 -------------------WERRLQIASES-----------------------AQGLEYL 674
++ L E A+G+E+L
Sbjct: 130 KQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL 189
Query: 675 HN-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEGGTHVSTTVVGTP-GYLD 731
+ C +HRD+ + NILL+E K+ DFGL+R I+ + +V P ++
Sbjct: 190 ASRKC----IHRDLAARNILLSENNVVKICDFGLARDIY--KDPDYVRKGDARLPLKWMA 243
Query: 732 PEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTL-IGQWVSSMLARGDIKNIVD 790
PE T +SDV+SFGV+L E+ + + +P + I + L G
Sbjct: 244 PESIFDKVYTTQSDVWSFGVLLWEIFS----LGASPYPGVQIDEEFCRRLKEGT------ 293
Query: 791 HRLQG-DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834
R++ ++ T ++ I L C H RPT +++V L D L
Sbjct: 294 -RMRAPEYATPEIYS---IMLDCWHNNPEDRPTFSELVEILGDLL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 46/231 (19%)
Query: 564 NFERVLGKGGFGTVYHGYLDD----KQVAVKMLSSSSVQGYKQFQA---EVELLIRAHHK 616
E +G+G +G VY + K+ A+K Q Q+ E+ LL H+
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHE 62
Query: 617 NLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWE--------RRLQIAS--- 665
N+ LV E A+ + +LL D A+ W+ +R+ I
Sbjct: 63 NVVSLVEVFLEHADKSV------------YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 666 ESA-----QGLEYLHNGCKPPIVHRDVKSANILL----NEKFQAKLADFGLSRIF--PVE 714
+S G+ YLH+ ++HRD+K ANIL+ E+ K+ D GL+R+F P++
Sbjct: 111 KSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167
Query: 715 GGTHVSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQ 764
+ VV T Y PE + R T+ D+++ G + EL+T +P+ +
Sbjct: 168 PLADLDPVVV-TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 6/96 (6%)
Query: 670 GLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGY 729
GL+Y+H+ ++HRD+K +N+LLN K+ DFGL+R +G T V T Y
Sbjct: 120 GLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYVVTRWY 174
Query: 730 LDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQ 764
PE ++ + T DV+S G + EL+ +P+
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP 210
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 60/223 (26%), Positives = 110/223 (49%), Gaps = 48/223 (21%)
Query: 565 FERV--LGKGGFGTVYHGY--LDDKQVAVKMLS---------SSSVQGYKQFQAEVELLI 611
+E+V +G+G +G VY + ++ +A+K + S++++ E+ LL
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-------EISLLK 56
Query: 612 RAHHKNLTIL--VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRL------QI 663
H N+ L V + ++ + L++E++ + +L+ H+ D + RL QI
Sbjct: 57 EMQHGNIVRLQDVVHSEK--RLYLVFEYL-DLDLKKHM--DSSPDFAKNPRLIKTYLYQI 111
Query: 664 ASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQA-KLADFGLSRIF--PVEGGTHVS 720
G+ Y H+ ++HRD+K N+L++ + A KLADFGL+R F PV TH
Sbjct: 112 LR----GIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH-- 162
Query: 721 TTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPV 762
V T Y PE + +R + D++S G + E++ +P+
Sbjct: 163 --EVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPL 203
|
Length = 294 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 25/232 (10%)
Query: 554 SYFDVLKITNNFERVLGKGGFGTVYHGY--LDDKQVAVKMLSS--SSVQGYKQFQAEVEL 609
S F VLK + +G G G V + + VAVK LS + K+ E+ L
Sbjct: 15 STFTVLKRYQQL-KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVL 73
Query: 610 LIRAHHKNLTILVGY------CDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI 663
L +HKN+ L+ +E ++ L+ E M A+L + L ER +
Sbjct: 74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-----DANLCQVIHMELDHERMSYL 128
Query: 664 ASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV 723
+ G+++LH+ I+HRD+K +NI++ K+ DFGL+R + T
Sbjct: 129 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPY 182
Query: 724 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQW 775
V T Y PE + E D++S G ++ EL+ G + Q T I QW
Sbjct: 183 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH---IDQW 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (144), Expect = 5e-09
Identities = 55/205 (26%), Positives = 83/205 (40%), Gaps = 58/205 (28%)
Query: 602 QFQAEVELLIRAHHKN---------------LTILVGYCDEG---ANMGLIYEFMANGNL 643
Q EV ++ HKN L IL+ +CD G N+ Y+ G +
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF--GKI 115
Query: 644 QAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPP----IVHRDVKSANILL----- 694
+ H + D I + L Y HN P ++HRD+K NI L
Sbjct: 116 EEHAIVD------------ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163
Query: 695 ------------NEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYI--SNRL 740
N + AK+ DFGLS+ +E H + VGTP Y PE + +
Sbjct: 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSY 220
Query: 741 TEKSDVYSFGVVLLELITGQPVIQK 765
+KSD+++ G ++ EL +G+ K
Sbjct: 221 DDKSDMWALGCIIYELCSGKTPFHK 245
|
Length = 1021 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 569 LGKGGFGTVYHGYLDDK---QVAVKMLSS--SSVQGYKQFQAEVELLIRAHHKNLTILVG 623
+G G +G+V + D K +VAVK LS S+ K+ E+ LL H+N+ +G
Sbjct: 25 VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV---IG 80
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQ------IASESAQGLEYLHNG 677
D + EF + L HL+ + + ++L + + +GL+Y+H+
Sbjct: 81 LLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 139
Query: 678 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYIS 737
I+HRD+K +N+ +NE + K+ DFGL+R E T V T Y PE ++
Sbjct: 140 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLN 191
Query: 738 -NRLTEKSDVYSFGVVLLELITGQPVIQKT 766
+ D++S G ++ EL+TG+ + T
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-09
Identities = 34/111 (30%), Positives = 57/111 (51%), Gaps = 18/111 (16%)
Query: 650 DKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 709
L E+++ +GL YLH I+HRDVK+ NI +N+ Q + D G ++
Sbjct: 155 PIDQALIIEKQI------LEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
Query: 710 IFPVEGGTHVSTTVVGTPGYLD---PEYYISNRLTEKSDVYSFGVVLLELI 757
FPV V+ +G G ++ PE ++ K+D++S G+VL E++
Sbjct: 206 -FPV-----VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 57/222 (25%)
Query: 569 LGKGGFGTVYHGYLDDKQ--VAVKMLS---------SSSVQGYKQFQAEVELLIRAHHKN 617
+G+G +GTV+ + VA+K + SS+++ E+ LL HKN
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-------EICLLKELKHKN 60
Query: 618 -------------LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIA 664
LT++ YCD+ Y NG++ +++ L
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKK---YFDSCNGDIDPEIVKSFMFQLL-------- 109
Query: 665 SESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF--PVEGGTHVSTT 722
+GL + H+ ++HRD+K N+L+N+ + KLADFGL+R F PV S
Sbjct: 110 ----KGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC---YSAE 159
Query: 723 VVGTPGYLDPEYYISNRLTEKS-DVYSFGVVLLELIT-GQPV 762
VV T Y P+ +L S D++S G + EL G+P+
Sbjct: 160 VV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 35/109 (32%), Positives = 58/109 (53%), Gaps = 9/109 (8%)
Query: 669 QGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS-TTVVGTP 727
+ L+Y+H + HRD+K NIL N + K+ DFGL+R+ + T + T V T
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 728 GYLDPEYYIS--NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQ 774
Y PE S ++ T D++S G + E++TG+P+ P + ++ Q
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF---PGKNVVHQ 216
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 16/202 (7%)
Query: 567 RVLGKGGFGTV--YHGYLDDKQVAVKMLSSSSVQGYKQ---FQAEVELLIRAHHKNLTIL 621
+V+G+G FG V K A+K+LS + F E +++ A+ + L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPP 681
+ + ++ E+M G+L +L+ + W + +E L+ +H+
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFY--TAEVVLALDAIHS---MG 162
Query: 682 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISN--- 738
++HRDVK N+LL++ KLADFG G T VGTP Y+ PE S
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA-VGTPDYISPEVLKSQGGD 221
Query: 739 -RLTEKSDVYSFGVVLLELITG 759
+ D +S GV L E++ G
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 57/227 (25%), Positives = 100/227 (44%), Gaps = 49/227 (21%)
Query: 569 LGKGGFGTVYHGYL----DDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGY 624
+G+G +G VY DD+ A+K + + + E+ LL H N+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--MSACREIALLRELKHPNV------ 60
Query: 625 CDEGANMGLIYEFMANGNLQAHLLEDKADTLCWER-RLQIASESAQ-------------- 669
+ L F+++ + + LL D A+ W + AS++ +
Sbjct: 61 ------ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 114
Query: 670 -----GLEYLHNGCKPPIVHRDVKSANILL----NEKFQAKLADFGLSRIF--PVEGGTH 718
G+ YLH ++HRD+K ANIL+ E+ + K+AD G +R+F P++
Sbjct: 115 YQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171
Query: 719 VSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQ 764
+ VV T Y PE + R T+ D+++ G + EL+T +P+
Sbjct: 172 LDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 64/254 (25%), Positives = 104/254 (40%), Gaps = 63/254 (24%)
Query: 563 NNFE--RVLGKGGFGTV--YHGYLDDKQVAVKMLSSSSVQGYKQFQ-----AEVELLIRA 613
+F +V+GKG FG V K A+K L S + +K+ Q AE ++L +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM--FKKDQLAHVKAERDVLAES 58
Query: 614 HHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWE-RRLQIASESAQGLE 672
+ L + + LI EF+ G+L L+ K DT + R +A E +E
Sbjct: 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI--KYDTFSEDVTRFYMA-ECVLAIE 115
Query: 673 YLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF-----------PVEGGTHVST 721
+H K +HRD+K NIL++ KL+DFGLS F ++G ++ +
Sbjct: 116 AVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNR 172
Query: 722 ----------------------------------TVVGTPGYLDPEYYISNRLTEKSDVY 747
+ VGTP Y+ PE ++ ++ D +
Sbjct: 173 IDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232
Query: 748 SFGVVLLELITGQP 761
S G ++ E + G P
Sbjct: 233 SLGAIMFECLIGWP 246
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 51/200 (25%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 567 RVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQGYKQF---QAEVELLIRAHHKNLTIL 621
RV+G+G + V L +D+ A+K++ V + Q E + +A +
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 622 VGYC-DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKP 680
+ C + + L+ E++ G+L H+ + L E A+E L +LH +
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLH---ER 115
Query: 681 PIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRL 740
I++RD+K N+LL+ KL D+G+ + G T ++T GTP Y+ PE
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRGEEY 173
Query: 741 TEKSDVYSFGVVLLELITGQ 760
D ++ GV++ E++ G+
Sbjct: 174 GFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 563 NNFE--RVLGKGGFGTVYHGYLDDKQ--VAVKMLSSSSVQGYKQFQA----EVELLIRAH 614
N FE V+G+G +G V + + VA+K S + ++ + E+++L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLK 58
Query: 615 HKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL 674
+N+ L + L++E++ L+ LLE+ + + E+ + S Q ++ +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEK---VRSYIYQLIKAI 113
Query: 675 HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEY 734
H K IVHRD+K N+L++ KL DFG +R EG T V T Y PE
Sbjct: 114 HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPEL 172
Query: 735 YISNRLTEKSDVYSFGVVLLELITGQPV 762
+ + D++S G +L EL GQP+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 569 LGKGGFGTVYHGYLDDK---QVAVKMLS---SSSVQGYKQFQAEVELLIRAHHKNLTILV 622
+G G +G+V Y D + +VAVK LS S + + ++ E+ LL H+N+ L+
Sbjct: 23 VGSGAYGSVCSAY-DTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLL 80
Query: 623 GYCDEGANMGLIYEFMANGNLQAHLLED--KADTLCWERRLQIASESAQGLEYLHNGCKP 680
++ E NL L + K L E + + +GL+Y+H+
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA--- 137
Query: 681 PIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYIS-NR 739
I+HRD+K +N+ +NE + ++ DFGL+R E T V T Y PE ++
Sbjct: 138 GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMH 192
Query: 740 LTEKSDVYSFGVVLLELITGQ 760
+ D++S G ++ EL+ G+
Sbjct: 193 YNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 25/219 (11%)
Query: 568 VLGKGGFGTVYHGYLDDKQV----AVKMLSSSSVQGYK---QFQAEVELLIRAHHKNLTI 620
++G+G FG V + +K A+K++ S + + F+ E ++L ++ +
Sbjct: 8 LVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQ 65
Query: 621 LVGYCDEGANMGLIYEFMANGNLQAHL--LEDKADTLCWERRLQIASESAQGLEYLHNGC 678
L + N+ L+ E+ G+L + L ED+ D E Q A+ + +H+
Sbjct: 66 LQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFD----EDMAQFYL--AELVLAIHSVH 119
Query: 679 KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISN 738
+ VHRD+K N+L++ KLADFG + S VGTP Y+ PE +
Sbjct: 120 QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN-KMVNSKLPVGTPDYIAPEVLTTM 178
Query: 739 RLTEKS------DVYSFGVVLLELITGQ-PVIQKTPQRT 770
K D +S GV+ E+I G+ P + T +T
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT 217
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 56/227 (24%), Positives = 101/227 (44%), Gaps = 49/227 (21%)
Query: 569 LGKGGFGTVYHGYL----DDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGY 624
+G+G +G VY D+K+ A+K + + + E+ LL H N+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNV------ 60
Query: 625 CDEGANMGLIYEFMANGNLQAHLLEDKADTLCW------------ERRLQIASESAQ--- 669
+ L F+++ + + LL D A+ W ++ +Q+ +
Sbjct: 61 ------IALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLL 114
Query: 670 -----GLEYLHNGCKPPIVHRDVKSANILL----NEKFQAKLADFGLSRIF--PVEGGTH 718
G+ YLH ++HRD+K ANIL+ E+ + K+AD G +R+F P++
Sbjct: 115 YQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171
Query: 719 VSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQ 764
+ VV T Y PE + R T+ D+++ G + EL+T +P+
Sbjct: 172 LDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 65/259 (25%), Positives = 106/259 (40%), Gaps = 68/259 (26%)
Query: 567 RVLGKGGFGTVYHGYLDD--KQVAVKMLSSSSVQGYKQ---FQAEVELLIRAHHKNLTIL 621
+ +G G FG V D A+K L + V Q +AE ++L A ++ + L
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLL------EDKADTLCWERRLQIASESAQGLEYLH 675
+ N+ + +++ G++ + L+ ED A R IA E +E +H
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-------RFYIA-ELTCAIESVH 118
Query: 676 NGCKPPIVHRDVKSANILLNEKFQAKLADFGL---------SRIFPVEGGTH-------- 718
K +HRD+K NIL++ KL DFGL S+ + + G H
Sbjct: 119 ---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY--QKGDHHRQDSMEP 173
Query: 719 --------------------------VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVV 752
++ ++VGTP Y+ PE + T+ D +S GV+
Sbjct: 174 SEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233
Query: 753 LLELITGQ-PVIQKTPQRT 770
L E++ GQ P + TP T
Sbjct: 234 LYEMLVGQPPFLADTPAET 252
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 67/272 (24%), Positives = 108/272 (39%), Gaps = 70/272 (25%)
Query: 567 RVLGKGGFGTVYHGYLDDKQV--AVKMLSSSSVQGYKQF---QAEVELLIRAHHKNLTIL 621
+ LG G FG V D + A+K L V Q +AE ++L A ++ + L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLL------EDKADTLCWERRLQIASESAQGLEYLH 675
+ N+ + +++ G++ + L+ ED A E L A ES + +
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAE--LTCAVESVHKMGF-- 122
Query: 676 NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP-------VEGGTHV--------- 719
+HRD+K NIL++ KL DFGL F + G HV
Sbjct: 123 -------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175
Query: 720 -----------------------------STTVVGTPGYLDPEYYISNRLTEKSDVYSFG 750
+ ++VGTP Y+ PE + T+ D +S G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235
Query: 751 VVLLELITGQ-PVIQKTPQRTLIG--QWVSSM 779
V+L E++ GQ P + +TP T + W +S+
Sbjct: 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 31/217 (14%)
Query: 563 NNFE--RVLGKGGFGTVYHGYLDDKQ--VAVKMLSSSSVQGYKQ---FQAEVELLIRAHH 615
++FE +V+G+G FG V + + A+K+L+ + + F+ E +L+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNL-------QAHLLEDKADTLCWERRLQIASESA 668
+ +T L + + L+ ++ G+L + L ED A E L I S
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAI--HSI 118
Query: 669 QGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPG 728
L Y VHRD+K N+LL+ +LADFG S + + GT S+ VGTP
Sbjct: 119 HQLHY---------VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPD 168
Query: 729 YLDPEYYIS-----NRLTEKSDVYSFGVVLLELITGQ 760
Y+ PE + + + D +S GV + E++ G+
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 18/203 (8%)
Query: 567 RVLGKGGFGTVY---HGYLDDKQVAVKMLSSSSVQGYKQ---FQAEVELLIRAHHKNLTI 620
+V+G+G FG V H K A+K+LS + F E +++ A+ +
Sbjct: 49 KVIGRGAFGEVQLVRHKS-TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 621 LVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKP 680
L + + ++ E+M G+L +L+ + W R +E L+ +H+
Sbjct: 108 LFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFY--TAEVVLALDAIHS---M 161
Query: 681 PIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISN-- 738
+HRDVK N+LL++ KLADFG EG T VGTP Y+ PE S
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYISPEVLKSQGG 220
Query: 739 --RLTEKSDVYSFGVVLLELITG 759
+ D +S GV L E++ G
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 4e-08
Identities = 49/200 (24%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQF---QAEVELLIRAHHKNLTIL 621
RV+G+G + V L ++ A+K++ V + Q E + +A + +
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 622 VGYCDEG-ANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKP 680
+ C + + + + E++ G+L H+ + L E ++E + L YLH +
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH---ER 115
Query: 681 PIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRL 740
I++RD+K N+LL+ + KL D+G+ + G T ++T GTP Y+ PE
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDY 173
Query: 741 TEKSDVYSFGVVLLELITGQ 760
D ++ GV++ E++ G+
Sbjct: 174 GFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 65/257 (25%), Positives = 104/257 (40%), Gaps = 60/257 (23%)
Query: 567 RVLGKGGFGTVYHGYLDDKQV--AVKMLSSSSVQGYKQF---QAEVELLIRAHHKNLTIL 621
+ LG G FG V D A+K L V Q +AE ++L A ++ + L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHL--LEDKADTLCWERRLQIASESAQGLEYLHNGCK 679
+ N+ + +++ G++ + L +E + L R IA E +E +H K
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA---RFYIA-ELTLAIESVH---K 119
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFP-------VEGGTHV------------- 719
+HRD+K NIL++ KL DFGL F + G+H+
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 720 -------------------------STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLL 754
+ ++VGTP Y+ PE + T+ D +S GV+L
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 755 ELITGQ-PVIQKTPQRT 770
E++ GQ P + TP T
Sbjct: 240 EMLVGQPPFLAPTPTET 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 35/119 (29%), Positives = 53/119 (44%), Gaps = 13/119 (10%)
Query: 651 KADTLCW---ERRLQIASESA------QGLEYLHNGCKPPIVHRDVKSANILLNEKFQAK 701
K D C+ +R + I A + ++YLH I+HRD+K+ NI +N
Sbjct: 166 KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVC 222
Query: 702 LADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 760
L DFG + FPV+ + GT PE + D++S G+VL E+ T
Sbjct: 223 LGDFG-AACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-07
Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 28/154 (18%)
Query: 571 KGGFGTVYHGY--LDDKQVAVK------MLSSSSVQGYKQFQAEVELLIRAHHKNLTILV 622
+G FG VY G + K AVK M++ + V Q QAE + L + + L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVH---QVQAERDALALSKSPFIVHLY 70
Query: 623 GYCDEGANMGLIYEFMANGNLQAHLL------EDKADTLCWERRLQIASESAQGLEYLHN 676
N+ L+ E++ G++++ L E+ A ++ SE A L+YLH
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA--------VKYISEVALALDYLH- 121
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710
+ I+HRD+K N+L++ + KL DFGLS++
Sbjct: 122 --RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 669 QGLEYLHNGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIF--PVEGGTHVSTTVVG 725
+G+ + H K ++HRD+K N+L++ +K K+AD GL R F PV+ TH T+
Sbjct: 121 KGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTL-- 175
Query: 726 TPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQPV 762
Y PE + S + D++S G + E+ QP+
Sbjct: 176 --WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 79/347 (22%), Positives = 140/347 (40%), Gaps = 98/347 (28%)
Query: 567 RVLGKGGFGTVYHGY---LDD----KQVAVKMLSSSSVQG-YKQFQAEVELLIR-AHHKN 617
+ LG+G FG V +D + VAVKML + ++ +E+++LI HH N
Sbjct: 13 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 72
Query: 618 --------------LTILVGYCDEG---------------------------ANMGLIYE 636
L ++V +C G + G I E
Sbjct: 73 VVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISE 132
Query: 637 FM---------ANGNLQAHLLEDKA----------------DTLCWERRLQIASESAQGL 671
+ + + + +E+K+ L E + + + A+G+
Sbjct: 133 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGM 192
Query: 672 EYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEGGTHVSTTVVGTP-GY 729
E+L +HRD+ + NILL+E K+ DFGL+R I+ + +V P +
Sbjct: 193 EFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY--KDPDYVRKGDARLPLKW 247
Query: 730 LDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTL-IGQWVSSMLARGDIKNI 788
+ PE T +SDV+SFGV+L E+ + + +P + I + L G
Sbjct: 248 MAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLKEGT---- 299
Query: 789 VDHRLQG-DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834
R++ D+ T +++ + L C H ++RPT +++V L + L
Sbjct: 300 ---RMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLL 340
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 567 RVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQGYKQF---QAEVELLIRAHHKNLTIL 621
RV+G+G + V L + A+K++ V + Q E + A N L
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETA--SNHPFL 58
Query: 622 VGY--CDEG-ANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGC 678
VG C + + + + EF++ G+L H+ + L E ++E + L +LH
Sbjct: 59 VGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHER- 115
Query: 679 KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISN 738
I++RD+K N+LL+ + KL D+G+ + G T ++T GTP Y+ PE
Sbjct: 116 --GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYIAPEILRGE 171
Query: 739 RLTEKSDVYSFGVVLLELITGQ 760
D ++ GV++ E++ G+
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 51/221 (23%)
Query: 567 RVLGKGGFGTVYHGYL-----DDKQVAVKML-----SSSSVQGYKQFQAEVELLIRAHHK 616
++LGK G GT K A+K + S V ++ QA L + H
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRL---SPHP 58
Query: 617 NLTIL--VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL 674
N+ L V + + + L++E M + NL L++ + L +R + + L+++
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELM-DMNLY-ELIKGRKRPLPEKRVKSYMYQLLKSLDHM 116
Query: 675 H-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPE 733
H NG I HRD+K NIL+ + KLADFG R + P Y +
Sbjct: 117 HRNG----IFHRDIKPENILIKDD-ILKLADFGSCR------------GIYSKPPYTE-- 157
Query: 734 YYISNR--------LTE-----KSDVYSFGVVLLELITGQP 761
YIS R LT+ K D+++ G V E+++ P
Sbjct: 158 -YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 26/205 (12%)
Query: 586 QVAVKM--LSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN- 642
V V++ L + + + K Q EV L H N+ G+ + +I FMA G+
Sbjct: 27 LVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSA 86
Query: 643 ---LQAHLLEDKADTLCWERRLQIASESAQGLEYLH-NGCKPPIVHRDVKSANILLNEKF 698
L+ + E ++ L I + +GL YLH NG +HR++K+++IL++
Sbjct: 87 NSLLKTYFPEGMSEALIG----NILFGALRGLNYLHQNGY----IHRNIKASHILISGDG 138
Query: 699 QAKLADFGLSRIFPVEGGTHVSTTVVGTPGY-------LDPEYYISNR--LTEKSDVYSF 749
L+ GLS ++ + + V P + L PE + KSD+YS
Sbjct: 139 LVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSV 196
Query: 750 GVVLLELITGQPVIQKTPQRTLIGQ 774
G+ EL TG+ Q + ++ Q
Sbjct: 197 GITACELATGRVPFQDMLRTQMLLQ 221
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-07
Identities = 48/174 (27%), Positives = 82/174 (47%), Gaps = 31/174 (17%)
Query: 661 LQIASESAQGLEYL-HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI------FPV 713
L+ +S+ AQG+++L C +HRDV + N+LL + AK+ DFGL+R + V
Sbjct: 215 LRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270
Query: 714 EGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP-QRTLI 772
+G + ++ PE T +SDV+S+G++L E+ + + K+P L+
Sbjct: 271 KGNARLPVK------WMAPESIFDCVYTVQSDVWSYGILLWEIFS----LGKSPYPGILV 320
Query: 773 GQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQV 826
M+ RG + DF ++ I C + T RPT +Q+
Sbjct: 321 NSKFYKMVKRG------YQMSRPDFAPPEIYS---IMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 7e-07
Identities = 47/156 (30%), Positives = 72/156 (46%), Gaps = 3/156 (1%)
Query: 410 RIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNL 469
++IS++LS + ++G+I + L ++E L L N+ TG +P L L L+VL L N
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344
Query: 470 QGSLPSGLSEKVKNGSLSLSVDGNRNLCPSASCKKKSNKFIFPVLASVVSFCILLALLAI 529
G +P L + L LS + P C N F + ++ + I +L A
Sbjct: 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLC-SSGNLFKLILFSNSLEGEIPKSLGAC 403
Query: 530 LQNLRR-RKQAGKKKGSLELENRKFSYFDVLKITNN 564
++LRR R Q G L E K L I+NN
Sbjct: 404 -RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNN 438
|
Length = 968 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 37/126 (29%), Positives = 65/126 (51%), Gaps = 7/126 (5%)
Query: 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN-GCKPPIVHRDVKSANIL 693
Y+ + ++ L +D ++ L L + A+G+E+L + C VHRD+ + N+L
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVL 269
Query: 694 LNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYYISNRLTEKSDVYSFGVV 752
L + K+ DFGL+R + +VS P ++ PE N T SDV+S+G++
Sbjct: 270 LAQGKIVKICDFGLARDI-MHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGIL 328
Query: 753 LLELIT 758
L E+ +
Sbjct: 329 LWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 44/148 (29%), Positives = 73/148 (49%), Gaps = 13/148 (8%)
Query: 622 VGYCD-EGANMGLIYE---FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN- 676
V Y D E +N Y+ A + L +++ L + + + + A G+E+L +
Sbjct: 199 VKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK 258
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYY 735
C VHRD+ + N+L+ E K+ DFGL+R + ++S P ++ PE
Sbjct: 259 NC----VHRDLAARNVLICEGKLVKICDFGLARDI-MRDSNYISKGSTFLPLKWMAPESI 313
Query: 736 ISNRLTEKSDVYSFGVVLLELIT--GQP 761
+N T SDV+SFG++L E+ T G P
Sbjct: 314 FNNLYTTLSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 55/226 (24%), Positives = 102/226 (45%), Gaps = 36/226 (15%)
Query: 569 LGKGGFGTVYHG----YLDDKQ-----VAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLT 619
LG+G F ++ G D + V +K+L S + F ++ + HK+L
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHLLEDK-ADTLCWERRLQIASESAQGLEYLHNGC 678
+ G C G ++ E++ G+L +L ++K + W +L++A + A L +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLED-- 118
Query: 679 KPPIVHRDVKSANILLNEKFQA--------KLADFGLS-RIFPVEGGTHVSTTVVGTPGY 729
+ H +V + N+LL + KL+D G+S + P E ++ +
Sbjct: 119 -KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE-------ILLERIPW 170
Query: 730 LDPEYYISN--RLTEKSDVYSFGVVLLELITG--QPVIQKTPQRTL 771
+ PE I N L+ +D +SFG L E+ +G +P+ Q+ L
Sbjct: 171 VPPE-CIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 35/130 (26%), Positives = 58/130 (44%), Gaps = 20/130 (15%)
Query: 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANIL 693
+Y FM + K L + R I + +EY+H+ ++HRD+K NI
Sbjct: 249 LYSFMYDEAFDW-----KDRPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIF 299
Query: 694 LNEKFQAKLADFGLSRIF-----PVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYS 748
LN + L DFG + F + G VGT PE + E +D++S
Sbjct: 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGW------VGTVATNSPEILAGDGYCEITDIWS 353
Query: 749 FGVVLLELIT 758
G++LL++++
Sbjct: 354 CGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 7/93 (7%)
Query: 668 AQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEGGTHVSTTVVGT 726
A+G+E+L +HRD+ + NILL+E K+ DFGL+R I+ + +V
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY--KDPDYVRKGSARL 238
Query: 727 P-GYLDPEYYISNRLTEKSDVYSFGVVLLELIT 758
P ++ PE T +SDV+SFGV+L E+ +
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 37/127 (29%), Positives = 61/127 (48%), Gaps = 12/127 (9%)
Query: 647 LLEDKADTLCWERRLQIASESAQGLEYLHN-GCKPPIVHRDVKSANILLNEKFQAKLADF 705
+LE+ L E L + + A+G+ +L + C +HRD+ + NILL K+ DF
Sbjct: 203 ILEEDELALDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDF 258
Query: 706 GLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT------- 758
GL+R + V ++ PE + T +SDV+S+G++L E+ +
Sbjct: 259 GLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP 318
Query: 759 GQPVIQK 765
G PV K
Sbjct: 319 GMPVDSK 325
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 569 LGKGGFGTVYHG--YLDD--KQVAVKML-SSSSVQGYKQFQAEVELLIRAHHKNLTILVG 623
+G G FG V Y D +V VK L +++S + +F + + H N+ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDK-----ADTLCWERRLQIASESAQGLEYLHNGC 678
C E L++E+ G+L+++L +++ + L +R +A E A G+ ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTHMH--- 116
Query: 679 KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEY---- 734
K +H D+ N L K+ D+G+ E +L PE
Sbjct: 117 KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 735 ---YISNRLTEKSDVYSFGVVLLELI--TGQP 761
I+ T+ S+V++ GV L EL QP
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQP 208
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-06
Identities = 26/69 (37%), Positives = 41/69 (59%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
P + +++LS++ ++G+I I S +S++ LDL N L G +P L L SL L L+ N
Sbjct: 140 PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ 199
Query: 469 LQGSLPSGL 477
L G +P L
Sbjct: 200 LVGQIPREL 208
|
Length = 968 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 5e-06
Identities = 65/243 (26%), Positives = 99/243 (40%), Gaps = 33/243 (13%)
Query: 569 LGKGGFGTVY----HGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGY 624
L G G V+ HG K+V VK +V G K E+++L H+ + L+
Sbjct: 100 LTPGSEGEVFVCTKHGDEQRKKVIVK-----AVTGGKTPGREIDILKTISHRAIINLI-- 152
Query: 625 CDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVH 684
+ M D++ L E+ + I + L YLH I+H
Sbjct: 153 -HAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIH 208
Query: 685 RDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV----VGTPGYLDPEYYISNRL 740
RDVK+ NI L+E A L DFG + + H T GT PE +
Sbjct: 209 RDVKTENIFLDEPENAVLGDFGAA----CKLDAHPDTPQCYGWSGTLETNSPELLALDPY 264
Query: 741 TEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWV--SSMLARGDIKNIVDHRLQGDFD 798
K+D++S G+VL E+ ++ TL G+ V SS R I+ + H L+ +
Sbjct: 265 CAKTDIWSAGLVLFEM-----SVKN---VTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316
Query: 799 TNT 801
+T
Sbjct: 317 GST 319
|
Length = 392 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 7e-06
Identities = 31/81 (38%), Positives = 42/81 (51%), Gaps = 1/81 (1%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
P + ++L+ + G + P F +E+LDLS+N +G VP L L L L LS N
Sbjct: 452 PSLQMLSLARNKFFGGL-PDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENK 510
Query: 469 LQGSLPSGLSEKVKNGSLSLS 489
L G +P LS K SL LS
Sbjct: 511 LSGEIPDELSSCKKLVSLDLS 531
|
Length = 968 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 1e-05
Identities = 29/99 (29%), Positives = 45/99 (45%), Gaps = 10/99 (10%)
Query: 663 IASESAQGLEYLHNGCKPPIVHRDVKSANILLNE-KFQAKLADFGLSRIFPVEGGTHVST 721
I + + L LH K I+H D+K N+L + K + L D+GL +I +
Sbjct: 114 IIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI------IGTPS 164
Query: 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 760
GT Y PE + D ++ GV+ EL+TG+
Sbjct: 165 CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 1e-05
Identities = 26/58 (44%), Positives = 37/58 (63%), Gaps = 2/58 (3%)
Query: 413 SINLSSSGIAGDIVPYIF-SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNL 469
S++LS++ + I F L +++ LDLS N+LT PE + L SLR L+LSGNNL
Sbjct: 4 SLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-05
Identities = 22/61 (36%), Positives = 37/61 (60%)
Query: 414 INLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSL 473
++L + + G I + +LTS+E L L+ N L G +P L +++SL+ + L NNL G +
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228
Query: 474 P 474
P
Sbjct: 229 P 229
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-05
Identities = 31/76 (40%), Positives = 43/76 (56%)
Query: 414 INLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSL 473
I L + ++G+I I LTS+ LDL N+LTGP+P L L++L+ L L N L G +
Sbjct: 217 IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI 276
Query: 474 PSGLSEKVKNGSLSLS 489
P + K SL LS
Sbjct: 277 PPSIFSLQKLISLDLS 292
|
Length = 968 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 38/142 (26%), Positives = 60/142 (42%), Gaps = 24/142 (16%)
Query: 633 LIYEFMANGNLQAHLL------EDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRD 686
L+ + G L +H+ E+ W A+E L+ LH + IV RD
Sbjct: 62 LVLQHAEGGKLWSHISKFLNIPEECVK--RW------AAEMVVALDALH---REGIVCRD 110
Query: 687 VKSANILLNEKFQAKLADFG-LSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSD 745
+ NILL+++ +L F S + G V Y PE + TE D
Sbjct: 111 LNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPEVGGISEETEACD 164
Query: 746 VYSFGVVLLELITGQPVIQKTP 767
+S G +L EL+TG+ +++ P
Sbjct: 165 WWSLGAILFELLTGKTLVECHP 186
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 40/129 (31%), Positives = 58/129 (44%), Gaps = 17/129 (13%)
Query: 567 RVLGKGGFGTVY----HGYLDDK---QVAVKMLSSSSVQGYKQFQAEVELLIRAH---HK 616
R LG G FG V HG + +VAVKML S++ KQ EL I +H H
Sbjct: 43 RTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMS-ELKIMSHLGPHL 101
Query: 617 NLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN 676
N+ L+G C +G + +I E+ G+L +L +K LQ + + L +
Sbjct: 102 NIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNK------HTFLQYYLDKNRDDGSLIS 155
Query: 677 GCKPPIVHR 685
G P+ R
Sbjct: 156 GGSTPLSQR 164
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 29/105 (27%), Positives = 46/105 (43%), Gaps = 18/105 (17%)
Query: 660 RLQIASESAQ---GLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGL------SRI 710
Q+ + + Q ++Y+H I+HRD+K+ N+L+N L DFG S
Sbjct: 259 LAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315
Query: 711 FPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLE 755
P G + GT PE + T D++S G+V+ E
Sbjct: 316 TPFHYG------IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 0.001
Identities = 23/72 (31%), Positives = 40/72 (55%), Gaps = 3/72 (4%)
Query: 406 NQSPRIISIN---LSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVL 462
+ + S+N L + + G I + +L +++ L L +N L+GP+P + LQ L L
Sbjct: 230 YEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISL 289
Query: 463 NLSGNNLQGSLP 474
+LS N+L G +P
Sbjct: 290 DLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 26/98 (26%), Positives = 48/98 (48%), Gaps = 3/98 (3%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
P + +++S++ + G I + + S++ L L++N G +P+ + L L+LS N
Sbjct: 428 PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQ 486
Query: 469 LQGSLPSGLSEKVKNGSLSLSVDGNRNLCPS--ASCKK 504
G++P L + L LS + P +SCKK
Sbjct: 487 FSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKK 524
|
Length = 968 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 65/241 (26%), Positives = 101/241 (41%), Gaps = 48/241 (19%)
Query: 543 KGSLELENRKFSYFDVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQ 602
+G E E + D L NN R L +V +K+L S
Sbjct: 19 EGGGEPEEDEMEDEDPLVEGNNNGREL----------------RVVLKVLDPSHRDIALA 62
Query: 603 FQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADT-LCWERRL 661
F L+ + H +L + G C G+ ++ EF+ +G L L ++K + W ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 662 QIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQA-------KLADFG-----LSR 709
+A + A L YL + +VH +V + NILL A KL+D G LSR
Sbjct: 121 TVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR 177
Query: 710 IFPVEGGTHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEL-ITGQ-PVIQKT 766
VE P ++ PE N L+ +D +SFG LLE+ G+ P+ ++T
Sbjct: 178 EERVE----------RIP-WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226
Query: 767 P 767
P
Sbjct: 227 P 227
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.002
Identities = 22/75 (29%), Positives = 41/75 (54%), Gaps = 1/75 (1%)
Query: 414 INLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSL 473
+ L + +G++ L + LD+S N+L G + ++ SL++L+L+ N G L
Sbjct: 409 VRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGL 468
Query: 474 P-SGLSEKVKNGSLS 487
P S S++++N LS
Sbjct: 469 PDSFGSKRLENLDLS 483
|
Length = 968 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 47/220 (21%)
Query: 568 VLGKGGFGTVYHGYLDD--KQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYC 625
++G G FG VY D ++VA+K + +Q + E+ ++ +H N+ L Y
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDYY 128
Query: 626 --------DEGANMGLIYEFMA-------------NGNLQAHLLEDKADTLCWERRLQIA 664
++ + ++ EF+ N L L++ + LC
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC-------- 180
Query: 665 SESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQA-KLADFGLSRIFPVEGGTHVSTTV 723
+ L Y+H+ I HRD+K N+L++ KL DFG ++ S +
Sbjct: 181 ----RALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL---AGQRSVSY 230
Query: 724 VGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQPV 762
+ + Y PE + + T D++S G ++ E+I G P+
Sbjct: 231 ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPI 270
|
Length = 440 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 36.3 bits (85), Expect = 0.002
Identities = 17/38 (44%), Positives = 26/38 (68%), Gaps = 2/38 (5%)
Query: 433 TSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQ 470
T++E+LDLS N +T +P L+ L +L L+LSGN +
Sbjct: 1 TNLETLDLSNNQITD-LPP-LSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 565 FERVLGKGGFGTVYH------GYLDDK-QVAVKMLSSSSVQGYKQ-FQAEVELLIR-AHH 615
F + LG G FG V G D+ +VAVKML +S+ ++ +E+++L H
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTL 655
KN+ L+G C G + +I E+ G+L + L KA+T
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDL-LNFLRKKAETF 140
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.003
Identities = 25/62 (40%), Positives = 34/62 (54%), Gaps = 4/62 (6%)
Query: 434 SIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSL-SLSVDG 492
+++SLDLS N LT L +L+VL+LSGNNL S+ + SL SL + G
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLP--SLRSLDLSG 57
Query: 493 NR 494
N
Sbjct: 58 NN 59
|
Length = 60 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 870 | |||
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.78 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.77 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.74 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.73 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.73 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.7 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.69 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.62 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.6 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.53 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.51 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.42 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.3 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.27 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.21 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.07 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.0 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.0 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.97 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.96 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.95 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.94 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.73 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.69 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.58 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 98.57 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.56 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.53 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.5 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.49 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.47 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.42 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.39 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.29 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.26 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.24 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.16 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 98.14 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.03 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 97.98 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.98 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 97.95 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.93 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.93 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.86 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.84 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 97.82 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.79 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.79 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 97.79 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.76 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.65 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.6 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.57 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 97.55 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 97.5 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 97.5 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 97.47 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.46 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.45 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.42 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.41 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.4 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.39 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 97.39 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 97.37 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.33 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 97.33 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 97.28 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 97.26 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 97.23 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 97.2 |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-84 Score=765.64 Aligned_cols=472 Identities=22% Similarity=0.357 Sum_probs=360.6
Q ss_pred HHhhhhccCCCCcEEeccCCCCCCccccCCCceEEecCCCccccCcceeeCCCCcccccccccccccccC--cCccccee
Q 002887 17 LTAVVHAQNQSGFISIDCGIPENENYADKVTGINYVSDAPYVDTAVSHSISPEYSKETVERQFSYLRSFP--EGIRNCYT 94 (870)
Q Consensus 17 ~~~~~~~~~~~~~~~idCG~~~~~~~~~~~~~~~~~~D~~~~~~g~~~~~~~~~~~~~~~~~~~t~R~Fp--~g~~ncY~ 94 (870)
+..++++++++++++||||++++.+ ++.+|++|++|..|+. |.....+.+ ....++|.|+|+|| +|+||||+
T Consensus 13 ~~~~~~~~~~~~~~~I~CGs~~~~~--~d~~~~~w~~D~~~~~-~~~~~~~~~---~~~~~~~~t~R~F~~~~g~~~cY~ 86 (623)
T PLN03150 13 AVLASLASPEPFTMRISCGARVNVR--TAPTNTLWYKDFAYTG-GIPANATRP---SFIAPPLKTLRYFPLSDGPENCYN 86 (623)
T ss_pred HhhcccccCCCccEEEeCCCCCCcc--cCCCCCEEcCCccccc-CccccccCc---ccccchhhccccCCcccccccceE
Confidence 3444556668899999999754432 2348999999999864 343333222 23467899999999 68899999
Q ss_pred cCCCCCCccEEEEeeeeeccCCCCCCCCceEEEEcceeeEEEEcCC--CccceeEEEEEecCCCceEEEEeecCCCCcee
Q 002887 95 LRPPNGDVKFLIRARFMYGNYDGLDKAPSFDLMLGADAWDSVQLQD--PRSIITKEIIHMPNKDYIHVCLVNTDSGIPFI 172 (870)
Q Consensus 95 l~~~~~~~~ylvR~~f~ygnyd~~~~~p~Fd~~~~~~~w~~v~~~~--~~~~~~~e~~~~~~~~~~~vcl~~t~~~~pfi 172 (870)
| ++.++||||||++|+|||||+++++|.|||++|||+|.+|+.+. +....++|+|+.+++++++|||+++++|+|||
T Consensus 87 ~-~~~~~g~ylVRl~F~~~~y~~~~~~~~Fdv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~~l~vcf~~~~~~~pFI 165 (623)
T PLN03150 87 I-NRVPKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPAI 165 (623)
T ss_pred e-eecCCCcEEEEEEeecCCcCCCCCCCceEEEECcEEEEEEecCcccCCCcEEEEEEEEecCCcEEEEEecCCCCCCce
Confidence 9 55778899999999999999999999999999999999998743 34457789999999999999999999999999
Q ss_pred eeeeeeecCCCCCCCCCCCCCCCCCCCceeeEEeeccCC---------CCccC--CceeccCCC---CCccccccccccC
Q 002887 173 SALELRPLTNSIYPPTASDLYRPTPTGSMSLVLRWDVGT---------PLDIY--DRIWWPDNF---KNVERISTSSNVN 238 (870)
Q Consensus 173 s~lEl~~l~~~~y~~~~~~~~~~~~~~~l~~~~R~~~g~---------p~D~~--dR~W~~~~~---~~~~~~st~~~~~ 238 (870)
|+||||||++++|+.... ...+.+|.+++|+++|+ |||+| ||+|.++.. ..|..+++...+.
T Consensus 166 s~iEv~~l~~~~y~~~~~----~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~~~~~st~~~I~ 241 (623)
T PLN03150 166 LSIEILQVDDKAYNFGPS----WGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIK 241 (623)
T ss_pred eEEEEEEcCccccccccc----ccCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccCCCcccccccccccc
Confidence 999999999999974320 12355799999999986 78999 999998754 4577787775553
Q ss_pred -CCCCCCCChHHhhhhceecCCCCCceEEeecccCCcceEEEEEeeeccchhcccccceEEEEEECCccccCCCCCCcc-
Q 002887 239 -PATSLFQPPVTVMQSAIIPANGSSSFWFSWESVSTVFKYYTCMYFSEFESEQAETRSREMNIYLNGRFWSEIPPPQYL- 316 (870)
Q Consensus 239 -~~~~~~~~P~~v~~tA~~~~~~~~~l~~~w~~~~~~~~y~v~lhFae~~~~~~~~~~R~F~i~~ng~~~~~~~~p~~~- 316 (870)
..+..+.+|+.|||||+++.++..++.+.|+ ++++.+|+|+|||||++.+....++|+||||+||+.+.+.+++...
T Consensus 242 ~~~~~~~~~P~~VyqTA~~~~~~~~~lty~~~-v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~~~ 320 (623)
T PLN03150 242 KASNAPNFYPESLYQSALVSTDTQPDLSYTMD-VDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMS 320 (623)
T ss_pred cccCCCccChHHHhhhhccccCCCCceEEEee-cCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhhhc
Confidence 2345677899999999998876677888876 6788999999999999754456689999999999987765443222
Q ss_pred ----ccee--eeeeeeccceEEEEEEeccCcchhhHHHHHHHhhhhchhcccCChhhHHHHHHHHhhcCCC--CCCCCCC
Q 002887 317 ----NTTT--HRLTATNAQQYVISIMQTKNSSLAPILNALEIYQEKEFLQLLTNQQDVDAIMKIKSKYEVK--RDWQGDP 388 (870)
Q Consensus 317 ----~~~~--~~~~~~~~~~~~~sl~~t~~s~lppilna~ei~~~~~~~~~~~~~~d~~al~~~k~~~~~~--~~w~~~p 388 (870)
.... ..+... .+.+++++.++..+ +|+|||+|||.+.+ ....|.+.|+.||+++|+.++.. .+|+|||
T Consensus 321 g~~~~~~~~~~~v~~~-~g~l~isl~p~~~s--~pilNaiEI~~~~~-~~~~t~~~~~~aL~~~k~~~~~~~~~~W~g~~ 396 (623)
T PLN03150 321 GERYTALVLNKTVAVS-GRTLTIVLQPKKGT--HAIINAIEVFEIIT-AESKTLLEEVSALQTLKSSLGLPLRFGWNGDP 396 (623)
T ss_pred CCcccceEEEeEEeec-CCeEEEEEeeCCCC--cceeeeeeeeeccc-cccccCchHHHHHHHHHHhcCCcccCCCCCCC
Confidence 1111 122223 47899999998755 69999999999888 56789999999999999998653 3899999
Q ss_pred CCCCCCCccceecCCCCC-CCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCC
Q 002887 389 CAPKVYMWQGINCSYDAN-QSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467 (870)
Q Consensus 389 C~~~~~~W~Gv~C~~~~~-~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N 467 (870)
|+|..+.|.||.|+.+.. ....|+.|+|++|+|+|.+|.+|++|++|+.|+|++|+|+|.+|..+++|++|+.|||++|
T Consensus 397 C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N 476 (623)
T PLN03150 397 CVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYN 476 (623)
T ss_pred CCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCC
Confidence 999889999999964221 1224666777777777666666666666666666666666666666666666666666666
Q ss_pred cCCCCCCCcccccccCCccc-----------------------cccCCCCCCCCC---Ccccc
Q 002887 468 NLQGSLPSGLSEKVKNGSLS-----------------------LSVDGNRNLCPS---ASCKK 504 (870)
Q Consensus 468 ~l~g~ip~~l~~~~~~~~l~-----------------------~~~~~n~~lc~~---~sc~~ 504 (870)
+|+|.+|+.++++++|+.|+ +.+.+|+.+|+. ..|..
T Consensus 477 ~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~~ 539 (623)
T PLN03150 477 SFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGP 539 (623)
T ss_pred CCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCCCCCCcc
Confidence 66666666666665555544 345578888975 35653
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-68 Score=590.31 Aligned_cols=318 Identities=42% Similarity=0.717 Sum_probs=270.5
Q ss_pred eccCCCCCCc-cccCCCceEEecCCCccccCcceeeCCC--CcccccccccccccccCcCcccceecCCCC-CCccEEEE
Q 002887 32 IDCGIPENEN-YADKVTGINYVSDAPYVDTAVSHSISPE--YSKETVERQFSYLRSFPEGIRNCYTLRPPN-GDVKFLIR 107 (870)
Q Consensus 32 idCG~~~~~~-~~~~~~~~~~~~D~~~~~~g~~~~~~~~--~~~~~~~~~~~t~R~Fp~g~~ncY~l~~~~-~~~~ylvR 107 (870)
||||++.+++ |+|+.|||+|++|.+|+++|++++|+.. .......++|+|+|+||+|+||||+|+..+ +|+|||||
T Consensus 1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~~i~~~~~~~~~~~~~~y~taR~F~~g~r~cY~l~~~~~~~~~yliR 80 (347)
T PF12819_consen 1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSGNISSQPDSSSSDSSPPYQTARIFPEGSRNCYTLPVTPPGGGKYLIR 80 (347)
T ss_pred CcCCCCCCCcccccCCCCcEEeCCCCcccCCCccccccccCCcCCccccccceEEEcCCCCccEEEeeccCCCCceEEEE
Confidence 8999988887 9999999999999999999999998422 223567899999999999999999996533 67899999
Q ss_pred eeeeeccCCCCC-----CCCceEEEEcceeeEEEEcCCCc-cceeEEEEE-ecCCCceEEEEeecCCCC-ceeeeeeeee
Q 002887 108 ARFMYGNYDGLD-----KAPSFDLMLGADAWDSVQLQDPR-SIITKEIIH-MPNKDYIHVCLVNTDSGI-PFISALELRP 179 (870)
Q Consensus 108 ~~f~ygnyd~~~-----~~p~Fd~~~~~~~w~~v~~~~~~-~~~~~e~~~-~~~~~~~~vcl~~t~~~~-pfis~lEl~~ 179 (870)
++|+||||||++ ++|.|||++|+|.|.+|+.+++. ...++|+++ +.++++++|||+++++|+ ||||+|||||
T Consensus 81 l~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~~pFIsaiEl~~ 160 (347)
T PF12819_consen 81 LHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGTFPFISAIELRP 160 (347)
T ss_pred EEeccccccccccccccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCCCCceeEEEEEE
Confidence 999999999985 36889999999999999988732 357889555 555899999999999998 9999999999
Q ss_pred cCCCCCCCCCCCCCCCCCCCceeeEEeeccCC-------CCccCCceeccCC-CCCcccccccccc--CCCCCCCCChHH
Q 002887 180 LTNSIYPPTASDLYRPTPTGSMSLVLRWDVGT-------PLDIYDRIWWPDN-FKNVERISTSSNV--NPATSLFQPPVT 249 (870)
Q Consensus 180 l~~~~y~~~~~~~~~~~~~~~l~~~~R~~~g~-------p~D~~dR~W~~~~-~~~~~~~st~~~~--~~~~~~~~~P~~ 249 (870)
|++++|+... ...+.+|.++.|+|||+ |+|+|||+|+|+. .+.|..++|...+ +...+.|.||.+
T Consensus 161 lp~~ly~~~~-----~~~s~~L~~~~R~n~G~~~~~iryp~D~~dR~W~~~~~~~~~~~ist~~~i~~~~~~~~~~~P~~ 235 (347)
T PF12819_consen 161 LPDSLYPDTD-----ANSSQALETVYRLNVGGSSSFIRYPDDTYDRIWQPYSSSPGWSNISTTSNININSSNNPYDAPSA 235 (347)
T ss_pred CCccceeccc-----cCCCceeEEEEeecCCCcccccCCCCCcceeeccccccCccccccccceeeecccCCccCcChHH
Confidence 9999996431 14566899999999998 7999999999874 5789999987544 456778999999
Q ss_pred hhhhceecCCCCCceEEeecccCCcceEEEEEeeeccchhcccccceEEEEEECCccccCCCCCCcccceee------ee
Q 002887 250 VMQSAIIPANGSSSFWFSWESVSTVFKYYTCMYFSEFESEQAETRSREMNIYLNGRFWSEIPPPQYLNTTTH------RL 323 (870)
Q Consensus 250 v~~tA~~~~~~~~~l~~~w~~~~~~~~y~v~lhFae~~~~~~~~~~R~F~i~~ng~~~~~~~~p~~~~~~~~------~~ 323 (870)
|||||+++.+.+.+++++|..++++.+|||+||||||+......++|+|||||||+.+.+.++|.++...+. .+
T Consensus 236 V~~TA~~~~~~s~~~nltw~~~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~~~~~~~~~~~~~~~~~d~~~ 315 (347)
T PF12819_consen 236 VYQTARTPSNSSDPLNLTWSFVDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYSDVSPPYLGADTVPYYSDYVV 315 (347)
T ss_pred HHHhhhcccccccceEEEeccCCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccCccCcccccCcceEeecceEE
Confidence 999999999988889999999889999999999999997323455899999999999988888877776442 22
Q ss_pred eeeccceEEEEEEeccCcchhhHHHHHHHhh
Q 002887 324 TATNAQQYVISIMQTKNSSLAPILNALEIYQ 354 (870)
Q Consensus 324 ~~~~~~~~~~sl~~t~~s~lppilna~ei~~ 354 (870)
....++.++|+|.++..|.|||||||+|||.
T Consensus 316 ~~~~~~~~~isL~~t~~S~lppiLNalEIy~ 346 (347)
T PF12819_consen 316 NVPDSGFLNISLGPTPDSTLPPILNALEIYK 346 (347)
T ss_pred EecCCCEEEEEEEeCCCCCcCceeEeeeeEe
Confidence 3344567899999999999999999999985
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-53 Score=470.27 Aligned_cols=285 Identities=53% Similarity=0.872 Sum_probs=252.5
Q ss_pred cccccCHHHHHHHHhhcc--ccccccCcEEEEEEEECC-eeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEE
Q 002887 549 ENRKFSYFDVLKITNNFE--RVLGKGGFGTVYHGYLDD-KQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYC 625 (870)
Q Consensus 549 ~~~~~~~~dl~~~t~~f~--~~LG~G~fG~Vy~~~~~~-~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~ 625 (870)
....|++.++.++|++|. +.||+|+||.||+|.+.+ +.||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 456799999999999998 699999999999999985 89999988776543145699999999999999999999999
Q ss_pred ecCC-eEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEe
Q 002887 626 DEGA-NMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLAD 704 (870)
Q Consensus 626 ~~~~-~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~D 704 (870)
.+.+ +.+||||||++|+|.++|+......++|.+|++||.++|+||+|||+.+.++|+|||||++|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 599999999999999999875433899999999999999999999999999999999999999999999999999
Q ss_pred ccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC--ccchHHHHHHHHhhc
Q 002887 705 FGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP--QRTLIGQWVSSMLAR 782 (870)
Q Consensus 705 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~--~~~~l~~~~~~~~~~ 782 (870)
||+|+..+.. ..+......||.+|+|||++..+..++|+|||||||+|+||+||+++.+... ....+..|+...+.+
T Consensus 221 FGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 9999765431 2222221189999999999999999999999999999999999999988653 445589999999999
Q ss_pred CCcchhcccccC-CCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 783 GDIKNIVDHRLQ-GDFDT-NTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 783 ~~~~~i~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
+.+.+++|+++. ..+.. +++.++..+|.+|++.+|++||+|.||+++|+.+.
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 999999999987 55554 68999999999999999999999999999996654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-50 Score=505.80 Aligned_cols=410 Identities=28% Similarity=0.471 Sum_probs=304.5
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
+.++.|+|++|.+.|.+|..+++|++|++|+|++|+++|.+|..++.|++|+.|||++|+++|.+|..+..+..+..|++
T Consensus 499 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l 578 (968)
T PLN00113 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNI 578 (968)
T ss_pred hccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEec
Confidence 46778888888888888888888888888888888888888888888888888888888888888888877777766654
Q ss_pred c---------------------cCCCCCCCCCC------ccccC-CCcceeEEEeehhhhhhHHHHHH-Hhhhhhccccc
Q 002887 489 S---------------------VDGNRNLCPSA------SCKKK-SNKFIFPVLASVVSFCILLALLA-ILQNLRRRKQA 539 (870)
Q Consensus 489 ~---------------------~~~n~~lc~~~------sc~~~-~~~~i~~v~~~~~~~~~ll~~~~-~~~~~rrrk~~ 539 (870)
+ +.||+.+|+.. .|... +......+++.++++++++++++ ++..+|+|+..
T Consensus 579 s~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (968)
T PLN00113 579 SHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNL 658 (968)
T ss_pred cCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcc
Confidence 3 45788888752 45432 11111112222222222222222 22222322211
Q ss_pred C-cc----cccccc------cccccCHHHHHHHHhhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHH
Q 002887 540 G-KK----KGSLEL------ENRKFSYFDVLKITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAE 606 (870)
Q Consensus 540 ~-~~----~~~~~~------~~~~~~~~dl~~~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~E 606 (870)
. ++ .+..+. ....+++.++.+. ....+.||+|+||.||+|+.. ++.||||++..... ...+|
T Consensus 659 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~ 733 (968)
T PLN00113 659 ELKRVENEDGTWELQFFDSKVSKSITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSE 733 (968)
T ss_pred cccccccccccccccccccccchhhhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHH
Confidence 1 11 111110 0112334444332 123468999999999999974 88999999865432 22456
Q ss_pred HHHHHHhccccceeEEEEEecCCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCC
Q 002887 607 VELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRD 686 (870)
Q Consensus 607 i~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrD 686 (870)
++.+++++||||++++++|.+....++||||+++|+|.++++ .++|.++.+|+.|+|+||+|||+.+.++|+|||
T Consensus 734 ~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~d 808 (968)
T PLN00113 734 IADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGN 808 (968)
T ss_pred HHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCC
Confidence 889999999999999999999999999999999999999984 389999999999999999999987777999999
Q ss_pred CCCCCEEEcCCCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 002887 687 VKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 766 (870)
Q Consensus 687 LKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~ 766 (870)
|||+||+++.++.+++. ||....... .....+++.|+|||++.+..++.|+|||||||++|||+||+.||+..
T Consensus 809 lkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~ 881 (968)
T PLN00113 809 LSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881 (968)
T ss_pred CCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence 99999999999988876 665543211 12236889999999999999999999999999999999999999654
Q ss_pred C-ccchHHHHHHHHhhcCCcchhcccccCCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 767 P-QRTLIGQWVSSMLARGDIKNIVDHRLQGD--FDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 767 ~-~~~~l~~~~~~~~~~~~~~~i~d~~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
. ....+.+|++..........++|+.+... ...++..++.+++.+|++.+|++||+|+||+++|+++.+
T Consensus 882 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 882 FGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 3 34557788877766666667777776443 345677789999999999999999999999999998654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=399.31 Aligned_cols=254 Identities=35% Similarity=0.541 Sum_probs=215.4
Q ss_pred cccccccCcEEEEEEEECCee-EEEEEeeccchhh--hHHHHHHHHHHHHhccccceeEEEEEecCC-eEEEEEEEccCC
Q 002887 566 ERVLGKGGFGTVYHGYLDDKQ-VAVKMLSSSSVQG--YKQFQAEVELLIRAHHKNLTILVGYCDEGA-NMGLIYEFMANG 641 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~~~~-vAVK~l~~~~~~~--~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~LV~Ey~~~g 641 (870)
.+.||+|+||+||+|.+.|+. ||||++....... .++|.+|+.+|.+++|||||+++|.|.+.. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 356999999999999999988 9999998764332 568999999999999999999999999987 799999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCC-ceeCCCCCCCEEEcCCC-cEEEEeccCCccccCCCCccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPP-IVHRDVKSANILLNEKF-QAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-IvHrDLKp~NILld~~~-~vkL~DFGla~~~~~~~~~~~ 719 (870)
+|.++++..+...+++..+++++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++...... ..
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~ 200 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TS 200 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc--cc
Confidence 999999875567899999999999999999999998 6 99999999999999997 99999999998653211 23
Q ss_pred cccccCCCCccCccccc--cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 720 STTVVGTPGYLDPEYYI--SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~--~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
.+...||+.|||||++. ...+++|+||||||+++|||+||+.||......... ...... ..+...
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~----~~v~~~---------~~Rp~~ 267 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVA----SAVVVG---------GLRPPI 267 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhc---------CCCCCC
Confidence 34478999999999999 568999999999999999999999999877652221 112212 222333
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHh
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e 837 (870)
+..+...+..++.+||+.+|++||++.+++..|+.+....
T Consensus 268 p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 268 PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 4446778889999999999999999999999999876543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=384.70 Aligned_cols=254 Identities=28% Similarity=0.452 Sum_probs=219.9
Q ss_pred hhccccccccCcEEEEEEEECCe-eEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 563 NNFERVLGKGGFGTVYHGYLDDK-QVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~~~-~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
..+.+.||+|-||.||.|.++++ .||+|.++... ...+.|.+|+++|++|+|+|||+++|.|..++..+||||||++|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 34557899999999999999966 89999998763 34478899999999999999999999999988999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.++|....+..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+.. .++......
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-~d~~Y~~~~ 362 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLI-GDDEYTASE 362 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccccc-CCCceeecC
Confidence 999999987778899999999999999999999999 9999999999999999999999999999954 333444444
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
...-...|.|||.+..++++.|||||||||+||||+| |+.|+......+.+. .++.| .+-+.+..
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~-----~le~G---------yRlp~P~~ 428 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLE-----LLERG---------YRLPRPEG 428 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHH-----HHhcc---------CcCCCCCC
Confidence 4556779999999999999999999999999999999 888988776544332 22333 33345667
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
++..+.+++..||+.+|++|||++.+...|+++..
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 88899999999999999999999999999988654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=361.89 Aligned_cols=255 Identities=27% Similarity=0.388 Sum_probs=212.0
Q ss_pred cccCHHHHHHHHhhccccccccCcEEEEEEEEC--CeeEEEEEeecc-chhhhHHHHHHHHHHHHhccccceeEEEEEec
Q 002887 551 RKFSYFDVLKITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS-SVQGYKQFQAEVELLIRAHHKNLTILVGYCDE 627 (870)
Q Consensus 551 ~~~~~~dl~~~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 627 (870)
..++..|+.+. +.||+|..|+|||++++ ++.+|+|.+... +....+++.+|++++++++||+||.++|.|..
T Consensus 74 ~~i~~~dle~~-----~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 74 NGISLSDLERL-----GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cccCHHHhhhh-----hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 34566666654 57999999999999997 888999999554 34556889999999999999999999999998
Q ss_pred CC-eEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEecc
Q 002887 628 GA-NMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFG 706 (870)
Q Consensus 628 ~~-~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFG 706 (870)
.. ...++||||.+|+|++.+... +.+++...-+|+.+|++||.|||+. .+||||||||+|||++..|++||+|||
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecccc
Confidence 88 499999999999999988643 5689999999999999999999963 399999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC-CccchHHHHHHHHhhcCCc
Q 002887 707 LSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT-PQRTLIGQWVSSMLARGDI 785 (870)
Q Consensus 707 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~-~~~~~l~~~~~~~~~~~~~ 785 (870)
.++.+... ...+.+||..|||||.+.++.|+.++||||||+.++|+.+|+.|+-.. .......+.+....
T Consensus 225 VS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv----- 295 (364)
T KOG0581|consen 225 VSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV----- 295 (364)
T ss_pred ccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-----
Confidence 99876322 456789999999999999999999999999999999999999999764 11222233222222
Q ss_pred chhcccccCCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 786 KNIVDHRLQGDFDT-NTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 786 ~~i~d~~l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+... ...+. ....++.+++..|+++||.+||+++|+++
T Consensus 296 ----~~pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 296 ----DEPP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred ----cCCC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2111 11222 36678899999999999999999999986
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=364.47 Aligned_cols=248 Identities=24% Similarity=0.408 Sum_probs=204.7
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhh-------hHHHHHHHHHHHHhccccceeEEEEEecCCeEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQG-------YKQFQAEVELLIRAHHKNLTILVGYCDEGANMGL 633 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~-------~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 633 (870)
+-..+.||+|+||.|-+|+.. ++.||||++.+..... ....++|+++|++++|||||++.+++...+..|+
T Consensus 174 yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Ym 253 (475)
T KOG0615|consen 174 YIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYM 253 (475)
T ss_pred eEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEE
Confidence 445689999999999999875 8999999998753221 1234799999999999999999999999999999
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC---CcEEEEeccCCcc
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK---FQAKLADFGLSRI 710 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~---~~vkL~DFGla~~ 710 (870)
|||||+||.|.+.+..+ +.+.+.....+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||+|+.
T Consensus 254 VlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 254 VLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred EEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999998754 4577778899999999999999999 99999999999999776 7799999999997
Q ss_pred ccCCCCccccccccCCCCccCccccccCC---CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcch
Q 002887 711 FPVEGGTHVSTTVVGTPGYLDPEYYISNR---LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKN 787 (870)
Q Consensus 711 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (870)
.. ......+.+||+.|.|||++.+.. +..+.|+||+||+||-+++|.+||.+......+.+. +..|+..
T Consensus 329 ~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ----I~~G~y~- 400 (475)
T KOG0615|consen 329 SG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ----ILKGRYA- 400 (475)
T ss_pred cc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH----HhcCccc-
Confidence 53 445677899999999999998764 345889999999999999999999876655422221 1122111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 788 IVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 788 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..........++.++++.++|..||++|||+.|+++
T Consensus 401 -----f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 401 -----FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -----ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 001223456778999999999999999999999986
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=376.99 Aligned_cols=244 Identities=25% Similarity=0.440 Sum_probs=210.4
Q ss_pred hhccccccccCcEEEEEEEE-C-CeeEEEEEeecc---chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYL-D-DKQVAVKMLSSS---SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~-~-~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
+...+.||+|||+.+|+++. . |+.||+|++.+. .....+...+|+++.+.|+|||||+++++|++.++.|+|.|+
T Consensus 20 Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLEL 99 (592)
T KOG0575|consen 20 YKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLEL 99 (592)
T ss_pred eeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEe
Confidence 44567999999999999997 4 999999999875 334456789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
|++++|.++++ +.+.+++.++..+++||+.||.|||+. +|+|||||..|++|++++++||+|||||..+..++
T Consensus 100 C~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-- 172 (592)
T KOG0575|consen 100 CHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-- 172 (592)
T ss_pred cCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc--
Confidence 99999999886 557899999999999999999999999 99999999999999999999999999999875443
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
....+.+|||.|+|||++.....+..+||||+||+||.||.|++||+...-.+....+..... .+
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y---------------~~ 237 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY---------------SM 237 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc---------------cc
Confidence 344678999999999999999999999999999999999999999987654433332211110 12
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+........+|+.++|+.+|.+|||+.+|+.
T Consensus 238 P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 238 PSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2344567789999999999999999999985
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=355.57 Aligned_cols=200 Identities=28% Similarity=0.515 Sum_probs=179.5
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.||+|+||+||+|+++ +..||||.+.+. .....+.+..|+++|+.++|||||.+++++..++..+||||||.+
T Consensus 14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~g 93 (429)
T KOG0595|consen 14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNG 93 (429)
T ss_pred ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCC
Confidence 3456999999999999986 889999999877 455667789999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC------CcEEEEeccCCccccCC
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK------FQAKLADFGLSRIFPVE 714 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~------~~vkL~DFGla~~~~~~ 714 (870)
|+|.++++.. ..+++.....++.|+|.||++||++ +||||||||+||||+.. -.+||+|||+|+.+.
T Consensus 94 GDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~-- 166 (429)
T KOG0595|consen 94 GDLSDYIRRR--GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ-- 166 (429)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC--
Confidence 9999999754 4799999999999999999999999 99999999999999865 468999999999874
Q ss_pred CCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchH
Q 002887 715 GGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLI 772 (870)
Q Consensus 715 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l 772 (870)
........+|++-|||||+++.++|+.|+|+||+|++||||++|++||+.....+.+
T Consensus 167 -~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~ 223 (429)
T KOG0595|consen 167 -PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELL 223 (429)
T ss_pred -chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence 234456789999999999999999999999999999999999999999876554443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=386.97 Aligned_cols=254 Identities=30% Similarity=0.505 Sum_probs=217.7
Q ss_pred hccccccccCcEEEEEEEEC-------CeeEEEEEeeccchh-hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSSVQ-GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 635 (870)
.+.+.||+|+||+||+|+.. .+-||||.++..... ..++|++|++++..++|||||+++|.|.+++.+++|+
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvF 568 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVF 568 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEE
Confidence 45678999999999999863 356999999987654 7889999999999999999999999999999999999
Q ss_pred EEccCCchhhhhhhccc--------cc----ccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEE
Q 002887 636 EFMANGNLQAHLLEDKA--------DT----LCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLA 703 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~--------~~----l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~ 703 (870)
|||..|+|.++|..... .. |+..+.+.||.|||.||+||-++ ..|||||..+|+|+.++..|||+
T Consensus 569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEec
Confidence 99999999999975432 23 88999999999999999999998 99999999999999999999999
Q ss_pred eccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhc
Q 002887 704 DFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLAR 782 (870)
Q Consensus 704 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~ 782 (870)
|||+++..-..+..+....-.-.++|||||.++.++++.++|||||||+|||+++ |+.|+.+...++.+ ..++.
T Consensus 646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI-----e~i~~ 720 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI-----ECIRA 720 (774)
T ss_pred ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH-----HHHHc
Confidence 9999986543333333333345679999999999999999999999999999998 99999877665533 33444
Q ss_pred CCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 783 GDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 783 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
|++ -..++.++.++.+|+..||+.+|++||+++||-..|+...
T Consensus 721 g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 721 GQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred CCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 543 2346678889999999999999999999999999998743
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=335.64 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=208.5
Q ss_pred hhccccccccCcEEEEEEEE--CCeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEE-EEecCCe-EEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVG-YCDEGAN-MGLIYE 636 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g-~~~~~~~-~~LV~E 636 (870)
+.+.++||+|.||+|||+.. ++..||.|.++-. ..+..+....|+.+|++++|||||++++ .+.+..+ .++|||
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE 100 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME 100 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence 44567899999999999986 4899999998744 3445667889999999999999999999 4555555 889999
Q ss_pred EccCCchhhhhhhc--ccccccHHHHHHHHHHHHHHHHHHHhCCCC-CceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 637 FMANGNLQAHLLED--KADTLCWERRLQIASESAQGLEYLHNGCKP-PIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 637 y~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
|+..|+|...++.- ..+.+++..+++++.|++.||.++|++... -|+||||||.||+|+.+|.+||+|||+++.+.
T Consensus 101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~- 179 (375)
T KOG0591|consen 101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS- 179 (375)
T ss_pred hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc-
Confidence 99999999988763 346799999999999999999999984321 38999999999999999999999999999874
Q ss_pred CCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccccc
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
.......+.+|||.||+||.+.+..|+.|+||||+||++|||+.-++||.+..... ....+..|+...+.
T Consensus 180 -s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~-----L~~KI~qgd~~~~p---- 249 (375)
T KOG0591|consen 180 -SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS-----LCKKIEQGDYPPLP---- 249 (375)
T ss_pred -chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH-----HHHHHHcCCCCCCc----
Confidence 33445567899999999999999999999999999999999999999998753222 22333344322111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 794 QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
+......+.+|+..|+..||++||+...+++.+..
T Consensus 250 ----~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 250 ----DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ----HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 24556788999999999999999997666665554
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=360.57 Aligned_cols=255 Identities=29% Similarity=0.496 Sum_probs=210.6
Q ss_pred ccccccccCcEEEEEEEECCeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 565 FERVLGKGGFGTVYHGYLDDKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
+.+.||+|+||+||+|+|.| .||||++... .....+.|++|+..+++-+|.||+-+.|+|..... .+|+.+|+|-+
T Consensus 396 l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsS 473 (678)
T KOG0193|consen 396 LGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSS 473 (678)
T ss_pred ccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCch
Confidence 35789999999999999986 5999999865 34467889999999999999999999999998777 99999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|+.+|+..+ ..++..+.+.||+|||+||.|||.+ +|||||||..||+|.+++.|||+|||++.....-.+......
T Consensus 474 LY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~q 549 (678)
T KOG0193|consen 474 LYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQ 549 (678)
T ss_pred hhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCC
Confidence 999997654 5789999999999999999999999 999999999999999999999999999986554444444455
Q ss_pred ccCCCCccCccccccC---CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 723 VVGTPGYLDPEYYISN---RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~---~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
..|...|||||+++.+ .+++.+||||||+|+|||+||..||.....+..+.. +..|.+ . +++. ....
T Consensus 550 p~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm-----VGrG~l--~--pd~s-~~~s 619 (678)
T KOG0193|consen 550 PHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM-----VGRGYL--M--PDLS-KIRS 619 (678)
T ss_pred CccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE-----eccccc--C--ccch-hhhc
Confidence 6788899999999754 589999999999999999999999984332222211 111110 0 1110 1123
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
.+..++.+|+..||..++++||.+.+|+.+|++++.
T Consensus 620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 620 NCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 556688899999999999999999999999999776
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=339.64 Aligned_cols=236 Identities=26% Similarity=0.389 Sum_probs=198.0
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
+.++||+|+||+||+++.. ++.+|+|++++... ...+...+|..+|.+++||.||++.-.|++.+++|+|+||+.
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 4579999999999999875 78899999987643 345667899999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
||.|..+|.+ ...+++..+.-++.+|+.||.|||+. +||||||||+|||||++|+++|+|||+|+..- .....
T Consensus 109 GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~--~~~~~ 181 (357)
T KOG0598|consen 109 GGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL--KDGDA 181 (357)
T ss_pred CccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc--cCCCc
Confidence 9999999964 35788998999999999999999999 99999999999999999999999999998542 22334
Q ss_pred cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
+...+||+.|||||++.+..|+..+|.||+|+++|||++|.+||....... +........ + ...+.
T Consensus 182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~----~~~~I~~~k---------~-~~~p~ 247 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK----MYDKILKGK---------L-PLPPG 247 (357)
T ss_pred cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH----HHHHHhcCc---------C-CCCCc
Confidence 456899999999999999999999999999999999999999998655333 332322221 0 01111
Q ss_pred HHHHHHHHHHHHccccCCCCCC
Q 002887 800 NTVWKAVEIALACIHTISTRRP 821 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RP 821 (870)
-......+++...++.+|++|-
T Consensus 248 ~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 248 YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred cCCHHHHHHHHHHhccCHHHhc
Confidence 2344677899999999999995
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=368.28 Aligned_cols=268 Identities=25% Similarity=0.416 Sum_probs=227.1
Q ss_pred cccCHHHHHHHHhhc-----------cccccccCcEEEEEEEEC-----CeeEEEEEeeccc-hhhhHHHHHHHHHHHHh
Q 002887 551 RKFSYFDVLKITNNF-----------ERVLGKGGFGTVYHGYLD-----DKQVAVKMLSSSS-VQGYKQFQAEVELLIRA 613 (870)
Q Consensus 551 ~~~~~~dl~~~t~~f-----------~~~LG~G~fG~Vy~~~~~-----~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l 613 (870)
..++|+|-.++..+| +++||.|-||.||+|+++ ...||||.++... ...+.+|..|+.+|.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 346777766666554 478999999999999986 3569999999874 44567899999999999
Q ss_pred ccccceeEEEEEecCCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEE
Q 002887 614 HHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANIL 693 (870)
Q Consensus 614 ~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NIL 693 (870)
.||||++|.|........++|+|||+||+|+.+|+.+.+ .+++.+...++++||.||.||.+. ++|||||.++|||
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNIL 763 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNIL 763 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhhee
Confidence 999999999999999999999999999999999987664 599999999999999999999988 9999999999999
Q ss_pred EcCCCcEEEEeccCCccccCCCCccc-cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccch
Q 002887 694 LNEKFQAKLADFGLSRIFPVEGGTHV-STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTL 771 (870)
Q Consensus 694 ld~~~~vkL~DFGla~~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~ 771 (870)
++.+..+|++|||+++.+.++..... .....-..+|.|||.+...+++.++|||||||||||.++ |.+||-+...++.
T Consensus 764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV 843 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 843 (996)
T ss_pred eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH
Confidence 99999999999999998754432211 122234579999999999999999999999999999887 9999987766554
Q ss_pred HHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 772 IGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 772 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
+.. + +...+-+-+++++..|.+|++.||++|-.+||.+.||+..|+..+..
T Consensus 844 Ika-----I---------e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 844 IKA-----I---------EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHH-----H---------HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 432 1 22233345678999999999999999999999999999999997754
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=351.69 Aligned_cols=257 Identities=30% Similarity=0.415 Sum_probs=203.6
Q ss_pred hhccccccccCcEEEEEEEEC-------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCC-eEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGA-NMG 632 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~-~~~ 632 (870)
..+.+.||+|+||.||+|.+. ++.||||++.... ....+.+.+|+.++.++ +||||++++++|.... ..+
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (338)
T cd05102 9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLM 88 (338)
T ss_pred ceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceE
Confidence 345689999999999999742 4579999997543 23346789999999999 8999999999987654 578
Q ss_pred EEEEEccCCchhhhhhhcc------------------------------------------------------------c
Q 002887 633 LIYEFMANGNLQAHLLEDK------------------------------------------------------------A 652 (870)
Q Consensus 633 LV~Ey~~~gsL~~~l~~~~------------------------------------------------------------~ 652 (870)
+||||+++|+|.+++.... .
T Consensus 89 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (338)
T cd05102 89 VIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWK 168 (338)
T ss_pred EEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccccc
Confidence 9999999999999886432 1
Q ss_pred ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccccccCCCCccCc
Q 002887 653 DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDP 732 (870)
Q Consensus 653 ~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 732 (870)
..+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++...............++..|+||
T Consensus 169 ~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 169 SPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 3488889999999999999999998 9999999999999999999999999999865332222222334567889999
Q ss_pred cccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHH
Q 002887 733 EYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALA 811 (870)
Q Consensus 733 E~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~ 811 (870)
|++.+..++.++|||||||++|||++ |+.||..........+ ....+... .........+.+++.+
T Consensus 246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~----~~~~~~~~---------~~~~~~~~~l~~li~~ 312 (338)
T cd05102 246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ----RLKDGTRM---------RAPENATPEIYRIMLA 312 (338)
T ss_pred HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH----HHhcCCCC---------CCCCCCCHHHHHHHHH
Confidence 99999999999999999999999997 9999976543222211 12222110 1122334578899999
Q ss_pred ccccCCCCCCCHHHHHHHHHHhhh
Q 002887 812 CIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 812 Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
|++.+|++|||+.|++++|++++.
T Consensus 313 cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 313 CWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=347.11 Aligned_cols=246 Identities=24% Similarity=0.359 Sum_probs=208.3
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
..|.+.||+|+|++|++|+.. ++.+|||++.+.- ....+-...|-++|.+| .||.|++|+..|++...+|+|+|
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe 154 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE 154 (604)
T ss_pred cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence 356789999999999999875 8999999997652 23345567889999999 99999999999999999999999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
|.++|+|.++|.+. ..|++.....++.+|+.||+|||+. |||||||||+|||||+||++||+|||.|+.+.....
T Consensus 155 ~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 155 YAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred ecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 99999999999743 6799999999999999999999999 999999999999999999999999999998754322
Q ss_pred c---------cc--cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCc
Q 002887 717 T---------HV--STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDI 785 (870)
Q Consensus 717 ~---------~~--~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~ 785 (870)
. .. ....+||..|.+||++..+..+..+|+|+|||+||+|+.|++||....+--.+.+++.-
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l------- 302 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL------- 302 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh-------
Confidence 2 11 24578999999999999999999999999999999999999999987654444333211
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 786 KNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 786 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.-+++...++.+.+|+.+.|..||.+|+|..||-+
T Consensus 303 --------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 303 --------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred --------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 12334444567889999999999999999988765
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=334.58 Aligned_cols=258 Identities=27% Similarity=0.394 Sum_probs=210.9
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchh-hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ-GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
+++.+.||.|..+.||+|+.. ++.||||++...... ..+.+++|+..++.++||||++++..|..+..+++||.||.
T Consensus 28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa 107 (516)
T KOG0582|consen 28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA 107 (516)
T ss_pred eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence 556789999999999999975 889999999876543 35889999999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+||+.+.+...-...+++..+..|++++++||.|||++ |.||||||+.||||+++|.+||+|||.+..+...+....
T Consensus 108 ~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~ 184 (516)
T KOG0582|consen 108 GGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQV 184 (516)
T ss_pred CCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCceee
Confidence 99999999887778899999999999999999999999 999999999999999999999999999876644332221
Q ss_pred -c-ccccCCCCccCcccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 720 -S-TTVVGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 720 -~-~~~~gt~~y~APE~~~~--~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
. ....||+.|||||+++. ..|+.|+||||||++..||.+|..||...+....+-. .+. +.........+..
T Consensus 185 ~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~----tLq-n~pp~~~t~~~~~ 259 (516)
T KOG0582|consen 185 TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL----TLQ-NDPPTLLTSGLDK 259 (516)
T ss_pred EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH----Hhc-CCCCCcccccCCh
Confidence 1 45689999999999754 4699999999999999999999999998775443321 111 1111111111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+........+.+++..|+++||++|||++++++
T Consensus 260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 112233346789999999999999999999974
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=338.38 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=204.3
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCC--eEEEEEEEccC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGA--NMGLIYEFMAN 640 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~LV~Ey~~~ 640 (870)
..+.||+|+||.||++... +...|||..........+.+++|+.+|.+++|||||+.+|...... .+++.|||+++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 3478999999999999986 6899999988764444677899999999999999999999865554 58899999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC-CCcEEEEeccCCccccC-CCCcc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE-KFQAKLADFGLSRIFPV-EGGTH 718 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~-~~~vkL~DFGla~~~~~-~~~~~ 718 (870)
|+|.+++....+ .+++..+..+++||++||+|||++ +|+||||||+|||++. ++.+||+|||+++.... .....
T Consensus 101 GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~ 176 (313)
T KOG0198|consen 101 GSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD 176 (313)
T ss_pred CcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence 999999987665 799999999999999999999998 9999999999999999 79999999999987642 11122
Q ss_pred ccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
......||+.|||||++..+ ....++||||+||++.||+||++||.... ....+.-.....+. ....
T Consensus 177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~---~~~~~~~~ig~~~~---------~P~i 244 (313)
T KOG0198|consen 177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF---EEAEALLLIGREDS---------LPEI 244 (313)
T ss_pred ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc---chHHHHHHHhccCC---------CCCC
Confidence 23457899999999999864 33459999999999999999999998631 11111111111111 1133
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
+........+++.+|++.+|++|||+.++++...-.
T Consensus 245 p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 245 PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 444566788999999999999999999999866543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=336.43 Aligned_cols=246 Identities=20% Similarity=0.341 Sum_probs=202.3
Q ss_pred ccccccCcEEEEEEEECCeeEEEEEeeccchhh---hHHHHHHHHHHHHhccccceeEEEEEec----CCeEEEEEEEcc
Q 002887 567 RVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQG---YKQFQAEVELLIRAHHKNLTILVGYCDE----GANMGLIYEFMA 639 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~---~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~LV~Ey~~ 639 (870)
..||+|++|.||+|.++++.||||+++...... .+.|.+|+.++++++||||++++|++.+ ....++||||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 479999999999999999999999997653332 4678899999999999999999999876 356889999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+|+|.+++... +.+++...++++.+++.||.|||+.. +++||||||+|||+++++.+||+|||+++.....
T Consensus 106 ~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----- 176 (283)
T PHA02988 106 RGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----- 176 (283)
T ss_pred CCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhccc-----
Confidence 99999998653 46899999999999999999999732 7889999999999999999999999998865321
Q ss_pred cccccCCCCccCcccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 720 STTVVGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~--~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......... ......+. ....
T Consensus 177 ~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~----~~i~~~~~---------~~~~ 243 (283)
T PHA02988 177 PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY----DLIINKNN---------SLKL 243 (283)
T ss_pred cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhcCC---------CCCC
Confidence 123468899999999976 68999999999999999999999999865433222 22221111 1112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
+......+.+++.+||+.+|++|||+.|+++.|+...
T Consensus 244 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 244 PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 2234567889999999999999999999999998753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=321.53 Aligned_cols=255 Identities=20% Similarity=0.283 Sum_probs=202.5
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
.++|+|+||.|||++.+ |+.||||++..... ...+-..+|+++|++++|+|+|.+++.|......+||+||++..-
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTv 87 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTV 87 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHH
Confidence 46999999999999986 89999999977643 334557899999999999999999999999999999999999854
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.+ |.+ ....++.....+++.|+++|+.|+|++ ++|||||||+|||++.++.+||||||+|+.+.. .....+.
T Consensus 88 L~e-Le~-~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~YTD 160 (396)
T KOG0593|consen 88 LHE-LER-YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDNYTD 160 (396)
T ss_pred HHH-HHh-ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC--Ccchhhh
Confidence 443 433 446788999999999999999999999 999999999999999999999999999998753 2334466
Q ss_pred ccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHH----------hhc-CCcc----
Q 002887 723 VVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSM----------LAR-GDIK---- 786 (870)
Q Consensus 723 ~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~----------~~~-~~~~---- 786 (870)
.+.|.+|.|||.+.+ ..|....||||+||++.||++|.+.|-+..+-+.+..+.+.+ ... +...
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l 240 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL 240 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence 788999999999998 579999999999999999999999998776655444333211 111 1111
Q ss_pred -hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 787 -NIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 787 -~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+.-+++..+..-.....-+++++..|++.||++|++-+|++.
T Consensus 241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111111111111233446889999999999999999999974
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=346.38 Aligned_cols=242 Identities=24% Similarity=0.383 Sum_probs=206.5
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCchh
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQ 644 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 644 (870)
++||+|+.|.||.|+.. ++.||||++........+-+.+|+.+|+..+|+|||.+++.|..+++.+.|||||++|+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 57999999999999864 7889999999887777777899999999999999999999999999999999999999999
Q ss_pred hhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccccc
Q 002887 645 AHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVV 724 (870)
Q Consensus 645 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 724 (870)
+.+.+ ..+++.++..|++++++||+|||.+ +|+|||||.+|||++.+|.+||+|||+|..+.... ......+
T Consensus 359 DvVt~---~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~--~KR~TmV 430 (550)
T KOG0578|consen 359 DVVTK---TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ--SKRSTMV 430 (550)
T ss_pred hhhhc---ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc--Ccccccc
Confidence 98854 3589999999999999999999999 99999999999999999999999999998874332 2456789
Q ss_pred CCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHH
Q 002887 725 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWK 804 (870)
Q Consensus 725 gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 804 (870)
||+.|||||+.....|.+|.||||||++++||+-|++||-....-..+. ++..... +.+ .........
T Consensus 431 GTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly-----LIa~ng~-----P~l--k~~~klS~~ 498 (550)
T KOG0578|consen 431 GTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNGT-----PKL--KNPEKLSPE 498 (550)
T ss_pred CCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH-----HHhhcCC-----CCc--CCccccCHH
Confidence 9999999999999999999999999999999999999997533221111 1111111 111 223455678
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 002887 805 AVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 805 l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+.++..+||+.|+++||++.|+++
T Consensus 499 ~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 499 LKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHHHHHHhhcchhcCCCHHHHhc
Confidence 889999999999999999999986
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.09 Aligned_cols=249 Identities=31% Similarity=0.511 Sum_probs=198.6
Q ss_pred ccccccccCcEEEEEEEEC------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
+.+.||.|.||.||+|.+. +..|+||.++... ....+.|.+|++.+++++||||++++|+|......++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999987 6789999996643 33478899999999999999999999999988889999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++|+|.+++.......+++.+++.|+.|+++||.|||+. +++|+||+++||++++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999877567899999999999999999999998 9999999999999999999999999999866322222
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
...........|+|||.+....++.++||||||+++|||++ |+.|+........ .... .++.. ..
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~----~~~~-~~~~~---------~~ 225 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI----IEKL-KQGQR---------LP 225 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH----HHHH-HTTEE---------TT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc----cccc-ccccc---------ce
Confidence 22334457789999999999999999999999999999999 7888876543222 2122 22211 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVIEL 830 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 830 (870)
........+.+++.+||..+|++||++.++++.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1223455688999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=336.81 Aligned_cols=260 Identities=25% Similarity=0.382 Sum_probs=203.2
Q ss_pred hhccccccccCcEEEEEEEEC------------------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD------------------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVG 623 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~------------------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g 623 (870)
+.+.+.||+|+||.||++.+. +..||+|.+.... .....+|.+|++++.+++||||+++++
T Consensus 7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 86 (304)
T cd05096 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLG 86 (304)
T ss_pred CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence 345688999999999999753 3369999987653 334567999999999999999999999
Q ss_pred EEecCCeEEEEEEEccCCchhhhhhhcc-----------------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCC
Q 002887 624 YCDEGANMGLIYEFMANGNLQAHLLEDK-----------------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRD 686 (870)
Q Consensus 624 ~~~~~~~~~LV~Ey~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrD 686 (870)
++.+....++||||+++|+|.+++.... ...++|..+++++.|++.||.|||+. +|+|||
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~d 163 (304)
T cd05096 87 VCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRD 163 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccC
Confidence 9999999999999999999999885432 13478899999999999999999998 999999
Q ss_pred CCCCCEEEcCCCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh--CCCCCC
Q 002887 687 VKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQ 764 (870)
Q Consensus 687 LKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt--G~~p~~ 764 (870)
|||+|||+++++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|||++ +..||.
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 243 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence 999999999999999999999986533222222233456789999999998899999999999999999987 567777
Q ss_pred CCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 765 KTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 765 ~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
.......+.. +.......... . ........+..+.+++.+|++.+|++|||+.||.+.|++
T Consensus 244 ~~~~~~~~~~-~~~~~~~~~~~-~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 244 ELTDEQVIEN-AGEFFRDQGRQ-V-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred cCCHHHHHHH-HHHHhhhcccc-c-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 6544333222 22222111100 0 001122345678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=334.60 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=204.5
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecC--CeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEG--ANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~LV~Ey~~~ 640 (870)
++||+|.||.||+|+.. |+.||+|++.... .....-..+||.+|++|+||||++|.+...+. ..+|||+|||+.
T Consensus 123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh 202 (560)
T KOG0600|consen 123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH 202 (560)
T ss_pred HHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc
Confidence 57999999999999975 8899999998664 33445568999999999999999999998776 689999999997
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
+|..++.. ..-.++..++..++.|++.||+|+|++ +|+|||||.+|||||.+|.+||+|||||+++.... ....
T Consensus 203 -DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~-~~~~ 276 (560)
T KOG0600|consen 203 -DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG-SAPY 276 (560)
T ss_pred -hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCC-Cccc
Confidence 67766643 345799999999999999999999999 99999999999999999999999999999885433 3345
Q ss_pred ccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc--CCcc--hhcccc---
Q 002887 721 TTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR--GDIK--NIVDHR--- 792 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~--~~~~--~i~d~~--- 792 (870)
+..+-|.+|.|||++.+. .|+...|+||.||||.||++|++.|++..+-+.+..+++-+=.. ..+. ++..-.
T Consensus 277 T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~k 356 (560)
T KOG0600|consen 277 TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFK 356 (560)
T ss_pred ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccC
Confidence 677889999999999875 69999999999999999999999999887766666555422111 0011 111000
Q ss_pred cCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 793 LQGDFD-------TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 793 l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
....+. .......++|+..+|..||.+|.|+.++++
T Consensus 357 p~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 357 PQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 001111 122346789999999999999999999875
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=341.42 Aligned_cols=238 Identities=27% Similarity=0.436 Sum_probs=204.2
Q ss_pred ccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCchhhh
Q 002887 567 RVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAH 646 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~ 646 (870)
+-||.|+.|.||+|++.++.||||+++... +.+++-|++|+|+||+.+.|.|.....+++|||||..|-|...
T Consensus 130 eWlGSGaQGAVF~Grl~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLHNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhhccCcccceeeeeccCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 569999999999999999999999875432 5678899999999999999999999999999999999999999
Q ss_pred hhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccccccCC
Q 002887 647 LLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGT 726 (870)
Q Consensus 647 l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt 726 (870)
|+. ++.++-.....+..+||.||.|||.+ +|||||||.-||||..+..+||+|||.++..... ...-.++||
T Consensus 203 Lka--~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGT 274 (904)
T KOG4721|consen 203 LKA--GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGT 274 (904)
T ss_pred Hhc--cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhh
Confidence 974 35788888899999999999999998 9999999999999999999999999999876322 334567999
Q ss_pred CCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHH
Q 002887 727 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAV 806 (870)
Q Consensus 727 ~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~ 806 (870)
..|||||++.....++|+|||||||||||||||.-||..-+....+.. +-...|.-..+..++..+.
T Consensus 275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG-------------VGsNsL~LpvPstcP~Gfk 341 (904)
T KOG4721|consen 275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG-------------VGSNSLHLPVPSTCPDGFK 341 (904)
T ss_pred HhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEe-------------ccCCcccccCcccCchHHH
Confidence 999999999999999999999999999999999999976543222110 1111223344567778888
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 807 EIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 807 ~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
-|+.+||+..|..||+++|++..|+-
T Consensus 342 lL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 342 LLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred HHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 99999999999999999999998864
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=346.02 Aligned_cols=255 Identities=26% Similarity=0.379 Sum_probs=203.9
Q ss_pred hhccccccccCcEEEEEEEE-------CCeeEEEEEeeccc-hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYL-------DDKQVAVKMLSSSS-VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGL 633 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~-------~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~L 633 (870)
..+.+.||+|+||.||+|.+ .+..||||+++... ....+.+.+|+.++..+ +||||++++++|..+...++
T Consensus 37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~l 116 (375)
T cd05104 37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLV 116 (375)
T ss_pred eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCccee
Confidence 34568999999999999974 14579999987543 33456788999999999 89999999999999999999
Q ss_pred EEEEccCCchhhhhhhcc--------------------------------------------------------------
Q 002887 634 IYEFMANGNLQAHLLEDK-------------------------------------------------------------- 651 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~-------------------------------------------------------------- 651 (870)
||||+++|+|.+++.+..
T Consensus 117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (375)
T cd05104 117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID 196 (375)
T ss_pred eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence 999999999999886432
Q ss_pred -----------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 652 -----------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 652 -----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
...++|..+.+++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++...........
T Consensus 197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 273 (375)
T cd05104 197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273 (375)
T ss_pred cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence 12478999999999999999999998 9999999999999999999999999999865333222222
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
....++..|+|||++.+..++.++|||||||++|||++ |..||..........++.. .+.. ...+.
T Consensus 274 ~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~----~~~~---------~~~~~ 340 (375)
T cd05104 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK----EGYR---------MLSPE 340 (375)
T ss_pred CCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH----hCcc---------CCCCC
Confidence 23345678999999999999999999999999999998 8899876544333333221 1110 01111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
....++.+++.+|++.+|++||++.||+++|++.
T Consensus 341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 2245688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=331.42 Aligned_cols=247 Identities=26% Similarity=0.351 Sum_probs=201.1
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
..+.||+|+||.||++... ++.||+|.+..... .....+.+|++++.+++|+|++++.+.+.+.+..++||||++
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05631 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecC
Confidence 4578999999999999874 88999999875432 233467889999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+|+|..++.......+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++...... ..
T Consensus 84 ~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~~ 157 (285)
T cd05631 84 GGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---ET 157 (285)
T ss_pred CCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC---Ce
Confidence 99999888655555789999999999999999999998 9999999999999999999999999999865321 12
Q ss_pred cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||................ ... ...+..
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~----------~~~~~~ 226 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV-KED----------QEEYSE 226 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh-hcc----------cccCCc
Confidence 234578999999999999999999999999999999999999998654432222211111 111 011222
Q ss_pred HHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002887 800 NTVWKAVEIALACIHTISTRRPT-----MNQVVI 828 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~ 828 (870)
.....+.+++.+|++.+|++||+ ++++++
T Consensus 227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 34457889999999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=307.74 Aligned_cols=257 Identities=23% Similarity=0.349 Sum_probs=206.9
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccchh--hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ--GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
.+.||+|.||.||+|+.. |+.||||+++..+.. -.....+|++.|+.++|+||+.+++.|...+...||+|||+.
T Consensus 7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t- 85 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT- 85 (318)
T ss_pred hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-
Confidence 368999999999999975 899999999876432 245678999999999999999999999999999999999986
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|+..++. +...++-.++..++.++++|++|||++ .|+||||||.|+|++.+|.+||+|||+++.+...... .+
T Consensus 86 dLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~--~~ 159 (318)
T KOG0659|consen 86 DLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI--QT 159 (318)
T ss_pred cHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcc--cc
Confidence 78777754 446788999999999999999999999 9999999999999999999999999999988544332 33
Q ss_pred cccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhh--cCC---cchhcccc-c-
Q 002887 722 TVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLA--RGD---IKNIVDHR-L- 793 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~--~~~---~~~i~d~~-l- 793 (870)
..+-|..|.|||.+.+. .|+...||||.||++.||+-|.+-|.+..+-+.+...++.+=- +.. +..+.|-. +
T Consensus 160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~ 239 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ 239 (318)
T ss_pred cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence 44788999999999875 5999999999999999999999888877766666555443211 111 11121110 0
Q ss_pred ------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 794 ------QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 794 ------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
....-......+++++..++..+|.+|+++.|++++
T Consensus 240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 011122345567999999999999999999999865
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=367.82 Aligned_cols=256 Identities=31% Similarity=0.442 Sum_probs=215.8
Q ss_pred hccccccccCcEEEEEEEEC---C----eeEEEEEeecc-chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD---D----KQVAVKMLSSS-SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~---~----~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 635 (870)
.+.+.||+|+||.||+|... + ..||||.++.. +.+...+|.+|..+|++++|||||+++|.|.+....++++
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~l 774 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILL 774 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEe
Confidence 35578999999999999874 2 24899998765 5567789999999999999999999999999999999999
Q ss_pred EEccCCchhhhhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCcc
Q 002887 636 EFMANGNLQAHLLEDK-----ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~ 710 (870)
|||++|+|..+|++.+ ...++....+.++.|||+|+.||+++ +.|||||.++|+||+....+||+|||+|+.
T Consensus 775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHh
Confidence 9999999999998763 35789999999999999999999999 999999999999999999999999999995
Q ss_pred ccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhc
Q 002887 711 FPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIV 789 (870)
Q Consensus 711 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~ 789 (870)
+-..+.........-...|||||.+..+.++.|+|||||||+|||++| |..||......+.+..+ .+.|+
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~----~~ggR----- 922 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV----LEGGR----- 922 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH----HhCCc-----
Confidence 533333322222234568999999999999999999999999999999 88999876655443322 23332
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 790 DHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 790 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
| +.+..++.++.+++..||+.+|++||++..+++.+..+...
T Consensus 923 ---L--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 923 ---L--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred ---c--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 2 23556788899999999999999999999999988887654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=339.80 Aligned_cols=243 Identities=25% Similarity=0.407 Sum_probs=203.7
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeecc----ch-hhhHHHHHHHHHHHHhc-cccceeEEEEEecCCeEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS----SV-QGYKQFQAEVELLIRAH-HKNLTILVGYCDEGANMGLI 634 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~----~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV 634 (870)
+.+.+.||+|+||+|+.|... +..||+|++... .. ...+.+.+|+.++++++ ||||++++.++....+.++|
T Consensus 19 y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~iv 98 (370)
T KOG0583|consen 19 YELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIV 98 (370)
T ss_pred eeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEE
Confidence 445689999999999999875 899999977654 11 23456678999999998 99999999999999999999
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC-CcEEEEeccCCccccC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK-FQAKLADFGLSRIFPV 713 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~-~~vkL~DFGla~~~~~ 713 (870)
|||+.+|+|.+++.+ ...+.+..+..++.|++.|++|||+. +|+||||||+|||+|.+ +++||+|||++....
T Consensus 99 mEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 99 MEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred EEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 999999999999976 45788899999999999999999998 99999999999999999 999999999998763
Q ss_pred CCCccccccccCCCCccCccccccCC-CC-ccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccc
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYISNR-LT-EKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDH 791 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~~~-~~-~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 791 (870)
.........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.......... +..+..
T Consensus 173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k-----i~~~~~------ 240 (370)
T KOG0583|consen 173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK-----IRKGEF------ 240 (370)
T ss_pred -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-----HhcCCc------
Confidence 2234456789999999999999877 76 789999999999999999999997443322222 222211
Q ss_pred ccCCCCCHHH-HHHHHHHHHHccccCCCCCCCHHHHH
Q 002887 792 RLQGDFDTNT-VWKAVEIALACIHTISTRRPTMNQVV 827 (870)
Q Consensus 792 ~l~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPsm~eVl 827 (870)
.++... ...+..++.+|+..+|.+|+++.+++
T Consensus 241 ----~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 241 ----KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ----cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 112222 67888999999999999999999998
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=344.65 Aligned_cols=256 Identities=29% Similarity=0.410 Sum_probs=203.6
Q ss_pred hhccccccccCcEEEEEEEEC-------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGL 633 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~L 633 (870)
..+.+.||+|+||.||+|+.. ++.||+|+++... ......+.+|+++++.+ +|+||++++++|......++
T Consensus 40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~l 119 (374)
T cd05106 40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLV 119 (374)
T ss_pred ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEE
Confidence 345689999999999999852 3479999997643 33356688999999999 89999999999999999999
Q ss_pred EEEEccCCchhhhhhhcc--------------------------------------------------------------
Q 002887 634 IYEFMANGNLQAHLLEDK-------------------------------------------------------------- 651 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~-------------------------------------------------------------- 651 (870)
||||+++|+|.+++....
T Consensus 120 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (374)
T cd05106 120 ITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKD 199 (374)
T ss_pred eHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccc
Confidence 999999999999885421
Q ss_pred ------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccccccC
Q 002887 652 ------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG 725 (870)
Q Consensus 652 ------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~g 725 (870)
...+++.++++++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...............+
T Consensus 200 ~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~ 276 (374)
T cd05106 200 EEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276 (374)
T ss_pred hhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCC
Confidence 12478899999999999999999998 999999999999999999999999999986533222222223345
Q ss_pred CCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHH
Q 002887 726 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWK 804 (870)
Q Consensus 726 t~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 804 (870)
+..|+|||++.+..++.++|||||||++|||++ |+.||..........+ ....+ .........+..
T Consensus 277 ~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~----~~~~~---------~~~~~~~~~~~~ 343 (374)
T cd05106 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK----MVKRG---------YQMSRPDFAPPE 343 (374)
T ss_pred ccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHH----HHHcc---------cCccCCCCCCHH
Confidence 678999999998899999999999999999997 9999976443222211 11111 011111122457
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 805 AVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 805 l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
+.+++.+|++.+|++||++.+|+++|++++
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=325.97 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=203.6
Q ss_pred HhhccccccccCcEEEEEEEEC-----CeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEE
Q 002887 562 TNNFERVLGKGGFGTVYHGYLD-----DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIY 635 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~-----~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 635 (870)
...+.+.||+|+||.||+|.+. +..||+|.++.... .....|.+|+.++++++||||+++++++..+...++||
T Consensus 6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 85 (266)
T cd05064 6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVT 85 (266)
T ss_pred HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEE
Confidence 3456789999999999999863 56899999886532 33467899999999999999999999999999999999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
||+++|+|.+++... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+|++|||.+......
T Consensus 86 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~- 160 (266)
T cd05064 86 EYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE- 160 (266)
T ss_pred EeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccccc-
Confidence 999999999988653 34789999999999999999999998 9999999999999999999999999987643211
Q ss_pred CccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccC
Q 002887 716 GTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794 (870)
Q Consensus 716 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 794 (870)
.........++..|+|||.+.+..++.++|||||||++||+++ |+.||........+.. ...+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~-----~~~~~~--------- 226 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA-----VEDGFR--------- 226 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH-----HHCCCC---------
Confidence 1111112345678999999999999999999999999999875 9999976544322211 111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 795 GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 795 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
.......+..+.+++.+|++.+|++||++.|+.+.|++.
T Consensus 227 ~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 111233456788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=333.84 Aligned_cols=256 Identities=25% Similarity=0.342 Sum_probs=207.1
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHH--HHHHHHHHHHhc-cccceeEEEEEecCC-eEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQ--FQAEVELLIRAH-HKNLTILVGYCDEGA-NMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~--f~~Ei~~l~~l~-H~nIv~l~g~~~~~~-~~~LV~Ey 637 (870)
...+.||.|.||.||+|+-. ++.||||+++..-.. +++ =.+|++.|++++ ||||+++.+.+.+.+ .+++||||
T Consensus 13 ~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~ 91 (538)
T KOG0661|consen 13 TVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEF 91 (538)
T ss_pred HHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHh
Confidence 34578999999999999864 889999999876332 333 268999999998 999999999998887 99999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
|+. +|.+.++++ .+.+++..+..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+... ..
T Consensus 92 Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~---Sk 163 (538)
T KOG0661|consen 92 MDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR---SK 163 (538)
T ss_pred hhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc---cC
Confidence 985 899988765 78999999999999999999999998 99999999999999999999999999999763 33
Q ss_pred cccccccCCCCccCccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcc---------h
Q 002887 718 HVSTTVVGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIK---------N 787 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~-~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~---------~ 787 (870)
...+..+.|.+|+|||++. .+-|+.+.|+||+|||++|+.+-++.|-+..+.+.+.++ .+++...... .
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KI-c~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKI-CEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHH-HHHhCCCccccchhHHHHHH
Confidence 4556788999999999986 567999999999999999999999999887766555443 2222211111 1
Q ss_pred hcccccCC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 788 IVDHRLQG-------DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 788 i~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
.+.-++.. ..-.....+.++++.+|+..||++|||+.|.++.
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111110 0011355688999999999999999999999874
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=323.95 Aligned_cols=252 Identities=27% Similarity=0.410 Sum_probs=206.2
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
..+.+.||+|++|.||+|... ++.||+|++.... ...+++.+|++++++++|+||+++++++......+++|||+++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 86 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence 345678999999999999975 7889999987543 3456789999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
++|.+++.......+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||++....... ....
T Consensus 87 ~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~-~~~~ 162 (263)
T cd05052 87 GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAH 162 (263)
T ss_pred CcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccce-eecc
Confidence 9999998766556789999999999999999999998 99999999999999999999999999998653221 1111
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
....++..|+|||++.+..++.++|||||||++|||++ |..||........ .... ..+ .......
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~----~~~~-~~~---------~~~~~~~ 228 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----YELL-EKG---------YRMERPE 228 (263)
T ss_pred CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHH-HCC---------CCCCCCC
Confidence 12234568999999999999999999999999999998 9999875433221 1111 111 1112223
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
..+..+.+++.+|++.+|++||++.|++++|+++
T Consensus 229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 3456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=327.12 Aligned_cols=252 Identities=29% Similarity=0.513 Sum_probs=205.3
Q ss_pred hccccccccCcEEEEEEEECC-------eeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLDD-------KQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~~-------~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 635 (870)
.+.+.||+|+||.||+|...+ ..|++|.+.... ......|.+|++++.+++||||+++++++......+++|
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 87 (283)
T cd05048 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF 87 (283)
T ss_pred chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence 345789999999999998742 569999987543 234567899999999999999999999999999999999
Q ss_pred EEccCCchhhhhhhccc--------------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEE
Q 002887 636 EFMANGNLQAHLLEDKA--------------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAK 701 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vk 701 (870)
||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEE
Confidence 99999999999865421 4688999999999999999999998 999999999999999999999
Q ss_pred EEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHh
Q 002887 702 LADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSML 780 (870)
Q Consensus 702 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~ 780 (870)
|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......+... .+
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~-----~i 239 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE-----MI 239 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----HH
Confidence 999999976533222222334456789999999998899999999999999999998 999997654432211 11
Q ss_pred hcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 781 ARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 781 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
..+.. .......+..+.+++.+|++.+|++||++.||++.|+.
T Consensus 240 ~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 RSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11211 11223455788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=342.10 Aligned_cols=254 Identities=27% Similarity=0.387 Sum_probs=208.9
Q ss_pred ccccccccCcEEEEEEEEC---C--ee-EEEEEeecc---chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD---D--KQ-VAVKMLSSS---SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIY 635 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~---~--~~-vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 635 (870)
+.++||+|+||.||+|.+. + .. ||||..+.. .....++|.+|++++++++|||||+++|++......++||
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence 3479999999999999985 1 23 899999863 3456788999999999999999999999999999999999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
|+|.||+|.++|.+... .++..+++.++.++|.||+|||++ +++||||.++|+|++.++.+||+|||+++...
T Consensus 241 El~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~--- 313 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS--- 313 (474)
T ss_pred EecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc---
Confidence 99999999999976543 699999999999999999999999 99999999999999999999999999987532
Q ss_pred Cccccc-cccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhccccc
Q 002887 716 GTHVST-TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 716 ~~~~~~-~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
...... ...-...|+|||.+....++.++|||||||++||+.+ |..||.+....+...+. ...+ .
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI----~~~~---------~ 380 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI----VKNG---------Y 380 (474)
T ss_pred ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH----HhcC---------c
Confidence 111111 2235679999999999999999999999999999999 88899876644322211 1111 1
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHhH
Q 002887 794 QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAMEI 838 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e~ 838 (870)
+...+...+..+..+..+|+..+|++||+|.++.+.|+.+.....
T Consensus 381 r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 381 RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 122333556677788889999999999999999999998765543
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=320.83 Aligned_cols=252 Identities=28% Similarity=0.428 Sum_probs=205.7
Q ss_pred HhhccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 562 TNNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
...+.+.||+|++|.||+|... ++.||+|.++... ...+++.+|++++++++|+||+++++++......++||||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05068 7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKY 85 (261)
T ss_pred heeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccC
Confidence 3456789999999999999976 6789999987653 2356789999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
++|.+++.......+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++..... .....
T Consensus 86 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~ 161 (261)
T cd05068 86 GSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED-IYEAR 161 (261)
T ss_pred CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC-ccccc
Confidence 9999999765556789999999999999999999998 9999999999999999999999999999876321 11111
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
.....+..|+|||++.+..++.++||||||++++||++ |+.||............ ..+. ......
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-----~~~~---------~~~~~~ 227 (261)
T cd05068 162 EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV-----DQGY---------RMPCPP 227 (261)
T ss_pred CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-----HcCC---------CCCCCC
Confidence 12223458999999998899999999999999999999 99999765433222211 1110 011122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
.....+.+++.+|++.+|++||++.++++.|++
T Consensus 228 ~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 228 GCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 344678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=332.38 Aligned_cols=240 Identities=30% Similarity=0.426 Sum_probs=206.5
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
.+.||+|+||.||||+-+ .+.||+|.+.+.. ....+.+.+|++++++++||||+.++++|+...+.++|.||+.+
T Consensus 7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g- 85 (808)
T KOG0597|consen 7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG- 85 (808)
T ss_pred HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-
Confidence 367999999999999876 6789999997653 34567789999999999999999999999999999999999997
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|..+|.. ...++++.+..|+.+++.||.|||+. +|+|||+||+|||++.++.+|++|||+|+.+. ..+...+
T Consensus 86 ~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~--~~t~vlt 158 (808)
T KOG0597|consen 86 DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMS--TNTSVLT 158 (808)
T ss_pred hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcc--cCceeee
Confidence 99999864 45799999999999999999999999 99999999999999999999999999999763 3566678
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
.+.|||-|||||+..++.|+..+|+||+||++|||.+|++||-... +.+.++..+.+. ...+...
T Consensus 159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s----i~~Lv~~I~~d~-----------v~~p~~~ 223 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS----ITQLVKSILKDP-----------VKPPSTA 223 (808)
T ss_pred eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH----HHHHHHHHhcCC-----------CCCcccc
Confidence 8899999999999999999999999999999999999999996433 333333333222 1112245
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...+..++...+++||.+|-+-.+++.
T Consensus 224 S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 224 SSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 566788999999999999999999975
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=327.22 Aligned_cols=255 Identities=28% Similarity=0.448 Sum_probs=208.4
Q ss_pred hccccccccCcEEEEEEEEC-------CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
.+.+.||+|+||.||+|... ...+++|.+........+.+.+|++++++++|+||+++++++......++|||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (291)
T cd05094 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFE 87 (291)
T ss_pred EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEe
Confidence 34578999999999999752 35689999887766666789999999999999999999999999999999999
Q ss_pred EccCCchhhhhhhcc--------------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEE
Q 002887 637 FMANGNLQAHLLEDK--------------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKL 702 (870)
Q Consensus 637 y~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL 702 (870)
|+++++|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||++++++.+||
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l 164 (291)
T cd05094 88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKI 164 (291)
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEE
Confidence 999999999986532 13589999999999999999999998 9999999999999999999999
Q ss_pred EeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhh
Q 002887 703 ADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLA 781 (870)
Q Consensus 703 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~ 781 (870)
+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||........... ..
T Consensus 165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~-----~~ 239 (291)
T cd05094 165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC-----IT 239 (291)
T ss_pred CCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----Hh
Confidence 99999976533222222234456788999999999999999999999999999999 9999876554322211 11
Q ss_pred cCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 782 RGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 782 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
.+.... .....+..+.+++.+|++.+|++||++.+|+++|+++..
T Consensus 240 ~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 240 QGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred CCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 221111 112234578899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=334.86 Aligned_cols=240 Identities=25% Similarity=0.340 Sum_probs=197.5
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.||+|+||.||+++.. ++.+|+|++.... ......+.+|++++++++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 7899999997642 233456788999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~ 153 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMK 153 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCccc
Confidence 999888643 4689999999999999999999998 9999999999999999999999999998753211 12233
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........... .. .+. ..++...
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~----~~-~~~----------~~~p~~~ 218 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----IL-MEE----------IRFPRTL 218 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH----HH-cCC----------CCCCCCC
Confidence 45799999999999999999999999999999999999999976543222111 11 111 0112233
Q ss_pred HHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002887 802 VWKAVEIALACIHTISTRRP-----TMNQVVI 828 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 828 (870)
...+.+++.+|++.||++|| ++.++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 45688999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=320.45 Aligned_cols=250 Identities=28% Similarity=0.451 Sum_probs=204.9
Q ss_pred hccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 564 NFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
.+.++||+|++|.||+|... ++.||+|.+..... ..+.+.+|+.++++++|+||+++++.+......+++|||+++|+
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (261)
T cd05072 9 KLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87 (261)
T ss_pred EEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCc
Confidence 44578999999999999976 67899998865432 35678999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.+++.......+++.+++.++.|+++||+|||+. +++||||||+||++++++.+||+|||++....... ......
T Consensus 88 L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 163 (261)
T cd05072 88 LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREG 163 (261)
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc-eeccCC
Confidence 99999766666789999999999999999999998 99999999999999999999999999998653221 112223
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
..++..|+|||++.+..++.++|||||||++|||++ |+.||........... ...+.. .......
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-----~~~~~~---------~~~~~~~ 229 (261)
T cd05072 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA-----LQRGYR---------MPRMENC 229 (261)
T ss_pred CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH-----HHcCCC---------CCCCCCC
Confidence 346678999999998889999999999999999998 9999975443322211 111110 0111223
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
...+.+++.+|++.+|++||++.++.+.|++
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 230 PDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 4568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=319.96 Aligned_cols=251 Identities=31% Similarity=0.479 Sum_probs=210.0
Q ss_pred hhccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.+.+.||+|+||.||+|... ++.+++|.+..........+.+|+++++.++|+||+++++++......++||||+++|
T Consensus 8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (261)
T cd05148 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKG 87 (261)
T ss_pred HHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccC
Confidence 445688999999999999987 6889999998776656678999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++.......+++.++..++.|++.||.|||+. +|+||||||+||++++++.+||+|||.+...... .....
T Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--~~~~~ 162 (261)
T cd05148 88 SLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED--VYLSS 162 (261)
T ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc--ccccc
Confidence 999999876667799999999999999999999998 9999999999999999999999999999765322 11122
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
...++..|+|||.+.+..++.++||||||+++++|++ |+.||........... .. .+ ........
T Consensus 163 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~----~~-~~---------~~~~~~~~ 228 (261)
T cd05148 163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ----IT-AG---------YRMPCPAK 228 (261)
T ss_pred CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH----HH-hC---------CcCCCCCC
Confidence 3446778999999988889999999999999999998 8999976553322221 11 11 11112234
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
....+.+++.+|++.+|++|||++++++.|+.
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 229 CPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 45678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=324.27 Aligned_cols=255 Identities=28% Similarity=0.439 Sum_probs=206.9
Q ss_pred hccccccccCcEEEEEEEEC-------CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
.+.+.||+|+||.||++... +..+|+|.+........+.+.+|++++++++|+||+++++++......++|||
T Consensus 8 ~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (288)
T cd05093 8 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE 87 (288)
T ss_pred eeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence 45678999999999999751 35689999887665666789999999999999999999999999999999999
Q ss_pred EccCCchhhhhhhcc-----------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEec
Q 002887 637 FMANGNLQAHLLEDK-----------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADF 705 (870)
Q Consensus 637 y~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DF 705 (870)
|+++++|.+++.... ...+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~df 164 (288)
T cd05093 88 YMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDF 164 (288)
T ss_pred cCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEeccC
Confidence 999999999886432 23589999999999999999999998 9999999999999999999999999
Q ss_pred cCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCC
Q 002887 706 GLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGD 784 (870)
Q Consensus 706 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~ 784 (870)
|+++...............++..|+|||++.+..++.++|||||||+++||++ |++||........... ...+.
T Consensus 165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~-----i~~~~ 239 (288)
T cd05093 165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC-----ITQGR 239 (288)
T ss_pred CccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCC
Confidence 99986532222122223445778999999998899999999999999999998 9999876543322221 11221
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 785 IKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 785 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
... ........+.+++.+|++.+|.+|||+.||++.|+++..
T Consensus 240 ~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 240 VLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred cCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 111 111234568999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=323.96 Aligned_cols=254 Identities=30% Similarity=0.460 Sum_probs=206.4
Q ss_pred HhhccccccccCcEEEEEEEEC-------CeeEEEEEeeccchh-hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEE
Q 002887 562 TNNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSSVQ-GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGL 633 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 633 (870)
...+.+.||+|+||.||+|... ++.||||.++..... ..+.+.+|++++++++|+||+++++++......++
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 85 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIM 85 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEE
Confidence 3455678999999999999863 367999999766444 45789999999999999999999999999999999
Q ss_pred EEEEccCCchhhhhhhcc------------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEE
Q 002887 634 IYEFMANGNLQAHLLEDK------------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAK 701 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vk 701 (870)
||||+++++|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+|
T Consensus 86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 86 VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred EEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeEE
Confidence 999999999999986532 24588999999999999999999998 999999999999999999999
Q ss_pred EEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHh
Q 002887 702 LADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSML 780 (870)
Q Consensus 702 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~ 780 (870)
|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||........... .
T Consensus 163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~-----~ 237 (280)
T cd05049 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC-----I 237 (280)
T ss_pred ECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-----H
Confidence 999999875432222222233456788999999999999999999999999999998 9999876544332211 1
Q ss_pred hcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 781 ARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 781 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
..+... .........+.+++.+||+.+|++||++.||++.|++
T Consensus 238 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 TQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 122111 1122345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=331.73 Aligned_cols=257 Identities=30% Similarity=0.440 Sum_probs=203.8
Q ss_pred hhccccccccCcEEEEEEEEC-------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHh-ccccceeEEEEEec-CCeEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRA-HHKNLTILVGYCDE-GANMG 632 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~-~~~~~ 632 (870)
+.+.+.||+|+||.||+|... ++.||+|++.... ....+.+.+|++++.++ +|+||++++++|.. +...+
T Consensus 9 ~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~ 88 (337)
T cd05054 9 LKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (337)
T ss_pred hhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEE
Confidence 455689999999999999742 3679999987543 23345678899999999 89999999998865 45688
Q ss_pred EEEEEccCCchhhhhhhcc-----------------------------------------------------------cc
Q 002887 633 LIYEFMANGNLQAHLLEDK-----------------------------------------------------------AD 653 (870)
Q Consensus 633 LV~Ey~~~gsL~~~l~~~~-----------------------------------------------------------~~ 653 (870)
+++||+++|+|.+++.... ..
T Consensus 89 ~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (337)
T cd05054 89 VIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKE 168 (337)
T ss_pred EEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhc
Confidence 9999999999998885432 13
Q ss_pred cccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccccccCCCCccCcc
Q 002887 654 TLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPE 733 (870)
Q Consensus 654 ~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 733 (870)
.++|..+.+++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+.............++..|+|||
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 689999999999999999999998 99999999999999999999999999998763332222223345677899999
Q ss_pred ccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHc
Q 002887 734 YYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALAC 812 (870)
Q Consensus 734 ~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C 812 (870)
++.+..++.++|||||||+++||++ |+.||........+.. ....+.. ...+......+.+++.+|
T Consensus 246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~----~~~~~~~---------~~~~~~~~~~~~~l~~~c 312 (337)
T cd05054 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR----RLKEGTR---------MRAPEYATPEIYSIMLDC 312 (337)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHH----HHhccCC---------CCCCccCCHHHHHHHHHH
Confidence 9999999999999999999999998 9999975433222221 1111111 111223345788999999
Q ss_pred cccCCCCCCCHHHHHHHHHHhhh
Q 002887 813 IHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 813 l~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
++.+|++||++.||+++|+++++
T Consensus 313 l~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 313 WHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=338.08 Aligned_cols=255 Identities=24% Similarity=0.382 Sum_probs=203.9
Q ss_pred hccccccccCcEEEEEEEEC-------CeeEEEEEeeccch-hhhHHHHHHHHHHHHhc-cccceeEEEEEecCCeEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAH-HKNLTILVGYCDEGANMGLI 634 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV 634 (870)
.+.+.||+|+||.||+|... +..||||++..... ...+.+.+|+++++++. ||||++++++|.+....++|
T Consensus 40 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv 119 (400)
T cd05105 40 VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYII 119 (400)
T ss_pred ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEE
Confidence 34578999999999999863 24699999975432 33467899999999996 99999999999999999999
Q ss_pred EEEccCCchhhhhhhcc---------------------------------------------------------------
Q 002887 635 YEFMANGNLQAHLLEDK--------------------------------------------------------------- 651 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~--------------------------------------------------------------- 651 (870)
|||+++|+|.+++....
T Consensus 120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (400)
T cd05105 120 TEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASK 199 (400)
T ss_pred EEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhh
Confidence 99999999998876431
Q ss_pred -------------------------------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcE
Q 002887 652 -------------------------------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQA 700 (870)
Q Consensus 652 -------------------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~v 700 (870)
...+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~~ 276 (400)
T cd05105 200 YSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKIV 276 (400)
T ss_pred hhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCEE
Confidence 12478889999999999999999998 99999999999999999999
Q ss_pred EEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHH
Q 002887 701 KLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSM 779 (870)
Q Consensus 701 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~ 779 (870)
||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||........... .
T Consensus 277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~----~ 352 (400)
T cd05105 277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN----K 352 (400)
T ss_pred EEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH----H
Confidence 9999999986533222222233456788999999999899999999999999999997 9999875433222211 1
Q ss_pred hhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 780 LARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 780 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
...+. ...........+.+++.+|++.+|++||++.+|+++|+++.
T Consensus 353 ~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 353 IKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 11111 11112234567889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.24 Aligned_cols=247 Identities=26% Similarity=0.446 Sum_probs=199.6
Q ss_pred hccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 564 NFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
.+.+.||+|+||.||++.+. +..+|+|.+.... ...+.+.+|++++++++||||+++++++......++||||+++|+
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (256)
T cd05114 7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC 85 (256)
T ss_pred EEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence 34578999999999999987 5689999876443 234678899999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++...... ......
T Consensus 86 L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~~~~~ 160 (256)
T cd05114 86 LLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSG 160 (256)
T ss_pred HHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc-eeccCC
Confidence 999886543 3689999999999999999999998 99999999999999999999999999987653221 111122
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
..++..|+|||++.+..++.++||||||+++|||++ |+.||........... .. .+.. .. .+...
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~----i~-~~~~--~~-------~~~~~ 226 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM----IS-RGFR--LY-------RPKLA 226 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HH-CCCC--CC-------CCCCC
Confidence 345678999999998889999999999999999999 8999976543322221 11 1110 00 11122
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVIEL 830 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 830 (870)
...+.+++.+|++.+|++||++.|+++.|
T Consensus 227 ~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 227 SMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 35688999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=331.76 Aligned_cols=238 Identities=25% Similarity=0.349 Sum_probs=194.7
Q ss_pred ccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCch
Q 002887 569 LGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL 643 (870)
Q Consensus 569 LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 643 (870)
||+|+||.||+++.. ++.||+|++.... ......+.+|++++.+++||||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999985 7789999987542 23446678899999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccccc
Q 002887 644 QAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV 723 (870)
Q Consensus 644 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~ 723 (870)
.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~ 153 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTF 153 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccccc
Confidence 9988643 4689999999999999999999998 9999999999999999999999999998754222 1223446
Q ss_pred cCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHH
Q 002887 724 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVW 803 (870)
Q Consensus 724 ~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 803 (870)
.||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........ ...+.....
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~----~~~~~~~~-----------~~~~~~~~~ 218 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM----YRKILQEP-----------LRFPDGFDR 218 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH----HHHHHcCC-----------CCCCCcCCH
Confidence 799999999999999999999999999999999999999976543222 22222110 011223345
Q ss_pred HHHHHHHHccccCCCCCCC---HHHHHH
Q 002887 804 KAVEIALACIHTISTRRPT---MNQVVI 828 (870)
Q Consensus 804 ~l~~l~~~Cl~~dP~~RPs---m~eVl~ 828 (870)
.+.+++.+|++.+|++||+ +.|++.
T Consensus 219 ~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 219 DAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 6789999999999999985 455543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=328.64 Aligned_cols=255 Identities=25% Similarity=0.409 Sum_probs=202.7
Q ss_pred hccccccccCcEEEEEEEEC--Ce----eEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DK----QVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~----~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
...+.||+|+||.||+|++. ++ .||+|++.... ....+++.+|+.+++.++|+||++++|+|... ..++++|
T Consensus 10 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e 88 (316)
T cd05108 10 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQ 88 (316)
T ss_pred eeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeeee
Confidence 34578999999999999863 33 48999987543 34456789999999999999999999999864 5779999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
|+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+.....
T Consensus 89 ~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 89 LMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred cCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 999999999987543 4688999999999999999999998 999999999999999999999999999987643322
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
........++..|+|||++.+..++.++|||||||++|||++ |+.||....... +.+ ....+. ..
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~----~~~~~~---------~~ 230 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISS----ILEKGE---------RL 230 (316)
T ss_pred ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHH----HHhCCC---------CC
Confidence 222223345678999999999999999999999999999998 999997644322 111 111111 00
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHh
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e 837 (870)
.....+...+.+++.+|++.+|++||++.+++..|..+....
T Consensus 231 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 231 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 111223456789999999999999999999999998876443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=321.83 Aligned_cols=253 Identities=25% Similarity=0.419 Sum_probs=201.5
Q ss_pred hhccccccccCcEEEEEEEEC-------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLI 634 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 634 (870)
..+.+.||+|+||.||+|.+. ++.||+|++.... .....++.+|+.+++.++|+||+++++++.+....++|
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 87 (277)
T cd05062 8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 87 (277)
T ss_pred ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEE
Confidence 345678999999999999864 3579999986532 23456788999999999999999999999999999999
Q ss_pred EEEccCCchhhhhhhccc--------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEecc
Q 002887 635 YEFMANGNLQAHLLEDKA--------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFG 706 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFG 706 (870)
|||+++|+|.+++...+. ..+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~dfg 164 (277)
T cd05062 88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG 164 (277)
T ss_pred EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCCC
Confidence 999999999998865321 3468899999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCc
Q 002887 707 LSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDI 785 (870)
Q Consensus 707 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~ 785 (870)
+++...............++..|+|||++.++.++.++|||||||++|||++ |+.||.......... . ...+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~----~-~~~~~~ 239 (277)
T cd05062 165 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR----F-VMEGGL 239 (277)
T ss_pred CccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----H-HHcCCc
Confidence 9875532222122223345778999999998899999999999999999999 788987654332221 1 111111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 786 KNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 786 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
. .........+.+++.+|++.+|++||++.|+++.|++
T Consensus 240 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 240 L---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1 1122344578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=306.28 Aligned_cols=230 Identities=26% Similarity=0.386 Sum_probs=196.2
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccchhh---hHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQG---YKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~---~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
.+.||.|+||+|..++.+ +..+|+|++.+...-. .+...+|..+|+.+.||.++++.+.|.+....+|||||.+|
T Consensus 49 ~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~G 128 (355)
T KOG0616|consen 49 LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPG 128 (355)
T ss_pred eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCC
Confidence 468999999999999986 7889999998875543 34567899999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|.|..++++ .+.++...+.-+|.||+.||+|||+. .|++|||||+|||||.+|.+||+|||.|+.... ..
T Consensus 129 GElFS~Lrk--~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-----rT 198 (355)
T KOG0616|consen 129 GELFSYLRK--SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-----RT 198 (355)
T ss_pred ccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC-----cE
Confidence 999999974 35799999999999999999999998 999999999999999999999999999997631 24
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
-+.+|||.|+|||.+.+..+..++|.|||||++|||+.|.+||..........+++ +++ + .++..
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~-----~~~--------v--~fP~~ 263 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL-----EGK--------V--KFPSY 263 (355)
T ss_pred EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH-----hCc--------c--cCCcc
Confidence 57899999999999999999999999999999999999999998765533222221 111 1 23444
Q ss_pred HHHHHHHHHHHccccCCCCC
Q 002887 801 TVWKAVEIALACIHTISTRR 820 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~R 820 (870)
....+.+|+...++.|-.+|
T Consensus 264 fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 264 FSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cCHHHHHHHHHHHhhhhHhh
Confidence 45567788888888888888
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.70 Aligned_cols=248 Identities=25% Similarity=0.372 Sum_probs=198.3
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCch
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL 643 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 643 (870)
+.||+|+||.||+|... ++.+|+|...... ......+.+|++++++++|+||++++++|......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999874 8889999876543 33456789999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccccc
Q 002887 644 QAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV 723 (870)
Q Consensus 644 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~ 723 (870)
.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTE-GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 9988643 34689999999999999999999998 9999999999999999999999999998754221111111112
Q ss_pred cCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHH
Q 002887 724 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTV 802 (870)
Q Consensus 724 ~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 802 (870)
..+..|+|||.+.++.++.++||||||+++|||++ |..||......... .....+ .........+
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~-----~~~~~~---------~~~~~~~~~~ 222 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR-----EAIEQG---------VRLPCPELCP 222 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH-----HHHHcC---------CCCCCcccCC
Confidence 23457999999998899999999999999999998 88888754332211 111111 1111222345
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 803 WKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 803 ~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
..+.+++.+|++.+|++||++.||.++|++
T Consensus 223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 223 DAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=331.00 Aligned_cols=260 Identities=26% Similarity=0.405 Sum_probs=217.8
Q ss_pred hccccccccCcEEEEEEEECC-eeEEEEEeeccchh-hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 564 NFERVLGKGGFGTVYHGYLDD-KQVAVKMLSSSSVQ-GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~~-~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
-|.++||+|-||+|..+..++ ..||||+++..... ..++|.+|+++|.+++||||+.++|.|..++..++|+|||++|
T Consensus 541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG 620 (807)
T KOG1094|consen 541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG 620 (807)
T ss_pred ehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence 356899999999999999985 89999999987544 4589999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++.++....+.-...++|+.|||.||+||.+. ++|||||.++|+|+|.++++||+|||+++-+-..+..+...
T Consensus 621 DLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqg 697 (807)
T KOG1094|consen 621 DLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQG 697 (807)
T ss_pred cHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceeeec
Confidence 999999887655566677888999999999999998 99999999999999999999999999999665555555555
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHh--CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt--G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
..+-.++|||+|.+..++++.++|||+||+++||+++ ...||.....++.... ..++.+.+..... ...+.
T Consensus 698 r~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven-~~~~~~~~~~~~~------l~~P~ 770 (807)
T KOG1094|consen 698 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN-AGEFFRDQGRQVV------LSRPP 770 (807)
T ss_pred ceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh-hhhhcCCCCccee------ccCCC
Confidence 6677889999999999999999999999999999875 6788887655443222 2233322221111 12244
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
-++.++.+++++||..+.++||+++++...|++.
T Consensus 771 ~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 771 ACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 5677889999999999999999999999998763
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=346.55 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=203.2
Q ss_pred hhccccccccCcEEEEEEEEC---CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 563 NNFERVLGKGGFGTVYHGYLD---DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~---~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
+.+.+.||+|++|.||+|... ++.||+|.+..........+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 455689999999999999864 56788888766555555678899999999999999999999999999999999999
Q ss_pred CCchhhhhhhc--ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 640 NGNLQAHLLED--KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 640 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999888643 234688999999999999999999998 9999999999999999999999999999876433222
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........+ ..... +... ..
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~----~~~~~-~~~~---------~~ 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM----QQVLY-GKYD---------PF 291 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHh-CCCC---------CC
Confidence 2334567999999999999999999999999999999999999999764432222 11111 1110 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+......+.+++.+|++.+|++||++.+++.
T Consensus 292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1223456889999999999999999999874
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.03 Aligned_cols=252 Identities=28% Similarity=0.422 Sum_probs=204.5
Q ss_pred hccccccccCcEEEEEEEEC-----CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD-----DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-----~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.+.||+|+||.||+|.+. ...||||.+.... ......|.+|+.++++++|+||+++++++......++||||
T Consensus 7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 86 (266)
T cd05033 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEY 86 (266)
T ss_pred eeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEc
Confidence 45689999999999999974 3478999987653 33456789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 87 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 87 MENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred CCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 99999999986543 3789999999999999999999998 9999999999999999999999999999876422222
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||......... + ....+.. ..
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~-~----~~~~~~~---------~~ 228 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI-K----AVEDGYR---------LP 228 (266)
T ss_pred eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH-H----HHHcCCC---------CC
Confidence 22223345678999999998899999999999999999998 99998654432211 1 1111110 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
........+.+++.+|++.+|++||++.||+++|+++
T Consensus 229 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1123345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.13 Aligned_cols=253 Identities=27% Similarity=0.469 Sum_probs=203.4
Q ss_pred hhccccccccCcEEEEEEEE------CCeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYL------DDKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIY 635 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~------~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 635 (870)
..+.+.||+|+||.||+|.. .++.+++|.+.... ......+.+|++++++++|+||+++++++..+...++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 86 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF 86 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence 34568899999999999985 25689999997543 334567899999999999999999999999999999999
Q ss_pred EEccCCchhhhhhhcc---------------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcE
Q 002887 636 EFMANGNLQAHLLEDK---------------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQA 700 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~v 700 (870)
||+++++|.+++.... ...+++.+.+.++.|++.||+|||++ +++||||||+|||+++++.+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcE
Confidence 9999999999885322 23588999999999999999999998 99999999999999999999
Q ss_pred EEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHH
Q 002887 701 KLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSM 779 (870)
Q Consensus 701 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~ 779 (870)
||+|||+++...............++..|+|||++.+..++.++||||||++++||++ |..||......... ..
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~-----~~ 238 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI-----EM 238 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-----HH
Confidence 9999999986543322223334456778999999988889999999999999999998 99998754432211 11
Q ss_pred hhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 780 LARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 780 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
...+.. ..........+.+++.+|++.+|++||++.+|.++|+.
T Consensus 239 ~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VRKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111 01122334578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=328.78 Aligned_cols=241 Identities=28% Similarity=0.443 Sum_probs=204.7
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCch
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL 643 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 643 (870)
+.||+|.||.||+|... ++.||+|++..... ...+..++|+.+|.+++++||.++++.+..+..+.++||||.+|++
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 68999999999999986 88999999987644 3457789999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccccc
Q 002887 644 QAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV 723 (870)
Q Consensus 644 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~ 723 (870)
.+.+... ..+++....-|+++++.||.|||.+ +.+|||||+.|||+..+|.+||+|||.+..+... .......
T Consensus 99 ~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~--~~rr~tf 171 (467)
T KOG0201|consen 99 LDLLKSG--NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT--VKRRKTF 171 (467)
T ss_pred hhhhccC--CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech--hhccccc
Confidence 9998533 3447788888999999999999999 9999999999999999999999999999876433 2233678
Q ss_pred cCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHH
Q 002887 724 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVW 803 (870)
Q Consensus 724 ~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 803 (870)
+||+.|||||++....|+.|+||||||++.+||.+|.+|+........+. ++.+.-....+.....
T Consensus 172 vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf--------------lIpk~~PP~L~~~~S~ 237 (467)
T KOG0201|consen 172 VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF--------------LIPKSAPPRLDGDFSP 237 (467)
T ss_pred cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE--------------eccCCCCCccccccCH
Confidence 99999999999998899999999999999999999999998766533211 1111112222334556
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 002887 804 KAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 804 ~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.+.+++..|++++|+.||++.++++
T Consensus 238 ~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 238 PFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhh
Confidence 7899999999999999999999985
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=324.75 Aligned_cols=262 Identities=28% Similarity=0.438 Sum_probs=203.2
Q ss_pred ccccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHH--hccccceeEEEEEecCC----eEEEEEEEc
Q 002887 565 FERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIR--AHHKNLTILVGYCDEGA----NMGLIYEFM 638 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~~~----~~~LV~Ey~ 638 (870)
+.++||+|+||.||||.+.++.||||++.... .+.|++|-++... ++|+||+++++.-..+. +..||++|.
T Consensus 214 l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLDNRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred hHHHhhcCccceeehhhccCceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 34689999999999999999999999997654 4567777777765 69999999999987766 899999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhC------CCCCceeCCCCCCCEEEcCCCcEEEEeccCCcccc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNG------CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 712 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~ 712 (870)
++|+|.++| +...++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+.+.|+|||+|..+.
T Consensus 291 ~kGsL~dyL---~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~ 367 (534)
T KOG3653|consen 291 PKGSLCDYL---KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE 367 (534)
T ss_pred cCCcHHHHH---HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence 999999999 456899999999999999999999975 47899999999999999999999999999999887
Q ss_pred CCCCccccccccCCCCccCccccccCC-C-----CccchHHHHHHHHHHHHhCCCCCCCC--C-----------ccchHH
Q 002887 713 VEGGTHVSTTVVGTPGYLDPEYYISNR-L-----TEKSDVYSFGVVLLELITGQPVIQKT--P-----------QRTLIG 773 (870)
Q Consensus 713 ~~~~~~~~~~~~gt~~y~APE~~~~~~-~-----~~ksDVwS~GvvL~elltG~~p~~~~--~-----------~~~~l~ 773 (870)
...........+||.+|||||++.+.. . -.+.||||+|.|||||++....++.. + ....+.
T Consensus 368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e 447 (534)
T KOG3653|consen 368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE 447 (534)
T ss_pred CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence 655555555589999999999997643 2 24689999999999999976544311 1 011112
Q ss_pred HHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 774 QWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 774 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
+.....+++.....+.+ .+. ....+..+.+.+..||..||+-|-|+.=|-+.+.++...
T Consensus 448 ~mq~~VV~kK~RP~~p~-~W~---~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 448 EMQELVVRKKQRPKIPD-AWR---KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred HHHHHHHhhccCCCChh-hhh---cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 21111122111111111 111 114466788999999999999999999998888775433
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=330.69 Aligned_cols=240 Identities=25% Similarity=0.347 Sum_probs=196.6
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.||+|+||.||++... ++.||+|++.... ......+.+|++++++++||||+++++.+......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999875 7899999997642 233456788999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~ 153 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMK 153 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCccc
Confidence 998887543 4689999999999999999999998 9999999999999999999999999998753221 11223
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
...|++.|+|||++.+..++.++|||||||++|||++|+.||............ .. +. . ..+...
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~----~~-~~------~----~~p~~~ 218 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI----LM-EE------I----RFPRTL 218 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH----hc-CC------C----CCCCCC
Confidence 457999999999999999999999999999999999999999765433322221 11 10 0 112223
Q ss_pred HHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002887 802 VWKAVEIALACIHTISTRRP-----TMNQVVI 828 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 828 (870)
...+.+++.+|++.+|++|| ++.++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 45678999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=326.41 Aligned_cols=241 Identities=25% Similarity=0.356 Sum_probs=198.4
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+|... ++.||+|++..... ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 83 (291)
T cd05612 4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYV 83 (291)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCC
Confidence 34578999999999999986 88999999975432 23456889999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 84 PGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 999999988643 4688999999999999999999998 9999999999999999999999999999865321
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||........... .. .+.. .++
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~----i~-~~~~----------~~~ 218 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK----IL-AGKL----------EFP 218 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HH-hCCc----------CCC
Confidence 1235689999999999988899999999999999999999999976543222211 11 1110 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPT-----MNQVVIE 829 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~~ 829 (870)
......+.+++.+|++.||++||+ +.|+++.
T Consensus 219 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 219 RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 223456789999999999999995 7777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=327.70 Aligned_cols=257 Identities=23% Similarity=0.299 Sum_probs=200.3
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
..+.||+|+||.||+++.. +..+|+|++.... ....+.+.+|++++++++||||+++++++..+...++||||+++|
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (331)
T cd06649 9 RISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 88 (331)
T ss_pred EEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCC
Confidence 3468999999999999986 7789999987652 234567899999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++... ..+++..+..++.|++.||.|||+.. +|+||||||+|||+++++.+||+|||++...... ...
T Consensus 89 ~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~ 160 (331)
T cd06649 89 SLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 160 (331)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc----ccc
Confidence 999998643 46889999999999999999999852 6999999999999999999999999998765321 223
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCC---c-------------
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGD---I------------- 785 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~---~------------- 785 (870)
...|+..|+|||++.+..++.++|||||||++|||++|+.||....... +..........+. .
T Consensus 161 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd06649 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRPVVDGEEGEPHSISPRPRPPGRP 239 (331)
T ss_pred cCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccccCCccccCccccccccc
Confidence 4578999999999999899999999999999999999999997544322 1111111000000 0
Q ss_pred --------------chhccccc---CCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002887 786 --------------KNIVDHRL---QGDF-DTNTVWKAVEIALACIHTISTRRPTMNQVVIEL 830 (870)
Q Consensus 786 --------------~~i~d~~l---~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 830 (870)
.+..+... .... .......+.+++.+||+.+|++|||+.|+++.-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000000 0000 112345788999999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=320.50 Aligned_cols=254 Identities=27% Similarity=0.416 Sum_probs=203.5
Q ss_pred ccccccccCcEEEEEEEEC-------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
+.+.||+|+||.||+|... ...+++|.+.... ....+++.+|+.+++.++||||+++++.|......++++|
T Consensus 4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 4578999999999999863 2568899887553 2345678999999999999999999999999999999999
Q ss_pred EccCCchhhhhhhcc----------------------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEE
Q 002887 637 FMANGNLQAHLLEDK----------------------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILL 694 (870)
Q Consensus 637 y~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILl 694 (870)
|+.+|+|.+++...+ ...+++..++.++.|++.||+|||+. +++||||||+|||+
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill 160 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLV 160 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEE
Confidence 999999999875421 13588999999999999999999988 99999999999999
Q ss_pred cCCCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHH
Q 002887 695 NEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIG 773 (870)
Q Consensus 695 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~ 773 (870)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||....... +.
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~ 239 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-LF 239 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH-HH
Confidence 9999999999999976533222112223345678999999988889999999999999999999 999997544322 11
Q ss_pred HHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 774 QWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 774 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
+ ....+ ............+.+++.+|++.+|++||++.|+++.|++++.
T Consensus 240 ~----~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 240 N----LLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred H----HHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1 11111 1111122334578899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=324.80 Aligned_cols=237 Identities=24% Similarity=0.369 Sum_probs=195.8
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccchh---hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ---GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~---~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
.+.||+|+||.||.++-+ |+.+|+|++++.... ..+....|-.+|....++.||+++-.|++.+.+||||||++|
T Consensus 146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG 225 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG 225 (550)
T ss_pred heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence 368999999999999875 899999999987543 345678899999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC-------
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV------- 713 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~------- 713 (870)
|++..+|.. ...|++..+..++.+++-|++-||+. |+|||||||+|+|||..|++||+||||+.-+..
T Consensus 226 GD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~ 300 (550)
T KOG0605|consen 226 GDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESY 300 (550)
T ss_pred ccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhh
Confidence 999999974 46899999999999999999999998 999999999999999999999999999864311
Q ss_pred ----------------CCC-----cc-----------------ccccccCCCCccCccccccCCCCccchHHHHHHHHHH
Q 002887 714 ----------------EGG-----TH-----------------VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLE 755 (870)
Q Consensus 714 ----------------~~~-----~~-----------------~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~e 755 (870)
+.. .. .....+|||.|||||++.+..|+..+|.||+|||+||
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyE 380 (550)
T KOG0605|consen 301 RLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYE 380 (550)
T ss_pred cchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHH
Confidence 000 00 0112469999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCccch---HHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 002887 756 LITGQPVIQKTPQRTL---IGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPT 822 (870)
Q Consensus 756 lltG~~p~~~~~~~~~---l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 822 (870)
||.|.+||........ +..|...+. .........+..++|.+|+. ||++|--
T Consensus 381 mLvGyPPF~s~tp~~T~rkI~nwr~~l~--------------fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 381 MLVGYPPFCSETPQETYRKIVNWRETLK--------------FPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhhhcc--------------CCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999987664333 333322221 11222334678899999999 9999986
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=321.88 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=206.1
Q ss_pred hhccccccccCcEEEEEEEEC-------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGL 633 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~L 633 (870)
..+.+.||+|+||.||++... +..+|||+++... ....+.+.+|+++++++ +|+||+++++++......++
T Consensus 37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 116 (302)
T cd05055 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILV 116 (302)
T ss_pred eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEE
Confidence 445689999999999999741 4579999987653 33456789999999999 79999999999999999999
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
||||+++|+|.+++.......+++.+++.++.|++.||+|||+. +|+|+||||+|||+++++.+|++|||+++....
T Consensus 117 v~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 117 ITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 99999999999998765555589999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccc
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHR 792 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 792 (870)
...........++..|+|||.+.+..++.++|||||||++|||++ |+.||..........+. ...+.
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~----~~~~~-------- 261 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL----IKEGY-------- 261 (302)
T ss_pred CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHH----HHcCC--------
Confidence 322112223346778999999999999999999999999999998 99998765543322221 11111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 793 LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 793 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
...........+.+++.+|+..+|++||++.|+++.|++.
T Consensus 262 -~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 -RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111122345788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.62 Aligned_cols=253 Identities=23% Similarity=0.387 Sum_probs=202.6
Q ss_pred hhccccccccCcEEEEEEEEC-------CeeEEEEEeeccchh-hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSSVQ-GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLI 634 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 634 (870)
..+.+.||+|+||.||+|... ++.||+|++...... ..+.+.+|+.++.+++||||+++++++......+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 345578999999999999863 367999999865432 345688999999999999999999999999999999
Q ss_pred EEEccCCchhhhhhhc--------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcE
Q 002887 635 YEFMANGNLQAHLLED--------------KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQA 700 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~v 700 (870)
+||+++++|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCce
Confidence 9999999999987532 123588999999999999999999998 99999999999999999999
Q ss_pred EEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHH
Q 002887 701 KLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSM 779 (870)
Q Consensus 701 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~ 779 (870)
||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||....... +....
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~~~i 239 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD----VIEMI 239 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHH
Confidence 9999999886533222222233456789999999988889999999999999999998 888887544322 22221
Q ss_pred hhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 780 LARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 780 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
. .+.. ..........+.+++..|++.+|++||++.||++.|+.
T Consensus 240 ~-~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 R-NRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H-cCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 1111 11223445668899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=300.41 Aligned_cols=244 Identities=27% Similarity=0.390 Sum_probs=211.2
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
++.+.||+|.||.||.|+.+ +-.||+|++.+... +..+++.+|+++...++||||+++++++.+....||++||.
T Consensus 25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya 104 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA 104 (281)
T ss_pred cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence 45689999999999999986 67899999987643 34568899999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
.+|++...|.+.+...++......+..|+|.||.|+|.. +|+||||||+|+|++.++..|++|||-+..-+ ..
T Consensus 105 ~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p----~~ 177 (281)
T KOG0580|consen 105 PRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SN 177 (281)
T ss_pred CCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC----CC
Confidence 999999999988888899999999999999999999988 99999999999999999999999999987542 34
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
.....+||..|.+||...+...+.+.|+|++|++.||++.|.+||......+...+..+.. + .++
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~--------~-------~~p 242 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD--------L-------KFP 242 (281)
T ss_pred CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc--------c-------cCC
Confidence 4567899999999999999999999999999999999999999998766444433322111 1 122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
......+.+++.+|+..+|.+|.+..||++.
T Consensus 243 ~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 3445678899999999999999999999764
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=329.70 Aligned_cols=241 Identities=26% Similarity=0.371 Sum_probs=197.1
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.||+|+||.||++... ++.||+|++.... ......+.+|+++++.++||||+++.+.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 7899999997642 234467788999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|..++... ..+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~ 153 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMK 153 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccc
Confidence 998887543 4689999999999999999999998 9999999999999999999999999998753221 12223
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..... +. . ..+...
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~----~~~~~-~~------~----~~p~~~ 218 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILM-ED------I----KFPRTL 218 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH----HHhcc-CC------c----cCCCCC
Confidence 457999999999999989999999999999999999999999764432211 11111 10 0 112233
Q ss_pred HHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002887 802 VWKAVEIALACIHTISTRRP-----TMNQVVIE 829 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 829 (870)
...+.+++.+|++.+|++|| ++.|+++.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 45678999999999999997 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=316.03 Aligned_cols=252 Identities=27% Similarity=0.402 Sum_probs=198.9
Q ss_pred ccccccccCcEEEEEEEEC--C--eeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecC------CeEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--D--KQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEG------ANMG 632 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~--~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~ 632 (870)
+.+.||+|+||.||+|... + ..+|+|.++.. .....+.+.+|++++++++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 4578999999999999975 2 25899988654 234456789999999999999999999987432 2468
Q ss_pred EEEEEccCCchhhhhhhc----ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCC
Q 002887 633 LIYEFMANGNLQAHLLED----KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 708 (870)
Q Consensus 633 LV~Ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla 708 (870)
+++||+++|+|.+++... ....+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 999999999999887432 234589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcch
Q 002887 709 RIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKN 787 (870)
Q Consensus 709 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (870)
+...............+++.|+|||++.+..++.++||||||+++|||++ |+.||........ . .....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----~-~~~~~~~~~- 233 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI----Y-DYLRQGNRL- 233 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH----H-HHHHcCCCC-
Confidence 86633221111223346778999999999899999999999999999999 8899875433221 1 112222111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 788 IVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 788 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
.........+.+++.+|++.+|++|||+.++++.|+++
T Consensus 234 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 234 --------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11123345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=318.84 Aligned_cols=259 Identities=19% Similarity=0.243 Sum_probs=199.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.+.+.||+|+||.||+++.. ++.+|+|++.... ....+.+.+|++++++++|+||+++++++...+..++||||++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07848 4 EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVE 83 (287)
T ss_pred eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCC
Confidence 34578999999999999986 7789999987643 2334667899999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
++.+..... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....... ...
T Consensus 84 ~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (287)
T cd07848 84 KNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NAN 157 (287)
T ss_pred CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-ccc
Confidence 987765432 235689999999999999999999998 99999999999999999999999999998653221 122
Q ss_pred cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHH-----------HHhhcCCcchh
Q 002887 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVS-----------SMLARGDIKNI 788 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~-----------~~~~~~~~~~i 788 (870)
.....|++.|+|||++.+..++.++|||||||++|||++|++||........+..... ...........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 2345789999999999988899999999999999999999999986543322221110 00001100000
Q ss_pred cccccCCC------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 789 VDHRLQGD------FDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 789 ~d~~l~~~------~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..+..... ........+.+++.+|++.+|++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00100000 01123456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=332.75 Aligned_cols=243 Identities=25% Similarity=0.377 Sum_probs=207.9
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+++.||+|+.|.|-.|++. |+.+|||++.+.. ......+++|+-+|+.+.|||++.+++.+.+..++|+|.||+
T Consensus 15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv 94 (786)
T KOG0588|consen 15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV 94 (786)
T ss_pred eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence 35678999999999999985 9999999997752 223456899999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|.|.+++.++ .++++.++.+++.||+.|+.|+|.. +|+||||||+|+|||..+++||+|||+|.+-. ...
T Consensus 95 ~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~---~gk 166 (786)
T KOG0588|consen 95 PGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV---PGK 166 (786)
T ss_pred CCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc---CCc
Confidence 999999999754 4789999999999999999999998 99999999999999999999999999998642 234
Q ss_pred ccccccCCCCccCccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLT-EKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~-~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
...+-+|.+.|.|||++++..|+ .++||||+||||+.||||+.||++..-...+.+ ++.|.. ++
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlK-----V~~G~f----------~M 231 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLK-----VQRGVF----------EM 231 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHH-----HHcCcc----------cC
Confidence 45667999999999999999875 789999999999999999999995444333322 333322 22
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
+.....++.+|+.+|+..||+.|.|++||.+.
T Consensus 232 Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 232 PSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred CCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 34566788999999999999999999999874
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=321.56 Aligned_cols=260 Identities=28% Similarity=0.431 Sum_probs=208.2
Q ss_pred HhhccccccccCcEEEEEEEEC---------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCe
Q 002887 562 TNNFERVLGKGGFGTVYHGYLD---------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGAN 630 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~---------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 630 (870)
...+.+.||+|+||.||+|+.. +..||+|.+.... ....+.+.+|+.+++.+ +|+||+++++++.....
T Consensus 16 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (304)
T cd05101 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 95 (304)
T ss_pred HeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCc
Confidence 3446689999999999999741 3468999987542 34456789999999999 89999999999999999
Q ss_pred EEEEEEEccCCchhhhhhhcc--------------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC
Q 002887 631 MGLIYEFMANGNLQAHLLEDK--------------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE 696 (870)
Q Consensus 631 ~~LV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~ 696 (870)
.++||||+++|+|.+++...+ ...+++.+++.++.|+++||.|||+. +++||||||+||++++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili~~ 172 (304)
T cd05101 96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTE 172 (304)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEEcC
Confidence 999999999999999987542 23588999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHH
Q 002887 697 KFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQW 775 (870)
Q Consensus 697 ~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~ 775 (870)
++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||....... +
T Consensus 173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~ 248 (304)
T cd05101 173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----L 248 (304)
T ss_pred CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH----H
Confidence 99999999999986643222222233456778999999998889999999999999999998 788886543222 2
Q ss_pred HHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHhH
Q 002887 776 VSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAMEI 838 (870)
Q Consensus 776 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e~ 838 (870)
.... ..+.. ..........+.+++.+|++.+|++||++.||++.|+++.....
T Consensus 249 ~~~~-~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 249 FKLL-KEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred HHHH-HcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 2221 11110 11122345678899999999999999999999999999876643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=329.81 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=201.7
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+|+.. ++.||+|++..... ...+.+.+|++++.+++||||+++++++......++||||+
T Consensus 4 ~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (333)
T cd05600 4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV 83 (333)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCC
Confidence 34578999999999999985 78999999976532 33456889999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----- 153 (333)
T cd05600 84 PGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----- 153 (333)
T ss_pred CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence 999999998643 4688999999999999999999998 999999999999999999999999999976532
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
......|++.|+|||++.+..++.++|||||||++|||++|+.||............. ... ..+.........
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~----~~~---~~~~~~~~~~~~ 226 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK----YWK---ETLQRPVYDDPR 226 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH----hcc---ccccCCCCCccc
Confidence 2345679999999999999999999999999999999999999998654333222111 000 000000000001
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
......+.+++.+|+..+|++||++.|+++.
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1335577899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=332.87 Aligned_cols=255 Identities=28% Similarity=0.411 Sum_probs=204.1
Q ss_pred hccccccccCcEEEEEEEEC-------CeeEEEEEeeccch-hhhHHHHHHHHHHHHhc-cccceeEEEEEecCCeEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAH-HKNLTILVGYCDEGANMGLI 634 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV 634 (870)
.+.+.||+|+||.||+|++. ++.||+|++..... ...+.+.+|++++.++. ||||++++++|......++|
T Consensus 40 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv 119 (401)
T cd05107 40 VLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYII 119 (401)
T ss_pred ehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEE
Confidence 34579999999999999864 35799999976532 33457889999999997 99999999999999999999
Q ss_pred EEEccCCchhhhhhhccc--------------------------------------------------------------
Q 002887 635 YEFMANGNLQAHLLEDKA-------------------------------------------------------------- 652 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~-------------------------------------------------------------- 652 (870)
+||+++|+|.+++++.+.
T Consensus 120 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (401)
T cd05107 120 TEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTV 199 (401)
T ss_pred EeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhh
Confidence 999999999998865321
Q ss_pred ----------------------------------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC
Q 002887 653 ----------------------------------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF 698 (870)
Q Consensus 653 ----------------------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~ 698 (870)
..+++..++.++.|++.||+|||+. +++||||||+|||+++++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~~ 276 (401)
T cd05107 200 KYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGK 276 (401)
T ss_pred hhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeCCC
Confidence 2467888999999999999999988 999999999999999999
Q ss_pred cEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHH
Q 002887 699 QAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVS 777 (870)
Q Consensus 699 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~ 777 (870)
.+||+|||+++...............++..|+|||.+.+..++.++|||||||+++||++ |+.||...........
T Consensus 277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~--- 353 (401)
T cd05107 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN--- 353 (401)
T ss_pred EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH---
Confidence 999999999986532222122223456788999999998889999999999999999998 8899875443222211
Q ss_pred HHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 778 SMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 778 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
.+..+. ....+......+.+++.+|++.+|++||+++||++.|++++
T Consensus 354 -~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 354 -AIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -HHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111121 11112233567889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=320.72 Aligned_cols=254 Identities=30% Similarity=0.470 Sum_probs=204.7
Q ss_pred hccccccccCcEEEEEEEEC-------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLI 634 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV 634 (870)
.+.+.||+|+||.||++... ...+|+|.+.... .....++.+|++++.++ +|+||+++++++..+...+++
T Consensus 15 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li 94 (293)
T cd05053 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVV 94 (293)
T ss_pred EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEE
Confidence 34578999999999999864 2579999987642 33446688999999999 899999999999999999999
Q ss_pred EEEccCCchhhhhhhc--------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcE
Q 002887 635 YEFMANGNLQAHLLED--------------KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQA 700 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~v 700 (870)
|||+++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~~ 171 (293)
T cd05053 95 VEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVM 171 (293)
T ss_pred EEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCeE
Confidence 9999999999998642 235689999999999999999999988 99999999999999999999
Q ss_pred EEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHH
Q 002887 701 KLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSM 779 (870)
Q Consensus 701 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~ 779 (870)
||+|||+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..||.......... .
T Consensus 172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~-----~ 246 (293)
T cd05053 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK-----L 246 (293)
T ss_pred EeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH-----H
Confidence 9999999986643222222223345678999999998899999999999999999998 999987544322211 1
Q ss_pred hhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 780 LARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 780 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
...+. ....+......+.+++.+|+..+|++|||+.|+++.|++++
T Consensus 247 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 247 LKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111 11122234567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=330.71 Aligned_cols=240 Identities=25% Similarity=0.386 Sum_probs=197.7
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+|+.. ++.||+|++..... ...+.+.+|++++++++||||+++++.+.+++..++||||+
T Consensus 21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 100 (329)
T PTZ00263 21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV 100 (329)
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCC
Confidence 45689999999999999986 78899999976432 33456889999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 101 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---- 171 (329)
T PTZ00263 101 VGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---- 171 (329)
T ss_pred CCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC----
Confidence 999999988643 4678889999999999999999998 9999999999999999999999999999865321
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||.......... . +..+.. ..+
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~----~-i~~~~~----------~~p 235 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE----K-ILAGRL----------KFP 235 (329)
T ss_pred -cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHH----H-HhcCCc----------CCC
Confidence 123579999999999999999999999999999999999999997544322211 1 111211 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPT-----MNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~ 828 (870)
......+.+++.+||+.||++||+ +.+++.
T Consensus 236 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 236 NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 122346789999999999999996 677664
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=320.48 Aligned_cols=260 Identities=25% Similarity=0.363 Sum_probs=202.3
Q ss_pred hhccccccccCcEEEEEEEECC----------------eeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLDD----------------KQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYC 625 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~~----------------~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~ 625 (870)
..+.+.||+|+||.||++...+ ..||+|.+.... ......|.+|++++++++|+|++++++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~ 86 (295)
T cd05097 7 LRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVC 86 (295)
T ss_pred CeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEE
Confidence 3456789999999999987632 248999987642 33456789999999999999999999999
Q ss_pred ecCCeEEEEEEEccCCchhhhhhhcc----------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEc
Q 002887 626 DEGANMGLIYEFMANGNLQAHLLEDK----------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLN 695 (870)
Q Consensus 626 ~~~~~~~LV~Ey~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld 695 (870)
......++||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+++
T Consensus 87 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill~ 163 (295)
T cd05097 87 VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVG 163 (295)
T ss_pred cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEEc
Confidence 99999999999999999999885432 12478999999999999999999998 999999999999999
Q ss_pred CCCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh--CCCCCCCCCccchHH
Q 002887 696 EKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTPQRTLIG 773 (870)
Q Consensus 696 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt--G~~p~~~~~~~~~l~ 773 (870)
+++.+||+|||++................++..|+|||++.++.++.++|||||||+++||++ |..||........+.
T Consensus 164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 243 (295)
T cd05097 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE 243 (295)
T ss_pred CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHH
Confidence 999999999999976533222222233345778999999998899999999999999999998 667877654433333
Q ss_pred HHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 774 QWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 774 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
.... ....... ..........+..+.+++.+|++.+|++||+|.+|++.|++
T Consensus 244 ~~~~-~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 244 NTGE-FFRNQGR------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHH-hhhhccc------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 2211 1111100 00011112234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=313.68 Aligned_cols=250 Identities=28% Similarity=0.452 Sum_probs=202.4
Q ss_pred hhccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
..+.+.||+|++|.||+|... +..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.+ ...+++|||++++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~ 85 (260)
T cd05070 8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKG 85 (260)
T ss_pred hhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCC
Confidence 345678999999999999876 67899999876433 34578999999999999999999998854 5688999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++.......+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++..+.... .....
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~ 161 (260)
T cd05070 86 SLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE-YTARQ 161 (260)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc-ccccc
Confidence 999998765556789999999999999999999998 99999999999999999999999999998653221 11112
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
...++..|+|||++.+..++.++|+||||++++||++ |+.||...........+ . .+ ........
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~----~-~~---------~~~~~~~~ 227 (260)
T cd05070 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV----E-RG---------YRMPCPQD 227 (260)
T ss_pred CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH----H-cC---------CCCCCCCc
Confidence 2345678999999988889999999999999999999 89999764433222211 1 11 01112233
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
....+.+++.+|++.+|++|||+.++.+.|++
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 228 CPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 45678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=322.71 Aligned_cols=258 Identities=30% Similarity=0.452 Sum_probs=205.7
Q ss_pred HhhccccccccCcEEEEEEEEC---------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCe
Q 002887 562 TNNFERVLGKGGFGTVYHGYLD---------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGAN 630 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~---------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 630 (870)
.+.+.+.||+|+||.||++... ...+|+|.+.... .....++.+|++++.++ +|+||+++++++.....
T Consensus 19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 98 (307)
T cd05098 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 98 (307)
T ss_pred HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 4556789999999999999853 2469999987642 33456788899999999 89999999999999999
Q ss_pred EEEEEEEccCCchhhhhhhccc--------------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC
Q 002887 631 MGLIYEFMANGNLQAHLLEDKA--------------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE 696 (870)
Q Consensus 631 ~~LV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~ 696 (870)
.++||||+++|+|.+++...+. ..+++.+++.++.|++.||+|||+. +++||||||+||++++
T Consensus 99 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~ 175 (307)
T cd05098 99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE 175 (307)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEcC
Confidence 9999999999999999975432 3589999999999999999999988 9999999999999999
Q ss_pred CCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHH
Q 002887 697 KFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQW 775 (870)
Q Consensus 697 ~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~ 775 (870)
++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... .
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~----~ 251 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----L 251 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH----H
Confidence 99999999999876532211111122234578999999998889999999999999999998 888886543222 1
Q ss_pred HHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 776 VSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 776 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
... ...+. ...........+.+++.+|++.+|++||+|.+|++.|++++..
T Consensus 252 ~~~-~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 252 FKL-LKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHH-HHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 111 11111 1112223456788999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.32 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=201.1
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch--------------hhhHHHHHHHHHHHHhccccceeEEEEEec-
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--------------QGYKQFQAEVELLIRAHHKNLTILVGYCDE- 627 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--------------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~- 627 (870)
+.+.||+|.||.|-+|+.. ++.||||++.+... ...+...+|+.+|++++|+|||+|++...+
T Consensus 101 l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP 180 (576)
T KOG0585|consen 101 LIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDP 180 (576)
T ss_pred hhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCc
Confidence 4568999999999999976 88999999976421 112467899999999999999999999966
Q ss_pred -CCeEEEEEEEccCCchhhhhhhccccc-ccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEec
Q 002887 628 -GANMGLIYEFMANGNLQAHLLEDKADT-LCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADF 705 (870)
Q Consensus 628 -~~~~~LV~Ey~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DF 705 (870)
.++.|||+|||..|.+...- ..+. ++..++.++++++..||+|||.+ +||||||||+|+||+++|++||+||
T Consensus 181 ~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 181 ESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred ccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEeecc
Confidence 46799999999998775432 2334 89999999999999999999999 9999999999999999999999999
Q ss_pred cCCccccCCC---CccccccccCCCCccCccccccCC----CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHH
Q 002887 706 GLSRIFPVEG---GTHVSTTVVGTPGYLDPEYYISNR----LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSS 778 (870)
Q Consensus 706 Gla~~~~~~~---~~~~~~~~~gt~~y~APE~~~~~~----~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~ 778 (870)
|.+..+.... .........||+.|+|||...++. .+.+.||||+||+||.|+.|+.||.+........+
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K---- 330 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK---- 330 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH----
Confidence 9998663221 111223468999999999998743 45789999999999999999999986554433322
Q ss_pred HhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 779 MLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 779 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
++...|.-....+..+.+.+|+.++|++||++|.+..+|....--..
T Consensus 331 ---------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 331 ---------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred ---------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 33333333334456778899999999999999999999977655433
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=315.05 Aligned_cols=252 Identities=26% Similarity=0.406 Sum_probs=200.9
Q ss_pred ccccccccCcEEEEEEEEC-----CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCe------E
Q 002887 565 FERVLGKGGFGTVYHGYLD-----DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGAN------M 631 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~-----~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~------~ 631 (870)
+.+.||+|+||.||+|... +..||+|+++... ......+.+|++.++.++|+||+++++++..... .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 4578999999999999874 2679999987543 2334678999999999999999999999866554 7
Q ss_pred EEEEEEccCCchhhhhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccC
Q 002887 632 GLIYEFMANGNLQAHLLEDK----ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGL 707 (870)
Q Consensus 632 ~LV~Ey~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGl 707 (870)
++++||+++|+|..++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccc
Confidence 89999999999998885432 24689999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcc
Q 002887 708 SRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIK 786 (870)
Q Consensus 708 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~ 786 (870)
++...............++..|+|||++.+..++.++|||||||++|||++ |..||....... ...... .+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~----~~~~~~-~~~~- 233 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE----IYDYLR-HGNR- 233 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHH-cCCC-
Confidence 986543322222222345678999999988889999999999999999999 889986544322 111111 1111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 787 NIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 787 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
..........+.+++.+|++.+|++||++.||++.|+++
T Consensus 234 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 --------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=317.49 Aligned_cols=244 Identities=22% Similarity=0.346 Sum_probs=195.9
Q ss_pred ccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCch
Q 002887 569 LGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL 643 (870)
Q Consensus 569 LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 643 (870)
||+|+||+||++... ++.+|+|++..... ...+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999875 78999999875432 2345678899999999999999999999999999999999999999
Q ss_pred hhhhhhc--ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 644 QAHLLED--KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 644 ~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
..++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++..+... .....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCC--Ccccc
Confidence 8877542 335689999999999999999999998 9999999999999999999999999999765322 12223
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
...|++.|+|||++.+..++.++|||||||++|||++|+.||................. ... .......
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~---------~~~--~~~~~~~ 224 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL---------NDS--VTYPDKF 224 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc---------ccC--CCCcccC
Confidence 45789999999999999999999999999999999999999976543222222111111 100 0122234
Q ss_pred HHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002887 802 VWKAVEIALACIHTISTRRP-----TMNQVVI 828 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 828 (870)
...+.+++.+|++.+|++|| +++++++
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 56788999999999999999 5566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=341.15 Aligned_cols=256 Identities=23% Similarity=0.308 Sum_probs=212.5
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhc-cccceeEEEE-Eec------CCeEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAH-HKNLTILVGY-CDE------GANMGL 633 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~-~~~------~~~~~L 633 (870)
.+++.|.+|||+.||.|... +.++|+|++-..+....+...+|+++|++|+ |+|||.+++. ... ..+.+|
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll 119 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL 119 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence 35689999999999999986 4899999998888888899999999999996 9999999993 211 246789
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
.||||++|.|-+++.......|++.++++|+.++++|+++||.. +++|||||||-+||||+.+++.||||||.+.....
T Consensus 120 LmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~ 198 (738)
T KOG1989|consen 120 LMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL 198 (738)
T ss_pred ehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccC
Confidence 99999999999999876666799999999999999999999985 88999999999999999999999999999874322
Q ss_pred CC-Cccc------cccccCCCCccCcccc---ccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC
Q 002887 714 EG-GTHV------STTVVGTPGYLDPEYY---ISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG 783 (870)
Q Consensus 714 ~~-~~~~------~~~~~gt~~y~APE~~---~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~ 783 (870)
.- .... .-...-|+.|+|||.+ .+..+++|+|||+|||+||-|+....||+....
T Consensus 199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--------------- 263 (738)
T KOG1989|consen 199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--------------- 263 (738)
T ss_pred CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---------------
Confidence 11 1110 0113468999999987 466799999999999999999999999986532
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHh
Q 002887 784 DIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837 (870)
Q Consensus 784 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e 837 (870)
..|++....-.-.......+.+||..||+.+|++||++-||+..+.++...+
T Consensus 264 --laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 264 --LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred --eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 1233333333333567889999999999999999999999999999877654
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=316.54 Aligned_cols=249 Identities=22% Similarity=0.309 Sum_probs=199.6
Q ss_pred ccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCch
Q 002887 569 LGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL 643 (870)
Q Consensus 569 LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 643 (870)
||+|+||.||++... ++.+|+|.+..... ...+.+..|++++++++||||+++.+.+..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 88999999865322 2234556799999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccccc
Q 002887 644 QAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV 723 (870)
Q Consensus 644 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~ 723 (870)
.+++.......+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++...... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeecc
Confidence 9888766656789999999999999999999998 9999999999999999999999999998765321 122345
Q ss_pred cCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHH
Q 002887 724 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVW 803 (870)
Q Consensus 724 ~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 803 (870)
.|+..|+|||++.+..++.++||||+||++|||++|+.||...........+........ ... .......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~~-~~~~~~~ 224 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE---------VKF-EHQNFTE 224 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc---------ccc-ccccCCH
Confidence 689999999999988899999999999999999999999975443222222222221110 000 0012344
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 804 KAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 804 ~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
.+.+++.+|++.+|++||+++|+++.+...
T Consensus 225 ~~~~li~~~L~~~P~~R~~~~~~~~~~~~h 254 (277)
T cd05607 225 ESKDICRLFLAKKPEDRLGSREKNDDPRKH 254 (277)
T ss_pred HHHHHHHHHhccCHhhCCCCccchhhhhcC
Confidence 678999999999999999998877555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=311.25 Aligned_cols=247 Identities=27% Similarity=0.444 Sum_probs=206.3
Q ss_pred hhccccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 563 NNFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
..+.+.||+|++|.||+|...++.||+|.+..... ..+++.+|+.++++++|+|++++++++......++||||+++++
T Consensus 8 ~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (256)
T cd05039 8 LKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS 86 (256)
T ss_pred ccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCc
Confidence 34568899999999999999999999999987644 56788999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.+++.......+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||.++..... ...
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~-----~~~ 158 (256)
T cd05039 87 LVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-----QDS 158 (256)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc-----ccc
Confidence 99998765555799999999999999999999998 9999999999999999999999999999865211 112
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
...+..|+|||++.++.++.++||||||++++||++ |+.||......... .....+. ........
T Consensus 159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-----~~~~~~~---------~~~~~~~~ 224 (256)
T cd05039 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-----PHVEKGY---------RMEAPEGC 224 (256)
T ss_pred CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-----HHHhcCC---------CCCCccCC
Confidence 334568999999998889999999999999999997 99998755432211 1111111 11112234
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
+..+.+++.+|+..+|++||+++|++++|+.
T Consensus 225 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 225 PPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 5678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=318.87 Aligned_cols=258 Identities=23% Similarity=0.350 Sum_probs=196.2
Q ss_pred hccccccccCcEEEEEEEEC---CeeEEEEEeeccch--hhhHHHHHHHHHHHHh---ccccceeEEEEEe-----cCCe
Q 002887 564 NFERVLGKGGFGTVYHGYLD---DKQVAVKMLSSSSV--QGYKQFQAEVELLIRA---HHKNLTILVGYCD-----EGAN 630 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~---~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~-----~~~~ 630 (870)
.+.+.||+|+||.||+|+.. ++.||+|++..... .....+.+|+.+++++ +||||++++++|. ....
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~ 83 (290)
T cd07862 4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 83 (290)
T ss_pred ceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCc
Confidence 34578999999999999863 67899999875432 2234566777777766 6999999999985 3456
Q ss_pred EEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCcc
Q 002887 631 MGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 631 ~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~ 710 (870)
.++||||+. ++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 84 LTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred EEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 899999997 5898888765556789999999999999999999998 999999999999999999999999999976
Q ss_pred ccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc--CCc-c-
Q 002887 711 FPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR--GDI-K- 786 (870)
Q Consensus 711 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~--~~~-~- 786 (870)
.... .......|++.|+|||.+.+..++.++|||||||++|||++|++||........+.+.+...... ... .
T Consensus 160 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 160 YSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred ccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 5322 22334578999999999998899999999999999999999999998766544443333211100 000 0
Q ss_pred -----hhcccccCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 787 -----NIVDHRLQGD---FDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 787 -----~i~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..+.+..... ........+.+++.+|++.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000000000 00122346779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=312.61 Aligned_cols=252 Identities=28% Similarity=0.430 Sum_probs=203.5
Q ss_pred hhccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.+.+.||+|+||.||+|... ...||+|++..... ..+.+.+|++++++++|+||+++++.+.+ ...++||||+++|
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~ 85 (262)
T cd05071 8 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 85 (262)
T ss_pred eeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCC
Confidence 456789999999999999886 45799999875432 34678999999999999999999998754 5678999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++.+.....+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||.++.+..... ....
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~~~ 161 (262)
T cd05071 86 SLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQ 161 (262)
T ss_pred cHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc-cccc
Confidence 999999765556789999999999999999999998 999999999999999999999999999976532221 1122
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
...++..|+|||+..+..++.++||||||+++|||++ |+.||........... ...+. .......
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~-----~~~~~---------~~~~~~~ 227 (262)
T cd05071 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-----VERGY---------RMPCPPE 227 (262)
T ss_pred CCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH-----HhcCC---------CCCCccc
Confidence 3446678999999988899999999999999999999 8888875543222111 11110 0111234
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
.+..+.+++.+|++.+|++||++.++++.|++..
T Consensus 228 ~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 228 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 4567889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=328.73 Aligned_cols=252 Identities=29% Similarity=0.413 Sum_probs=216.9
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
..++||.|-||.||.|+|+ ...||||.++... ...++|..|..+|+.++|||+|+++|.|..+..+|+|+|||.+|+
T Consensus 271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGN 349 (1157)
T KOG4278|consen 271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGN 349 (1157)
T ss_pred eeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCcc
Confidence 4578999999999999998 6789999998764 457899999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.++|++.....++--..+.++.||+.||+||..+ +.|||||..+|+|+.++..+||+|||+++++..+..+. ...
T Consensus 350 LLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA-HAG 425 (1157)
T KOG4278|consen 350 LLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA-HAG 425 (1157)
T ss_pred HHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceec-ccC
Confidence 99999998888888888899999999999999988 99999999999999999999999999999885432211 112
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
..-.+.|.|||-+.-..++.|+|||+|||+|||+.| |..||-+.+- .+ + ..++.+..+.+.++.+
T Consensus 426 AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl----Sq-V---------Y~LLEkgyRM~~PeGC 491 (1157)
T KOG4278|consen 426 AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQ-V---------YGLLEKGYRMDGPEGC 491 (1157)
T ss_pred ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH----HH-H---------HHHHhccccccCCCCC
Confidence 223568999999999999999999999999999998 7778765432 11 2 2334444555667789
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
++++.+|+..||+.+|.+||+++|+-+.++.++.
T Consensus 492 PpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 492 PPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred CHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 9999999999999999999999999999988764
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=310.74 Aligned_cols=246 Identities=26% Similarity=0.392 Sum_probs=204.2
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.||+|++|.||+|... ++.+++|.+... .....+.+.+|++++++++|||++++++++.+....++||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08529 4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAEN 83 (256)
T ss_pred EeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCC
Confidence 4578999999999999985 788999998754 234556789999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
++|.+++.......+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||+++..... ....
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~~~~ 158 (256)
T cd08529 84 GDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNFA 158 (256)
T ss_pred CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCc--cchh
Confidence 9999999876567899999999999999999999998 9999999999999999999999999998865332 1222
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
....|++.|+|||++.+..++.++|+||||++++||++|+.||........... ...+.. ......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~---------~~~~~~ 224 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK-----IIRGVF---------PPVSQM 224 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHcCCC---------CCCccc
Confidence 345688999999999998999999999999999999999999976553222111 111111 111223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
....+.+++.+|++.+|++||++.++++.
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 44678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=317.67 Aligned_cols=264 Identities=26% Similarity=0.370 Sum_probs=202.1
Q ss_pred hccccccccCcEEEEEEEE------CCeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecC--CeEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYL------DDKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEG--ANMGLI 634 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~------~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~LV 634 (870)
.+.+.||+|+||.||++.. .++.||+|.+..... .....|.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 3457899999999988653 267899999876532 3456788999999999999999999998654 357899
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
|||+++|+|.+++.. ..+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 87 ~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 87 MEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred ecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 999999999998854 3589999999999999999999998 9999999999999999999999999999866432
Q ss_pred CCcc-ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCcc-chHHHHHHHHhhcCCcchhcccc
Q 002887 715 GGTH-VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQR-TLIGQWVSSMLARGDIKNIVDHR 792 (870)
Q Consensus 715 ~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~-~~l~~~~~~~~~~~~~~~i~d~~ 792 (870)
.... ......++..|+|||.+.+..++.++||||||++++||++|+.|+...... .....+.........+.+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 2111 112234566799999998888999999999999999999999998654321 01111000000011111222222
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 793 LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 793 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
.....+...+..+.+++.+|++.+|++||++++|+++|+++
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 22222334557899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=317.64 Aligned_cols=251 Identities=28% Similarity=0.440 Sum_probs=202.9
Q ss_pred ccccccccCcEEEEEEEE-------CCeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYL-------DDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~-------~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
+.+.||+|+||.||++.. .+..+++|.+........+.+.+|++++++++|+||+++++++......++++||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (280)
T cd05092 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEY 88 (280)
T ss_pred eccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEec
Confidence 457899999999999964 2567899998876666677899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhccc-------------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEe
Q 002887 638 MANGNLQAHLLEDKA-------------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLAD 704 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~D 704 (870)
+++|+|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~d 165 (280)
T cd05092 89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGD 165 (280)
T ss_pred CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEECC
Confidence 999999999865432 3589999999999999999999998 999999999999999999999999
Q ss_pred ccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcC
Q 002887 705 FGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARG 783 (870)
Q Consensus 705 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~ 783 (870)
||+++...............+++.|+|||++.+..++.++|||||||++|||++ |++||.......... .. ..+
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~----~~-~~~ 240 (280)
T cd05092 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE----CI-TQG 240 (280)
T ss_pred CCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH----HH-HcC
Confidence 999875532221112223345678999999999999999999999999999998 899986544322211 11 111
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 784 DIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 784 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
.. ...+...+..+.+++.+|++.+|++||++.||.+.|++
T Consensus 241 ~~---------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 241 RE---------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred cc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 10 01112334568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=317.97 Aligned_cols=248 Identities=26% Similarity=0.347 Sum_probs=200.9
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
..+.||+|+||.||++... ++.||+|++..... .....+.+|++++++++|+||+++++.+..++..++||||++
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05605 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccC
Confidence 4578999999999999975 78999999875432 223457789999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+|+|.+++.......+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++...... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---~~ 157 (285)
T cd05605 84 GGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG---ET 157 (285)
T ss_pred CCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC---Cc
Confidence 99999888655556799999999999999999999998 9999999999999999999999999998765321 11
Q ss_pred cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||...........+. ..+..+ ......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~-~~~~~~----------~~~~~~ 226 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE-RRVKED----------QEEYSE 226 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH-HHhhhc----------ccccCc
Confidence 234578999999999998889999999999999999999999998654332222211 111111 111223
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002887 800 NTVWKAVEIALACIHTISTRRP-----TMNQVVIE 829 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 829 (870)
.....+.+++.+|++.||++|| ++.++++.
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 3456788999999999999999 77777553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=311.98 Aligned_cols=247 Identities=28% Similarity=0.452 Sum_probs=199.3
Q ss_pred hccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 564 NFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
.+.+.||+|+||.||+|.+. +..+|+|++..... ....+.+|++++++++|+||+++++++......++||||+++++
T Consensus 7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05059 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGC 85 (256)
T ss_pred chhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCC
Confidence 35678999999999999886 55799999865432 33568889999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.+++.... ..+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||+++..... .......
T Consensus 86 L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~-~~~~~~~ 160 (256)
T cd05059 86 LLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD-QYTSSQG 160 (256)
T ss_pred HHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccc-cccccCC
Confidence 999986543 3689999999999999999999998 9999999999999999999999999998765321 1111112
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||........... ...+ .........
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-----~~~~---------~~~~~~~~~ 226 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES-----VSAG---------YRLYRPKLA 226 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH-----HHcC---------CcCCCCCCC
Confidence 234467999999999999999999999999999999 8999976543322111 1111 011112234
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVIEL 830 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 830 (870)
+..+.+++.+|+..+|++|||+.|++++|
T Consensus 227 ~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 56789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=316.01 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=199.1
Q ss_pred ccccccccCcEEEEEEEEC--Ce----eEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DK----QVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~----~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
+.+.||+|+||.||+|.+. ++ .+++|.+..... ....++..|+..+++++||||+++++++.. ...++++||
T Consensus 11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~ 89 (279)
T cd05111 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQL 89 (279)
T ss_pred eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEe
Confidence 3478999999999999973 43 477888754432 334677888889999999999999999864 457889999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++|+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++........
T Consensus 90 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T cd05111 90 SPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165 (279)
T ss_pred CCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence 9999999998653 34689999999999999999999998 9999999999999999999999999999866433322
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
.......++..|+|||++.++.++.++|||||||++|||++ |+.||....... ..+ .+..+... ..
T Consensus 166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~----~~~~~~~~--~~------ 232 (279)
T cd05111 166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPD----LLEKGERL--AQ------ 232 (279)
T ss_pred cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHH----HHHCCCcC--CC------
Confidence 22334567789999999998899999999999999999998 999997654322 111 12222111 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
.......+.+++.+|+..+|++|||+.|++++|+.+.
T Consensus 233 -~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 233 -PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred -CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1112345678999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=326.31 Aligned_cols=247 Identities=26% Similarity=0.397 Sum_probs=214.3
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCe-EEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGAN-MGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-~~LV~Ey~ 638 (870)
...+.+|+|+||.++..+++ ++.+++|.+..... ...+...+|+.++++++|||||.+.+.+.+++. .++||+|+
T Consensus 7 e~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~ 86 (426)
T KOG0589|consen 7 EVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYC 86 (426)
T ss_pred hhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeec
Confidence 34578999999999988775 78899999876543 334467899999999999999999999999888 99999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
+||++.+.+.+.++..++++++..++.|++.|+.|||++ +|+|||||+.||+++.+..+||+|||+|+.+..+. .
T Consensus 87 eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~ 161 (426)
T KOG0589|consen 87 EGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--S 161 (426)
T ss_pred CCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch--h
Confidence 999999999988888899999999999999999999988 99999999999999999999999999999875432 3
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
......||+.||.||.+.+..|..|+||||+||++|||++-+++|...+......+..... ....+
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~--------------~~Plp 227 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL--------------YSPLP 227 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc--------------CCCCC
Confidence 4567899999999999999999999999999999999999999998776555444432222 12334
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
......+..++..|+..+|+.||++.+++.+
T Consensus 228 ~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 228 SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 5566788899999999999999999999986
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=326.87 Aligned_cols=242 Identities=24% Similarity=0.358 Sum_probs=190.8
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
.+.||+|+||.||+|+.. ++.||||++..... ...+.+.+|++++++++|+||+++++++......++||||+++|+
T Consensus 79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 158 (353)
T PLN00034 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS 158 (353)
T ss_pred hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCc
Confidence 468999999999999985 78999999875432 345678999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.... ...+..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+... ......
T Consensus 159 L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~ 227 (353)
T PLN00034 159 LEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--MDPCNS 227 (353)
T ss_pred ccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc--cccccc
Confidence 86532 345677889999999999999998 9999999999999999999999999999865322 112234
Q ss_pred ccCCCCccCcccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 723 VVGTPGYLDPEYYIS-----NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 723 ~~gt~~y~APE~~~~-----~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
..|+..|+|||++.. ...+.++|||||||++|||++|+.||........ ......... + .....
T Consensus 228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~-~---------~~~~~ 296 (353)
T PLN00034 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW-ASLMCAICM-S---------QPPEA 296 (353)
T ss_pred cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHHHhc-c---------CCCCC
Confidence 579999999998753 2345689999999999999999999974332221 111111100 0 00111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
.......+.+++.+||+.+|++||++.|+++.
T Consensus 297 ~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 297 PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22344578899999999999999999999874
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=312.00 Aligned_cols=254 Identities=28% Similarity=0.430 Sum_probs=206.0
Q ss_pred HHHHhhccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 559 LKITNNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 559 ~~~t~~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+...++.++||+|+||.||+|... ++.+|+|.+..... ....+.+|++++++++|+|++++++++. ....+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 3455667789999999999999976 78899999876543 3467899999999999999999999874 4578999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++++|.+++.......+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++...... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~-~~ 157 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN-EY 157 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC-Cc
Confidence 9999999998766666799999999999999999999988 9999999999999999999999999999765322 11
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
.......++..|+|||++....++.++||||||++++||++ |+.||........... . ..+. ...
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~----~-~~~~---------~~~ 223 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN----L-ERGY---------RMP 223 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH----H-HcCC---------CCC
Confidence 12223346678999999998889999999999999999999 9999976543322211 1 1110 011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
........+.+++.+|++.+|++||++++++..|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 112234578999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=316.18 Aligned_cols=253 Identities=28% Similarity=0.441 Sum_probs=204.0
Q ss_pred hhccccccccCcEEEEEEEEC-------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLI 634 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 634 (870)
..+.+.||+|+||.||+|... ++.||+|.+.... ......+.+|+.+++.++|+||+++++++......++|
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 87 (277)
T cd05032 8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVV 87 (277)
T ss_pred eeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEE
Confidence 344578999999999999874 2679999987553 23456788999999999999999999999999999999
Q ss_pred EEEccCCchhhhhhhccc--------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEecc
Q 002887 635 YEFMANGNLQAHLLEDKA--------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFG 706 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFG 706 (870)
|||+++|+|.+++..... ..++|..++.++.|++.||.|||+. +++||||||+||++++++.+||+|||
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~dfg 164 (277)
T cd05032 88 MELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFG 164 (277)
T ss_pred EecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCcc
Confidence 999999999999865322 3478999999999999999999988 99999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCc
Q 002887 707 LSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDI 785 (870)
Q Consensus 707 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~ 785 (870)
+++...............++..|+|||.+.++.++.++|||||||++|||++ |+.||......... ++. ..+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-~~~----~~~~~ 239 (277)
T cd05032 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL-KFV----IDGGH 239 (277)
T ss_pred cchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH-HHH----hcCCC
Confidence 9886543322222334456789999999988889999999999999999998 99998754433221 111 11111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 786 KNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 786 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
. ..+......+.+++.+|++.+|++|||+.|+++.|++
T Consensus 240 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 240 L---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1 1122235678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=318.07 Aligned_cols=260 Identities=28% Similarity=0.412 Sum_probs=205.2
Q ss_pred hhccccccccCcEEEEEEEECC------------------eeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLDD------------------KQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVG 623 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~~------------------~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g 623 (870)
..+.+.||+|+||.||++...+ ..||+|++.... ....+.+.+|++++++++|+|++++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 86 (296)
T cd05051 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLG 86 (296)
T ss_pred CcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 3456899999999999988642 458999987653 334567899999999999999999999
Q ss_pred EEecCCeEEEEEEEccCCchhhhhhhcc---------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEE
Q 002887 624 YCDEGANMGLIYEFMANGNLQAHLLEDK---------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILL 694 (870)
Q Consensus 624 ~~~~~~~~~LV~Ey~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILl 694 (870)
++..+...++++||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nili 163 (296)
T cd05051 87 VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLV 163 (296)
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhceee
Confidence 9999999999999999999999986543 13689999999999999999999998 99999999999999
Q ss_pred cCCCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh--CCCCCCCCCccchH
Q 002887 695 NEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTPQRTLI 772 (870)
Q Consensus 695 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt--G~~p~~~~~~~~~l 772 (870)
++++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........+
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI 243 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHH
Confidence 9999999999999876533322223334556789999999998889999999999999999998 67788655433222
Q ss_pred HHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 773 GQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 773 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
+.............. .......+..+.+++.+|++.+|++|||+.||++.|++
T Consensus 244 -~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 244 -ENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -HHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111111111111 11122334678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=311.03 Aligned_cols=247 Identities=27% Similarity=0.418 Sum_probs=201.7
Q ss_pred hhccccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEe-cCCeEEEEEEEccCC
Q 002887 563 NNFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCD-EGANMGLIYEFMANG 641 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~-~~~~~~LV~Ey~~~g 641 (870)
..+.+.||+|+||.||++...++.+++|.+.... ..+.+.+|+.++++++|+|++++++++. .+...++++||++++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 85 (256)
T ss_pred CeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence 3456899999999999999999999999986543 3457899999999999999999999764 456789999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++.......+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++...... ..
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-----~~ 157 (256)
T cd05082 86 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QD 157 (256)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc-----CC
Confidence 999998766556689999999999999999999998 9999999999999999999999999998754221 12
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
...++..|+|||++.+..++.++|||||||++|||++ |+.||....... ..... ..+. .......
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~----~~~~~-~~~~---------~~~~~~~ 223 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRV-EKGY---------KMDAPDG 223 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH-hcCC---------CCCCCCC
Confidence 2344568999999998889999999999999999998 999987543222 11111 1111 1111223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
....+.+++.+|++.+|++|||+.++++.|+++
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 224 CPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=325.39 Aligned_cols=240 Identities=27% Similarity=0.413 Sum_probs=195.2
Q ss_pred ccccccCcEEEEEEEE-----CCeeEEEEEeeccc----hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 567 RVLGKGGFGTVYHGYL-----DDKQVAVKMLSSSS----VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~-----~~~~vAVK~l~~~~----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
+.||+|+||.||+++. .++.||+|+++... ......+.+|+++++.++||||+++++.+..+...++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 36789999997642 22345678899999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++|+|.+++... ..+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 154 (323)
T cd05584 82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE--G 154 (323)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccC--C
Confidence 9999999988643 4578888899999999999999998 9999999999999999999999999998753221 1
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||.......... ... .+.. ..
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~----~~~-~~~~----------~~ 219 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID----KIL-KGKL----------NL 219 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH----HHH-cCCC----------CC
Confidence 22234579999999999998889999999999999999999999998654332221 111 1110 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRP-----TMNQVVI 828 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 828 (870)
+......+.+++.+|++.+|++|| ++.++++
T Consensus 220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 222345678999999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=312.85 Aligned_cols=248 Identities=26% Similarity=0.423 Sum_probs=200.0
Q ss_pred hccccccccCcEEEEEEEECC-eeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 564 NFERVLGKGGFGTVYHGYLDD-KQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~~-~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
.+.+.||+|+||.||+|.+.+ ..+|+|.+..... ...+|.+|+.++.+++||||+++++++.+....++||||+++|+
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05113 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC 85 (256)
T ss_pred EEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCc
Confidence 456789999999999998874 4699999875432 34678999999999999999999999999889999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++...... ......
T Consensus 86 l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~~~ 160 (256)
T cd05113 86 LLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVG 160 (256)
T ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc-eeecCC
Confidence 999886543 3689999999999999999999998 99999999999999999999999999987653221 111122
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
..++..|+|||++.+..++.++||||||+++|||++ |+.||.......... ... .+.. .......
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~----~~~-~~~~---------~~~~~~~ 226 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE----KVS-QGLR---------LYRPHLA 226 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH----HHh-cCCC---------CCCCCCC
Confidence 345678999999998889999999999999999999 999987554322111 111 1110 0111123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVIELN 831 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 831 (870)
...+.+++.+||+.+|++||++.++++.|+
T Consensus 227 ~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 227 SEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 467889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=310.95 Aligned_cols=250 Identities=28% Similarity=0.436 Sum_probs=201.5
Q ss_pred hhccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
..+.+.||+|++|.||+|... +..+|+|.+..... ..+.+.+|++++++++|+|++++++++.. ...+++|||+++|
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~ 85 (260)
T cd05069 8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKG 85 (260)
T ss_pred eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCC
Confidence 445678999999999999986 45799998765432 34678899999999999999999998854 5688999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++.......+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++....... .....
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~~~~~ 161 (260)
T cd05069 86 SLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-YTARQ 161 (260)
T ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc-ccccC
Confidence 999999765556689999999999999999999998 99999999999999999999999999997653221 11122
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
...++..|+|||+..+..++.++|+||||+++|||++ |+.||........... ...+. .......
T Consensus 162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-----~~~~~---------~~~~~~~ 227 (260)
T cd05069 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ-----VERGY---------RMPCPQG 227 (260)
T ss_pred CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCC---------CCCCCcc
Confidence 2346678999999998899999999999999999999 8999976543322211 11110 0111223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
.+..+.+++.+|++.+|++||++.+|++.|++
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 228 CPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 45678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=309.33 Aligned_cols=248 Identities=31% Similarity=0.466 Sum_probs=205.7
Q ss_pred ccccccCcEEEEEEEEC-----CeeEEEEEeeccchhh-hHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLD-----DKQVAVKMLSSSSVQG-YKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~-----~~~vAVK~l~~~~~~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.||+|+||.||+|... +..+++|.+....... .+.+.+|++.+..++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 46999999999999986 6789999998764433 67889999999999999999999999999999999999999
Q ss_pred Cchhhhhhhcc-------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 641 GNLQAHLLEDK-------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 641 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
++|.+++.... ...+++..+..++.|+++||+|||++ +++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999987642 36799999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccc
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHR 792 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 792 (870)
...........++..|+|||.+....++.++||||+|++++||++ |+.||......... .... .+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~----~~~~-~~~-------- 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL----EYLR-KGY-------- 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH----HHHH-cCC--------
Confidence 332233344567889999999988899999999999999999999 69999866432221 1111 111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002887 793 LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELN 831 (870)
Q Consensus 793 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 831 (870)
...........+.+++.+|++.+|++||++.|+++.|+
T Consensus 225 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 -RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01112233567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.79 Aligned_cols=246 Identities=25% Similarity=0.401 Sum_probs=197.4
Q ss_pred cccccCcEEEEEEEEC----CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 568 VLGKGGFGTVYHGYLD----DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 568 ~LG~G~fG~Vy~~~~~----~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
.||+|+||.||+|.+. ++.+|+|+++... ....+++.+|+.++++++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999752 6789999986543 234567899999999999999999999986 45678999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc-cc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH-VS 720 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~-~~ 720 (870)
+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.......... ..
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999988643 4689999999999999999999998 99999999999999999999999999998653322111 11
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
....++..|+|||.+....++.++|+|||||++|||++ |+.||........ .+ .++.+.. ...+.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~----~i~~~~~---------~~~~~ 221 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV-TQ----MIESGER---------MECPQ 221 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HH----HHHCCCC---------CCCCC
Confidence 22334678999999988889999999999999999998 9999976543221 11 1222211 11222
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
.....+.+++.+|++.+|++||++.+|++.|++.
T Consensus 222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 3456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=329.97 Aligned_cols=237 Identities=25% Similarity=0.403 Sum_probs=201.8
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.|.++||+|+||+|+++..+ ++.+|||++++... .+.+..+.|..++... +||.++.++.+++..++.+.||||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 45689999999999999986 67899999998743 4566778888888887 599999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+.||++..+. +.+.+++..+.-++..|+.||.|||++ +||+||||.+|||||.+|.+||+|||+++... ...
T Consensus 451 ~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m--~~g 522 (694)
T KOG0694|consen 451 VAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM--GQG 522 (694)
T ss_pred cCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC--CCC
Confidence 9999955444 446799999999999999999999999 99999999999999999999999999998642 233
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
..+.+.+||+.|||||++.++.|+..+|.|||||+|||||.|+.||.+.++++....+ +..+ ..+
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI----~~d~-----------~~y 587 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI----VNDE-----------VRY 587 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----hcCC-----------CCC
Confidence 4567899999999999999999999999999999999999999999987765544332 2111 123
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTM 823 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm 823 (870)
+.....+.+.|+.+.+.++|++|--+
T Consensus 588 P~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 588 PRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCcccHHHHHHHHHHhccCcccccCC
Confidence 44455677899999999999999876
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.96 Aligned_cols=258 Identities=22% Similarity=0.305 Sum_probs=194.2
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
.+.+.||+|+||.||+|+.. ++.||+|++..... .....+.+|++++++++||||+++++++..+...++||||+.
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~- 86 (303)
T cd07869 8 EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH- 86 (303)
T ss_pred eEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-
Confidence 34578999999999999985 78899999875532 223457889999999999999999999999999999999996
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..... ....
T Consensus 87 ~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~ 160 (303)
T cd07869 87 TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP--SHTY 160 (303)
T ss_pred cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC--CccC
Confidence 5777777543 34688899999999999999999998 9999999999999999999999999998754221 1222
Q ss_pred ccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCC---cc---h--hccc
Q 002887 721 TTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGD---IK---N--IVDH 791 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~---~~---~--i~d~ 791 (870)
....+++.|+|||++.+ ..++.++||||+||++|||++|+.||..........+.......... .. . ..++
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 34568999999999875 45889999999999999999999999865432111111111110000 00 0 0000
Q ss_pred -ccC--CCCCH-------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 792 -RLQ--GDFDT-------NTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 792 -~l~--~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
... ..... .....+.+++.+|++.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000 00000 11245779999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.65 Aligned_cols=258 Identities=22% Similarity=0.307 Sum_probs=197.2
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
.+.+.||+|+||.||+|... ++.||+|+++.... .....+.+|++++++++||||+++++++......++||||+++
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 87 (288)
T cd07871 8 VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS 87 (288)
T ss_pred eEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc
Confidence 34578999999999999875 78899999875432 2345678999999999999999999999999999999999985
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++..... ....
T Consensus 88 -~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--~~~~ 160 (288)
T cd07871 88 -DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP--TKTY 160 (288)
T ss_pred -CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC--Cccc
Confidence 888877543 34578999999999999999999998 9999999999999999999999999998754222 1122
Q ss_pred ccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc-----------CCcchh
Q 002887 721 TTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR-----------GDIKNI 788 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~-----------~~~~~i 788 (870)
....+++.|+|||++.+ ..++.++||||+||++|||++|++||........+.......-.. ......
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 34568899999999875 568999999999999999999999997655433332222111000 000011
Q ss_pred cccccCCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 789 VDHRLQGDF----DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 789 ~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..+...... .......+.+++.+|++.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 111110000 0112346789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=327.70 Aligned_cols=241 Identities=24% Similarity=0.341 Sum_probs=195.9
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.||+|+||.||++... ++.||+|++.... ......+.+|++++..++||||+++.+++......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999874 7899999997642 223456788999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHh-CCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
+|..++... ..+++..+..++.|++.||+|||+ . +|+||||||+|||+++++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~ 153 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATM 153 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Cccc
Confidence 999887543 468999999999999999999997 5 8999999999999999999999999998753222 1122
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ... .+. ..++..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~----~i~-~~~----------~~~p~~ 218 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LIL-MEE----------IRFPRT 218 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHH----HHh-cCC----------CCCCCC
Confidence 34579999999999999999999999999999999999999997654322211 111 110 011222
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002887 801 TVWKAVEIALACIHTISTRRP-----TMNQVVIE 829 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 829 (870)
....+.+++.+|++.+|++|+ ++.++++.
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 345678999999999999996 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.81 Aligned_cols=254 Identities=31% Similarity=0.467 Sum_probs=201.5
Q ss_pred hccccccccCcEEEEEEEEC--C--eeEEEEEeecc-chhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--D--KQVAVKMLSSS-SVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~--~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.+.||+|+||.||+|... + ..+++|.++.. .....+.+.+|++++.++ +||||+++++++......++++||
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 84 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY 84 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence 35678999999999999875 3 24788888753 334456789999999999 799999999999999999999999
Q ss_pred ccCCchhhhhhhcc--------------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEE
Q 002887 638 MANGNLQAHLLEDK--------------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLA 703 (870)
Q Consensus 638 ~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~ 703 (870)
+++|+|.+++.+.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEEC
Confidence 99999999986532 13588999999999999999999998 99999999999999999999999
Q ss_pred eccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhc
Q 002887 704 DFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLAR 782 (870)
Q Consensus 704 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~ 782 (870)
|||++..... .........+..|+|||++.+..++.++|||||||++|||++ |+.||........... .. .
T Consensus 162 dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~----~~-~ 233 (297)
T cd05089 162 DFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK----LP-Q 233 (297)
T ss_pred CcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----Hh-c
Confidence 9999864211 111111233567999999998889999999999999999998 9999976543322211 11 1
Q ss_pred CCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHh
Q 002887 783 GDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837 (870)
Q Consensus 783 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e 837 (870)
+ ............+.+++.+|++.+|.+||++.+++++|+++....
T Consensus 234 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 234 G---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred C---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1 111112233457889999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=324.40 Aligned_cols=248 Identities=25% Similarity=0.338 Sum_probs=197.0
Q ss_pred hccccccccCcEEEEEEEE-----CCeeEEEEEeeccc----hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEE
Q 002887 564 NFERVLGKGGFGTVYHGYL-----DDKQVAVKMLSSSS----VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGL 633 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~-----~~~~vAVK~l~~~~----~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~L 633 (870)
.+.+.||+|+||.||+++. .++.+|+|++.... ....+.+.+|++++.++ +|+||+++++++......++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 3467899999999999875 36789999987542 22345678899999999 59999999999999999999
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 83 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 83 ILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 99999999999988643 4689999999999999999999998 999999999999999999999999999986532
Q ss_pred CCCccccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccc
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHR 792 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 792 (870)
.. ........||+.|+|||++.+. .++.++|||||||++|||++|+.||................... ++
T Consensus 158 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------~~- 228 (332)
T cd05614 158 EE-KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC-------DP- 228 (332)
T ss_pred cC-CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC-------CC-
Confidence 22 1222345799999999999865 47889999999999999999999997544332222222222111 11
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002887 793 LQGDFDTNTVWKAVEIALACIHTISTRRP-----TMNQVVI 828 (870)
Q Consensus 793 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 828 (870)
.........+.+++.+|++.+|++|| +++++++
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 229 ---PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11223345678999999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=314.36 Aligned_cols=257 Identities=25% Similarity=0.369 Sum_probs=205.2
Q ss_pred HhhccccccccCcEEEEEEEEC------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEec-CCeEEE
Q 002887 562 TNNFERVLGKGGFGTVYHGYLD------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDE-GANMGL 633 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~L 633 (870)
.+.+.+.||+|+||.||+|... +..|++|++.... ....+.+.+|+.++++++|+||+++++++.. ....++
T Consensus 7 ~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 86 (280)
T cd05043 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFV 86 (280)
T ss_pred heEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEE
Confidence 3445689999999999999975 3778999887542 3345678899999999999999999998866 467889
Q ss_pred EEEEccCCchhhhhhhccc------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccC
Q 002887 634 IYEFMANGNLQAHLLEDKA------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGL 707 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGl 707 (870)
++||+++|+|.+++..... ..+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 87 ~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 87 LYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred EEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCCC
Confidence 9999999999999865422 4689999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcc
Q 002887 708 SRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIK 786 (870)
Q Consensus 708 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~ 786 (870)
++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||....... +..+. ..+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~----~~~~-- 236 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYL----KDGY-- 236 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-HHHHH----HcCC--
Confidence 986533322222233456778999999998889999999999999999999 999997653322 22211 1111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 787 NIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 787 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
........+..+.+++.+|+..+|++|||+.|++++|+++..
T Consensus 237 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 237 -------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 001112234578899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.00 Aligned_cols=246 Identities=25% Similarity=0.381 Sum_probs=198.7
Q ss_pred ccccccCcEEEEEEEEC-CeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCchh
Q 002887 567 RVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQ 644 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 644 (870)
++||+|+||.||+|... ++.+|+|++..... .....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46999999999999876 67899999876533 23456889999999999999999999999999999999999999999
Q ss_pred hhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccccc
Q 002887 645 AHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVV 724 (870)
Q Consensus 645 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 724 (870)
+++.... ..+++..++.++.|++.||.|||+. +++||||||+||++++++.+||+|||++...... .........
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG-IYSSSGLKQ 155 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccc-ccccCCCCC
Confidence 9886533 4688999999999999999999988 9999999999999999999999999998754211 111112234
Q ss_pred CCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHH
Q 002887 725 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVW 803 (870)
Q Consensus 725 gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 803 (870)
++..|+|||++.+..++.++||||||+++||+++ |..||.......... ....+. ..........
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~-----~~~~~~---------~~~~~~~~~~ 221 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE-----QVEKGY---------RMSCPQKCPD 221 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-----HHHcCC---------CCCCCCCCCH
Confidence 4678999999998899999999999999999998 999997554322111 111111 1111223456
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002887 804 KAVEIALACIHTISTRRPTMNQVVIELN 831 (870)
Q Consensus 804 ~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 831 (870)
.+.+++.+|++.+|++||++.|++++|.
T Consensus 222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 222 DVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 7899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=328.02 Aligned_cols=242 Identities=24% Similarity=0.328 Sum_probs=197.9
Q ss_pred hhccccccccCcEEEEEEEEC---CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD---DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~---~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
+.+.+.||+|+||.||+|... +..||+|++.... ....+.+.+|+++++.++||||+++++++.+....++|||
T Consensus 32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E 111 (340)
T PTZ00426 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE 111 (340)
T ss_pred cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence 445689999999999999864 3579999987542 2334568899999999999999999999999999999999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 112 y~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-- 184 (340)
T PTZ00426 112 FVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184 (340)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence 99999999998643 4688999999999999999999998 9999999999999999999999999999865321
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........... +..+.. .
T Consensus 185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~-----i~~~~~----------~ 246 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK-----ILEGII----------Y 246 (340)
T ss_pred ---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH-----HhcCCC----------C
Confidence 2345799999999999988899999999999999999999999986543222111 111110 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRP-----TMNQVVIE 829 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 829 (870)
++......+.+++.+|++.+|++|+ +++|+++.
T Consensus 247 ~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1222234578999999999999995 78887653
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=312.51 Aligned_cols=249 Identities=29% Similarity=0.439 Sum_probs=200.0
Q ss_pred ccccccCcEEEEEEEECC--------eeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 567 RVLGKGGFGTVYHGYLDD--------KQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~--------~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
+.||+|+||.||+|+..+ +.+++|.+.... ......+.+|++++++++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998742 578999886543 23456789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC-----cEEEEeccC
Q 002887 638 MANGNLQAHLLEDK-----ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF-----QAKLADFGL 707 (870)
Q Consensus 638 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~-----~vkL~DFGl 707 (870)
+++++|.+++.... ...+++.+++.++.|++.||.|||+. +++|+||||+||+++.+. .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999987532 23488999999999999999999988 999999999999999887 899999999
Q ss_pred CccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcc
Q 002887 708 SRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIK 786 (870)
Q Consensus 708 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~ 786 (870)
++...............++..|+|||++.++.++.++|||||||++|||++ |+.||......... . . ...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~-~---~-~~~~~-- 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL-Q---H-VTAGG-- 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH-H---H-HhcCC--
Confidence 876533222222233456788999999999999999999999999999998 99998754432211 1 1 11110
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 787 NIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 787 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
........+..+.+++.+|++.+|++||++.+|+++|++
T Consensus 231 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 -------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 011122345678899999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=311.79 Aligned_cols=252 Identities=25% Similarity=0.400 Sum_probs=202.2
Q ss_pred hccccccccCcEEEEEEEEC--C---eeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--D---KQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~---~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
...+.||+|+||.||+|+.. + ..+++|.+.... ....+.+.+|++++++++|+|++++++++...+..++||||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (268)
T cd05063 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY 87 (268)
T ss_pred eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence 34578999999999999974 2 368999987552 33456789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++++|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 88 MENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 99999999886533 5689999999999999999999998 9999999999999999999999999998765322111
Q ss_pred cc-cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 718 HV-STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 718 ~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
.. ......+..|+|||++....++.++|||||||++|||++ |+.||........ ..... .+. ..
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~----~~~i~-~~~---------~~ 229 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV----MKAIN-DGF---------RL 229 (268)
T ss_pred ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH----HHHHh-cCC---------CC
Confidence 11 111223457999999998889999999999999999998 9999975443221 22211 110 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
.........+.+++.+|++.+|++||++.+|++.|+++
T Consensus 230 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=324.27 Aligned_cols=241 Identities=27% Similarity=0.380 Sum_probs=195.6
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.||+|+||.||+|+.. ++.||+|++.... ....+.+..|.+++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999986 6789999997642 23345677888888876 899999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|...+... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~ 153 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTT 153 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccC--Cccc
Confidence 9999888643 4688999999999999999999998 9999999999999999999999999998754222 1222
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
....|++.|+|||++.+..++.++|||||||++|||++|+.||........... ... +.. ..+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~----i~~-~~~----------~~p~~ 218 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES----ILH-DDV----------LYPVW 218 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH----HHc-CCC----------CCCCC
Confidence 345789999999999998999999999999999999999999986554332222 111 110 01112
Q ss_pred HHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 002887 801 TVWKAVEIALACIHTISTRRP-------TMNQVVIE 829 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RP-------sm~eVl~~ 829 (870)
....+.+++.+|++.+|++|| ++.++++.
T Consensus 219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 235678999999999999999 77777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=314.64 Aligned_cols=251 Identities=28% Similarity=0.422 Sum_probs=199.4
Q ss_pred ccccccccCcEEEEEEEECC-------eeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLDD-------KQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~~-------~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
+.+.||+|++|.||+|.+.+ ..|++|...... ......|.+|+.++++++|+||+++++++.+....++|||
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 89 (277)
T cd05036 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLE 89 (277)
T ss_pred eeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEe
Confidence 45789999999999998843 578899886543 3344578999999999999999999999999999999999
Q ss_pred EccCCchhhhhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC---cEEEEeccCC
Q 002887 637 FMANGNLQAHLLEDKA-----DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF---QAKLADFGLS 708 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~---~vkL~DFGla 708 (870)
|+++++|.+++.+.+. ..++|..+++++.||+.||+|||+. +++||||||+||+++.++ .+||+|||++
T Consensus 90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~ 166 (277)
T cd05036 90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMA 166 (277)
T ss_pred cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCccc
Confidence 9999999999876432 3689999999999999999999998 999999999999998765 5999999999
Q ss_pred ccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcch
Q 002887 709 RIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKN 787 (870)
Q Consensus 709 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (870)
+................+..|+|||++.+..++.++|||||||++|||++ |+.||......... ......+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~----~~~~~~~~--- 239 (277)
T cd05036 167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM----EFVTGGGR--- 239 (277)
T ss_pred cccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHHHcCCc---
Confidence 86532211111122234568999999999999999999999999999997 99999765433221 11111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 788 IVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 788 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
...+...+..+.+++.+|++.+|++||++.+|++.|++
T Consensus 240 -------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 240 -------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 11122334678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.94 Aligned_cols=248 Identities=29% Similarity=0.457 Sum_probs=197.3
Q ss_pred ccccccCcEEEEEEEEC--C--eeEEEEEeeccc-hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLD--D--KQVAVKMLSSSS-VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~--~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.||+|+||.||+|... + ..+++|.++... ....+.+.+|++++.++ +||||+++++++......+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46999999999999975 3 347888887532 34456788999999999 899999999999999999999999999
Q ss_pred Cchhhhhhhcc--------------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEecc
Q 002887 641 GNLQAHLLEDK--------------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFG 706 (870)
Q Consensus 641 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFG 706 (870)
|+|.+++.... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 13588999999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCc
Q 002887 707 LSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDI 785 (870)
Q Consensus 707 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~ 785 (870)
++..... .........+..|+|||++....++.++|||||||+++||++ |+.||.......... ... .+.
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~----~~~-~~~- 228 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----KLP-QGY- 228 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHH----HHh-CCC-
Confidence 9853211 111112234567999999988889999999999999999997 999997544322211 111 110
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 786 KNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 786 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
...........+.+++.+|+..+|.+||++.|++++|++++
T Consensus 229 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 --------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11111223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=313.94 Aligned_cols=252 Identities=20% Similarity=0.330 Sum_probs=197.7
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCC-----eEEEEEEEc
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGA-----NMGLIYEFM 638 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~LV~Ey~ 638 (870)
.+++|.|+||.||+|+.. ++.||||+.-.... --.+|+++|++++|||||+++-+|.... ...+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 378999999999999986 78999999765432 2267999999999999999999885432 345899999
Q ss_pred cCCchhhhhhhc--ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC-CcEEEEeccCCccccCCC
Q 002887 639 ANGNLQAHLLED--KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK-FQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 639 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~-~~vkL~DFGla~~~~~~~ 715 (870)
+. +|.+.++.. ....++...+.-+..|+.+||.|||+. +|+||||||+|+|+|.+ |.+||||||.|+.+...+
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 97 888888642 235677778888999999999999997 99999999999999987 899999999999875443
Q ss_pred CccccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc-------CCc--
Q 002887 716 GTHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR-------GDI-- 785 (870)
Q Consensus 716 ~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~-------~~~-- 785 (870)
. .....-|..|.|||.+.+. .|+.+.||||.|||+.||+-|++.|.+.+....+..+++-+=.. ...
T Consensus 181 p---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 181 P---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred C---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence 2 2455678899999999875 69999999999999999999999999877666666655422110 000
Q ss_pred chhcccccCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 786 KNIVDHRLQG-----DFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 786 ~~i~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.+.-.+.+.. -.......+.++++.++++.+|++|.++.|+++
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0111122211 123345678899999999999999999999985
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=322.93 Aligned_cols=237 Identities=27% Similarity=0.387 Sum_probs=190.7
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.||+|+||.||+|+.. ++.||+|+++... ....+.+..|..++..+ +||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999986 6789999997642 22334556677777654 899999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~ 153 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA 153 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence 9999888643 4688999999999999999999998 99999999999999999999999999997542221 223
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........... ... .. ...+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~----i~~-~~----------~~~~~~ 218 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS----ILN-DR----------PHFPRW 218 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH----HHc-CC----------CCCCCC
Confidence 456799999999999998999999999999999999999999986543322211 111 10 111222
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHH
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQ 825 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~e 825 (870)
....+.+++.+|++.+|++||++.+
T Consensus 219 ~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 219 ISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChH
Confidence 3446778999999999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=323.57 Aligned_cols=259 Identities=23% Similarity=0.367 Sum_probs=194.3
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecC-----CeEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEG-----ANMGLI 634 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~LV 634 (870)
.+.+.||+|+||.||+|+.. ++.||||++... ......++.+|++++++++||||+++++++... ...++|
T Consensus 3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv 82 (338)
T cd07859 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 82 (338)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEE
Confidence 35678999999999999975 789999998753 223345688999999999999999999988543 347999
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
|||+. ++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 83 ~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 83 FELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 99996 6888887533 4689999999999999999999998 9999999999999999999999999999754322
Q ss_pred CCc-cccccccCCCCccCcccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHh-----------
Q 002887 715 GGT-HVSTTVVGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSML----------- 780 (870)
Q Consensus 715 ~~~-~~~~~~~gt~~y~APE~~~~--~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~----------- 780 (870)
... .......|++.|+|||++.+ ..++.++|||||||++|||++|++||........+.. +....
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~i 235 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL-ITDLLGTPSPETISRV 235 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH-HHHHhCCCCHHHHHHh
Confidence 211 12234579999999999875 6789999999999999999999999976543221111 11100
Q ss_pred hcCCcchhcc---cccCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 781 ARGDIKNIVD---HRLQGDFD---TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 781 ~~~~~~~i~d---~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
......+.+. +....... ......+.+++.+|++.+|++||+++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000100 00000000 1123467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=307.62 Aligned_cols=248 Identities=25% Similarity=0.361 Sum_probs=203.1
Q ss_pred ccccccCcEEEEEEEEC---C--eeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLD---D--KQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~---~--~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.||+|++|.||+|.+. + ..||+|.+..... ...+.+.+|++++++++|+||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 46899999999999874 2 3689999987765 566789999999999999999999999988 889999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc-c
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH-V 719 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~-~ 719 (870)
|+|.+++.......+++.....++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.+....... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999998765435789999999999999999999998 99999999999999999999999999998764322211 1
Q ss_pred cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
.....++..|+|||++.+..++.++|||||||+++||++ |+.||...........+ ...+.. ....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~---------~~~~ 223 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI----DKEGER---------LERP 223 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HhcCCc---------CCCC
Confidence 223457789999999999899999999999999999999 99999765443322221 111110 0111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIELN 831 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 831 (870)
...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 233467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=323.12 Aligned_cols=240 Identities=22% Similarity=0.336 Sum_probs=192.5
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.||+|+||.||+++.. ++.+|+|++.... ....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 7789999998642 23345678888888877 899999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTT 153 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCcc
Confidence 9998887543 4689999999999999999999998 9999999999999999999999999998753221 1222
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCc----cchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQ----RTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~----~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+.. .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------C
Confidence 346799999999999999999999999999999999999999963221 11122222222222211 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTM 823 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm 823 (870)
.+......+.+++.+|++.+|++||+.
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 222344567899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=323.61 Aligned_cols=235 Identities=29% Similarity=0.391 Sum_probs=192.0
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.||+|+||.||+|+.. ++.||+|++.... ....+.+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999985 7889999987542 23345677888888876 699999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTT 153 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCcc
Confidence 9999888643 4688999999999999999999998 9999999999999999999999999998753221 1223
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........... .. .+.. ..+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~----i~-~~~~----------~~~~~ 218 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----IL-NDEV----------VYPTW 218 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH----Hh-cCCC----------CCCCC
Confidence 345799999999999988999999999999999999999999986554332221 11 1110 11112
Q ss_pred HHHHHHHHHHHccccCCCCCCCH
Q 002887 801 TVWKAVEIALACIHTISTRRPTM 823 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm 823 (870)
....+.+++.+|++.+|++||++
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 LSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCHHHHHHHHHHcccCHHHCCCC
Confidence 34567899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=307.63 Aligned_cols=248 Identities=27% Similarity=0.403 Sum_probs=199.3
Q ss_pred ccccccCcEEEEEEEEC--C---eeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLD--D---KQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~---~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.||+|+||.||+|++. + ..+|+|.+..... ...+++.+|+++++++.|+|++++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999864 2 6799999886644 34567899999999999999999999876 4568999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc-
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV- 719 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~- 719 (870)
|+|.+++.... .+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999996543 689999999999999999999998 999999999999999999999999999986633221111
Q ss_pred cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... +.+++ ..+.. ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~-~~~~~----~~~~~---------~~~~ 220 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-VIAML----ESGER---------LPRP 220 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH-HHHHH----HcCCc---------CCCC
Confidence 112224568999999998899999999999999999998 999997654322 22221 11110 0112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
...+..+.+++.+|+..+|++||++.++++.|+++.
T Consensus 221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 233457889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=339.90 Aligned_cols=250 Identities=25% Similarity=0.345 Sum_probs=200.8
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCC--------e
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGA--------N 630 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--------~ 630 (870)
+.+.+.||+|+||.||+|+.. ++.||||++.... ......+++|+..+..++|+|++++.+.+.... .
T Consensus 34 Y~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~ 113 (496)
T PTZ00283 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLM 113 (496)
T ss_pred EEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceE
Confidence 345689999999999999874 8899999987643 334567889999999999999999988764332 3
Q ss_pred EEEEEEEccCCchhhhhhhc--ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCC
Q 002887 631 MGLIYEFMANGNLQAHLLED--KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 708 (870)
Q Consensus 631 ~~LV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla 708 (870)
.++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 114 i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred EEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 67999999999999988653 235689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchh
Q 002887 709 RIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNI 788 (870)
Q Consensus 709 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i 788 (870)
+.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||....... ++..... +..
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~----~~~~~~~-~~~--- 262 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE----VMHKTLA-GRY--- 262 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHhc-CCC---
Confidence 86643222223345679999999999999999999999999999999999999997644322 2222211 111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 789 VDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 789 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
...+......+.+++.+|++.+|++||++.++++.
T Consensus 263 ------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 263 ------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11222345678899999999999999999999763
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=312.88 Aligned_cols=252 Identities=26% Similarity=0.409 Sum_probs=200.1
Q ss_pred hccccccccCcEEEEEEEEC--Ce----eEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DK----QVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~----~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
.+.+.||+|+||.||+|.+. ++ .||+|++.... ....+.+.+|+.++..++|+||+++++++... ..++++|
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~ 88 (279)
T cd05109 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQ 88 (279)
T ss_pred eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEE
Confidence 34578999999999999863 43 48999987543 33456788999999999999999999999764 5779999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
|+++|+|.+++.+. ...+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 89 ~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 89 LMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred cCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 99999999998653 24689999999999999999999998 999999999999999999999999999987643222
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
........++..|+|||...+..++.++|||||||++|||++ |+.||+...... +..++ ..+.. .
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~----~~~~~---------~ 230 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-IPDLL----EKGER---------L 230 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHH----HCCCc---------C
Confidence 211222345678999999998899999999999999999998 899987544322 22221 11111 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
.........+.+++.+|++.+|++||++.++++.|+++.
T Consensus 231 ~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 231 PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111223456889999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=307.73 Aligned_cols=247 Identities=23% Similarity=0.398 Sum_probs=198.0
Q ss_pred cccccCcEEEEEEEEC----CeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 568 VLGKGGFGTVYHGYLD----DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 568 ~LG~G~fG~Vy~~~~~----~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
.||+|+||.||+|.+. +..||+|++..... ...+.+.+|+.++++++|+||+++++++.. ...++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999864 45699999876543 334678999999999999999999999864 57899999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc-cc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV-ST 721 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~-~~ 721 (870)
|.+++... ...+++..+++++.|++.||+|||++ +++||||||+||+++.++.+||+|||++........... ..
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99988643 35789999999999999999999998 999999999999999999999999999976533222111 12
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
...++..|+|||++....++.++|||||||++|||++ |+.||......... ..+..+. ....+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-----~~~~~~~---------~~~~~~~ 222 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-----SFIEQGK---------RLDCPAE 222 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-----HHHHCCC---------CCCCCCC
Confidence 2234578999999988889999999999999999996 99999765433211 1122221 1122234
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
...++.+++.+|+..+|++||++.+|.+.|+..
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=322.98 Aligned_cols=241 Identities=24% Similarity=0.373 Sum_probs=192.4
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHH---HHhccccceeEEEEEecCCeEEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELL---IRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l---~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
+.+.||+|+||.||+|... ++.||||+++... ....+.+.+|++++ ++++||||+++++++..+...++|||
T Consensus 3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E 82 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME 82 (324)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence 4578999999999999875 7889999997542 22334566666655 45689999999999999999999999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
|+++|+|...+. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 83 ~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-- 154 (324)
T cd05589 83 YAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-- 154 (324)
T ss_pred CCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC--
Confidence 999999988874 34689999999999999999999998 9999999999999999999999999998753221
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
........|++.|+|||.+.+..++.++|||||||++|||++|+.||........... ... +.. .
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~----i~~-~~~----------~ 219 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS----IVN-DEV----------R 219 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH----HHh-CCC----------C
Confidence 1223456799999999999999999999999999999999999999986543332221 111 110 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPT-----MNQVVI 828 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~ 828 (870)
.+......+.+++.+|++.+|++||+ +.++++
T Consensus 220 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11223456789999999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=308.75 Aligned_cols=252 Identities=26% Similarity=0.322 Sum_probs=193.9
Q ss_pred ccccccCcEEEEEEEEC----CeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 567 RVLGKGGFGTVYHGYLD----DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~----~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.||+|+||.||+|... +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999864 35689998876542 33457889999999999999999999999999999999999999
Q ss_pred chhhhhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 642 NLQAHLLEDKA---DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 642 sL~~~l~~~~~---~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
+|.+++...+. ...++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999865332 3567788889999999999999998 99999999999999999999999999987543222212
Q ss_pred ccccccCCCCccCccccccC-------CCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcc
Q 002887 719 VSTTVVGTPGYLDPEYYISN-------RLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVD 790 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~-------~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d 790 (870)
......++..|+|||++... .++.++|+||||+++|||++ |+.||........... .. .+....+.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~ 232 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY----TV-REQQLKLPK 232 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH----Hh-hcccCCCCC
Confidence 22334578889999998642 35789999999999999996 9999976543322111 11 111112222
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002887 791 HRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELN 831 (870)
Q Consensus 791 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 831 (870)
+.+.. .....+.+++.+|+ .+|++|||+.||++.|+
T Consensus 233 ~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 233 PRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22211 22335677889998 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=308.03 Aligned_cols=254 Identities=23% Similarity=0.323 Sum_probs=204.4
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeecc---chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS---SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+|+.. ++.||||.+... .......+.+|+++++.++|||++++++++......++++||+
T Consensus 5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08228 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELA 84 (267)
T ss_pred eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEec
Confidence 34678999999999999974 789999987643 2233456889999999999999999999999999999999999
Q ss_pred cCCchhhhhhhc--ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 639 ANGNLQAHLLED--KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 639 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
++|+|.+++... ....+++..++.++.|+++||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~- 160 (267)
T cd08228 85 DAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred CCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence 999999887542 234588999999999999999999998 99999999999999999999999999988653221
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
.......|++.|+|||.+.+..++.++|+||||+++|||++|+.||...... ...+..... ... ....
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~~~-~~~--------~~~~ 228 (267)
T cd08228 161 -TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQKIE-QCD--------YPPL 228 (267)
T ss_pred -HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc--HHHHHHHHh-cCC--------CCCC
Confidence 1223456888999999999888999999999999999999999998643321 122222111 111 0011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
........+.+++.+|++.+|++||++.+|++.++++
T Consensus 229 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1223456788999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=316.84 Aligned_cols=254 Identities=29% Similarity=0.464 Sum_probs=200.8
Q ss_pred hccccccccCcEEEEEEEEC--Ce--eEEEEEeecc-chhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DK--QVAVKMLSSS-SVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~--~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.+.||+|+||.||+|.+. +. .+++|.+... .....+.+.+|++++.++ +|+||+++++++..+...++|+||
T Consensus 10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 89 (303)
T cd05088 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 89 (303)
T ss_pred eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence 45688999999999999874 43 4677777643 233456788999999999 899999999999999999999999
Q ss_pred ccCCchhhhhhhcc--------------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEE
Q 002887 638 MANGNLQAHLLEDK--------------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLA 703 (870)
Q Consensus 638 ~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~ 703 (870)
+++|+|.+++.+.. ...+++.+++.++.|++.||+|||+. +++||||||+|||+++++.+||+
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeC
Confidence 99999999986542 13588999999999999999999998 99999999999999999999999
Q ss_pred eccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhc
Q 002887 704 DFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLAR 782 (870)
Q Consensus 704 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~ 782 (870)
|||++..... ........++..|+|||++.+..++.++|||||||+++||+| |..||.......... .. ..
T Consensus 167 dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~~-~~ 238 (303)
T cd05088 167 DFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----KL-PQ 238 (303)
T ss_pred ccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH----HH-hc
Confidence 9999863211 111112234668999999988889999999999999999998 999997544322111 11 11
Q ss_pred CCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHh
Q 002887 783 GDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837 (870)
Q Consensus 783 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e 837 (870)
+ ............+.+++.+|++.+|++||++.+++++|+++...+
T Consensus 239 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 239 G---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred C---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1 011111223456789999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=314.19 Aligned_cols=255 Identities=26% Similarity=0.400 Sum_probs=201.6
Q ss_pred hhccccccccCcEEEEEEEEC-------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLI 634 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 634 (870)
+.+.+.||+|+||.||+|... +..||+|.+.... ......+.+|+.++++++|+||+++++++......++|
T Consensus 8 ~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (288)
T cd05061 8 ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVV 87 (288)
T ss_pred ceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 345679999999999999753 3479999886543 23345678899999999999999999999999999999
Q ss_pred EEEccCCchhhhhhhcc--------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEecc
Q 002887 635 YEFMANGNLQAHLLEDK--------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFG 706 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFG 706 (870)
|||+++|+|.+++.... ...+++..+.+++.|++.||.|||+. +|+||||||+||++++++.+||+|||
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~Dfg 164 (288)
T cd05061 88 MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFG 164 (288)
T ss_pred EeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECcCC
Confidence 99999999999996532 13456788899999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCc
Q 002887 707 LSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDI 785 (870)
Q Consensus 707 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~ 785 (870)
+++...............++..|+|||.+.++.++.++|||||||++|||++ |+.||....... +...... +..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~----~~~~~~~-~~~ 239 (288)
T cd05061 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ----VLKFVMD-GGY 239 (288)
T ss_pred ccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHc-CCC
Confidence 9886533222122222345678999999998899999999999999999998 788987644322 1111111 111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 786 KNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 786 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
. .........+.+++.+|++.+|++|||+.++++.|++.+
T Consensus 240 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 240 L---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0 111233467899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.65 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=202.8
Q ss_pred hhccccccccCcEEEEEEEEC--C---eeEEEEEeecc-chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--D---KQVAVKMLSSS-SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~---~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
.++.+.||+|+||.||+|... + ..||||++... .....++|..|+.++++++||||+++++++.++...++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 456789999999999999975 2 35999998764 33445789999999999999999999999999999999999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
|+++|+|.+++... ...+++.+++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 86 FMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred cCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 99999999988654 34689999999999999999999998 999999999999999999999999999876533222
Q ss_pred cccccc-cc--CCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccc
Q 002887 717 THVSTT-VV--GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHR 792 (870)
Q Consensus 717 ~~~~~~-~~--gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 792 (870)
...... .. .+..|+|||++.+..++.++|||||||++|||++ |+.||....... ..+++. .+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-~~~~i~----~~~-------- 228 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-VINAIE----QDY-------- 228 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-HHHHHH----cCC--------
Confidence 111111 11 2457999999998899999999999999999987 999997654322 222211 110
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 793 LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 793 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
......+.+..+.+++.+|++.+|++||++.+|+.+|+++
T Consensus 229 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 -RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0111223455688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=320.00 Aligned_cols=256 Identities=22% Similarity=0.312 Sum_probs=198.4
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
+++.+.||+|+||.||++... ++.+|+|++.... ......+.+|++++++++|+||++++++|.+....++||||++
T Consensus 7 y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (333)
T cd06650 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 86 (333)
T ss_pred hheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCC
Confidence 445678999999999999986 7789999887642 2345678999999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+|+|.+++... ..+++..+..++.+++.||.|||+. .+|+||||||+|||+++++.+||+|||++...... .
T Consensus 87 ~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----~ 158 (333)
T cd06650 87 GGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----M 158 (333)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----c
Confidence 99999998643 4588899999999999999999974 26999999999999999999999999998755221 1
Q ss_pred cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcc-------------
Q 002887 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIK------------- 786 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~------------- 786 (870)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||........ ....... ..+...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL-ELMFGCP-VEGDPAESETSPRPRPPGR 236 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH-HHHhcCc-ccCCccccccCcccCCccc
Confidence 2345689999999999988899999999999999999999999975433211 1111000 000000
Q ss_pred ----------------hhcccccC---CCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 787 ----------------NIVDHRLQ---GDFD-TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 787 ----------------~i~d~~l~---~~~~-~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.+.+.... .... .....++.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 00000000 0000 012356789999999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=309.94 Aligned_cols=248 Identities=25% Similarity=0.417 Sum_probs=211.2
Q ss_pred HHHHhhccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEE
Q 002887 559 LKITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGL 633 (870)
Q Consensus 559 ~~~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 633 (870)
++..+++.+.||+|.||+|-+|+.. |+.||||.+++... ++.-.+.+|+++|..++||||+.++..|.+.+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 3455677789999999999999863 99999999987644 344567899999999999999999999999999999
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
||||..+|.|.+++.+. +.|++.+...+++||..|+.|+|.+ +++|||||.+|||||+++++||+|||++-.+..
T Consensus 131 vMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 131 VMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999999754 5799999999999999999999998 999999999999999999999999999988743
Q ss_pred CCCccccccccCCCCccCccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccc
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYISNRLT-EKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHR 792 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~~~~~-~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 792 (870)
.....+.+|++-|.+||.+.+..|. +..|.||+||+||.|+.|..||++.+....+.++- .|...
T Consensus 206 ---~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs-----~GaYr------ 271 (668)
T KOG0611|consen 206 ---KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQIS-----RGAYR------ 271 (668)
T ss_pred ---ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhh-----ccccc------
Confidence 3455678999999999999988874 78999999999999999999999877655544432 22111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002887 793 LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIEL 830 (870)
Q Consensus 793 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 830 (870)
..+.+....-|+.+|+..+|++|.|+.+|....
T Consensus 272 -----EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 272 -----EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -----CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 122334456789999999999999999997654
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=295.84 Aligned_cols=259 Identities=22% Similarity=0.303 Sum_probs=209.6
Q ss_pred hhccccccccCcEEEEEEEE--CCeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecC-----CeEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEG-----ANMGLIY 635 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~LV~ 635 (870)
+.+.+.||+|||+.||.++. .++.+|+|++...+.++.+..++|++..++++|||++++++++..+ ...++++
T Consensus 23 yri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~ 102 (302)
T KOG2345|consen 23 YRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLL 102 (302)
T ss_pred EEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEe
Confidence 45668999999999999884 4888999999998888888999999999999999999999988443 3489999
Q ss_pred EEccCCchhhhhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 636 EFMANGNLQAHLLEDK--ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
+|...|+|.+.+...+ +..+++.+.+.|+.++++||++||+. .++++||||||.|||+.+++.+++.|||.++..+-
T Consensus 103 Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i 181 (302)
T KOG2345|consen 103 PYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPI 181 (302)
T ss_pred ehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccce
Confidence 9999999999987653 45799999999999999999999997 55799999999999999999999999999986532
Q ss_pred CCCcc-------ccccccCCCCccCccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC
Q 002887 714 EGGTH-------VSTTVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG 783 (870)
Q Consensus 714 ~~~~~-------~~~~~~gt~~y~APE~~~---~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~ 783 (870)
.-... .......|..|.|||.+. +...++++|||||||+||+|+.|..||+...+.. |
T Consensus 182 ~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G------------g 249 (302)
T KOG2345|consen 182 QIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG------------G 249 (302)
T ss_pred EeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC------------C
Confidence 21111 112234688999999985 4468899999999999999999999997533211 1
Q ss_pred Cc-chhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 784 DI-KNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 784 ~~-~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
.+ ..+....+....+....+.+.+++.+|++.||.+||++.+++..+++.+
T Consensus 250 SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 250 SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11 1222223322223336778999999999999999999999999998754
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=321.98 Aligned_cols=245 Identities=21% Similarity=0.324 Sum_probs=196.6
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.||+|+||.||+++.. ++.||+|+++... ....+.++.|..++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999985 7889999998642 23345678899999998 799999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~ 153 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTT 153 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC--CCcc
Confidence 9998887543 5799999999999999999999998 9999999999999999999999999998743211 1223
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCc----cchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQ----RTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~----~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
....||+.|+|||++.+..++.++|+|||||++|||++|+.||+.... ......+.......+.. .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~ 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------C
Confidence 346799999999999999999999999999999999999999964321 11122233222222211 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPT------MNQVVI 828 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPs------m~eVl~ 828 (870)
.+......+.+++.+|++.+|++||+ +.|+++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 12223456889999999999999997 667754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=322.22 Aligned_cols=257 Identities=28% Similarity=0.411 Sum_probs=200.7
Q ss_pred hhccccccccCcEEEEEEEE-------CCeeEEEEEeeccc-hhhhHHHHHHHHHHHHh-ccccceeEEEEEecC-CeEE
Q 002887 563 NNFERVLGKGGFGTVYHGYL-------DDKQVAVKMLSSSS-VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEG-ANMG 632 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~-------~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~-~~~~ 632 (870)
..+.+.||+|+||.||+|.. .++.||||+++... ......+.+|+.++.++ +|+||++++++|... ...+
T Consensus 9 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (343)
T cd05103 9 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (343)
T ss_pred hcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceE
Confidence 45678999999999999974 25789999997643 23345688999999999 789999999988654 4678
Q ss_pred EEEEEccCCchhhhhhhcc-------------------------------------------------------------
Q 002887 633 LIYEFMANGNLQAHLLEDK------------------------------------------------------------- 651 (870)
Q Consensus 633 LV~Ey~~~gsL~~~l~~~~------------------------------------------------------------- 651 (870)
++|||+++|+|.+++....
T Consensus 89 lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (343)
T cd05103 89 VIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQ 168 (343)
T ss_pred EEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhh
Confidence 9999999999999886432
Q ss_pred ----cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccccccCCC
Q 002887 652 ----ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP 727 (870)
Q Consensus 652 ----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~ 727 (870)
...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||++................++.
T Consensus 169 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 169 EDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred hhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 12478889999999999999999998 99999999999999999999999999998653222222222334567
Q ss_pred CccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHH
Q 002887 728 GYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAV 806 (870)
Q Consensus 728 ~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~ 806 (870)
.|+|||.+.+..++.++||||||+++|||++ |..||.......... .....+... ..+......+.
T Consensus 246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~----~~~~~~~~~---------~~~~~~~~~~~ 312 (343)
T cd05103 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC----RRLKEGTRM---------RAPDYTTPEMY 312 (343)
T ss_pred ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHH----HHHhccCCC---------CCCCCCCHHHH
Confidence 8999999999899999999999999999997 999987543222111 112222111 01111234678
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 807 EIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 807 ~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
+++.+|++.+|++||++.||++.|+.+.+
T Consensus 313 ~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 313 QTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=307.96 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=204.5
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|++|.||++... ++.++||.+.... .....++.+|+++++.++|+||+++++++.++...+++|||+
T Consensus 5 ~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08229 5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELA 84 (267)
T ss_pred hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEec
Confidence 34578999999999999964 8899999886532 234467889999999999999999999999999999999999
Q ss_pred cCCchhhhhhhc--ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 639 ANGNLQAHLLED--KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 639 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
++++|.+++... ....+++..++.++.|+++||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd08229 85 DAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred CCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence 999999988642 235689999999999999999999998 99999999999999999999999999987653221
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
.......|+..|+|||++.+..++.++|+||||+++|||++|+.||...... ...+..... .. ..+.+
T Consensus 161 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~-~~-----~~~~~--- 228 (267)
T cd08229 161 -TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIE-QC-----DYPPL--- 228 (267)
T ss_pred -cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch--HHHHhhhhh-cC-----CCCCC---
Confidence 1223456889999999999888999999999999999999999998654321 111111111 10 01111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
........+.+++.+|++.+|++||||.+|++++++.
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1123456788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=313.96 Aligned_cols=261 Identities=26% Similarity=0.432 Sum_probs=200.3
Q ss_pred hccccccccCcEEEEEEEE------CCeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEec--CCeEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYL------DDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDE--GANMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~------~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~LV~ 635 (870)
.+.+.||+|+||.||++.. .++.||+|++........+.+.+|++++++++|+||+++++++.. ....++|+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 86 (284)
T cd05081 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM 86 (284)
T ss_pred eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence 3457899999999999975 267899999987766667789999999999999999999998754 34688999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 87 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 87 EYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 9999999999986432 4689999999999999999999998 99999999999999999999999999998764322
Q ss_pred Cccc-cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCC-------cch
Q 002887 716 GTHV-STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGD-------IKN 787 (870)
Q Consensus 716 ~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~-------~~~ 787 (870)
.... .....++..|+|||++.+..++.++|||||||+++||++|..++...... +....-.... +.+
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-----FMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-----hhhhcccccccccchHHHHH
Confidence 2111 11223445699999999888999999999999999999988765432210 0000000000 001
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 788 IVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 788 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
.+...............+.+++.+|++.+|++|||+.||+++|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1111111111223456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=316.41 Aligned_cols=255 Identities=30% Similarity=0.468 Sum_probs=202.5
Q ss_pred hccccccccCcEEEEEEEEC---------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD---------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMG 632 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~---------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 632 (870)
.+.+.||+|+||.||++... ...+|+|++.... ......+.+|+++++++ +|+||++++++|......+
T Consensus 15 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 94 (314)
T cd05099 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLY 94 (314)
T ss_pred eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceE
Confidence 45689999999999999752 3568999987542 33456788999999999 6999999999999989999
Q ss_pred EEEEEccCCchhhhhhhcc--------------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC
Q 002887 633 LIYEFMANGNLQAHLLEDK--------------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF 698 (870)
Q Consensus 633 LV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~ 698 (870)
++|||+++|+|.+++.... ...+++.+++.++.|++.||.|||+. +++||||||+||++++++
T Consensus 95 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~ 171 (314)
T cd05099 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDN 171 (314)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcCCC
Confidence 9999999999999986532 24589999999999999999999998 999999999999999999
Q ss_pred cEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHH
Q 002887 699 QAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVS 777 (870)
Q Consensus 699 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~ 777 (870)
.+||+|||+++...............++..|+|||++.++.++.++||||||+++|||++ |+.||..........
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---- 247 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK---- 247 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH----
Confidence 999999999986532211111122234567999999998889999999999999999999 888986544322211
Q ss_pred HHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 778 SMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 778 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
....+.. ..........+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 248 -~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 248 -LLREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred -HHHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111111 11122334577899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.33 Aligned_cols=252 Identities=29% Similarity=0.463 Sum_probs=201.9
Q ss_pred hccccccccCcEEEEEEEEC-------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 635 (870)
.+.+.||+|+||.||++... ++.+|+|++.... ....+++.+|++++++++||||+++++++..+...++|+
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 87 (288)
T cd05050 8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLF 87 (288)
T ss_pred eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEE
Confidence 34578999999999999863 5789999987653 234567899999999999999999999999999999999
Q ss_pred EEccCCchhhhhhhccc--------------------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEc
Q 002887 636 EFMANGNLQAHLLEDKA--------------------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLN 695 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~--------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld 695 (870)
||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~~ 164 (288)
T cd05050 88 EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVG 164 (288)
T ss_pred ecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEec
Confidence 99999999999864321 3478899999999999999999998 999999999999999
Q ss_pred CCCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHH
Q 002887 696 EKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQ 774 (870)
Q Consensus 696 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~ 774 (870)
+++.+||+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~---- 240 (288)
T cd05050 165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE---- 240 (288)
T ss_pred CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence 999999999999875533222222223345678999999998899999999999999999998 888886544322
Q ss_pred HHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 775 WVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 775 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
+... ...+... .........+.+++.+|++.+|++|||+.|+++.|++
T Consensus 241 ~~~~-~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 VIYY-VRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHH-HhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111 2222211 1122344678899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.59 Aligned_cols=239 Identities=27% Similarity=0.402 Sum_probs=192.2
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.||+|+||.||+|... ++.||+|+++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999986 6789999997652 22344566788888764 999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|..++... ..+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..... ....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKT 153 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCce
Confidence 9999988643 4688999999999999999999998 9999999999999999999999999998753211 1122
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........... . ..+. +. .+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~----i-~~~~------~~----~~~~ 218 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS----I-RMDN------PC----YPRW 218 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHH----H-HhCC------CC----CCcc
Confidence 345789999999999998999999999999999999999999976543222211 1 1110 11 1112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHH-HHH
Q 002887 801 TVWKAVEIALACIHTISTRRPTMN-QVV 827 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~-eVl 827 (870)
....+.+++.+|++.+|++||++. ++.
T Consensus 219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 219 LTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 334678999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=307.82 Aligned_cols=251 Identities=29% Similarity=0.455 Sum_probs=204.6
Q ss_pred hhccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
..+.+.||+|++|.||+|..+ ++.+|||.+..... ..+++.+|++++++++|+||+++++++......++||||++++
T Consensus 8 ~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 86 (261)
T cd05034 8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKG 86 (261)
T ss_pred eeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCC
Confidence 345688999999999999976 57799999876433 3467899999999999999999999999989999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++.......+++..+..++.+++.||.|||++ +++|+||||+||++++++.+||+|||++..+.... .....
T Consensus 87 ~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~ 162 (261)
T cd05034 87 SLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YTARE 162 (261)
T ss_pred CHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh-hhhhh
Confidence 999999776556799999999999999999999998 99999999999999999999999999987653211 11112
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
...++..|+|||.+.+..++.++|+||||++++||++ |+.||........+..+ .. + .....+..
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~----~~-~---------~~~~~~~~ 228 (261)
T cd05034 163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV----ER-G---------YRMPRPPN 228 (261)
T ss_pred ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----Hc-C---------CCCCCCCC
Confidence 2234568999999998889999999999999999999 99999765433222221 11 1 00111122
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
.+..+.+++.+|++.+|++||+++++.+.|++
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 229 CPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 34578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=311.62 Aligned_cols=246 Identities=26% Similarity=0.346 Sum_probs=198.7
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
.+.||+|+||+||+|... ++.+|+|.+..... .....+.+|++++++++|+|++++.+.+..++..++||||+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 468999999999999985 78999999876432 2234578899999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++...... ...
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~---~~~ 158 (285)
T cd05632 85 GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG---ESI 158 (285)
T ss_pred ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC---Ccc
Confidence 9999888765555799999999999999999999998 9999999999999999999999999998754321 112
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
....|+..|+|||++.+..++.++|+|||||++|||++|+.||...........+..... .+. ......
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~-~~~----------~~~~~~ 227 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVL-ETE----------EVYSAK 227 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhh-ccc----------cccCcc
Confidence 345789999999999988999999999999999999999999986544332222221111 110 011222
Q ss_pred HHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002887 801 TVWKAVEIALACIHTISTRRPT-----MNQVVI 828 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~ 828 (870)
....+.+++..|++.+|++||+ +.++++
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 3456789999999999999999 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=306.93 Aligned_cols=247 Identities=25% Similarity=0.394 Sum_probs=203.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeecc-chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS-SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
.+.+.||+|+||.||++... ++.+|+|.+... .....+.+.+|+.++++++|+|++++++.+..+...+++|||+++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 35678999999999999875 788999998654 234456788999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|.+++.......+++..++.++.|++.||.|||+. +|+|+||||+||++++++.++++|||++...... ....
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~~~ 157 (255)
T cd08219 83 GDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GAYA 157 (255)
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccc--cccc
Confidence 9999988765666789999999999999999999998 9999999999999999999999999998765322 1222
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
....|++.|+|||++.+..++.++|+||||+++++|++|+.||........... ...+... ..+..
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~---------~~~~~ 223 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK-----VCQGSYK---------PLPSH 223 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH-----HhcCCCC---------CCCcc
Confidence 345688999999999988899999999999999999999999976443222111 1112111 11122
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
....+.+++.+|++.+|++||++.+++..
T Consensus 224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 224 YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 34567899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=320.63 Aligned_cols=240 Identities=27% Similarity=0.373 Sum_probs=195.2
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.||+|+||.||++... ++.+|+|+++... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999986 6789999998642 23345677888999888 799999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|..++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTT 153 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCcc
Confidence 9999888643 4689999999999999999999998 9999999999999999999999999998743211 1222
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
....|++.|+|||++.+..++.++|||||||++|||++|+.||......... ..... +. ...+..
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~----~~i~~-~~----------~~~~~~ 218 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF----QSILE-DE----------VRYPRW 218 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH----HHHHc-CC----------CCCCCc
Confidence 3456899999999999999999999999999999999999999765432221 11111 11 011122
Q ss_pred HHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 002887 801 TVWKAVEIALACIHTISTRRPTM-----NQVVI 828 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm-----~eVl~ 828 (870)
....+.+++.+|++.+|++||++ .++++
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 34567899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=307.12 Aligned_cols=251 Identities=27% Similarity=0.427 Sum_probs=203.4
Q ss_pred HhhccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 562 TNNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
...+.+.||+|+||.||++... +..+++|.+.... ...+.+.+|++++++++|+||+++.+.+.+ ...+++|||+++
T Consensus 7 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05073 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAK 84 (260)
T ss_pred ceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCC
Confidence 4456789999999999999875 6679999887543 234678899999999999999999999987 778999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|.+++.......+++.+++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...... .....
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~-~~~~~ 160 (260)
T cd05073 85 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN-EYTAR 160 (260)
T ss_pred CcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC-Ccccc
Confidence 9999999766566789999999999999999999998 9999999999999999999999999998765322 11112
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
....++..|+|||++....++.++|+|||||+++++++ |+.||......... ++ +..+.. .....
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~-~~----~~~~~~---------~~~~~ 226 (260)
T cd05073 161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-RA----LERGYR---------MPRPE 226 (260)
T ss_pred cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH-HH----HhCCCC---------CCCcc
Confidence 22345678999999998889999999999999999999 99999764432221 11 111110 11112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
.....+.+++.+|++.+|++||++.++.++|+.
T Consensus 227 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 227 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 334568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=320.14 Aligned_cols=262 Identities=29% Similarity=0.444 Sum_probs=207.4
Q ss_pred HHHHhhccccccccCcEEEEEEEEC---------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHh-ccccceeEEEEEec
Q 002887 559 LKITNNFERVLGKGGFGTVYHGYLD---------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRA-HHKNLTILVGYCDE 627 (870)
Q Consensus 559 ~~~t~~f~~~LG~G~fG~Vy~~~~~---------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 627 (870)
......+.+.||+|+||.||++... ...||+|.+.... ....+++.+|++++.++ +|+||++++++|..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 3344566789999999999999752 2368999887542 33457889999999999 89999999999999
Q ss_pred CCeEEEEEEEccCCchhhhhhhcc--------------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEE
Q 002887 628 GANMGLIYEFMANGNLQAHLLEDK--------------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANIL 693 (870)
Q Consensus 628 ~~~~~LV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NIL 693 (870)
....++++||+++|+|.+++.+.. ...++|.+++.++.|+++||+|||+. +++||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEE
Confidence 999999999999999999986532 23588999999999999999999998 9999999999999
Q ss_pred EcCCCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchH
Q 002887 694 LNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLI 772 (870)
Q Consensus 694 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l 772 (870)
+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||........
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~- 245 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL- 245 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH-
Confidence 99999999999999976532211111222344568999999999999999999999999999998 8888876543222
Q ss_pred HHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHh
Q 002887 773 GQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837 (870)
Q Consensus 773 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e 837 (870)
..... .+. ...........+.+++.+|++.+|++||++.|+++.|+++....
T Consensus 246 ---~~~~~-~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 246 ---FKLLK-EGH---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred ---HHHHH-cCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11111 111 01112233457889999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=326.70 Aligned_cols=249 Identities=22% Similarity=0.323 Sum_probs=194.3
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
+.+.||+|+||.||+|+.. ++.+|+|++.... ....+.+.+|++++++++|+||+++++++.+....++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~ 84 (381)
T cd05626 5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (381)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 3578999999999999985 7889999997643 2334568899999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc--
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT-- 717 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~-- 717 (870)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 85 gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 85 GGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 99999988643 4688899999999999999999998 9999999999999999999999999997643110000
Q ss_pred -------------------------------------------cccccccCCCCccCccccccCCCCccchHHHHHHHHH
Q 002887 718 -------------------------------------------HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLL 754 (870)
Q Consensus 718 -------------------------------------------~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ 754 (870)
.......||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence 0012347999999999999888999999999999999
Q ss_pred HHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHH--ccccCCCCCCCHHHHHHH
Q 002887 755 ELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALA--CIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 755 elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPsm~eVl~~ 829 (870)
||++|+.||............ ..... .+...........+.+++.+ |+..++..||++.|+++.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i----~~~~~-------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKV----INWEN-------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHH----Hcccc-------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999999765432222111 11000 00011111223456677766 666777779999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.44 Aligned_cols=239 Identities=27% Similarity=0.381 Sum_probs=192.5
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.||+|+||.||+|+.. ++.||+|+++... ....+.+..|..++... +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999986 7889999997642 22345567788888765 899999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|..++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRA 153 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCce
Confidence 9999888643 4688999999999999999999998 999999999999999999999999999874321 11223
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........... .. .+ .+ ..+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~----~~-~~------~~----~~~~~ 218 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES----IR-VD------TP----HYPRW 218 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH----HH-hC------CC----CCCCC
Confidence 456799999999999999999999999999999999999999976543322211 11 11 01 11112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHH-HHH
Q 002887 801 TVWKAVEIALACIHTISTRRPTMN-QVV 827 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~-eVl 827 (870)
...++.+++.+|++.||++||++. ++.
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 345678999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=322.82 Aligned_cols=237 Identities=28% Similarity=0.381 Sum_probs=189.9
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHH-HHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVE-LLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.||+|+||.||+|+.. ++.||+|++..... ...+++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999985 78999999976432 22334455554 55778999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|..++.. ...+++..+..++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++..... ....
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (323)
T cd05575 81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTT 153 (323)
T ss_pred CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCcc
Confidence 999988864 34688999999999999999999998 9999999999999999999999999998753211 1223
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .... +. + .....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~----~i~~-~~--------~--~~~~~ 218 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD----NILN-KP--------L--RLKPN 218 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH----HHHc-CC--------C--CCCCC
Confidence 34579999999999999999999999999999999999999997654322221 1111 10 0 11112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHH
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQ 825 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~e 825 (870)
....+.+++.+|++.+|++||++.+
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 219 ISVSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred CCHHHHHHHHHHhhcCHHhCCCCCC
Confidence 3456789999999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=307.24 Aligned_cols=252 Identities=25% Similarity=0.322 Sum_probs=192.3
Q ss_pred ccccccCcEEEEEEEEC----CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 567 RVLGKGGFGTVYHGYLD----DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~----~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.||+|+||.||+|... ...+++|.+.... ......|.+|++.++.++|+||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 35899999999999753 3568888876543 233457889999999999999999999999999999999999999
Q ss_pred chhhhhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 642 NLQAHLLEDKA---DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 642 sL~~~l~~~~~---~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
+|.+++..... ...++...+.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999876432 3456888899999999999999998 99999999999999999999999999987543222112
Q ss_pred ccccccCCCCccCcccccc-------CCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcc
Q 002887 719 VSTTVVGTPGYLDPEYYIS-------NRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVD 790 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~-------~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d 790 (870)
......++..|+|||++.. ..++.++|||||||++|||++ |+.||........+.. ....+. ..+.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~----~~~~~~-~~~~~ 232 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQ----VVREQD-IKLPK 232 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH----HhhccC-ccCCC
Confidence 2233446778999999753 356889999999999999999 7888875543332222 122111 11222
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002887 791 HRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELN 831 (870)
Q Consensus 791 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 831 (870)
+.+ .......+.+++..|+ .+|++||+++||++.|.
T Consensus 233 ~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 233 PQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred Ccc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222 2233455667888888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=311.58 Aligned_cols=259 Identities=24% Similarity=0.382 Sum_probs=201.3
Q ss_pred hccccccccCcEEEEEEEEC------------------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD------------------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGY 624 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~------------------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~ 624 (870)
.+.+.||+|+||.||++... ...+|+|++.... ......+.+|++++++++|+||++++++
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~ 87 (296)
T cd05095 8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAV 87 (296)
T ss_pred eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 45678999999999998542 3368999987653 3345678999999999999999999999
Q ss_pred EecCCeEEEEEEEccCCchhhhhhhccc---------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEc
Q 002887 625 CDEGANMGLIYEFMANGNLQAHLLEDKA---------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLN 695 (870)
Q Consensus 625 ~~~~~~~~LV~Ey~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld 695 (870)
+......++||||+++|+|.+++..... ..+++.++..++.|++.||+|||+. +++||||||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili~ 164 (296)
T cd05095 88 CITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVG 164 (296)
T ss_pred EecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEEc
Confidence 9999999999999999999998865321 3478899999999999999999998 999999999999999
Q ss_pred CCCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh--CCCCCCCCCccchHH
Q 002887 696 EKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTPQRTLIG 773 (870)
Q Consensus 696 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt--G~~p~~~~~~~~~l~ 773 (870)
+++.++|+|||+++.+.............++..|+|||...++.++.++|||||||++|||++ |..||..........
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 244 (296)
T cd05095 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIE 244 (296)
T ss_pred CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 999999999999976533221122223345678999999888889999999999999999998 778886544333222
Q ss_pred HHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 774 QWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 774 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
.. ........... .......+...+.+++.+|++.+|++||++.||++.|++
T Consensus 245 ~~-~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 245 NT-GEFFRDQGRQV------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH-HHHHhhccccc------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 11111110000 001122344678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=299.59 Aligned_cols=255 Identities=21% Similarity=0.290 Sum_probs=202.0
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccchh--hhHHHHHHHHHHHHhccccceeEEEEEec--CCeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ--GYKQFQAEVELLIRAHHKNLTILVGYCDE--GANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~LV~Ey~~~ 640 (870)
+.|++|+||.||+|+.+ ++.||+|+++..... ---.-.+|+.+|.+++|||||.+...... -+..++|||||+.
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh 161 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH 161 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence 57999999999999986 889999999865422 12235799999999999999999888743 4679999999997
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
+|...+... .+++...+..-+..|+++|++|||.+ -|+|||||++|+|+++.|.+||+|||+|+.+... ....
T Consensus 162 -DLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp--~k~~ 234 (419)
T KOG0663|consen 162 -DLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP--LKPY 234 (419)
T ss_pred -hHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC--cccC
Confidence 777776543 36889999999999999999999999 9999999999999999999999999999987432 3445
Q ss_pred ccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC--Cc---chh--cc--
Q 002887 721 TTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG--DI---KNI--VD-- 790 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~--~~---~~i--~d-- 790 (870)
+..+-|.+|.|||.+.+. .|+...|+||+|||+.||+++++.|.+..+.+.+.+++.-+=... .+ .++ +.
T Consensus 235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~ 314 (419)
T KOG0663|consen 235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM 314 (419)
T ss_pred cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence 667889999999999876 499999999999999999999999998887777766654331110 00 000 00
Q ss_pred -------cccCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 791 -------HRLQGDFDTN-TVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 791 -------~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..+...+... ....-+++....+..||++|-|+.|.++
T Consensus 315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0111111111 2356678999999999999999999875
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=303.16 Aligned_cols=247 Identities=27% Similarity=0.400 Sum_probs=200.0
Q ss_pred ccccccCcEEEEEEEEC-CeeEEEEEeeccchh-hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCchh
Q 002887 567 RVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQ-GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQ 644 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 644 (870)
++||+|++|.||++... ++.|++|++...... ..+.+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999987 889999998765443 5568899999999999999999999999999999999999999999
Q ss_pred hhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccccc
Q 002887 645 AHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVV 724 (870)
Q Consensus 645 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 724 (870)
+++... ...+++..++.++.+++.||+|||++ +++||||||+||++++++.+||+|||++................
T Consensus 81 ~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 998653 34688999999999999999999998 99999999999999999999999999987543211111111223
Q ss_pred CCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHH
Q 002887 725 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVW 803 (870)
Q Consensus 725 gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 803 (870)
++..|+|||.+.++.++.++|+||||++++||++ |..||........... ...+. ....+...+.
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~-----~~~~~---------~~~~~~~~~~ 222 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-----IESGY---------RMPAPQLCPE 222 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH-----HhcCC---------CCCCCccCCH
Confidence 4567999999998899999999999999999999 8888865543221111 11110 1111223455
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002887 804 KAVEIALACIHTISTRRPTMNQVVIELN 831 (870)
Q Consensus 804 ~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 831 (870)
.+.+++.+|++.+|++||++.||++.|+
T Consensus 223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 223 EIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 7889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=307.72 Aligned_cols=252 Identities=26% Similarity=0.420 Sum_probs=202.2
Q ss_pred hccccccccCcEEEEEEEEC-----CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD-----DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-----~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.+.||+|+||.||+|... +..+|+|.++... ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (267)
T cd05066 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEY 86 (267)
T ss_pred EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence 45689999999999999863 3368999987543 23456789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++++|.+++.... ..+++.+++.++.|++.||.|||+. +++||||||+|||++.++.++|+|||++.........
T Consensus 87 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 87 MENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 99999999986543 4689999999999999999999998 9999999999999999999999999999876432211
Q ss_pred cc-cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 718 HV-STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 718 ~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
.. .....++..|+|||++.+..++.++|+||||++++|+++ |+.||......... ... .++. ..
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~-~~~----~~~~---------~~ 228 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI-KAI----EEGY---------RL 228 (267)
T ss_pred eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHH-HHH----hCCC---------cC
Confidence 11 112234568999999998889999999999999999887 99999765432221 111 1110 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
......+..+.+++.+|++.+|++||+|.++++.|+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11223456778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=319.96 Aligned_cols=238 Identities=26% Similarity=0.375 Sum_probs=192.3
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccc-cceeEEEEEecCCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHK-NLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~-nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.+.||+|+||.||+|+.. ++.||+|++.... ....+.+..|.+++..++|+ +|+++.+++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence 35678999999999999986 6789999997642 23456678899999999765 588899999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..... .
T Consensus 83 ~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~--~ 155 (324)
T cd05587 83 VNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--G 155 (324)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC--C
Confidence 9999999888643 4688999999999999999999998 9999999999999999999999999998743211 1
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||............ . ... ..+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i----~-~~~----------~~~ 220 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI----M-EHN----------VSY 220 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH----H-cCC----------CCC
Confidence 1223457999999999999999999999999999999999999999865543322211 1 110 111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTM 823 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm 823 (870)
+......+.+++.+|++.+|++||+.
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 221 PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 22234567899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=326.41 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=201.6
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+|+.. ++.||+|++..... .....+.+|++++..++|+||+++++.+.++...++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (350)
T cd05573 4 EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYM 83 (350)
T ss_pred eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCC
Confidence 34578999999999999986 88999999976432 34467889999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC---
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG--- 715 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~--- 715 (870)
++|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 84 PGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999999998754 5789999999999999999999998 99999999999999999999999999998653322
Q ss_pred ------------------------CccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccch
Q 002887 716 ------------------------GTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTL 771 (870)
Q Consensus 716 ------------------------~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~ 771 (870)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 00122345799999999999999999999999999999999999999986553222
Q ss_pred HHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 002887 772 IGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPT-MNQVVIE 829 (870)
Q Consensus 772 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-m~eVl~~ 829 (870)
..+ ..... ..+...........+.+++.+|+. +|++||+ +.|+++.
T Consensus 239 ~~~----i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 239 YNK----IINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHH----HhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 111 11100 001111111135678899999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=323.69 Aligned_cols=249 Identities=24% Similarity=0.405 Sum_probs=192.1
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
+.+.||+|+||.||++... ++.+|+|++..... .....+.+|+.++.+++|+||+++++.+.+....++||||++
T Consensus 5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence 4578999999999999875 78999999976432 234567889999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc--
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT-- 717 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~-- 717 (870)
+|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 85 gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 85 GGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 99999998643 4689999999999999999999998 9999999999999999999999999998754321100
Q ss_pred -------------------------------cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 002887 718 -------------------------------HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 766 (870)
Q Consensus 718 -------------------------------~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~ 766 (870)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0012357999999999999999999999999999999999999999765
Q ss_pred CccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHH--ccccCCCCCCCHHHHHHH
Q 002887 767 PQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALA--CIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 767 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPsm~eVl~~ 829 (870)
.......+ ..... ..+..+ .. ......+.+++.+ |...++..||++.|+++.
T Consensus 240 ~~~~~~~~----i~~~~--~~~~~p---~~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 240 TPQETYKK----VMNWK--ETLIFP---PE--VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CHHHHHHH----HHcCc--CcccCC---Cc--CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 43332221 11100 001001 00 0122345555555 333344567999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=305.64 Aligned_cols=250 Identities=29% Similarity=0.423 Sum_probs=194.4
Q ss_pred ccccccCcEEEEEEEEC-----CeeEEEEEeecc-chhhhHHHHHHHHHHHHhccccceeEEEEEe-cCCeEEEEEEEcc
Q 002887 567 RVLGKGGFGTVYHGYLD-----DKQVAVKMLSSS-SVQGYKQFQAEVELLIRAHHKNLTILVGYCD-EGANMGLIYEFMA 639 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~-----~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~-~~~~~~LV~Ey~~ 639 (870)
+.||+|+||.||+|.+. ...+|+|++... .....+.+.+|+.+++.++|||++++++++. .+...++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999863 356999998643 3344567889999999999999999999875 4556889999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc-
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH- 718 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~- 718 (870)
+|+|.+++.... ..+++..++.++.|+++||+|||+. +++||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999986533 3467888899999999999999998 99999999999999999999999999987553221111
Q ss_pred -ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhC-CCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 719 -VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITG-QPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 719 -~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG-~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
......++..|+|||++.+..++.++|||||||++|||++| .+||....... ...... .+.. ..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~----~~~~~~-~~~~---------~~ 222 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD----ITVYLL-QGRR---------LL 222 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHh-cCCC---------CC
Confidence 11233457789999999888999999999999999999995 55665433221 111111 1110 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
.....+..+.+++.+|++.+|++||++.||+++|+++.
T Consensus 223 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 223 QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 11123456889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=324.22 Aligned_cols=248 Identities=21% Similarity=0.275 Sum_probs=199.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+++.. ++.+|+|+++.... ...+.+.+|+.+++.++|+||+++++++.+....++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ 83 (330)
T ss_pred eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCC
Confidence 35678999999999999975 78999999986532 24456889999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+.... ..
T Consensus 84 ~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~ 158 (330)
T cd05601 84 PGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MV 158 (330)
T ss_pred CCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC-ce
Confidence 999999988654 24689999999999999999999998 99999999999999999999999999998663322 22
Q ss_pred ccccccCCCCccCccccc------cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccc
Q 002887 719 VSTTVVGTPGYLDPEYYI------SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHR 792 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~------~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 792 (870)
......||+.|+|||++. ...++.++|||||||++|||++|+.||.......... ..........
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~----~i~~~~~~~~----- 229 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN----NIMNFQRFLK----- 229 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH----HHHcCCCccC-----
Confidence 233457899999999986 4567899999999999999999999997654332222 2221111000
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 793 LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 793 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..........+.+++..|++ +|++||++.++++
T Consensus 230 --~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 230 --FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred --CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 01111234567889999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=326.00 Aligned_cols=247 Identities=24% Similarity=0.357 Sum_probs=196.3
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
+.+.||+|+||.||+++.. ++.||||++.... ......+.+|++++..++|+||+++++++.++...++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (364)
T cd05599 5 SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP 84 (364)
T ss_pred EEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCC
Confidence 4578999999999999985 7899999997642 2334567899999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc-
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH- 718 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~- 718 (870)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 85 ~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 85 GGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred CcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 99999998643 4689999999999999999999998 99999999999999999999999999987542211000
Q ss_pred -----------------------------------ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q 002887 719 -----------------------------------VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVI 763 (870)
Q Consensus 719 -----------------------------------~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~ 763 (870)
......||+.|+|||++....++.++|||||||++|||++|+.||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 011246999999999999999999999999999999999999999
Q ss_pred CCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 002887 764 QKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPT---MNQVVI 828 (870)
Q Consensus 764 ~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---m~eVl~ 828 (870)
........... ..... ..+...........+.+++.+|+. +|.+|++ +.|+++
T Consensus 240 ~~~~~~~~~~~----i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 240 CSDNPQETYRK----IINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCHHHHHHH----HHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 86543322211 11100 001101111224467788888986 8999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=305.65 Aligned_cols=257 Identities=23% Similarity=0.342 Sum_probs=201.2
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeec--cchhhhHHHHHHHHHHHHhccccceeEEEEEec-----CCeEEEEEEE
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSS--SSVQGYKQFQAEVELLIRAHHKNLTILVGYCDE-----GANMGLIYEF 637 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~--~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-----~~~~~LV~Ey 637 (870)
+.||+|++|.|.++... ++.||||++.. ......++..+|+++|+.++|+||+.+.+.+.. -.+.|+|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 67999999999999986 89999999973 344566778999999999999999999998854 4578999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
|+ .+|...++. ++.|+...+..++.|+++||.|+|+. +|+||||||+|+|++.+...||+|||+|+........
T Consensus 108 Me-tDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 108 ME-TDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred Hh-hHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 95 478887753 34599999999999999999999999 9999999999999999999999999999987543233
Q ss_pred cccccccCCCCccCccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHH----------HHhhcCCcc
Q 002887 718 HVSTTVVGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVS----------SMLARGDIK 786 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~-~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~----------~~~~~~~~~ 786 (870)
...+..+.|.+|.|||++. ...|+...||||.||++.||++|++.|-+.+.-..+..... ..+......
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 4446778899999999986 46799999999999999999999999988764443332221 111111111
Q ss_pred hhcccccC---CCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 787 NIVDHRLQ---GDF---DTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 787 ~i~d~~l~---~~~---~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
..+..... ..+ -.......+++..+||..||.+|+|++|.++.
T Consensus 262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111100 011 01334578899999999999999999998764
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=323.06 Aligned_cols=243 Identities=29% Similarity=0.364 Sum_probs=192.7
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHH-HHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVE-LLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.||+|+||.||+|+.. ++.+|+|++.... .....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999875 7899999997642 223344555554 46778999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (325)
T cd05604 81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTT 153 (325)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCc
Confidence 999888753 34689999999999999999999998 9999999999999999999999999998753211 1223
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
....|++.|+|||++.+..++.++|||||||++|||++|+.||.......... .... +. + .....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~----~~~~-~~--------~--~~~~~ 218 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD----NILH-KP--------L--VLRPG 218 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH----HHHc-CC--------c--cCCCC
Confidence 45579999999999999999999999999999999999999997654322221 1111 11 0 01112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVIELN 831 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 831 (870)
....+.+++.+|++.+|++||++++.++++.
T Consensus 219 ~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05604 219 ASLTAWSILEELLEKDRQRRLGAKEDFLEIQ 249 (325)
T ss_pred CCHHHHHHHHHHhccCHHhcCCCCCCHHHHh
Confidence 3456778999999999999999875544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=306.73 Aligned_cols=239 Identities=23% Similarity=0.381 Sum_probs=190.5
Q ss_pred ccccccCcEEEEEEEEC--------------CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEE
Q 002887 567 RVLGKGGFGTVYHGYLD--------------DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMG 632 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--------------~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 632 (870)
+.||+|+||.||+|++. ...|++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 46899999999999853 2358899887665555667899999999999999999999999999999
Q ss_pred EEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCc-------EEEEec
Q 002887 633 LIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQ-------AKLADF 705 (870)
Q Consensus 633 LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~-------vkL~DF 705 (870)
+||||+++|+|..++... ...+++..+++++.|+++||+|||+. +|+||||||+|||++.++. +|++||
T Consensus 81 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999998887543 34689999999999999999999998 9999999999999987664 899999
Q ss_pred cCCccccCCCCccccccccCCCCccCccccc-cCCCCccchHHHHHHHHHHHH-hCCCCCCCCCccchHHHHHHHHhhcC
Q 002887 706 GLSRIFPVEGGTHVSTTVVGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELI-TGQPVIQKTPQRTLIGQWVSSMLARG 783 (870)
Q Consensus 706 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~ksDVwS~GvvL~ell-tG~~p~~~~~~~~~l~~~~~~~~~~~ 783 (870)
|++..... .....++..|+|||++. +..++.++|||||||++|||+ +|+.|+......... ... .+
T Consensus 157 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-----~~~-~~ 224 (262)
T cd05077 157 GIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-----RFY-EG 224 (262)
T ss_pred CCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-----HHH-hc
Confidence 99865421 12345788999999987 466899999999999999998 588887653321110 111 11
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002887 784 DIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELN 831 (870)
Q Consensus 784 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 831 (870)
.. . ........+.+++.+|++.+|++||++.++++.|+
T Consensus 225 ~~--------~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 225 QC--------M--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred Cc--------c--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00 0 01112356789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=307.84 Aligned_cols=255 Identities=25% Similarity=0.378 Sum_probs=203.6
Q ss_pred HhhccccccccCcEEEEEEEECC-----eeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEE
Q 002887 562 TNNFERVLGKGGFGTVYHGYLDD-----KQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIY 635 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~~-----~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 635 (870)
...+.+.||+|+||.||+|...+ ..|++|...... ....+.+.+|+.++++++|+||+++++++.. ...++||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~ 85 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVM 85 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEE
Confidence 34466899999999999998642 368999887654 3455689999999999999999999999875 4578999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~- 160 (270)
T cd05056 86 ELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE- 160 (270)
T ss_pred EcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccc-
Confidence 9999999999986533 4689999999999999999999998 9999999999999999999999999998765332
Q ss_pred CccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccC
Q 002887 716 GTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794 (870)
Q Consensus 716 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 794 (870)
.........++..|+|||.+....++.++||||||++++||++ |+.||........... ...+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~-----~~~~~~--------- 226 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR-----IENGER--------- 226 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-----HHcCCc---------
Confidence 1111223344568999999988889999999999999999996 9999976654332211 111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 795 GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 795 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
.......+..+.+++.+|+..+|++|||+.++++.|+++...
T Consensus 227 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 227 LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 011223345788999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=325.49 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=197.2
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+++.. ++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.++...++||||+
T Consensus 46 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05596 46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYM 125 (370)
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCC
Confidence 45578999999999999985 7889999997532 223445788999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|+|.+++.. ..++...+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++...... ...
T Consensus 126 ~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~-~~~ 198 (370)
T cd05596 126 PGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN-GMV 198 (370)
T ss_pred CCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC-Ccc
Confidence 99999998853 3578888899999999999999998 9999999999999999999999999999765322 112
Q ss_pred ccccccCCCCccCccccccC----CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccC
Q 002887 719 VSTTVVGTPGYLDPEYYISN----RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~----~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 794 (870)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||..........+ ...... .+.
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~----i~~~~~-------~~~ 267 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK----IMDHKN-------SLT 267 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHH----HHcCCC-------cCC
Confidence 22346799999999998653 378999999999999999999999986543322221 111100 011
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002887 795 GDFDTNTVWKAVEIALACIHTISTR--RPTMNQVVIE 829 (870)
Q Consensus 795 ~~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~eVl~~ 829 (870)
..........+.+++.+|++.+|++ ||++.|+++.
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0111123467789999999999988 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=322.44 Aligned_cols=237 Identities=26% Similarity=0.341 Sum_probs=193.3
Q ss_pred ccccccCcEEEEEEEE-----CCeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 567 RVLGKGGFGTVYHGYL-----DDKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~-----~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
+.||+|+||.||+++. .++.+|+|++..... .....+..|++++++++||||+++++++......++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 368899999986532 234567889999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++..... ...
T Consensus 82 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~ 154 (318)
T cd05582 82 GGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKK 154 (318)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CCc
Confidence 9999998854 34689999999999999999999998 9999999999999999999999999998764322 122
Q ss_pred cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||........... ... +.. ..+.
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~----i~~-~~~----------~~p~ 219 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM----ILK-AKL----------GMPQ 219 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHH----HHc-CCC----------CCCC
Confidence 2345789999999999988899999999999999999999999976543222211 111 110 1122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHH
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMNQ 825 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~e 825 (870)
.....+.+++.+|++.+|++||++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 23456789999999999999999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=311.51 Aligned_cols=244 Identities=23% Similarity=0.346 Sum_probs=200.1
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
..+.||+|++|.||+|+.. ++.+++|.+........+.+.+|+.+++.++|+|++++++.+..+...++||||+++++
T Consensus 24 ~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~ 103 (296)
T cd06654 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (296)
T ss_pred eEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCC
Confidence 3468999999999999864 78999999987666666788999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... .....
T Consensus 104 L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~ 175 (296)
T cd06654 104 LTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRST 175 (296)
T ss_pred HHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc--cccCc
Confidence 9998843 3578999999999999999999998 99999999999999999999999999987643221 11233
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTV 802 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 802 (870)
..+++.|+|||.+.+..++.++|||||||++|||++|+.||........... ....+. +. ........
T Consensus 176 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~----~~~~~~------~~--~~~~~~~~ 243 (296)
T cd06654 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL----IATNGT------PE--LQNPEKLS 243 (296)
T ss_pred ccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH----HhcCCC------CC--CCCccccC
Confidence 4688999999999988899999999999999999999999975443221111 111110 00 01122344
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 803 WKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 803 ~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..+.+++.+|+..+|++||++.|+++
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 244 AIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 56889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=304.31 Aligned_cols=250 Identities=29% Similarity=0.481 Sum_probs=200.8
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhH--HHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYK--QFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~--~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.+.+.||+|+||.||+++.. ++.+|+|++......... ...+|+.++++++|+||+++++++......++||||++
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 35678999999999999987 668999999887544332 34569999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+++|.+++. ....+++..+..++.|+++||++||+. +|+|+||||+||++++++.++|+|||.+... ......
T Consensus 82 ~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~ 154 (260)
T PF00069_consen 82 GGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNEN 154 (260)
T ss_dssp TEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSE
T ss_pred ccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--cccccc
Confidence 999999996 346789999999999999999999998 9999999999999999999999999998754 122233
Q ss_pred cccccCCCCccCccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 720 STTVVGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~-~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
.....++..|+|||++. +...+.++||||+|+++++|++|+.||........... ....... .. .... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~-~~~~~~~----~~-~~~~--~~~ 226 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI-IEKILKR----PL-PSSS--QQS 226 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH-HHHHHHT----HH-HHHT--TSH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh-hhhcccc----cc-cccc--ccc
Confidence 44567899999999998 78899999999999999999999999987622221111 1111100 00 0000 000
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
......+.+++.+|++.+|++||++.|+++
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111268899999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.80 Aligned_cols=254 Identities=23% Similarity=0.353 Sum_probs=205.8
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeecc---chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS---SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|++|.||+|... ++.+|+|.++.. .....+.+.+|++++++++|+|++++++++......++||||+
T Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (267)
T cd08224 5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELA 84 (267)
T ss_pred eeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecC
Confidence 45688999999999999985 889999988643 2233567899999999999999999999999999999999999
Q ss_pred cCCchhhhhhhc--ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 639 ANGNLQAHLLED--KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 639 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
++|+|..++... ....+++.+++.++.++++||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~- 160 (267)
T cd08224 85 DAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred CCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCC-
Confidence 999999988643 235689999999999999999999998 99999999999999999999999999987653221
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
.......++..|+|||.+.+..++.++|+|||||++|+|++|+.||..... ...+.... ...+.. ..
T Consensus 161 -~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~-~~~~~~---------~~ 227 (267)
T cd08224 161 -TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKK-IEKCDY---------PP 227 (267)
T ss_pred -cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc--cHHHHHhh-hhcCCC---------CC
Confidence 112334688899999999988899999999999999999999999864331 11121111 111111 11
Q ss_pred CC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 797 FD-TNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 797 ~~-~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
.. ......+.+++.+|+..+|++||++.+|+++|+++.
T Consensus 228 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11 134557889999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=318.42 Aligned_cols=238 Identities=26% Similarity=0.363 Sum_probs=192.4
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.+.||+|+||.||+|+.. ++.||+|++..... ...+.+..|..++..+ +|++|+++.+++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence 34578999999999999986 67899999976432 2334567788888777 688999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++|+|...+... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..... .
T Consensus 83 ~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~--~ 155 (323)
T cd05616 83 VNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--G 155 (323)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC--C
Confidence 9999999888543 4688999999999999999999998 9999999999999999999999999998754221 1
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ .. +. ..+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i----~~-~~----------~~~ 220 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI----ME-HN----------VAY 220 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH----Hh-CC----------CCC
Confidence 2233567999999999999999999999999999999999999999865543322221 11 11 111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTM 823 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm 823 (870)
+......+.+++.+|++.+|++|++.
T Consensus 221 p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 221 PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 22334567899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=342.41 Aligned_cols=259 Identities=22% Similarity=0.332 Sum_probs=202.9
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+|+.. ++.||+|++.... ....++|.+|++++++++||||+++++++.+.+..++||||+
T Consensus 5 eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~ 84 (932)
T PRK13184 5 DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYI 84 (932)
T ss_pred EEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcC
Confidence 34578999999999999975 7899999987542 223467899999999999999999999999999999999999
Q ss_pred cCCchhhhhhhc---------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCc
Q 002887 639 ANGNLQAHLLED---------KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 709 (870)
Q Consensus 639 ~~gsL~~~l~~~---------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~ 709 (870)
++|+|.+++... ....+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 85 eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred CCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999988642 123567788899999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCc----------------cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHH
Q 002887 710 IFPVEGGT----------------HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIG 773 (870)
Q Consensus 710 ~~~~~~~~----------------~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~ 773 (870)
........ .......||+.|+|||++.+..++.++|||||||+++||+||+.||..........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~ 241 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY 241 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh
Confidence 65211100 01123469999999999999999999999999999999999999997643221110
Q ss_pred HHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhhhHh
Q 002887 774 QWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRP-TMNQVVIELNDCLAME 837 (870)
Q Consensus 774 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-sm~eVl~~L~~~~~~e 837 (870)
. .. +.++.-. ......+..+.+++.+|++.+|++|| ++.++.+.|+..+..+
T Consensus 242 ~--------~~---i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 242 R--------DV---ILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred h--------hh---ccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 0 00 0011000 00113345678999999999999996 6778888888866543
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=316.33 Aligned_cols=256 Identities=19% Similarity=0.262 Sum_probs=196.6
Q ss_pred cccccccc--CcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 565 FERVLGKG--GFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 565 f~~~LG~G--~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
+.++||+| +|++||++... ++.||+|++.... ....+.+++|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45689999 78999999875 7899999997653 233456788999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.++++||+........+...
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999998765556689999999999999999999998 99999999999999999999999998754332111110
Q ss_pred -----ccccccCCCCccCcccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcc-
Q 002887 719 -----VSTTVVGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVD- 790 (870)
Q Consensus 719 -----~~~~~~gt~~y~APE~~~~--~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d- 790 (870)
......++..|+|||++.+ ..++.++|||||||+++||++|+.||.............. +......+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~-----~~~~~~~~~ 233 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN-----GTVPCLLDT 233 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc-----CCccccccc
Confidence 1122346778999999976 4588999999999999999999999976543222111111 10000000
Q ss_pred ------------------ccc-----------------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 791 ------------------HRL-----------------QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 791 ------------------~~l-----------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
... ...........+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 00011223457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=320.93 Aligned_cols=244 Identities=27% Similarity=0.386 Sum_probs=192.5
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHH-HHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEV-ELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei-~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.||+|+||.||+++.. ++.+|+|++..... .....+..|. .+++.++|+||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999986 67899999976432 2223344444 456778999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|.+++... ..++......++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~ 153 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTT 153 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCc
Confidence 9999988643 4577888889999999999999998 9999999999999999999999999998754221 1223
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
....||+.|+|||++.+..++.++|||||||++|||++|++||.......... ...... + .....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~----~i~~~~---------~--~~~~~ 218 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD----NILNKP---------L--QLKPN 218 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHH----HHHhCC---------c--CCCCC
Confidence 45679999999999999999999999999999999999999997654332221 111110 0 11122
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
....+.+++.+|++.+|++||++.+.+.++.+
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 219 ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 34567899999999999999998865554444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=311.37 Aligned_cols=256 Identities=27% Similarity=0.463 Sum_probs=203.6
Q ss_pred hccccccccCcEEEEEEEEC------CeeEEEEEeeccchh-hhHHHHHHHHHHHHhccccceeEEEEEec--CCeEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD------DKQVAVKMLSSSSVQ-GYKQFQAEVELLIRAHHKNLTILVGYCDE--GANMGLI 634 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~------~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~LV 634 (870)
.+.+.||+|+||.||+|.+. ++.+|||++...... ..+.|.+|++++++++|+||+++++++.. ....+++
T Consensus 7 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 86 (284)
T cd05038 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI 86 (284)
T ss_pred hhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEE
Confidence 34578999999999999864 578999999866443 46789999999999999999999999977 5678999
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
|||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 87 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 87 MEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred EecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 99999999999986543 3589999999999999999999998 9999999999999999999999999999876422
Q ss_pred CCcc-ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccc-----------hHHHHHHHHhhc
Q 002887 715 GGTH-VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRT-----------LIGQWVSSMLAR 782 (870)
Q Consensus 715 ~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~-----------~l~~~~~~~~~~ 782 (870)
.... ......++..|+|||.+.+..++.++||||||++++||++|+.|+....... ....+. ..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-- 239 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL-ELL-- 239 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH-HHH--
Confidence 2211 1122345567999999998899999999999999999999999886533211 011111 111
Q ss_pred CCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 783 GDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 783 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
..............++.+++.+|++.+|++||+|.||+++|+++
T Consensus 240 -------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 -------KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred -------HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111111223446789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=302.32 Aligned_cols=247 Identities=24% Similarity=0.401 Sum_probs=201.2
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEec-CCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDE-GANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~LV~Ey~ 638 (870)
.+.+.||+|++|.||++... ++.+|+|++.... ....+.+.+|++++++++|+|++++++.+.. ....+++|||+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC 82 (257)
T ss_pred eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEeccc
Confidence 45688999999999999875 6789999987543 2345678899999999999999999998764 44678999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++++|.+++.......+++.+++.++.+++.|+++||+. +++||||||+||++++++.++|+|||++....... .
T Consensus 83 ~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~ 157 (257)
T cd08223 83 EGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--D 157 (257)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC--C
Confidence 999999999776566799999999999999999999998 99999999999999999999999999998653221 2
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
......+++.|+|||++.+..++.++||||||++++||++|+.||....... +..... .+.. ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~----~~~~~~-~~~~---------~~~~ 223 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS----LVYRII-EGKL---------PPMP 223 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHH-hcCC---------CCCc
Confidence 2334568899999999999999999999999999999999999997544322 121211 1211 1112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
......+.+++.+|++.+|++||++.++++.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 2344678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=306.71 Aligned_cols=260 Identities=25% Similarity=0.372 Sum_probs=198.6
Q ss_pred ccccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHH--HHhccccceeEEEEEecC----CeEEEEEEEc
Q 002887 565 FERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELL--IRAHHKNLTILVGYCDEG----ANMGLIYEFM 638 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l--~~l~H~nIv~l~g~~~~~----~~~~LV~Ey~ 638 (870)
+.+.||+|.||.||+|.|.|+.||||++...+.. .+.+|.++. ..|+|+||+.+++.-..+ .+++||++|.
T Consensus 215 L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH 291 (513)
T KOG2052|consen 215 LQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH 291 (513)
T ss_pred EEEEecCccccceeeccccCCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence 3578999999999999999999999999877554 345555555 456999999999876443 3689999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHh-----CCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN-----GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-----~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
+.|||.++|.+ ..++-...++++..+|.||+|||. +.+|.|.|||||+.|||+.+++.+.|+|+|||.....
T Consensus 292 e~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~ 368 (513)
T KOG2052|consen 292 EHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 368 (513)
T ss_pred cCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecc
Confidence 99999999954 679999999999999999999995 3589999999999999999999999999999987654
Q ss_pred CCCc--cccccccCCCCccCccccccCC------CCccchHHHHHHHHHHHHhC----------CCCCCCCCcc-chHHH
Q 002887 714 EGGT--HVSTTVVGTPGYLDPEYYISNR------LTEKSDVYSFGVVLLELITG----------QPVIQKTPQR-TLIGQ 774 (870)
Q Consensus 714 ~~~~--~~~~~~~gt~~y~APE~~~~~~------~~~ksDVwS~GvvL~elltG----------~~p~~~~~~~-~~l~~ 774 (870)
+... ...+..+||.+|||||++.... .-..+||||||.|+||+... ++||.+.-.. ....+
T Consensus 369 ~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~ee 448 (513)
T KOG2052|consen 369 DTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEE 448 (513)
T ss_pred cCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHH
Confidence 3222 1234578999999999996542 12469999999999999853 3455433211 11111
Q ss_pred HHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 775 WVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 775 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
++..+-..++.-.++.++ .+.+.+..+.+++..||..+|.-|-|+-.+-+.|.++.
T Consensus 449 -MrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 449 -MRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred -HhcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 111111111111122221 24577888999999999999999999999999998866
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=307.93 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=198.8
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.+.||+|+||.||+|+.. ++.||+|++..........+++|+.++.+++|+||+++++.+..+...++|+||+++
T Consensus 11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~ 90 (267)
T cd06646 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGG 90 (267)
T ss_pred cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCC
Confidence 345578999999999999974 788999999766545556788999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++....... ...
T Consensus 91 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~ 163 (267)
T cd06646 91 GSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AKR 163 (267)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc--ccc
Confidence 9999988643 4688999999999999999999998 99999999999999999999999999998653211 112
Q ss_pred ccccCCCCccCccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 721 TTVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~---~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
....|+..|+|||.+. ...++.++|||||||+++||++|+.||...........+ ... ....+.+. .
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-----~~~---~~~~~~~~--~ 233 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-----SKS---NFQPPKLK--D 233 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-----ecC---CCCCCCCc--c
Confidence 3346888999999884 345788999999999999999999998644322111110 000 00011111 0
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVIEL 830 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 830 (870)
.......+.+++.+|++.+|++||+++++++.|
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 112345788999999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=319.72 Aligned_cols=236 Identities=27% Similarity=0.381 Sum_probs=188.6
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHH-HHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVE-LLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.||+|+||.||+|+.. ++.+|+|++..... .....+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999985 78899999976432 22334555554 57888999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|..++.. ...+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (321)
T cd05603 81 GELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETT 153 (321)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCcc
Confidence 999888754 34678888999999999999999998 9999999999999999999999999998753211 1222
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
....|++.|+|||++.+..++.++|||||||++|||++|+.||........ ...... + .+ ..+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~-~--------~~--~~~~~ 218 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM----YDNILH-K--------PL--QLPGG 218 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH----HHHHhc-C--------CC--CCCCC
Confidence 345789999999999988999999999999999999999999976543221 111111 1 11 11223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHH
Q 002887 801 TVWKAVEIALACIHTISTRRPTMN 824 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~ 824 (870)
....+.+++.+|++.+|++||+..
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCHHHHHHHHHHccCCHhhcCCCC
Confidence 345688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=321.08 Aligned_cols=276 Identities=25% Similarity=0.320 Sum_probs=226.8
Q ss_pred cccccccCcEEEEEEEEC---Ce--eEEEEEeeccchh-hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 566 ERVLGKGGFGTVYHGYLD---DK--QVAVKMLSSSSVQ-GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~---~~--~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.|+||+|.||.|++|.|+ |+ .||||.++..... ....|.+|+.+|.+|+|+|+++|+|...+ ....+|+|.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 478999999999999996 43 5899999877554 66789999999999999999999999987 67889999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
.|+|.+.|++.....|-......++.|||.||.||.++ ++|||||..+|+||-....+||+||||.+-+...+....
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 99999999886666788888899999999999999999 999999999999999999999999999998754443332
Q ss_pred c-ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 720 S-TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 720 ~-~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
. ....-...|+|||.+...+++.++|||+|||++|||+| |+.||-+......+. .+|..-+-..
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~--------------~iD~~erLpR 336 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILK--------------NIDAGERLPR 336 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHH--------------hccccccCCC
Confidence 2 23345678999999999999999999999999999999 778987755433322 2232222345
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHhHhhhcccCCCCCCCccchhhccccc
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAMEIARTKAHETAPDGTPDELMIDLNLH 862 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (870)
++.+.+.|.+++..||..+|++|||+..+.+.+-. .|.......+.-...+|+-|.+++|+.
T Consensus 337 Pk~csedIY~imk~cWah~paDRptFsair~~~~l---~eaqp~~a~~~~d~~ep~aLh~~kgD~ 398 (1039)
T KOG0199|consen 337 PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL---AEAQPAVARETYDSIEPGALHLTKGDE 398 (1039)
T ss_pred CCCChHHHHHHHHHhccCCccccccHHHHHHhHHH---HhcCCceeeeeccccCCCceeeccCCe
Confidence 67889999999999999999999999999866543 334444444556667777787777754
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=303.81 Aligned_cols=245 Identities=27% Similarity=0.443 Sum_probs=200.1
Q ss_pred hhccccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 563 NNFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
..+.+.||+|+||.||++...++.+|+|...... ..+.+.+|+.++++++|+|++++++++... ..+++|||+++++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~ 84 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGN 84 (254)
T ss_pred ceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCC
Confidence 3456899999999999999889999999986542 346789999999999999999999998764 5799999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.+++.......+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...... ...
T Consensus 85 L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~ 156 (254)
T cd05083 85 LVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDN 156 (254)
T ss_pred HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc-----CCC
Confidence 99999766556789999999999999999999988 9999999999999999999999999998754211 122
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
...+..|+|||.+.+..++.++|+||||++++||++ |+.||........ .. ....+. ........
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~----~~-~~~~~~---------~~~~~~~~ 222 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV----KE-CVEKGY---------RMEPPEGC 222 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH----HH-HHhCCC---------CCCCCCcC
Confidence 334568999999988899999999999999999998 9999976543221 11 111111 11112234
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
+..+.+++.+|++.+|++||++.++++.|++
T Consensus 223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 223 PADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 5678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.04 Aligned_cols=247 Identities=24% Similarity=0.394 Sum_probs=198.6
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch-----hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-----QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-----~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
..+.||+|++|.||++... ++.+++|.+..... ...+.+.+|++++++++||||+++++++.+....++|+||
T Consensus 6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 85 (263)
T cd06625 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY 85 (263)
T ss_pred ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEE
Confidence 3578999999999999864 78999999865421 1235688999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++++++++|+|||+++........
T Consensus 86 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 86 MPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred CCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 9999999988643 4688899999999999999999998 9999999999999999999999999998765321111
Q ss_pred c-ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 718 H-VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 718 ~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
. ......++..|+|||++.+..++.++||||||+++|||++|+.||..........+ ..... ....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~---------~~~~ 227 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQP---------TNPQ 227 (263)
T ss_pred cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH----HhccC---------CCCC
Confidence 1 11234678899999999998899999999999999999999999975433222111 11111 1112
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
.+......+.+++.+|+..+|++||++.|+++.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 228 LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 223344568899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.54 Aligned_cols=239 Identities=22% Similarity=0.367 Sum_probs=191.4
Q ss_pred ccccccCcEEEEEEEEC---------CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 567 RVLGKGGFGTVYHGYLD---------DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~---------~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
+.||+|+||.||+|... ...+++|.+........+.+.+|+.+++.++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46999999999999864 234888888766555567889999999999999999999999998999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCc--------EEEEeccCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQ--------AKLADFGLSR 709 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~--------vkL~DFGla~ 709 (870)
+++|+|.+++...+ ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++. ++++|||++.
T Consensus 81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999986543 3689999999999999999999998 9999999999999988765 6999999886
Q ss_pred cccCCCCccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCC-CCCCCCCccchHHHHHHHHhhcCCcch
Q 002887 710 IFPVEGGTHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQ-PVIQKTPQRTLIGQWVSSMLARGDIKN 787 (870)
Q Consensus 710 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~-~p~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (870)
.... .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+........ .. ....
T Consensus 157 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~----~~~~----- 220 (258)
T cd05078 157 TVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQ----FYED----- 220 (258)
T ss_pred ccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HH----HHHc-----
Confidence 5421 123467889999999986 45789999999999999999995 55543322111 11 1110
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002887 788 IVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELN 831 (870)
Q Consensus 788 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 831 (870)
. ...+.....++.+++.+|++.+|++|||+++++++|+
T Consensus 221 ----~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ----R--HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----c--ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 1112223356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=308.73 Aligned_cols=247 Identities=27% Similarity=0.362 Sum_probs=198.9
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
..+.||+|+||.||++... ++.+|+|.+..... .....+.+|+.++++++|++++++++.+...+..++||||++
T Consensus 4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence 3468999999999999986 78999999875432 223457789999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+++|.+++.......+++..++.++.|++.||.|||+. +|+||||||+||++++++.++|+|||++...... ..
T Consensus 84 g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~---~~ 157 (285)
T cd05630 84 GGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QT 157 (285)
T ss_pred CCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC---cc
Confidence 99999988665556799999999999999999999988 9999999999999999999999999998754321 11
Q ss_pred cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||........... ........ ......
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~-~~~~~~~~----------~~~~~~ 226 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE-VERLVKEV----------QEEYSE 226 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH-HHhhhhhh----------hhhcCc
Confidence 2335789999999999998999999999999999999999999986443211111 11111100 001112
Q ss_pred HHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002887 800 NTVWKAVEIALACIHTISTRRPT-----MNQVVI 828 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~ 828 (870)
.....+.+++.+|++.+|++||| +.|+++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 23456789999999999999999 888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=322.39 Aligned_cols=253 Identities=19% Similarity=0.202 Sum_probs=192.1
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.+.||+|+||.||++... ++.||+|.... ..+.+|++++++++||||+++++++......++|+|++.
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~- 166 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK- 166 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-
Confidence 345678999999999999975 78899997532 356889999999999999999999999999999999986
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
++|..++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 167 ~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~~~~~ 240 (391)
T PHA03212 167 TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-NANKY 240 (391)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc-ccccc
Confidence 6788877543 4688999999999999999999998 9999999999999999999999999999753221 11222
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCc-------cchHHHHHHHHhhc---------CC
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQ-------RTLIGQWVSSMLAR---------GD 784 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~-------~~~l~~~~~~~~~~---------~~ 784 (870)
....||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ...+.......-.. ..
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~ 320 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320 (391)
T ss_pred ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence 345799999999999998999999999999999999999987754321 11111111110000 00
Q ss_pred cchhc----cc--ccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 785 IKNIV----DH--RLQGDFD-----TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 785 ~~~i~----d~--~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+.+.. .. ....... ......+.+++.+|++.||++|||++|+++
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 00 0000000 123457889999999999999999999985
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=308.22 Aligned_cols=258 Identities=25% Similarity=0.331 Sum_probs=194.8
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHh---ccccceeEEEEEec-----CCeE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRA---HHKNLTILVGYCDE-----GANM 631 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~-----~~~~ 631 (870)
.+.+.||+|+||.||+|... ++.||+|.++.... .....+.+|+++++++ +||||+++++++.. ....
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~ 82 (288)
T cd07863 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV 82 (288)
T ss_pred eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence 34578999999999999975 78899999875422 2233556777777665 69999999998854 3457
Q ss_pred EEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccc
Q 002887 632 GLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 711 (870)
Q Consensus 632 ~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~ 711 (870)
++||||+.+ +|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 83 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 83 TLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred EEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 899999985 788888665556689999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC--Ccc-h-
Q 002887 712 PVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG--DIK-N- 787 (870)
Q Consensus 712 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~--~~~-~- 787 (870)
... .......|+..|+|||++.+..++.++||||+||++|||++|++||........+.+.....-... ... .
T Consensus 159 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 159 SCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred cCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 322 122345688999999999988999999999999999999999999976554433333322111000 000 0
Q ss_pred -----hcccccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 788 -----IVDHRLQG---DFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 788 -----i~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.+.+.... .........+.+++.+|++.||++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 001123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=303.69 Aligned_cols=237 Identities=26% Similarity=0.396 Sum_probs=190.7
Q ss_pred ccccccCcEEEEEEEECCe------------eEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEE
Q 002887 567 RVLGKGGFGTVYHGYLDDK------------QVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLI 634 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~~------------~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 634 (870)
+.||+|+||.||+|...+. .+++|.+...... ...|.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 4699999999999998632 3788877655433 6788999999999999999999999988 778999
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC-------cEEEEeccC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF-------QAKLADFGL 707 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~-------~vkL~DFGl 707 (870)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999886543 3689999999999999999999998 999999999999999888 799999999
Q ss_pred CccccCCCCccccccccCCCCccCccccccC--CCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCC
Q 002887 708 SRIFPVEGGTHVSTTVVGTPGYLDPEYYISN--RLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGD 784 (870)
Q Consensus 708 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~ 784 (870)
+..... .....++..|+|||++.+. .++.++||||||+++|||++ |..|+......... .+. ....
T Consensus 155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~-~~~---~~~~- 223 (259)
T cd05037 155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-RFY---QDQH- 223 (259)
T ss_pred cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH-HHH---hcCC-
Confidence 876422 2234567789999999876 78999999999999999999 57777654322111 111 1000
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002887 785 IKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELN 831 (870)
Q Consensus 785 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 831 (870)
.+ .......+.+++.+|++.+|++||++.||++.|+
T Consensus 224 -------~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 -------RL----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -------CC----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 1111267889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=308.24 Aligned_cols=237 Identities=25% Similarity=0.401 Sum_probs=188.7
Q ss_pred cccccCcEEEEEEEEC--------------------------CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeE
Q 002887 568 VLGKGGFGTVYHGYLD--------------------------DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTIL 621 (870)
Q Consensus 568 ~LG~G~fG~Vy~~~~~--------------------------~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l 621 (870)
.||+|+||.||+|.+. ...|++|++.........+|.+|+.++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5899999999999752 13588999876655555678899999999999999999
Q ss_pred EEEEecCCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC---
Q 002887 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF--- 698 (870)
Q Consensus 622 ~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~--- 698 (870)
+++|.+....++||||+++|+|..++.+. ...+++..++.++.|+++||+|||+. +|+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999888643 34688999999999999999999998 999999999999998654
Q ss_pred ----cEEEEeccCCccccCCCCccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHH-hCCCCCCCCCccchH
Q 002887 699 ----QAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELI-TGQPVIQKTPQRTLI 772 (870)
Q Consensus 699 ----~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~ell-tG~~p~~~~~~~~~l 772 (870)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||........
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~- 230 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK- 230 (274)
T ss_pred CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence 3799999987643211 22357788999998875 56899999999999999995 79999875433221
Q ss_pred HHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002887 773 GQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIEL 830 (870)
Q Consensus 773 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 830 (870)
..+ .... ..+ .......+.+++.+|++.+|++||++.+|++.|
T Consensus 231 ~~~----~~~~-------~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 ERF----YEKK-------HRL----PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHH----HHhc-------cCC----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 111 1110 001 111123678999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=329.66 Aligned_cols=254 Identities=20% Similarity=0.321 Sum_probs=189.8
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecC--------CeEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEG--------ANMGL 633 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--------~~~~L 633 (870)
.+.+.||+|+||.||+|... ++.||||++.... ....+|+.++++++|+||+++++++... ...++
T Consensus 69 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 69 KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred EEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 45678999999999999974 7889999886432 2345799999999999999999886432 23668
Q ss_pred EEEEccCCchhhhhhh--cccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC-cEEEEeccCCcc
Q 002887 634 IYEFMANGNLQAHLLE--DKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF-QAKLADFGLSRI 710 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~-~vkL~DFGla~~ 710 (870)
||||+++ +|.+++.. .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++.
T Consensus 145 vmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 145 VMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 9999985 66666543 2345789999999999999999999998 999999999999999665 799999999986
Q ss_pred ccCCCCccccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc-------
Q 002887 711 FPVEGGTHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR------- 782 (870)
Q Consensus 711 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~------- 782 (870)
+... .......||+.|+|||++.+. .++.++|||||||++|||++|++||.+......+.+.....-..
T Consensus 221 ~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 297 (440)
T PTZ00036 221 LLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297 (440)
T ss_pred ccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 5322 122345789999999998764 68999999999999999999999998765444333332211000
Q ss_pred --CCcchh-----cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 783 --GDIKNI-----VDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 783 --~~~~~i-----~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
....++ ....+...++.....++.+++.+||+.+|++|||+.|+++
T Consensus 298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000000 0001111111223457889999999999999999999984
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=323.54 Aligned_cols=248 Identities=24% Similarity=0.322 Sum_probs=195.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+++.. ++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.++...++||||+
T Consensus 46 ~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05621 46 DVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYM 125 (370)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCC
Confidence 44578999999999999986 7789999987532 223456789999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++...... ...
T Consensus 126 ~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~-~~~ 198 (370)
T cd05621 126 PGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET-GMV 198 (370)
T ss_pred CCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccC-Cce
Confidence 99999998853 3578899999999999999999998 9999999999999999999999999999865322 122
Q ss_pred ccccccCCCCccCccccccC----CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccC
Q 002887 719 VSTTVVGTPGYLDPEYYISN----RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~----~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 794 (870)
......||+.|+|||++.+. .++.++||||+||++|||++|+.||..........+ ...... .+.
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~----i~~~~~-------~~~ 267 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK----IMDHKN-------SLN 267 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCc-------ccC
Confidence 22456799999999999754 378899999999999999999999976543322222 111110 011
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002887 795 GDFDTNTVWKAVEIALACIHTISTR--RPTMNQVVIE 829 (870)
Q Consensus 795 ~~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~eVl~~ 829 (870)
..........+.+++..|++.++++ ||++.|+++.
T Consensus 268 ~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111123456778888999755543 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=316.78 Aligned_cols=238 Identities=26% Similarity=0.391 Sum_probs=192.3
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhc-cccceeEEEEEecCCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAH-HKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
++.+.||+|+||.||+|... ++.||+|++.... ....+.+..|..++..+. |++|+++.+++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence 45689999999999999875 7889999997642 233456778888988885 56788899999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..... .
T Consensus 83 ~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~--~ 155 (323)
T cd05615 83 VNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD--G 155 (323)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC--C
Confidence 9999999988543 4689999999999999999999998 9999999999999999999999999998754222 1
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .... +. ...
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~----~i~~-~~----------~~~ 220 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQ----SIME-HN----------VSY 220 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHHh-CC----------CCC
Confidence 22334569999999999998889999999999999999999999998654332221 1111 11 011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTM 823 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm 823 (870)
+......+.+++.+|++.+|++|++.
T Consensus 221 p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 221 PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 22234567899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=324.84 Aligned_cols=248 Identities=25% Similarity=0.353 Sum_probs=194.0
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
+.+.||+|+||.||++... ++.||||++.... ....+.+++|++++++++||||+++++++.+....++||||++
T Consensus 5 ~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 84 (377)
T cd05629 5 TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLP 84 (377)
T ss_pred EeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCC
Confidence 4578999999999999875 7899999987543 2334568899999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc--
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT-- 717 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~-- 717 (870)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 85 gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 85 GGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 99999988643 4688899999999999999999998 9999999999999999999999999998643211000
Q ss_pred ----------c---------------------------------ccccccCCCCccCccccccCCCCccchHHHHHHHHH
Q 002887 718 ----------H---------------------------------VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLL 754 (870)
Q Consensus 718 ----------~---------------------------------~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ 754 (870)
. ......||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence 0 001246999999999999989999999999999999
Q ss_pred HHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 002887 755 ELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRR---PTMNQVVIE 829 (870)
Q Consensus 755 elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Psm~eVl~~ 829 (870)
||++|+.||........... ...... .+.-.........+.+++.+|++ +|.+| |++.|+++.
T Consensus 240 elltG~~Pf~~~~~~~~~~~----i~~~~~-------~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRK----IINWRE-------TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHH----HHccCC-------ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999976543222221 111000 00000011233567789999997 66665 699998874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=305.07 Aligned_cols=246 Identities=25% Similarity=0.370 Sum_probs=198.3
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
+.+.||+|+||.||+|... +..+++|.+........+.+.+|+++++.++|+|++++++++..+...++|+||+++++
T Consensus 9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~ 88 (282)
T cd06643 9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA 88 (282)
T ss_pred HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCc
Confidence 3467999999999999986 67889999877666666788999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|..++... ...+++..+..++.|+++||.|||+. +++||||||+||+++.++.+||+|||++...... ......
T Consensus 89 l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~ 162 (282)
T cd06643 89 VDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDS 162 (282)
T ss_pred HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccc--cccccc
Confidence 98877542 34689999999999999999999998 9999999999999999999999999998754221 122234
Q ss_pred ccCCCCccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 723 VVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 723 ~~gt~~y~APE~~~-----~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
..++..|+|||++. +..++.++|||||||++|||++|++||..........+... .. . +.+ ..
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~----~~-~-----~~~--~~ 230 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK----SE-P-----PTL--AQ 230 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh----cC-C-----CCC--CC
Confidence 56889999999984 34577899999999999999999999976443222222111 00 0 000 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+......+.+++.+|++.+|++||++.++++
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1223457889999999999999999998875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=310.79 Aligned_cols=252 Identities=26% Similarity=0.427 Sum_probs=199.1
Q ss_pred cccccccCcEEEEEEEEC--Ce----eEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 566 ERVLGKGGFGTVYHGYLD--DK----QVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~----~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.||+|+||.||+|.+. ++ .+|+|.+..... ....++.+|+.++++++|+||++++++|... ..++++||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~ 90 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM 90 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence 368999999999999873 43 478888875432 3344688999999999999999999999754 567999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.+.......
T Consensus 91 ~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 166 (303)
T cd05110 91 PHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 166 (303)
T ss_pred CCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCccccc
Confidence 999999988653 34688999999999999999999998 99999999999999999999999999998764332222
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
......++..|+|||++.+..++.++||||||+++|||++ |+.||....... ..++ ...+.. + ..
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~----~~~~~~-------~--~~ 232 (303)
T cd05110 167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDL----LEKGER-------L--PQ 232 (303)
T ss_pred ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHH----HHCCCC-------C--CC
Confidence 2223445778999999998899999999999999999998 899987543222 2222 211111 0 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
.......+.+++.+|+..+|++||++++++++|+++...
T Consensus 233 ~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 233 PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 112345678999999999999999999999999986544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=295.14 Aligned_cols=244 Identities=23% Similarity=0.359 Sum_probs=203.0
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.||+|.|+.||+.... |+..|+|++... +..+.+++.+|+.+.+.++||||+++...+.+....++|+|+|+|
T Consensus 15 l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G 94 (355)
T KOG0033|consen 15 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 94 (355)
T ss_pred HHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccc
Confidence 4468999999999998775 888888887644 334678899999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC---CCcEEEEeccCCccccCCCCc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE---KFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~---~~~vkL~DFGla~~~~~~~~~ 717 (870)
++|..-+... ..+++..+-..++||++||.|+|.+ +|||||+||+|+||-. ..-+||+|||+|..+. +.
T Consensus 95 ~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~---~g 166 (355)
T KOG0033|consen 95 GELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN---DG 166 (355)
T ss_pred hHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC---Cc
Confidence 9998766533 4677778888999999999999999 9999999999999943 3458999999999874 34
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
......+|||+|||||++....|+..+|||+.||+||-|+.|++||.+........++....+. ..+..
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd-----------~~~~~ 235 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYD-----------YPSPE 235 (355)
T ss_pred cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccC-----------CCCcc
Confidence 4556789999999999999999999999999999999999999999986665555544322221 11112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVV 827 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl 827 (870)
-....+...+++.+|+..||.+|.|+.|.+
T Consensus 236 w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 236 WDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred cCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 234556788999999999999999998875
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.36 Aligned_cols=245 Identities=27% Similarity=0.432 Sum_probs=194.8
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEEEecC------CeEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEG------ANMGLIY 635 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~------~~~~LV~ 635 (870)
+.+.||+|+||.||+|... ++.+|+|++.... .....+.+|+.++.++ +|+|++++++++... ...+++|
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~ 88 (272)
T cd06637 10 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 88 (272)
T ss_pred HHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEE
Confidence 3468999999999999875 7889999987553 3345788999999998 799999999998653 4588999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
||+++|+|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 89 e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~- 164 (272)
T cd06637 89 EFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT- 164 (272)
T ss_pred EcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceecccc-
Confidence 999999999998765556799999999999999999999998 9999999999999999999999999998765321
Q ss_pred CccccccccCCCCccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcc
Q 002887 716 GTHVSTTVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVD 790 (870)
Q Consensus 716 ~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d 790 (870)
........|+..|+|||++. ...++.++|||||||++|||++|+.||........... ..... .
T Consensus 165 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~-----~~~~~-----~ 233 (272)
T cd06637 165 -VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-----IPRNP-----A 233 (272)
T ss_pred -cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH-----HhcCC-----C
Confidence 12234467899999999986 33578899999999999999999999975432211110 00000 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 791 HRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 791 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..+ ........+.+++.+|+..+|.+|||+.|+++
T Consensus 234 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 234 PRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 111 11123456789999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=315.39 Aligned_cols=240 Identities=23% Similarity=0.327 Sum_probs=192.1
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.||+|+||.||++... ++.+|+|+++.... ...+.+.+|+.++.++ +|+||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 68899999986532 3345678899999888 699999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTT 153 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCce
Confidence 9998887543 4689999999999999999999998 9999999999999999999999999998753211 1223
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCcc--chHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQR--TLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~--~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....++.......... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RIP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CCC
Confidence 3467999999999999999999999999999999999999999643221 1112222222211110 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTM 823 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm 823 (870)
......+.+++.+|++.+|++||++
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 2234567899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=321.62 Aligned_cols=257 Identities=22% Similarity=0.338 Sum_probs=195.8
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecCC-----eEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGA-----NMGLIY 635 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~LV~ 635 (870)
..+.||+|+||.||++... ++.||+|++... .....+++.+|+++++.++|+||+++++++.... ..++|+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 4578999999999999974 889999998653 2234567889999999999999999999998766 789999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
||+. ++|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 84 e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 84 ELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred eccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 9997 467776643 35689999999999999999999998 99999999999999999999999999998653221
Q ss_pred CccccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcch-------
Q 002887 716 GTHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKN------- 787 (870)
Q Consensus 716 ~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~------- 787 (870)
........++..|+|||++.+. .++.++|||||||+++||++|+.||........+..... ........+
T Consensus 158 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 158 -SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD-LLGTPSLEAMRSACEG 235 (372)
T ss_pred -cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHH-HcCCCCHHHHHHhhHH
Confidence 1222344678999999999874 478999999999999999999999986654332222111 100000000
Q ss_pred ----hcccccC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 788 ----IVDHRLQ-------GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 788 ----i~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
+...... ..........+.+++.+|++.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000 00111234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.30 Aligned_cols=243 Identities=28% Similarity=0.382 Sum_probs=194.6
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeecc-chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS-SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.+.||+|+||.||+|+.. ++.+|+|++... .....+++.+|++++++++||||+++++++......++||||++++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 84 (279)
T cd06619 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGG 84 (279)
T ss_pred heeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCC
Confidence 4578999999999999874 788999998754 2334567899999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|..+. .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++...... ...
T Consensus 85 ~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~ 151 (279)
T cd06619 85 SLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAK 151 (279)
T ss_pred ChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----ccc
Confidence 986542 467888899999999999999998 9999999999999999999999999998755221 223
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccch---HHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTL---IGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~---l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
...|+..|+|||++.+..++.++|+||||+++|+|++|+.||........ ...+........ .+.+ ..
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~---~~ 222 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------PPVL---PV 222 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------CCCC---CC
Confidence 45789999999999988999999999999999999999999975432111 111111111000 0111 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
......+.+++.+|++.+|++||+++|+++.
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1234567899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=324.50 Aligned_cols=247 Identities=22% Similarity=0.308 Sum_probs=191.2
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
..+.||+|+||.||+|+.. ++.+|+|++..... ...+.+.+|++++++++|+||+++++.+.++...++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (382)
T cd05625 5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP 84 (382)
T ss_pred EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence 3578999999999999975 78899999976432 234568899999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC---
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG--- 716 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~--- 716 (870)
+|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+.....
T Consensus 85 gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 85 GGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 99999988643 4678889999999999999999998 999999999999999999999999999753311000
Q ss_pred ------------------------------------------ccccccccCCCCccCccccccCCCCccchHHHHHHHHH
Q 002887 717 ------------------------------------------THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLL 754 (870)
Q Consensus 717 ------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ 754 (870)
........||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence 00012346999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 002887 755 ELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPT---MNQVVI 828 (870)
Q Consensus 755 elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---m~eVl~ 828 (870)
||++|++||..........+. .... ..+...........+.+++.+++ .+|++|++ +.|+++
T Consensus 240 elltG~~Pf~~~~~~~~~~~i----~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKV----INWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHH----HccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 999999999865432222111 1100 01111111122345566666654 48999997 777764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=309.93 Aligned_cols=256 Identities=27% Similarity=0.414 Sum_probs=200.3
Q ss_pred hccccccccCcEEEEEEEE------CCeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecC--CeEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYL------DDKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEG--ANMGLI 634 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~------~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~LV 634 (870)
...+.||+|+||.||++.. .++.||+|.++... ......+.+|++++++++|+|++++.+++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (284)
T cd05079 7 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 86 (284)
T ss_pred hhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEE
Confidence 3457899999999999974 26789999987553 33456789999999999999999999999775 568899
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
|||+++++|.+++.+. ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.+...
T Consensus 87 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 87 MEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred EEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 9999999999988643 24689999999999999999999998 9999999999999999999999999999866432
Q ss_pred CCc-cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCc-----------cchHHHHHHHHhhc
Q 002887 715 GGT-HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQ-----------RTLIGQWVSSMLAR 782 (870)
Q Consensus 715 ~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~-----------~~~l~~~~~~~~~~ 782 (870)
... .......++..|+|||++.+..++.++||||||+++|||++++.|...... ......++. ....
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 241 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR-VLEE 241 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-HHHc
Confidence 221 112234567789999999888899999999999999999998776432110 001111111 1111
Q ss_pred CCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 783 GDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 783 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
+. ........+..+.+++.+|++.+|++||++.++++.|+++
T Consensus 242 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 242 GK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred Cc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11 1111223456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.34 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=202.3
Q ss_pred hccccccccCcEEEEEEEEC--C----eeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--D----KQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~----~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
.+.+.||+|+||.||+|... + ..+|+|.+..... ....++.+|++++++++|+|+++++++|.. ...++|+|
T Consensus 10 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 88 (279)
T cd05057 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQ 88 (279)
T ss_pred EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEe
Confidence 45578999999999999864 2 2589998876543 345678999999999999999999999987 78899999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
|+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 89 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 164 (279)
T cd05057 89 LMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164 (279)
T ss_pred cCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence 999999999986543 3589999999999999999999998 999999999999999999999999999987643222
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
........++..|+|||.+....++.++|+||||++++|+++ |+.||....... +.+ . ...+.. .
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~---~-~~~~~~---------~ 230 (279)
T cd05057 165 EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-IPD---L-LEKGER---------L 230 (279)
T ss_pred ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-HHH---H-HhCCCC---------C
Confidence 221122234568999999988889999999999999999999 999997654322 111 1 111110 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
..+..+...+.+++.+|+..+|++||++.++++.|+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 231 PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111233567899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.63 Aligned_cols=248 Identities=26% Similarity=0.366 Sum_probs=203.8
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.+.+.||+|+||.||.++.. ++.+++|.+... .....+++.+|++++++++|+||+++++++.+....+++|||++
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (256)
T cd08221 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN 82 (256)
T ss_pred eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence 34578999999999888764 788999998654 23455678999999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+|+|.+++.......+++..+..++.|+++||.|||+. +++||||||+||++++++.+||+|||++........ .
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~ 157 (256)
T cd08221 83 GGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--M 157 (256)
T ss_pred CCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc--c
Confidence 99999999766556789999999999999999999998 999999999999999999999999999986533221 2
Q ss_pred cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
.....+++.|+|||.+.+...+.++||||||++++||++|+.||..........+ .. .+... ....
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~----~~-~~~~~---------~~~~ 223 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK----IV-QGNYT---------PVVS 223 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HH-cCCCC---------CCcc
Confidence 2345689999999999888899999999999999999999999976443222222 11 11111 1112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMNQVVIEL 830 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 830 (870)
.....+.+++.+|++.+|++||++.++++.+
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 3345688999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=305.71 Aligned_cols=242 Identities=27% Similarity=0.425 Sum_probs=198.5
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
.+.||+|+||.||+|... ++.||+|.+.... ....+.+.+|++++++++|+||+++++++......++||||+++++
T Consensus 9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06642 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred HHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCc
Confidence 467999999999999875 7789999987543 3345678999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.+++. ...+++..+..++.|+++|+.|||+. +++|+||+|+||++++++.++|+|||++...... ......
T Consensus 89 L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~~~~~ 160 (277)
T cd06642 89 ALDLLK---PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKRNT 160 (277)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCc--chhhhc
Confidence 998884 34688999999999999999999998 9999999999999999999999999998765322 112233
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTV 802 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 802 (870)
..++..|+|||++.+..++.++|||||||+++||++|+.|+.......... ....+. .........
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----~~~~~~---------~~~~~~~~~ 226 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-----LIPKNS---------PPTLEGQYS 226 (277)
T ss_pred ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-----hhhcCC---------CCCCCcccC
Confidence 468889999999998889999999999999999999999987543322111 011110 111222345
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 803 WKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 803 ~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
..+.+++.+|++.+|++||+|.+|++.
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 227 KPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 678899999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=301.51 Aligned_cols=251 Identities=21% Similarity=0.296 Sum_probs=191.0
Q ss_pred cccccCcEEEEEEEEC-C---eeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 568 VLGKGGFGTVYHGYLD-D---KQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 568 ~LG~G~fG~Vy~~~~~-~---~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
.||+|+||.||+|... + ..+++|.+.... ....+.|.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 6999999999999753 2 345677665443 3345689999999999999999999999999999999999999999
Q ss_pred hhhhhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 643 LQAHLLEDK--ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 643 L~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|.+++.+.. ...+++..+..++.|+++||+|||+. +++||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999987542 24567778889999999999999998 9999999999999999999999999998643211111122
Q ss_pred ccccCCCCccCcccccc-------CCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccc
Q 002887 721 TTVVGTPGYLDPEYYIS-------NRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHR 792 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~-------~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 792 (870)
....++..|+|||++.. ..++.++||||||+++|||++ |..||........... .... ....+.++.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~ 233 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNH----VIKD-QQVKLFKPQ 233 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHhh-cccccCCCc
Confidence 34567889999999853 245789999999999999997 5678865443322222 2222 222333333
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002887 793 LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELN 831 (870)
Q Consensus 793 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 831 (870)
+... ....+.+++..|+ .+|++||+++||+++|.
T Consensus 234 ~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 234 LELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3322 2345677888999 57999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.90 Aligned_cols=247 Identities=25% Similarity=0.485 Sum_probs=199.5
Q ss_pred hccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 564 NFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
.+.+.||+|+||.||++.+. +..+|+|.+..... ...+|.+|++++++++|||++++++++......++|+||+++++
T Consensus 7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd05112 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC 85 (256)
T ss_pred EEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence 45678999999999999886 78899998875432 34578999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.+++.... ..+++..+..++.+++.|++|||+. +++||||||+||+++.++.+||+|||++...... .......
T Consensus 86 L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~-~~~~~~~ 160 (256)
T cd05112 86 LSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD-QYTSSTG 160 (256)
T ss_pred HHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccC-cccccCC
Confidence 999886433 4588999999999999999999998 9999999999999999999999999998755322 1111122
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
..++.+|+|||++.++.++.++||||||+++|||++ |+.||......... ... ..+. ....+. ..
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~----~~~-~~~~--~~~~~~-------~~ 226 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV----ETI-NAGF--RLYKPR-------LA 226 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH----HHH-hCCC--CCCCCC-------CC
Confidence 335678999999998899999999999999999998 99999754432222 111 1110 111111 12
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVIEL 830 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 830 (870)
...+.+++.+|++.+|++||++.|++++|
T Consensus 227 ~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 227 SQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 35788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=299.66 Aligned_cols=257 Identities=23% Similarity=0.317 Sum_probs=203.6
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhcccc-ceeEEEEEecCC------eEEEEE
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKN-LTILVGYCDEGA------NMGLIY 635 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~------~~~LV~ 635 (870)
++||+|+||+||+|+.. |+.||+|++..... ..-....+|+.+|++++|+| |+.+.+++...+ ..++|+
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvf 96 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVF 96 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEE
Confidence 46999999999999975 88999999987643 23345689999999999999 999999998877 788999
Q ss_pred EEccCCchhhhhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 636 EFMANGNLQAHLLEDKA--DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
||++. +|..++..... ..++...+..++.|+++||+|||++ +|+||||||+|||++++|.+||+|||+|+.+.-
T Consensus 97 e~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i 172 (323)
T KOG0594|consen 97 EFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFSI 172 (323)
T ss_pred Eeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHhcC
Confidence 99986 78888765443 4677788999999999999999999 999999999999999999999999999996632
Q ss_pred CCCccccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc---CC--cch
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR---GD--IKN 787 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~---~~--~~~ 787 (870)
. ....+..++|..|.|||++.+. .|+...||||+||++.||+++++.|.+..+.+.+...++-+=.. .| ...
T Consensus 173 p--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~ 250 (323)
T KOG0594|consen 173 P--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSS 250 (323)
T ss_pred C--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccc
Confidence 2 2234556789999999999987 69999999999999999999999998887766665554422211 11 011
Q ss_pred hcccc-----cCCCCC--H---HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 788 IVDHR-----LQGDFD--T---NTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 788 i~d~~-----l~~~~~--~---~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
+.+-. .....+ . .......+++.+|++.+|.+|.|++.++++
T Consensus 251 ~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 251 LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11111 110111 1 111467899999999999999999999886
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=299.47 Aligned_cols=248 Identities=29% Similarity=0.466 Sum_probs=201.5
Q ss_pred ccccccccCcEEEEEEEECC------eeEEEEEeeccchh-hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLDD------KQVAVKMLSSSSVQ-GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~~------~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
+.+.||+|+||.||++.... ..||+|.+...... ..+.+.+|++.+..++|+||+++++++.+....+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 45789999999999999863 78999999765433 567899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++++|.+++.......+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 9999999998765443489999999999999999999998 9999999999999999999999999999866432111
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
......+++.|+|||.+.+..++.++||||+|++++||++ |++||......... .... .+.. ..
T Consensus 160 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~----~~~~-~~~~---------~~ 224 (258)
T smart00219 160 -KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVL----EYLK-KGYR---------LP 224 (258)
T ss_pred -ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHh-cCCC---------CC
Confidence 1112337789999999988889999999999999999998 78888754332211 1111 1111 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVIEL 830 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 830 (870)
........+.+++.+|+..+|++|||+.|++++|
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1122455788999999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.56 Aligned_cols=246 Identities=23% Similarity=0.382 Sum_probs=202.1
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.+.+.||+|+||.+|++... ++.+++|.+.... ....+++.+|++++++++|+||+++++++......++|+||++
T Consensus 3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08218 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE 82 (256)
T ss_pred eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence 34578999999999999875 7889999987542 3345678999999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+++|.+++.......+++.+++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~--~~~ 157 (256)
T cd08218 83 GGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST--VEL 157 (256)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcc--hhh
Confidence 99999988765555789999999999999999999998 9999999999999999999999999999765321 112
Q ss_pred cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
.....|++.|+|||++.+...+.++|+|||||++++|++|+.||........ +..... +.. .....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~----~~~~~~-~~~---------~~~~~ 223 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL----VLKIIR-GSY---------PPVSS 223 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH----HHHHhc-CCC---------CCCcc
Confidence 2334688899999999988999999999999999999999999875433222 222211 111 01122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.....+.+++.+|++.+|++||+|.||++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 33456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=313.38 Aligned_cols=258 Identities=27% Similarity=0.412 Sum_probs=216.8
Q ss_pred hhccccccccCcEEEEEEEEC----Ce--eEEEEEeecc-chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD----DK--QVAVKMLSSS-SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIY 635 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~----~~--~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 635 (870)
..+.++||+|-||.||+|.+. |+ .||||..+.. .....+.|.+|..++++++||||++++|.|.+. ..++||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 345679999999999999974 33 4888988774 445678899999999999999999999999874 688999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
|.++.|.|.++|..++ ..|+......++.||..||+|||+. +.|||||..+|||+.....+||+|||+++.+..+.
T Consensus 470 EL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred ecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 9999999999997654 5788899999999999999999999 99999999999999999999999999999885543
Q ss_pred CccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccC
Q 002887 716 GTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794 (870)
Q Consensus 716 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 794 (870)
... .+...-.+.|||||.+.-.+++.++|||-|||.+||++. |..||++-...+.+. .++.| -+
T Consensus 546 yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-----~iEnG---------eR 610 (974)
T KOG4257|consen 546 YYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-----HIENG---------ER 610 (974)
T ss_pred hhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-----EecCC---------CC
Confidence 333 334556789999999999999999999999999999886 999998755433221 12222 12
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHhHhh
Q 002887 795 GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAMEIAR 840 (870)
Q Consensus 795 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e~~~ 840 (870)
.+.++.++..+..++.+||..+|.+||.+.|+...|.+++.+|...
T Consensus 611 lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~ 656 (974)
T KOG4257|consen 611 LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKIN 656 (974)
T ss_pred CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhh
Confidence 3456788899999999999999999999999999999999866443
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.40 Aligned_cols=244 Identities=24% Similarity=0.397 Sum_probs=195.6
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCchh
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQ 644 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 644 (870)
..||+|+||.||+|... +..|++|.+........+.+.+|++++++++|+||+++++++..+...++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 58999999999999875 6679999988776666778999999999999999999999999999999999999999999
Q ss_pred hhhhhcccccc--cHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC-CCcEEEEeccCCccccCCCCccccc
Q 002887 645 AHLLEDKADTL--CWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE-KFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 645 ~~l~~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~-~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+++.... ..+ ++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||++...... .....
T Consensus 94 ~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~ 167 (268)
T cd06624 94 ALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTE 167 (268)
T ss_pred HHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccC--CCccc
Confidence 9986532 234 7888899999999999999998 9999999999999986 679999999998755321 11223
Q ss_pred cccCCCCccCccccccCC--CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 722 TVVGTPGYLDPEYYISNR--LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~--~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
...|+..|+|||++.+.. ++.++||||||+++|+|++|+.||........ ..+..... ......+.
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-~~~~~~~~-----------~~~~~~~~ 235 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-AMFKVGMF-----------KIHPEIPE 235 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-hHhhhhhh-----------ccCCCCCc
Confidence 346889999999986543 78899999999999999999999975432111 11111000 00111223
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.....+.+++.+|++.+|++|||+.|+++
T Consensus 236 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 236 SLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 34456889999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=321.30 Aligned_cols=256 Identities=21% Similarity=0.260 Sum_probs=196.5
Q ss_pred HhhccccccccCcEEEEEEEEC----CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 562 TNNFERVLGKGGFGTVYHGYLD----DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~----~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.+.+.||+|+||.||++... ++.|++|.+... +.+.+|++++++++|+||+++++++......+++||+
T Consensus 93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 3556689999999999999753 467899987653 3456899999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+. ++|.+++. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 168 ~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 168 YK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred cC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 86 57888773 335789999999999999999999998 9999999999999999999999999999765433222
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccch---HHHHHHHHhhcCCc-------ch
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTL---IGQWVSSMLARGDI-------KN 787 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~---l~~~~~~~~~~~~~-------~~ 787 (870)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ +....+. ...... ..
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~-~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC-MQVHPLEFPQNGSTN 320 (392)
T ss_pred ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH-hccCccccCCccchh
Confidence 233356799999999999999999999999999999999999999976543221 1111111 100000 00
Q ss_pred h------cccccCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 788 I------VDHRLQGDFD-------TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 788 i------~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
+ ........+. ......+.+++.+|++.+|++|||+.|++..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0000000000 1123467789999999999999999999875
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=323.61 Aligned_cols=248 Identities=22% Similarity=0.317 Sum_probs=193.2
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
+.+.||+|+||.||+++.. ++.||||++..... ...+.+.+|++++.+++|+||+++++.+.+++..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (376)
T cd05598 5 KIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (376)
T ss_pred EEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCC
Confidence 4578999999999999975 78999999875432 234567899999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC----
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG---- 715 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~---- 715 (870)
+|+|.+++... ..++...+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 85 ~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 85 GGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 99999998643 4678888999999999999999998 99999999999999999999999999975331000
Q ss_pred -------------------------------------CccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh
Q 002887 716 -------------------------------------GTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 758 (870)
Q Consensus 716 -------------------------------------~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt 758 (870)
.........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence 0000123479999999999999999999999999999999999
Q ss_pred CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 002887 759 GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRP---TMNQVVIE 829 (870)
Q Consensus 759 G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---sm~eVl~~ 829 (870)
|+.||........... ..... ..+...........+.+++.+|+ .+|++|+ ++.|+++.
T Consensus 240 G~~Pf~~~~~~~~~~~----i~~~~-------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 240 GQPPFLADTPAETQLK----VINWE-------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCCCCHHHHHHH----HhccC-------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999986543222111 11100 00001111122345667777765 4999999 88988754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=301.43 Aligned_cols=248 Identities=23% Similarity=0.349 Sum_probs=198.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
.+.+.||+|+||.||+|... ++.+|+|.++.........+++|+.+++.++||||+++++.+..++..++|+||++++
T Consensus 12 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 91 (267)
T cd06645 12 ELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGG 91 (267)
T ss_pred HHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCC
Confidence 34578999999999999874 7889999998765555667889999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++... ..+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++...... .....
T Consensus 92 ~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~~~ 164 (267)
T cd06645 92 SLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRK 164 (267)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc--ccccc
Confidence 999988543 4689999999999999999999998 9999999999999999999999999998755321 12223
Q ss_pred cccCCCCccCccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 722 TVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 722 ~~~gt~~y~APE~~~---~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
...|+..|+|||++. ...++.++|+|||||++|||++|+.||............ . .... ..+.+.. .
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~----~-~~~~---~~~~~~~--~ 234 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM----T-KSNF---QPPKLKD--K 234 (267)
T ss_pred cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh----h-ccCC---CCCcccc--c
Confidence 457899999999975 455889999999999999999999998654432211111 1 0100 0011110 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
......+.+++.+|++.+|++||++.+|++
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 235 MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 112345789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=324.77 Aligned_cols=254 Identities=20% Similarity=0.247 Sum_probs=191.9
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
+.+.||+|+||.||++... ++.||||... ...+.+|++++++++|+||+++++++..+...++|||++. ++
T Consensus 173 i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~ 245 (461)
T PHA03211 173 IHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SD 245 (461)
T ss_pred EEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CC
Confidence 4578999999999999986 6789999642 2346789999999999999999999999999999999995 68
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|..++... ...++|.+++.|+.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.............
T Consensus 246 L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 321 (461)
T PHA03211 246 LYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321 (461)
T ss_pred HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccc
Confidence 88877543 34799999999999999999999998 999999999999999999999999999986533222222334
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCc-------cchHHHHHHHHhhc-CCcchhcc----
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQ-------RTLIGQWVSSMLAR-GDIKNIVD---- 790 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~-------~~~l~~~~~~~~~~-~~~~~i~d---- 790 (870)
..||..|+|||++.+..++.++|||||||++|||++|..++..... ...+.+.+...... ........
T Consensus 322 ~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~ 401 (461)
T PHA03211 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLV 401 (461)
T ss_pred cCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHH
Confidence 6799999999999999999999999999999999998866533211 11122222111100 00000000
Q ss_pred ----c----ccCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 791 ----H----RLQGDFD-------TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 791 ----~----~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
. ....... ......+.+++.+||+.||++|||+.|+++.
T Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 402 SQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 0000000 0112357899999999999999999999864
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=300.97 Aligned_cols=245 Identities=25% Similarity=0.411 Sum_probs=197.8
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccchh---------hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ---------GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGL 633 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~---------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 633 (870)
+.+.||+|++|.||+|... ++.+|+|.+...... ..+.+++|++++++++|+||+++++++.+....++
T Consensus 4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI 83 (267)
T ss_pred ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence 4578999999999999874 788999988654221 22568899999999999999999999999999999
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
|+||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.++....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 84 FLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999998643 4688999999999999999999998 999999999999999999999999999986642
Q ss_pred CCCc----cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhc
Q 002887 714 EGGT----HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIV 789 (870)
Q Consensus 714 ~~~~----~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~ 789 (870)
.... .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||..........+ .. .. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~-~~-----~ 228 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK----IG-EN-----A 228 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHH----Hh-cc-----C
Confidence 2111 111234588899999999988899999999999999999999999986433221111 00 00 1
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 790 DHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 790 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
. ...+......+.+++.+|++.+|++||++.|+++
T Consensus 229 ~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 229 S----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred C----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1 1122234567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=306.47 Aligned_cols=244 Identities=22% Similarity=0.335 Sum_probs=200.5
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
+.+.||.|++|.||+|... ++.|++|.+........+.+.+|+++++.++|+|++++++++......++|+||+++++
T Consensus 23 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 102 (296)
T cd06655 23 RYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGS 102 (296)
T ss_pred EEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCc
Confidence 3468999999999999864 88999999977655566788999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|..++.. ..+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||++....... .....
T Consensus 103 L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~ 174 (296)
T cd06655 103 LTDVVTE---TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--SKRST 174 (296)
T ss_pred HHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc--ccCCC
Confidence 9998843 3589999999999999999999998 99999999999999999999999999987653221 11233
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTV 802 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 802 (870)
..++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+ .. .... .+ .......
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~----~~-~~~~-----~~--~~~~~~~ 242 (296)
T cd06655 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----AT-NGTP-----EL--QNPEKLS 242 (296)
T ss_pred cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----Hh-cCCc-----cc--CCcccCC
Confidence 46888999999999888999999999999999999999999765543222111 10 1000 01 1122334
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 803 WKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 803 ~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..+.+++.+|+..+|++||++.++++
T Consensus 243 ~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 243 PIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 56789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=300.00 Aligned_cols=242 Identities=26% Similarity=0.413 Sum_probs=200.3
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
.+.||+|+||.||+|... ++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+....++||||+++|+
T Consensus 9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06640 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred hhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCc
Confidence 467999999999999875 7889999987543 3445678999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.+++.. ..+++.+...++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++...... ......
T Consensus 89 L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~ 160 (277)
T cd06640 89 ALDLLRA---GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKRNT 160 (277)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCC--cccccc
Confidence 9998853 4688999999999999999999998 9999999999999999999999999999765322 122234
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTV 802 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 802 (870)
..++..|+|||++.+...+.++|+|||||++|||++|+.||.......... ....+ ..........
T Consensus 161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----~~~~~---------~~~~~~~~~~ 226 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-----LIPKN---------NPPTLTGEFS 226 (277)
T ss_pred ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-----hhhcC---------CCCCCchhhh
Confidence 567889999999998889999999999999999999999997544322111 01111 1112234556
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 803 WKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 803 ~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
..+.+++.+|++.+|++||++.++++.
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 227 KPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 788899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=304.30 Aligned_cols=246 Identities=24% Similarity=0.368 Sum_probs=198.4
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
+.+.||+|+||.||+|... ++.+++|.+........+.+.+|++++++++|+|++++++.+..+...++||||+++++
T Consensus 16 i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 95 (292)
T cd06644 16 IIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGA 95 (292)
T ss_pred hhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCc
Confidence 4568999999999999985 78899999987766667789999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|..++.+.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...... ......
T Consensus 96 l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~ 169 (292)
T cd06644 96 VDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQRRDS 169 (292)
T ss_pred HHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc--ccccce
Confidence 988775433 4689999999999999999999998 9999999999999999999999999998753221 122234
Q ss_pred ccCCCCccCcccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 723 VVGTPGYLDPEYYIS-----NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 723 ~~gt~~y~APE~~~~-----~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
..++..|+|||++.+ ..++.++|||||||++|||++|++||..........++ .. ... +.+ ..
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~----~~-~~~-----~~~--~~ 237 (292)
T cd06644 170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI----AK-SEP-----PTL--SQ 237 (292)
T ss_pred ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHH----hc-CCC-----ccC--CC
Confidence 568889999999853 34678999999999999999999999754432222111 11 100 010 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+......+.+++.+|++.+|++||++.|+++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 2233456889999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=297.74 Aligned_cols=245 Identities=26% Similarity=0.384 Sum_probs=200.6
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
.+.+.||+|++|.||+|... ++.+++|.+..... .+++.+|++++++++|+|++++++++......++++||++++
T Consensus 6 ~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 83 (256)
T cd06612 6 DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAG 83 (256)
T ss_pred hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCC
Confidence 34578999999999999986 68899999876533 678999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++... ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++....... ....
T Consensus 84 ~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~~ 157 (256)
T cd06612 84 SVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--AKRN 157 (256)
T ss_pred cHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc--cccc
Confidence 999988543 35789999999999999999999998 99999999999999999999999999988653221 1223
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
...++..|+|||++.+..++.++||||||++++||++|+.||............ ... ..+.+ ..+...
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-----~~~-----~~~~~--~~~~~~ 225 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-----PNK-----PPPTL--SDPEKW 225 (256)
T ss_pred cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-----ccC-----CCCCC--Cchhhc
Confidence 455888999999999889999999999999999999999999764432211110 000 00001 112223
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...+.+++.+|++.+|++|||+.||++
T Consensus 226 ~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 226 SPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 457889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=301.67 Aligned_cols=243 Identities=28% Similarity=0.440 Sum_probs=199.4
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.+.||.|++|.||+|... ++.+|+|.+.... ......+.+|++++++++|+|++++++++.++...++|+||++++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (274)
T cd06609 5 LLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGG 84 (274)
T ss_pred hhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCC
Confidence 4568999999999999975 7899999987653 344567899999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++...... ....
T Consensus 85 ~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~ 156 (274)
T cd06609 85 SCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRN 156 (274)
T ss_pred cHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc--cccc
Confidence 999998543 789999999999999999999998 99999999999999999999999999998764221 2223
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
...++..|+|||++.+..++.++||||||+++|||++|+.||.......... ....+.. +.+.. ...
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~-----~~~~~~~-----~~~~~---~~~ 223 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF-----LIPKNNP-----PSLEG---NKF 223 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH-----HhhhcCC-----CCCcc---ccc
Confidence 4568889999999998889999999999999999999999997544221111 1111111 11111 013
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...+.+++.+|+..+|++||+++++++
T Consensus 224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 224 SKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 456889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=305.09 Aligned_cols=252 Identities=27% Similarity=0.314 Sum_probs=201.8
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
..+.+.||+|+||.||++... ++.+|+|++.... ....+.+.+|+++++.++|+||+++++++......++||||++
T Consensus 7 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (284)
T cd06620 7 LETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMD 86 (284)
T ss_pred HHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCC
Confidence 344578999999999999986 7889999887543 3345778999999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+++|.+++.+. ..+++..+..++.+++.||.|||+. .+++||||||+||++++++.++|+|||++...... .
T Consensus 87 ~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~----~ 158 (284)
T cd06620 87 CGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----I 158 (284)
T ss_pred CCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh----c
Confidence 99999887643 4689999999999999999999973 27999999999999999999999999998654211 1
Q ss_pred cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccc-------hHHHHHHHHhhcCCcchhcccc
Q 002887 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRT-------LIGQWVSSMLARGDIKNIVDHR 792 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~-------~l~~~~~~~~~~~~~~~i~d~~ 792 (870)
.....|+..|+|||++.+..++.++|+|||||+++||++|+.||....... .+..+........ .+.
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 232 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PPR 232 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CCC
Confidence 224578999999999988889999999999999999999999998644321 1112222222111 001
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002887 793 LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELN 831 (870)
Q Consensus 793 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 831 (870)
+ ........+.+++.+|++.+|++||++.|++++..
T Consensus 233 ~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 233 L---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred C---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 1 01124457889999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=307.23 Aligned_cols=257 Identities=22% Similarity=0.297 Sum_probs=198.3
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeecc-chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS-SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.+.||+|+||.||++... +..+|+|.+... ......++.+|++++.+++||||+++++++..++..++||||++++
T Consensus 5 ~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~ 84 (308)
T cd06615 5 KLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 84 (308)
T ss_pred EEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCC
Confidence 4578999999999999975 678899988754 2334466889999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++... ..+++..+..++.|+++||.|||+. .+++||||||+|||+++++.+||+|||++...... ...
T Consensus 85 ~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~ 156 (308)
T cd06615 85 SLDQVLKKA--GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 156 (308)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc----ccc
Confidence 999998643 5688999999999999999999973 28999999999999999999999999998754221 123
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCc----------------
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDI---------------- 785 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~---------------- 785 (870)
...|+..|+|||++.+..++.++|+||||++++||++|+.||...... ....+..........
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235 (308)
T ss_pred cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh-hHHHhhcCccccccccCCcccccCCCCCccc
Confidence 457889999999998888999999999999999999999998654322 111111111000000
Q ss_pred ----chhcccccC---CCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002887 786 ----KNIVDHRLQ---GDFD-TNTVWKAVEIALACIHTISTRRPTMNQVVIEL 830 (870)
Q Consensus 786 ----~~i~d~~l~---~~~~-~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 830 (870)
.+..+.... ...+ ......+.+++.+|+..+|++||+++||++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000000 0000 11344688999999999999999999998763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=289.25 Aligned_cols=244 Identities=25% Similarity=0.379 Sum_probs=199.9
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccch-----h---hhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEE
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-----Q---GYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLI 634 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-----~---~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV 634 (870)
.++||.|..+.|-+..++ +++.|+|++..... . -.+.-.+|+.+|+++ .||+|+.+.+++......++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 478999999999988875 88999999865321 1 123456799999998 799999999999999999999
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
+|.|+.|.|.++|.+. -.++++...+|++|+.+|++|||.. +||||||||+|||+|++.++||+|||.++.+.+.
T Consensus 102 Fdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 9999999999999643 4789999999999999999999998 9999999999999999999999999999987543
Q ss_pred CCccccccccCCCCccCcccccc------CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchh
Q 002887 715 GGTHVSTTVVGTPGYLDPEYYIS------NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNI 788 (870)
Q Consensus 715 ~~~~~~~~~~gt~~y~APE~~~~------~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i 788 (870)
......+|||+|+|||.+.- ..|+...|+||+||++|.|+.|.+||-...+... ..++.+|..+ +
T Consensus 177 ---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM-----LR~ImeGkyq-F 247 (411)
T KOG0599|consen 177 ---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM-----LRMIMEGKYQ-F 247 (411)
T ss_pred ---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH-----HHHHHhcccc-c
Confidence 34567899999999999853 3588899999999999999999999974333222 2233333221 1
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 789 VDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 789 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
-. +.-.+......+++.+|++.||++|-|++|+++
T Consensus 248 ~s-----peWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 248 RS-----PEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred CC-----cchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11 112245567889999999999999999999986
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=318.73 Aligned_cols=243 Identities=27% Similarity=0.423 Sum_probs=204.3
Q ss_pred cccccCcEEEEEEEECC--eeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCchhh
Q 002887 568 VLGKGGFGTVYHGYLDD--KQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQA 645 (870)
Q Consensus 568 ~LG~G~fG~Vy~~~~~~--~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~ 645 (870)
+||+|.||+||.|+... ..+|||-+........+.+.+|+.+-+.++|+|||+++|.|.+.+..-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999864 4579999988877777889999999999999999999999999999999999999999999
Q ss_pred hhhhcccccc--cHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC-CCcEEEEeccCCccccCCCCcccccc
Q 002887 646 HLLEDKADTL--CWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE-KFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 646 ~l~~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~-~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
.|+.. -.++ .+.++-.+.+||++||.|||++ .|||||||-+|||++. .|.+||+|||.++.+. +-+..+.+
T Consensus 662 LLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TET 735 (1226)
T KOG4279|consen 662 LLRSK-WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTET 735 (1226)
T ss_pred HHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhc--cCCccccc
Confidence 88643 2455 6777888999999999999999 9999999999999975 6899999999998762 34455677
Q ss_pred ccCCCCccCccccccC--CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 723 VVGTPGYLDPEYYISN--RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~--~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
..||..|||||++..+ .|...+|||||||++.||.||++||......... +.+-|-. ..-.+.+.+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA------MFkVGmy------KvHP~iPee 803 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA------MFKVGMY------KVHPPIPEE 803 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh------hhhhcce------ecCCCCcHH
Confidence 8999999999999765 4899999999999999999999999876532210 1111100 112345667
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...+...++++|+.++|.+||+++++++
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 7888999999999999999999999986
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=297.53 Aligned_cols=246 Identities=25% Similarity=0.385 Sum_probs=200.8
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.+.+.||+|++|.||++... ++.+|+|.+.... ....+.+.+|++++++++|+|++++++.+..+...++|+||++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP 82 (256)
T ss_pred eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence 34578999999999999875 7889999987642 3345678999999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC-CcEEEEeccCCccccCCCCcc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK-FQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~-~~vkL~DFGla~~~~~~~~~~ 718 (870)
+++|.+++.......+++..+.+++.++++||+|||++ +++||||||+||+++++ +.+||+|||++.......
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--- 156 (256)
T cd08220 83 GGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--- 156 (256)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---
Confidence 99999999776566789999999999999999999998 99999999999999865 468999999998653221
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
......++..|+|||.+.+...+.++||||||+++++|++|+.||........... ... +.. ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~----~~~-~~~---------~~~~ 222 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK----IMS-GTF---------APIS 222 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHH----HHh-cCC---------CCCC
Confidence 12235688899999999988899999999999999999999999976543322211 111 110 1111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
......+.+++.+|++.+|++|||+.|+++.
T Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 2234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=318.86 Aligned_cols=249 Identities=24% Similarity=0.311 Sum_probs=194.9
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
+.+.+.||+|+||.||+++.. ++.+|+|++.... ....+.+.+|+.+++.++||||+++++.+.++...++||||
T Consensus 45 y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey 124 (371)
T cd05622 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 124 (371)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence 344578999999999999986 7889999987532 22345578899999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++|+|.+++.. ..++...+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 125 ~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~-~~ 197 (371)
T cd05622 125 MPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GM 197 (371)
T ss_pred CCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC-Cc
Confidence 999999998853 3578888999999999999999998 9999999999999999999999999999865322 22
Q ss_pred cccccccCCCCccCccccccC----CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccccc
Q 002887 718 HVSTTVVGTPGYLDPEYYISN----RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~----~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||..........+ .........+
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~----i~~~~~~~~~----- 268 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK----IMNHKNSLTF----- 268 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHH----HHcCCCcccC-----
Confidence 223456799999999998754 378999999999999999999999986543322222 1111110001
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002887 794 QGDFDTNTVWKAVEIALACIHTISTR--RPTMNQVVIE 829 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~eVl~~ 829 (870)
.........+.+++.+|+..++.+ ||++.|+++.
T Consensus 269 --~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 269 --PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred --CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 111233456778999999844433 7899888874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=303.92 Aligned_cols=258 Identities=24% Similarity=0.308 Sum_probs=196.0
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.||+|++|.||+|+.. ++.||+|++..... ...+.+.+|+.++++++|+|++++++++.++...++||||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (285)
T cd07861 4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS- 82 (285)
T ss_pred EeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-
Confidence 4578999999999999975 78899999865422 234678899999999999999999999999999999999998
Q ss_pred Cchhhhhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 641 GNLQAHLLEDK-ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 641 gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
++|.+++.... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++...... ...
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~ 157 (285)
T cd07861 83 MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VRV 157 (285)
T ss_pred CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCC--ccc
Confidence 57888775533 36789999999999999999999998 9999999999999999999999999998754322 122
Q ss_pred cccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC-----------Ccch
Q 002887 720 STTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG-----------DIKN 787 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~-----------~~~~ 787 (870)
.....+++.|+|||++.+. .++.++|||||||+++||++|++||.................... ....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 2334578899999988754 578999999999999999999999986543322222211110000 0000
Q ss_pred hcccccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 788 IVDHRLQG---DFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 788 i~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..+..... ........++.+++.+|++.||++|||+.+|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 001123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=305.55 Aligned_cols=245 Identities=22% Similarity=0.344 Sum_probs=199.8
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
.+.+.||+|++|.||++... ++.||+|.+........+.+.+|+.+++.++|+|++++++++..+...++||||++++
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (297)
T cd06656 22 TRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 101 (297)
T ss_pred eeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCC
Confidence 34578999999999999964 8899999998765555677899999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++.+ ..+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++....... ....
T Consensus 102 ~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 173 (297)
T cd06656 102 SLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRS 173 (297)
T ss_pred CHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc--cCcC
Confidence 99998853 4578999999999999999999998 99999999999999999999999999987653221 1223
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
...+++.|+|||.+.+..++.++|+|||||++|+|++|+.||........... ....+ .+. .......
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~----~~~~~------~~~--~~~~~~~ 241 (297)
T cd06656 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IATNG------TPE--LQNPERL 241 (297)
T ss_pred cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee----eccCC------CCC--CCCcccc
Confidence 45688899999999988899999999999999999999999975432211100 00000 000 0112233
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...+.+++.+|++.+|++||++.++++
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 242 SAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 456789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=301.69 Aligned_cols=252 Identities=27% Similarity=0.387 Sum_probs=197.4
Q ss_pred ccccccccCcEEEEEEEEC-----CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCC------eE
Q 002887 565 FERVLGKGGFGTVYHGYLD-----DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGA------NM 631 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~-----~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~ 631 (870)
+.+.||+|+||.||+|.+. ++.||||++.... ....+++.+|++++++++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 4578999999999999863 5789999987642 334567889999999999999999999885532 24
Q ss_pred EEEEEEccCCchhhhhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccC
Q 002887 632 GLIYEFMANGNLQAHLLEDK----ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGL 707 (870)
Q Consensus 632 ~LV~Ey~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGl 707 (870)
++++||+++|+|..++.... ...+++...++++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccc
Confidence 68899999999988765322 23578999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcc
Q 002887 708 SRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIK 786 (870)
Q Consensus 708 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~ 786 (870)
++...............++..|++||.+....++.++|||||||++|||++ |++||....... +..+. ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~-~~~~~---~~~~~~- 234 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-IYNYL---IKGNRL- 234 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH-HHHHH---HcCCcC-
Confidence 886533221122223345678999999998889999999999999999999 889987544322 11111 111110
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 787 NIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 787 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
.........+.+++.+|++.+|++||++.|+++.|+++
T Consensus 235 ---------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 235 ---------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01123345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=296.90 Aligned_cols=249 Identities=26% Similarity=0.319 Sum_probs=208.4
Q ss_pred ccccccCcEEEEEEEECC--eeEEEEEeeccchh---hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 567 RVLGKGGFGTVYHGYLDD--KQVAVKMLSSSSVQ---GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~--~~vAVK~l~~~~~~---~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.||+|.-|+||.+.+.+ ...|+|++.+.... ...+.+.|-+||+.++||.+..|++.++.+...+++||||+||
T Consensus 83 k~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGG 162 (459)
T KOG0610|consen 83 KRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGG 162 (459)
T ss_pred HHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCc
Confidence 579999999999999984 78999999887443 4456788999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC--------
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV-------- 713 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~-------- 713 (870)
+|...++++..+.++...+.-++.+++-||+|||.. |||.|||||+||||.++|++-|+||.|+.....
T Consensus 163 dL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~ 239 (459)
T KOG0610|consen 163 DLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSS 239 (459)
T ss_pred cHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccC
Confidence 999999888889999999999999999999999998 999999999999999999999999999754310
Q ss_pred -------------------------CCC---------------------ccccccccCCCCccCccccccCCCCccchHH
Q 002887 714 -------------------------EGG---------------------THVSTTVVGTPGYLDPEYYISNRLTEKSDVY 747 (870)
Q Consensus 714 -------------------------~~~---------------------~~~~~~~~gt~~y~APE~~~~~~~~~ksDVw 747 (870)
... ...+...+||-.|+|||++.+...+.++|.|
T Consensus 240 ~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWW 319 (459)
T KOG0610|consen 240 SPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWW 319 (459)
T ss_pred CCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHH
Confidence 000 0112345789999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 002887 748 SFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVV 827 (870)
Q Consensus 748 S~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl 827 (870)
+|||++|||+.|..||.+......+...+ -+.+.-....+.+..+.+||.+.|.+||++|-..+.=.
T Consensus 320 tfGIflYEmLyG~TPFKG~~~~~Tl~NIv-------------~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA 386 (459)
T KOG0610|consen 320 TFGIFLYEMLYGTTPFKGSNNKETLRNIV-------------GQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGA 386 (459)
T ss_pred HHHHHHHHHHhCCCCcCCCCchhhHHHHh-------------cCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccch
Confidence 99999999999999999887766555433 22222223336678899999999999999999833333
Q ss_pred HHHH
Q 002887 828 IELN 831 (870)
Q Consensus 828 ~~L~ 831 (870)
.+++
T Consensus 387 ~eIK 390 (459)
T KOG0610|consen 387 AEIK 390 (459)
T ss_pred HHhh
Confidence 3333
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=296.76 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=202.9
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
.+.+.||+|++|.||+|... ++.+++|.+........+.+.+|++++++++||||+++++++......+++|||++++
T Consensus 6 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~ 85 (262)
T cd06613 6 ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG 85 (262)
T ss_pred EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCC
Confidence 34578999999999999975 6789999998776666788999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++...... .....
T Consensus 86 ~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~~~~ 159 (262)
T cd06613 86 SLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--IAKRK 159 (262)
T ss_pred cHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh--hhccc
Confidence 999987643 25688999999999999999999998 9999999999999999999999999998765321 11223
Q ss_pred cccCCCCccCccccccC---CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 722 TVVGTPGYLDPEYYISN---RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~---~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
...++..|+|||.+.+. .++.++|+||||++++||++|+.||............. .... ....+ ...
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~-----~~~~---~~~~~--~~~ 229 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS-----KSNF---PPPKL--KDK 229 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----hccC---CCccc--cch
Confidence 45688899999999876 78999999999999999999999997654332222111 1100 00111 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
......+.+++.+|+..+|.+||++.+|+.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 234567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=300.74 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=200.2
Q ss_pred cccccccCcEEEEEEEEC-------CeeEEEEEeeccchh-hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 566 ERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSSVQ-GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.||+|+||.||+|+.. .+.+++|.+...... ..+.+.+|++++++++|+||+++++++.+....++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 467999999999999863 457999988765443 456789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhccc-------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCcc
Q 002887 638 MANGNLQAHLLEDKA-------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~ 710 (870)
+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++++|||++..
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~~ 166 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKD 166 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccccccc
Confidence 999999999875442 2689999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhc
Q 002887 711 FPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIV 789 (870)
Q Consensus 711 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~ 789 (870)
.... .........++..|+|||.+.+...+.++||||||+++++|++ |..||.......... . ...+...
T Consensus 167 ~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~----~-~~~~~~~--- 237 (275)
T cd05046 167 VYNS-EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN----R-LQAGKLE--- 237 (275)
T ss_pred cCcc-cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHH----H-HHcCCcC---
Confidence 4221 1112223356778999999988889999999999999999999 788886544322211 1 1111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002887 790 DHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELN 831 (870)
Q Consensus 790 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 831 (870)
.......+..+.+++.+|++.+|++||++.|++++|+
T Consensus 238 -----~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 -----LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1112234457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=308.15 Aligned_cols=258 Identities=20% Similarity=0.317 Sum_probs=195.7
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
...+.||+|+||.||+|+.. ++.||+|.++.... .....+.+|++++++++|+||+++++++..++..++||||+++
T Consensus 9 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 88 (309)
T cd07872 9 IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK 88 (309)
T ss_pred EEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC
Confidence 34578999999999999875 77899999875432 2334678899999999999999999999999999999999985
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++...... ...
T Consensus 89 -~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~ 161 (309)
T cd07872 89 -DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--KTY 161 (309)
T ss_pred -CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc--ccc
Confidence 777777543 34588999999999999999999998 99999999999999999999999999987542221 122
Q ss_pred ccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC--Ccc------hhccc
Q 002887 721 TTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG--DIK------NIVDH 791 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~--~~~------~i~d~ 791 (870)
....+++.|+|||.+.+ ..++.++|||||||++|||++|++||........+.......-... ... ...+.
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 33467899999999865 4688999999999999999999999976554333222211110000 000 00000
Q ss_pred ccCC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 792 RLQG-------DFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 792 ~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.... .........+.+++.+|++.+|++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000 000123446789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=313.69 Aligned_cols=255 Identities=24% Similarity=0.306 Sum_probs=192.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecCC------eEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGA------NMGL 633 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~~L 633 (870)
...+.||+|+||.||++... ++.||+|++... .......+.+|+.+++.++||||+++++++.... ..++
T Consensus 24 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 103 (359)
T cd07876 24 QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYL 103 (359)
T ss_pred EEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEE
Confidence 34578999999999999875 789999998654 2334567889999999999999999999986443 5799
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
||||+++ +|...+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 104 v~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 104 VMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred EEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 9999986 4555542 2478889999999999999999998 999999999999999999999999999975421
Q ss_pred CCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHH---------------
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSS--------------- 778 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~--------------- 778 (870)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...............
T Consensus 176 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 176 ---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred ---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 12223457899999999999999999999999999999999999999865432221111110
Q ss_pred ---Hhhc-CCc-----chhcccccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 779 ---MLAR-GDI-----KNIVDHRLQ---GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 779 ---~~~~-~~~-----~~i~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
.... ... .+....... ..........+.+++.+|++.||++|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 000 000000000 00011123567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=299.23 Aligned_cols=250 Identities=26% Similarity=0.352 Sum_probs=198.8
Q ss_pred ccccccccCcEEEEEEEEC---CeeEEEEEeeccc----------hhhhHHHHHHHHHHHH-hccccceeEEEEEecCCe
Q 002887 565 FERVLGKGGFGTVYHGYLD---DKQVAVKMLSSSS----------VQGYKQFQAEVELLIR-AHHKNLTILVGYCDEGAN 630 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~---~~~vAVK~l~~~~----------~~~~~~f~~Ei~~l~~-l~H~nIv~l~g~~~~~~~ 630 (870)
+.+.||+|+||.||+|... ++.+|+|.+.... .....++.+|+.++.+ ++|+||+++++++.+...
T Consensus 4 ~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 83 (269)
T cd08528 4 VLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDR 83 (269)
T ss_pred hhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCe
Confidence 4568999999999999985 4789999876421 2234557788888875 799999999999999999
Q ss_pred EEEEEEEccCCchhhhhhhc--ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCC
Q 002887 631 MGLIYEFMANGNLQAHLLED--KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 708 (870)
Q Consensus 631 ~~LV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla 708 (870)
.+++|||+++++|.+++... ....+++..++.++.|++.||.|||+. .+++||||||+||++++++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 84 LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecccce
Confidence 99999999999999887542 335689999999999999999999963 18999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchh
Q 002887 709 RIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNI 788 (870)
Q Consensus 709 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i 788 (870)
....... ......|+..|+|||.+.+..++.++||||||+++|||++|++||.......... ... .+...
T Consensus 162 ~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~----~~~-~~~~~-- 231 (269)
T cd08528 162 KQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT----KIV-EAVYE-- 231 (269)
T ss_pred eeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH----HHh-hccCC--
Confidence 8653221 2344568899999999998889999999999999999999999997544322211 111 11111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 789 VDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 789 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
..........+.+++.+|++.+|++||++.||..++++
T Consensus 232 ------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 232 ------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 00111234578899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=301.27 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=200.4
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
.+.+.||+|++|.||++... ++.+|+|..........+.|.+|++++++++|+|++++++.+..+...++||||++++
T Consensus 8 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (280)
T cd06611 8 EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGG 87 (280)
T ss_pred HHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCC
Confidence 34467999999999999985 7889999998776666678999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++.+. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++...... .....
T Consensus 88 ~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~~~~ 161 (280)
T cd06611 88 ALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQKRD 161 (280)
T ss_pred cHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc--ccccc
Confidence 999988643 34689999999999999999999998 9999999999999999999999999998754221 12223
Q ss_pred cccCCCCccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 722 TVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 722 ~~~gt~~y~APE~~~-----~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
...+++.|+|||.+. ...++.++|+||||+++|||++|+.||..........++ . .+.. +.+ .
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~----~-~~~~-----~~~--~ 229 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI----L-KSEP-----PTL--D 229 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHH----h-cCCC-----CCc--C
Confidence 456889999999975 344678999999999999999999999765433222221 1 1110 011 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
.+......+.+++.+|++.+|++||++.++++.
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 112234567899999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=303.40 Aligned_cols=244 Identities=23% Similarity=0.389 Sum_probs=209.7
Q ss_pred hhccccccccCcEEEEEEEE--CCeeEEEEEeeccchh--hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 563 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQ--GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
+++++.||+|.|..|-.|++ .|..||||++.+.... ....+.+|+..|+.++|||||++++.......+|||+|.=
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 45678899999999999875 5999999999887544 3457889999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEE-cCCCcEEEEeccCCccccCCCCc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILL-NEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILl-d~~~~vkL~DFGla~~~~~~~~~ 717 (870)
.+|+|.+++.+. ...+++....+++.||+.|+.|+|+. ++|||||||+||.+ .+-|-+||.|||++-.+.+.
T Consensus 100 D~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--- 172 (864)
T KOG4717|consen 100 DGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--- 172 (864)
T ss_pred CCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc---
Confidence 999999999864 36799999999999999999999998 99999999999877 56688999999999877443
Q ss_pred cccccccCCCCccCccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLT-EKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~-~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
...+..+|+..|-|||.+.+..|+ ++.||||+||+||.|++|++||+...+.+.+.. ++|-.. .
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm-------------ImDCKY--t 237 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM-------------IMDCKY--T 237 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh-------------hhcccc--c
Confidence 344677999999999999999887 679999999999999999999998776554433 333222 2
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.+.....++.+||..|+..||++|.+.+||+.
T Consensus 238 vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 238 VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 35567788999999999999999999888763
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=307.93 Aligned_cols=196 Identities=26% Similarity=0.394 Sum_probs=159.8
Q ss_pred cccccccCcEEEEEEEEC----CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEec--CCeEEEEEEEcc
Q 002887 566 ERVLGKGGFGTVYHGYLD----DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDE--GANMGLIYEFMA 639 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~----~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~LV~Ey~~ 639 (870)
.++||+|+||.||+|+.. ++.+|+|.+..... ...+.+|++++++++||||+++++.+.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 368999999999999864 46799999865432 3457889999999999999999998854 456789999987
Q ss_pred CCchhhhhhhc-------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEE----cCCCcEEEEeccCC
Q 002887 640 NGNLQAHLLED-------KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILL----NEKFQAKLADFGLS 708 (870)
Q Consensus 640 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILl----d~~~~vkL~DFGla 708 (870)
+ +|.+++... +...+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 777766432 123588999999999999999999998 99999999999999 45678999999999
Q ss_pred ccccCCCCc-cccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 002887 709 RIFPVEGGT-HVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTP 767 (870)
Q Consensus 709 ~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~ 767 (870)
+........ .......||+.|+|||++.+. .++.++||||+||+++||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 866332111 122346789999999999774 58999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=310.37 Aligned_cols=246 Identities=26% Similarity=0.396 Sum_probs=209.4
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchh---hhHHHHHHHHHHHHhc-cccceeEEEEEecCCeEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ---GYKQFQAEVELLIRAH-HKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~---~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E 636 (870)
+.+.+.||+|.||.||+++.. |+.+|+|.+.+.... ......+|+.+|+++. |||||.+.+.+......++|||
T Consensus 37 Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmE 116 (382)
T KOG0032|consen 37 YELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVME 116 (382)
T ss_pred EEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEE
Confidence 455689999999999999986 889999999876543 3457899999999998 9999999999999999999999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC----CcEEEEeccCCcccc
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK----FQAKLADFGLSRIFP 712 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~----~~vkL~DFGla~~~~ 712 (870)
++.||.|.+.+.+. .+++..+..++.|++.|+.|||+. +|+||||||+|+|+... +.+|++|||++....
T Consensus 117 L~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 117 LCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred ecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 99999999999765 399999999999999999999998 99999999999999643 479999999999774
Q ss_pred CCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccc
Q 002887 713 VEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHR 792 (870)
Q Consensus 713 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 792 (870)
. .......+||+.|+|||++....|+..+||||+||++|.|++|.+||..........+. ..+.. .
T Consensus 191 ~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i-----~~~~~------~ 256 (382)
T KOG0032|consen 191 P---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI-----LRGDF------D 256 (382)
T ss_pred C---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH-----HcCCC------C
Confidence 3 34556789999999999999999999999999999999999999999876654443321 12221 1
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 793 LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 793 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...+.-......+.+++..|+..||.+|+|+.++++
T Consensus 257 f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 257 FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 112223345677889999999999999999999998
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=298.30 Aligned_cols=258 Identities=23% Similarity=0.304 Sum_probs=197.8
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
++.+.||+|++|.||+|+.. ++.||+|++..... ...+.+.+|++++++++|+|++++++++......++||||++
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~ 83 (286)
T cd07847 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD 83 (286)
T ss_pred eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccC
Confidence 34578999999999999985 78999999865432 234567899999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
++.|..++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........ .
T Consensus 84 ~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~ 156 (286)
T cd07847 84 HTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--D 156 (286)
T ss_pred ccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc--c
Confidence 9888876643 34689999999999999999999998 999999999999999999999999999986633221 2
Q ss_pred cccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhh----------cCC-cch
Q 002887 720 STTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLA----------RGD-IKN 787 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~----------~~~-~~~ 787 (870)
.....++..|+|||++.+ ..++.++||||||++++||++|+.||........+..+...... ... ...
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 233457889999999876 45789999999999999999999999865543322222111100 000 000
Q ss_pred hcccccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 788 IVDHRLQGDFD-----TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 788 i~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...+....... ......+.+++.+|++.+|++||++.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00011000000 112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=312.86 Aligned_cols=255 Identities=22% Similarity=0.292 Sum_probs=192.8
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecC------CeEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEG------ANMGL 633 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~L 633 (870)
...+.||+|+||.||++... ++.||||++.... ....+.+.+|+.+++.++|+||+++++++... ...++
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 99 (355)
T cd07874 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYL 99 (355)
T ss_pred eEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEE
Confidence 34578999999999999875 7889999987542 23446778899999999999999999988543 35789
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
||||+++ ++.+.+. ..+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 100 v~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 100 VMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred Ehhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 9999976 5655553 3478899999999999999999998 999999999999999999999999999975422
Q ss_pred CCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHH---------------
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSS--------------- 778 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~--------------- 778 (870)
........||..|+|||++.+..++.++|||||||++|||++|+.||............+..
T Consensus 172 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 172 ---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred ---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 12223457899999999999989999999999999999999999999765432222111111
Q ss_pred ---Hhhc-CCcchhcccc-----cC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 779 ---MLAR-GDIKNIVDHR-----LQ---GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 779 ---~~~~-~~~~~i~d~~-----l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
.... .....+..+. +. ..........+.+++.+|++.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 0000000000 00 00111234567899999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=311.71 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=194.5
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+++.. ++.+|+|++.... ......+.+|..++..++|+||+++++++.+.+..++||||+
T Consensus 4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~ 83 (331)
T cd05624 4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYY 83 (331)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 34578999999999999976 6789999987532 223445788999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|+|.+++.+. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 84 ~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~ 158 (331)
T cd05624 84 VGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TV 158 (331)
T ss_pred CCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-ce
Confidence 999999998653 24688999999999999999999998 99999999999999999999999999997653322 12
Q ss_pred ccccccCCCCccCcccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccccc
Q 002887 719 VSTTVVGTPGYLDPEYYIS-----NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
......|++.|+|||++.+ +.++.++|||||||++|||++|+.||.......... .....+... .+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~----~i~~~~~~~-----~~ 229 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG----KIMNHEERF-----QF 229 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH----HHHcCCCcc-----cC
Confidence 2234579999999999875 467889999999999999999999997654322221 111111000 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002887 794 QGDFDTNTVWKAVEIALACIHTISTR--RPTMNQVVIE 829 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~eVl~~ 829 (870)
. .........+.+++.+|+...+++ |++++++++.
T Consensus 230 p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 230 P-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred C-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 001123456788888988865544 4688888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=310.69 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=193.5
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+++.. ++.+|+|++.... ......+.+|+.++..++|++|+++.+.+.+....++||||+
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~ 83 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY 83 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence 34578999999999999986 6789999986532 223345788999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|+|.+++.+. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...... ...
T Consensus 84 ~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-~~~ 158 (332)
T cd05623 84 VGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTV 158 (332)
T ss_pred CCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC-Ccc
Confidence 999999998653 24688999999999999999999998 9999999999999999999999999998755322 222
Q ss_pred ccccccCCCCccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccccc
Q 002887 719 VSTTVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
......||+.|+|||++. ...++.++|||||||++|||++|+.||.......... .......... .
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~----~i~~~~~~~~-----~ 229 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG----KIMNHKERFQ-----F 229 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH----HHhCCCcccc-----C
Confidence 233457999999999986 3458899999999999999999999997654322222 1211110000 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 002887 794 QGDFDTNTVWKAVEIALACIHTIST--RRPTMNQVVIE 829 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~--~RPsm~eVl~~ 829 (870)
..........+.+++.+|+..+++ .||++.|+++.
T Consensus 230 -p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 -PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 001112345677788887755443 47899999765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=314.13 Aligned_cols=255 Identities=22% Similarity=0.303 Sum_probs=193.4
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecC------CeEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEG------ANMGL 633 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~L 633 (870)
.+.+.||+|+||.||+++.. ++.||||++.... ....+.+.+|+.+++.++||||+++++.+... ...++
T Consensus 27 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~l 106 (364)
T cd07875 27 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106 (364)
T ss_pred eEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEE
Confidence 34578999999999999875 7889999987542 23446678999999999999999999987543 35799
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
||||+++ +|...+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 107 v~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 107 VMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred EEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 9999976 5666553 3478889999999999999999998 999999999999999999999999999976422
Q ss_pred CCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHh-------------
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSML------------- 780 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~------------- 780 (870)
........|+..|+|||++.+..++.++|||||||++|||++|+.||................-
T Consensus 179 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 179 ---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred ---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 1222345789999999999999999999999999999999999999976654332222211100
Q ss_pred -----hc-CCc-----chhcccccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 781 -----AR-GDI-----KNIVDHRLQ---GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 781 -----~~-~~~-----~~i~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
.. ... .......+. ..........+.+++.+|++.||++|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 000 000000000 00111223567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=296.31 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=203.7
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
.+.+.||+|++|.||+|... +..+++|++.... ....+.+.+|++.++.++|+|++++++.+..+...++|+|++++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG 83 (267)
T ss_pred eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence 34678999999999999974 7789999987543 23557789999999999999999999999999999999999999
Q ss_pred Cchhhhhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc-
Q 002887 641 GNLQAHLLEDKA-DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH- 718 (870)
Q Consensus 641 gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~- 718 (870)
++|.+++..... ..+++.....++.|++.||+|||+. +++||||||+||++++++.++|+|||++..+.......
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 84 GSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred CcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 999999876433 5789999999999999999999998 99999999999999999999999999988664332221
Q ss_pred -ccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 719 -VSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 719 -~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
......|+..|+|||++... ..+.++|+|||||+++||++|+.||..........+... .. .+.+...
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~----~~------~~~~~~~ 230 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ----ND------PPSLETG 230 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc----CC------CCCcCCc
Confidence 22344688999999999877 789999999999999999999999976544332222211 10 1111111
Q ss_pred C-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 797 F-DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 797 ~-~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
. .......+.+++.+|++.+|++||++.|+++
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1 1234567889999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=314.80 Aligned_cols=239 Identities=25% Similarity=0.355 Sum_probs=187.0
Q ss_pred ccccCcEEEEEEEEC--CeeEEEEEeeccchh---hhHHHHHHHHHHHHh---ccccceeEEEEEecCCeEEEEEEEccC
Q 002887 569 LGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ---GYKQFQAEVELLIRA---HHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 569 LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~---~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
||+|+||.||+|+.. ++.||||++...... ....+..|..++.+. +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999875 789999998754322 223455666777665 699999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|..++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++..... ....
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~ 153 (330)
T cd05586 81 GELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTT 153 (330)
T ss_pred ChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--CCCc
Confidence 999988864 34689999999999999999999998 9999999999999999999999999998753221 1223
Q ss_pred ccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 721 TTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||........... +..+.. .+. ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~-----i~~~~~------~~~---~~ 219 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN-----IAFGKV------RFP---KN 219 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHH-----HHcCCC------CCC---Cc
Confidence 456799999999999765 489999999999999999999999976543222111 111111 111 01
Q ss_pred HHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 002887 800 NTVWKAVEIALACIHTISTRRPT----MNQVVI 828 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPs----m~eVl~ 828 (870)
.....+.+++.+|++.+|++||+ +.|+++
T Consensus 220 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 12346678999999999999995 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=316.53 Aligned_cols=247 Identities=25% Similarity=0.402 Sum_probs=192.2
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
+.+.||+|+||.||++... ++.||+|++.... ......+.+|+.++.+++|+||+++++.+.+....++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (360)
T cd05627 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP 84 (360)
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 4578999999999999875 7889999997542 2234567889999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc--
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT-- 717 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~-- 717 (870)
+|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+......
T Consensus 85 gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 85 GGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred CccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 99999998643 4688999999999999999999998 9999999999999999999999999998754221100
Q ss_pred -------------------------------cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 002887 718 -------------------------------HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 766 (870)
Q Consensus 718 -------------------------------~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~ 766 (870)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 0012347999999999999999999999999999999999999999765
Q ss_pred CccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 002887 767 PQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPT---MNQVVI 828 (870)
Q Consensus 767 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---m~eVl~ 828 (870)
........ ...... .+. ... .......+.+++.+|+ .+|++|++ +.|+++
T Consensus 240 ~~~~~~~~----i~~~~~--~~~---~p~--~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 240 TPQETYRK----VMNWKE--TLV---FPP--EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CHHHHHHH----HHcCCC--cee---cCC--CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 43322211 111000 000 000 0112345677777766 49999995 555554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=310.13 Aligned_cols=251 Identities=23% Similarity=0.323 Sum_probs=193.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+++.. ++.||+|++.... ....+.+.+|+.++..++|+||+++++++.++...++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (331)
T cd05597 4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYY 83 (331)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecC
Confidence 35678999999999999975 7889999997532 223456889999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|+|.+++.+. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...... ...
T Consensus 84 ~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 158 (331)
T cd05597 84 VGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD-GTV 158 (331)
T ss_pred CCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC-CCc
Confidence 999999998642 34688999999999999999999998 9999999999999999999999999998765322 122
Q ss_pred ccccccCCCCccCcccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccccc
Q 002887 719 VSTTVVGTPGYLDPEYYIS-----NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
......||+.|+|||++.. +.++.++|||||||++|||++|+.||.......... ..........+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~----~i~~~~~~~~~~---- 230 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG----KIMNHKEHFQFP---- 230 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH----HHHcCCCcccCC----
Confidence 2233569999999999863 457889999999999999999999997644322221 122111111110
Q ss_pred CCCCCHHHHHHHHHHHHHcccc--CCCCCCCHHHHHHH
Q 002887 794 QGDFDTNTVWKAVEIALACIHT--ISTRRPTMNQVVIE 829 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPsm~eVl~~ 829 (870)
.........+.+++.+|+.. ++..||++.++++.
T Consensus 231 --~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 231 --PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred --CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00112344567777776644 44448899998865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=296.67 Aligned_cols=247 Identities=28% Similarity=0.437 Sum_probs=197.4
Q ss_pred ccccccccCcEEEEEEEEC-CeeEEEEEeeccc------hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSS------VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
..+.||+|+||.||+|... ++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+....++++||
T Consensus 4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF 83 (265)
T ss_pred ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence 3468999999999999875 7889999886432 12235688999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC-
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG- 716 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~- 716 (870)
+++++|.+++.+. ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++|+|||++........
T Consensus 84 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 84 VPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 9999999998643 4678999999999999999999998 999999999999999999999999999875422111
Q ss_pred ---ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccccc
Q 002887 717 ---THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 717 ---~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
........|+..|+|||++.+..++.++||||||++++||++|+.||............ ....+. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~---~~~~~~-----~--- 227 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI---GAHRGL-----M--- 227 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh---hhccCC-----C---
Confidence 11123356889999999999888999999999999999999999999754332211110 000010 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 794 QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..........+.+++.+|++.+|++||++.|+++
T Consensus 228 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 -PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1112234456789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=305.91 Aligned_cols=243 Identities=24% Similarity=0.350 Sum_probs=198.6
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCchh
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQ 644 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 644 (870)
..||+|+||.||++... ++.||||.+........+.+.+|+.++++++|+|++++++.+..++..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 46999999999999874 7889999987766566677899999999999999999999999999999999999999999
Q ss_pred hhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccccc
Q 002887 645 AHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVV 724 (870)
Q Consensus 645 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 724 (870)
+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++...... ........
T Consensus 108 ~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~~ 179 (292)
T cd06658 108 DIVTH---TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKSLV 179 (292)
T ss_pred HHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccc--cccCceee
Confidence 98743 3588999999999999999999998 9999999999999999999999999998754322 12223456
Q ss_pred CCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHH
Q 002887 725 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWK 804 (870)
Q Consensus 725 gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 804 (870)
|+..|+|||.+.+..++.++||||||++++||++|+.||............ .. ...+.+.. .......
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~-----~~-----~~~~~~~~--~~~~~~~ 247 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-----RD-----NLPPRVKD--SHKVSSV 247 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----Hh-----cCCCcccc--ccccCHH
Confidence 889999999998888999999999999999999999999754432221111 00 11111111 1123446
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 002887 805 AVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 805 l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
+.+++.+|+..+|++|||++|+++.
T Consensus 248 ~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 248 LRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHccCChhHCcCHHHHhhC
Confidence 7789999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=319.76 Aligned_cols=243 Identities=27% Similarity=0.471 Sum_probs=194.6
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeec----cchhhhHHHHHHHHHHHHhccccceeEEEEEecCCe--EEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSS----SSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGAN--MGLIYE 636 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~----~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~LV~E 636 (870)
|.++||+|+|-+||||..+ |.+||=-.++. .+....++|..|+.+|+.|+|+||++++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4578999999999999986 55555222221 233455789999999999999999999999977665 778999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC-CcEEEEeccCCccccCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK-FQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~-~~vkL~DFGla~~~~~~~ 715 (870)
.|..|+|..++.+. +.++.+..+.+++||++||.|||++ .|+|+|||||.+||+|+.+ |.|||+|+|||..+...
T Consensus 124 L~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred cccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence 99999999999754 4678889999999999999999997 7899999999999999865 89999999999987322
Q ss_pred CccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 716 GTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 716 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
....++|||.|||||.+. ..|++.+||||||+.++||+|+..||..-.....+.+-+.+-.....+..+-|
T Consensus 200 ---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d----- 270 (632)
T KOG0584|consen 200 ---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD----- 270 (632)
T ss_pred ---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC-----
Confidence 223489999999999987 78999999999999999999999999765443333222222222222222222
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+++.++|.+|+.. .++|||+.|+++
T Consensus 271 -------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 271 -------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 3567999999999 999999999985
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=297.40 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=196.0
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccch----------hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEE
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV----------QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGL 633 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~----------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 633 (870)
.+.||+|++|.||+|... ++.+|+|.+..... ...+.+.+|++++++++|+|++++++++......++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 468999999999999864 78899998864211 113467889999999999999999999999999999
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||+++....
T Consensus 86 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 86 FLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred EEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 99999999999988654 4689999999999999999999998 999999999999999999999999999976532
Q ss_pred CCCccccccccCCCCccCccccccCC--CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccc
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYISNR--LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDH 791 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~~~--~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 791 (870)
...........|+..|+|||.+.... ++.++|+||||++++||++|+.||..........+ .. .......+..
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~ 235 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK----LG-NKRSAPPIPP 235 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHH----hh-ccccCCcCCc
Confidence 21122223456889999999987654 88999999999999999999999964332211111 11 0111111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 792 RLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 792 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.........+.+++.+|++.+|++||++.||++
T Consensus 236 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 236 ----DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111233567889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=322.72 Aligned_cols=250 Identities=26% Similarity=0.416 Sum_probs=212.3
Q ss_pred cccccccCcEEEEEEEEC------CeeEEEEEeecc-chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 566 ERVLGKGGFGTVYHGYLD------DKQVAVKMLSSS-SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~------~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.++||+|+||+||+|.|- .-+||+|++... ..+...++.+|+.+|.+++|||+++++|+|.... ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 368999999999999983 346899998765 4456788999999999999999999999998766 88999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
+.|+|.++++.++ ..+--...+.|..|||+||.|||++ .++||||..+|||+..-..+||.|||+++.+..++...
T Consensus 780 P~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 780 PLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred ccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999998754 5677888999999999999999998 99999999999999999999999999999987666555
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
......-.+.|||-|.+....++.++|||||||++||++| |..|+++...++ +...++.|+ +-..
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-----I~dlle~ge---------RLsq 921 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-----IPDLLEKGE---------RLSQ 921 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-----hhHHHhccc---------cCCC
Confidence 4555556778999999999999999999999999999998 999998776433 222333332 1223
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
+.-+...+..++.+||..|++.||+++++..++.+..
T Consensus 922 PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 922 PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 4456778889999999999999999999999888754
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=299.81 Aligned_cols=259 Identities=21% Similarity=0.312 Sum_probs=200.4
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.+.+.||+|++|.||+|... ++.|++|++.... ....+.+.+|+.++++++|+|++++++++..+...++|+||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~- 81 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM- 81 (286)
T ss_pred eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-
Confidence 35578999999999999975 7899999987654 233567899999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+++|.+++.... ..+++.++..++.|+++||+|||+. +++|+||||+||++++++.++|+|||++........ ..
T Consensus 82 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (286)
T cd07832 82 PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RL 156 (286)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Cc
Confidence 999999886543 5789999999999999999999998 999999999999999999999999999986643221 12
Q ss_pred cccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCC------------cc
Q 002887 720 STTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGD------------IK 786 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~------------~~ 786 (870)
.....++..|+|||.+.+. .++.++||||+|++++||++|+++|........+.... ....... ..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVF-RTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHH-HHcCCCChHHHhhccCcchhh
Confidence 2345688999999998754 46899999999999999999988886544332222211 1111000 00
Q ss_pred hhcccccC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 787 NIVDHRLQ----GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 787 ~i~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
.+..+.-. .....+....+.+++.+|++.+|++||+++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 00011234678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=295.25 Aligned_cols=249 Identities=25% Similarity=0.351 Sum_probs=199.6
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEec--CCeEEEEEEEc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDE--GANMGLIYEFM 638 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~LV~Ey~ 638 (870)
+.+.||.|+||.||++... ++.+|+|.+.... ....+++.+|++++++++|+|++++++++.. +...+++|||+
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~ 83 (265)
T cd08217 4 VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYC 83 (265)
T ss_pred eeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhc
Confidence 4578999999999999875 7889999987542 3345678899999999999999999998753 45678999999
Q ss_pred cCCchhhhhhhc--ccccccHHHHHHHHHHHHHHHHHHHhCC--CCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 639 ANGNLQAHLLED--KADTLCWERRLQIASESAQGLEYLHNGC--KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 639 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
++++|.+++... ....+++..++.++.|+++||+|||..+ +.+++|+||||+||++++++.+||+|||++......
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 163 (265)
T cd08217 84 EGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163 (265)
T ss_pred cCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCC
Confidence 999999998653 2357899999999999999999999332 339999999999999999999999999999876432
Q ss_pred CCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccC
Q 002887 715 GGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794 (870)
Q Consensus 715 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 794 (870)
. .......+++.|+|||.+.+..++.++|+||||+++++|++|+.||......... . ....+..
T Consensus 164 ~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----~-~~~~~~~--------- 227 (265)
T cd08217 164 S--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA----S-KIKEGKF--------- 227 (265)
T ss_pred c--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHH----H-HHhcCCC---------
Confidence 2 1123456899999999999888999999999999999999999999865432211 1 1111211
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 795 GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 795 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
..........+.+++.+|++.+|++||++.+|++.
T Consensus 228 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 12223445678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=305.26 Aligned_cols=243 Identities=23% Similarity=0.329 Sum_probs=198.5
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCchh
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQ 644 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 644 (870)
..||+|+||.||++... ++.||+|.+........+.+.+|+.++..++|||++++++++..+...++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 46999999999999874 8899999997665555677889999999999999999999999999999999999999998
Q ss_pred hhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccccc
Q 002887 645 AHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVV 724 (870)
Q Consensus 645 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 724 (870)
.++.. ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....... .......
T Consensus 107 ~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~ 178 (297)
T cd06659 107 DIVSQ---TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLV 178 (297)
T ss_pred HHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccccee
Confidence 87743 4688999999999999999999998 99999999999999999999999999987553221 2223456
Q ss_pred CCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHH
Q 002887 725 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWK 804 (870)
Q Consensus 725 gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 804 (870)
|+..|+|||++.+..++.++|||||||+++||++|+.||........+..+ ..... ..+ .........
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-----~~~~~-----~~~--~~~~~~~~~ 246 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-----RDSPP-----PKL--KNAHKISPV 246 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----hccCC-----CCc--cccCCCCHH
Confidence 889999999999888999999999999999999999999755432222111 11100 000 001122346
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 002887 805 AVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 805 l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
+.+++.+|++.+|++||++.++++.
T Consensus 247 l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 247 LRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhhC
Confidence 7899999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=298.97 Aligned_cols=248 Identities=26% Similarity=0.406 Sum_probs=197.4
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeecc-chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS-SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
++.+.||+|+||.||++... ++.+|+|.+... .......+.+|++++++++|+||+++++.+......++||||+++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (286)
T cd06622 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA 83 (286)
T ss_pred hhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCC
Confidence 34578999999999999986 889999988754 333456789999999999999999999999999999999999999
Q ss_pred Cchhhhhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 641 GNLQAHLLEDK-ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 641 gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
++|..++.... ...+++..+..++.|+++||.|||++ .+|+||||||+||+++.++.+||+|||++..+... .
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~ 157 (286)
T cd06622 84 GSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS----L 157 (286)
T ss_pred CCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC----c
Confidence 99988886432 24789999999999999999999963 28999999999999999999999999998754211 2
Q ss_pred cccccCCCCccCccccccCC------CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccccc
Q 002887 720 STTVVGTPGYLDPEYYISNR------LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~------~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
.....++..|+|||.+.+.. ++.++|+|||||++|||++|+.||........... ..... .+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~-~~~--------- 226 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ-LSAIV-DGD--------- 226 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH-HHHHh-hcC---------
Confidence 23346888999999986543 47899999999999999999999975433221111 11111 111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 794 QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...........+.+++.+|++.+|++||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 01122234567789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=302.01 Aligned_cols=258 Identities=24% Similarity=0.318 Sum_probs=198.4
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccchh-----hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ-----GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
+.+.||+|++|.||+|... ++.|++|.+...... ....+..|++++++++|+||+++++++.+....++||||
T Consensus 4 ~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (298)
T cd07841 4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEF 83 (298)
T ss_pred eeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEcc
Confidence 4568999999999999975 789999999765332 234567899999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+ +|+|.+++.... ..+++..+..++.|+++||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 156 (298)
T cd07841 84 M-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-- 156 (298)
T ss_pred c-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--
Confidence 9 899999886533 3699999999999999999999998 99999999999999999999999999998653321
Q ss_pred cccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc--------CCcchh
Q 002887 718 HVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR--------GDIKNI 788 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~--------~~~~~i 788 (870)
.......++..|+|||.+.+ ..++.++|||||||+++||++|.++|........+.+.....-.. ......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T cd07841 157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY 236 (298)
T ss_pred ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence 12223456788999999865 457899999999999999999988887654433333222111000 000000
Q ss_pred cccccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 789 VDHRLQGDFD-----TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 789 ~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
.........+ ......+.+++.+|++.+|++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000001111 2234678899999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=295.00 Aligned_cols=245 Identities=24% Similarity=0.411 Sum_probs=190.6
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc-----hhhhHHHHHHHHHHHHhccccceeEEEEEec--CCeEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-----VQGYKQFQAEVELLIRAHHKNLTILVGYCDE--GANMGLIY 635 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~LV~ 635 (870)
..+.||+|+||.||+|... ++.+++|++.... ....+.+.+|++++++++|+||+++++++.+ ....++++
T Consensus 6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence 3578999999999999874 7889999886432 1234568899999999999999999998865 35678999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
||+++++|.+++... ..+++...+.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 86 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 86 EYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 999999999988643 3588999999999999999999988 99999999999999999999999999987553211
Q ss_pred C-ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccC
Q 002887 716 G-THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794 (870)
Q Consensus 716 ~-~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 794 (870)
. ........++..|+|||++.+..++.++|||||||++|||++|+.||.......... ....... .
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~----~~~~~~~-----~---- 227 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF----KIATQPT-----N---- 227 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH----HHhcCCC-----C----
Confidence 1 111123458889999999998889999999999999999999999997543222111 1111110 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 795 GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 795 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...+......+.+++ +|+..+|++||+++||++
T Consensus 228 ~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 228 PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111222334455555 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=302.65 Aligned_cols=252 Identities=25% Similarity=0.310 Sum_probs=201.8
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccchh---hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ---GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~---~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
..+.||+|++|.||++... ++.+|+|.+...... ..+.+.+|++++++++|+||+++++.+......++||||+.
T Consensus 5 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (316)
T cd05574 5 KIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCP 84 (316)
T ss_pred EeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecC
Confidence 4578999999999999985 789999999765332 45678899999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc--
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT-- 717 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~-- 717 (870)
+++|.+++.......+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (316)
T cd05574 85 GGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161 (316)
T ss_pred CCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence 99999998765556799999999999999999999998 9999999999999999999999999998754221100
Q ss_pred -------------------------cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchH
Q 002887 718 -------------------------HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLI 772 (870)
Q Consensus 718 -------------------------~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l 772 (870)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.||.........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~ 241 (316)
T cd05574 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETF 241 (316)
T ss_pred cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHH
Confidence 0112346788999999999888999999999999999999999999765533222
Q ss_pred HHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 773 GQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 773 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
.+. . +..............+.+++.+|++.+|++||+++..++++..
T Consensus 242 ~~~----~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 242 SNI----L---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHH----h---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 111 1 1111111111245678999999999999999995555444444
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=304.14 Aligned_cols=194 Identities=26% Similarity=0.402 Sum_probs=158.7
Q ss_pred ccccccCcEEEEEEEEC----CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEe--cCCeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLD----DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCD--EGANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~----~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~~LV~Ey~~~ 640 (870)
++||+|+||.||+|+.. ++.+|+|.+..... ...+.+|++++++++||||+++++++. .+...++|+||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999964 46799999875432 345788999999999999999999884 35578899999885
Q ss_pred Cchhhhhhhc-------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEE----cCCCcEEEEeccCCc
Q 002887 641 GNLQAHLLED-------KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILL----NEKFQAKLADFGLSR 709 (870)
Q Consensus 641 gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILl----d~~~~vkL~DFGla~ 709 (870)
+|.+.+... ....+++..+..++.|++.||.|||+. +|+||||||+|||+ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 666665422 123588999999999999999999998 99999999999999 566789999999998
Q ss_pred cccCCCCc-cccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 002887 710 IFPVEGGT-HVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKT 766 (870)
Q Consensus 710 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~ 766 (870)
........ .......||+.|+|||++.+. .++.++|||||||++|||+||++||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 65332111 122345789999999998764 5889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=312.99 Aligned_cols=257 Identities=24% Similarity=0.335 Sum_probs=205.6
Q ss_pred HhhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhc-c-----ccceeEEEEEecCCeEEE
Q 002887 562 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAH-H-----KNLTILVGYCDEGANMGL 633 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H-----~nIv~l~g~~~~~~~~~L 633 (870)
.+.+.+.||+|+||.|-++... ++.||||+++.... -..+.+.|+.+|..++ | -|+|++++++...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 4556789999999999999875 88999999988743 3455688999999996 4 379999999999999999
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC--cEEEEeccCCccc
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF--QAKLADFGLSRIF 711 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~--~vkL~DFGla~~~ 711 (870)
|+|.+.. +|.++++.++...++...+..++.||+.||..||+. +|||+||||+||||.+-. .+||+|||.++..
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9998875 999999999889999999999999999999999988 999999999999997643 6999999999865
Q ss_pred cCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHH-------HHhhcCC
Q 002887 712 PVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVS-------SMLARGD 784 (870)
Q Consensus 712 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~-------~~~~~~~ 784 (870)
.. .....+.+..|.|||++.+..|+.+.||||||||+.||.+|.+.|.+..+.+.+..++. .+++.+.
T Consensus 342 ~q-----~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 342 SQ-----RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred CC-----cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 21 12256778899999999999999999999999999999999999988776655544432 1111100
Q ss_pred -cchhccc--------------------------------ccCC-C-------CCHHHHHHHHHHHHHccccCCCCCCCH
Q 002887 785 -IKNIVDH--------------------------------RLQG-D-------FDTNTVWKAVEIALACIHTISTRRPTM 823 (870)
Q Consensus 785 -~~~i~d~--------------------------------~l~~-~-------~~~~~~~~l~~l~~~Cl~~dP~~RPsm 823 (870)
....++. .... . .....-..+++++.+|++.||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 0001110 0000 0 011334567899999999999999999
Q ss_pred HHHHH
Q 002887 824 NQVVI 828 (870)
Q Consensus 824 ~eVl~ 828 (870)
.|.++
T Consensus 497 ~qal~ 501 (586)
T KOG0667|consen 497 AQALN 501 (586)
T ss_pred HHHhc
Confidence 99986
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=293.52 Aligned_cols=243 Identities=27% Similarity=0.397 Sum_probs=198.3
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc-----hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-----VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
..+.||+|++|.||+|... ++.|++|.+.... ....+.+.+|++++++++|+|++++++++..+...++++||
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL 83 (258)
T ss_pred ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence 3478999999999999975 7899999986543 22456789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++++|.+++... ..+++..+..++.|+++||+|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 84 VPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 9999999988643 3588999999999999999999998 99999999999999999999999999987653221
Q ss_pred cccccccCCCCccCccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
......|+..|+|||.+.... ++.++|+||||+++++|++|+.||..........++ ...... ..
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~~~~~---------~~ 222 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI----GRSKEL---------PP 222 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHH----HhcccC---------CC
Confidence 223456889999999997766 899999999999999999999999765422221111 110111 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.+......+.+++.+|++.+|++||++.++++
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 12233466789999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=302.42 Aligned_cols=257 Identities=23% Similarity=0.332 Sum_probs=196.1
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.||+|+||.||+|... ++.+|+|++..... ...+.+.+|+++++.++|+||+++++++..+...++|+||+++
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (286)
T cd07846 5 NLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH 84 (286)
T ss_pred EeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCc
Confidence 4578999999999999985 78899998765432 2345688999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
++|..+... ...+++.+++.++.|+++||+|||+. +++||||+|+||++++++.++|+|||++....... ...
T Consensus 85 ~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (286)
T cd07846 85 TVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVY 157 (286)
T ss_pred cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--ccc
Confidence 988876643 23589999999999999999999998 99999999999999999999999999987653222 222
Q ss_pred ccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc-CCcchh------cccc
Q 002887 721 TTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR-GDIKNI------VDHR 792 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~-~~~~~i------~d~~ 792 (870)
....++..|+|||++.+ ..++.++||||||++++||++|++||..................- ...... .+..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 34567889999999875 457889999999999999999999987544322111111000000 000000 0000
Q ss_pred cCCCC---------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 793 LQGDF---------DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 793 l~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..... .......+.+++.+|++.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000 1123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=302.50 Aligned_cols=258 Identities=22% Similarity=0.328 Sum_probs=195.5
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
.+.+.||+|+||.||+|+.. ++.||+|.+..... .....+.+|+.++++++|+||+++++++..+...++||||++
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~- 87 (301)
T cd07873 9 IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD- 87 (301)
T ss_pred EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-
Confidence 34578999999999999875 78899999875432 233467889999999999999999999999999999999998
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++...... ....
T Consensus 88 ~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~ 161 (301)
T cd07873 88 KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TKTY 161 (301)
T ss_pred cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC--CCcc
Confidence 5888877543 34688999999999999999999998 9999999999999999999999999998754222 1122
Q ss_pred ccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhh--cCCcchhcc-------
Q 002887 721 TTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLA--RGDIKNIVD------- 790 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~--~~~~~~i~d------- 790 (870)
....+++.|+|||.+.+. .++.++|||||||++|||++|++||.................. ......+.+
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence 334578899999998754 5788999999999999999999999765433222111111000 000011100
Q ss_pred --cccCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 791 --HRLQGD----FDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 791 --~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+..... ........+.+++.+|++.+|++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 01123446789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=295.74 Aligned_cols=244 Identities=27% Similarity=0.421 Sum_probs=199.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
.+.+.||+|+||.||+|... ++.+|+|...... ....+.+.+|++++.+++|+||+++++++..+...++||||+++
T Consensus 7 ~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06641 7 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 86 (277)
T ss_pred hhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCC
Confidence 34568999999999999874 7889999986543 23446788999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++...... ....
T Consensus 87 ~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~--~~~~ 158 (277)
T cd06641 87 GSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIKR 158 (277)
T ss_pred CcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccc--hhhh
Confidence 999998843 4689999999999999999999998 9999999999999999999999999998765322 1122
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
....++..|+|||.+.+...+.++|+|||||++++|++|+.||........ ... ...+.. ......
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~~-~~~~~~---------~~~~~~ 224 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV----LFL-IPKNNP---------PTLEGN 224 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH----HHH-HhcCCC---------CCCCcc
Confidence 345688899999999888899999999999999999999999975432211 111 111110 111223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
....+.+++.+|++.+|++||++.++++.
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 225 YSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 44668899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=300.01 Aligned_cols=258 Identities=21% Similarity=0.302 Sum_probs=197.3
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
..+.||+|++|.||+|+.. ++.||||++.... ......+.+|++++++++||||+++++++.+....++||||+.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (284)
T cd07860 4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH- 82 (284)
T ss_pred eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence 3468999999999999875 7889999987543 2233578899999999999999999999999999999999996
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
++|..++.......+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++...... ....
T Consensus 83 ~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~~~~ 157 (284)
T cd07860 83 QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTY 157 (284)
T ss_pred cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccC--cccc
Confidence 5888888766667799999999999999999999998 9999999999999999999999999998765322 1122
Q ss_pred ccccCCCCccCccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCC-----cchh------
Q 002887 721 TTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGD-----IKNI------ 788 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~-~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~-----~~~i------ 788 (870)
....++..|+|||++.+.. ++.++||||||+++|||+||+.||..........+.....-.... ...+
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 3345788999999987654 688999999999999999999999765543333332221110000 0000
Q ss_pred cccccCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 789 VDHRLQGD---FDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 789 ~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+....... ........+.+++.+|++.+|++||+++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000 00112345779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=295.00 Aligned_cols=246 Identities=25% Similarity=0.404 Sum_probs=200.3
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.||+|+||.||+|... +..+|+|.+.... ....+.+.+|++++++++|+|++++++.+......++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (257)
T cd08225 4 IIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDG 83 (257)
T ss_pred EEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCC
Confidence 4578999999999999985 7889999987642 23445788999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC-cEEEEeccCCccccCCCCccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF-QAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~-~vkL~DFGla~~~~~~~~~~~ 719 (870)
++|.+++.+.....+++..+..++.|+++||.|||+. +++|+||||+||++++++ .+||+|||.+...... ...
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--~~~ 158 (257)
T cd08225 84 GDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--MEL 158 (257)
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC--ccc
Confidence 9999999766556789999999999999999999998 999999999999999885 4699999998765322 122
Q ss_pred cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
.....|++.|+|||++.+..++.++|+||||++++||++|+.||...... +++..... +... ....
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~-~~~~---------~~~~ 224 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH----QLVLKICQ-GYFA---------PISP 224 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHhc-ccCC---------CCCC
Confidence 23346889999999998888999999999999999999999999754322 22222221 1111 1111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
.....+.+++.+|++.+|++|||+.|+++.
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 225 NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 233568899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=298.88 Aligned_cols=247 Identities=24% Similarity=0.352 Sum_probs=192.9
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEEEe-----cCCeEEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGYCD-----EGANMGLIYE 636 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~-----~~~~~~LV~E 636 (870)
+.+.||+|+||.||++... ++.+|+|++.... ....++.+|+.+++++ +|+|++++++++. .+...++|||
T Consensus 22 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 100 (286)
T cd06638 22 IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE 100 (286)
T ss_pred eeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEe
Confidence 3478999999999999875 7889999876532 2235678899999999 6999999999884 3456899999
Q ss_pred EccCCchhhhhhhc--ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 637 FMANGNLQAHLLED--KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 637 y~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
|+++++|.+++... ....+++..+..++.|+++||.|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 177 (286)
T cd06638 101 LCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177 (286)
T ss_pred ecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecccC
Confidence 99999999887532 235688999999999999999999998 9999999999999999999999999998765322
Q ss_pred CCccccccccCCCCccCcccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhc
Q 002887 715 GGTHVSTTVVGTPGYLDPEYYIS-----NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIV 789 (870)
Q Consensus 715 ~~~~~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~ 789 (870)
........|++.|+|||++.. ..++.++|||||||++|||++|+.||........+.+. .........
T Consensus 178 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~ 250 (286)
T cd06638 178 --RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI-----PRNPPPTLH 250 (286)
T ss_pred --CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc-----cccCCCccc
Confidence 112234568999999999853 44788999999999999999999999765432221111 001000011
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 790 DHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 790 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
+ .......+.+++.+|++.+|++||++.|+++.
T Consensus 251 ~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 251 Q-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred C-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1 11123468899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=304.07 Aligned_cols=259 Identities=21% Similarity=0.273 Sum_probs=196.5
Q ss_pred cccccc--CcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 567 RVLGKG--GFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G--~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.||+| +||+||+++.. ++.||+|++.... ....+.+++|+.+++.++||||+++++++..+...++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 99999999984 8999999987542 23456789999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc-
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV- 719 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~- 719 (870)
++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+...........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999988766556789999999999999999999988 999999999999999999999999986543322111110
Q ss_pred ----cccccCCCCccCccccccC--CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHH--------------
Q 002887 720 ----STTVVGTPGYLDPEYYISN--RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSM-------------- 779 (870)
Q Consensus 720 ----~~~~~gt~~y~APE~~~~~--~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~-------------- 779 (870)
.....++..|+|||++.+. .++.++|||||||+++||++|+.||................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 0112345679999999764 47899999999999999999999997654332222211100
Q ss_pred ------------------hhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 780 ------------------LARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 780 ------------------~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...+......+..+...........+.+++.+|++.+|++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000000111111222222345678899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=299.11 Aligned_cols=254 Identities=25% Similarity=0.328 Sum_probs=197.0
Q ss_pred HHHHHHhhc--cccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEEEecC---
Q 002887 557 DVLKITNNF--ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEG--- 628 (870)
Q Consensus 557 dl~~~t~~f--~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~--- 628 (870)
++.+++.+| .+.||+|+||.||++... ++.+|+|.+..... ....+.+|+.++.++ +|+|++++++++...
T Consensus 16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred cCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 333444444 468999999999999985 78899999865432 245678899999999 899999999998653
Q ss_pred --CeEEEEEEEccCCchhhhhhhc--ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEe
Q 002887 629 --ANMGLIYEFMANGNLQAHLLED--KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLAD 704 (870)
Q Consensus 629 --~~~~LV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~D 704 (870)
...++|+||+++|+|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~d 171 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVD 171 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEee
Confidence 3589999999999999987542 335789999999999999999999998 999999999999999999999999
Q ss_pred ccCCccccCCCCccccccccCCCCccCccccccC-----CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHH
Q 002887 705 FGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISN-----RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSM 779 (870)
Q Consensus 705 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~ 779 (870)
||++....... .......|+..|+|||++... .++.++|||||||++|||++|+.||........+.++.
T Consensus 172 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~--- 246 (291)
T cd06639 172 FGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP--- 246 (291)
T ss_pred cccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh---
Confidence 99987653221 112335688999999998643 36889999999999999999999997654332222211
Q ss_pred hhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 780 LARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 780 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.+....+.+ .......+.+++.+|++.+|++||++.|+++
T Consensus 247 --~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 247 --RNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred --cCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111111 1223346889999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=294.57 Aligned_cols=246 Identities=27% Similarity=0.360 Sum_probs=200.3
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.+.||+|++|.||++... ++.+++|++.... ....+++.+|++++++++|+||+++++.+......++++||++++
T Consensus 5 ~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (265)
T cd06605 5 YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGG 84 (265)
T ss_pred HHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCC
Confidence 3468999999999999986 7889999987653 344567899999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHh-CCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
+|.+++.... ..+++.....++.|++.||+|||+ . +++||||||+||++++++.++|+|||.+...... ..
T Consensus 85 ~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~----~~ 156 (265)
T cd06605 85 SLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS----LA 156 (265)
T ss_pred cHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH----Hh
Confidence 9999886543 578899999999999999999998 6 9999999999999999999999999998755221 11
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCc-cchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQ-RTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~-~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
....++..|+|||++.+..++.++||||||+++++|++|+.||..... .....+.......... .....
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~ 226 (265)
T cd06605 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP----------PRLPS 226 (265)
T ss_pred hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC----------CCCCh
Confidence 126788899999999999999999999999999999999999975432 1122222222221110 01111
Q ss_pred -HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 800 -NTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 800 -~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.....+.+++.+|+..+|++|||+.|++.
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 227 GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 14556889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=292.83 Aligned_cols=248 Identities=22% Similarity=0.393 Sum_probs=198.6
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccc------hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS------VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.||+|++|.||+|... ++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 84 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence 468999999999999864 7899999987532 12346789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC-cEEEEeccCCccccCCCC
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF-QAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~-~vkL~DFGla~~~~~~~~ 716 (870)
+++++|.+++.+. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .+||+|||.+........
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 85 MAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred cCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 9999999988643 4688999999999999999999998 999999999999998776 599999999876643211
Q ss_pred c--cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccC
Q 002887 717 T--HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794 (870)
Q Consensus 717 ~--~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 794 (870)
. .......++..|+|||.+.+..++.++|+||+|+++++|++|+.||...........+. ..... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~---------~~~ 229 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF-KIASA---------TTA 229 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH-HHhcc---------CCC
Confidence 1 11223468899999999988889999999999999999999999997543322221111 11100 011
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 795 GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 795 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...+......+.+++.+|++.+|++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 230 PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 2223345567889999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=301.58 Aligned_cols=252 Identities=22% Similarity=0.308 Sum_probs=198.7
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
+.+.||+|+||.||++... ++.|++|.+..... ...+.+.+|+++++.++|+||+++++.+..+...++||||++
T Consensus 5 ~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (305)
T cd05609 5 TIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVE 84 (305)
T ss_pred EeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 4578999999999999986 67899999876532 334578899999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC----
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG---- 715 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~---- 715 (870)
+++|.+++... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 85 g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 85 GGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 99999998643 4689999999999999999999998 99999999999999999999999999986421100
Q ss_pred ---------CccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcc
Q 002887 716 ---------GTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIK 786 (870)
Q Consensus 716 ---------~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~ 786 (870)
.........++..|+|||++....++.++|+||||+++|||++|+.||.+....... ..... +..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~----~~~~~-~~~- 233 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF----GQVIS-DDI- 233 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHh-ccc-
Confidence 000112245788999999998888999999999999999999999999754332222 11111 100
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 787 NIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 787 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
..+.. .......+.+++.+|++.+|++||++.++.+.|+..
T Consensus 234 --~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 234 --EWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred --CCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 00110 112345678999999999999999977777666653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=308.65 Aligned_cols=187 Identities=25% Similarity=0.356 Sum_probs=159.8
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.+.||+|+||.||+|+.. ++.||+|+.... ....|+.++++++|+||+++++++......++|+||+.
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 140 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS- 140 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-
Confidence 345679999999999999986 568999975432 23568999999999999999999999999999999995
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
++|.+++.. ....+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 141 ~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~ 213 (357)
T PHA03209 141 SDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PAF 213 (357)
T ss_pred CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC---ccc
Confidence 578887754 335789999999999999999999998 9999999999999999999999999998753211 122
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVI 763 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~ 763 (870)
....||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 3456899999999999999999999999999999999865544
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=331.46 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=194.3
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEec--CCeEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDE--GANMGLIYE 636 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~LV~E 636 (870)
+.+.+.||+|+||.||++... ++.+|+|.+.... ......|..|+.++.+++||||+++++++.. ....++|||
T Consensus 15 YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVME 94 (1021)
T PTZ00266 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILME 94 (1021)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEe
Confidence 445689999999999999986 6789999987542 2345678999999999999999999998854 456899999
Q ss_pred EccCCchhhhhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCC----CCceeCCCCCCCEEEcCC-------------
Q 002887 637 FMANGNLQAHLLEDK--ADTLCWERRLQIASESAQGLEYLHNGCK----PPIVHRDVKSANILLNEK------------- 697 (870)
Q Consensus 637 y~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~----~~IvHrDLKp~NILld~~------------- 697 (870)
|+++|+|.++|.... ...+++..++.|+.||+.||+|||+... .+|+||||||+||||+.+
T Consensus 95 Y~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n 174 (1021)
T PTZ00266 95 FCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174 (1021)
T ss_pred CCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccc
Confidence 999999999886532 2569999999999999999999998521 369999999999999643
Q ss_pred ----CcEEEEeccCCccccCCCCccccccccCCCCccCcccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCCccch
Q 002887 698 ----FQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTL 771 (870)
Q Consensus 698 ----~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~ 771 (870)
..+||+|||++..+... .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||.......
T Consensus 175 ~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~- 250 (1021)
T PTZ00266 175 LNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS- 250 (1021)
T ss_pred cCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH-
Confidence 34899999999865322 12234579999999999864 458899999999999999999999997544322
Q ss_pred HHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 772 IGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 772 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..+.. +..+ +.+.. ......+.+|+..||+.+|++||++.|+++
T Consensus 251 --qli~~-lk~~-------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 251 --QLISE-LKRG-------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred --HHHHH-HhcC-------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 22211 1111 01100 112456889999999999999999999984
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=297.77 Aligned_cols=257 Identities=19% Similarity=0.262 Sum_probs=193.5
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.+.+.||+|+||.||+|+.. ++.+|+|++..... .....+.+|++++++++|+|++++++++.+....++|+||++
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD 82 (284)
T ss_pred eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence 34578999999999999985 88999999875422 223567889999999999999999999999999999999997
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+ +|.+++... ...+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 83 ~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--~~~ 155 (284)
T cd07839 83 Q-DLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VRC 155 (284)
T ss_pred C-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCC--CCC
Confidence 4 777776543 34689999999999999999999998 9999999999999999999999999998765322 112
Q ss_pred cccccCCCCccCccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCCcc-chHHHHHHHHhhcCC------cchhccc
Q 002887 720 STTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTPQR-TLIGQWVSSMLARGD------IKNIVDH 791 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~-~~~ksDVwS~GvvL~elltG~~p~~~~~~~-~~l~~~~~~~~~~~~------~~~i~d~ 791 (870)
.....++..|+|||++.+.. ++.++|||||||++|||++|+.|+...... ..+... ........ .....+.
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI-FRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHH-HHHhCCCChHHhHHhhhcccc
Confidence 23346788999999987654 789999999999999999999886543322 111111 11110000 0000110
Q ss_pred ccCCCC---------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 792 RLQGDF---------DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 792 ~l~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...... .......+.+++.+|++.+|++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000 1123457789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=291.41 Aligned_cols=248 Identities=25% Similarity=0.340 Sum_probs=199.0
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccchh--hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ--GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
..+.||+|++|.||+|... ++.+++|.+...... ..+.+.+|++++++++|+||+++++.+...+..++|+||+++
T Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06626 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSG 83 (264)
T ss_pred eeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCC
Confidence 4578999999999999874 788999998866443 567899999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc-
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV- 719 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~- 719 (870)
++|.+++... ..+++..+..++.++++||.|||+. +|+|+||||+||++++++.+||+|||++...........
T Consensus 84 ~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 84 GTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 9999988643 3578999999999999999999998 999999999999999999999999999887643222111
Q ss_pred -cccccCCCCccCccccccCC---CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 720 -STTVVGTPGYLDPEYYISNR---LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 720 -~~~~~gt~~y~APE~~~~~~---~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
.....++..|+|||++.+.. .+.++||||||++++||++|+.||............. . .+. .+.+.
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~---~-~~~-----~~~~~- 228 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHV---G-AGH-----KPPIP- 228 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHH---h-cCC-----CCCCC-
Confidence 12346788999999998766 8899999999999999999999997554222111111 1 010 01110
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
........+.+++.+|++.+|++||++.|++.
T Consensus 229 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 229 -DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11123556789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=291.01 Aligned_cols=245 Identities=23% Similarity=0.368 Sum_probs=192.6
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc-----hhhhHHHHHHHHHHHHhccccceeEEEEEecC--CeEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-----VQGYKQFQAEVELLIRAHHKNLTILVGYCDEG--ANMGLIY 635 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~LV~ 635 (870)
..+.||+|+||.||+|... ++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.+. ...+++|
T Consensus 6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence 3578999999999999975 7889999886431 12345788999999999999999999998764 4678999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
||+++++|.+++... ..+++...++++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 86 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 86 EHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 999999999988643 3578889999999999999999998 99999999999999999999999999987543211
Q ss_pred C-ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccC
Q 002887 716 G-THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794 (870)
Q Consensus 716 ~-~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 794 (870)
. ........|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ...... ..
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~---------~~ 227 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF----KIATQP---------TN 227 (265)
T ss_pred ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH----HHhcCC---------CC
Confidence 1 111233468889999999988889999999999999999999999997543222111 111110 01
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 795 GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 795 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...+......+.+++.+|+. +|++||+++||++
T Consensus 228 ~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 228 PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 12233445677888899985 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=295.74 Aligned_cols=245 Identities=25% Similarity=0.421 Sum_probs=194.2
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEEEec------CCeEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGYCDE------GANMGLIY 635 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~------~~~~~LV~ 635 (870)
+.+.||+|+||.||+|... ++.+|+|++.... ....++..|+.++.++ +|+|++++++++.. ....+++|
T Consensus 20 ~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~ 98 (282)
T cd06636 20 LVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVM 98 (282)
T ss_pred hheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEE
Confidence 3478999999999999985 7889999986653 2345688899999998 79999999999853 45789999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
||+++|+|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~- 174 (282)
T cd06636 99 EFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT- 174 (282)
T ss_pred EeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhcc-
Confidence 999999999998766666788999999999999999999998 9999999999999999999999999998754221
Q ss_pred CccccccccCCCCccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcc
Q 002887 716 GTHVSTTVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVD 790 (870)
Q Consensus 716 ~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d 790 (870)
........|+..|+|||.+. ...++.++|+|||||++|||++|+.||........... .. .. ..
T Consensus 175 -~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~----~~-~~-----~~ 243 (282)
T cd06636 175 -VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL----IP-RN-----PP 243 (282)
T ss_pred -ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh----Hh-hC-----CC
Confidence 11223456889999999986 34578899999999999999999999975432211111 00 00 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 791 HRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 791 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+.+ ........+.+++.+|++.+|++||++.|+++
T Consensus 244 ~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 244 PKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 111 11234457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=307.62 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=190.5
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecC------CeEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEG------ANMGLI 634 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~LV 634 (870)
..+.||+|+||.||+|... ++.||||++.... ....+.+.+|++++++++|+||+++++++... ...+++
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 98 (343)
T cd07878 19 NLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLV 98 (343)
T ss_pred hheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEE
Confidence 3478999999999999875 7789999987542 22345678899999999999999999887533 356889
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
+|++ +++|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 99 ~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 99 TNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred eecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 9987 678887763 34689999999999999999999998 9999999999999999999999999999865321
Q ss_pred CCccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc----------C
Q 002887 715 GGTHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR----------G 783 (870)
Q Consensus 715 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~----------~ 783 (870)
.....|++.|+|||++.+ ..++.++|||||||++|||++|+.||........+..+....-.. +
T Consensus 172 -----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07878 172 -----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246 (343)
T ss_pred -----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence 234568999999999876 568899999999999999999999997654333333222111000 0
Q ss_pred CcchhcccccCCCCC--------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 784 DIKNIVDHRLQGDFD--------TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 784 ~~~~i~d~~l~~~~~--------~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
....... .+. ... ......+.+++.+|++.||++|||+.|+++.
T Consensus 247 ~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 247 HARKYIQ-SLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hHHHHhh-ccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 000 000 0112357799999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=292.85 Aligned_cols=247 Identities=26% Similarity=0.400 Sum_probs=196.2
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEEEecCC------eEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGA------NMGLI 634 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~------~~~LV 634 (870)
.+.+.||+|++|.||+|... ++.+++|++..... ..+++.+|+++++++ +|+||+++++++.... ..++|
T Consensus 9 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv 87 (275)
T cd06608 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLV 87 (275)
T ss_pred eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEE
Confidence 34578999999999999985 67899999876543 346789999999999 7999999999996543 48999
Q ss_pred EEEccCCchhhhhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCcccc
Q 002887 635 YEFMANGNLQAHLLEDK--ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 712 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~ 712 (870)
|||+++++|.+++.... ...+++..+..++.|+++||.|||+. +++||||+|+||++++++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~ 164 (275)
T cd06608 88 MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164 (275)
T ss_pred EEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceecc
Confidence 99999999999886543 46789999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCccccccccCCCCccCcccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcch
Q 002887 713 VEGGTHVSTTVVGTPGYLDPEYYIS-----NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKN 787 (870)
Q Consensus 713 ~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (870)
.. ........|+..|+|||++.. ..++.++|||||||++++|++|+.||..........+. . .+..
T Consensus 165 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----~-~~~~-- 235 (275)
T cd06608 165 ST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI----P-RNPP-- 235 (275)
T ss_pred cc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh----h-ccCC--
Confidence 21 122234568899999998753 34678999999999999999999999754332222221 1 1100
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 788 IVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 788 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+.+ .........+.+++.+|+..+|++|||+.|+++
T Consensus 236 ---~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 236 ---PTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ---CCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111 111224457889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=296.07 Aligned_cols=242 Identities=22% Similarity=0.322 Sum_probs=198.5
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCchh
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQ 644 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 644 (870)
+.||+|++|.||++... ++.+++|++........+.+.+|+.+++.++|+|++++++++...+..++++||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 68999999999999874 7889999987665555667899999999999999999999999999999999999999999
Q ss_pred hhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccccc
Q 002887 645 AHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVV 724 (870)
Q Consensus 645 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 724 (870)
+++.. ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+...... ........
T Consensus 105 ~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~ 176 (285)
T cd06648 105 DIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRKSLV 176 (285)
T ss_pred HHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccC--Cccccccc
Confidence 98854 4689999999999999999999998 9999999999999999999999999988754322 11223456
Q ss_pred CCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHH
Q 002887 725 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWK 804 (870)
Q Consensus 725 gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 804 (870)
|+..|+|||.+.+..++.++||||||++++||++|+.||........ ..... .+. .+.+. ........
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~----~~~~~-~~~-----~~~~~--~~~~~~~~ 244 (285)
T cd06648 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA----MKRIR-DNL-----PPKLK--NLHKVSPR 244 (285)
T ss_pred CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH----HHHHH-hcC-----CCCCc--ccccCCHH
Confidence 88999999999888899999999999999999999999875432221 11111 111 01111 11123457
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 002887 805 AVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 805 l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+.+++.+|++.+|++||++.++++
T Consensus 245 l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 245 LRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHcccChhhCcCHHHHcc
Confidence 899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=290.87 Aligned_cols=241 Identities=22% Similarity=0.363 Sum_probs=204.4
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCch
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL 643 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 643 (870)
.++||+|+||.||+|.++ |+.+|||.+...+ +.+++..|+.++.+++.|++|+++|.+.....+++|||||-.|++
T Consensus 38 ~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi 115 (502)
T KOG0574|consen 38 VGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI 115 (502)
T ss_pred HHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence 357999999999999986 8999999987653 467889999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccccc
Q 002887 644 QAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV 723 (870)
Q Consensus 644 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~ 723 (870)
.+.++. +.++|++.++..+++..++||+|||.. .-+|||||+.||||+.+|.+||+|||.+..+.+ .....+.+
T Consensus 116 SDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKRNTV 189 (502)
T KOG0574|consen 116 SDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKRNTV 189 (502)
T ss_pred HHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhhCcc
Confidence 998754 567999999999999999999999988 789999999999999999999999999976532 23345678
Q ss_pred cCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC--HHH
Q 002887 724 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD--TNT 801 (870)
Q Consensus 724 ~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~--~~~ 801 (870)
+||+.|||||++..-.|+.++||||+|+...||..|++||........+.. +.......+. +.-
T Consensus 190 IGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM--------------IPT~PPPTF~KPE~W 255 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM--------------IPTKPPPTFKKPEEW 255 (502)
T ss_pred ccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe--------------ccCCCCCCCCChHhh
Confidence 999999999999999999999999999999999999999987654322110 1111112222 233
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
....-+++..|+-+.|++|-|+-++++
T Consensus 256 S~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 256 SSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 457789999999999999999999865
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=296.75 Aligned_cols=258 Identities=20% Similarity=0.290 Sum_probs=197.5
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
..+.||+|++|.||+|... ++.||+|++..... ...+.+.+|++++++++|+|++++++++.++...+++|||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence 3468999999999999874 88999999875532 233568899999999999999999999999999999999995
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
++|.+++.......+++..++.++.|+++||+|||+. +++||||+|+||++++++.++|+|||++...... ....
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~ 156 (283)
T cd07835 82 LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTY 156 (283)
T ss_pred cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cccc
Confidence 6899888665545789999999999999999999998 9999999999999999999999999998754222 1112
Q ss_pred ccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCC--------cchhcc-
Q 002887 721 TTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGD--------IKNIVD- 790 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~--------~~~i~d- 790 (870)
....++..|+|||++.+. .++.++|+||||+++|||++|++||..........+.......... +.+...
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 233568899999988764 4789999999999999999999999765543333332221110000 000000
Q ss_pred -cccC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 791 -HRLQ----GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 791 -~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+... ..........+.+++.+|++.+|++||+++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 0001123357889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=296.14 Aligned_cols=256 Identities=22% Similarity=0.333 Sum_probs=192.5
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccchh-hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ-GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.+.||+|++|.||+|+.. ++.||+|.+...... ....+.+|++++++++|+||+++++++.+....++||||+.+
T Consensus 9 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 87 (291)
T cd07844 9 KLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT- 87 (291)
T ss_pred EEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-
Confidence 4578999999999999975 789999998754322 234567899999999999999999999999999999999985
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++.... ..+++.....++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++...... ....
T Consensus 88 ~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~ 161 (291)
T cd07844 88 DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--KTYS 161 (291)
T ss_pred CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC--cccc
Confidence 8988876543 4788999999999999999999998 99999999999999999999999999987542111 1122
Q ss_pred cccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCcc-chHHHHHHHHhhcC---Ccchh------c-
Q 002887 722 TVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQR-TLIGQWVSSMLARG---DIKNI------V- 789 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~-~~l~~~~~~~~~~~---~~~~i------~- 789 (870)
...++..|+|||++.+ ..++.++||||+|+++|||++|+.||...... ..+.... ...... ..... .
T Consensus 162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIF-RVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHH-HhcCCCChhhhhhhhhcccccc
Confidence 3356789999999875 45889999999999999999999999755421 1111111 111000 00000 0
Q ss_pred -------ccccCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 790 -------DHRLQGDF-DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 790 -------d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...+.... .......+.+++.+|++.+|++||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000 0011256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=297.77 Aligned_cols=259 Identities=22% Similarity=0.314 Sum_probs=199.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
++.+.||+|++|.||+|... ++.|++|+++... ....+.+.+|++++++++|+||+++++++..++..++||||++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 83 (288)
T cd07833 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVE 83 (288)
T ss_pred eEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCC
Confidence 45678999999999999986 7889999987542 2334678999999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
++.+..... +...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++........ ..
T Consensus 84 ~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (288)
T cd07833 84 RTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SP 157 (288)
T ss_pred CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-cc
Confidence 877765543 234589999999999999999999998 999999999999999999999999999887643321 12
Q ss_pred cccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHH-----------hhcCCcc-
Q 002887 720 STTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSM-----------LARGDIK- 786 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~-----------~~~~~~~- 786 (870)
.....++..|+|||++.+. .++.++||||||+++|+|++|++||........+....... .......
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 2345678899999999888 78999999999999999999999997654322221111000 0000000
Q ss_pred ----hhcccc-cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 787 ----NIVDHR-LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 787 ----~i~d~~-l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+..++. +...+......++.+++.+|+..+|++||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000 000111123577899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=289.70 Aligned_cols=247 Identities=25% Similarity=0.366 Sum_probs=203.1
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.+.||+|++|.||+|... ++.+++|++..... ...+.+.+|++.+.+++|+|++++++++......++|+||++++
T Consensus 5 ~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06623 5 RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGG 84 (264)
T ss_pred eeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCC
Confidence 4578999999999999986 78999999877644 44678999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHh-CCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
+|.+++... ..+++..++.++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||++....... ...
T Consensus 85 ~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~ 157 (264)
T cd06623 85 SLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL--DQC 157 (264)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC--Ccc
Confidence 999998643 578999999999999999999999 7 99999999999999999999999999988653222 112
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
....++..|+|||.+.+..++.++|+||||+++|||++|+.||....... ..+....... +.. ......
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~-~~~---------~~~~~~ 226 (264)
T cd06623 158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS-FFELMQAICD-GPP---------PSLPAE 226 (264)
T ss_pred cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC-HHHHHHHHhc-CCC---------CCCCcc
Confidence 24567889999999998889999999999999999999999997654211 1111111111 100 111222
Q ss_pred -HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 801 -TVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 801 -~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
....+.+++.+|+..+|++||++.|+++.
T Consensus 227 ~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 227 EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 45688999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=296.07 Aligned_cols=257 Identities=19% Similarity=0.277 Sum_probs=196.0
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccchh--hhHHHHHHHHHHHHhccccceeEEEEEecC--CeEEEEEEEc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ--GYKQFQAEVELLIRAHHKNLTILVGYCDEG--ANMGLIYEFM 638 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~LV~Ey~ 638 (870)
+.+.||+|+||.||+|... ++.+++|.++..... ....+.+|++++.+++||||+++++++... ...++||||+
T Consensus 9 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~ 88 (293)
T cd07843 9 KLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV 88 (293)
T ss_pred hhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhc
Confidence 4578999999999999986 788999999754322 234567899999999999999999998777 8899999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++ +|.+.+.... ..+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||++....... .
T Consensus 89 ~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~ 161 (293)
T cd07843 89 EH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL--K 161 (293)
T ss_pred Cc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc--c
Confidence 84 8888775433 4689999999999999999999998 99999999999999999999999999988653321 1
Q ss_pred ccccccCCCCccCccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhh----------------
Q 002887 719 VSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLA---------------- 781 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~-~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~---------------- 781 (870)
......+++.|+|||.+.+.. .+.++|+||||++++||++|++||..........+.......
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 223345788999999987644 689999999999999999999999865543322222111100
Q ss_pred cCCcchhcccccCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 782 RGDIKNIVDHRLQGDFDTN-TVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 782 ~~~~~~i~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...........+...+... ....+.+++.+|++.+|++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000001111111112211 3556789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=293.88 Aligned_cols=245 Identities=23% Similarity=0.341 Sum_probs=194.9
Q ss_pred ccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCch
Q 002887 569 LGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL 643 (870)
Q Consensus 569 LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 643 (870)
||+|+||+||++... ++.+|+|.+..... .....+.+|++++++++|||++++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 78999999875432 2344567899999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccccc
Q 002887 644 QAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV 723 (870)
Q Consensus 644 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~ 723 (870)
.+++.......+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||.+..... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccc
Confidence 9998765555799999999999999999999998 999999999999999999999999999876532 1122334
Q ss_pred cCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHH
Q 002887 724 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVW 803 (870)
Q Consensus 724 ~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 803 (870)
.++..|+|||++.+..++.++||||||+++++|++|+.||.................. ...........
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~ 223 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE-----------MAVEYPDKFSP 223 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-----------ccccCCccCCH
Confidence 6788999999998888999999999999999999999999765432221111111000 00111223355
Q ss_pred HHHHHHHHccccCCCCCCCHHH-HHHHH
Q 002887 804 KAVEIALACIHTISTRRPTMNQ-VVIEL 830 (870)
Q Consensus 804 ~l~~l~~~Cl~~dP~~RPsm~e-Vl~~L 830 (870)
.+.+++.+|++.+|++||+.++ .+..|
T Consensus 224 ~~~~li~~~l~~~p~~R~~~~~~~~~~l 251 (277)
T cd05577 224 EAKDLCEALLQKDPEKRLGCRGGSADEV 251 (277)
T ss_pred HHHHHHHHHccCChhHccCCCcccHHHH
Confidence 7789999999999999995555 33333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=286.05 Aligned_cols=245 Identities=29% Similarity=0.461 Sum_probs=201.9
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
..+.||+|++|.||++... ++.+++|++........+.+.+|++++++++|+|++++++++......++++||+++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 83 (253)
T cd05122 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS 83 (253)
T ss_pred eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence 3578999999999999986 78899999987665566789999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.+++.... ..+++..+..++.|+++||.|||+. +++||||+|+||++++++.++|+|||.+........ ...
T Consensus 84 L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~ 156 (253)
T cd05122 84 LKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNT 156 (253)
T ss_pred HHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccc
Confidence 999886542 5789999999999999999999997 999999999999999999999999999886643221 334
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTV 802 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 802 (870)
..++..|+|||.+.+...+.++|+||||+++++|++|+.||............ .. ........ .....
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~-------~~~~~ 224 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI----AT-NGPPGLRN-------PEKWS 224 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH----Hh-cCCCCcCc-------ccccC
Confidence 56889999999999888999999999999999999999999765322211111 10 11111100 11124
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 803 WKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 803 ~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..+.+++.+|++.+|++|||+.|+++
T Consensus 225 ~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 225 DEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 56889999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=317.62 Aligned_cols=255 Identities=18% Similarity=0.273 Sum_probs=187.7
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccc------cceeEEEEEecC-CeEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHK------NLTILVGYCDEG-ANMGL 633 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~------nIv~l~g~~~~~-~~~~L 633 (870)
+.+.+.||+|+||.||+|... ++.||||+++... .....+..|++++.+++|. +++++++++... .+.++
T Consensus 131 y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~i 209 (467)
T PTZ00284 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCI 209 (467)
T ss_pred EEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEE
Confidence 344578999999999999875 7889999997532 2234567788888887654 488888988764 46888
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC---------------
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF--------------- 698 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~--------------- 698 (870)
|||++ +++|.+++.+. ..+++..+..|+.||+.||+|||++ .+|+||||||+|||++.++
T Consensus 210 v~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 210 VMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred EEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 88887 67888887643 4689999999999999999999973 2899999999999998765
Q ss_pred -cEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002887 699 -QAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVS 777 (870)
Q Consensus 699 -~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~ 777 (870)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|++||........+..+..
T Consensus 285 ~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 285 CRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred ceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 49999999876421 223456899999999999999999999999999999999999999986554332221111
Q ss_pred HHh-------h---cCCcchhcccc--cCCCC---------------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 778 SML-------A---RGDIKNIVDHR--LQGDF---------------DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 778 ~~~-------~---~~~~~~i~d~~--l~~~~---------------~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..- . .....++++.. +.... .......+.+|+.+||+.||++|||++|+++
T Consensus 360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 000 0 00000011000 00000 0012345779999999999999999999986
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=291.84 Aligned_cols=253 Identities=25% Similarity=0.296 Sum_probs=196.8
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecC--CeEEEEEEEcc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEG--ANMGLIYEFMA 639 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~LV~Ey~~ 639 (870)
..+.||.|++|.||++... ++.+|+|.+..... ....++.+|++++++++|+||++++++|... ...++||||++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 84 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE 84 (287)
T ss_pred EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence 3468999999999999985 78899999875432 3456789999999999999999999998653 46899999999
Q ss_pred CCchhhhhhhc--ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 640 NGNLQAHLLED--KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 640 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++|.+++... ....+++.....++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--- 158 (287)
T cd06621 85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS--- 158 (287)
T ss_pred CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccc---
Confidence 99998877542 335688999999999999999999998 9999999999999999999999999998754221
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCcc-chHHHHHHHHhhcCCcchhcccccCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQR-TLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~-~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ....+....... .....+ .... .
T Consensus 159 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~--~ 233 (287)
T cd06621 159 -LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPEL-KDEP--G 233 (287)
T ss_pred -ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhh-ccCC--C
Confidence 112345788999999999889999999999999999999999999765321 111111111111 011111 0000 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
........+.+++.+|++.+|++|||+.|+++
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 01123567889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=292.58 Aligned_cols=243 Identities=25% Similarity=0.426 Sum_probs=196.0
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhc---cccceeEEEEEecCCeEEEEEEEc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAH---HKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
+.+.||+|+||.||+|... ++.+|+|.+.... ....+++.+|++++++++ |+|++++++++..+...++||||+
T Consensus 5 ~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06917 5 RLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYA 84 (277)
T ss_pred hhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecC
Confidence 3468999999999999974 7899999987542 334567889999999997 999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++++|.+++.. ..+++...+.++.|++.||.|||+. +++||||+|+||++++++.++|+|||++....... .
T Consensus 85 ~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~ 156 (277)
T cd06917 85 EGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--S 156 (277)
T ss_pred CCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--c
Confidence 99999998743 3789999999999999999999998 99999999999999999999999999998764322 2
Q ss_pred ccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
......|+..|+|||.+.++ .++.++|+||||+++|+|++|+.||........ .. ..... ..+.+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~----~~-~~~~~-----~~~~~~~-- 224 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA----MM-LIPKS-----KPPRLED-- 224 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh----hh-ccccC-----CCCCCCc--
Confidence 22344688999999998754 468999999999999999999999975432211 10 01000 1111111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
......+.+++.+|++.+|++||++.|+++
T Consensus 225 -~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 225 -NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred -ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 113457889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=297.94 Aligned_cols=246 Identities=23% Similarity=0.344 Sum_probs=199.9
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
.+.+.||+|+||.||++... ++.+++|.+........+.+.+|+.++++++|||++++++.+...+..++|+||++++
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (293)
T cd06647 22 TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGG 101 (293)
T ss_pred eeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCC
Confidence 34578999999999999864 7889999987655555677899999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++.+ ..+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++....... ....
T Consensus 102 ~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--~~~~ 173 (293)
T cd06647 102 SLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRS 173 (293)
T ss_pred cHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc--cccc
Confidence 99998853 3578999999999999999999998 99999999999999999999999999987653322 1223
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
...+++.|+|||.+....++.++|+||||+++||+++|+.||........+..+ ...+ ..........
T Consensus 174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~----~~~~--------~~~~~~~~~~ 241 (293)
T cd06647 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----ATNG--------TPELQNPEKL 241 (293)
T ss_pred cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh----hcCC--------CCCCCCcccc
Confidence 346888999999998888999999999999999999999999754432211110 0000 0001112233
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
...+.+++.+|++.+|++||++.+++..
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 4568899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=296.39 Aligned_cols=239 Identities=26% Similarity=0.405 Sum_probs=196.6
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|++|.||++... ++.+|+|++.... ....+.+.+|++++++++||||+++++++.++...++||||+
T Consensus 4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (290)
T cd05580 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYV 83 (290)
T ss_pred EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecC
Confidence 34578999999999999985 7899999987543 233466889999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++++|.+++... ..+++..+..++.|+++||.|||+. +++||||||+||++++++.+||+|||++......
T Consensus 84 ~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 84 PGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 999999998644 5789999999999999999999998 9999999999999999999999999998865322
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
.....+++.|+|||.+.+...+.++||||||+++++|++|+.||..........+ ...+.. ..+
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~----------~~~ 218 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK-----ILEGKV----------RFP 218 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HhcCCc----------cCC
Confidence 2345688999999999888889999999999999999999999976542211111 111111 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRP-----TMNQVV 827 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl 827 (870)
......+.+++.+|++.+|++|| +++|++
T Consensus 219 ~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 219 SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 22345778999999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=294.25 Aligned_cols=258 Identities=24% Similarity=0.327 Sum_probs=197.2
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecC--CeEEEEEEEc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEG--ANMGLIYEFM 638 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~LV~Ey~ 638 (870)
+.+.||+|++|.||+|+.. ++.+|+|++.... ....+.+.+|++++++++|+|++++++++... ...++|+||+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM 82 (287)
T ss_pred eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence 4578999999999999986 6899999998763 33345688999999999999999999999887 8899999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++ +|.+++.... ..+++..++.++.|+++||+|||+. +++|+||||+||++++++.+||+|||++........ .
T Consensus 83 ~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (287)
T cd07840 83 DH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-A 156 (287)
T ss_pred cc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-c
Confidence 85 8888775432 4789999999999999999999998 999999999999999999999999999986643221 1
Q ss_pred ccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhh--cCCcchhcc-----
Q 002887 719 VSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLA--RGDIKNIVD----- 790 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~--~~~~~~i~d----- 790 (870)
......++..|+|||.+.+ ..++.++||||||++++||++|+.||................-. ........+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 2233456788999998765 45789999999999999999999999765543322222111100 000000000
Q ss_pred ---------cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 791 ---------HRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 791 ---------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..+.......+...+.+++.+|++.+|++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000001112567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=297.12 Aligned_cols=261 Identities=19% Similarity=0.229 Sum_probs=198.5
Q ss_pred cccccccCcEEEEEEEECCeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCch
Q 002887 566 ERVLGKGGFGTVYHGYLDDKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL 643 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 643 (870)
.+.+|.|+++.||++..+++.||||++... .....+.+.+|++++++++|+||+++++++.+....+++|||+++|+|
T Consensus 7 ~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 7 GKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred hHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 345667777778887778999999998765 334557899999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc-----c
Q 002887 644 QAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT-----H 718 (870)
Q Consensus 644 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~-----~ 718 (870)
.+++.......+++.....++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+......+.. .
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9999766556788999999999999999999998 9999999999999999999999999998755322111 1
Q ss_pred ccccccCCCCccCcccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHh----hcC-------Cc
Q 002887 719 VSTTVVGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSML----ARG-------DI 785 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~--~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~----~~~-------~~ 785 (870)
......++..|+|||++.. ..++.++|+|||||+++||++|+.||..........+...... ... ..
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 1123457788999999876 3588999999999999999999999986543322211111000 000 00
Q ss_pred ch----hccccc----CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 786 KN----IVDHRL----QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 786 ~~----i~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
.. ..++.. ...........+.+++.+||+.+|++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00 000000 001112334578899999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-32 Score=295.26 Aligned_cols=242 Identities=27% Similarity=0.393 Sum_probs=193.1
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
...+.||+|+||.||+|... ++.||+|.+.... ....+.+.+|+++++.++|||++++.++|......++|+||+
T Consensus 18 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 97 (307)
T cd06607 18 TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC 97 (307)
T ss_pred hhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhh
Confidence 34578999999999999975 7899999986432 233457889999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
. |++.+.+... ...+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||++......
T Consensus 98 ~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---- 168 (307)
T cd06607 98 L-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---- 168 (307)
T ss_pred C-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence 7 5666666432 34689999999999999999999998 9999999999999999999999999998754221
Q ss_pred ccccccCCCCccCccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 719 VSTTVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~---~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
....++..|+|||++. .+.++.++||||||+++|||++|++||........... ...+.. +.+
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~-----~~~~~~-----~~~-- 234 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-----IAQNDS-----PTL-- 234 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH-----HhcCCC-----CCC--
Confidence 2346788999999884 35688999999999999999999999975543221111 111100 001
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
........+.+++.+|++.+|++||++.+|+..
T Consensus 235 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 235 -SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 112234578899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=293.46 Aligned_cols=244 Identities=25% Similarity=0.378 Sum_probs=200.3
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCch
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL 643 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 643 (870)
.+.||+|++|.||+|... ++.+++|++..... ..+.+.+|++++++++|+|++++++.+......++|+||+++++|
T Consensus 24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 102 (286)
T cd06614 24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL 102 (286)
T ss_pred hHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcH
Confidence 468999999999999986 88899999986644 556789999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccccc
Q 002887 644 QAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV 723 (870)
Q Consensus 644 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~ 723 (870)
.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....... ......
T Consensus 103 ~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 176 (286)
T cd06614 103 TDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK--SKRNSV 176 (286)
T ss_pred HHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch--hhhccc
Confidence 99987543 4799999999999999999999998 99999999999999999999999999987553221 122344
Q ss_pred cCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHH
Q 002887 724 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVW 803 (870)
Q Consensus 724 ~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 803 (870)
.++..|+|||++.+..++.++|+||||+++|+|++|+.||...........+ . ....... ........
T Consensus 177 ~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~----~-~~~~~~~-------~~~~~~~~ 244 (286)
T cd06614 177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI----T-TKGIPPL-------KNPEKWSP 244 (286)
T ss_pred cCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----H-hcCCCCC-------cchhhCCH
Confidence 5788999999998888999999999999999999999999754433222211 1 1111100 00111345
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 002887 804 KAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 804 ~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.+.+++.+|++.+|.+||++.++++
T Consensus 245 ~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 245 EFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhh
Confidence 6889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=294.71 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=192.7
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhc-cccceeEEEEEecCCeEEEEEEEccCC
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAH-HKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
.+.||+|+||.||++... ++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||+..
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~- 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI- 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence 367999999999999985 7899999987543 234567889999999996 99999999999999999999999874
Q ss_pred chhh---hhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 642 NLQA---HLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 642 sL~~---~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++.+ .+.......+++..+..++.++++||+|||+. .+++||||||+||+++.++.+||+|||++...... .
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~---~ 162 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS---I 162 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC---C
Confidence 4433 33333346789999999999999999999974 28999999999999999999999999998765322 1
Q ss_pred ccccccCCCCccCccccccC---CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 719 VSTTVVGTPGYLDPEYYISN---RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~---~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
......|+..|+|||++.+. .++.++|||||||++|||++|+.||..... ..+....... +. .+.+..
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~-~~-----~~~~~~ 233 (288)
T cd06616 163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---VFDQLTQVVK-GD-----PPILSN 233 (288)
T ss_pred ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---HHHHHhhhcC-CC-----CCcCCC
Confidence 12234688899999999766 689999999999999999999999975431 1111111111 11 111222
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
.........+.+++.+|++.+|++|||+.||++.
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2222355678999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=284.58 Aligned_cols=246 Identities=24% Similarity=0.386 Sum_probs=202.2
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecC--CeEEEEEEEcc
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEG--ANMGLIYEFMA 639 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~LV~Ey~~ 639 (870)
.+.||+|++|.||+|... ++.|++|++..... ...+.+.+|++++++++|+||+++++.+... ...++++||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 478999999999999986 88999999876643 4567889999999999999999999999988 88999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+++|.+++.... .+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||.+...........
T Consensus 85 ~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 85 GGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 999999986543 789999999999999999999998 999999999999999999999999999887643322111
Q ss_pred cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
.....++..|+|||.+.+...+.++||||||+++++|++|+.||....... ....... ........+.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~---------~~~~~~~~~~ 227 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM---AALYKIG---------SSGEPPEIPE 227 (260)
T ss_pred ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---HHHHhcc---------ccCCCcCCCc
Confidence 344568899999999988889999999999999999999999998655111 1111111 0011112223
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.....+.+++.+|++.+|++||++.|+++
T Consensus 228 ~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 228 HLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 33567889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=305.39 Aligned_cols=238 Identities=28% Similarity=0.400 Sum_probs=196.8
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeecc---chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSS---SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.||.|+||.||-|+.. .+.||||++.-. +...+..+..|+..|.+++|||++.+.|+|-.+...+||||||-|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG- 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG- 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-
Confidence 56999999999999875 778999999754 445678899999999999999999999999999999999999975
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+-.+.+.- ..+++-.-.+..|+.+.++||+|||+. +.||||||+.||||++.|.|||+|||.|.+.. ...
T Consensus 111 SAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------PAn 180 (948)
T KOG0577|consen 111 SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMA------PAN 180 (948)
T ss_pred cHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcC------chh
Confidence 55665533 346788899999999999999999998 99999999999999999999999999987652 345
Q ss_pred cccCCCCccCccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 722 TVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 722 ~~~gt~~y~APE~~~---~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
.++|||.|||||++. .+.|+-|+||||+|++..||...++|...+.....+..++. .+ .|.|. .
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ-----Ne-----sPtLq---s 247 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-----NE-----SPTLQ---S 247 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh-----cC-----CCCCC---C
Confidence 789999999999985 46799999999999999999999999876665443333221 11 11222 2
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.+=...+..++..|+++-|.+|||..++++
T Consensus 248 ~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 248 NEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred chhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 233456778999999999999999988743
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=302.06 Aligned_cols=247 Identities=22% Similarity=0.328 Sum_probs=202.3
Q ss_pred hccccccccCcEEEEEEEEC-CeeEEEEEeecc--chhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSS--SVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
...+.||+||.++||++... .+.+|+|++... ..+....|.+|+..|.++ .|.+|+++++|-..+..+||||||=+
T Consensus 364 eilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd 443 (677)
T KOG0596|consen 364 EILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGD 443 (677)
T ss_pred hHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeeccc
Confidence 34478999999999999987 456788776543 345567899999999999 59999999999999999999999754
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
.+|..+|.........| .+..+..|++.|+.++|++ +|||.||||.|+|+-+ |.+||+|||+|..+..+...-.
T Consensus 444 -~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~ 517 (677)
T KOG0596|consen 444 -IDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIV 517 (677)
T ss_pred -ccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCcccccee
Confidence 58988887766555556 7788999999999999999 9999999999999987 4999999999998877766667
Q ss_pred cccccCCCCccCccccccC-----------CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchh
Q 002887 720 STTVVGTPGYLDPEYYISN-----------RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNI 788 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~-----------~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i 788 (870)
....+||+.||+||.+... +++.++||||+||+||+|+.|++||+.... .|. .+..+
T Consensus 518 kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~~a-------Kl~aI 585 (677)
T KOG0596|consen 518 KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----QIA-------KLHAI 585 (677)
T ss_pred eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----HHH-------HHHhh
Confidence 7788999999999998532 266889999999999999999999974221 121 23456
Q ss_pred cccccCCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 789 VDHRLQGDFDT-NTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 789 ~d~~l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.|+.-..+++. ....++++++..||+.||++||+..++++
T Consensus 586 ~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 586 TDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred cCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 66655444543 23334999999999999999999999986
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=291.52 Aligned_cols=257 Identities=21% Similarity=0.304 Sum_probs=191.2
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccchh-hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ-GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.+.||+|+||.||+|... ++.+++|++...... ....+.+|++++++++|+||+++.+++..+...++|+||+. +
T Consensus 9 ~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~ 87 (291)
T cd07870 9 NLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-T 87 (291)
T ss_pred EEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-C
Confidence 4578999999999999875 789999998765332 23467889999999999999999999999999999999996 6
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
++.+++... ...+.+..+..++.|++.||.|||+. +|+||||||+||+++.++++||+|||+++...... ....
T Consensus 88 ~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~ 161 (291)
T cd07870 88 DLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--QTYS 161 (291)
T ss_pred CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC--CCCC
Confidence 777666443 24578888999999999999999998 99999999999999999999999999987542221 1123
Q ss_pred cccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCcc-chHHHHHHHH-----------hh-cCCcch
Q 002887 722 TVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQR-TLIGQWVSSM-----------LA-RGDIKN 787 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~-~~l~~~~~~~-----------~~-~~~~~~ 787 (870)
...+++.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.+..... .. ......
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence 34578899999998764 5788999999999999999999999754421 1111110000 00 000000
Q ss_pred hcccccCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 788 IVDHRLQGDF-----DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 788 i~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.......... .......+.+++.+|++.+|++|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000 0012456789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=290.87 Aligned_cols=246 Identities=25% Similarity=0.387 Sum_probs=198.5
Q ss_pred ccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCch
Q 002887 569 LGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL 643 (870)
Q Consensus 569 LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 643 (870)
||+|+||.||+++.. ++.+++|.+..... ...+.+.+|++++++++|+|++++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 88999999876543 3456789999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC------c
Q 002887 644 QAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG------T 717 (870)
Q Consensus 644 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~------~ 717 (870)
.+++... ..+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 9988643 3789999999999999999999998 999999999999999999999999999875432211 1
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
.......++..|+|||.......+.++||||||++++||++|+.||.......... .... +.. ....
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~----~~~~-~~~--------~~~~ 222 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ----NILN-GKI--------EWPE 222 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHhc-CCc--------CCCc
Confidence 12234567889999999988889999999999999999999999997654332221 1111 111 0000
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
.......+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 223 DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 11125677899999999999999999777666653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-32 Score=287.58 Aligned_cols=235 Identities=23% Similarity=0.328 Sum_probs=192.9
Q ss_pred ccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCch
Q 002887 569 LGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL 643 (870)
Q Consensus 569 LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 643 (870)
||+|++|.||+++.. ++.+++|++..... ...+.+.+|++++++++|+||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999987 88999999875432 3346789999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccccc
Q 002887 644 QAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV 723 (870)
Q Consensus 644 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~ 723 (870)
.+++... ..+++..+..++.|+++||.|||+. +++|+||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~ 152 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF 152 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence 9998643 4588999999999999999999998 99999999999999999999999999998653221 22334
Q ss_pred cCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHH
Q 002887 724 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVW 803 (870)
Q Consensus 724 ~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 803 (870)
.++..|+|||.+.+..++.++|+||||+++|||++|+.||...... ..+....... .......+.....
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~---------~~~~~~~~~~~~~ 221 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED--PMEIYNDILK---------GNGKLEFPNYIDK 221 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC--HHHHHHHHhc---------cCCCCCCCcccCH
Confidence 6888999999998888999999999999999999999999765421 1122222111 0111122223356
Q ss_pred HHHHHHHHccccCCCCCCC
Q 002887 804 KAVEIALACIHTISTRRPT 822 (870)
Q Consensus 804 ~l~~l~~~Cl~~dP~~RPs 822 (870)
.+.+++.+|++.+|++||+
T Consensus 222 ~~~~~i~~~l~~~p~~R~~ 240 (262)
T cd05572 222 AAKDLIKQLLRRNPEERLG 240 (262)
T ss_pred HHHHHHHHHccCChhhCcC
Confidence 7899999999999999999
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-31 Score=294.74 Aligned_cols=242 Identities=27% Similarity=0.376 Sum_probs=194.1
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
..+.||+|+||.||+|+.. ++.+|+|++.... ....+.+.+|++++++++|+|++++++++.++...++||||+.
T Consensus 29 ~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 108 (317)
T cd06635 29 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL 108 (317)
T ss_pred hhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC
Confidence 3467999999999999974 7889999987542 2334578899999999999999999999999999999999997
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+ ++.+.+... ...+++.++..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||++.....
T Consensus 109 g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------ 177 (317)
T cd06635 109 G-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ 177 (317)
T ss_pred C-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC------
Confidence 4 777766433 35689999999999999999999998 999999999999999999999999999875421
Q ss_pred cccccCCCCccCccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 720 STTVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~---~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
.....|+..|+|||++. .+.++.++|||||||++|||++|+.||...........+.. .+. ...
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~----~~~---------~~~ 244 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NES---------PTL 244 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh----ccC---------CCC
Confidence 12346888999999974 45688999999999999999999999876443322222211 110 001
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVIEL 830 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 830 (870)
........+.+++.+|++.+|++||++.++++.+
T Consensus 245 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred CCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 1123345688999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=286.35 Aligned_cols=245 Identities=27% Similarity=0.416 Sum_probs=203.3
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.||+|++|.||++... ++.+++|++..... ...+.+.+|++++++++|+|++++++.+..+...++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~ 83 (258)
T cd08215 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83 (258)
T ss_pred EEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCC
Confidence 4578999999999999986 88999999976543 4566789999999999999999999999999999999999999
Q ss_pred Cchhhhhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 641 GNLQAHLLEDK--ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 641 gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|.+++.+.. ...+++..+..++.++++||.|||+. +++|+||+|+||++++++.++|+|||.+....... .
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~ 158 (258)
T cd08215 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--D 158 (258)
T ss_pred CcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc--c
Confidence 99999987643 46799999999999999999999998 99999999999999999999999999998653322 2
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
......|++.|+|||...+..++.++|+||+|+++++|++|+.||........ ...... ... ...+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----~~~~~~-~~~---------~~~~ 224 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL----ALKILK-GQY---------PPIP 224 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH----HHHHhc-CCC---------CCCC
Confidence 23345688899999999888899999999999999999999999976543222 222111 111 1112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
......+.+++.+|+..+|++||++.|+++
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 225 SQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 233457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=290.05 Aligned_cols=257 Identities=23% Similarity=0.327 Sum_probs=197.7
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHh---ccccceeEEEEEecCCe-----EE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRA---HHKNLTILVGYCDEGAN-----MG 632 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~-----~~ 632 (870)
+.+.||+|+||.||+|+.. ++.+|+|++..... .....+.+|++++.++ +|+|++++++++...+. .+
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 82 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT 82 (287)
T ss_pred EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence 4578999999999999986 78999999975422 2234566788877766 59999999999987776 99
Q ss_pred EEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCcccc
Q 002887 633 LIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 712 (870)
Q Consensus 633 LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~ 712 (870)
++|||+.+ +|.+++.......+++..+..++.|+++||.|||+. +++|+||||+||++++++.+||+|||++....
T Consensus 83 l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 83 LVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred EEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 99999985 788888665445699999999999999999999998 99999999999999999999999999997653
Q ss_pred CCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcc------
Q 002887 713 VEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIK------ 786 (870)
Q Consensus 713 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~------ 786 (870)
.... .....++..|+|||++.+..++.++|+|||||+++||++|++||........+.++.......+...
T Consensus 159 ~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 159 FEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred CCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 2211 1233578899999999998999999999999999999999999987655444444433221111100
Q ss_pred ---hhcccccCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 787 ---NIVDHRLQGDF---DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 787 ---~i~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
........... ..+....+.+++.+|++.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000001 1133467789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=292.59 Aligned_cols=245 Identities=24% Similarity=0.310 Sum_probs=188.9
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHH-HHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVEL-LIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.||+|+||.||++... ++.||+|++.... .....++..|+.. ++..+|+|++++++++..+...+++|||++
T Consensus 5 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~- 83 (283)
T cd06617 5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD- 83 (283)
T ss_pred EEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-
Confidence 4578999999999999985 8899999987653 2233455566665 556689999999999999999999999997
Q ss_pred Cchhhhhhhc--ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 641 GNLQAHLLED--KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 641 gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
|+|.+++... ....+++..++.++.|++.||+|||+++ +++||||||+||+++.++.+||+|||++...... .
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---~ 158 (283)
T cd06617 84 TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---V 158 (283)
T ss_pred ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc---c
Confidence 5787776542 2357899999999999999999999752 7999999999999999999999999998765321 1
Q ss_pred ccccccCCCCccCcccccc----CCCCccchHHHHHHHHHHHHhCCCCCCCCCcc-chHHHHHHHHhhcCCcchhccccc
Q 002887 719 VSTTVVGTPGYLDPEYYIS----NRLTEKSDVYSFGVVLLELITGQPVIQKTPQR-TLIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~----~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~-~~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||...... ..+.. ... +.. +.+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~-~~~-----~~~ 228 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ----VVE-EPS-----PQL 228 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH----HHh-cCC-----CCC
Confidence 2233568889999998865 44688999999999999999999999643221 11111 111 100 111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 794 QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
. .......+.+++.+|+..+|++||++.++++
T Consensus 229 ~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 229 P---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred C---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 1123456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=293.47 Aligned_cols=242 Identities=22% Similarity=0.323 Sum_probs=197.2
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCchh
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQ 644 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 644 (870)
..||+|+||.||++... ++.||+|++..........+.+|+.++++++|+|++++++.+...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999884 7899999987655555677899999999999999999999999999999999999999999
Q ss_pred hhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccccc
Q 002887 645 AHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVV 724 (870)
Q Consensus 645 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 724 (870)
+++.. ..+++.....++.|++.||+|||+. +++||||||+||++++++.++|+|||++....... .......
T Consensus 106 ~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~ 177 (292)
T cd06657 106 DIVTH---TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV 177 (292)
T ss_pred HHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence 87742 3578999999999999999999998 99999999999999999999999999987553221 1223456
Q ss_pred CCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHH
Q 002887 725 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWK 804 (870)
Q Consensus 725 gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 804 (870)
|+..|+|||++.+..++.++|+||||++++||++|+.||........... .. .+ ..+.+.. .......
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~-~~----~~-----~~~~~~~--~~~~~~~ 245 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-IR----DN-----LPPKLKN--LHKVSPS 245 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HH----hh-----CCcccCC--cccCCHH
Confidence 88999999999888899999999999999999999999975443222111 11 11 0111110 1123446
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 002887 805 AVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 805 l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+.+++.+|++.+|.+||++.++++
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHhc
Confidence 788999999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=293.09 Aligned_cols=257 Identities=20% Similarity=0.284 Sum_probs=193.8
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.||+|++|.||+|... ++.||+|++..... ...+.+.+|++++++++|+||+++++++......++||||++
T Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 84 (294)
T PLN00009 6 KVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD- 84 (294)
T ss_pred EEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-
Confidence 4578999999999999975 78899999865432 234568899999999999999999999999999999999996
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC-CCcEEEEeccCCccccCCCCccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE-KFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~-~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
++|.+++.......+++..+..++.|++.||+|||+. +++||||||+||++++ ++.+||+|||++...... ...
T Consensus 85 ~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~--~~~ 159 (294)
T PLN00009 85 LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--VRT 159 (294)
T ss_pred ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC--ccc
Confidence 5787777654444568888899999999999999998 9999999999999985 567999999999754321 111
Q ss_pred cccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC---Ccc---hhcc--
Q 002887 720 STTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG---DIK---NIVD-- 790 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~---~~~---~i~d-- 790 (870)
.....+++.|+|||++.+. .++.++||||||+++|+|+||++||........+.+.... .... ... .+.+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRI-LGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hCCCChhhccccccchhhh
Confidence 2334678899999998764 5789999999999999999999999765443322221110 0000 000 0000
Q ss_pred ---cccCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 791 ---HRLQGD----FDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 791 ---~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+..... ........+.+++.+|++.+|++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 01123456789999999999999999999986
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=289.89 Aligned_cols=241 Identities=24% Similarity=0.350 Sum_probs=198.3
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||++... ++.+|+|.+..... ...+.+.+|++++++++||||+++++.+.++...++|+||+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL 82 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence 35678999999999999986 88999999976432 34577899999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++++|.+++... ..+++..+..++.|+++||.|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 83 ~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--- 154 (258)
T cd05578 83 LGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--- 154 (258)
T ss_pred CCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---
Confidence 999999988643 4788999999999999999999998 99999999999999999999999999987653321
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...... .. .+........ ....+
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~-~~~~~~~~~~----------~~~~~ 222 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IR-DQIRAKQETA----------DVLYP 222 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-HH-HHHHHHhccc----------cccCc
Confidence 223456888999999999888999999999999999999999999865532 11 1111111110 01122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMN 824 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~ 824 (870)
......+.+++.+|++.+|++||++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~~~~ 248 (258)
T cd05578 223 ATWSTEAIDAINKLLERDPQKRLGDN 248 (258)
T ss_pred ccCcHHHHHHHHHHccCChhHcCCcc
Confidence 23346788999999999999999994
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=294.99 Aligned_cols=261 Identities=20% Similarity=0.302 Sum_probs=194.4
Q ss_pred hccccccccCcEEEEEEEEC----CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecC--CeEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD----DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEG--ANMGLI 634 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~----~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~LV 634 (870)
.+.+.||+|++|.||+|... ++.+|+|.+.... ....+.+.+|++++.+++||||+++++++... ...++|
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 82 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL 82 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence 34578999999999999984 5889999998743 33346678899999999999999999999888 789999
Q ss_pred EEEccCCchhhhhhhcc---cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC----CCcEEEEeccC
Q 002887 635 YEFMANGNLQAHLLEDK---ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE----KFQAKLADFGL 707 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~----~~~vkL~DFGl 707 (870)
|||+++ ++.+.+.... ...++...+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999986 5666554322 23688999999999999999999998 9999999999999999 99999999999
Q ss_pred CccccCCCC-ccccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccc---------hHHHHH
Q 002887 708 SRIFPVEGG-THVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRT---------LIGQWV 776 (870)
Q Consensus 708 a~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~---------~l~~~~ 776 (870)
+........ ........++..|+|||++.+. .++.++|||||||+++||++|++||....... .+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 986533222 1122345678899999988764 57899999999999999999999997654321 111111
Q ss_pred HHHhh-----------cCCcchhcccccCCCCC---------H--HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 777 SSMLA-----------RGDIKNIVDHRLQGDFD---------T--NTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 777 ~~~~~-----------~~~~~~i~d~~l~~~~~---------~--~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..+-. ........+......+. . .....+.+++.+|++.+|++|||+.|+++
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11000 00000000000001111 0 23346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-33 Score=305.08 Aligned_cols=244 Identities=23% Similarity=0.392 Sum_probs=202.9
Q ss_pred ccccccCcEEEEEEEECCe--eEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCchh
Q 002887 567 RVLGKGGFGTVYHGYLDDK--QVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQ 644 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~~--~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 644 (870)
..||.|+||.||+|..+.. ..|-|++...+....+.|.-|+++|..++||+||++++.|...+.++++.|||.||.++
T Consensus 38 GELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVD 117 (1187)
T KOG0579|consen 38 GELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVD 117 (1187)
T ss_pred hhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHh
Confidence 4689999999999998733 35778888888888889999999999999999999999999999999999999999998
Q ss_pred hhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccccc
Q 002887 645 AHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVV 724 (870)
Q Consensus 645 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 724 (870)
..+.+- ++.|+..++.-+++|++.||.|||++ +|||||||+.|||++-+|.++|+|||.+.... .........+
T Consensus 118 aimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkRDsFI 191 (1187)
T KOG0579|consen 118 AIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKRDSFI 191 (1187)
T ss_pred HHHHHh-ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch--hHHhhhcccc
Confidence 887664 46899999999999999999999999 99999999999999999999999999986532 2233456789
Q ss_pred CCCCccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 725 GTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 725 gt~~y~APE~~~-----~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
|||.|||||+.+ ...|+.++||||||++|.||..+.+|.........+.++.++ .-..++. +.
T Consensus 192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS-----ePPTLlq-------PS 259 (1187)
T KOG0579|consen 192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-----EPPTLLQ-------PS 259 (1187)
T ss_pred CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc-----CCCcccC-------cc
Confidence 999999999985 456999999999999999999999998776655444433221 1111111 11
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.-...+.++..+|+.++|..||++.++++
T Consensus 260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 260 HWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 22345678999999999999999999974
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=283.85 Aligned_cols=243 Identities=27% Similarity=0.436 Sum_probs=200.4
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.||+|++|.||++... ++.+++|.+..... ...+.+.+|++++.+++|+|++++++++..+...++++||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (254)
T cd06627 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAEN 83 (254)
T ss_pred eeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCC
Confidence 4578999999999999875 78899999987654 4557889999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++....... ...
T Consensus 84 ~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~ 156 (254)
T cd06627 84 GSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS--KDD 156 (254)
T ss_pred CcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc--ccc
Confidence 9999988644 5789999999999999999999998 99999999999999999999999999998664322 112
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
....++..|+|||...+...+.++||||+|+++++|++|+.||..........+ .. .... ...+..
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~----~~-~~~~---------~~~~~~ 222 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR----IV-QDDH---------PPLPEG 222 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----Hh-ccCC---------CCCCCC
Confidence 345688899999999888889999999999999999999999975442211111 11 0100 111223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
....+.+++.+|+..+|++||++.|++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 3457789999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=289.95 Aligned_cols=258 Identities=21% Similarity=0.315 Sum_probs=197.2
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.+.||+|++|.||+|+.. ++.||||.+..... .....+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 82 (284)
T cd07836 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK- 82 (284)
T ss_pred EeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-
Confidence 4578999999999999985 88899999876533 2345678899999999999999999999999999999999985
Q ss_pred chhhhhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 642 NLQAHLLEDK-ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 642 sL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++...... ....
T Consensus 83 ~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~~~~ 157 (284)
T cd07836 83 DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VNTF 157 (284)
T ss_pred cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--cccc
Confidence 7888775433 24689999999999999999999998 9999999999999999999999999999754321 1122
Q ss_pred ccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc--CCcchhcc-cccCCC
Q 002887 721 TTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR--GDIKNIVD-HRLQGD 796 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~--~~~~~i~d-~~l~~~ 796 (870)
....++..|++||++.+. .++.++||||||+++|||++|+.||..........+........ .....+.+ +.+...
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 334578899999998664 57889999999999999999999998665433332222111000 00000000 000000
Q ss_pred -----------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 797 -----------FDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 797 -----------~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
........+.+++.+|++.+|++||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=286.67 Aligned_cols=243 Identities=25% Similarity=0.346 Sum_probs=190.2
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccchh---hhHHHHHHHHHH-HHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ---GYKQFQAEVELL-IRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~---~~~~f~~Ei~~l-~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.||+|++|.||+|... ++.||+|.+...... ....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999984 789999998764322 223344555444 445899999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
++|.+++... ..+++..+..++.|+++||.|||+. +++||||+|+||++++++.+||+|||++..... .
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~ 150 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N 150 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence 9999988643 4688999999999999999999998 999999999999999999999999999875421 2
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
....++..|+|||.+.+..++.++||||||+++|||++|..||........... .. .+... ........
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~-~~~~~------~~~~~~~~ 219 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDN----IL-SRRIN------WPEEVKEF 219 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HH-hcccC------CCCccccc
Confidence 334688899999999888889999999999999999999999976543222111 11 11100 01111113
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVIELN 831 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 831 (870)
....+.+++.+|++.+|++||++.++.+.|+
T Consensus 220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 220 CSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred CCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 3467889999999999999998877655544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=285.44 Aligned_cols=243 Identities=25% Similarity=0.385 Sum_probs=200.7
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.||+|++|.||++... ++.+++|.+.... .....++.+|++++++++|+||+++++++......++|+||+++
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd08530 4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPF 83 (256)
T ss_pred EeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCC
Confidence 4578999999999999875 7789999987542 23456778899999999999999999999999999999999999
Q ss_pred Cchhhhhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 641 GNLQAHLLEDK--ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 641 gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|.+++.+.. ...+++..++.++.|+++||+|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---- 156 (256)
T cd08530 84 GDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN---- 156 (256)
T ss_pred CCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC----
Confidence 99999886532 35689999999999999999999998 9999999999999999999999999999876432
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
......++..|+|||.+.+..++.++|+||||++++||++|+.||........... ...+.. ....
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~-----~~~~~~---------~~~~ 222 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK-----VQRGKY---------PPIP 222 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HhcCCC---------CCCc
Confidence 22235688899999999998899999999999999999999999976543222111 111111 1122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
......+.+++.+|++.+|++||++.|+++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred hhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 244567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=299.82 Aligned_cols=254 Identities=23% Similarity=0.311 Sum_probs=192.3
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecC------CeEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEG------ANMGLI 634 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~LV 634 (870)
..+.||+|+||.||+|... ++.||+|.+... .......+.+|++++++++|+||+++++++... ...++|
T Consensus 20 ~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 99 (353)
T cd07850 20 NLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLV 99 (353)
T ss_pred EEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEE
Confidence 3578999999999999975 889999998643 233445678899999999999999999988543 357999
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
|||+.+ +|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~e~~~~-~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 100 MELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred EeccCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 999974 77776642 288899999999999999999998 9999999999999999999999999999865321
Q ss_pred CCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHH----------------
Q 002887 715 GGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSS---------------- 778 (870)
Q Consensus 715 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~---------------- 778 (870)
.......++..|+|||.+.+..++.++|||||||++++|++|+.||...+...........
T Consensus 172 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 172 ---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred ---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 1123346788999999999999999999999999999999999999755432211111100
Q ss_pred --HhhcC------CcchhcccccCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 779 --MLARG------DIKNIVDHRLQG----DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 779 --~~~~~------~~~~i~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
..... ...++....+.. .........+.+++.+|++.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 000111111100 0011345578899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=293.89 Aligned_cols=240 Identities=25% Similarity=0.349 Sum_probs=199.1
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
++||+|+||.||-.... |+-+|.|++.+... +...-..+|-.+|.+++.+.||.+--.|...+.+++|+..|.||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 69999999999987764 88899998876533 33445688999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.-||.......+++..+.-++.+|+.||++||.. .||.|||||+|||||+.|+++|+|.|+|..++.. ....
T Consensus 271 DLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g---~~~~ 344 (591)
T KOG0986|consen 271 DLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG---KPIR 344 (591)
T ss_pred ceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCC---Cccc
Confidence 999999877777899999999999999999999999 9999999999999999999999999999987432 2334
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
..+||.+|||||++.++.|+...|.||+||++|||+.|+.||........-.+.-+..+. -..++++..
T Consensus 345 ~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~-----------~~~ey~~kF 413 (591)
T KOG0986|consen 345 GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE-----------DPEEYSDKF 413 (591)
T ss_pred cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc-----------chhhccccc
Confidence 558999999999999999999999999999999999999999754332211111111110 112345556
Q ss_pred HHHHHHHHHHccccCCCCCCCH
Q 002887 802 VWKAVEIALACIHTISTRRPTM 823 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm 823 (870)
.+++.++....|++||++|-.-
T Consensus 414 S~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 414 SEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred CHHHHHHHHHHHccCHHHhccC
Confidence 6778888899999999998643
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=289.10 Aligned_cols=254 Identities=23% Similarity=0.270 Sum_probs=191.2
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhc-cccceeEEEEEecC--CeEEEEEEEc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAH-HKNLTILVGYCDEG--ANMGLIYEFM 638 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~LV~Ey~ 638 (870)
+.+.||+|+||.||+|... ++.+|+|+++... ........+|+.++.++. |+|++++++++.+. +..++|+||+
T Consensus 3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM 82 (282)
T ss_pred eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence 4578999999999999874 7889999987642 222234457888898885 99999999999887 8899999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
+ |+|.+.+.... ..++|.++..++.|++.||+|||+. +++||||||+||++++ +.+||+|||+++......
T Consensus 83 ~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~--- 153 (282)
T cd07831 83 D-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP--- 153 (282)
T ss_pred C-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC---
Confidence 7 57877775432 4689999999999999999999998 9999999999999999 999999999998653221
Q ss_pred ccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc-----------CCcc
Q 002887 719 VSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR-----------GDIK 786 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~-----------~~~~ 786 (870)
......++..|+|||++.+ +.++.++|||||||++|||++|++||......... .+....... ....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI-AKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHH-HHHHHHcCCCCHHHHHhhcccccc
Confidence 1123457889999998754 55788999999999999999999999765432222 111111110 0000
Q ss_pred hhcccccCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 787 NIVDHRLQG----DFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 787 ~i~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
....+.... .........+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000 001134578899999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=288.49 Aligned_cols=241 Identities=24% Similarity=0.357 Sum_probs=186.9
Q ss_pred cccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHH---hccccceeEEEEEecCCeEEEEEEEcc
Q 002887 568 VLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIR---AHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 568 ~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~---l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.||+|+||.||++... ++.+|+|.+..... .....+.+|..++.. .+|+|++.+.+.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 78999999875432 112234445444443 479999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.++|+|||++...... .
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~ 151 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K 151 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc----C
Confidence 99999888643 4689999999999999999999998 9999999999999999999999999998754221 1
Q ss_pred cccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 720 STTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
.....|+..|+|||.+.+ ..++.++|+|||||+++||++|+.||........ .. ...... ......+
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~-~~~~~~----------~~~~~~~ 219 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HE-IDRMTL----------TVNVELP 219 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HH-HHHHhh----------cCCcCCc
Confidence 223468999999999874 5588999999999999999999999975433221 11 111110 0011122
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRP-----TMNQVVIE 829 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 829 (870)
......+.+++.+|++.+|++|| +++|+++.
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 33456788999999999999999 58888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=290.58 Aligned_cols=258 Identities=18% Similarity=0.241 Sum_probs=192.6
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhc-cccceeEEEEEecCCe-----EEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAH-HKNLTILVGYCDEGAN-----MGLI 634 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~-----~~LV 634 (870)
..+.||+|+||.||+|... ++.||+|.+..... .....+.+|+.++++++ |+||+++++++..... .++|
T Consensus 5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv 84 (295)
T cd07837 5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV 84 (295)
T ss_pred EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence 4578999999999999975 78999998765432 23456888999999994 6999999999977665 8999
Q ss_pred EEEccCCchhhhhhhcc---cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC-CCcEEEEeccCCcc
Q 002887 635 YEFMANGNLQAHLLEDK---ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE-KFQAKLADFGLSRI 710 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~-~~~vkL~DFGla~~ 710 (870)
|||+++ +|.+++.... ...+++..+..++.||++||.|||+. +|+||||||+||+++. ++.+||+|||++..
T Consensus 85 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 85 FEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred eeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 999986 7888776532 24689999999999999999999998 9999999999999999 88999999999876
Q ss_pred ccCCCCccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCC-----
Q 002887 711 FPVEGGTHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGD----- 784 (870)
Q Consensus 711 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~----- 784 (870)
+.... .......+++.|+|||++.+ ..++.++|+||||+++|||++|+.||..........+..........
T Consensus 161 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T cd07837 161 FSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238 (295)
T ss_pred cCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 53221 11223356889999998865 45789999999999999999999999765433322222211100000
Q ss_pred cchhcc----cccCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 785 IKNIVD----HRLQG----DFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 785 ~~~i~d----~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.....+ +.... .........+.+++.+|++.+|++||++.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 00000 001123466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=289.86 Aligned_cols=252 Identities=24% Similarity=0.299 Sum_probs=199.5
Q ss_pred ccccccccCcEEEEEEEEC-----CeeEEEEEeeccc----hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD-----DKQVAVKMLSSSS----VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLI 634 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~-----~~~vAVK~l~~~~----~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV 634 (870)
+.+.||+|++|.||+++.. ++.+|||.++... ....+.+.+|++++.++ +|+||+++++.+..+...++|
T Consensus 4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 83 (288)
T cd05583 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI 83 (288)
T ss_pred EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence 4578999999999998752 5789999987542 22345688999999999 699999999999999999999
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
|||+++|+|.+++... ..+++..+..++.|+++||.|||+. +++||||||+||+++.++.++|+|||+++.+...
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 84 LDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999988643 4688999999999999999999988 9999999999999999999999999998765332
Q ss_pred CCccccccccCCCCccCccccccCC--CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccc
Q 002887 715 GGTHVSTTVVGTPGYLDPEYYISNR--LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHR 792 (870)
Q Consensus 715 ~~~~~~~~~~gt~~y~APE~~~~~~--~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 792 (870)
. ........|+..|+|||.+.+.. .+.++||||||++++||++|+.||...........+.+......
T Consensus 159 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------- 228 (288)
T cd05583 159 E-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK--------- 228 (288)
T ss_pred c-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC---------
Confidence 2 11223346889999999987665 78899999999999999999999964332222222222222110
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 793 LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 793 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
..........+.+++.+|++.+|++|||+.++.+.|+..
T Consensus 229 --~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 --PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 111122335678999999999999999999998877764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=296.24 Aligned_cols=259 Identities=24% Similarity=0.369 Sum_probs=194.5
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHh-ccccceeEEEEEecC--CeEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEG--ANMGLIYE 636 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~--~~~~LV~E 636 (870)
.+.+.||+|+||.||+|... ++.+|+|++... .......+.+|+.+++++ +|+||++++++|... ...++|||
T Consensus 10 ~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07852 10 EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFE 89 (337)
T ss_pred HHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEec
Confidence 44578999999999999875 788999988643 223445678899999999 999999999998653 46899999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
|++ ++|..++.. ..++|..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 90 ~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 90 YME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred ccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 998 588887753 2788999999999999999999998 999999999999999999999999999986643322
Q ss_pred c---cccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHh----------hc
Q 002887 717 T---HVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSML----------AR 782 (870)
Q Consensus 717 ~---~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~----------~~ 782 (870)
. .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||..........+.....- ..
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence 1 12234568899999998865 4578899999999999999999999976543322222111100 00
Q ss_pred CCcchhcccccC------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 783 GDIKNIVDHRLQ------GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 783 ~~~~~i~d~~l~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
.....+++.... ..........+.+++.+|++.+|++|||+.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000011110000 00011134678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=287.88 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=194.7
Q ss_pred ccccccccCcEEEEEEEE-----CCeeEEEEEeeccch----hhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEE
Q 002887 565 FERVLGKGGFGTVYHGYL-----DDKQVAVKMLSSSSV----QGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLI 634 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~-----~~~~vAVK~l~~~~~----~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV 634 (870)
+.+.||+|+||.||++.. .++.||+|++..... ...+.+.+|++++.++ +|+||+++.+.+..+...++|
T Consensus 4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (290)
T cd05613 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLI 83 (290)
T ss_pred eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEE
Confidence 457899999999999986 378899999876422 2346678899999999 699999999999999999999
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
+||+++++|.+++... ..+++..+..++.|+++||.|||+. +++||||||+|||+++++.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 84 LDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 9999999999998643 4688899999999999999999998 9999999999999999999999999999765322
Q ss_pred CCccccccccCCCCccCccccccC--CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccc
Q 002887 715 GGTHVSTTVVGTPGYLDPEYYISN--RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHR 792 (870)
Q Consensus 715 ~~~~~~~~~~gt~~y~APE~~~~~--~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 792 (870)
. ........|+..|+|||.+... .++.++||||||+++|+|++|+.||...........+........
T Consensus 159 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 228 (290)
T cd05613 159 E-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--------- 228 (290)
T ss_pred c-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC---------
Confidence 1 1222345688999999998753 467899999999999999999999975433322333332222111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002887 793 LQGDFDTNTVWKAVEIALACIHTISTRRP-----TMNQVVI 828 (870)
Q Consensus 793 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 828 (870)
...+......+.+++.+|++.+|++|| ++.+++.
T Consensus 229 --~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 --PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 112223445678999999999999997 5566544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=289.32 Aligned_cols=259 Identities=25% Similarity=0.325 Sum_probs=194.7
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCC---------
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGA--------- 629 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--------- 629 (870)
+.+.+.||+|+||.||+|... ++.||+|+++... ......+.+|++++++++|||++++++++.+..
T Consensus 9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 88 (302)
T cd07864 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDK 88 (302)
T ss_pred hheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccC
Confidence 345678999999999999985 7889999987543 223356788999999999999999999987654
Q ss_pred -eEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCC
Q 002887 630 -NMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 708 (870)
Q Consensus 630 -~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla 708 (870)
..++|+||+++ ++...+... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 89 ~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 89 GAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred CcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCccccc
Confidence 78999999986 666665433 34689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc--CCc
Q 002887 709 RIFPVEGGTHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR--GDI 785 (870)
Q Consensus 709 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~--~~~ 785 (870)
........ .......++..|+|||.+.+ ..++.++|||||||+++||++|++||........+.......-.. ...
T Consensus 164 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 164 RLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred ccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 86643221 22223356788999998865 357889999999999999999999998655433333222211100 000
Q ss_pred chhc--------cc------ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 786 KNIV--------DH------RLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 786 ~~i~--------d~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..+. +. .+... ....+..+.+++.+|++.+|++||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 243 PDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 00 00000 0123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=286.69 Aligned_cols=256 Identities=23% Similarity=0.301 Sum_probs=198.5
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
.+.||+|++|.||++... ++.+++|.+..... .....+.+|++++++++|+||+++++++..+...++|+||+++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~- 82 (283)
T cd05118 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT- 82 (283)
T ss_pred ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-
Confidence 467999999999999975 78899999876533 2456788999999999999999999999999999999999985
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++.... ..+++..+..++.|+++||.|||+. +|+|+||||+||++++++.+||+|||.+....... ....
T Consensus 83 ~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~ 156 (283)
T cd05118 83 DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT 156 (283)
T ss_pred CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence 8888776533 5789999999999999999999998 99999999999999999999999999987664332 1223
Q ss_pred cccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc--CCcchhcc--------
Q 002887 722 TVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR--GDIKNIVD-------- 790 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~--~~~~~i~d-------- 790 (870)
...++..|+|||.+.+. ..+.++|+||||+++++|++|+.||........+.......... .....+.+
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 34678899999999876 78999999999999999999999997655433222211110000 00000000
Q ss_pred ---cccC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 791 ---HRLQ--GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 791 ---~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.... .........++.+++.+|++.+|.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0011234568899999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=287.36 Aligned_cols=257 Identities=23% Similarity=0.324 Sum_probs=195.6
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch-hhhHHHHHHHHHHHHhc-cccceeEEEEEecCCeEEEEEEEccC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAH-HKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.||+|++|.||+|+.. ++.|++|++..... .......+|+..+.+++ |+|++++++++..+...++||||+ +
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 81 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-E 81 (283)
T ss_pred eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-C
Confidence 4578999999999999985 67899999875432 22234567899999998 999999999999999999999999 7
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|.+.+.......+++.+++.++.|++.||.|||+. +++|+||||+||++++++.++|+|||++...... ...
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~---~~~ 155 (283)
T cd07830 82 GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR---PPY 155 (283)
T ss_pred CCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCC---CCc
Confidence 8999888765556789999999999999999999998 9999999999999999999999999999765321 112
Q ss_pred ccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHH------------HHHHHhhcCCcch
Q 002887 721 TTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQ------------WVSSMLARGDIKN 787 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~------------~~~~~~~~~~~~~ 787 (870)
....++..|+|||++.+ ..++.++|+||||++++||++|++||..........+ |............
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 33467889999998854 4578999999999999999999999965543222211 1111111111110
Q ss_pred hcccccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 788 IVDHRLQG---DFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 788 i~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.+...... .........+.+++.+|++.+|++||+++|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000 000112467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=289.27 Aligned_cols=256 Identities=23% Similarity=0.309 Sum_probs=192.1
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccchh--hhHHHHHHHHHHHHhccccceeEEEEEecC--CeEEEEEEEc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ--GYKQFQAEVELLIRAHHKNLTILVGYCDEG--ANMGLIYEFM 638 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~LV~Ey~ 638 (870)
+.+.||+|+||.||+|... ++.||+|.++..... ....+.+|+.++++++|+|++++++++.+. ...++||||+
T Consensus 11 ~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 90 (309)
T cd07845 11 KLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYC 90 (309)
T ss_pred EeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecC
Confidence 4578999999999999985 889999998754322 233467899999999999999999998654 4689999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
.+ +|.+++.... ..+++.++..++.|+++||+|||+. +++||||||+||++++++.+||+|||++....... .
T Consensus 91 ~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~--~ 163 (309)
T cd07845 91 EQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA--K 163 (309)
T ss_pred CC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCcc--C
Confidence 75 7877775432 5689999999999999999999998 99999999999999999999999999998664321 1
Q ss_pred ccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC--Cc-chhcc----
Q 002887 719 VSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG--DI-KNIVD---- 790 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~--~~-~~i~d---- 790 (870)
......++..|+|||.+.+ ..++.++||||+||++|||++|++||........+...... .... .. ..+.+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQL-LGTPNESIWPGFSDLPLV 242 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-cCCCChhhchhhhccccc
Confidence 1223345788999999875 45789999999999999999999999765543332222111 1000 00 00000
Q ss_pred --cccCC-CCC------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 791 --HRLQG-DFD------TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 791 --~~l~~-~~~------~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..+.. ... ......+.+++.+|++.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 000 112456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=298.33 Aligned_cols=258 Identities=23% Similarity=0.350 Sum_probs=192.6
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecC-----CeEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEG-----ANMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~LV~ 635 (870)
.+.+.||+|+||.||+|+.. ++.||+|++.... ......+.+|+.++++++|+||+++++++... ...++|+
T Consensus 8 ~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 87 (336)
T cd07849 8 QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQ 87 (336)
T ss_pred EEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEe
Confidence 34578999999999999875 7899999986432 23345678899999999999999999987543 3579999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
||+.+ +|...+. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 88 e~~~~-~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 88 ELMET-DLYKLIK---TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred hhccc-CHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 99975 7776663 35689999999999999999999998 99999999999999999999999999987653221
Q ss_pred Cc-cccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCC---cchhcc
Q 002887 716 GT-HVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGD---IKNIVD 790 (870)
Q Consensus 716 ~~-~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~---~~~i~d 790 (870)
.. .......|+..|+|||.+.+ ..++.++|||||||+++||++|+.||...........+ ...+.... ...+.+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLI-LGVLGTPSQEDLNCIIS 239 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHHcCCCCHHHHHHhhc
Confidence 11 11233568899999998765 46889999999999999999999999765432222111 11111110 011110
Q ss_pred cc-------c--CCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 791 HR-------L--QGDFD-----TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 791 ~~-------l--~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
.. . ..... ......+.+++.+|++.+|++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0 00000 1224568899999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=281.34 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=194.5
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeecc-----chhhhHHHHHHHHHHHHhccccceeEEEEEecC--CeEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS-----SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEG--ANMGLI 634 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~LV 634 (870)
.+.+.||+|+||.||+|... ++.+|+|.+... .....+.+++|++++++++|+||+++++++.+. ...+++
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF 84 (264)
T ss_pred eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence 35679999999999999874 789999987532 123446789999999999999999999998664 457899
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
+||+++++|.+++... ..+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++.....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 85 VEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 9999999999988643 3578999999999999999999998 9999999999999999999999999999865321
Q ss_pred CC-ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccccc
Q 002887 715 GG-THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 715 ~~-~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
.. ........++..|+|||++.+...+.++|+|||||+++||++|+.||..........+ .... ..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~---------~~ 226 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK----IATQ---------PT 226 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHH----HHcC---------CC
Confidence 11 1111235688999999999988899999999999999999999999975433222111 1110 11
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 794 QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
....+......+.+++.+|++ +|..||+..+++.
T Consensus 227 ~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 112233455678899999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=288.58 Aligned_cols=255 Identities=16% Similarity=0.177 Sum_probs=178.8
Q ss_pred hhccccccccCcEEEEEEEECC-----eeEEEEEeeccchhhh-----------HHHHHHHHHHHHhccccceeEEEEEe
Q 002887 563 NNFERVLGKGGFGTVYHGYLDD-----KQVAVKMLSSSSVQGY-----------KQFQAEVELLIRAHHKNLTILVGYCD 626 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~~-----~~vAVK~l~~~~~~~~-----------~~f~~Ei~~l~~l~H~nIv~l~g~~~ 626 (870)
+.+.+.||+|+||.||+|...+ ..+++|+......... .....+...+..++|+|++++++++.
T Consensus 14 y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 93 (294)
T PHA02882 14 WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGS 93 (294)
T ss_pred eEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeee
Confidence 4456899999999999999753 3566665433221110 11122334455668999999999775
Q ss_pred cCC----eEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEE
Q 002887 627 EGA----NMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKL 702 (870)
Q Consensus 627 ~~~----~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL 702 (870)
... ..++++|++.. ++.+.+.. ....++..+..|+.|+++||+|||+. +|+||||||+|||++.++.++|
T Consensus 94 ~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 94 FKRCRMYYRFILLEKLVE-NTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EecCCceEEEEEEehhcc-CHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEE
Confidence 543 33566666543 44444432 22357888899999999999999998 9999999999999999999999
Q ss_pred EeccCCccccCCCCc-----cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002887 703 ADFGLSRIFPVEGGT-----HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVS 777 (870)
Q Consensus 703 ~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~ 777 (870)
+|||+++.+...+.. .......||+.|+|||+..+..++.++|||||||+++||++|+.||..............
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 999999876432211 112234699999999999999999999999999999999999999987643222211111
Q ss_pred HHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002887 778 SMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIEL 830 (870)
Q Consensus 778 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 830 (870)
... +..+....+. .......+.+++..|++.+|++||++.++++.|
T Consensus 248 ~~~----~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 248 CDF----IKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHH----HHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 000 0111111111 112246688999999999999999999999876
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=288.38 Aligned_cols=259 Identities=23% Similarity=0.323 Sum_probs=190.2
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCC--------eE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGA--------NM 631 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--------~~ 631 (870)
...+.||+|+||.||+|... ++.||||.+..... .....+.+|++++++++||||++++++|.... ..
T Consensus 15 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 94 (310)
T cd07865 15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSF 94 (310)
T ss_pred EEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceE
Confidence 44578999999999999985 78999999865432 22345678999999999999999999986644 45
Q ss_pred EEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccc
Q 002887 632 GLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 711 (870)
Q Consensus 632 ~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~ 711 (870)
++||||+.+ +|.+.+... ...+++.++..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++...
T Consensus 95 ~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 95 YLVFEFCEH-DLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred EEEEcCCCc-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 999999975 777766432 34689999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCc--cccccccCCCCccCccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhh---cCCc
Q 002887 712 PVEGGT--HVSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLA---RGDI 785 (870)
Q Consensus 712 ~~~~~~--~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~---~~~~ 785 (870)
...... .......++..|+|||.+.+.. ++.++||||||++++||++|++||.......... .+..... .+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 248 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT-LISQLCGSITPEVW 248 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCChhhc
Confidence 332211 1122345788999999987654 7889999999999999999999997654322211 1111110 0000
Q ss_pred c-----hhccc-ccCCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 786 K-----NIVDH-RLQGDFD---------TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 786 ~-----~i~d~-~l~~~~~---------~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
. +..+. .+..... ......+.+++.+|+..+|++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 00000 0000000 011245679999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=287.95 Aligned_cols=248 Identities=22% Similarity=0.327 Sum_probs=190.7
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch-hhhHHHHHHHHHHHHhc-cccceeEEEEEecCCeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAH-HKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.+.+.||+|++|.||+|... ++.||||+++.... ....++..|+.++.+.. |+||++++++|..+...+++|||+.
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 34579999999999999987 88999999976432 33456677887777775 9999999999999999999999986
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+ ++...+.. ....+++..+..++.|+++||+|||+. .+|+||||+|+||++++++.+||+|||++..+... ..
T Consensus 98 ~-~l~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~---~~ 170 (296)
T cd06618 98 T-CLDKLLKR-IQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS---KA 170 (296)
T ss_pred c-CHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCC---Cc
Confidence 4 66665543 234789999999999999999999973 28999999999999999999999999998765321 11
Q ss_pred cccccCCCCccCccccccCC----CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 720 STTVVGTPGYLDPEYYISNR----LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~----~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
.....++..|+|||.+.+.. ++.++|+||||+++|||++|+.||....... +......... .. .+
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~-~~-----~~-- 239 (296)
T cd06618 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF---EVLTKILQEE-PP-----SL-- 239 (296)
T ss_pred ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH---HHHHHHhcCC-CC-----CC--
Confidence 22335788999999987554 7889999999999999999999996533211 1111111111 00 00
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
.........+.+++.+|++.+|++||++.++++.
T Consensus 240 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111234568899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=278.05 Aligned_cols=261 Identities=23% Similarity=0.362 Sum_probs=205.6
Q ss_pred CHHHHHHHHhhccccccccCcEEEEEEEE--CCeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCe
Q 002887 554 SYFDVLKITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGAN 630 (870)
Q Consensus 554 ~~~dl~~~t~~f~~~LG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 630 (870)
+++|+.+.|. +.||+|+++.|--++. .+.++|||++.+.......+..+|++++..+ .|+||+.++++|.++..
T Consensus 74 ~F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 3567777775 6899999999987764 4999999999998778888999999999998 69999999999999999
Q ss_pred EEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCc---EEEEeccC
Q 002887 631 MGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQ---AKLADFGL 707 (870)
Q Consensus 631 ~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~---vkL~DFGl 707 (870)
+|||||-|.||.|..++++. +.+++.++-++.++|+.||.+||.+ +|.||||||+|||-.+... +||+||.+
T Consensus 151 FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecccc
Confidence 99999999999999999754 5799999999999999999999998 9999999999999976554 79999988
Q ss_pred CccccCCC-----CccccccccCCCCccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccch------
Q 002887 708 SRIFPVEG-----GTHVSTTVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTL------ 771 (870)
Q Consensus 708 a~~~~~~~-----~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~------ 771 (870)
..-+.... .+....+.+|+..|||||+.. ...|+.++|.||+|||||-|++|.+||.+....+-
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 65432111 112223567889999999873 34589999999999999999999999987653211
Q ss_pred ----HHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 772 ----IGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 772 ----l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
-.+-.-..+++|.. ++.|+.+ .....+..+++...+..++.+|-++.+++.
T Consensus 306 ~Cr~CQ~~LFesIQEGkY-eFPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 306 VCRVCQNKLFESIQEGKY-EFPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccHHHHHHHHHHHhccCC-cCChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 01111112222211 1111111 134567789999999999999999999986
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=284.03 Aligned_cols=240 Identities=24% Similarity=0.344 Sum_probs=186.6
Q ss_pred cccccCcEEEEEEEEC--CeeEEEEEeeccchh---hhHHHHHHHHH---HHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 568 VLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ---GYKQFQAEVEL---LIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 568 ~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~---~~~~f~~Ei~~---l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.||+|+||.||++... ++.||+|.+...... ....+..|..+ +....|++|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 789999998764322 12223444443 344579999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+|+|..++.. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++..+... .
T Consensus 81 g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~ 151 (278)
T cd05606 81 GGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K 151 (278)
T ss_pred CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----C
Confidence 9999988853 34699999999999999999999998 9999999999999999999999999998755321 1
Q ss_pred cccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 720 STTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
.....|+..|+|||.+.++ .++.++||||+|++++||++|+.||.......... . ...... .+. ...
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~-~~~~~~------~~~----~~~ 219 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-I-DRMTLT------MAV----ELP 219 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-H-HHHhhc------cCC----CCC
Confidence 2234689999999999754 68999999999999999999999997653222111 0 000000 011 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRP-----TMNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 828 (870)
......+.+++.+|+..+|.+|| ++.++++
T Consensus 220 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 220 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 22346788999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=288.77 Aligned_cols=242 Identities=27% Similarity=0.375 Sum_probs=192.5
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeecc---chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS---SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
.+.||+|++|.||+|+.. ++.+++|.+... .....+++.+|+++++.++|+|++++++++......++|+||+.
T Consensus 20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 98 (308)
T cd06634 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 98 (308)
T ss_pred HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-
Confidence 467999999999999975 778999998643 22334578899999999999999999999999999999999997
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|++.+.+... ...+++.++..++.|++.||.|||+. +++||||||+||++++++.+||+|||++..... .
T Consensus 99 ~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~------~ 168 (308)
T cd06634 99 GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------A 168 (308)
T ss_pred CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC------c
Confidence 5777766433 34689999999999999999999998 999999999999999999999999999875422 1
Q ss_pred ccccCCCCccCccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 721 TTVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~---~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
....++..|+|||++. ...++.++|||||||++|||++|+.||...........+. .+.. +.. .
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-----~~~~-----~~~---~ 235 (308)
T cd06634 169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-----QNES-----PAL---Q 235 (308)
T ss_pred ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh-----hcCC-----CCc---C
Confidence 2346788999999975 3567889999999999999999999986543322221111 1110 000 1
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVIELN 831 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 831 (870)
.......+.+++.+|++.+|++||++.++++.-.
T Consensus 236 ~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 1233456789999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=314.05 Aligned_cols=255 Identities=28% Similarity=0.440 Sum_probs=208.5
Q ss_pred hccccccccCcEEEEEEEEC---------CeeEEEEEeeccch-hhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD---------DKQVAVKMLSSSSV-QGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMG 632 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~---------~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 632 (870)
.+.+.||+|.||.|++|... ...||||.++.... ...+.+..|+++++.+ +|+|++.++|+|..+...+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 34569999999999999853 34699999987643 4567899999999999 6999999999999999999
Q ss_pred EEEEEccCCchhhhhhhcc------------c--ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC
Q 002887 633 LIYEFMANGNLQAHLLEDK------------A--DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF 698 (870)
Q Consensus 633 LV~Ey~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~ 698 (870)
+|+||++.|+|..++++.+ . ..++....+.++.|||.|++||++. +++||||.++|||+.++.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCC
Confidence 9999999999999998766 0 1388999999999999999999999 999999999999999999
Q ss_pred cEEEEeccCCccccCCCCccccccc-cCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHH
Q 002887 699 QAKLADFGLSRIFPVEGGTHVSTTV-VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWV 776 (870)
Q Consensus 699 ~vkL~DFGla~~~~~~~~~~~~~~~-~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~ 776 (870)
.+||+|||+++.....+........ .-...|||||.+....++.|+|||||||+||||+| |..||.+......+.+
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~-- 533 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE-- 533 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH--
Confidence 9999999999865433322211111 13456999999999999999999999999999998 8888876332222222
Q ss_pred HHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 777 SSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 777 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
.+++|.. .+.+..+..++.+++..||+.+|++||++.|+++.++..+
T Consensus 534 --~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 534 --FLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred --HHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 3444421 2334456778889999999999999999999999999954
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=286.24 Aligned_cols=239 Identities=27% Similarity=0.392 Sum_probs=190.8
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.||+|+||.||+|+.. ++.+++|++..... ...+.+.+|++++++++|+|++++++++.+....++||||+. |
T Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 105 (313)
T cd06633 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-G 105 (313)
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-C
Confidence 57999999999999974 78899999875422 334568899999999999999999999999999999999996 5
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
++.+.+... ...+++.++..++.|++.||.|||+. +++||||||+||++++++.+||+|||++.... ...
T Consensus 106 ~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~~~ 175 (313)
T cd06633 106 SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS------PAN 175 (313)
T ss_pred CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC------CCC
Confidence 777766432 35689999999999999999999998 99999999999999999999999999986431 122
Q ss_pred cccCCCCccCccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 722 TVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 722 ~~~gt~~y~APE~~~---~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
...|+..|+|||++. ...++.++|||||||++|||++|++||........... ..... .. .. ..
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~----~~~~~-~~-----~~---~~ 242 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQND-SP-----TL---QS 242 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHhcC-CC-----CC---Cc
Confidence 456888999999984 35688899999999999999999999876543222211 11111 10 00 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
......+.+++.+|++.+|++||++.+++..
T Consensus 243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223457899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=292.66 Aligned_cols=256 Identities=24% Similarity=0.319 Sum_probs=193.5
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccchhh--------------hHHHHHHHHHHHHhccccceeEEEEEecCC
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQG--------------YKQFQAEVELLIRAHHKNLTILVGYCDEGA 629 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~--------------~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 629 (870)
.+.||+|+||.||+|... ++.||||++....... ...+.+|++++++++|+||+++++++..+.
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 467999999999999875 7899999986543221 124678999999999999999999999999
Q ss_pred eEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCc
Q 002887 630 NMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 709 (870)
Q Consensus 630 ~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~ 709 (870)
..++||||+. |+|.+++.. ...+++.....++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred cEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCcccee
Confidence 9999999997 588888753 34588999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCC------------CccccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002887 710 IFPVEG------------GTHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWV 776 (870)
Q Consensus 710 ~~~~~~------------~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~ 776 (870)
...... .........++..|+|||++.+. .++.++|+|||||+++||++|++||........+....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~ 247 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 653110 01111233567889999998764 46899999999999999999999998665433332221
Q ss_pred HHHhhcCC---cchhcc--------cccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 777 SSMLARGD---IKNIVD--------HRLQG---DFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 777 ~~~~~~~~---~~~i~d--------~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
. ...... .....+ ..... .........+.+++.+|++.+|++||++.|++.
T Consensus 248 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 248 E-LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred H-HhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1 111110 000000 00000 000122456889999999999999999999985
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=294.11 Aligned_cols=259 Identities=19% Similarity=0.293 Sum_probs=194.7
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEec----CCeEEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDE----GANMGLIYE 636 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~LV~E 636 (870)
+.+.||+|++|.||+|... ++.||+|++.... ....+.+.+|+.++++++|+||+++++++.. ....++|+|
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 88 (334)
T cd07855 9 PIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88 (334)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEe
Confidence 4578999999999999875 8899999987642 2345667889999999999999999988753 356899999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
|+. |+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 89 ~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 89 LME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred hhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 996 588888753 34589999999999999999999998 999999999999999999999999999976533221
Q ss_pred c--cccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHH----------HhhcC
Q 002887 717 T--HVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSS----------MLARG 783 (870)
Q Consensus 717 ~--~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~----------~~~~~ 783 (870)
. .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........+...... ....+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 1 11234578899999999865 46889999999999999999999999765432222111110 00001
Q ss_pred Ccchhcccc-cCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 784 DIKNIVDHR-LQGDFD-----TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 784 ~~~~i~d~~-l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
.+.+..+.. ...... ......+.+++.+|++.+|++||++.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111111100 000111 1235678999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=279.82 Aligned_cols=232 Identities=21% Similarity=0.270 Sum_probs=183.7
Q ss_pred ccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEccCCchhh
Q 002887 569 LGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMANGNLQA 645 (870)
Q Consensus 569 LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~ 645 (870)
||+|+||.||++... +..+|+|......... .|+.....+ +|+|++++++.+...+..++||||+++|+|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 599999999999875 7789999986543211 122222222 79999999999999999999999999999999
Q ss_pred hhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC-cEEEEeccCCccccCCCCcccccccc
Q 002887 646 HLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF-QAKLADFGLSRIFPVEGGTHVSTTVV 724 (870)
Q Consensus 646 ~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~-~vkL~DFGla~~~~~~~~~~~~~~~~ 724 (870)
++... ..+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||++...... ....
T Consensus 99 ~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~ 167 (267)
T PHA03390 99 LLKKE--GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYD 167 (267)
T ss_pred HHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccCC
Confidence 98654 3789999999999999999999998 999999999999999998 9999999998765321 2346
Q ss_pred CCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccc-hHHHHHHHHhhcCCcchhcccccCCCCCHHHHH
Q 002887 725 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRT-LIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVW 803 (870)
Q Consensus 725 gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~-~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 803 (870)
++..|+|||++.+..++.++||||||++++||++|+.||....... ....+.... . . . .........
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-~--------~--~~~~~~~~~ 235 (267)
T PHA03390 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-Q-K--------K--LPFIKNVSK 235 (267)
T ss_pred CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-c-c--------c--CCcccccCH
Confidence 8899999999998889999999999999999999999998544322 122222111 0 0 0 011123456
Q ss_pred HHHHHHHHccccCCCCCCC-HHHHHH
Q 002887 804 KAVEIALACIHTISTRRPT-MNQVVI 828 (870)
Q Consensus 804 ~l~~l~~~Cl~~dP~~RPs-m~eVl~ 828 (870)
.+.+++.+|++.+|++||+ ++|+++
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 236 NANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHHHhccChhhCCchHHHHhc
Confidence 7889999999999999995 688764
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=307.87 Aligned_cols=262 Identities=19% Similarity=0.247 Sum_probs=182.7
Q ss_pred HhhccccccccCcEEEEEEEEC---CeeEEEE------------------EeeccchhhhHHHHHHHHHHHHhcccccee
Q 002887 562 TNNFERVLGKGGFGTVYHGYLD---DKQVAVK------------------MLSSSSVQGYKQFQAEVELLIRAHHKNLTI 620 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~---~~~vAVK------------------~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~ 620 (870)
.+.+.+.||+|+||.||++... +...+.| .+.. .......+++|++++++++|+||++
T Consensus 149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCCcCc
Confidence 3455689999999999998754 1112222 1111 1123456889999999999999999
Q ss_pred EEEEEecCCeEEEEEEEccCCchhhhhhhcc---cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC
Q 002887 621 LVGYCDEGANMGLIYEFMANGNLQAHLLEDK---ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK 697 (870)
Q Consensus 621 l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~ 697 (870)
+++++...+..++|+|++.+ +|.+++.... .......+...|+.|++.||+|||+. +|+||||||+|||++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 228 IEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCD 303 (501)
T ss_pred EeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC
Confidence 99999999999999999864 6666654322 12234566778999999999999998 99999999999999999
Q ss_pred CcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCC-CCCCCCc--cchHHH
Q 002887 698 FQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP-VIQKTPQ--RTLIGQ 774 (870)
Q Consensus 698 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~-p~~~~~~--~~~l~~ 774 (870)
+.+||+|||+++.+... .........||..|+|||++.+..++.++|||||||++|||++|+. |+..... ...+.+
T Consensus 304 ~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKE-REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCEEEEeCCCceecCcc-cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 99999999999876322 1222234679999999999999999999999999999999999875 4433221 111211
Q ss_pred HHHHHhh-cCC-------cchhcccc-cCC---CC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 775 WVSSMLA-RGD-------IKNIVDHR-LQG---DF-----DTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 775 ~~~~~~~-~~~-------~~~i~d~~-l~~---~~-----~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
....... .+. +.+.++.. +.. .. .......+.+++.+|++.||++|||+.|+++.
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111000 000 00000000 000 00 00112356778999999999999999999863
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=299.91 Aligned_cols=270 Identities=27% Similarity=0.374 Sum_probs=205.1
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCC------eEEEEEE
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGA------NMGLIYE 636 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~~LV~E 636 (870)
.+.||+|+||.||+|+.+ |+.||||.+.... ....+...+|+++|++++|+|||++++.-.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 368999999999999975 9999999998753 334566789999999999999999998865543 5789999
Q ss_pred EccCCchhhhhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEc--CCCc--EEEEeccCCccc
Q 002887 637 FMANGNLQAHLLEDK-ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLN--EKFQ--AKLADFGLSRIF 711 (870)
Q Consensus 637 y~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld--~~~~--vkL~DFGla~~~ 711 (870)
||.+|+|...|.+.. ...|++.+.+.++.++..||.|||++ +|+||||||.||++- .+|+ .||+|||.|+.+
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 999999999997653 36899999999999999999999998 999999999999993 3343 699999999987
Q ss_pred cCCCCccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchH--HHHHHHHhhcCCcchh
Q 002887 712 PVEGGTHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLI--GQWVSSMLARGDIKNI 788 (870)
Q Consensus 712 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l--~~~~~~~~~~~~~~~i 788 (870)
..+ .......||..|.+||.+.. +.++..+|.|||||++||++||..||......... ..|....-.....--.
T Consensus 175 ~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 175 DDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred CCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 433 25567899999999999984 78999999999999999999999999765543222 1222111111111111
Q ss_pred cccccCCC------------CCHHHHHHHHHHHHHccccCCCCCC--CHHHHHHHHHHhhhHhHhhh
Q 002887 789 VDHRLQGD------------FDTNTVWKAVEIALACIHTISTRRP--TMNQVVIELNDCLAMEIART 841 (870)
Q Consensus 789 ~d~~l~~~------------~~~~~~~~l~~l~~~Cl~~dP~~RP--sm~eVl~~L~~~~~~e~~~~ 841 (870)
.++...++ ........+-.....++..+|++|. ...+.-.++.+|+.+..-+.
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vvhi 318 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVVHI 318 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhheeEE
Confidence 11111111 1122334455667777888889998 77777777777776654433
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=283.50 Aligned_cols=256 Identities=23% Similarity=0.321 Sum_probs=197.4
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.||+|++|.||+|+.. ++.+++|++.... ....+.+..|++++++++|+|++++++++.+....++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 3467999999999999986 7899999998753 3334677899999999999999999999999999999999998
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
++|.+++.... ..+++..+..++.|+++||+|||+. +|+||||+|+||++++++.+||+|||++....... ...
T Consensus 82 ~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~--~~~ 155 (282)
T cd07829 82 MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--RTY 155 (282)
T ss_pred cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCc--ccc
Confidence 58999886543 4689999999999999999999998 99999999999999999999999999998653221 122
Q ss_pred ccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCC---c---chh--ccc
Q 002887 721 TTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGD---I---KNI--VDH 791 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~---~---~~i--~d~ 791 (870)
....++..|+|||.+.+. .++.++||||||++++||++|++||........+.+... ...... . ..+ .+.
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ-ILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHH-HhCCCcHHHHHhhcccccccc
Confidence 234567789999998776 789999999999999999999999976543222222111 110000 0 000 000
Q ss_pred ccC----CCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 792 RLQ----GDF---DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 792 ~l~----~~~---~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
... ... .......+.+++.+|++.+|++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000 000 0112457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=281.91 Aligned_cols=245 Identities=25% Similarity=0.347 Sum_probs=193.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc-----hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-----VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
.+.+.||+|+||.||+++.. +..+++|.++... .....++..|+.++++++|||++++++++.+....++|||
T Consensus 3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (260)
T cd08222 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITE 82 (260)
T ss_pred eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEE
Confidence 35678999999999999875 4456666654321 2233457789999999999999999999999999999999
Q ss_pred EccCCchhhhhhhc--ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 637 FMANGNLQAHLLED--KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 637 y~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
|+++++|.+++.+. ....+++..++.++.|+++||.|||+. +++|+||||+||++++ +.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 83 YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred eCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 99999999888652 345799999999999999999999998 9999999999999986 46999999998765322
Q ss_pred CCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccC
Q 002887 715 GGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794 (870)
Q Consensus 715 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 794 (870)
. .......|+..|+|||.+.+..++.++|+||||+++++|++|+.||....... ...... .+. .
T Consensus 159 ~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~----~~~~~~-~~~---------~ 222 (260)
T cd08222 159 C--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS----VVLRIV-EGP---------T 222 (260)
T ss_pred c--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHHH-cCC---------C
Confidence 1 22234567889999999988888999999999999999999999986433211 111111 111 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 795 GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 795 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...+......+.+++.+|++.+|++||++.|+++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1122344567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=287.22 Aligned_cols=260 Identities=22% Similarity=0.293 Sum_probs=190.7
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchh--hhHHHHHHHHHHHHhccccceeEEEEEecC--------CeE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ--GYKQFQAEVELLIRAHHKNLTILVGYCDEG--------ANM 631 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--------~~~ 631 (870)
.+.+.||+|++|.||+|... ++.+++|++...... ....+.+|++++++++|+||+++++++.+. ...
T Consensus 11 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 90 (311)
T cd07866 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSV 90 (311)
T ss_pred EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceE
Confidence 34578999999999999985 788999998654322 234578899999999999999999987543 346
Q ss_pred EEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccc
Q 002887 632 GLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 711 (870)
Q Consensus 632 ~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~ 711 (870)
++|+||+.. ++...+... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++...
T Consensus 91 ~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 91 YMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred EEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 899999975 566655432 34699999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCc---------cccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhh
Q 002887 712 PVEGGT---------HVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLA 781 (870)
Q Consensus 712 ~~~~~~---------~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~ 781 (870)
...... .......+++.|+|||.+.+. .++.++|||||||+++||++|++||..................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 322111 111234568889999988654 5889999999999999999999999765543333222211100
Q ss_pred cC--------CcchhcccccCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 782 RG--------DIKNIVDHRLQGDFD-------TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 782 ~~--------~~~~i~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.. .+....+........ ......+.+++.+|++.+|++|||+.|++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00 000000000000000 112256889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=284.18 Aligned_cols=245 Identities=24% Similarity=0.394 Sum_probs=198.5
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhc-cccceeEEEEEecCCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAH-HKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.+.||+|++|.||++... ++.+++|++.... ....+.+.+|++++.+++ |+||+++++.+..++..++||||
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd05581 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEY 83 (280)
T ss_pred eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcC
Confidence 34578999999999999985 8899999987532 233467889999999998 99999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++|||++.........
T Consensus 84 ~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 84 APNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999999988643 3799999999999999999999998 9999999999999999999999999998865332211
Q ss_pred ------------------cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHH
Q 002887 718 ------------------HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSM 779 (870)
Q Consensus 718 ------------------~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~ 779 (870)
.......++..|+|||.......+.++|+||||++++++++|+.||........... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~ 234 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK----I 234 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----H
Confidence 112234578899999999888899999999999999999999999986543222111 1
Q ss_pred hhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 002887 780 LARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTM----NQVVI 828 (870)
Q Consensus 780 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm----~eVl~ 828 (870)
.. . ....+......+.+++.+|++.+|++||++ +|+++
T Consensus 235 ~~-~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 235 LK-L----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred Hh-c----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 10 0 011222335568899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=322.74 Aligned_cols=244 Identities=25% Similarity=0.325 Sum_probs=196.7
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
..||.|.||.||-|... |...|+|-++.. .....+...+|+.++..++|||+|+++|.-.+.+..++.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 58999999999999864 888899987654 33445678899999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc--ccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT--HVS 720 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~--~~~ 720 (870)
|.+.+... ...++.....+..|++.|++|||++ +||||||||.||+|+.+|.+|++|||.|..+...... ...
T Consensus 1321 La~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1321 LASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred HHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence 99988643 3455666667889999999999999 9999999999999999999999999999877543211 122
Q ss_pred ccccCCCCccCccccccCC---CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 721 TTVVGTPGYLDPEYYISNR---LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~---~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
....||+.|||||++.+.+ ...++||||+|||++||+||++||...+.+..+- .++..|.. ...
T Consensus 1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIM----y~V~~gh~---------Pq~ 1462 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIM----YHVAAGHK---------PQI 1462 (1509)
T ss_pred HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHH----hHHhccCC---------CCC
Confidence 4568999999999997643 5678999999999999999999998766543321 12222322 222
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+.....+-.+++.+|++.||++|.++.|+++
T Consensus 1463 P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1463 PERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred chhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 3335556679999999999999988886654
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=293.89 Aligned_cols=241 Identities=24% Similarity=0.413 Sum_probs=201.8
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.+.+.||+|.|++|..|++. +.+||+|.+.+... ...+.+.+|+++++.++|||||+++++......+++||||..
T Consensus 59 ~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~ 138 (596)
T KOG0586|consen 59 VIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYAS 138 (596)
T ss_pred eeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEecc
Confidence 34578999999999999975 89999999987643 334568999999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+|.+.+++.... .+....+..++.|+.+|++|||++ .|+|||||++||||+.++++||+|||++..+. ....
T Consensus 139 ~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~~~~ 210 (596)
T KOG0586|consen 139 GGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD---YGLM 210 (596)
T ss_pred CchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec---cccc
Confidence 999999997543 455588888999999999999999 99999999999999999999999999999874 3455
Q ss_pred cccccCCCCccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC-
Q 002887 720 STTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF- 797 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~~-~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~- 797 (870)
....+|++.|.|||++.+..+ .+++|+||+|+++|-|+.|..||++..-... -++.+.+.+
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-----------------r~rvl~gk~r 273 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-----------------RPRVLRGKYR 273 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-----------------cchheeeeec
Confidence 567899999999999998775 5899999999999999999999986542221 111222222
Q ss_pred -CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 798 -DTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 798 -~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
+-.....+.+++.+.+-.+|.+|+++.++.+.
T Consensus 274 Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 274 IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11223456788999999999999999999763
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=291.05 Aligned_cols=255 Identities=22% Similarity=0.361 Sum_probs=192.9
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecC-----CeEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEG-----ANMGLIY 635 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~LV~ 635 (870)
..+.||+|+||.||+|+.. ++.||||.+... .......+.+|+.+++.++|+||+++++++... ...++|+
T Consensus 9 ~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07858 9 PIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY 88 (337)
T ss_pred EEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEE
Confidence 3568999999999999975 789999998753 223345678899999999999999999988644 3579999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 89 e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 89 ELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred eCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 9996 678887753 34689999999999999999999998 99999999999999999999999999998653221
Q ss_pred CccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhh-----------cC
Q 002887 716 GTHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLA-----------RG 783 (870)
Q Consensus 716 ~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~-----------~~ 783 (870)
.......++..|+|||.+.. ..++.++|||||||++|+|++|++||............. .... .+
T Consensus 163 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 163 --DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLIT-ELLGSPSEEDLGFIRNE 239 (337)
T ss_pred --ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH-HHhCCCChHHhhhcCch
Confidence 22234467889999998865 468899999999999999999999997543221111111 1000 00
Q ss_pred Ccchhcc-------cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 784 DIKNIVD-------HRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 784 ~~~~i~d-------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
.....+. ..+. .........+.+++.+|++.+|++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 240 KARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000 0000 0011235678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=287.95 Aligned_cols=256 Identities=23% Similarity=0.352 Sum_probs=189.6
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecC------CeEEEEE
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEG------ANMGLIY 635 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~LV~ 635 (870)
.+.||+|+||.||+|+.. ++.||+|++.... ......+.+|++++++++|+||+++++++... ...++|+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 478999999999999874 8899999987532 22345678999999999999999999998654 3468999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
||+.. +|..++ ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 100 e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-- 169 (342)
T cd07879 100 PYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADA-- 169 (342)
T ss_pred ccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC--
Confidence 99974 555543 24688999999999999999999998 999999999999999999999999999875421
Q ss_pred CccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHH----------hhcCC
Q 002887 716 GTHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSM----------LARGD 784 (870)
Q Consensus 716 ~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~----------~~~~~ 784 (870)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........+....... .....
T Consensus 170 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (342)
T cd07879 170 ---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246 (342)
T ss_pred ---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence 1123467889999999876 468899999999999999999999998654322222111100 00000
Q ss_pred cchhccc--c-cCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHhh
Q 002887 785 IKNIVDH--R-LQGDFD---TNTVWKAVEIALACIHTISTRRPTMNQVVIE--LNDCL 834 (870)
Q Consensus 785 ~~~i~d~--~-l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~--L~~~~ 834 (870)
....... . ...... ......+.+++.+|++.+|++||++.|++.. ++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000000 0 000000 1123467899999999999999999999854 65543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=273.73 Aligned_cols=236 Identities=26% Similarity=0.352 Sum_probs=195.4
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
+|.++||+|.||+|-.++-+ ++.+|+|++++.-. .....-..|-.+|+..+||.+..+.-.++..+++|.||||.
T Consensus 171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya 250 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA 250 (516)
T ss_pred hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence 34578999999999999876 88999999987633 23344567889999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
.||.|.-+|.+ .+.+++....-+-.+|+.||.|||++ +||.||||.+|.|||++|++||+|||+|+.-- ....
T Consensus 251 nGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~~g~ 323 (516)
T KOG0690|consen 251 NGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--KYGD 323 (516)
T ss_pred cCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc--cccc
Confidence 99999999864 45788888888999999999999998 99999999999999999999999999998532 2234
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
.....+|||.|+|||++....|....|.|.+|||+|||++|+.||...+.+....-+...- + .++
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed--------~-------kFP 388 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED--------L-------KFP 388 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh--------c-------cCC
Confidence 4567899999999999999999999999999999999999999998665544332211111 1 123
Q ss_pred HHHHHHHHHHHHHccccCCCCCC
Q 002887 799 TNTVWKAVEIALACIHTISTRRP 821 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RP 821 (870)
.....+...+....+.+||++|-
T Consensus 389 r~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 389 RTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ccCCHHHHHHHHHHhhcChHhhc
Confidence 33344567788889999999995
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=266.73 Aligned_cols=244 Identities=23% Similarity=0.360 Sum_probs=192.7
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeecc-chhhhHHHHHHHHHHHHhc-cccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSS-SVQGYKQFQAEVELLIRAH-HKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
..||.|+.|.|+++++. +..+|||.+... +....+++...+.++.+.+ .|.||+.+|+|.......+.||.|.. .
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C 176 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-C 176 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-H
Confidence 46999999999999986 699999999765 3445566777777777765 89999999999999999999998854 3
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
++.++ ..-.+++++...-++...+.+||.||.+++ +|+|||+||+|||+|+.|++|++|||++..+.. ....+.
T Consensus 177 ~ekLl-krik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---SkAhtr 250 (391)
T KOG0983|consen 177 AEKLL-KRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---SKAHTR 250 (391)
T ss_pred HHHHH-HHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec---cccccc
Confidence 33344 333457888888899999999999999874 999999999999999999999999999987632 233355
Q ss_pred ccCCCCccCcccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCcc-chHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 723 VVGTPGYLDPEYYIS---NRLTEKSDVYSFGVVLLELITGQPVIQKTPQR-TLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 723 ~~gt~~y~APE~~~~---~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~-~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
.+|.+.|||||.+.- .+|+-++||||||+.|+||.||+.||..-..+ +.+.. .+.++ .|.|.+.
T Consensus 251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltk----vln~e------PP~L~~~-- 318 (391)
T KOG0983|consen 251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTK----VLNEE------PPLLPGH-- 318 (391)
T ss_pred ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHH----HHhcC------CCCCCcc--
Confidence 679999999999963 46899999999999999999999999874432 22222 22211 1333322
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
........++...||++|+.+||...++++.
T Consensus 319 ~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 319 MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 2256678899999999999999999998763
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=289.90 Aligned_cols=259 Identities=23% Similarity=0.356 Sum_probs=199.2
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCC-----eEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGA-----NMGLI 634 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~LV 634 (870)
.+.+.||+|++|.||+|+.. ++.+|+|++.... ....+.+.+|+++++.++|+||+++++++.... ..+++
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 82 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV 82 (330)
T ss_pred eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence 34578999999999999975 7899999987653 344567899999999999999999999997765 78999
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
|||+++ +|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 83 ~e~~~~-~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 83 TELMET-DLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred ecchhh-hHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 999984 788877543 3799999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCc-cccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc----------
Q 002887 715 GGT-HVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR---------- 782 (870)
Q Consensus 715 ~~~-~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~---------- 782 (870)
... .......++..|+|||.+.+. .++.++|+||||+++++|++|++||.............. ....
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~ 235 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVE-VLGTPSEEDLKFIT 235 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH-hcCCCChhHhhhcc
Confidence 210 112345678899999999887 789999999999999999999999976654322221111 0000
Q ss_pred -CCcchhccc-ccCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 783 -GDIKNIVDH-RLQGD-----FDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 783 -~~~~~i~d~-~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
....+.+.. ..... ........+.+++.+||+.+|++||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000000 00000 011234578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=286.37 Aligned_cols=253 Identities=22% Similarity=0.315 Sum_probs=190.1
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEec-CCeEEEEEEEcc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDE-GANMGLIYEFMA 639 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~LV~Ey~~ 639 (870)
+.+.||+|+||.||++... ++.||+|++... .....+.+.+|++++.+++|||++++.+++.. ....++++||+.
T Consensus 14 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~~ 93 (328)
T cd07856 14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLG 93 (328)
T ss_pred EEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehhc
Confidence 3579999999999999865 788999988643 22334678899999999999999999998865 567899999984
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
++|..++. ...+++.....++.|+++||.|||+. +|+||||||+||++++++.+||+|||++..... .
T Consensus 94 -~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-----~ 161 (328)
T cd07856 94 -TDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDP-----Q 161 (328)
T ss_pred -cCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCC-----C
Confidence 58887774 34578888899999999999999998 999999999999999999999999999875421 1
Q ss_pred cccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHH-----------HHHHHhhcCCcch
Q 002887 720 STTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQ-----------WVSSMLARGDIKN 787 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~-----------~~~~~~~~~~~~~ 787 (870)
.....++..|+|||++.+ ..++.++||||||++++||++|++||........... +...........-
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 123457889999999866 5689999999999999999999999976543221111 1111111110000
Q ss_pred hcccccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 788 IVDHRLQGDFD-----TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 788 i~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
+.........+ ......+.+++.+|++.+|++||++.+++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000111111 1124678899999999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=273.54 Aligned_cols=235 Identities=29% Similarity=0.414 Sum_probs=193.6
Q ss_pred ccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCch
Q 002887 569 LGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL 643 (870)
Q Consensus 569 LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 643 (870)
||+|+||.||++... ++.+++|.+..... .....+..|++++++++|+|++++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999986 78999999876533 2445789999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccccc
Q 002887 644 QAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV 723 (870)
Q Consensus 644 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~ 723 (870)
.+++... ..+++.....++.|+++||.|||+. +++|+||||+||++++++.++|+|||++....... ......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 153 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF 153 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence 9998644 3689999999999999999999998 99999999999999999999999999987653221 123345
Q ss_pred cCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHH
Q 002887 724 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVW 803 (870)
Q Consensus 724 ~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 803 (870)
.++..|+|||...+...+.++|+||||++++||++|+.||....... ....... + . ...+.....
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~-~--------~--~~~~~~~~~ 218 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE----IYEKILK-D--------P--LRFPEFLSP 218 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHhc-C--------C--CCCCCCCCH
Confidence 68889999999988889999999999999999999999997554321 1111111 1 0 112222245
Q ss_pred HHHHHHHHccccCCCCCCCHHH
Q 002887 804 KAVEIALACIHTISTRRPTMNQ 825 (870)
Q Consensus 804 ~l~~l~~~Cl~~dP~~RPsm~e 825 (870)
.+.+++.+|+..+|++||++.+
T Consensus 219 ~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 219 EARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHhcCCHhhCCCccc
Confidence 6789999999999999999965
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=287.30 Aligned_cols=258 Identities=23% Similarity=0.328 Sum_probs=191.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecC-------------
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEG------------- 628 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------------- 628 (870)
.+.+.||+|+||.||+|... ++.||+|++........+.+.+|++++++++|+||+++++.+...
T Consensus 8 ~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (342)
T cd07854 8 MDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTE 87 (342)
T ss_pred EEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccc
Confidence 34578999999999999975 789999999777666667889999999999999999999776543
Q ss_pred -CeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEc-CCCcEEEEecc
Q 002887 629 -ANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLN-EKFQAKLADFG 706 (870)
Q Consensus 629 -~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld-~~~~vkL~DFG 706 (870)
...++|+||++ ++|.+++. ...+++..+..++.|+++||.|||+. +|+||||||+||+++ +++.+||+|||
T Consensus 88 ~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 88 LNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcc
Confidence 35789999997 58877774 24688999999999999999999998 999999999999997 45678999999
Q ss_pred CCccccCCCCc-cccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhh--c
Q 002887 707 LSRIFPVEGGT-HVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLA--R 782 (870)
Q Consensus 707 la~~~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~--~ 782 (870)
+++........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||.................. .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 99765321111 11123457889999998754 45888999999999999999999999765433222221111000 0
Q ss_pred ---CCcc----h-hcccccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 783 ---GDIK----N-IVDHRLQGDFD-----TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 783 ---~~~~----~-i~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.... . ........... ......+.+++.+|++.+|++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000 0 00000000000 122356789999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=269.14 Aligned_cols=244 Identities=23% Similarity=0.323 Sum_probs=198.6
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEEEec----CCeEEEEEEEcc
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGYCDE----GANMGLIYEFMA 639 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~~~LV~Ey~~ 639 (870)
++||-|-.|+|-....+ ++..|+|++... ....+|+++--+. .|+|||.+++.+.+ ...+++|||.|+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 68999999999999886 788999998654 4457888876665 79999999998854 456789999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC---CCcEEEEeccCCccccCCCC
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE---KFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~---~~~vkL~DFGla~~~~~~~~ 716 (870)
||.|...+.++....+++.++-.|++||..|+.|||+. +|.||||||+|+|... |..+||+|||+|+.-. .
T Consensus 143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~---~ 216 (400)
T KOG0604|consen 143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ---E 216 (400)
T ss_pred chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccC---C
Confidence 99999999988888999999999999999999999998 9999999999999964 4568999999998542 2
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
.....+.+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||-...... +..-.+..++.|.. ++.+++
T Consensus 217 ~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-ispgMk~rI~~gqy-~FP~pE---- 290 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGMKRRIRTGQY-EFPEPE---- 290 (400)
T ss_pred CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-CChhHHhHhhccCc-cCCChh----
Confidence 334456788999999999999999999999999999999999999997655422 22223333333321 111111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
-....+...+++...|..+|.+|-|+.|+..
T Consensus 291 -Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 291 -WSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred -HhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 1355677889999999999999999999864
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=286.98 Aligned_cols=261 Identities=23% Similarity=0.334 Sum_probs=191.9
Q ss_pred HHHHHHhhc--cccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecC--
Q 002887 557 DVLKITNNF--ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEG-- 628 (870)
Q Consensus 557 dl~~~t~~f--~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-- 628 (870)
++..+++++ .+.||+|+||.||+|... ++.||+|++.... ....+.+.+|++++.+++|+||+++.+++...
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 334444444 468999999999999864 8899999987542 22345678899999999999999999988543
Q ss_pred ----CeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEe
Q 002887 629 ----ANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLAD 704 (870)
Q Consensus 629 ----~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~D 704 (870)
...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~d 163 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD 163 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEec
Confidence 3467777776 7788877642 3589999999999999999999998 999999999999999999999999
Q ss_pred ccCCccccCCCCccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhh--
Q 002887 705 FGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLA-- 781 (870)
Q Consensus 705 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~-- 781 (870)
||++..... ......++..|+|||.+.+ ..++.++|||||||+++||++|+.||........+.........
T Consensus 164 fg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (345)
T cd07877 164 FGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238 (345)
T ss_pred ccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999875421 1233467889999999876 56889999999999999999999999654433222221111100
Q ss_pred --------cCCcchh---cccccCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 782 --------RGDIKNI---VDHRLQGDFD---TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 782 --------~~~~~~i---~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
....... ++......+. ......+.+++.+|++.+|++||++.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000 0000000000 0123467899999999999999999998864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=284.70 Aligned_cols=259 Identities=25% Similarity=0.317 Sum_probs=189.9
Q ss_pred hccccccccCcEEEEEEEEC----CeeEEEEEeeccc--hhhhHHHHHHHHHHHHh-ccccceeEEEEEecC----CeEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD----DKQVAVKMLSSSS--VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEG----ANMG 632 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~----~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~----~~~~ 632 (870)
.+.+.||+|+||.||++... ++.+|+|++.... ....+.+.+|+++++++ +|+||+++++.+... ...+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 34578999999999999975 5589999987532 22345678899999999 599999999875432 4567
Q ss_pred EEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCcccc
Q 002887 633 LIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 712 (870)
Q Consensus 633 LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~ 712 (870)
+++||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.+.
T Consensus 83 ~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 83 LYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 8888886 588888753 35689999999999999999999998 99999999999999999999999999998653
Q ss_pred CCCCc--cccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHh---------
Q 002887 713 VEGGT--HVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSML--------- 780 (870)
Q Consensus 713 ~~~~~--~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~--------- 780 (870)
..... .......|+..|+|||++.+ ..++.++|+||+||++++|++|++||........+.+.+...-
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 22111 11233468999999998865 4689999999999999999999999976553322222111100
Q ss_pred -hcCCcchhcc---cccCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 781 -ARGDIKNIVD---HRLQGD---FDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 781 -~~~~~~~i~d---~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.......... ..-... ........+.+++.+|++.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 000000 00112457889999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=284.36 Aligned_cols=252 Identities=26% Similarity=0.351 Sum_probs=189.4
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCC------eEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGA------NMGLI 634 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~~LV 634 (870)
..+.||+|+||.||++... ++.||||++.... ....+.+.+|++++++++|+||+++++.+.... ..++|
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07880 19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98 (343)
T ss_pred EEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEE
Confidence 3468999999999999875 7889999986432 223456889999999999999999999986543 45899
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
|||+ +++|..++. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 99 ~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 99 MPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred EecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 9998 678887774 34689999999999999999999998 9999999999999999999999999998754221
Q ss_pred CCccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHH----------HhhcC
Q 002887 715 GGTHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSS----------MLARG 783 (870)
Q Consensus 715 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~----------~~~~~ 783 (870)
.....+++.|+|||.+.+ ..++.++|+||||+++++|++|+.||..........+.... .+...
T Consensus 172 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07880 172 -----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246 (343)
T ss_pred -----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence 223467889999999876 45889999999999999999999999865432222111110 00000
Q ss_pred Ccchhccc--ccCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 784 DIKNIVDH--RLQG----DFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 784 ~~~~i~d~--~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
........ .... .........+.+++.+|++.+|++|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 0000 001123346789999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=305.25 Aligned_cols=249 Identities=27% Similarity=0.418 Sum_probs=186.7
Q ss_pred hhcc--ccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEec----------
Q 002887 563 NNFE--RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDE---------- 627 (870)
Q Consensus 563 ~~f~--~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~---------- 627 (870)
.+|+ +.||+||||.|||++.+ |+.+|||++.... ........+|+..|.+|+|||+|+++..+.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 4454 47999999999999875 9999999998763 3445678899999999999999988621100
Q ss_pred --------------------------------------------------------------------------------
Q 002887 628 -------------------------------------------------------------------------------- 627 (870)
Q Consensus 628 -------------------------------------------------------------------------------- 627 (870)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ---------------------C--------CeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCC
Q 002887 628 ---------------------G--------ANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGC 678 (870)
Q Consensus 628 ---------------------~--------~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 678 (870)
+ ..+|+=||||+...+.+.+.++.... .-...++++++|++||+|+|++
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~- 716 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQ- 716 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhC-
Confidence 0 11456789999877777776543221 3566789999999999999999
Q ss_pred CCCceeCCCCCCCEEEcCCCcEEEEeccCCcccc----------------CCCCccccccccCCCCccCccccccC---C
Q 002887 679 KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP----------------VEGGTHVSTTVVGTPGYLDPEYYISN---R 739 (870)
Q Consensus 679 ~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~APE~~~~~---~ 739 (870)
+||||||||.||+||++..|||+|||+|+... ........+..+||.-|+|||++.+. +
T Consensus 717 --giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 717 --GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred --ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 99999999999999999999999999998721 00111234567899999999999754 5
Q ss_pred CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCC
Q 002887 740 LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTR 819 (870)
Q Consensus 740 ~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~ 819 (870)
|+.|+|+||+|||++||+. ||....++.. +..-++.+.+..- ..+.......-..++.++++.||.+
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~----iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~k 861 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMERAS----ILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSK 861 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHHHH----HHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCcc
Confidence 9999999999999999996 5664433222 1222334433221 1223344455678999999999999
Q ss_pred CCCHHHHHH
Q 002887 820 RPTMNQVVI 828 (870)
Q Consensus 820 RPsm~eVl~ 828 (870)
|||+.|++.
T Consensus 862 RPtA~eLL~ 870 (1351)
T KOG1035|consen 862 RPTATELLN 870 (1351)
T ss_pred CCCHHHHhh
Confidence 999999974
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=270.97 Aligned_cols=259 Identities=24% Similarity=0.322 Sum_probs=201.8
Q ss_pred cccCHHHHHHHHhhccccccccCcEEEEEEEEC--CeeEEEEEeeccch-hhhHHHHHHHHHHHHh-ccccceeEEEEEe
Q 002887 551 RKFSYFDVLKITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-QGYKQFQAEVELLIRA-HHKNLTILVGYCD 626 (870)
Q Consensus 551 ~~~~~~dl~~~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~ 626 (870)
..|+-.++.+. ..||.|+||+|+|-.++ |+..|||+++.... .+.+++..|.+...+- +.||||+++|.+.
T Consensus 59 ~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F 133 (361)
T KOG1006|consen 59 HTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF 133 (361)
T ss_pred cccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence 34555555554 46999999999999987 89999999987755 5667888888876665 7999999999999
Q ss_pred cCCeEEEEEEEccCCchhhh---hhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEE
Q 002887 627 EGANMGLIYEFMANGNLQAH---LLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLA 703 (870)
Q Consensus 627 ~~~~~~LV~Ey~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~ 703 (870)
.+...++.||.|.- ||+.+ +...+...+++...-.|..-...||.||.+. .+|||||+||+|||||..|.+||+
T Consensus 134 ~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLC 210 (361)
T KOG1006|consen 134 SEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLC 210 (361)
T ss_pred cCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeee
Confidence 99999999999964 55432 3333456788888888999999999999976 499999999999999999999999
Q ss_pred eccCCccccCCCCccccccccCCCCccCcccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhh
Q 002887 704 DFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLA 781 (870)
Q Consensus 704 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~ 781 (870)
|||++..+. .+...+..+|...|||||.+.. ..|+-++||||+|++|+|+.||+.|+..-.. ..+.+...+
T Consensus 211 DFGIcGqLv---~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv- 283 (361)
T KOG1006|consen 211 DFGICGQLV---DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVV- 283 (361)
T ss_pred cccchHhHH---HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHH-
Confidence 999997653 2334456688999999999963 3489999999999999999999999986442 112222222
Q ss_pred cCCcchhcccccCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 782 RGDIKNIVDHRLQGDF-DTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 782 ~~~~~~i~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
.|+. |.|.... ..+....+..++..|+.+|-..||...++.++
T Consensus 284 ~gdp-----p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 284 IGDP-----PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cCCC-----CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2221 1222221 23456788999999999999999999998764
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=286.38 Aligned_cols=252 Identities=24% Similarity=0.350 Sum_probs=190.6
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecCCe------EEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGAN------MGLI 634 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~------~~LV 634 (870)
+.+.||+|++|.||+|+.. ++.||+|++... .....+.+.+|+.++++++|+|++++++++..... .++|
T Consensus 19 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07851 19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98 (343)
T ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEE
Confidence 3478999999999999985 788999998653 22334567889999999999999999988765544 8999
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
+||+ +++|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 99 ~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 99 THLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred EecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 9998 5688888743 4689999999999999999999998 9999999999999999999999999998765221
Q ss_pred CCccccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHh----------hcC
Q 002887 715 GGTHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSML----------ARG 783 (870)
Q Consensus 715 ~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~----------~~~ 783 (870)
.....++..|+|||.+.+. .++.++|||||||+++||++|+.||........+.......- ...
T Consensus 172 -----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07851 172 -----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE 246 (343)
T ss_pred -----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence 2334678899999998653 678999999999999999999999975543222221111100 000
Q ss_pred Ccchhccccc---CCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 784 DIKNIVDHRL---QGDFD---TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 784 ~~~~i~d~~l---~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.....+.... ...+. ......+.+++.+|++.+|++|||+.||++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000000 00000 112467889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=270.82 Aligned_cols=252 Identities=27% Similarity=0.367 Sum_probs=204.0
Q ss_pred ccccccccCcEEEEEEEEC-------CeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecC-CeEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEG-ANMGLIY 635 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~LV~ 635 (870)
+..++-+|.||.||+|.|. .+.|.||.++.+.. -....+..|.-.+..+.|||+.++.+.+.+. ...+.+|
T Consensus 288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence 3457999999999999774 24577887776533 3445678888899999999999999998664 5678889
Q ss_pred EEccCCchhhhhhhcc------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCc
Q 002887 636 EFMANGNLQAHLLEDK------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 709 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~ 709 (870)
.++.-|+|..+|...+ .+.++-.+...++.|++.|++|||.. +|||.||..+|.++|+..++||+|=.+++
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhcc
Confidence 9999999999998432 36788889999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchh
Q 002887 710 IFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNI 788 (870)
Q Consensus 710 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i 788 (870)
.+-+.+..-.-..-.....||+||.+....+++.+|||||||+||||+| |+.|+.+.+..+. ..++.+|
T Consensus 445 DLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm-----~~ylkdG----- 514 (563)
T KOG1024|consen 445 DLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM-----EHYLKDG----- 514 (563)
T ss_pred ccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-----HHHHhcc-----
Confidence 7644332222223345678999999999999999999999999999998 8999987654432 2223333
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 789 VDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 789 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
.++.. +-.++.++..++.-||...|++||+++|++.-|.|-
T Consensus 515 --yRlaQ--P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 515 --YRLAQ--PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred --ceecC--CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 23333 346788999999999999999999999999999873
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=303.78 Aligned_cols=140 Identities=31% Similarity=0.433 Sum_probs=126.2
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
+.+.||+|+||.||+|... ++.||||+++... ......+.+|+.++..++|+||+++++.+......++||||+.
T Consensus 8 i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~ 87 (669)
T cd05610 8 IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLI 87 (669)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCC
Confidence 4578999999999999987 8899999997543 2234678899999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 709 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~ 709 (870)
+++|.+++... ..+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 88 g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 88 GGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999988643 4688899999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=287.91 Aligned_cols=234 Identities=25% Similarity=0.380 Sum_probs=193.3
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
.+...+|.|+|+.|-.+... ++..+||++..... +-.+|+.++.+. +|+||+++.+.+.++.+.++|||.+.+
T Consensus 325 ~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g 400 (612)
T KOG0603|consen 325 EFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG 400 (612)
T ss_pred ccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence 45567999999999999875 78899999987632 235677676666 799999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEE-cCCCcEEEEeccCCccccCCCCccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILL-NEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILl-d~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
|-+.+.+...+ ... ..+..|+.+|+.|+.|||++ +|+||||||+|||+ ++.++++|+|||.++....+
T Consensus 401 ~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----- 469 (612)
T KOG0603|consen 401 GELLRRIRSKP--EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----- 469 (612)
T ss_pred cHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-----
Confidence 98888775432 222 67778999999999999998 99999999999999 68899999999999876433
Q ss_pred cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
....+-|..|.|||++....+++++|+||||++||+||+|+.||...+....+ ...+.. +.++.
T Consensus 470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei----~~~i~~------------~~~s~ 533 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEI----HTRIQM------------PKFSE 533 (612)
T ss_pred hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHH----HHhhcC------------Ccccc
Confidence 33456788999999999999999999999999999999999999876654221 111222 23345
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.......+|+.+||+.+|.+||+|.|+..
T Consensus 534 ~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 534 CVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 56678899999999999999999999865
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=289.87 Aligned_cols=247 Identities=25% Similarity=0.398 Sum_probs=205.2
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEEEe-----cCCeEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGYCD-----EGANMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~-----~~~~~~LV~ 635 (870)
.|.+.||+|.+|.||+++.. ++.+|+|++..... ..++.+.|.++|+.. .|||++.++|++. .+++++|||
T Consensus 22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM 100 (953)
T KOG0587|consen 22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM 100 (953)
T ss_pred EEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence 45689999999999999864 88899999876543 346778899999887 7999999999984 357899999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
|||.+||..+.+..-.+..+.|..+..|++.++.|+.|||.+ .++|||+|-.||||++++.+||+|||.+..+ +.
T Consensus 101 EfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQl--ds 175 (953)
T KOG0587|consen 101 EFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DS 175 (953)
T ss_pred eccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeee--ec
Confidence 999999999999887788999999999999999999999999 9999999999999999999999999999865 33
Q ss_pred CccccccccCCCCccCccccccC-----CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcc
Q 002887 716 GTHVSTTVVGTPGYLDPEYYISN-----RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVD 790 (870)
Q Consensus 716 ~~~~~~~~~gt~~y~APE~~~~~-----~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d 790 (870)
........+||+.|||||++... .|+.++|+||+|++..||--|.+|+.++.....+..+ .-.
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I------------pRN 243 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI------------PRN 243 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC------------CCC
Confidence 44556678999999999999643 3778999999999999999999999877654333221 011
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 791 HRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 791 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
|...-..+..=..++.+++..|+.+|-++||++.++++
T Consensus 244 PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 244 PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11222223445667889999999999999999998864
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=263.47 Aligned_cols=199 Identities=27% Similarity=0.365 Sum_probs=166.3
Q ss_pred ccccccccCcEEEEEEEEC------CeeEEEEEeeccchh--hhHHHHHHHHHHHHhccccceeEEEEEec-CCeEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD------DKQVAVKMLSSSSVQ--GYKQFQAEVELLIRAHHKNLTILVGYCDE-GANMGLIY 635 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~------~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~LV~ 635 (870)
....||+|.+|.||+|.-. .+.+|+|+++..+.. .....-+|+.+++.++|+|++.+...+.+ +...++++
T Consensus 28 ~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~f 107 (438)
T KOG0666|consen 28 GIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLF 107 (438)
T ss_pred ccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEe
Confidence 3467999999999999643 346899999876332 23456899999999999999999998876 77899999
Q ss_pred EEccCCchhhhhhhcc---cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC----CcEEEEeccCC
Q 002887 636 EFMANGNLQAHLLEDK---ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK----FQAKLADFGLS 708 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~----~~vkL~DFGla 708 (870)
||.+. +|.+.++..+ .+.++-..+..|+.||+.|+.|||++ =|+||||||.|||+..+ |.+||+|+|++
T Consensus 108 dYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 108 DYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred hhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 99997 7877776543 35788899999999999999999999 79999999999999888 89999999999
Q ss_pred ccccCCCCcc-ccccccCCCCccCccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCC
Q 002887 709 RIFPVEGGTH-VSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTP 767 (870)
Q Consensus 709 ~~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~-~~~ksDVwS~GvvL~elltG~~p~~~~~ 767 (870)
+.+...-... ....++-|..|.|||.+.+.+ |+.+.||||.||++.||+|-++.|.+..
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 9885432222 234567899999999999764 8999999999999999999998887543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=272.58 Aligned_cols=238 Identities=26% Similarity=0.376 Sum_probs=195.5
Q ss_pred HhhccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEE
Q 002887 562 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIY 635 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~ 635 (870)
..+|..+||+|+||+|..|..+ ++.+|||++++.-. .+.+--+.|-++|... +-|.++++..+++.-+.++.||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 3578899999999999999876 56699999987522 2233345677777766 6778999999999999999999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
||+.+|+|--++++ -..+.+..+.-+|.+||-||-+||++ +|+.||||.+||+||.+|++||+|||+++.-- -
T Consensus 430 EyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni--~ 502 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--F 502 (683)
T ss_pred EEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc--c
Confidence 99999999888853 35678888999999999999999999 99999999999999999999999999998532 1
Q ss_pred CccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 716 GTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 716 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
....+.+.+||+.|+|||.+..+.|...+|.|||||+||||+.|++||++.++.+....+. +.. .
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~-------------ehn--v 567 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM-------------EHN--V 567 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-------------Hcc--C
Confidence 2334567899999999999999999999999999999999999999999887766544322 111 2
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRP 821 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RP 821 (870)
.++.....+..++....+.+.|.+|-
T Consensus 568 syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 568 SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cCcccccHHHHHHHHHHhhcCCcccc
Confidence 34445556677788888888888884
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=265.76 Aligned_cols=221 Identities=22% Similarity=0.195 Sum_probs=177.4
Q ss_pred cCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCchhhhhhh
Q 002887 572 GGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLE 649 (870)
Q Consensus 572 G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~ 649 (870)
|.+|.||+++.. ++.+|+|++.... .+.+|...+....|||++++++++.+....++||||+++|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999985 7889999987653 234455556666899999999999999999999999999999998864
Q ss_pred cccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccccccCCCCc
Q 002887 650 DKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGY 729 (870)
Q Consensus 650 ~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y 729 (870)
. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++++|||.+...... .....++..|
T Consensus 79 ~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y 148 (237)
T cd05576 79 F--LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMY 148 (237)
T ss_pred h--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccc
Confidence 3 3589999999999999999999998 9999999999999999999999999987654221 1233456789
Q ss_pred cCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHH
Q 002887 730 LDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIA 809 (870)
Q Consensus 730 ~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~ 809 (870)
+|||...+..++.++|+||+|++++||++|+.|+........ .... ...+......+.+++
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---------------~~~~----~~~~~~~~~~~~~li 209 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN---------------THTT----LNIPEWVSEEARSLL 209 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc---------------cccc----cCCcccCCHHHHHHH
Confidence 999999888899999999999999999999988753221100 0000 011222345678999
Q ss_pred HHccccCCCCCCCHHHH
Q 002887 810 LACIHTISTRRPTMNQV 826 (870)
Q Consensus 810 ~~Cl~~dP~~RPsm~eV 826 (870)
.+|++.||++||++.+.
T Consensus 210 ~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 210 QQLLQFNPTERLGAGVA 226 (237)
T ss_pred HHHccCCHHHhcCCCcc
Confidence 99999999999997433
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=261.60 Aligned_cols=237 Identities=29% Similarity=0.419 Sum_probs=194.2
Q ss_pred CcEEEEEEEEC--CeeEEEEEeeccchhh-hHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCchhhhhhh
Q 002887 573 GFGTVYHGYLD--DKQVAVKMLSSSSVQG-YKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLE 649 (870)
Q Consensus 573 ~fG~Vy~~~~~--~~~vAVK~l~~~~~~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~ 649 (870)
+||.||+|... ++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 6899999998765544 67899999999999999999999999999999999999999999998865
Q ss_pred cccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccccccCCCCc
Q 002887 650 DKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGY 729 (870)
Q Consensus 650 ~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y 729 (870)
.. .+++..+..++.++++++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 81 ~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~ 152 (244)
T smart00220 81 RG--RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY 152 (244)
T ss_pred cc--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence 43 388999999999999999999998 99999999999999999999999999998764321 23345688899
Q ss_pred cCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHH
Q 002887 730 LDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIA 809 (870)
Q Consensus 730 ~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~ 809 (870)
++||.+.+...+.++||||||+++++|++|+.||..........++.. .+.... ..........+.+++
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~----~~~~~~-------~~~~~~~~~~~~~~i 221 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG----KPKPPF-------PPPEWKISPEAKDLI 221 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh----ccCCCC-------ccccccCCHHHHHHH
Confidence 999999988899999999999999999999999976433222222211 111000 000001345788999
Q ss_pred HHccccCCCCCCCHHHHHH
Q 002887 810 LACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 810 ~~Cl~~dP~~RPsm~eVl~ 828 (870)
.+|+..+|++||++.++++
T Consensus 222 ~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 222 RKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHccCCchhccCHHHHhh
Confidence 9999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=269.62 Aligned_cols=251 Identities=25% Similarity=0.355 Sum_probs=197.4
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch--h-----hhHHHHHHHHHHHHhccccceeEEEEEec-CCeEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--Q-----GYKQFQAEVELLIRAHHKNLTILVGYCDE-GANMGLI 634 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~-----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~LV 634 (870)
+..+||+|+|+.||+|..- .+.||||+-..... . -.+...+|..+-+.+.||.||++++++.- .+.+|-|
T Consensus 467 lLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTV 546 (775)
T KOG1151|consen 467 LLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTV 546 (775)
T ss_pred HHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceee
Confidence 3468999999999999863 77899998654321 1 12346789999999999999999999954 4578899
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC---CCcEEEEeccCCccc
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE---KFQAKLADFGLSRIF 711 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~---~~~vkL~DFGla~~~ 711 (870)
+|||+|.+|+-+|... +.+++.++..|+.||+.||.||.+. +++|||-||||.||||-+ -|.+||.|||+++++
T Consensus 547 LEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIM 623 (775)
T KOG1151|consen 547 LEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIM 623 (775)
T ss_pred eeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhc
Confidence 9999999999999644 5789999999999999999999987 889999999999999954 478999999999998
Q ss_pred cCCCCcc-----ccccccCCCCccCccccccC----CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc
Q 002887 712 PVEGGTH-----VSTTVVGTPGYLDPEYYISN----RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR 782 (870)
Q Consensus 712 ~~~~~~~-----~~~~~~gt~~y~APE~~~~~----~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~ 782 (870)
..++..+ .....+||.+|++||.+.-+ +++.|+||||.||++|+++.|+.||........+.+.
T Consensus 624 dddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe------- 696 (775)
T KOG1151|consen 624 DDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE------- 696 (775)
T ss_pred cCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh-------
Confidence 6554432 34557899999999998643 5889999999999999999999999876544333221
Q ss_pred CCcchhccc-ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 783 GDIKNIVDH-RLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 783 ~~~~~i~d~-~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.. ++.. ...-+..+....+...+|.+|++..-++|....|+..
T Consensus 697 NT---IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 697 NT---ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hc---hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11 1111 1111112345567889999999999999987777653
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=274.54 Aligned_cols=242 Identities=26% Similarity=0.364 Sum_probs=196.6
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
++.||.|-||+||-|++. |+.||||++.+... ....++.+|+.+|.+++||.||.+-..|+..+..+.|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 479999999999999986 99999999987543 2346789999999999999999999999999999999999975
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC---CcEEEEeccCCccccCCCCcc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK---FQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~---~~vkL~DFGla~~~~~~~~~~ 718 (870)
+..+.+.......|+...-..++.||+.||.|||.+ +|+|+||||+||||.+. -++||+|||.|+++. ...
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg---Eks 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG---EKS 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecc---hhh
Confidence 555555555556788888889999999999999999 99999999999999654 479999999999873 334
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
....++||+.|+|||++..+.|...-|+||.||++|--++|..||....+-.+..+-+.-+ ...+--
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFM-------------yPp~PW 788 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFM-------------YPPNPW 788 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccc-------------cCCCch
Confidence 5567899999999999999999999999999999999999999998643321111100000 011112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVV 827 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl 827 (870)
.+.....+++|...++..=++|-|...-+
T Consensus 789 ~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 789 SEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred hhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 35556778999999999888888877654
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=295.14 Aligned_cols=245 Identities=25% Similarity=0.346 Sum_probs=197.4
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeecc---chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS---SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.++||+|+||.|..++++ ++.+|.|++.+- ......-|..|-.+|..-+.+-|+.+.-.|++..++|+|||||
T Consensus 78 eilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~ 157 (1317)
T KOG0612|consen 78 EILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYM 157 (1317)
T ss_pred HHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecc
Confidence 34578999999999999986 788999999873 3345567899999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
+||+|..++.... .++...+..++..|.-||+-||+. |+|||||||+|||||..|++||+|||.|-.+.. ++..
T Consensus 158 pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~-dG~V 231 (1317)
T KOG0612|consen 158 PGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA-DGTV 231 (1317)
T ss_pred cCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCC-CCcE
Confidence 9999999886433 788888999999999999999998 999999999999999999999999999987743 3445
Q ss_pred ccccccCCCCccCcccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccc--
Q 002887 719 VSTTVVGTPGYLDPEYYIS-----NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDH-- 791 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~-- 791 (870)
.+...+|||.|++||++.. +.|+..+|.||+||++|||+.|..||....- ...+ . .|++.
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl---veTY-~---------KIm~hk~ 298 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL---VETY-G---------KIMNHKE 298 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH---HHHH-H---------HHhchhh
Confidence 5667789999999999962 5689999999999999999999999964321 1111 1 12222
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 002887 792 RLQGDFDTNTVWKAVEIALACIHTISTRRPT---MNQVVI 828 (870)
Q Consensus 792 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---m~eVl~ 828 (870)
.+.-+-....+....+||.+.+. +|+.|-. +.++-.
T Consensus 299 ~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 299 SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 11111112456677888887766 5788877 666643
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=232.81 Aligned_cols=255 Identities=21% Similarity=0.309 Sum_probs=195.2
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
++||+|.+|+||+|+.. ++.||+|+++.... ..-....+|+-+|+.++|+|||++++....+....+|+|||.. +
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-d 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-H
Confidence 57999999999999975 78899999876532 2345678999999999999999999999999999999999975 5
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|..+... -...++...+..++.|+++||.++|++ ++.||||||+|.|++.+|+.|++|||+++.+.-. ......
T Consensus 87 lkkyfds-lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip--vrcysa 160 (292)
T KOG0662|consen 87 LKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VRCYSA 160 (292)
T ss_pred HHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc--eEeeec
Confidence 6655533 235688889999999999999999998 9999999999999999999999999999876322 223344
Q ss_pred ccCCCCccCccccccCC-CCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHH--hhcCC---cchhcccccCC
Q 002887 723 VVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSM--LARGD---IKNIVDHRLQG 795 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~-~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~--~~~~~---~~~i~d~~l~~ 795 (870)
.+-|..|.+|.++.+.+ |+...|+||-||++.|+.. |++.|-+.+..+.+.++++.+ ..++. +..+.|.....
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp 240 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP 240 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence 56789999999999865 8899999999999999986 677777666555555554432 11221 23344433333
Q ss_pred CCCH-----HHHH----HHHHHHHHccccCCCCCCCHHHHHH
Q 002887 796 DFDT-----NTVW----KAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 796 ~~~~-----~~~~----~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.++. +..+ .=.++..+.+.-+|.+|.++++.++
T Consensus 241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 3321 1222 2246777777778999999887664
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=278.32 Aligned_cols=250 Identities=19% Similarity=0.244 Sum_probs=176.6
Q ss_pred ccccccccCcEEEEEEEE------------------CCeeEEEEEeeccchhhhHH--------------HHHHHHHHHH
Q 002887 565 FERVLGKGGFGTVYHGYL------------------DDKQVAVKMLSSSSVQGYKQ--------------FQAEVELLIR 612 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~------------------~~~~vAVK~l~~~~~~~~~~--------------f~~Ei~~l~~ 612 (870)
+.++||+|+||.||+|.+ .++.||||++........++ +..|+.++.+
T Consensus 149 i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~ 228 (507)
T PLN03224 149 LRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAK 228 (507)
T ss_pred EeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHH
Confidence 457999999999999964 14579999987654332222 3457777888
Q ss_pred hccccc-----eeEEEEEec--------CCeEEEEEEEccCCchhhhhhhcc----------------------cccccH
Q 002887 613 AHHKNL-----TILVGYCDE--------GANMGLIYEFMANGNLQAHLLEDK----------------------ADTLCW 657 (870)
Q Consensus 613 l~H~nI-----v~l~g~~~~--------~~~~~LV~Ey~~~gsL~~~l~~~~----------------------~~~l~~ 657 (870)
++|.++ ++++++|.. +...+|||||+++|+|.++++... ...++|
T Consensus 229 l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~ 308 (507)
T PLN03224 229 IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI 308 (507)
T ss_pred hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence 877655 677787753 356899999999999999886421 123567
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccccccCCCCccCcccccc
Q 002887 658 ERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYIS 737 (870)
Q Consensus 658 ~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~ 737 (870)
..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||++....... ........+++.|+|||.+..
T Consensus 309 ~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aPE~l~~ 384 (507)
T PLN03224 309 NVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPPEELVM 384 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeChhhhcC
Confidence 88999999999999999998 99999999999999999999999999997553221 111122345789999999864
Q ss_pred CCC----------------------CccchHHHHHHHHHHHHhCCC-CCCCCCc--------cchHHHHHHHHhhcCCcc
Q 002887 738 NRL----------------------TEKSDVYSFGVVLLELITGQP-VIQKTPQ--------RTLIGQWVSSMLARGDIK 786 (870)
Q Consensus 738 ~~~----------------------~~ksDVwS~GvvL~elltG~~-p~~~~~~--------~~~l~~~~~~~~~~~~~~ 786 (870)
... ..+.||||+||+++||++|.. |+..... ...+..|... ...
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--~~~--- 459 (507)
T PLN03224 385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--KGQ--- 459 (507)
T ss_pred CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--ccc---
Confidence 321 235799999999999999875 6653221 1112222110 000
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHH
Q 002887 787 NIVDHRLQGDFDTNTVWKAVEIALACIHTIS---TRRPTMNQVVI 828 (870)
Q Consensus 787 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPsm~eVl~ 828 (870)
...-...........+++.+++..+| .+|+|++|+++
T Consensus 460 -----~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 460 -----KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred -----CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 01011112334667889999999766 68999999985
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-29 Score=262.17 Aligned_cols=265 Identities=21% Similarity=0.305 Sum_probs=203.6
Q ss_pred cCHHHHHHHHhhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhcc--cc----ceeEEEE
Q 002887 553 FSYFDVLKITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHH--KN----LTILVGY 624 (870)
Q Consensus 553 ~~~~dl~~~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H--~n----Iv~l~g~ 624 (870)
+...|.+...+.....+|+|.||.|-+.... +..||||+++.-.. -.+..+-|+++|.++.+ |+ +|.+.++
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 3334444445555678999999999998875 67899999876532 23445789999999932 22 7888899
Q ss_pred EecCCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC--------
Q 002887 625 CDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE-------- 696 (870)
Q Consensus 625 ~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~-------- 696 (870)
+.-.++.++|+|.| |-|+.+++.++.-.+++..++..|+.|+++++++||+. +++|-||||+|||+.+
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEec
Confidence 99999999999987 34899999988888999999999999999999999998 9999999999999932
Q ss_pred ------------CCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCC
Q 002887 697 ------------KFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQ 764 (870)
Q Consensus 697 ------------~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~ 764 (870)
+..+||+|||.|+.-.. -...++.|..|.|||++.+-.++..+||||+||||.|+.||...|+
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 34589999999986421 1256788999999999999999999999999999999999999998
Q ss_pred CCCccchHHHHHHHHh-----------------hcCCc-----------chhccccc----CCCCCHHHHHHHHHHHHHc
Q 002887 765 KTPQRTLIGQWVSSML-----------------ARGDI-----------KNIVDHRL----QGDFDTNTVWKAVEIALAC 812 (870)
Q Consensus 765 ~~~~~~~l~~~~~~~~-----------------~~~~~-----------~~i~d~~l----~~~~~~~~~~~l~~l~~~C 812 (870)
..+..+.+.. +...+ ..|.+ ..+.++.. .......+..++++|+.++
T Consensus 311 tHen~EHLaM-MerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 311 THENLEHLAM-MERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred cCCcHHHHHH-HHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 7765444321 11111 11111 11111110 0111345667899999999
Q ss_pred cccCCCCCCCHHHHHH
Q 002887 813 IHTISTRRPTMNQVVI 828 (870)
Q Consensus 813 l~~dP~~RPsm~eVl~ 828 (870)
+..||.+|+|++|+++
T Consensus 390 L~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 390 LEFDPARRITLREALS 405 (415)
T ss_pred HccCccccccHHHHhc
Confidence 9999999999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=284.08 Aligned_cols=252 Identities=20% Similarity=0.271 Sum_probs=163.0
Q ss_pred hccccccccCcEEEEEEEEC------CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEE------EecCCeE
Q 002887 564 NFERVLGKGGFGTVYHGYLD------DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGY------CDEGANM 631 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~------~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~------~~~~~~~ 631 (870)
.+.+.||+|+||.||+|++. +..||||++...... +.+..| .+....+.++..++.. +..+...
T Consensus 135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (566)
T PLN03225 135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEY 210 (566)
T ss_pred EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCce
Confidence 34579999999999999975 468999987643211 111111 1122222222222111 3456789
Q ss_pred EEEEEEccCCchhhhhhhccc------------------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEE
Q 002887 632 GLIYEFMANGNLQAHLLEDKA------------------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANIL 693 (870)
Q Consensus 632 ~LV~Ey~~~gsL~~~l~~~~~------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NIL 693 (870)
++||||+.+++|.+++..... .......+..++.|++.||+|||+. +|+||||||+|||
T Consensus 211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NIL 287 (566)
T PLN03225 211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNII 287 (566)
T ss_pred EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEE
Confidence 999999999999998864321 0112334567999999999999998 9999999999999
Q ss_pred EcC-CCcEEEEeccCCccccCCCCccccccccCCCCccCccccccC----------------------CCCccchHHHHH
Q 002887 694 LNE-KFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISN----------------------RLTEKSDVYSFG 750 (870)
Q Consensus 694 ld~-~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------------------~~~~ksDVwS~G 750 (870)
+++ ++.+||+|||+++.+... .........+++.|+|||.+... .++.++||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 986 579999999999865322 22233456789999999966322 234567999999
Q ss_pred HHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCC-c---chhccccc----CCCCC--HHHHHHHHHHHHHccccCCCCC
Q 002887 751 VVLLELITGQPVIQKTPQRTLIGQWVSSMLARGD-I---KNIVDHRL----QGDFD--TNTVWKAVEIALACIHTISTRR 820 (870)
Q Consensus 751 vvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~-~---~~i~d~~l----~~~~~--~~~~~~l~~l~~~Cl~~dP~~R 820 (870)
|+||||+++..+++.. ..++.......+. . .....+.. ...+. ........+|+.+|++.||++|
T Consensus 367 viL~el~~~~~~~~~~-----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 367 LIFLQMAFPNLRSDSN-----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHhCcCCCchH-----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 9999999977664421 1111111111110 0 01111110 00000 0112234589999999999999
Q ss_pred CCHHHHHH
Q 002887 821 PTMNQVVI 828 (870)
Q Consensus 821 Psm~eVl~ 828 (870)
||+.|+++
T Consensus 442 ~ta~e~L~ 449 (566)
T PLN03225 442 ISAKAALA 449 (566)
T ss_pred CCHHHHhC
Confidence 99999986
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-29 Score=283.50 Aligned_cols=241 Identities=27% Similarity=0.413 Sum_probs=187.1
Q ss_pred cccccccCcEE-EEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEccCCch
Q 002887 566 ERVLGKGGFGT-VYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMANGNL 643 (870)
Q Consensus 566 ~~~LG~G~fG~-Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 643 (870)
.+++|.|+.|+ ||+|.++++.||||++-... ..-.++|+..|+.- +|||||++++.-.+....|+..|.|.. +|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL 589 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SL 589 (903)
T ss_pred HHHcccCCCCcEEEEEeeCCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hH
Confidence 36899999976 89999999999999986543 23458999999998 799999999999999999999999975 89
Q ss_pred hhhhhhc--ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC---C--CcEEEEeccCCccccCCCC
Q 002887 644 QAHLLED--KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE---K--FQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 644 ~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~---~--~~vkL~DFGla~~~~~~~~ 716 (870)
.+++... ......-.....+..|++.||+|||+. +||||||||.||||+. + .+++|+|||+++.+..+..
T Consensus 590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred HHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 9988763 111111134467889999999999997 9999999999999976 3 5789999999998854433
Q ss_pred cc-ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhC-CCCCCCCCccchHHHHHHHHhhcCCcchhcccccC
Q 002887 717 TH-VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITG-QPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794 (870)
Q Consensus 717 ~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG-~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 794 (870)
.. ......||-+|+|||++...+-+..+||||+|||+|+.++| ..||+..-.++. ..+. +.. .++ .+.
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~------NIl~-~~~-~L~--~L~ 736 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA------NILT-GNY-TLV--HLE 736 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh------hhhc-Ccc-cee--eec
Confidence 32 23567899999999999998888899999999999999996 899986543221 0111 100 000 011
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 002887 795 GDFDTNTVWKAVEIALACIHTISTRRPTMNQVV 827 (870)
Q Consensus 795 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl 827 (870)
. ..++ ...+||.+|+..+|..||++.+|+
T Consensus 737 ~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 737 P--LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred c--CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 1 1112 778999999999999999999996
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-29 Score=248.75 Aligned_cols=256 Identities=24% Similarity=0.371 Sum_probs=189.2
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEec--------CCeEEEE
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDE--------GANMGLI 634 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--------~~~~~LV 634 (870)
.+||+|.||.||+|+.+ ++.||+|+.... ...--....+|+++|..++|+|++.+++.|.. ....++|
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 47999999999999875 778888775432 22223446899999999999999999998843 2348999
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
+++|+. +|...|.. ....++..++.+++.++..||.|+|.. .|+|||+|+.|+|++.++.+||+|||+++.+...
T Consensus 103 f~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~~ 177 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFSTS 177 (376)
T ss_pred HHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceecc
Confidence 999986 67766643 335789999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCc--cccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHh---hcCCcchh
Q 002887 715 GGT--HVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSML---ARGDIKNI 788 (870)
Q Consensus 715 ~~~--~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~---~~~~~~~i 788 (870)
... ...+..+-|..|.+||.+.+. .++++.|||+-||++.||.||.+.+++..+...+.- ++.+. .++-+.++
T Consensus 178 ~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~-Is~LcGs~tkevWP~~ 256 (376)
T KOG0669|consen 178 KNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHL-ISQLCGSITKEVWPNV 256 (376)
T ss_pred cccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHH-HHHHhccCCcccCCCc
Confidence 221 223445669999999999876 589999999999999999999999987664443321 11111 11111110
Q ss_pred --------c--ccccCCCCC--HHHH------HHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 789 --------V--DHRLQGDFD--TNTV------WKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 789 --------~--d~~l~~~~~--~~~~------~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+ .|--.+.+. ++.. ...++++..++..||.+|+.+.+++.
T Consensus 257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 1 000001110 0111 25678999999999999999988863
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-28 Score=233.65 Aligned_cols=195 Identities=26% Similarity=0.363 Sum_probs=163.0
Q ss_pred ccccccCcEEEEEEEE--CCeeEEEEEeecc-chhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 567 RVLGKGGFGTVYHGYL--DDKQVAVKMLSSS-SVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~--~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
+.||+|++|.|-+-++ .|+..|+|++... ..+..++...|+.+..+. .+|.+|.++|......+.++.||.|.. |
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-S 130 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-S 130 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-h
Confidence 4699999999877766 4999999999765 345566778888877665 799999999999999999999999974 6
Q ss_pred hhhhhhh--cccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 643 LQAHLLE--DKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 643 L~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+.+-.+ .++..+++...-+|+..+.+||.|||++ ..|+|||+||+|||++.+|++|+||||.+..+.+ +-..
T Consensus 131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d---SiAk 205 (282)
T KOG0984|consen 131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVD---SIAK 205 (282)
T ss_pred HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehh---hhHH
Confidence 6554433 2557888999999999999999999987 5999999999999999999999999999987632 2223
Q ss_pred ccccCCCCccCcccccc----CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 002887 721 TTVVGTPGYLDPEYYIS----NRLTEKSDVYSFGVVLLELITGQPVIQKTP 767 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~----~~~~~ksDVwS~GvvL~elltG~~p~~~~~ 767 (870)
+...|...|||||.+.. ..|+-|+||||+|+.+.||.+++.||....
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 44678889999999863 368899999999999999999999997654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=264.47 Aligned_cols=234 Identities=22% Similarity=0.336 Sum_probs=194.6
Q ss_pred cccccCcEEEEEEEECCee--EEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 568 VLGKGGFGTVYHGYLDDKQ--VAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 568 ~LG~G~fG~Vy~~~~~~~~--vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
.||-|+||.|=.....++. .|+|++++... ...+....|-.+|..++.+.||+++-.|.+....|+.||-|-||.
T Consensus 427 TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGE 506 (732)
T KOG0614|consen 427 TLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGE 506 (732)
T ss_pred hcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCch
Confidence 6999999999999887555 78888876533 233456789999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|...|++ ...++......++..+++|++|||.+ +||.|||||+|.+||.+|-+||.|||.|+.+... ..+-+
T Consensus 507 lWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g---~KTwT 578 (732)
T KOG0614|consen 507 LWTILRD--RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG---RKTWT 578 (732)
T ss_pred hhhhhhh--cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC---Cceee
Confidence 9999864 35788888899999999999999998 9999999999999999999999999999987433 34457
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTV 802 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 802 (870)
.+||+.|.|||++.....+.++|.||+|++++||++|.+||.+.+.......+.+.. |. ..++....
T Consensus 579 FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi----------d~---i~~Pr~I~ 645 (732)
T KOG0614|consen 579 FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI----------DK---IEFPRRIT 645 (732)
T ss_pred ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh----------hh---hhcccccc
Confidence 899999999999999999999999999999999999999999876543322222111 10 12333444
Q ss_pred HHHHHHHHHccccCCCCCCC
Q 002887 803 WKAVEIALACIHTISTRRPT 822 (870)
Q Consensus 803 ~~l~~l~~~Cl~~dP~~RPs 822 (870)
....+++.+.+..+|.+|-.
T Consensus 646 k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 646 KTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hhHHHHHHHHHhcCcHhhhc
Confidence 56678888989999999975
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-26 Score=232.16 Aligned_cols=209 Identities=34% Similarity=0.609 Sum_probs=183.5
Q ss_pred ccccCcEEEEEEEEC--CeeEEEEEeeccchh-hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCchhh
Q 002887 569 LGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ-GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQA 645 (870)
Q Consensus 569 LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~ 645 (870)
||+|.+|.||++... ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999987 889999999876443 35678999999999999999999999999999999999999999999
Q ss_pred hhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC-CCcEEEEeccCCccccCCCCcccccccc
Q 002887 646 HLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE-KFQAKLADFGLSRIFPVEGGTHVSTTVV 724 (870)
Q Consensus 646 ~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~-~~~vkL~DFGla~~~~~~~~~~~~~~~~ 724 (870)
++.... ..+++..+..++.++++++.+||+. +++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV 154 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence 886432 4688999999999999999999998 9999999999999999 89999999999986532211 123356
Q ss_pred CCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHH
Q 002887 725 GTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVW 803 (870)
Q Consensus 725 gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 803 (870)
+...|++||..... ..+.+.|+|++|+++++| .
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------~ 188 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------P 188 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------H
Confidence 78899999999877 888999999999999998 4
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 804 KAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 804 ~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
.+.+++..|++.+|++||++.++++.
T Consensus 189 ~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 189 ELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 56789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-27 Score=241.32 Aligned_cols=240 Identities=21% Similarity=0.330 Sum_probs=190.6
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
+.++||+|++.+|..+++. ++.+|+|++++.-. .+..-.+.|-.+..+. +||.+|-+..+++.+..+++|.||+
T Consensus 254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence 3478999999999999986 78899999887522 2233356677777665 8999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|+|--++. +.+.++++.+..+..+|.-||.|||+. +|+.||||..|+|+|..|++||.|+|+++.--.+ ..
T Consensus 334 ~ggdlmfhmq--rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~--gd 406 (593)
T KOG0695|consen 334 NGGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP--GD 406 (593)
T ss_pred cCcceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCC--Cc
Confidence 9999987775 445799999999999999999999999 9999999999999999999999999999854322 33
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC---ccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP---QRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~---~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
.+.+.+||+.|+|||.+.+..|....|.|++||+++||+.|+.||+--. .......+.-+.+-+ +.++.
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile--------kqiri 478 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE--------KQIRI 478 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh--------hcccc
Confidence 4567899999999999999999999999999999999999999997432 122222332222222 22221
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRP 821 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RP 821 (870)
+.....+...+...-+.+||++|-
T Consensus 479 --prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 479 --PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --cceeehhhHHHHHHhhcCCcHHhc
Confidence 222334556777888999999884
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=255.31 Aligned_cols=196 Identities=26% Similarity=0.405 Sum_probs=166.5
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccchh---hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ---GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~---~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.||-|+||+|.+++.- ...+|.|.+.+...- .....++|-.||.....+-||+|+-.|++++.+|+||||++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 57999999999999754 556899998876443 2345688999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCcccc---------
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP--------- 712 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~--------- 712 (870)
++-.+|.+. .-+.+..+..++.++..|+++.|.. |.|||||||+|||||.+|++||.|||||.-+.
T Consensus 715 DmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 715 DMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred cHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 999988743 4677888888899999999999988 99999999999999999999999999987431
Q ss_pred CCC----------------Cc---------------cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCC
Q 002887 713 VEG----------------GT---------------HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761 (870)
Q Consensus 713 ~~~----------------~~---------------~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~ 761 (870)
..+ +. ......+||+.|+|||++....++..+|.||.||||+||+.|++
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~ 869 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQP 869 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCC
Confidence 000 00 00123469999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 002887 762 VIQKTP 767 (870)
Q Consensus 762 p~~~~~ 767 (870)
||....
T Consensus 870 pf~~~t 875 (1034)
T KOG0608|consen 870 PFLADT 875 (1034)
T ss_pred CccCCC
Confidence 997544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-27 Score=238.76 Aligned_cols=257 Identities=23% Similarity=0.397 Sum_probs=190.0
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecC-----CeEEEEEE
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEG-----ANMGLIYE 636 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~LV~E 636 (870)
++.||.|+||.||..... |+.||.|++..- +....+.+.+|+++|..++|.|++..++...-. .+.|.++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 478999999999999875 899999998764 334567889999999999999999888776443 24667778
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
.|.. +|...+. ..+.++-..++-++.||++||+|||+. +|.||||||.|.|++.|...||+|||+++.-..++.
T Consensus 138 LmQS-DLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 138 LMQS-DLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHh-hhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 7764 5665553 456788889999999999999999998 999999999999999999999999999987544433
Q ss_pred ccccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHh-----------hcCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSML-----------ARGD 784 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~-----------~~~~ 784 (870)
.+ .+..+-|..|.|||.+++. .|+...||||.||++.||+..+-.|+....-+.+.- +..++ -+|.
T Consensus 212 ~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~l-ItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 212 LN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQM-IIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHH-HHHHhCCCcHHHHHHHhhhh
Confidence 33 2334567899999999976 589999999999999999998888876543222211 11111 1121
Q ss_pred cchhcccccCCC-----C----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002887 785 IKNIVDHRLQGD-----F----DTNTVWKAVEIALACIHTISTRRPTMNQVVIEL 830 (870)
Q Consensus 785 ~~~i~d~~l~~~-----~----~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 830 (870)
-..++....+.. + ........+++.+.++..||+.|.+..+.+..+
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 111221111110 0 112233456778888999999999988887654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=239.21 Aligned_cols=129 Identities=27% Similarity=0.438 Sum_probs=110.4
Q ss_pred HhhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhc-----c---ccceeEEEEEe----c
Q 002887 562 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAH-----H---KNLTILVGYCD----E 627 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-----H---~nIv~l~g~~~----~ 627 (870)
.+-..++||=|.|++||++... .+.||+|+.+... .-.+....|+++|++++ | ..||+|+++|. .
T Consensus 79 RY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 79 RYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred eEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 3445689999999999999976 6789999987643 22345689999999983 3 35999999994 4
Q ss_pred CCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEE
Q 002887 628 GANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILL 694 (870)
Q Consensus 628 ~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILl 694 (870)
+.+.+||+|++ |-+|..+|.....+.++...+.+|++||+.||.|||.+| +|||.||||+|||+
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 67899999988 458999998888889999999999999999999999998 99999999999999
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=226.13 Aligned_cols=196 Identities=34% Similarity=0.493 Sum_probs=170.8
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccchh-hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ-GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.+.||+|++|.||++... ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 4578999999999999986 588999999876554 5678899999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++..... .+++.....++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus 83 ~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (225)
T smart00221 83 DLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLK 157 (225)
T ss_pred CHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cccc
Confidence 99998865432 288999999999999999999998 999999999999999999999999999987643321 1223
Q ss_pred cccCCCCccCcccc-ccCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 002887 722 TVVGTPGYLDPEYY-ISNRLTEKSDVYSFGVVLLELITGQPVIQK 765 (870)
Q Consensus 722 ~~~gt~~y~APE~~-~~~~~~~ksDVwS~GvvL~elltG~~p~~~ 765 (870)
...++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 45678899999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=219.45 Aligned_cols=251 Identities=18% Similarity=0.304 Sum_probs=189.7
Q ss_pred hccccccccCcEEEEEEEE--CCeeEEEEEeeccchhhhHHHHHHHHHHHHhc-cccceeEEEEEecC--CeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQGYKQFQAEVELLIRAH-HKNLTILVGYCDEG--ANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~LV~Ey~ 638 (870)
++.+++|+|.+++||.|.. +++.++||+++... .+.+.+|+++|..+. ||||+++++...+. ....||+||+
T Consensus 41 eivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v 117 (338)
T KOG0668|consen 41 EIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYV 117 (338)
T ss_pred HHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhh
Confidence 3456899999999999984 47889999997643 467899999999996 99999999998664 4577999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC-CcEEEEeccCCccccCCCCc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK-FQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~-~~vkL~DFGla~~~~~~~~~ 717 (870)
.+.+....- ..++...+..++.++++||.|+|+. ||.|||+||.|+++|.. -..+|+|+|+|.++.+....
T Consensus 118 ~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY 189 (338)
T KOG0668|consen 118 NNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
T ss_pred ccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCcee
Confidence 987765543 4677788889999999999999999 99999999999999965 46899999999987543222
Q ss_pred cccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCC-ccchHHHHHHH--------Hhhc-----
Q 002887 718 HVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTP-QRTLIGQWVSS--------MLAR----- 782 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~-~~~~l~~~~~~--------~~~~----- 782 (870)
+..+.+..|.-||.+.. +.|+..-|+|||||++..|+..+.||.... ..+.++++++- .+.+
T Consensus 190 ---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 190 ---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred ---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 33455677889999875 458889999999999999999999986554 33445444331 1111
Q ss_pred -CCcchhcccccCC-------CCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 783 -GDIKNIVDHRLQG-------DFDT-NTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 783 -~~~~~i~d~~l~~-------~~~~-~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.+..+++....+. ..+. -...++++++.+.+..|-++|||++|...
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1111111111100 0011 12367889999999999999999999864
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=231.40 Aligned_cols=248 Identities=25% Similarity=0.315 Sum_probs=189.6
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEec------CCeEEEEEE
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDE------GANMGLIYE 636 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------~~~~~LV~E 636 (870)
+.+|.|.- .|..+... +++||+|++... .....++..+|...+..++|+|+++++.++.- ..+.++|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 45788877 56666554 889999998654 34456778999999999999999999999843 346889999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
+|.. +|...+. ..++-.....|..|++.|+.|||+. +|+||||||+||++..++.+||.|||+++.. +.
T Consensus 102 ~m~~-nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e---~~ 170 (369)
T KOG0665|consen 102 LMDA-NLCQVIL----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTE---DT 170 (369)
T ss_pred hhhh-HHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhccc---Cc
Confidence 9974 7777765 3466677889999999999999999 9999999999999999999999999999853 22
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCc-----------
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDI----------- 785 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~----------- 785 (870)
....+..+.|..|.|||++.+..+.+.+||||.||++.||++|+..|.+.. .+.+|.+..-.-|..
T Consensus 171 ~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d---~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 171 DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD---HIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch---HHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 235566788999999999998889999999999999999999998887433 344554322211110
Q ss_pred ----------------ch-hcccccCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 786 ----------------KN-IVDHRLQG--DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 786 ----------------~~-i~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
.+ +.|..... +.+.-....+.+++.+||-.+|++|-++.++++.
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 11111111 1112234567799999999999999999998763
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-26 Score=254.06 Aligned_cols=246 Identities=24% Similarity=0.346 Sum_probs=201.4
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
+...+|.|.+|.|||++.. ++..|||+++.......+-.++|+-+++.++|+||+.++|.+...+..++.||||.+|+
T Consensus 19 llqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs 98 (829)
T KOG0576|consen 19 LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS 98 (829)
T ss_pred heeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence 3468999999999999975 88999999998877788888999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|++.-+ -...+++.++..++++.++||+|||+. +-+|||||-.|||+++.+.+|++|||.+..+. ........
T Consensus 99 lQdiy~--~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqit--ati~Krks 171 (829)
T KOG0576|consen 99 LQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQIT--ATIAKRKS 171 (829)
T ss_pred ccceee--ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhh--hhhhhhhc
Confidence 988543 335788999999999999999999998 88999999999999999999999999987652 22234567
Q ss_pred ccCCCCccCccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccc-ccCCCCC
Q 002887 723 VVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDH-RLQGDFD 798 (870)
Q Consensus 723 ~~gt~~y~APE~~~---~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~-~l~~~~~ 798 (870)
.+||+.|||||+.. .+.|.+++|||+.|+...|+-.-++|.........+.-.-++ .+++ .+...
T Consensus 172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS---------~~qpp~lkDk-- 240 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS---------GFQPPTLKDK-- 240 (829)
T ss_pred ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc---------CCCCCcccCC--
Confidence 89999999999974 566999999999999999999888887665544333221111 1221 11111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..-...+-+++..|+.++|++||++..+++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 112345678999999999999999988754
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=244.84 Aligned_cols=189 Identities=22% Similarity=0.346 Sum_probs=163.3
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccchh--------hhHHHHHHHHHHHHhc---cccceeEEEEEecCCeEEE
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ--------GYKQFQAEVELLIRAH---HKNLTILVGYCDEGANMGL 633 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~--------~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~L 633 (870)
+.+|+|+||.|+.+.++ ...|+||.+.+...- ..-..-.|+++|..++ |+||++++++|++.+.++|
T Consensus 567 q~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl 646 (772)
T KOG1152|consen 567 QPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYL 646 (772)
T ss_pred eeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEE
Confidence 67999999999999987 678999999876431 1123567999999997 9999999999999999999
Q ss_pred EEEEc-cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCcccc
Q 002887 634 IYEFM-ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 712 (870)
Q Consensus 634 V~Ey~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~ 712 (870)
+||-. ++.+|.+++..+ ..+++.++..|++||+.|+++||++ +|||||||-+||.++.+|-+||+|||.+....
T Consensus 647 ~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~~k 721 (772)
T KOG1152|consen 647 ETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK 721 (772)
T ss_pred EecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhhhc
Confidence 99965 567888888644 4689999999999999999999999 99999999999999999999999999987652
Q ss_pred CCCCccccccccCCCCccCccccccCCCC-ccchHHHHHHHHHHHHhCCCCCC
Q 002887 713 VEGGTHVSTTVVGTPGYLDPEYYISNRLT-EKSDVYSFGVVLLELITGQPVIQ 764 (870)
Q Consensus 713 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~-~ksDVwS~GvvL~elltG~~p~~ 764 (870)
...-...+||.+|.|||++.+.+|- ..-|||++|++||.++....||-
T Consensus 722 ----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 722 ----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 2234567899999999999998864 56899999999999998888874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=216.43 Aligned_cols=248 Identities=19% Similarity=0.299 Sum_probs=180.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEE-EecCCeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGY-CDEGANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~-~~~~~~~~LV~Ey~~ 639 (870)
++.+.||+|.||.+-.+.++ .+.+++|-+.... ...++|.+|..---.| .|.||+.-++. |+..+..+.++||++
T Consensus 27 ~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP 105 (378)
T KOG1345|consen 27 TINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAP 105 (378)
T ss_pred hHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCc
Confidence 44578999999999999997 5678999887653 3457788887654444 68899877654 556667788999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEc--CCCcEEEEeccCCccccCCCCc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLN--EKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld--~~~~vkL~DFGla~~~~~~~~~ 717 (870)
.|+|.+-+. ...+.+....+++.|++.|+.|||++ ++||||||.+|||+- +..++||+|||+.+... .
T Consensus 106 ~gdL~snv~---~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g----~ 175 (378)
T KOG1345|consen 106 RGDLRSNVE---AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG----T 175 (378)
T ss_pred cchhhhhcC---cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC----c
Confidence 999998874 45678888999999999999999999 999999999999993 34589999999987531 1
Q ss_pred cccccccCCCCccCccccccC-----CCCccchHHHHHHHHHHHHhCCCCCCCCCc-cchHHHHHHHHhhcCCcchhccc
Q 002887 718 HVSTTVVGTPGYLDPEYYISN-----RLTEKSDVYSFGVVLLELITGQPVIQKTPQ-RTLIGQWVSSMLARGDIKNIVDH 791 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~-----~~~~ksDVwS~GvvL~elltG~~p~~~~~~-~~~l~~~~~~~~~~~~~~~i~d~ 791 (870)
......-+..|.+||..... ...+.+|+|.||++++.++||++||+.... .....+|. .+..+...
T Consensus 176 -tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~--~w~~rk~~----- 247 (378)
T KOG1345|consen 176 -TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE--QWLKRKNP----- 247 (378)
T ss_pred -eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH--HHhcccCc-----
Confidence 11223345679999987532 356789999999999999999999985432 22223332 22222221
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002887 792 RLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELN 831 (870)
Q Consensus 792 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 831 (870)
++...+. ...++++.+-.+-+..++++|=...++.++.+
T Consensus 248 ~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 248 ALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred cCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 1111111 12345667777888899999966666655543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-24 Score=232.62 Aligned_cols=269 Identities=23% Similarity=0.276 Sum_probs=204.5
Q ss_pred cccCHHHHHHHHhhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhc------cccceeEE
Q 002887 551 RKFSYFDVLKITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAH------HKNLTILV 622 (870)
Q Consensus 551 ~~~~~~dl~~~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~------H~nIv~l~ 622 (870)
.++.+.+++...+...-..|+|-|+.|.+|... ++.||||++...... .+.=..|+++|++|+ .-++++++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 345667888888877788999999999999976 889999999987554 344578999999995 34688999
Q ss_pred EEEecCCeEEEEEEEccCCchhhhhhhc-ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC-cE
Q 002887 623 GYCDEGANMGLIYEFMANGNLQAHLLED-KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF-QA 700 (870)
Q Consensus 623 g~~~~~~~~~LV~Ey~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~-~v 700 (870)
-.|...+++|||+|-+.. +|.+.|..- +.-.|....+..++.|+.-||..|... +|+|.||||.|||+++.- .+
T Consensus 501 r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCccee
Confidence 999999999999997764 788888653 335688889999999999999999987 999999999999999875 57
Q ss_pred EEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHH----
Q 002887 701 KLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWV---- 776 (870)
Q Consensus 701 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~---- 776 (870)
||||||.|....... .+...-+..|.|||++.+-.|+...|+||.||.||||.||+-.|.+......+.-.+
T Consensus 577 KLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 577 KLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred eeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 999999997653221 122233457999999999999999999999999999999998887765433332111
Q ss_pred ---HHHhhcCCcch-hcc--------------------------c------ccCC--CCC---HHHHHHHHHHHHHcccc
Q 002887 777 ---SSMLARGDIKN-IVD--------------------------H------RLQG--DFD---TNTVWKAVEIALACIHT 815 (870)
Q Consensus 777 ---~~~~~~~~~~~-i~d--------------------------~------~l~~--~~~---~~~~~~l~~l~~~Cl~~ 815 (870)
..+++.|...+ -+| | .|.+ .++ ......+.+|...|+..
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 12333332110 011 1 0111 011 23455778999999999
Q ss_pred CCCCCCCHHHHHH
Q 002887 816 ISTRRPTMNQVVI 828 (870)
Q Consensus 816 dP~~RPsm~eVl~ 828 (870)
||++|-|..|.++
T Consensus 733 dP~KRit~nqAL~ 745 (752)
T KOG0670|consen 733 DPEKRITVNQALK 745 (752)
T ss_pred ChhhcCCHHHHhc
Confidence 9999999998875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=208.76 Aligned_cols=167 Identities=22% Similarity=0.232 Sum_probs=127.7
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|.+++... ...++|.++..|+.|+++||+|||++ + ||+|||+++++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc------
Confidence 6888888643 45699999999999999999999987 4 999999999999999 9998865321
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccc-hHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRT-LIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~-~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
...|++.|+|||++.+..++.++|||||||++|||++|+.||....... .+..+...... . ++.- .....
T Consensus 63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-~------~~~~-~~~~~ 133 (176)
T smart00750 63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA-D------DPRD-RSNLE 133 (176)
T ss_pred -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc-C------Cccc-cccHH
Confidence 1268899999999999999999999999999999999999997544322 22222211110 0 0000 00111
Q ss_pred HHH--HHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 800 NTV--WKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 800 ~~~--~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
... ..+.+++.+|++.+|++||++.|+++.+....
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 222 26899999999999999999999999987754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-24 Score=264.45 Aligned_cols=197 Identities=16% Similarity=0.172 Sum_probs=139.3
Q ss_pred HHhcc-ccceeEEEEE-------ecCCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 002887 611 IRAHH-KNLTILVGYC-------DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPI 682 (870)
Q Consensus 611 ~~l~H-~nIv~l~g~~-------~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~I 682 (870)
+.++| +||+.++++| .+....+.++||+ +++|.+++... ...+++.+++.++.||++||+|||++ +|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 34556 6888888887 2234567788887 55999999643 35699999999999999999999998 99
Q ss_pred eeCCCCCCCEEEcCCCc-------------------EEEEeccCCccccCCCC--------------ccccccccCCCCc
Q 002887 683 VHRDVKSANILLNEKFQ-------------------AKLADFGLSRIFPVEGG--------------THVSTTVVGTPGY 729 (870)
Q Consensus 683 vHrDLKp~NILld~~~~-------------------vkL~DFGla~~~~~~~~--------------~~~~~~~~gt~~y 729 (870)
+||||||+||||+..+. +|++|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999965444 55555555543210000 0001123578899
Q ss_pred cCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHH
Q 002887 730 LDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIA 809 (870)
Q Consensus 730 ~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~ 809 (870)
||||++.+..++.++|||||||+||||++|.+|+..... ....+... .+.+.. ........+++
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~---------~~~~~~-----~~~~~~~~~~~ 245 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHR---------VLPPQI-----LLNWPKEASFC 245 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHh---------hcChhh-----hhcCHHHHHHH
Confidence 999999999999999999999999999999888653211 11111100 111111 11233456888
Q ss_pred HHccccCCCCCCCHHHHHH
Q 002887 810 LACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 810 ~~Cl~~dP~~RPsm~eVl~ 828 (870)
.+|++.+|++||+|.|+++
T Consensus 246 ~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 246 LWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHhCCCChhhCcChHHHhh
Confidence 9999999999999999975
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-23 Score=209.85 Aligned_cols=249 Identities=19% Similarity=0.310 Sum_probs=199.4
Q ss_pred ccccccccCcEEEEEEEECCeeEEEEEeeccchh--hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 565 FERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQ--GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
+..+|.+...|+.|+|+|+|..+++|++...... ..+.|..|.-.|+-+.||||++++|.|....+..+|..||+.|+
T Consensus 194 l~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 3346889999999999999999999998765433 34679999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|...|++...-..+-.++.+++.++|+|++|||+. .+-|..--|.+..+++|++.+++|+- +-+++ +.....
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kf------sfqe~g 345 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF------SFQEVG 345 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-cccee------eeeccc
Confidence 99999988777788899999999999999999986 44455567899999999999988752 11111 111122
Q ss_pred ccCCCCccCccccccCC---CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 723 VVGTPGYLDPEYYISNR---LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~---~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
..-.+.||+||.++... .-+.+|+|||.+++|||.|...||......+.--+ +.-..|+...+.
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk-------------ialeglrv~ipp 412 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK-------------IALEGLRVHIPP 412 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh-------------hhhccccccCCC
Confidence 34568999999998654 33679999999999999999999987664332211 111233444555
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
.....+.+++.-|+..||.+||.+..|+-.|+..+
T Consensus 413 gis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 413 GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 66677889999999999999999999999998753
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-22 Score=216.65 Aligned_cols=253 Identities=22% Similarity=0.331 Sum_probs=188.9
Q ss_pred cccccccCcEEEEEEEEC-----CeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEcc
Q 002887 566 ERVLGKGGFGTVYHGYLD-----DKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~-----~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.++||+|.|++||++.+. .+.||+|.+...+. .....+|+++|..+ .+.||+++.+++...++..+|+||++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 478999999999999853 56799999876543 35578999999999 69999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC-CcEEEEeccCCccccCC----
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK-FQAKLADFGLSRIFPVE---- 714 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~-~~vkL~DFGla~~~~~~---- 714 (870)
.....++.. .++...+..+++.+..||.++|++ +||||||||+|+|.+.. +.-.|.|||+|......
T Consensus 119 H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~ 190 (418)
T KOG1167|consen 119 HDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTE 190 (418)
T ss_pred ccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhhhh
Confidence 988777763 466888999999999999999999 99999999999999864 56789999998721100
Q ss_pred --------------C------------------------CccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHH
Q 002887 715 --------------G------------------------GTHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLE 755 (870)
Q Consensus 715 --------------~------------------------~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~e 755 (870)
+ ........+||+||.|||++.. ..-+.++||||.||+++.
T Consensus 191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls 270 (418)
T KOG1167|consen 191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS 270 (418)
T ss_pred hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence 0 0000112469999999999975 457889999999999999
Q ss_pred HHhCCCCCCCCCc-cchHHHHHH---------HHhhcCC--cch---------h------cc-cccC---------CCCC
Q 002887 756 LITGQPVIQKTPQ-RTLIGQWVS---------SMLARGD--IKN---------I------VD-HRLQ---------GDFD 798 (870)
Q Consensus 756 lltG~~p~~~~~~-~~~l~~~~~---------~~~~~~~--~~~---------i------~d-~~l~---------~~~~ 798 (870)
+++++.||..... -..+.+.+. ...-.|. +.+ . ++ ..+. ....
T Consensus 271 lls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~ 350 (418)
T KOG1167|consen 271 LLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGS 350 (418)
T ss_pred hhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccc
Confidence 9999999876542 223332221 1111122 110 0 00 0000 0001
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+.....++++..+|++.+|.+|-|+++.++
T Consensus 351 d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 351 DVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 122346889999999999999999999986
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.2e-21 Score=211.31 Aligned_cols=161 Identities=19% Similarity=0.185 Sum_probs=124.7
Q ss_pred hhccccccccCcEEEEEEEEC---CeeEEEEEeecc-----chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD---DKQVAVKMLSSS-----SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLI 634 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~---~~~vAVK~l~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 634 (870)
+.+.+.||+|+||+||+|++. ++.+|||++... .....+.|.+|+++|++++|+|+++.+..+ ...++|
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~~~LV 96 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GKDGLV 96 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CCcEEE
Confidence 345678999999999999873 667899987533 122345689999999999999998543322 457999
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCC-CCCCEEEcCCCcEEEEeccCCccccC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDV-KSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDL-Kp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
|||+++++|... . ... ...++.++++||.|||+. +|+|||| ||+|||++.++++||+|||+++.+..
T Consensus 97 mE~~~G~~L~~~-~--~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 97 RGWTEGVPLHLA-R--PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred EEccCCCCHHHh-C--ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 999999998632 1 111 146788999999999998 9999999 99999999999999999999997754
Q ss_pred CCCccc------cccccCCCCccCccccccC
Q 002887 714 EGGTHV------STTVVGTPGYLDPEYYISN 738 (870)
Q Consensus 714 ~~~~~~------~~~~~gt~~y~APE~~~~~ 738 (870)
.+.... .....+++.|+|||++...
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 432221 1356788899999998643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-19 Score=199.61 Aligned_cols=261 Identities=20% Similarity=0.243 Sum_probs=194.7
Q ss_pred hhccccccccCcEEEEEEEECC---eeEEEEEeeccchhhhHHHHHHHHHHHHhcc----ccceeEEEEE-ecCCeEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLDD---KQVAVKMLSSSSVQGYKQFQAEVELLIRAHH----KNLTILVGYC-DEGANMGLI 634 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~~---~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H----~nIv~l~g~~-~~~~~~~LV 634 (870)
+.+.+.||+|+||.||++.... ..+|+|............+..|+.++..+.+ +++..+++.. ......++|
T Consensus 20 ~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iV 99 (322)
T KOG1164|consen 20 YKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIV 99 (322)
T ss_pred eEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEE
Confidence 3456899999999999999763 4688888776543333378889999999873 5788888888 477788899
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC-----CcEEEEeccCCc
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK-----FQAKLADFGLSR 709 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~-----~~vkL~DFGla~ 709 (870)
|+.+ |.+|.++......+.++..+.+.|+.|++.+|++||+. +++||||||.|+++... ..+.|.|||+++
T Consensus 100 M~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 100 MSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred Eecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 8865 66888876555567899999999999999999999998 99999999999999865 468999999998
Q ss_pred --cccCCCCc---cc---cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhh
Q 002887 710 --IFPVEGGT---HV---STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLA 781 (870)
Q Consensus 710 --~~~~~~~~---~~---~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~ 781 (870)
.+...... .. .....||..|.+++...+...+.+.|+||++.++.|++.|..||..........+......
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~- 254 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR- 254 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh-
Confidence 33222221 11 1234599999999999999999999999999999999999999976543322222111111
Q ss_pred cCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHh
Q 002887 782 RGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837 (870)
Q Consensus 782 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e 837 (870)
.. .... ........+.++...+-..+..++|....+...|++....+
T Consensus 255 ~~----~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 255 KL----LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hh----cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 00 0000 11122344556666666689999999999999988866443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-19 Score=194.64 Aligned_cols=256 Identities=28% Similarity=0.441 Sum_probs=196.3
Q ss_pred ccccccccCcEEEEEEEECCeeEEEEEeeccchh---hhHHHHHHHHHHHHhccc-cceeEEEEEecCCeEEEEEEEccC
Q 002887 565 FERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQ---GYKQFQAEVELLIRAHHK-NLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~---~~~~f~~Ei~~l~~l~H~-nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
..+.||.|+||.||++... +.+++|.+...... ....+.+|+.++..+.|+ +++++.+.+......+++++++.+
T Consensus 4 ~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 82 (384)
T COG0515 4 ILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82 (384)
T ss_pred eEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence 3467999999999999988 78899998766433 367899999999999988 799999999777778999999999
Q ss_pred Cchhhhhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC-cEEEEeccCCccccCCCCcc
Q 002887 641 GNLQAHLLEDKA-DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF-QAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 641 gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~-~vkL~DFGla~~~~~~~~~~ 718 (870)
+++.+.+..... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++.+.......
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (384)
T COG0515 83 GSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS 159 (384)
T ss_pred CcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence 999966543321 2688899999999999999999998 899999999999999998 79999999998654332221
Q ss_pred ----ccccccCCCCccCcccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCc---cchHHHHHHHHhhcCCcchh
Q 002887 719 ----VSTTVVGTPGYLDPEYYIS---NRLTEKSDVYSFGVVLLELITGQPVIQKTPQ---RTLIGQWVSSMLARGDIKNI 788 (870)
Q Consensus 719 ----~~~~~~gt~~y~APE~~~~---~~~~~ksDVwS~GvvL~elltG~~p~~~~~~---~~~l~~~~~~~~~~~~~~~i 788 (870)
......|+..|+|||.+.+ .......|+||+|++++++++|..|+..... .......+..... . .
T Consensus 160 ~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~-~ 234 (384)
T COG0515 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT----P-S 234 (384)
T ss_pred cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC----c-c
Confidence 3456789999999999987 5788999999999999999999999765443 1111111111110 0 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 789 VDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 789 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
................+.+++..|+..+|..|.++.+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000002223567889999999999999999988765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7e-20 Score=215.74 Aligned_cols=252 Identities=21% Similarity=0.232 Sum_probs=184.8
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEee----c-cch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLS----S-SSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~----~-~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
..+++|.|++|.|+..... .+..+.|... . ... .....+..|+.+-..++|+|++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3468999999977776543 3333333322 1 111 111225667777788999999888877777666666699
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
|+++ +|...+.+. ..+....+-.++.|++.|+.|||+. +|.|||+|++|+++..++.+||+|||.+..+.....
T Consensus 402 ~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 999988643 3677888889999999999999999 999999999999999999999999999987754444
Q ss_pred c--cccccccCCCCccCccccccCCCCcc-chHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccccc
Q 002887 717 T--HVSTTVVGTPGYLDPEYYISNRLTEK-SDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 717 ~--~~~~~~~gt~~y~APE~~~~~~~~~k-sDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
. ......+|+-.|+|||.+.+..|++. .||||.|+++..|++|+.||......+... ......++......+
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~~~~~~~~~~~~~-- 550 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTNNYSDQRNIFEGP-- 550 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhhccccccccccCh--
Confidence 3 55667889999999999999998864 899999999999999999997655433211 000111111000000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 794 QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.......+.....++.++++.+|.+|-||++|++
T Consensus 551 -~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 551 -NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0011233456678999999999999999999975
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.5e-18 Score=177.55 Aligned_cols=201 Identities=18% Similarity=0.315 Sum_probs=169.5
Q ss_pred hccccccccCcEEEEEEEE--CCeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
...++||+|+||..+.|+. .+++||||.-...+ ...++..|....+.| ..+.|...+-|-.++.+-.||+|.+ |
T Consensus 31 rVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 31 RVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred eeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 4568899999999999985 59999999876543 346788899999888 5788988888889988899999977 5
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC-----CcEEEEeccCCccccCCC
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK-----FQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~-----~~vkL~DFGla~~~~~~~ 715 (870)
-||+++. +..++.++.+++..||.|++.-++|+|++ .+|.|||||+|+||..- ..+.++|||+|+.+.+..
T Consensus 108 PSLEDLF-D~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 108 PSLEDLF-DLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred cCHHHHH-HHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 5787755 45667899999999999999999999999 99999999999999643 358999999999885432
Q ss_pred Cc-----cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccch
Q 002887 716 GT-----HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTL 771 (870)
Q Consensus 716 ~~-----~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~ 771 (870)
.. .......||.+||+-....+..-+.+.|+=|+|-++++.|-|..||++......
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn 244 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN 244 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch
Confidence 22 223456899999999999999999999999999999999999999998765443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.9e-19 Score=181.05 Aligned_cols=171 Identities=12% Similarity=0.113 Sum_probs=130.4
Q ss_pred HHHhhccccccccCcEEEEEEEECCeeEEEEEeeccchhhhH---H------HHHHHHHHHHhccccceeEEEEEecC--
Q 002887 560 KITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYK---Q------FQAEVELLIRAHHKNLTILVGYCDEG-- 628 (870)
Q Consensus 560 ~~t~~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~---~------f~~Ei~~l~~l~H~nIv~l~g~~~~~-- 628 (870)
+-.+...+++|.|+||.||....++..+|||.+........+ . +++|+..+.+++|++|..+..++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 333445689999999999997777778999999765332222 2 68999999999999999998885432
Q ss_pred ------CeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEE
Q 002887 629 ------ANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKL 702 (870)
Q Consensus 629 ------~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL 702 (870)
...+++|||++|.+|.++.. ++. ....+++.+|..||+. +++|||+||+||++++++ ++|
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEE
Confidence 35789999999999977631 222 3456999999999998 999999999999999988 999
Q ss_pred EeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh
Q 002887 703 ADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 758 (870)
Q Consensus 703 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt 758 (870)
+|||.......+... ..+.....+..++|+|+||+.+..+..
T Consensus 176 iDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 176 IDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 999988654211100 113344556789999999999876543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.9e-19 Score=197.03 Aligned_cols=218 Identities=24% Similarity=0.368 Sum_probs=166.1
Q ss_pred HHHhccccceeEEEEEecCCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCc-eeCCCC
Q 002887 610 LIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPI-VHRDVK 688 (870)
Q Consensus 610 l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~I-vHrDLK 688 (870)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....++|.......++++.||.|||+. +| .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeec
Confidence 3568899999999999999999999999999999999865 456799999999999999999999987 55 899999
Q ss_pred CCCEEEcCCCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCC-------CCccchHHHHHHHHHHHHhCCC
Q 002887 689 SANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNR-------LTEKSDVYSFGVVLLELITGQP 761 (870)
Q Consensus 689 p~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-------~~~ksDVwS~GvvL~elltG~~ 761 (870)
++|.++|....+||+|||+.................-..-|.|||.+.... .+.++||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999988763211111111222345799999997631 4678999999999999999999
Q ss_pred CCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 762 VIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 762 p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
||..........+.+.... ++ ....+.|.+... .+....+..++..||..+|++||++++|-..++.+..
T Consensus 157 ~~~~~~~~~~~~eii~~~~-~~-~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVK-KG-GSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCChHHHHHHHH-hc-CCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9987553332233332222 11 112222222211 1344478999999999999999999999888876654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=175.45 Aligned_cols=138 Identities=18% Similarity=0.192 Sum_probs=107.1
Q ss_pred cccccccCcEEEEEEEEC-CeeEEEEEeeccchh--h-------hHH-----------------HHHHHHHHHHhccccc
Q 002887 566 ERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQ--G-------YKQ-----------------FQAEVELLIRAHHKNL 618 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~--~-------~~~-----------------f~~Ei~~l~~l~H~nI 618 (870)
.+.||+|++|.||+|... |+.||||+++..... . ... .+.|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 367999999999999985 899999999754211 0 112 2359999999988776
Q ss_pred eeEEEEEecCCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHH-HhCCCCCceeCCCCCCCEEEcCC
Q 002887 619 TILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL-HNGCKPPIVHRDVKSANILLNEK 697 (870)
Q Consensus 619 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~IvHrDLKp~NILld~~ 697 (870)
.....+.. ...++||||++++++...... ...+++.....++.|++.+|.|| |+. +|+||||||+|||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~~- 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYHD- 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEEC-
Confidence 43332222 234899999999877654322 34688999999999999999999 677 9999999999999984
Q ss_pred CcEEEEeccCCccc
Q 002887 698 FQAKLADFGLSRIF 711 (870)
Q Consensus 698 ~~vkL~DFGla~~~ 711 (870)
+.++|+|||++...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-17 Score=168.75 Aligned_cols=138 Identities=20% Similarity=0.219 Sum_probs=109.4
Q ss_pred cccccccCcEEEEEEEEC-CeeEEEEEeeccchhh--------------------------hHHHHHHHHHHHHhccccc
Q 002887 566 ERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQG--------------------------YKQFQAEVELLIRAHHKNL 618 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~--------------------------~~~f~~Ei~~l~~l~H~nI 618 (870)
.+.||+|++|.||+|... |+.||||+++...... ...++.|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 367999999999999986 9999999987642110 1124678999999999987
Q ss_pred eeEEEEEecCCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHh-CCCCCceeCCCCCCCEEEcCC
Q 002887 619 TILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN-GCKPPIVHRDVKSANILLNEK 697 (870)
Q Consensus 619 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~IvHrDLKp~NILld~~ 697 (870)
.....+... ..++||||++++++..... ....++......++.|++.++.+||+ . +|+||||||+||+++ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence 544443332 2489999999886544322 22356788899999999999999999 7 999999999999999 7
Q ss_pred CcEEEEeccCCccc
Q 002887 698 FQAKLADFGLSRIF 711 (870)
Q Consensus 698 ~~vkL~DFGla~~~ 711 (870)
++++|+|||++...
T Consensus 154 ~~~~liDFG~a~~~ 167 (190)
T cd05145 154 GKPYIIDVSQAVEL 167 (190)
T ss_pred CCEEEEEcccceec
Confidence 89999999999865
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=166.78 Aligned_cols=201 Identities=22% Similarity=0.306 Sum_probs=164.5
Q ss_pred hhccccccccCcEEEEEEEE--CCeeEEEEEeeccchhhhHHHHHHHHHHHHhcc-ccceeEEEEEecCCeEEEEEEEcc
Q 002887 563 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHH-KNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
+.+.++||.|+||.+|.|.. .|+.||||+-+.... ..++..|.++...++| ..|..+..+..++..-.+|||.+
T Consensus 17 y~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL- 93 (341)
T KOG1163|consen 17 YKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL- 93 (341)
T ss_pred eEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-
Confidence 34568999999999999986 399999999765533 3567788999999865 56777888888999999999977
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC---CcEEEEeccCCccccCCCC
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK---FQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~---~~vkL~DFGla~~~~~~~~ 716 (870)
+-+|++.+.-. .+.++..+.+-++-|++.-++|+|.+ +.+||||||+|+|..-+ ..+.++|||+++.+.+...
T Consensus 94 GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 94 GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 56888876543 35788999999999999999999998 99999999999999754 4689999999998743321
Q ss_pred c-----cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccc
Q 002887 717 T-----HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRT 770 (870)
Q Consensus 717 ~-----~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~ 770 (870)
. .......||.+|.+-....+..-+.+.|+=|+|.+|.+..-|..||++.....
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 1 12245679999999888887778889999999999999999999999876443
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-16 Score=188.65 Aligned_cols=72 Identities=50% Similarity=0.752 Sum_probs=68.7
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSE 479 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~ 479 (870)
..+++.|+|++|+|+|.+|+.+++|++|+.|+|++|+|+|.+|+.+++|++|+.|+|++|+|+|.+|..+..
T Consensus 441 L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~ 512 (623)
T PLN03150 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG 512 (623)
T ss_pred CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhh
Confidence 357899999999999999999999999999999999999999999999999999999999999999998765
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.8e-17 Score=164.16 Aligned_cols=184 Identities=16% Similarity=0.116 Sum_probs=139.8
Q ss_pred cccccccCcEEEEEEEECCeeEEEEEeeccchh----hhHHHHHHHHHHHHhc-cccceeEEEEEecCCeEEEEEEEccC
Q 002887 566 ERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQ----GYKQFQAEVELLIRAH-HKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~----~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
...|++|+||+||.+.-.+.+++.+.+.....- ....|.+|+++|++++ |+++.+++++ ...+++|||++|
T Consensus 7 ~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 7 NEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred ceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence 368999999999988777888888877665431 1235889999999995 5789999886 456999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCC-CCCCEEEcCCCcEEEEeccCCccccCCCCc--
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDV-KSANILLNEKFQAKLADFGLSRIFPVEGGT-- 717 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDL-Kp~NILld~~~~vkL~DFGla~~~~~~~~~-- 717 (870)
.+|...+.. ....++.|++++|.++|++ +|+|||| ||+|||++.++.++|+|||++.........
T Consensus 83 ~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 83 AAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred ccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 888654321 1135778999999999999 9999999 799999999999999999999865332210
Q ss_pred --c--c-----cccccCCCCccCccccccC-CC-CccchHHHHHHHHHHHHhCCCCCCC
Q 002887 718 --H--V-----STTVVGTPGYLDPEYYISN-RL-TEKSDVYSFGVVLLELITGQPVIQK 765 (870)
Q Consensus 718 --~--~-----~~~~~gt~~y~APE~~~~~-~~-~~ksDVwS~GvvL~elltG~~p~~~ 765 (870)
. . ......++.|++|+...-. .. -...+.++-|.-+|.++||+.+.-.
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0 1112467788888765422 22 2567899999999999999987643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.4e-18 Score=201.58 Aligned_cols=248 Identities=20% Similarity=0.250 Sum_probs=173.4
Q ss_pred hccccccccCcEEEEEEEECCeeEEEEEeeccch-hhhHHHHHHHHH--HHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSV-QGYKQFQAEVEL--LIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~--l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
.+.+.||.+.|=+|.+|+.....|+||++-++.. -..+.|.++++- ...++|||.+++.-......-.|||-+|..+
T Consensus 26 ~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh 105 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH 105 (1431)
T ss_pred eeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh
Confidence 4567899999999999999866699999977653 234445444433 4556999999887776555666677777765
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccc--cCCCCcc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF--PVEGGTH 718 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~--~~~~~~~ 718 (870)
+|.+.+. .+.-+...+.+.|+.|++.||..+|.. +|+|||||.+|||++.=.-+.|+||..-+.. +.++...
T Consensus 106 -nLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 106 -NLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred -hhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 7888774 234567778889999999999999998 9999999999999999889999999765532 2221111
Q ss_pred ---ccccccCCCCccCccccccC-----------CCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcC
Q 002887 719 ---VSTTVVGTPGYLDPEYYISN-----------RLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARG 783 (870)
Q Consensus 719 ---~~~~~~gt~~y~APE~~~~~-----------~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~ 783 (870)
.-.+-..-..|+|||.+... ..+++.||||.||++.||++ |+++|.-.. +..+ +.|
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~aY-----r~~ 250 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLAY-----RSG 250 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHhH-----hcc
Confidence 11122233479999998542 25788999999999999998 688875221 1111 111
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002887 784 DIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELN 831 (870)
Q Consensus 784 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 831 (870)
. ...... +.+..+ ...+..+++.|++.||.+|-++++.++.-.
T Consensus 251 ~-~~~~e~-~Le~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 251 N-ADDPEQ-LLEKIE---DVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred C-ccCHHH-HHHhCc---CccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 0 000000 000011 114678999999999999999999998733
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.5e-17 Score=170.85 Aligned_cols=227 Identities=20% Similarity=0.263 Sum_probs=146.5
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhc----------cccceeEEEEE-----
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAH----------HKNLTILVGYC----- 625 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~----------H~nIv~l~g~~----- 625 (870)
.+.||.|+++.||.++.. ++++|||+..... ....+++++|.-....+. |-.++.-++..
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 468999999999999986 6999999986543 234566777665544422 22222222221
Q ss_pred ----ecC---C-----eEEEEEEEccCCchhhhhhh---cc--cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCC
Q 002887 626 ----DEG---A-----NMGLIYEFMANGNLQAHLLE---DK--ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVK 688 (870)
Q Consensus 626 ----~~~---~-----~~~LV~Ey~~~gsL~~~l~~---~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLK 688 (870)
... . +.+++|+-+. ++|.+.+.. .. ...+....++.+..|+++.+++||+. +++|+|||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence 111 1 2356677664 578776542 11 13455667788889999999999999 99999999
Q ss_pred CCCEEEcCCCcEEEEeccCCccccCCCCccccccccCCCCccCccccccC--------CCCccchHHHHHHHHHHHHhCC
Q 002887 689 SANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISN--------RLTEKSDVYSFGVVLLELITGQ 760 (870)
Q Consensus 689 p~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--------~~~~ksDVwS~GvvL~elltG~ 760 (870)
|+|++++.+|.++|+||+...... ..... ...+..|.+||..... .++.+.|.|++|+++|.|.+|+
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g----~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAG----TRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETT----EEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred eeeEEEcCCCCEEEcChHHHeecC----ceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999999999998775431 11111 3455789999987542 4788999999999999999999
Q ss_pred CCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCC
Q 002887 761 PVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRR 820 (870)
Q Consensus 761 ~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 820 (870)
.||+........ .| .+. ... +.++.+.+|+..+++.+|++|
T Consensus 248 lPf~~~~~~~~~-~~----------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADP-EW----------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTS-GG----------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccc-cc----------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 999865432211 00 111 223 667788999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-17 Score=188.03 Aligned_cols=232 Identities=25% Similarity=0.264 Sum_probs=178.2
Q ss_pred cccccCcEEEEEEE-----ECCeeEEEEEeeccchh--hhHHHHHHHHHHHHhc-cccceeEEEEEecCCeEEEEEEEcc
Q 002887 568 VLGKGGFGTVYHGY-----LDDKQVAVKMLSSSSVQ--GYKQFQAEVELLIRAH-HKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 568 ~LG~G~fG~Vy~~~-----~~~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.+|+|++|.|+... ..++-+|.|.+++.... .......|..++..++ ||.++++.-.++.+.+.+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999998653 23677888888765332 1224567888888886 9999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+|.|...+.. ...++......+...++-|++++|+. +|+|||+|++||+++.+|++++.|||+++..-...
T Consensus 81 gg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 81 GGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred cchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 9999887753 34566667777888999999999998 99999999999999999999999999998653221
Q ss_pred cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
..+||..|||||++. .....+|.||||++++||+||-.||.. +.. +..+. .. ...+.
T Consensus 152 --~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~----~~Il~---------~~--~~~p~ 208 (612)
T KOG0603|consen 152 --IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTM----KRILK---------AE--LEMPR 208 (612)
T ss_pred --hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHH----HHHhh---------hc--cCCch
Confidence 228999999999997 567889999999999999999999986 111 11111 01 12334
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH-HHHHHHH
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMN-QVVIELN 831 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~-eVl~~L~ 831 (870)
+-...+.++...++..+|..|--.. +++.+++
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 4455666777888888888886553 4444433
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.7e-16 Score=162.03 Aligned_cols=133 Identities=20% Similarity=0.250 Sum_probs=104.4
Q ss_pred ccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHh-----ccccceeEEEEEecCC---e-EEEEEEE
Q 002887 567 RVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRA-----HHKNLTILVGYCDEGA---N-MGLIYEF 637 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-----~H~nIv~l~g~~~~~~---~-~~LV~Ey 637 (870)
+.||+|+||.||... .....+||++........+.+.+|+.+++.+ .||||++++|++.++. . ..+|+||
T Consensus 8 ~~LG~G~~~~Vy~hp-~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~ 86 (210)
T PRK10345 8 SPLGTGRHRKCYAHP-EDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADF 86 (210)
T ss_pred ceecCCCceEEEECC-CCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecC
Confidence 689999999999622 2333479988765555567899999999999 5799999999998864 3 3378999
Q ss_pred --ccCCchhhhhhhcccccccHHHHHHHHHHHHHHH-HHHHhCCCCCceeCCCCCCCEEEcC----CCcEEEEec-cCC
Q 002887 638 --MANGNLQAHLLEDKADTLCWERRLQIASESAQGL-EYLHNGCKPPIVHRDVKSANILLNE----KFQAKLADF-GLS 708 (870)
Q Consensus 638 --~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL-~yLH~~~~~~IvHrDLKp~NILld~----~~~vkL~DF-Gla 708 (870)
+.+|+|.+++.+. .+++. ..++.+++.++ +|||++ +|+||||||+|||++. +.+++|+|| |..
T Consensus 87 ~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 87 DGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred CCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 6689999999542 35544 35677888777 999999 9999999999999974 347999994 543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.2e-16 Score=188.17 Aligned_cols=245 Identities=18% Similarity=0.186 Sum_probs=174.7
Q ss_pred hccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhc---cccceeEEEEEecCCeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAH---HKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.+.+.||+|+||+||+|... ++.||+|+-+....... ---.+++.+|+ -+.|..+...+.-.+..+||+||.+
T Consensus 701 ~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~ 777 (974)
T KOG1166|consen 701 CISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSP 777 (974)
T ss_pred EEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccc
Confidence 34678999999999999976 88999999876643321 11112333333 2344455555556677889999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEc-------CCCcEEEEeccCCcccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLN-------EKFQAKLADFGLSRIFP 712 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld-------~~~~vkL~DFGla~~~~ 712 (870)
.|+|.+++. ..+.++|...+.++.|+++.+++||.. +|||+||||+|+||. ++..++|+|||.+..+.
T Consensus 778 ~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 778 YGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred cccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 999999996 556899999999999999999999998 999999999999994 23468999999987654
Q ss_pred CCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccc
Q 002887 713 VEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHR 792 (870)
Q Consensus 713 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 792 (870)
.-.....-....+|-.+-.+|...+..++..+|.|.+.-+++-||.|+.-- ...|.. ..++..
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q----------------~~~g~~-~~~~~~ 915 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME----------------VKNGSS-WMVKTN 915 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH----------------hcCCcc-eecccc
Confidence 322233445677888999999999999999999999999999999986321 111111 112222
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 793 LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 793 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
+......+.-.+++++++. .+-..=|...++...+++.+..
T Consensus 916 ~~Ry~~~~~W~~~F~~lLN---~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 916 FPRYWKRDMWNKFFDLLLN---PDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred chhhhhHHHHHHHHHHHhC---cCcccchhHHHHHHHHHHHHHH
Confidence 2211122333344454444 5555667777887788776644
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.7e-16 Score=161.16 Aligned_cols=134 Identities=19% Similarity=0.346 Sum_probs=114.2
Q ss_pred ccccccCcEEEEEEEECCeeEEEEEeeccchh--------hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 567 RVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQ--------GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~--------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
+.||+|++|.||+|.+.+..+++|+....... ....+.+|++++..++|+++.....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 57999999999999999999999986543211 1245788999999999999887777777777889999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~ 710 (870)
++++|.+.+.... + .+..++.+++.+|.+||+. +++|||++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999998875321 2 7889999999999999998 999999999999999 78999999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.6e-16 Score=158.57 Aligned_cols=130 Identities=24% Similarity=0.344 Sum_probs=108.0
Q ss_pred cccccCcEEEEEEEECCeeEEEEEeeccch--------hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 568 VLGKGGFGTVYHGYLDDKQVAVKMLSSSSV--------QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 568 ~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~--------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.||+|++|.||+|.+.+..+++|+...... ....++.+|++++..++|+++.....++......++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 489999999999999899999998654321 113567889999999999876655555666667799999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCcc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~ 710 (870)
+++|.+.+..... .++.+++++|.+||+. +++|||+||.||+++ ++.++++|||++..
T Consensus 81 g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGND---------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcHH---------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999887743211 7899999999999998 999999999999999 78999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.7e-15 Score=157.14 Aligned_cols=138 Identities=20% Similarity=0.251 Sum_probs=107.2
Q ss_pred hccccccccCcEEEEEEE-E--CCeeEEEEEeeccchh------------------------hhHHHHHHHHHHHHhccc
Q 002887 564 NFERVLGKGGFGTVYHGY-L--DDKQVAVKMLSSSSVQ------------------------GYKQFQAEVELLIRAHHK 616 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~-~--~~~~vAVK~l~~~~~~------------------------~~~~f~~Ei~~l~~l~H~ 616 (870)
.+.+.||+|++|.||+|. . .++.||+|+++..... ....++.|++.+.++.+.
T Consensus 31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~ 110 (237)
T smart00090 31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA 110 (237)
T ss_pred HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 456789999999999998 3 4899999998754210 012357899999999764
Q ss_pred c--ceeEEEEEecCCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCC-ceeCCCCCCCEE
Q 002887 617 N--LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPP-IVHRDVKSANIL 693 (870)
Q Consensus 617 n--Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-IvHrDLKp~NIL 693 (870)
. +.+.+++ ...++||||+++++|....... ..+...+...++.|++.++.+||+. + |+||||||+||+
T Consensus 111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIl 181 (237)
T smart00090 111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNIL 181 (237)
T ss_pred CCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEE
Confidence 3 3344443 2358999999998887654322 2355566789999999999999998 8 999999999999
Q ss_pred EcCCCcEEEEeccCCccc
Q 002887 694 LNEKFQAKLADFGLSRIF 711 (870)
Q Consensus 694 ld~~~~vkL~DFGla~~~ 711 (870)
++ +++++|+|||.+...
T Consensus 182 i~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 182 VH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EE-CCCEEEEEChhhhcc
Confidence 99 889999999998754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.1e-15 Score=178.17 Aligned_cols=131 Identities=21% Similarity=0.321 Sum_probs=110.8
Q ss_pred cccccccCcEEEEEEEECCeeEEEEEeeccc--------hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 566 ERVLGKGGFGTVYHGYLDDKQVAVKMLSSSS--------VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~--------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.||+|+||.||+|.+.+..+++|+..... ....+.+.+|++++.+++|++++....++......++||||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~ 417 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY 417 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence 5789999999999999887666666543211 11235688999999999999999888888777788999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCcc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~ 710 (870)
+++++|.+++. .+..++.+++++|.|||+. +++||||||+|||+ +++.++|+|||+++.
T Consensus 418 ~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 418 IGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred cCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999988774 3567899999999999998 99999999999999 677999999999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.2e-15 Score=150.52 Aligned_cols=134 Identities=16% Similarity=0.169 Sum_probs=106.0
Q ss_pred hhccccccccCcEEEEEEEEC-CeeEEEEEeeccchh----------------------hhHHHHHHHHHHHHhcccc--
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQ----------------------GYKQFQAEVELLIRAHHKN-- 617 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~----------------------~~~~f~~Ei~~l~~l~H~n-- 617 (870)
+.+.+.||+|+||.||++... ++.||||++...... ....+..|+.++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 445688999999999999985 899999987653210 0123577899999998874
Q ss_pred ceeEEEEEecCCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC
Q 002887 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK 697 (870)
Q Consensus 618 Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~ 697 (870)
+...++. ...++||||+++++|...... .....++.+++.++.++|+. +|+||||||+||+++++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCC
Confidence 4444442 345899999999998765421 23467889999999999998 99999999999999999
Q ss_pred CcEEEEeccCCccc
Q 002887 698 FQAKLADFGLSRIF 711 (870)
Q Consensus 698 ~~vkL~DFGla~~~ 711 (870)
++++|+|||++...
T Consensus 162 ~~~~liDfg~~~~~ 175 (198)
T cd05144 162 EKIYIIDWPQMVST 175 (198)
T ss_pred CcEEEEECCccccC
Confidence 99999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.6e-16 Score=174.16 Aligned_cols=175 Identities=23% Similarity=0.346 Sum_probs=130.7
Q ss_pred eEEEEEEEccCCchhhhhhhc-ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCC
Q 002887 630 NMGLIYEFMANGNLQAHLLED-KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 708 (870)
Q Consensus 630 ~~~LV~Ey~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla 708 (870)
..++.|++|+..+|.+|+.+. .....+|...+.++.|++.|++| + +.+|||+||.||....+.++||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 477899999999999999743 44678899999999999999999 4 8999999999999999999999999998
Q ss_pred ccccCCC----CccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCC
Q 002887 709 RIFPVEG----GTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGD 784 (870)
Q Consensus 709 ~~~~~~~----~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~ 784 (870)
....... .....+...||..||+||.+.++.|+.|+||||+|++|+|++. +|....+... ....++.|.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~----t~~d~r~g~ 476 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIA----TLTDIRDGI 476 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHH----hhhhhhcCC
Confidence 8664333 1223456789999999999999999999999999999999997 2221111100 111122232
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 002887 785 IKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQV 826 (870)
Q Consensus 785 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eV 826 (870)
+. +....+ -.+-..+.++++...|.+||+..++
T Consensus 477 ip----~~~~~d-----~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 477 IP----PEFLQD-----YPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred CC----hHHhhc-----CcHHHHHHHHhcCCCcccCchHHHH
Confidence 22 111111 1223478889999999999944443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.2e-15 Score=156.57 Aligned_cols=197 Identities=19% Similarity=0.202 Sum_probs=136.5
Q ss_pred ccccceeEEEEEec---------------------------CCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHH
Q 002887 614 HHKNLTILVGYCDE---------------------------GANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASE 666 (870)
Q Consensus 614 ~H~nIv~l~g~~~~---------------------------~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 666 (870)
+|||||++.++|.+ ...+|+||...+. +|.+++.. +..+...+.-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~---~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT---RHRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc---CCCchHHHHHHHHH
Confidence 69999999877632 2347788876654 78777743 34555667778899
Q ss_pred HHHHHHHHHhCCCCCceeCCCCCCCEEE--cCCC--cEEEEeccCCccccCCCCc----cccccccCCCCccCccccccC
Q 002887 667 SAQGLEYLHNGCKPPIVHRDVKSANILL--NEKF--QAKLADFGLSRIFPVEGGT----HVSTTVVGTPGYLDPEYYISN 738 (870)
Q Consensus 667 ia~aL~yLH~~~~~~IvHrDLKp~NILl--d~~~--~vkL~DFGla~~~~~~~~~----~~~~~~~gt~~y~APE~~~~~ 738 (870)
+++|+.|||.+ +|.|||+|++|||+ |+|+ ...|+|||++---...+-. .-.-..-|...-||||+....
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999998 99999999999999 4443 4689999987532111000 001123467789999998642
Q ss_pred C------CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHc
Q 002887 739 R------LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALAC 812 (870)
Q Consensus 739 ~------~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C 812 (870)
. .-.|+|.|+.|.+.||+++...||-...+..... ..+++.++ ...++.++..+.+++...
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~----r~Yqe~qL---------Palp~~vpp~~rqlV~~l 493 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT----RTYQESQL---------PALPSRVPPVARQLVFDL 493 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech----hhhhhhhC---------CCCcccCChHHHHHHHHH
Confidence 2 3468999999999999999999997532211100 00111111 233455667788999999
Q ss_pred cccCCCCCCCHHHHHHHH
Q 002887 813 IHTISTRRPTMNQVVIEL 830 (870)
Q Consensus 813 l~~dP~~RPsm~eVl~~L 830 (870)
++++|.+||+..-....|
T Consensus 494 L~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 494 LKRDPSKRVSPNIAANVL 511 (598)
T ss_pred hcCCccccCCccHHHhHH
Confidence 999999999876554444
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.1e-14 Score=136.98 Aligned_cols=133 Identities=20% Similarity=0.181 Sum_probs=115.6
Q ss_pred ccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhcc--ccceeEEEEEecCCeEEEEEEEccCCchh
Q 002887 567 RVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHH--KNLTILVGYCDEGANMGLIYEFMANGNLQ 644 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 644 (870)
+.||+|.++.||++...++.+++|....... ...+.+|+.++..++| ..+.+++++....+..++++||++++.+.
T Consensus 4 ~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred eecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 5799999999999999888999999866543 4678999999999987 48999999988888899999999988776
Q ss_pred hhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCcc
Q 002887 645 AHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 645 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~ 710 (870)
.. +......++.++++++++||.....+++|+|+||+||++++.+.++++|||.+..
T Consensus 82 ~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 82 EV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 53 4566778899999999999986545799999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.3e-15 Score=173.45 Aligned_cols=201 Identities=24% Similarity=0.342 Sum_probs=140.7
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCchh
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQ 644 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 644 (870)
+.|..|++|.||..+++ .++.|.|+ .+++.-- ++ ++.....|.+| |+-.
T Consensus 89 klisngAygavylvrh~~trqrfa~ki-Nkq~lil----Rn---ilt~a~npfvv---------------------gDc~ 139 (1205)
T KOG0606|consen 89 KLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLIL----RN---ILTFAGNPFVV---------------------GDCA 139 (1205)
T ss_pred EeeccCCCCceeeeeccccccchhhcc-cccchhh----hc---cccccCCccee---------------------chhh
Confidence 68999999999999887 67788743 3322110 00 22222333332 3333
Q ss_pred hhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC---------
Q 002887 645 AHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG--------- 715 (870)
Q Consensus 645 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~--------- 715 (870)
..+... ..++. +++.+++|||+. +|+|||+||+|.+++.=|++|+.|||+.+......
T Consensus 140 tllk~~--g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I 206 (1205)
T KOG0606|consen 140 TLLKNI--GPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHI 206 (1205)
T ss_pred hhcccC--CCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcch
Confidence 333221 22222 227789999998 99999999999999999999999999987532110
Q ss_pred ----CccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccc
Q 002887 716 ----GTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDH 791 (870)
Q Consensus 716 ----~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 791 (870)
.......++||+.|+|||++..+.|..-+|.|++|+++||.+.|+.||.+...++.+.+.+...+.
T Consensus 207 ~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~---------- 276 (1205)
T KOG0606|consen 207 EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE---------- 276 (1205)
T ss_pred HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc----------
Confidence 001123468999999999999999999999999999999999999999987666665554332221
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 002887 792 RLQGDFDTNTVWKAVEIALACIHTISTRRP 821 (870)
Q Consensus 792 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 821 (870)
..+.+.....++.+++.+.++.+|.+|-
T Consensus 277 --wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 277 --WPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred --ccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 1122344456788899999999999996
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-13 Score=140.60 Aligned_cols=135 Identities=21% Similarity=0.235 Sum_probs=98.1
Q ss_pred cccccccCcEEEEEEEEC-CeeEEEEEeeccchh--hhHH----------------------HHHHHHHHHHhcccc--c
Q 002887 566 ERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQ--GYKQ----------------------FQAEVELLIRAHHKN--L 618 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~--~~~~----------------------f~~Ei~~l~~l~H~n--I 618 (870)
.+.||+|+||.||+|... ++.||||++...... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999987 899999998754221 1111 135666666665543 3
Q ss_pred eeEEEEEecCCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHh-CCCCCceeCCCCCCCEEEcCC
Q 002887 619 TILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN-GCKPPIVHRDVKSANILLNEK 697 (870)
Q Consensus 619 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~IvHrDLKp~NILld~~ 697 (870)
.+.+++ ...++||||++++.+......... .. .....++.+++.++.++|. . +|+||||||+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-C
Confidence 444443 245899999999654322111110 11 5678899999999999998 6 999999999999999 8
Q ss_pred CcEEEEeccCCccc
Q 002887 698 FQAKLADFGLSRIF 711 (870)
Q Consensus 698 ~~vkL~DFGla~~~ 711 (870)
+.++++|||.+...
T Consensus 151 ~~~~liDfg~a~~~ 164 (187)
T cd05119 151 GKVYIIDVPQAVEI 164 (187)
T ss_pred CcEEEEECcccccc
Confidence 89999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.3e-13 Score=143.81 Aligned_cols=135 Identities=21% Similarity=0.207 Sum_probs=106.3
Q ss_pred cccc-ccCcEEEEEEEECCeeEEEEEeeccch-------------hhhHHHHHHHHHHHHhccccc--eeEEEEEecCC-
Q 002887 567 RVLG-KGGFGTVYHGYLDDKQVAVKMLSSSSV-------------QGYKQFQAEVELLIRAHHKNL--TILVGYCDEGA- 629 (870)
Q Consensus 567 ~~LG-~G~fG~Vy~~~~~~~~vAVK~l~~~~~-------------~~~~~f~~Ei~~l~~l~H~nI--v~l~g~~~~~~- 629 (870)
..|| .|+.|+||.....+..++||+...... .....+.+|++++.+++|+++ +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 5788 899999999999999999998854211 123467889999999998885 66777654322
Q ss_pred ---eEEEEEEEccC-CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEec
Q 002887 630 ---NMGLIYEFMAN-GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADF 705 (870)
Q Consensus 630 ---~~~LV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DF 705 (870)
..++|+|++++ .+|.+++.. ..++.. .+.+++++|.+||+. +|+||||||.|||++.++.++|+||
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEEC
Confidence 23599999997 688887743 234433 367899999999998 9999999999999999999999999
Q ss_pred cCCccc
Q 002887 706 GLSRIF 711 (870)
Q Consensus 706 Gla~~~ 711 (870)
|.+...
T Consensus 187 g~~~~~ 192 (239)
T PRK01723 187 DRGELR 192 (239)
T ss_pred CCcccC
Confidence 988753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.5e-14 Score=170.83 Aligned_cols=251 Identities=21% Similarity=0.318 Sum_probs=187.7
Q ss_pred hccccccccCcEEEEEEEEC---CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhc-cccceeEEEEEecCCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD---DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAH-HKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~---~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.+.||+|+|+.|-..... ...+|+|.+.... .........|..+-..+. |+|++.+++...+....+++.+|
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~ 102 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY 102 (601)
T ss_pred cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence 34467999999999877653 3446666665543 223344455777777776 99999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHH-hCCCCCceeCCCCCCCEEEcCCC-cEEEEeccCCccccC-C
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH-NGCKPPIVHRDVKSANILLNEKF-QAKLADFGLSRIFPV-E 714 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~IvHrDLKp~NILld~~~-~vkL~DFGla~~~~~-~ 714 (870)
..++++.+.+.+......+......++.|+..++.|+| .. ++.|||+||+|.+++..+ ..+++|||+|..+.. .
T Consensus 103 s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 103 SDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred ccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 99999988873222224556677789999999999999 76 999999999999999999 999999999998866 4
Q ss_pred CCccccccccC-CCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccc-hHHHHHHHHhhcCCcchhccc
Q 002887 715 GGTHVSTTVVG-TPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRT-LIGQWVSSMLARGDIKNIVDH 791 (870)
Q Consensus 715 ~~~~~~~~~~g-t~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~-~l~~~~~~~~~~~~~~~i~d~ 791 (870)
+.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...... ....|.... +..
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~------ 250 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK---GRF------ 250 (601)
T ss_pred CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc---ccc------
Confidence 44555566778 9999999999884 45678999999999999999999998655332 112221111 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 792 RLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 792 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.............++..+++..+|..|.+.+++..
T Consensus 251 --~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 251 --TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --ccCccccCChhhhhcccccccCCchhccccccccc
Confidence 00111122335567778888899999999888754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.2e-11 Score=142.00 Aligned_cols=138 Identities=20% Similarity=0.181 Sum_probs=98.4
Q ss_pred ccccccCcEEEEEEEEC-CeeEEEEEeeccchhhh----------------------------------------HHHHH
Q 002887 567 RVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGY----------------------------------------KQFQA 605 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~----------------------------------------~~f~~ 605 (870)
+.||.|++|.||+|++. |+.||||+.+....... -.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999986 99999999865311000 02445
Q ss_pred HHHHHHHhc----cccceeEEEEE-ecCCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHH-HHHHHHhCCC
Q 002887 606 EVELLIRAH----HKNLTILVGYC-DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQ-GLEYLHNGCK 679 (870)
Q Consensus 606 Ei~~l~~l~----H~nIv~l~g~~-~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-aL~yLH~~~~ 679 (870)
|+..+.+++ |.+-+.+-..+ ......+|||||++|++|.+...... ... .+.+++..++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~---~~~~ia~~~~~~~l~ql~~~-- 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGL---DRKALAENLARSFLNQVLRD-- 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCC---CHHHHHHHHHHHHHHHHHhC--
Confidence 666565552 33333333333 22446799999999999988764321 112 23456666666 46788887
Q ss_pred CCceeCCCCCCCEEEcCCCcEEEEeccCCccc
Q 002887 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIF 711 (870)
Q Consensus 680 ~~IvHrDLKp~NILld~~~~vkL~DFGla~~~ 711 (870)
+++|+|+||.||+++++++++++|||++..+
T Consensus 277 -g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 277 -GFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred -CceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 9999999999999999999999999999766
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=8.8e-12 Score=130.25 Aligned_cols=203 Identities=20% Similarity=0.353 Sum_probs=140.0
Q ss_pred HHHHHHhccccceeEEEEEecC-----CeEEEEEEEccCCchhhhhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCC
Q 002887 607 VELLIRAHHKNLTILVGYCDEG-----ANMGLIYEFMANGNLQAHLLEDK--ADTLCWERRLQIASESAQGLEYLHNGCK 679 (870)
Q Consensus 607 i~~l~~l~H~nIv~l~g~~~~~-----~~~~LV~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 679 (870)
..-|.++.|.|||++..|+.+. .+..++.|||.-|++.++|++.+ ...+......+++.||..||.|||+ |.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 3456677899999999988543 45788999999999999998753 3567777788999999999999998 58
Q ss_pred CCceeCCCCCCCEEEcCCCcEEEEeccCCccccC--CCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHH
Q 002887 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV--EGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELI 757 (870)
Q Consensus 680 ~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~--~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ell 757 (870)
|+|+|+++..+-|++..++-+|+.--.-...-.. ...........+-++|.|||+-.....+-.+|||+||...+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 9999999999999999998888742111000000 00001112335678999999988888889999999999999998
Q ss_pred hCCCC-CCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 758 TGQPV-IQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 758 tG~~p-~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.|.-- -........-.... +.. . .+...+ =.+++..|++..|..||+|++++.
T Consensus 277 ilEiq~tnseS~~~~ee~ia-~~i-----~-~len~l-----------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIA-NVI-----I-GLENGL-----------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcceeehhhhhh-hhe-----e-eccCcc-----------ccCcCcccccCCCCCCcchhhhhc
Confidence 87632 11111100000000 000 0 000011 125677999999999999999854
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.5e-11 Score=119.09 Aligned_cols=129 Identities=19% Similarity=0.123 Sum_probs=98.1
Q ss_pred ccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhcccccee-EEEEEecCCeEEEEEEEccCCchhh
Q 002887 567 RVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTI-LVGYCDEGANMGLIYEFMANGNLQA 645 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~-l~g~~~~~~~~~LV~Ey~~~gsL~~ 645 (870)
+.|+.|.++.||++...++.+++|+...... ....+..|++++..+.+.++++ ++.+.. ...++||||+++.++..
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccc
Confidence 4689999999999999999999999765432 2345688999999997666554 444332 34579999999988764
Q ss_pred hhhhcccccccHHHHHHHHHHHHHHHHHHHhCC--CCCceeCCCCCCCEEEcCCCcEEEEeccCCc
Q 002887 646 HLLEDKADTLCWERRLQIASESAQGLEYLHNGC--KPPIVHRDVKSANILLNEKFQAKLADFGLSR 709 (870)
Q Consensus 646 ~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~IvHrDLKp~NILld~~~~vkL~DFGla~ 709 (870)
.- .....++.+++++|+.||+.. ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 81 ~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 81 ED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 31 011345678999999999872 12369999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.2e-11 Score=154.74 Aligned_cols=122 Identities=34% Similarity=0.643 Sum_probs=89.7
Q ss_pred ccCChhhHHHHHHHHhhcC----CCCCCC-CCCCCCCCCCccceecCCCCCCCCcEEEEEcCCCCCcccCcccccccCcc
Q 002887 361 LLTNQQDVDAIMKIKSKYE----VKRDWQ-GDPCAPKVYMWQGINCSYDANQSPRIISINLSSSGIAGDIVPYIFSLTSI 435 (870)
Q Consensus 361 ~~~~~~d~~al~~~k~~~~----~~~~w~-~~pC~~~~~~W~Gv~C~~~~~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L 435 (870)
..+.++|..||++||+.+. ...+|+ ++.|| .|.||.|++ ..+|+.|+|++|+++|.+|+.++.|++|
T Consensus 24 ~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c----~w~gv~c~~----~~~v~~L~L~~~~i~~~~~~~~~~l~~L 95 (968)
T PLN00113 24 SMLHAEELELLLSFKSSINDPLKYLSNWNSSADVC----LWQGITCNN----SSRVVSIDLSGKNISGKISSAIFRLPYI 95 (968)
T ss_pred cCCCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC----cCcceecCC----CCcEEEEEecCCCccccCChHHhCCCCC
Confidence 4457789999999999874 356896 34454 799999974 3478888888888888888888888888
Q ss_pred cccccccCcCCCCCCcccc-CcCCCCeEEecCCcCCCC----------------------CCCcccccccCCcccccc
Q 002887 436 ESLDLSKNSLTGPVPEFLA-ELQSLRVLNLSGNNLQGS----------------------LPSGLSEKVKNGSLSLSV 490 (870)
Q Consensus 436 ~~L~Ls~N~l~g~iP~~~~-~l~~L~~L~ls~N~l~g~----------------------ip~~l~~~~~~~~l~~~~ 490 (870)
+.|+|++|+++|.+|..+. .+++|++|+|++|+++|. +|..++.+.+|+.|+++.
T Consensus 96 ~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~ 173 (968)
T PLN00113 96 QTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGG 173 (968)
T ss_pred CEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECcc
Confidence 8888888888888887654 666666666666666554 455555566666666653
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.07 E-value=8.7e-09 Score=119.91 Aligned_cols=135 Identities=14% Similarity=0.133 Sum_probs=89.0
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccchh---------------------------------h-hH------HHH
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ---------------------------------G-YK------QFQ 604 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~---------------------------------~-~~------~f~ 604 (870)
+.||.|++|.||+|++. |+.||||+.+..-.. . .+ .|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 47999999999999985 799999999754110 0 01 234
Q ss_pred HHHHHHHHhc----cccceeEEEEEec-CCeEEEEEEEccCCchhhhh--hhccc--ccccHHHHHHHHHHHHHHHHHHH
Q 002887 605 AEVELLIRAH----HKNLTILVGYCDE-GANMGLIYEFMANGNLQAHL--LEDKA--DTLCWERRLQIASESAQGLEYLH 675 (870)
Q Consensus 605 ~Ei~~l~~l~----H~nIv~l~g~~~~-~~~~~LV~Ey~~~gsL~~~l--~~~~~--~~l~~~~~~~i~~~ia~aL~yLH 675 (870)
+|+..+.+++ +.+.+.+-..+.+ ....+|||||++|+.+.+.- ..... +.+.......++.|+ +
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 4555555543 4444444343332 45678999999999997642 11110 123222223333333 3
Q ss_pred hCCCCCceeCCCCCCCEEEcCCC----cEEEEeccCCccc
Q 002887 676 NGCKPPIVHRDVKSANILLNEKF----QAKLADFGLSRIF 711 (870)
Q Consensus 676 ~~~~~~IvHrDLKp~NILld~~~----~vkL~DFGla~~~ 711 (870)
.. +++|+|+||.||+++.++ ++++.|||++..+
T Consensus 278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 34 999999999999999988 9999999998765
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.00 E-value=4.1e-09 Score=109.54 Aligned_cols=141 Identities=19% Similarity=0.265 Sum_probs=110.7
Q ss_pred ccccccCcEEEEEEEECC-eeEEEEEeeccch-hhhHHHHHHHHHHHHhccc--cceeEEEEEecCC---eEEEEEEEcc
Q 002887 567 RVLGKGGFGTVYHGYLDD-KQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHK--NLTILVGYCDEGA---NMGLIYEFMA 639 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~-~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~~~~---~~~LV~Ey~~ 639 (870)
+.|+.|..+.||++...+ +.+++|+...... .....+..|++++..+++. ++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 468999999999998875 8999999765432 2356789999999999764 4567788776643 5689999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGC----------------------------------------- 678 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~----------------------------------------- 678 (870)
+.++.+.+.. ..++..++..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988776531 34677778888889999998888531
Q ss_pred ------------CCCceeCCCCCCCEEEcC--CCcEEEEeccCCcc
Q 002887 679 ------------KPPIVHRDVKSANILLNE--KFQAKLADFGLSRI 710 (870)
Q Consensus 679 ------------~~~IvHrDLKp~NILld~--~~~vkL~DFGla~~ 710 (870)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=6.7e-09 Score=118.98 Aligned_cols=163 Identities=20% Similarity=0.205 Sum_probs=122.2
Q ss_pred CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCchhhhhhhcccccccHHHHHHH
Q 002887 584 DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI 663 (870)
Q Consensus 584 ~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i 663 (870)
+.+|.|...+...........+-++.|+.+|||||++++.........|+|+|-+. -|...+.+. ........
T Consensus 37 ~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-----~~~~v~~G 109 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-----GKEEVCLG 109 (690)
T ss_pred CCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----HHHHHHHH
Confidence 77888888876655334556788899999999999999999999999999999874 345555332 23445557
Q ss_pred HHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCcc
Q 002887 664 ASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEK 743 (870)
Q Consensus 664 ~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k 743 (870)
+.||+.||.+||+.| +++|++|.-+-|+++..|+.||++|-++.....-.. ......--..|..|+.+.... -.
T Consensus 110 l~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s 183 (690)
T KOG1243|consen 110 LFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WS 183 (690)
T ss_pred HHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cc
Confidence 889999999999775 899999999999999999999999988765421111 111111222455666543322 34
Q ss_pred chHHHHHHHHHHHHhC
Q 002887 744 SDVYSFGVVLLELITG 759 (870)
Q Consensus 744 sDVwS~GvvL~elltG 759 (870)
.|.|-|||+++|++.|
T Consensus 184 ~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 184 IDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhhHHHHHHHHhCc
Confidence 6999999999999999
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=7.1e-09 Score=101.22 Aligned_cols=141 Identities=21% Similarity=0.255 Sum_probs=107.4
Q ss_pred ccccccCcEEEEEEEECCeeEEEEEeeccc--------hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 567 RVLGKGGFGTVYHGYLDDKQVAVKMLSSSS--------VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~--------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
..|-||+-+.|+++.+.|+...||.-.... .-..++-.+|++.|.+++--.|....-++.+...-.++|||+
T Consensus 13 ~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~ 92 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFI 92 (229)
T ss_pred eeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEec
Confidence 578999999999999999998887653321 112456788999999997666665555666666778999999
Q ss_pred cC-CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC---cEEEEeccCCcc
Q 002887 639 AN-GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF---QAKLADFGLSRI 710 (870)
Q Consensus 639 ~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~---~vkL~DFGla~~ 710 (870)
++ .++.+++................+..|-+.+.-||.+ +|+|+||..+||+|..++ .+.++|||++..
T Consensus 93 ~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 93 DGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred cchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 87 4677777654333333333367888999999999999 999999999999997655 358999999854
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.3e-10 Score=126.85 Aligned_cols=247 Identities=21% Similarity=0.178 Sum_probs=173.0
Q ss_pred HHhhccccccc--cCcEEEEEEEE--C--CeeEEEEEeecc--chhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeE
Q 002887 561 ITNNFERVLGK--GGFGTVYHGYL--D--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANM 631 (870)
Q Consensus 561 ~t~~f~~~LG~--G~fG~Vy~~~~--~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 631 (870)
-...+.+.+|. |.+|.||.+.. . +..+|+|+-+.. .......=.+|+...+++ .|+|.++....+.+++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34455678999 99999999987 3 677888884332 223333335667777777 599999988888888888
Q ss_pred EEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHH----HHHHHHhCCCCCceeCCCCCCCEEEcCC-CcEEEEecc
Q 002887 632 GLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQ----GLEYLHNGCKPPIVHRDVKSANILLNEK-FQAKLADFG 706 (870)
Q Consensus 632 ~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----aL~yLH~~~~~~IvHrDLKp~NILld~~-~~vkL~DFG 706 (870)
++-+|++. .+|..+.+... ..++....+.+..+..+ ||.++|+. +++|-|+||.||+...+ ...+++|||
T Consensus 194 fiqtE~~~-~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeecccc-chhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcc
Confidence 88889876 56766654322 33556667777777777 99999998 99999999999999999 889999999
Q ss_pred CCccccCCCCccc---cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC
Q 002887 707 LSRIFPVEGGTHV---STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG 783 (870)
Q Consensus 707 la~~~~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~ 783 (870)
+...+....-... .....|...|++||... +.++..+|+|++|.+.++..+|......... ..|. .++.+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~----~~W~--~~r~~ 341 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN----SSWS--QLRQG 341 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC----CCcc--ccccc
Confidence 9987754332211 22236788999999874 5678899999999999999998765443210 0110 00000
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 002887 784 DIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVV 827 (870)
Q Consensus 784 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl 827 (870)
. +..++...-..++...+..+++.+|..|++.+.+.
T Consensus 342 ~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 342 Y--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred c--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 0 11122222223444588899999999999876664
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.2e-08 Score=103.56 Aligned_cols=135 Identities=19% Similarity=0.167 Sum_probs=97.0
Q ss_pred ccccccCcEEEEEEEEC--------CeeEEEEEeeccch----------------------hhhHHH----HHHHHHHHH
Q 002887 567 RVLGKGGFGTVYHGYLD--------DKQVAVKMLSSSSV----------------------QGYKQF----QAEVELLIR 612 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--------~~~vAVK~l~~~~~----------------------~~~~~f----~~Ei~~l~~ 612 (870)
..||.|-=+.||.|... +..+|||+.+.... ...+.+ ++|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999754 36899999753210 001122 389999999
Q ss_pred hccc--cceeEEEEEecCCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHH-HhCCCCCceeCCCCC
Q 002887 613 AHHK--NLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL-HNGCKPPIVHRDVKS 689 (870)
Q Consensus 613 l~H~--nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~IvHrDLKp 689 (870)
+... ++...+++ ...++||||+.+..+..... +...++..+...+..+++.+|..| |.. +|+||||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L--kd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL--KDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh--hccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 8543 45566654 46789999998754422111 112344456677889999999999 776 999999999
Q ss_pred CCEEEcCCCcEEEEeccCCccc
Q 002887 690 ANILLNEKFQAKLADFGLSRIF 711 (870)
Q Consensus 690 ~NILld~~~~vkL~DFGla~~~ 711 (870)
.|||+++ +.++|+|||.+...
T Consensus 154 ~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 154 YNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred HHEEEEC-CcEEEEECCCceeC
Confidence 9999974 68999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.2e-08 Score=100.40 Aligned_cols=131 Identities=21% Similarity=0.296 Sum_probs=103.5
Q ss_pred ccccccCcEEEEEEEECCeeEEEEEeeccch-----h---hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 567 RVLGKGGFGTVYHGYLDDKQVAVKMLSSSSV-----Q---GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~-----~---~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
..+++|+=+.+|.+.+.|.++++|.-..... . ....-.+|+.++.+++--.|....=+..+.....++|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 3588999999999988887777776433211 1 1234568999999997766666666667777889999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~ 710 (870)
++-.|.+.+... +..++..+=.-+.-||.. +|+|+||.++||++..+. +.++|||++..
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999888888543 356777788888999998 999999999999999875 99999999864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=7.2e-08 Score=103.28 Aligned_cols=140 Identities=16% Similarity=0.095 Sum_probs=102.9
Q ss_pred cccccCcEEEEEEEECCeeEEEEEeeccchh-hhH----------HHHHHHHHHHHhccccc--eeEEEEEec-----CC
Q 002887 568 VLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQ-GYK----------QFQAEVELLIRAHHKNL--TILVGYCDE-----GA 629 (870)
Q Consensus 568 ~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~-~~~----------~f~~Ei~~l~~l~H~nI--v~l~g~~~~-----~~ 629 (870)
.+-+-....|.+..+.|+.+.||+....... ..+ .+.+|...+.++...+| ...+++... ..
T Consensus 29 ~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 29 VFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 4444444557788888999999987543311 111 37899999988854444 344555533 23
Q ss_pred eEEEEEEEccCC-chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC-------CCcEE
Q 002887 630 NMGLIYEFMANG-NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE-------KFQAK 701 (870)
Q Consensus 630 ~~~LV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~-------~~~vk 701 (870)
..++|+|++++- +|.+++........+...+..++.++++.+..||.. +|+|+|++++|||++. +..+.
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEE
Confidence 578999999986 788887533233455667788999999999999999 9999999999999985 46899
Q ss_pred EEeccCCcc
Q 002887 702 LADFGLSRI 710 (870)
Q Consensus 702 L~DFGla~~ 710 (870)
++||+.+..
T Consensus 186 LIDl~r~~~ 194 (268)
T PRK15123 186 VIDLHRAQI 194 (268)
T ss_pred EEECCcccc
Confidence 999998753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.73 E-value=3.2e-07 Score=102.16 Aligned_cols=167 Identities=17% Similarity=0.202 Sum_probs=129.0
Q ss_pred CcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEe----cCCeEEEEEEEccC-Cchhh
Q 002887 573 GFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCD----EGANMGLIYEFMAN-GNLQA 645 (870)
Q Consensus 573 ~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~----~~~~~~LV~Ey~~~-gsL~~ 645 (870)
--.+.||+... |..+++|+++....+....-..-+++++++.|.|+|++.+.+. .+...++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 34678998864 8899999996655444444466788999999999999998875 34568999999986 56655
Q ss_pred hhhhc-------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCcccc
Q 002887 646 HLLED-------------KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 712 (870)
Q Consensus 646 ~l~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~ 712 (870)
.-... .+...++...+.++.|+..||.++|+. |+.-+-|.+++||++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 43221 123567888999999999999999999 99999999999999999999999999887664
Q ss_pred CCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCC
Q 002887 713 VEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761 (870)
Q Consensus 713 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~ 761 (870)
.+.. |-+. -..+-|.=.||.+++.|.||..
T Consensus 445 ~d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPT----------------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCC----------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 3320 1111 1245789999999999999964
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.2e-08 Score=116.13 Aligned_cols=239 Identities=21% Similarity=0.208 Sum_probs=166.4
Q ss_pred cccccccCcEEEEEEEEC---CeeEEEEEeeccchhhhHH--HHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEcc
Q 002887 566 ERVLGKGGFGTVYHGYLD---DKQVAVKMLSSSSVQGYKQ--FQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~---~~~vAVK~l~~~~~~~~~~--f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
...||.|.|+.|++.... +..+++|.+.........+ -..|+.+...+ .|.+++.....+..-.+.++--||++
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 467999999999987653 6778888887654332222 24566666665 57788877766666677778899999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC-CcEEEEeccCCccccCCCCcc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK-FQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~-~~vkL~DFGla~~~~~~~~~~ 718 (870)
++++...+ .....++...++++..|++.++.++|+. ..+|+|+||+||++..+ +..++.|||++..+...
T Consensus 350 ~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~---- 420 (524)
T KOG0601|consen 350 GGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS---- 420 (524)
T ss_pred Ccchhhhh--HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccccee----
Confidence 99887655 2334677788899999999999999987 99999999999999886 78899999998642111
Q ss_pred ccccccCCCCcc--CccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 719 VSTTVVGTPGYL--DPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 719 ~~~~~~gt~~y~--APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
.....+.-++. +++......+..+.|++|||.-+.|.++|...-.... +|. .+..+.+. .
T Consensus 421 -~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~------~~~--~i~~~~~p---------~ 482 (524)
T KOG0601|consen 421 -SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV------QSL--TIRSGDTP---------N 482 (524)
T ss_pred -cccccccccccccchhhccccccccccccccccccccccccCcccCcccc------cce--eeeccccc---------C
Confidence 11112233344 5555556678899999999999999999875322111 110 01111111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
... ....+..++..+...+++.||.+.++....+.
T Consensus 483 ~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 483 LPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred CCc-hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 111 12556678888999999999999888766554
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=8.7e-09 Score=98.76 Aligned_cols=82 Identities=29% Similarity=0.460 Sum_probs=78.1
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
...|+.|.|++|.|+ .+|+.|+.|.+|+.|+|++|++. .+|.++++|++|+.|+++-|+|. .+|..++.++.+..|+
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 357899999999999 99999999999999999999999 89999999999999999999998 8999999999999999
Q ss_pred cccCC
Q 002887 488 LSVDG 492 (870)
Q Consensus 488 ~~~~~ 492 (870)
++|++
T Consensus 109 ltynn 113 (264)
T KOG0617|consen 109 LTYNN 113 (264)
T ss_pred ccccc
Confidence 99875
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=98.57 E-value=2e-07 Score=93.47 Aligned_cols=138 Identities=18% Similarity=0.307 Sum_probs=76.6
Q ss_pred EEeccCCCCCCccccCCCceEEecCCCccccCcc-----------eeeCCCCcccccccccccccccCcCcccceecCCC
Q 002887 30 ISIDCGIPENENYADKVTGINYVSDAPYVDTAVS-----------HSISPEYSKETVERQFSYLRSFPEGIRNCYTLRPP 98 (870)
Q Consensus 30 ~~idCG~~~~~~~~~~~~~~~~~~D~~~~~~g~~-----------~~~~~~~~~~~~~~~~~t~R~Fp~g~~ncY~l~~~ 98 (870)
+.||||+ ..+ ++..|+.|.+|..|..++.. ...........-...|+|-|+=|. ...|.+| +
T Consensus 3 ~~IN~Gg---~~~-~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~--~f~Y~ip-~ 75 (174)
T PF11721_consen 3 LRINAGG---PAY-TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPS--SFSYDIP-V 75 (174)
T ss_dssp EEEEETS---SSE-EETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SS--SEEEEEE--
T ss_pred EEEECCC---Ccc-cCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCC--ceEEEEe-c
Confidence 5799995 333 45689999999999755551 011111112334577889999433 5799994 4
Q ss_pred CCCccEEEEeee---eeccCCCCCCCC---ceEEEEccee-eEEEEcCCC---cc-ceeEEE-EEecCCCceEEEEee--
Q 002887 99 NGDVKFLIRARF---MYGNYDGLDKAP---SFDLMLGADA-WDSVQLQDP---RS-IITKEI-IHMPNKDYIHVCLVN-- 164 (870)
Q Consensus 99 ~~~~~ylvR~~f---~ygnyd~~~~~p---~Fd~~~~~~~-w~~v~~~~~---~~-~~~~e~-~~~~~~~~~~vcl~~-- 164 (870)
.+.|.|-||++| +++. ++....| +||++++|+. ...+++... .. ....+. -+.+.++.+.|+|..
T Consensus 76 ~~~G~Y~V~L~FaE~~~~~-~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~~ 154 (174)
T PF11721_consen 76 VPNGTYTVRLHFAELYFGA-SGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWAG 154 (174)
T ss_dssp -S-EEEEEEEEEE-SSS---------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE-
T ss_pred CCCcEEEEEEEeccccccc-cccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEecC
Confidence 566789999999 4444 3333333 6999999965 667765321 11 233344 234578899999996
Q ss_pred ---------cCCCCceeeee
Q 002887 165 ---------TDSGIPFISAL 175 (870)
Q Consensus 165 ---------t~~~~pfis~l 175 (870)
...|.|.||||
T Consensus 155 ~~~~~i~~~~~~~~p~IsaI 174 (174)
T PF11721_consen 155 KGTLCIPFIGSYGNPLISAI 174 (174)
T ss_dssp -SEEEEEEESSSSSSSEEEE
T ss_pred CCcEEeeccccCCCcEEeeC
Confidence 44566888886
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.56 E-value=5.8e-07 Score=91.01 Aligned_cols=124 Identities=23% Similarity=0.262 Sum_probs=80.2
Q ss_pred EEEEEEEC-CeeEEEEEeeccch--------------------------hhhHHHHHHHHHHHHhccc--cceeEEEEEe
Q 002887 576 TVYHGYLD-DKQVAVKMLSSSSV--------------------------QGYKQFQAEVELLIRAHHK--NLTILVGYCD 626 (870)
Q Consensus 576 ~Vy~~~~~-~~~vAVK~l~~~~~--------------------------~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~ 626 (870)
.||.|... +..+|||+.+.... ......++|++.|.++... ++.+++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38999875 88999999754200 0112367899999999766 455555443
Q ss_pred cCCeEEEEEEEcc--CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHH-HhCCCCCceeCCCCCCCEEEcCCCcEEEE
Q 002887 627 EGANMGLIYEFMA--NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL-HNGCKPPIVHRDVKSANILLNEKFQAKLA 703 (870)
Q Consensus 627 ~~~~~~LV~Ey~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~IvHrDLKp~NILld~~~~vkL~ 703 (870)
...+||||++ +..+.. +... .++......++.+++..+..+ |.. +|+|+||.+.|||++++ .+.++
T Consensus 80 ---~~~ivME~I~~~G~~~~~-l~~~---~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPR-LKDV---DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGC-HHHC---GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhh-HHhc---cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 3479999999 544433 3222 122344566777888866664 666 99999999999999998 99999
Q ss_pred eccCCccc
Q 002887 704 DFGLSRIF 711 (870)
Q Consensus 704 DFGla~~~ 711 (870)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.6e-08 Score=120.44 Aligned_cols=240 Identities=21% Similarity=0.289 Sum_probs=152.3
Q ss_pred cccccCcEEEEEEEEC--CeeEEEEEeecc---chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 568 VLGKGGFGTVYHGYLD--DKQVAVKMLSSS---SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 568 ~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
-+-.|.++.++.+.-. +...+.|..... .....+....+-.++...+||-++.....+.......|+++|..+++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 4566777777765432 222222222111 11111222222233333345555544444555677899999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC--------
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE-------- 714 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~-------- 714 (870)
|...|+... ..+..-.......+.++++|||.. .+.|||++|.|+|...++..+++|||........
T Consensus 891 ~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg 965 (1205)
T KOG0606|consen 891 LPSKLHNSG--CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSG 965 (1205)
T ss_pred chhhhhcCC--CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCCccc
Confidence 998886433 344334445566788899999987 7999999999999999999999999843321100
Q ss_pred -------------C--------CccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHH
Q 002887 715 -------------G--------GTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIG 773 (870)
Q Consensus 715 -------------~--------~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~ 773 (870)
. .........||+.|.+||...+......+|.|+.|++++|.++|.+||..........
T Consensus 966 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ 1045 (1205)
T KOG0606|consen 966 PSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFE 1045 (1205)
T ss_pred ccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhh
Confidence 0 0011223568999999999999999999999999999999999999998655433221
Q ss_pred HHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 002887 774 QWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMN 824 (870)
Q Consensus 774 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~ 824 (870)
++.. +.. . ......+......+++...+..+|.+|-.|.
T Consensus 1046 ----ni~~-~~~------~-~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1046 ----NILN-RDI------P-WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred ----cccc-CCC------C-CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 1111 000 0 0112223344566777777788888887665
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=3.1e-06 Score=92.24 Aligned_cols=259 Identities=19% Similarity=0.225 Sum_probs=153.5
Q ss_pred cccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEEE-------ecCCeEEEEEEE
Q 002887 566 ERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGYC-------DEGANMGLIYEF 637 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~-------~~~~~~~LV~Ey 637 (870)
.+.||+|+-+.+|-----+..| -|+.......... +.+..|.+. .||-+-.-+.+= ..+....++|..
T Consensus 16 gr~LgqGgea~ly~l~e~~d~V-AKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRDQV-AKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred CccccCCccceeeecchhhchh-heeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 4689999999999542222223 3555544332221 222333333 455433322221 112225566666
Q ss_pred ccCCchhhhhhh-----cccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCcccc
Q 002887 638 MANGNLQAHLLE-----DKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 712 (870)
Q Consensus 638 ~~~gsL~~~l~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~ 712 (870)
+.+..--..+.. ..-...+|...++.++.+|.+.+-||+. +.+-+|+.++|+|+++++.+.|.|=..-...
T Consensus 92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~- 167 (637)
T COG4248 92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN- 167 (637)
T ss_pred CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec-
Confidence 655311111111 1224578999999999999999999998 9999999999999999999999875432221
Q ss_pred CCCCccccccccCCCCccCccccc-----cCCCCccchHHHHHHHHHHHHhC-CCCCCCCCccchHHHHHHHHhhcCCcc
Q 002887 713 VEGGTHVSTTVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITG-QPVIQKTPQRTLIGQWVSSMLARGDIK 786 (870)
Q Consensus 713 ~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwS~GvvL~elltG-~~p~~~~~~~~~l~~~~~~~~~~~~~~ 786 (870)
.........+|...|.+||.-. +-.-+...|.|.+|+++++++.| ++||.+.........-....+..|...
T Consensus 168 --~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 168 --ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred --cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 1122233457889999999865 33457789999999999999987 899987542111000000011112111
Q ss_pred hhcccc--cC---CCCC-HHHHHHHHHHHHHccccC--CCCCCCHHHHHHHHHHhh
Q 002887 787 NIVDHR--LQ---GDFD-TNTVWKAVEIALACIHTI--STRRPTMNQVVIELNDCL 834 (870)
Q Consensus 787 ~i~d~~--l~---~~~~-~~~~~~l~~l~~~Cl~~d--P~~RPsm~eVl~~L~~~~ 834 (870)
.--|.+ +. ...+ .--...+..+-.+|+... +.-|||++..+..|.+..
T Consensus 246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 111111 00 0111 112345666777888764 578999999988887743
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.49 E-value=7.2e-08 Score=78.92 Aligned_cols=61 Identities=38% Similarity=0.533 Sum_probs=53.3
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcC
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNL 469 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l 469 (870)
++++.|+|++|+|+..-+..|.++++|++|+|++|+++..-|..|..|++|+.|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4688999999999944445788999999999999999977778899999999999999986
|
... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.9e-06 Score=87.92 Aligned_cols=138 Identities=17% Similarity=0.133 Sum_probs=106.1
Q ss_pred ccccCcEEEEEEEECCeeEEEEEeeccc------hhhhHHHHHHHHHHHHhcccc--ceeEEEEEec-----CCeEEEEE
Q 002887 569 LGKGGFGTVYHGYLDDKQVAVKMLSSSS------VQGYKQFQAEVELLIRAHHKN--LTILVGYCDE-----GANMGLIY 635 (870)
Q Consensus 569 LG~G~fG~Vy~~~~~~~~vAVK~l~~~~------~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~~~~-----~~~~~LV~ 635 (870)
-|+||-+-|++-.++|+.+-+|+-...- +-....|.+|+..|.++...+ +.+.+ ++.. .-.-.||+
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 4678999999999888889999875321 235678999999999985443 33444 3321 22467899
Q ss_pred EEccC-CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCc--EEEEeccCCcc
Q 002887 636 EFMAN-GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQ--AKLADFGLSRI 710 (870)
Q Consensus 636 Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~--vkL~DFGla~~ 710 (870)
|-+.+ -+|.+++.+....+.+...+..++.++++.+.-||+. ++.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 5788787554445667778889999999999999999 9999999999999986666 99999987653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.1e-06 Score=88.77 Aligned_cols=107 Identities=22% Similarity=0.204 Sum_probs=83.5
Q ss_pred hHHHHHHHHHHHHhcccc--ceeEEEEEecC----CeEEEEEEEccCC-chhhhhhhcccccccHHHHHHHHHHHHHHHH
Q 002887 600 YKQFQAEVELLIRAHHKN--LTILVGYCDEG----ANMGLIYEFMANG-NLQAHLLEDKADTLCWERRLQIASESAQGLE 672 (870)
Q Consensus 600 ~~~f~~Ei~~l~~l~H~n--Iv~l~g~~~~~----~~~~LV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~ 672 (870)
.....+|...+.+++... ..+.+++.... ...++|+|++++. +|.+++..... ++......++.++++.+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 346788888888885443 34556665442 2457999999984 78888754222 556677899999999999
Q ss_pred HHHhCCCCCceeCCCCCCCEEEcCCC---cEEEEeccCCccc
Q 002887 673 YLHNGCKPPIVHRDVKSANILLNEKF---QAKLADFGLSRIF 711 (870)
Q Consensus 673 yLH~~~~~~IvHrDLKp~NILld~~~---~vkL~DFGla~~~ 711 (870)
-||+. +|+|+|++++|||++.+. .+.++||+-++..
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.9e-05 Score=91.67 Aligned_cols=140 Identities=18% Similarity=0.212 Sum_probs=91.9
Q ss_pred hcc-ccccccCcEEEEEEEEC-CeeEEEEEeeccchh------------------------------hhH----------
Q 002887 564 NFE-RVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQ------------------------------GYK---------- 601 (870)
Q Consensus 564 ~f~-~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~------------------------------~~~---------- 601 (870)
+|+ +.|+.++-|.||+|++. |+.||||+.+..-.. ..+
T Consensus 127 eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El 206 (517)
T COG0661 127 EFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL 206 (517)
T ss_pred HcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence 454 58999999999999998 999999998642110 001
Q ss_pred HHHHHHHHHHHh----c-cccceeEEEEE-ecCCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHH-HHHH
Q 002887 602 QFQAEVELLIRA----H-HKNLTILVGYC-DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQG-LEYL 674 (870)
Q Consensus 602 ~f~~Ei~~l~~l----~-H~nIv~l~g~~-~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~a-L~yL 674 (870)
.+.+|...+.++ + .+++ ++=..| +-.....|+|||++|..+.+...-.. ..++ +..++..++++ +..+
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d---~k~ia~~~~~~f~~q~ 281 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGID---RKELAELLVRAFLRQL 281 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCC---HHHHHHHHHHHHHHHH
Confidence 133344444444 2 2333 333333 33567889999999998888743222 3444 23344444333 2222
Q ss_pred HhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccc
Q 002887 675 HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 711 (870)
Q Consensus 675 H~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~ 711 (870)
-.. +..|.|.+|.||+++.++++.+.|||+...+
T Consensus 282 ~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 282 LRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred Hhc---CccccCCCccceEEecCCcEEEEcCcceecC
Confidence 223 8999999999999999999999999998755
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=9e-08 Score=91.91 Aligned_cols=145 Identities=19% Similarity=0.301 Sum_probs=107.3
Q ss_pred EEEEEeccCcchhhHHHHHHHhhhhchh--cccCChhhHHHHHHHHhhcCCCCCCCCCCCCCCCCCccceecCCCCCCCC
Q 002887 332 VISIMQTKNSSLAPILNALEIYQEKEFL--QLLTNQQDVDAIMKIKSKYEVKRDWQGDPCAPKVYMWQGINCSYDANQSP 409 (870)
Q Consensus 332 ~~sl~~t~~s~lppilna~ei~~~~~~~--~~~~~~~d~~al~~~k~~~~~~~~w~~~pC~~~~~~W~Gv~C~~~~~~~~ 409 (870)
.++|.-++.+.+||=|+-+--+.++++. +....|.....|.++|-..-...-.+--|- ..+..+
T Consensus 37 rLtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~~lpr--------------gfgs~p 102 (264)
T KOG0617|consen 37 RLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLNILPR--------------GFGSFP 102 (264)
T ss_pred hhhcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhhcCcc--------------ccCCCc
Confidence 4555677778888877655444444433 446788888888887754210000011111 113457
Q ss_pred cEEEEEcCCCCCcc-cCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 410 RIISINLSSSGIAG-DIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 410 ~l~~l~L~~n~l~G-~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
.+..|||+.|+|+- .+|..|.-|+.|+.|+|+.|.|. .+|..+++|++|+.|.|..|.|- ++|.+++.+.+++.|++
T Consensus 103 ~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhi 180 (264)
T KOG0617|consen 103 ALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHI 180 (264)
T ss_pred hhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhc
Confidence 88999999999874 68999999999999999999998 89999999999999999999998 89999999999998776
Q ss_pred ccCCCC
Q 002887 489 SVDGNR 494 (870)
Q Consensus 489 ~~~~n~ 494 (870)
. ||.
T Consensus 181 q--gnr 184 (264)
T KOG0617|consen 181 Q--GNR 184 (264)
T ss_pred c--cce
Confidence 5 664
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=7.6e-06 Score=85.45 Aligned_cols=134 Identities=19% Similarity=0.185 Sum_probs=96.4
Q ss_pred hhccccccccCcEEEEEEEEC-CeeEEEEEeeccch----------------------hhhHHHHHHHHHHHHhccc--c
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSV----------------------QGYKQFQAEVELLIRAHHK--N 617 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~----------------------~~~~~f~~Ei~~l~~l~H~--n 617 (870)
+.+.+.||-|-=+.||.|... |.++|||.-+.... -.....++|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345679999999999999987 99999998543210 1123467899999998655 5
Q ss_pred ceeEEEEEecCCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC
Q 002887 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK 697 (870)
Q Consensus 618 Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~ 697 (870)
+.+.+++ +...+||||+++--|...- ++-...-.|+..|++-+..+-.. ||||+|+.+-||+++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence 5555543 4568999999986554422 12223344555555555555555 99999999999999999
Q ss_pred CcEEEEeccCCcc
Q 002887 698 FQAKLADFGLSRI 710 (870)
Q Consensus 698 ~~vkL~DFGla~~ 710 (870)
|.+.++||--+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999976653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=3.4e-07 Score=105.69 Aligned_cols=152 Identities=22% Similarity=0.325 Sum_probs=103.8
Q ss_pred HHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc-------ccccCCCCccCccccc
Q 002887 664 ASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS-------TTVVGTPGYLDPEYYI 736 (870)
Q Consensus 664 ~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~-------~~~~gt~~y~APE~~~ 736 (870)
+.+++.|+.|+|.. .++||++|.|++|.+++++..||+.|+.+............ ....-...|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 44566999999976 59999999999999999999999999988654321111110 1112346899999999
Q ss_pred cCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHcccc
Q 002887 737 SNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHT 815 (870)
Q Consensus 737 ~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~ 815 (870)
+...+.++|+||+||+++.+.. |+..+..... .......... .+.. ...+..+.+.++.+=+.+.+..
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~~~~~~~---------~~~~-~~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSYSFSRNL---------LNAG-AFGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCC-cchhhhhhcc---------cccc-cccccccCcHHHHHHHHHHhcC
Confidence 9889999999999999999994 5544433221 1111110000 0111 1122345567788888899999
Q ss_pred CCCCCCCHHHHHH
Q 002887 816 ISTRRPTMNQVVI 828 (870)
Q Consensus 816 dP~~RPsm~eVl~ 828 (870)
++.-||++.++..
T Consensus 252 ~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 252 DSAVRPTLDLLLS 264 (700)
T ss_pred CcccCcchhhhhc
Confidence 9999998777643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.9e-05 Score=81.43 Aligned_cols=138 Identities=17% Similarity=0.283 Sum_probs=85.5
Q ss_pred ccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhccccc--eeEEEEEecCCeEEEEEEEccCCc-h
Q 002887 567 RVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNL--TILVGYCDEGANMGLIYEFMANGN-L 643 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI--v~l~g~~~~~~~~~LV~Ey~~~gs-L 643 (870)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-.+ .+.++++...+...+|||+++|.. +
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 46899999999984 35567788876533 23456889999999865444 677788777777889999999863 2
Q ss_pred hhhh---------------------hhcccccccHHHHHH-HHH----------HHHH-HHHHHHhC-CCCCceeCCCCC
Q 002887 644 QAHL---------------------LEDKADTLCWERRLQ-IAS----------ESAQ-GLEYLHNG-CKPPIVHRDVKS 689 (870)
Q Consensus 644 ~~~l---------------------~~~~~~~l~~~~~~~-i~~----------~ia~-aL~yLH~~-~~~~IvHrDLKp 689 (870)
...+ +.............. +.. .+.+ ...+|... ..+.++|+|+.|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 1111 100000111111000 000 0111 12222211 134678999999
Q ss_pred CCEEEcCCCcEEEEeccCCc
Q 002887 690 ANILLNEKFQAKLADFGLSR 709 (870)
Q Consensus 690 ~NILld~~~~vkL~DFGla~ 709 (870)
.||++++++ +.++||+.+.
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CcEEEcCCC-cEEEechhcC
Confidence 999999988 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=98.14 E-value=4e-06 Score=84.13 Aligned_cols=100 Identities=21% Similarity=0.265 Sum_probs=56.1
Q ss_pred EEeeccCCC--CccCCceeccCCC---CCcccccc-----ccccCCCCCCCCChHHhhhhceecCCCCCceEEeecccCC
Q 002887 204 VLRWDVGTP--LDIYDRIWWPDNF---KNVERIST-----SSNVNPATSLFQPPVTVMQSAIIPANGSSSFWFSWESVST 273 (870)
Q Consensus 204 ~~R~~~g~p--~D~~dR~W~~~~~---~~~~~~st-----~~~~~~~~~~~~~P~~v~~tA~~~~~~~~~l~~~w~~~~~ 273 (870)
+.|+|+|++ +|...+.|+++.. ..|.-..+ .............+..+|||+.... ..+.+..+ ..+
T Consensus 2 ~~~IN~Gg~~~~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~---~~f~Y~ip-~~~ 77 (174)
T PF11721_consen 2 VLRINAGGPAYTDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGP---SSFSYDIP-VVP 77 (174)
T ss_dssp EEEEEETSSSEEETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----S---SSEEEEEE---S
T ss_pred EEEEECCCCcccCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCC---CceEEEEe-cCC
Confidence 579999984 6899999998744 23310100 0011122223345789999999732 24555543 355
Q ss_pred cceEEEEEeeeccchhccc------ccceEEEEEECCccccC
Q 002887 274 VFKYYTCMYFSEFESEQAE------TRSREMNIYLNGRFWSE 309 (870)
Q Consensus 274 ~~~y~v~lhFae~~~~~~~------~~~R~F~i~~ng~~~~~ 309 (870)
+-.|-|.|||||+.. .. .++|+|||++||+.+.+
T Consensus 78 ~G~Y~V~L~FaE~~~--~~~~~~~~~G~RvFdV~v~g~~vl~ 117 (174)
T PF11721_consen 78 NGTYTVRLHFAELYF--GASGGASGPGQRVFDVYVNGETVLK 117 (174)
T ss_dssp -EEEEEEEEEE-SSS----------SSSS-EEEEETTEEEEE
T ss_pred CcEEEEEEEeccccc--cccccccCCCceEEEEEecceEEEe
Confidence 667999999999975 45 78999999999998764
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.03 E-value=1.2e-06 Score=94.44 Aligned_cols=79 Identities=32% Similarity=0.426 Sum_probs=62.7
Q ss_pred cEEEEEcCCCCCcccCccccc-ccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 410 RIISINLSSSGIAGDIVPYIF-SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 410 ~l~~l~L~~n~l~G~ip~~~~-~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
.+..|.++.|+|. .+|.++. +|.+|..|||..|++. ++|++++-|.+|+.||||+|.++ .+|.+++++ .++.|.+
T Consensus 229 ~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~l 304 (565)
T KOG0472|consen 229 LLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLAL 304 (565)
T ss_pred HHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhh
Confidence 4666777777777 7888866 7888888888888888 88888888888888888888888 678888887 6666554
Q ss_pred ccCCCC
Q 002887 489 SVDGNR 494 (870)
Q Consensus 489 ~~~~n~ 494 (870)
. |||
T Consensus 305 e--GNP 308 (565)
T KOG0472|consen 305 E--GNP 308 (565)
T ss_pred c--CCc
Confidence 3 775
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.00 E-value=2.7e-06 Score=95.94 Aligned_cols=139 Identities=22% Similarity=0.308 Sum_probs=79.8
Q ss_pred EEEEeccCcchhhHHHHHHHhhhh--chhcccCChhhHHHHHHHHhhc---CCCCCCCCCCCCCCCCCccceecCCCCCC
Q 002887 333 ISIMQTKNSSLAPILNALEIYQEK--EFLQLLTNQQDVDAIMKIKSKY---EVKRDWQGDPCAPKVYMWQGINCSYDANQ 407 (870)
Q Consensus 333 ~sl~~t~~s~lppilna~ei~~~~--~~~~~~~~~~d~~al~~~k~~~---~~~~~w~~~pC~~~~~~W~Gv~C~~~~~~ 407 (870)
+.|..|...-+|-.+.++.-+.-+ .+++..+.-.++..|-.+++.. +.+.+ +|-|- +-..
T Consensus 37 LkLnrt~L~~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKn-sGiP~--------------diF~ 101 (1255)
T KOG0444|consen 37 LKLNRTKLEQVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKN-SGIPT--------------DIFR 101 (1255)
T ss_pred EEechhhhhhChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhcccccc-CCCCc--------------hhcc
Confidence 456677777778777765443322 2344445555555555555432 22221 12221 1122
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccc-cCcCCCCeEEecCCcCCCCCCCcccccccCCcc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFL-AELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSL 486 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l 486 (870)
...++.|||++|+|. ..|..+-+-+++-.|+||+|++. +||..+ -+|+.|-+||||+|+|. .+|+.+..+..|++|
T Consensus 102 l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL 178 (1255)
T KOG0444|consen 102 LKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTL 178 (1255)
T ss_pred cccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhh
Confidence 345666777777776 66777777777777777777776 666654 46677777777777776 666666555555555
Q ss_pred ccc
Q 002887 487 SLS 489 (870)
Q Consensus 487 ~~~ 489 (870)
.++
T Consensus 179 ~Ls 181 (1255)
T KOG0444|consen 179 KLS 181 (1255)
T ss_pred hcC
Confidence 544
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.98 E-value=2.7e-06 Score=91.86 Aligned_cols=115 Identities=23% Similarity=0.288 Sum_probs=85.2
Q ss_pred cCChhhHHHHHHHHhhc---CCCCCCCCCCCCCCCCCccceecCCCCCCCCcEEEEEcCCCCCcccCcccccccCccccc
Q 002887 362 LTNQQDVDAIMKIKSKY---EVKRDWQGDPCAPKVYMWQGINCSYDANQSPRIISINLSSSGIAGDIVPYIFSLTSIESL 438 (870)
Q Consensus 362 ~~~~~d~~al~~~k~~~---~~~~~w~~~pC~~~~~~W~Gv~C~~~~~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L 438 (870)
.+.|+++.-+.++.... +...+|.+.-- | ..++++.|+|++|-|. .+|.+++.+..|+.|
T Consensus 401 ~elPk~L~~lkelvT~l~lsnn~isfv~~~l-----------~-----~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~L 463 (565)
T KOG0472|consen 401 CELPKRLVELKELVTDLVLSNNKISFVPLEL-----------S-----QLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTL 463 (565)
T ss_pred hhhhhhhHHHHHHHHHHHhhcCccccchHHH-----------H-----hhhcceeeecccchhh-hcchhhhhhhhhhee
Confidence 45556665555555543 22445554321 2 2468888999988887 899999999999999
Q ss_pred ccccCcCC----------------------CCCCcc-ccCcCCCCeEEecCCcCCCCCCCcccccccCCccccccCCCCC
Q 002887 439 DLSKNSLT----------------------GPVPEF-LAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSVDGNRN 495 (870)
Q Consensus 439 ~Ls~N~l~----------------------g~iP~~-~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~~~~n~~ 495 (870)
|||+|+|. |.+|.. +.+|.+|+.|||.+|.+. .||+.++++.+++.|.+. ||+.
T Consensus 464 nlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~--gNpf 540 (565)
T KOG0472|consen 464 NLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELD--GNPF 540 (565)
T ss_pred cccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEec--CCcc
Confidence 99988665 234444 888999999999999998 999999999999987776 7865
Q ss_pred C
Q 002887 496 L 496 (870)
Q Consensus 496 l 496 (870)
-
T Consensus 541 r 541 (565)
T KOG0472|consen 541 R 541 (565)
T ss_pred C
Confidence 4
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.98 E-value=7.2e-05 Score=78.03 Aligned_cols=142 Identities=18% Similarity=0.202 Sum_probs=85.6
Q ss_pred ccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhcccc--ceeEEEEEec---CCeEEEEEEEccCC
Q 002887 567 RVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKN--LTILVGYCDE---GANMGLIYEFMANG 641 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~~~~---~~~~~LV~Ey~~~g 641 (870)
+.|+.|..+.||+....+..+++|..... .....+.+|..++..+.... +.+++.++.. ....+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 46889999999999998889999997655 44567788999998886443 4566664422 23468999999998
Q ss_pred chhh----------------hhh---hc--ccccccHHH---------HHHH------------HHHHHH-HHHHHHh--
Q 002887 642 NLQA----------------HLL---ED--KADTLCWER---------RLQI------------ASESAQ-GLEYLHN-- 676 (870)
Q Consensus 642 sL~~----------------~l~---~~--~~~~l~~~~---------~~~i------------~~~ia~-aL~yLH~-- 676 (870)
.+.. .+. .. ....+.+.. .... ...+.+ .+..+++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 7776 111 10 000011100 0000 112222 3333332
Q ss_pred --CCCCCceeCCCCCCCEEEc-CCCcEEEEeccCCcc
Q 002887 677 --GCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRI 710 (870)
Q Consensus 677 --~~~~~IvHrDLKp~NILld-~~~~vkL~DFGla~~ 710 (870)
.....++|+|+.++||+++ +++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2345799999999999999 666778999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=97.95 E-value=3.4e-06 Score=68.96 Aligned_cols=58 Identities=40% Similarity=0.489 Sum_probs=51.1
Q ss_pred CcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccccc
Q 002887 433 TSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSV 490 (870)
Q Consensus 433 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~~ 490 (870)
++|++|+|++|+|+..-+..|..+++|+.|+|++|+++...|..+..+++++.|+++.
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~ 58 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSN 58 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETS
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcC
Confidence 4799999999999954456889999999999999999977778899999999988873
|
... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00011 Score=77.91 Aligned_cols=138 Identities=17% Similarity=0.126 Sum_probs=85.9
Q ss_pred ccccCc-EEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhc-cccceeEEEEEecCCeEEEEEEEccCCchhhh
Q 002887 569 LGKGGF-GTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAH-HKNLTILVGYCDEGANMGLIYEFMANGNLQAH 646 (870)
Q Consensus 569 LG~G~f-G~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~ 646 (870)
|-.|.. ..||+....+..+.||+..... .....+|+++++.+. +--+.+++++....+..++|||+++|.++...
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 334444 7899998777788888876543 345678999998884 43455777777766678899999999877643
Q ss_pred hh-------------------hcccc--ccc--HHHHHHHHH--------------------HHHHHHHHHHhC----CC
Q 002887 647 LL-------------------EDKAD--TLC--WERRLQIAS--------------------ESAQGLEYLHNG----CK 679 (870)
Q Consensus 647 l~-------------------~~~~~--~l~--~~~~~~i~~--------------------~ia~aL~yLH~~----~~ 679 (870)
.. ..... .+. ....+.... .+...+..|-.. ..
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 21 00000 000 000010000 011112222111 13
Q ss_pred CCceeCCCCCCCEEEcCCCcEEEEeccCCc
Q 002887 680 PPIVHRDVKSANILLNEKFQAKLADFGLSR 709 (870)
Q Consensus 680 ~~IvHrDLKp~NILld~~~~vkL~DFGla~ 709 (870)
+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 468999999999999998778999999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00012 Score=75.04 Aligned_cols=129 Identities=14% Similarity=0.109 Sum_probs=85.0
Q ss_pred ccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHH---------HHHHHHHHHhccc---cceeEEEEE-----ecCC
Q 002887 567 RVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQF---------QAEVELLIRAHHK---NLTILVGYC-----DEGA 629 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f---------~~Ei~~l~~l~H~---nIv~l~g~~-----~~~~ 629 (870)
+++-......|.+-..+++..++|..+......++.| .+++..+.+++.. ....++... .-..
T Consensus 37 kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~ 116 (229)
T PF06176_consen 37 KVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTS 116 (229)
T ss_pred EeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeecccee
Confidence 4555556666777777789999998876543333332 2334444444322 222222222 2234
Q ss_pred eEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCc
Q 002887 630 NMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 709 (870)
Q Consensus 630 ~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~ 709 (870)
..+++|||++|..|.+... ++. .++..+++++.-||+. |+.|+|.+|+|++++++ .++++||+..+
T Consensus 117 ~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred EEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEEECcccc
Confidence 5678999999988766431 221 3556677889999998 99999999999999966 49999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.86 E-value=8.4e-06 Score=61.81 Aligned_cols=37 Identities=43% Similarity=0.652 Sum_probs=29.9
Q ss_pred CcccccccccCcCCCCCCccccCcCCCCeEEecCCcCC
Q 002887 433 TSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQ 470 (870)
Q Consensus 433 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~ 470 (870)
++|++|+|++|+|+ .||..|++|++|+.|+|++|+++
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 46888888888888 78887888888999999888887
|
... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00014 Score=84.33 Aligned_cols=156 Identities=20% Similarity=0.236 Sum_probs=96.7
Q ss_pred ccccCHHHHHHHHh------------hcc-ccccccCcEEEEEEEEC-CeeEEEEEeeccchhh----------------
Q 002887 550 NRKFSYFDVLKITN------------NFE-RVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQG---------------- 599 (870)
Q Consensus 550 ~~~~~~~dl~~~t~------------~f~-~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~---------------- 599 (870)
...++++|+.++-. .|+ +.||.-+.|.||+|++. |+.||||+-+..-...
T Consensus 137 ~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~ 216 (538)
T KOG1235|consen 137 APPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQ 216 (538)
T ss_pred CCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHH
Confidence 34556666555432 343 68999999999999997 8889999975421100
Q ss_pred ---------------hH------HHHHHHHHHHH----hccccc---eeEEEEE-ecCCeEEEEEEEccCCchhhhhhhc
Q 002887 600 ---------------YK------QFQAEVELLIR----AHHKNL---TILVGYC-DEGANMGLIYEFMANGNLQAHLLED 650 (870)
Q Consensus 600 ---------------~~------~f~~Ei~~l~~----l~H~nI---v~l~g~~-~~~~~~~LV~Ey~~~gsL~~~l~~~ 650 (870)
.+ .|.+|.+-..+ ++|-+. |.+=..+ .-.....|+||||+|..+.+.-.-
T Consensus 217 k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i- 295 (538)
T KOG1235|consen 217 KFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI- 295 (538)
T ss_pred HhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH-
Confidence 00 14444443333 345551 1122222 223568999999999888764321
Q ss_pred ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC----CCcEEEEeccCCccc
Q 002887 651 KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE----KFQAKLADFGLSRIF 711 (870)
Q Consensus 651 ~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~----~~~vkL~DFGla~~~ 711 (870)
....++... |+..+.++ |+++-...|.+|+|=+|.||+++. ++++.+-|||+...+
T Consensus 296 ~~~gi~~~~---i~~~l~~~--~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 296 DKRGISPHD---ILNKLVEA--YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HHcCCCHHH---HHHHHHHH--HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 223444443 33333332 333333348999999999999994 678999999998865
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.82 E-value=7.8e-06 Score=96.72 Aligned_cols=144 Identities=25% Similarity=0.290 Sum_probs=73.1
Q ss_pred EEEEEeccCcchhhH--------HHHHHHhhhhchhcccCChhhHHHHHHHHhhcCCCCCCCCCCCCCCCCCccceecCC
Q 002887 332 VISIMQTKNSSLAPI--------LNALEIYQEKEFLQLLTNQQDVDAIMKIKSKYEVKRDWQGDPCAPKVYMWQGINCSY 403 (870)
Q Consensus 332 ~~sl~~t~~s~lppi--------lna~ei~~~~~~~~~~~~~~d~~al~~~k~~~~~~~~w~~~pC~~~~~~W~Gv~C~~ 403 (870)
++.|.++....+|+. ++++++.......-....+.-..+|+.|.-.-+.+ +|.| |.-+.|.
T Consensus 314 tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~L----td~c------~p~l~~~- 382 (1081)
T KOG0618|consen 314 TLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHL----TDSC------FPVLVNF- 382 (1081)
T ss_pred eeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcc----cccc------hhhhccc-
Confidence 456667777777653 23333321111111123333344444444333322 5667 4444443
Q ss_pred CCCCCCcEEEEEcCCCCCcccCccc-ccccCcccccccccCcCCCCCCcc----------------------ccCcCCCC
Q 002887 404 DANQSPRIISINLSSSGIAGDIVPY-IFSLTSIESLDLSKNSLTGPVPEF----------------------LAELQSLR 460 (870)
Q Consensus 404 ~~~~~~~l~~l~L~~n~l~G~ip~~-~~~l~~L~~L~Ls~N~l~g~iP~~----------------------~~~l~~L~ 460 (870)
.+++.|+|++|.|. ++|.+ +.+|..|+.|+||+|.|+ .||++ +.+++.|+
T Consensus 383 -----~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fPe~~~l~qL~ 455 (1081)
T KOG0618|consen 383 -----KHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFPELAQLPQLK 455 (1081)
T ss_pred -----cceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeechhhhhcCcce
Confidence 36777777777776 55554 666667777777777666 45544 45555555
Q ss_pred eEEecCCcCCCCCCCcccccccCCccccccCCCCC
Q 002887 461 VLNLSGNNLQGSLPSGLSEKVKNGSLSLSVDGNRN 495 (870)
Q Consensus 461 ~L~ls~N~l~g~ip~~l~~~~~~~~l~~~~~~n~~ 495 (870)
.+|||.|+|+-..-......++|+.|+++ ||..
T Consensus 456 ~lDlS~N~L~~~~l~~~~p~p~LkyLdlS--GN~~ 488 (1081)
T KOG0618|consen 456 VLDLSCNNLSEVTLPEALPSPNLKYLDLS--GNTR 488 (1081)
T ss_pred EEecccchhhhhhhhhhCCCcccceeecc--CCcc
Confidence 56666665552221111122455555554 6653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00017 Score=70.86 Aligned_cols=128 Identities=19% Similarity=0.171 Sum_probs=89.2
Q ss_pred cccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCchhh
Q 002887 566 ERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQA 645 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~ 645 (870)
.+.||+|++|.||+|.+.+..+|+|+-+..+ ....++.|+++|..++-.++.+=+-.+.+. .+.|||..|-.|.+
T Consensus 27 ~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~---~i~me~i~G~~L~~ 101 (201)
T COG2112 27 EKELAKGTTSVVYLGEWRGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED---FIRMEYIDGRPLGK 101 (201)
T ss_pred hhhhhcccccEEEEeeccCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh---hhhhhhhcCcchhh
Confidence 3679999999999999999999999977654 357789999999999887776555444332 24499999888776
Q ss_pred hhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCC-CCEEEcCCCcEEEEeccCCcc
Q 002887 646 HLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKS-ANILLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 646 ~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp-~NILld~~~~vkL~DFGla~~ 710 (870)
+-... +-.+. ..++++---|-.. +|-|+.|.- ..++|-.+..+.|+||..|+.
T Consensus 102 ~~~~~-----~rk~l----~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 102 LEIGG-----DRKHL----LRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhcc-----cHHHH----HHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 54321 12222 2334442333333 888998864 444444444999999998874
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.79 E-value=8.9e-05 Score=75.35 Aligned_cols=104 Identities=24% Similarity=0.230 Sum_probs=83.2
Q ss_pred HHHHHHHHHhcc-ccceeEEEEEecCCeEEEEEEEccCCchhhhhhh-cccccccHHHHHHHHHHHHHHHHHHHhCCCCC
Q 002887 604 QAEVELLIRAHH-KNLTILVGYCDEGANMGLIYEFMANGNLQAHLLE-DKADTLCWERRLQIASESAQGLEYLHNGCKPP 681 (870)
Q Consensus 604 ~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 681 (870)
..|.-++..+++ +++.+++|+|.. +++.||...+++...-.. .+-...+|..|.+||.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468888888876 699999999954 689999998766421000 01124689999999999999999999865556
Q ss_pred ceeCCCCCCCEEEcCCCcEEEEeccCCccc
Q 002887 682 IVHRDVKSANILLNEKFQAKLADFGLSRIF 711 (870)
Q Consensus 682 IvHrDLKp~NILld~~~~vkL~DFGla~~~ 711 (870)
+.-.|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=97.79 E-value=1.4e-05 Score=79.83 Aligned_cols=80 Identities=33% Similarity=0.425 Sum_probs=34.2
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccc-cCcCCCCeEEecCCcCCCCCC--CcccccccCCc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFL-AELQSLRVLNLSGNNLQGSLP--SGLSEKVKNGS 485 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~l~~L~~L~ls~N~l~g~ip--~~l~~~~~~~~ 485 (870)
.+++.|+|++|+|+ .|+ .+..|++|+.|+|++|+++ .|++.+ ..+++|+.|+|++|++.. +- ..+..+++|..
T Consensus 42 ~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~-l~~l~~L~~l~~L~~ 117 (175)
T PF14580_consen 42 DKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISD-LNELEPLSSLPKLRV 117 (175)
T ss_dssp TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---S-CCCCGGGGG-TT--E
T ss_pred cCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCC-hHHhHHHHcCCCcce
Confidence 47888999999998 554 5788899999999999998 566555 468999999999999873 22 24555666666
Q ss_pred cccccCCCC
Q 002887 486 LSLSVDGNR 494 (870)
Q Consensus 486 l~~~~~~n~ 494 (870)
|++. |||
T Consensus 118 L~L~--~NP 124 (175)
T PF14580_consen 118 LSLE--GNP 124 (175)
T ss_dssp EE-T--T-G
T ss_pred eecc--CCc
Confidence 5554 665
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.76 E-value=7.3e-06 Score=93.71 Aligned_cols=180 Identities=22% Similarity=0.215 Sum_probs=131.4
Q ss_pred cccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhcccc-ceeEEEEEecCCeEEEEEEEccCC-chh
Q 002887 568 VLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKN-LTILVGYCDEGANMGLIYEFMANG-NLQ 644 (870)
Q Consensus 568 ~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~LV~Ey~~~g-sL~ 644 (870)
-.++|++++++|.+-. .+....+.+... ....-++++|.+++||| .+..++-+..+....++++++.++ +..
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 4688999999998765 333334444332 44567889999999999 777777777778888999999877 221
Q ss_pred hhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccccc
Q 002887 645 AHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVV 724 (870)
Q Consensus 645 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 724 (870)
... ......+...+...+.+.-++++++||+. .=+||| ||+..+ +..|..||+....+.+.. ......
T Consensus 324 ~~~-~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~ 391 (829)
T KOG0576|consen 324 LEM-TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAI 391 (829)
T ss_pred ccC-ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc---ccccCC
Confidence 111 01112334445566777888999999976 458898 777766 588999999887664322 345668
Q ss_pred CCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCC
Q 002887 725 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQ 764 (870)
Q Consensus 725 gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~ 764 (870)
+++.++|||+.....+..+.|+|+.|+--.+|--|-+|-.
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 9999999999999999999999999987777777776643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00063 Score=70.71 Aligned_cols=135 Identities=19% Similarity=0.205 Sum_probs=90.4
Q ss_pred ccccccCcEEEEEEEEC-CeeEEEEEeeccchhh---------hHH---------------HHHHHHHHHHhc--cccce
Q 002887 567 RVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQG---------YKQ---------------FQAEVELLIRAH--HKNLT 619 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~---------~~~---------------f~~Ei~~l~~l~--H~nIv 619 (870)
-.|+.|.-+.||+|.-. +..+|||+.+...... ... ..+|+.-|.++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 36778888899999865 8899999986542211 011 245666777763 23334
Q ss_pred eEEEEEecCCeEEEEEEEccCC-chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC
Q 002887 620 ILVGYCDEGANMGLIYEFMANG-NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF 698 (870)
Q Consensus 620 ~l~g~~~~~~~~~LV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~ 698 (870)
+.+++.. -.|||||+... .-.-.|.+ -.+.......+..++++.+.-|-.. .++||+||..-|||+. ++
T Consensus 134 ~Pi~~~~----nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 134 EPIAFRN----NVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DG 203 (268)
T ss_pred CceeecC----CeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CC
Confidence 4444443 36999999654 22222211 1222335667778888888888763 2999999999999999 78
Q ss_pred cEEEEeccCCccc
Q 002887 699 QAKLADFGLSRIF 711 (870)
Q Consensus 699 ~vkL~DFGla~~~ 711 (870)
.+.++|+|-+...
T Consensus 204 ~p~iID~~QaV~~ 216 (268)
T COG1718 204 EPYIIDVSQAVTI 216 (268)
T ss_pred eEEEEECcccccc
Confidence 9999999988644
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00077 Score=84.16 Aligned_cols=144 Identities=15% Similarity=0.249 Sum_probs=91.0
Q ss_pred ccccccCcEEEEEEEECC----eeEEEEEeeccc-hhhhHHHHHHHHHHHHhc-cccc--eeEEEEEecC---CeEEEEE
Q 002887 567 RVLGKGGFGTVYHGYLDD----KQVAVKMLSSSS-VQGYKQFQAEVELLIRAH-HKNL--TILVGYCDEG---ANMGLIY 635 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~----~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-H~nI--v~l~g~~~~~---~~~~LV~ 635 (870)
+.++.|.++.+|+....+ ..+++|+..... ......+.+|+++++.+. |.++ .+++.+|.+. ...++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 468999999999987763 467777765432 223356889999999995 6665 7788888664 4578999
Q ss_pred EEccCCchhhh-----------------------hhhcccc---------cccH--HHHHHH---------------HHH
Q 002887 636 EFMANGNLQAH-----------------------LLEDKAD---------TLCW--ERRLQI---------------ASE 666 (870)
Q Consensus 636 Ey~~~gsL~~~-----------------------l~~~~~~---------~l~~--~~~~~i---------------~~~ 666 (870)
||+++..+.+. |+..... +..+ .+...+ ...
T Consensus 124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~ 203 (822)
T PLN02876 124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK 203 (822)
T ss_pred EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence 99998653321 1100000 0011 011110 112
Q ss_pred HHHHHHHHHhCCC--------CCceeCCCCCCCEEEcC-CCc-EEEEeccCCcc
Q 002887 667 SAQGLEYLHNGCK--------PPIVHRDVKSANILLNE-KFQ-AKLADFGLSRI 710 (870)
Q Consensus 667 ia~aL~yLH~~~~--------~~IvHrDLKp~NILld~-~~~-vkL~DFGla~~ 710 (870)
+.+.+.+|..+.. +.++|+|+++.||+++. +.+ +-|.||.++..
T Consensus 204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 3344567754321 35999999999999985 334 57999999875
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0012 Score=72.37 Aligned_cols=75 Identities=12% Similarity=0.035 Sum_probs=56.9
Q ss_pred ccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhcc---ccceeEEEEEec---CCeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHH---KNLTILVGYCDE---GANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H---~nIv~l~g~~~~---~~~~~LV~Ey~~~ 640 (870)
+.||+|..+.||+....+..+.+|..+.. .....|..|.+.|+.+.. -.+.++++.|.. .+..++|||++++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGNPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCCEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 57999999999998876556777774431 123578999999999853 357788888754 3568999999998
Q ss_pred Cch
Q 002887 641 GNL 643 (870)
Q Consensus 641 gsL 643 (870)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00064 Score=76.01 Aligned_cols=150 Identities=13% Similarity=0.202 Sum_probs=92.3
Q ss_pred cEEeccCCCC-CCccccCCCceEEecC---CCccccCcceeeC---CCCcccccccccccccccCcCcccceec--CCCC
Q 002887 29 FISIDCGIPE-NENYADKVTGINYVSD---APYVDTAVSHSIS---PEYSKETVERQFSYLRSFPEGIRNCYTL--RPPN 99 (870)
Q Consensus 29 ~~~idCG~~~-~~~~~~~~~~~~~~~D---~~~~~~g~~~~~~---~~~~~~~~~~~~~t~R~Fp~g~~ncY~l--~~~~ 99 (870)
+..+|||+.. ...|.||.-.|.|.+. .+...-..+..|. ...........|+|.|.-.....+ ++| ..+.
T Consensus 180 ~~R~n~G~~~~~iryp~D~~dR~W~~~~~~~~~~~ist~~~i~~~~~~~~~~~P~~V~~TA~~~~~~s~~-~nltw~~~~ 258 (347)
T PF12819_consen 180 VYRLNVGGSSSFIRYPDDTYDRIWQPYSSSPGWSNISTTSNININSSNNPYDAPSAVYQTARTPSNSSDP-LNLTWSFVD 258 (347)
T ss_pred EEeecCCCcccccCCCCCcceeeccccccCccccccccceeeecccCCccCcChHHHHHhhhcccccccc-eEEEeccCC
Confidence 5679999643 2778889999999963 2232222222332 111123446778899888766422 444 3467
Q ss_pred CCccEEEEeeee--eccCCCCCCCCceEEEEcceeeEE-EEcCCCc---cceeEEEEE-ecCCCceEEEEeecCCC--Cc
Q 002887 100 GDVKFLIRARFM--YGNYDGLDKAPSFDLMLGADAWDS-VQLQDPR---SIITKEIIH-MPNKDYIHVCLVNTDSG--IP 170 (870)
Q Consensus 100 ~~~~ylvR~~f~--ygnyd~~~~~p~Fd~~~~~~~w~~-v~~~~~~---~~~~~e~~~-~~~~~~~~vcl~~t~~~--~p 170 (870)
++-.|+||.||- -..-.+ ...-.||++++|..|.. +...... .+++...++ +..+..+.|.|.++... .|
T Consensus 259 ~~~~y~v~lHFaEi~~~~~~-~~~R~F~IyiN~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~isL~~t~~S~lpp 337 (347)
T PF12819_consen 259 PGFSYYVRLHFAEIQSLSPN-NNQREFDIYINGQTAYSDVSPPYLGADTVPYYSDYVVNVPDSGFLNISLGPTPDSTLPP 337 (347)
T ss_pred CCccEEEEEEEeecccccCC-CCeEEEEEEECCeEccCccCcccccCcceEeecceEEEecCCCEEEEEEEeCCCCCcCc
Confidence 788999999992 211111 11357999999999873 3221111 112334444 44456799999999655 49
Q ss_pred eeeeeeeeec
Q 002887 171 FISALELRPL 180 (870)
Q Consensus 171 fis~lEl~~l 180 (870)
+|||+|+..+
T Consensus 338 iLNalEIy~v 347 (347)
T PF12819_consen 338 ILNALEIYKV 347 (347)
T ss_pred eeEeeeeEeC
Confidence 9999999753
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.50 E-value=1.1e-05 Score=91.28 Aligned_cols=78 Identities=28% Similarity=0.391 Sum_probs=48.7
Q ss_pred cEEEEEcCCCCCcccCcccccccCcccccccccCcCCC-CCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 410 RIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTG-PVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 410 ~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g-~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
++.+|+|+.|+|+ .+|..+..|+.|+.|++.+|+|+= -||..+|.|..|+.+.+++|+|. -+|++++.+.+|+.|.+
T Consensus 269 ~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L 346 (1255)
T KOG0444|consen 269 NLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKL 346 (1255)
T ss_pred hhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcc
Confidence 4556677777776 666666666666666666666542 25666666666666666666665 56666666655555544
Q ss_pred c
Q 002887 489 S 489 (870)
Q Consensus 489 ~ 489 (870)
+
T Consensus 347 ~ 347 (1255)
T KOG0444|consen 347 D 347 (1255)
T ss_pred c
Confidence 3
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=97.50 E-value=3.7e-05 Score=76.79 Aligned_cols=77 Identities=32% Similarity=0.430 Sum_probs=27.2
Q ss_pred CcEEEEEcCCCCCcccCccccc-ccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCccc-ccccCCcc
Q 002887 409 PRIISINLSSSGIAGDIVPYIF-SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLS-EKVKNGSL 486 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~-~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~-~~~~~~~l 486 (870)
.+++.|+|.+|+|+ .| ..++ .|++|+.||||+|.++ .|+ .+..|+.|+.|+|++|+++ .+++.+. .+++|..|
T Consensus 19 ~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 19 VKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL 93 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred cccccccccccccc-cc-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence 47889999999998 55 3576 6899999999999999 565 4788999999999999999 6765553 57889988
Q ss_pred cccc
Q 002887 487 SLSV 490 (870)
Q Consensus 487 ~~~~ 490 (870)
.++.
T Consensus 94 ~L~~ 97 (175)
T PF14580_consen 94 YLSN 97 (175)
T ss_dssp E-TT
T ss_pred ECcC
Confidence 8863
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=97.47 E-value=3.8e-05 Score=93.09 Aligned_cols=71 Identities=21% Similarity=0.309 Sum_probs=36.4
Q ss_pred cEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccccc
Q 002887 410 RIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLS 489 (870)
Q Consensus 410 ~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~ 489 (870)
.+..|+|++|.|+ .+|... ++|+.|+|++|+|+ .||..+ .+|+.|+|++|+|+ .||..++.+.++..|+++
T Consensus 383 ~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs 453 (788)
T PRK15387 383 GLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 453 (788)
T ss_pred ccceEEecCCccc-CCCCcc---cCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence 4555566666655 244322 34555555555555 255422 34455555555555 555555555555544443
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00095 Score=71.39 Aligned_cols=138 Identities=14% Similarity=0.047 Sum_probs=81.2
Q ss_pred cccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhccccce-eEEEEEecCCeEEEEEEEccCCchhhh
Q 002887 568 VLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLT-ILVGYCDEGANMGLIYEFMANGNLQAH 646 (870)
Q Consensus 568 ~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~LV~Ey~~~gsL~~~ 646 (870)
.+..|-.+.+|+....++.+++|..........-...+|.++++.+....++ ++++.+. ..+||||++|..+...
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 3566888899998877888889876543222112357899999998654443 3444432 3689999998765421
Q ss_pred -----------------hhhcc--cccccHHHH-HHHHHH---------HHHHHHHHHhC-----CCCCceeCCCCCCCE
Q 002887 647 -----------------LLEDK--ADTLCWERR-LQIASE---------SAQGLEYLHNG-----CKPPIVHRDVKSANI 692 (870)
Q Consensus 647 -----------------l~~~~--~~~l~~~~~-~~i~~~---------ia~aL~yLH~~-----~~~~IvHrDLKp~NI 692 (870)
++... ...++...+ .....+ +.+.+..+... ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 11100 011222111 111111 11112222211 123589999999999
Q ss_pred EEcCCCcEEEEeccCCcc
Q 002887 693 LLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 693 Lld~~~~vkL~DFGla~~ 710 (870)
++++++ +.++||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999988753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0016 Score=66.20 Aligned_cols=124 Identities=26% Similarity=0.339 Sum_probs=88.3
Q ss_pred HhhccccccccCc-EEEEEEEECCeeEEEEEeec---cch------------------hhhHHHHHHHHHHHHhc---cc
Q 002887 562 TNNFERVLGKGGF-GTVYHGYLDDKQVAVKMLSS---SSV------------------QGYKQFQAEVELLIRAH---HK 616 (870)
Q Consensus 562 t~~f~~~LG~G~f-G~Vy~~~~~~~~vAVK~l~~---~~~------------------~~~~~f~~Ei~~l~~l~---H~ 616 (870)
..+|.+.||.|.. |.||+++..|+.+|+|++.. ... .-...|..|+....+++ +.
T Consensus 38 ~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e 117 (207)
T PF13095_consen 38 DIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGRE 117 (207)
T ss_pred cEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcccc
Confidence 3456689999999 99999999999999999432 000 11235888999888884 44
Q ss_pred cc--eeEEEEEecC------------------CeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHh
Q 002887 617 NL--TILVGYCDEG------------------ANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN 676 (870)
Q Consensus 617 nI--v~l~g~~~~~------------------~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~ 676 (870)
++ |+.+||..-. ....+|.||.+... .+. .+-+.+|.+-|..+|.
T Consensus 118 ~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 118 GLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKILHK 182 (207)
T ss_pred CceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHHHHH
Confidence 55 8889987221 12457888776532 111 2335566777888998
Q ss_pred CCCCCceeCCCCCCCEEEcCCCcEEEEeccCC
Q 002887 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLS 708 (870)
Q Consensus 677 ~~~~~IvHrDLKp~NILld~~~~vkL~DFGla 708 (870)
. +|+-+|+|+.|.. .-||+|||.+
T Consensus 183 ~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 183 L---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred C---CeeeccCcccccc-----CCEEEecccC
Confidence 7 9999999999975 4589999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0012 Score=69.70 Aligned_cols=73 Identities=15% Similarity=0.208 Sum_probs=45.5
Q ss_pred ccccccCcE-EEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhccc---cceeEEEEEecC---CeEEEEEEEcc
Q 002887 567 RVLGKGGFG-TVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHK---NLTILVGYCDEG---ANMGLIYEFMA 639 (870)
Q Consensus 567 ~~LG~G~fG-~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~---nIv~l~g~~~~~---~~~~LV~Ey~~ 639 (870)
+.|+.|+.. .||+. +..+++|..+... ....+.+|.+++..+... .+.+.++..... ...+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 356766665 58875 3456677654422 235788999999888532 233444444332 23478999999
Q ss_pred CCchh
Q 002887 640 NGNLQ 644 (870)
Q Consensus 640 ~gsL~ 644 (870)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 87764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0026 Score=65.03 Aligned_cols=132 Identities=21% Similarity=0.353 Sum_probs=91.8
Q ss_pred ccccccCcEEEEEEEECCeeEEEEEeeccc----------------hhhhHHHHHHHHHHHHhc------cccceeEEEE
Q 002887 567 RVLGKGGFGTVYHGYLDDKQVAVKMLSSSS----------------VQGYKQFQAEVELLIRAH------HKNLTILVGY 624 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~----------------~~~~~~f~~Ei~~l~~l~------H~nIv~l~g~ 624 (870)
..||+|+.-.||.--. +...+||+..... ....++..+|+.-...+. +..|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 5799999999986422 4456788887655 223566777887777666 7889999999
Q ss_pred EecCCeEEEEEEEccC--C----chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC
Q 002887 625 CDEGANMGLIYEFMAN--G----NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF 698 (870)
Q Consensus 625 ~~~~~~~~LV~Ey~~~--g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~ 698 (870)
........+|+|.+.+ | +|.+++.+ ..++. ... ..+-+-..||-+. +|+.+|++|+||++....
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~---~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-ELR---QALDEFKRYLLDH---HIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-HHH---HHHHHHHHHHHHc---CCeecCCCcccEEEEecC
Confidence 9999999999998754 3 45555532 23444 222 3333445667666 899999999999996432
Q ss_pred ----cEEEEe-ccCCc
Q 002887 699 ----QAKLAD-FGLSR 709 (870)
Q Consensus 699 ----~vkL~D-FGla~ 709 (870)
.+.|+| ||...
T Consensus 156 ~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 156 SGEFRLVLIDGLGEKE 171 (199)
T ss_pred CCceEEEEEeCCCCcc
Confidence 577777 45443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0021 Score=67.68 Aligned_cols=73 Identities=18% Similarity=0.203 Sum_probs=48.5
Q ss_pred ccccccCcEEEEEEEEC---CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccce-eEEEEEecCCeEEEEEEEccCCc
Q 002887 567 RVLGKGGFGTVYHGYLD---DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLT-ILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~---~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
+.|..|-...+|+.... ++.+++|+...... ......+|+.++..+....++ ++++.+. ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 45778888999998865 46788887654322 122335789999998544444 4444333 248999999876
Q ss_pred hh
Q 002887 643 LQ 644 (870)
Q Consensus 643 L~ 644 (870)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 53
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.39 E-value=2.5e-05 Score=72.95 Aligned_cols=78 Identities=28% Similarity=0.361 Sum_probs=66.8
Q ss_pred CCcEEEEEcCCCCCcccCccccccc-CcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSL-TSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSL 486 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l-~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l 486 (870)
..+++.++|++|+|. .+|+.|... +.++.|+|++|.|+ .+|.++..++.|+.|++++|.|. ..|.-+..+.++..|
T Consensus 52 ~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~L 128 (177)
T KOG4579|consen 52 GYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDML 128 (177)
T ss_pred CceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHh
Confidence 347899999999999 778777665 58999999999999 89999999999999999999998 778888777766655
Q ss_pred cc
Q 002887 487 SL 488 (870)
Q Consensus 487 ~~ 488 (870)
+.
T Consensus 129 ds 130 (177)
T KOG4579|consen 129 DS 130 (177)
T ss_pred cC
Confidence 43
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.00044 Score=84.33 Aligned_cols=43 Identities=7% Similarity=0.009 Sum_probs=29.3
Q ss_pred HHHHhhhhchhcccCChhhHHHHHHHHhhcC---C----CCCCCC--CCCCC
Q 002887 349 ALEIYQEKEFLQLLTNQQDVDAIMKIKSKYE---V----KRDWQG--DPCAP 391 (870)
Q Consensus 349 a~ei~~~~~~~~~~~~~~d~~al~~~k~~~~---~----~~~w~~--~pC~~ 391 (870)
|++....+=+...+|.+.++..+.++.+.+. . ...|+| +.|.-
T Consensus 46 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~ 97 (754)
T PRK15370 46 AQNCIAYLCHPPETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCIL 97 (754)
T ss_pred HHHHHHHHhCCCCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCccccc
Confidence 4444444445667899999999999998762 2 345876 57853
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00015 Score=54.64 Aligned_cols=33 Identities=36% Similarity=0.947 Sum_probs=24.5
Q ss_pred hhhHHHHHHHHhhcC-----CCCCCCC----CCCCCCCCCccceecC
Q 002887 365 QQDVDAIMKIKSKYE-----VKRDWQG----DPCAPKVYMWQGINCS 402 (870)
Q Consensus 365 ~~d~~al~~~k~~~~-----~~~~w~~----~pC~~~~~~W~Gv~C~ 402 (870)
++|++||++||+++. .+.+|+. +|| +|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C-----~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC-----SWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC-----CSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCe-----eeccEEeC
Confidence 579999999999874 3679963 566 79999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.00011 Score=55.77 Aligned_cols=36 Identities=31% Similarity=0.587 Sum_probs=32.5
Q ss_pred cEEEEEcCCCCCcccCcccccccCcccccccccCcCC
Q 002887 410 RIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLT 446 (870)
Q Consensus 410 ~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~ 446 (870)
.++.|+|++|+|+ .||++|++|++|+.|+|++|+++
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 6789999999999 79999999999999999999998
|
... |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.33 E-value=7.7e-05 Score=80.89 Aligned_cols=91 Identities=21% Similarity=0.259 Sum_probs=80.2
Q ss_pred CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCc
Q 002887 406 NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGS 485 (870)
Q Consensus 406 ~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~ 485 (870)
...++++.|+|++|.|++.=+..|..+..|+.|.|..|+|.-.--..|.+|..|+.|+|.+|+++-.-|-.+-.+..++.
T Consensus 271 ~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~ 350 (498)
T KOG4237|consen 271 KKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLST 350 (498)
T ss_pred hhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeee
Confidence 35789999999999999999999999999999999999998444556788999999999999999888888888888888
Q ss_pred cccccCCCCCCCC
Q 002887 486 LSLSVDGNRNLCP 498 (870)
Q Consensus 486 l~~~~~~n~~lc~ 498 (870)
|.+- +|+..|.
T Consensus 351 l~l~--~Np~~Cn 361 (498)
T KOG4237|consen 351 LNLL--SNPFNCN 361 (498)
T ss_pred eehc--cCcccCc
Confidence 7765 8888876
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.28 E-value=7.9e-05 Score=84.21 Aligned_cols=83 Identities=25% Similarity=0.288 Sum_probs=72.5
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
..+..|+|..|+++-.--..+.+|+.|+.|+||+|.+...=++.+.-.++|+.||||+|+++---|.++..+..|..|.+
T Consensus 269 ~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL 348 (873)
T KOG4194|consen 269 EKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL 348 (873)
T ss_pred cccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence 37889999999999777778999999999999999999877999999999999999999999666677888888887777
Q ss_pred ccC
Q 002887 489 SVD 491 (870)
Q Consensus 489 ~~~ 491 (870)
+.|
T Consensus 349 s~N 351 (873)
T KOG4194|consen 349 SHN 351 (873)
T ss_pred ccc
Confidence 643
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.00021 Score=80.87 Aligned_cols=85 Identities=25% Similarity=0.330 Sum_probs=75.7
Q ss_pred CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCc
Q 002887 406 NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGS 485 (870)
Q Consensus 406 ~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~ 485 (870)
..++.+..|+|++|.|+-.=+..|-+|.+|+.++|.+|.|+ .||.+.....+|+.|+|.+|.++..-.++|..++.+++
T Consensus 75 ~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrs 153 (873)
T KOG4194|consen 75 FLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRS 153 (873)
T ss_pred cCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhh
Confidence 45567789999999999888888999999999999999999 99998777788999999999999666778999999999
Q ss_pred cccccC
Q 002887 486 LSLSVD 491 (870)
Q Consensus 486 l~~~~~ 491 (870)
|++|-|
T Consensus 154 lDLSrN 159 (873)
T KOG4194|consen 154 LDLSRN 159 (873)
T ss_pred hhhhhc
Confidence 998844
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.23 E-value=8.6e-05 Score=80.53 Aligned_cols=85 Identities=31% Similarity=0.475 Sum_probs=68.4
Q ss_pred eecCCCC------CCCCcEEEEEcCCCCCcccCcc-cccccCcccccccccCcCCCCCCccccCcCCCCeEEecC-CcCC
Q 002887 399 INCSYDA------NQSPRIISINLSSSGIAGDIVP-YIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG-NNLQ 470 (870)
Q Consensus 399 v~C~~~~------~~~~~l~~l~L~~n~l~G~ip~-~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~-N~l~ 470 (870)
|+|+..+ +.++..+.|.|..|+|+ .||+ .|+.|++|+.||||+|+++-.-|+.|..|++|..|-|-+ |+++
T Consensus 51 VdCr~~GL~eVP~~LP~~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~ 129 (498)
T KOG4237|consen 51 VDCRGKGLTEVPANLPPETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT 129 (498)
T ss_pred EEccCCCcccCcccCCCcceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh
Confidence 8898743 56788899999999999 6665 599999999999999999988899999999888775555 8898
Q ss_pred CCCCCc-ccccccCCc
Q 002887 471 GSLPSG-LSEKVKNGS 485 (870)
Q Consensus 471 g~ip~~-l~~~~~~~~ 485 (870)
.+|.. +..+..++.
T Consensus 130 -~l~k~~F~gL~slqr 144 (498)
T KOG4237|consen 130 -DLPKGAFGGLSSLQR 144 (498)
T ss_pred -hhhhhHhhhHHHHHH
Confidence 77763 444444443
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0001 Score=87.55 Aligned_cols=77 Identities=35% Similarity=0.482 Sum_probs=36.8
Q ss_pred EEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccccc
Q 002887 411 IISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSV 490 (870)
Q Consensus 411 l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~~ 490 (870)
+.+|+|++|.++ .+|..|..+..|+.|.++.|.+. .+|.+.+++.+|++|+|.+|++. .+|.++..+.++..|++++
T Consensus 47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSF 123 (1081)
T ss_pred eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccch
Confidence 445555554443 44444444444444444444444 44444444444444444444444 4444444444444444443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 870 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-48 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-48 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-46 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-46 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-42 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-42 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-41 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-39 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-28 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-19 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-19 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-19 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-19 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-19 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-19 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-19 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-19 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-19 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-19 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-18 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-17 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-17 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-17 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-17 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-17 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-17 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-16 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-16 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-16 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-16 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-16 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-16 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 8e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 455 bits (1173), Expect = e-155
Identities = 121/301 (40%), Positives = 174/301 (57%), Gaps = 10/301 (3%)
Query: 544 GSLELENRKFSYFDVLKITNNF--ERVLGKGGFGTVYHGYLDD-KQVAVKMLSSSSVQGY 600
+ E+ + D+ + TNNF + ++G G FG VY G L D +VA+K + S QG
Sbjct: 20 YLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGI 79
Query: 601 KQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADT--LCWE 658
++F+ E+E L H +L L+G+CDE M LIY++M NGNL+ HL T + WE
Sbjct: 80 EEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWE 139
Query: 659 RRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718
+RL+I +A+GL YLH I+HRDVKS NILL+E F K+ DFG+S+ TH
Sbjct: 140 QRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196
Query: 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQR--TLIGQWV 776
+ST V GT GY+DPEY+I RLTEKSDVYSFGVVL E++ + I ++ R + +W
Sbjct: 197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256
Query: 777 SSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836
G ++ IVD L ++ K + A+ C+ S RP+M V+ +L L +
Sbjct: 257 VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316
Query: 837 E 837
+
Sbjct: 317 Q 317
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 380 bits (979), Expect = e-126
Identities = 103/300 (34%), Positives = 171/300 (57%), Gaps = 21/300 (7%)
Query: 551 RKFSYFDVLKITNNFER--------VLGKGGFGTVYHGYLDDKQVAVKMLSS----SSVQ 598
FS++++ +TNNF+ +G+GGFG VY GY+++ VAVK L++ ++ +
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEE 72
Query: 599 GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLE-DKADTLCW 657
+QF E++++ + H+NL L+G+ +G ++ L+Y +M NG+L L D L W
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 658 ERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717
R +IA +A G+ +LH +HRD+KSANILL+E F AK++DFGL+R T
Sbjct: 133 HMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT-PQRTLIGQWV 776
+++ +VGT Y+ PE + +T KSD+YSFGVVLLE+ITG P + + + L+
Sbjct: 190 VMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD-IK 247
Query: 777 SSMLA-RGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835
+ I++ +D ++ D D+ +V +A C+H +RP + +V L + A
Sbjct: 248 EEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 379 bits (975), Expect = e-125
Identities = 117/287 (40%), Positives = 174/287 (60%), Gaps = 11/287 (3%)
Query: 551 RKFSYFDVLKITNNF--ERVLGKGGFGTVYHGYLDD-KQVAVKMLSSSSVQGYK-QFQAE 606
++FS ++ ++NF + +LG+GGFG VY G L D VAVK L QG + QFQ E
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 607 VELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKAD--TLCWERRLQIA 664
VE++ A H+NL L G+C L+Y +MANG++ + L E L W +R +IA
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 665 SESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVV 724
SA+GL YLH+ C P I+HRDVK+ANILL+E+F+A + DFGL+++ THV+T V
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAVR 196
Query: 725 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP----QRTLIGQWVSSML 780
GT G++ PEY + + +EK+DV+ +GV+LLELITGQ ++ WV +L
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 781 ARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVV 827
++ +VD LQG++ V + +++AL C + RP M++VV
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 1e-81
Identities = 75/311 (24%), Positives = 122/311 (39%), Gaps = 30/311 (9%)
Query: 553 FSYFDVLKITNNFE--RVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELL 610
++ + + V +G FG V+ L ++ VAVK+ Q + Q + EV L
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSW-QNEYEVYSL 72
Query: 611 IRAHHKNLTILVGYCDEGANMG----LIYEFMANGNLQAHLLEDKADTLCWERRLQIASE 666
H+N+ +G G ++ LI F G+L L KA+ + W IA
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAET 129
Query: 667 SAQGLEYLH-------NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719
A+GL YLH +G KP I HRD+KS N+LL A +ADFGL+ F
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 720 STTVVGTPGYLDPEY-----YISNRLTEKSDVYSFGVVLLELITGQPVIQKT--PQRTLI 772
+ VGT Y+ PE + D+Y+ G+VL EL +
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 773 GQWVSSMLARGDIKNIVDHRLQ-----GDFDTNTVWKAV-EIALACIHTISTRRPTMNQV 826
+ + + D++ +V H+ + + + + E C + R + V
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309
Query: 827 VIELNDCLAME 837
+ +
Sbjct: 310 GERITQMQRLT 320
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 9e-67
Identities = 85/271 (31%), Positives = 131/271 (48%), Gaps = 19/271 (7%)
Query: 565 FERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQG--YKQFQAEVELLIRAHHKNLTILV 622
+ +G G FGTV+ VAVK+L +F EV ++ R H N+ + +
Sbjct: 41 IKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 623 GYCDEGANMGLIYEFMANGNLQAHLLEDKA-DTLCWERRLQIASESAQGLEYLHNGCKPP 681
G + N+ ++ E+++ G+L L + A + L RRL +A + A+G+ YLHN PP
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159
Query: 682 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLT 741
IVHR++KS N+L+++K+ K+ DFGLSR+ + S + GTP ++ PE
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSN 217
Query: 742 EKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801
EKSDVYSFGV+L EL T Q P L V + + RL+ + N
Sbjct: 218 EKSDVYSFGVILWELATLQ-----QPWGNLNPAQVVAAVGFKCK------RLEIPRNLNP 266
Query: 802 VWKAVEIALACIHTISTRRPTMNQVVIELND 832
I C +RP+ ++ L
Sbjct: 267 QVA--AIIEGCWTNEPWKRPSFATIMDLLRP 295
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 3e-63
Identities = 76/274 (27%), Positives = 130/274 (47%), Gaps = 22/274 (8%)
Query: 565 FERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQG--YKQFQAEVELLIRAHHKNLTILV 622
+ +G G FGTVY G VAVKML+ ++ + F+ EV +L + H N+ + +
Sbjct: 28 VGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 623 GYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPI 682
GY + ++ ++ +L HL ++ + IA ++A+G++YLH I
Sbjct: 87 GYSTAP-QLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLH---AKSI 141
Query: 683 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPE---YYISNR 739
+HRD+KS NI L+E K+ DFGL+ G+H + G+ ++ PE SN
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 740 LTEKSDVYSFGVVLLELITGQ-PVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798
+ +SDVY+FG+VL EL+TGQ P + +I V D+ + +
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM-VGRGSLSPDLSKVRS-------N 253
Query: 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832
K + C+ RP+ +++ E+ +
Sbjct: 254 CPKRMK--RLMAECLKKKRDERPSFPRILAEIEE 285
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 4e-63
Identities = 85/285 (29%), Positives = 133/285 (46%), Gaps = 38/285 (13%)
Query: 565 FERVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQG-------YKQFQAEVELLIRAHH 615
+E+ +GKGGFG V+ G L D VA+K L +G +++FQ EV ++ +H
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH 675
N+ L G M + EF+ G+L H L DKA + W +L++ + A G+EY+
Sbjct: 83 PNIVKLYGLMHNPPRM--VMEFVPCGDLY-HRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 676 NGCKPPIVHRDVKSANILLNEK-----FQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYL 730
N PPIVHRD++S NI L AK+ADFGLS+ H + ++G ++
Sbjct: 140 N-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-----VHSVSGLLGNFQWM 193
Query: 731 DPE--YYISNRLTEKSDVYSFGVVLLELITGQ-PVIQKTPQRTLIGQWVSSMLARGDIKN 787
PE TEK+D YSF ++L ++TG+ P + + + + R I
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253
Query: 788 IVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832
RL + C +RP + +V EL++
Sbjct: 254 DCPPRL------------RNVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-62
Identities = 67/274 (24%), Positives = 116/274 (42%), Gaps = 23/274 (8%)
Query: 565 FERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGY 624
E V+G+G FG V K VA+K + S S + K F E+ L R +H N+ L G
Sbjct: 12 VEEVVGRGAFGVVCKAKWRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 69
Query: 625 CDEGANMGLIYEFMANGNLQAHLL-EDKADTLCWERRLQIASESAQGLEYLHNGCKPPIV 683
C + L+ E+ G+L L + + + +QG+ YLH+ ++
Sbjct: 70 CLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 684 HRDVKSANILLNEKFQ-AKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTE 742
HRD+K N+LL K+ DFG + T G+ ++ PE + + +E
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 743 KSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTV 802
K DV+S+G++L E+IT + P + G + + N R +
Sbjct: 183 KCDVFSWGIILWEVITRR-----KPFDEIGG---PAFRIMWAVHN--GTRPPLIKNLPKP 232
Query: 803 WKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836
+ + C ++RP+M ++V + +
Sbjct: 233 IE--SLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 1e-61
Identities = 69/319 (21%), Positives = 119/319 (37%), Gaps = 40/319 (12%)
Query: 565 FERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGY 624
++G+G +G VY G LD++ VAVK+ S ++ Q + + + + H N+ +
Sbjct: 17 LLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDNIARFIVG 75
Query: 625 CDEGANMG-----LIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN--- 676
+ G L+ E+ NG+L +L T W ++A +GL YLH
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRLAHSVTRGLAYLHTELP 132
Query: 677 ---GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF------PVEGGTHVSTTVVGTP 727
KP I HRD+ S N+L+ ++DFGLS + + + VGT
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTI 192
Query: 728 GYLDPEY-------YISNRLTEKSDVYSFGVVLLELITG----QPVIQKTPQRTLIGQWV 776
Y+ PE ++ D+Y+ G++ E+ P + V
Sbjct: 193 RYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEV 252
Query: 777 SSMLARGDIKNIVDHRLQ-------GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829
+ D++ +V Q ++ V E C + R T
Sbjct: 253 GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312
Query: 830 LNDCLAMEIARTKAHETAP 848
+ + L M R K+
Sbjct: 313 MAE-LMMIWERNKSVSPTA 330
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-61
Identities = 57/280 (20%), Positives = 108/280 (38%), Gaps = 36/280 (12%)
Query: 564 NFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQG--YKQFQAEVELLIRAHHKNLTIL 621
NF L + G ++ G + VK+L + F E L H N+ +
Sbjct: 13 NFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 622 VGYCDE--GANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCK 679
+G C + LI +M G+L L E + + ++ A + A+G+ +LH +
Sbjct: 73 LGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LE 131
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPE---YYI 736
P I + S +++++E A+++ + F S + P ++ PE
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEALQKKP 184
Query: 737 SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTL----IGQWVSSMLARGDIKNIVDHR 792
+ +D++SF V+L EL+T + P L IG V+ R I +
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE-----VPFADLSNMEIGMKVALEGLRPTIPPGISPH 239
Query: 793 LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832
+ ++ C++ +RP + +V L
Sbjct: 240 VS------------KLMKICMNEDPAKRPKFDMIVPILEK 267
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 4e-61
Identities = 73/280 (26%), Positives = 125/280 (44%), Gaps = 32/280 (11%)
Query: 565 FERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQ----GYKQFQAEVELLIRAHHKNLTI 620
E ++G GGFG VY + +VAVK + + + E +L H N+
Sbjct: 11 LEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 621 LVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKP 680
L G C + N+ L+ EF G L L + + + A + A+G+ YLH+
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIP---PDILVNWAVQIARGMNYLHDEAIV 127
Query: 681 PIVHRDVKSANILLNEKFQ--------AKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDP 732
PI+HRD+KS+NIL+ +K + K+ DFGL+R + + G ++ P
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAP 183
Query: 733 EYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHR 792
E ++ ++ SDV+S+GV+L EL+TG + P R + G V+ +A +
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTG-----EVPFRGIDGLAVAYGVAMNKL------A 232
Query: 793 LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832
L + ++ C + RP+ ++ +L
Sbjct: 233 LPIPSTCPEPFA--KLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 1e-59
Identities = 64/282 (22%), Positives = 108/282 (38%), Gaps = 33/282 (11%)
Query: 565 FERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQG--YKQFQAEVELLIRAHHKNLTILV 622
++GKG FG VYHG +VA++++ K F+ EV + H+N+ + +
Sbjct: 37 IGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 623 GYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPI 682
G C ++ +I L ++ D L + QIA E +G+ YLH I
Sbjct: 96 GACMSPPHLAIITSLCKGRTLY-SVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGI 151
Query: 683 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS---TTVVGTPGYLDPEYYISNR 739
+H+D+KS N+ + + + DFGL I V G +L PE
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 740 L---------TEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVD 790
++ SDV++ G + EL + P +T + + + G N+
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHARE-----WPFKTQPAEAIIWQMGTGMKPNLSQ 265
Query: 791 HRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832
+I L C RPT +++ L
Sbjct: 266 I------GMGKEIS--DILLFCWAFEQEERPTFTKLMDMLEK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 5e-58
Identities = 73/299 (24%), Positives = 120/299 (40%), Gaps = 32/299 (10%)
Query: 565 FERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVE--LLIRAHHKNLTILV 622
+ +GKG +G V+ G ++VAVK+ + + E E + H+N+ +
Sbjct: 41 MVKQIGKGRYGEVWMGKWRGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 623 GYCDEG----ANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH--- 675
+G + LI ++ NG+L +L K+ TL + L++A S GL +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 676 --NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH--VSTTVVGTPGYLD 731
KP I HRD+KS NIL+ + +AD GL+ F + T VGT Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 732 PE------YYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTL-IGQWVSSMLARGD 784
PE + +D+YSFG++L E+ + L V S + D
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
Query: 785 IKNIV---DHRL---QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837
++ IV R + + ++ C R T +V L +
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 2e-57
Identities = 67/294 (22%), Positives = 117/294 (39%), Gaps = 32/294 (10%)
Query: 565 FERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVEL--LIRAHHKNLTILV 622
+GKG +G V+ G + VAVK+ SS + K + E EL + H+N+ +
Sbjct: 12 LLECVGKGRYGEVWRGSWQGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFI 68
Query: 623 GYCDEGANMG----LIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH--- 675
+ LI + G+L +L + TL L+I A GL +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 676 --NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV--STTVVGTPGYLD 731
KP I HRD+KS NIL+ + Q +AD GL+ + + VGT Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 732 PE------YYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTL-IGQWVSSMLARGD 784
PE ++ D+++FG+VL E+ V + + D
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 785 IKNIVDHR-----LQGDFDTNTVWKAV-EIALACIHTISTRRPTMNQVVIELND 832
++ +V + + ++ ++ ++ C + + R T ++ L
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 6e-57
Identities = 67/299 (22%), Positives = 121/299 (40%), Gaps = 32/299 (10%)
Query: 565 FERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVE--LLIRAHHKNLTILV 622
+ +GKG FG V+ G ++VAVK+ SS + + + E E + H+N+ +
Sbjct: 46 LQESIGKGRFGEVWRGKWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 102
Query: 623 GYC----DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH--- 675
+ L+ ++ +G+L +L T+ E +++A +A GL +LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 676 --NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH--VSTTVVGTPGYLD 731
KP I HRD+KS NIL+ + +AD GL+ T VGT Y+
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 732 PE------YYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTL-IGQWVSSMLARGD 784
PE +++D+Y+ G+V E+ + L V S + +
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279
Query: 785 IKNIV-DHRLQGDFDTNTVWKAVEIALA-----CIHTISTRRPTMNQVVIELNDCLAME 837
++ +V + +L+ + +A C + R T ++ L+ E
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 4e-55
Identities = 67/282 (23%), Positives = 106/282 (37%), Gaps = 30/282 (10%)
Query: 565 FERVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILV 622
VLGKG FG + + +K L + + F EV+++ H N+ +
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 623 GYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPI 682
G + + I E++ G L+ +++ W +R+ A + A G+ YLH I
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRG-IIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 683 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT------------HVSTTVVGTPGYL 730
+HRD+ S N L+ E +ADFGL+R+ E TVVG P ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 731 DPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVD 790
PE EK DV+SFG+VL E+I RT+
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCP 249
Query: 791 HRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832
I + C +RP+ ++ L
Sbjct: 250 PSF------------FPITVRCCDLDPEKRPSFVKLEHWLET 279
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVK--MLSSSSVQGYKQFQAEVELLIRAHHKNLTI 620
F+ +G+G F TVY G +VA + ++F+ E E+L H N+
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 621 LVGY----CDEGANMGLIYEFMANGNLQAHLLEDKADTL----CWERRLQIASESAQGLE 672
+ L+ E M +G L+ +L K + W R QI +GL+
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR--QIL----KGLQ 143
Query: 673 YLHNGCKPPIVHRDVKSANILLNEKF-QAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLD 731
+LH PPI+HRD+K NI + K+ D GL+ + + V+GTP ++
Sbjct: 144 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMA 198
Query: 732 PEYYISNRLTEKSDVYSFGVVLLELITGQP 761
PE Y + E DVY+FG+ +LE+ T +
Sbjct: 199 PEMY-EEKYDESVDVYAFGMCMLEMATSEY 227
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 79/306 (25%), Positives = 128/306 (41%), Gaps = 23/306 (7%)
Query: 565 FERVLGKGGFGTVYHGYLDDK------QVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNL 618
+ LGKG FG+V D VAVK L S + FQ E+++L H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 619 TILVGYC--DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH- 675
G ++ L+ E++ +G L+ L + L R L +S+ +G+EYL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGS 145
Query: 676 NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEY 734
C VHRD+ + NIL+ + K+ADFGL+++ P++ +V +P + PE
Sbjct: 146 RRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 735 YISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVD-H 791
N + +SDV+SFGVVL EL T + ++G ++ + +
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ 261
Query: 792 RLQGDFD-TNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL-AMEIARTKAHETAPD 849
RL V E+ C RP+ + + +L+ T A P+
Sbjct: 262 RLPAPPACPAEVH---ELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPE 318
Query: 850 GTPDEL 855
G L
Sbjct: 319 GKHHSL 324
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-39
Identities = 69/283 (24%), Positives = 116/283 (40%), Gaps = 34/283 (12%)
Query: 565 FERVLGKGGFGTVYHGYL--DDKQVAVKML-SSSSVQGYKQFQAEVELLIRAHHKNLTIL 621
+G+G FG V+ G L D+ VAVK + +F E +L + H N+ L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPP 681
+G C + + ++ E + G+ L + L + LQ+ ++A G+EYL
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE---SKC 233
Query: 682 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG------TPGYLDPEYY 735
+HRD+ + N L+ EK K++DFG+SR G + ++ + T PE
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPVKWTA----PEAL 287
Query: 736 ISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794
R + +SDV+SFG++L E + G +P L Q + +G RL
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGA-----SPYPNLSNQQTREFVEKG-------GRL- 334
Query: 795 GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837
+ C +RP+ + + EL
Sbjct: 335 -PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 71/318 (22%), Positives = 129/318 (40%), Gaps = 48/318 (15%)
Query: 544 GSLELENRKFSYFDVLKITNN---FERVLGKGGFGTVYHGYLDDKQ------VAVKML-S 593
G + E + + D R LG+G FG V D + VAVK L
Sbjct: 1 GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP 60
Query: 594 SSSVQGYKQFQAEVELLIRAHHKNLTILVGYC--DEGANMGLIYEFMANGNLQAHLLEDK 651
S + E+E+L +H+N+ G C D G + LI EF+ +G+L+ +L ++K
Sbjct: 61 ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK 120
Query: 652 ADTLCWERRLQIASESAQGLEYLHN-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710
+ + +++L+ A + +G++YL + VHRD+ + N+L+ + Q K+ DFGL++
Sbjct: 121 -NKINLKQQLKYAVQICKGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKA 175
Query: 711 FPVEGGTHVSTTVVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT------- 758
+ + PE + ++ SDV+SFGV L EL+T
Sbjct: 176 IETDKEYYTVK----DDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231
Query: 759 ---GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD-TNTVWKAVEIALACIH 814
+ + + + L G RL + + V+ ++ C
Sbjct: 232 PMALFLKMIGPTHGQMTVTRLVNTLKEG-------KRLPCPPNCPDEVY---QLMRKCWE 281
Query: 815 TISTRRPTMNQVVIELND 832
+ R + ++
Sbjct: 282 FQPSNRTSFQNLIEGFEA 299
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 77/294 (26%), Positives = 128/294 (43%), Gaps = 45/294 (15%)
Query: 565 FERVLGKGGFGTVYHGYLDDKQ------VAVKMLSSSSVQGYKQFQAEVELLIRAHHKNL 618
F + LGKG FG+V D Q VAVK L S+ + + F+ E+E+L H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 619 TILVGYC--DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH- 675
G C N+ LI E++ G+L+ +L + K + + + LQ S+ +G+EYL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT 132
Query: 676 NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYL----- 730
+HRD+ + NIL+ + + K+ DFGL+++ P + PG
Sbjct: 133 KRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWY 184
Query: 731 DPEYYISNRLTEKSDVYSFGVVLLELIT-----------GQPVIQKTPQRTLIGQWVSSM 779
PE ++ + SDV+SFGVVL EL T +I Q +I + +
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 780 LARGDIKNIVDHRLQGDFD-TNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832
L RL + ++ I C + +RP+ + + ++
Sbjct: 245 LKNN-------GRLPRPDGCPDEIY---MIMTECWNNNVNQRPSFRDLALRVDQ 288
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 9e-38
Identities = 63/197 (31%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 565 FERVLGKGGFGTVYHGYLDDKQ--VAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILV 622
+ LG G +G VY G VAVK L +++ ++F E ++ H NL L+
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 282
Query: 623 GYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPI 682
G C +I EFM GNL +L E + L +A++ + +EYL
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---F 339
Query: 683 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYYISNRLT 741
+HR++ + N L+ E K+ADFGLSR+ + G T+ + P + PE N+ +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397
Query: 742 EKSDVYSFGVVLLELIT 758
KSDV++FGV+L E+ T
Sbjct: 398 IKSDVWAFGVLLWEIAT 414
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-37
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 27/203 (13%)
Query: 565 FERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGY 624
+ +GKG FG V G +VAVK + + + + F AE ++ + H NL L+G
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254
Query: 625 C-DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL-HNGCKPPI 682
+E + ++ E+MA G+L +L L + L+ + + + +EYL N
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---- 310
Query: 683 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG-------TPGYLDPEYY 735
VHRD+ + N+L++E AK++DFGL++ S+T T PE
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTA----PEAL 358
Query: 736 ISNRLTEKSDVYSFGVVLLELIT 758
+ + KSDV+SFG++L E+ +
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYS 381
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 27/203 (13%)
Query: 565 FERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGY 624
+ +GKG FG V G +VAVK + + + + F AE ++ + H NL L+G
Sbjct: 25 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82
Query: 625 C-DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL-HNGCKPPI 682
+E + ++ E+MA G+L +L L + L+ + + + +EYL N
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---- 138
Query: 683 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG-------TPGYLDPEYY 735
VHRD+ + N+L++E AK++DFGL++ S+T T PE
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTA----PEAL 186
Query: 736 ISNRLTEKSDVYSFGVVLLELIT 758
+ + KSDV+SFG++L E+ +
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYS 209
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 76/294 (25%), Positives = 129/294 (43%), Gaps = 45/294 (15%)
Query: 565 FERVLGKGGFGTVYHGYLD------DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNL 618
F + LGKG FG+V D + VAVK L S+ + + F+ E+E+L H N+
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 619 TILVGYC--DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH- 675
G C N+ LI E++ G+L+ +L + K + + + LQ S+ +G+EYL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT 163
Query: 676 NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYL----- 730
+HRD+ + NIL+ + + K+ DFGL+++ P + + PG
Sbjct: 164 KRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPGESPIFWY 215
Query: 731 DPEYYISNRLTEKSDVYSFGVVLLELIT-----------GQPVIQKTPQRTLIGQWVSSM 779
PE ++ + SDV+SFGVVL EL T +I Q +I + +
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275
Query: 780 LARGDIKNIVDHRLQGDFD-TNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832
L RL + ++ I C + +RP+ + + ++
Sbjct: 276 LKNN-------GRLPRPDGCPDEIY---MIMTECWNNNVNQRPSFRDLALRVDQ 319
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 59/216 (27%), Positives = 86/216 (39%), Gaps = 34/216 (15%)
Query: 567 RVLGKGGFGTVYHGY--LDDKQVAVKM--LSSSSVQGYKQFQAEVELLIRAHHKN----- 617
+G G +G D K + K S + + +EV LL H N
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 618 ----------LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASES 667
L I++ YC+ G +I + +L E+ Q+
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER---QYLDEEFV----LRVMTQLTL-- 122
Query: 668 AQGLEYLH--NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG 725
L+ H + ++HRD+K AN+ L+ K KL DFGL+RI T + T VG
Sbjct: 123 --ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVG 178
Query: 726 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
TP Y+ PE EKSD++S G +L EL P
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 5e-37
Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 9/196 (4%)
Query: 565 FERVLGKGGFGTVYHGYLDDK-QVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVG 623
E LG+G FG V+ G + +VA+K L ++ + F E +++ + H+ L L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 246
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIV 683
E ++ E+M+ G+L L + L + + +A++ A G+ Y+ V
Sbjct: 247 VVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 302
Query: 684 HRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYYISNRLTE 742
HRD+++ANIL+ E K+ADFGL+R+ +E + + P + PE + R T
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 743 KSDVYSFGVVLLELIT 758
KSDV+SFG++L EL T
Sbjct: 361 KSDVWSFGILLTELTT 376
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-37
Identities = 72/294 (24%), Positives = 122/294 (41%), Gaps = 47/294 (15%)
Query: 565 FERVLGKGGFGTVYHGYLDDK------QVAVKML-SSSSVQGYKQFQAEVELLIRAHHKN 617
R LG+G FG V D VAVK L + + Q ++ E+++L +H++
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 618 LTILVGYC--DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH 675
+ G C A++ L+ E++ G+L+ +L ++ + L A + +G+ YLH
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 676 -NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYL---- 730
+HRD+ + N+LL+ K+ DFGL++ P + V G
Sbjct: 152 AQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFW 203
Query: 731 -DPEYYISNRLTEKSDVYSFGVVLLELIT----------GQPVIQKTPQRTLIGQWVSSM 779
PE + SDV+SFGV L EL+T + Q + ++ +
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263
Query: 780 LARGDIKNIVDHRL-QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832
L RG RL + D V+ + C T ++ RPT ++ L
Sbjct: 264 LERG-------ERLPRPDKCPAEVY---HLMKNCWETEASFRPTFENLIPILKT 307
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-37
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 563 NNFE--RVLGKGGFGTVYHGY--LDDKQVAVKM--LSSSSVQGYKQFQAEVELLIRAHHK 616
+ + +G+G FG D +Q +K +S S + ++ + EV +L H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 617 NLTILVGYCD---EGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEY 673
N+ V Y + E ++ ++ ++ G+L + K ++ L + L++
Sbjct: 84 NI---VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140
Query: 674 LHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPE 733
+H+ I+HRD+KS NI L + +L DFG++R+ ++ +GTP YL PE
Sbjct: 141 VHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLSPE 195
Query: 734 YYISNRLTEKSDVYSFGVVLLELITGQP 761
+ KSD+++ G VL EL T +
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLKH 223
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 76/298 (25%), Positives = 124/298 (41%), Gaps = 54/298 (18%)
Query: 565 FERVLGKGGFGTVYHGYLDDK-----QVAVKML--SSSSVQGYKQFQAEVELLIRAHHKN 617
++LG+G FG+V G L + +VAVK + +SS + ++F +E + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 618 LTILVGYCDEGANMG-----LIYEFMANGNL----QAHLLEDKADTLCWERRLQIASESA 668
+ L+G C E ++ G +I FM G+L LE + + L+ + A
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 669 QGLEYL--HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEGGTHVSTTVVG 725
G+EYL N +HRD+ + N +L + +ADFGLS+ I+ G
Sbjct: 158 LGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIY------SGDYYRQG 206
Query: 726 TPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTPQRTLIGQWVSS 778
+ E T KSDV++FGV + E+ T P +
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE------MYD 260
Query: 779 MLARGDIKNIVDHRLQG-DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835
L G HRL+ + + ++ EI +C T RPT + + ++L L
Sbjct: 261 YLLHG-------HRLKQPEDCLDELY---EIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-36
Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 9/196 (4%)
Query: 565 FERVLGKGGFGTVYHGYLDDK-QVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVG 623
E LG+G FG V+ G + +VA+K L ++ + F E +++ + H+ L L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIV 683
E ++ E+M+ G+L L + L + + +A++ A G+ Y+ V
Sbjct: 330 VVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 385
Query: 684 HRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYYISNRLTE 742
HRD+++ANIL+ E K+ADFGL+R+ +E + + P + PE + R T
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 743 KSDVYSFGVVLLELIT 758
KSDV+SFG++L EL T
Sbjct: 444 KSDVWSFGILLTELTT 459
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 25/205 (12%)
Query: 565 FERVLGKGGFGTVYHGYLDDK--QVAVKML--SSSSVQGYKQFQAEVELLIRAHHKNLTI 620
+ LG G +G VY G VAVK L + V+ +F E ++ H NL
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQ 73
Query: 621 LVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL--HNGC 678
L+G C +I EFM GNL +L E + L +A++ + +EYL N
Sbjct: 74 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 131
Query: 679 KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT-----VVGTPGYLDPE 733
+HRD+ + N L+ E K+ADFGLSR+ + G T+ + + T PE
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA----PE 182
Query: 734 YYISNRLTEKSDVYSFGVVLLELIT 758
N+ + KSDV++FGV+L E+ T
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 72/287 (25%), Positives = 119/287 (41%), Gaps = 45/287 (15%)
Query: 565 FERVLGKGGFGTVYHGYLDDK------QVAVKML-SSSSVQGYKQFQAEVELLIRAHHKN 617
+VLG G FGTVY G + VA+K L ++S + K+ E ++ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL--H 675
+ L+G C LI + M G L ++ E K D + + L + A+G+ YL
Sbjct: 79 VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 676 NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG------TPGY 729
+VHRD+ + N+L+ K+ DFGL+++ + G
Sbjct: 137 R-----LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVPIKWMA-- 187
Query: 730 LDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNI 788
E + T +SDV+S+GV + EL+T G P + +SS+L +G
Sbjct: 188 --LESILHRIYTHQSDVWSYGVTVWELMTFGS-----KPYDGIPASEISSILEKG----- 235
Query: 789 VDHRLQGDFD-TNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834
RL T V+ I C + RP +++IE +
Sbjct: 236 --ERLPQPPICTIDVY---MIMRKCWMIDADSRPKFRELIIEFSKMA 277
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-36
Identities = 69/215 (32%), Positives = 104/215 (48%), Gaps = 29/215 (13%)
Query: 565 FERVLGKGGFGTVYHGYLDDK-----QVAVKML-SSSSVQGYKQFQAEVELLIRAHHKNL 618
+RV+GKG FG VYHG D+ Q A+K L + +Q + F E L+ +H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 619 TILVGYC--DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL-- 674
L+G EG ++ +M +G+L + + + + + A+G+EYL
Sbjct: 85 LALIGIMLPPEGLPH-VLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAE 142
Query: 675 HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR------IFPVEGGTHVSTTVVGTPG 728
VHRD+ + N +L+E F K+ADFGL+R + V+ H V T
Sbjct: 143 QK-----FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA- 196
Query: 729 YLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 761
E + R T KSDV+SFGV+L EL+T P
Sbjct: 197 ---LESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 73/299 (24%), Positives = 116/299 (38%), Gaps = 55/299 (18%)
Query: 565 FERVLGKGGFGTVYHGYLDDK-----QVAVKML--SSSSVQGYKQFQAEVELLIRAHHKN 617
R+LGKG FG+V L + +VAVKML + ++F E + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 618 LTILVGYC------DEGANMGLIYEFMANGN----LQAHLLEDKADTLCWERRLQIASES 667
+ LVG +I FM +G+ L A + + L + ++ +
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 668 AQGLEYL--HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEGGTHVSTTVV 724
A G+EYL N +HRD+ + N +L E +ADFGLSR I+
Sbjct: 147 ACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIY------SGDYYRQ 195
Query: 725 GTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTPQRTLIGQWVS 777
G L E N T SDV++FGV + E++T P +
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE------IY 249
Query: 778 SMLARGDIKNIVDHRLQG-DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835
+ L G +RL+ V+ ++ C +RP+ + +EL + L
Sbjct: 250 NYLIGG-------NRLKQPPECMEEVY---DLMYQCWSADPKQRPSFTCLRMELENILG 298
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-35
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 565 FERVLGKGGFGTVYHGYLDDK-QVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVG 623
E+ LG G FG V+ + +VAVK + S+ + F AE ++ H L L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHA 250
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL--HNGCKPP 681
+ +I EFMA G+L L D+ + + +++ A+G+ ++ N
Sbjct: 251 VVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----- 304
Query: 682 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT-----VVGTPGYLDPEYYI 736
+HRD+++ANIL++ K+ADFGL+R+ +E + + + T PE
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTA----PEAIN 358
Query: 737 SNRLTEKSDVYSFGVVLLELIT 758
T KSDV+SFG++L+E++T
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVT 380
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 23/203 (11%)
Query: 565 FERVLGKGGFGTVYHGYLDDK-QVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVG 623
LG G FG V+ GY + +VAVK L S+ F AE L+ + H+ L L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA 75
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL-HNGCKPPI 682
+ +I E+M NG+L L L + L +A++ A+G+ ++
Sbjct: 76 VVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---- 130
Query: 683 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG-------TPGYLDPEYY 735
+HRD+++ANIL+++ K+ADFGL+R+ +E + T G T PE
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARL--IEDNEY--TAREGAKFPIKWTA----PEAI 182
Query: 736 ISNRLTEKSDVYSFGVVLLELIT 758
T KSDV+SFG++L E++T
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVT 205
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 70/314 (22%), Positives = 126/314 (40%), Gaps = 48/314 (15%)
Query: 565 FERVLGKGGFGTVYHGYLDD-------KQVAVKML-SSSSVQGYKQFQAEVELLIRAHHK 616
R LG+G FG VY G +VA+K + ++S++ +F E ++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 617 NLTILVGYCDEGANMGLIYEFMANGNLQAHLLE--------DKADTLCWERRLQIASESA 668
++ L+G +G +I E M G+L+++L + +Q+A E A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 669 QGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPG 728
G+ YL+ VHRD+ + N ++ E F K+ DFG++R + G G
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYET---DYYRKGGKG 200
Query: 729 YL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTPQRTLIGQWVSSMLA 781
L PE T SDV+SFGVVL E+ T QP + ++ V +
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------VLRFVM 254
Query: 782 RGDIKNIVDHRLQGDFDT-NTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAMEIAR 840
G L + + ++ E+ C RP+ +++ + + +
Sbjct: 255 EG-------GLLDKPDNCPDMLF---ELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 304
Query: 841 TKAHETAPDGTPDE 854
+ + + P+
Sbjct: 305 VSFYYSEENKLPEP 318
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 55/215 (25%), Positives = 82/215 (38%), Gaps = 21/215 (9%)
Query: 565 FERVLGKGGFGTVY--HGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILV 622
F + LG+GGF V G D A+K + Q ++ Q E ++ +H N+ LV
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 623 GYCDEGANMG----LIYEFMANGNLQAHLLEDKADTLCW-ERR-LQIASESAQGLEYLHN 676
YC L+ F G L + K E + L + +GLE +H
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH- 151
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS-------TTVVGTPGY 729
HRD+K NILL ++ Q L D G + T Y
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 730 LDPE---YYISNRLTEKSDVYSFGVVLLELITGQP 761
PE + E++DV+S G VL ++ G+
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 70/286 (24%), Positives = 126/286 (44%), Gaps = 46/286 (16%)
Query: 566 ERVLGKGGFGTVYHGYLDDK----QVAVKML--SSSSVQGYKQFQAEVELLIRAHHKNLT 619
++ LG G FGTV GY K VAVK+L ++ + AE ++ + + +
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL--HNG 677
++G C+ + M L+ E G L +L +++ + + +++ + + G++YL N
Sbjct: 82 RMIGICEAESWM-LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN- 137
Query: 678 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG-------TPGYL 730
VHRD+ + N+LL + AK++DFGLS+ + + + T
Sbjct: 138 ----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT--HGKWPVKWYA--- 188
Query: 731 DPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIV 789
PE + + KSDV+SFGV++ E + GQ P R + G V++ML +G
Sbjct: 189 -PECINYYKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSEVTAMLEKG------ 236
Query: 790 DHRLQGDFD-TNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834
R+ ++ ++ C RP V + L +
Sbjct: 237 -ERMGCPAGCPREMY---DLMNLCWTYDVENRPGFAAVELRLRNYY 278
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 23/203 (11%)
Query: 565 FERVLGKGGFGTVYHGYLDDK-QVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVG 623
F + +G G FG V+ GY +K +VA+K + ++ + F E E++++ H L L G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYG 70
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL-HNGCKPPI 682
C E A + L+ EFM +G L +L + E L + + +G+ YL
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACV---- 125
Query: 683 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG-------TPGYLDPEYY 735
+HRD+ + N L+ E K++DFG++R V + T+ G PE +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQY--TSSTGTKFPVKWAS----PEVF 177
Query: 736 ISNRLTEKSDVYSFGVVLLELIT 758
+R + KSDV+SFGV++ E+ +
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFS 200
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 56/205 (27%), Positives = 80/205 (39%), Gaps = 18/205 (8%)
Query: 565 FERVLGKGGFGTVYHGYLDDK-----QVAVKML---SSSSVQGYKQFQAEVELLIRAHHK 616
LG G FG V G D VAVK L S + F EV + H+
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 617 NLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL-- 674
NL L G ++ E G+L L + + + A + A+G+ YL
Sbjct: 82 NLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES 139
Query: 675 HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPE 733
+HRD+ + N+LL + K+ DFGL R P +V P + PE
Sbjct: 140 KR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 734 YYISNRLTEKSDVYSFGVVLLELIT 758
+ + SD + FGV L E+ T
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 565 FERVLGKGGFGTVYHGYLDDK-QVAVKML--SSSSVQGYKQFQAEVELLIRAHHKNLTIL 621
+ LG G FG V G + VAVKM+ S S +F E + +++ H L
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKF 68
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL-HNGCKP 680
G C + + ++ E+++NG L +L L + L++ + +G+ +L +
Sbjct: 69 YGVCSKEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQF-- 125
Query: 681 PIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG-------TPGYLDPE 733
+HRD+ + N L++ K++DFG++R V +VS+ G + PE
Sbjct: 126 --IHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSV--GTKFPVKWSA----PE 175
Query: 734 YYISNRLTEKSDVYSFGVVLLELIT 758
+ + + KSDV++FG+++ E+ +
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 68/227 (29%), Positives = 99/227 (43%), Gaps = 40/227 (17%)
Query: 565 FERVLGKGGFGTVYHGYL-------DDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKN 617
+R LG+G FG V+ D VAVK L ++ K FQ E ELL H++
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHL--------------LEDKADTLCWERRLQI 663
+ G C +G + +++E+M +G+L L L + L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 664 ASESAQGLEYL--HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721
AS+ A G+ YL + VHRD+ + N L+ K+ DFG+SR
Sbjct: 139 ASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDV-----YSTDY 188
Query: 722 TVVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 761
VG L PE + + T +SDV+SFGV+L E+ T QP
Sbjct: 189 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 75/303 (24%), Positives = 121/303 (39%), Gaps = 54/303 (17%)
Query: 565 FERVLGKGGFGTVYHGYLDD-------KQVAVKML-SSSSVQGYKQFQAEVELLIR-AHH 615
F + LG G FG V +VAVKML S++ + +E++++ H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNLQAHL------------LEDKADTLCWERRLQI 663
+N+ L+G C G + +I E+ G+L L T L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 664 ASESAQGLEYL-HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722
+S+ AQG+ +L C +HRDV + N+LL AK+ DFGL+R + S
Sbjct: 170 SSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMND-----SNY 220
Query: 723 VVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTPQRTLIGQW 775
+V L PE T +SDV+S+G++L E+ + P L+
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY-----PGILVNSK 275
Query: 776 VSSMLARGDIKNIVDHRL-QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834
++ G +++ Q F ++ I AC T RPT Q+ L +
Sbjct: 276 FYKLVKDG-------YQMAQPAFAPKNIY---SIMQACWALEPTHRPTFQQICSFLQEQA 325
Query: 835 AME 837
+
Sbjct: 326 QED 328
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 77/297 (25%), Positives = 130/297 (43%), Gaps = 44/297 (14%)
Query: 556 FDVLKITNNFERVLGKGGFGTVYHGYLDDK-----QVAVKML-SSSSVQGYKQFQAEVEL 609
L + F V+G+G FG VYHG L D AVK L + + QF E +
Sbjct: 22 PSSLIVH--FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 79
Query: 610 LIRAHHKNLTILVGYC-DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESA 668
+ H N+ L+G C + ++ +M +G+L+ + + + + + A
Sbjct: 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVA 138
Query: 669 QGLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR------IFPVEGGTHVST 721
+G++YL VHRD+ + N +L+EKF K+ADFGL+R + V T
Sbjct: 139 KGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 194
Query: 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTPQRTLIGQWVSSM 779
V E + + T KSDV+SFGV+L EL+T P ++
Sbjct: 195 PVKWMA----LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVY 244
Query: 780 LARGDIKNIVDHRLQG-DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835
L +G RL ++ + ++ E+ L C H + RP+ +++V ++ +
Sbjct: 245 LLQG-------RRLLQPEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAIFS 291
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-35
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 567 RVLGKGGFGTVYHGY--LDDKQVAVK---MLSSSSVQGYKQFQAEVELLIRAHHKNLTIL 621
+ +G+G F VY LD VA+K + + E++LL + +H N +
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN--V- 94
Query: 622 VGYCD---EGANMGLIYEFMANGNLQAHLLEDKADTLCW-ERR-LQIASESAQGLEYLHN 676
+ Y E + ++ E G+L + K ER + + LE++H+
Sbjct: 95 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYI 736
++HRD+K AN+ + KL D GL R F T + ++VGTP Y+ PE
Sbjct: 155 ---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIH 209
Query: 737 SNRLTEKSDVYSFGVVLLELITGQP 761
N KSD++S G +L E+ Q
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQS 234
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-35
Identities = 68/226 (30%), Positives = 98/226 (43%), Gaps = 39/226 (17%)
Query: 565 FERVLGKGGFGTVYHGYL-------DDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKN 617
+ LG+G FG V+ D VAVK L +S + FQ E ELL H++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERR-------------LQIA 664
+ G C EG + +++E+M +G+L L D L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 665 SESAQGLEYL--HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722
S+ A G+ YL + VHRD+ + N L+ + K+ DFG+SR
Sbjct: 165 SQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIY-----STDYY 214
Query: 723 VVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 761
VG L PE + + T +SDV+SFGVVL E+ T QP
Sbjct: 215 RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-35
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 27/209 (12%)
Query: 565 FERVLGKGGFGTVYHGYL-----DDKQVAVKML-SSSSVQGYKQFQAEVELLIRAHHKNL 618
E+++G G G V +G L D VA+K L + + + + F +E ++ + H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 619 TILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL--HN 676
L G G ++ E+M NG+L L + + + G+ YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG-------TPGY 729
VHRD+ + N+L++ K++DFGLSR+ + +TT G T
Sbjct: 172 -----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT--GGKIPIRWTA-- 222
Query: 730 LDPEYYISNRLTEKSDVYSFGVVLLELIT 758
PE + SDV+SFGVV+ E++
Sbjct: 223 --PEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-35
Identities = 61/205 (29%), Positives = 107/205 (52%), Gaps = 27/205 (13%)
Query: 565 FERVLGKGGFGTVYHGYLDDK-QVAVKML--SSSSVQGYKQFQAEVELLIRAHHKNLTIL 621
F + LG G FG V +G + VA+KM+ S S +F E ++++ H+ L L
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQL 84
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL-HNGCKP 680
G C + + +I E+MANG L +L E + ++ L++ + + +EYL
Sbjct: 85 YGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQF-- 141
Query: 681 PIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG-------TPGYLDPE 733
+HRD+ + N L+N++ K++DFGLSR V + T+ VG +P PE
Sbjct: 142 --LHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEY--TSSVGSKFPVRWSP----PE 191
Query: 734 YYISNRLTEKSDVYSFGVVLLELIT 758
+ ++ + KSD+++FGV++ E+ +
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 72/313 (23%), Positives = 123/313 (39%), Gaps = 50/313 (15%)
Query: 565 FERVLGKGGFGTVYHGYLDDK------QVAVKML-SSSSVQGYKQFQAEVELLIRAHHKN 617
+VLG G FGTV+ G + V +K++ S Q ++ + + H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL--H 675
+ L+G C + L+ +++ G+L H+ + + L + L + A+G+ YL H
Sbjct: 77 IVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 676 NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG------TPGY 729
+VHR++ + N+LL Q ++ADFG++ + +
Sbjct: 135 G-----MVHRNLAARNVLLKSPSQVQVADFGVADL--LPPDDKQLLYSEAKTPIKWMA-- 185
Query: 730 LDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNI 788
E + T +SDV+S+GV + EL+T G P L V +L +G
Sbjct: 186 --LESIHFGKYTHQSDVWSYGVTVWELMTFGA-----EPYAGLRLAEVPDLLEKG----- 233
Query: 789 VDHRL-QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA-----MEIARTK 842
RL Q T V+ + + C RPT ++ E + I R
Sbjct: 234 --ERLAQPQICTIDVY---MVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRES 288
Query: 843 AHETAPDGTPDEL 855
AP P L
Sbjct: 289 GPGIAPGPEPHGL 301
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 62/295 (21%), Positives = 122/295 (41%), Gaps = 44/295 (14%)
Query: 566 ERVLGKGGFGTVYHGYLDDK----QVAVKML-SSSSVQGYKQFQAEVELLIRAHHKNLTI 620
+ LG G FG+V G + VA+K+L + ++ E +++ + + +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 621 LVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL--HNGC 678
L+G C A M L+ E G L L+ + + + ++ + + G++YL N
Sbjct: 75 LIGVCQAEALM-LVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN-- 130
Query: 679 KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG-------TPGYLD 731
VHRD+ + N+LL + AK++DFGLS+ + + + +
Sbjct: 131 ---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWYA---- 181
Query: 732 PEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVD 790
PE + + +SDV+S+GV + E ++ GQ P + + G V + + +G
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPEVMAFIEQG------- 229
Query: 791 HRLQGDFD-TNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAMEIARTKAH 844
R++ + ++ + C RP V + C ++ + H
Sbjct: 230 KRMECPPECPPELY---ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 76/310 (24%), Positives = 133/310 (42%), Gaps = 65/310 (20%)
Query: 565 FERVLGKGGFGTVYHGYLDD---------KQVAVKML-SSSSVQGYKQFQAEVELLIR-A 613
+ LG+G FG V VAVKML ++ + +E+E++
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 614 HHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLE--------------DKADTLCWER 659
HKN+ L+G C + + +I E+ + GNL+ +L + + ++
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 660 RLQIASESAQGLEYL--HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717
+ + A+G+EYL +HRD+ + N+L+ E K+ADFGL+R
Sbjct: 159 LVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARD------- 206
Query: 718 HVSTT---VVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQ 768
++ T G L PE T +SDV+SFGV++ E+ T G +P
Sbjct: 207 -INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG-----SPY 260
Query: 769 RTLIGQWVSSMLARGDIKNIVDHRL-QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVV 827
+ + + +L G HR+ + TN ++ + C H + ++RPT Q+V
Sbjct: 261 PGIPVEELFKLLKEG-------HRMDKPANCTNELY---MMMRDCWHAVPSQRPTFKQLV 310
Query: 828 IELNDCLAME 837
+L+ L +
Sbjct: 311 EDLDRILTLT 320
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 69/287 (24%), Positives = 114/287 (39%), Gaps = 41/287 (14%)
Query: 565 FERVLGKGGFGTVYHGYLDDK-----QVAVKML-SSSSVQGYKQFQAEVELLIRAHHKNL 618
R +G+G FG V+ G VA+K + +S ++F E + + H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 619 TILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL-HNG 677
L+G E +I E G L++ L K +L + A + + L YL
Sbjct: 79 VKLIGVITENPVW-IIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR 136
Query: 678 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT-----VVGTPGYLDP 732
VHRD+ + N+L++ KL DFGLSR +E T+ + + P
Sbjct: 137 F----VHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMA----P 186
Query: 733 EYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDH 791
E R T SDV+ FGV + E++ G P + + V + G
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRIENG-------E 234
Query: 792 RLQGDFD-TNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837
RL + T++ + C +RRP ++ +L+ L E
Sbjct: 235 RLPMPPNCPPTLY---SLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 30/209 (14%)
Query: 565 FERVLGKGGFGTVYHGYLDDK-----QVAVKML-SSSSVQGYKQFQAEVELLIRAHHKNL 618
R+LG+G FG VY G + VAVK ++ ++F +E ++ H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 619 TILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL--HN 676
L+G +E +I E G L +L +K ++L + + + + + YL N
Sbjct: 76 VKLIGIIEEEPTW-IIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESIN 133
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG-------TPGY 729
VHRD+ NIL+ KL DFGLSR +E + +
Sbjct: 134 -----CVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKAS--VTRLPIKWMS-- 182
Query: 730 LDPEYYISNRLTEKSDVYSFGVVLLELIT 758
PE R T SDV+ F V + E+++
Sbjct: 183 --PESINFRRFTTASDVWMFAVCMWEILS 209
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-34
Identities = 77/308 (25%), Positives = 134/308 (43%), Gaps = 61/308 (19%)
Query: 565 FERVLGKGGFGTVYHGYLDD---------KQVAVKML-SSSSVQGYKQFQAEVELLIR-A 613
+ LG+G FG V VAVKML ++ + +E+E++
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 614 HHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLE--------------DKADTLCWER 659
HKN+ L+G C + + +I E+ + GNL+ +L + + ++
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 660 RLQIASESAQGLEYL--HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEGG 716
+ + A+G+EYL +HRD+ + N+L+ E K+ADFGL+R I
Sbjct: 205 LVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDIN----- 254
Query: 717 THVSTTVVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRT 770
++ T G L PE T +SDV+SFGV++ E+ T G +P
Sbjct: 255 -NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG-----SPYPG 308
Query: 771 LIGQWVSSMLARGDIKNIVDHRL-QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829
+ + + +L G HR+ + TN ++ + C H + ++RPT Q+V +
Sbjct: 309 IPVEELFKLLKEG-------HRMDKPANCTNELY---MMMRDCWHAVPSQRPTFKQLVED 358
Query: 830 LNDCLAME 837
L+ L +
Sbjct: 359 LDRILTLT 366
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 67/232 (28%), Positives = 102/232 (43%), Gaps = 47/232 (20%)
Query: 565 FERVLGKGGFGTVYHGYLDD-------KQVAVKML-SSSSVQGYKQFQAEVELLIR-AHH 615
+ LG+G FG V + VAVKML ++ ++ +E+++LI HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 616 KNLTILVGYC-DEGANMGLIYEFMANGNLQAHL--------------LEDKADTLCWERR 660
N+ L+G C G + +I EF GNL +L + D L E
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 661 LQIASESAQGLEYL-HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719
+ + + A+G+E+L C +HRD+ + NILL+EK K+ DFGL+R +
Sbjct: 151 ICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARD--------I 198
Query: 720 STT---VVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 761
V L PE T +SDV+SFGV+L E+ + P
Sbjct: 199 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 54/230 (23%), Positives = 95/230 (41%), Gaps = 25/230 (10%)
Query: 549 ENRKFSYFDVLKITNNFERVLGKGGFGTVYHGYLDDKQ-VAVKM--LSSSSVQGYKQFQA 605
EN F V + + +G GG V+ + KQ A+K L + Q ++
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN 75
Query: 606 EVELLIRAHHKNLTI--LVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI 663
E+ L + + I L Y + ++ E N +L + L + K+ +
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS--Y 132
Query: 664 ASESAQGLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722
+ + +H +G IVH D+K AN L+ + KL DFG++ + + V +
Sbjct: 133 WKNMLEAVHTIHQHG----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS 187
Query: 723 VVGTPGYLDPE-----------YYISNRLTEKSDVYSFGVVLLELITGQP 761
VGT Y+ PE ++++ KSDV+S G +L + G+
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 60/240 (25%), Positives = 94/240 (39%), Gaps = 19/240 (7%)
Query: 531 QNLRRRKQAGKKKGSLELENRKFSYFDVLKIT-NNFE--RVLGKGGFGTVYHGY--LDDK 585
L+ R+ + + + S L++ + +F+ LG G +G V+ D +
Sbjct: 24 HQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGR 83
Query: 586 QVAVK--MLSSSSVQGYKQFQAEVELLIR-AHHKNLTILVGYCDEGANMGLIYEFMANGN 642
AVK M + + AEV + H L +EG + L E +
Sbjct: 84 LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPS 142
Query: 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLH-NGCKPPIVHRDVKSANILLNEKFQAK 701
LQ H A +L + ++ L +LH G +VH DVK ANI L + + K
Sbjct: 143 LQQHCEAWGA-SLPEAQVWGYLRDTLLALAHLHSQG----LVHLDVKPANIFLGPRGRCK 197
Query: 702 LADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
L DFGL G G P Y+ PE + +DV+S G+ +LE+
Sbjct: 198 LGDFGLLVELGTAGAGE---VQEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 77/311 (24%), Positives = 130/311 (41%), Gaps = 81/311 (26%)
Query: 565 FERVLGKGGFGTVYHGYLDDKQ----VAVKML-SSSSVQGYKQFQAEVELLIR-AHHKNL 618
F+ V+G+G FG V + A+K + +S ++ F E+E+L + HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 619 TILVGYCDEGANMGLIYEFMANGNLQAHL--------------LEDKADTLCWERRLQIA 664
L+G C+ + L E+ +GNL L A TL ++ L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 665 SESAQGLEYL-HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV 723
++ A+G++YL +HRD+ + NIL+ E + AK+ADFGLSR
Sbjct: 149 ADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR-------------- 190
Query: 724 VGTPGYLDPEYYIS------------------NRLTEKSDVYSFGVVLLELIT-GQPVIQ 764
E Y+ + T SDV+S+GV+L E+++ G
Sbjct: 191 -------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG---- 239
Query: 765 KTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD-TNTVWKAVEIALACIHTISTRRPTM 823
TP + + L +G +RL+ + + V+ ++ C RP+
Sbjct: 240 -TPYCGMTCAELYEKLPQG-------YRLEKPLNCDDEVY---DLMRQCWREKPYERPSF 288
Query: 824 NQVVIELNDCL 834
Q+++ LN L
Sbjct: 289 AQILVSLNRML 299
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 49/222 (22%), Positives = 97/222 (43%), Gaps = 30/222 (13%)
Query: 560 KITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHH 615
+ +F+ ++G GGFG V+ +D K +K + ++ ++ + EV+ L + H
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDH 63
Query: 616 KN----------------LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWER 659
N + + + + EF G L+ + + + + L
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 660 RLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719
L++ + +G++Y+H+ +++RD+K +NI L + Q K+ DFGL
Sbjct: 124 ALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGK 177
Query: 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
T GT Y+ PE S ++ D+Y+ G++L EL+
Sbjct: 178 RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-34
Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 27/222 (12%)
Query: 556 FDVLKITNNFERVLGKGGFGTVYHGYLDDK-----QVAVKML-SSSSVQGYKQFQAEVEL 609
L + F V+G+G FG VYHG L D AVK L + + QF E +
Sbjct: 86 PSSLIVH--FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 143
Query: 610 LIRAHHKNLTILVGYC-DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESA 668
+ H N+ L+G C + ++ +M +G+L+ + + + + + A
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVA 202
Query: 669 QGLEYL-HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG-- 725
+G+++L VHRD+ + N +L+EKF K+ADFGL+R + V
Sbjct: 203 KGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 258
Query: 726 ----TPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 761
E + + T KSDV+SFGV+L EL+T P
Sbjct: 259 PVKWMA----LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-34
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 26/209 (12%)
Query: 565 FERVLGKGGFGTVYHGYL------DDKQVAVKML-SSSSVQGYKQFQAEVELLIRAHHKN 617
++V+G G FG VY G L + VA+K L + + + F E ++ + H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL-HN 676
+ L G + M +I E+M NG L L E + + + A G++YL +
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG-------TPGY 729
VHRD+ + NIL+N K++DFGLSR+ +E + T G T
Sbjct: 167 NY----VHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWTA-- 218
Query: 730 LDPEYYISNRLTEKSDVYSFGVVLLELIT 758
PE + T SDV+SFG+V+ E++T
Sbjct: 219 --PEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-34
Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 45/287 (15%)
Query: 565 FERVLGKGGFGTVYHGYLDDK------QVAVKML-SSSSVQGYKQFQAEVELLIRAHHKN 617
+VLG G FGTVY G + VA+K L ++S + K+ E ++ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL--H 675
+ L+G C LI + M G L ++ E K D + + L + A+G+ YL
Sbjct: 79 VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 676 NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG------TPGY 729
+VHRD+ + N+L+ K+ DFGL+++ + G
Sbjct: 137 R-----LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVPIKWMA-- 187
Query: 730 LDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNI 788
E + T +SDV+S+GV + EL+T G P + +SS+L +G
Sbjct: 188 --LESILHRIYTHQSDVWSYGVTVWELMTFGS-----KPYDGIPASEISSILEKG----- 235
Query: 789 VDHRLQGDFD-TNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834
RL T V+ I + C + RP +++IE +
Sbjct: 236 --ERLPQPPICTIDVY---MIMVKCWMIDADSRPKFRELIIEFSKMA 277
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-34
Identities = 63/238 (26%), Positives = 98/238 (41%), Gaps = 53/238 (22%)
Query: 565 FERVLGKGGFGTVYHGYLDD-------KQVAVKML-SSSSVQGYKQFQAEVELLIRAHHK 616
+ LG+G FG V VAVKML ++S + +E +L + +H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 617 NLTILVGYCDEGANMGLIYEFMANGNLQAHL----------------------LEDKADT 654
++ L G C + + LI E+ G+L+ L
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 655 LCWERRLQIASESAQGLEYL-HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713
L + A + +QG++YL VHRD+ + NIL+ E + K++DFGLSR
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGLSR---- 198
Query: 714 EGGTHVSTT---VVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 761
V V + G + E + T +SDV+SFGV+L E++T G P
Sbjct: 199 ----DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-34
Identities = 87/335 (25%), Positives = 143/335 (42%), Gaps = 65/335 (19%)
Query: 565 FERVLGKGGFGTVYHGYLDD---------KQVAVKML-SSSSVQGYKQFQAEVELLIR-A 613
+ LG+G FG V +VAVKML S ++ + +E+E++
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 614 HHKNLTILVGYCDEGANMGLIYEFMANGNLQAHL--------------LEDKADTLCWER 659
HKN+ L+G C + + +I E+ + GNL+ +L + + L +
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 660 RLQIASESAQGLEYL-HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEGGT 717
+ A + A+G+EYL C +HRD+ + N+L+ E K+ADFGL+R I
Sbjct: 193 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIH------ 242
Query: 718 HVSTTVVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTPQRT 770
H+ T G L PE T +SDV+SFGV+L E+ T G P +
Sbjct: 243 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE- 301
Query: 771 LIGQWVSSMLARGDIKNIVDHRL-QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829
+ +L G HR+ + TN ++ + C H + ++RPT Q+V +
Sbjct: 302 -----LFKLLKEG-------HRMDKPSNCTNELY---MMMRDCWHAVPSQRPTFKQLVED 346
Query: 830 LNDCLAM----EIARTKAHETAPDGTPDELMIDLN 860
L+ +A+ E+ H P + N
Sbjct: 347 LDRIVALTSNQEMGYYHHHHHHDYDIPTTENLYFN 381
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 64/230 (27%), Positives = 96/230 (41%), Gaps = 42/230 (18%)
Query: 565 FERVLGKGGFGTVYHGYLDD-------KQVAVKML-SSSSVQGYKQFQAEVELLIR-AHH 615
F + LG G FG V VAVKML S+ + + +E+++L +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNLQAHL----------------LEDKADTLCWER 659
N+ L+G C G +I E+ G+L L +ED L E
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 660 RLQIASESAQGLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718
L + + A+G+ +L C +HRD+ + NILL K+ DFGL+R +
Sbjct: 147 LLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDS--- 199
Query: 719 VSTTVVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 761
VV L PE + T +SDV+S+G+ L EL + P
Sbjct: 200 --NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 565 FERVLGKGGFGTVYHGYL-----DDKQVAVKML-SSSSVQGYKQFQAEVELLIRAHHKNL 618
++V+G G FG V G L + VA+K L + + + F E ++ + H N+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 619 TILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL-HNG 677
L G + + ++ E+M NG+L + L + + + + A G++YL G
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 678 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT-----VVGTPGYLDP 732
VHRD+ + NIL+N K++DFGL R+ + +T + T P
Sbjct: 168 Y----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS----P 219
Query: 733 EYYISNRLTEKSDVYSFGVVLLELIT 758
E + T SDV+S+G+VL E+++
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 566 ERVLGKGGFGTVYHGYLD---DKQVAVKMLSS--SSVQGYKQ-FQAEVELLIRAHHKNLT 619
R++G+GG G VY D ++ VA+K++S SS ++ Q E R ++
Sbjct: 39 RRLVGRGGMGDVYEAE-DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV- 96
Query: 620 ILVGYCDEGANMGLIY---EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH- 675
V D G G +Y + +L A L L R + I + L+ H
Sbjct: 97 --VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHA 152
Query: 676 NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYY 735
G HRDVK NIL++ A L DFG++ E T + VGT Y+ PE +
Sbjct: 153 AG----ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERF 207
Query: 736 ISNRLTEKSDVYSFGVVLLELITGQP 761
+ T ++D+Y+ VL E +TG P
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSP 233
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 58/242 (23%), Positives = 99/242 (40%), Gaps = 57/242 (23%)
Query: 559 LKITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAH 614
L+ ++FE VLG+G FG V LD + A+K + + + +EV LL +
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLN 60
Query: 615 HKNLTILVG-YCDEGANMGL---------IY---EFMANGNLQAHL-----LEDKADTLC 656
H+ + + + + ++ E+ NG L + + + +
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 657 WERRLQIASESAQGLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF---- 711
R QI L Y+H G I+HRD+K NI ++E K+ DFGL++
Sbjct: 121 LFR--QILE----ALSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 712 --------PVEGGTHVSTTVVGTPGYLDPE------YYISNRLTEKSDVYSFGVVLLELI 757
+ G + T+ +GT Y+ E +Y EK D+YS G++ E+I
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFEMI 225
Query: 758 TG 759
Sbjct: 226 YP 227
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 49/215 (22%), Positives = 90/215 (41%), Gaps = 31/215 (14%)
Query: 567 RVLGKGGFGTVYHGYLDDKQ-VAVKM-----LSSSSVQGYKQFQAEVELLIRAHHKNLTI 620
+ +G GG V+ + KQ A+K + ++ Y+ E+ L + + I
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQHSDKI 71
Query: 621 --LVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH-NG 677
L Y + ++ E N +L + L + K+ + + + +H +G
Sbjct: 72 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS--YWKNMLEAVHTIHQHG 128
Query: 678 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPE---- 733
IVH D+K AN L+ + KL DFG++ + + V + VGT Y+ PE
Sbjct: 129 ----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 734 -------YYISNRLTEKSDVYSFGVVLLELITGQP 761
++++ KSDV+S G +L + G+
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-33
Identities = 70/284 (24%), Positives = 116/284 (40%), Gaps = 35/284 (12%)
Query: 565 FERVLGKGGFGTVYHGYLDDK-----QVAVKML-SSSSVQGYKQFQAEVELLIRAHHKNL 618
R +G+G FG V+ G VA+K + +S ++F E + + H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 619 TILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL--HN 676
L+G E +I E G L++ L K +L + A + + L YL
Sbjct: 454 VKLIGVITENPVW-IIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKR 511
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP-GYLDPEYY 735
VHRD+ + N+L++ KL DFGLSR +E T+ + P ++ PE
Sbjct: 512 -----FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESI 564
Query: 736 ISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794
R T SDV+ FGV + E++ G P + + V + G RL
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRIENG-------ERLP 612
Query: 795 GDFD-TNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837
+ T++ + C +RRP ++ +L+ L E
Sbjct: 613 MPPNCPPTLY---SLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 65/222 (29%), Positives = 98/222 (44%), Gaps = 35/222 (15%)
Query: 565 FERVLGKGGFGTVYHGYLDDK-------QVAVKML-SSSSVQGYKQFQAEVELLIRAHHK 616
R LG G FG VY G + QVAVK L S Q F E ++ + +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 617 NLTILVGYCDEGANMGLIYEFMANGNLQAHLLE-----DKADTLCWERRLQIASESAQGL 671
N+ +G + ++ E MA G+L++ L E + +L L +A + A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 672 EYL-HNGCKPPIVHRDVKSANILLN---EKFQAKLADFGLSR-IFPVEGGTHVSTTVVGT 726
+YL N +HRD+ + N LL AK+ DFG++R I+ S G
Sbjct: 154 QYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY------RASYYRKGG 203
Query: 727 PGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 761
L PE ++ T K+D +SFGV+L E+ + P
Sbjct: 204 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-33
Identities = 51/254 (20%), Positives = 99/254 (38%), Gaps = 34/254 (13%)
Query: 531 QNLRRRKQAGKKKGSLELENRKFSYFDVLKITNN---FERVLGKGGFGTVYHGYLDDKQ- 586
R+ G+ + + S + + + + +G GG V+ + KQ
Sbjct: 23 AKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQI 82
Query: 587 VAVKM-----LSSSSVQGYKQFQAEVELLIRAHHKNLTI--LVGYCDEGANMGLIYEFMA 639
A+K + ++ Y+ E+ L + + I L Y + ++ E
Sbjct: 83 YAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-G 138
Query: 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH-NGCKPPIVHRDVKSANILLNEKF 698
N +L + L + K+ + + + +H +G IVH D+K AN L+ +
Sbjct: 139 NIDLNSWLKKKKSIDPWERKS--YWKNMLEAVHTIHQHG----IVHSDLKPANFLIVDG- 191
Query: 699 QAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPE-----------YYISNRLTEKSDVY 747
KL DFG++ + + V + VG Y+ PE ++++ KSDV+
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
Query: 748 SFGVVLLELITGQP 761
S G +L + G+
Sbjct: 252 SLGCILYYMTYGKT 265
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 41/228 (17%)
Query: 565 FERVLGKGGFGTVYHGYL-------DDKQVAVKML-SSSSVQGYKQFQAEVELLIRAHHK 616
F LG+ FG VY G+L + VA+K L + ++F+ E L R H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 617 NLTILVGYCDEGANMGLIYEFMANGNLQAHL--------------LEDKADTLCWERRLQ 662
N+ L+G + + +I+ + ++G+L L L +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 663 IASESAQGLEYL--HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720
+ ++ A G+EYL H+ +VH+D+ + N+L+ +K K++D GL R V
Sbjct: 133 LVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFRE--VYAA---D 182
Query: 721 TTVVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 761
+ L PE + + + SD++S+GVVL E+ + QP
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 567 RVLGKGGFGTVYHGY-LDDKQ-VAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGY 624
VLGKG +G VY G L ++ +A+K + + + E+ L HKN+ +G
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 625 CDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRL--QIASESAQGLEYLHNGCKPPI 682
E + + E + G+L + LL K L + + +GL+YLH+ I
Sbjct: 88 FSENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---I 143
Query: 683 VHRDVKSANILLNEKF-QAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRL- 740
VHRD+K N+L+N K++DFG S+ + G + T GT Y+ PE
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 741 -TEKSDVYSFGVVLLELITGQP 761
+ +D++S G ++E+ TG+P
Sbjct: 202 YGKAADIWSLGCTIIEMATGKP 223
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 60/313 (19%), Positives = 112/313 (35%), Gaps = 73/313 (23%)
Query: 565 FERVLGKGGFGTVYHGYLDDK---------QVAVKMLSSSSVQGYKQFQAEVELLIRAHH 615
F LG+G F ++ G + +V +K+L + + F ++ + H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL- 674
K+L + G C G L+ EF+ G+L +L ++K + + +L++A + A + +L
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLE 130
Query: 675 -HNGCKPPIVHRDVKSANILLNEKFQ--------AKLADFGLSRIFPVEGGTHVSTTVVG 725
+ ++H +V + NILL + KL+D G+S
Sbjct: 131 ENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-------------- 171
Query: 726 TPGYLDPEYY-----------ISN--RLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTL 771
L + I N L +D +SFG L E+ + G P L
Sbjct: 172 ----LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD-----KPLSAL 222
Query: 772 IGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELN 831
Q H+L + + C+ RP+ ++ +LN
Sbjct: 223 DSQRKLQFYEDR-------HQLPAPKAA-ELA---NLINNCMDYEPDHRPSFRAIIRDLN 271
Query: 832 DCLAMEIARTKAH 844
++ +H
Sbjct: 272 SLFTPDLVPRGSH 284
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-33
Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 31/223 (13%)
Query: 566 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIR-AHHKNLTILV 622
RVL +GGF VY ++ A+K L S+ + + EV + + + H N+ V
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI---V 89
Query: 623 GYCDEGANMG----------LIYEFMANGNLQAHLLEDKADTLCWERR-LQIASESAQGL 671
+C + L+ + G L L + ++ L+I ++ + +
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 672 EYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST---------- 721
+++H KPPI+HRD+K N+LL+ + KL DFG + S
Sbjct: 150 QHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 722 TVVGTPGYLDPE---YYISNRLTEKSDVYSFGVVLLELITGQP 761
T TP Y PE Y + + EK D+++ G +L L Q
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-32
Identities = 48/206 (23%), Positives = 77/206 (37%), Gaps = 26/206 (12%)
Query: 566 ERVLGKGGFGTVYHGY---LDDKQVAVKMLSSSSVQGYKQ-FQAEVELLIRAHHKNL-TI 620
+ + GG G +Y ++ + V +K L S + AE + L H ++ I
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 621 L-VGYCDEGANMGLIY---EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH- 675
+ + Y E++ +L+ L + E L YLH
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLHS 200
Query: 676 NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYY 735
G +V+ D+K NI+L E+ Q KL D G + GTPG+ PE
Sbjct: 201 IG----LVYNDLKPENIMLTEE-QLKLIDLGAVSRI-----NSFGY-LYGTPGFQAPEI- 248
Query: 736 ISNRLTEKSDVYSFGVVLLELITGQP 761
+ T +D+Y+ G L L P
Sbjct: 249 VRTGPTVATDIYTVGRTLAALTLDLP 274
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 566 ERVLGKGGFGTVYHGY--LDDKQVAVKMLS---SSSVQGYKQFQAEVELLIRAHHKNLTI 620
LG GG TVY + + +VA+K + + K+F+ EV + H+N+
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI-- 73
Query: 621 LVGYCDEGANMGLIY---EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH-N 676
V D Y E++ L ++ L + + ++ G+++ H
Sbjct: 74 -VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDM 130
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYI 736
IVHRD+K NIL++ K+ DFG+++ T + V+GT Y PE
Sbjct: 131 R----IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAK 185
Query: 737 SNRLTEKSDVYSFGVVLLELITGQP 761
E +D+YS G+VL E++ G+P
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEP 210
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 64/238 (26%), Positives = 103/238 (43%), Gaps = 53/238 (22%)
Query: 565 FERVLGKGGFGTVYHGYLDD-------KQVAVKML-SSSSVQGYKQFQAEVELLIR-AHH 615
F +VLG G FG V + QVAVKML + + +E++++ + H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNLQAHL---------------------LEDKADT 654
+N+ L+G C + LI+E+ G+L +L E+ +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 655 LCWERRLQIASESAQGLEYL-HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713
L +E L A + A+G+E+L C VHRD+ + N+L+ K+ DFGL+R
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLAR---- 220
Query: 714 EGGTHVSTT---VVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 761
+ + VV L PE T KSDV+S+G++L E+ + P
Sbjct: 221 ----DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 35/222 (15%)
Query: 565 FERVLGKGGFGTVYHGYL-------DDKQVAVKML-SSSSVQGYKQFQAEVELLIRAHHK 616
R LG G FG VY G + QVAVK L S Q F E ++ + +H+
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 617 NLTILVGYCDEGANMGLIYEFMANGNLQAHLLE-----DKADTLCWERRLQIASESAQGL 671
N+ +G + ++ E MA G+L++ L E + +L L +A + A G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 672 EYL-HNGCKPPIVHRDVKSANILLN---EKFQAKLADFGLSR-IFPVEGGTHVSTTVVGT 726
+YL N +HRD+ + N LL AK+ DFG++R I+ G
Sbjct: 195 QYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY------RAGYYRKGG 244
Query: 727 PGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 761
L PE ++ T K+D +SFGV+L E+ + P
Sbjct: 245 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-32
Identities = 60/283 (21%), Positives = 119/283 (42%), Gaps = 40/283 (14%)
Query: 566 ERVLGKGGFGTVYHGYLDDK----QVAVKML-SSSSVQGYKQFQAEVELLIRAHHKNLTI 620
+ LG G FG+V G + VA+K+L + ++ E +++ + + +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 621 LVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL--HNGC 678
L+G C A M L+ E G L L+ + + + ++ + + G++YL N
Sbjct: 401 LIGVCQAEALM-LVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN-- 456
Query: 679 KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT-----VVGTPGYLDPE 733
VHR++ + N+LL + AK++DFGLS+ + + + + + PE
Sbjct: 457 ---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PE 509
Query: 734 YYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHR 792
+ + +SDV+S+GV + E ++ GQ P + + G V + + +G R
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPEVMAFIEQG-------KR 557
Query: 793 LQGDFD-TNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834
++ + ++ + C RP V + C
Sbjct: 558 MECPPECPPELY---ALMSDCWIYKWEDRPDFLTVEQRMRACY 597
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 47/231 (20%), Positives = 88/231 (38%), Gaps = 43/231 (18%)
Query: 563 NNFE--RVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYK-----------------QF 603
N++ R L +G F + D+K A+K S ++ + F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 604 QAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRL-- 661
+ E++++ ++ G + +IYE+M N ++ + +
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150
Query: 662 --------QIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713
+ + Y+HN + I HRDVK +NIL+++ + KL+DFG S
Sbjct: 151 QVIKCIIKSVLN----SFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV- 203
Query: 714 EGGTHVSTTVVGTPGYLDPEYYISNRLT---EKSDVYSFGVVLLELITGQP 761
GT ++ PE + SN + K D++S G+ L +
Sbjct: 204 ---DKKIKGSRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 70/237 (29%), Positives = 98/237 (41%), Gaps = 51/237 (21%)
Query: 565 FERVLGKGGFGTVYHGYLDD-------KQVAVKML-SSSSVQGYKQFQAEVELLIRAHHK 616
+ R +G+G FG V+ VAVKML +S FQ E L+ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 617 NLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERR---------------- 660
N+ L+G C G M L++E+MA G+L L T+C
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 661 ------LQIASESAQGLEYL--HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IF 711
L IA + A G+ YL VHRD+ + N L+ E K+ADFGLSR I+
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 712 PVEGGTHVSTTVVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 761
+ PE NR T +SDV+++GVVL E+ + QP
Sbjct: 226 ------SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 67/213 (31%), Positives = 97/213 (45%), Gaps = 30/213 (14%)
Query: 563 NNFE--RVLGKGGFGTVYHG-YLDDKQ-VAVKMLSSSSVQGYK---QFQAEVELLIRAHH 615
+FE R LGKG FG VY K +A+K+L + ++ Q + EVE+ H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNLQAHLL------EDKADTLCWERRLQIASESAQ 669
N+ L GY + + LI E+ G + L E + +E A
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT------AT--YITELAN 120
Query: 670 GLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGY 729
L Y H ++HRD+K N+LL + K+ADFG S V + T + GT Y
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDY 173
Query: 730 LDPEYYISNRL-TEKSDVYSFGVVLLELITGQP 761
L PE I R+ EK D++S GV+ E + G+P
Sbjct: 174 LPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKP 205
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 55/227 (24%), Positives = 91/227 (40%), Gaps = 37/227 (16%)
Query: 563 NNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQ-FQAEVELLIRAHHKN 617
+FE + LG+GGFG V+ +DD A+K + + + ++ EV+ L + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 618 LTILVGYCD------------EGANMGLIY---EFMANGNLQAHLLEDKADTLCWERR-L 661
I V Y + + +Y + NL+ + L
Sbjct: 65 --I-VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 662 QIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI----------F 711
I + A+ +E+LH+ ++HRD+K +NI K+ DFGL
Sbjct: 122 HIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 712 PVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 758
T VGT Y+ PE N + K D++S G++L EL+
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-31
Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 21/212 (9%)
Query: 560 KITNNFERVLGKGGFGTVYH-GYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIR-AHHKN 617
KI+ + VLG G GT+ + G D++ VAVK + + EV+LL H N
Sbjct: 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPN 79
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH-N 676
+ + + E A LQ +E K + + ++ GL +LH
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCA-ATLQ-EYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137
Query: 677 GCKPPIVHRDVKSANILLNEK-----FQAKLADFGLSRIF-PVEGGTHVSTTVVGTPGYL 730
IVHRD+K NIL++ +A ++DFGL + + V GT G++
Sbjct: 138 N----IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 731 DPEYYISN---RLTEKSDVYSFGVVLLELITG 759
PE + T D++S G V +I+
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 566 ERVLGKGGFGTVYHGY--LDDKQVAVKMLS---SSSVQGYKQFQAEVELLIRAHHKNL-T 619
+LG GG V+ D + VAVK+L + Y +F+ E + +H +
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 620 IL-VGYCDEGANMGLIY---EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH 675
+ G E L Y E++ L+ + + + +R +++ +++ Q L + H
Sbjct: 77 VYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSH 133
Query: 676 -NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST-TVVGTPGYLDPE 733
NG I+HRDVK ANI+++ K+ DFG++R G + T V+GT YL PE
Sbjct: 134 QNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 734 YYISNRLTEKSDVYSFGVVLLELITGQP 761
+ + +SDVYS G VL E++TG+P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 33/216 (15%)
Query: 563 NNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYK---QFQAEVELLIRAHH 615
+F+ +LGKG F VY +VA+KM+ ++ + Q EV++ + H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNLQAHLL-------EDKADTLCWERRL--QIASE 666
++ L Y ++ + L+ E NG + +L E++A R QI +
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEA------RHFMHQIIT- 123
Query: 667 SAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGT 726
G+ YLH+ I+HRD+ +N+LL K+ADFGL+ + H T+ GT
Sbjct: 124 ---GMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH--YTLCGT 175
Query: 727 PGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQP 761
P Y+ PE + +SDV+S G + L+ G+P
Sbjct: 176 PNYISPE-IATRSAHGLESDVWSLGCMFYTLLIGRP 210
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 54/221 (24%), Positives = 83/221 (37%), Gaps = 34/221 (15%)
Query: 564 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQG-YKQFQAEVELLIRAHHKNLTI 620
+LG+G V+ G A+K+ ++ S E E+L + +HKN+
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 621 L--VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWE---RRL--QIASESAQGLEY 673
L + + LI EF G+L L E E + + G+ +
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG----GMNH 127
Query: 674 LH-NGCKPPIVHRDVKSANILL----NEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPG 728
L NG IVHR++K NI+ + + KL DFG +R ++ GT
Sbjct: 128 LRENG----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVSLYGTEE 180
Query: 729 YLDPEYYISNRL--------TEKSDVYSFGVVLLELITGQP 761
YL P+ Y L D++S GV TG
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 18/203 (8%)
Query: 567 RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYK---QFQAEVELLIRAHHKNLTIL 621
R LGKGGF + + A K++ S + + E+ + H+++
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRL--QIASESAQGLEYLHNGCK 679
G+ ++ + ++ E +L KA T R QI G +YLH
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL----GCQYLHRNR- 135
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNR 739
++HRD+K N+ LNE + K+ DFGL+ +G + GTP Y+ PE +S +
Sbjct: 136 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KVLCGTPNYIAPE-VLSKK 190
Query: 740 L-TEKSDVYSFGVVLLELITGQP 761
+ + DV+S G ++ L+ G+P
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKP 213
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 18/203 (8%)
Query: 567 RVLGKGGFGTVYHGYLDD--KQVAVKMLSSSSVQGYK---QFQAEVELLIRAHHKNLTIL 621
R LGKGGF + D + A K++ S + + E+ + H+++
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRL--QIASESAQGLEYLHNGCK 679
G+ ++ + ++ E +L KA T R QI G +YLH
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL----GCQYLHRNR- 161
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNR 739
++HRD+K N+ LNE + K+ DFGL+ +G + GTP Y+ PE +S +
Sbjct: 162 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KVLCGTPNYIAPE-VLSKK 216
Query: 740 L-TEKSDVYSFGVVLLELITGQP 761
+ + DV+S G ++ L+ G+P
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKP 239
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 29/226 (12%)
Query: 568 VLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQ-FQAEVELLIRAHHKNLTILVGY 624
+GKG FG V+ G K VA+K++ + + Q E+ +L + +T G
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 625 CDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIAS---ESAQGLEYLHNGCKPP 681
+ + +I E++ G+ LLE E QIA+ E +GL+YLH+ K
Sbjct: 89 YLKDTKLWIIMEYLGGGSAL-DLLEPGPLD---ET--QIATILREILKGLDYLHSEKK-- 140
Query: 682 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLT 741
+HRD+K+AN+LL+E + KLADFG++ T VGTP ++ PE +
Sbjct: 141 -IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYD 197
Query: 742 EKSDVYSFGVVLLELITGQP---------VIQKTPQR---TLIGQW 775
K+D++S G+ +EL G+P V+ P+ TL G +
Sbjct: 198 SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNY 243
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-30
Identities = 54/221 (24%), Positives = 83/221 (37%), Gaps = 34/221 (15%)
Query: 564 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQG-YKQFQAEVELLIRAHHKNLTI 620
+LG+G V+ G A+K+ ++ S E E+L + +HKN+
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 621 L--VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWE---RRL--QIASESAQGLEY 673
L + + LI EF G+L L E E + + G+ +
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG----GMNH 127
Query: 674 LH-NGCKPPIVHRDVKSANILL----NEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPG 728
L NG IVHR++K NI+ + + KL DFG +R ++ GT
Sbjct: 128 LRENG----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVSLYGTEE 180
Query: 729 YLDPEYYISNRL--------TEKSDVYSFGVVLLELITGQP 761
YL P+ Y L D++S GV TG
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-30
Identities = 29/237 (12%), Positives = 61/237 (25%), Gaps = 47/237 (19%)
Query: 567 RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSS---------------------------- 596
VLG+ + V + +
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 597 VQGYKQFQAEVELLIRAHHKNLT-ILVGYCDEGANMGLIYEFMANGNLQAHL-----LED 650
+ + +F +L+ K + + + D NLQ
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 651 KADTLCWERRLQIASESAQGLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 709
+L RLQ+ + + L LH G +VH ++ +I+L+++ L F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 710 IFPVEGGTHVSTTVVGTPGYLDPE-----YYISNRLTEKSDVYSFGVVLLELITGQP 761
+ P + +T D ++ G+ + +
Sbjct: 260 RDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 21/236 (8%), Positives = 52/236 (22%), Gaps = 49/236 (20%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQG---YKQFQAEVELLIRAHHKNLT 619
L G V+ + A+K+ + + ++ R ++
Sbjct: 66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPE 125
Query: 620 ILVGYC--------------------------DEGANMGLIYEFMANGNLQA-----HLL 648
AN L+ + +L+ +
Sbjct: 126 EARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV 184
Query: 649 EDKADTLCWERRLQIASESAQGLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGL 707
+ ++ + L G +VH N+ + + L D
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQSKG----LVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 708 SRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRL--TEKSDVYSFGVVLLELITGQP 761
Y E+ ++ T + + G+ + +
Sbjct: 241 LWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 563 NNFE--RVLGKGGFGTVYHG-YLDDKQ-VAVKMLSSSSVQGYK---QFQAEVELLIRAHH 615
++F+ R LGKG FG VY +K +A+K+L S ++ Q + E+E+ H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNLQAHLL------EDKADTLCWERRLQIASESAQ 669
N+ + Y + + L+ EF G L L E ++ T ++A
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME----ELAD---- 125
Query: 670 GLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGY 729
L Y H + ++HRD+K N+L+ K + K+ADFG S P + T+ GT Y
Sbjct: 126 ALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP----SLRRRTMCGTLDY 178
Query: 730 LDPEYYISNRL-TEKSDVYSFGVVLLELITGQP 761
L PE I + EK D++ GV+ E + G P
Sbjct: 179 LPPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMP 210
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 43/300 (14%), Positives = 89/300 (29%), Gaps = 53/300 (17%)
Query: 541 KKKGSLELENRKFSYFDVLKITNNFERVLGKGGFGTVYHGYLDD-------KQVAVKMLS 593
K K +L ++ +LG+G F VY D ++ +K+
Sbjct: 55 KPKTEFQLGSKLVY----------VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK 104
Query: 594 SSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKAD 653
++ + +E L + L+ E + G L + K
Sbjct: 105 PANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNT 164
Query: 654 T---LCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQA---------- 700
+ + A +E +H+ I+H D+K N +L F
Sbjct: 165 PEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221
Query: 701 -KLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITG 759
L D G S + + T T G+ E + + D + + ++ G
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281
Query: 760 QP--------------VIQKTPQRTLIGQWVSSML-----ARGDIKNIVDHRLQGDFDTN 800
+ ++ P + ++ ML +++ +L+ F +
Sbjct: 282 TYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-29
Identities = 59/215 (27%), Positives = 90/215 (41%), Gaps = 29/215 (13%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQ-FQAEVELLIRAHHKNLTIL 621
+ LG GGFG V +QVA+K ++ + E++++ + +H N+
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 622 VGYCDEGANMG------LIYEFMANGNLQAHLLEDKADTLCWE---RRL--QIASESAQG 670
D + L E+ G+L+ +L + + E R L I+S
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS----A 133
Query: 671 LEYLH-NGCKPPIVHRDVKSANILLNEKFQA---KLADFGLSRIFPVEGGTHVSTTVVGT 726
L YLH N I+HRD+K NI+L Q K+ D G ++ + T VGT
Sbjct: 134 LRYLHENR----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD---QGELCTEFVGT 186
Query: 727 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
YL PE + T D +SFG + E ITG
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 53/240 (22%), Positives = 93/240 (38%), Gaps = 20/240 (8%)
Query: 531 QNLRRRKQAGKKKGSLELENRKFSYFDVLKITNNFER--VLGKGGFGTVYHGYLDD--KQ 586
+ R + +G L E K ++ + + +G+G FG V+ Q
Sbjct: 26 KLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQ 85
Query: 587 VAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAH 646
AVK + + E+ + L G EG + + E + G+L
Sbjct: 86 CAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQL 140
Query: 647 LLEDKADTLCWERRLQ-IASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK-FQAKLAD 704
+ + E R ++ +GLEYLH I+H DVK+ N+LL+ +A L D
Sbjct: 141 IKQMGCLP---EDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCD 194
Query: 705 FGLSRIFPVEGGTHVST---TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
FG + +G + GT ++ PE + K D++S ++L ++ G
Sbjct: 195 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 51/210 (24%), Positives = 96/210 (45%), Gaps = 29/210 (13%)
Query: 567 RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGY 624
LG G FG VY A K++ + S + + + E+E+L H + L+G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 625 CDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIAS---ESAQGLEYLHNGCKPP 681
+ ++ EF G + A ++ + L QI + + L +LH+
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDA-IMLELDRGL---TEPQIQVVCRQMLEALNFLHSKRI-- 138
Query: 682 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST-----TVVGTPGYLDPEYYI 736
+HRD+K+ N+L+ + +LADFG+S ++ T + +GTP ++ PE +
Sbjct: 139 -IHRDLKAGNVLMTLEGDIRLADFGVS-------AKNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 737 SNRLTE-----KSDVYSFGVVLLELITGQP 761
+ + K+D++S G+ L+E+ +P
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEP 220
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-29
Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 31/213 (14%)
Query: 564 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQG---YKQFQAEVELLIRAHHKNL 618
+RVLGKG FG V + ++ AVK++S V+ + EV+LL + H N+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 619 TILVGYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRLQIASESAQGLE 672
L + ++ L+ E G L + E A + Q+ S G+
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII----RQVLS----GIT 140
Query: 673 YLH-NGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPG 728
Y+H N IVHRD+K N+LL ++ ++ DFGLS F + +GT
Sbjct: 141 YMHKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAY 193
Query: 729 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
Y+ PE + EK DV+S GV+L L++G P
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVILYILLSGCP 225
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 50/210 (23%), Positives = 84/210 (40%), Gaps = 28/210 (13%)
Query: 564 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTIL 621
E +G+G +G V + A K + V+ +F+ E+E++ H N+ L
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 622 VGYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRLQIASESAQGLEYLH 675
++ ++ L+ E G L + E A + + S + Y H
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK----DVLS----AVAYCH 123
Query: 676 -NGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLD 731
+ HRD+K N L + KL DFGL+ F + T VGTP Y+
Sbjct: 124 KLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF---KPGKMMRTKVGTPYYVS 176
Query: 732 PEYYISNRLTEKSDVYSFGVVLLELITGQP 761
P+ + + D +S GV++ L+ G P
Sbjct: 177 PQ-VLEGLYGPECDEWSAGVMMYVLLCGYP 205
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 37/230 (16%)
Query: 568 VLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQ-FQAEVELLIRAHHKNLTILVGY 624
V+G G V Y ++VA+K ++ Q E++ + + HH N+
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 625 CDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRL---QIAS---ESAQGLEYLH-NG 677
+ L+ + ++ G++ + A L IA+ E +GLEYLH NG
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 141
Query: 678 CKPPIVHRDVKSANILLNEKFQAKLADFGLS-RIFPVEGGTHVS--TTVVGTPGYLDPE- 733
+HRDVK+ NILL E ++ADFG+S + T T VGTP ++ PE
Sbjct: 142 ----QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 734 -----YYISNRLTEKSDVYSFGVVLLELITGQP---------VIQKTPQR 769
Y K+D++SFG+ +EL TG V+ T Q
Sbjct: 198 MEQVRGY-----DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 57/239 (23%), Positives = 114/239 (47%), Gaps = 24/239 (10%)
Query: 530 LQNLRRRKQAGKKKGSLELENRKFSYFDVLKITNNFERV--LGKGGFGTVYHGY--LDDK 585
L+ ++ R ++ L+ ++ + F+ + LG+G +G+VY +
Sbjct: 2 LETVQLRNPPRRQLKKLDEDSLT------KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQ 55
Query: 586 QVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQA 645
VA+K + ++ E+ ++ + ++ G + ++ ++ E+ G++
Sbjct: 56 IVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD 113
Query: 646 HLLEDKADTLCWERRLQIAS---ESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKL 702
++ + TL +IA+ + +GLEYLH K +HRD+K+ NILLN + AKL
Sbjct: 114 -IIRLRNKTL---TEDEIATILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKL 166
Query: 703 ADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
ADFG++ + TV+GTP ++ PE +D++S G+ +E+ G+P
Sbjct: 167 ADFGVAGQ--LTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKP 223
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 28/210 (13%)
Query: 564 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTIL 621
F VLG G F V+ L K A+K + S + E+ +L + H+N+ L
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 622 VGYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRLQIASESAQGLEYLH 675
+ + L+ + ++ G L + E A + Q+ S ++YLH
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI----QQVLS----AVKYLH 123
Query: 676 -NGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLD 731
NG IVHRD+K N+L E + + DFGLS++ + +T GTPGY+
Sbjct: 124 ENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGYVA 175
Query: 732 PEYYISNRLTEKSDVYSFGVVLLELITGQP 761
PE ++ D +S GV+ L+ G P
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVITYILLCGYP 205
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-28
Identities = 63/241 (26%), Positives = 103/241 (42%), Gaps = 32/241 (13%)
Query: 537 KQAGKKKGSLELENRKFSYFDVLKITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKML 592
++ +G L+ F ++ ++ + LG G +G V + + A+K++
Sbjct: 11 RENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKII 70
Query: 593 SSSSVQG--YKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL------Q 644
+SV + EV +L H N+ L + ++ N L+ E G L +
Sbjct: 71 RKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR 130
Query: 645 AHLLEDKADTLCWERRLQIASESAQGLEYLH-NGCKPPIVHRDVKSANILL---NEKFQA 700
E A + Q+ S G+ YLH + IVHRD+K N+LL +
Sbjct: 131 MKFNEVDAAVII----KQVLS----GVTYLHKHN----IVHRDLKPENLLLESKEKDALI 178
Query: 701 KLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 760
K+ DFGLS +F +GT Y+ PE + + EK DV+S GV+L L+ G
Sbjct: 179 KIVDFGLSAVF---ENQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
Query: 761 P 761
P
Sbjct: 235 P 235
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 53/222 (23%), Positives = 85/222 (38%), Gaps = 40/222 (18%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQ---------FQAEVELLIR- 612
+ +LG+G V K+ AVK++ + + EV++L +
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 613 AHHKNLTILVGYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRLQIASE 666
+ H N+ L + L+++ M G L + L E + + +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM----RALLE- 135
Query: 667 SAQGLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG 725
+ LH IVHRD+K NILL++ KL DFG S V G
Sbjct: 136 ---VICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCG 185
Query: 726 TPGYLDPE------YYISNRLTEKSDVYSFGVVLLELITGQP 761
TP YL PE ++ D++S GV++ L+ G P
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 569 LGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCD 626
+G+G GTVY ++VA++ ++ + E+ ++ + N+ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 627 EGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIAS---ESAQGLEYLHNGCKPPIV 683
G + ++ E++A G+L + E D E QIA+ E Q LE+LH+ +
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMD----EG--QIAAVCRECLQALEFLHSNQV---I 138
Query: 684 HRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEK 743
HRD+KS NILL KL DFG + +T+VGTP ++ PE K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 744 SDVYSFGVVLLELITGQP 761
D++S G++ +E+I G+P
Sbjct: 197 VDIWSLGIMAIEMIEGEP 214
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 55/254 (21%), Positives = 103/254 (40%), Gaps = 41/254 (16%)
Query: 534 RRRKQAGKKKGSLELENRKFSYFDVLKITNNFE--RVLGKGGFGTVYHGY--LDDKQVAV 589
+ + S+ E+ + + ++ V+G+G V + AV
Sbjct: 65 QPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAV 124
Query: 590 KMLSSSSVQG--------YKQFQAEVELLIR-AHHKNLTILVGYCDEGANMGLIYEFMAN 640
K++ ++ + + + E +L + A H ++ L+ + + M L+++ M
Sbjct: 125 KIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRK 184
Query: 641 GNL------QAHLLEDKADTLCWERRLQIASESAQGLEYLH-NGCKPPIVHRDVKSANIL 693
G L + L E + ++ + + +LH N IVHRD+K NIL
Sbjct: 185 GELFDYLTEKVALSEKETRSIM----RSLLE----AVSFLHANN----IVHRDLKPENIL 232
Query: 694 LNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPE------YYISNRLTEKSDVY 747
L++ Q +L+DFG S + GTPGYL PE ++ D++
Sbjct: 233 LDDNMQIRLSDFGFSCHL---EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLW 289
Query: 748 SFGVVLLELITGQP 761
+ GV+L L+ G P
Sbjct: 290 ACGVILFTLLAGSP 303
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-28
Identities = 62/237 (26%), Positives = 102/237 (43%), Gaps = 24/237 (10%)
Query: 540 GKKKGSLELEN---RKFSYFDVLKITNN------FERV--LGKGGFGTVYHGYL--DDKQ 586
GKK LEL+ ++ F K FE++ LG G G V+
Sbjct: 1 GKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLV 60
Query: 587 VAVK-MLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQA 645
+A K + Q E+++L + + G + + E M G+L
Sbjct: 61 MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 646 HLLEDKADTLCWERRL-QIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLAD 704
L + E+ L +++ +GL YL K I+HRDVK +NIL+N + + KL D
Sbjct: 121 VLKKAGRIP---EQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCD 175
Query: 705 FGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
FG+S ++ + VGT Y+ PE + +SD++S G+ L+E+ G+
Sbjct: 176 FGVSGQL----IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 228
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-28
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 564 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQG--YKQFQAEVELLIRAHHKNLT 619
N +LGKG FG V + ++ AVK+++ +S + EVELL + H N+
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 620 ILVGYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRLQIASESAQGLEY 673
L ++ ++ ++ E G L + E A + Q+ S G+ Y
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII----KQVFS----GITY 136
Query: 674 LH-NGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGY 729
+H + IVHRD+K NILL + K+ DFGLS F +GT Y
Sbjct: 137 MHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYY 189
Query: 730 LDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
+ PE + EK DV+S GV+L L++G P
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVILYILLSGTP 220
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 56/284 (19%), Positives = 98/284 (34%), Gaps = 65/284 (22%)
Query: 532 NLRRRKQAGKKKGSLELENRKFSYFDVLKITNNFE--RVLGKGGFGTVYHGY--LDDKQV 587
+ +G++ + + ++ + +G+G +G V
Sbjct: 2 HHHHHHSSGRENLYFQGGSLL-------ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIR 54
Query: 588 AVKM-----LSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642
A+K+ + + + ++ + EV L+ + HH N+ L ++ + L+ E G+
Sbjct: 55 AIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGH 114
Query: 643 LQAHLLEDKADTLCWERRLQIASESA---------------------------------- 668
L L D+ + ++
Sbjct: 115 LLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM 174
Query: 669 ----QGLEYLH-NGCKPPIVHRDVKSANILLNEKFQA--KLADFGLSRIFPV--EGGTHV 719
L YLH G I HRD+K N L + KL DFGLS+ F G +
Sbjct: 175 RQIFSALHYLHNQG----ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYG 230
Query: 720 STTVVGTPGYLDPE--YYISNRLTEKSDVYSFGVVLLELITGQP 761
TT GTP ++ PE + K D +S GV+L L+ G
Sbjct: 231 MTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 35/245 (14%), Positives = 71/245 (28%), Gaps = 62/245 (25%)
Query: 567 RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSS---------------------------- 596
VLG+ + V + +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 597 VQGYKQFQAEVELLIRAHHKNLTILVGYCDEG--ANMGLIYEFMAN------GNLQAHLL 648
+ + +F +L+ K + + + + +Y M + L +H
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 649 EDKADTLCWERRLQIASESAQGLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGL 707
K +L RLQ+ + + L LH G +VH ++ +I+L+++ L F
Sbjct: 199 THK--SLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEH 252
Query: 708 SRIFPVEGGTHVSTTVVGTPGYLDPEY-----------YISNRLTEKSDVYSFGVVLLEL 756
V G + G+ PE +T D ++ G+V+ +
Sbjct: 253 L----VRDGA--RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306
Query: 757 ITGQP 761
Sbjct: 307 WCADL 311
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 564 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQG--YKQFQAEVELLIRAHHKNLT 619
N +LGKG FG V + ++ AVK+++ +S + EVELL + H N+
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 620 ILVGYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRLQIASESAQGLEY 673
L ++ ++ ++ E G L + E A + Q+ S G+ Y
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII----KQVFS----GITY 136
Query: 674 LH-NGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGY 729
+H + IVHRD+K NILL + K+ DFGLS F +GT Y
Sbjct: 137 MHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYY 189
Query: 730 LDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
+ PE + EK DV+S GV+L L++G P
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVILYILLSGTP 220
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-28
Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 39/221 (17%)
Query: 564 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQG--------YKQFQAEVELLIRA 613
+ LG G G V + K+VA++++S + E+E+L +
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 614 HHKNLTILVGYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRLQIASES 667
+H + + + D + ++ E M G L L E Q+
Sbjct: 198 NHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF----YQMLL-- 250
Query: 668 AQGLEYLH-NGCKPPIVHRDVKSANILLNEK---FQAKLADFGLSRIFPVEGGTHVSTTV 723
++YLH NG I+HRD+K N+LL+ + K+ DFG S+I G T + T+
Sbjct: 251 --AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTL 301
Query: 724 VGTPGYLDPE---YYISNRLTEKSDVYSFGVVLLELITGQP 761
GTP YL PE + D +S GV+L ++G P
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 59/215 (27%), Positives = 90/215 (41%), Gaps = 33/215 (15%)
Query: 564 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQG-YKQFQAEVELLIRAHHKNLTI 620
F+R LG G FG V+ + +K ++ Q +Q +AE+E+L H N+
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 621 LVGYCDEGANMGLIYEFMANGNL----------QAHLLEDKADTLCWERRLQIASESAQG 670
+ ++ NM ++ E G L L E L Q+ +
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK----QMMN----A 136
Query: 671 LEYLH-NGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGTHVSTTVVGT 726
L Y H +VH+D+K NIL + K+ DFGL+ +F ST GT
Sbjct: 137 LAYFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF---KSDEHSTNAAGT 189
Query: 727 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
Y+ PE +T K D++S GVV+ L+TG
Sbjct: 190 ALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCL 223
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-28
Identities = 56/231 (24%), Positives = 86/231 (37%), Gaps = 48/231 (20%)
Query: 564 NFERVLGKGGFGTVYH-GYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIR-AHHKNLTIL 621
E++LG G GTV G + VAVK + E++LL H N+
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRY 74
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRL----------QIASESAQGL 671
+ + E N NLQ L+E K + + QIAS G+
Sbjct: 75 YCSETTDRFLYIALELC-NLNLQ-DLVESKNVSDENLKLQKEYNPISLLRQIAS----GV 128
Query: 672 EYLH-NGCKPPIVHRDVKSANILLNEK-------------FQAKLADFGLSRIFPVEGGT 717
+LH I+HRD+K NIL++ + ++DFGL + +
Sbjct: 129 AHLHSLK----IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 718 HVST--TVVGTPGYLDPE-------YYISNRLTEKSDVYSFGVVLLELITG 759
+ GT G+ PE RLT D++S G V +++
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-27
Identities = 49/211 (23%), Positives = 78/211 (36%), Gaps = 24/211 (11%)
Query: 568 VLGKG--GFGTVYHGY--LDDKQVAVKM--LSSSSVQGYKQFQAEVELLIRAHHKNLTIL 621
V+GKG TV + V V+ L + S + Q E+ + +H N+
Sbjct: 32 VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIAS---ESAQGLEYLH-NG 677
+ ++ FMA G+ + L+ E IA + L+Y+H G
Sbjct: 92 RATFIADNELWVVTSFMAYGSAK-DLICTHFMDGMNEL--AIAYILQGVLKALDYIHHMG 148
Query: 678 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG-----THVSTTVVGTPGYLDP 732
VHR VK+++IL++ + L+ + G V +L P
Sbjct: 149 Y----VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 733 EYYISNRL--TEKSDVYSFGVVLLELITGQP 761
E N KSD+YS G+ EL G
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHV 235
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 62/222 (27%), Positives = 89/222 (40%), Gaps = 41/222 (18%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGY-------------KQFQAEVEL 609
R LG G +G V + A+K++ S ++ E+ L
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 610 LIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRLQI 663
L H N+ L ++ L+ EF G L + E A + QI
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIM----KQI 155
Query: 664 ASESAQGLEYLH-NGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGTHV 719
S G+ YLH + IVHRD+K NILL N K+ DFGLS F +
Sbjct: 156 LS----GICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF---SKDYK 204
Query: 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
+GT Y+ PE + + EK DV+S GV++ L+ G P
Sbjct: 205 LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP 245
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 24/202 (11%)
Query: 569 LGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCD 626
+G+G G V +QVAVKM+ Q + EV ++ H N+ +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 627 EGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIAS---ESAQGLEYLHNGCKPPIV 683
G + ++ EF+ G L + + + + E QIA+ Q L YLH +
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVRLN----EE--QIATVCEAVLQALAYLHAQGV---I 163
Query: 684 HRDVKSANILLNEKFQAKLADFG----LSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNR 739
HRD+KS +ILL + KL+DFG +S+ P ++VGTP ++ PE +
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP------KRKSLVGTPYWMAPEVISRSL 217
Query: 740 LTEKSDVYSFGVVLLELITGQP 761
+ D++S G++++E++ G+P
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEP 239
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 58/238 (24%), Positives = 100/238 (42%), Gaps = 29/238 (12%)
Query: 538 QAGKKKGSLELENRKFSY----FDVLKITNNFERVLGKGGFGTVYHGYL--DDKQVAVK- 590
+GK+ G L + +++ + L +G G G V+ +AVK
Sbjct: 5 SSGKQTGYLTIGGQRYQAEINDLENLG-------EMGSGTCGQVWKMRFRKTGHVIAVKQ 57
Query: 591 MLSSSSVQGYKQFQAEVELLIRAH-HKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLE 649
M S + + K+ ++++++++H + G ++ + E M A L+
Sbjct: 58 MRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTC---AEKLK 114
Query: 650 DKADTLCWERRL-QIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 708
+ ER L ++ + L YL ++HRDVK +NILL+E+ Q KL DFG+S
Sbjct: 115 KRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGIS 172
Query: 709 RIFPVEGGTHVSTTVVGTPGYLDPE-----YYISNRLTEKSDVYSFGVVLLELITGQP 761
G Y+ PE ++DV+S G+ L+EL TGQ
Sbjct: 173 GRL---VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 69/244 (28%), Positives = 106/244 (43%), Gaps = 28/244 (11%)
Query: 531 QNLRRRKQAGKKKGSLELE--NRKFSYFDVLKITNNFERVLGKGGFGTVYHGY--LDDKQ 586
Q AG + GSL+ F D K+ ++ +G G FG VY + +
Sbjct: 23 QGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLRE-IGHGSFGAVYFARDVRNSEV 81
Query: 587 VAVKMLS---SSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL 643
VA+K +S S + ++ EV L + H N G L+ E+
Sbjct: 82 VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS 141
Query: 644 QAHLLEDKADTLCWERRLQIAS---ESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQA 700
LLE L + ++IA+ + QGL YLH+ +HRDVK+ NILL+E
Sbjct: 142 D--LLEVHKKPL---QEVEIAAVTHGALQGLAYLHSHNM---IHRDVKAGNILLSEPGLV 193
Query: 701 KLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTE---KSDVYSFGVVLLELI 757
KL DFG + + + VGTP ++ PE ++ + K DV+S G+ +EL
Sbjct: 194 KLGDFGSA------SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247
Query: 758 TGQP 761
+P
Sbjct: 248 ERKP 251
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 29/212 (13%)
Query: 564 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQG--YKQFQAEVELLIRAHHKNLT 619
+ + LGKG F V + A K++++ + +++ + E + + H N+
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 620 ILVGYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRLQIASESAQGLEY 673
L E + L+++ + G L + E A QI + Y
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI----QQILE----SIAY 120
Query: 674 LH-NGCKPPIVHRDVKSANILLNEKFQA---KLADFGLSRIFPVEGGTHVSTTVVGTPGY 729
H NG IVHR++K N+LL K + KLADFGL+ + GTPGY
Sbjct: 121 CHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGY 173
Query: 730 LDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
L PE + ++ D+++ GV+L L+ G P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYP 205
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 48/209 (22%), Positives = 89/209 (42%), Gaps = 26/209 (12%)
Query: 568 VLGKGGFGTVYHGYL--DDKQVAVK-MLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVG 623
LG+G +G V + +AVK + ++ + Q K+ ++++ +R G
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRL------QIASESAQGLEYLHNG 677
++ + E M L + + + + +IA + LE+LH+
Sbjct: 74 ALFREGDVWICMELMDTS-----LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 678 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYIS 737
++HRDVK +N+L+N Q K+ DFG+S G Y+ PE I+
Sbjct: 129 LS--VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDDVAKDIDAGCKPYMAPE-RIN 182
Query: 738 NRLTE-----KSDVYSFGVVLLELITGQP 761
L + KSD++S G+ ++EL +
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAILRF 211
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 52/212 (24%), Positives = 87/212 (41%), Gaps = 32/212 (15%)
Query: 564 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIR-AHHKNLTI 620
+ +G G + + + AVK++ S E+E+L+R H N+
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNIIT 80
Query: 621 LVGYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRLQIASESAQGLEYL 674
L D+G + ++ E M G L Q E +A + I +EYL
Sbjct: 81 LKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL----FTITK----TVEYL 132
Query: 675 H-NGCKPPIVHRDVKSANILLNEKFQA----KLADFGLSRIFPVEGGTHVSTTVVGTPGY 729
H G +VHRD+K +NIL ++ ++ DFG ++ E G + T T +
Sbjct: 133 HAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANF 186
Query: 730 LDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
+ PE D++S GV+L ++TG
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTMLTGYT 218
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 62/239 (25%), Positives = 106/239 (44%), Gaps = 31/239 (12%)
Query: 545 SLELENRKFSYFDVLKITN---NFERV--LGKGGFGTVYHGY--LDDKQVAVKMLSSSSV 597
+ + R D+ + + FE V +G G +G VY G + A+K++ +
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG- 61
Query: 598 QGYKQFQAEVELLIRA-HHKNLT------ILVGYCDEGANMGLIYEFMANGNLQAHLLED 650
++ + E+ +L + HH+N+ I + L+ EF G++ +
Sbjct: 62 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT 121
Query: 651 KADTLCWERRLQIAS---ESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGL 707
K +TL + IA E +GL +LH +HRD+K N+LL E + KL DFG+
Sbjct: 122 KGNTL---KEEWIAYICREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGV 175
Query: 708 SRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTE-----KSDVYSFGVVLLELITGQP 761
S G T +GTP ++ PE + + KSD++S G+ +E+ G P
Sbjct: 176 SAQLDRTVGRR--NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-27
Identities = 59/221 (26%), Positives = 91/221 (41%), Gaps = 39/221 (17%)
Query: 564 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQG--------YKQFQAEVELLIRA 613
+ LG G G V + K+VA+K++S + E+E+L +
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 614 HHKNLTILVGYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRLQIASES 667
+H + + + D + ++ E M G L L E Q+
Sbjct: 73 NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYF----YQMLL-- 125
Query: 668 AQGLEYLH-NGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGTHVSTTV 723
++YLH NG I+HRD+K N+LL E K+ DFG S+I G T + T+
Sbjct: 126 --AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTL 176
Query: 724 VGTPGYLDPE---YYISNRLTEKSDVYSFGVVLLELITGQP 761
GTP YL PE + D +S GV+L ++G P
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-27
Identities = 45/210 (21%), Positives = 81/210 (38%), Gaps = 27/210 (12%)
Query: 564 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTIL 621
+ LG G FG V+ + K +++ + E+ ++ + HH L L
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 622 VGYCDEGANMGLIYEFMANGNL-------QAHLLEDKADTLCWERRLQIASESAQGLEYL 674
++ M LI EF++ G L + E + Q GL+++
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM----RQACE----GLKHM 165
Query: 675 H-NGCKPPIVHRDVKSANILLNEKFQA--KLADFGLSRIFPVEGGTHVSTTVVGTPGYLD 731
H + IVH D+K NI+ K + K+ DFGL+ + T +
Sbjct: 166 HEHS----IVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAA 218
Query: 732 PEYYISNRLTEKSDVYSFGVVLLELITGQP 761
PE + +D+++ GV+ L++G
Sbjct: 219 PEIVDREPVGFYTDMWAIGVLGYVLLSGLS 248
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 30/213 (14%)
Query: 564 NFERVLGKGGFGTVY--HGYLDDKQVAVKMLSSSSVQGYKQFQ---AEVELLIRAHHKNL 618
F ++LG+G F TV ++ A+K+L + + E +++ R H
Sbjct: 33 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 619 TILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI---------ASESAQ 669
L + + + NG L ++ R++ +E
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGELLKYI-----------RKIGSFDETCTRFYTAEIVS 141
Query: 670 GLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPG 728
LEYLH G I+HRD+K NILLNE ++ DFG +++ E + + VGT
Sbjct: 142 ALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197
Query: 729 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
Y+ PE + SD+++ G ++ +L+ G P
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 230
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 29/211 (13%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQG--YKQFQAEVELLIRAHHKNLTI 620
+ LGKG F V + A K++++ + +++ + E + + H N+
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 621 LVGYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRLQIASESAQGLEYL 674
L E + L+++ + G L + E A QI + Y
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI----QQILE----SIAYC 144
Query: 675 H-NGCKPPIVHRDVKSANILLNEKFQA---KLADFGLSRIFPVEGGTHVSTTVVGTPGYL 730
H NG IVHR++K N+LL K + KLADFGL+ + GTPGYL
Sbjct: 145 HSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGYL 197
Query: 731 DPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
PE + ++ D+++ GV+L L+ G P
Sbjct: 198 SPEVLKKDPYSKPVDIWACGVILYILLVGYP 228
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 56/217 (25%), Positives = 87/217 (40%), Gaps = 34/217 (15%)
Query: 564 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQG------YKQFQAEVELLIRAHH 615
LG G F V K+ A K + + ++ + EV +L H
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRLQIASESAQ 669
N+ L + ++ LI E ++ G L + L ED+A QI
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL----KQILD---- 119
Query: 670 GLEYLH-NGCKPPIVHRDVKSANILLNEKFQA----KLADFGLSRIFPVEGGTHVSTTVV 724
G+ YLH I H D+K NI+L +K KL DFG++ E G +
Sbjct: 120 GVHYLHSKR----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEF-KNIF 172
Query: 725 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
GTP ++ PE L ++D++S GV+ L++G
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 209
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 44/247 (17%), Positives = 87/247 (35%), Gaps = 47/247 (19%)
Query: 544 GSLELENRKFSYFDVLKITNNFERVLGKGGFGTVYHGY--LDDKQVAVK--MLSSSSVQG 599
G++ +++R + F L+ +G G FG+V+ LD A+K +
Sbjct: 1 GAMGMKSRYTTEFHELE-------KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD 53
Query: 600 YKQFQAEVELLIR-AHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCW- 657
+ EV H ++ E +M + E+ G+L + E+ +
Sbjct: 54 EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFK 113
Query: 658 ERRLQ-IASESAQGLEYLH-NGCKPPIVHRDVKSANILLNE------------------- 696
E L+ + + +GL Y+H +VH D+K +NI ++
Sbjct: 114 EAELKDLLLQVGRGLRYIHSMS----LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169
Query: 697 KFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRL--TEKSDVYSFGVVLL 754
K K+ D G G +L E + K+D+++ + ++
Sbjct: 170 KVMFKIGDLGHVTRIS------SPQVEEGDSRFLANE-VLQENYTHLPKADIFALALTVV 222
Query: 755 ELITGQP 761
+P
Sbjct: 223 CAAGAEP 229
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 568 VLGKGGFGTVYHGYL--DDKQVAVK-MLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVG 623
+G+G +G+V + +AVK + S+ + KQ ++++++R+ + G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 624 YCDEGANMGLIYEFMANG--NLQAHLLEDKADTLCWERRL-QIASESAQGLEYLHNGCKP 680
+ + E M+ ++ D + E L +I + + L +L K
Sbjct: 89 ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIP-EEILGKITLATVKALNHLKENLK- 146
Query: 681 PIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRL 740
I+HRD+K +NILL+ KL DFG+S + T G Y+ PE I
Sbjct: 147 -IIHRDIKPSNILLDRSGNIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPE-RIDPSA 201
Query: 741 TE-----KSDVYSFGVVLLELITGQP 761
+ +SDV+S G+ L EL TG+
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRF 227
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-26
Identities = 55/211 (26%), Positives = 86/211 (40%), Gaps = 28/211 (13%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQ--FQAEVELLIRAHHKNLTI 620
LGKG F V L ++ A ++++ + + E + H N+
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 621 LVGYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRLQIASESAQGLEYL 674
L E + LI++ + G L + + E A QI + +
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI----QQILE----AVLHC 126
Query: 675 H-NGCKPPIVHRDVKSANILLNEKFQA---KLADFGLSRIFPVEGGTHVSTTVVGTPGYL 730
H G +VHR++K N+LL K + KLADFGL+ EG GTPGYL
Sbjct: 127 HQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV--EGEQQAWFGFAGTPGYL 180
Query: 731 DPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
PE + + D+++ GV+L L+ G P
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVILYILLVGYP 211
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 38/219 (17%)
Query: 564 NFERVLGKGGFGTVYHGYLDDK----QVAVKMLSSSSVQG------YKQFQAEVELLIRA 613
+ LG G F V +K + A K + + ++ + EV +L +
Sbjct: 15 DIGEELGSGQFAIVKKC--REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 614 HHKNLTILVGYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRLQIASES 667
H N+ L + ++ LI E ++ G L + L E++A + QI
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI----KQILD-- 126
Query: 668 AQGLEYLH-NGCKPPIVHRDVKSANILLNEK----FQAKLADFGLSRIFPVEGGTHVSTT 722
G+ YLH I H D+K NI+L +K KL DFGL+
Sbjct: 127 --GVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKN 177
Query: 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
+ GTP ++ PE L ++D++S GV+ L++G
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 30/209 (14%)
Query: 566 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIR-AHHKNLTILV 622
++ LG+G F ++ AVK++S Q E+ L H N+ L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME---ANTQKEITALKLCEGHPNIVKLH 72
Query: 623 GYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRLQIASESAQGLEYLH- 675
+ + L+ E + G L + H E +A + ++ S + ++H
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIM----RKLVS----AVSHMHD 124
Query: 676 NGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDP 732
G +VHRD+K N+L N+ + K+ DFG +R+ P + T T Y P
Sbjct: 125 VG----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHYAAP 178
Query: 733 EYYISNRLTEKSDVYSFGVVLLELITGQP 761
E N E D++S GV+L +++GQ
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQV 207
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-26
Identities = 52/210 (24%), Positives = 82/210 (39%), Gaps = 27/210 (12%)
Query: 564 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTIL 621
+ LG G FG V+ A K + + + + E++ + H L L
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 622 VGYCDEGANMGLIYEFMANGNL-------QAHLLEDKADTLCWERRLQIASESAQGLEYL 674
++ M +IYEFM+ G L + ED+A Q+ GL ++
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM----RQVCK----GLCHM 271
Query: 675 H-NGCKPPIVHRDVKSANILLNEKFQA--KLADFGLSRIFPVEGGTHVSTTVVGTPGYLD 731
H N VH D+K NI+ K KL DFGL+ + V GT +
Sbjct: 272 HENN----YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSV-KVTTGTAEFAA 324
Query: 732 PEYYISNRLTEKSDVYSFGVVLLELITGQP 761
PE + +D++S GV+ L++G
Sbjct: 325 PEVAEGKPVGYYTDMWSVGVLSYILLSGLS 354
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-26
Identities = 54/218 (24%), Positives = 81/218 (37%), Gaps = 35/218 (16%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVKM-----LSSSSVQGYKQFQAEVELLIRAHHKN 617
V+GKG F V +Q AVK+ +SS + + E + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 618 LTILVGYCDEGANMGLIYEFMANGNL----------QAHLLEDKADTLCWERRLQIASES 667
+ L+ + +++EFM +L E A QI
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR----QILE-- 141
Query: 668 AQGLEYLH-NGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGTHVSTTV 723
L Y H N I+HRDVK +LL KL FG++ G V+
Sbjct: 142 --ALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGR 193
Query: 724 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
VGTP ++ PE + DV+ GV+L L++G
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 34/217 (15%)
Query: 564 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQ------FQAEVELLIRAHH 615
+ LG G F V + A K + + ++ + EV +L + H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRLQIASESAQ 669
N+ L + ++ LI E ++ G L + L E++A + QI
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI----KQILD---- 126
Query: 670 GLEYLH-NGCKPPIVHRDVKSANILLNEK----FQAKLADFGLSRIFPVEGGTHVSTTVV 724
G+ YLH I H D+K NI+L +K KL DFGL+ +
Sbjct: 127 GVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIF 179
Query: 725 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
GTP ++ PE L ++D++S GV+ L++G
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 55/214 (25%), Positives = 86/214 (40%), Gaps = 32/214 (14%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQ----GYKQFQAEVELLIRAHHKNL 618
+LG+G +G V + AVK+L ++ G + E++LL R HKN+
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 619 TIL--VGYCDEGANMGLIYEFMANGNL-------QAHLLEDKADTLCWERRL--QIASES 667
L V Y +E M ++ E+ G + +A Q+
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQA------HGYFCQLID-- 120
Query: 668 AQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTP 727
GLEYLH+ IVH+D+K N+LL K++ G++ T G+P
Sbjct: 121 --GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 728 GYLDPEYYISNRLTE--KSDVYSFGVVLLELITG 759
+ PE K D++S GV L + TG
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 51/247 (20%), Positives = 99/247 (40%), Gaps = 35/247 (14%)
Query: 535 RRKQAGKKKGSLELENRKFSYFDVLKITNNFE--------RVLGKGGFGTVYHGY--LDD 584
+ K+ + F + V +LG G FG V+
Sbjct: 55 KSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATG 114
Query: 585 KQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL- 643
++A K++ + ++ ++ + E+ ++ + H NL L + ++ L+ E++ G L
Sbjct: 115 LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174
Query: 644 -----QAHLL-EDKADTLCWERRLQIASESAQGLEYLH-NGCKPPIVHRDVKSANILLNE 696
+++ L E QI G+ ++H I+H D+K NIL
Sbjct: 175 DRIIDESYNLTELDTILFM----KQICE----GIRHMHQMY----ILHLDLKPENILCVN 222
Query: 697 KFQA--KLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLL 754
+ K+ DFGL+R + GTP +L PE + ++ +D++S GV+
Sbjct: 223 RDAKQIKIIDFGLARRY---KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAY 279
Query: 755 ELITGQP 761
L++G
Sbjct: 280 MLLSGLS 286
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 66/293 (22%), Positives = 117/293 (39%), Gaps = 49/293 (16%)
Query: 566 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIR-AHHKNLTILV 622
E VLG+G V + ++ AVK++ + EVE+L + H+N+ L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 623 GYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRLQIASESAQGLEYLH- 675
+ +E L++E M G++ + H E +A + +AS L++LH
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVV----QDVAS----ALDFLHN 129
Query: 676 NGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEG-----GTHVSTTVVGTP 727
G I HRD+K NIL N+ K+ DF L + G T T G+
Sbjct: 130 KG----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 728 GYLDPE-----YYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP---QRTLIGQWVSSM 779
Y+ PE ++ ++ D++S GV+L L++G P P + W
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP-----PFVGRCGSDCGWDRGE 240
Query: 780 LARGDIKNIVDHRLQGDFD-TNTVWKAV-EIA----LACIHTISTRRPTMNQV 826
+ + +G ++ + W + A + + +R + QV
Sbjct: 241 ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQV 293
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 53/217 (24%), Positives = 86/217 (39%), Gaps = 34/217 (15%)
Query: 564 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQG------YKQFQAEVELLIRAHH 615
+ LG G F V Q A K + + + + EV +L H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRLQIASESAQ 669
N+ L + ++ LI E +A G L + L E++A QI +
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL----KQILN---- 125
Query: 670 GLEYLH-NGCKPPIVHRDVKSANILLNEKFQA----KLADFGLSRIFPVEGGTHVSTTVV 724
G+ YLH I H D+K NI+L ++ K+ DFGL+ + +
Sbjct: 126 GVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIF 178
Query: 725 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
GTP ++ PE L ++D++S GV+ L++G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 56/238 (23%), Positives = 93/238 (39%), Gaps = 29/238 (12%)
Query: 541 KKKGSLELENRKFSYFDVLKITNNFE---RVLGKGGFGTVYHGY--LDDKQVAVKMLSSS 595
++L + + N + + LG+G F V ++ A K L
Sbjct: 6 HHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKR 65
Query: 596 SVQG--YKQFQAEVELLIR-AHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKA 652
+ E+ +L + L + + + LI E+ A G + + L + A
Sbjct: 66 RRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELA 125
Query: 653 DTLCWERR-----LQIASESAQGLEYLH-NGCKPPIVHRDVKSANILL---NEKFQAKLA 703
+ + E QI G+ YLH N IVH D+K NILL K+
Sbjct: 126 EMVS-ENDVIRLIKQILE----GVYYLHQNN----IVHLDLKPQNILLSSIYPLGDIKIV 176
Query: 704 DFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
DFG+SR G ++GTP YL PE + +T +D+++ G++ L+T
Sbjct: 177 DFGMSRKI---GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTS 231
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 42/210 (20%), Positives = 86/210 (40%), Gaps = 28/210 (13%)
Query: 564 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTIL 621
LG+G FG V+ K K + + E+ +L A H+N+ L
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHL 66
Query: 622 VGYCDEGANMGLIYEFMANGNL-------QAHLLEDKADTLCWERRLQIASESAQGLEYL 674
+ + +I+EF++ ++ L E + + Q+ L++L
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYV----HQVCE----ALQFL 118
Query: 675 H-NGCKPPIVHRDVKSANILLNEKFQA--KLADFGLSRIFPVEGGTHVSTTVVGTPGYLD 731
H + I H D++ NI+ + + K+ +FG +R + G + + P Y
Sbjct: 119 HSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNF-RLLFTAPEYYA 171
Query: 732 PEYYISNRLTEKSDVYSFGVVLLELITGQP 761
PE + + ++ +D++S G ++ L++G
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQG-YKQFQAEVELLIRAHHKNLTIL 621
+ LG+G +G V + ++ VAVK++ + + E+ + +H+N+
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 622 VGYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRL--QIASESAQGLEY 673
G+ EG L E+ + G L + E A +R Q+ + G+ Y
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA------QRFFHQLMA----GVVY 120
Query: 674 LH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDP 732
LH G I HRD+K N+LL+E+ K++DFGL+ +F + + GT Y+ P
Sbjct: 121 LHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 733 EYYISNRL--TEKSDVYSFGVVLLELITG 759
E + R E DV+S G+VL ++ G
Sbjct: 177 E-LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-25
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 42/221 (19%)
Query: 563 NNFE--RVLGKGGFGTVYHGYL----DDKQV-AVKMLSSSSVQGYKQFQ---AEVELLIR 612
++FE R +GKG FG V + D K++ A+K ++ + + E++++
Sbjct: 15 DHFEILRAIGKGSFGKVC---IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 613 AHHKNLTILVGYC--DEGANMGLIYEFMANGNLQAHL------LEDKADTLCWERRLQIA 664
H L L Y DE +M ++ + + G+L+ HL E+ +L I
Sbjct: 72 LEHPFLVNLW-YSFQDEE-DMFMVVDLLLGGDLRYHLQQNVHFKEETV-------KLFIC 122
Query: 665 SESAQGLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV 723
E L+YL I+HRD+K NILL+E + DF ++ + P E TT+
Sbjct: 123 -ELVMALDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTM 174
Query: 724 VGTPGYLDPEYYISNRLTEKS---DVYSFGVVLLELITGQP 761
GT Y+ PE + S + S D +S GV EL+ G+
Sbjct: 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 74/331 (22%), Positives = 135/331 (40%), Gaps = 67/331 (20%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQ--GYKQFQAEVELLIRAHHKNLTI 620
+ +GKG F V L ++VA+K++ + + ++ EV ++ +H N+
Sbjct: 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 621 LVGYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRL--QIASESAQGLE 672
L + + LI E+ + G + + E +A R QI S ++
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA------RSKFRQIVS----AVQ 128
Query: 673 YLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDP 732
Y H IVHRD+K+ N+LL+ K+ADFG S F G + G P Y P
Sbjct: 129 YCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLDAF-CGAPPYAAP 182
Query: 733 EYYISNRLTE--KSDVYSFGVVLLELITGQ-----PVIQKTPQRTLIGQ-----WVSS-- 778
E + + + DV+S GV+L L++G +++ +R L G+ ++S+
Sbjct: 183 E-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDC 241
Query: 779 ------MLA-----RGDIKNIVDHR-LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQV 826
L RG ++ I+ R + + + + VE L +Q
Sbjct: 242 ENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDIS----------DQK 291
Query: 827 VIELNDCLAMEIARTKAHETAPDGTPDELMI 857
I++ + M ++ + E+ DE+
Sbjct: 292 RIDI--MVGMGYSQEEIQESLSKMKYDEITA 320
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 62/239 (25%), Positives = 96/239 (40%), Gaps = 65/239 (27%)
Query: 567 RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQA------------------- 605
+GKG +G V Y D+ A+K+LS + F
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 606 -------EVELLIRAHHKNLTILVGYCD--EGANMGLIY---EFMANGNL-----QAHLL 648
E+ +L + H N+ LV + + N +Y E + G + L
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLV---EVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLS 135
Query: 649 EDKADTLCWERRL--QIASESAQGLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADF 705
ED+A R + G+EYLH I+HRD+K +N+L+ E K+ADF
Sbjct: 136 EDQA------RFYFQDLIK----GIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADF 181
Query: 706 GLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTE----KSDVYSFGVVLLELITGQ 760
G+S F +G + + VGTP ++ PE +S DV++ GV L + GQ
Sbjct: 182 GVSNEF--KGSDALLSNTVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-24
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 16/209 (7%)
Query: 563 NNFE--RVLGKGGFGTVYHG-YLDDKQV-AVKMLSSSSV---QGYKQFQAEVELLIRAHH 615
+ F RVLG+GGFG V+ ++ A K L+ + +GY+ E ++L + H
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 616 KNLTILVGYCDE-GANMGLIYEFMANGNLQAHLLEDKADTLCW-ERRLQI-ASESAQGLE 672
+ + L Y E ++ L+ M G+++ H+ D + E R ++ GLE
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 673 YLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDP 732
+LH I++RD+K N+LL++ +++D GL+ + GTPG++ P
Sbjct: 304 HLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAP 358
Query: 733 EYYISNRLTEKSDVYSFGVVLLELITGQP 761
E + D ++ GV L E+I +
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAARG 387
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 60/209 (28%), Positives = 88/209 (42%), Gaps = 29/209 (13%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILV 622
E LG+G VY K A+K+L + + K + E+ +L+R H N+ L
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLK 114
Query: 623 GYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRLQIASESAQGLEYLH- 675
+ + L+ E + G L + + E A QI + YLH
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK----QILE----AVAYLHE 166
Query: 676 NGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDP 732
NG IVHRD+K N+L K+ADFGLS+I + TV GTPGY P
Sbjct: 167 NG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPGYCAP 219
Query: 733 EYYISNRLTEKSDVYSFGVVLLELITGQP 761
E + D++S G++ L+ G
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILLCGFE 248
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQG-YKQFQAEVELLIRAHHKNLTIL 621
+ LG+G +G V + ++ VAVK++ + + E+ + +H+N+
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 622 VGYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRL--QIASESAQGLEY 673
G+ EG L E+ + G L + E A +R Q+ + G+ Y
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA------QRFFHQLMA----GVVY 120
Query: 674 LH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDP 732
LH G I HRD+K N+LL+E+ K++DFGL+ +F + + GT Y+ P
Sbjct: 121 LHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 733 EYYISNRL--TEKSDVYSFGVVLLELITG 759
E + R E DV+S G+VL ++ G
Sbjct: 177 E-LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-24
Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 563 NNFE--RVLGKGGFGTVYHG-YLDDKQV-AVKMLSSSSV---QGYKQFQAEVELLIRAHH 615
N F RVLGKGGFG V ++ A K L + +G E ++L + +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 616 KNLTILVGYCDE-GANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL 674
+ + L Y E + L+ M G+L+ H+ R + A+E GLE L
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 675 HNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEY 734
H + IV+RD+K NILL++ +++D GL+ P VGT GY+ PE
Sbjct: 303 H---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK---GRVGTVGYMAPEV 356
Query: 735 YISNRLTEKSDVYSFGVVLLELITGQP 761
+ R T D ++ G +L E+I GQ
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQS 383
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-24
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 563 NNFE--RVLGKGGFGTVYHG-YLDDKQV-AVKMLSSSSVQGYKQFQ---AEVELLIRAHH 615
N+F R++G+GGFG VY D ++ A+K L ++ + E +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 616 KNLTILVG--YCDE-GANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI-ASESAQGL 671
+ +V Y + I + M G+L HL + + E ++ A+E GL
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---EADMRFYAAEIILGL 305
Query: 672 EYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLD 731
E++H +V+RD+K ANILL+E +++D GL+ F + H VGT GY+
Sbjct: 306 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH---ASVGTHGYMA 358
Query: 732 PEYYISNRLTEKS-DVYSFGVVLLELITGQP 761
PE + S D +S G +L +L+ G
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 8e-24
Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 38/225 (16%)
Query: 556 FDVLKITNNFERVLGKGGFGTVYHGYL----DDKQV-AVKMLSSSSVQGYKQ---FQAEV 607
F++LK V+G+G F V + QV A+K+++ + + F+ E
Sbjct: 63 FEILK-------VIGRGAFSEVA---VVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREER 112
Query: 608 ELLIRAHHKNLTILVGYC--DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI-A 664
++L+ + +T L + DE + L+ E+ G+L L K +
Sbjct: 113 DVLVNGDRRWITQLH-FAFQDEN-YLYLVMEYYVGGDLLTLL--SKFGERIPAEMARFYL 168
Query: 665 SESAQGLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV 723
+E ++ +H G VHRD+K NILL+ +LADFG +G S
Sbjct: 169 AEIVMAIDSVHRLG----YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVA 223
Query: 724 VGTPGYLDPEYYISNRLTEKSDVY-------SFGVVLLELITGQP 761
VGTP YL PE + + Y + GV E+ GQ
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 34/222 (15%)
Query: 556 FDVLKITNNFERVLGKGGFGTVYHGYL----DDKQV-AVKMLSSSSVQGYKQ---FQAEV 607
F++LK V+G+G FG V + + +V A+K+L+ + + F+ E
Sbjct: 76 FEILK-------VIGRGAFGEVA---VVKLKNADKVFAMKILNKWEMLKRAETACFREER 125
Query: 608 ELLIRAHHKNLTILVGYC--DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI-A 664
++L+ K +T L Y D+ N+ L+ ++ G+L L K + E +
Sbjct: 126 DVLVNGDSKWITTLH-YAFQDDN-NLYLVMDYYVGGDLLTLL--SKFEDRLPEEMARFYL 181
Query: 665 SESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVV 724
+E ++ +H + VHRD+K NIL++ +LADFG +E GT S+ V
Sbjct: 182 AEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAV 237
Query: 725 GTPGYLDPEYYISNRLTEKS-----DVYSFGVVLLELITGQP 761
GTP Y+ PE + + D +S GV + E++ G+
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 52/251 (20%), Positives = 101/251 (40%), Gaps = 43/251 (17%)
Query: 530 LQNLRRRKQAGKKKGSLELENRKFSYFDVLKITNNFERVLGKGGFGTVYHGY--LDDKQV 587
+ + +G + E +K++ D +++ ++VLG G G V + ++
Sbjct: 1 MAHHHHHHSSGLEVLFQGPEPKKYAVTDDYQLS---KQVLGLGVNGKVLECFHRRTGQKC 57
Query: 588 AVKMLSSSSVQGYKQFQAEVELLIR-AHHKNLTILVGYCDEGANMG----LIYEFMANGN 642
A+K+L S + + EV+ + + ++ ++ + + +I E M G
Sbjct: 58 ALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGE 112
Query: 643 L--------QAHLLEDKADTLCWERRLQIASESAQGLEYLH-NGCKPPIVHRDVKSANIL 693
L E +A + I + +++LH + I HRDVK N+L
Sbjct: 113 LFSRIQERGDQAFTEREAAEIM----RDIGT----AIQFLHSHN----IAHRDVKPENLL 160
Query: 694 L---NEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFG 750
+ KL DFG ++ + T TP Y+ PE + + D++S G
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETT----QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 216
Query: 751 VVLLELITGQP 761
V++ L+ G P
Sbjct: 217 VIMYILLCGFP 227
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 54/215 (25%), Positives = 82/215 (38%), Gaps = 38/215 (17%)
Query: 566 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSV--------QGYKQFQAEVELLIRAHH 615
LG G FG V+ +K+V VK + V + E+ +L R H
Sbjct: 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGN-----LQAH--LLEDKADTLCWERRL--QIASE 666
N+ ++ + L+ E +G + H L E A + Q+ S
Sbjct: 89 ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLA------SYIFRQLVS- 141
Query: 667 SAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGT 726
+ YL I+HRD+K NI++ E F KL DFG + E G T GT
Sbjct: 142 ---AVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYTF-CGT 192
Query: 727 PGYLDPEYYISNRLTE--KSDVYSFGVVLLELITG 759
Y PE + + +++S GV L L+
Sbjct: 193 IEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 51/224 (22%), Positives = 91/224 (40%), Gaps = 54/224 (24%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQA------EVELLIRAHH- 615
+LG GGFG+VY G D+ VA+K + + + + EV LL +
Sbjct: 47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106
Query: 616 --------------KNLTILVGYCDEGANMGLIYEFMA-NGNLQAHLLEDKADTLCWERR 660
+ +++ + + +++F+ G LQ E+ A R
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPE---PVQDLFDFITERGALQ----EELA------RS 153
Query: 661 L--QIASESAQGLEYLHNGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIFPVEGGT 717
Q+ + + HN ++HRD+K NIL++ + + KL DFG + T
Sbjct: 154 FFWQVLE----AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DT 203
Query: 718 HVSTTVVGTPGYLDPEYYISNRLTE--KSDVYSFGVVLLELITG 759
+ GT Y PE +I + V+S G++L +++ G
Sbjct: 204 VYTDF-DGTRVYSPPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 245
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 44/219 (20%)
Query: 566 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQA------EVELLIRAH--- 614
+LGKGGFGTV+ G+ D QVA+K++ + V G+ EV LL +
Sbjct: 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 615 -HKNLTILVGYCDEGANMGLIYEFMANGN-----LQAH--LLEDKADTLCWERRL--QIA 664
H + L+ + + L+ E + L E + R Q+
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS------RCFFGQVV 149
Query: 665 SESAQGLEYLH-NGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIFPVEGGTHVSTT 722
+ +++ H G +VHRD+K NIL++ + AKL DFG + +
Sbjct: 150 A----AIQHCHSRG----VVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYTDF 198
Query: 723 VVGTPGYLDPEYYISNRLTE--KSDVYSFGVVLLELITG 759
GT Y PE +IS + V+S G++L +++ G
Sbjct: 199 -DGTRVYSPPE-WISRHQYHALPATVWSLGILLYDMVCG 235
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 32/209 (15%)
Query: 566 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQG---YKQFQAEVELLIRAHHKNLTI 620
LG G FG V G L +VAVK+L+ ++ + + E++ L H ++
Sbjct: 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 621 LVGYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRL--QIASESAQGLE 672
L + ++ E+++ G L + E +A RRL QI S ++
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA------RRLFQQILS----AVD 125
Query: 673 YLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDP 732
Y H +VHRD+K N+LL+ AK+ADFGLS + G + T+ G+P Y P
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRTS-CGSPNYAAP 179
Query: 733 EYYISNRLTE--KSDVYSFGVVLLELITG 759
E IS RL + D++S GV+L L+ G
Sbjct: 180 E-VISGRLYAGPEVDIWSCGVILYALLCG 207
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-22
Identities = 60/246 (24%), Positives = 96/246 (39%), Gaps = 42/246 (17%)
Query: 535 RRKQAGKKKGSLELENRKFSYFDVLKITNNFERVLGKGGFGTVYHGY--LDDKQVAVKML 592
+Q + L+ +K + D K+ +VLG G G V + ++ A+KML
Sbjct: 39 PPQQFPQFHVKSGLQIKKNAIIDDYKV---TSQVLGLGINGKVLQIFNKRTQEKFALKML 95
Query: 593 SSSSVQGYKQFQAEVELLIR-AHHKNLTILVG-YCDEGANMGLIY---EFMANGNL---- 643
+ + EVEL R + ++ +V Y + A + E + G L
Sbjct: 96 QDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 150
Query: 644 ----QAHLLEDKADTLCWERRLQIASESAQGLEYLH-NGCKPPIVHRDVKSANILLNEKF 698
E +A + I ++YLH I HRDVK N+L K
Sbjct: 151 QDRGDQAFTEREASEIM----KSIGE----AIQYLHSIN----IAHRDVKPENLLYTSKR 198
Query: 699 QA---KLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLE 755
KL DFG ++ + TT TP Y+ PE + + D++S GV++
Sbjct: 199 PNAILKLTDFGFAKETT---SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI 255
Query: 756 LITGQP 761
L+ G P
Sbjct: 256 LLCGYP 261
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 6e-22
Identities = 45/243 (18%), Positives = 78/243 (32%), Gaps = 28/243 (11%)
Query: 535 RRKQAGKKKGSLELENRKFSYFDVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSS 594
R + + E + + + I F L +
Sbjct: 40 RLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPL 99
Query: 595 SSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIY---EFMANGNLQAHLLEDK 651
SS ++ + + VG + +Y + NL+ +
Sbjct: 100 SSPSPMDAPSVKIRRM---DPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC 156
Query: 652 ADT-----LCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFG 706
+ +C +QIA +E+LH+ ++HRD+K +NI K+ DFG
Sbjct: 157 SLEDREHGVCLHIFIQIAE----AVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFG 209
Query: 707 LSRI----------FPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEL 756
L T VGT Y+ PE N + K D++S G++L EL
Sbjct: 210 LVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269
Query: 757 ITG 759
+
Sbjct: 270 LYS 272
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 59/240 (24%), Positives = 105/240 (43%), Gaps = 45/240 (18%)
Query: 536 RKQAGKKKGSLELENRKFSYFDVLKITNNFERVLGKGGFGTVY--HGYLDDKQVAVKMLS 593
+K + + +L+ FD +K LG G FG V A+K+L
Sbjct: 28 KKWETPSQNTAQLDQ-----FDRIK-------TLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 594 SSSVQGYKQFQ---AEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLED 650
V KQ + E +L + L L + +N+ ++ E++A G + +HL
Sbjct: 76 KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 651 KADTLCWERRLQI---------ASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAK 701
RR+ A++ EYLH+ +++RD+K N+L++++ +
Sbjct: 133 --------RRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181
Query: 702 LADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
+ DFG ++ V+G T T+ GTP L PE +S + D ++ GV++ E+ G P
Sbjct: 182 VTDFGFAKR--VKGRTW---TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 2e-21
Identities = 65/212 (30%), Positives = 111/212 (52%), Gaps = 24/212 (11%)
Query: 563 NNFE--RVLGKGGFGTVY----HGYLDDKQV-AVKMLSSSSVQGYKQFQ--AEVELLIRA 613
+ FE +VLG+G FG V+ D +Q+ A+K+L ++++ + + E ++L+
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 614 HHKNLTILVGYC--DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI-ASESAQG 670
+H + L Y EG + LI +F+ G+L L ++ T E ++ +E A
Sbjct: 84 NHPFIVKLH-YAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFT---EEDVKFYLAELALA 138
Query: 671 LEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGY 729
L++LH G I++RD+K NILL+E+ KL DFGLS+ + + GT Y
Sbjct: 139 LDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEY 192
Query: 730 LDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
+ PE T+ +D +SFGV++ E++TG
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 71/344 (20%), Positives = 114/344 (33%), Gaps = 71/344 (20%)
Query: 566 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVG 623
+ +G G FG L + VAVK + + + Q E+ H N+
Sbjct: 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-ENVQREIINHRSLRHPNIVRFKE 83
Query: 624 YCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRL--QIASESAQGLEYLH 675
++ +I E+ + G L ED+A R Q+ S G+ Y H
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGRFSEDEA------RFFFQQLLS----GVSYCH 133
Query: 676 NGCKPPIVHRDVKSANILLNEKFQA--KLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPE 733
+ I HRD+K N LL+ K+ DFG S+ + + VGTP Y+ PE
Sbjct: 134 SMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 187
Query: 734 YYISNRLTE--KSDVYSFGVVLLELITG---------QPVIQKTPQRTLIGQ-------W 775
+ + + +DV+S GV L ++ G +KT QR L +
Sbjct: 188 -VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR 246
Query: 776 VSS--------ML-----ARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPT 822
+S + R I I H W + ++ +T
Sbjct: 247 ISPECCHLISRIFVADPATRISIPEIKTHS----------WFLKNLPADLMNESNTGSQF 296
Query: 823 MNQVVIELNDCLAMEIARTKAHETAPDGTPDELMIDLNLHSDVF 866
+ M+I + D+ M D D
Sbjct: 297 QEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNLDLDDDM 340
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-21
Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 33/220 (15%)
Query: 556 FDVLKITNNFERVLGKGGFGTVYHGYL----DDKQV-AVKMLSSSSVQGYKQ---FQAEV 607
++V+K V+G+G FG V L ++V A+K+LS + F E
Sbjct: 71 YEVVK-------VIGRGAFGEVQ---LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 608 ELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI-ASE 666
+++ A+ + L + + ++ E+M G+L + E+ + +E
Sbjct: 121 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP----EKWARFYTAE 176
Query: 667 SAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGT 726
L+ +H +HRDVK N+LL++ KLADFG EG T VGT
Sbjct: 177 VVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGT 232
Query: 727 PGYLDPEYYISNRLTEKS-----DVYSFGVVLLELITGQP 761
P Y+ PE + ++ + D +S GV L E++ G
Sbjct: 233 PDYISPE-VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 566 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYK---QFQAEVELLIRAHHKNLTI 620
LG+G FG V ++VA+K +S ++ + + E+ L H ++
Sbjct: 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 621 LVGYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRL--QIASESAQGLE 672
L ++ ++ E+ A G L + + ED+ RR QI +E
Sbjct: 74 LYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEG------RRFFQQIIC----AIE 122
Query: 673 YLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDP 732
Y H IVHRD+K N+LL++ K+ADFGLS I G + T+ G+P Y P
Sbjct: 123 YCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKTS-CGSPNYAAP 176
Query: 733 EYYISNRLTE--KSDVYSFGVVLLELITG 759
E I+ +L + DV+S G+VL ++ G
Sbjct: 177 E-VINGKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 32/209 (15%)
Query: 566 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQG---YKQFQAEVELLIRAHHKNLTI 620
LG G FG V G L +VAVK+L+ ++ + + E++ L H ++
Sbjct: 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 621 LVGYCDEGANMGLIYEFMANGNL------QAHLLEDKADTLCWERRL--QIASESAQGLE 672
L +++ ++ E+++ G L L E ++ RRL QI S G++
Sbjct: 81 LYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES------RRLFQQILS----GVD 130
Query: 673 YLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDP 732
Y H +VHRD+K N+LL+ AK+ADFGLS + G + T+ G+P Y P
Sbjct: 131 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRTS-CGSPNYAAP 184
Query: 733 EYYISNRLTE--KSDVYSFGVVLLELITG 759
E IS RL + D++S GV+L L+ G
Sbjct: 185 E-VISGRLYAGPEVDIWSSGVILYALLCG 212
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-20
Identities = 64/237 (27%), Positives = 107/237 (45%), Gaps = 33/237 (13%)
Query: 540 GKKKGSLELENRKFSY--FDVLKITNNFERVLGKGGFGTVY----HGYLDDKQV-AVKML 592
G + S+ K F++L+ VLGKGG+G V+ + ++ A+K+L
Sbjct: 1 GSSETSVNRGPEKIRPECFELLR-------VLGKGGYGKVFQVRKVTGANTGKIFAMKVL 53
Query: 593 SSSS-VQGYKQF---QAEVELLIRAHHKNLTILVGYC--DEGANMGLIYEFMANGNLQAH 646
+ V+ K +AE +L H + L+ Y G + LI E+++ G L
Sbjct: 54 KKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLI-YAFQTGG-KLYLILEYLSGGELFMQ 111
Query: 647 LLEDKADTLCWERRLQI-ASESAQGLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLAD 704
L + E +E + L +LH G I++RD+K NI+LN + KL D
Sbjct: 112 LEREGIFM---EDTACFYLAEISMALGHLHQKG----IIYRDLKPENIMLNHQGHVKLTD 164
Query: 705 FGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
FGL + +G + T GT Y+ PE + + D +S G ++ +++TG P
Sbjct: 165 FGLCKESIHDGTV--THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 43/219 (19%)
Query: 563 NNFE--RVLGKGGFGTVYHGYL-----DDKQVAVKMLSSSSVQGYKQFQ---AEVELLIR 612
+F+ R LG G FG V+ L + + A+K+L V KQ + E +L
Sbjct: 6 QDFQILRTLGTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 613 AHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI--------- 663
H + + G + + +I +++ G L + L R+ Q
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL-----------RKSQRFPNPVAKFY 111
Query: 664 ASESAQGLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722
A+E LEYLH I++RD+K NILL++ K+ DFG ++ V T+ T
Sbjct: 112 AAEVCLALEYLHSKD----IIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTY---T 162
Query: 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
+ GTP Y+ PE + + D +SFG+++ E++ G
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 563 NNFE--RVLGKGGFGTVYHG-YLDDKQV-AVKMLSSSSVQGYKQF---QAEVELLIRAHH 615
N FE ++LGKG FG V + A+K+L + + E +L + H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 616 KNLTILVGYC-DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI-ASESAQGLEY 673
LT L Y + + E+ G L HL ++ + E R + +E L+Y
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFS---EDRARFYGAEIVSALDY 263
Query: 674 LHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPE 733
LH+ + +V+RD+K N++L++ K+ DFGL + +G T T GTP YL PE
Sbjct: 264 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPE 319
Query: 734 YYISNRLTEKSDVYSFGVVLLELITGQP 761
N D + GVV+ E++ G+
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 93.1 bits (231), Expect = 2e-20
Identities = 76/350 (21%), Positives = 128/350 (36%), Gaps = 101/350 (28%)
Query: 565 FERVLGKGGFGTVYHGYL-------DDKQVAVKML-SSSSVQGYKQFQAEVELLIRA-HH 615
+ LG+G FG V + VAVKML ++ ++ +E+++LI HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 616 KN--------------LTILVGYCDEG--------------ANMGLIYEFMANGNLQAHL 647
N L ++V +C G F + +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 648 LEDKA-------------------------------------DTLCWERRLQIASESAQG 670
D D L E + + + A+G
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 671 LEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPG-Y 729
+E+L + +HRD+ + NILL+EK K+ DFGL+R + +V P +
Sbjct: 206 MEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDI-YKDPDYVRKGDARLPLKW 261
Query: 730 LDPEYYISNRLTEKSDVYSFGVVLLELIT-GQ---PVIQKTPQRTLIGQWVSSMLARGDI 785
+ PE T +SDV+SFGV+L E+ + G P ++ + L G
Sbjct: 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRRLKEG-- 312
Query: 786 KNIVDHRL-QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834
R+ D+ T ++ + L C H ++RPT +++V L + L
Sbjct: 313 -----TRMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEHLGNLL 354
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 560 KIT-NNFE--RVLGKGGFGTVYHG-YLDDKQV-AVKMLSSSSVQGYKQF---QAEVELLI 611
K+T N+F+ ++LGKG FG V + A+K+L + + E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 612 RAHHKNLTILVGYC-DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI-ASESAQ 669
H LT L Y + + E+ G L HL ++ T E R + +E
Sbjct: 61 NTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFT---EERARFYGAEIVS 116
Query: 670 GLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPG 728
LEYLH +V+RD+K N++L++ K+ DFGL + +G T T GTP
Sbjct: 117 ALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPE 170
Query: 729 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
YL PE N D + GVV+ E++ G+
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 25/207 (12%), Positives = 51/207 (24%), Gaps = 53/207 (25%)
Query: 566 ERVLGKGGFGTVYHGYLD---DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNL- 618
G + D D+QVA+ + V ++ + L R +
Sbjct: 36 LIFHGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 619 TILVGYCDEGANMGLIY---EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH 675
+L D E++ G+LQ + ++ A + H
Sbjct: 95 RVL----DVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAAAADAAH 146
Query: 676 -NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEY 734
G + + + ++ LA P +
Sbjct: 147 RAG----VALSIDHPSRVRVSIDGDVVLAY----------------------PATMPDA- 179
Query: 735 YISNRLTEKSDVYSFGVVLLELITGQP 761
+ D+ G L L+ +
Sbjct: 180 ------NPQDDIRGIGASLYALLVNRW 200
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-19
Identities = 67/217 (30%), Positives = 100/217 (46%), Gaps = 28/217 (12%)
Query: 563 NNFE--RVLGKGGFGTVY----HGYLDDKQV-AVKMLSSSS-VQGYKQF---QAEVELLI 611
NFE +VLG G +G V+ D ++ A+K+L ++ VQ K + E ++L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 612 RA-HHKNLTILVGYC--DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI-ASES 667
L L Y E + LI +++ G L HL + + T E +QI E
Sbjct: 114 HIRQSPFLVTLH-YAFQTET-KLHLILDYINGGELFTHLSQRERFT---EHEVQIYVGEI 168
Query: 668 AQGLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGT 726
LE+LH G I++RD+K NILL+ L DFGLS+ F V T + GT
Sbjct: 169 VLALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCGT 223
Query: 727 PGYLDPEYYISNRL--TEKSDVYSFGVVLLELITGQP 761
Y+ P+ + D +S GV++ EL+TG
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 5e-19
Identities = 70/234 (29%), Positives = 105/234 (44%), Gaps = 24/234 (10%)
Query: 540 GKKKGSLELENRKFSYFDVLKITN-NFERVLGKGGFGTVYHG-YLDDKQV-AVKMLSSSS 596
G K+ S E + + L I N F RVLGKG FG V + + AVK+L
Sbjct: 1 GPKESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV 60
Query: 597 VQGYKQF---QAEVELLIRA-HHKNLTILVGYCDEGANMGLIY---EFMANGNLQAHLLE 649
+ E +L A +H LT L C + ++ EF+ G+L H+ +
Sbjct: 61 ILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQ--TPDRLFFVMEFVNGGDLMFHIQK 117
Query: 650 DKADTLCWERRLQI-ASESAQGLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGL 707
+ E R + A+E L +LH G I++RD+K N+LL+ + KLADFG+
Sbjct: 118 SRRFD---EARARFYAAEIISALMFLHDKG----IIYRDLKLDNVLLDHEGHCKLADFGM 170
Query: 708 SRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
+ G T + T GTP Y+ PE D ++ GV+L E++ G
Sbjct: 171 CKEGICNGVT--TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 6e-19
Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 14/96 (14%)
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGS 472
I+L+ + +A D+ + ++ LDL N + G +P+ L +L+ L LN+S NNL G
Sbjct: 225 KIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283
Query: 473 LPSGLSEKVKNGSLS----LSVDGNRNLC--PSASC 502
+P G G+L + N+ LC P +C
Sbjct: 284 IPQG-------GNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 42/169 (24%), Positives = 70/169 (41%), Gaps = 46/169 (27%)
Query: 362 LTNQQDVDAIMKIKSKY---EVKRDWQG--DPCAPKVYMWQGINCSYDANQSPRIISINL 416
L N QD A+++IK W D C W G+ C Q+ R+ +++L
Sbjct: 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRT---WLGVLCD-TDTQTYRVNNLDL 57
Query: 417 SSSGIA---------------------------GDIVPYIFSLTSIESLDLSKNSLTGPV 449
S + G I P I LT + L ++ +++G +
Sbjct: 58 SGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI 117
Query: 450 PEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS----LSVDGNR 494
P+FL+++++L L+ S N L G+LP + SL ++ DGNR
Sbjct: 118 PDFLSQIKTLVTLDFSYNALSGTLPPSI------SSLPNLVGITFDGNR 160
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 3e-13
Identities = 18/86 (20%), Positives = 45/86 (52%), Gaps = 1/86 (1%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
++ + ++ + ++G I ++ + ++ +LD S N+L+G +P ++ L +L + GN
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 469 LQGSLPSGLSEKVKNGSLSLSVDGNR 494
+ G++P S+++ NR
Sbjct: 161 ISGAIPDSYG-SFSKLFTSMTISRNR 185
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 6e-12
Identities = 16/65 (24%), Positives = 32/65 (49%), Gaps = 1/65 (1%)
Query: 411 IISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQ 470
S+ +S + + G I P +L ++ +DLS+N L G ++ + ++L+ N+L
Sbjct: 176 FTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234
Query: 471 GSLPS 475
L
Sbjct: 235 FDLGK 239
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 4e-11
Identities = 22/82 (26%), Positives = 37/82 (45%), Gaps = 2/82 (2%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTS-IESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
P ++ I + I+G I S + S+ +S+N LTG +P A L +L ++LS N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRN 207
Query: 468 NLQGSLPSGLSEKVKNGSLSLS 489
L+G + L+
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLA 229
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 16/64 (25%), Positives = 30/64 (46%), Gaps = 1/64 (1%)
Query: 411 IISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQ 470
+ ++L ++ I G + + L + SL++S N+L G +P+ LQ V + N
Sbjct: 246 LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN-LQRFDVSAYANNKCL 304
Query: 471 GSLP 474
P
Sbjct: 305 CGSP 308
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-18
Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 564 NFERVLGKGGFGTVYHG-YLDDKQV-AVKMLSSSSVQGYKQF---QAEVELLIRA-HHKN 617
+F +V+GKG FG V + ++ AVK+L ++ K+ +E +L++ H
Sbjct: 41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 618 LTILVGYC--DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI-ASESAQGLEYL 674
L L + + + +++ G L HL ++ E R + A+E A L YL
Sbjct: 101 LVGLH-FSFQTAD-KLYFVLDYINGGELFYHLQRERCFL---EPRARFYAAEIASALGYL 155
Query: 675 H-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPE 733
H IV+RD+K NILL+ + L DFGL + T ++T GTP YL PE
Sbjct: 156 HSLN----IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPE 209
Query: 734 YYISNRLTEKSDVYSFGVVLLELITGQP 761
D + G VL E++ G P
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 67/228 (29%), Positives = 102/228 (44%), Gaps = 26/228 (11%)
Query: 547 ELENRKFSYFDVLKITN-NFERVLGKGGFGTVYHG-YLDDKQV-AVKMLSSSSVQGYKQF 603
EL + S LKI + ++LGKG FG V+ + Q A+K L V
Sbjct: 2 ELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD-- 59
Query: 604 QAEVE--------LLIRAHHKNLTILVGYC-DEGANMGLIYEFMANGNLQAHLLEDKADT 654
+VE L + H LT + N+ + E++ G+L H+
Sbjct: 60 --DVECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHI--QSCHK 114
Query: 655 LCWERRLQIASESAQGLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713
R A+E GL++LH G IV+RD+K NILL++ K+ADFG+ + +
Sbjct: 115 FDLSRATFYAAEIILGLQFLHSKG----IVYRDLKLDNILLDKDGHIKIADFGMCKENML 170
Query: 714 EGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
+ T GTP Y+ PE + + D +SFGV+L E++ GQ
Sbjct: 171 GDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 4e-18
Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 564 NFERVLGKGGFGTVYHG-YLDDKQV-AVKMLSSSSVQGYKQFQAEVE--------LLIRA 613
NF VLGKG FG V ++ AVK+L V +VE L +
Sbjct: 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD----DVECTMVEKRVLALPG 399
Query: 614 HHKNLTILVGYC-DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLE 672
LT L C + + E++ G+L H+ + + A+E A GL
Sbjct: 400 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLF 456
Query: 673 YLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDP 732
+L I++RD+K N++L+ + K+ADFG+ + +G T + T GTP Y+ P
Sbjct: 457 FLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAP 511
Query: 733 EYYISNRLTEKSDVYSFGVVLLELITGQP 761
E + D ++FGV+L E++ GQ
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 8e-18
Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 41/227 (18%)
Query: 557 DVLKITNNFERV--LGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQ---FQA--EV 607
DV +E++ LG+G F TVY ++ VA+K + K A E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 608 ELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTL------CWERRL 661
+LL H N+ L+ +N+ L+++FM +L +++D + L +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDL-EVIIKDNSLVLTPSHIKAYMLMT 121
Query: 662 QIASESAQGLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720
QGLEYLH + I+HRD+K N+LL+E KLADFGL++ F +
Sbjct: 122 ------LQGLEYLHQHW----ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-- 169
Query: 721 TTVVGTPGYLDPE------YYISNRLTEKSDVYSFGVVLLELITGQP 761
T V T Y PE Y D+++ G +L EL+ P
Sbjct: 170 THQVVTRWYRAPELLFGARMY-----GVGVDMWAVGCILAELLLRVP 211
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 9e-18
Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 564 NFERVLGKGGFGTVYHG-YLDDKQV-AVKMLSSSSVQGYKQFQAEVE--------LLIRA 613
NF VLGKG FG V ++ AVK+L V +VE L +
Sbjct: 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD----DVECTMVEKRVLALPG 78
Query: 614 HHKNLTILVGYC-DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLE 672
LT L C + + E++ G+L H+ + + A+E A GL
Sbjct: 79 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLF 135
Query: 673 YLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLD 731
+L G I++RD+K N++L+ + K+ADFG+ + +G T + T GTP Y+
Sbjct: 136 FLQSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIA 189
Query: 732 PEYYISNRLTEKSDVYSFGVVLLELITGQP 761
PE + D ++FGV+L E++ GQ
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 563 NNFE--RVLGKGGFGTVYHG-YLDDKQV-AVKMLSSSSVQGYKQF---QAEVELLIRA-H 614
+F+ RV+G+G + V ++ A+K++ V + Q E + +A +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 615 HKNLTILVGYCDE-GANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQI-ASESAQGLE 672
H L L C + + + + E++ G+L H+ + E + ++E + L
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP---EEHARFYSAEISLALN 124
Query: 673 YLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLD 731
YLH G I++RD+K N+LL+ + KL D+G+ + G T ++T GTP Y+
Sbjct: 125 YLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIA 178
Query: 732 PEYYISNRLTEKSDVYSFGVVLLELITGQP 761
PE D ++ GV++ E++ G+
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRS 208
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 57/234 (24%), Positives = 109/234 (46%), Gaps = 31/234 (13%)
Query: 537 KQAGKKKGSLELENRKFSYFDVLKITNNFERVLGKGGFGTVYHG-YLDDKQV-AVKMLSS 594
+++GK SL L++ FD+L+ V+G+G + V ++ A++++
Sbjct: 40 RESGKASSSLGLQD-----FDLLR-------VIGRGSYAKVLLVRLKKTDRIYAMRVVKK 87
Query: 595 SSVQGYKQF---QAEVELLIRA-HHKNLTILVGYCDE-GANMGLIYEFMANGNLQAHLLE 649
V + Q E + +A +H L L C + + + + E++ G+L H+
Sbjct: 88 ELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQR 146
Query: 650 DKADTLCWERRLQI-ASESAQGLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGL 707
+ E + ++E + L YLH G I++RD+K N+LL+ + KL D+G+
Sbjct: 147 QRKLP---EEHARFYSAEISLALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGM 199
Query: 708 SRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
+ G T ++T GTP Y+ PE D ++ GV++ E++ G+
Sbjct: 200 CKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 251
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-17
Identities = 31/102 (30%), Positives = 47/102 (46%), Gaps = 16/102 (15%)
Query: 382 RDWQG--DPCAPKVYMWQGINCSYDANQSPRIISINLSS---SGIAGDIVPYIFSLTSIE 436
DW +PC + G+ C ++ SI+LSS + + + SLT +E
Sbjct: 31 PDWSSNKNPCT-----FDGVTCR-----DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLE 80
Query: 437 SLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLS 478
SL LS + + G V F SL L+LS N+L G + + S
Sbjct: 81 SLFLSNSHINGSVSGF-KCSASLTSLDLSRNSLSGPVTTLTS 121
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-16
Identities = 27/91 (29%), Positives = 40/91 (43%), Gaps = 11/91 (12%)
Query: 411 IISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQ 470
+ +NL + I+G I + L + LDLS N L G +P+ ++ L L ++LS NNL
Sbjct: 658 LFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717
Query: 471 GSLPSGLSEKVKNGSLS----LSVDGNRNLC 497
G +P G N LC
Sbjct: 718 GPIPEM-------GQFETFPPAKFLNNPGLC 741
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-15
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 4/90 (4%)
Query: 406 NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLS 465
N + + L ++G G I P + + + + SL LS N L+G +P L L LR L L
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450
Query: 466 GNNLQGSLPSGLSEKVKNGSL-SLSVDGNR 494
N L+G +P L +L +L +D N
Sbjct: 451 LNMLEGEIPQELM---YVKTLETLILDFND 477
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 5e-15
Identities = 23/81 (28%), Positives = 39/81 (48%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
N++S G P + S+ LD+S N L+G +P+ + + L +LNL N+
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667
Query: 469 LQGSLPSGLSEKVKNGSLSLS 489
+ GS+P + + L LS
Sbjct: 668 ISGSIPDEVGDLRGLNILDLS 688
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 5e-15
Identities = 20/77 (25%), Positives = 43/77 (55%), Gaps = 3/77 (3%)
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGS 472
+++SS+ + I P++ ++++ LD+S N L+G ++ L++LN+S N G
Sbjct: 204 FLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGP 262
Query: 473 LPSGLSEKVKNGSLSLS 489
+P + ++ LSL+
Sbjct: 263 IPPLPLKSLQ--YLSLA 277
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-14
Identities = 29/87 (33%), Positives = 49/87 (56%), Gaps = 4/87 (4%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
++S++LS + ++G I + SL+ + L L N L G +P+ L +++L L L N+
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477
Query: 469 LQGSLPSGLSEKVKNGSL-SLSVDGNR 494
L G +PSGLS +L +S+ NR
Sbjct: 478 LTGEIPSGLS---NCTNLNWISLSNNR 501
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-14
Identities = 24/84 (28%), Positives = 42/84 (50%), Gaps = 3/84 (3%)
Query: 407 QSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG 466
+ +++S + ++GD I + T ++ L++S N GP+P L+SL+ L+L+
Sbjct: 221 DCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAE 278
Query: 467 NNLQGSLPSGLSEKVKN-GSLSLS 489
N G +P LS L LS
Sbjct: 279 NKFTGEIPDFLSGACDTLTGLDLS 302
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-14
Identities = 28/87 (32%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 405 ANQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVP-EFLAELQSLRVLN 463
+ + ++LS + G + P+ S + +ESL LS N+ +G +P + L +++ L+VL+
Sbjct: 290 SGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLD 349
Query: 464 LSGNNLQGSLPSGLSEKVKNGSLSLSV 490
LS N G LP L+ N S SL
Sbjct: 350 LSFNEFSGELPESLT----NLSASLLT 372
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-13
Identities = 19/73 (26%), Positives = 39/73 (53%), Gaps = 3/73 (4%)
Query: 406 NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLS 465
+ + + +S + I+GD+ + ++E LD+S N+ + +P L + +L+ L++S
Sbjct: 175 DGCGELKHLAISGNKISGDV-D-VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDIS 231
Query: 466 GNNLQGSLPSGLS 478
GN L G +S
Sbjct: 232 GNKLSGDFSRAIS 244
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 5e-13
Identities = 26/92 (28%), Positives = 48/92 (52%), Gaps = 4/92 (4%)
Query: 407 QSPRIISINLSSSGIAGDIVPY--IFSLTSIESLDLSKNSLTGPVP-EFLAELQSLRVLN 463
S + S++LS + ++G + + S + ++ L++S N+L P +L SL VL+
Sbjct: 98 CSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLD 157
Query: 464 LSGNNLQGSLPSGLSEKVKNGSL-SLSVDGNR 494
LS N++ G+ G G L L++ GN+
Sbjct: 158 LSANSISGANVVGWVLSDGCGELKHLAISGNK 189
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 8e-13
Identities = 20/70 (28%), Positives = 42/70 (60%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
+ ++ L + + G+I + + T++ + LS N LTG +P+++ L++L +L LS N+
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 469 LQGSLPSGLS 478
G++P+ L
Sbjct: 526 FSGNIPAELG 535
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-12
Identities = 28/88 (31%), Positives = 44/88 (50%), Gaps = 2/88 (2%)
Query: 409 PRIISINLSSSGIAGDIVP-YIFSLTSIESLDLSKNSLTGPVPEFLAEL-QSLRVLNLSG 466
+ S+ LSS+ +G++ + + ++ LDLS N +G +PE L L SL L+LS
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377
Query: 467 NNLQGSLPSGLSEKVKNGSLSLSVDGNR 494
NN G + L + KN L + N
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNG 405
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-12
Identities = 25/83 (30%), Positives = 38/83 (45%), Gaps = 2/83 (2%)
Query: 409 PRIISINLSSSGIAGDIVPYIF-SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ ++L+ + G+I ++ + ++ LDLS N G VP F L L LS N
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328
Query: 468 NLQGSLPSGLSEKVKN-GSLSLS 489
N G LP K++ L LS
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLS 351
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-12
Identities = 24/83 (28%), Positives = 43/83 (51%), Gaps = 6/83 (7%)
Query: 412 ISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQG 471
I+LS++ + G+I +I L ++ L LS NS +G +P L + +SL L+L+ N G
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552
Query: 472 SLPSGLSEKVKNGSLSLSVDGNR 494
++P+ + S + N
Sbjct: 553 TIPAAM------FKQSGKIAANF 569
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-12
Identities = 22/82 (26%), Positives = 42/82 (51%), Gaps = 4/82 (4%)
Query: 414 INLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSL 473
+ L + + G+I + + ++E+L L N LTG +P L+ +L ++LS N L G +
Sbjct: 447 LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI 506
Query: 474 PSGLSEKVKNGSLS-LSVDGNR 494
P + + +L+ L + N
Sbjct: 507 PKWIG---RLENLAILKLSNNS 525
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 6e-12
Identities = 12/91 (13%), Positives = 27/91 (29%)
Query: 399 INCSYDANQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQS 458
+ + + G + L++ +++ G S
Sbjct: 574 RYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGS 633
Query: 459 LRVLNLSGNNLQGSLPSGLSEKVKNGSLSLS 489
+ L++S N L G +P + L+L
Sbjct: 634 MMFLDMSYNMLSGYIPKEIGSMPYLFILNLG 664
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 8e-07
Identities = 13/86 (15%), Positives = 31/86 (36%), Gaps = 4/86 (4%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
+ + LS++ +G+I + S+ LDL+ N G +P + + ++ N
Sbjct: 514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANF 569
Query: 469 LQGSLPSGLSEKVKNGSLSLSVDGNR 494
+ G + + +
Sbjct: 570 IAGKRYVYIKNDGMKKECHGAGNLLE 595
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 5e-17
Identities = 62/247 (25%), Positives = 107/247 (43%), Gaps = 40/247 (16%)
Query: 550 NRKFSYFDVLKITNNFE--------RVLGKGGFGTVYHGY--LDDKQVAVKMLSS--SSV 597
+ +F +V T F + +G G G V Y + D+ VA+K LS +
Sbjct: 45 DNQFYSVEVGDST--FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ 102
Query: 598 QGYKQFQAEVELLIRAHHKNLTILV------GYCDEGANMGLIYEFMA---NGNLQAHLL 648
K+ E+ L+ +HKN+ L+ +E ++ L+ E M +Q L
Sbjct: 103 THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD 162
Query: 649 EDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 708
++ L + Q+ G+++LH+ I+HRD+K +NI++ K+ DFGL+
Sbjct: 163 HERMSYLLY----QML----CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211
Query: 709 RIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQ 768
R + T V T Y PE + E D++S G ++ E++ + + P
Sbjct: 212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF---PG 265
Query: 769 RTLIGQW 775
R I QW
Sbjct: 266 RDYIDQW 272
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 5e-17
Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 35/216 (16%)
Query: 563 NNFERV--LGKGGFGTVYHGY-LDDKQVAVKML---------SSSSVQGYKQFQAEVELL 610
++++ +G+G +G VY + VA+K + S++++ E+ LL
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-------EISLL 73
Query: 611 IRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQ- 669
HH N+ L+ + L++EFM +L +L++ L + QI Q
Sbjct: 74 KELHHPNIVSLIDVIHSERCLTLVFEFMEK-DL-KKVLDENKTGL---QDSQIKIYLYQL 128
Query: 670 --GLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGT 726
G+ + H + I+HRD+K N+L+N KLADFGL+R F + ++ T V T
Sbjct: 129 LRGVAHCHQHR----ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVT 182
Query: 727 PGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQP 761
Y P+ + S + + D++S G + E+ITG+P
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 8e-17
Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 42/222 (18%)
Query: 563 NNFERV--LGKGGFGTVYHGY--LDDKQVAVKMLS--------SSSVQGYKQFQAEVELL 610
+ F+++ LG G + TVY G VA+K + S++++ E+ L+
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-------EISLM 57
Query: 611 IRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWER--RLQIASESA 668
H+N+ L + L++EFM + +L ++ + +
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFM-DNDL-KKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 669 Q---GLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG 725
Q GL + H I+HRD+K N+L+N++ Q KL DFGL+R F + T ++ V
Sbjct: 116 QLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVV 170
Query: 726 TPGYLDPE------YYISNRLTEKSDVYSFGVVLLELITGQP 761
T Y P+ Y + D++S G +L E+ITG+P
Sbjct: 171 TLWYRAPDVLMGSRTY-----STSIDIWSCGCILAEMITGKP 207
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 59/240 (24%), Positives = 105/240 (43%), Gaps = 33/240 (13%)
Query: 534 RRRKQAGKKKGSLELENRKFSYFDVLKITNNFERVLGKGGFGTVYHGYLDDKQ----VAV 589
+G G+ L + ++ L ++G+G +G V +K VA+
Sbjct: 5 HHHHSSGVDLGTENLYFQSMEKYENLG-------LVGEGSYGMVMKCR--NKDTGRIVAI 55
Query: 590 K-MLSSSSVQGYKQFQA--EVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAH 646
K L S + K A E++LL + H+NL L+ C + L++EF+ + +
Sbjct: 56 KKFLESDDDKMVK-KIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTIL-D 112
Query: 647 LLEDKADTLCWERRLQIASESAQ---GLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKL 702
LE + L ++ + Q G+ + H + I+HRD+K NIL+++ KL
Sbjct: 113 DLELFPNGLDYQ---VVQKYLFQIINGIGFCHSHN----IIHRDIKPENILVSQSGVVKL 165
Query: 703 ADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQP 761
DFG +R G + V T Y PE + + + DV++ G ++ E+ G+P
Sbjct: 166 CDFGFARTLAAPGEVY--DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEP 223
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 563 NNFERV--LGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQA--EVELLIRAHHK 616
+ ++ LG+G + TVY G L D VA+K + +G A EV LL H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP-CTAIREVSLLKDLKHA 60
Query: 617 NLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQ---GLEY 673
N+ L ++ L++E++ + +L L+D + + + Q GL Y
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYL-DKDL-KQYLDDCGNII---NMHNVKLFLFQLLRGLAY 115
Query: 674 LHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPE 733
H ++HRD+K N+L+NE+ + KLADFGL+R + T+ V T Y P+
Sbjct: 116 CHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLWYRPPD 170
Query: 734 YYI-SNRLTEKSDVYSFGVVLLELITGQP 761
+ S + + D++ G + E+ TG+P
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRP 199
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 58/245 (23%), Positives = 106/245 (43%), Gaps = 36/245 (14%)
Query: 550 NRKFSYFDVLK----ITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSS--SSVQG 599
+ F ++ + ++ + +G G G V Y + ++ VA+K LS +
Sbjct: 8 DNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH 67
Query: 600 YKQFQAEVELLIRAHHKNLTILV------GYCDEGANMGLIYEFMA---NGNLQAHLLED 650
K+ E+ L+ +HKN+ L+ +E ++ ++ E M +Q L +
Sbjct: 68 AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 127
Query: 651 KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710
+ L + Q+ G+++LH+ I+HRD+K +NI++ K+ DFGL+R
Sbjct: 128 RMSYLLY----QML----CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 176
Query: 711 FPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRT 770
+ T V T Y PE + E D++S G ++ E+I G + P
Sbjct: 177 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF---PGTD 230
Query: 771 LIGQW 775
I QW
Sbjct: 231 HIDQW 235
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 60/240 (25%), Positives = 109/240 (45%), Gaps = 54/240 (22%)
Query: 560 KITNNFERV---LGKGGFGTVYHG----YLDDKQVAVKM-----LSSSSVQGYKQFQAEV 607
++ + FE +G+G +G VY DDK A+K +S S+ + E+
Sbjct: 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-------EI 69
Query: 608 ELLIRAHHKNLTILVGYCDEGANMG--LIYEFMANGNLQAHLLEDKADTLCWERRLQIAS 665
LL H N+ L A+ L++++ + +L H+++ + ++ +Q+
Sbjct: 70 ALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DL-WHIIKFHRASKANKKPVQLPR 127
Query: 666 ESA--------QGLEYLH-NGCKPPIVHRDVKSANILL----NEKFQAKLADFGLSRIF- 711
G+ YLH N ++HRD+K ANIL+ E+ + K+AD G +R+F
Sbjct: 128 GMVKSLLYQILDGIHYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
Query: 712 -PVEGGTHVSTTVVGTPGYLDPE------YYISNRLTEKSDVYSFGVVLLELITGQPVIQ 764
P++ + VV T Y PE +Y T+ D+++ G + EL+T +P+
Sbjct: 184 SPLKPLADLDPVVV-TFWYRAPELLLGARHY-----TKAIDIWAIGCIFAELLTSEPIFH 237
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 22/212 (10%)
Query: 561 ITNNFERV--LGKGGFGTVYHGYLDDKQ----VAVK-MLSSSSVQGYKQFQA--EVELLI 611
+ +E++ +G+G +G V+ ++ VA+K L S K A E+ +L
Sbjct: 1 MMEKYEKIGKIGEGSYGVVFKCR--NRDTGQIVAIKKFLESEDDPVIK-KIALREIRMLK 57
Query: 612 RAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGL 671
+ H NL L+ + L++E+ + + H L+ + I ++ Q +
Sbjct: 58 QLKHPNLVNLLEVFRRKRRLHLVFEYC-DHTVL-HELDRYQRGVPEHLVKSITWQTLQAV 115
Query: 672 EYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYL 730
+ H + +HRDVK NIL+ + KL DFG +R+ + V T Y
Sbjct: 116 NFCHKHN----CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYR 169
Query: 731 DPEYYISNRLTEKS-DVYSFGVVLLELITGQP 761
PE + + DV++ G V EL++G P
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGVP 201
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 3e-16
Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 47/222 (21%)
Query: 563 NNFERV--LGKGGFGTVYHGYLDDKQ---VAVKML---------SSSSVQGYKQFQAEVE 608
+ + +G+G +G VY + A+K + S++++ E+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ--NNYGETFALKKIRLEKEDEGIPSTTIR-------EIS 52
Query: 609 LLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESA 668
+L H N+ L + L++E + + +L LL+ L + S
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDL-KKLLDVCEGGL---ESVTAKSFLL 107
Query: 669 Q---GLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG 725
Q G+ Y H+ ++HRD+K N+L+N + + K+ADFGL+R F + + T +
Sbjct: 108 QLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIV 162
Query: 726 TPGYLDPE------YYISNRLTEKSDVYSFGVVLLELITGQP 761
T Y P+ Y + D++S G + E++ G P
Sbjct: 163 TLWYRAPDVLMGSKKY-----STTIDIWSVGCIFAEMVNGTP 199
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 6e-16
Identities = 59/235 (25%), Positives = 100/235 (42%), Gaps = 54/235 (22%)
Query: 563 NNFERV--LGKGGFGTVYHG--YLDDKQVAVKML---------SSSSVQGYKQFQAEVEL 609
+ +E++ +G+G FG V+ ++VA+K + ++++ E+++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-------EIKI 69
Query: 610 LIRAHHKNLTILVGYC-----DEGANMGLIY---EFMANGNLQAHLLEDKADTLCWERRL 661
L H+N+ L+ C G IY +F + +L A LL +
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DL-AGLLSNVLVKFTLS--- 124
Query: 662 QIASESAQ---GLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF--PVEG 715
+I GL Y+H N I+HRD+K+AN+L+ KLADFGL+R F
Sbjct: 125 EIKRVMQMLLNGLYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 716 GTHVSTTVVGTPGYLDPE------YYISNRLTEKSDVYSFGVVLLELITGQPVIQ 764
+ T V T Y PE Y D++ G ++ E+ T P++Q
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDY-----GPPIDLWGAGCIMAEMWTRSPIMQ 230
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 37/218 (16%)
Query: 563 NNFERV--LGKGGFGTVYHGY--LDDKQVAVKML---------SSSSVQGYKQFQAEVEL 609
+E++ +G+G +GTV+ + VA+K + SS+++ E+ L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-------EICL 54
Query: 610 LIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQ 669
L HKN+ L + L++EF + +L + L + S Q
Sbjct: 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDL-KKYFDSCNGDL---DPEIVKSFLFQ 109
Query: 670 ---GLEYLH-NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG 725
GL + H ++HRD+K N+L+N + KLA+FGL+R F + + + V
Sbjct: 110 LLKGLGFCHSRN----VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVV 163
Query: 726 TPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELIT-GQP 761
T Y P+ + + D++S G + EL G+P
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 44/225 (19%)
Query: 563 NNFERV--LGKGGFGTVY---HGYLDDKQVAVKML---------SSSSVQGYKQFQAEVE 608
+E V +G+G +G V+ + VA+K + S+++ EV
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-------EVA 63
Query: 609 LL---IRAHHKN----LTILVG-YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERR 660
+L H N + D + L++E + + +L L+ +
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDL-TTYLDKVPEPGVPTE- 120
Query: 661 LQIASESAQ---GLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG- 716
I Q GL++LH+ +VHRD+K NIL+ Q KLADFGL+RI+ +
Sbjct: 121 -TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL 176
Query: 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
T V VV T Y PE + + D++S G + E+ +P
Sbjct: 177 TSV---VV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 62/223 (27%), Positives = 92/223 (41%), Gaps = 32/223 (14%)
Query: 563 NNFERV--LGKGGFGTVYHGY--LDDKQVAVKMLS-SSSVQGYKQFQA----EVELLIR- 612
+ +E V +G G +GTVY VA+K + + G EV LL R
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 613 --AHHKN----LTILVG-YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIAS 665
H N + + D + L++E + +L L+ I
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DL-RTYLDKAPPPGLPAE--TIKD 124
Query: 666 ESAQ---GLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG-THVST 721
Q GL++LH C IVHRD+K NIL+ KLADFGL+RI+ + T V
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV-- 179
Query: 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQ 764
VV T Y PE + + D++S G + E+ +P+
Sbjct: 180 -VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 220
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 50/213 (23%), Positives = 80/213 (37%), Gaps = 26/213 (12%)
Query: 567 RVLGKGGFGTVYHGY-LDDKQVAVKMLSSSSVQGYKQ--FQA---------EVELLIRAH 614
R + G +G V G + VA+K + ++ G E+ LL H
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 615 HKNLTIL--VGYCDEGANMGLIY---EFMANGNLQAHLLEDKADTLCWERRLQIASESAQ 669
H N+ L + E M +Y E M +L ++ D+ + +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLA-QVIHDQRIVISPQHIQYFMYHILL 145
Query: 670 GLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGY 729
GL LH +VHRD+ NILL + + DF L+R + T V Y
Sbjct: 146 GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWY 199
Query: 730 LDPEYYIS-NRLTEKSDVYSFGVVLLELITGQP 761
PE + T+ D++S G V+ E+ +
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 36/234 (15%)
Query: 548 LENRKFSYFDVLK----ITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSS--SSV 597
+ + F DV K + + +G G +G+V ++VA+K LS S
Sbjct: 5 IRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE 64
Query: 598 QGYKQFQAEVELLIRAHHKNLTILV------GYCDEGANMGLIYEFMA---NGNLQAHLL 648
K+ E+ LL H+N+ L+ + L+ FM +
Sbjct: 65 IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFS 124
Query: 649 EDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 708
E+K L + Q+ +GL+Y+H+ +VHRD+K N+ +NE + K+ DFGL+
Sbjct: 125 EEKIQYLVY----QML----KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173
Query: 709 RIFPVEGGTHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQP 761
R E T V T Y PE +S + D++S G ++ E++TG+
Sbjct: 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 50/224 (22%), Positives = 93/224 (41%), Gaps = 40/224 (17%)
Query: 563 NNFERV--LGKGGFGTVYHGY--LDDKQVAVKML---------SSSSVQGYKQFQAEVEL 609
+ + R+ LG+G +G VY + ++ VA+K + ++++ EV L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-------EVSL 86
Query: 610 LIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERR---LQIASE 666
L H+N+ L + LI+E+ N +L ++ D + Q+
Sbjct: 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DL-KKYMDKNPDVSMRVIKSFLYQLI-- 142
Query: 667 SAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQA-----KLADFGLSRIFPVEGGTHVST 721
G+ + H +HRD+K N+LL+ + K+ DFGL+R F + T
Sbjct: 143 --NGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--T 195
Query: 722 TVVGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQPVIQ 764
+ T Y PE + S + D++S + E++ P+
Sbjct: 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 36/219 (16%)
Query: 567 RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTIL--- 621
+ LG GG G V+ DK+VA+K + + Q K E++++ R H N+ +
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 622 -----------VGYCDEGANMGLIYEFMANGNLQA-----HLLEDKADTLCWERRLQIAS 665
VG E ++ ++ E+M +L LLE+ A + Q+
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMY----QLL- 130
Query: 666 ESAQGLEYLHNGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIF-PVEGGTHVSTTV 723
+GL+Y+H+ ++HRD+K AN+ +N E K+ DFGL+RI P +
Sbjct: 131 ---RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 724 VGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQP 761
+ T Y P +S N T+ D+++ G + E++TG+
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 50/216 (23%), Positives = 77/216 (35%), Gaps = 60/216 (27%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIR-AHHKNLTIL 621
+VLG G G V + ++ A+KML + + EVEL R + ++ +
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 76
Query: 622 VG-YCDEGANMGLIY---EFMANGNL--------QAHLLEDKADTLCWERRLQIASESAQ 669
V Y + A + E + G L E +A + I
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM----KSIGE---- 128
Query: 670 GLEYLH-NGCKPPIVHRDVKSANILLNEKFQA---KLADFGLSRIFPVEGGTHVSTTVVG 725
++YLH I HRDVK N+L K KL DFG ++ G
Sbjct: 129 AIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTGE--------- 173
Query: 726 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
Y + D++S GV++ L+ G P
Sbjct: 174 --KY-----------DKSCDMWSLGVIMYILLCGYP 196
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 43/218 (19%)
Query: 567 RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQA---------EVELLIRAHH 615
+G+G +G V Y L+ +VA+K +S F+ E+++L+R H
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIKILLRFRH 84
Query: 616 KNLTIL--VGYCDEGANMGLIY---EFMANGNLQA-----HLLEDKADTLCWERRLQIAS 665
+N+ + + M +Y + M +L HL D + QI
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLY----QIL- 138
Query: 666 ESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI-FPVEGGTHVSTTVV 724
+GL+Y+H+ ++HRD+K +N+LLN K+ DFGL+R+ P T T V
Sbjct: 139 ---RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 725 GTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQP 761
T Y PE ++ T+ D++S G +L E+++ +P
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 51/232 (21%), Positives = 86/232 (37%), Gaps = 51/232 (21%)
Query: 560 KITNNFE--RVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQGYKQFQ---------AE 606
K + F+ R+ G+G FGTV G VA+K K Q
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK----------KVIQDPRFRNRELQI 69
Query: 607 VELLIRAHHKNLTIL--VGYCDEGANMG-----LIYEFMANGNLQAHLLEDKADTLCWER 659
++ L HH N+ L Y + ++ E++ L + R
Sbjct: 70 MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCC------RNYYRR 122
Query: 660 RLQIASESAQ--------GLEYLHNGCKPPIVHRDVKSANILLNEK-FQAKLADFGLSRI 710
++ + + LH + HRD+K N+L+NE KL DFG ++
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181
Query: 711 FPVEGGTHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQP 761
+V+ + + Y PE N+ T D++S G + E++ G+P
Sbjct: 182 L-SPSEPNVAY--ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 8e-13
Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 33/230 (14%)
Query: 551 RKFSYFDVLKITNNFE--------RVLGKGGFGTVYHGY--LDDKQVAVKMLSS--SSVQ 598
F +V K +E + +G G +G V +VA+K L S
Sbjct: 9 SGFYRQEVTKTA--WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL 66
Query: 599 GYKQFQAEVELLIRAHHKNLTILV------GYCDEGANMGLIYEFMANGNLQAHLLEDKA 652
K+ E+ LL H+N+ L+ D+ + L+ FM +L + K
Sbjct: 67 FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM---KH 122
Query: 653 DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 712
+ L +R + + +GL Y+H I+HRD+K N+ +NE + K+ DFGL+R
Sbjct: 123 EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD 179
Query: 713 VEGGTHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQP 761
E T V T Y PE ++ T+ D++S G ++ E+ITG+
Sbjct: 180 SE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 49/228 (21%), Positives = 83/228 (36%), Gaps = 64/228 (28%)
Query: 566 ERVLGKGGFGTVYHGYL-DDKQVAVKMLSSSSVQGYKQFQA------EVELLIRAHHKNL 618
+V+G G FG V+ L + +VA+K K Q E++++ H N+
Sbjct: 45 CKVIGNGSFGVVFQAKLVESDEVAIK----------KVLQDKRFKNRELQIMRIVKHPNV 94
Query: 619 TILVGYCDEGANMG------LIYEFMANGNLQAHLLEDKADTLCWERRLQIASES----- 667
L + + L+ E++ + + + Q
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRH-------YAKLKQTMPMLLIKLY 146
Query: 668 ----AQGLEYLHNGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIF-PVEGGTH-VS 720
+ L Y+H+ I HRD+K N+LL+ KL DFG ++I E +
Sbjct: 147 MYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC 203
Query: 721 T-------TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
+ + G Y T D++S G V+ EL+ GQP
Sbjct: 204 SRYYRAPELIFGATNY-----------TTNIDIWSTGCVMAELMQGQP 240
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 52/220 (23%), Positives = 87/220 (39%), Gaps = 36/220 (16%)
Query: 567 RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGY 624
R LG G F TV+ +++ VA+K++ + + E++LL N
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLL---QRVNDADNTKE 80
Query: 625 CDEGAN--MGLIYEFMANGNLQAH------LLEDKADTLCWERRLQ---------IASES 667
GAN + L+ F G H +L + L + + I+ +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 668 AQGLEYLHNGCKPPIVHRDVKSANILLNE------KFQAKLADFGLSRIFPVEGGTHVST 721
GL+Y+H C I+H D+K N+L+ Q K+AD G + + T
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLG-NACW----YDEHYT 193
Query: 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
+ T Y PE + +D++S ++ ELITG
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 49/231 (21%), Positives = 96/231 (41%), Gaps = 39/231 (16%)
Query: 549 ENRKFSYFDVLKITNNFE--------RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQ 598
+R Y+D + R LG+G + V+ ++++V VK+L
Sbjct: 16 THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL------ 69
Query: 599 GYKQFQA-----EVELLIR-AHHKNLTIL--VGYCDEGANMGLIYEFMANGNLQAHLLED 650
K + E+++L N+ L + L++E + N + + L +
Sbjct: 70 --KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFK-QLYQT 126
Query: 651 KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSR 709
D +I + L+Y H+ I+HRDVK N++++ E + +L D+GL+
Sbjct: 127 LTDYDIRFYMYEIL----KALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179
Query: 710 IFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKS-DVYSFGVVLLELITG 759
F G + V + + PE + ++ + S D++S G +L +I
Sbjct: 180 -FYHPGQEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 227
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-12
Identities = 21/82 (25%), Positives = 34/82 (41%), Gaps = 1/82 (1%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ + ++ + + +P IF+ L ++ LDLS+ L P L SL+VLN+S N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 504
Query: 468 NLQGSLPSGLSEKVKNGSLSLS 489
N L S
Sbjct: 505 NFFSLDTFPYKCLNSLQVLDYS 526
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 19/84 (22%), Positives = 36/84 (42%), Gaps = 2/84 (2%)
Query: 408 SPRIISINLSSSGIAGDIVPYIF-SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG 466
++ ++ S + +F SL ++ LD+S L SL VL ++G
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 467 NNLQGSLPSGLSEKVKN-GSLSLS 489
N+ Q + + +++N L LS
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLS 478
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 7e-11
Identities = 20/89 (22%), Positives = 38/89 (42%), Gaps = 1/89 (1%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
+ ++LS + SL+S++ L++S N+ L SL+VL+ S N+
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 469 LQGSLPSGLSEKVKNGSLSLSVDGNRNLC 497
+ S L + + L++ N C
Sbjct: 530 IMTSKKQELQHFPSSLA-FLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 5e-10
Identities = 16/71 (22%), Positives = 27/71 (38%)
Query: 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+++LS + + FS ++ LDLS+ + L L L L+GN
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 468 NLQGSLPSGLS 478
+Q S
Sbjct: 87 PIQSLALGAFS 97
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-09
Identities = 15/71 (21%), Positives = 27/71 (38%), Gaps = 2/71 (2%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
P + ++LS I I + L+ + +L L+ N + + L SL+ L
Sbjct: 52 PELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110
Query: 468 NLQGSLPSGLS 478
NL +
Sbjct: 111 NLASLENFPIG 121
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-09
Identities = 15/68 (22%), Positives = 26/68 (38%), Gaps = 1/68 (1%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAEL-QSLRVLNLSGN 467
+ +N+S + L S++ LD S N + + L SL LNL+ N
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 468 NLQGSLPS 475
+ +
Sbjct: 554 DFACTCEH 561
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 15/71 (21%), Positives = 33/71 (46%), Gaps = 1/71 (1%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
+ ++ L+ + I + L+S++ L + +L + L++L+ LN++ N
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 469 LQG-SLPSGLS 478
+Q LP S
Sbjct: 136 IQSFKLPEYFS 146
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-08
Identities = 23/84 (27%), Positives = 40/84 (47%), Gaps = 4/84 (4%)
Query: 409 PRIISINLSSSGIA--GDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG 466
P + ++LS +G++ G F TS++ LDLS N + FL L+ L L+
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFL-GLEQLEHLDFQH 405
Query: 467 NNLQGSLPSGLSEKVKN-GSLSLS 489
+NL+ + ++N L +S
Sbjct: 406 SNLKQMSEFSVFLSLRNLIYLDIS 429
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 4e-07
Identities = 20/75 (26%), Positives = 33/75 (44%), Gaps = 5/75 (6%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRV----LN 463
+ +N++ + I +P FS LT++E LDLS N + L L + + L+
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 464 LSGNNLQGSLPSGLS 478
LS N + P
Sbjct: 184 LSLNPMNFIQPGAFK 198
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 19/66 (28%), Positives = 29/66 (43%), Gaps = 3/66 (4%)
Query: 415 NLSSSGIAGDIVPYIFSLTSIESLDLSKNSLT--GPVPEFLAELQSLRVLNLSGNNLQGS 472
L+ + G L S+E LDLS+N L+ G + SL+ L+LS N +
Sbjct: 329 RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT- 387
Query: 473 LPSGLS 478
+ S
Sbjct: 388 MSSNFL 393
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 8e-06
Identities = 18/85 (21%), Positives = 33/85 (38%), Gaps = 3/85 (3%)
Query: 412 ISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPE-FLAELQSLRVLNLSGNNLQ 470
+S++LS + + I P F + L L N + V + + L L V L +
Sbjct: 180 LSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 471 GSLPSGLSEKVKNGSL-SLSVDGNR 494
+K L +L+++ R
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFR 263
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 13/82 (15%), Positives = 29/82 (35%), Gaps = 4/82 (4%)
Query: 407 QSPRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLS 465
+ I L+ D + +F+ LT++ S L ++ + + L L
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELV 312
Query: 466 GNNLQGSLPSGLSEKVKNGSLS 487
G P+ + +K + +
Sbjct: 313 NCKF-GQFPTLKLKSLKRLTFT 333
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 57/233 (24%), Positives = 88/233 (37%), Gaps = 73/233 (31%)
Query: 566 ERVLGKGGFGTVYHGYLDD--KQVAVKMLSSSSVQGYKQFQA------EVELLIRAHHKN 617
+V+G G FG VY L D + VA+K K Q E++++ + H N
Sbjct: 59 TKVIGNGSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLDHCN 108
Query: 618 LTIL------VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASES---- 667
+ L G + + L+ +++ + + R Q
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARH-------YSRAKQTLPVIYVKL 160
Query: 668 -----AQGLEYLHNGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIFPVEGGTHVST 721
+ L Y+H+ I HRD+K N+LL+ + KL DFG ++ V G +VS
Sbjct: 161 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS- 215
Query: 722 TVVGTPGYLDPEYYISNRL-------------TEKSDVYSFGVVLLELITGQP 761
YI +R T DV+S G VL EL+ GQP
Sbjct: 216 -------------YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 6e-12
Identities = 53/231 (22%), Positives = 87/231 (37%), Gaps = 62/231 (26%)
Query: 567 RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQA---------EVELLIRAHH 615
+LG+G +G V + VA+K + F E+++L H
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIKILKHFKH 68
Query: 616 KNLTIL--VGYCDEGANMGLIY---EFMA---NGNLQAHLLEDK------ADTLCWERRL 661
+N+ + + D N +Y E M + + +L D TL
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR----- 123
Query: 662 QIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721
++ LH ++HRD+K +N+L+N K+ DFGL+RI +
Sbjct: 124 --------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 722 TV--------VGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQP 761
T V T Y PE + S + + DV+S G +L EL +P
Sbjct: 173 TGQQSGMVEFVATRWYRAPE--VMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 51/281 (18%), Positives = 99/281 (35%), Gaps = 70/281 (24%)
Query: 534 RRRKQAGKKKGSLELENRKFSYFDVLKITNNFE--RVLGKGGFGTVYHGY--LDDKQVAV 589
+ ++ + + +N+ ++G+G +G VY Y +K VA+
Sbjct: 3 HHHHHSSGRENLYFQGIKNV------HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAI 56
Query: 590 KMLSSSSVQGYKQFQA---------EVELLIRAHHKNLT-----ILVGYCDEGANMGLIY 635
K ++ + F+ E+ +L R + I+ + + ++
Sbjct: 57 KKVN-------RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL 109
Query: 636 EFMANGNLQA------HLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKS 689
E + +L+ L E+ T+ + + G ++H I+HRD+K
Sbjct: 110 EIADS-DLKKLFKTPIFLTEEHIKTILY----NLL----LGENFIHES---GIIHRDLKP 157
Query: 690 ANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTE------- 742
AN LLN+ K+ DFGL+R E T++ + + +LT
Sbjct: 158 ANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWY 217
Query: 743 -------------KS-DVYSFGVVLLELITGQPVIQKTPQR 769
KS D++S G + EL+ P
Sbjct: 218 RAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-11
Identities = 27/185 (14%), Positives = 53/185 (28%), Gaps = 16/185 (8%)
Query: 360 QLLTNQQDVDAIMKIKSKYEVKRDWQGDPCAPKVYMWQ---GINCSYDANQSPRIISINL 416
LT+ V + ++Y +W G N S + + N
Sbjct: 10 NALTDDAIVPIKLSRTAEYI-------KDYLALKEIWDALNGKNWSQQGFGTQPGANWNF 62
Query: 417 SSSGIAGDIVPYIF--SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQG--- 471
+ P + S + L L +G VP+ + +L L VL L + +
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 472 -SLPSGLSEKVKNGSLSLSVDGNRNLCPSASCKKKSNKFIFPVLASVVSFCILLALLAIL 530
P G+S + + + ++ + I + S + I
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182
Query: 531 QNLRR 535
+
Sbjct: 183 LKDTQ 187
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 11/83 (13%), Positives = 28/83 (33%), Gaps = 3/83 (3%)
Query: 415 NLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLP 474
+ + + I S+ L + N + + ++ VL++ N
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKIT---PNISVLDIKDNPNISIDL 604
Query: 475 SGLSEKVKNGSLSLSVDGNRNLC 497
S + ++ G L D +++
Sbjct: 605 SYVCPYIEAGMYMLFYDKTQDIR 627
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-09
Identities = 13/87 (14%), Positives = 29/87 (33%), Gaps = 13/87 (14%)
Query: 425 IVPYIFSLTSIESL------DLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLS 478
+ ++++ D N PE + SL L + N+++ + ++
Sbjct: 528 FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKIT 586
Query: 479 EKVKNGSLSLSVDGNRNLC--PSASCK 503
+ L + N N+ S C
Sbjct: 587 PNIS----VLDIKDNPNISIDLSYVCP 609
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-09
Identities = 16/83 (19%), Positives = 28/83 (33%), Gaps = 6/83 (7%)
Query: 414 INLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSL 473
I + P F ++ S++LS N ++ E + L +NL GN L +
Sbjct: 414 IGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-I 472
Query: 474 PSGLSEKVKNGSLSLSVDGNRNL 496
P + + L
Sbjct: 473 PKNS-----LKDENENFKNTYLL 490
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 10/86 (11%), Positives = 28/86 (32%), Gaps = 6/86 (6%)
Query: 415 NLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQG--- 471
N + +L + +++ +P FL L ++++N++ N
Sbjct: 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQ 290
Query: 472 --SLPSGLSEKVKNGSL-SLSVDGNR 494
L++ + + + N
Sbjct: 291 LKDDWQALADAPVGEKIQIIYIGYNN 316
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 14/54 (25%), Positives = 25/54 (46%), Gaps = 1/54 (1%)
Query: 423 GDIVPYIFSLTSIESLDLSKNSL-TGPVPEFLAELQSLRVLNLSGNNLQGSLPS 475
+ I+ + + N+L T PV L +++ L +L N L+G LP+
Sbjct: 295 WQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA 348
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-08
Identities = 19/93 (20%), Positives = 30/93 (32%), Gaps = 13/93 (13%)
Query: 413 SINLSS-------SGIAGDIVPYIFSLTSIESLDLSKNSLTG-PVPEFLAELQSLRVLNL 464
SINL D + + S+DL N LT L L ++L
Sbjct: 461 SINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDL 520
Query: 465 SGNNLQGSLPSGLSEKVKNGSL-SLSVDGNRNL 496
S N+ P+ + +L + R+
Sbjct: 521 SYNSFSK-FPTQPL---NSSTLKGFGIRNQRDA 549
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 16/86 (18%), Positives = 33/86 (38%), Gaps = 10/86 (11%)
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGS 472
+ + + G +P S + SL+L+ N +T F + + L+ + N L+
Sbjct: 334 MLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-Y 391
Query: 473 LPSGLSEKVKNGSLS----LSVDGNR 494
+P+ S+S + N
Sbjct: 392 IPNIFD----AKSVSVMSAIDFSYNE 413
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 10/84 (11%), Positives = 21/84 (25%), Gaps = 1/84 (1%)
Query: 406 NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLS 465
+I ++S I + N++T V + + L LR +
Sbjct: 156 EDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMG 214
Query: 466 GNNLQGSLPSGLSEKVKNGSLSLS 489
+ E +
Sbjct: 215 NSPFVAENICEAWENENSEYAQQY 238
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 22/94 (23%), Positives = 38/94 (40%), Gaps = 18/94 (19%)
Query: 413 SINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTG-------PVPEFLAELQSLRVLNL 464
SINLS++ I+ +FS + + S++L N LT E L ++L
Sbjct: 437 SINLSNNQISK-FPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495
Query: 465 SGNNLQGSLPSGLSEKVKNGSLS----LSVDGNR 494
N L + LS+ + +L + + N
Sbjct: 496 RFNKL-----TKLSDDFRATTLPYLVGIDLSYNS 524
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 15/107 (14%), Positives = 29/107 (27%), Gaps = 30/107 (28%)
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAE----------------- 455
I S+ I + + LT + + + E
Sbjct: 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKW 245
Query: 456 --LQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS----LSVDGNRNL 496
L+ L + + LP+ L +L ++V NR +
Sbjct: 246 DNLKDLTDVEVYNCPNLTKLPTFL------KALPEMQLINVACNRGI 286
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 11/77 (14%), Positives = 25/77 (32%), Gaps = 7/77 (9%)
Query: 425 IVPYIFS-LTSIESLDLSKNSLTG-PVPEFLAELQSLRVLNLSGNNLQGSLPSGLS---- 478
I +E+L + N L P + + ++ S N +
Sbjct: 368 IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP 427
Query: 479 EKVKNGSL-SLSVDGNR 494
K ++ S+++ N+
Sbjct: 428 TPFKGINVSSINLSNNQ 444
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 9e-06
Identities = 6/82 (7%), Positives = 30/82 (36%), Gaps = 9/82 (10%)
Query: 406 NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLT--------GPVPEFLAELQ 457
+ + + + + + ++ +L ++ ++++ N +
Sbjct: 246 DNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGE 305
Query: 458 SLRVLNLSGNNLQ-GSLPSGLS 478
++++ + NNL+ + + L
Sbjct: 306 KIQIIYIGYNNLKTFPVETSLQ 327
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 4/69 (5%), Positives = 15/69 (21%), Gaps = 3/69 (4%)
Query: 413 SINLSSSGIAGDIVPYIF--SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQ 470
V Y + + ++ + + + + NN+
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI- 195
Query: 471 GSLPSGLSE 479
+ +
Sbjct: 196 TFVSKAVMR 204
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 43/237 (18%)
Query: 549 ENRKFSYFDVLKITNNFE--------RVLGKGGFGTVY--HGYLDDKQVAVKMLSS--SS 596
E F ++ K +E +G G +G+V +VAVK LS S
Sbjct: 11 ERPTFYRQELNKTI--WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 68
Query: 597 VQGYKQFQAEVELLIRAHHKNLTILV------GYCDEGANMGLIYEFMANGNLQA----- 645
+ K+ E+ LL H+N+ L+ +E ++ L+ M +L
Sbjct: 69 IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 127
Query: 646 HLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADF 705
L +D L + QI +GL+Y+H+ I+HRD+K +N+ +NE + K+ DF
Sbjct: 128 KLTDDHVQFLIY----QIL----RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 176
Query: 706 GLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQP 761
GL+R E T V T Y PE ++ + D++S G ++ EL+TG+
Sbjct: 177 GLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 46/248 (18%), Positives = 82/248 (33%), Gaps = 57/248 (22%)
Query: 560 KITNNFE--RVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQGYKQFQA-EVELLIRAH 614
+ + + LG G FG V + K+ A+K V +++ E++++
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK-----VLQDPRYKNRELDIMKVLD 58
Query: 615 HKNLTIL--VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWE-------------- 658
H N+ L Y + L
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 659 -------RRLQIASESAQ----------------GLEYLHNGCKPPIVHRDVKSANILLN 695
+ L+ S + + ++H+ I HRD+K N+L+N
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVN 175
Query: 696 -EKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVL 753
+ KL DFG ++ + V+ + + Y PE + T D++S G V
Sbjct: 176 SKDNTLKLCDFGSAKKL-IPSEPSVAY--ICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 754 LELITGQP 761
ELI G+P
Sbjct: 233 GELILGKP 240
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-11
Identities = 23/91 (25%), Positives = 42/91 (46%), Gaps = 3/91 (3%)
Query: 407 QSPRIISINLSSSGIAG--DIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNL 464
Q + + LS++ I IF+ +S++ L+LS N + P + L L L
Sbjct: 143 QLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFL 202
Query: 465 SGNNLQGSLPSGLSEKVKNGSL-SLSVDGNR 494
+ L SL L ++ N S+ +LS+ ++
Sbjct: 203 NNVQLGPSLTEKLCLELANTSIRNLSLSNSQ 233
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-10
Identities = 21/90 (23%), Positives = 34/90 (37%), Gaps = 3/90 (3%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ +NL S+G I +F L ++ +DL N+L SL+ LNL N
Sbjct: 536 SHLHILNLESNGFDE-IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594
Query: 468 NLQGSLPSGLSEKVKNGSLSLSVDGNRNLC 497
+ +N + L + N C
Sbjct: 595 LITSVEKKVFGPAFRNLT-ELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 18/88 (20%), Positives = 33/88 (37%), Gaps = 3/88 (3%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ ++L + I ++ + L +I + LS N A + SL+ L L
Sbjct: 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRV 464
Query: 468 NLQGSLPSGLSEKVKNGSL-SLSVDGNR 494
L+ + S S +L L + N
Sbjct: 465 ALKN-VDSSPSPFQPLRNLTILDLSNNN 491
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 24/95 (25%), Positives = 40/95 (42%), Gaps = 4/95 (4%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
+ ++L S+ I ++ +LDLS N L+ +L++L+ L LS N
Sbjct: 97 TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK 156
Query: 469 LQGSLPSGLSEKVKNGSL-SLSVDGNR--NLCPSA 500
+Q L S + N SL L + N+ P
Sbjct: 157 IQA-LKSEELDIFANSSLKKLELSSNQIKEFSPGC 190
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 6e-09
Identities = 18/88 (20%), Positives = 40/88 (45%), Gaps = 6/88 (6%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
++ S+++ + I+ + P + L ++ L+L N L+ + A +L L+L N
Sbjct: 49 SQLTSLDVGFNTISK-LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSN 107
Query: 468 NLQGSLPSGLSEKVKNGSL-SLSVDGNR 494
++Q + K +L +L + N
Sbjct: 108 SIQKIKNNPFV---KQKNLITLDLSHNG 132
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 7e-09
Identities = 18/75 (24%), Positives = 32/75 (42%)
Query: 415 NLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLP 474
L G + ++ L+ + L+L N E +L L++++L NNL
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
Query: 475 SGLSEKVKNGSLSLS 489
S + +V SL+L
Sbjct: 578 SVFNNQVSLKSLNLQ 592
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 18/82 (21%), Positives = 34/82 (41%), Gaps = 2/82 (2%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
P + +NL + ++ + F+ T++ L L NS+ + ++L L+LS N
Sbjct: 73 PMLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHN 131
Query: 468 NLQGSLPSGLSEKVKNGSLSLS 489
L + + L LS
Sbjct: 132 GLSSTKLGTQVQLENLQELLLS 153
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 23/90 (25%), Positives = 38/90 (42%), Gaps = 7/90 (7%)
Query: 409 PRIISINLSSSGIAG-DIVPYIF-SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG 466
P + + L + D P F L ++ LDLS N++ + L L+ L +L+L
Sbjct: 454 PSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQH 513
Query: 467 NNLQGSLPSGLSEKVKNGSLSLSVDGNRNL 496
NNL + L + G + G +L
Sbjct: 514 NNL-----ARLWKHANPGGPIYFLKGLSHL 538
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 17/93 (18%), Positives = 38/93 (40%), Gaps = 5/93 (5%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPE-FLAELQSLRVLNLSG 466
+ I+L + + + +F+ S++SL+L KN +T + F ++L L++
Sbjct: 560 FELKIIDLGLNNLNT-LPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRF 618
Query: 467 NNLQGSLPS--GLSEKVKNGSLSLSVDGNRNLC 497
N + S + ++ + LC
Sbjct: 619 NPFDCTCESIAWFVNWINETHTNIPELSSHYLC 651
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 17/95 (17%), Positives = 36/95 (37%), Gaps = 7/95 (7%)
Query: 407 QSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG 466
+ + ++LS + + L +E L N++ L L ++R LNL
Sbjct: 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305
Query: 467 NNLQGSLPSGLSEKVKNGSLS-------LSVDGNR 494
+ + S+ K+ + S L+++ N
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDND 340
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 6/86 (6%)
Query: 411 IISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNL 469
I +NL+ + + + F+ + + SLD+ N+++ PE +L L+VLNL N L
Sbjct: 27 ITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85
Query: 470 QGSLPSGLSEKVKNGSL-SLSVDGNR 494
+ +L L + N
Sbjct: 86 SQLSDKTFAF---CTNLTELHLMSNS 108
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-08
Identities = 15/72 (20%), Positives = 30/72 (41%), Gaps = 4/72 (5%)
Query: 409 PRIISINLSSSGI-AGDIVPYIFS---LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNL 464
+ ++LS+S + F + + L+L+KN ++ + + L L VL+L
Sbjct: 353 INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDL 412
Query: 465 SGNNLQGSLPSG 476
N + L
Sbjct: 413 GLNEIGQELTGQ 424
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 8e-08
Identities = 17/75 (22%), Positives = 33/75 (44%), Gaps = 5/75 (6%)
Query: 409 PRIISINLSSSGIAGDIVPYIF---SLTSIESLDLSKNSLTGPVPEFLAELQ--SLRVLN 463
R+ + L++ + + + + TSI +L LS + L+ L+ +L +L+
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254
Query: 464 LSGNNLQGSLPSGLS 478
LS NNL +
Sbjct: 255 LSYNNLNVVGNDSFA 269
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 17/87 (19%), Positives = 37/87 (42%), Gaps = 4/87 (4%)
Query: 411 IISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNL 469
++S + + I + F L +E L++ N + G L +L+ L+LS +
Sbjct: 307 FTKQSISLASLPK-IDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT 365
Query: 470 Q-GSLPSGLSEKVKNGSL-SLSVDGNR 494
+L + + + L L++ N+
Sbjct: 366 SLRTLTNETFVSLAHSPLHILNLTKNK 392
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-05
Identities = 17/97 (17%), Positives = 35/97 (36%), Gaps = 13/97 (13%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKN---------SLTGPVPEFLAELQSL 459
P++ L + I + L ++ L+L ++ SL L+ L
Sbjct: 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331
Query: 460 RVLNLSGNNLQGSLPSGLSEKVKNGSL-SLSVDGNRN 495
LN+ N++ G + + +L LS+ +
Sbjct: 332 EHLNMEDNDIPGIKSNMFT---GLINLKYLSLSNSFT 365
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 10/47 (21%), Positives = 16/47 (34%)
Query: 432 LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLS 478
T+I L+L+ N L L L++ N + P
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQ 70
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-05
Identities = 17/75 (22%), Positives = 28/75 (37%), Gaps = 4/75 (5%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKN--SLTGPVPEFLAELQ--SLRVLNL 464
+ +N+ + I G L +++ L LS + SL E L L +LNL
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388
Query: 465 SGNNLQGSLPSGLSE 479
+ N + S
Sbjct: 389 TKNKISKIESDAFSW 403
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 53/266 (19%), Positives = 95/266 (35%), Gaps = 50/266 (18%)
Query: 534 RRRKQAGKKKGSLELENRKFSYFDVLKITNN----FERVLGKGGFGTVYHGYL------- 582
+ QAG++ + +F+ +++ +G+GGFG +Y +
Sbjct: 4 VKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVG 63
Query: 583 DDKQVAVKMLSSSSVQ------GYKQFQAEVELLIRAHHKNLTIL----VGYCDEGANMG 632
D VK+ S + Y++ ++ + L L G
Sbjct: 64 SDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNG 123
Query: 633 LIYEFMA----NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVK 688
Y FM +LQ + E A + LQ++ LEY+H VH D+K
Sbjct: 124 KSYRFMIMDRFGSDLQ-KIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIK 179
Query: 689 SANILLNEKFQAK--LADFGLSRIFPVEGGTHV------STTVVGTPGYLDPEYYIS--- 737
++N+LLN K + L D+GL+ + G H GT + S
Sbjct: 180 ASNLLLNYKNPDQVYLVDYGLAYRY-CPEGVHKAYAADPKRCHDGTI------EFTSIDA 232
Query: 738 ---NRLTEKSDVYSFGVVLLELITGQ 760
+ + D+ G +++ +TG
Sbjct: 233 HNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 45/240 (18%), Positives = 94/240 (39%), Gaps = 54/240 (22%)
Query: 532 NLRRRKQAGKKKGSLELENRKFSYFDVLKITNNFE--RVLGKGGFGTVYHGY--LDDKQV 587
R++ + K S+ + + +I + +E ++G G +G V Y L+ + V
Sbjct: 28 QQRKQHHSSKPTASMPRPHSDW------QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVV 81
Query: 588 AVKMLSSSSVQGYKQFQA---------EVELLIRAHHKNLTIL--VGYCDEGANMGLIY- 635
A+K + + F+ E+ +L R +H ++ + + + +Y
Sbjct: 82 AIKKIL-------RVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134
Query: 636 --EFMANGNLQA------HLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDV 687
E + + + +L E TL + + G++Y+H+ I+HRD+
Sbjct: 135 VLEIA-DSDFKKLFRTPVYLTELHIKTLLY----NLL----VGVKYVHSA---GILHRDL 182
Query: 688 KSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNR-----LTE 742
K AN L+N+ K+ DFGL+R + + ++ + + LT
Sbjct: 183 KPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTG 242
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 56/239 (23%), Positives = 101/239 (42%), Gaps = 66/239 (27%)
Query: 567 RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQA---------EVELLIR-AH 614
+ LGKG +G V+ + VAVK + FQ E+ +L +
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIMILTELSG 67
Query: 615 HKNLTIL--VGYCDEGANMGLIYEFMA---NGNLQAHLLEDK------ADTLCWERRLQI 663
H+N+ L V D ++ L++++M + ++A++LE +
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIK------- 120
Query: 664 ASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTV 723
++YLH+G ++HRD+K +NILLN + K+ADFGLSR F + +
Sbjct: 121 ------VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 724 VGTPGYLDPEY-------YI-------------SNRLTEKSDVYSFGVVLLELITGQPV 762
+ + Y+ S + T+ D++S G +L E++ G+P+
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 58/221 (26%), Positives = 90/221 (40%), Gaps = 46/221 (20%)
Query: 567 RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELL-------------- 610
+V+GKG FG V Y + VA+KM+ + + ++Q E+ +L
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 611 IRA----HHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQ-IAS 665
I +N + E +M L YE + Q L ++ A
Sbjct: 162 IHMLENFTFRNHICMTF---ELLSMNL-YELIKKNKFQGFSLP----------LVRKFAH 207
Query: 666 ESAQGLEYLHNGCKPPIVHRDVKSANILLNE--KFQAKLADFGLSRIFPVEGGTHVSTTV 723
Q L+ LH K I+H D+K NILL + + K+ DFG S E T
Sbjct: 208 SILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQRV--YTY 259
Query: 724 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQ 764
+ + Y PE + R D++S G +L EL+TG P++
Sbjct: 260 IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 59.9 bits (144), Expect = 1e-09
Identities = 38/263 (14%), Positives = 67/263 (25%), Gaps = 63/263 (23%)
Query: 556 FDVLKITNNFERV--LGKGGFGTVYHGYLDDKQVAVKML---SSSSVQGYKQ-----FQA 605
F T +R +G+G FG V+ D VA+K++ V G Q
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 606 EVELL---------IRAHHKNLTILVG-----------YCDEGANMG------------- 632
E+ + + + L +
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 633 ------LIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRD 686
++ EF G + + I + L HRD
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSS---LATAKSILHQLTASLAVAEA--SLRFEHRD 187
Query: 687 VKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDV 746
+ N+LL + KL + + + + Y +S + V
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGKSSTI--PSCGLQVSIID-------YTLSRLERDGIVV 238
Query: 747 YSFGVVLLELITGQPVIQKTPQR 769
+ + +L TG Q R
Sbjct: 239 FCDVSMDEDLFTGDGDYQFDIYR 261
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 48/227 (21%), Positives = 77/227 (33%), Gaps = 43/227 (18%)
Query: 566 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVG 623
+ +G GGFG +Y + ++ A ++ Q +E++ R K+
Sbjct: 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY-QENGPLFSELKFYQRVAKKDCIKKWI 100
Query: 624 YCDEGANMGL--IYEFMANGNLQAH-------LL-EDKADTLCWERR------LQIASES 667
+ +G+ Y L D LQ+
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRM 160
Query: 668 AQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAK--LADFGLSRIFPVEGGTHV------ 719
LEY+H VH D+K+AN+LL K + LAD+GLS + G H
Sbjct: 161 LDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY-CPNGNHKQYQENP 216
Query: 720 STTVVGTPGYLDPEYYIS------NRLTEKSDVYSFGVVLLELITGQ 760
GT + S L+ +SDV G +L + G+
Sbjct: 217 RKGHNGTI------EFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 19/82 (23%), Positives = 37/82 (45%), Gaps = 1/82 (1%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ ++ ++ + + + +F+ T++ LDLSK L L L++LN+S N
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507
Query: 468 NLQGSLPSGLSEKVKNGSLSLS 489
NL S ++ +L S
Sbjct: 508 NLLFLDSSHYNQLYSLSTLDCS 529
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 18/83 (21%), Positives = 31/83 (37%), Gaps = 2/83 (2%)
Query: 409 PRIISINLSSSGIAGDIVPYIF-SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ ++ S + F SL + LD+S + L SL L ++GN
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458
Query: 468 NLQGSLPSGLSEKVKN-GSLSLS 489
+ + + S + N L LS
Sbjct: 459 SFKDNTLSNVFANTTNLTFLDLS 481
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 19/100 (19%), Positives = 41/100 (41%), Gaps = 4/100 (4%)
Query: 396 WQGINCSYDANQSPRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLA 454
++ S + + ++LS + I +F L ++ L++S N+L
Sbjct: 460 FKDNTLSNVFANTTNLTFLDLSKCQLEQ-ISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518
Query: 455 ELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSVDGNR 494
+L SL L+ S N ++ + L K+ + ++ N
Sbjct: 519 QLYSLSTLDCSFNRIE-TSKGILQHFPKSLA-FFNLTNNS 556
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 17/89 (19%), Positives = 40/89 (44%), Gaps = 3/89 (3%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTG-PVPEFLAELQSLRVLNLSGN 467
+ ++ + +A I L +++ L+++ N + +P + + L +L ++LS N
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163
Query: 468 NLQGSLPSGLS--EKVKNGSLSLSVDGNR 494
+Q + L + +LSL + N
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNP 192
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 14/62 (22%), Positives = 29/62 (46%), Gaps = 2/62 (3%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
R+ +N+S + + + ++ L S+ +LD S N + +SL NL+ N
Sbjct: 497 HRLQLLNMSHNNLLF-LDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555
Query: 468 NL 469
++
Sbjct: 556 SV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 20/96 (20%), Positives = 39/96 (40%), Gaps = 7/96 (7%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ ++ L+ + I P FS LTS+E+L + L + +L +L+ LN++ N
Sbjct: 80 HHLSNLILTGNPIQS-FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHN 138
Query: 468 NLQGSLPSGLSEKVKN-GSLSLSVDGNR--NLCPSA 500
+ + N + LS N + +
Sbjct: 139 FIHSCKLPAYFSNLTNLVHVDLS--YNYIQTITVND 172
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 4e-07
Identities = 21/88 (23%), Positives = 33/88 (37%), Gaps = 6/88 (6%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ ++LS I I + L + +L L+ N + P + L SL L
Sbjct: 56 SELQWLDLSRCEIET-IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET 114
Query: 468 NLQGSLPSGLSEKVKNGSL-SLSVDGNR 494
L SL S ++ L L+V N
Sbjct: 115 KLA-SLESFPIGQLIT--LKKLNVAHNF 139
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 6/86 (6%)
Query: 411 IISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNL 469
+I+LS + + + Y FS + ++ LDLS+ + + L L L L+GN +
Sbjct: 34 TKNIDLSFNPLKI-LKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 470 QGSLPSGLSEKVKNGSL-SLSVDGNR 494
Q P S SL +L +
Sbjct: 93 QSFSPGSFSG---LTSLENLVAVETK 115
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 14/71 (19%), Positives = 26/71 (36%), Gaps = 3/71 (4%)
Query: 409 PRIISINLSSSGIA--GDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG 466
P + ++LS + ++ G S+ LDLS N L+ L+ L+
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM-SANFMGLEELQHLDFQH 408
Query: 467 NNLQGSLPSGL 477
+ L+
Sbjct: 409 STLKRVTEFSA 419
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 13/60 (21%), Positives = 25/60 (41%), Gaps = 3/60 (5%)
Query: 412 ISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQG 471
I+ ++ + I S S +++DLS N L + L+ L+LS ++
Sbjct: 14 ITYQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET 70
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 9e-05
Identities = 14/95 (14%), Positives = 28/95 (29%), Gaps = 6/95 (6%)
Query: 406 NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPE-FLAELQSLRVLNL 464
+S+++S + I I F + L L N + + + L L L V L
Sbjct: 178 ENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 465 SGNNLQGSLP-SGLSEKVKNGSLSLSV---DGNRN 495
+ + G +++
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYT 271
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 14/81 (17%), Positives = 27/81 (33%), Gaps = 7/81 (8%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
+ +++L+ I + + +SL + + L L L+ L L+ N
Sbjct: 285 ANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLD---LPFLKSLTLTMNK 339
Query: 469 LQGSLPSGLSEKVKNGSLSLS 489
S + L LS
Sbjct: 340 GSISFKKVALPSLS--YLDLS 358
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 8e-04
Identities = 20/81 (24%), Positives = 35/81 (43%), Gaps = 9/81 (11%)
Query: 406 NQSPRIISINLSS------SGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQ-- 457
Q + +++L + G I +L S+ LDLS+N+L+ ++L
Sbjct: 317 CQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTN 376
Query: 458 SLRVLNLSGNNLQGSLPSGLS 478
SLR L+LS N + +
Sbjct: 377 SLRHLDLSFNGAI-IMSANFM 396
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 7e-09
Identities = 19/83 (22%), Positives = 36/83 (43%), Gaps = 2/83 (2%)
Query: 409 PRIISINLSSSGIAGDIVPYIF-SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
++ ++ S + +F SL ++ LD+S L SL VL ++GN
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455
Query: 468 NLQGSLPSGLSEKVKN-GSLSLS 489
+ Q + + +++N L LS
Sbjct: 456 SFQENFLPDIFTELRNLTFLDLS 478
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 21/64 (32%), Positives = 36/64 (56%), Gaps = 2/64 (3%)
Query: 415 NLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSL 473
++ + + +P IF+ L ++ LDLS+ L P L SL+VLN++ N L+ S+
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SV 509
Query: 474 PSGL 477
P G+
Sbjct: 510 PDGI 513
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 19/83 (22%), Positives = 35/83 (42%), Gaps = 4/83 (4%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
P + ++LS I I + L+ + +L L+ N + + L SL+ L
Sbjct: 52 PELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110
Query: 468 NLQGSLPSGLSEKVKN-GSLSLS 489
NL SL + +K L+++
Sbjct: 111 NLA-SLENFPIGHLKTLKELNVA 132
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 18/79 (22%), Positives = 35/79 (44%), Gaps = 4/79 (5%)
Query: 414 INLSSSGIAG-DIVPYIF-SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQG 471
++LS +G++ TS++ LDLS N + + L+ L L+ +NL+
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQ 410
Query: 472 SLPSGLSEKVKN-GSLSLS 489
+ ++N L +S
Sbjct: 411 MSEFSVFLSLRNLIYLDIS 429
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 15/69 (21%), Positives = 33/69 (47%), Gaps = 3/69 (4%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ ++ L+ + I + FS L+S++ L + +L + L++L+ LN++ N
Sbjct: 76 SHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN 134
Query: 468 NLQGSLPSG 476
+Q S
Sbjct: 135 LIQ-SFKLP 142
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 16/63 (25%), Positives = 29/63 (46%), Gaps = 2/63 (3%)
Query: 414 INLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGS 472
++LS + + P F+ L+S++ L+++ N L L SL+ + L N S
Sbjct: 475 LDLSQCQLEQ-LSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533
Query: 473 LPS 475
P
Sbjct: 534 CPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 23/98 (23%), Positives = 36/98 (36%), Gaps = 10/98 (10%)
Query: 387 DPCAPKVYMWQGINCSYD------ANQSPRIISINLSSSGIAGDIVPYIFS-LTSIESLD 439
+PC V C N +++LS + + + Y F ++ LD
Sbjct: 1 EPCVEVVPNIT-YQCMELNFYKIPDNLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLD 58
Query: 440 LSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGL 477
LS+ + L L L L+GN +Q SL G
Sbjct: 59 LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGA 95
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 22/86 (25%), Positives = 41/86 (47%), Gaps = 6/86 (6%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRV----LN 463
+ +N++ + I +P FS LT++E LDLS N + L L + + L+
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 464 LSGNNLQGSLPSGLSEKVKNGSLSLS 489
LS N + + G ++++ L+L
Sbjct: 184 LSLNPMN-FIQPGAFKEIRLHKLTLR 208
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 7e-09
Identities = 66/426 (15%), Positives = 124/426 (29%), Gaps = 100/426 (23%)
Query: 15 VALTAVVHAQNQSG-F-ISI-DCGIPENENYADKVTGINYVSDAPYVDTAVSHSISPEYS 71
V L+ V + F +++ +C PE + + + Y D + + HS + +
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETV--LEMLQKLLYQIDPNWTSRS-DHSSNIKLR 226
Query: 72 KETVERQFSYL---RSFPEG------IRNCYTLRPPNGDVKFLIRAR------------- 109
+++ + L + + ++N N K L+ R
Sbjct: 227 IHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT 286
Query: 110 ---FMYGNYDGLDKAPSFDLMLGADAWDSVQLQD-PR----------SIITKEIIHMPN- 154
+ + L L+L + + QD PR SII + I
Sbjct: 287 THISLDHHSMTLTPDEVKSLLL---KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLAT 343
Query: 155 -KDYIHVCLVNTDSGIPFISALELRPLTNSIYPPTASDLYRPTPTGSMSLVLRWDVGTPL 213
++ HV N D + +E N + P ++ +S V P
Sbjct: 344 WDNWKHV---NCD---KLTTIIESS--LNVLEPAEYRKMFD-----RLS-VFPPSAHIPT 389
Query: 214 DIYDRIWWPDNFKNVERISTSS------NVNPATSLFQPP------------VTVMQSAI 255
+ IW+ +V + P S P + +I
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSI 449
Query: 256 IPANGSSSFWFSWESVSTVFKYYTCMYFSE--FESEQAETRSREMNIYLNGRFWSEIPPP 313
+ + S + + Y + E E + ++L+ RF
Sbjct: 450 VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLE----- 504
Query: 314 QYLNTTTHRLTATNAQQYVISIMQTKNSSLAPILNALEIYQEKEFLQLLTNQQDVDAIMK 373
H TA NA S+ L L+ Y+ ++ V+AI+
Sbjct: 505 ---QKIRHDSTAWNAS-----------GSILNTLQQLKFYKPYICDNDPKYERLVNAILD 550
Query: 374 IKSKYE 379
K E
Sbjct: 551 FLPKIE 556
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 6e-06
Identities = 81/545 (14%), Positives = 163/545 (29%), Gaps = 151/545 (27%)
Query: 321 HRLTATNAQQY----VISIMQTKNSSLAPILNALEIYQEKEFLQLLTNQQDVDAIMKIKS 376
H T QY ++S+ + ++ + ++ + + +++++D I+ K
Sbjct: 6 HMDFETGEHQYQYKDILSVFEDA------FVDNFDCKDVQDMPKSILSKEEIDHIIMSKD 59
Query: 377 KYEVKRDWQGDPCAPKVYMWQGINCSYDANQSPRIISINLSSSGIAGDIVPYIFSLTSI- 435
S + + L + Y F ++ I
Sbjct: 60 AVS------------GTLRLFWTLLSKQEEMVQKFVEEVLRIN--------YKFLMSPIK 99
Query: 436 -ESLDLS---------KNSLTGPVPEF-------LAELQSLR--VLNLSGNN---LQGSL 473
E S ++ L F L LR +L L + G L
Sbjct: 100 TEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVL 159
Query: 474 PSGLSEKVKNGSLSLSVDGNRNLCPSASCKKKSNKFIF-----------PVLASVVSFCI 522
SG + ++L V C S + K + IF VL +
Sbjct: 160 GSGKT------WVALDV------CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY 207
Query: 523 LL-----ALLAILQNLRRRKQAGKKKGSLELENRKF--SYF---DV--LKITNNFE---R 567
+ + N++ R + + + L+++ + +V K N F +
Sbjct: 208 QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCK 267
Query: 568 VLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDE 627
+L T KQV S + + + ++L+ Y D
Sbjct: 268 IL----LTT------RFKQVT----DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDC 313
Query: 628 GANMGLIYEFMANGN-----LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPI 682
L E + N + A + D T W+ + H C
Sbjct: 314 RPQD-LPRE-VLTTNPRRLSIIAESIRDGLAT--WDN-------------WKHVNCDK-- 354
Query: 683 VHRDVK-SANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLT 741
+ ++ S N+L +++ +FP H+ T ++ + D +
Sbjct: 355 LTTIIESSLNVLEPAEYRKMFDRLS---VFPP--SAHIPTILLSLI-WFDVIKSDVMVVV 408
Query: 742 EKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDI----KNIVDH-RLQGD 796
K YS L+ QP K ++ ++ + + ++IVDH +
Sbjct: 409 NKLHKYS-------LVEKQP---KESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKT 458
Query: 797 FDTNT 801
FD++
Sbjct: 459 FDSDD 463
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 9e-09
Identities = 15/102 (14%), Positives = 34/102 (33%), Gaps = 5/102 (4%)
Query: 396 WQGINCSYDANQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAE 455
G++ + + R+ ++L+ G G + I LT ++ L +S T F E
Sbjct: 314 QPGVDL----DNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDE 369
Query: 456 LQSLRVLNLSGNNLQGSLPSGLSEKVKN-GSLSLSVDGNRNL 496
+ + + ++ + + L D
Sbjct: 370 ELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN 411
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 1e-08
Identities = 14/83 (16%), Positives = 31/83 (37%), Gaps = 3/83 (3%)
Query: 415 NLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLP 474
+ + I I + S+ L + N + V E L L +L+++ N
Sbjct: 788 DAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDV 844
Query: 475 SGLSEKVKNGSLSLSVDGNRNLC 497
+ + ++ G L D +++
Sbjct: 845 TSVCPYIEAGMYVLLYDKTQDIR 867
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 23/111 (20%), Positives = 42/111 (37%), Gaps = 18/111 (16%)
Query: 396 WQGINCSYDANQSPRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLT-------G 447
+ I+CS D + ++ LS + I +F+ + I ++ LS N +T
Sbjct: 660 GRNISCSMDDYKGINASTVTLSYNEIQK-FPTELFATGSPISTIILSNNLMTSIPENSLK 718
Query: 448 PVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS----LSVDGNR 494
P L ++L N L + LS+ + +L + V N
Sbjct: 719 PKDGNYKNTYLLTTIDLRFNKL-----TSLSDDFRATTLPYLSNMDVSYNC 764
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 10/74 (13%), Positives = 29/74 (39%), Gaps = 11/74 (14%)
Query: 429 IFSLTSIESLDLSK------NSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVK 482
+ + +++ + N + P + SL L + N+++ + L+ ++
Sbjct: 772 PLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQLY 830
Query: 483 NGSLSLSVDGNRNL 496
L ++ N N+
Sbjct: 831 --ILDIA--DNPNI 840
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 11/66 (16%), Positives = 24/66 (36%)
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGS 472
N + + +L + ++L +P+FL +L L+ LN++ N +
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530
Query: 473 LPSGLS 478
Sbjct: 531 AQLKAD 536
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 12/80 (15%), Positives = 24/80 (30%), Gaps = 4/80 (5%)
Query: 418 SSGIAGDIVPYIFSLTSIESLDLSKNSLTG-PVPEFLAELQSLRVLNLSGNNLQGSLPSG 476
+ + ++DL N LT L L +++S N S P+
Sbjct: 713 PENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQ 771
Query: 477 LSEKVKNGSLSLSVDGNRNL 496
+ + + R+
Sbjct: 772 PLNSSQLKAFGIR--HQRDA 789
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 12/67 (17%), Positives = 25/67 (37%), Gaps = 3/67 (4%)
Query: 410 RIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTG-PVPEFLAELQSLRVLNLSGNN 468
R IS + + + I+ + N+L P L ++ L +L+ N
Sbjct: 526 RGISAAQLKADW-TRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNK 584
Query: 469 LQGSLPS 475
++ L +
Sbjct: 585 VR-HLEA 590
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 5e-06
Identities = 10/54 (18%), Positives = 20/54 (37%), Gaps = 1/54 (1%)
Query: 425 IVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLS 478
+ + + L L N + +F A + L S N L+ +P+ +
Sbjct: 587 HLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFN 639
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 5e-06
Identities = 20/118 (16%), Positives = 35/118 (29%), Gaps = 24/118 (20%)
Query: 397 QGINCSYDANQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGP-------- 448
+ D+ S + I ++ I I I LT ++ + + + T
Sbjct: 413 EMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWED 471
Query: 449 -----------VPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSL-SLSVDGNR 494
+ L+ L + L LP L L SL++ NR
Sbjct: 472 ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLY---DLPELQSLNIACNR 526
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 13/67 (19%), Positives = 24/67 (35%), Gaps = 7/67 (10%)
Query: 429 IFSLTSIESLDLSKNSLTGPVPEFLAELQ-----SLRVLNLSGNNLQGSLPSGLSEKVKN 483
S+ + S+D S N + + + + LS N +Q P+ L
Sbjct: 640 AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK-FPTELFATGSP 698
Query: 484 -GSLSLS 489
++ LS
Sbjct: 699 ISTIILS 705
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 13/68 (19%), Positives = 33/68 (48%), Gaps = 1/68 (1%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
+ ++L+++ ++ ++ + L++++ L LS N + SL L++ GN
Sbjct: 278 SGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNT 336
Query: 469 LQGSLPSG 476
+ L +G
Sbjct: 337 KRLELGTG 344
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 18/88 (20%), Positives = 35/88 (39%), Gaps = 2/88 (2%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
P++ ++L+ + + F L ++ L+LS + L + L +L+ LNL GN
Sbjct: 400 PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGN 459
Query: 468 NLQGSLPSGLSEKVKNGSL-SLSVDGNR 494
+ + G L L +
Sbjct: 460 HFPKGNIQKTNSLQTLGRLEILVLSFCD 487
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-08
Identities = 19/89 (21%), Positives = 32/89 (35%), Gaps = 6/89 (6%)
Query: 409 PRIISINLSSSGIAGDIV--PYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLS 465
P + +NL + + L +E L LS L+ L+ + ++LS
Sbjct: 449 PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLS 508
Query: 466 GNNLQGSLPSGLSEKVKNGSLSLSVDGNR 494
N L S LS + L++ N
Sbjct: 509 HNRLTSSSIEALS---HLKGIYLNLASNH 534
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 21/94 (22%), Positives = 39/94 (41%), Gaps = 3/94 (3%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRV--LNLSG 466
+ S+ L S+ I+ +P F ++ LD N++ E ++ LQ LNL+G
Sbjct: 129 KTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNG 188
Query: 467 NNLQGSLPSGLSEKVKNGSLSLSVDGNRNLCPSA 500
N++ + G + SL+ N +
Sbjct: 189 NDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKG 221
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 16/82 (19%), Positives = 30/82 (36%), Gaps = 2/82 (2%)
Query: 409 PRIISINLSSSGIAGDIVPYIF-SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ ++L+ I I F S +++L L+ N L L+ ++L+ L
Sbjct: 57 INLTFLDLTRCQIYW-IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQT 115
Query: 468 NLQGSLPSGLSEKVKNGSLSLS 489
+ L + SL L
Sbjct: 116 GISSIDFIPLHNQKTLESLYLG 137
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 18/87 (20%), Positives = 36/87 (41%), Gaps = 2/87 (2%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ + +GI+ I ++ESL L N ++ + L+VL+ N
Sbjct: 105 KALKHLFFIQTGISS-IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163
Query: 468 NLQGSLPSGLSEKVKNGSLSLSVDGNR 494
+ +S + +LSL+++GN
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGND 190
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 6e-07
Identities = 16/66 (24%), Positives = 26/66 (39%), Gaps = 2/66 (3%)
Query: 414 INLSSSGIAG-DIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQG 471
++LS I D L+ ++SL+LS N E E L +L+L+ L+
Sbjct: 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414
Query: 472 SLPSGL 477
Sbjct: 415 KDAQSP 420
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 7e-07
Identities = 13/96 (13%), Positives = 31/96 (32%), Gaps = 8/96 (8%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
R+ ++ L+++ + + S +++ L + ++ L ++L L L N
Sbjct: 81 HRLDTLVLTANPLIF-MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSN 139
Query: 468 NLQGSLPSGLSEKVKNGSL-SLSVDGNR--NLCPSA 500
++ L L N L
Sbjct: 140 HISSIKLPKGF---PTEKLKVLDFQNNAIHYLSKED 172
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 9e-07
Identities = 19/69 (27%), Positives = 27/69 (39%), Gaps = 3/69 (4%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTG-PVPEFLAELQSLRVLNLSG 466
+ S+NLS + + F +E LDL+ L L L+VLNLS
Sbjct: 376 SHLQSLNLSYNEPLS-LKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSH 434
Query: 467 NNLQGSLPS 475
+ L S
Sbjct: 435 SLLDISSEQ 443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 9e-07
Identities = 14/64 (21%), Positives = 26/64 (40%), Gaps = 1/64 (1%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
+ ++LS + + S L+L+ N ++ +P L L R +NL N
Sbjct: 500 KMMNHVDLSHNRLTS-SSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNP 558
Query: 469 LQGS 472
L +
Sbjct: 559 LDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 15/69 (21%), Positives = 26/69 (37%), Gaps = 2/69 (2%)
Query: 411 IISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNL 469
+ S + + I FS L ++ LDL++ + + L L L+ N L
Sbjct: 35 TECLEFSFNVLPT-IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93
Query: 470 QGSLPSGLS 478
+ LS
Sbjct: 94 IFMAETALS 102
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 21/93 (22%), Positives = 35/93 (37%), Gaps = 9/93 (9%)
Query: 406 NQSPRIISINLSSSGIAGDIVPYIF---SLTSIESLDLSKNSLTGPVPEFLAELQSLRVL 462
+ + DI P +F S+ES++L K+ L+ L
Sbjct: 225 STIQSLWLGTFEDMDDE-DISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQEL 283
Query: 463 NLSGNNLQGSLPSGLSEKVKNGSL-SLSVDGNR 494
+L+ +L LPSGL +L L + N+
Sbjct: 284 DLTATHLS-ELPSGLV---GLSTLKKLVLSANK 312
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 24/82 (29%), Positives = 42/82 (51%), Gaps = 3/82 (3%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
R+ + LS ++ I + F+ L + +DLS N LT E L+ L+ + LNL+ N
Sbjct: 476 GRLEILVLSFCDLSS-IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASN 533
Query: 468 NLQGSLPSGLSEKVKNGSLSLS 489
++ LPS L + +++L
Sbjct: 534 HISIILPSLLPILSQQRTINLR 555
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-05
Identities = 15/72 (20%), Positives = 31/72 (43%), Gaps = 3/72 (4%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPV-PEFLAELQSLRVLNLSG 466
+ + LS++ + S S+ L + N+ + L L++LR L+LS
Sbjct: 301 STLKKLVLSANKFEN-LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSH 359
Query: 467 NNLQGSLPSGLS 478
++++ S L
Sbjct: 360 DDIETSDCCNLQ 371
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 17/91 (18%), Positives = 37/91 (40%), Gaps = 5/91 (5%)
Query: 407 QSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLA--ELQSLRVLNL 464
Q +S+NL+ + I I P F +SL+ + + L +QSL +
Sbjct: 177 QQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTF 235
Query: 465 SGNNLQGSLPSGLSEKVKNGSL-SLSVDGNR 494
+ + + + E + S+ S+++ +
Sbjct: 236 EDMDDE-DISPAVFEGLCEMSVESINLQKHY 265
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 45/215 (20%), Positives = 86/215 (40%), Gaps = 20/215 (9%)
Query: 559 LKITNNF--ERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIR-A 613
L++ N + R +G G FG +Y G ++VA+K+ + + Q E ++
Sbjct: 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQ 62
Query: 614 HHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEY 673
+ + EG ++ E + G L + + L +A + +EY
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 674 LHNGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIF-PVEGGTHV----STTVVG 725
+H+ +HRDVK N L+ + + DFGL++ + H+ + + G
Sbjct: 121 IHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177
Query: 726 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 760
T Y ++ + + D+ S G VL+ G
Sbjct: 178 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 39/235 (16%), Positives = 76/235 (32%), Gaps = 56/235 (23%)
Query: 566 ERVLGKGGFGTVYHGY----------LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRA-- 613
+ + G +Y ++ ++K+ + + E RA
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG-----RLFNEQNFFQRAAK 101
Query: 614 HHKNLTILVGYCDEGANMGLIYEFMANGNLQAHL--------LEDKADTLCWERR----- 660
+ Y + F + + L L+ D + +
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALD-VSPKHVLSERS 160
Query: 661 -LQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAK--LADFGLSRIFPVEGGT 717
LQ+A LE+LH VH +V + NI ++ + Q++ LA +G + + G
Sbjct: 161 VLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY-CPSGK 216
Query: 718 HV------STTVVGTPGYLDPEYYIS------NRLTEKSDVYSFGVVLLELITGQ 760
HV + G +IS + +SD+ S G +L+ + G
Sbjct: 217 HVAYVEGSRSPHEGDL------EFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 49/230 (21%), Positives = 88/230 (38%), Gaps = 46/230 (20%)
Query: 558 VLKITNNF--ERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRA 613
VL + NF + +G G FG + G ++ VA+K+ S Q E +
Sbjct: 4 VLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQL 61
Query: 614 HH-KNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERR------LQIASE 666
+ + + G ++ E L LED D LC +R L IA +
Sbjct: 62 GSGDGIPQVYYFGPCGKYNAMVLE------LLGPSLEDLFD-LC-DRTFSLKTVLMIAIQ 113
Query: 667 SAQGLEYLHNGCKPPIVHRDVKSANILL-----NEKFQAKLADFGLSRIF-PVEGGTHV- 719
+EY+H+ +++RDVK N L+ + + DF L++ + E H+
Sbjct: 114 LISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIP 170
Query: 720 ---STTVVGTPGYLDPEYYIS------NRLTEKSDVYSFGVVLLELITGQ 760
++ GT Y+S + + D+ + G + + + G
Sbjct: 171 YREHKSLTGTA------RYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 58/262 (22%), Positives = 92/262 (35%), Gaps = 84/262 (32%)
Query: 569 LGKGGFGTVY--HGYLDDKQVAVKMLSSSSVQGYKQFQAEVELL--IRA---HHKNLTIL 621
LG G F TV+ K VA+K++ S+ + E+ LL +R + N ++
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 622 VGYCD----EGAN---MGLIYEFMANGNLQAHLLEDKADTLCWERRL------QIASESA 668
V D G N + +++E + HLL+ + L +I +
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVL-----GHHLLKWII--KSNYQGLPLPCVKKIIQQVL 156
Query: 669 QGLEYLHNGCKPPIVHRDVKSANILLN--------------------------------- 695
QGL+YLH C+ I+H D+K NILL+
Sbjct: 157 QGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 696 ----------------EKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNR 739
EK + K+AD G + T + T Y E I +
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACW-----VHKHFTEDIQTRQYRSLEVLIGSG 269
Query: 740 LTEKSDVYSFGVVLLELITGQP 761
+D++S + EL TG
Sbjct: 270 YNTPADIWSTACMAFELATGDY 291
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 46/221 (20%), Positives = 84/221 (38%), Gaps = 44/221 (19%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELL-IRAHHKNLTIL 621
R +G+G FG ++ G L+++QVA+K S Q + E + A + +
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERR------LQIASESAQGLEYLH 675
+ EG + L+ + L LED D LC R+ A + ++ +H
Sbjct: 72 YYFGQEGLHNVLVID------LLGPSLEDLLD-LC-GRKFSVKTVAMAAKQMLARVQSIH 123
Query: 676 NGCKPPIVHRDVKSANILLNEKFQAK-----LADFGLSRIF-PVEGGTHV----STTVVG 725
+V+RD+K N L+ + DFG+ + + H+ + G
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
Query: 726 TPGYLDPEYYIS------NRLTEKSDVYSFGVVLLELITGQ 760
T Y+S + + D+ + G V + + G
Sbjct: 181 TA------RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 4e-08
Identities = 16/83 (19%), Positives = 34/83 (40%), Gaps = 5/83 (6%)
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGS 472
+ + + D +P + LTS+ LD+S ++ + + L + ++LS N
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151
Query: 473 LPSGLSEKVKNGSL-SLSVDGNR 494
+ L L SL++ +
Sbjct: 152 I-MPLK---TLPELKSLNIQFDG 170
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 5e-08
Identities = 17/77 (22%), Positives = 37/77 (48%), Gaps = 2/77 (2%)
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGS 472
+ +++ + P I L+++E L + +T L+ L SL +L++S + S
Sbjct: 70 DLTINNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS 127
Query: 473 LPSGLSEKVKNGSLSLS 489
+ + ++ K S+ LS
Sbjct: 128 ILTKINTLPKVNSIDLS 144
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 15/90 (16%), Positives = 34/90 (37%), Gaps = 4/90 (4%)
Query: 411 IISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQ 470
+ I L++ + D+ I +I+ L ++ T ++ L +L L + G ++
Sbjct: 46 LTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVT 101
Query: 471 GSLPSGLSEKVKNGSLSLSVDGNRNLCPSA 500
LS L +S + + +
Sbjct: 102 SDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 9e-05
Identities = 15/57 (26%), Positives = 26/57 (45%), Gaps = 1/57 (1%)
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNL 469
+++S S I+ I +L + S+DLS N L L L+ LN+ + +
Sbjct: 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIMPLKTLPELKSLNIQFDGV 171
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 22/76 (28%), Positives = 29/76 (38%), Gaps = 4/76 (5%)
Query: 415 NLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTG-PVPEFLAELQSLRVLNLSGNNLQGSL 473
N +G + ++ LDLS NSL L LNLS L+ +
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QV 268
Query: 474 PSGLSEKVKNGSLSLS 489
P GL K+ L LS
Sbjct: 269 PKGLPAKLS--VLDLS 282
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 19/65 (29%), Positives = 30/65 (46%), Gaps = 5/65 (7%)
Query: 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
++ S+NLS +G+ + + + + LDLS N L P EL + L+L GN
Sbjct: 252 PSQLNSLNLSFTGLKQ-VPKGLPA--KLSVLDLSYNRLDR-NP-SPDELPQVGNLSLKGN 306
Query: 468 NLQGS 472
S
Sbjct: 307 PFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 17/89 (19%), Positives = 36/89 (40%), Gaps = 7/89 (7%)
Query: 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLA----ELQSLRVLN 463
P + ++++ + + ++ +LDLS N G A + +L+VL
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 464 LSGNNLQ---GSLPSGLSEKVKNGSLSLS 489
L ++ G + + +V+ L LS
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLS 236
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 16/82 (19%), Positives = 30/82 (36%), Gaps = 4/82 (4%)
Query: 412 ISINLSSSGIAGDIVPYIFSLTSIESLDLSKN---SLTGPVPEFLAELQSLRVLNLSGNN 468
+S N +++ L L + +G A L+ L+LS N+
Sbjct: 180 LSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239
Query: 469 LQGSLPSGLSEKVKN-GSLSLS 489
L+ + + + SL+LS
Sbjct: 240 LRDAAGAPSCDWPSQLNSLNLS 261
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 10/61 (16%), Positives = 22/61 (36%), Gaps = 1/61 (1%)
Query: 415 NLSSSGIAGDIVP-YIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSL 473
N+S + + + ++ L +++ E + +L L+LS N G
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189
Query: 474 P 474
Sbjct: 190 G 190
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 44/221 (19%)
Query: 567 RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGY-KQFQAEVELL------------- 610
++GKG FG V Y ++ + VA+K++ + + + Q Q EV LL
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKN--KKAFLNQAQIEVRLLELMNKHDTEMKYY 117
Query: 611 -IRAH----HKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIAS 665
+ +N LV E + L Y+ + N N + L + A
Sbjct: 118 IVHLKRHFMFRNHLCLVF---EMLSYNL-YDLLRNTNFRGVSLNLTR---------KFAQ 164
Query: 666 ESAQGLEYLHNGCKPPIVHRDVKSANILL--NEKFQAKLADFGLSRIFPVEGGTHVSTTV 723
+ L +L + I+H D+K NILL ++ K+ DFG S G
Sbjct: 165 QMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQ--LGQRI--YQY 218
Query: 724 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQ 764
+ + Y PE + D++S G +L+E+ TG+P+
Sbjct: 219 IQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS 259
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 7e-08
Identities = 17/88 (19%), Positives = 37/88 (42%), Gaps = 9/88 (10%)
Query: 414 INLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSL 473
+ + ++G+ ++ + +E+L L++N L +P +A L LR L++ L
Sbjct: 109 MTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTEL 166
Query: 474 PSGLSEKVKNGSLS-------LSVDGNR 494
P L+ +G L ++
Sbjct: 167 PEPLASTDASGEHQGLVNLQSLRLEWTG 194
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 19/94 (20%), Positives = 39/94 (41%), Gaps = 13/94 (13%)
Query: 407 QSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG 466
P +++ L S + F L+ ++ + + L +P+ + + L L L+
Sbjct: 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLAR 136
Query: 467 NNLQGSLPSGLSEKVKNGSLS----LSVDGNRNL 496
N L+ +LP+ + SL+ LS+ L
Sbjct: 137 NPLR-ALPASI------ASLNRLRELSIRACPEL 163
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 6e-07
Identities = 17/72 (23%), Positives = 25/72 (34%), Gaps = 10/72 (13%)
Query: 429 IFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS- 487
I L +E LDL + P L+ L L + +LP + L+
Sbjct: 225 IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDI------HRLTQ 278
Query: 488 ---LSVDGNRNL 496
L + G NL
Sbjct: 279 LEKLDLRGCVNL 290
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 11/49 (22%), Positives = 22/49 (44%), Gaps = 1/49 (2%)
Query: 429 IFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGL 477
I +L +++SL + + L+ + + L L L+L G + P
Sbjct: 202 IANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIF 249
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 6e-06
Identities = 12/51 (23%), Positives = 24/51 (47%), Gaps = 2/51 (3%)
Query: 429 IFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSE 479
L +++SL L + +P +A LQ+L+ L + + L +L +
Sbjct: 179 HQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHH 227
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 13/62 (20%), Positives = 25/62 (40%), Gaps = 2/62 (3%)
Query: 429 IFSLTSIESLDLS-KNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487
++ L L ++L +P + L L L+L G LPS +++ N +
Sbjct: 249 FGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIIL 307
Query: 488 LS 489
+
Sbjct: 308 VP 309
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 15/79 (18%), Positives = 26/79 (32%), Gaps = 20/79 (25%)
Query: 429 IFSLTSIESLDLSK-NSLT--------GPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSE 479
I SL + L + LT L +L+ L L ++ SLP+ +
Sbjct: 146 IASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASI-- 202
Query: 480 KVKNGSLS----LSVDGNR 494
+L L + +
Sbjct: 203 ----ANLQNLKSLKIRNSP 217
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 4e-04
Identities = 13/49 (26%), Positives = 22/49 (44%), Gaps = 1/49 (2%)
Query: 429 IFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGL 477
I LT +E LDL +P +A+L + ++ + +LQ L
Sbjct: 273 IHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP-PHLQAQLDQHR 320
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 47/221 (21%), Positives = 92/221 (41%), Gaps = 32/221 (14%)
Query: 559 LKITNNF--ERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIR-A 613
++ N F R +G G FG +Y G +++VA+K+ + + + Q E ++
Sbjct: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQ 60
Query: 614 HHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERR------LQIASES 667
+ + + EG L+ + L LED + R+ L +A +
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMD------LLGPSLEDLFNFCS--RKLSLKTVLMLADQM 112
Query: 668 AQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAK---LADFGLSRIF-PVEGGTHV---- 719
+E++H+ +HRD+K N L+ +A + DFGL++ + H+
Sbjct: 113 INRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169
Query: 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 760
+ + GT Y ++ + + D+ S G VL+ + G
Sbjct: 170 NKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 6e-07
Identities = 18/84 (21%), Positives = 41/84 (48%), Gaps = 4/84 (4%)
Query: 406 NQSPRIISINLSSSGIAG-DIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLN 463
P + ++ LS + + I L ++ SLD+S+N+ P+P+ + +R LN
Sbjct: 358 GAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLN 416
Query: 464 LSGNNLQGSLPSGLSEKVKNGSLS 487
LS ++ + + + + ++ +S
Sbjct: 417 LSSTGIR-VVKTCIPQTLEVLDVS 439
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 12/62 (19%), Positives = 24/62 (38%), Gaps = 2/62 (3%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
PR+ + +S + + +P + + +S+N L L SL+ + L N
Sbjct: 451 PRLQELYISRNKL--KTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNP 508
Query: 469 LQ 470
Sbjct: 509 WD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 26/165 (15%), Positives = 51/165 (30%), Gaps = 3/165 (1%)
Query: 409 PRIISINLSSSGIAGDIVPYIF-SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ + + + + + S+ I L L + + F L S+R L L
Sbjct: 148 TSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206
Query: 468 NLQGSLPSGLSEKVKNGSLS-LSVDGNRNLCPSASCKKKSNKFIFPVLASVVSFCILLAL 526
NL S L + + L+ G+ S + K ++I + C L L
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGL 266
Query: 527 LAILQNLRRRKQAGKKKGSLELENRKFSYFDVLKITNNFERVLGK 571
+ K ++ + F + + +L K
Sbjct: 267 GDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK 311
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 15/83 (18%), Positives = 34/83 (40%), Gaps = 3/83 (3%)
Query: 414 INLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGS 472
+++ + + ++S L ++ + + + + F L+SL L+LS N +
Sbjct: 291 LHIPQFYLFY-DLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEE 349
Query: 473 LPSGLSEKVKNGSL-SLSVDGNR 494
+ K SL +L + N
Sbjct: 350 YLKNSACKGAWPSLQTLVLSQNH 372
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 12/65 (18%), Positives = 26/65 (40%), Gaps = 3/65 (4%)
Query: 414 INLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTG-PVPEFLAELQSLRVLNLSGNNLQG 471
++LS + ++ + F L+S++ L+L N V L +L+ L +
Sbjct: 79 LDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFS 137
Query: 472 SLPSG 476
+
Sbjct: 138 EIRRI 142
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 28/83 (33%), Positives = 38/83 (45%), Gaps = 3/83 (3%)
Query: 409 PRIISINLSSSGIAGDIVPYIF-SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ + L SS I I F SL S+E LDLS N L+ + L SL+ LNL GN
Sbjct: 50 ANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGN 108
Query: 468 NLQGSLPSGLSEKVKN-GSLSLS 489
Q + L + N +L +
Sbjct: 109 PYQTLGVTSLFPNLTNLQTLRIG 131
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 18/71 (25%), Positives = 31/71 (43%), Gaps = 6/71 (8%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLT---GPVPEFLAELQSLRVLNL 464
++ I + +S + + L S+E LDLS+N + SL+ L L
Sbjct: 310 EKVKRITVENSKV-FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368
Query: 465 SGNNLQGSLPS 475
S N+L+ S+
Sbjct: 369 SQNHLR-SMQK 378
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 18/71 (25%), Positives = 31/71 (43%), Gaps = 3/71 (4%)
Query: 408 SPRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG 466
+ + S++LS + I I +++ L L + + + L SL L+LS
Sbjct: 25 TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSD 83
Query: 467 NNLQGSLPSGL 477
N+L SL S
Sbjct: 84 NHLS-SLSSSW 93
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 19/87 (21%), Positives = 34/87 (39%), Gaps = 12/87 (13%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
+ S+++S + + + L+LS + V + Q+L VL++S NN
Sbjct: 387 KNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNN 442
Query: 469 LQGSLPSGLSEKVKNGSL-SLSVDGNR 494
L S L L L + N+
Sbjct: 443 LD-SFSLFLP------RLQELYISRNK 462
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 12/76 (15%), Positives = 31/76 (40%), Gaps = 2/76 (2%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ ++ + + +I F+ LTS+ L++ SL + L ++ + L L +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
Query: 468 NLQGSLPSGLSEKVKN 483
L ++ + +
Sbjct: 183 ESA-FLLEIFADILSS 197
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 10/60 (16%), Positives = 26/60 (43%), Gaps = 2/60 (3%)
Query: 431 SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKN-GSLSLS 489
+I L + + L + + L+ ++ + + + + +P S+ +K+ L LS
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLS 342
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 22/68 (32%), Positives = 35/68 (51%), Gaps = 8/68 (11%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
++ +NLSS+GI + I ++E LD+S N+L F L L+ L +S N
Sbjct: 410 EKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLD----SFSLFLPRLQELYISRNK 462
Query: 469 LQGSLPSG 476
L+ +LP
Sbjct: 463 LK-TLPDA 469
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 1e-06
Identities = 21/92 (22%), Positives = 40/92 (43%), Gaps = 11/92 (11%)
Query: 409 PRIISINLSSSGI----AGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLN 463
P + + L + + ++ +F L+ ++ L L+ N L P + L +LR L+
Sbjct: 451 PSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLS 510
Query: 464 LSGNNLQGSLPSGLSEKVKNGSL-SLSVDGNR 494
L+ N L + LS +L L + N+
Sbjct: 511 LNSNRL-----TVLSHNDLPANLEILDISRNQ 537
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 14/63 (22%), Positives = 23/63 (36%), Gaps = 1/63 (1%)
Query: 409 PRIISINLSSSGIAGDIVPYIF-SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
++ + L S I F +L ++ LDL + + P+ L L L L
Sbjct: 48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFC 107
Query: 468 NLQ 470
L
Sbjct: 108 GLS 110
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 14/76 (18%), Positives = 31/76 (40%), Gaps = 3/76 (3%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ +NL+ + I I F L +++ L+LS N L L + ++L N
Sbjct: 290 KDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348
Query: 468 NLQGSLPSGLSEKVKN 483
++ + + ++
Sbjct: 349 HIA-IIQDQTFKFLEK 363
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 21/80 (26%), Positives = 37/80 (46%), Gaps = 2/80 (2%)
Query: 413 SINLSSSGIAG-DIVPYIFSLTSIESLDLSKNSLTG-PVPEFLAELQSLRVLNLSGNNLQ 470
I+LS + + DI+ ++ + ++ L L++N + + +E SL L L N LQ
Sbjct: 405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ 464
Query: 471 GSLPSGLSEKVKNGSLSLSV 490
+ + L V G L V
Sbjct: 465 LAWETELCWDVFEGLSHLQV 484
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 22/90 (24%), Positives = 38/90 (42%), Gaps = 7/90 (7%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPV--PEFLAELQSLRVLNLS 465
P + ++L SS I + P F L + L L L+ V + L++L L+LS
Sbjct: 73 PNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLS 131
Query: 466 GNNLQGSLPSGLSEKVKN-GSLSLSVDGNR 494
N ++ K+ + S+ S N+
Sbjct: 132 KNQIRSLYLHPSFGKLNSLKSIDFS--SNQ 159
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 19/67 (28%), Positives = 32/67 (47%), Gaps = 3/67 (4%)
Query: 411 IISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNL 469
+ ++LS + + +F L ++ L+L+ N + E L +L+VLNLS N L
Sbjct: 268 VRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
Query: 470 QGSLPSG 476
L S
Sbjct: 327 G-ELYSS 332
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 10/45 (22%), Positives = 17/45 (37%)
Query: 432 LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSG 476
L + E L LS N + L+ L++L L ++
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKE 67
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 16/63 (25%), Positives = 29/63 (46%), Gaps = 2/63 (3%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ +NLS + + G++ F L + +DL KN + + L+ L+ L+L N
Sbjct: 314 DNLQVLNLSYNLL-GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDN 372
Query: 468 NLQ 470
L
Sbjct: 373 ALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 23/93 (24%), Positives = 38/93 (40%), Gaps = 7/93 (7%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQ--SLRVLNLS 465
+ ++LS + I + F L S++S+D S N + L LQ +L +L+
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182
Query: 466 GNNLQGSLPSGLS---EKVKNGSLS-LSVDGNR 494
N+L + +N L L V GN
Sbjct: 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNG 215
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 22/92 (23%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
++ + L + I I S L ++ L L N L+ VP L +L+ L+V+ L N
Sbjct: 217 SKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTN 274
Query: 468 NLQGSLP----SGLSEKVKNGSLS-LSVDGNR 494
N+ + + VK + +S+ N
Sbjct: 275 NIT-KVGVNDFCPVGFGVKRAYYNGISLFNNP 305
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 15/55 (27%), Positives = 23/55 (41%), Gaps = 2/55 (3%)
Query: 425 IVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLS 478
I + + L L N + L+ L +LR L+L N L +P+GL
Sbjct: 208 IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLP 261
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 20/88 (22%), Positives = 40/88 (45%), Gaps = 7/88 (7%)
Query: 408 SPRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG 466
SP ++L ++ I+ ++ F L + +L L N ++ + + L+ L+ L +S
Sbjct: 53 SPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111
Query: 467 NNLQGSLPSGLSEKVKNGSLSLSVDGNR 494
N+L +P L + L + NR
Sbjct: 112 NHLV-EIPPNLPSSLV----ELRIHDNR 134
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 6/88 (6%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
++ +NL+ I +I Y F+ +I+ L + N++ P + L VL L N
Sbjct: 69 RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 127
Query: 468 NLQGSLPSGLSEKVKNGSL-SLSVDGNR 494
+L SLP G+ L +LS+ N
Sbjct: 128 DLS-SLPRGIFH--NTPKLTTLSMSNNN 152
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 21/88 (23%), Positives = 43/88 (48%), Gaps = 8/88 (9%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
P ++ ++LS + + I+ + F + +E L +S N L + + + +L+VL+LS N
Sbjct: 248 PGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHN 305
Query: 468 NLQGSLPSGLSEKVKNGSL-SLSVDGNR 494
+L + + L +L +D N
Sbjct: 306 HLL-HVERNQPQ---FDRLENLYLDHNS 329
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 19/85 (22%), Positives = 36/85 (42%), Gaps = 7/85 (8%)
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGS 472
+ +S++ + + Y + +++ LDLS N L V + L L L N++ +
Sbjct: 276 RLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-T 332
Query: 473 LPSGLSEKVKNGSLSLSVDGNRNLC 497
L +KN L++ N C
Sbjct: 333 LKLSTHHTLKN----LTLSHNDWDC 353
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 13/84 (15%), Positives = 30/84 (35%), Gaps = 6/84 (7%)
Query: 413 SINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQG 471
+ +S + + + +E L+L+ + A +++ L + N ++
Sbjct: 49 IVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR- 106
Query: 472 SLPSGLSEKVKN-GSLSLSVDGNR 494
LP + + V L L N
Sbjct: 107 YLPPHVFQNVPLLTVLVLE--RND 128
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 8/76 (10%), Positives = 28/76 (36%), Gaps = 3/76 (3%)
Query: 404 DANQSPRIISINLSSSGIAGDIV--PYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRV 461
D+N + ++ D+ +L + + + +++ L + + +
Sbjct: 14 DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVEL 73
Query: 462 LNLSGNNLQGSLPSGL 477
LNL+ ++ + +
Sbjct: 74 LNLNDLQIE-EIDTYA 88
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 14/70 (20%), Positives = 28/70 (40%), Gaps = 3/70 (4%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
I + + + I + P++F + + L L +N L+ L L++S N
Sbjct: 93 HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNN 151
Query: 468 NLQGSLPSGL 477
NL+ +
Sbjct: 152 NLE-RIEDDT 160
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 18/87 (20%), Positives = 33/87 (37%), Gaps = 7/87 (8%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
P + + L + ++ + IF + +L +S N+L + SL+ L LS N
Sbjct: 117 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 175
Query: 468 NLQGSLPSGLSEKVKNGSLSLSVDGNR 494
L + L + +V N
Sbjct: 176 RLT-HVDLSLIPSLF----HANVSYNL 197
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 15/70 (21%), Positives = 27/70 (38%), Gaps = 5/70 (7%)
Query: 426 VPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGS 485
++ + + +DLS N L + ++Q L L +S N L +L +
Sbjct: 241 TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQ---PIPT 296
Query: 486 L-SLSVDGNR 494
L L + N
Sbjct: 297 LKVLDLSHNH 306
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 19/82 (23%), Positives = 34/82 (41%), Gaps = 8/82 (9%)
Query: 415 NLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSL 473
++ S + + + +++ LDLS N L+ LA L +LNLS N L
Sbjct: 16 KVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL---- 70
Query: 474 PSGLSEKVKNGSL-SLSVDGNR 494
+ +L +L ++ N
Sbjct: 71 -YETLDLESLSTLRTLDLNNNY 91
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 11/50 (22%), Positives = 19/50 (38%), Gaps = 2/50 (4%)
Query: 429 IFSLTSIESLDLSKNSLTG-PVPEFLAELQSLRVLNLSGNNLQGSLPSGL 477
+ ++ LDL N + E A +L LNL N + + +
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV 188
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 20/71 (28%), Positives = 34/71 (47%), Gaps = 5/71 (7%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ ++LS + ++ I + T +E L+LS N L + L +LR L+L+ N
Sbjct: 34 WNVKELDLSGNPLS-QISAADLAPFTKLELLNLSSNVLYE-TLDL-ESLSTLRTLDLNNN 90
Query: 468 NLQGSLPSGLS 478
+Q L G S
Sbjct: 91 YVQ-ELLVGPS 100
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 24/130 (18%), Positives = 46/130 (35%), Gaps = 10/130 (7%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
++ +++LSS+ +A + P S + + L N L + + L Q+L +L GN
Sbjct: 191 AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNG 248
Query: 469 LQ-GSLPSGLSEKVKNGSLSLSVDGNRNLCPSASCKKKSNKFIFPVLASVVSFCILLALL 527
G+L S+ + +++ C P L ++C
Sbjct: 249 FHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT-------VPTLGHYGAYCCEDLPA 301
Query: 528 AILQNLRRRK 537
L K
Sbjct: 302 PFADRLIALK 311
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 9/50 (18%), Positives = 21/50 (42%)
Query: 429 IFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLS 478
+ + ++ +SL + +++ L+LSGN L + L+
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLA 55
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 16/88 (18%), Positives = 33/88 (37%), Gaps = 8/88 (9%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
R+ ++L + I + + ++E L+L N + V L+ L+LS N
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSN 201
Query: 468 NLQGSLPSGLSEKVKNGSL-SLSVDGNR 494
L + + +S+ N+
Sbjct: 202 KLA-FMGPEFQ---SAAGVTWISLRNNK 225
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 11/50 (22%), Positives = 19/50 (38%), Gaps = 2/50 (4%)
Query: 429 IFSLTSIESLDLSKNSLTG-PVPEFLAELQSLRVLNLSGNNLQGSLPSGL 477
+ ++ LDL N + E A +L LNL N + + +
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV 188
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 16/62 (25%), Positives = 26/62 (41%), Gaps = 3/62 (4%)
Query: 415 NLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSL 473
++ S + + + +++ LDLS N L+ LA L +LNLS N L
Sbjct: 16 KVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ET 73
Query: 474 PS 475
Sbjct: 74 LD 75
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 18/108 (16%), Positives = 32/108 (29%), Gaps = 9/108 (8%)
Query: 429 IFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQ-GSLPSGLSEKVKNGSLS 487
S + + L N L + + L Q+L +L GN G+L S+ + +++
Sbjct: 210 FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA 268
Query: 488 LSVDGNRNLCPSASCKKKSNKFIFPVLASVVSFCILLALLAILQNLRR 535
C P L ++C L
Sbjct: 269 KQTVKKLTGQNEEECT-------VPTLGHYGAYCCEDLPAPFADRLIA 309
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 8/48 (16%), Positives = 20/48 (41%), Gaps = 1/48 (2%)
Query: 429 IFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSG 476
+ + ++ +SL + +++ L+LSGN L + +
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAA 52
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 19/69 (27%), Positives = 33/69 (47%), Gaps = 5/69 (7%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ ++LS + ++ I + T +E L+LS N L + L +LR L+L+ N
Sbjct: 34 WNVKELDLSGNPLS-QISAADLAPFTKLELLNLSSNVLYE-TLDL-ESLSTLRTLDLNNN 90
Query: 468 NLQGSLPSG 476
+Q L G
Sbjct: 91 YVQ-ELLVG 98
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 16/88 (18%), Positives = 33/88 (37%), Gaps = 8/88 (9%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
R+ ++L + I + + ++E L+L N + V L+ L+LS N
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSN 201
Query: 468 NLQGSLPSGLSEKVKNGSL-SLSVDGNR 494
L + + +S+ N+
Sbjct: 202 KLA-FMGPEFQ---SAAGVTWISLRNNK 225
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 6/88 (6%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
++ +NL+ I +I Y F+ +I+ L + N++ P + L VL L N
Sbjct: 75 RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 133
Query: 468 NLQGSLPSGLSEKVKNGSL-SLSVDGNR 494
+L SLP G+ L +LS+ N
Sbjct: 134 DLS-SLPRGIFH--NTPKLTTLSMSNNN 158
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 21/88 (23%), Positives = 43/88 (48%), Gaps = 8/88 (9%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
P ++ ++LS + + I+ + F + +E L +S N L + + + +L+VL+LS N
Sbjct: 254 PGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHN 311
Query: 468 NLQGSLPSGLSEKVKNGSL-SLSVDGNR 494
+L + + L +L +D N
Sbjct: 312 HLL-HVERNQP---QFDRLENLYLDHNS 335
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 19/84 (22%), Positives = 36/84 (42%), Gaps = 7/84 (8%)
Query: 414 INLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSL 473
+ +S++ + + Y + +++ LDLS N L V + L L L N++ +L
Sbjct: 283 LYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TL 339
Query: 474 PSGLSEKVKNGSLSLSVDGNRNLC 497
+KN L++ N C
Sbjct: 340 KLSTHHTLKN----LTLSHNDWDC 359
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 13/88 (14%), Positives = 30/88 (34%), Gaps = 6/88 (6%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ +S + + + +E L+L+ + A +++ L + N
Sbjct: 51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 109
Query: 468 NLQGSLPSGLSEKVKN-GSLSLSVDGNR 494
++ LP + + V L L N
Sbjct: 110 AIR-YLPPHVFQNVPLLTVLVLE--RND 134
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 6e-05
Identities = 8/75 (10%), Positives = 28/75 (37%), Gaps = 3/75 (4%)
Query: 404 DANQSPRIISINLSSSGIAGDIV--PYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRV 461
D+N + ++ D+ +L + + + +++ L + + +
Sbjct: 20 DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVEL 79
Query: 462 LNLSGNNLQGSLPSG 476
LNL+ ++ + +
Sbjct: 80 LNLNDLQIE-EIDTY 93
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 7e-05
Identities = 18/87 (20%), Positives = 34/87 (39%), Gaps = 7/87 (8%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
P + + L + ++ + IF + +L +S N+L + SL+ L LS N
Sbjct: 123 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 181
Query: 468 NLQGSLPSGLSEKVKNGSLSLSVDGNR 494
L + L + + +V N
Sbjct: 182 RLT-HVDLSLIPSLFH----ANVSYNL 203
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 15/70 (21%), Positives = 27/70 (38%), Gaps = 5/70 (7%)
Query: 426 VPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGS 485
++ + + +DLS N L + ++Q L L +S N L +L +
Sbjct: 247 TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQ---PIPT 302
Query: 486 L-SLSVDGNR 494
L L + N
Sbjct: 303 LKVLDLSHNH 312
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 19/89 (21%), Positives = 35/89 (39%), Gaps = 8/89 (8%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
P + ++LS + + + +E+L L NS+ + L+ +L+ L LS N+
Sbjct: 301 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHND 356
Query: 469 LQGSLPSGLSEKVKNGSLSLSVDGNRNLC 497
+ L V +VD C
Sbjct: 357 WDCNSLRALFRNVAR----PAVDDADQHC 381
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 58/280 (20%), Positives = 101/280 (36%), Gaps = 74/280 (26%)
Query: 532 NLRRRKQAGKKKGSLELENRKFSYFDVL--KITNNFE--RVLGKGGFGTVYHGY--LDDK 585
+ +G++ + ++ + + N F R +G G FG V + K
Sbjct: 2 HHHHHHSSGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKK 61
Query: 586 QVAVKMLSSSSVQGY-KQFQAEVELL--IRAHHKNLTILVGYCDE--------------G 628
AVK++ + ++ Y + + E ++L I+ N +V Y + G
Sbjct: 62 YYAVKVVRN--IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLG 119
Query: 629 ANMGLIYEFM-ANGNLQAHLLEDKADTLCWERRLQ-IASESAQGLEYLHNGCKPPIVHRD 686
+ +YE + N H+ ++ E + L YL + H D
Sbjct: 120 PS---LYEIITRNNYNGFHI-----------EDIKLYCIEILKALNYLRK-MS--LTHTD 162
Query: 687 VKSANILLNEKFQA-------------------------KLADFGLSRIFPVEGGTHVST 721
+K NILL++ + KL DFG F + H
Sbjct: 163 LKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-CATF--KSDYH--G 217
Query: 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
+++ T Y PE ++ SD++SFG VL EL TG
Sbjct: 218 SIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 49.8 bits (120), Expect = 2e-06
Identities = 17/62 (27%), Positives = 31/62 (50%), Gaps = 2/62 (3%)
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGS 472
+N+ S+ I+ + + +L+ + SL L+ N L E + L +L L LS N++
Sbjct: 269 MLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326
Query: 473 LP 474
P
Sbjct: 327 RP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 6e-06
Identities = 23/88 (26%), Positives = 40/88 (45%), Gaps = 8/88 (9%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
+ +NL+ + I + + +L + +L + N +T L L +LR L L+ +N
Sbjct: 66 TNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDN 121
Query: 469 LQGSLPSGLSEKVKNGSLSLSVDGNRNL 496
+ S L+ K SL+L N NL
Sbjct: 122 ISD--ISPLANLTKMYSLNLG--ANHNL 145
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 18/84 (21%), Positives = 38/84 (45%), Gaps = 11/84 (13%)
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGS 472
+ L+ I+ + + +LT + SL+L N L+ + L L ++ + ++
Sbjct: 114 ELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDV 170
Query: 473 LP-SGLSEKVKNGSL-SLSVDGNR 494
P + L+ L SLS++ N+
Sbjct: 171 TPIANLT------DLYSLSLNYNQ 188
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 3e-05
Identities = 20/81 (24%), Positives = 35/81 (43%), Gaps = 6/81 (7%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
I + ++ +A + I LT++E L+L+ N +T P L+ L L L + N
Sbjct: 44 ESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNK 99
Query: 469 LQGSLPSGLSEKVKNGSLSLS 489
+ + S L L L+
Sbjct: 100 I--TDISALQNLTNLRELYLN 118
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 3e-05
Identities = 14/58 (24%), Positives = 31/58 (53%), Gaps = 2/58 (3%)
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQ 470
S+ L+++ + + + I LT++ +L LS+N +T P LA L + + + ++
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 4e-05
Identities = 16/83 (19%), Positives = 30/83 (36%), Gaps = 10/83 (12%)
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGS 472
+ I + + ++T + SL + N +T LA L L L + N +
Sbjct: 203 YFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDL--SPLANLSQLTWLEIGTNQISD- 257
Query: 473 LPSGLSEKVKNGSL-SLSVDGNR 494
+ + L L+V N+
Sbjct: 258 -INAVK---DLTKLKMLNVGSNQ 276
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 9e-05
Identities = 14/58 (24%), Positives = 23/58 (39%), Gaps = 4/58 (6%)
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQ 470
++ + I I P L L K S+T V EL+S+ L ++G +
Sbjct: 4 TLATLPAPI-NQIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 2e-04
Identities = 11/63 (17%), Positives = 31/63 (49%), Gaps = 4/63 (6%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
R+ S+ + ++ I + + +L+ + L++ N ++ + +L L++LN+ N
Sbjct: 221 TRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQ 276
Query: 469 LQG 471
+
Sbjct: 277 ISD 279
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 7e-04
Identities = 20/88 (22%), Positives = 35/88 (39%), Gaps = 12/88 (13%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
+ + ++ S + V I +LT + SL L+ N + LA L SL N
Sbjct: 155 TGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDI--SPLASLTSLHYFTAYVNQ 210
Query: 469 LQGSLP-SGLSEKVKNGSL-SLSVDGNR 494
+ P + ++ L SL + N+
Sbjct: 211 ITDITPVANMT------RLNSLKIGNNK 232
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 49.6 bits (117), Expect = 3e-06
Identities = 17/101 (16%), Positives = 40/101 (39%), Gaps = 12/101 (11%)
Query: 405 ANQSPRIISINLSSSGIAGDIVPYIFS---LTSIESLDLSKNSLTGPVPEFLAE----LQ 457
++ P + + + + +V L +E++D+S LT L + ++
Sbjct: 248 KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIK 307
Query: 458 SLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSVDGNRNLCP 498
L+ +N+ N L + L + SL + +D + +
Sbjct: 308 HLKFINMKYNYLSDEMKKELQK-----SLPMKIDVSDSQEY 343
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 17/71 (23%), Positives = 32/71 (45%), Gaps = 3/71 (4%)
Query: 408 SPRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG 466
++L + I + F+ +E L+L++N ++ P L +LR L L
Sbjct: 31 PTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS 89
Query: 467 NNLQGSLPSGL 477
N L+ +P G+
Sbjct: 90 NRLK-LIPLGV 99
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 15/70 (21%), Positives = 31/70 (44%), Gaps = 3/70 (4%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
P + + L+ + ++ + P F+ L ++ +L L N L L +L L++S N
Sbjct: 56 PHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISEN 114
Query: 468 NLQGSLPSGL 477
+ L +
Sbjct: 115 KIV-ILLDYM 123
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 18/69 (26%), Positives = 34/69 (49%), Gaps = 3/69 (4%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ +++S + I ++ Y+F L +++SL++ N L + L SL L L
Sbjct: 104 SNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKC 162
Query: 468 NLQGSLPSG 476
NL S+P+
Sbjct: 163 NLT-SIPTE 170
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 14/82 (17%), Positives = 27/82 (32%), Gaps = 2/82 (2%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ + L + I S L + L L ++ L L+VL +S
Sbjct: 152 NSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW 210
Query: 468 NLQGSLPSGLSEKVKNGSLSLS 489
++ + SLS++
Sbjct: 211 PYLDTMTPNCLYGLNLTSLSIT 232
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 15/68 (22%), Positives = 28/68 (41%), Gaps = 1/68 (1%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
R+ + +S + P ++ SL ++ +LT + L LR LNLS N
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNP 259
Query: 469 LQGSLPSG 476
+ ++
Sbjct: 260 IS-TIEGS 266
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 14/65 (21%), Positives = 33/65 (50%), Gaps = 3/65 (4%)
Query: 413 SINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQG 471
++ L S+ + I +F+ L+++ LD+S+N + + +L +L+ L + N+L
Sbjct: 84 TLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV- 141
Query: 472 SLPSG 476
+
Sbjct: 142 YISHR 146
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 20/69 (28%), Positives = 31/69 (44%), Gaps = 3/69 (4%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ S+ + + + I FS L S+E L L K +LT E L+ L L VL L
Sbjct: 128 YNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHL 186
Query: 468 NLQGSLPSG 476
N+ ++
Sbjct: 187 NIN-AIRDY 194
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 7e-04
Identities = 18/63 (28%), Positives = 26/63 (41%), Gaps = 2/63 (3%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
R+ I L +A + PY F L + L++S N LT + +L L L N
Sbjct: 272 LRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN 330
Query: 468 NLQ 470
L
Sbjct: 331 PLA 333
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 13/72 (18%), Positives = 27/72 (37%), Gaps = 1/72 (1%)
Query: 425 IVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNG 484
I P S T ++ ++LT +P ++S + + + + P G E+ +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 485 SLSLSVDGNRNL 496
L +R
Sbjct: 62 VSRLRDCLDRQA 73
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 22/64 (34%), Positives = 27/64 (42%), Gaps = 10/64 (15%)
Query: 431 SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSV 490
+ESL S NSLT +PE L+SL V N + L LP L L V
Sbjct: 89 LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS-DLPPLLEY--------LGV 138
Query: 491 DGNR 494
N+
Sbjct: 139 SNNQ 142
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 4e-05
Identities = 18/65 (27%), Positives = 25/65 (38%), Gaps = 12/65 (18%)
Query: 431 SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSL-SLS 489
S+E L++S N L E A L L S N+L +P +L L
Sbjct: 315 LPPSLEELNVSNNKLI----ELPALPPRLERLIASFNHLA-EVPELP------QNLKQLH 363
Query: 490 VDGNR 494
V+ N
Sbjct: 364 VEYNP 368
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 15/65 (23%), Positives = 21/65 (32%), Gaps = 12/65 (18%)
Query: 431 SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSL-SLS 489
++ L+ S N + SL LN+S N L LP+ L L
Sbjct: 295 LPPNLYYLNASSNEIR----SLCDLPPSLEELNVSNNKLI-ELPALP------PRLERLI 343
Query: 490 VDGNR 494
N
Sbjct: 344 ASFNH 348
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 16/89 (17%), Positives = 31/89 (34%), Gaps = 28/89 (31%)
Query: 426 VPYIFSLTSIESLDLSKNSLTGPVPEFLAELQ-------------------SLRVLNLSG 466
+P + + + ++ +D+ NSL +P+ L+ L +
Sbjct: 146 LPELQNSSFLKIIDVDNNSLKK-LPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADN 204
Query: 467 NNLQGSLPSGLSEKVKNGSL-SLSVDGNR 494
N+L+ LP SL S+ N
Sbjct: 205 NSLK-KLPDLP------LSLESIVAGNNI 226
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 14/49 (28%), Positives = 20/49 (40%), Gaps = 5/49 (10%)
Query: 431 SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSE 479
+E L S N L VPE Q+L+ L++ N L+ P
Sbjct: 335 LPPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLR-EFPDIPES 378
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 8e-04
Identities = 19/65 (29%), Positives = 24/65 (36%), Gaps = 12/65 (18%)
Query: 432 LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSL-SLSV 490
L+L+ L+ +PE L L S N+L LP SL SL V
Sbjct: 70 DRQAHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELP------QSLKSLLV 118
Query: 491 DGNRN 495
D N
Sbjct: 119 DNNNL 123
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 6e-06
Identities = 33/155 (21%), Positives = 62/155 (40%), Gaps = 24/155 (15%)
Query: 342 SLAPILNALE-IYQEKEFLQLLTNQQDVDAIMKIKSKYEVKRDWQGDPCAPKVYMWQGIN 400
++ ++ AL+ + EKE LQ + + VD + + +
Sbjct: 387 TIILLMRALDPLLYEKETLQYFSTLKAVDPM------------RAAYLDDLRSKFLLENS 434
Query: 401 CSYDANQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLR 460
R++ +L+ + ++ ++ L + LDLS N L +P LA L+ L
Sbjct: 435 VLKMEYADVRVL--HLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLE 489
Query: 461 VLNLSGNNLQGSLPSGLSEKVKNGSL-SLSVDGNR 494
VL S N L+ ++ G++ L L + NR
Sbjct: 490 VLQASDNALE-NVD-GVA---NLPRLQELLLCNNR 519
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 17/64 (26%), Positives = 29/64 (45%), Gaps = 10/64 (15%)
Query: 431 SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSV 490
+ +L++S N LT +P L L + + +L +LPSGL + L +
Sbjct: 79 LPPELRTLEVSGNQLTS-LPVLPPGLLELSIFSNPLTHLP-ALPSGLCK--------LWI 128
Query: 491 DGNR 494
GN+
Sbjct: 129 FGNQ 132
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 20/77 (25%), Positives = 31/77 (40%), Gaps = 8/77 (10%)
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGS 472
+N+ SG+ + + I +L + N+LT A LR L +SGN L S
Sbjct: 44 VLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT----SLPALPPELRTLEVSGNQLT-S 95
Query: 473 LPSGLSEKVKNGSLSLS 489
LP ++ S
Sbjct: 96 LPVLPPGLLELSIFSNP 112
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 15/39 (38%), Positives = 21/39 (53%), Gaps = 1/39 (2%)
Query: 431 SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNL 469
+ + SL + +N LT +PE L L S +NL GN L
Sbjct: 259 LPSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPL 296
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 21/65 (32%), Positives = 29/65 (44%), Gaps = 12/65 (18%)
Query: 431 SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSL-SLS 489
+ ++ L +S N LT +P L+ L +SGN L SLP L SLS
Sbjct: 219 LPSGLKELIVSGNRLTS-LPV---LPSELKELMVSGNRLT-SLPMLP------SGLLSLS 267
Query: 490 VDGNR 494
V N+
Sbjct: 268 VYRNQ 272
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 17/65 (26%), Positives = 21/65 (32%), Gaps = 12/65 (18%)
Query: 431 SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSL-SLS 489
++ L +S N L A L L N L SLP L LS
Sbjct: 139 LPPGLQELSVSDNQLA----SLPALPSELCKLWAYNNQLT-SLPMLP------SGLQELS 187
Query: 490 VDGNR 494
V N+
Sbjct: 188 VSDNQ 192
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 16/65 (24%), Positives = 22/65 (33%), Gaps = 12/65 (18%)
Query: 431 SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSL-SLS 489
+ + L N LT L+ L++S N L SLP+ L L
Sbjct: 159 LPSELCKLWAYNNQLT----SLPMLPSGLQELSVSDNQLA-SLPTLP------SELYKLW 207
Query: 490 VDGNR 494
NR
Sbjct: 208 AYNNR 212
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 17/68 (25%), Positives = 28/68 (41%), Gaps = 15/68 (22%)
Query: 431 SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS--- 487
+ ++ L +S N LT +P L L++ N L LP L LS
Sbjct: 239 LPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESL------IHLSSET 287
Query: 488 -LSVDGNR 494
++++GN
Sbjct: 288 TVNLEGNP 295
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 15/88 (17%), Positives = 33/88 (37%), Gaps = 2/88 (2%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTG-PVPEFLAELQSLRVLNLSG 466
++ I + ++ I P L ++ L + L P + +L ++
Sbjct: 80 SKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITD 139
Query: 467 NNLQGSLPSGLSEKVKNGSLSLSVDGNR 494
N S+P + + N +L+L + N
Sbjct: 140 NPYMTSIPVNAFQGLCNETLTLKLYNNG 167
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 17/65 (26%), Positives = 29/65 (44%), Gaps = 3/65 (4%)
Query: 431 SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKN-GSLSLS 489
SL ++ LD+S L SL VL ++GN+ Q + + +++N L LS
Sbjct: 124 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183
Query: 490 VDGNR 494
+
Sbjct: 184 --QCQ 186
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 5/88 (5%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ + ++ + + +P IF+ L ++ LDLS+ L P L SL+VLN+S N
Sbjct: 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 209
Query: 468 NLQGSLPSGLSEKVKNGSL-SLSVDGNR 494
N SL + + + SL L N
Sbjct: 210 NFF-SLDTFPYKCLN--SLQVLDYSLNH 234
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 19/84 (22%), Positives = 38/84 (45%), Gaps = 3/84 (3%)
Query: 415 NLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSL 473
+LS + + P F+ L+S++ L++S N+ L SL+VL+ S N++ +
Sbjct: 181 DLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TS 238
Query: 474 PSGLSEKVKNGSLSLSVDGNRNLC 497
+ + L++ N C
Sbjct: 239 KKQELQHFPSSLAFLNLTQNDFAC 262
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 14/71 (19%), Positives = 31/71 (43%), Gaps = 5/71 (7%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTG-PVPEFLAELQSLRVLNLSG 466
+ ++LS +G+ + F L +E LD ++L L++L L++S
Sbjct: 78 TSLKYLDLSFNGVI--TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 135
Query: 467 NNLQGSLPSGL 477
+ + +G+
Sbjct: 136 THTR-VAFNGI 145
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 18/77 (23%), Positives = 31/77 (40%), Gaps = 5/77 (6%)
Query: 405 ANQSPRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLT--GPVPEFLAELQSLRV 461
+ L S+ + + +F LT + L LS N L+ G + SL+
Sbjct: 24 TGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKY 82
Query: 462 LNLSGNNLQGSLPSGLS 478
L+LS N + ++ S
Sbjct: 83 LDLSFNGVI-TMSSNFL 98
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 16/71 (22%), Positives = 32/71 (45%), Gaps = 3/71 (4%)
Query: 409 PRIISINLSSSGIA-GDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG 466
++ ++LSS+G++ TS++ LDLS N + + L+ L L+
Sbjct: 52 TQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQH 110
Query: 467 NNLQGSLPSGL 477
+NL+ +
Sbjct: 111 SNLKQMSEFSV 121
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 19/70 (27%), Positives = 31/70 (44%), Gaps = 3/70 (4%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ + LS + I I F+ L ++ +L+L N LT L L+ L L N
Sbjct: 88 RHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNN 146
Query: 468 NLQGSLPSGL 477
++ S+PS
Sbjct: 147 PIE-SIPSYA 155
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 18/70 (25%), Positives = 30/70 (42%), Gaps = 3/70 (4%)
Query: 425 IVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKN 483
I P F L ++ L + ++ + LQSL +NL+ NNL LP L + +
Sbjct: 222 IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHH 280
Query: 484 GSLSLSVDGN 493
+ + N
Sbjct: 281 -LERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 13/51 (25%), Positives = 23/51 (45%), Gaps = 1/51 (1%)
Query: 426 VPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSG 476
+P + L ++ LDLS N L+ P L L+ L + + +Q +
Sbjct: 200 IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERN 249
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 20/70 (28%), Positives = 29/70 (41%), Gaps = 3/70 (4%)
Query: 408 SPRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG 466
S +NL + I I F L +E L LS+N + L +L L L
Sbjct: 63 STNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121
Query: 467 NNLQGSLPSG 476
N L ++P+G
Sbjct: 122 NRLT-TIPNG 130
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 54/248 (21%), Positives = 87/248 (35%), Gaps = 74/248 (29%)
Query: 561 ITNNFE--RVLGKGGFGTVYHGY---LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHH 615
+ +E LG+G FG V QVA+K++ + V Y++ A +E+ +
Sbjct: 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN--VGKYRE-AARLEINV---- 69
Query: 616 KNLTILVGYCDEGAN---------------------MGL-IYEFMANGNLQAHLLEDKAD 653
L + E +G +EF+ N Q + L
Sbjct: 70 --LKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPL----- 122
Query: 654 TLCWERRLQ-IASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQA------------ 700
++ +A + L +LH + + H D+K NIL
Sbjct: 123 -----PHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174
Query: 701 -------KLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVL 753
++ADFG S F + H TT+V T Y PE + + DV+S G +L
Sbjct: 175 SVKNTSIRVADFG-SATF--DHEHH--TTIVATRHYRPPEVILELGWAQPCDVWSIGCIL 229
Query: 754 LELITGQP 761
E G
Sbjct: 230 FEYYRGFT 237
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 54/254 (21%), Positives = 90/254 (35%), Gaps = 86/254 (33%)
Query: 561 ITNNFE--RVLGKGGFGTVYHGY---LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHH 615
++ +E LG+G FG V + VAVK++ + V Y + A E+ +
Sbjct: 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN--VDRYCE-AARSEIQV---- 64
Query: 616 KNLTILVGYCDEGAN---------------------MGL-IYEFM-ANGNLQAHLLEDKA 652
L L +GL Y+F+ NG L L
Sbjct: 65 --LEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRL----- 117
Query: 653 DTLCWERRLQ-IASESAQGLEYLHNGCKPPIVHRDVKSANILLNE--------------- 696
++ +A + + + +LH+ K + H D+K NIL +
Sbjct: 118 ------DHIRKMAYQICKSVNFLHS-NK--LTHTDLKPENILFVQSDYTEAYNPKIKRDE 168
Query: 697 ----KFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPE-----YYISNRLTEKSDVY 747
K+ DFG S + + H +T+V T Y PE + ++ DV+
Sbjct: 169 RTLINPDIKVVDFG-SATY--DDEHH--STLVSTRHYRAPEVILALGW-----SQPCDVW 218
Query: 748 SFGVVLLELITGQP 761
S G +L+E G
Sbjct: 219 SIGCILIEYYLGFT 232
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 12/63 (19%), Positives = 26/63 (41%), Gaps = 4/63 (6%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
++ ++ GI + + L ++ ++ S N LT P L L L + ++ N
Sbjct: 46 DQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 101
Query: 469 LQG 471
+
Sbjct: 102 IAD 104
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 5e-05
Identities = 14/59 (23%), Positives = 27/59 (45%), Gaps = 4/59 (6%)
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQG 471
IN S++ + + + +LT + + ++ N + P LA L +L L L N +
Sbjct: 72 QINFSNNQLTD--ITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD 126
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 7e-05
Identities = 22/84 (26%), Positives = 40/84 (47%), Gaps = 12/84 (14%)
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGS 472
S+ +++ I+ + + LT+++ L L+ N L LA L +L L+L+ N +
Sbjct: 203 SLIATNNQISD--ITPLGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQISNL 258
Query: 473 LP-SGLSEKVKNGSL-SLSVDGNR 494
P SGL+ L L + N+
Sbjct: 259 APLSGLT------KLTELKLGANQ 276
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 9/61 (14%), Positives = 20/61 (32%), Gaps = 4/61 (6%)
Query: 411 IISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQ 470
+ L + + L + +L + + + + L +L +N S N L
Sbjct: 26 KMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLT 81
Query: 471 G 471
Sbjct: 82 D 82
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 16/62 (25%), Positives = 33/62 (53%), Gaps = 4/62 (6%)
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGS 472
+ L ++ I+ + + LT++ +L+L++N L P ++ L++L L L NN+
Sbjct: 269 ELKLGANQISN--ISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDI 324
Query: 473 LP 474
P
Sbjct: 325 SP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 19/66 (28%), Positives = 35/66 (53%), Gaps = 6/66 (9%)
Query: 429 IFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488
+ +LT++E LD+S N ++ LA+L +L L + N + P G+ + L
Sbjct: 173 LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGILTNLD----EL 226
Query: 489 SVDGNR 494
S++GN+
Sbjct: 227 SLNGNQ 232
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 15/59 (25%), Positives = 29/59 (49%), Gaps = 4/59 (6%)
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQG 471
++L+ + + + + SLT++ LDL+ N ++ P L+ L L L L N +
Sbjct: 225 ELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN 279
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 4e-04
Identities = 13/62 (20%), Positives = 26/62 (41%), Gaps = 4/62 (6%)
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGS 472
+ L + I+ + + SLT ++ L N ++ LA L ++ L+ N +
Sbjct: 313 YLTLYFNNISD--ISPVSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSAGHNQISDL 368
Query: 473 LP 474
P
Sbjct: 369 TP 370
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 15/62 (24%), Positives = 31/62 (50%), Gaps = 5/62 (8%)
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGS 472
+ L ++ I + + +LT++ L+LS N+++ L+ L SL+ L+ N +
Sbjct: 116 GLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDL 170
Query: 473 LP 474
P
Sbjct: 171 KP 172
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 20/71 (28%), Positives = 32/71 (45%), Gaps = 3/71 (4%)
Query: 408 SPRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG 466
P ++L ++ I +I F L ++ +L L N ++ P A L L L LS
Sbjct: 51 PPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109
Query: 467 NNLQGSLPSGL 477
N L+ LP +
Sbjct: 110 NQLK-ELPEKM 119
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 16/69 (23%), Positives = 32/69 (46%), Gaps = 4/69 (5%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ + LS + I+ + + + L L+ N L VP LA+ + ++V+ L N
Sbjct: 216 NNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNN 273
Query: 468 NLQGSLPSG 476
N+ ++ S
Sbjct: 274 NIS-AIGSN 281
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 15/76 (19%), Positives = 30/76 (39%), Gaps = 14/76 (18%)
Query: 425 IVPYIFS-LTSIESLDLSKNSLTGPV--PEFLAELQSLRVLNLSGNNL---QGSLPSGLS 478
+ +F+ L + ++L N L ++ L + ++ N+ LP L+
Sbjct: 136 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT 195
Query: 479 EKVKNGSLSLSVDGNR 494
E L +DGN+
Sbjct: 196 E--------LHLDGNK 203
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 18/70 (25%), Positives = 35/70 (50%), Gaps = 6/70 (8%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ ++ L ++ I+ I P F+ L +E L LSKN L +PE + ++L+ L + N
Sbjct: 76 KNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHEN 131
Query: 468 NLQGSLPSGL 477
+ + +
Sbjct: 132 EIT-KVRKSV 140
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 17/55 (30%), Positives = 26/55 (47%), Gaps = 2/55 (3%)
Query: 425 IVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLS 478
+ L ++ L LS NS++ LA LR L+L+ N L +P GL+
Sbjct: 207 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 260
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 13/95 (13%), Positives = 36/95 (37%), Gaps = 13/95 (13%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTG------PVPEFLAELQSLRV 461
P + ++L+++ + VP + I+ + L N+++ P + + S
Sbjct: 240 PHLRELHLNNNKLV--KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSG 297
Query: 462 LNLSGNNLQ-GSLPSGLSEKVKNGSL-SLSVDGNR 494
++L N +Q + V ++ + +
Sbjct: 298 VSLFSNPVQYWEIQPSTFRCVYV--RAAVQLGNYK 330
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 20/90 (22%), Positives = 37/90 (41%), Gaps = 4/90 (4%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSK-NSLTGPVPEFLAELQSLRVLNLSG 466
+ I +S + + I +FS L + + + K N+L PE L +L+ L +S
Sbjct: 54 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 113
Query: 467 NNLQGSLPSGLSEKVKNGSLSLSVDGNRNL 496
++ LP + L + N N+
Sbjct: 114 TGIK-HLPDVHKIHSLQ-KVLLDIQDNINI 141
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 23/88 (26%), Positives = 37/88 (42%), Gaps = 5/88 (5%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ + L + I I F+ L S+ +L+L N LT L LR L L N
Sbjct: 99 HHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNN 157
Query: 468 NLQGSLPSGLSEKVKN-GSLSLSVDGNR 494
++ S+PS +V + L L + +
Sbjct: 158 PIE-SIPSYAFNRVPSLMRLDLG-ELKK 183
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 21/70 (30%), Positives = 33/70 (47%), Gaps = 3/70 (4%)
Query: 425 IVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKN 483
I P F L+S++ L + + ++ L SL LNL+ NNL SLP L ++
Sbjct: 233 IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRY 291
Query: 484 GSLSLSVDGN 493
+ L + N
Sbjct: 292 -LVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 21/71 (29%), Positives = 27/71 (38%), Gaps = 3/71 (4%)
Query: 408 SPRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG 466
+NL + I I F L +E L L +NS+ L SL L L
Sbjct: 74 PSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132
Query: 467 NNLQGSLPSGL 477
N L +PSG
Sbjct: 133 NWLT-VIPSGA 142
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 22/79 (27%), Positives = 38/79 (48%), Gaps = 3/79 (3%)
Query: 400 NCSYDANQSPRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQS 458
N ++ ++ + + +LS S I ++ +FS T +E L L++N + L
Sbjct: 266 NFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH 324
Query: 459 LRVLNLSGNNLQGSLPSGL 477
L LNLS N L S+ S +
Sbjct: 325 LLKLNLSQNFLG-SIDSRM 342
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 19/84 (22%), Positives = 30/84 (35%), Gaps = 5/84 (5%)
Query: 414 INLSSSGIAGDIVPYIF-SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGS 472
+ + I F L+S+ L L N L +L VL L+ NL G+
Sbjct: 59 LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGA 118
Query: 473 -LPSGLSEKVKNGSL-SLSVDGNR 494
L + + + L L + N
Sbjct: 119 VLSGNFFKPLTS--LEMLVLRDNN 140
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 8e-04
Identities = 17/65 (26%), Positives = 31/65 (47%), Gaps = 4/65 (6%)
Query: 415 NLSSSGIAGDIVPY-IFS-LTSIESLDLSKNSLTGPVPE-FLAELQSLRVLNLSGNNLQG 471
L+ + G ++ F LTS+E L L N++ P F ++ VL+L+ N ++
Sbjct: 109 TLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK- 167
Query: 472 SLPSG 476
S+
Sbjct: 168 SICEE 172
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 20/177 (11%), Positives = 54/177 (30%), Gaps = 31/177 (17%)
Query: 200 SMSLVLRWDVGTP--LDIYDRIWWPDN-FKNVERISTSSNVNPATSLFQPPVTVMQSAII 256
+ ++ + G +D++ + D V R S P + Q+
Sbjct: 3 ADKVIWAVNAGGESHVDVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERY 62
Query: 257 PANGSSSFWFSWE-SVSTVFKYYTCMYFSEFESEQAETRSREMNIYLNGRFW-------- 307
+ F ++ + +Y + F+E Q++ + ++ +NG
Sbjct: 63 -----NEDSFGYDIPIKEEGEYVLVLKFAEVYFAQSQQKV--FDVRVNGHTVVKDLDIFD 115
Query: 308 ---SEIPPPQYLNTTT-------HRLTATNAQQYVISIMQTKNSSLAPILNALEIYQ 354
+ + + +T + + ++ + P + AL I +
Sbjct: 116 RVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDN--PKVCALFIMK 170
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 20/66 (30%), Positives = 30/66 (45%), Gaps = 7/66 (10%)
Query: 431 SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSE--KVKNGSLSL 488
TS+E L + N LT +PE +SL L++S N L+ SLP+ + +
Sbjct: 158 LPTSLEVLSVRNNQLTF-LPE---LPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFF 212
Query: 489 SVDGNR 494
NR
Sbjct: 213 RCRENR 218
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 16/65 (24%), Positives = 24/65 (36%), Gaps = 12/65 (18%)
Query: 431 SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSL-SLS 489
S+E LD N L+ SL+ L++ N L LP L ++
Sbjct: 98 LPASLEYLDACDNRLS----TLPELPASLKHLDVDNNQLT-MLPELP------ALLEYIN 146
Query: 490 VDGNR 494
D N+
Sbjct: 147 ADNNQ 151
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 17/64 (26%), Positives = 25/64 (39%), Gaps = 12/64 (18%)
Query: 432 LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSL-SLSV 490
I L++++N+L SL L+ N L +LP SL L V
Sbjct: 79 PPQITVLEITQNALI----SLPELPASLEYLDACDNRLS-TLPELP------ASLKHLDV 127
Query: 491 DGNR 494
D N+
Sbjct: 128 DNNQ 131
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 17/65 (26%), Positives = 23/65 (35%), Gaps = 12/65 (18%)
Query: 431 SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSL-SLS 489
+E ++ N LT SL VL++ N L LP SL +L
Sbjct: 138 LPALLEYINADNNQLT----MLPELPTSLEVLSVRNNQLT-FLPELP------ESLEALD 186
Query: 490 VDGNR 494
V N
Sbjct: 187 VSTNL 191
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 18/86 (20%), Positives = 27/86 (31%), Gaps = 10/86 (11%)
Query: 412 ISINLSS---SGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468
+S N SG D ++N + E L + L L+ N
Sbjct: 13 LSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLN 70
Query: 469 LQGSLPSGLSEKVKNGSLSLSVDGNR 494
L SLP L ++ L + N
Sbjct: 71 LS-SLPDNLPPQIT----VLEITQNA 91
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 18/74 (24%), Positives = 37/74 (50%), Gaps = 8/74 (10%)
Query: 427 PYIFS-LTSIESLDLSKNSLTG-PVPEFLAELQSLRVLNLSGNNLQGSLPSG----LSEK 480
+ L +++ L+++ N + +PE+ + L +L L+LS N +Q S+ L +
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLH-Q 174
Query: 481 VKNGSLSLSVDGNR 494
+ +LSL + N
Sbjct: 175 MPLLNLSLDLSLNP 188
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 18/65 (27%), Positives = 30/65 (46%), Gaps = 3/65 (4%)
Query: 413 SINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQG 471
S+ LS + + I F + ++ LDLS N L ++LQ+L VL L N++
Sbjct: 68 SLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV- 125
Query: 472 SLPSG 476
+
Sbjct: 126 VVDRN 130
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 19/69 (27%), Positives = 30/69 (43%), Gaps = 6/69 (8%)
Query: 433 TSIESLDLSKNSLTGPVPEFLAEL----QSLRVLNLSGNNLQGSLPSGLSEKVK-NGSL- 486
T ++ + PV LAE+ +L+ LN+ N + GS L E ++ N SL
Sbjct: 65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLI 124
Query: 487 SLSVDGNRN 495
L +D
Sbjct: 125 ELRIDNQSQ 133
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 17/60 (28%), Positives = 31/60 (51%), Gaps = 3/60 (5%)
Query: 431 SLTSIESLDLSKNSLT-GPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLS 489
+ S++ LD+S+NS++ + +SL LN+S N L ++ L ++K L L
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKV--LDLH 429
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 11/44 (25%), Positives = 20/44 (45%), Gaps = 1/44 (2%)
Query: 433 TSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSG 476
L++S+N ++ + L LR+L +S N +Q L
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDIS 63
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 18/60 (30%), Positives = 23/60 (38%), Gaps = 1/60 (1%)
Query: 415 NLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLP 474
N + SG + ++ LD S N LT V E L L L L N L+ L
Sbjct: 306 NFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELS 364
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 16/54 (29%), Positives = 24/54 (44%), Gaps = 2/54 (3%)
Query: 425 IVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGL 477
+ F L S++ L L +N + P +L L L L NNL +LP+
Sbjct: 168 VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEA 220
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 23/65 (35%), Positives = 29/65 (44%), Gaps = 4/65 (6%)
Query: 415 NLSSSGIAGDIVPYIFS-LTSIESLDLSKNS-LTGPVPEFLAELQSLRVLNLSGNNLQGS 472
L S+ +A I F+ L +E LDLS N+ L P L L L+L LQ
Sbjct: 62 WLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-E 119
Query: 473 LPSGL 477
L GL
Sbjct: 120 LGPGL 124
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 15/70 (21%), Positives = 22/70 (31%), Gaps = 2/70 (2%)
Query: 408 SPRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG 466
I L + I+ + F ++ L L N L L L L+LS
Sbjct: 31 PAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89
Query: 467 NNLQGSLPSG 476
N S+
Sbjct: 90 NAQLRSVDPA 99
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 11/47 (23%), Positives = 19/47 (40%), Gaps = 1/47 (2%)
Query: 431 SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGL 477
LT +E L++ + L P+ L +Q++ L L L
Sbjct: 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIF 217
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 20/94 (21%), Positives = 37/94 (39%), Gaps = 12/94 (12%)
Query: 402 SYDANQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRV 461
+ Q + S++ +S I + I LT + L + N++T + L++ +L
Sbjct: 35 TISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNITT-LD--LSQNTNLTY 89
Query: 462 LNLSGNNLQGSLPSGLSEKVKNGSL-SLSVDGNR 494
L N L +L L L+ D N+
Sbjct: 90 LACDSNKLT-NLDVT-----PLTKLTYLNCDTNK 117
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 19/97 (19%), Positives = 37/97 (38%), Gaps = 14/97 (14%)
Query: 407 QSPRIISINLSSSGIAGDIVPYIFSL-----TSIESLDLSKNSLTGPVPEFLAEL----Q 457
P + ++LS + + + + +E L L SL+ E LA +
Sbjct: 111 TLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKP 170
Query: 458 SLRVLNLSGNNLQGS----LPSGLSE-KVKNGSLSLS 489
+ L +S N++ + L GL + + +L L
Sbjct: 171 DFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLE 207
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 21/91 (23%), Positives = 35/91 (38%), Gaps = 9/91 (9%)
Query: 407 QSPRIISINLSSSGIAGDIVPYIFSL-----TSIESLDLSKNSLTGPVPEFLAEL----Q 457
+P + +NL S+ + V + I+ L L LTG L+
Sbjct: 54 VNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLP 113
Query: 458 SLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488
+L+ L+LS N L + L E + + L
Sbjct: 114 TLQELHLSDNLLGDAGLQLLCEGLLDPQCRL 144
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 9e-04
Identities = 14/88 (15%), Positives = 29/88 (32%), Gaps = 7/88 (7%)
Query: 406 NQSPRIISINLSSSGI-AGDIVPYIFSLTSIESLDLSKNSLT----GPVPEFLAELQSLR 460
+ I S+++ + + L + + L LT + L +L
Sbjct: 2 SLD--IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA 59
Query: 461 VLNLSGNNLQGSLPSGLSEKVKNGSLSL 488
LNL N L + + ++ S +
Sbjct: 60 ELNLRSNELGDVGVHCVLQGLQTPSCKI 87
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 16/104 (15%), Positives = 40/104 (38%), Gaps = 11/104 (10%)
Query: 405 ANQSPRIISINLSSSGIAGDIVPYIFSL----TSIESLDLSKNSLTGPVPEFLAEL---- 456
++ ++S+NL + + G + + L ++++ L + + E L
Sbjct: 221 SSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAF 280
Query: 457 ---QSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSVDGNRNLC 497
Q + +++ +G + S +S ++ S V N C
Sbjct: 281 PNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQC 324
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 12/63 (19%), Positives = 30/63 (47%), Gaps = 3/63 (4%)
Query: 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ ++ I + + +L + + L LS N++ L+ +++LR+L+L N
Sbjct: 24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE--KISSLSGMENLRILSLGRN 80
Query: 468 NLQ 470
++
Sbjct: 81 LIK 83
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 41.3 bits (96), Expect = 9e-04
Identities = 21/92 (22%), Positives = 34/92 (36%), Gaps = 6/92 (6%)
Query: 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
+ + + + + L + +L + K+ L P+ L LNLS N
Sbjct: 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90
Query: 468 NLQGSLPSGLSEKVKNGSLS-LSVDGNRNLCP 498
L+ SL V+ SL L + GN C
Sbjct: 91 ALE-SLSWKT---VQGLSLQELVLSGNPLHCS 118
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 870 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.71 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.58 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.5 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.49 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.44 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.42 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.34 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.27 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.26 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.23 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.21 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.18 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.16 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.15 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.11 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.11 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.09 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.02 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.0 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.97 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 98.94 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 98.92 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 98.88 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.88 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 98.88 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 98.87 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 98.85 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 98.82 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 98.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 98.77 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 98.76 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 98.76 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 98.76 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 98.75 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 98.73 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.72 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 98.72 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 98.72 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.71 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 98.7 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 98.7 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.7 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 98.68 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 98.67 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 98.66 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 98.65 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 98.65 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.63 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 98.62 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.62 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 98.62 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.61 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 98.6 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.58 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.58 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.58 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.58 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 98.57 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 98.57 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 98.56 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 98.55 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 98.54 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 98.54 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 98.53 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 98.52 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 98.52 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 98.51 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 98.51 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.51 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 98.51 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 98.51 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.51 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 98.5 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 98.5 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.5 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 98.49 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 98.47 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 98.46 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.45 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 98.43 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.43 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 98.43 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.41 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.41 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.41 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 98.4 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 98.39 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.38 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 98.37 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.37 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.36 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.35 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 98.34 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.33 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.32 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.32 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 98.32 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.31 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.31 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.31 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.3 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 98.28 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 98.28 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.27 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.26 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.24 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.24 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.22 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.22 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.22 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.2 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.19 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.19 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.17 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.15 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.15 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.14 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.13 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.13 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.11 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.09 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.02 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.02 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.0 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 97.98 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 97.97 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 97.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 97.95 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 97.94 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 97.94 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 97.93 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 97.92 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 97.91 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 97.9 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 97.9 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 97.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 97.86 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 97.82 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 97.82 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 97.79 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 97.79 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 97.75 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 97.73 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 97.73 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.73 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 97.7 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 97.66 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.65 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.58 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 97.57 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 97.53 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 97.41 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 97.35 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.29 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.28 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 97.06 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.04 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.97 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.91 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.87 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.78 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 96.68 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.64 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 96.61 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.59 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.44 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 96.43 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 96.36 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.31 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.16 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 95.89 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 95.89 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 95.83 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 95.64 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.5 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.33 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 95.32 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 94.74 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.5 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 94.22 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 94.05 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.72 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 93.2 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.28 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 84.64 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 83.69 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 81.23 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=448.22 Aligned_cols=255 Identities=28% Similarity=0.427 Sum_probs=208.1
Q ss_pred hccccccccCcEEEEEEEEC-------CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
.+.+.||+|+||+||+|++. ++.||||+++.......++|.+|+++|++++|||||+++|+|.+....++|||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 34678999999999999863 57899999988777777899999999999999999999999999999999999
Q ss_pred EccCCchhhhhhhcc-------------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEE
Q 002887 637 FMANGNLQAHLLEDK-------------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLA 703 (870)
Q Consensus 637 y~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~ 703 (870)
||++|+|.++++... ...++|.+++.|+.|||+||+|||+. +|+||||||+||||++++.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEc
Confidence 999999999987542 24699999999999999999999998 99999999999999999999999
Q ss_pred eccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhc
Q 002887 704 DFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLAR 782 (870)
Q Consensus 704 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~ 782 (870)
|||+++.....+.........||+.|||||++.+..++.++|||||||+||||+| |+.||........+.. +..
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~-----i~~ 275 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC-----ITQ 275 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH-----HHH
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH-----HHc
Confidence 9999987644443444456789999999999999999999999999999999999 8999987654332221 222
Q ss_pred CCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 783 GDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 783 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
+. ..+.+..++..+.+|+.+||+.||++||||.||+++|+.+.+
T Consensus 276 g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 276 GR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp TC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 21 112233455678899999999999999999999999998653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=449.18 Aligned_cols=256 Identities=23% Similarity=0.405 Sum_probs=214.8
Q ss_pred HHhhccccccccCcEEEEEEEEC-------CeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEE
Q 002887 561 ITNNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMG 632 (870)
Q Consensus 561 ~t~~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 632 (870)
.+.+|.+.||+|+||+||+|++. ++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+....+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34567789999999999999973 57899999976533 34578999999999999999999999999999999
Q ss_pred EEEEEccCCchhhhhhhcc--------------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC
Q 002887 633 LIYEFMANGNLQAHLLEDK--------------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF 698 (870)
Q Consensus 633 LV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~ 698 (870)
+|||||++|+|.++|.... ...++|.+++.|+.|||+||+|||++ +||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 9999999999999996532 24699999999999999999999998 999999999999999999
Q ss_pred cEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHH
Q 002887 699 QAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVS 777 (870)
Q Consensus 699 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~ 777 (870)
++||+|||+++.....+.........||+.|||||++.++.++.++|||||||+||||+| |+.||.+....+...
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~---- 258 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE---- 258 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH----
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH----
Confidence 999999999987644433344456789999999999999999999999999999999999 899998765433221
Q ss_pred HHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 778 SMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 778 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
.+..+.. .+.+..++..+.+++.+||+.+|++||||.||++.|+..
T Consensus 259 -~i~~~~~---------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 -MIRNRQV---------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp -HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -HHHcCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2222221 122344567789999999999999999999999999853
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=446.33 Aligned_cols=254 Identities=28% Similarity=0.442 Sum_probs=214.6
Q ss_pred hccccccccCcEEEEEEEEC-------CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
.+.+.||+|+||+||+|++. ++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..++|||
T Consensus 16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 95 (299)
T 4asz_A 16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE 95 (299)
T ss_dssp EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 35689999999999999863 57899999988777777899999999999999999999999999999999999
Q ss_pred EccCCchhhhhhhcc-----------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEec
Q 002887 637 FMANGNLQAHLLEDK-----------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADF 705 (870)
Q Consensus 637 y~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DF 705 (870)
||++|+|.++|.... ...++|.+++.|+.|||+||+|||++ +|+||||||+||||++++.+||+||
T Consensus 96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DF 172 (299)
T 4asz_A 96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDF 172 (299)
T ss_dssp CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCc
Confidence 999999999997542 35799999999999999999999998 9999999999999999999999999
Q ss_pred cCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCC
Q 002887 706 GLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGD 784 (870)
Q Consensus 706 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~ 784 (870)
|+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||......+.+.. +..+.
T Consensus 173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~-----i~~~~ 247 (299)
T 4asz_A 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC-----ITQGR 247 (299)
T ss_dssp SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-----HHHTC
T ss_pred ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-----HHcCC
Confidence 99987644333333445679999999999999999999999999999999999 8999987654332222 22222
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 785 IKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 785 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
. ...+..++..+.+++.+||+.||++||||+||++.|+++.
T Consensus 248 ~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 248 V---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1 1223345567889999999999999999999999998854
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=437.97 Aligned_cols=255 Identities=29% Similarity=0.512 Sum_probs=204.0
Q ss_pred hccccccccCcEEEEEEEECCeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 564 NFERVLGKGGFGTVYHGYLDDKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
.+.+.||+|+||+||+|++.+ .||||+++.. .....+.|.+|++++++++|||||+++|+|.+ +..++|||||++|
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gG 116 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGS 116 (307)
T ss_dssp CEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSC
T ss_pred EEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCC
Confidence 356889999999999999876 5999998754 33456789999999999999999999999865 5689999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.++|...+ ..++|.+++.|+.|||+||+|||++ +||||||||+||||++++++||+|||+|+............
T Consensus 117 sL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~ 192 (307)
T 3omv_A 117 SLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVE 192 (307)
T ss_dssp BHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-----------
T ss_pred CHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeec
Confidence 9999996543 4699999999999999999999998 99999999999999999999999999998765444444455
Q ss_pred cccCCCCccCcccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 722 TVVGTPGYLDPEYYIS---NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~---~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
...||+.|||||++.+ +.++.++|||||||+||||+||+.||........+... +..+. ..+.+ ....
T Consensus 193 ~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~----~~~~~----~~p~~-~~~~ 263 (307)
T 3omv_A 193 QPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM----VGRGY----ASPDL-SKLY 263 (307)
T ss_dssp -CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH----HHTTC----CCCCS-TTSC
T ss_pred ccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH----HhcCC----CCCCc-cccc
Confidence 6789999999999964 35899999999999999999999999865543333222 22221 11111 1223
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
..++..+.+++.+||+.+|++||||.||++.|+.+
T Consensus 264 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 264 KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 34566788999999999999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=430.52 Aligned_cols=258 Identities=29% Similarity=0.403 Sum_probs=214.1
Q ss_pred hhccccccccCcEEEEEEEEC-------CeeEEEEEeeccch-hhhHHHHHHHHHHHHhcc-ccceeEEEEEecC-CeEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHH-KNLTILVGYCDEG-ANMG 632 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~-~~~~ 632 (870)
..+.+.||+|+||+||+|.+. ++.||||++..... ...++|.+|+++|.+++| ||||+++|+|.+. ...+
T Consensus 66 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~ 145 (353)
T 4ase_A 66 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 145 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred eEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEE
Confidence 345689999999999999874 25799999976543 345779999999999965 8999999999764 5689
Q ss_pred EEEEEccCCchhhhhhhccc--------------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC
Q 002887 633 LIYEFMANGNLQAHLLEDKA--------------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF 698 (870)
Q Consensus 633 LV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~ 698 (870)
+|||||++|+|.++|+..+. ..++|.+++.++.|||+||+|||++ +||||||||+|||+++++
T Consensus 146 iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 146 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKN 222 (353)
T ss_dssp EEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCCCC
Confidence 99999999999999975432 4589999999999999999999998 999999999999999999
Q ss_pred cEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHH
Q 002887 699 QAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVS 777 (870)
Q Consensus 699 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~ 777 (870)
.+||+|||+|+.+..+..........||+.|||||++.++.++.++|||||||+||||+| |+.||........+.+
T Consensus 223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~--- 299 (353)
T 4ase_A 223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR--- 299 (353)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH---
T ss_pred CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH---
Confidence 999999999997754444444556789999999999999999999999999999999998 9999987654333322
Q ss_pred HHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 778 SMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 778 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
.+..+.. ...+.....++.+++.+||+.||++|||+.||++.|+++++.
T Consensus 300 -~i~~g~~---------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 300 -RLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp -HHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHcCCC---------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 2222211 122334456788999999999999999999999999998754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=423.97 Aligned_cols=264 Identities=23% Similarity=0.315 Sum_probs=202.4
Q ss_pred hccccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCC----eEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGA----NMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~LV~Ey~~ 639 (870)
.+.+.||+|+||+||+|+++|+.||||++...... ...++.|+..+.+++|||||+++++|.+.+ ..+||||||+
T Consensus 6 ~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~ 84 (303)
T 3hmm_A 6 VLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEEEEEeeCCCeEEEEEEECCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCC
Confidence 35689999999999999999999999999765322 223355666677889999999999997653 5799999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhC-----CCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNG-----CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-----~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
+|+|.+++.. ..++|..+++++.|+++||+|||++ +.++|+||||||+||||++++++||+|||+++.....
T Consensus 85 ~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 161 (303)
T 3hmm_A 85 HGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp TCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred CCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence 9999999954 4699999999999999999999976 2568999999999999999999999999999876433
Q ss_pred CCcc--ccccccCCCCccCccccccC------CCCccchHHHHHHHHHHHHhCCCCCCCCCcc-----------chHHHH
Q 002887 715 GGTH--VSTTVVGTPGYLDPEYYISN------RLTEKSDVYSFGVVLLELITGQPVIQKTPQR-----------TLIGQW 775 (870)
Q Consensus 715 ~~~~--~~~~~~gt~~y~APE~~~~~------~~~~ksDVwS~GvvL~elltG~~p~~~~~~~-----------~~l~~~ 775 (870)
.... ......||+.|||||++.+. .++.++|||||||+||||+||++|+...... .....+
T Consensus 162 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~ 241 (303)
T 3hmm_A 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp TTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred CCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHH
Confidence 2221 22346799999999999764 3678999999999999999998876533211 112222
Q ss_pred HHHHhhcCCcchhcccccCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 776 VSSMLARGDIKNIVDHRLQGD-FDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 776 ~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
.......+ .++.+... .+.+....+.+++.+||+.||++||||.||+++|+++.+.
T Consensus 242 ~~~~~~~~-----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 242 RKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHTTSC-----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhccc-----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 22211111 11222111 1235667889999999999999999999999999987654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=429.18 Aligned_cols=247 Identities=22% Similarity=0.365 Sum_probs=203.6
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
+.+.+.||+|+||+||+|+.. ++.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..++|||||
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~ 105 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC 105 (350)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 345678999999999999986 8899999997653 334577999999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|+|.+++...+...+++.++..|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+.+.. ...
T Consensus 106 ~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~ 180 (350)
T 4b9d_A 106 EGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVE 180 (350)
T ss_dssp TTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH--HHH
T ss_pred CCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC--Ccc
Confidence 999999999876667789999999999999999999998 999999999999999999999999999986521 122
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
.....+||+.|||||++.+..|+.++|||||||++|||++|++||........+.+. .. +... ...
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i----~~-~~~~---------~~~ 246 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI----IS-GSFP---------PVS 246 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH----HH-TCCC---------CCC
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH----Hc-CCCC---------CCC
Confidence 334568999999999999999999999999999999999999999876544333322 21 1111 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
......+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 247 LHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 234457889999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=422.87 Aligned_cols=245 Identities=22% Similarity=0.297 Sum_probs=207.7
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
++.+.||+|+||.||+|+.. ++.||||++........+.+.+|+++|++++|||||++++++.+++..++|||||++|
T Consensus 77 ~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 156 (346)
T 4fih_A 77 DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 156 (346)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTE
T ss_pred EEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence 34568999999999999986 8899999998776666778999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++.+ ..+++.++..++.||+.||+|||++ +|+||||||+||||+.++++||+|||+|+.+... .....
T Consensus 157 ~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~ 228 (346)
T 4fih_A 157 ALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRK 228 (346)
T ss_dssp EHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SCCBC
T ss_pred cHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC--CCccc
Confidence 99998854 4699999999999999999999999 9999999999999999999999999999876432 22345
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
..+||+.|||||++.+..|+.++|||||||++|||++|++||........+... . .+. .+.+ ......
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i----~-~~~-----~~~~--~~~~~~ 296 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI----R-DNL-----PPRL--KNLHKV 296 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----H-HSS-----CCCC--SCGGGS
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH----H-cCC-----CCCC--CccccC
Confidence 678999999999999999999999999999999999999999865543332221 1 110 1111 112234
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...+.+++.+||+.||++|||+.|+++
T Consensus 297 s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 297 SPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 567889999999999999999999865
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=420.09 Aligned_cols=250 Identities=21% Similarity=0.262 Sum_probs=206.9
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
+.++||+|+||.||+|+.. ++.||||+++... .+.+|+.++++++|||||++++++.++...++|||||++|+
T Consensus 62 ~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 136 (336)
T 4g3f_A 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136 (336)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 4568999999999999986 8899999997642 23579999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC-cEEEEeccCCccccCCCCcc---
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF-QAKLADFGLSRIFPVEGGTH--- 718 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~-~vkL~DFGla~~~~~~~~~~--- 718 (870)
|.+++.+. ..+++.++..++.||+.||+|||++ +|+||||||+||||+.++ ++||+|||+|+.+..++...
T Consensus 137 L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 137 LGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp HHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred HHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 99999643 4699999999999999999999998 999999999999999987 69999999999764432221
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
.....+||+.|||||++.+..++.++|||||||++|||+||++||..........+.... . . .+ ...+
T Consensus 212 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~----~-~------~~-~~~~ 279 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE----P-P------PI-REIP 279 (336)
T ss_dssp --CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS----C-C------GG-GGSC
T ss_pred cCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC----C-C------Cc-hhcC
Confidence 223467999999999999999999999999999999999999999876655544433221 1 0 00 0122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
......+.+++.+||+.||++|||+.|+++.|...+..
T Consensus 280 ~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 33456788999999999999999999999999887643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=411.34 Aligned_cols=245 Identities=26% Similarity=0.436 Sum_probs=197.8
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEec----CCeEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDE----GANMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~LV~ 635 (870)
.|.+.||+|+||.||+|.+. +..||+|++.... ....+.|.+|++++++++|||||++++++.. +...++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 35678999999999999986 7889999997653 3345679999999999999999999999864 34589999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC-CCcEEEEeccCCccccCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE-KFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~-~~~vkL~DFGla~~~~~~ 714 (870)
|||++|+|.+++.+. ..+++..+..++.||+.||+|||++ .++|+||||||+||||+. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~-- 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-- 183 (290)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC--
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC--
Confidence 999999999999643 5799999999999999999999987 224999999999999984 7999999999998542
Q ss_pred CCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccC
Q 002887 715 GGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794 (870)
Q Consensus 715 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 794 (870)
.......+||+.|||||++.+ +++.++|||||||++|||+||+.||........+.+ .+..+.....+
T Consensus 184 --~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~----~i~~~~~~~~~----- 251 (290)
T 3fpq_A 184 --ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR----RVTSGVKPASF----- 251 (290)
T ss_dssp --TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH----HHTTTCCCGGG-----
T ss_pred --CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHH----HHHcCCCCCCC-----
Confidence 123346789999999998864 699999999999999999999999976543322222 12222111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 795 GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 795 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+......+.+++.+||+.||++|||+.|+++
T Consensus 252 ---~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 ---DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122346889999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=416.76 Aligned_cols=245 Identities=23% Similarity=0.368 Sum_probs=209.2
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
+++.+.||+|+||+||+|+.. ++.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..++||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 456789999999999999986 8899999997643 23456789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++|+|.+++.+. ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+......
T Consensus 114 ~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 114 AKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 9999999999643 4799999999999999999999999 9999999999999999999999999999987544444
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
......+||+.|||||++.+..++.++||||+||++|||++|++||..........+.. .+.. .+
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~-----~~~~----------~~ 253 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII-----KLEY----------DF 253 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HTCC----------CC
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----cCCC----------CC
Confidence 45567799999999999999999999999999999999999999998765443333221 1111 12
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVV 827 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl 827 (870)
+......+.+++.+||+.||++|||++|++
T Consensus 254 p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 223345688999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=423.77 Aligned_cols=245 Identities=22% Similarity=0.299 Sum_probs=207.5
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
.+.+.||+|+||.||+|+.. ++.||||++........+.+.+|+++|++++|||||++++++.+.+..++|||||++|
T Consensus 154 ~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG 233 (423)
T 4fie_A 154 DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 233 (423)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCC
Confidence 34578999999999999986 8999999998776666778999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++.. ..+++.++..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.+... .....
T Consensus 234 ~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~ 305 (423)
T 4fie_A 234 ALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRK 305 (423)
T ss_dssp EHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS--CCCBC
T ss_pred cHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCC--Ccccc
Confidence 99998853 4699999999999999999999999 9999999999999999999999999999876432 22345
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
..+||+.|||||++.+..|+.++|||||||++|||++|++||........+..+ ..+. .+.+ ......
T Consensus 306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-----~~~~-----~~~~--~~~~~~ 373 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-----RDNL-----PPRL--KNLHKV 373 (423)
T ss_dssp CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-----HHSC-----CCCC--SCTTSS
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-----HcCC-----CCCC--cccccC
Confidence 678999999999999999999999999999999999999999865543332221 1111 1111 111233
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...+.+|+.+||+.||++|||+.|+++
T Consensus 374 s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 374 SPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 457889999999999999999999865
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=398.91 Aligned_cols=242 Identities=22% Similarity=0.362 Sum_probs=189.9
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
+.+.+.||+|+||+||+|+.. ++.||||++..... ...+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 94 (275)
T 3hyh_A 15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY 94 (275)
T ss_dssp CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 455689999999999999975 89999999976532 3346789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+ +|+|.+++.+. ..+++.++..++.|++.||+|||++ +|+||||||+|||+++++++||+|||+|+.... .
T Consensus 95 ~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---~ 165 (275)
T 3hyh_A 95 A-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---G 165 (275)
T ss_dssp C-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred C-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC---C
Confidence 9 68999988643 4799999999999999999999999 999999999999999999999999999986532 2
Q ss_pred cccccccCCCCccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
......+||+.|||||++.+..+ +.++||||+||++|||++|+.||........... .. .+.. .
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~----i~-~~~~----------~ 230 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKN----IS-NGVY----------T 230 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HH-HTCC----------C
T ss_pred CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HH-cCCC----------C
Confidence 23345789999999999998876 5799999999999999999999986543332222 11 1211 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
++......+.+++.+||+.||++|||+.|+++
T Consensus 231 ~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 12223456789999999999999999999976
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=406.04 Aligned_cols=239 Identities=25% Similarity=0.336 Sum_probs=193.9
Q ss_pred hhccccccccCcEEEEEEEE-----CCeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYL-----DDKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIY 635 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~-----~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 635 (870)
+++.+.||+|+||+||+|+. .++.||||+++.... .....+.+|+++|++++|||||++++++.+.+..++||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 45678999999999999986 267899999976532 23456889999999999999999999999999999999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
|||++|+|.+++.+. ..+++.++..++.|++.||+|||++ +|+||||||+|||+++++++||+|||+|+.....
T Consensus 106 Ey~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 179 (304)
T 3ubd_A 106 DFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH- 179 (304)
T ss_dssp CCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCC-
Confidence 999999999999643 4799999999999999999999999 9999999999999999999999999999865322
Q ss_pred CccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 716 GTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 716 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
.......+||+.|||||++.+..++.++||||+||++|||+||++||........+... . .+..
T Consensus 180 -~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i----~-~~~~---------- 243 (304)
T 3ubd_A 180 -EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI----L-KAKL---------- 243 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----H-HCCC----------
T ss_pred -CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH----H-cCCC----------
Confidence 22334578999999999999999999999999999999999999999876544333322 1 1111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTM 823 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm 823 (870)
.++......+.+++.+||+.||++|||+
T Consensus 244 ~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 1222344678899999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=391.86 Aligned_cols=247 Identities=21% Similarity=0.291 Sum_probs=186.3
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCC----------
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGA---------- 629 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~---------- 629 (870)
+++.+.||+|+||.||+|+.. ++.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 345689999999999999986 88999999976543 34567899999999999999999999986543
Q ss_pred --eEEEEEEEccCCchhhhhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEecc
Q 002887 630 --NMGLIYEFMANGNLQAHLLEDKA-DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFG 706 (870)
Q Consensus 630 --~~~LV~Ey~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFG 706 (870)
..++|||||++|+|.+++..... ...++..++.|+.||++||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCc
Confidence 36899999999999999975432 4466778899999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCcc----------ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002887 707 LSRIFPVEGGTH----------VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWV 776 (870)
Q Consensus 707 la~~~~~~~~~~----------~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~ 776 (870)
+|+.+....... ..+..+||+.|||||++.+..++.++|||||||++|||++ ||..... .... .
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--~~~~-~ 237 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--RVRT-L 237 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--HHHH-H
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--HHHH-H
Confidence 998764332111 1234579999999999999999999999999999999997 6653211 1111 1
Q ss_pred HHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 777 SSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 777 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
. ......... ........+.+++.+||+.||++|||+.|+++
T Consensus 238 ~-~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 238 T-DVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp H-HHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H-HHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 111111110 01233345678999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=378.20 Aligned_cols=268 Identities=42% Similarity=0.719 Sum_probs=235.6
Q ss_pred cccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCchh
Q 002887 566 ERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQ 644 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 644 (870)
.+.||+|+||.||+|++. ++.||||++........+.+.+|++++++++||||+++++++.+....++||||+++|+|.
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 123 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence 478999999999999986 8899999998776667788999999999999999999999999999999999999999999
Q ss_pred hhhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 645 AHLLEDKA--DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 645 ~~l~~~~~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
+++..... ..++|..++.++.|+++||+|||++ +|+||||||+||++++++.+||+|||+++.............
T Consensus 124 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 200 (321)
T 2qkw_B 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200 (321)
T ss_dssp GGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCC
T ss_pred HHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccccccccc
Confidence 99865432 3599999999999999999999998 999999999999999999999999999986543333333445
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCc--cchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQ--RTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~--~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
..||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......|.......+.+..++++.+......+
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (321)
T 2qkw_B 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE 280 (321)
T ss_dssp CEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHH
T ss_pred cCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHH
Confidence 5689999999999999999999999999999999999999976542 33456676666777777888888887777888
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
....+.+++.+|++.+|++|||+.||++.|++++..
T Consensus 281 ~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 281 SLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp HHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 999999999999999999999999999999998754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=386.04 Aligned_cols=259 Identities=19% Similarity=0.300 Sum_probs=201.7
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEec------CCeEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDE------GANMG 632 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------~~~~~ 632 (870)
+.+.+.||+|+||.||+|+.. |+.||||+++... ....+.+.+|+++|++++|||||++++++.. ....+
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence 345689999999999999986 8999999997543 2345678899999999999999999998753 36789
Q ss_pred EEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCcccc
Q 002887 633 LIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 712 (870)
Q Consensus 633 LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~ 712 (870)
+|||||+ |+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 136 ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 136 VVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 9999996 679988864 35799999999999999999999999 99999999999999999999999999998763
Q ss_pred CCC--CccccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCC-----
Q 002887 713 VEG--GTHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGD----- 784 (870)
Q Consensus 713 ~~~--~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~----- 784 (870)
... ........+||+.|||||++.+. .++.++||||+||++|||++|++||.+......+..+.........
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 321 12234567899999999998875 4699999999999999999999999877655554444332211100
Q ss_pred -----cchhcccccCC--CCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 785 -----IKNIVDHRLQG--DFD-----TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 785 -----~~~i~d~~l~~--~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
....+. .+.. ..+ ......+.+|+.+||+.||++|||+.|+++
T Consensus 290 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 290 VGAERVRAYIQ-SLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp ----CHHHHHH-SSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhh-cCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 0000 001 112356789999999999999999999876
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=380.41 Aligned_cols=282 Identities=41% Similarity=0.726 Sum_probs=244.4
Q ss_pred cccCHHHHHHHHhhc--cccccccCcEEEEEEEEC-CeeEEEEEeeccchh-hhHHHHHHHHHHHHhccccceeEEEEEe
Q 002887 551 RKFSYFDVLKITNNF--ERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQ-GYKQFQAEVELLIRAHHKNLTILVGYCD 626 (870)
Q Consensus 551 ~~~~~~dl~~~t~~f--~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~ 626 (870)
..+++.++..+..+| .+.||+|+||.||+|... ++.||||++...... ....+.+|++++++++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 567788888777766 479999999999999875 889999999765432 3347899999999999999999999999
Q ss_pred cCCeEEEEEEEccCCchhhhhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEe
Q 002887 627 EGANMGLIYEFMANGNLQAHLLEDKA--DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLAD 704 (870)
Q Consensus 627 ~~~~~~LV~Ey~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~D 704 (870)
.....++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+.++|+||||||+|||+++++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 99999999999999999999976432 4599999999999999999999998777999999999999999999999999
Q ss_pred ccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCC----CCccchHHHHHHHHh
Q 002887 705 FGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK----TPQRTLIGQWVSSML 780 (870)
Q Consensus 705 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~----~~~~~~l~~~~~~~~ 780 (870)
||+++..... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.. .........|+....
T Consensus 178 fg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 178 FGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CSSCEECCSS-SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred CccccccCcc-cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 9999876322 22334456699999999999998999999999999999999999999962 334456778888888
Q ss_pred hcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 781 ARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 781 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
.......+.+..+...........+.+++.+|++.+|++|||+.||+++|++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 88888888888888888889999999999999999999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=378.39 Aligned_cols=256 Identities=22% Similarity=0.304 Sum_probs=194.1
Q ss_pred hhccccccccCcEEEEEEEEC-----CeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-----DKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-----~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
+.+.+.||+|+||+||+|+.+ ++.||||++.... ...++.+|+++|+++ +||||+++++++.+.++.++|||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE 100 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP 100 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence 345689999999999999863 5789999987653 235678999999998 69999999999999999999999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC-CcEEEEeccCCccccCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK-FQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~-~~vkL~DFGla~~~~~~~ 715 (870)
|+++|+|.+++. .+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+......
T Consensus 101 ~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 101 YLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp CCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred CCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 999999999883 588999999999999999999999 99999999999999877 799999999998653221
Q ss_pred C--------------------------ccccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCc
Q 002887 716 G--------------------------THVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQ 768 (870)
Q Consensus 716 ~--------------------------~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~ 768 (870)
. .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 1 0112345799999999999875 589999999999999999999999965543
Q ss_pred c-chHHHHHHHH-----------hhc----------CCcchhcc---------cccC---------CCCCHHHHHHHHHH
Q 002887 769 R-TLIGQWVSSM-----------LAR----------GDIKNIVD---------HRLQ---------GDFDTNTVWKAVEI 808 (870)
Q Consensus 769 ~-~~l~~~~~~~-----------~~~----------~~~~~i~d---------~~l~---------~~~~~~~~~~l~~l 808 (870)
. ..+..+..-. ... ........ +.+. .........++.+|
T Consensus 253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 2 2222221100 000 00000000 0000 00011233567899
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 002887 809 ALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 809 ~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+.+||+.||++|||++|+++
T Consensus 333 l~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 333 LDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHCcCChhHCcCHHHHhc
Confidence 99999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=363.17 Aligned_cols=280 Identities=36% Similarity=0.667 Sum_probs=234.6
Q ss_pred ccccCHHHHHHHHhhcc--------ccccccCcEEEEEEEECCeeEEEEEeeccc----hhhhHHHHHHHHHHHHhcccc
Q 002887 550 NRKFSYFDVLKITNNFE--------RVLGKGGFGTVYHGYLDDKQVAVKMLSSSS----VQGYKQFQAEVELLIRAHHKN 617 (870)
Q Consensus 550 ~~~~~~~dl~~~t~~f~--------~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~----~~~~~~f~~Ei~~l~~l~H~n 617 (870)
...|++.++.+++.+|. +.||+|+||.||+|..+++.||||++.... ....+.+.+|++++++++|||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 36789999999999886 569999999999999999999999987532 234567899999999999999
Q ss_pred ceeEEEEEecCCeEEEEEEEccCCchhhhhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC
Q 002887 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDK-ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE 696 (870)
Q Consensus 618 Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~ 696 (870)
|+++++++.+....++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+. +|+||||||+||++++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 9999999999999999999999999999986543 35699999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002887 697 KFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWV 776 (870)
Q Consensus 697 ~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~ 776 (870)
++.+||+|||+++...............|++.|+|||.+.+ .++.++||||||+++|||++|++||........+..+.
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 99999999999987643333333445679999999998864 58899999999999999999999998766555444444
Q ss_pred HHHhhc-CCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 777 SSMLAR-GDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 777 ~~~~~~-~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
...... ..+.+.+++.+. .........+.+++.+|++.+|++|||+.||++.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 248 EEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 433322 223445555442 345677888999999999999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=400.04 Aligned_cols=248 Identities=20% Similarity=0.301 Sum_probs=207.9
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.+.||+|+||.||+|+.. ++.||+|++........+.+.+|+++|++++|||||++++++.+....++|||||++
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g 238 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence 356689999999999999986 889999999887666677899999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC--CcEEEEeccCCccccCCCCcc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK--FQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~--~~vkL~DFGla~~~~~~~~~~ 718 (870)
|+|.+++... ...+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.+... .
T Consensus 239 g~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~---~ 311 (573)
T 3uto_A 239 GELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---Q 311 (573)
T ss_dssp CBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT---S
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC---C
Confidence 9999988643 34799999999999999999999999 99999999999999854 89999999999976322 2
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
.....+||+.|||||++.+..++.++||||+||++|||++|++||.+......+... . .+.. .+.....
T Consensus 312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i----~-~~~~------~~~~~~~ 380 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV----K-SCDW------NMDDSAF 380 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH----H-TTCC------CCCSGGG
T ss_pred ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH----H-hCCC------CCCcccc
Confidence 334568999999999999999999999999999999999999999876554433222 1 1110 0000011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
......+.+|+.+||+.||++|||+.|+++
T Consensus 381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 381 SGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 123456789999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=361.96 Aligned_cols=256 Identities=31% Similarity=0.489 Sum_probs=203.2
Q ss_pred hccccccccCcEEEEEEEECCeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 564 NFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
.+.+.||+|+||.||+|+..++.||||++.... ....+++.+|++++++++||||+++++++......++||||+++|
T Consensus 40 ~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 119 (309)
T 3p86_A 40 NIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119 (309)
T ss_dssp EEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTC
T ss_pred eeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCC
Confidence 446799999999999999999999999997653 334567899999999999999999999999999999999999999
Q ss_pred chhhhhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCCC--ceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 642 NLQAHLLEDKA-DTLCWERRLQIASESAQGLEYLHNGCKPP--IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 642 sL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
+|.+++..... ..+++..++.++.|+++||+|||+. + |+||||||+|||+++++.+||+|||+++..... ..
T Consensus 120 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~ 194 (309)
T 3p86_A 120 SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST--FL 194 (309)
T ss_dssp BHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------------
T ss_pred cHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc--cc
Confidence 99999875432 3599999999999999999999998 7 999999999999999999999999999754221 22
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ...... ....+
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~----~~~~~~---------~~~~~ 261 (309)
T 3p86_A 195 SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA----VGFKCK---------RLEIP 261 (309)
T ss_dssp -------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH----HHHSCC---------CCCCC
T ss_pred ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhcCC---------CCCCC
Confidence 23456799999999999999999999999999999999999999986554332211 111110 11222
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHh
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e 837 (870)
......+.+++.+|++.+|++|||+.|+++.|++++...
T Consensus 262 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 334457889999999999999999999999999877543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=368.12 Aligned_cols=257 Identities=28% Similarity=0.455 Sum_probs=213.3
Q ss_pred hccccccccCcEEEEEEEEC---------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD---------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMG 632 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~---------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 632 (870)
.+.+.||+|+||.||+|... +..||||+++... ....+.+.+|+++++++ +||||++++++|......+
T Consensus 84 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ 163 (370)
T 2psq_A 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 163 (370)
T ss_dssp EEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCE
T ss_pred EeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEE
Confidence 45679999999999999862 3569999997653 34457799999999999 8999999999999999999
Q ss_pred EEEEEccCCchhhhhhhccc--------------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC
Q 002887 633 LIYEFMANGNLQAHLLEDKA--------------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF 698 (870)
Q Consensus 633 LV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~ 698 (870)
+||||+++|+|.+++..... ..+++..++.++.|+++||+|||++ +|+||||||+|||++.++
T Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~ 240 (370)
T 2psq_A 164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENN 240 (370)
T ss_dssp EEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTC
T ss_pred EEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCCC
Confidence 99999999999999976432 3589999999999999999999998 999999999999999999
Q ss_pred cEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHH
Q 002887 699 QAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVS 777 (870)
Q Consensus 699 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~ 777 (870)
.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...........
T Consensus 241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~--- 317 (370)
T 2psq_A 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL--- 317 (370)
T ss_dssp CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---
T ss_pred CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---
Confidence 999999999987643333333344567889999999999999999999999999999999 9999987654433221
Q ss_pred HHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHh
Q 002887 778 SMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837 (870)
Q Consensus 778 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e 837 (870)
+..+. ....+......+.+++.+||+.+|++||++.|+++.|++++...
T Consensus 318 --~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 318 --LKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp --HHTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --HhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 11111 11122334567889999999999999999999999999987653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=388.68 Aligned_cols=244 Identities=25% Similarity=0.348 Sum_probs=196.1
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHH---HHHHHHhccccceeEEEEEecCCeEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAE---VELLIRAHHKNLTILVGYCDEGANMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~E---i~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 635 (870)
.+.+.||+|+||.||+|+.. ++.||||++.+... .......+| +.+++.++|||||++++++.+.+..++||
T Consensus 192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVm 271 (689)
T 3v5w_A 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 271 (689)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEE
Confidence 45689999999999999986 88999999976432 122233344 55566678999999999999999999999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
|||+||+|.++|.+. ..+++..+..++.||+.||+|||++ +||||||||+||||+.+|++||+|||+|+.+...
T Consensus 272 Ey~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~- 345 (689)
T 3v5w_A 272 DLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 345 (689)
T ss_dssp CCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCC-
Confidence 999999999999653 4699999999999999999999998 9999999999999999999999999999876332
Q ss_pred CccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccC
Q 002887 716 GTHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794 (870)
Q Consensus 716 ~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 794 (870)
.....+||+.|||||++.. ..|+.++|+||+||++|||++|++||........ .+....... ..
T Consensus 346 ---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-~~i~~~i~~-~~---------- 410 (689)
T 3v5w_A 346 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLT-MA---------- 410 (689)
T ss_dssp ---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-HHHHHHHHH-CC----------
T ss_pred ---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhhcC-CC----------
Confidence 2345689999999999975 5799999999999999999999999975433221 121222111 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002887 795 GDFDTNTVWKAVEIALACIHTISTRRPT-----MNQVVI 828 (870)
Q Consensus 795 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~ 828 (870)
..++......+.+|+.+||+.||++|++ +.||.+
T Consensus 411 ~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1122334567889999999999999998 677754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=357.04 Aligned_cols=257 Identities=27% Similarity=0.388 Sum_probs=209.3
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
.+.+.||+|+||.||+|... ++.||+|++........+.|.+|++++++++||||+++++++.++...++||||+++|
T Consensus 13 ~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 92 (310)
T 3s95_A 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGG 92 (310)
T ss_dssp EEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCC
Confidence 34579999999999999986 8899999997776677788999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc---
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH--- 718 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~--- 718 (870)
+|.+++... ...+++.+++.++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 93 ~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 168 (310)
T 3s95_A 93 TLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168 (310)
T ss_dssp BHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred cHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence 999998653 35699999999999999999999998 99999999999999999999999999998763322111
Q ss_pred ---------ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhc
Q 002887 719 ---------VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIV 789 (870)
Q Consensus 719 ---------~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~ 789 (870)
......||+.|+|||++.+..++.++||||||+++|||++|..|+........... .......
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~--------~~~~~~~ 240 (310)
T 3s95_A 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG--------LNVRGFL 240 (310)
T ss_dssp -----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS--------BCHHHHH
T ss_pred ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh--------hhhhccc
Confidence 11145799999999999999999999999999999999999999875432111000 0000011
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 790 DHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 790 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
+... +......+.+++.+|++.+|++|||+.|+++.|+++...
T Consensus 241 ~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 241 DRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp HHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1111 122234578999999999999999999999999987643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=360.70 Aligned_cols=264 Identities=26% Similarity=0.369 Sum_probs=207.7
Q ss_pred hccccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCC----eEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGA----NMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~LV~Ey~~ 639 (870)
.+.+.||+|+||.||+|++.++.||||++..... ....++.|+.++++++||||+++++++.... ..++||||++
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~ 105 (322)
T 3soc_A 27 QLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHE 105 (322)
T ss_dssp EEEEEEECSTTCEEEEEEETTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred hhhheecccCceEEEEEEECCCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCC
Confidence 3457999999999999999999999999976533 3345677899999999999999999997744 4799999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhC-------CCCCceeCCCCCCCEEEcCCCcEEEEeccCCcccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNG-------CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 712 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-------~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~ 712 (870)
+|+|.+++.. ..+++..+..++.|+++||+|||+. ++++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 106 ~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~ 182 (322)
T 3soc_A 106 KGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182 (322)
T ss_dssp TCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEEC
T ss_pred CCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccc
Confidence 9999999954 4599999999999999999999975 23489999999999999999999999999998765
Q ss_pred CCCCccccccccCCCCccCccccccC-----CCCccchHHHHHHHHHHHHhCCCCCCCCCccc------------hHHHH
Q 002887 713 VEGGTHVSTTVVGTPGYLDPEYYISN-----RLTEKSDVYSFGVVLLELITGQPVIQKTPQRT------------LIGQW 775 (870)
Q Consensus 713 ~~~~~~~~~~~~gt~~y~APE~~~~~-----~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~------------~l~~~ 775 (870)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....+
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (322)
T 3soc_A 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDM 262 (322)
T ss_dssp TTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHH
T ss_pred cccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhh
Confidence 44333334456799999999999863 45678999999999999999999997643211 11111
Q ss_pred HHHHhhcCCcchhcccccCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 776 VSSMLARGDIKNIVDHRLQGDF-DTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 776 ~~~~~~~~~~~~i~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
........ . .+.+.... .......+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 263 ~~~~~~~~-~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 263 QEVVVHKK-K----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHTTSC-C----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhhccc-C----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11111111 1 11111111 224567799999999999999999999999999987653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=352.61 Aligned_cols=245 Identities=22% Similarity=0.339 Sum_probs=205.6
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
.+.+.||+|+||.||+|... ++.||||++........+.+.+|+.++++++||||+++++++..++..++||||+++|
T Consensus 23 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (297)
T 3fxz_A 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 102 (297)
T ss_dssp CCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCC
Confidence 34578999999999999864 8899999998776666778899999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++.+ ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... ....
T Consensus 103 ~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 174 (297)
T 3fxz_A 103 SLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRS 174 (297)
T ss_dssp BHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCBC
T ss_pred CHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--cccC
Confidence 99999854 3589999999999999999999998 99999999999999999999999999998764322 2234
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
...||+.|+|||++.+..++.++|||||||++|||++|+.||............ ...+.. ........
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~----~~~~~~--------~~~~~~~~ 242 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI----ATNGTP--------ELQNPEKL 242 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----HHHCSC--------CCSCGGGS
T ss_pred CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhCCCC--------CCCCcccc
Confidence 567999999999999999999999999999999999999999765543322221 111110 01112234
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...+.+++.+|++.||++|||+.|+++
T Consensus 243 ~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 243 SAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 556889999999999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=354.12 Aligned_cols=261 Identities=21% Similarity=0.285 Sum_probs=213.4
Q ss_pred ccccccCHHHHHHHHhh------------ccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHh
Q 002887 548 LENRKFSYFDVLKITNN------------FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRA 613 (870)
Q Consensus 548 ~~~~~~~~~dl~~~t~~------------f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l 613 (870)
.....+++.++.+++.. ..+.||+|+||.||+|+.. ++.||||++........+.+.+|+.+++++
T Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l 99 (321)
T 2c30_A 20 FQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY 99 (321)
T ss_dssp -----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC
T ss_pred ecCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC
Confidence 34456788888887754 2358999999999999985 889999999877666677899999999999
Q ss_pred ccccceeEEEEEecCCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEE
Q 002887 614 HHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANIL 693 (870)
Q Consensus 614 ~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NIL 693 (870)
+||||+++++++......++||||+++|+|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+|||
T Consensus 100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 173 (321)
T 2c30_A 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence 999999999999999999999999999999998853 4689999999999999999999998 9999999999999
Q ss_pred EcCCCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHH
Q 002887 694 LNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIG 773 (870)
Q Consensus 694 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~ 773 (870)
++.++.+||+|||++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~ 251 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 251 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred ECCCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999998764321 22345679999999999999999999999999999999999999997654332221
Q ss_pred HHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 774 QWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 774 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
. .. ... .+.+ .........+.+++.+|++.+|++|||+.|+++
T Consensus 252 ~----~~-~~~-----~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 252 R----LR-DSP-----PPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp H----HH-HSS-----CCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred H----Hh-cCC-----CCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 11 111 1111 111233456889999999999999999999976
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=360.29 Aligned_cols=258 Identities=29% Similarity=0.409 Sum_probs=210.0
Q ss_pred hhccccccccCcEEEEEEEEC-------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCe-EE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGAN-MG 632 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~-~~ 632 (870)
+.+.+.||+|+||.||+|++. ++.||||++.... ....+.+.+|++++.++ +||||+++++++.+... .+
T Consensus 24 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~ 103 (359)
T 3vhe_A 24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 103 (359)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred eeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceE
Confidence 345689999999999999842 4789999998653 33456799999999999 89999999999987554 89
Q ss_pred EEEEEccCCchhhhhhhccc------------------------------------------------------------
Q 002887 633 LIYEFMANGNLQAHLLEDKA------------------------------------------------------------ 652 (870)
Q Consensus 633 LV~Ey~~~gsL~~~l~~~~~------------------------------------------------------------ 652 (870)
+||||+++|+|.+++.....
T Consensus 104 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (359)
T 3vhe_A 104 VIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE 183 (359)
T ss_dssp EEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------
T ss_pred EEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccccc
Confidence 99999999999999876432
Q ss_pred ----ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccccccCCCC
Q 002887 653 ----DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPG 728 (870)
Q Consensus 653 ----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~ 728 (870)
..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...............||+.
T Consensus 184 ~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~ 260 (359)
T 3vhe_A 184 DLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260 (359)
T ss_dssp CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred chhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCce
Confidence 1289999999999999999999999 999999999999999999999999999987644443344455678999
Q ss_pred ccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHH
Q 002887 729 YLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVE 807 (870)
Q Consensus 729 y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~ 807 (870)
|+|||++.+..++.++|||||||++|||++ |+.||............+ ..+.. ..........+.+
T Consensus 261 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~----~~~~~---------~~~~~~~~~~l~~ 327 (359)
T 3vhe_A 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----KEGTR---------MRAPDYTTPEMYQ 327 (359)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH----HHTCC---------CCCCTTCCHHHHH
T ss_pred eEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHH----HcCCC---------CCCCCCCCHHHHH
Confidence 999999999999999999999999999998 999998765433332221 11111 1112233456889
Q ss_pred HHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 808 IALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 808 l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
++.+|++.+|++|||+.||++.|++++..
T Consensus 328 li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 328 TMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 99999999999999999999999997743
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=357.09 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=208.1
Q ss_pred hccccccccCcEEEEEEEEC-----CeeEEEEEeecc-chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD-----DKQVAVKMLSSS-SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-----~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.+.||+|+||.||+|.+. +..||||++... .....+.|.+|++++++++||||+++++++.++...++||||
T Consensus 52 ~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 131 (325)
T 3kul_A 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEY 131 (325)
T ss_dssp EEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEEC
T ss_pred EEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeC
Confidence 44578999999999999984 456999999865 334457799999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 132 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 207 (325)
T 3kul_A 132 MENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207 (325)
T ss_dssp CTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----C
T ss_pred CCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCccc
Confidence 9999999998543 34699999999999999999999998 9999999999999999999999999999876433221
Q ss_pred -cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 718 -HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 718 -~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||............ . .+ ...
T Consensus 208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~----~-~~---------~~~ 273 (325)
T 3kul_A 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV----E-EG---------YRL 273 (325)
T ss_dssp CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH----H-TT---------CCC
T ss_pred eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH----H-cC---------CCC
Confidence 12233456788999999999999999999999999999999 99999765543322221 1 11 111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
.........+.+++.+|++.+|++|||+.||+++|++++..
T Consensus 274 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 274 PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 22234456788999999999999999999999999997643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=364.35 Aligned_cols=259 Identities=30% Similarity=0.451 Sum_probs=213.9
Q ss_pred hhccccccccCcEEEEEEEEC---------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD---------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANM 631 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~---------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 631 (870)
..+.+.||+|+||.||+|+.. +..||||++.... ....+++.+|+++++++ +||||+++++++......
T Consensus 71 y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 150 (382)
T 3tt0_A 71 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 150 (382)
T ss_dssp EEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred eEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCce
Confidence 345689999999999999863 2579999997653 34457789999999999 999999999999999999
Q ss_pred EEEEEEccCCchhhhhhhccc--------------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC
Q 002887 632 GLIYEFMANGNLQAHLLEDKA--------------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK 697 (870)
Q Consensus 632 ~LV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~ 697 (870)
++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|||++++
T Consensus 151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 227 (382)
T 3tt0_A 151 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTED 227 (382)
T ss_dssp EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT
T ss_pred EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcCC
Confidence 999999999999999976542 4599999999999999999999998 99999999999999999
Q ss_pred CcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHH
Q 002887 698 FQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWV 776 (870)
Q Consensus 698 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~ 776 (870)
+.+||+|||+++...............+|+.|+|||++.+..++.++|||||||+++||++ |+.||..........
T Consensus 228 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~--- 304 (382)
T 3tt0_A 228 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--- 304 (382)
T ss_dssp CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH---
T ss_pred CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---
Confidence 9999999999987644333333445567889999999999999999999999999999999 999997655332221
Q ss_pred HHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHhH
Q 002887 777 SSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAMEI 838 (870)
Q Consensus 777 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e~ 838 (870)
.+..+. ...........+.+++.+||+.+|++|||+.||++.|++++....
T Consensus 305 --~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 305 --LLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp --HHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred --HHHcCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 111121 111122344578899999999999999999999999999876543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=371.10 Aligned_cols=250 Identities=27% Similarity=0.427 Sum_probs=209.7
Q ss_pred hccccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCC-eEEEEEEEccCCc
Q 002887 564 NFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGA-NMGLIYEFMANGN 642 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~LV~Ey~~~gs 642 (870)
.+.+.||+|+||.||+|.+.++.||||+++... ..+.|.+|++++++++||||+++++++.+.. ..++||||+++|+
T Consensus 196 ~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~ 273 (450)
T 1k9a_A 196 KLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 273 (450)
T ss_dssp EEEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCB
T ss_pred EEEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCc
Confidence 345799999999999999999999999998654 4578999999999999999999999987665 7899999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.+++.......+++..++.++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++..... ...
T Consensus 274 L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~ 345 (450)
T 1k9a_A 274 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDT 345 (450)
T ss_dssp HHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC----------
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----ccC
Confidence 99999876555689999999999999999999998 9999999999999999999999999999854211 123
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
..+++.|+|||++.+..++.++|||||||++|||++ |+.||........... +..+. ....+...
T Consensus 346 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-----i~~~~---------~~~~p~~~ 411 (450)
T 1k9a_A 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-----VEKGY---------KMDAPDGC 411 (450)
T ss_dssp -CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH-----HHTTC---------CCCCCTTC
T ss_pred CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCC---------CCCCCCcC
Confidence 367889999999999999999999999999999998 9999987654433221 11221 11223345
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHh
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e 837 (870)
+..+.+++.+||+.+|++|||+.|+++.|+++...+
T Consensus 412 ~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 412 PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 567889999999999999999999999999876543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=349.17 Aligned_cols=257 Identities=26% Similarity=0.335 Sum_probs=200.9
Q ss_pred hccccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHH--hccccceeEEEEEec----CCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIR--AHHKNLTILVGYCDE----GANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~----~~~~~LV~Ey 637 (870)
.+.+.||+|+||.||+|+.+++.||||++.... ...+..|.+++.. ++||||+++++++.. ....++||||
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~ 87 (301)
T 3q4u_A 11 TLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHY 87 (301)
T ss_dssp EEEEEEEECSSEEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred EEEEeeccCCCcEEEEEEECCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhh
Confidence 456899999999999999999999999986543 3456677777777 799999999998644 3458899999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHH--------hCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH--------NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 709 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH--------~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~ 709 (870)
+++|+|.+++. ...+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 161 (301)
T 3q4u_A 88 HEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLAV 161 (301)
T ss_dssp CTTCBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ccCCCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCee
Confidence 99999999994 346999999999999999999999 66 99999999999999999999999999998
Q ss_pred cccCCCCcc--ccccccCCCCccCccccccC------CCCccchHHHHHHHHHHHHhC----------CCCCCCCCccc-
Q 002887 710 IFPVEGGTH--VSTTVVGTPGYLDPEYYISN------RLTEKSDVYSFGVVLLELITG----------QPVIQKTPQRT- 770 (870)
Q Consensus 710 ~~~~~~~~~--~~~~~~gt~~y~APE~~~~~------~~~~ksDVwS~GvvL~elltG----------~~p~~~~~~~~- 770 (870)
......... ......||+.|+|||++.+. .++.++|||||||++|||++| +.||.......
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~ 241 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc
Confidence 664332221 12334799999999999876 455799999999999999999 88886543222
Q ss_pred hHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 771 LIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 771 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
............+....+.. ..........+.+++.+||+.+|++|||+.||+++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 242 SFEDMRKVVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CHHHHHHHHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred chhhhhHHHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 22222222211111111100 011235678899999999999999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=364.69 Aligned_cols=257 Identities=27% Similarity=0.407 Sum_probs=210.0
Q ss_pred hccccccccCcEEEEEEEEC-------CeeEEEEEeecc-chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSS-SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 635 (870)
.+.+.||+|+||.||+|.+. ++.||||++... ......++.+|+.++++++||||+++++++......++||
T Consensus 74 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 153 (367)
T 3l9p_A 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILL 153 (367)
T ss_dssp EEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEE
Confidence 45688999999999999953 568999999754 3344567899999999999999999999999999999999
Q ss_pred EEccCCchhhhhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC---cEEEEeccC
Q 002887 636 EFMANGNLQAHLLEDKA-----DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF---QAKLADFGL 707 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~---~vkL~DFGl 707 (870)
||+++|+|.+++..... ..+++..++.++.|+++||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 154 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG~ 230 (367)
T 3l9p_A 154 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230 (367)
T ss_dssp ECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred EeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence 99999999999976432 4599999999999999999999999 999999999999999555 599999999
Q ss_pred CccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcc
Q 002887 708 SRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIK 786 (870)
Q Consensus 708 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~ 786 (870)
++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||........... .. .+.
T Consensus 231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~----i~-~~~-- 303 (367)
T 3l9p_A 231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF----VT-SGG-- 303 (367)
T ss_dssp HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH----HH-TTC--
T ss_pred ccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HH-cCC--
Confidence 986533322333345578999999999999999999999999999999998 9999986554332211 11 111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHh
Q 002887 787 NIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837 (870)
Q Consensus 787 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e 837 (870)
...........+.+++.+||+.+|++||++.||++.|+.+....
T Consensus 304 -------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 304 -------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred -------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 11112234456889999999999999999999999999876543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=355.69 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=202.1
Q ss_pred hccccccccCcEEEEEEEEC--Ce----eEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DK----QVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~----~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
.+.+.||+|+||.||+|++. ++ .||+|.+.... ....+++.+|++++++++||||++++++|.... .++|+|
T Consensus 18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e 96 (327)
T 3poz_A 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQ 96 (327)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEE
T ss_pred ccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEE
Confidence 34579999999999999974 33 36888876543 345578999999999999999999999998754 789999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
|+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 97 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 97 LMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp CCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred ecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence 999999999987543 5689999999999999999999998 999999999999999999999999999987654443
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......... .. +..+. ..
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~----~~~~~---------~~ 238 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI----LEKGE---------RL 238 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HH----HHTTC---------CC
T ss_pred cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-HH----HHcCC---------CC
Confidence 333445567889999999999999999999999999999999 99999876544322 11 11111 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
.........+.+++.+||+.+|++||++.|++++|+.+...
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 239 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 22233455788999999999999999999999999987643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=366.73 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=207.5
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
.+.+.||+|+||.||+|.+. ++.||||+++... ....++|.+|++++++++||||++++++|......++||||+++
T Consensus 117 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 196 (377)
T 3cbl_A 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 196 (377)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred EEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCC
Confidence 45689999999999999986 8899999987653 23456789999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++...........
T Consensus 197 g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~ 272 (377)
T 3cbl_A 197 GDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272 (377)
T ss_dssp CBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence 9999998643 34689999999999999999999998 9999999999999999999999999999864221111111
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
....+++.|+|||.+.++.++.++|||||||++|||++ |+.||........ ...+..+. ....+.
T Consensus 273 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~-----~~~~~~~~---------~~~~~~ 338 (377)
T 3cbl_A 273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-----REFVEKGG---------RLPCPE 338 (377)
T ss_dssp SCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH-----HHHHHTTC---------CCCCCT
T ss_pred CCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-----HHHHHcCC---------CCCCCC
Confidence 12235678999999999999999999999999999998 9999986543321 11222221 111223
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
..+..+.+++.+||+.+|++|||+.+|++.|+++..
T Consensus 339 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 339 LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 345678899999999999999999999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=354.65 Aligned_cols=243 Identities=23% Similarity=0.397 Sum_probs=203.4
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.+.+.||+|+||.||+|... ++.||||++.... ....+.+.+|++++++++||||+++++++......++||||++
T Consensus 18 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 97 (328)
T 3fe3_A 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYAS 97 (328)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCC
Confidence 34579999999999999984 8899999997653 3445678899999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...... ..
T Consensus 98 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~---~~ 169 (328)
T 3fe3_A 98 GGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GK 169 (328)
T ss_dssp TCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS---CG
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC---Cc
Confidence 99999998654 4689999999999999999999998 9999999999999999999999999999866322 23
Q ss_pred cccccCCCCccCccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 720 STTVVGTPGYLDPEYYISNRLT-EKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~~~-~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
.....||+.|+|||++.+..+. .++||||+||++|||++|+.||........... .. .+.. ..+
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~----i~-~~~~----------~~p 234 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER----VL-RGKY----------RIP 234 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HH-HCCC----------CCC
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHH----HH-hCCC----------CCC
Confidence 4556899999999999988765 799999999999999999999987554332221 11 1111 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
......+.+++.+|++.||++|||+.|+++.
T Consensus 235 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 235 FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2234567899999999999999999999763
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=348.46 Aligned_cols=260 Identities=27% Similarity=0.427 Sum_probs=205.6
Q ss_pred hhccccccccCcEEEEEEEE------CCeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEec--CCeEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYL------DDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDE--GANMGLI 634 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~------~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~LV 634 (870)
+.+.+.||+|+||.||+|++ .++.||||++........+.+.+|++++++++||||+++++++.. ....++|
T Consensus 12 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 91 (295)
T 3ugc_A 12 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 91 (295)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEE
T ss_pred hhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEE
Confidence 34568999999999999985 378999999988776777889999999999999999999999854 3568999
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 92 MEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp EECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred EEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence 99999999999986543 4699999999999999999999998 9999999999999999999999999999876433
Q ss_pred CCc-cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCcc-----------chHHHHHHHHhhc
Q 002887 715 GGT-HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQR-----------TLIGQWVSSMLAR 782 (870)
Q Consensus 715 ~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~-----------~~l~~~~~~~~~~ 782 (870)
... .......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ............
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 246 (295)
T 3ugc_A 168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK- 246 (295)
T ss_dssp --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH-
T ss_pred cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh-
Confidence 221 1223345777899999999999999999999999999999999988643211 000001111111
Q ss_pred CCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 783 GDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 783 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
.......+......+.+++.+||+.+|++|||+.|++++|+++..
T Consensus 247 --------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 247 --------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp --------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 111122233455678999999999999999999999999998753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=348.64 Aligned_cols=258 Identities=26% Similarity=0.380 Sum_probs=213.6
Q ss_pred hhccccccccCcEEEEEEEE-------CCeeEEEEEeeccch-hhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYL-------DDKQVAVKMLSSSSV-QGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGL 633 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~-------~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~L 633 (870)
+.+.+.||+|+||.||+|+. .++.||||++..... ...+.+.+|+++++++ +||||+++++++......++
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 104 (313)
T 1t46_A 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 104 (313)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred hhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEE
Confidence 34568999999999999985 257899999986533 3457789999999999 99999999999999999999
Q ss_pred EEEEccCCchhhhhhhccc----------------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC
Q 002887 634 IYEFMANGNLQAHLLEDKA----------------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK 697 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~ 697 (870)
||||+++|+|.+++..... ..+++..++.++.|+++||+|||+. +|+||||||+||+++++
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG 181 (313)
T ss_dssp EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETT
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCC
Confidence 9999999999999876542 2489999999999999999999998 99999999999999999
Q ss_pred CcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHH
Q 002887 698 FQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWV 776 (870)
Q Consensus 698 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~ 776 (870)
+.+||+|||+++...............+++.|+|||++.+..++.++||||||++++||++ |+.||..........+..
T Consensus 182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 261 (313)
T 1t46_A 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261 (313)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHh
Confidence 9999999999987654433333344567889999999999999999999999999999999 999998765443333222
Q ss_pred HHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 777 SSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 777 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
.. +. ...........+.+++.+|++.+|++|||+.|++++|++++..
T Consensus 262 ~~----~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 262 KE----GF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp HH----TC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cc----CC---------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 21 11 1111223346788999999999999999999999999987643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=343.63 Aligned_cols=252 Identities=26% Similarity=0.436 Sum_probs=208.6
Q ss_pred hccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 564 NFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
.+.+.||+|+||.||+|... ++.||+|++..... ..+++.+|++++++++||||+++++++.+....++||||+++|+
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (269)
T 4hcu_A 13 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 91 (269)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred eeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCc
Confidence 45679999999999999985 88899999986543 34678999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++..... .......
T Consensus 92 L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 166 (269)
T 4hcu_A 92 LSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTG 166 (269)
T ss_dssp HHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHSTTS
T ss_pred HHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc-ccccccC
Confidence 99998653 34689999999999999999999998 9999999999999999999999999999865321 1112234
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
..+++.|+|||++.+..++.++||||+|++++||++ |+.||............ . .+ .....+...
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~----~-~~---------~~~~~~~~~ 232 (269)
T 4hcu_A 167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI----S-TG---------FRLYKPRLA 232 (269)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH----H-TT---------CCCCCCTTS
T ss_pred cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH----h-cC---------ccCCCCCcC
Confidence 456788999999999999999999999999999999 99999865543322221 1 11 011112223
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
...+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 233 ~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 233 STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 4568899999999999999999999999999764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=363.25 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=198.1
Q ss_pred hccccccccCcEEEEEEEEC-----CeeEEEEEeecc-chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD-----DKQVAVKMLSSS-SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-----~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.+.||+|+||.||+|+.. +..||||+++.. .....+.|.+|++++++++||||+++++++.+....++||||
T Consensus 48 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 127 (373)
T 2qol_A 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEY 127 (373)
T ss_dssp CCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeC
Confidence 44679999999999999864 567999999765 334456799999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++|+|.+++... ...+++.+++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 128 ~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 203 (373)
T 2qol_A 128 MENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203 (373)
T ss_dssp CTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence 9999999998643 35699999999999999999999998 9999999999999999999999999999876432211
Q ss_pred c-ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 718 H-VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 718 ~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
. ......+++.|+|||++.+..++.++|||||||++|||++ |+.||........... +..+ ...
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~-----i~~~---------~~~ 269 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA-----VDEG---------YRL 269 (373)
T ss_dssp ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH-----HHTT---------EEC
T ss_pred ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcC---------CCC
Confidence 1 1122345778999999999999999999999999999998 9999976554322211 1111 111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
.........+.+++.+|++.+|++||++.||+++|++++..
T Consensus 270 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 270 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 22234456788999999999999999999999999998654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=357.99 Aligned_cols=255 Identities=29% Similarity=0.453 Sum_probs=209.7
Q ss_pred hccccccccCcEEEEEEEECC-------eeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLDD-------KQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~~-------~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 635 (870)
.+.+.||+|+||.||+|+..+ +.||||+++... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 50 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 129 (343)
T 1luf_A 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF 129 (343)
T ss_dssp EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEE
Confidence 345789999999999999853 789999998653 334567999999999999999999999999999999999
Q ss_pred EEccCCchhhhhhhcc----------------------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEE
Q 002887 636 EFMANGNLQAHLLEDK----------------------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANIL 693 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NIL 693 (870)
||+++|+|.+++.... ...+++.+++.++.|+++||+|||++ +|+||||||+|||
T Consensus 130 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl 206 (343)
T 1luf_A 130 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL 206 (343)
T ss_dssp ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred ecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEE
Confidence 9999999999997642 15689999999999999999999998 9999999999999
Q ss_pred EcCCCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchH
Q 002887 694 LNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLI 772 (870)
Q Consensus 694 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l 772 (870)
+++++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.........
T Consensus 207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 286 (343)
T 1luf_A 207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI 286 (343)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHH
Confidence 99999999999999986533222223344568899999999999999999999999999999999 99999765433222
Q ss_pred HHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 773 GQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 773 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
. .+..+... ..+......+.+++.+|++.+|++||++.||++.|+++..
T Consensus 287 ~-----~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 287 Y-----YVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp H-----HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred H-----HHhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 1 12222111 1122344578899999999999999999999999998764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=342.62 Aligned_cols=250 Identities=27% Similarity=0.449 Sum_probs=195.5
Q ss_pred hccccccccCcEEEEEEEECCeeEEEEEeeccch----hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSV----QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~----~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.+.+.||+|+||.||+|.+.++.||||++..... ...+.+.+|++++++++||||+++++++......++||||++
T Consensus 10 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (271)
T 3dtc_A 10 TLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFAR 89 (271)
T ss_dssp EEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCT
T ss_pred eeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCC
Confidence 4567999999999999999999999999876432 234678999999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC--------CCcEEEEeccCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE--------KFQAKLADFGLSRIF 711 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~--------~~~vkL~DFGla~~~ 711 (870)
+++|.+++. ...+++..+..++.|+++||+|||++...+|+||||||+||+++. ++.+||+|||+++..
T Consensus 90 ~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~ 166 (271)
T 3dtc_A 90 GGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW 166 (271)
T ss_dssp TEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----
T ss_pred CCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccc
Confidence 999999884 457899999999999999999999982223999999999999986 678999999999865
Q ss_pred cCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccc
Q 002887 712 PVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDH 791 (870)
Q Consensus 712 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 791 (870)
... ......|++.|+|||.+.+..++.++||||||++++||++|+.||........... ....
T Consensus 167 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~--------- 229 (271)
T 3dtc_A 167 HRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG----VAMN--------- 229 (271)
T ss_dssp -------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH----HHTS---------
T ss_pred ccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh----hhcC---------
Confidence 322 12245789999999999999999999999999999999999999986553322211 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 792 RLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 792 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
.............+.+++.+|++.+|++|||+.|+++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111122334456788999999999999999999999999863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=345.40 Aligned_cols=266 Identities=22% Similarity=0.295 Sum_probs=212.3
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCC--eEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGA--NMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+|... ++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||||+
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 91 (319)
T 4euu_A 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91 (319)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred EEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCC
Confidence 45679999999999999986 8899999997654 234567889999999999999999999997655 789999999
Q ss_pred cCCchhhhhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEE----cCCCcEEEEeccCCccccC
Q 002887 639 ANGNLQAHLLEDKA-DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILL----NEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 639 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILl----d~~~~vkL~DFGla~~~~~ 713 (870)
++|+|.+++..... ..+++..++.++.|+++||+|||+. +|+||||||+|||+ +.++.+||+|||+++....
T Consensus 92 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~ 168 (319)
T 4euu_A 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (319)
T ss_dssp TTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred CCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence 99999999976433 3499999999999999999999999 99999999999999 8888999999999987643
Q ss_pred CCCccccccccCCCCccCccccc--------cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCC-
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYI--------SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGD- 784 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~--------~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~- 784 (870)
.. ......||+.|+|||++. +..++.++|||||||++|||++|+.||..........+..........
T Consensus 169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~ 245 (319)
T 4euu_A 169 DE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245 (319)
T ss_dssp TC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCT
T ss_pred CC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCc
Confidence 22 223457999999999986 467899999999999999999999999765543333333333332211
Q ss_pred --cchhc---------ccc--cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 785 --IKNIV---------DHR--LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 785 --~~~i~---------d~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
...+. ... ............+.+++.+||+.||++|||+.|+++...+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 11000 001 1123345677889999999999999999999999999987543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=341.67 Aligned_cols=254 Identities=22% Similarity=0.378 Sum_probs=208.8
Q ss_pred hhccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.+.+.||+|+||.||+|... +..||+|++..... ..+++.+|++++.+++||||+++++++.+....++||||++++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (268)
T 3sxs_A 10 ITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNG 88 (268)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred eeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCC
Confidence 345679999999999999987 66899999976543 3467899999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++...... ......
T Consensus 89 ~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~~~ 163 (268)
T 3sxs_A 89 CLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD-QYVSSV 163 (268)
T ss_dssp BHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT-CEEECC
T ss_pred cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh-hhhccc
Confidence 999998653 34699999999999999999999998 9999999999999999999999999999865332 222223
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
...+++.|+|||.+.+..++.++||||||++++||++ |+.||............ . .+. ....+..
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~----~-~~~---------~~~~~~~ 229 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV----S-QGH---------RLYRPHL 229 (268)
T ss_dssp SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----H-TTC---------CCCCCTT
T ss_pred CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH----H-cCC---------CCCCCCc
Confidence 4456778999999998899999999999999999999 99999865543322221 1 111 0011122
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
....+.+++.+|++.+|++|||+.|+++.|+.+...
T Consensus 230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 230 ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 345688999999999999999999999999987654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=354.65 Aligned_cols=258 Identities=28% Similarity=0.396 Sum_probs=210.1
Q ss_pred hhccccccccCcEEEEEEEE-------CCeeEEEEEeeccc-hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYL-------DDKQVAVKMLSSSS-VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGL 633 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~-------~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~L 633 (870)
+.+.+.||+|+||.||+|.. .++.||||++.... ....+.+.+|+.++.++ +||||+++++++......++
T Consensus 47 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 126 (344)
T 1rjb_A 47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 126 (344)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEE
Confidence 34568999999999999996 25679999997643 33457799999999999 99999999999999999999
Q ss_pred EEEEccCCchhhhhhhccc---------------------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCE
Q 002887 634 IYEFMANGNLQAHLLEDKA---------------------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANI 692 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NI 692 (870)
||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NI 203 (344)
T 1rjb_A 127 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNV 203 (344)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGE
T ss_pred EEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhE
Confidence 9999999999999976432 3489999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccch
Q 002887 693 LLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTL 771 (870)
Q Consensus 693 Lld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~ 771 (870)
|++.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|||+| |+.||........
T Consensus 204 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 283 (344)
T 1rjb_A 204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 283 (344)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred EEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH
Confidence 999999999999999987654433333445567889999999999999999999999999999998 9999987654443
Q ss_pred HHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 772 IGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 772 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
....+ ..+. ....+......+.+++.+||+.+|++|||+.|+++.|+.++..
T Consensus 284 ~~~~~----~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 284 FYKLI----QNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp HHHHH----HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHHH----hcCC---------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 33322 1111 1112223356788999999999999999999999999987654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=344.00 Aligned_cols=254 Identities=27% Similarity=0.427 Sum_probs=206.6
Q ss_pred hccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 564 NFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
.+.+.||+|+||.||++.+. +..||+|++..... ..+++.+|++++++++|+||+++++++.+....++||||+++|+
T Consensus 27 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 105 (283)
T 3gen_A 27 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 105 (283)
T ss_dssp EEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCB
T ss_pred HhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCc
Confidence 44589999999999999987 67899999986543 34678999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.+++... ...+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++..... .......
T Consensus 106 L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 180 (283)
T 3gen_A 106 LLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVG 180 (283)
T ss_dssp HHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH-HHHSTTS
T ss_pred HHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc-ccccccC
Confidence 99998653 34699999999999999999999998 9999999999999999999999999999865321 1112233
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
..+|+.|+|||++.+..++.++||||||+++|||++ |+.||............ ..+ .....+...
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-----~~~---------~~~~~~~~~ 246 (283)
T 3gen_A 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-----AQG---------LRLYRPHLA 246 (283)
T ss_dssp TTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-----HTT---------CCCCCCTTC
T ss_pred CccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH-----hcc---------cCCCCCCcC
Confidence 456788999999999999999999999999999998 99999875543322221 111 011112223
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHh
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e 837 (870)
...+.+++.+|++.+|++|||+.|+++.|+++...|
T Consensus 247 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 247 SEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 457889999999999999999999999999987543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=375.27 Aligned_cols=253 Identities=27% Similarity=0.408 Sum_probs=213.2
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
..+.+.||+|+||.||+|.+. +..||||+++.... ..++|.+|++++++++||||++++++|......++||||+++
T Consensus 222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~ 300 (495)
T 1opk_A 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 300 (495)
T ss_dssp EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCC
Confidence 345689999999999999987 78999999976533 457899999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++..... .....
T Consensus 301 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~ 376 (495)
T 1opk_A 301 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAH 376 (495)
T ss_dssp CBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTC-CEECC
T ss_pred CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCC-ceeec
Confidence 9999999876667799999999999999999999998 9999999999999999999999999999876322 22222
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
....+++.|+|||++....++.++|||||||++|||++ |+.||.......... . +..+ .....+.
T Consensus 377 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~-~----~~~~---------~~~~~~~ 442 (495)
T 1opk_A 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-L----LEKD---------YRMERPE 442 (495)
T ss_dssp TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-H----HHTT---------CCCCCCT
T ss_pred CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-H----HHcC---------CCCCCCC
Confidence 33456789999999999999999999999999999999 999998765433221 1 1111 1122233
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
.....+.+++.+||+.+|++|||+.||+++|+++.
T Consensus 443 ~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 443 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 44567889999999999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=354.79 Aligned_cols=248 Identities=22% Similarity=0.338 Sum_probs=201.2
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
.+.+.||+|+||.||+|+.. ++.||||++..... ...+.+.+|+.++++++||||+++++++.++...++||||+++
T Consensus 10 ~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 89 (323)
T 3tki_A 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 89 (323)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCC
Confidence 34679999999999999986 88999999976533 3346789999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.........
T Consensus 90 ~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 90 GELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp EEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 999999863 34699999999999999999999998 9999999999999999999999999999876433333334
Q ss_pred ccccCCCCccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccch-HHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 721 TTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPQRTL-IGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~-~~ksDVwS~GvvL~elltG~~p~~~~~~~~~-l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
....||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ...|.. ... .....
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~----~~~---------~~~~~ 231 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE----KKT---------YLNPW 231 (323)
T ss_dssp CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT----TCT---------TSTTG
T ss_pred CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc----ccc---------cCCcc
Confidence 45689999999999987765 7899999999999999999999986554322 222111 110 00111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
......+.+++.+|++.+|++|||+.|+++.
T Consensus 232 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 232 KKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 2334567899999999999999999999763
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=372.58 Aligned_cols=251 Identities=27% Similarity=0.431 Sum_probs=208.7
Q ss_pred hccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 564 NFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
.+.+.||+|+||.||+|.+. ++.||||+++... ...+.|.+|++++++++||||+++++++. ....++||||+++|+
T Consensus 191 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~ 268 (454)
T 1qcf_A 191 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGS 268 (454)
T ss_dssp EEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred EEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCc
Confidence 45689999999999999997 7889999998654 34678999999999999999999999987 567899999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .......
T Consensus 269 L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~~~~ 344 (454)
T 1qcf_A 269 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN-EYTAREG 344 (454)
T ss_dssp HHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH-HHHTTCS
T ss_pred HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC-ceeccCC
Confidence 99999765555789999999999999999999998 9999999999999999999999999999865321 1111233
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
..+++.|+|||++..+.++.++|||||||++|||++ |+.||........... +..+. ....+...
T Consensus 345 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~-----i~~~~---------~~~~~~~~ 410 (454)
T 1qcf_A 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-----LERGY---------RMPRPENC 410 (454)
T ss_dssp SSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-----HHHTC---------CCCCCTTS
T ss_pred CcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCC---------CCCCCCCC
Confidence 456788999999999999999999999999999999 9999986554332221 11111 11122344
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
+..+.+++.+||+.+|++|||+.+|+++|+++.
T Consensus 411 ~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 411 PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 567889999999999999999999999999865
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=348.75 Aligned_cols=255 Identities=27% Similarity=0.417 Sum_probs=211.8
Q ss_pred hccccccccCcEEEEEEEEC-------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 635 (870)
.+.+.||+|+||.||+|... ++.||||++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 105 (314)
T 2ivs_A 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIV 105 (314)
T ss_dssp EEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEE
Confidence 45678999999999999862 4789999997653 344577899999999999999999999999999999999
Q ss_pred EEccCCchhhhhhhccc----------------------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEE
Q 002887 636 EFMANGNLQAHLLEDKA----------------------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANIL 693 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NIL 693 (870)
||+++|+|.+++..... ..+++..++.++.|+++||+|||++ +|+||||||+||+
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NIl 182 (314)
T 2ivs_A 106 EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNIL 182 (314)
T ss_dssp ECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred eecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheEE
Confidence 99999999999976432 3589999999999999999999998 9999999999999
Q ss_pred EcCCCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchH
Q 002887 694 LNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLI 772 (870)
Q Consensus 694 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l 772 (870)
+++++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.........
T Consensus 183 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 262 (314)
T 2ivs_A 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262 (314)
T ss_dssp EETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999987644333333344567889999999999999999999999999999999 99999876544322
Q ss_pred HHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 773 GQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 773 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
.. +..+. ...........+.+++.+|++.+|++||++.|+++.|++++.
T Consensus 263 ~~-----~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 263 NL-----LKTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp HH-----HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH-----hhcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 21 11111 111223345678899999999999999999999999999764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=345.94 Aligned_cols=256 Identities=27% Similarity=0.394 Sum_probs=215.4
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.+.||+|+||.||+|... ++.||+|++.... ...+.+.+|++++++++||||+++++++.+....++||||+++
T Consensus 15 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 93 (288)
T 3kfa_A 15 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 93 (288)
T ss_dssp EEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred eeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCC
Confidence 445689999999999999987 7899999997643 3457789999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
++|.+++.......+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...... .....
T Consensus 94 ~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~~ 169 (288)
T 3kfa_A 94 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAH 169 (288)
T ss_dssp EEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS-SSEEE
T ss_pred CcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCC-ccccc
Confidence 9999999876667799999999999999999999999 9999999999999999999999999999876432 22223
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||............ ..+ .......
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~-----~~~---------~~~~~~~ 235 (288)
T 3kfa_A 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-----EKD---------YRMERPE 235 (288)
T ss_dssp TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-----HTT---------CCCCCCT
T ss_pred cCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----hcc---------CCCCCCC
Confidence 34567889999999999999999999999999999999 99999876544332211 111 1112223
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHh
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e 837 (870)
.....+.+++.+|++.+|++|||+.|+++.|+++....
T Consensus 236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 34567889999999999999999999999999987654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=352.27 Aligned_cols=257 Identities=27% Similarity=0.403 Sum_probs=197.4
Q ss_pred hhccccccccCcEEEEEEEEC--Ce---eEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeE----
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DK---QVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANM---- 631 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~---~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~---- 631 (870)
+.+.+.||+|+||.||+|... ++ .||||++... .....+.+.+|++++++++||||+++++++......
T Consensus 25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (323)
T 3qup_A 25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLP 104 (323)
T ss_dssp CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------
T ss_pred eEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCC
Confidence 345689999999999999875 22 7999999765 334567899999999999999999999999877655
Q ss_pred --EEEEEEccCCchhhhhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEec
Q 002887 632 --GLIYEFMANGNLQAHLLEDKA----DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADF 705 (870)
Q Consensus 632 --~LV~Ey~~~gsL~~~l~~~~~----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DF 705 (870)
++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCC
T ss_pred ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeec
Confidence 899999999999999865432 2589999999999999999999999 9999999999999999999999999
Q ss_pred cCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCC
Q 002887 706 GLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGD 784 (870)
Q Consensus 706 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~ 784 (870)
|+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||............ .. +.
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~----~~-~~ 256 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL----IG-GN 256 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HT-TC
T ss_pred cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH----hc-CC
Confidence 99987643333233344567889999999999999999999999999999999 99999876554433221 11 11
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 785 IKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 785 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
...........+.+++.+|++.+|++|||+.|+++.|++++.-
T Consensus 257 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 257 ---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0112223446788999999999999999999999999998754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=341.26 Aligned_cols=248 Identities=21% Similarity=0.330 Sum_probs=206.1
Q ss_pred hccccccccCcEEEEEEEECCeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecC--CeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEG--ANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~LV~Ey~~ 639 (870)
.+.+.||+|+||.||+|+++++.||||++.... ....+.+.+|+.++++++||||+++++++.+. ...++||||++
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 92 (271)
T 3kmu_A 13 NFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP 92 (271)
T ss_dssp EEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCT
T ss_pred HHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccC
Confidence 456799999999999999999999999998653 34456799999999999999999999999887 78899999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCC--ceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPP--IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+|+|.+++.......+++..++.++.|+++||+|||+. + |+||||||+||++++++.++|+|||++....
T Consensus 93 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~----- 164 (271)
T 3kmu_A 93 YGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ----- 164 (271)
T ss_dssp TCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-----
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec-----
Confidence 99999999876555799999999999999999999987 6 9999999999999999999999998875431
Q ss_pred cccccccCCCCccCccccccCCCCc---cchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTE---KSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~---ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 794 (870)
.....||+.|+|||.+.+...+. ++||||||+++|||++|+.||........... ....+ ..
T Consensus 165 --~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~---------~~ 229 (271)
T 3kmu_A 165 --SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK----VALEG---------LR 229 (271)
T ss_dssp --CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH----HHHSC---------CC
T ss_pred --ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH----HHhcC---------CC
Confidence 12356899999999998765444 89999999999999999999986554332221 12111 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 795 GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 795 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
...+......+.+++.+|++.+|++|||+.|+++.|+++.
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 230 PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1222334557889999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=348.08 Aligned_cols=256 Identities=23% Similarity=0.382 Sum_probs=203.9
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+|... ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 93 (294)
T 4eqm_A 14 KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYI 93 (294)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCC
Confidence 45679999999999999975 7899999986542 334567899999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 94 ~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 167 (294)
T 4eqm_A 94 EGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET-SLT 167 (294)
T ss_dssp CSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc-ccc
Confidence 999999998643 4689999999999999999999998 9999999999999999999999999999865322 122
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ...... .... .. ...
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~----~~~~~~-~~~~-~~----~~~ 237 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI----KHIQDS-VPNV-TT----DVR 237 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH----HHHSSC-CCCH-HH----HSC
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH----HHhhcc-CCCc-ch----hcc
Confidence 2344679999999999999999999999999999999999999998654332211 111111 1100 00 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhhh
Q 002887 799 TNTVWKAVEIALACIHTISTRRP-TMNQVVIELNDCLA 835 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RP-sm~eVl~~L~~~~~ 835 (870)
...+..+.+++.+|++.+|++|| ++.++.+.|+.++.
T Consensus 238 ~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 22345788999999999999999 99999999987653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=352.96 Aligned_cols=255 Identities=23% Similarity=0.368 Sum_probs=203.8
Q ss_pred hccccccccCcEEEEEEEEC--Cee----EEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQ----VAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~----vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
.+.+.||+|+||.||+|.+. ++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. +...++|||
T Consensus 16 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e 94 (325)
T 3kex_A 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQ 94 (325)
T ss_dssp EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEE
T ss_pred eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEE
Confidence 34578999999999999974 443 7888875443 334567889999999999999999999986 456889999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
|+++|+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 95 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 95 YLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp CCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred eCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 99999999998654 35789999999999999999999999 999999999999999999999999999998754444
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
........|+..|+|||++.+..++.++|||||||++|||++ |+.||........... +..+.. .
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-----~~~~~~---------~ 236 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL-----LEKGER---------L 236 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH-----HHTTCB---------C
T ss_pred cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH-----HHcCCC---------C
Confidence 444455678889999999999999999999999999999999 9999987554332211 111111 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHh
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e 837 (870)
.........+.+++.+|++.+|++||++.|+++.|+.+....
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 237 AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 111122335678999999999999999999999999876543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=350.33 Aligned_cols=243 Identities=26% Similarity=0.363 Sum_probs=202.9
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+++.. ++.||+|++.... ....+.+.+|+.++++++||||+++++++......++||||+
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~ 87 (337)
T 1o6l_A 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 87 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 34579999999999999986 8899999997652 234567889999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 88 ~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~ 160 (337)
T 1o6l_A 88 NGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GA 160 (337)
T ss_dssp TTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--TC
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC--CC
Confidence 999999988643 4689999999999999999999998 9999999999999999999999999999854222 22
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
......||+.|+|||++.+..++.++|+|||||++|||++|+.||........... ... +.. .++
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~----i~~-~~~----------~~p 225 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----ILM-EEI----------RFP 225 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHH-CCC----------CCC
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHH----HHc-CCC----------CCC
Confidence 33456899999999999999999999999999999999999999976543322221 111 110 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRP-----TMNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 828 (870)
......+.+++.+|++.+|++|| ++.|+++
T Consensus 226 ~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 23345788999999999999999 8999876
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=341.99 Aligned_cols=256 Identities=25% Similarity=0.336 Sum_probs=198.7
Q ss_pred hhccccccccCcEEEEEEEEC-----CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-----DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-----~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
+.+.+.||+|+||.||+|... +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e 95 (281)
T 1mp8_A 17 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME 95 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred eEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEe
Confidence 445689999999999999874 3569999987643 344567899999999999999999999985 457889999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
|+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 96 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 170 (281)
T 1mp8_A 96 LCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-T 170 (281)
T ss_dssp CCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcc-c
Confidence 99999999998643 34689999999999999999999998 9999999999999999999999999999876322 1
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
........+++.|+|||.+.+..++.++||||||+++|||++ |+.||............ ..+.. .
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i-----~~~~~---------~ 236 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-----ENGER---------L 236 (281)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-----HTTCC---------C
T ss_pred ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH-----HcCCC---------C
Confidence 122234457789999999999999999999999999999997 99999876554432221 11110 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHhH
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAMEI 838 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e~ 838 (870)
.........+.+++.+|++.+|++|||+.|+++.|++++..+.
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 237 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 1223345678899999999999999999999999999876543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=350.02 Aligned_cols=257 Identities=28% Similarity=0.390 Sum_probs=211.6
Q ss_pred hccccccccCcEEEEEEEEC--C-----eeEEEEEeeccc-hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--D-----KQVAVKMLSSSS-VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLI 634 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~-----~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV 634 (870)
.+.+.||+|+||.||+|... + +.||+|++.... ....+.+.+|+++++++ +||||+++++++......++|
T Consensus 49 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 128 (333)
T 2i1m_A 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI 128 (333)
T ss_dssp EEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEE
Confidence 45689999999999999974 2 479999997653 33456789999999999 899999999999999999999
Q ss_pred EEEccCCchhhhhhhcc------------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEE
Q 002887 635 YEFMANGNLQAHLLEDK------------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKL 702 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL 702 (870)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||
T Consensus 129 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl 205 (333)
T 2i1m_A 129 TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKI 205 (333)
T ss_dssp EECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEEB
T ss_pred EecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeEEE
Confidence 99999999999987543 24579999999999999999999998 9999999999999999999999
Q ss_pred EeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhh
Q 002887 703 ADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLA 781 (870)
Q Consensus 703 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~ 781 (870)
+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||..........+....
T Consensus 206 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~--- 282 (333)
T 2i1m_A 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD--- 282 (333)
T ss_dssp CCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHH---
T ss_pred CccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhc---
Confidence 99999987644433333344567889999999999999999999999999999999 99999876544333332221
Q ss_pred cCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 782 RGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 782 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
+. ....+......+.+++.+|++.+|++|||+.||++.|+++...
T Consensus 283 -~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 283 -GY---------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp -TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CC---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 11 1111222345788999999999999999999999999987654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=368.62 Aligned_cols=251 Identities=28% Similarity=0.437 Sum_probs=204.1
Q ss_pred hccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 564 NFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
.+.+.||+|+||.||+|.+. +..||||+++... ...++|.+|++++++++||||+++++++.+ ...++||||+++|+
T Consensus 187 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gs 264 (452)
T 1fmk_A 187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 264 (452)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred eeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCC
Confidence 45678999999999999998 5789999998654 235679999999999999999999999976 67899999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++..... .......
T Consensus 265 L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~ 340 (452)
T 1fmk_A 265 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQG 340 (452)
T ss_dssp HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCC-ceecccC
Confidence 99999765556799999999999999999999998 9999999999999999999999999999876322 1122233
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
..+++.|+|||++.++.++.++|||||||++|||++ |+.||........... +..+. ....+...
T Consensus 341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-----i~~~~---------~~~~~~~~ 406 (452)
T 1fmk_A 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-----VERGY---------RMPCPPEC 406 (452)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-----HHTTC---------CCCCCTTS
T ss_pred CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCC---------CCCCCCCC
Confidence 457789999999999999999999999999999999 9999986554332211 11121 11223344
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
+..+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus 407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 567889999999999999999999999999865
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=342.65 Aligned_cols=257 Identities=31% Similarity=0.537 Sum_probs=196.2
Q ss_pred hhccccccccCcEEEEEEEECCeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 563 NNFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.+.||+|+||.||+|+..+ .||||+++... ....+.+.+|++++++++|+||+++++++. ....++||||+++
T Consensus 26 y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~ 103 (289)
T 3og7_A 26 ITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEG 103 (289)
T ss_dssp CEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCE
T ss_pred eeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEEecCC
Confidence 3456899999999999998766 49999987553 344577999999999999999999999764 5568999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...........
T Consensus 104 ~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (289)
T 3og7_A 104 SSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179 (289)
T ss_dssp EEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------------
T ss_pred CcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccccccc
Confidence 9999988643 35699999999999999999999998 9999999999999999999999999999865433333334
Q ss_pred ccccCCCCccCccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 721 TTVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~---~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
....||+.|+|||.+. +..++.++||||||+++|||++|+.||........+.+.+. .+... +.+ ...
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~----~~~~~----~~~-~~~ 250 (289)
T 3og7_A 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG----RGSLS----PDL-SKV 250 (289)
T ss_dssp ----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHH----HTSCC----CCT-TSS
T ss_pred cccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhc----ccccC----cch-hhc
Confidence 4567999999999986 56688899999999999999999999987654443333222 22111 111 111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
....+..+.+++.+|++.+|++|||+.|++++|+++.
T Consensus 251 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 2234567889999999999999999999999999865
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=349.56 Aligned_cols=259 Identities=25% Similarity=0.405 Sum_probs=211.3
Q ss_pred hhccccccccCcEEEEEEEEC-------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLI 634 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 634 (870)
+.+.+.||+|+||.||+|+.. ++.||||++.... ......+.+|++++++++||||+++++++.+....++|
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 106 (322)
T 1p4o_A 27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 106 (322)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEE
Confidence 345689999999999999864 5789999997653 33456789999999999999999999999999999999
Q ss_pred EEEccCCchhhhhhhccc--------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEecc
Q 002887 635 YEFMANGNLQAHLLEDKA--------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFG 706 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFG 706 (870)
|||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 107 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg 183 (322)
T 1p4o_A 107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG 183 (322)
T ss_dssp EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcCc
Confidence 999999999999875431 4578999999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCc
Q 002887 707 LSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDI 785 (870)
Q Consensus 707 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~ 785 (870)
+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||.......... ... .+..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~----~~~-~~~~ 258 (322)
T 1p4o_A 184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR----FVM-EGGL 258 (322)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH----HHH-TTCC
T ss_pred cccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH----HHH-cCCc
Confidence 9986543322233344567889999999999999999999999999999999 899997654332221 111 1111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHhH
Q 002887 786 KNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAMEI 838 (870)
Q Consensus 786 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e~ 838 (870)
..........+.+++.+|++.+|++|||+.|+++.|++......
T Consensus 259 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~ 302 (322)
T 1p4o_A 259 ---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 302 (322)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCC
Confidence 11122344568899999999999999999999999999765443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=343.96 Aligned_cols=251 Identities=22% Similarity=0.360 Sum_probs=201.8
Q ss_pred hhccccccccCcEEEEEEEEC--C-------eeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--D-------KQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGL 633 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~-------~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 633 (870)
+.+.+.||+|+||.||+|... + ..||+|++........+.+.+|++++++++||||+++++++..+...++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (289)
T 4fvq_A 10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENIL 89 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEE
T ss_pred eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEE
Confidence 345689999999999999875 3 5699999987766677889999999999999999999999999999999
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCc--------EEEEec
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQ--------AKLADF 705 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~--------vkL~DF 705 (870)
||||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+||
T Consensus 90 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 90 VQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp EEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred EEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 99999999999999653 34589999999999999999999999 9999999999999998887 999999
Q ss_pred cCCccccCCCCccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCC-CCCCCCccchHHHHHHHHhhcC
Q 002887 706 GLSRIFPVEGGTHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQP-VIQKTPQRTLIGQWVSSMLARG 783 (870)
Q Consensus 706 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~-p~~~~~~~~~l~~~~~~~~~~~ 783 (870)
|++..... .....|++.|+|||++.+ ..++.++||||||+++|||++|.. |+....... ..... ....
T Consensus 166 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~---~~~~ 235 (289)
T 4fvq_A 166 GISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFY---EDRH 235 (289)
T ss_dssp CSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHH---HTTC
T ss_pred cccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHh---hccC
Confidence 99875421 223457899999999987 679999999999999999999654 444333221 11111 1111
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHhHh
Q 002887 784 DIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAMEIA 839 (870)
Q Consensus 784 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e~~ 839 (870)
. .+......+.+++.+|++.+|++|||+.|+++.|++++.-..+
T Consensus 236 ~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 236 Q------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp C------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred C------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 1 1111123577999999999999999999999999998764433
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=348.56 Aligned_cols=258 Identities=28% Similarity=0.448 Sum_probs=211.4
Q ss_pred hhccccccccCcEEEEEEEEC---------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD---------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANM 631 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~---------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 631 (870)
+.+.+.||+|+||.||+|... +..||||++.... ....+.+.+|+++++++ +||||+++++++......
T Consensus 37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 116 (334)
T 2pvf_A 37 LTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 116 (334)
T ss_dssp EEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCC
T ss_pred eEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCce
Confidence 445689999999999999863 4679999997653 34457789999999999 999999999999999999
Q ss_pred EEEEEEccCCchhhhhhhccc--------------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC
Q 002887 632 GLIYEFMANGNLQAHLLEDKA--------------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK 697 (870)
Q Consensus 632 ~LV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~ 697 (870)
++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.+
T Consensus 117 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 193 (334)
T 2pvf_A 117 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193 (334)
T ss_dssp EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred EEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcCC
Confidence 999999999999999976432 3489999999999999999999998 99999999999999999
Q ss_pred CcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHH
Q 002887 698 FQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWV 776 (870)
Q Consensus 698 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~ 776 (870)
+.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||...........
T Consensus 194 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-- 271 (334)
T 2pvf_A 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL-- 271 (334)
T ss_dssp CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH--
T ss_pred CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH--
Confidence 9999999999987643332223344567889999999999899999999999999999999 9999976543322211
Q ss_pred HHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHh
Q 002887 777 SSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837 (870)
Q Consensus 777 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e 837 (870)
+..+.. ..........+.+++.+|++.+|++||++.|+++.|++++...
T Consensus 272 ---~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 272 ---LKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp ---HHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---HhcCCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 111111 1112234457889999999999999999999999999987653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=337.60 Aligned_cols=254 Identities=28% Similarity=0.428 Sum_probs=208.6
Q ss_pred hhccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.+.+.||+|+||.||+|... ++.||||++.... ...+.+.+|++++++++||||+++++++.. +..++||||++++
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~ 92 (279)
T 1qpc_A 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENG 92 (279)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTC
T ss_pred hhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCC
Confidence 345689999999999999987 6789999997653 235678999999999999999999999874 5689999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++.......+++..++.++.|+++||+|||+. +|+||||||+||++++++.+||+|||++...... ......
T Consensus 93 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 168 (279)
T 1qpc_A 93 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTARE 168 (279)
T ss_dssp BHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CEECCT
T ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCc-cccccc
Confidence 999999765445799999999999999999999998 9999999999999999999999999999876322 222223
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
...++..|+|||.+.+..++.++||||||++++||++ |+.||.......... .. ..+. .......
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~----~~-~~~~---------~~~~~~~ 234 (279)
T 1qpc_A 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ----NL-ERGY---------RMVRPDN 234 (279)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----HH-HTTC---------CCCCCTT
T ss_pred CCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHH----HH-hccc---------CCCCccc
Confidence 4457889999999998899999999999999999999 999997654432221 11 1111 1111223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
....+.+++.+|++.+|++|||+.++++.|+++...
T Consensus 235 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 446788999999999999999999999999997643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=346.60 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=203.9
Q ss_pred HhhccccccccCcEEEEEEEEC--CeeEEEEEeeccchh------hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEE
Q 002887 562 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ------GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGL 633 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 633 (870)
.+.+.+.||+|+||.||++... ++.||+|++...... ..+.+.+|++++++++||||+++++++......++
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 91 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 91 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3456789999999999999986 889999999765322 35678999999999999999999999999999999
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC----cEEEEeccCCc
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF----QAKLADFGLSR 709 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~----~vkL~DFGla~ 709 (870)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++ .+||+|||+++
T Consensus 92 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 92 ILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 9999999999999864 35699999999999999999999998 999999999999999887 89999999998
Q ss_pred cccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhc
Q 002887 710 IFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIV 789 (870)
Q Consensus 710 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~ 789 (870)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........+.... . ... ..
T Consensus 167 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~----~-~~~-~~- 236 (326)
T 2y0a_A 167 KIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS----A-VNY-EF- 236 (326)
T ss_dssp ECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH----H-TCC-CC-
T ss_pred ECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH----h-cCC-Cc-
Confidence 763221 2234679999999999998999999999999999999999999997655433322211 1 100 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 790 DHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 790 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.... .......+.+++.+|++.+|++|||+.|+++
T Consensus 237 ~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 237 EDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CHHH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred Cccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 0122356789999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=343.07 Aligned_cols=258 Identities=29% Similarity=0.413 Sum_probs=210.2
Q ss_pred hhccccccccCcEEEEEEEEC-------CeeEEEEEeeccch-hhhHHHHHHHHHHHHh-ccccceeEEEEEecCC-eEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSSV-QGYKQFQAEVELLIRA-HHKNLTILVGYCDEGA-NMG 632 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~-~~~ 632 (870)
+.+.+.||+|+||.||+|+.. ++.||||++..... ...+.+.+|++++.++ +||||+++++++.... ..+
T Consensus 29 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~ 108 (316)
T 2xir_A 29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 108 (316)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred eeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceE
Confidence 345689999999999999852 57899999976533 3456789999999999 7999999999987754 489
Q ss_pred EEEEEccCCchhhhhhhccc--------------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC
Q 002887 633 LIYEFMANGNLQAHLLEDKA--------------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF 698 (870)
Q Consensus 633 LV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~ 698 (870)
+||||+++|+|.+++..... ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~ 185 (316)
T 2xir_A 109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKN 185 (316)
T ss_dssp EEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCC
Confidence 99999999999999976542 2289999999999999999999998 999999999999999999
Q ss_pred cEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHH
Q 002887 699 QAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVS 777 (870)
Q Consensus 699 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~ 777 (870)
.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||............
T Consensus 186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~-- 263 (316)
T 2xir_A 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-- 263 (316)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH--
T ss_pred CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHH--
Confidence 999999999987644333333445668899999999999999999999999999999998 99999765543322221
Q ss_pred HHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 778 SMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 778 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
...+.. ..........+.+++.+|++.+|++|||+.|+++.|++++..
T Consensus 264 --~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 264 --LKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp --HHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --hccCcc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 111111 111222345688999999999999999999999999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=352.43 Aligned_cols=266 Identities=26% Similarity=0.351 Sum_probs=210.1
Q ss_pred hhccccccccCcEEEEEEEE------CCeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEe--cCCeEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYL------DDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCD--EGANMGLI 634 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~------~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~~LV 634 (870)
+.+.+.||+|+||.||++++ .++.||||++........+.+.+|++++++++|+||+++++++. +....++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 104 (327)
T 3lxl_A 25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLV 104 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEE
T ss_pred hhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEE
Confidence 34568999999999999985 37889999998877667788999999999999999999999886 45668899
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 105 MEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 99999999999986533 4699999999999999999999998 9999999999999999999999999999876433
Q ss_pred CCcc-ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC------Ccch
Q 002887 715 GGTH-VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG------DIKN 787 (870)
Q Consensus 715 ~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~------~~~~ 787 (870)
.... ......|++.|+|||++.+..++.++||||||++++||++|+.||....... ........ .+.+
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF-----LRMMGCERDVPALSRLLE 255 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HHHCC----CCHHHHHHH
T ss_pred CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh-----hhhcccccccccHHHHHH
Confidence 2221 2234568888999999999999999999999999999999999986432210 00000000 0011
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHh
Q 002887 788 IVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837 (870)
Q Consensus 788 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e 837 (870)
.+...............+.+++.+|++.+|++|||+.|+++.|+.+....
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11122222333445667899999999999999999999999999876544
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=354.00 Aligned_cols=250 Identities=21% Similarity=0.325 Sum_probs=202.4
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCch
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL 643 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 643 (870)
.+.||+|+||.||+|... ++.||+|++........+.+.+|++++++++||||+++++++.+....++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 367999999999999975 889999999887666778899999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEE--cCCCcEEEEeccCCccccCCCCccccc
Q 002887 644 QAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILL--NEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 644 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILl--d~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||+ ++++.+||+|||+++.+... ....
T Consensus 174 ~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~---~~~~ 246 (373)
T 2x4f_A 174 FDRIIDE-SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR---EKLK 246 (373)
T ss_dssp HHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT---CBCC
T ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc---cccc
Confidence 9988643 34689999999999999999999998 99999999999999 56789999999999876332 2223
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........+.++... .. ...... ....
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~----~~--~~~~~~-----~~~~ 315 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC----RW--DLEDEE-----FQDI 315 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT----CC--CSCSGG-----GTTS
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----cC--CCChhh-----hccC
Confidence 457999999999999999999999999999999999999999876554433332221 10 000000 1123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH--HHHHh
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVI--ELNDC 833 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~--~L~~~ 833 (870)
...+.+++.+|++.+|++|||+.|+++ .+++.
T Consensus 316 ~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 316 SEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 457889999999999999999999997 55553
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=353.48 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=203.5
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchh------hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ------GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLI 634 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 634 (870)
+.+.+.||+|+||.||+++.. ++.||+|++...... ..+.+.+|+.++++++||||+++++++.+....++|
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 93 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI 93 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence 345689999999999999986 889999999865332 246789999999999999999999999999999999
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC----cEEEEeccCCcc
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF----QAKLADFGLSRI 710 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~----~vkL~DFGla~~ 710 (870)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||+++++ .+||+|||+++.
T Consensus 94 ~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 94 LELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 999999999999864 34799999999999999999999998 999999999999998877 799999999987
Q ss_pred ccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcc
Q 002887 711 FPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVD 790 (870)
Q Consensus 711 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d 790 (870)
.... .......||+.|+|||++.+..++.++|||||||++|||++|++||........+..+ . .+... ++
T Consensus 169 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i----~-~~~~~--~~ 238 (361)
T 2yab_A 169 IEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI----T-AVSYD--FD 238 (361)
T ss_dssp CCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH----H-TTCCC--CC
T ss_pred cCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----H-hcCCC--CC
Confidence 6332 2234567999999999999989999999999999999999999999875543332221 1 11100 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 791 HRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 791 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+.. .......+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 239 EEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 0122456889999999999999999999985
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=340.33 Aligned_cols=244 Identities=24% Similarity=0.381 Sum_probs=193.7
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch--------------------------hhhHHHHHHHHHHHHhcc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--------------------------QGYKQFQAEVELLIRAHH 615 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--------------------------~~~~~f~~Ei~~l~~l~H 615 (870)
.+.+.||+|+||.||+|+.. ++.||||++..... ...+.+.+|++++++++|
T Consensus 16 ~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 95 (298)
T 2zv2_A 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDH 95 (298)
T ss_dssp EEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCC
T ss_pred EEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCC
Confidence 45679999999999999875 88999999976432 123568999999999999
Q ss_pred ccceeEEEEEec--CCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEE
Q 002887 616 KNLTILVGYCDE--GANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANIL 693 (870)
Q Consensus 616 ~nIv~l~g~~~~--~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NIL 693 (870)
|||+++++++.+ ....++||||+++++|.+++. ...+++..+..++.|+++||+|||++ +|+||||||+|||
T Consensus 96 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 96 PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLL 169 (298)
T ss_dssp TTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred CCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEE
Confidence 999999999986 568899999999999988763 35799999999999999999999998 9999999999999
Q ss_pred EcCCCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCC---CCccchHHHHHHHHHHHHhCCCCCCCCCccc
Q 002887 694 LNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNR---LTEKSDVYSFGVVLLELITGQPVIQKTPQRT 770 (870)
Q Consensus 694 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~~~ksDVwS~GvvL~elltG~~p~~~~~~~~ 770 (870)
++.++.+||+|||+++..... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 247 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence 999999999999999876322 22234567999999999998765 4788999999999999999999997654322
Q ss_pred hHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 771 LIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 771 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
. ... +..+... ..........+.+++.+|++.||++|||+.|+++
T Consensus 248 ~----~~~-~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 248 L----HSK-IKSQALE--------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp H----HHH-HHHCCCC--------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred H----HHH-HhcccCC--------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1 111 1111110 0111123456889999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=339.00 Aligned_cols=250 Identities=27% Similarity=0.426 Sum_probs=202.1
Q ss_pred hccccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecC-CeEEEEEEEccCCc
Q 002887 564 NFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEG-ANMGLIYEFMANGN 642 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~LV~Ey~~~gs 642 (870)
.+.+.||+|+||.||++..+++.||||++.... ..+.+.+|++++++++||||+++++++.+. ...++||||+++|+
T Consensus 24 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~ 101 (278)
T 1byg_A 24 KLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 101 (278)
T ss_dssp EEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred eEEeEEecCCCceEEEEEEcCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCC
Confidence 456799999999999999999999999997653 456789999999999999999999997654 47899999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.+++.......+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++...... ...
T Consensus 102 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~~~ 173 (278)
T 1byg_A 102 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDT 173 (278)
T ss_dssp HHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred HHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc-----ccC
Confidence 99999765545589999999999999999999998 9999999999999999999999999998754321 223
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
..+++.|+|||.+.+..++.++||||||++++||++ |+.||........... ...+. ........
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~-----~~~~~---------~~~~~~~~ 239 (278)
T 1byg_A 174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-----VEKGY---------KMDAPDGC 239 (278)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-----HTTTC---------CCCCCTTC
T ss_pred CCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HhcCC---------CCCCcccC
Confidence 467889999999999999999999999999999998 9999986654332221 11111 11122334
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHh
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e 837 (870)
...+.+++.+|++.+|++||++.|+++.|+++...+
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 240 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 567889999999999999999999999999976543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=352.69 Aligned_cols=243 Identities=27% Similarity=0.347 Sum_probs=198.2
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.+.||+|+||.||+|+.. ++.||||+++... ....+.+.+|..++..+ +||||+++++++.+....++||||
T Consensus 26 ~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~ 105 (353)
T 3txo_A 26 EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEF 105 (353)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeC
Confidence 45689999999999999986 7899999998652 23446678999999998 799999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++|+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.... ..
T Consensus 106 ~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~--~~ 178 (353)
T 3txo_A 106 VNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC--NG 178 (353)
T ss_dssp CCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc--CC
Confidence 9999999998653 4699999999999999999999998 999999999999999999999999999985422 22
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||............ .. +. ..+
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i----~~-~~----------~~~ 243 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI----LN-DE----------VVY 243 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HH-CC----------CCC
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH----Hc-CC----------CCC
Confidence 2344568999999999999889999999999999999999999999876544333222 11 11 111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTM------NQVVI 828 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm------~eVl~ 828 (870)
+......+.+++.+|++.+|++||++ .|+++
T Consensus 244 p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 244 PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 22234567899999999999999998 66654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=342.27 Aligned_cols=252 Identities=26% Similarity=0.424 Sum_probs=198.9
Q ss_pred hccccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCch
Q 002887 564 NFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNL 643 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 643 (870)
.+.+.||+|+||.||+|++.++.||||++... ...+.|.+|++++++++||||+++++++.+ ..++||||+++|+|
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L 86 (307)
T 2eva_A 11 EVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSL 86 (307)
T ss_dssp EEEEEEECCSSSEEEEEEETTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBH
T ss_pred eeeeEeecCCCceEEEEEECCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCH
Confidence 34678999999999999999999999998654 345778999999999999999999999874 47899999999999
Q ss_pred hhhhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCc-EEEEeccCCccccCCCCccccc
Q 002887 644 QAHLLEDKA-DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQ-AKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 644 ~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~-vkL~DFGla~~~~~~~~~~~~~ 721 (870)
.+++..... ..+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++...... ..
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~ 161 (307)
T 2eva_A 87 YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MT 161 (307)
T ss_dssp HHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------------
T ss_pred HHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----cc
Confidence 999975432 35789999999999999999999943349999999999999998886 799999999755221 22
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...........| ... .+.. .......
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~-~~~~---------~~~~~~~ 229 (307)
T 2eva_A 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW--AVH-NGTR---------PPLIKNL 229 (307)
T ss_dssp ---CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH--HHH-TTCC---------CCCBTTC
T ss_pred cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH--HHh-cCCC---------CCccccc
Confidence 346899999999999999999999999999999999999999765432211111 111 1111 1111223
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
...+.+++.+|++.+|++|||+.|+++.|+.+...
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 45688999999999999999999999999987543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=343.74 Aligned_cols=258 Identities=17% Similarity=0.198 Sum_probs=207.1
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
.+.+.||+|+||.||+|+.. ++.||||++..... .+.+.+|+++++++ +|+||+++++++..+...++||||+ +
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (330)
T 2izr_A 12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-G 88 (330)
T ss_dssp EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-C
Confidence 34579999999999999964 89999999876532 35689999999999 9999999999999999999999999 9
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCc-----EEEEeccCCccccCCC
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQ-----AKLADFGLSRIFPVEG 715 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~-----vkL~DFGla~~~~~~~ 715 (870)
++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.+....
T Consensus 89 ~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 89 PSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 9999998654 45799999999999999999999998 9999999999999999887 9999999998764332
Q ss_pred Ccc-----ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcc
Q 002887 716 GTH-----VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVD 790 (870)
Q Consensus 716 ~~~-----~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d 790 (870)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ........ .. ...
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~-~~~i~~~~-~~-~~~ 241 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKER-YQKIGDTK-RA-TPI 241 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHH-HHHHHHHH-HH-SCH
T ss_pred CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHH-HHHHHhhh-cc-CCH
Confidence 211 12456799999999999999999999999999999999999999987543332211 11111000 00 000
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 791 HRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 791 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
..+. ...+ .+.+++..|++.+|++||++.+|++.|+++...
T Consensus 242 ~~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 242 EVLC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp HHHT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 0000 0122 788999999999999999999999999987654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=344.05 Aligned_cols=266 Identities=23% Similarity=0.325 Sum_probs=210.2
Q ss_pred HHHHHhhccccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHH--hccccceeEEEEEecCC----eE
Q 002887 558 VLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIR--AHHKNLTILVGYCDEGA----NM 631 (870)
Q Consensus 558 l~~~t~~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~~~----~~ 631 (870)
.....+.+.+.||+|+||.||+|+..++.||||++.... .+.+.+|++++.. ++||||+++++++.... ..
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred cccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 334445667899999999999999999999999996542 3567889999988 79999999999998776 78
Q ss_pred EEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHH--------hCCCCCceeCCCCCCCEEEcCCCcEEEE
Q 002887 632 GLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH--------NGCKPPIVHRDVKSANILLNEKFQAKLA 703 (870)
Q Consensus 632 ~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH--------~~~~~~IvHrDLKp~NILld~~~~vkL~ 703 (870)
++||||+++|+|.+++.. ..+++..++.++.|++.||+||| +. +|+||||||+|||++.++++||+
T Consensus 116 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp EEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEEC
T ss_pred EEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEE
Confidence 999999999999999954 46899999999999999999999 66 99999999999999999999999
Q ss_pred eccCCccccCCCCcc--ccccccCCCCccCccccccCC------CCccchHHHHHHHHHHHHhC----------CCCCCC
Q 002887 704 DFGLSRIFPVEGGTH--VSTTVVGTPGYLDPEYYISNR------LTEKSDVYSFGVVLLELITG----------QPVIQK 765 (870)
Q Consensus 704 DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~------~~~ksDVwS~GvvL~elltG----------~~p~~~ 765 (870)
|||++.......... ......||+.|+|||++.+.. ++.++|||||||++|||++| +.||..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence 999998764332211 224457999999999997653 33689999999999999999 778865
Q ss_pred CCcc-chHHHHHHHHhhcCCcchhcccccCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHh
Q 002887 766 TPQR-TLIGQWVSSMLARGDIKNIVDHRLQGD-FDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837 (870)
Q Consensus 766 ~~~~-~~l~~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e 837 (870)
.... .....+........ . .+.+... ...+....+.+++.+||+.+|++|||+.||++.|+++...+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 270 LVPSDPSVEEMRKVVCEQK-L----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp TSCSSCCHHHHHHHHTTSC-C----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cCcCcccHHHHHHHHHHHH-h----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 4322 22333332222111 1 1111111 12366778999999999999999999999999999976543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=342.68 Aligned_cols=258 Identities=22% Similarity=0.326 Sum_probs=200.5
Q ss_pred hccccccccCcEEEEEEEEC-CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
.+.+.||+|+||.||+|+.. ++.||+|++..... ...+.+.+|++++++++||||+++++++.+....++||||+++
T Consensus 24 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 103 (311)
T 3niz_A 24 QKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK 103 (311)
T ss_dssp EEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE
T ss_pred HhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC
Confidence 34578999999999999986 88999999975432 2346788999999999999999999999999999999999985
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
+|.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 104 -~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~ 176 (311)
T 3niz_A 104 -DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP--VRSY 176 (311)
T ss_dssp -EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC--CC--
T ss_pred -CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC--cccc
Confidence 787777543 34689999999999999999999998 9999999999999999999999999999865322 2223
Q ss_pred ccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC--Ccchh------ccc
Q 002887 721 TTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG--DIKNI------VDH 791 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~--~~~~i------~d~ 791 (870)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........+.......-... ..... .+.
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 256 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR 256 (311)
T ss_dssp -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSC
T ss_pred cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhc
Confidence 44578999999999976 5689999999999999999999999987766555554433221110 00000 000
Q ss_pred ccC--CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 792 RLQ--GDFD-----TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 792 ~l~--~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
... .... .....++.+++.+|++.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 0000 112356789999999999999999999975
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=342.27 Aligned_cols=264 Identities=25% Similarity=0.343 Sum_probs=201.3
Q ss_pred HhhccccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHh--ccccceeEEEEEecC----CeEEEEE
Q 002887 562 TNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRA--HHKNLTILVGYCDEG----ANMGLIY 635 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l--~H~nIv~l~g~~~~~----~~~~LV~ 635 (870)
.+.+.+.||+|+||.||+|+..++.||||++..... ..+..|.+++..+ +||||+++++++... ...++||
T Consensus 38 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 114 (337)
T 3mdy_A 38 QIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLIT 114 (337)
T ss_dssp HCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEE
T ss_pred ceEEEeEeecCCCeEEEEEEECCceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEE
Confidence 445678999999999999999999999999865432 3445555555554 999999999999877 6889999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCC-----CCCceeCCCCCCCEEEcCCCcEEEEeccCCcc
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGC-----KPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~IvHrDLKp~NILld~~~~vkL~DFGla~~ 710 (870)
||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+|||+++.
T Consensus 115 e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 191 (337)
T 3mdy_A 115 DYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK 191 (337)
T ss_dssp CCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred eccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCcee
Confidence 99999999999953 36899999999999999999999752 44899999999999999999999999999976
Q ss_pred ccCCCCcc--ccccccCCCCccCccccccCCCCcc------chHHHHHHHHHHHHhC----------CCCCCCCCccchH
Q 002887 711 FPVEGGTH--VSTTVVGTPGYLDPEYYISNRLTEK------SDVYSFGVVLLELITG----------QPVIQKTPQRTLI 772 (870)
Q Consensus 711 ~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~k------sDVwS~GvvL~elltG----------~~p~~~~~~~~~l 772 (870)
+....... ......||+.|+|||++.+.....+ +|||||||++|||++| +.||.........
T Consensus 192 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~ 271 (337)
T 3mdy_A 192 FISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271 (337)
T ss_dssp CC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred eccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc
Confidence 64322211 1234579999999999988776665 9999999999999999 6666544322211
Q ss_pred HHHHHHHhhcCCcchhcccccCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 773 GQWVSSMLARGDIKNIVDHRLQGDF-DTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 773 ~~~~~~~~~~~~~~~i~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
.............. +.+.... .......+.+++.+||+.+|++|||+.||++.|+++..
T Consensus 272 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 272 YEDMREIVCIKKLR----PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp HHHHHHHHTTSCCC----CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhHHHHhhhccC----ccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 11112222111111 1111111 23677889999999999999999999999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=357.31 Aligned_cols=248 Identities=22% Similarity=0.297 Sum_probs=203.1
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
+.+.+.||+|+||.||++... ++.+|+|++.... ....+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 13 Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 92 (444)
T 3soa_A 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLV 92 (444)
T ss_dssp EEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeC
Confidence 455689999999999999875 8999999997653 234567899999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEc---CCCcEEEEeccCCccccCCC
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLN---EKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld---~~~~vkL~DFGla~~~~~~~ 715 (870)
++|+|.+.+... ..+++..+..++.|++.||+|||++ +|+||||||+|||++ +++.+||+|||+++.....
T Consensus 93 ~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~- 166 (444)
T 3soa_A 93 TGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE- 166 (444)
T ss_dssp BCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT-
T ss_pred CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC-
Confidence 999999988754 4689999999999999999999999 999999999999998 4678999999999866332
Q ss_pred CccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 716 GTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 716 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
........||+.|+|||++.+..++.++||||+||++|+|++|++||............. .+... . ..
T Consensus 167 -~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~-----~~~~~-~-----~~ 234 (444)
T 3soa_A 167 -QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK-----AGAYD-F-----PS 234 (444)
T ss_dssp -CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-----HTCCC-C-----CT
T ss_pred -CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-----hCCCC-C-----Cc
Confidence 222345689999999999999999999999999999999999999998665443332221 11110 0 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.........+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 235 PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111233457889999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=337.10 Aligned_cols=256 Identities=26% Similarity=0.369 Sum_probs=205.9
Q ss_pred hccccccccCcEEEEEEEEC-----CeeEEEEEeecc-chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD-----DKQVAVKMLSSS-SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-----~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.+.||+|+||.||+|+.. +..||+|++... .....+.+.+|++++++++||||+++++++.+ ...++||||
T Consensus 15 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 93 (281)
T 3cc6_A 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMEL 93 (281)
T ss_dssp EEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred EEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEec
Confidence 34689999999999999864 235999999765 33456789999999999999999999999875 456899999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++....... .
T Consensus 94 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 168 (281)
T 3cc6_A 94 YPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED-Y 168 (281)
T ss_dssp CTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred CCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccccc-c
Confidence 9999999998653 34689999999999999999999998 99999999999999999999999999998653321 1
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
.......+++.|+|||++.+..++.++||||||+++|||++ |+.||........... +..+.. ..
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~-----~~~~~~---------~~ 234 (281)
T 3cc6_A 169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV-----LEKGDR---------LP 234 (281)
T ss_dssp ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH-----HHHTCC---------CC
T ss_pred cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH-----HhcCCC---------CC
Confidence 22234567889999999999999999999999999999998 9999976554433221 111110 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHhHh
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAMEIA 839 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e~~ 839 (870)
........+.+++.+|++.+|++||++.|+++.|+++...+..
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 277 (281)
T 3cc6_A 235 KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277 (281)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence 1222345688999999999999999999999999998877643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=348.30 Aligned_cols=268 Identities=24% Similarity=0.361 Sum_probs=208.6
Q ss_pred hccccccccCcEEEEEEEE------CCeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEec--CCeEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYL------DDKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDE--GANMGLI 634 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~------~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~LV 634 (870)
.+.+.||+|+||.||++.+ .++.||||++.... ....+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 4567899999999999875 37889999998653 3446778999999999999999999999977 4678999
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
|||+++|+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 114 ~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp ECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 999999999999854 3589999999999999999999998 9999999999999999999999999999876433
Q ss_pred CCc-cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccch-HHHHHHHHhhcCCcchhcccc
Q 002887 715 GGT-HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTL-IGQWVSSMLARGDIKNIVDHR 792 (870)
Q Consensus 715 ~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~-l~~~~~~~~~~~~~~~i~d~~ 792 (870)
... .......++..|+|||++.+..++.++||||||++++||++|+.||........ ...+.........+.+.++..
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence 221 123345688899999999998999999999999999999999999875321100 000000000000111122222
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHh
Q 002887 793 LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837 (870)
Q Consensus 793 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e 837 (870)
............+.+++.+|++.+|++|||+.|+++.|+++...-
T Consensus 268 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 268 ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 222333445678899999999999999999999999999876543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=349.39 Aligned_cols=248 Identities=23% Similarity=0.359 Sum_probs=203.3
Q ss_pred HhhccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 562 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.+.+.||+|+||.||+|... ++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~ 109 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 109 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 3455689999999999999986 8899999997653 33456789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC---cEEEEeccCCccccCC
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF---QAKLADFGLSRIFPVE 714 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~---~vkL~DFGla~~~~~~ 714 (870)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||++......
T Consensus 110 ~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 110 VTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999999988643 4689999999999999999999998 999999999999998654 5999999999866322
Q ss_pred CCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccC
Q 002887 715 GGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794 (870)
Q Consensus 715 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 794 (870)
.......||+.|+|||++.+..++.++|||||||++|||++|++||............ ..+... ..
T Consensus 185 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-----~~~~~~------~~ 250 (362)
T 2bdw_A 185 ---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-----KAGAYD------YP 250 (362)
T ss_dssp ---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HHTCCC------CC
T ss_pred ---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-----HhCCCC------CC
Confidence 2234567999999999999989999999999999999999999999865543322221 111110 00
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 795 GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 795 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..........+.+++.+|++.||++||++.|+++
T Consensus 251 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 251 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0011233467889999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=351.76 Aligned_cols=265 Identities=18% Similarity=0.190 Sum_probs=205.8
Q ss_pred hhccccccccCcEEEEEEEEC-------CeeEEEEEeeccchhhh-----------HHHHHHHHHHHHhccccceeEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSSVQGY-----------KQFQAEVELLIRAHHKNLTILVGY 624 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~~~~~-----------~~f~~Ei~~l~~l~H~nIv~l~g~ 624 (870)
+.+.+.||+|+||.||+|.+. ++.||||++........ ..+..|+..+..++|+||++++++
T Consensus 37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~ 116 (364)
T 3op5_A 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS 116 (364)
T ss_dssp EEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEE
T ss_pred EEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEee
Confidence 345689999999999999874 36899999876542111 123345556666789999999999
Q ss_pred EecC----CeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEc--CCC
Q 002887 625 CDEG----ANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLN--EKF 698 (870)
Q Consensus 625 ~~~~----~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld--~~~ 698 (870)
+... ...++||||+ +++|.+++... ...+++..++.|+.|++.||+|||+. +|+||||||+|||++ .++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 117 GLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTT
T ss_pred eeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCC
Confidence 8764 4589999999 99999998653 35799999999999999999999999 999999999999999 889
Q ss_pred cEEEEeccCCccccCCCCc-----cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHH
Q 002887 699 QAKLADFGLSRIFPVEGGT-----HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIG 773 (870)
Q Consensus 699 ~vkL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~ 773 (870)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 9999999999876432211 11134459999999999999999999999999999999999999998644333333
Q ss_pred HHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 774 QWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 774 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
.+...... ..+.+++++.+.. ...+..+.+++..|++.+|++||++.+|++.|++++..
T Consensus 272 ~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 272 RDSKIRYR-ENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp HHHHHHHH-HCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhh-hhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 33322222 2344455554432 12345788999999999999999999999999998754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=347.22 Aligned_cols=246 Identities=18% Similarity=0.277 Sum_probs=203.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
.+.+.||+|+||.||++... ++.+|+|.+.... .....+.+|++++++++||||+++++++.+....++||||+++|
T Consensus 8 ~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~ 86 (321)
T 1tki_A 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred EeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCC
Confidence 45678999999999999986 7899999987543 34567899999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC--CCcEEEEeccCCccccCCCCccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE--KFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~--~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.+... ..
T Consensus 87 ~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~---~~ 159 (321)
T 1tki_A 87 DIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DN 159 (321)
T ss_dssp BHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT---CE
T ss_pred CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC---Cc
Confidence 999988543 34689999999999999999999998 9999999999999997 789999999999876322 22
Q ss_pred cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ .... .. .+... ..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i----~~~~-~~--~~~~~----~~ 228 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI----MNAE-YT--FDEEA----FK 228 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----HHTC-CC--CCHHH----HT
T ss_pred cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH----HcCC-CC--CChhh----hc
Confidence 34567999999999999888999999999999999999999999875543332222 1111 00 00000 01
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.....+.+++.+|++.||++|||+.|+++
T Consensus 229 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 229 EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 22457889999999999999999999987
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=334.50 Aligned_cols=252 Identities=26% Similarity=0.428 Sum_probs=207.9
Q ss_pred hccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 564 NFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
.+.+.||+|+||.||+|... ++.||+|++..... ..+.+.+|++++++++||||+++++++.+....++||||+++++
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (267)
T 3t9t_A 11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC 89 (267)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCB
T ss_pred eeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCc
Confidence 45678999999999999985 78899999986543 34678999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||++...... .......
T Consensus 90 L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~ 164 (267)
T 3t9t_A 90 LSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTG 164 (267)
T ss_dssp HHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHSTTS
T ss_pred HHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc-ccccccc
Confidence 99998653 34689999999999999999999998 9999999999999999999999999999865321 1112233
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
..++..|+|||++.+..++.++||||||+++|||++ |+.||........... . ..+. ....+...
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----i-~~~~---------~~~~~~~~ 230 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----I-STGF---------RLYKPRLA 230 (267)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----H-HTTC---------CCCCCTTS
T ss_pred ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH----H-hcCC---------cCCCCccC
Confidence 457788999999998999999999999999999999 8999986543332221 1 1111 01112223
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
...+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 231 STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 4568899999999999999999999999999764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=360.59 Aligned_cols=249 Identities=25% Similarity=0.331 Sum_probs=202.1
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
+.++||+|+||.||+|+.. ++.||+|++..... ...+.+.+|+.++.+++||||++++++|.+....++||||++
T Consensus 78 ~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~ 157 (437)
T 4aw2_A 78 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYV 157 (437)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCC
Confidence 3579999999999999986 78899999976432 223458999999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 158 gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~-~~~~ 232 (437)
T 4aw2_A 158 GGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQ 232 (437)
T ss_dssp TCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-SCEE
T ss_pred CCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccC-CCcc
Confidence 99999999653 35699999999999999999999998 9999999999999999999999999999866332 2233
Q ss_pred cccccCCCCccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccC
Q 002887 720 STTVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~-----~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 794 (870)
.....||+.|+|||++. ...++.++|||||||++|||++|++||..........+....... +.-+.
T Consensus 233 ~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------~~~p~-- 304 (437)
T 4aw2_A 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER------FQFPT-- 304 (437)
T ss_dssp CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH------CCCCS--
T ss_pred cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc------ccCCc--
Confidence 34568999999999997 457899999999999999999999999876544433332211110 00010
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 002887 795 GDFDTNTVWKAVEIALACIHTISTR--RPTMNQVVI 828 (870)
Q Consensus 795 ~~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~eVl~ 828 (870)
........+.+++.+|+..+|++ ||+++|+++
T Consensus 305 --~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 305 --QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp --SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred --ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 11123456789999999888888 999999876
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=337.21 Aligned_cols=248 Identities=30% Similarity=0.530 Sum_probs=200.6
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchh-------hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ-------GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLI 634 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~-------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 634 (870)
.+.+.||+|+||.||+|+.. ++.||+|++...... ..+.+.+|++++++++||||+++++++.+.. ++|
T Consensus 22 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv 99 (287)
T 4f0f_A 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMV 99 (287)
T ss_dssp EEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEE
T ss_pred eehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEE
Confidence 45678999999999999985 889999998654322 1267899999999999999999999997665 699
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCC--ceeCCCCCCCEEEcCCCc-----EEEEeccC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPP--IVHRDVKSANILLNEKFQ-----AKLADFGL 707 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--IvHrDLKp~NILld~~~~-----vkL~DFGl 707 (870)
|||+++|+|.+.+.+. ...+++..++.++.|++.||+|||+. + |+||||||+|||++.++. +||+|||+
T Consensus 100 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 100 MEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp EECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred EEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 9999999999888653 35799999999999999999999998 7 999999999999988776 99999999
Q ss_pred CccccCCCCccccccccCCCCccCccccc--cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCc
Q 002887 708 SRIFPVEGGTHVSTTVVGTPGYLDPEYYI--SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDI 785 (870)
Q Consensus 708 a~~~~~~~~~~~~~~~~gt~~y~APE~~~--~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~ 785 (870)
++... .......||+.|+|||++. ...++.++|||||||++|||++|+.||........ .........+
T Consensus 176 ~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~-- 246 (287)
T 4f0f_A 176 SQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI--KFINMIREEG-- 246 (287)
T ss_dssp CBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH--HHHHHHHHSC--
T ss_pred ccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH--HHHHHHhccC--
Confidence 97532 1234567999999999984 45578999999999999999999999986553322 1111111111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 786 KNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 786 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
............+.+++.+|++.+|++|||+.|+++.|+++
T Consensus 247 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 247 -------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11222334456788999999999999999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=334.24 Aligned_cols=257 Identities=21% Similarity=0.387 Sum_probs=209.6
Q ss_pred ccccccCcEEEEEEEE----CCeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 567 RVLGKGGFGTVYHGYL----DDKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~----~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.||+|+||.||+|.. .+..||||++.... ....+.+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 4899999999999986 36789999998753 34567799999999999999999999999 456789999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc-cc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH-VS 720 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~-~~ 720 (870)
+|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||++.......... ..
T Consensus 95 ~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 170 (287)
T 1u59_A 95 PLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 170 (287)
T ss_dssp EHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred CHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecc
Confidence 999988643 35699999999999999999999998 99999999999999999999999999998764332221 12
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......... .+..+. ....+.
T Consensus 171 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-----~i~~~~---------~~~~~~ 236 (287)
T 1u59_A 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-----FIEQGK---------RMECPP 236 (287)
T ss_dssp CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH-----HHHTTC---------CCCCCT
T ss_pred ccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH-----HHhcCC---------cCCCCC
Confidence 33456889999999998899999999999999999999 999998655433221 111111 112223
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHhHhhhc
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAMEIARTK 842 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e~~~~~ 842 (870)
.....+.+++.+|++.+|++||++.|+++.|+++........+
T Consensus 237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 279 (287)
T 1u59_A 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279 (287)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence 4456788999999999999999999999999998765444443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=346.60 Aligned_cols=254 Identities=26% Similarity=0.397 Sum_probs=199.5
Q ss_pred hccccccccCcEEEEEEEEC--Cee----EEEEEeecc-chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQ----VAVKMLSSS-SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~----vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
.+.+.||+|+||.||+|.+. ++. ||+|.+... .....+.+.+|+.++++++||||+++++++.... .++|+|
T Consensus 18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~ 96 (327)
T 3lzb_A 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQ 96 (327)
T ss_dssp EEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEEC
T ss_pred eEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEE
Confidence 34579999999999999974 443 577777543 3345678999999999999999999999998754 789999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
|+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 97 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 97 LMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp CCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred ecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 99999999998754 34689999999999999999999998 999999999999999999999999999987644333
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........... +..+. ..
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-----~~~~~---------~~ 238 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEKGE---------RL 238 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-----HHTTC---------CC
T ss_pred cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-----HHcCC---------CC
Confidence 333344567889999999999999999999999999999999 9999987655432211 11111 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
.........+.+++.+|++.+|++||++.|+++.|+++...
T Consensus 239 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 239 PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 12233445788999999999999999999999999997754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=338.40 Aligned_cols=256 Identities=16% Similarity=0.218 Sum_probs=207.2
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
.+.+.||+|+||.||+|... ++.||||++.... ..+.+.+|+.++.++ +|+|++++++++.+....++||||+ +
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 89 (298)
T 1csn_A 13 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 89 (298)
T ss_dssp EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-C
Confidence 45678999999999999964 8999999986543 345688999999999 8999999999999999999999999 9
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCc-----EEEEeccCCccccCCC
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQ-----AKLADFGLSRIFPVEG 715 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~-----vkL~DFGla~~~~~~~ 715 (870)
++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++. +||+|||+++......
T Consensus 90 ~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 90 PSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred CCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 9999998653 34699999999999999999999998 9999999999999987776 9999999998764332
Q ss_pred Cc-----cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHH--HHHHhhcCCcchh
Q 002887 716 GT-----HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQW--VSSMLARGDIKNI 788 (870)
Q Consensus 716 ~~-----~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~--~~~~~~~~~~~~i 788 (870)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+ +...........
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 244 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE- 244 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH-
T ss_pred ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH-
Confidence 21 1234567999999999999999999999999999999999999999875433222111 111111111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 789 VDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 789 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
+ ....+..+.+++.+|++.+|++||++.+|++.|+++..
T Consensus 245 ----~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 245 ----L----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp ----H----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred ----H----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 1 11234578899999999999999999999999999764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=349.58 Aligned_cols=243 Identities=21% Similarity=0.333 Sum_probs=197.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.+.||+|+||.||+++.. ++.||+|+++.... ...+.+.+|..++.++ +||||+++++++.+....++||||
T Consensus 55 ~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~ 134 (396)
T 4dc2_A 55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 134 (396)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEc
Confidence 45689999999999999986 78899999986532 2345678999999887 899999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++|+|..++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 135 ~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~--~ 207 (396)
T 4dc2_A 135 VNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--G 207 (396)
T ss_dssp CTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--T
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccC--C
Confidence 9999999988643 4699999999999999999999998 9999999999999999999999999999853222 2
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccch----HHHHHHHHhhcCCcchhccccc
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTL----IGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~----l~~~~~~~~~~~~~~~i~d~~l 793 (870)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...........+.
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--------- 278 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--------- 278 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC---------
T ss_pred CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc---------
Confidence 234567899999999999999999999999999999999999999964331110 1111111111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002887 794 QGDFDTNTVWKAVEIALACIHTISTRRPTM 823 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm 823 (870)
..++......+.+++.+||+.||++||++
T Consensus 279 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 -IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11222344578899999999999999995
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=352.19 Aligned_cols=264 Identities=18% Similarity=0.237 Sum_probs=204.4
Q ss_pred hhcccccccc--CcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEE
Q 002887 563 NNFERVLGKG--GFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 563 ~~f~~~LG~G--~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
+.+.+.||+| +||.||+|+.. ++.||||++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 106 (389)
T 3gni_B 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 106 (389)
T ss_dssp EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEE
Confidence 3456899999 99999999986 8899999997653 3345678899999999999999999999999999999999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
|+++|+|.+++.......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.+........
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~ 183 (389)
T 3gni_B 107 FMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183 (389)
T ss_dssp CCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred ccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence 99999999999876667799999999999999999999998 999999999999999999999999999875432211
Q ss_pred c-----cccccccCCCCccCcccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc-------
Q 002887 717 T-----HVSTTVVGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR------- 782 (870)
Q Consensus 717 ~-----~~~~~~~gt~~y~APE~~~~--~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~------- 782 (870)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........+.+........
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (389)
T 3gni_B 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI 263 (389)
T ss_dssp ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------
T ss_pred cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccc
Confidence 1 11223478999999999987 578999999999999999999999998765443332221111000
Q ss_pred --C-------------Ccchhcc---cc------cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 783 --G-------------DIKNIVD---HR------LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 783 --~-------------~~~~i~d---~~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
. ...+... +. ............+.+++.+||+.||++|||+.|+++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 0000000 00 0000112234568899999999999999999999853
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=343.27 Aligned_cols=254 Identities=27% Similarity=0.417 Sum_probs=201.4
Q ss_pred ccccccccCcEEEEEEEEC------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
+.+.||+|+||.||+|... +..||||++.... ......+.+|++++++++||||+++++++......++||||
T Consensus 48 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 127 (333)
T 1mqb_A 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 127 (333)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeC
Confidence 3478999999999999874 2359999997653 33456789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++|+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 128 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 203 (333)
T 1mqb_A 128 MENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203 (333)
T ss_dssp CTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred CCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence 9999999998653 35789999999999999999999998 9999999999999999999999999999876432211
Q ss_pred -cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 718 -HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 718 -~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
.......+++.|+|||++.+..++.++||||||+++|||++ |+.||.......... . +..+. ..
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~----~-~~~~~---------~~ 269 (333)
T 1mqb_A 204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK----A-INDGF---------RL 269 (333)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----H-HHTTC---------CC
T ss_pred ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHH----H-HHCCC---------cC
Confidence 11223456788999999999999999999999999999999 999997654432221 1 11111 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
.........+.+++.+||+.+|++||++.|+++.|++++..
T Consensus 270 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 270 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11223456788999999999999999999999999997754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=371.41 Aligned_cols=252 Identities=28% Similarity=0.431 Sum_probs=208.7
Q ss_pred hhccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
..+.+.||+|+||.||+|.+. +..||||+++... ...++|.+|++++++++|+||+++++++.+ ...++||||+++|
T Consensus 269 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~g 346 (535)
T 2h8h_A 269 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 346 (535)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTE
T ss_pred hhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCC
Confidence 345689999999999999998 5789999998654 235679999999999999999999999976 6789999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++.......+++.+++.|+.||++||+|||++ +|+||||||+|||+++++.+||+|||+++..... ......
T Consensus 347 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~ 422 (535)
T 2h8h_A 347 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQ 422 (535)
T ss_dssp EHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH-HHHTTC
T ss_pred cHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC-ceeccc
Confidence 999999765556799999999999999999999998 9999999999999999999999999999865321 111122
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
...++..|+|||++....++.++|||||||++|||++ |+.||........+.. +..+. .......
T Consensus 423 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~-----i~~~~---------~~~~~~~ 488 (535)
T 2h8h_A 423 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-----VERGY---------RMPCPPE 488 (535)
T ss_dssp STTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH-----HHTTC---------CCCCCTT
T ss_pred CCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCC---------CCCCCCC
Confidence 3456789999999999999999999999999999999 9999986554332221 11221 1112234
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
....+.+++.+||+.+|++|||+.+|+++|+++.
T Consensus 489 ~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 489 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 4567889999999999999999999999999865
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=351.90 Aligned_cols=248 Identities=19% Similarity=0.281 Sum_probs=205.3
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.+.||+|+||.||+|... ++.||+|++..........+.+|++++++++||||+++++++.+....++||||+++
T Consensus 53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~g 132 (387)
T 1kob_A 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132 (387)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence 345689999999999999985 788999999877655667899999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC--CCcEEEEeccCCccccCCCCcc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE--KFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~--~~~vkL~DFGla~~~~~~~~~~ 718 (870)
|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++..... .
T Consensus 133 g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~---~ 205 (387)
T 1kob_A 133 GELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---E 205 (387)
T ss_dssp CBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT---S
T ss_pred CcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC---c
Confidence 9999988643 34689999999999999999999998 9999999999999974 477999999999876332 2
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........+... .... . .......
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i----~~~~-~------~~~~~~~ 274 (387)
T 1kob_A 206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV----KRCD-W------EFDEDAF 274 (387)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH----HHCC-C------CCCSSTT
T ss_pred ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHH----HhCC-C------CCCcccc
Confidence 223457999999999999999999999999999999999999999875543332221 1111 0 0111111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
......+.+++.+||+.||++|||+.|+++
T Consensus 275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 233457889999999999999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=348.21 Aligned_cols=250 Identities=22% Similarity=0.326 Sum_probs=201.9
Q ss_pred HhhccccccccCcEEEEEEEEC--CeeEEEEEeeccch-----hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEE
Q 002887 562 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-----QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLI 634 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-----~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 634 (870)
.+.+.+.||+|+||.||+|... ++.||||++..... ...+.+.+|++++++++||||+++++++.+....++|
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 104 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV 104 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 4556789999999999999985 88999999875422 1356789999999999999999999999999999999
Q ss_pred EEEccCCchhhhhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCc---EEEEeccCCc
Q 002887 635 YEFMANGNLQAHLLEDK--ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQ---AKLADFGLSR 709 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~---vkL~DFGla~ 709 (870)
|||+++|+|.+.+.... ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++. +||+|||+++
T Consensus 105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 99999999988876542 24589999999999999999999998 9999999999999987655 9999999998
Q ss_pred cccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhc
Q 002887 710 IFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIV 789 (870)
Q Consensus 710 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~ 789 (870)
..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ..... .+... .
T Consensus 182 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~----~~~i~-~~~~~--~ 251 (351)
T 3c0i_A 182 QLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RL----FEGII-KGKYK--M 251 (351)
T ss_dssp ECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HH----HHHHH-HTCCC--C
T ss_pred EecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HH----HHHHH-cCCCC--C
Confidence 76332 2223456799999999999999999999999999999999999999976422 11 11111 11110 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 790 DHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 790 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.+... ......+.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 252 NPRQW----SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Ccccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 122457889999999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=351.18 Aligned_cols=268 Identities=22% Similarity=0.282 Sum_probs=212.8
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCC--eEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGA--NMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+|+.. ++.||||++..... ...+.+.+|++++++++||||+++++++.... ..++||||+
T Consensus 12 ~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~ 91 (396)
T 4eut_A 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91 (396)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCC
T ss_pred EEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecC
Confidence 45679999999999999986 88999999976532 34567889999999999999999999997755 779999999
Q ss_pred cCCchhhhhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEE----cCCCcEEEEeccCCccccC
Q 002887 639 ANGNLQAHLLEDKA-DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILL----NEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 639 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILl----d~~~~vkL~DFGla~~~~~ 713 (870)
++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++....
T Consensus 92 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~ 168 (396)
T 4eut_A 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (396)
T ss_dssp TTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred CCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence 99999999976433 3499999999999999999999998 99999999999999 7888899999999986532
Q ss_pred CCCccccccccCCCCccCcccccc--------CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCC-
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYIS--------NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGD- 784 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~--------~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~- 784 (870)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........+..........
T Consensus 169 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~ 245 (396)
T 4eut_A 169 ---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245 (396)
T ss_dssp ---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCT
T ss_pred ---CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCc
Confidence 222345679999999999865 46788999999999999999999999764432222232333322211
Q ss_pred --cchh---------cccc--cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHh
Q 002887 785 --IKNI---------VDHR--LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837 (870)
Q Consensus 785 --~~~i---------~d~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e 837 (870)
...+ .... ............+.+++.+|++.||++||++.|+++.+++++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 0000 0001 111234567788899999999999999999999999999987653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=344.69 Aligned_cols=247 Identities=21% Similarity=0.332 Sum_probs=194.3
Q ss_pred hccccccccCcEEEEEEEEC-CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhcc--ccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHH--KNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||++... ++.||||++.... ....+.+.+|++++.+++| +||+++++++......++||| +
T Consensus 12 ~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~ 90 (343)
T 3dbq_A 12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-C 90 (343)
T ss_dssp EEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-C
T ss_pred EEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-C
Confidence 45689999999999999886 7889999987543 3345778999999999976 999999999999999999999 6
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
.+|+|.+++... ..+++.++..++.|+++||+|||+. +|+||||||+|||++ ++.+||+|||+++.........
T Consensus 91 ~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 164 (343)
T 3dbq_A 91 GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 164 (343)
T ss_dssp CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence 788999998753 5689999999999999999999998 999999999999997 5789999999998764433333
Q ss_pred ccccccCCCCccCcccccc-----------CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcch
Q 002887 719 VSTTVVGTPGYLDPEYYIS-----------NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKN 787 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~-----------~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (870)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .. ...
T Consensus 165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~-~~~--------- 232 (343)
T 3dbq_A 165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SK-LHA--------- 232 (343)
T ss_dssp -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HH-HHH---------
T ss_pred cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH--HH-HHH---------
Confidence 3445689999999999865 678999999999999999999999997543321 11 111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 788 IVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 788 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
++++......+......+.+++.+||+.+|++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 233 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 122222222233334568899999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=341.68 Aligned_cols=240 Identities=25% Similarity=0.359 Sum_probs=201.5
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+++.. ++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 9 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~ 88 (318)
T 1fot_A 9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI 88 (318)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCC
Confidence 44579999999999999985 88999999976532 33466789999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~----- 158 (318)
T 1fot_A 89 EGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----- 158 (318)
T ss_dssp CSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----
T ss_pred CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC-----
Confidence 999999998643 4689999999999999999999998 999999999999999999999999999986532
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
......||+.|+|||++.+..++.++|+|||||++|||++|+.||..........+ ... +. + .++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~----i~~-~~--------~--~~p 223 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK----ILN-AE--------L--RFP 223 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHH-CC--------C--CCC
T ss_pred ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH----HHh-CC--------C--CCC
Confidence 22346799999999999999999999999999999999999999976544332222 221 11 0 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRP-----TMNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 828 (870)
......+.+++.+|++.+|++|| ++.|+++
T Consensus 224 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 224 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 22345788999999999999999 8888874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=342.92 Aligned_cols=258 Identities=26% Similarity=0.393 Sum_probs=205.0
Q ss_pred hhccccccccCcEEEEEEEE------CCeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecC--CeEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYL------DDKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEG--ANMGL 633 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~------~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~L 633 (870)
+.+.+.||+|+||.||+|++ .++.||||++.... ....+.+.+|++++++++||||+++++++... ...++
T Consensus 23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 102 (302)
T 4e5w_A 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 102 (302)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence 34567999999999999984 37899999997553 33457789999999999999999999999876 66899
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 103 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 103 IMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp EEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 99999999999998653 34689999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCc-cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC-----------ccchHHHHHHHHhh
Q 002887 714 EGGT-HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP-----------QRTLIGQWVSSMLA 781 (870)
Q Consensus 714 ~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~-----------~~~~l~~~~~~~~~ 781 (870)
.... .......||..|+|||++.+..++.++||||||+++|||++|+.|+.... ......... ....
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 257 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV-NTLK 257 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH-HHHH
T ss_pred CCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH-HHHh
Confidence 3222 22334568888999999999999999999999999999999999864321 011111111 1111
Q ss_pred cCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 782 RGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 782 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
.+ .....+......+.+++.+|++.+|++|||+.|++++|++++
T Consensus 258 ~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 258 EG---------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp TT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cc---------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11 112223344567889999999999999999999999999865
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=338.40 Aligned_cols=259 Identities=24% Similarity=0.324 Sum_probs=193.8
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
.+.+.||+|+||.||+|... ++.||+|++..... ...+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~- 86 (317)
T 2pmi_A 8 KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD- 86 (317)
T ss_dssp -----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-
T ss_pred eEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-
Confidence 34578999999999999875 88999999976533 334678899999999999999999999999999999999999
Q ss_pred Cchhhhhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 641 GNLQAHLLEDK----ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 641 gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
|+|.+++.... ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-- 161 (317)
T 2pmi_A 87 NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP-- 161 (317)
T ss_dssp CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSC--
T ss_pred CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCC--
Confidence 58988886542 24689999999999999999999998 9999999999999999999999999999875322
Q ss_pred ccccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC--Ccchh-----
Q 002887 717 THVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG--DIKNI----- 788 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~--~~~~i----- 788 (870)
........||+.|+|||++.+. .++.++|||||||++|||++|+.||........+.......-... .....
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (317)
T 2pmi_A 162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241 (317)
T ss_dssp CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence 1223345789999999999764 689999999999999999999999987665444443332211100 00000
Q ss_pred cccccC------------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 789 VDHRLQ------------GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 789 ~d~~l~------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..+... ..........+.+++.+|++.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000000 0001122357889999999999999999999875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=355.45 Aligned_cols=247 Identities=24% Similarity=0.309 Sum_probs=201.7
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
+.+.||+|+||.||+|+.. ++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++||||++
T Consensus 73 ~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ 152 (410)
T 3v8s_A 73 VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 152 (410)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 3579999999999999986 78899999976422 233558899999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 153 gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~-~~~~ 225 (410)
T 3v8s_A 153 GGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GMVR 225 (410)
T ss_dssp TEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-SEEE
T ss_pred CCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccC-Cccc
Confidence 9999998853 3589999999999999999999998 9999999999999999999999999999876322 2223
Q ss_pred cccccCCCCccCccccccCC----CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 720 STTVVGTPGYLDPEYYISNR----LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~----~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
.....||+.|+|||++.+.. ++.++|||||||++|||++|+.||..........++...... +..
T Consensus 226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-----------~~~ 294 (410)
T 3v8s_A 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS-----------LTF 294 (410)
T ss_dssp CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-----------CCC
T ss_pred ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc-----------ccC
Confidence 34678999999999998665 789999999999999999999999866544333332211110 000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002887 796 DFDTNTVWKAVEIALACIHTISTR--RPTMNQVVIE 829 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~eVl~~ 829 (870)
.........+.+++.+|++.+|++ ||++.||++.
T Consensus 295 p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 295 PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 111123456889999999999998 9999999863
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=334.93 Aligned_cols=255 Identities=27% Similarity=0.378 Sum_probs=203.6
Q ss_pred ccccccccCcEEEEEEEEC-----CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeE-EEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD-----DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANM-GLIYEF 637 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~-----~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~-~LV~Ey 637 (870)
..+.||+|+||.||+|.+. +..+|+|++.... ....+.+.+|++++++++||||+++++++.+.+.. ++||||
T Consensus 25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence 3478999999999999863 2369999987643 34557889999999999999999999999876655 999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC--
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG-- 715 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~-- 715 (870)
+.+|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 105 ~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 105 MCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp CTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred ccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 999999999865 345789999999999999999999998 99999999999999999999999999998653221
Q ss_pred CccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 716 GTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 716 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
.........+++.|+|||.+.+..++.++||||||+++|||++|..|+.............. .+. ..
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~----~~~---------~~ 247 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA----QGR---------RL 247 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH----TTC---------CC
T ss_pred ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh----cCC---------CC
Confidence 11122345678899999999999999999999999999999996555443333333222211 111 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
..+......+.+++.+|++.+|++|||+.|++++|++++..
T Consensus 248 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 248 PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11223345788999999999999999999999999997643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=343.04 Aligned_cols=252 Identities=23% Similarity=0.281 Sum_probs=198.8
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccc-----hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-----VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIY 635 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 635 (870)
+.+.+.||+|+||.||+|... ++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 28 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 107 (345)
T 3hko_A 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVM 107 (345)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEE
Confidence 445689999999999999985 7789999987542 344578999999999999999999999999999999999
Q ss_pred EEccCCchhhhhhhc--------------------------------------ccccccHHHHHHHHHHHHHHHHHHHhC
Q 002887 636 EFMANGNLQAHLLED--------------------------------------KADTLCWERRLQIASESAQGLEYLHNG 677 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~ 677 (870)
||+++|+|.+++... ....+++..+..++.|+++||+|||+.
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 187 (345)
T 3hko_A 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ 187 (345)
T ss_dssp ECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred eCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 999999999988421 022356788899999999999999999
Q ss_pred CCCCceeCCCCCCCEEEcCCC--cEEEEeccCCccccCCCCc--cccccccCCCCccCcccccc--CCCCccchHHHHHH
Q 002887 678 CKPPIVHRDVKSANILLNEKF--QAKLADFGLSRIFPVEGGT--HVSTTVVGTPGYLDPEYYIS--NRLTEKSDVYSFGV 751 (870)
Q Consensus 678 ~~~~IvHrDLKp~NILld~~~--~vkL~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~--~~~~~ksDVwS~Gv 751 (870)
+|+||||||+|||++.++ .+||+|||+++.+...... .......||+.|+|||++.+ ..++.++|||||||
T Consensus 188 ---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 188 ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp ---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred ---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 999999999999998776 8999999999865332211 12345679999999999975 67899999999999
Q ss_pred HHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 752 VLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 752 vL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
++|||++|+.||..........+. ...... ... .........+.+++.+|++.+|++||++.|+++
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~----~~~~~~--~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQV----LNKKLC--FEN-----PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHH----HHCCCC--TTS-----GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHCCCCCCCCChHHHHHHH----Hhcccc--cCC-----cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 999999999999876554433322 111100 000 001123457889999999999999999999986
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=347.81 Aligned_cols=242 Identities=25% Similarity=0.385 Sum_probs=201.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.+.||+|+||.||+|+.. ++.||+|+++... ....+.+..|..++.++ +||||+++++++.+....++||||
T Consensus 20 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~ 99 (345)
T 1xjd_A 20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEY 99 (345)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence 34689999999999999986 8899999998653 23345678899999987 999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 100 ~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~ 172 (345)
T 1xjd_A 100 LNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--D 172 (345)
T ss_dssp CTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--T
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccC--C
Confidence 9999999998643 4689999999999999999999998 9999999999999999999999999999854222 2
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
.......||+.|+|||++.+..++.++|+|||||++|||++|+.||........... ... +. ..+
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~----i~~-~~----------~~~ 237 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS----IRM-DN----------PFY 237 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHH-CC----------CCC
T ss_pred CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HHh-CC----------CCC
Confidence 224556899999999999999999999999999999999999999986554332222 111 11 111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMN-QVV 827 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~-eVl 827 (870)
+......+.+++.+|++.+|++||++. |++
T Consensus 238 p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 238 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 222345788999999999999999997 654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=337.45 Aligned_cols=260 Identities=24% Similarity=0.312 Sum_probs=202.7
Q ss_pred HhhccccccccCcEEEEEEEEC--CeeEEEEEeeccch-----hhhHHHHHHHHHHHHhc---cccceeEEEEEecCC--
Q 002887 562 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-----QGYKQFQAEVELLIRAH---HKNLTILVGYCDEGA-- 629 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-----~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~-- 629 (870)
.+.+.+.||+|+||.||+|+.. ++.||||++..... .....+.+|++++++++ ||||+++++++....
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~ 89 (308)
T 3g33_A 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD 89 (308)
T ss_dssp CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSS
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCC
Confidence 3455689999999999999964 88999999875421 12346678888877775 999999999997655
Q ss_pred ---eEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEecc
Q 002887 630 ---NMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFG 706 (870)
Q Consensus 630 ---~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFG 706 (870)
..++||||+. |+|.+++.......+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 90 REIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp SEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 4789999998 5999999776666699999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC--C
Q 002887 707 LSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG--D 784 (870)
Q Consensus 707 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~--~ 784 (870)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|++||........+.+.....-... .
T Consensus 166 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (308)
T 3g33_A 166 LARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242 (308)
T ss_dssp CTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 99865322 223456799999999999999999999999999999999999999987665555444433221110 0
Q ss_pred cch---hcccccCC--CC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 785 IKN---IVDHRLQG--DF-----DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 785 ~~~---i~d~~l~~--~~-----~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
... .....+.. .. ..+....+.+++.+|++.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 243 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp SCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 000 00000000 00 0123457889999999999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=334.25 Aligned_cols=258 Identities=19% Similarity=0.244 Sum_probs=198.9
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.+.+.||+|+||.||+|... ++.||||++..... ...+.+.+|++++++++||||+++++++.++...++||||++
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (292)
T 3o0g_A 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84 (292)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCC
Confidence 34578999999999999985 78899999976532 334678899999999999999999999999999999999998
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+ ++.+.+.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 85 ~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 157 (292)
T 3o0g_A 85 Q-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRC 157 (292)
T ss_dssp E-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC--CSC
T ss_pred C-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc--ccc
Confidence 6 55555543 235799999999999999999999999 9999999999999999999999999999865322 222
Q ss_pred cccccCCCCccCccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCC-ccchHHHHHHHHhhc--CCcc---hhcccc
Q 002887 720 STTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTP-QRTLIGQWVSSMLAR--GDIK---NIVDHR 792 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~-~~~ksDVwS~GvvL~elltG~~p~~~~~-~~~~l~~~~~~~~~~--~~~~---~i~d~~ 792 (870)
.....||+.|+|||++.+.. ++.++|||||||+++||++|+.|+.... ....+.......... .... ...+..
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 34567899999999998766 8999999999999999999888864443 333333322221111 0000 000000
Q ss_pred ---------cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 793 ---------LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 793 ---------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
............+.+++.+|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000111234567889999999999999999999975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=342.11 Aligned_cols=256 Identities=27% Similarity=0.387 Sum_probs=196.5
Q ss_pred hhccccccccCcEEEEEEEEC-----CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCe-----
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-----DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGAN----- 630 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-----~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----- 630 (870)
+.+.+.||+|+||.||+|... ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 115 (313)
T 3brb_A 36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPK 115 (313)
T ss_dssp EEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------C
T ss_pred eeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcc
Confidence 345678999999999999864 3479999987542 3445678999999999999999999999977553
Q ss_pred EEEEEEEccCCchhhhhhhc----ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEecc
Q 002887 631 MGLIYEFMANGNLQAHLLED----KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFG 706 (870)
Q Consensus 631 ~~LV~Ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFG 706 (870)
.++||||+++|+|.+++... ....+++..++.++.|+++||.|||+. +|+||||||+||++++++.+||+|||
T Consensus 116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecC
Confidence 49999999999999988542 335799999999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCc
Q 002887 707 LSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDI 785 (870)
Q Consensus 707 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~ 785 (870)
+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||............ . .+..
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~----~-~~~~ 267 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL----L-HGHR 267 (313)
T ss_dssp CC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH----H-TTCC
T ss_pred cceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH----H-cCCC
Confidence 9987643322223344567889999999999999999999999999999999 88999766544332221 1 1110
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 786 KNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 786 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
..........+.+++.+|++.+|++|||+.++++.|++++.
T Consensus 268 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 268 ---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp ---------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11122344578899999999999999999999999998764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=334.63 Aligned_cols=258 Identities=20% Similarity=0.299 Sum_probs=199.1
Q ss_pred hccccccccCcEEEEEEEEC-CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
.+.+.||+|+||.||+|+.. ++.||+|++..... ...+.+.+|++++++++||||+++++++......++||||+++
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (288)
T 1ob3_A 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ 84 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred hhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC
Confidence 34578999999999999987 88999999976532 2346788999999999999999999999999999999999985
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
+|.+++... ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 85 -~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 157 (288)
T 1ob3_A 85 -DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKY 157 (288)
T ss_dssp -EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred -CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcc--cccc
Confidence 888887543 35689999999999999999999998 9999999999999999999999999999865321 1223
Q ss_pred ccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC--Ccch-----hcccc
Q 002887 721 TTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG--DIKN-----IVDHR 792 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~--~~~~-----i~d~~ 792 (870)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||........+.+.....-... .... ..++.
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 345789999999999764 589999999999999999999999987665444443332211110 0000 00111
Q ss_pred cC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 793 LQ-------GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 793 l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.. ..........+.+++.+|++.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 10 0011223467789999999999999999999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=340.84 Aligned_cols=244 Identities=25% Similarity=0.367 Sum_probs=192.2
Q ss_pred hhccccccccCcEEEEEEEE-----CCeeEEEEEeeccc----hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYL-----DDKQVAVKMLSSSS----VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGL 633 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~-----~~~~vAVK~l~~~~----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 633 (870)
+.+.+.||+|+||.||+++. .++.||+|+++... ......+.+|++++++++||||+++++++......++
T Consensus 19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 98 (327)
T 3a62_A 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYL 98 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEE
T ss_pred eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEE
Confidence 34568999999999999987 37899999997653 2334567899999999999999999999999999999
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 99 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 99 ILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp EEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred EEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 99999999999998643 4688999999999999999999998 999999999999999999999999999975422
Q ss_pred CCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccccc
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||............ .. +.
T Consensus 174 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i----~~-~~--------- 237 (327)
T 3a62_A 174 D--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI----LK-CK--------- 237 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH----HH-TC---------
T ss_pred C--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHH----Hh-CC---------
Confidence 2 12234567999999999999999999999999999999999999999865543332221 11 11
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002887 794 QGDFDTNTVWKAVEIALACIHTISTRRP-----TMNQVVI 828 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 828 (870)
...+......+.+++.+|++.+|++|| ++.|+++
T Consensus 238 -~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 -LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 011223345788999999999999999 6777765
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=343.02 Aligned_cols=257 Identities=26% Similarity=0.395 Sum_probs=205.0
Q ss_pred hhccccccccCcEEEEEEEEC-------CeeEEEEEeecc-chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSS-SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLI 634 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 634 (870)
+.+.+.||+|+||.||+|++. ++.||||++... ......++.+|+.++++++||||+++++++......++|
T Consensus 32 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (327)
T 2yfx_A 32 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL 111 (327)
T ss_dssp CEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEE
Confidence 445689999999999999842 567999999754 334556789999999999999999999999999999999
Q ss_pred EEEccCCchhhhhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC---CCcEEEEecc
Q 002887 635 YEFMANGNLQAHLLEDKA-----DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE---KFQAKLADFG 706 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~---~~~vkL~DFG 706 (870)
|||+++|+|.+++..... ..+++..++.++.|++.||.|||+. +|+||||||+|||++. +..+||+|||
T Consensus 112 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Dfg 188 (327)
T 2yfx_A 112 MELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 188 (327)
T ss_dssp EECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECccc
Confidence 999999999999976532 4589999999999999999999998 9999999999999994 4469999999
Q ss_pred CCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCc
Q 002887 707 LSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDI 785 (870)
Q Consensus 707 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~ 785 (870)
+++...............|++.|+|||++.+..++.++||||||+++|||++ |+.||.......... . +..+..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~-~~~~~~ 263 (327)
T 2yfx_A 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE----F-VTSGGR 263 (327)
T ss_dssp HHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH----H-HHTTCC
T ss_pred cccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHH----H-HhcCCC
Confidence 9986543332233344568899999999999999999999999999999998 999997654332211 1 111111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 786 KNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 786 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
..........+.+++.+||+.+|++||++.|+++.|+.+...
T Consensus 264 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 264 ---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 111223345788999999999999999999999999987654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=341.10 Aligned_cols=243 Identities=22% Similarity=0.337 Sum_probs=197.6
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.+.||+|+||.||+++.. ++.||+|++.... ....+.+.+|..++.++ +||||+++++++......++||||
T Consensus 12 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~ 91 (345)
T 3a8x_A 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 91 (345)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeC
Confidence 44579999999999999986 8899999998653 23445688999999998 899999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++..... .
T Consensus 92 ~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~--~ 164 (345)
T 3a8x_A 92 VNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--G 164 (345)
T ss_dssp CCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT--T
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC--C
Confidence 9999999988643 4689999999999999999999998 9999999999999999999999999999854222 2
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccc----hHHHHHHHHhhcCCcchhccccc
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRT----LIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~----~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ............+..
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-------- 236 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-------- 236 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--------
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--------
Confidence 23345689999999999999999999999999999999999999997532111 011111111111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002887 794 QGDFDTNTVWKAVEIALACIHTISTRRPTM 823 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm 823 (870)
.++......+.+++.+||+.+|++||++
T Consensus 237 --~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 --RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred --CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1222344578899999999999999995
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=334.05 Aligned_cols=257 Identities=25% Similarity=0.399 Sum_probs=205.8
Q ss_pred ccc-cccccCcEEEEEEEEC----CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 565 FER-VLGKGGFGTVYHGYLD----DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 565 f~~-~LG~G~fG~Vy~~~~~----~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
+.+ .||+|+||.||+|.+. ++.||||++..... ...+++.+|++++++++||||+++++++ .....++||||
T Consensus 20 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~ 98 (291)
T 1xbb_A 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEM 98 (291)
T ss_dssp EEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEEC
T ss_pred hccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEe
Confidence 344 8999999999999652 57899999976532 3356799999999999999999999999 56778999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++++|.+++... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 99 AELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp CTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 9999999999653 4689999999999999999999998 9999999999999999999999999999876433222
Q ss_pred c-ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 718 H-VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 718 ~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
. ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......... ..+..+.. .
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-----~~~~~~~~---------~ 239 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-----AMLEKGER---------M 239 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-----HHHHTTCC---------C
T ss_pred ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-----HHHHcCCC---------C
Confidence 1 1223456789999999998889999999999999999999 99999865543221 11222211 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHhHhhh
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAMEIART 841 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e~~~~ 841 (870)
..+......+.+++.+|++.+|++||++.||++.|+++........
T Consensus 240 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 285 (291)
T 1xbb_A 240 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 285 (291)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcc
Confidence 1223345678899999999999999999999999999887654443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=336.76 Aligned_cols=254 Identities=29% Similarity=0.438 Sum_probs=201.5
Q ss_pred hccccccccCcEEEEEEEEC-----CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEe-cCCeEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD-----DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCD-EGANMGLIYE 636 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-----~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~-~~~~~~LV~E 636 (870)
.+.+.||+|+||.||+|... ...+|+|.+.... ....+.+.+|++++++++||||++++++|. .+...++|||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 107 (298)
T 3f66_A 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 107 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEE
T ss_pred hhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEe
Confidence 45689999999999999864 2358999987643 345577899999999999999999999864 4567899999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
|+++|+|.+++.. ....+++..++.++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 108 ~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 108 YMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp CCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred CCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 9999999999864 335689999999999999999999998 999999999999999999999999999986532211
Q ss_pred --ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhccccc
Q 002887 717 --THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 717 --~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
........+|+.|+|||.+.+..++.++||||||++++||++ |.+||............ . .+..
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~----~-~~~~-------- 250 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----L-QGRR-------- 250 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH----H-TTCC--------
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH----h-cCCC--------
Confidence 112234567889999999999999999999999999999999 55666654443322221 1 1110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 794 QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
...+......+.+++.+|++.+|++|||+.|++++|++++.
T Consensus 251 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 251 -LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 01112234568899999999999999999999999999765
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=348.57 Aligned_cols=248 Identities=20% Similarity=0.316 Sum_probs=195.7
Q ss_pred hhccccccccCcEEEEEEEEC-CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhc--cccceeEEEEEecCCeEEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAH--HKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
+.+.+.||+|+||.||++... ++.||||++.... ....+.+.+|++++.+++ |+||+++++++......++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 345679999999999999886 7889999997643 344577899999999996 5999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+.+++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++.+......
T Consensus 137 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 137 CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 6788999998754 4788999999999999999999998 999999999999996 579999999999876433333
Q ss_pred cccccccCCCCccCcccccc-----------CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcc
Q 002887 718 HVSTTVVGTPGYLDPEYYIS-----------NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIK 786 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~-----------~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~ 786 (870)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ......
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~~~------- 280 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAI------- 280 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHH-------
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH---HHHHHH-------
Confidence 33445689999999999865 368899999999999999999999997643221 111111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 787 NIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 787 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
+++......+......+.+++.+||+.+|++|||+.|+++.
T Consensus 281 --~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 281 --IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp --HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --hCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 22222122222224568899999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=344.34 Aligned_cols=245 Identities=25% Similarity=0.369 Sum_probs=186.3
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
.+.+.||+|+||.||+|+.. ++.||||++.... ..+.+.+|++++++++||||+++++++......++||||+++|
T Consensus 56 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 133 (349)
T 2w4o_A 56 EVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG 133 (349)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCC
Confidence 44679999999999999986 6789999997653 3466889999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC---CCcEEEEeccCCccccCCCCcc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE---KFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~---~~~vkL~DFGla~~~~~~~~~~ 718 (870)
+|.+++... ..+++.++..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++..... .
T Consensus 134 ~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~---~ 205 (349)
T 2w4o_A 134 ELFDRIVEK--GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---V 205 (349)
T ss_dssp BHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc---c
Confidence 999988643 4689999999999999999999998 9999999999999975 889999999999865321 2
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ..... +... ......
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~~i~~-~~~~------~~~~~~ 275 (349)
T 2w4o_A 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF---RRILN-CEYY------FISPWW 275 (349)
T ss_dssp -------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHH---HHHHT-TCCC------CCTTTT
T ss_pred ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHH---HHHHh-CCCc------cCCchh
Confidence 2345679999999999999999999999999999999999999997654432211 11111 1110 011111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
......+.+++.+|++.||++|||+.|+++
T Consensus 276 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 234557889999999999999999999876
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=329.04 Aligned_cols=246 Identities=22% Similarity=0.340 Sum_probs=202.9
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.+.||+|+||.||+|... +..+|+|++........+.+.+|++++++++||||+++++++.+....++||||+++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (277)
T 3f3z_A 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG 90 (277)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCC
Confidence 445689999999999999986 668999999877666678899999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEE---cCCCcEEEEeccCCccccCCCCc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILl---d~~~~vkL~DFGla~~~~~~~~~ 717 (870)
++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++......
T Consensus 91 ~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~--- 162 (277)
T 3f3z_A 91 GELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--- 162 (277)
T ss_dssp CBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT---
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc---
Confidence 9999988643 4689999999999999999999998 99999999999999 78899999999999865322
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
.......||+.|+|||.+.+. ++.++||||||++++||++|+.||...........+ ..+... ......
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~-~~~~~~---- 231 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI-----REGTFT-FPEKDW---- 231 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HHCCCC-CCHHHH----
T ss_pred cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH-----HhCCCC-CCchhh----
Confidence 223455799999999998654 899999999999999999999999875543332221 111110 000000
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
......+.+++.+|++.+|++|||+.|+++
T Consensus 232 -~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 232 -LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 022457889999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=335.62 Aligned_cols=260 Identities=22% Similarity=0.311 Sum_probs=198.7
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeecc---chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS---SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
+.+.+.||+|+||.||+|... ++.||||++... .....+.+.+|++++++++||||+++++++......++||||
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 113 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 113 (310)
T ss_dssp EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEec
Confidence 345689999999999999974 889999999753 234456789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhc--ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 638 MANGNLQAHLLED--KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 638 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
+++|+|.+++... ....+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~- 189 (310)
T 2wqm_A 114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 189 (310)
T ss_dssp CCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred CCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC-
Confidence 9999999988653 245689999999999999999999998 9999999999999999999999999999865322
Q ss_pred CccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 716 GTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 716 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
........|++.|+|||++.+..++.++||||||+++|||++|+.||...... ...+... ...+....
T Consensus 190 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~-~~~~~~~~-------- 257 (310)
T 2wqm_A 190 -TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKK-IEQCDYPP-------- 257 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC--HHHHHHH-HHTTCSCC--------
T ss_pred -CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh--HHHHHHH-hhcccCCC--------
Confidence 12223457899999999999999999999999999999999999999754321 1122211 11111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHhH
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAMEI 838 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e~ 838 (870)
.........+.+++.+|++.||++|||+.||++.|+++.+...
T Consensus 258 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 258 LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 0112234578899999999999999999999999999775543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=345.13 Aligned_cols=243 Identities=25% Similarity=0.350 Sum_probs=200.6
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.+.||+|+||.||+|+.. ++.||+|++.... ....+.+..|..++..+ +||+|+++++++.+....++||||
T Consensus 23 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~ 102 (353)
T 2i0e_A 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 102 (353)
T ss_dssp EEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeC
Confidence 45689999999999999986 6789999998653 23446678899999887 899999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 103 ~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~ 175 (353)
T 2i0e_A 103 VNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--G 175 (353)
T ss_dssp CCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--T
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccC--C
Confidence 9999999998643 4689999999999999999999998 9999999999999999999999999999854222 2
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
.......||+.|+|||++.+..++.++|+|||||++|||++|+.||........... ... +. ..+
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~----i~~-~~----------~~~ 240 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IME-HN----------VAY 240 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHH-CC----------CCC
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHH----HHh-CC----------CCC
Confidence 233456899999999999999999999999999999999999999986554332222 221 11 112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPT-----MNQVVI 828 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~ 828 (870)
+......+.+++.+|++.+|++||+ ++|+++
T Consensus 241 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 241 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 2234467889999999999999995 466654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=338.96 Aligned_cols=261 Identities=21% Similarity=0.291 Sum_probs=207.1
Q ss_pred cccCHHHHHHHHhhcc-ccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHh-ccccceeEEEE
Q 002887 551 RKFSYFDVLKITNNFE-RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRA-HHKNLTILVGY 624 (870)
Q Consensus 551 ~~~~~~dl~~~t~~f~-~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l-~H~nIv~l~g~ 624 (870)
..|...+.....+.+. +.||+|+||.||+|... ++.||+|++..... .....+.+|+.++.++ +||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3344444444444444 78999999999999986 88999999986533 3356789999999999 56999999999
Q ss_pred EecCCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC---CCcEE
Q 002887 625 CDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE---KFQAK 701 (870)
Q Consensus 625 ~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~---~~~vk 701 (870)
+.+....++||||+++|+|.+++.......+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+|
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence 99999999999999999999998766667899999999999999999999998 9999999999999998 78999
Q ss_pred EEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhh
Q 002887 702 LADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLA 781 (870)
Q Consensus 702 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~ 781 (870)
|+|||+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..............
T Consensus 175 L~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~---- 247 (327)
T 3lm5_A 175 IVDFGMSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ---- 247 (327)
T ss_dssp ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----
T ss_pred EeeCccccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh----
Confidence 9999999876322 222346799999999999999999999999999999999999999987654333222111
Q ss_pred cCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 782 RGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 782 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.. ..............+.+++.+|++.+|++|||+.|+++
T Consensus 248 -~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 248 -VN------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp -TC------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -cc------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 00 00111112234456889999999999999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=339.35 Aligned_cols=245 Identities=22% Similarity=0.251 Sum_probs=192.1
Q ss_pred HHHHhhccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEE
Q 002887 559 LKITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGL 633 (870)
Q Consensus 559 ~~~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~L 633 (870)
....+...+.||+|+||+||+|+.. ++.||||++.... .....++..|+..+.++ +|+||++++++|.++...++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3344556689999999999999986 8899999986542 23334556666666665 99999999999999999999
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
||||+ +++|.+++... ...++|..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 135 v~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred EEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 99999 66888887654 35699999999999999999999998 999999999999999999999999999986532
Q ss_pred CCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccccc
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
........||+.|+|||++.+ .++.++|||||||++|||++|..|+..... .. .+..+.... .+
T Consensus 210 ---~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~-----~~~~~~~~~----~~ 273 (311)
T 3p1a_A 210 ---AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQ-----QLRQGYLPP----EF 273 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HH-----HHTTTCCCH----HH
T ss_pred ---CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HH-----HHhccCCCc----cc
Confidence 222345579999999999875 789999999999999999999776643211 11 111111111 11
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 794 QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.......+.+++.+|++.+|++|||+.|+++
T Consensus 274 ----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 274 ----TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1123457889999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=368.28 Aligned_cols=250 Identities=22% Similarity=0.393 Sum_probs=202.6
Q ss_pred cccccCcEEEEEEEEC----CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 568 VLGKGGFGTVYHGYLD----DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 568 ~LG~G~fG~Vy~~~~~----~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
.||+|+||.||+|.+. +..||||+++... ....++|.+|++++++++||||++++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999873 4579999998653 3356789999999999999999999999976 56899999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc-ccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH-VST 721 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~-~~~ 721 (870)
|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.+....... ...
T Consensus 422 L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 422 LHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp HHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 99998653 45699999999999999999999998 99999999999999999999999999998764322111 122
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
...+++.|+|||++.+..++.++|||||||++|||++ |+.||.......... .+..+. ....+..
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~-----~i~~~~---------~~~~p~~ 563 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-----FIEQGK---------RMECPPE 563 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH-----HHHTTC---------CCCCCTT
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-----HHHcCC---------CCCCCCc
Confidence 3346789999999999999999999999999999998 999998765433221 122221 1122334
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
....+.+++.+||+.+|++||++.+|++.|+++...
T Consensus 564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 564 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 556788999999999999999999999999987643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=342.47 Aligned_cols=261 Identities=20% Similarity=0.219 Sum_probs=196.9
Q ss_pred hhccccccccCcEEEEEEEEC-----CeeEEEEEeeccchh-----------hhHHHHHHHHHHHHhccccceeEEEEEe
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-----DKQVAVKMLSSSSVQ-----------GYKQFQAEVELLIRAHHKNLTILVGYCD 626 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-----~~~vAVK~l~~~~~~-----------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~ 626 (870)
+.+.+.||+|+||.||+|... +..+|||+....... ....+.+|+..+..++||||+++++++.
T Consensus 39 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~ 118 (345)
T 2v62_A 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGL 118 (345)
T ss_dssp EEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEE
T ss_pred EEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccc
Confidence 345689999999999999984 578999998765321 1234667888899999999999999998
Q ss_pred c----CCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC--cE
Q 002887 627 E----GANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF--QA 700 (870)
Q Consensus 627 ~----~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~--~v 700 (870)
. ....++||||+ +++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+
T Consensus 119 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 119 TEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSE
T ss_pred cccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcE
Confidence 7 77899999999 999999986543 799999999999999999999998 999999999999999887 99
Q ss_pred EEEeccCCccccCCCC-----ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002887 701 KLADFGLSRIFPVEGG-----THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQW 775 (870)
Q Consensus 701 kL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~ 775 (870)
||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 9999999987633211 11124557999999999999999999999999999999999999999643222221121
Q ss_pred HHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 776 VSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 776 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
........ ....+..... .......+.+++.+|++.+|++||++.+|++.|++.
T Consensus 273 ~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 273 AKTNLLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHhhccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 22111111 1111111110 112345788999999999999999999999999874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=343.27 Aligned_cols=262 Identities=23% Similarity=0.372 Sum_probs=195.2
Q ss_pred hccccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHH--HHHhccccceeEEEEEe-----cCCeEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVEL--LIRAHHKNLTILVGYCD-----EGANMGLIYE 636 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~--l~~l~H~nIv~l~g~~~-----~~~~~~LV~E 636 (870)
.+.+.||+|+||.||+|+..++.||||++..... ..+..|.++ +..++|+||+++++.+. .....++|||
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 92 (336)
T 3g2f_A 16 KLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVME 92 (336)
T ss_dssp EEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEEC
T ss_pred heeeecccCCCeEEEEEEECCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEe
Confidence 3457999999999999999999999999975432 334444444 45589999999998653 2335789999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCC------CCCceeCCCCCCCEEEcCCCcEEEEeccCCcc
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGC------KPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------~~~IvHrDLKp~NILld~~~~vkL~DFGla~~ 710 (870)
|+++|+|.+++.. ...++..+..++.|+++||+|||+.+ .++|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~ 169 (336)
T 3g2f_A 93 YYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169 (336)
T ss_dssp CCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceee
Confidence 9999999999954 34589999999999999999999763 33899999999999999999999999999987
Q ss_pred ccCCCC------ccccccccCCCCccCcccccc-------CCCCccchHHHHHHHHHHHHhCCCCCCCCCccch------
Q 002887 711 FPVEGG------THVSTTVVGTPGYLDPEYYIS-------NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTL------ 771 (870)
Q Consensus 711 ~~~~~~------~~~~~~~~gt~~y~APE~~~~-------~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~------ 771 (870)
+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~ 249 (336)
T 3g2f_A 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249 (336)
T ss_dssp CSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTH
T ss_pred cccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhh
Confidence 643211 112234579999999999976 3566789999999999999999777644321110
Q ss_pred --------HHHHHHHHhhcCCcchhcccccCCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 772 --------IGQWVSSMLARGDIKNIVDHRLQGD--FDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 772 --------l~~~~~~~~~~~~~~~i~d~~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
...+ ......... .+.+... ........+.+++.+||+.+|++|||+.|+++.|++++..
T Consensus 250 ~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 250 TEVGNHPTFEDM-QVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp HHHCSSCCHHHH-HHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cccCCCchHHHH-Hhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 0111 111111111 1111111 1234667899999999999999999999999999997733
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=342.90 Aligned_cols=242 Identities=24% Similarity=0.340 Sum_probs=199.5
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+|... ++.||||++..... ...+.+.+|+++++.++||||+++++++......++||||+
T Consensus 12 ~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 91 (336)
T 3h4j_B 12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA 91 (336)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC
Confidence 45689999999999999984 88999999976422 23457899999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
+|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++...... .
T Consensus 92 -~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~---~ 162 (336)
T 3h4j_B 92 -GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---N 162 (336)
T ss_dssp -CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS---B
T ss_pred -CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC---c
Confidence 68998888653 4689999999999999999999999 9999999999999999999999999999865322 2
Q ss_pred ccccccCCCCccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~-~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... ..+.... ...
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------------~~i~~~~--~~~ 227 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-------------KKVNSCV--YVM 227 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-------------CCCCSSC--CCC
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-------------HHHHcCC--CCC
Confidence 2345679999999999988775 78999999999999999999999764322110 0010000 112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
+......+.+++.+|++.||++|||+.|+++.
T Consensus 228 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 228 PDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 23345678899999999999999999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=344.84 Aligned_cols=249 Identities=20% Similarity=0.285 Sum_probs=194.0
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.+.||+|+||.||+++.. ++.||||++..... ..+.+.+|+.++++++||||+++++++......++||||+++
T Consensus 22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 100 (361)
T 3uc3_A 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG 100 (361)
T ss_dssp EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCC
Confidence 345689999999999999986 88999999976532 346788999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCc--EEEEeccCCccccCCCCcc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQ--AKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~--vkL~DFGla~~~~~~~~~~ 718 (870)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++..... .
T Consensus 101 ~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~---~ 172 (361)
T 3uc3_A 101 GELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---S 172 (361)
T ss_dssp CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc---C
Confidence 9999988643 4699999999999999999999998 9999999999999988775 999999999743211 2
Q ss_pred ccccccCCCCccCccccccCCCCcc-chHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEK-SDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~k-sDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
......||+.|+|||++.+..++.+ +|||||||++|||++|+.||..........+......... .....
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~---------~~~~~ 243 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK---------YSIPD 243 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC---------CCCCT
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC---------CCCCC
Confidence 2234579999999999988887665 8999999999999999999987665444444443333211 11111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
.......+.+++.+||+.+|++|||+.|+++.
T Consensus 244 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11234567899999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=342.64 Aligned_cols=259 Identities=16% Similarity=0.169 Sum_probs=205.5
Q ss_pred hccccccccCcEEEEEEEEC----------CeeEEEEEeeccchhhhHHHHHHHHHHHHhcccccee-------------
Q 002887 564 NFERVLGKGGFGTVYHGYLD----------DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTI------------- 620 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~----------~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~------------- 620 (870)
.+.+.||+|+||.||+|+.. ++.||||++... +.+.+|++++++++||||++
T Consensus 45 ~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 119 (352)
T 2jii_A 45 KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI 119 (352)
T ss_dssp EEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC
T ss_pred EEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCc
Confidence 45689999999999999874 578999998754 46889999999999999987
Q ss_pred --EEEEEec-CCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC
Q 002887 621 --LVGYCDE-GANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK 697 (870)
Q Consensus 621 --l~g~~~~-~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~ 697 (870)
+++++.. ....++||||+ +++|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||++.+
T Consensus 120 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 120 PTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPE 195 (352)
T ss_dssp CCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEETT
T ss_pred cchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcCC
Confidence 6777765 67889999999 99999999866557899999999999999999999999 99999999999999999
Q ss_pred C--cEEEEeccCCccccCCCCc-----cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC-cc
Q 002887 698 F--QAKLADFGLSRIFPVEGGT-----HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP-QR 769 (870)
Q Consensus 698 ~--~vkL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~-~~ 769 (870)
+ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 275 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT 275 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH
Confidence 8 9999999999866432211 11234579999999999999999999999999999999999999998654 22
Q ss_pred chHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 770 TLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 770 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
..+.......... ...+.+.... .......+.+++.+|++.+|++||++.||+++|++++..
T Consensus 276 ~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 276 EDIMKQKQKFVDK--PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp HHHHHHHHHHHHS--CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCC--hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 2222222222111 1111111100 112246788999999999999999999999999997644
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=330.09 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=202.7
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.+.+.||+|+||.||+|... ++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 88 (284)
T 3kk8_A 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 88 (284)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCC
Confidence 34579999999999999986 7899999997653 3345678899999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCc---EEEEeccCCccccCCCC
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQ---AKLADFGLSRIFPVEGG 716 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~---vkL~DFGla~~~~~~~~ 716 (870)
+++|.+.+... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++......
T Consensus 89 ~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~-- 161 (284)
T 3kk8_A 89 GGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-- 161 (284)
T ss_dssp SCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS--
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC--
Confidence 99999888643 4689999999999999999999998 9999999999999987665 999999999765322
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
.......|++.|+|||++.+..++.++||||||+++++|++|+.||............. .+... ....
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-----~~~~~------~~~~ 229 (284)
T 3kk8_A 162 -EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK-----AGAYD------YPSP 229 (284)
T ss_dssp -CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HTCCC------CCTT
T ss_pred -ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH-----hcccc------CCch
Confidence 22334679999999999999999999999999999999999999997655433322221 11110 0001
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
........+.+++.+|++.+|++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 230 EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 112234568899999999999999999999873
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=349.06 Aligned_cols=245 Identities=22% Similarity=0.325 Sum_probs=188.9
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHH-hccccceeEEEEEec----CCeEEEEEEEcc
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIR-AHHKNLTILVGYCDE----GANMGLIYEFMA 639 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~-l~H~nIv~l~g~~~~----~~~~~LV~Ey~~ 639 (870)
+.||+|+||.||++... ++.||||++... ..+.+|++++.+ .+||||+++++++.. ....++||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 68999999999999986 788999998643 456788888755 489999999998865 567899999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC---CCcEEEEeccCCccccCCCC
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE---KFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~---~~~vkL~DFGla~~~~~~~~ 716 (870)
+|+|.+++.......+++..+..|+.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 143 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~-- 217 (400)
T 1nxk_A 143 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-- 217 (400)
T ss_dssp SEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCC--
Confidence 99999999765556799999999999999999999998 9999999999999998 789999999999865321
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||............. ..+..+... +...
T Consensus 218 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-~~i~~~~~~------~~~~ 289 (400)
T 1nxk_A 218 -NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-TRIRMGQYE------FPNP 289 (400)
T ss_dssp ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH-HHHHHTCCC------CCTT
T ss_pred -CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH-HHHHcCccc------CCCc
Confidence 22345678999999999999999999999999999999999999997654322100000 111111110 0001
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
........+.+++.+||+.||++|||+.|+++.
T Consensus 290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 112334578899999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=330.71 Aligned_cols=246 Identities=24% Similarity=0.376 Sum_probs=203.9
Q ss_pred HHHhhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEec----------
Q 002887 560 KITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDE---------- 627 (870)
Q Consensus 560 ~~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~---------- 627 (870)
...+...+.||+|+||.||+|... ++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 334455689999999999999986 8899999997653 467899999999999999999998854
Q ss_pred ------CCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEE
Q 002887 628 ------GANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAK 701 (870)
Q Consensus 628 ------~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vk 701 (870)
....++||||+++|+|.+++.......+++..++.++.|++.||.|||+. +|+||||||+||++++++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEE
Confidence 44578999999999999999876667899999999999999999999998 999999999999999999999
Q ss_pred EEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhh
Q 002887 702 LADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLA 781 (870)
Q Consensus 702 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~ 781 (870)
|+|||++....... ......|++.|+|||++.+..++.++||||||+++|||++|..|+... ..+.. .+.
T Consensus 163 l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------~~~~~-~~~ 232 (284)
T 2a19_B 163 IGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------SKFFT-DLR 232 (284)
T ss_dssp ECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH------HHHHH-HHH
T ss_pred ECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH------HHHHH-Hhh
Confidence 99999998764322 223457999999999999999999999999999999999999886421 11111 111
Q ss_pred cCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 782 RGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 782 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
.+.. .......+.+++.+|++.+|++|||+.|+++.|+.+.
T Consensus 233 ~~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 233 DGII------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp TTCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred cccc------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 1111 1122345779999999999999999999999998764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=370.10 Aligned_cols=249 Identities=25% Similarity=0.415 Sum_probs=201.5
Q ss_pred ccccccCcEEEEEEEEC----CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLD----DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~----~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.||+|+||.||+|.+. ++.||||+++.... ...+++.+|++++++++||||++++++|.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999763 57899999986533 335789999999999999999999999965 568899999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc-cc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT-HV 719 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~-~~ 719 (870)
|+|.+++.. ...+++..++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.+...... ..
T Consensus 454 g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 999999964 35689999999999999999999998 9999999999999999999999999999876433221 22
Q ss_pred cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......... ..+..+. ....+
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-----~~i~~~~---------~~~~p 594 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-----AMLEKGE---------RMGCP 594 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-----HHHHTTC---------CCCCC
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----HHHHcCC---------CCCCC
Confidence 233457789999999999999999999999999999998 99999876543322 1122221 11223
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
......+.+++.+||+.+|++||++.+|+++|+++..
T Consensus 595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 595 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 3445678899999999999999999999999998653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=344.74 Aligned_cols=240 Identities=22% Similarity=0.329 Sum_probs=201.6
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+++.. ++.||+|++..... ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 44 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 123 (350)
T 1rdq_E 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123 (350)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCC
Confidence 34579999999999999985 88999999976532 33467889999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 ~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---- 194 (350)
T 1rdq_E 124 AGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp TTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC----
Confidence 999999998653 4689999999999999999999998 9999999999999999999999999999865321
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ . .+.. .++
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i----~-~~~~----------~~p 258 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----V-SGKV----------RFP 258 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----H-HCCC----------CCC
T ss_pred -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHH----H-cCCC----------CCC
Confidence 23467999999999999999999999999999999999999999865443322221 1 1111 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPT-----MNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~ 828 (870)
......+.+++.+|++.||++||+ +.|+++
T Consensus 259 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 233457889999999999999998 777764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=361.04 Aligned_cols=248 Identities=26% Similarity=0.342 Sum_probs=205.7
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+|+.. ++.||+|++..... .....+.+|++++++++||||+++++++.+....++||||+
T Consensus 187 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~ 266 (576)
T 2acx_A 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 266 (576)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcC
Confidence 34578999999999999985 88999999976532 33456889999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|+|.+++.......+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 267 ~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~---~ 340 (576)
T 2acx_A 267 NGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---Q 340 (576)
T ss_dssp CSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT---C
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC---c
Confidence 999999999766556699999999999999999999998 9999999999999999999999999999876322 2
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.................. . ...++
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~----------~~~~p 409 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-V----------PEEYS 409 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-C----------CCCCC
T ss_pred cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-c----------cccCC
Confidence 233458999999999999989999999999999999999999999875533222222222111 1 11122
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRP-----TMNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 828 (870)
......+.+++.+|++.||++|| ++.||++
T Consensus 410 ~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 410 ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 33446788999999999999999 7788865
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=343.35 Aligned_cols=255 Identities=23% Similarity=0.364 Sum_probs=193.9
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCe----EEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGAN----MGL 633 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----~~L 633 (870)
+.+.+.||+|+||.||+|+.. ++.||||++.... ......+.+|++++++++||||+++++++..... .++
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~l 93 (311)
T 3ork_A 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 93 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEE
Confidence 345689999999999999974 8899999997653 2334678999999999999999999999876543 499
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 94 v~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 94 VMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 99999999999998643 4689999999999999999999998 999999999999999999999999999986643
Q ss_pred CCCc-cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccc
Q 002887 714 EGGT-HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHR 792 (870)
Q Consensus 714 ~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 792 (870)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..........+ ......... ..
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~----~~~~~~~~~---~~ 241 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ----HVREDPIPP---SA 241 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHCCCCCH---HH
T ss_pred cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HhcCCCCCc---cc
Confidence 2221 222345799999999999999999999999999999999999999986554332222 121111100 00
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH-HHHHHh
Q 002887 793 LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVV-IELNDC 833 (870)
Q Consensus 793 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl-~~L~~~ 833 (870)
. .......+.+++.+|++.||++||+..+++ +.+...
T Consensus 242 ~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 242 R----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp H----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred c----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0 112345688999999999999999666655 455443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=349.68 Aligned_cols=254 Identities=28% Similarity=0.432 Sum_probs=195.4
Q ss_pred hccccccccCcEEEEEEEEC---C--eeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEec-CCeEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD---D--KQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDE-GANMGLIYE 636 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~---~--~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~LV~E 636 (870)
.+.+.||+|+||.||+|.+. + ..||||.+.... ....++|.+|+.++++++||||++++++|.+ ....++|||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence 34578999999999999863 2 358999987543 3456789999999999999999999999754 457899999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
|+++|+|.+++.. ....+++..++.++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 172 ~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 172 YMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp CCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 9999999999864 335689999999999999999999998 999999999999999999999999999986533221
Q ss_pred c--cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhccccc
Q 002887 717 T--HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 717 ~--~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
. .......+++.|+|||++.+..++.++|||||||++|||++ |.+||........... ...+..
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~-----~~~~~~-------- 314 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-----LLQGRR-------- 314 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH-----HHTTCC--------
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH-----HHcCCC--------
Confidence 1 11233467889999999999999999999999999999999 6778876554332221 111110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 794 QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
...+......+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 315 -~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 315 -LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 01122334578899999999999999999999999998764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=337.28 Aligned_cols=246 Identities=21% Similarity=0.300 Sum_probs=194.1
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCC-----------
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGA----------- 629 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----------- 629 (870)
.+.+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 9 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~ 88 (332)
T 3qd2_B 9 EPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEI 88 (332)
T ss_dssp EEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-
T ss_pred ceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhh
Confidence 45689999999999999985 8899999997543 335577999999999999999999999986543
Q ss_pred ----------------------------------------------eEEEEEEEccCCchhhhhhhccc-ccccHHHHHH
Q 002887 630 ----------------------------------------------NMGLIYEFMANGNLQAHLLEDKA-DTLCWERRLQ 662 (870)
Q Consensus 630 ----------------------------------------------~~~LV~Ey~~~gsL~~~l~~~~~-~~l~~~~~~~ 662 (870)
..++||||+++|+|.+++..... ...++..++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 168 (332)
T 3qd2_B 89 WLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLH 168 (332)
T ss_dssp -------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHH
T ss_pred hhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHH
Confidence 27899999999999999976433 4567778999
Q ss_pred HHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc----------cccccccCCCCccCc
Q 002887 663 IASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT----------HVSTTVVGTPGYLDP 732 (870)
Q Consensus 663 i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~----------~~~~~~~gt~~y~AP 732 (870)
++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........ .......||+.|+||
T Consensus 169 i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 245 (332)
T 3qd2_B 169 IFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245 (332)
T ss_dssp HHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred HHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence 999999999999998 9999999999999999999999999999876433211 122345799999999
Q ss_pred cccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHc
Q 002887 733 EYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALAC 812 (870)
Q Consensus 733 E~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C 812 (870)
|++.+..++.++|||||||++|||++|..|+.. ..... .......... ........+.+++.+|
T Consensus 246 E~~~~~~~~~~~Di~slG~il~el~~~~~~~~~------~~~~~-~~~~~~~~~~---------~~~~~~~~~~~li~~~ 309 (332)
T 3qd2_B 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQME------RVRII-TDVRNLKFPL---------LFTQKYPQEHMMVQDM 309 (332)
T ss_dssp HHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH------HHHHH-HHHHTTCCCH---------HHHHHCHHHHHHHHHH
T ss_pred HHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH------HHHHH-HHhhccCCCc---------ccccCChhHHHHHHHH
Confidence 999999999999999999999999998776421 11111 1111111110 0123345678999999
Q ss_pred cccCCCCCCCHHHHHH
Q 002887 813 IHTISTRRPTMNQVVI 828 (870)
Q Consensus 813 l~~dP~~RPsm~eVl~ 828 (870)
++.+|++|||+.|+++
T Consensus 310 l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 310 LSPSPTERPEATDIIE 325 (332)
T ss_dssp HCSSGGGSCCHHHHHH
T ss_pred ccCCCCcCCCHHHHhh
Confidence 9999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=337.27 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=203.8
Q ss_pred HhhccccccccCcEEEEEEEEC--CeeEEEEEeeccchh------hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEE
Q 002887 562 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ------GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGL 633 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 633 (870)
.+.+.+.||+|+||.||+|... ++.||+|++...... ..+.+.+|++++++++||||+++++++.+....++
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (321)
T 2a2a_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92 (321)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3456789999999999999986 889999999765322 35678999999999999999999999999999999
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC----cEEEEeccCCc
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF----QAKLADFGLSR 709 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~----~vkL~DFGla~ 709 (870)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++ .+||+|||++.
T Consensus 93 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 93 ILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 9999999999999864 35689999999999999999999998 999999999999999888 79999999998
Q ss_pred cccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhc
Q 002887 710 IFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIV 789 (870)
Q Consensus 710 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~ 789 (870)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||............ . .... -.
T Consensus 168 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i----~-~~~~--~~ 237 (321)
T 2a2a_A 168 EIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI----T-SVSY--DF 237 (321)
T ss_dssp ECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH----H-TTCC--CC
T ss_pred ecCcc---ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH----H-hccc--cc
Confidence 76332 1223457999999999999999999999999999999999999999765543332221 1 1100 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 790 DHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 790 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
++... ......+.+++.+|++.+|++|||+.|+++
T Consensus 238 ~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 238 DEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred Chhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000 122356889999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=339.10 Aligned_cols=252 Identities=23% Similarity=0.300 Sum_probs=186.2
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhc-cccceeEEEEEe--------cCCeE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAH-HKNLTILVGYCD--------EGANM 631 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~--------~~~~~ 631 (870)
+.+.+.||+|+||.||+|+.. ++.||||++........+.+.+|+.++.++. ||||+++++++. .....
T Consensus 30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 109 (337)
T 3ll6_A 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109 (337)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEE
T ss_pred EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceE
Confidence 345689999999999999984 8899999997776666778999999999996 999999999993 34458
Q ss_pred EEEEEEccCCchhhhhhhc-ccccccHHHHHHHHHHHHHHHHHHHhCCCCC--ceeCCCCCCCEEEcCCCcEEEEeccCC
Q 002887 632 GLIYEFMANGNLQAHLLED-KADTLCWERRLQIASESAQGLEYLHNGCKPP--IVHRDVKSANILLNEKFQAKLADFGLS 708 (870)
Q Consensus 632 ~LV~Ey~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--IvHrDLKp~NILld~~~~vkL~DFGla 708 (870)
++||||+. |+|.+++... ....+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++
T Consensus 110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 110 LLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred EEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 89999996 7898888653 335699999999999999999999998 7 999999999999999999999999999
Q ss_pred ccccCCCCcc----------ccccccCCCCccCcccc---ccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002887 709 RIFPVEGGTH----------VSTTVVGTPGYLDPEYY---ISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQW 775 (870)
Q Consensus 709 ~~~~~~~~~~----------~~~~~~gt~~y~APE~~---~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~ 775 (870)
+......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--- 262 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV--- 262 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh---
Confidence 8764322111 11244689999999998 5667899999999999999999999999754322111
Q ss_pred HHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 776 VSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 776 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
...............+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 263 --------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 263 --------------NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp -----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------------cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0111111111222347789999999999999999999999998764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=327.16 Aligned_cols=248 Identities=22% Similarity=0.333 Sum_probs=203.0
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
+.+.+.||+|+||.||+|... ++.||||++.... ....+.+.+|+.++++++||||+++++++.++...++||||++
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (276)
T 2yex_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (276)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecC
Confidence 345689999999999999986 8899999997553 3345778999999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++...........
T Consensus 89 ~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 89 GGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp TEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 9999998853 34689999999999999999999998 999999999999999999999999999986643322233
Q ss_pred cccccCCCCccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccc-hHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 720 STTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPQRT-LIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~~-~~ksDVwS~GvvL~elltG~~p~~~~~~~~-~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
.....|++.|+|||.+.+..+ +.++||||||++++||++|+.||....... ....|.. .... ...
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~---------~~~ 230 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE----KKTY---------LNP 230 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT----TCTT---------STT
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh----cccc---------cCc
Confidence 345679999999999987664 789999999999999999999998655432 2222211 1000 001
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.......+.+++.+|++.+|++|||+.|+++
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 1233456789999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=344.57 Aligned_cols=245 Identities=24% Similarity=0.338 Sum_probs=200.5
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||++... ++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 18 ~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 97 (384)
T 4fr4_A 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLL 97 (384)
T ss_dssp EEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecC
Confidence 45689999999999999986 7889999997643 234567889999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|+|..++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+... .
T Consensus 98 ~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~---~ 169 (384)
T 4fr4_A 98 LGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---T 169 (384)
T ss_dssp TTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT---C
T ss_pred CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC---C
Confidence 99999999864 34699999999999999999999998 9999999999999999999999999999876322 2
Q ss_pred ccccccCCCCccCcccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 719 VSTTVVGTPGYLDPEYYIS---NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~---~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||........ ......... .. .
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-~~~~~~~~~-~~----------~ 237 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFET-TV----------V 237 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-HHHHHHHHH-CC----------C
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-HHHHHHHhh-cc----------c
Confidence 3345689999999999974 4589999999999999999999999975443221 121111111 10 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPT-MNQVVI 828 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-m~eVl~ 828 (870)
.++......+.+++.+||+.+|++||+ +.+|.+
T Consensus 238 ~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 122334467889999999999999998 666653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=340.46 Aligned_cols=242 Identities=27% Similarity=0.382 Sum_probs=197.9
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
...+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|++++++++||||+++++++......++||||+
T Consensus 57 ~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 136 (348)
T 1u5q_A 57 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 136 (348)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecC
Confidence 34578999999999999974 8899999997542 234567899999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
. |+|.+.+... ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 137 ~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----- 206 (348)
T 1u5q_A 137 L-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 206 (348)
T ss_dssp S-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred C-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----
Confidence 8 6787777543 35789999999999999999999998 999999999999999999999999999986532
Q ss_pred ccccccCCCCccCccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 719 VSTTVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~---~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
.....||+.|+|||++. .+.++.++|||||||++|||++|+.||........+.. ...... +.+
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~----~~~~~~------~~~-- 273 (348)
T 1u5q_A 207 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNES------PAL-- 273 (348)
T ss_dssp -BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCC------CCC--
T ss_pred -CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHhcCC------CCC--
Confidence 23457999999999985 56789999999999999999999999976543332222 111110 111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
........+.+++.+||+.+|++|||+.|+++.
T Consensus 274 -~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 274 -QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111234567899999999999999999999863
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=357.76 Aligned_cols=243 Identities=24% Similarity=0.332 Sum_probs=193.1
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+|... ++.||||++.... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 151 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 230 (446)
T 4ejn_A 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 230 (446)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCC
T ss_pred EEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeC
Confidence 34579999999999999975 8899999997642 233456788999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHh-CCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
++|+|.+++... ..+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 231 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~ 303 (446)
T 4ejn_A 231 NGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--G 303 (446)
T ss_dssp SSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCC--C
Confidence 999999988643 478999999999999999999998 7 9999999999999999999999999999854222 2
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||............ .... ..+
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i----~~~~-----------~~~ 368 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI----LMEE-----------IRF 368 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HHCC-----------CCC
T ss_pred cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH----HhCC-----------CCC
Confidence 2334578999999999999999999999999999999999999999765543322221 1111 011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRP-----TMNQVVI 828 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 828 (870)
+......+.+++.+||+.||++|| +++|+++
T Consensus 369 p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 369 PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 223345788999999999999999 9999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=339.80 Aligned_cols=245 Identities=23% Similarity=0.347 Sum_probs=179.1
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhc-cccceeEEEEEecCCeEEEEEEEccCCch
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAH-HKNLTILVGYCDEGANMGLIYEFMANGNL 643 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 643 (870)
+.||+|+||.||+|... ++.||||++... ....+.+|+.++++++ ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 68999999999999986 789999999754 3456789999999997 99999999999999999999999999999
Q ss_pred hhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC---cEEEEeccCCccccCCCCcccc
Q 002887 644 QAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF---QAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 644 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~---~vkL~DFGla~~~~~~~~~~~~ 720 (870)
.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++..... ....
T Consensus 94 ~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~~ 166 (325)
T 3kn6_A 94 FERIKKK--KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPL 166 (325)
T ss_dssp HHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC--CCcc
Confidence 9998653 5799999999999999999999998 999999999999998765 8999999999865322 2233
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCcc---chHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQR---TLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~---~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+.... +..+... .....
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-i~~~~~~------~~~~~ 239 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-IKKGDFS------FEGEA 239 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH-HTTTCCC------CCSHH
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH-HHcCCCC------CCccc
Confidence 4567899999999999999999999999999999999999999764421 111121111 1122110 00000
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.......+.+++.+|++.||++|||+.|+++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0123467889999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=337.67 Aligned_cols=259 Identities=27% Similarity=0.428 Sum_probs=207.6
Q ss_pred hccccccccCcEEEEEEEE------CCeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCC--eEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYL------DDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGA--NMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~------~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~LV~ 635 (870)
.+.+.||+|+||.||++++ .++.||||++........+.+.+|++++++++||||+++++++.... ..++||
T Consensus 44 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 123 (326)
T 2w1i_A 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM 123 (326)
T ss_dssp EEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEE
T ss_pred eeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEE
Confidence 4568999999999999985 37899999998776666788999999999999999999999987654 689999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
||+++|+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 124 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 124 EYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp CCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred ECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 999999999998654 34689999999999999999999998 99999999999999999999999999998764332
Q ss_pred Ccc-ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCcc-----------chHHHHHHHHhhcC
Q 002887 716 GTH-VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQR-----------TLIGQWVSSMLARG 783 (870)
Q Consensus 716 ~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~-----------~~l~~~~~~~~~~~ 783 (870)
... ......++..|+|||.+.+..++.++||||||++++||++|+.|+...... ..........+.
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 277 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK-- 277 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH--
T ss_pred cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh--
Confidence 211 123345778899999999988999999999999999999999988642110 000001111111
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 784 DIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 784 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
..............+.+++.+|++.+|++|||+.||++.|+++..
T Consensus 278 -------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 278 -------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp -------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111112233445678899999999999999999999999998754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=339.22 Aligned_cols=254 Identities=30% Similarity=0.460 Sum_probs=203.6
Q ss_pred hhccccccccCcEEEEEEEEC--Cee--EEEEEeecc-chhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQ--VAVKMLSSS-SVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~--vAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
+.+.+.||+|+||.||+|+.. +.. +|+|.+... .....+.+.+|+++++++ +||||+++++++.+....++|||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 106 (327)
T 1fvr_A 27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 106 (327)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEe
Confidence 345689999999999999875 554 499998754 233456789999999999 99999999999999999999999
Q ss_pred EccCCchhhhhhhcc--------------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEE
Q 002887 637 FMANGNLQAHLLEDK--------------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKL 702 (870)
Q Consensus 637 y~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL 702 (870)
|+++|+|.+++.... ...+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEE
Confidence 999999999987543 24689999999999999999999998 9999999999999999999999
Q ss_pred EeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhh
Q 002887 703 ADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLA 781 (870)
Q Consensus 703 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~ 781 (870)
+|||+++.... ........+++.|+|||++.+..++.++||||||+++|||++ |+.||......... .. +.
T Consensus 184 ~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~----~~-~~ 255 (327)
T 1fvr_A 184 ADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY----EK-LP 255 (327)
T ss_dssp CCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HH-GG
T ss_pred cccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH----HH-hh
Confidence 99999874321 112233457889999999998889999999999999999998 99999765433221 11 11
Q ss_pred cCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 782 RGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 782 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
.+. ...........+.+++.+|++.+|++|||+.|+++.|++++..
T Consensus 256 ~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 256 QGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp GTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111 1112223446788999999999999999999999999997754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=338.96 Aligned_cols=255 Identities=22% Similarity=0.258 Sum_probs=201.7
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhc-----cccceeEEEEEecCCeEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAH-----HKNLTILVGYCDEGANMGLIY 635 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-----H~nIv~l~g~~~~~~~~~LV~ 635 (870)
+.+.+.||+|+||.||+|+.. ++.||||++.... ...+.+..|++++++++ ||||+++++++......++||
T Consensus 37 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~ 115 (360)
T 3llt_A 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIF 115 (360)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEE
T ss_pred EEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEE
Confidence 344689999999999999984 8899999997542 34456788999999996 999999999999999999999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC-------------------
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE------------------- 696 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~------------------- 696 (870)
||+ +++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 116 e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 191 (360)
T 3llt_A 116 EPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191 (360)
T ss_dssp CCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred cCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhcccccccc
Confidence 999 89999999876666799999999999999999999998 9999999999999975
Q ss_pred ------CCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccc
Q 002887 697 ------KFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRT 770 (870)
Q Consensus 697 ------~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~ 770 (870)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 192 ~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 266 (360)
T 3llt_A 192 QIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHME 266 (360)
T ss_dssp EEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHH
Confidence 789999999999864321 234678999999999999999999999999999999999999998765443
Q ss_pred hHHHHHHHHhhcCC-----------cchhccc-----ccCCCCC-H---------------HHHHHHHHHHHHccccCCC
Q 002887 771 LIGQWVSSMLARGD-----------IKNIVDH-----RLQGDFD-T---------------NTVWKAVEIALACIHTIST 818 (870)
Q Consensus 771 ~l~~~~~~~~~~~~-----------~~~i~d~-----~l~~~~~-~---------------~~~~~l~~l~~~Cl~~dP~ 818 (870)
.+..... ....-. ....++. .+..... . .....+.+++.+||+.||+
T Consensus 267 ~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 345 (360)
T 3llt_A 267 HLAMMES-IIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPT 345 (360)
T ss_dssp HHHHHHH-HTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHH-hcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChh
Confidence 3322211 110000 0000000 0000000 0 0115677999999999999
Q ss_pred CCCCHHHHHH
Q 002887 819 RRPTMNQVVI 828 (870)
Q Consensus 819 ~RPsm~eVl~ 828 (870)
+|||+.|+++
T Consensus 346 ~Rpta~elL~ 355 (360)
T 3llt_A 346 LRPSPAELLK 355 (360)
T ss_dssp GSCCHHHHTT
T ss_pred hCCCHHHHhc
Confidence 9999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=333.99 Aligned_cols=258 Identities=22% Similarity=0.302 Sum_probs=196.9
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.+.+.||+|+||.||+|... ++.||||++..... ...+.+.+|++++++++||||+++++++......++||||++
T Consensus 6 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (311)
T 4agu_A 6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD 85 (311)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCC
Confidence 34578999999999999986 88999999866532 235678899999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...... ...
T Consensus 86 ~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 158 (311)
T 4agu_A 86 HTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP--SDY 158 (311)
T ss_dssp EEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc--ccc
Confidence 9999887753 35689999999999999999999998 9999999999999999999999999999875322 222
Q ss_pred cccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHh----------hcCC-cc-
Q 002887 720 STTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSML----------ARGD-IK- 786 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~----------~~~~-~~- 786 (870)
.....||+.|+|||++.+ ..++.++||||||++++||++|+.||................- .... ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 345578999999999976 5689999999999999999999999987664443332221110 0000 00
Q ss_pred -hhcccccCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 787 -NIVDHRLQGDF---DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 787 -~i~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.+.++.-.... .......+.+++.+|++.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000000000 0123456889999999999999999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=349.45 Aligned_cols=248 Identities=23% Similarity=0.285 Sum_probs=199.9
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
+.+.||+|+||.||+++.. ++.||+|++..... ...+.+.+|..++.+++||||+++++++.+....++||||++
T Consensus 65 ~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~ 144 (412)
T 2vd5_A 65 ILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYV 144 (412)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCC
Confidence 3478999999999999985 88999999976432 234568899999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+|+|.+++.+. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++..... ....
T Consensus 145 gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~-~~~~ 219 (412)
T 2vd5_A 145 GGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD-GTVR 219 (412)
T ss_dssp SCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-SCEE
T ss_pred CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCC-Cccc
Confidence 99999999653 34789999999999999999999998 9999999999999999999999999999876432 2222
Q ss_pred cccccCCCCccCccccc-------cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccc
Q 002887 720 STTVVGTPGYLDPEYYI-------SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHR 792 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~-------~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 792 (870)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||..........++...... +.-+
T Consensus 220 ~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~------~~~p- 292 (412)
T 2vd5_A 220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH------LSLP- 292 (412)
T ss_dssp CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH------CCCC-
T ss_pred cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC------cCCC-
Confidence 34568999999999997 356899999999999999999999999876544333332211100 0001
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHH
Q 002887 793 LQGDFDTNTVWKAVEIALACIHTISTRR---PTMNQVVI 828 (870)
Q Consensus 793 l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Psm~eVl~ 828 (870)
.........+.+++.+|++ +|++| |+++|+++
T Consensus 293 ---~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 293 ---LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp -------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ---ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 0112234578899999999 99998 58888864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=348.44 Aligned_cols=259 Identities=23% Similarity=0.393 Sum_probs=190.7
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHhc-cccceeEEEEEecCC--eEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRAH-HKNLTILVGYCDEGA--NMGLIY 635 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~--~~~LV~ 635 (870)
+.+.+.||+|+||.||+|... ++.||||++... .....+.+.+|+.++.++. ||||+++++++...+ ..++||
T Consensus 11 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 90 (388)
T 3oz6_A 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVF 90 (388)
T ss_dssp EEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEE
T ss_pred eEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEe
Confidence 345689999999999999875 889999998653 3344567889999999997 999999999997543 689999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
|||+ |+|..++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 91 e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 91 DYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp ECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred cccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 9998 588888853 4689999999999999999999998 99999999999999999999999999998653211
Q ss_pred -------------------CccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002887 716 -------------------GTHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQW 775 (870)
Q Consensus 716 -------------------~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~ 775 (870)
.........||+.|+|||++.+ ..++.++|||||||+++||++|++||.+......+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 1112344579999999999986 67899999999999999999999999877654444443
Q ss_pred HHHHhhcCCcchh-----------c----------ccccCCCC------------CHHHHHHHHHHHHHccccCCCCCCC
Q 002887 776 VSSMLARGDIKNI-----------V----------DHRLQGDF------------DTNTVWKAVEIALACIHTISTRRPT 822 (870)
Q Consensus 776 ~~~~~~~~~~~~i-----------~----------d~~l~~~~------------~~~~~~~l~~l~~~Cl~~dP~~RPs 822 (870)
.. .+.......+ + .......+ .......+.+++.+||+.||++|||
T Consensus 244 ~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 244 IG-VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HH-HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HH-hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 32 1111000000 0 00000000 0022456889999999999999999
Q ss_pred HHHHHHH
Q 002887 823 MNQVVIE 829 (870)
Q Consensus 823 m~eVl~~ 829 (870)
+.|+++.
T Consensus 323 ~~e~l~H 329 (388)
T 3oz6_A 323 ANDALKH 329 (388)
T ss_dssp HHHHTTS
T ss_pred HHHHhCC
Confidence 9999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=329.15 Aligned_cols=242 Identities=28% Similarity=0.403 Sum_probs=198.7
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+|... ++.||+|++..... .....+.+|++++++++||||+++++++.+....++||||+
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (279)
T 3fdn_A 12 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA 91 (279)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecC
Confidence 34578999999999999986 67899999876432 23467899999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..... .
T Consensus 92 ~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~----~ 162 (279)
T 3fdn_A 92 PLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----S 162 (279)
T ss_dssp TTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc----c
Confidence 999999988643 4689999999999999999999998 999999999999999999999999999865422 1
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
......|++.|+|||.+.+..++.++||||||++++||++|+.||............ . .. ....+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~-~~----------~~~~~ 227 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----S-RV----------EFTFP 227 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----H-HT----------CCCCC
T ss_pred cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH----H-hC----------CCCCC
Confidence 223457899999999999999999999999999999999999999865533322211 1 11 01122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
......+.+++.+|++.+|++|||+.|+++.
T Consensus 228 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 228 DFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 2334567899999999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.95 Aligned_cols=247 Identities=24% Similarity=0.389 Sum_probs=201.4
Q ss_pred HhhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 562 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.+.+.+.||+|+||.||+++.. ++.||+|++........+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS 89 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCC
Confidence 3456689999999999999985 88999999987655555678999999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEE---cCCCcEEEEeccCCccccCCCC
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILl---d~~~~vkL~DFGla~~~~~~~~ 716 (870)
+++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++ ++++.+||+|||++.....
T Consensus 90 ~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~--- 161 (304)
T 2jam_A 90 GGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--- 161 (304)
T ss_dssp SCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC---
T ss_pred CccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC---
Confidence 99999988643 4689999999999999999999998 99999999999999 7889999999999875421
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
.......|++.|+|||++.+..++.++||||||+++|||++|+.||...........+ ..+... ....
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i-----~~~~~~------~~~~ 229 (304)
T 2jam_A 162 -GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI-----KEGYYE------FESP 229 (304)
T ss_dssp -BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-----HHCCCC------CCTT
T ss_pred -CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-----HcCCCC------CCcc
Confidence 1223456999999999999999999999999999999999999999865543322221 111110 0111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
........+.+++.+|++.+|++|||+.|+++
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 230 FWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 12234467889999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=343.11 Aligned_cols=251 Identities=23% Similarity=0.317 Sum_probs=203.5
Q ss_pred hhccccccccCcEEEEEEEE-----CCeeEEEEEeeccc----hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEE
Q 002887 563 NNFERVLGKGGFGTVYHGYL-----DDKQVAVKMLSSSS----VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMG 632 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~-----~~~~vAVK~l~~~~----~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 632 (870)
+.+.+.||+|+||.||+++. .++.||||+++... ....+.+.+|++++.++ +|+||+++++++......+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 34568999999999999997 47899999987542 23446678899999999 6999999999999999999
Q ss_pred EEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCcccc
Q 002887 633 LIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 712 (870)
Q Consensus 633 LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~ 712 (870)
+||||+++|+|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 136 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 999999999999998643 4689999999999999999999998 99999999999999999999999999998653
Q ss_pred CCCCccccccccCCCCccCccccccC--CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcc
Q 002887 713 VEGGTHVSTTVVGTPGYLDPEYYISN--RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVD 790 (870)
Q Consensus 713 ~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d 790 (870)
.. .........||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+........
T Consensus 211 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------- 282 (355)
T 1vzo_A 211 AD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE------- 282 (355)
T ss_dssp GG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC-------
T ss_pred cC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC-------
Confidence 22 22223456799999999999863 478999999999999999999999986554444444333332211
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 002887 791 HRLQGDFDTNTVWKAVEIALACIHTISTRRP-----TMNQVVIEL 830 (870)
Q Consensus 791 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~L 830 (870)
...+......+.+++.+||+.||++|| ++.|+++..
T Consensus 283 ----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 ----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 112233445678999999999999999 899988643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=336.42 Aligned_cols=255 Identities=23% Similarity=0.259 Sum_probs=201.6
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEe----cCCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCD----EGANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~----~~~~~~LV~Ey 637 (870)
.+.+.||+|+||.||+++.. ++.||||++........+.+.+|++++++++||||+++++++. .....++||||
T Consensus 32 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 111 (317)
T 2buj_A 32 LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPF 111 (317)
T ss_dssp EEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEEC
T ss_pred EEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEe
Confidence 45679999999999999974 8899999998776667788999999999999999999999986 34578899999
Q ss_pred ccCCchhhhhhhc--ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 638 MANGNLQAHLLED--KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 638 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
+++|+|.+++... ....+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 112 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 188 (317)
T 2buj_A 112 FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188 (317)
T ss_dssp CTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEE
T ss_pred CCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhccccc
Confidence 9999999988753 345799999999999999999999998 99999999999999999999999999987542111
Q ss_pred Ccc-------ccccccCCCCccCccccccCC---CCccchHHHHHHHHHHHHhCCCCCCCCCcc-chHHHHHHHHhhcCC
Q 002887 716 GTH-------VSTTVVGTPGYLDPEYYISNR---LTEKSDVYSFGVVLLELITGQPVIQKTPQR-TLIGQWVSSMLARGD 784 (870)
Q Consensus 716 ~~~-------~~~~~~gt~~y~APE~~~~~~---~~~ksDVwS~GvvL~elltG~~p~~~~~~~-~~l~~~~~~~~~~~~ 784 (870)
... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... ...... ...
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~----~~~-- 262 (317)
T 2buj_A 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA----VQN-- 262 (317)
T ss_dssp ESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH----HHC--
T ss_pred ccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH----hhc--
Confidence 000 112345799999999987554 689999999999999999999998632111 111111 100
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 785 IKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 785 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
.............+.+++.+|++.+|++||++.|+++.|+.+.
T Consensus 263 -------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 263 -------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp -------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred -------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 1111112233457889999999999999999999999998753
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=327.37 Aligned_cols=256 Identities=19% Similarity=0.259 Sum_probs=203.3
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEE-ecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYC-DEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~-~~~~~~~LV~Ey~~~ 640 (870)
.+.+.||+|+||.||+|+.. ++.||||++..... .+++.+|++++++++|++++..+..+ ......++||||+ +
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (296)
T 3uzp_A 12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 88 (296)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-C
Confidence 34579999999999999964 89999999876532 35689999999999998877666665 5667789999999 8
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEE---cCCCcEEEEeccCCccccCCCCc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILl---d~~~~vkL~DFGla~~~~~~~~~ 717 (870)
++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||+ ++++.+||+|||+++........
T Consensus 89 ~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 89 PSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 9999998643 35699999999999999999999998 99999999999999 58889999999999876433221
Q ss_pred c-----ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCc---cchHHHHHHHHhhcCCcchhc
Q 002887 718 H-----VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQ---RTLIGQWVSSMLARGDIKNIV 789 (870)
Q Consensus 718 ~-----~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~---~~~l~~~~~~~~~~~~~~~i~ 789 (870)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ............... .
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~---- 239 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-I---- 239 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-H----
T ss_pred cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-h----
Confidence 1 12456799999999999999999999999999999999999999986432 222222222111110 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 790 DHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 790 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
+.+. ...+..+.+++.+|++.+|++|||+.||++.|+++...
T Consensus 240 -~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 240 -EVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp -HHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -HHHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 0011 12235688999999999999999999999999987643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=341.40 Aligned_cols=248 Identities=15% Similarity=0.152 Sum_probs=202.8
Q ss_pred hccccccccCcEEEEEEE-----E--CCeeEEEEEeeccchhhhHHHHHHHHHHHHhc---cccceeEEEEEecCCeEEE
Q 002887 564 NFERVLGKGGFGTVYHGY-----L--DDKQVAVKMLSSSSVQGYKQFQAEVELLIRAH---HKNLTILVGYCDEGANMGL 633 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~-----~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~L 633 (870)
.+.+.||+|+||.||+|. . .++.||||++.... ..++..|++++.+++ |+||+++++++...+..++
T Consensus 68 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~l 144 (365)
T 3e7e_A 68 YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL 144 (365)
T ss_dssp EEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEE
T ss_pred EEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEE
Confidence 345789999999999994 2 37899999997653 346778888888876 9999999999999999999
Q ss_pred EEEEccCCchhhhhhhc---ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC-----------CCc
Q 002887 634 IYEFMANGNLQAHLLED---KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE-----------KFQ 699 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~-----------~~~ 699 (870)
||||+++|+|.+++... ....+++..++.|+.|+++||+|||+. +|+||||||+|||++. ++.
T Consensus 145 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~ 221 (365)
T 3e7e_A 145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221 (365)
T ss_dssp EECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CTT
T ss_pred EEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccCC
Confidence 99999999999999753 235799999999999999999999998 9999999999999998 899
Q ss_pred EEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHH
Q 002887 700 AKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSM 779 (870)
Q Consensus 700 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~ 779 (870)
+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------- 293 (365)
T 3e7e_A 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-------- 293 (365)
T ss_dssp EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--------
T ss_pred EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce--------
Confidence 999999999765433334445567899999999999999999999999999999999999999864322110
Q ss_pred hhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHHHhhhH
Q 002887 780 LARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRR-PTMNQVVIELNDCLAM 836 (870)
Q Consensus 780 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Psm~eVl~~L~~~~~~ 836 (870)
.+...+... .....+.+++..|++.+|.+| |++.++.+.|++.+..
T Consensus 294 --------~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 294 --------KPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp --------EECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --------eechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 011111111 123456688899999999998 6889999999987754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=350.38 Aligned_cols=254 Identities=22% Similarity=0.279 Sum_probs=193.9
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecC------CeEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEG------ANMGL 633 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~L 633 (870)
.+.+.||+|+||.||+|+.. ++.||||++... .....+++.+|+.+++.++||||+++++++... ...++
T Consensus 65 ~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l 144 (464)
T 3ttj_A 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 144 (464)
T ss_dssp EEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred EEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEE
Confidence 34578999999999999875 889999999764 334456789999999999999999999999654 45799
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
||||++++ |.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 145 v~E~~~~~-l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 145 VMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp EEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred EEeCCCCC-HHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 99999875 555553 2488999999999999999999999 999999999999999999999999999986532
Q ss_pred CCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc-----CC----
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR-----GD---- 784 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~-----~~---- 784 (870)
........||+.|+|||++.+..++.++||||+||+++||++|+.||.+......+...+...-.. ..
T Consensus 217 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~ 293 (464)
T 3ttj_A 217 ---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293 (464)
T ss_dssp ---CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred ---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence 223345689999999999999999999999999999999999999998766544433332211100 00
Q ss_pred ---------------cchhcccccCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 785 ---------------IKNIVDHRLQGDFD---TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 785 ---------------~~~i~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
....+...+..... ......+.+++.+||+.||++|||+.|+++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00011111110001 122567899999999999999999999976
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=328.14 Aligned_cols=248 Identities=24% Similarity=0.354 Sum_probs=200.6
Q ss_pred HhhccccccccCcEEEEEEEEC--CeeEEEEEeeccchh------hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEE
Q 002887 562 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ------GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGL 633 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 633 (870)
.+.+.+.||+|+||.||++... ++.||+|++...... ..+.+.+|++++++++||||+++++++......++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 85 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence 3456789999999999999986 889999998765321 35678999999999999999999999999999999
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC----cEEEEeccCCc
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF----QAKLADFGLSR 709 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~----~vkL~DFGla~ 709 (870)
||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++ .+||+|||++.
T Consensus 86 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 86 ILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 99999999999998643 4689999999999999999999998 999999999999999877 89999999998
Q ss_pred cccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhc
Q 002887 710 IFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIV 789 (870)
Q Consensus 710 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~ 789 (870)
..... .......|++.|+|||++.+..++.++||||||++++||++|+.||...........+ . ..... .
T Consensus 161 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~-~~~~~--~ 230 (283)
T 3bhy_A 161 KIEAG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI----S-AVNYD--F 230 (283)
T ss_dssp ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----H-TTCCC--C
T ss_pred eccCC---CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh----H-hcccC--C
Confidence 65322 1223456899999999999999999999999999999999999999865543322221 1 11000 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 790 DHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 790 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+... .......+.+++.+|++.+|++||++.|+++
T Consensus 231 ~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 231 DEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0000 0122356889999999999999999999987
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=329.46 Aligned_cols=247 Identities=26% Similarity=0.371 Sum_probs=196.3
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
+.+.+.||+|+||.||++... ++.+|+|++..... ...+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 103 (285)
T 3is5_A 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCE 103 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCC
Confidence 455689999999999999985 78999999976543 345788999999999999999999999999999999999999
Q ss_pred CCchhhhhhhc--ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEE---cCCCcEEEEeccCCccccCC
Q 002887 640 NGNLQAHLLED--KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 640 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILl---d~~~~vkL~DFGla~~~~~~ 714 (870)
+|+|.+.+... ....+++..+..++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||++......
T Consensus 104 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 104 GGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred CCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 99999988654 236799999999999999999999998 99999999999999 45678999999999865322
Q ss_pred CCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccC
Q 002887 715 GGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794 (870)
Q Consensus 715 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 794 (870)
.......|++.|+|||.+. +.++.++||||||++++||++|+.||........... ...... ...
T Consensus 181 ---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~----~~~~~~-------~~~ 245 (285)
T 3is5_A 181 ---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK----ATYKEP-------NYA 245 (285)
T ss_dssp ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCC-------CCC
T ss_pred ---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh----hccCCc-------ccc
Confidence 2234567999999999875 5689999999999999999999999986553322111 111110 000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 795 GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 795 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.. .......+.+++.+|++.||++|||+.|+++
T Consensus 246 ~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 246 VE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp C---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0112356789999999999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=331.07 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=194.3
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEccCCch
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMANGNL 643 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 643 (870)
+.||+|+||.||+|... ++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 67999999999999874 889999999877655667899999999995 799999999999999999999999999999
Q ss_pred hhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCc---EEEEeccCCccccCCCCc---
Q 002887 644 QAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQ---AKLADFGLSRIFPVEGGT--- 717 (870)
Q Consensus 644 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~---vkL~DFGla~~~~~~~~~--- 717 (870)
.+++... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++. +||+|||++.........
T Consensus 99 ~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 173 (316)
T 2ac3_A 99 LSHIHKR--RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173 (316)
T ss_dssp HHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----------
T ss_pred HHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccc
Confidence 9998653 4689999999999999999999999 9999999999999998776 999999999765322111
Q ss_pred --cccccccCCCCccCcccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCccch----------HHHHHHHHh
Q 002887 718 --HVSTTVVGTPGYLDPEYYIS-----NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTL----------IGQWVSSML 780 (870)
Q Consensus 718 --~~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~----------l~~~~~~~~ 780 (870)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ........+
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 253 (316)
T 2ac3_A 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI 253 (316)
T ss_dssp --------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHH
T ss_pred cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHH
Confidence 11223469999999999975 4588999999999999999999999976542210 000011111
Q ss_pred hcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 781 ARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 781 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..+... ...... ......+.+++.+|++.||++|||+.|+++
T Consensus 254 ~~~~~~-~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 254 QEGKYE-FPDKDW-----AHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHCCCC-CCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hccCcc-cCchhc-----ccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 111110 000000 112457889999999999999999999976
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=347.46 Aligned_cols=248 Identities=27% Similarity=0.372 Sum_probs=195.0
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHH-HHHhccccceeEEEEEecCCeEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVEL-LIRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
+.+.+.||+|+||.||+|+.. ++.||+|++..... ...+.+.+|..+ ++.++||||+++++++.+....++|||
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E 119 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 119 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence 345689999999999999986 77899999976542 233455667666 467899999999999999999999999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
|+++|+|.+++.+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~-- 192 (373)
T 2r5t_A 120 YINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-- 192 (373)
T ss_dssp CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC--
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC--
Confidence 99999999998643 4688999999999999999999998 9999999999999999999999999999864222
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
........||+.|+|||++.+..++.++|+|||||++|||++|+.||...........+ ... . + .
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i----~~~-~--------~--~ 257 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI----LNK-P--------L--Q 257 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH----HHS-C--------C--C
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----Hhc-c--------c--C
Confidence 22334568999999999999999999999999999999999999999865543322222 211 1 1 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 832 (870)
+.......+.+++.+|++.||++||++.+.++++.+
T Consensus 258 ~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~ 293 (373)
T 2r5t_A 258 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKS 293 (373)
T ss_dssp CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHT
T ss_pred CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhC
Confidence 122234568899999999999999998765555544
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=331.68 Aligned_cols=249 Identities=26% Similarity=0.368 Sum_probs=201.3
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEe--cCCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCD--EGANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~~LV~Ey 637 (870)
.+.+.||+|+||.||++... ++.||+|++.... ....+.+.+|++++++++||||+++++++. .....++||||
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 88 (279)
T 2w5a_A 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88 (279)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEEC
T ss_pred eeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeC
Confidence 34578999999999999985 7899999997643 334567899999999999999999999874 46688999999
Q ss_pred ccCCchhhhhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCCC-----ceeCCCCCCCEEEcCCCcEEEEeccCCcc
Q 002887 638 MANGNLQAHLLEDK--ADTLCWERRLQIASESAQGLEYLHNGCKPP-----IVHRDVKSANILLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 638 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-----IvHrDLKp~NILld~~~~vkL~DFGla~~ 710 (870)
+++|+|.+++.... ...+++..++.++.|++.||+|||+. + |+||||||+||++++++.+||+|||+++.
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 89 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp CTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred CCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 99999999987543 24599999999999999999999998 6 99999999999999999999999999986
Q ss_pred ccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcc
Q 002887 711 FPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVD 790 (870)
Q Consensus 711 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d 790 (870)
.... ........|++.|+|||.+.+..++.++||||||+++|||++|+.||.......... .+..+...
T Consensus 166 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~i~~~~~~---- 234 (279)
T 2w5a_A 166 LNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG-----KIREGKFR---- 234 (279)
T ss_dssp C-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----HHHHTCCC----
T ss_pred eccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHH-----HHhhcccc----
Confidence 5322 222334578999999999999899999999999999999999999998655332221 12222211
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002887 791 HRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELN 831 (870)
Q Consensus 791 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 831 (870)
..+......+.+++.+|++.+|++||++.||++.+.
T Consensus 235 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 235 -----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred -----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 112233457889999999999999999999998654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=353.94 Aligned_cols=242 Identities=24% Similarity=0.365 Sum_probs=202.3
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+|+.. ++.||||++..... ...+.+.+|+++++.++||||+++++++......++||||+
T Consensus 19 ~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 98 (476)
T 2y94_A 19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYV 98 (476)
T ss_dssp EEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45678999999999999986 88999999976532 23467899999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|+|.+++.+ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 99 ~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~---~ 170 (476)
T 2y94_A 99 SGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---E 170 (476)
T ss_dssp SSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT---C
T ss_pred CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc---c
Confidence 99999999864 34699999999999999999999998 9999999999999999999999999999876322 2
Q ss_pred ccccccCCCCccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~-~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........... .. .+.. ..
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~----i~-~~~~----------~~ 235 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK----IC-DGIF----------YT 235 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH----HH-TTCC----------CC
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH----Hh-cCCc----------CC
Confidence 2345679999999999988765 6899999999999999999999986554332222 11 1111 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+......+.+++.+|++.||++|||+.|+++
T Consensus 236 p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 236 PQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 1123356789999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=331.70 Aligned_cols=247 Identities=23% Similarity=0.313 Sum_probs=198.8
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc----hhhhHHHHHHHHHHHHhccccceeEEEEE--ecCCeEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS----VQGYKQFQAEVELLIRAHHKNLTILVGYC--DEGANMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~--~~~~~~~LV~ 635 (870)
.+.+.||+|+||.||++... ++.||+|++.... ....+.+.+|++++++++|+||+++++++ .+....++||
T Consensus 8 ~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (305)
T 2wtk_C 8 LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVM 87 (305)
T ss_dssp CCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEE
T ss_pred eEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEe
Confidence 45689999999999999985 7899999997653 23456789999999999999999999998 4456789999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
||++++ |.+.+.......+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 88 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 88 EYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp ECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred hhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 999987 77777665567899999999999999999999998 99999999999999999999999999998764333
Q ss_pred CccccccccCCCCccCccccccCC--CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccccc
Q 002887 716 GTHVSTTVVGTPGYLDPEYYISNR--LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 716 ~~~~~~~~~gt~~y~APE~~~~~~--~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
.........|++.|+|||++.+.. .+.++||||||+++|||++|+.||........... +..+..
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----i~~~~~-------- 230 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN-----IGKGSY-------- 230 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-----HHHCCC--------
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH-----HhcCCC--------
Confidence 333334567999999999997654 47899999999999999999999986543222211 111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 794 QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
.........+.+++.+|++.||++|||+.|+++.
T Consensus 231 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 --AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp --CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1122334567899999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=355.95 Aligned_cols=244 Identities=22% Similarity=0.381 Sum_probs=202.3
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
+.+.||+|+||.||+++.. ++.||+|++..... ...+.+.+|++++++++||||+++++++......++||||++
T Consensus 189 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~ 268 (543)
T 3c4z_A 189 DFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMN 268 (543)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEecc
Confidence 3478999999999999985 88999999976532 334678899999999999999999999999999999999999
Q ss_pred CCchhhhhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 640 NGNLQAHLLEDK--ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 640 ~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+|+|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 269 gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~-- 343 (543)
T 3c4z_A 269 GGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-- 343 (543)
T ss_dssp TCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--
T ss_pred CCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCC--
Confidence 999999987543 35699999999999999999999998 99999999999999999999999999998763321
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..........++........ ..+
T Consensus 344 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~-----------~~~ 412 (543)
T 3c4z_A 344 TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-----------VTY 412 (543)
T ss_dssp CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC-----------CCC
T ss_pred cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc-----------cCC
Confidence 223445899999999999999999999999999999999999999987644333333333322211 112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMN 824 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~ 824 (870)
+......+.+++.+|++.+|++||++.
T Consensus 413 p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 413 PDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred CcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 233456788999999999999999763
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=324.94 Aligned_cols=257 Identities=18% Similarity=0.250 Sum_probs=202.8
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEE-ecCCeEEEEEEEcc
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYC-DEGANMGLIYEFMA 639 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~-~~~~~~~LV~Ey~~ 639 (870)
+.+.+.||+|+||.||+|+.. ++.||||++..... .+++.+|++++++++|++++..+..+ ......++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 4hgt_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence 345689999999999999964 88999998765432 35688999999999988877776666 6677889999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEE---cCCCcEEEEeccCCccccCCCC
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILl---d~~~~vkL~DFGla~~~~~~~~ 716 (870)
+++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++.......
T Consensus 88 ~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 88 GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 99999988643 34699999999999999999999999 99999999999999 7899999999999987643322
Q ss_pred c-----cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCcc---chHHHHHHHHhhcCCcchh
Q 002887 717 T-----HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQR---TLIGQWVSSMLARGDIKNI 788 (870)
Q Consensus 717 ~-----~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~---~~l~~~~~~~~~~~~~~~i 788 (870)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ............. ..
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~--- 239 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PI--- 239 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-CH---
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-hh---
Confidence 1 1223567999999999999999999999999999999999999999865432 2222221111110 00
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 789 VDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 789 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
+.+. ...+..+.+++.+|++.+|++|||+.||++.|+++...
T Consensus 240 --~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 240 --EVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp --HHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred --hhhh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 0000 11235788999999999999999999999999997643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=329.82 Aligned_cols=244 Identities=24% Similarity=0.408 Sum_probs=180.2
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+|... ++.||||++..... ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 14 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (278)
T 3cok_A 14 KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMC 93 (278)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecC
Confidence 34578999999999999974 88999999976432 22467899999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++....... .
T Consensus 94 ~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--~ 167 (278)
T 3cok_A 94 HNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--E 167 (278)
T ss_dssp TTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred CCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--C
Confidence 999999988643 35789999999999999999999998 99999999999999999999999999998653221 1
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
......|++.|+|||.+.+..++.++||||||++++||++|+.||........... +..... ..+
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------------~~~~~~--~~~ 232 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK-------------VVLADY--EMP 232 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------CCSSCC--CCC
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH-------------Hhhccc--CCc
Confidence 22345789999999999988899999999999999999999999976543322111 000000 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
......+.+++.+|++.+|++|||+.|+++
T Consensus 233 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 233 SFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 233457889999999999999999999976
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.82 Aligned_cols=244 Identities=22% Similarity=0.371 Sum_probs=202.7
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||++... ++.+|+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 97 (294)
T 2rku_A 18 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC 97 (294)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecC
Confidence 34578999999999999986 7889999987652 234567899999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++....... .
T Consensus 98 ~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~ 170 (294)
T 2rku_A 98 RRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--E 170 (294)
T ss_dssp TTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT--C
T ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc--c
Confidence 999999987543 4689999999999999999999998 99999999999999999999999999998753222 2
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
......|++.|+|||++.+..++.++||||||++++||++|+.||........... .. .+.. ..+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~-~~~~----------~~~ 235 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR----IK-KNEY----------SIP 235 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HH-TTCC----------CCC
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----Hh-hccC----------CCc
Confidence 23446799999999999988899999999999999999999999986553322211 11 1110 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
......+.+++.+|++.+|++|||+.|+++.
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 236 KHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 2233567899999999999999999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=334.15 Aligned_cols=255 Identities=22% Similarity=0.288 Sum_probs=197.4
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+|... ++.||+|++..... ...+.+.+|++++++++||||+++++++......++||||+
T Consensus 37 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 116 (309)
T 2h34_A 37 RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLI 116 (309)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEec
Confidence 45689999999999999975 88999999976532 23467899999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++...... ...
T Consensus 117 ~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-~~~ 190 (309)
T 2h34_A 117 NGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE-KLT 190 (309)
T ss_dssp CCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccc-ccc
Confidence 999999998643 4689999999999999999999998 9999999999999999999999999999765322 112
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
......|++.|+|||++.+..++.++||||||+++|||++|+.||...... ............ + ....
T Consensus 191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~----~---~~~~ 258 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-----VMGAHINQAIPR----P---STVR 258 (309)
T ss_dssp ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-----HHHHHHHSCCCC----G---GGTS
T ss_pred cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-----HHHHHhccCCCC----c---cccC
Confidence 233457899999999999999999999999999999999999999764432 111122111100 0 0111
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhhhH
Q 002887 799 TNTVWKAVEIALACIHTISTRRP-TMNQVVIELNDCLAM 836 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RP-sm~eVl~~L~~~~~~ 836 (870)
...+..+.+++.+|++.+|++|| +++++++.|++.+..
T Consensus 259 ~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 259 PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 22344688999999999999999 999999999986543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=327.19 Aligned_cols=245 Identities=24% Similarity=0.374 Sum_probs=197.1
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCchh
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQ 644 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 644 (870)
..||+|+||.||+|... ++.||||++........+.+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 48999999999999985 7889999998776666778999999999999999999999999999999999999999999
Q ss_pred hhhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC-CCcEEEEeccCCccccCCCCcccccc
Q 002887 645 AHLLEDK-ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE-KFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 645 ~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~-~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
+++.... ...+++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||++...... ......
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~ 182 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--NPCTET 182 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CC
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC--CCcccc
Confidence 9987643 23567899999999999999999998 9999999999999998 899999999999865322 122345
Q ss_pred ccCCCCccCccccccCC--CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 723 VVGTPGYLDPEYYISNR--LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~--~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
..|++.|+|||++.+.. ++.++||||||+++|||++|+.||.......... ...... ......+..
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~----------~~~~~~~~~ 250 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM--FKVGMF----------KVHPEIPES 250 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH--HHHHHH----------CCCCCCCTT
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH--Hhhccc----------ccccccccc
Confidence 57899999999997653 8899999999999999999999997543221111 111000 011122233
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
....+.+++.+|++.+|++||++.|+++
T Consensus 251 ~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 251 MSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp SCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 4457889999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=327.08 Aligned_cols=243 Identities=26% Similarity=0.419 Sum_probs=195.9
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEec----CCeEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDE----GANMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~LV~ 635 (870)
.+.+.||+|+||.||+|... +..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++||
T Consensus 29 ~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 108 (290)
T 1t4h_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEE
Confidence 34578999999999999986 6789999987653 3445678999999999999999999998865 45689999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCC--ceeCCCCCCCEEEc-CCCcEEEEeccCCcccc
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPP--IVHRDVKSANILLN-EKFQAKLADFGLSRIFP 712 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--IvHrDLKp~NILld-~~~~vkL~DFGla~~~~ 712 (870)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||++ +++.+||+|||++....
T Consensus 109 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 109 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 999999999999643 5689999999999999999999998 6 99999999999998 78999999999997542
Q ss_pred CCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccc
Q 002887 713 VEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHR 792 (870)
Q Consensus 713 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 792 (870)
. .......|++.|+|||++. +.++.++||||||+++++|++|+.||........... ... .+......
T Consensus 184 ~----~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~---~~~-~~~~~~~~--- 251 (290)
T 1t4h_A 184 A----SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVT-SGVKPASF--- 251 (290)
T ss_dssp T----TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH---HHT-TTCCCGGG---
T ss_pred c----cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHH---HHh-ccCCcccc---
Confidence 2 2233457999999999886 4589999999999999999999999976544322221 111 11111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 793 LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 793 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+......+.+++.+|++.+|++|||+.|+++
T Consensus 252 -----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 252 -----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1122346889999999999999999999985
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=344.06 Aligned_cols=248 Identities=23% Similarity=0.379 Sum_probs=190.6
Q ss_pred HhhccccccccCcEEEEEEEEC--CeeEEEEEeeccch--------hhhHHHHHHHHHHHHhccccceeEEEEEecCCeE
Q 002887 562 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--------QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANM 631 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 631 (870)
.+.+.+.||+|+||.||+|... ++.||||++..... .....+.+|++++++++||||+++++++.. ...
T Consensus 136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~ 214 (419)
T 3i6u_A 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDY 214 (419)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEE
T ss_pred cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cce
Confidence 3456689999999999999986 78999999976421 223458899999999999999999999864 568
Q ss_pred EEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC---cEEEEeccCC
Q 002887 632 GLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF---QAKLADFGLS 708 (870)
Q Consensus 632 ~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~---~vkL~DFGla 708 (870)
++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus 215 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 215 YIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred EEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecccc
Confidence 999999999999998864 35699999999999999999999998 999999999999997544 5999999999
Q ss_pred ccccCCCCccccccccCCCCccCcccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCc
Q 002887 709 RIFPVEGGTHVSTTVVGTPGYLDPEYYIS---NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDI 785 (870)
Q Consensus 709 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~ 785 (870)
+.... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||........+.+.+ ..+..
T Consensus 290 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i----~~~~~ 362 (419)
T 3i6u_A 290 KILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI----TSGKY 362 (419)
T ss_dssp TSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH----HTTCC
T ss_pred eecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH----hcCCC
Confidence 87532 223345679999999999863 568889999999999999999999998655443333221 11111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 786 KNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 786 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.. . +.. .......+.+++.+|++.+|++|||+.|+++
T Consensus 363 ~~-~-~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 363 NF-I-PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CC-C-HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CC-C-chh----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00 0 000 0123457889999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=329.56 Aligned_cols=243 Identities=27% Similarity=0.422 Sum_probs=202.6
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
..+.||+|+||.||+|... ++.||||++.... ....+.+.+|+.++++++||||+++++++......++||||++++
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 105 (303)
T 3a7i_A 26 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 105 (303)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred HhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCC
Confidence 4578999999999999875 8899999997654 334578899999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...... .....
T Consensus 106 ~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~ 177 (303)
T 3a7i_A 106 SALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIKRN 177 (303)
T ss_dssp EHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT--BCCBC
T ss_pred cHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc--ccccC
Confidence 99998853 5689999999999999999999998 9999999999999999999999999999865332 12234
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
...|++.|+|||++.+..++.++||||||++++||++|+.||........... ...+.. + ......
T Consensus 178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~-----~----~~~~~~ 243 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL-----IPKNNP-----P----TLEGNY 243 (303)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-----HHHSCC-----C----CCCSSC
T ss_pred ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH-----hhcCCC-----C----CCcccc
Confidence 56789999999999999999999999999999999999999976543322211 111111 1 112223
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
...+.+++.+|++.+|++|||+.|+++.
T Consensus 244 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 244 SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 4568899999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=337.53 Aligned_cols=258 Identities=22% Similarity=0.343 Sum_probs=199.1
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.+.+.||+|+||.||+|+.. ++.||||++..... ...+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 107 (331)
T 4aaa_A 28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD 107 (331)
T ss_dssp EEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCC
Confidence 34579999999999999986 88999999866533 234567899999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 108 ~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 180 (331)
T 4aaa_A 108 HTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEV 180 (331)
T ss_dssp EEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred cchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC--ccc
Confidence 9999887643 34699999999999999999999999 9999999999999999999999999999865322 222
Q ss_pred cccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHh----------hc-CCcch
Q 002887 720 STTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSML----------AR-GDIKN 787 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~----------~~-~~~~~ 787 (870)
.....|++.|+|||++.+. .++.++|||||||++|||++|+.||........+.......- .. .....
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 3445789999999999875 789999999999999999999999987665444333322110 00 00001
Q ss_pred hcccccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 788 IVDHRLQGDFD-----TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 788 i~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...+.+..... ......+.+++.+|++.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11111111111 123467899999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=337.26 Aligned_cols=238 Identities=24% Similarity=0.355 Sum_probs=198.1
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccch--------hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--------QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMG 632 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 632 (870)
+.+.+.||+|+||.||+|+.. ++.||||++..... ...+.+.+|++++++++||||+++++++.+....+
T Consensus 26 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 105 (335)
T 3dls_A 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQ 105 (335)
T ss_dssp EEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEE
Confidence 344679999999999999875 88999999986532 13456789999999999999999999999999999
Q ss_pred EEEEEccCC-chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccc
Q 002887 633 LIYEFMANG-NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 711 (870)
Q Consensus 633 LV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~ 711 (870)
+||||+.+| +|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 106 lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 106 LVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 999999877 999888643 4699999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCccccccccCCCCccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcc
Q 002887 712 PVEGGTHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVD 790 (870)
Q Consensus 712 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d 790 (870)
... .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ..
T Consensus 181 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------------~~ 238 (335)
T 3dls_A 181 ERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------------VE 238 (335)
T ss_dssp CTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------------TT
T ss_pred CCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------------Hh
Confidence 332 22334679999999999988776 78999999999999999999999752210 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 791 HRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 791 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
.... .+......+.+++.+|++.+|++|||+.|+++.
T Consensus 239 ~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 AAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1110 111234568899999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=335.98 Aligned_cols=243 Identities=22% Similarity=0.363 Sum_probs=202.3
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||++... ++.+|+|++.... ....+.+.+|+.++++++|+||+++++++.+....++||||+
T Consensus 44 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 123 (335)
T 2owb_A 44 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC 123 (335)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecC
Confidence 34578999999999999986 7789999987652 234567899999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++++|.+++... ..+++.++..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 124 ~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~ 196 (335)
T 2owb_A 124 RRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--E 196 (335)
T ss_dssp TTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT--C
T ss_pred CCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCc--c
Confidence 999999987643 4689999999999999999999998 99999999999999999999999999998763222 2
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
......|++.|+|||++.+..++.++||||||+++|||++|+.||............ . .+.. ...
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~-~~~~----------~~~ 261 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI----K-KNEY----------SIP 261 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----H-HTCC----------CCC
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH----h-cCCC----------CCC
Confidence 234567999999999999988999999999999999999999999865433222211 1 1110 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
......+.+++.+|++.||++||++.|+++
T Consensus 262 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 262 KHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 223346789999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=336.83 Aligned_cols=247 Identities=23% Similarity=0.378 Sum_probs=198.6
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEcc
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
+.+.+.||+|+||.||++... ++.||||++..... ...+|++++.++ +||||+++++++.++...++||||++
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 99 (342)
T 2qr7_A 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK 99 (342)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence 445689999999999999986 88999999976532 346788899888 79999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC----CcEEEEeccCCccccCCC
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK----FQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~----~~vkL~DFGla~~~~~~~ 715 (870)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+.++ +.+||+|||+++......
T Consensus 100 gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 100 GGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp SCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 99999988643 4689999999999999999999998 99999999999998543 359999999998764322
Q ss_pred CccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 716 GTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 716 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+..... ..+... +..
T Consensus 175 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~~~~i-~~~~~~------~~~ 244 (342)
T 2qr7_A 175 --GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD-TPEEILARI-GSGKFS------LSG 244 (342)
T ss_dssp --CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS-CHHHHHHHH-HHCCCC------CCS
T ss_pred --CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC-CHHHHHHHH-ccCCcc------cCc
Confidence 2234567899999999998888999999999999999999999999754322 122222222 222111 111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.........+.+++.+|++.||++||++.|+++
T Consensus 245 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 245 GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 112234567889999999999999999999886
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=329.21 Aligned_cols=256 Identities=24% Similarity=0.338 Sum_probs=196.8
Q ss_pred hhccccccccCcEEEEEEEEC---C--eeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD---D--KQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLI 634 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~---~--~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 634 (870)
+.+.+.||+|+||.||+|++. + ..||||+++... ....+.+.+|++++++++||||+++++++.... .++|
T Consensus 20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v 98 (291)
T 1u46_A 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMV 98 (291)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEE
T ss_pred eeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceee
Confidence 345678999999999999863 2 258999987542 344578899999999999999999999998764 8899
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
+||+++|+|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 99 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 99 TELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp EECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred EecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 9999999999998654 35689999999999999999999998 9999999999999999999999999999876433
Q ss_pred CCcc-ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccc
Q 002887 715 GGTH-VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHR 792 (870)
Q Consensus 715 ~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 792 (870)
.... ......++..|+|||++.+..++.++||||||++++||++ |+.||.......... .....+.
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----~~~~~~~-------- 242 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH----KIDKEGE-------- 242 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHTSCC--------
T ss_pred ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH----HHHccCC--------
Confidence 2221 2234567889999999998889999999999999999999 999998665433222 2221111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 793 LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 793 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
...........+.+++.+|++.+|++|||+.++++.|+++...
T Consensus 243 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 243 -RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 0111223456788999999999999999999999999986543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=325.98 Aligned_cols=241 Identities=27% Similarity=0.382 Sum_probs=201.3
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+|... ++.||+|++..... ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 17 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 96 (284)
T 2vgo_A 17 DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFA 96 (284)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeC
Confidence 44679999999999999986 78899999976432 23467899999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|+|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++..... .
T Consensus 97 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~----~ 167 (284)
T 2vgo_A 97 PRGELYKELQKH--GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----L 167 (284)
T ss_dssp TTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS----S
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc----c
Confidence 999999998654 4689999999999999999999998 999999999999999999999999999875432 1
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
......|++.|+|||++.+..++.++||||||++++||++|+.||........... .. ... ...+
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~-~~~----------~~~~ 232 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR----IV-NVD----------LKFP 232 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HH-TTC----------CCCC
T ss_pred ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH----Hh-ccc----------cCCC
Confidence 22345789999999999999999999999999999999999999986543322211 11 111 1112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
......+.+++.+|++.+|++||++.|+++
T Consensus 233 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 233 PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 233456789999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=330.66 Aligned_cols=251 Identities=19% Similarity=0.297 Sum_probs=196.3
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhc-cccceeEEEEEec--CCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAH-HKNLTILVGYCDE--GANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~--~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+|+.. ++.||||++.... .+.+.+|++++++++ ||||+++++++.. ....++||||+
T Consensus 39 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~ 115 (330)
T 3nsz_A 39 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 115 (330)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred EEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence 45689999999999999874 8899999987543 467899999999997 9999999999987 66789999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC-cEEEEeccCCccccCCCCc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF-QAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~-~vkL~DFGla~~~~~~~~~ 717 (870)
++++|.+++. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++......
T Consensus 116 ~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-- 185 (330)
T 3nsz_A 116 NNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-- 185 (330)
T ss_dssp CCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC--
T ss_pred CchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC--
Confidence 9999998873 488999999999999999999998 999999999999999776 89999999998663322
Q ss_pred cccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCcc-chHHHHHHHH--------hhcCCc--
Q 002887 718 HVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQR-TLIGQWVSSM--------LARGDI-- 785 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~-~~l~~~~~~~--------~~~~~~-- 785 (870)
......|+..|+|||++.+ ..++.++|||||||+++||++|+.||...... ..+....... ......
T Consensus 186 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 186 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 2344578999999999987 67899999999999999999999999654422 2222211110 000000
Q ss_pred ----chhc--------ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 786 ----KNIV--------DHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 786 ----~~i~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.+.. ...............+.+++.+|++.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 000111111224567899999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=335.09 Aligned_cols=260 Identities=24% Similarity=0.297 Sum_probs=200.2
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchh-----hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ-----GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIY 635 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 635 (870)
+.+.+.||+|+||.||+|+.. ++.||||++...... ..+.+.+|++++++++||||+++++++......++||
T Consensus 12 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 91 (346)
T 1ua2_A 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF 91 (346)
T ss_dssp -CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred cEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEE
Confidence 345679999999999999985 789999999754221 2356889999999999999999999999999999999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
||+++ +|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 92 e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~- 165 (346)
T 1ua2_A 92 DFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP- 165 (346)
T ss_dssp ECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-
T ss_pred EcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCC-
Confidence 99986 788877543 34688999999999999999999998 9999999999999999999999999999866322
Q ss_pred CccccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC--Ccch---hc
Q 002887 716 GTHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG--DIKN---IV 789 (870)
Q Consensus 716 ~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~--~~~~---i~ 789 (870)
........||+.|+|||++.+. .++.++|||||||++|||++|++||........+.+.....-... ...+ ..
T Consensus 166 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (346)
T 1ua2_A 166 -NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244 (346)
T ss_dssp -CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred -cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence 2223456789999999999764 489999999999999999999999987665544444333221110 0000 00
Q ss_pred ccccC---CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 790 DHRLQ---GDFD-----TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 790 d~~l~---~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
+.... .... ......+.+++.+|++.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000 0001 1234678999999999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=323.73 Aligned_cols=240 Identities=19% Similarity=0.254 Sum_probs=195.5
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
+.+.+.||+|+||.||+|... ++.||+|++.... .....++.+|+..+.++ +||||+++++++.+....++||||
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 92 (289)
T 1x8b_A 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEY 92 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEe
Confidence 345689999999999999985 8899999998642 33456788999999999 999999999999999999999999
Q ss_pred ccCCchhhhhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC------------------
Q 002887 638 MANGNLQAHLLEDKA--DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK------------------ 697 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~------------------ 697 (870)
+++|+|.+++..... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.+
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 93 CNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp CTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------------
T ss_pred cCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 999999999976432 5689999999999999999999998 99999999999999844
Q ss_pred -CcEEEEeccCCccccCCCCccccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002887 698 -FQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQW 775 (870)
Q Consensus 698 -~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~ 775 (870)
..+||+|||++...... ....||+.|+|||.+.+. .++.++|||||||+++||++|++++..... ...
T Consensus 170 ~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~- 239 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHE- 239 (289)
T ss_dssp CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHH-
T ss_pred ceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHH-
Confidence 47999999999865322 234589999999999876 567899999999999999999987653321 111
Q ss_pred HHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 776 VSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 776 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+..+... ..+......+.+++.+|++.+|++|||+.|+++
T Consensus 240 ----~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 240 ----IRQGRLP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ----HHTTCCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHcCCCC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1122111 112223457889999999999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=334.35 Aligned_cols=257 Identities=19% Similarity=0.279 Sum_probs=192.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.+.+.||+|+||.||+|+.. ++.||||++..... ...+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 37 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 116 (329)
T 3gbz_A 37 RRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE 116 (329)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC
Confidence 34579999999999999875 88999999975533 234567899999999999999999999999999999999998
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEE-----cCCCcEEEEeccCCccccCC
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILL-----NEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILl-----d~~~~vkL~DFGla~~~~~~ 714 (870)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++.....
T Consensus 117 -~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 117 -NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp -EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred -CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 4999988643 3589999999999999999999998 99999999999999 45556999999999865322
Q ss_pred CCccccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCC--cchhc-c
Q 002887 715 GGTHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGD--IKNIV-D 790 (870)
Q Consensus 715 ~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~--~~~i~-d 790 (870)
........||+.|+|||++.+. .++.++|||||||++|||++|+.||........+.+.....-.... ..... .
T Consensus 191 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (329)
T 3gbz_A 191 --IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred --ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence 2223445789999999999875 4899999999999999999999999876655444443332211100 00000 0
Q ss_pred ccc-------CCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 791 HRL-------QGDF-----DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 791 ~~l-------~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+.. .... .......+.+++.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 0000 0113357789999999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=345.41 Aligned_cols=256 Identities=24% Similarity=0.313 Sum_probs=203.1
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHh------ccccceeEEEEEecCCeEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRA------HHKNLTILVGYCDEGANMGLI 634 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l------~H~nIv~l~g~~~~~~~~~LV 634 (870)
+.+.+.||+|+||.||+|... ++.||||++.... ...+++.+|++++..+ +|+||+++++++......++|
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 177 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEE
Confidence 345689999999999999876 7899999997643 3346778899999888 466999999999999999999
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCc--EEEEeccCCcccc
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQ--AKLADFGLSRIFP 712 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~--vkL~DFGla~~~~ 712 (870)
|||+. ++|.+++.......+++..+..++.|+++||+|||+. +|+||||||+|||++.++. +||+|||+++...
T Consensus 178 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 178 FELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp ECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 99997 6899998876666799999999999999999999998 9999999999999999987 9999999997542
Q ss_pred CCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc--------CC
Q 002887 713 VEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR--------GD 784 (870)
Q Consensus 713 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~--------~~ 784 (870)
. ......||+.|+|||++.+..++.++|||||||++|||++|++||........+..+....-.. ..
T Consensus 254 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~ 328 (429)
T 3kvw_A 254 Q-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKR 328 (429)
T ss_dssp C-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTT
T ss_pred C-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhh
Confidence 1 1234578999999999999999999999999999999999999998776555444433211000 00
Q ss_pred cchhcccc---------------------------cCC---CC------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 785 IKNIVDHR---------------------------LQG---DF------DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 785 ~~~i~d~~---------------------------l~~---~~------~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
....++.. +.. .. .......+.+++.+||+.||++|||+.|+++
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~ 408 (429)
T 3kvw_A 329 AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR 408 (429)
T ss_dssp HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence 00011000 000 00 0011456889999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=347.46 Aligned_cols=241 Identities=18% Similarity=0.124 Sum_probs=188.2
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeecc---chhhhHHHHHHH---HHHHHhccccceeEE-------EEEecCC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS---SVQGYKQFQAEV---ELLIRAHHKNLTILV-------GYCDEGA 629 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~---~~~~~~~f~~Ei---~~l~~l~H~nIv~l~-------g~~~~~~ 629 (870)
+.+.||+|+||.||+|+.. ++.||||++... .....+.+.+|+ +++++++||||++++ +++...+
T Consensus 77 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 156 (377)
T 3byv_A 77 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 156 (377)
T ss_dssp EEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTT
T ss_pred EcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccC
Confidence 3578999999999999964 889999999743 334557889999 555566899999998 6665543
Q ss_pred -----------------eEEEEEEEccCCchhhhhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCC
Q 002887 630 -----------------NMGLIYEFMANGNLQAHLLEDK-----ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDV 687 (870)
Q Consensus 630 -----------------~~~LV~Ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDL 687 (870)
..++||||+ +|+|.+++.... ...+++..++.|+.|+++||+|||++ +|+||||
T Consensus 157 ~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDi 232 (377)
T 3byv_A 157 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL 232 (377)
T ss_dssp SCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred CccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 278999999 689999987532 13466789999999999999999999 9999999
Q ss_pred CCCCEEEcCCCcEEEEeccCCccccCCCCccccccccCCCCccCccccccC-----------CCCccchHHHHHHHHHHH
Q 002887 688 KSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISN-----------RLTEKSDVYSFGVVLLEL 756 (870)
Q Consensus 688 Kp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~~~ksDVwS~GvvL~el 756 (870)
||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||++|||
T Consensus 233 kp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 233 RPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 9999999999999999999998531 12345567 999999999887 899999999999999999
Q ss_pred HhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHhh
Q 002887 757 ITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI--ELNDCL 834 (870)
Q Consensus 757 ltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~--~L~~~~ 834 (870)
++|+.||........ ...+... .......+.+++.+||+.||++|||+.|+++ .++++.
T Consensus 307 ltg~~Pf~~~~~~~~-------------~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 307 WCADLPITKDAALGG-------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp HHSSCCC------CC-------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred HHCCCCCcccccccc-------------hhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 999999975432211 1111110 0122356889999999999999999999986 444433
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=322.46 Aligned_cols=243 Identities=23% Similarity=0.359 Sum_probs=192.9
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||+|... ++.||||++..... ...+.+.+|++++++++||||+++++++......++||||+
T Consensus 14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (276)
T 2h6d_A 14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV 93 (276)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEecc
Confidence 34578999999999999986 88999999976532 33467899999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++...... .
T Consensus 94 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~---~ 165 (276)
T 2h6d_A 94 SGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---E 165 (276)
T ss_dssp CSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred CCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC---c
Confidence 999999998653 4689999999999999999999998 9999999999999999999999999999865322 2
Q ss_pred ccccccCCCCccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~-~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
......|++.|+|||.+.+..+ +.++||||||++++||++|+.||........... +..+.. ..
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-----~~~~~~----------~~ 230 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK-----IRGGVF----------YI 230 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHHCCC----------CC
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH-----hhcCcc----------cC
Confidence 2234578999999999987765 6899999999999999999999976543322211 111110 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
+......+.+++.+|++.+|++|||+.|+++.
T Consensus 231 ~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 12234567899999999999999999999873
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=328.67 Aligned_cols=247 Identities=22% Similarity=0.353 Sum_probs=196.5
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
.+.+.||+|+||.||+|... ++.||+|++........+.+.+|++++++++||||+++++++......++||||++++
T Consensus 22 ~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (302)
T 2j7t_A 22 EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGG 101 (302)
T ss_dssp EEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTE
T ss_pred eecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCC
Confidence 44578999999999999986 7899999998776666788999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...... .....
T Consensus 102 ~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~ 175 (302)
T 2j7t_A 102 AVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKRD 175 (302)
T ss_dssp EHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HHC--
T ss_pred cHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc--ccccc
Confidence 999988653 35689999999999999999999998 9999999999999999999999999987543111 11123
Q ss_pred cccCCCCccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 722 TVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 722 ~~~gt~~y~APE~~~-----~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
...|++.|+|||++. ...++.++||||||+++|||++|+.||............ .... .... .
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~-~~~~-------~ 243 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI----AKSD-PPTL-------L 243 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----HHSC-CCCC-------S
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH----hccC-Cccc-------C
Confidence 456899999999984 567899999999999999999999999865543332221 1111 1000 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
........+.+++.+|++.+|++|||+.|+++
T Consensus 244 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 12233457889999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=348.81 Aligned_cols=248 Identities=26% Similarity=0.372 Sum_probs=201.4
Q ss_pred HhhccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 562 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.+.+.||+|+||.||+|+.. ++.||||++.... ......+.+|++++++++||||+++++++......++||||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 102 (486)
T 3mwu_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102 (486)
T ss_dssp HEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEc
Confidence 3556789999999999999986 8899999997542 23456789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEc---CCCcEEEEeccCCccccCC
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLN---EKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld---~~~~vkL~DFGla~~~~~~ 714 (870)
+++|+|.+.+... ..+++..+..++.|++.||.|||+. +|+||||||+|||++ .++.+||+|||+++.+...
T Consensus 103 ~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 103 YTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999999988654 4689999999999999999999998 999999999999995 4567999999999866322
Q ss_pred CCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccC
Q 002887 715 GGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794 (870)
Q Consensus 715 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 794 (870)
.......||+.|+|||++.+ .++.++||||+||++|+|++|++||........+.... .+.... .
T Consensus 178 ---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-----~~~~~~------~ 242 (486)
T 3mwu_A 178 ---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE-----TGKYAF------D 242 (486)
T ss_dssp -------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HTCCCS------C
T ss_pred ---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----hCCCCC------C
Confidence 22345679999999999875 58999999999999999999999998765443332221 111100 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 795 GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 795 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
..........+.+++.+||+.+|++|||+.|+++.
T Consensus 243 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00012334578899999999999999999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=349.60 Aligned_cols=246 Identities=26% Similarity=0.387 Sum_probs=197.2
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
+.+.+.||+|+||.||+|+.. ++.||+|++.... ......+.+|+.++++++||||+++++++.+....++||||+
T Consensus 39 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 118 (494)
T 3lij_A 39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY 118 (494)
T ss_dssp EEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence 455689999999999999986 7889999997653 234567899999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC---CcEEEEeccCCccccCCC
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK---FQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~---~~vkL~DFGla~~~~~~~ 715 (870)
++|+|.+.+... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.. +.+||+|||+++.....
T Consensus 119 ~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~- 192 (494)
T 3lij_A 119 KGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ- 192 (494)
T ss_dssp CSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-
Confidence 999999988643 4689999999999999999999998 99999999999999764 45999999999876422
Q ss_pred CccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 716 GTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 716 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
.......||+.|+|||++. +.++.++||||+||++|+|++|++||........+.... .+... ...+.+
T Consensus 193 --~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-----~~~~~-~~~~~~-- 261 (494)
T 3lij_A 193 --KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE-----KGKYT-FDSPEW-- 261 (494)
T ss_dssp --BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HTCCC-CCSGGG--
T ss_pred --ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----hCCCC-CCchhc--
Confidence 2234567999999999886 568999999999999999999999998765543332221 11110 000111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
......+.+++.+||+.+|++|||+.|+++
T Consensus 262 ---~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 262 ---KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp ---TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 123456889999999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=340.11 Aligned_cols=255 Identities=20% Similarity=0.279 Sum_probs=195.8
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEec-------------
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDE------------- 627 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------------- 627 (870)
+.+.+.||+|+||.||+|+.. ++.||||++.... ....+|++++++++||||+++++++..
T Consensus 9 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~ 84 (383)
T 3eb0_A 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84 (383)
T ss_dssp EEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred EEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence 345689999999999999974 8899999987543 233579999999999999999999843
Q ss_pred -------------------------CCeEEEEEEEccCCchhhhhhh--cccccccHHHHHHHHHHHHHHHHHHHhCCCC
Q 002887 628 -------------------------GANMGLIYEFMANGNLQAHLLE--DKADTLCWERRLQIASESAQGLEYLHNGCKP 680 (870)
Q Consensus 628 -------------------------~~~~~LV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~ 680 (870)
....++||||++ |+|.+.+.. .....+++..+..++.|+++||+|||+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 160 (383)
T 3eb0_A 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL--- 160 (383)
T ss_dssp -------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 334889999999 588777754 2346799999999999999999999998
Q ss_pred CceeCCCCCCCEEEc-CCCcEEEEeccCCccccCCCCccccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHh
Q 002887 681 PIVHRDVKSANILLN-EKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELIT 758 (870)
Q Consensus 681 ~IvHrDLKp~NILld-~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~ellt 758 (870)
+|+||||||+|||++ +++.+||+|||+++.+... .......||+.|+|||++.+. .++.++||||+||++|||++
T Consensus 161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT---SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC---CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 999999999999998 6889999999999866332 223345789999999998875 48999999999999999999
Q ss_pred CCCCCCCCCccchHHHHHHHHhhc---------CCcchhcccccC-----CCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 002887 759 GQPVIQKTPQRTLIGQWVSSMLAR---------GDIKNIVDHRLQ-----GDFDTNTVWKAVEIALACIHTISTRRPTMN 824 (870)
Q Consensus 759 G~~p~~~~~~~~~l~~~~~~~~~~---------~~~~~i~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~ 824 (870)
|++||........+.+.+...-.. ....+..-+.+. ...+......+.+++.+|++.+|++|||+.
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 999998776555544443321110 000000000100 011222345688999999999999999999
Q ss_pred HHHH
Q 002887 825 QVVI 828 (870)
Q Consensus 825 eVl~ 828 (870)
|+++
T Consensus 318 e~l~ 321 (383)
T 3eb0_A 318 EAMA 321 (383)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9984
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=335.80 Aligned_cols=254 Identities=20% Similarity=0.272 Sum_probs=203.7
Q ss_pred hccccccccCcEEEEEEEECCeeEEEEEeeccchhh-----------------hHHHHHHHHHHHHhccccceeEEEEEe
Q 002887 564 NFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQG-----------------YKQFQAEVELLIRAHHKNLTILVGYCD 626 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~-----------------~~~f~~Ei~~l~~l~H~nIv~l~g~~~ 626 (870)
.+.+.||+|+||.||+|...++.||||++....... .+.+.+|++++++++||||+++++++.
T Consensus 34 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 113 (348)
T 2pml_X 34 RIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIIT 113 (348)
T ss_dssp EEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEE
T ss_pred EEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 445789999999999999999999999997653221 178999999999999999999999999
Q ss_pred cCCeEEEEEEEccCCchhhh------hhhcccccccHHHHHHHHHHHHHHHHHHHh-CCCCCceeCCCCCCCEEEcCCCc
Q 002887 627 EGANMGLIYEFMANGNLQAH------LLEDKADTLCWERRLQIASESAQGLEYLHN-GCKPPIVHRDVKSANILLNEKFQ 699 (870)
Q Consensus 627 ~~~~~~LV~Ey~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~IvHrDLKp~NILld~~~~ 699 (870)
+.+..++||||+++|+|.++ +.......+++..+..++.|++.||.|||+ . +|+||||||+||+++.++.
T Consensus 114 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~~~~ 190 (348)
T 2pml_X 114 NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDKNGR 190 (348)
T ss_dssp SSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECTTSC
T ss_pred eCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcCCCc
Confidence 99999999999999999998 654445789999999999999999999998 7 9999999999999999999
Q ss_pred EEEEeccCCccccCCCCccccccccCCCCccCccccccC-CCCc-cchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002887 700 AKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISN-RLTE-KSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVS 777 (870)
Q Consensus 700 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~-ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~ 777 (870)
+||+|||++...... ......|++.|+|||++.+. .++. ++||||||++++||++|+.||..........+.
T Consensus 191 ~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-- 264 (348)
T 2pml_X 191 VKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN-- 264 (348)
T ss_dssp EEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH--
T ss_pred EEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH--
Confidence 999999999865322 33456799999999999877 5666 999999999999999999999876542222211
Q ss_pred HHhhcCCcchhcc------cccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 778 SMLARGDIKNIVD------HRLQ---GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 778 ~~~~~~~~~~i~d------~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+..+......+ +... ..........+.+++.+|++.+|++|||+.|+++
T Consensus 265 --i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 265 --IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11121110000 0000 0001234467889999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=325.00 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=196.2
Q ss_pred HHhhccccccccCcEEEEEEEEC--CeeEEEEEeeccch--------hhhHHHHHHHHHHHHhccccceeEEEEEecCCe
Q 002887 561 ITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--------QGYKQFQAEVELLIRAHHKNLTILVGYCDEGAN 630 (870)
Q Consensus 561 ~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 630 (870)
..+.+.+.||+|+||.||+|... ++.||||++..... .....+.+|++++++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 34556789999999999999985 78999999875421 22346889999999999999999999997654
Q ss_pred EEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCc---EEEEeccC
Q 002887 631 MGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQ---AKLADFGL 707 (870)
Q Consensus 631 ~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~---vkL~DFGl 707 (870)
.++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 89 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 8999999999999998864 35789999999999999999999998 9999999999999987665 99999999
Q ss_pred CccccCCCCccccccccCCCCccCccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCC
Q 002887 708 SRIFPVEGGTHVSTTVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGD 784 (870)
Q Consensus 708 a~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~ 784 (870)
++.... ........||+.|+|||++. ...++.++|||||||++|||++|+.||........+...+. .+.
T Consensus 164 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----~~~ 236 (322)
T 2ycf_A 164 SKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT----SGK 236 (322)
T ss_dssp CEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHH----HTC
T ss_pred ceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHH----hCc
Confidence 986532 22234457999999999974 46689999999999999999999999986554433332221 111
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 785 IKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 785 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
... .+... ......+.+++.+|++.||++||++.|+++
T Consensus 237 ~~~--~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 237 YNF--IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCC--CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccc--Cchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 100 00000 122457889999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=334.94 Aligned_cols=258 Identities=21% Similarity=0.318 Sum_probs=194.5
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchh-hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ-GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
.+.+.||+|+||.||+|+.. ++.||||++...... ....+.+|++++++++||||+++++++......++||||++
T Consensus 5 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 83 (324)
T 3mtl_A 5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD- 83 (324)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-
T ss_pred EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-
Confidence 34578999999999999986 788999999765332 22356689999999999999999999999999999999998
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 84 ~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~ 157 (324)
T 3mtl_A 84 KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TKTY 157 (324)
T ss_dssp EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC--cccc
Confidence 5888887653 35689999999999999999999998 9999999999999999999999999999764322 2223
Q ss_pred ccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc--CCcchhccc------
Q 002887 721 TTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR--GDIKNIVDH------ 791 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~--~~~~~i~d~------ 791 (870)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........+.......-.. .........
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 34578999999999976 568999999999999999999999998766554444333221111 001111000
Q ss_pred ---ccCCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 792 ---RLQGDF----DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 792 ---~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...... .......+.+++.+|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 0122356789999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=332.61 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=189.8
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecCC------eEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGA------NMGL 633 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~~L 633 (870)
.+.+.||+|+||.||+|+.. ++.||||++... .....+.+.+|+.++++++||||+++++++.... ..++
T Consensus 28 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~l 107 (371)
T 2xrw_A 28 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 107 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEE
T ss_pred eEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEE
Confidence 34578999999999999875 889999999764 2334567889999999999999999999997654 7899
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
||||+++ +|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 108 v~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 108 VMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred EEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 9999985 6777764 3588999999999999999999998 999999999999999999999999999986532
Q ss_pred CCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHH--------------
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSM-------------- 779 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~-------------- 779 (870)
........||+.|+|||++.+..++.++|||||||++|||++|+.||................
T Consensus 180 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 180 ---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred ---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 122344679999999999999999999999999999999999999998765433222221100
Q ss_pred ----hhcC------CcchhcccccCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 780 ----LARG------DIKNIVDHRLQGDF---DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 780 ----~~~~------~~~~i~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.... .....+........ .......+.+++.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0000 00000100110111 1123567899999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.62 Aligned_cols=246 Identities=24% Similarity=0.337 Sum_probs=200.1
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---------hhhhHHHHHHHHHHHHhc-cccceeEEEEEecCCeE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---------VQGYKQFQAEVELLIRAH-HKNLTILVGYCDEGANM 631 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---------~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~ 631 (870)
.+.+.||+|+||.||+|... ++.||||++.... ....+.+.+|++++++++ ||||+++++++......
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 99 (298)
T 1phk_A 20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 99 (298)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred ceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeE
Confidence 34578999999999999985 7899999997543 123456889999999995 99999999999999999
Q ss_pred EEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccc
Q 002887 632 GLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 711 (870)
Q Consensus 632 ~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~ 711 (870)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 100 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 100 FLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 9999999999999998643 4689999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCccccccccCCCCccCccccc------cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCc
Q 002887 712 PVEGGTHVSTTVVGTPGYLDPEYYI------SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDI 785 (870)
Q Consensus 712 ~~~~~~~~~~~~~gt~~y~APE~~~------~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~ 785 (870)
... .......|++.|+|||++. ...++.++||||||++++||++|+.||........... .. .+..
T Consensus 175 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~-~~~~ 246 (298)
T 1phk_A 175 DPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----IM-SGNY 246 (298)
T ss_dssp CTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HH-HTCC
T ss_pred CCC---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH----Hh-cCCc
Confidence 322 2234467899999999985 45688999999999999999999999976543322221 11 1111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 786 KNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 786 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
. ............+.+++.+|++.+|++|||+.|+++
T Consensus 247 ~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 247 Q------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp C------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred c------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0 001111234567889999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=334.93 Aligned_cols=247 Identities=23% Similarity=0.377 Sum_probs=199.6
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccch--------hhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--------QGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANM 631 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--------~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 631 (870)
+.+.+.||+|+||.||+|+.. ++.||||++..... ...+.+.+|+.+++++ +||||+++++++......
T Consensus 96 y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 175 (365)
T 2y7j_A 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEE
T ss_pred cccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEE
Confidence 344579999999999999985 88999999875431 1245678999999999 899999999999999999
Q ss_pred EEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccc
Q 002887 632 GLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 711 (870)
Q Consensus 632 ~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~ 711 (870)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++..+
T Consensus 176 ~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 176 FLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 9999999999999998643 4689999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCccccccccCCCCccCcccccc------CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCc
Q 002887 712 PVEGGTHVSTTVVGTPGYLDPEYYIS------NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDI 785 (870)
Q Consensus 712 ~~~~~~~~~~~~~gt~~y~APE~~~~------~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~ 785 (870)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... +..+..
T Consensus 251 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~-----i~~~~~ 322 (365)
T 2y7j_A 251 EPG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM-----IMEGQY 322 (365)
T ss_dssp CTT---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHHTCC
T ss_pred CCC---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH-----HHhCCC
Confidence 432 22345679999999999864 3578899999999999999999999976543322221 111111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 786 KNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 786 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
. ...+.+ ......+.+++.+|++.+|++|||+.|+++
T Consensus 323 ~-~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 323 Q-FSSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp C-CCHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C-CCCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 000000 012356889999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=328.26 Aligned_cols=245 Identities=26% Similarity=0.414 Sum_probs=193.9
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEEEec------CCeEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGYCDE------GANMGLIY 635 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~------~~~~~LV~ 635 (870)
+.+.||+|+||.||+|+.. ++.||||++.... ...+.+.+|+.+++++ +||||+++++++.. ....++||
T Consensus 28 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~ 106 (326)
T 2x7f_A 28 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 106 (326)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEE
T ss_pred EEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEE
Confidence 4579999999999999984 8899999987543 3456789999999999 89999999999976 46789999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
||+++|+|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~- 182 (326)
T 2x7f_A 107 EFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT- 182 (326)
T ss_dssp ECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC------
T ss_pred EcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCcC-
Confidence 999999999999876667899999999999999999999998 9999999999999999999999999999865322
Q ss_pred CccccccccCCCCccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcc
Q 002887 716 GTHVSTTVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVD 790 (870)
Q Consensus 716 ~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d 790 (870)
........|++.|+|||++. +..++.++|||||||++|||++|+.||............ .. +..
T Consensus 183 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~-~~~----- 251 (326)
T 2x7f_A 183 -VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----PR-NPA----- 251 (326)
T ss_dssp ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----HH-SCC-----
T ss_pred -ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh----hc-Ccc-----
Confidence 11223457899999999997 566899999999999999999999999765533222211 11 111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 791 HRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 791 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+.+ ........+.+++.+||+.+|++||++.|+++
T Consensus 252 ~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 252 PRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111 11123457889999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=350.85 Aligned_cols=247 Identities=25% Similarity=0.386 Sum_probs=203.4
Q ss_pred HhhccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEE
Q 002887 562 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
.+.+.+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 106 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 4556789999999999999985 8899999997543 2345678999999999999999999999999999999999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEE---cCCCcEEEEeccCCccccC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILl---d~~~~vkL~DFGla~~~~~ 713 (870)
|+.+|+|.+.+... ..+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 107 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 107 VYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp CCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 99999999988643 4699999999999999999999999 99999999999999 5678999999999987632
Q ss_pred CCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccccc
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
. .......||+.|+|||++.+ .++.++||||+||++|+|++|++||........+..+ ..+... .
T Consensus 182 ~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-----~~~~~~------~ 246 (484)
T 3nyv_A 182 S---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV-----EKGKYT------F 246 (484)
T ss_dssp C---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HHCCCC------C
T ss_pred c---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-----HcCCCC------C
Confidence 2 22344579999999999876 6899999999999999999999999876544333222 112111 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 794 QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...........+.+++.+|++.+|++|||+.|+++
T Consensus 247 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00011233467889999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=335.64 Aligned_cols=256 Identities=23% Similarity=0.344 Sum_probs=199.9
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhc--------cccceeEEEEEe----cC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAH--------HKNLTILVGYCD----EG 628 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~--------H~nIv~l~g~~~----~~ 628 (870)
+.+.+.||+|+||.||+|+.. ++.||||++... ....+.+.+|++++++++ |+||+++++++. ..
T Consensus 39 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~ 117 (397)
T 1wak_A 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNG 117 (397)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTE
T ss_pred EEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCC
Confidence 445689999999999999875 889999999754 334567899999999996 788999999987 56
Q ss_pred CeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC----------
Q 002887 629 ANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF---------- 698 (870)
Q Consensus 629 ~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~---------- 698 (870)
...++||||+ +++|.+.+.......+++..+..++.|+++||+|||+++ +|+||||||+|||++.++
T Consensus 118 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 118 THICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp EEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred ceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 6899999999 566777776655567999999999999999999999853 899999999999999775
Q ss_pred ---------------------------------------cEEEEeccCCccccCCCCccccccccCCCCccCccccccCC
Q 002887 699 ---------------------------------------QAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNR 739 (870)
Q Consensus 699 ---------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~ 739 (870)
.+||+|||+++..... .....||+.|+|||++.+..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSC
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcCCC
Confidence 7999999999865321 23457899999999999999
Q ss_pred CCccchHHHHHHHHHHHHhCCCCCCCCCccc------hHHHHHHHHhh--------cCCc-chhcccc--c---------
Q 002887 740 LTEKSDVYSFGVVLLELITGQPVIQKTPQRT------LIGQWVSSMLA--------RGDI-KNIVDHR--L--------- 793 (870)
Q Consensus 740 ~~~ksDVwS~GvvL~elltG~~p~~~~~~~~------~l~~~~~~~~~--------~~~~-~~i~d~~--l--------- 793 (870)
++.++|||||||++|||++|+.||....... .+... ..... .+.. .+.+... +
T Consensus 270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALI-IELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHH-HHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHH-HHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 9999999999999999999999997654221 11111 11110 0100 0000000 0
Q ss_pred --------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 794 --------QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 794 --------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...........+.+++.+||+.||++|||+.|+++
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 01234566778999999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=342.01 Aligned_cols=190 Identities=25% Similarity=0.384 Sum_probs=150.5
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEec-----CCeEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDE-----GANMGL 633 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-----~~~~~L 633 (870)
+.+.+.||+|+||.||+|+.. ++.||||++... .....+++.+|+++|++++||||+++++++.. ....++
T Consensus 55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 134 (458)
T 3rp9_A 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134 (458)
T ss_dssp EEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence 345689999999999999875 789999999754 33445778999999999999999999999943 357899
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
||||+. |+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 135 v~e~~~-~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 135 VLEIAD-SDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EECCCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEeccc-cchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 999885 688888853 35699999999999999999999998 999999999999999999999999999987642
Q ss_pred CCCc-------------------------cccccccCCCCccCcccc-ccCCCCccchHHHHHHHHHHHHh
Q 002887 714 EGGT-------------------------HVSTTVVGTPGYLDPEYY-ISNRLTEKSDVYSFGVVLLELIT 758 (870)
Q Consensus 714 ~~~~-------------------------~~~~~~~gt~~y~APE~~-~~~~~~~ksDVwS~GvvL~ellt 758 (870)
.... ......+||+.|+|||++ ....++.++|||||||++|||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 2111 123445789999999986 45679999999999999999999
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=325.57 Aligned_cols=255 Identities=18% Similarity=0.286 Sum_probs=203.3
Q ss_pred hhccccccccCcEEEEEEEE---CCeeEEEEEeeccchhhhHHHHHHHHHHHHhcccc------ceeEEEEEecCCeEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYL---DDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKN------LTILVGYCDEGANMGL 633 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~---~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~l~g~~~~~~~~~L 633 (870)
+.+.+.||+|+||.||+|.. .++.||||++.... ...+.+.+|++++++++|++ ++++++++......++
T Consensus 16 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~l 94 (339)
T 1z57_A 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICI 94 (339)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEE
T ss_pred eEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEE
Confidence 44568999999999999987 37899999997543 34567899999999998775 9999999999999999
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC-----------------
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE----------------- 696 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~----------------- 696 (870)
||||+ +++|.+++.......+++..+..++.|+++||+|||++ +|+||||||+|||++.
T Consensus 95 v~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 95 VFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 99999 88999999776656799999999999999999999998 9999999999999987
Q ss_pred --CCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHH
Q 002887 697 --KFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQ 774 (870)
Q Consensus 697 --~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~ 774 (870)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 245 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245 (339)
T ss_dssp ESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH
T ss_pred ccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 668999999999864221 2345789999999999999999999999999999999999999987654433322
Q ss_pred HHHHHhhc--------CCcchhcc--------------------ccc--CCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 002887 775 WVSSMLAR--------GDIKNIVD--------------------HRL--QGDFDTNTVWKAVEIALACIHTISTRRPTMN 824 (870)
Q Consensus 775 ~~~~~~~~--------~~~~~i~d--------------------~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~ 824 (870)
... .... ........ ..+ ...........+.+++.+|++.||++|||+.
T Consensus 246 ~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 324 (339)
T 1z57_A 246 MER-ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR 324 (339)
T ss_dssp HHH-HHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHH-HhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence 211 1100 00000000 000 0111235567899999999999999999999
Q ss_pred HHHH
Q 002887 825 QVVI 828 (870)
Q Consensus 825 eVl~ 828 (870)
|+++
T Consensus 325 ell~ 328 (339)
T 1z57_A 325 EALK 328 (339)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=343.95 Aligned_cols=254 Identities=22% Similarity=0.297 Sum_probs=193.8
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecC------CeEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEG------ANMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~LV~ 635 (870)
...+.||+|+||.||+|++. ++.||||++.... ..+.+|++++++++|+||+++++++... ...++||
T Consensus 57 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred EeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 44578999999999999985 8899999986542 2345799999999999999999998432 2367899
Q ss_pred EEccCCchhhhhhh--cccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC-CcEEEEeccCCcccc
Q 002887 636 EFMANGNLQAHLLE--DKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK-FQAKLADFGLSRIFP 712 (870)
Q Consensus 636 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~-~~vkL~DFGla~~~~ 712 (870)
||+++ ++.+.+.. .....+++..+..++.|+++||+|||+. +|+||||||+|||++.+ +.+||+|||+++.+.
T Consensus 133 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp ECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred hcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99986 56555543 2346799999999999999999999998 99999999999999965 678999999998763
Q ss_pred CCCCccccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc---------
Q 002887 713 VEGGTHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR--------- 782 (870)
Q Consensus 713 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~--------- 782 (870)
... ......||+.|+|||++.+. .++.++|||||||++|||++|++||........+.++++..-..
T Consensus 209 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~ 285 (420)
T 1j1b_A 209 RGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285 (420)
T ss_dssp TTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred cCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 322 22345789999999999765 79999999999999999999999998776555554444321100
Q ss_pred CCcchhcccccCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 783 GDIKNIVDHRLQGD-----FDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 783 ~~~~~i~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
....+...+.+... +.......+.+|+.+||+.||++||++.|+++
T Consensus 286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00011111111000 11223467899999999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=337.36 Aligned_cols=257 Identities=22% Similarity=0.287 Sum_probs=200.1
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
.+.+.||+|+||.||+|... ++.||+|++.... ....+.+.+|++++++++||||+++++++..+...++||||+++
T Consensus 36 ~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 115 (360)
T 3eqc_A 36 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115 (360)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCC
Confidence 34578999999999999986 8899999998653 34457789999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|.+++... ..+++..+..++.|++.||+|||+.+ +|+||||||+|||++.++.+||+|||++..... ...
T Consensus 116 ~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----~~~ 187 (360)
T 3eqc_A 116 GSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMA 187 (360)
T ss_dssp CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----HC-
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc----ccc
Confidence 9999998653 46899999999999999999999831 799999999999999999999999999875421 122
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHH---------------------
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSM--------------------- 779 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~--------------------- 779 (870)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+....
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267 (360)
T ss_dssp ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence 34579999999999999999999999999999999999999998654322111100000
Q ss_pred ----hhcCCcchhccc----ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 780 ----LARGDIKNIVDH----RLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 780 ----~~~~~~~~i~d~----~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.......+.++. .............+.+++.+|++.+|++|||+.|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000011110 0000011123457889999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=331.19 Aligned_cols=257 Identities=25% Similarity=0.393 Sum_probs=184.2
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
.+.+.||+|+||.||+|... ++.||||++.... ....+++.+|++++++++||||+++++++...+..++||||+++
T Consensus 18 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 97 (303)
T 2vwi_A 18 ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 97 (303)
T ss_dssp EEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTT
T ss_pred hhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccC
Confidence 45679999999999999874 8899999987543 23456788999999999999999999999999999999999999
Q ss_pred Cchhhhhhhc------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 641 GNLQAHLLED------KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 641 gsL~~~l~~~------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 174 (303)
T 2vwi_A 98 GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174 (303)
T ss_dssp CBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred CchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence 9999988642 234689999999999999999999998 9999999999999999999999999998765332
Q ss_pred CC---ccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcc
Q 002887 715 GG---THVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVD 790 (870)
Q Consensus 715 ~~---~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d 790 (870)
.. ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||............ .. +.......
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~~-~~~~~~~~ 249 (303)
T 2vwi_A 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT----LQ-NDPPSLET 249 (303)
T ss_dssp -------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH----HT-SSCCCTTC
T ss_pred CCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH----hc-cCCCcccc
Confidence 11 112234579999999999876 56899999999999999999999999876544332211 11 11111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 791 HRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 791 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..............+.+++.+|++.+|++||++.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00001111223356789999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=335.82 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=193.1
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecCC------eEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGA------NMGL 633 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~~L 633 (870)
.+.+.||+|+||.||+|... ++.||||++... .....+++.+|++++++++||||+++++++.... ..++
T Consensus 28 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l 107 (367)
T 1cm8_A 28 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL 107 (367)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEE
Confidence 34578999999999999985 889999998653 2334567899999999999999999999997653 4699
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
||||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 108 v~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 108 VMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp EEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 99999 7899998854 4689999999999999999999998 999999999999999999999999999986532
Q ss_pred CCCccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC---------
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG--------- 783 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~--------- 783 (870)
......+|+.|+|||++.+ ..++.++||||+||+++||++|+.||........+.......-...
T Consensus 181 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 181 -----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp -----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred -----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 1234578999999999987 6799999999999999999999999987665444333322110000
Q ss_pred -Ccchhc-------ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 784 -DIKNIV-------DHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 784 -~~~~i~-------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.....+ ...+. .........+.+++.+|++.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000000 00000 011223467889999999999999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=325.42 Aligned_cols=258 Identities=23% Similarity=0.344 Sum_probs=201.7
Q ss_pred hccccccccCcEEEEEEEEC---CeeEEEEEeeccch--hhhHHHHHHHHHHHHh---ccccceeEEEEEe-----cCCe
Q 002887 564 NFERVLGKGGFGTVYHGYLD---DKQVAVKMLSSSSV--QGYKQFQAEVELLIRA---HHKNLTILVGYCD-----EGAN 630 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~---~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~-----~~~~ 630 (870)
.+.+.||+|+||.||+|... ++.||+|++..... .....+.+|+.+++++ +||||+++++++. ....
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 93 (326)
T 1blx_A 14 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 93 (326)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred eeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCce
Confidence 34679999999999999973 78899999875432 2234677888888777 8999999999987 5667
Q ss_pred EEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCcc
Q 002887 631 MGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 631 ~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~ 710 (870)
.++||||++ |+|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 94 LTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp EEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred EEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 899999998 6999998776656799999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC---Ccch
Q 002887 711 FPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG---DIKN 787 (870)
Q Consensus 711 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~---~~~~ 787 (870)
... ........|++.|+|||++.+..++.++||||||+++|||++|+.||........+.......-... +...
T Consensus 170 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 170 YSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred ccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 532 1233456789999999999999999999999999999999999999987665444443332211110 0000
Q ss_pred ------hcccc---cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 788 ------IVDHR---LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 788 ------i~d~~---l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.+... ............+.+++.+|++.+|++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 000111234467889999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=359.09 Aligned_cols=255 Identities=25% Similarity=0.345 Sum_probs=204.6
Q ss_pred hhccccccccCcEEEEEEEEC-----CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-----DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-----~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
..+.+.||+|+||.||+|.+. +..||||++.... ....+.|.+|+.++++++||||+++++++.+ +..++|||
T Consensus 392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv~E 470 (656)
T 2j0j_A 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIME 470 (656)
T ss_dssp EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEEEE
Confidence 345678999999999999974 4569999987643 3345779999999999999999999999854 56899999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
|+++|+|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 471 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~-~ 545 (656)
T 2j0j_A 471 LCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-T 545 (656)
T ss_dssp CCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred cCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCC-c
Confidence 99999999998643 34689999999999999999999998 9999999999999999999999999999876322 2
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
........+++.|+|||++.+..++.++|||||||++|||++ |+.||............ ..+.. .
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i-----~~~~~---------~ 611 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-----ENGER---------L 611 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-----HHTCC---------C
T ss_pred ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-----HcCCC---------C
Confidence 222234567789999999999999999999999999999997 99999866543322221 11110 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHh
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e 837 (870)
..+......+.+++.+|++.+|++|||+.|+++.|++++..+
T Consensus 612 ~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 612 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 122334567889999999999999999999999999987554
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=340.76 Aligned_cols=256 Identities=18% Similarity=0.266 Sum_probs=204.3
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhcc-ccceeEEEEEecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHH-KNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
.+.+.||+|+||.||+|+.. ++.||||++..... ..++.+|+++++.++| +++..+..++.+....++||||+ +
T Consensus 10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g 86 (483)
T 3sv0_A 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (483)
T ss_dssp ECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-C
Confidence 45689999999999999975 88999998876533 3568899999999977 55666666677788899999999 9
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEE---cCCCcEEEEeccCCccccCCCCc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILl---d~~~~vkL~DFGla~~~~~~~~~ 717 (870)
++|.+++... ...+++..++.|+.||+.||+|||++ +|+||||||+|||+ ++++.+||+|||+++.+......
T Consensus 87 ~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 87 PSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 9999998643 35799999999999999999999998 99999999999999 68899999999999876433221
Q ss_pred -----cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHH---HHHHhhcCCcchhc
Q 002887 718 -----HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQW---VSSMLARGDIKNIV 789 (870)
Q Consensus 718 -----~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~---~~~~~~~~~~~~i~ 789 (870)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ..... ......+.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-~~~~~~l~ 241 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-ATSIEALC 241 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH-HSCHHHHH
T ss_pred cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc-cccHHHHh
Confidence 1123567999999999999999999999999999999999999999876543322211 11111 11111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 790 DHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 790 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
.....++.+++..|++.+|++||++.+|+++|++++..
T Consensus 242 ---------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 242 ---------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp ---------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ---------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 11235788999999999999999999999999998754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=338.61 Aligned_cols=249 Identities=10% Similarity=-0.016 Sum_probs=180.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHh--ccccceeEE-------EEEecC-
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRA--HHKNLTILV-------GYCDEG- 628 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l--~H~nIv~l~-------g~~~~~- 628 (870)
.+.+.||+|+||.||+|... ++.||||++..... ...+.+.+|++++..+ +||||++++ +.+...
T Consensus 65 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~ 144 (371)
T 3q60_A 65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS 144 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETT
T ss_pred eeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCC
Confidence 34578999999999999975 88999999987543 3455678886666666 599988755 343322
Q ss_pred ----------------CeEEEEEEEccCCchhhhhhhcccccccHHHH------HHHHHHHHHHHHHHHhCCCCCceeCC
Q 002887 629 ----------------ANMGLIYEFMANGNLQAHLLEDKADTLCWERR------LQIASESAQGLEYLHNGCKPPIVHRD 686 (870)
Q Consensus 629 ----------------~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~aL~yLH~~~~~~IvHrD 686 (870)
...++||||++ |+|.+++.... ..+.+..+ +.++.|+++||+|||++ +|+|||
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrD 219 (371)
T 3q60_A 145 QPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGH 219 (371)
T ss_dssp SCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCc
Confidence 34799999999 89999997642 23455566 78889999999999998 999999
Q ss_pred CCCCCEEEcCCCcEEEEeccCCccccCCCCccccccccCCCCccCcccccc--CCCCccchHHHHHHHHHHHHhCCCCCC
Q 002887 687 VKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLELITGQPVIQ 764 (870)
Q Consensus 687 LKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~ksDVwS~GvvL~elltG~~p~~ 764 (870)
|||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999986521 1124457799999999987 679999999999999999999999998
Q ss_pred CCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 765 KTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 765 ~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
........ ..............+...........+.+++.+||+.||++|||+.|+++
T Consensus 295 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 295 LVTPGIKG------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp BCCTTCTT------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CcCccccc------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 65322100 00000000011111111111234567889999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=361.26 Aligned_cols=243 Identities=25% Similarity=0.352 Sum_probs=202.2
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.+.||+|+||.||+|+.. ++.||||+++... ....+.+..|..++..+ +|++|+++++++.+....++||||
T Consensus 344 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~ 423 (674)
T 3pfq_A 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 423 (674)
T ss_dssp EEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEEC
T ss_pred EEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeC
Confidence 45679999999999999986 7789999998642 23456678899999887 799999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++|+|..++... ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++..... .
T Consensus 424 ~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~--~ 496 (674)
T 3pfq_A 424 VNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--G 496 (674)
T ss_dssp CCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCT--T
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccC--C
Confidence 9999999999753 4699999999999999999999998 9999999999999999999999999999864222 2
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
.......||+.|+|||++.+..++.++|||||||++|||++|++||........... ... +. ..+
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~----i~~-~~----------~~~ 561 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IME-HN----------VAY 561 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHS-SC----------CCC
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHH----HHh-CC----------CCC
Confidence 234567899999999999999999999999999999999999999987554333222 221 11 112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTM-----NQVVI 828 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm-----~eVl~ 828 (870)
+......+.+|+.+||+.||++||++ +||++
T Consensus 562 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 562 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 23345678899999999999999997 55543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=324.97 Aligned_cols=246 Identities=23% Similarity=0.359 Sum_probs=198.8
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.+.||+|+||.||+|... ++.||+|++.... ..+.+.+|++++++++||||+++++++......++||||+++
T Consensus 31 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (314)
T 3com_A 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGA 108 (314)
T ss_dssp EEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred hhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCC
Confidence 345679999999999999986 8899999997653 346789999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...... ....
T Consensus 109 ~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~ 182 (314)
T 3com_A 109 GSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT--MAKR 182 (314)
T ss_dssp EEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--BSCB
T ss_pred CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--cccc
Confidence 999998853 245789999999999999999999998 9999999999999999999999999999865322 1223
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||........... ....... .+ .....
T Consensus 183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~-----~~--~~~~~ 250 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM-----IPTNPPP-----TF--RKPEL 250 (314)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-----HHHSCCC-----CC--SSGGG
T ss_pred CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH-----HhcCCCc-----cc--CCccc
Confidence 445789999999999998999999999999999999999999986543222111 1111100 00 11122
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
....+.+++.+|++.+|++|||+.|+++
T Consensus 251 ~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 251 WSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp SCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 3457889999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=323.23 Aligned_cols=258 Identities=23% Similarity=0.325 Sum_probs=193.6
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEe--------------c
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCD--------------E 627 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~--------------~ 627 (870)
...+.||+|+||.||+|... ++.||+|++........+++.+|++++++++||||+++++++. +
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 93 (320)
T 2i6l_A 14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTE 93 (320)
T ss_dssp EEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCS
T ss_pred eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccc
Confidence 34578999999999999986 8899999998777677788999999999999999999999873 4
Q ss_pred CCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEc-CCCcEEEEecc
Q 002887 628 GANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLN-EKFQAKLADFG 706 (870)
Q Consensus 628 ~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld-~~~~vkL~DFG 706 (870)
....++||||++ |+|.+++.. ..+++..+..++.|+++||+|||++ +|+||||||+||+++ +++.+||+|||
T Consensus 94 ~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 94 LNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp CSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred cCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCc
Confidence 467899999998 699998843 4689999999999999999999998 999999999999997 56799999999
Q ss_pred CCccccCCCC-ccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc--
Q 002887 707 LSRIFPVEGG-THVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR-- 782 (870)
Q Consensus 707 la~~~~~~~~-~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~-- 782 (870)
+++....... ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...................
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (320)
T 2i6l_A 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246 (320)
T ss_dssp TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCH
T ss_pred cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence 9986532211 112234567999999999875 678999999999999999999999998766443333322211000
Q ss_pred -------CCcchhcccccCCC-C-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 783 -------GDIKNIVDHRLQGD-F-----DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 783 -------~~~~~i~d~~l~~~-~-----~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..+...+....... . .......+.+++.+|++.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000000001000 0 0123467889999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=323.74 Aligned_cols=247 Identities=20% Similarity=0.321 Sum_probs=192.6
Q ss_pred hccccccccCcEEEEEEEEC-CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhc--cccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAH--HKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
.+.+.||+|+||.||++... ++.||||++.... ....+.+.+|++++.+++ |+||+++++++......++||| +
T Consensus 31 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~ 109 (313)
T 3cek_A 31 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-C 109 (313)
T ss_dssp EEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-C
T ss_pred EEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-c
Confidence 44579999999999999986 7889999997543 345577899999999997 4999999999999999999999 6
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
.+++|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+|||+++ +.+||+|||+++.........
T Consensus 110 ~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~ 183 (313)
T 3cek_A 110 GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSV 183 (313)
T ss_dssp CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--------
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCccccc
Confidence 788999998753 4689999999999999999999998 9999999999999975 799999999998764333322
Q ss_pred ccccccCCCCccCcccccc-----------CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcch
Q 002887 719 VSTTVVGTPGYLDPEYYIS-----------NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKN 787 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~-----------~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (870)
......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||........ ......
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~------- 253 (313)
T 3cek_A 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAII------- 253 (313)
T ss_dssp ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHH-------
T ss_pred cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH---HHHHHH-------
Confidence 3345679999999999875 4688899999999999999999999976433211 111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 788 IVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 788 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
++.............+.+++.+|++.+|++||++.|+++.
T Consensus 254 --~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 254 --DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp --CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1111112222234578899999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=337.68 Aligned_cols=256 Identities=22% Similarity=0.312 Sum_probs=193.9
Q ss_pred hhccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCC------eEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGA------NMGLIY 635 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~~LV~ 635 (870)
+.+.+.||+|+||.||+|+.. +..+|+|++..... ...+|++++++++||||+++++++.... ..++||
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 345689999999999999986 66799998865432 2347999999999999999999995433 378999
Q ss_pred EEccCCchhhhhhh-cccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEc-CCCcEEEEeccCCccccC
Q 002887 636 EFMANGNLQAHLLE-DKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 636 Ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld-~~~~vkL~DFGla~~~~~ 713 (870)
||++++.+...... .....+++..+..++.|+++||+|||+. +|+||||||+|||++ .++.+||+|||+++....
T Consensus 118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 99997644433221 2246799999999999999999999998 999999999999999 799999999999987633
Q ss_pred CCCccccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCC--c----c
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGD--I----K 786 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~--~----~ 786 (870)
.. ......||+.|+|||++.+. .++.++|||||||++|||++|++||........+.++.+..-.... + .
T Consensus 195 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 271 (394)
T 4e7w_A 195 GE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271 (394)
T ss_dssp TC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred CC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 22 22345789999999999765 5899999999999999999999999877655554444332110000 0 0
Q ss_pred hhcccccC--------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 787 NIVDHRLQ--------GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 787 ~i~d~~l~--------~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
......+. ..+.......+.+++.+||+.||++|||+.|+++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00000000 0011123457899999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=321.94 Aligned_cols=247 Identities=21% Similarity=0.237 Sum_probs=182.9
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch-h-hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-Q-GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.+.+.||+|+||.||+|... ++.||||++..... . ..+.+.++...++.++||||+++++++.++...++||||++
T Consensus 10 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 89 (290)
T 3fme_A 10 EPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD 89 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS
T ss_pred hhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc
Confidence 45679999999999999984 89999999976522 2 22334455556777899999999999999999999999998
Q ss_pred CCchhhhhhhc--ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 640 NGNLQAHLLED--KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 640 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
|+|.+++... ....+++..+..++.|++.||+|||+++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 90 -~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 163 (290)
T 3fme_A 90 -TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD--- 163 (290)
T ss_dssp -EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------------
T ss_pred -cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccccc---
Confidence 5887777542 3467999999999999999999999842 8999999999999999999999999999865322
Q ss_pred cccccccCCCCccCcccc----ccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccccc
Q 002887 718 HVSTTVVGTPGYLDPEYY----ISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~----~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
.......||+.|+|||++ .+..++.++||||||++++||++|+.||........ . ..........
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~-~~~~~~~~~~-------- 232 (290)
T 3fme_A 164 VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ--Q-LKQVVEEPSP-------- 232 (290)
T ss_dssp ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH--H-HHHHHHSCCC--------
T ss_pred ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH--H-HHHHhccCCC--------
Confidence 222345799999999996 456789999999999999999999999975432211 1 1111211110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 794 QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..........+.+++.+|++.+|++|||+.|+++
T Consensus 233 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 233 -QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1111223456889999999999999999999987
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=327.38 Aligned_cols=261 Identities=21% Similarity=0.295 Sum_probs=198.4
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEec--------CCe
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDE--------GAN 630 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--------~~~ 630 (870)
+.+.+.||+|+||.||+|+.. ++.||||++..... .....+.+|++++++++||||+++++++.. ...
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (351)
T 3mi9_A 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 98 (351)
T ss_dssp EEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CE
T ss_pred eeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCce
Confidence 345678999999999999985 88999999865532 234578899999999999999999999976 346
Q ss_pred EEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCcc
Q 002887 631 MGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 631 ~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~ 710 (870)
.++||||+++ +|.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 99 IYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp EEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 8999999985 677766543 34699999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCC--ccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc--CCc
Q 002887 711 FPVEGG--THVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR--GDI 785 (870)
Q Consensus 711 ~~~~~~--~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~--~~~ 785 (870)
+..... ........||+.|+|||++.+ ..++.++|||||||+++||++|++||........+.......... ...
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 253 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 642221 122345678999999999976 458999999999999999999999998766544433322211100 000
Q ss_pred chhccccc-------CC-CCCH-HH------HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 786 KNIVDHRL-------QG-DFDT-NT------VWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 786 ~~i~d~~l-------~~-~~~~-~~------~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...-...+ .. .... .. ...+.+++.+|++.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 01000000 00 0011 11 245789999999999999999999886
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=348.60 Aligned_cols=246 Identities=27% Similarity=0.370 Sum_probs=197.7
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccch-------------hhhHHHHHHHHHHHHhccccceeEEEEEec
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-------------QGYKQFQAEVELLIRAHHKNLTILVGYCDE 627 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-------------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 627 (870)
+.+.+.||+|+||.||+|... ++.||+|++..... ...+.+.+|+.++++++||||+++++++.+
T Consensus 38 Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 117 (504)
T 3q5i_A 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED 117 (504)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred eEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 344679999999999999986 78899999976432 234678999999999999999999999999
Q ss_pred CCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC---cEEEEe
Q 002887 628 GANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF---QAKLAD 704 (870)
Q Consensus 628 ~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~---~vkL~D 704 (870)
....++||||+++|+|.+.+... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 118 ~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 118 KKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred CCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 99999999999999999988643 4699999999999999999999998 999999999999998876 699999
Q ss_pred ccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCC
Q 002887 705 FGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGD 784 (870)
Q Consensus 705 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~ 784 (870)
||+++..... .......||+.|+|||++. +.++.++||||+||++|+|++|++||........+... ..+.
T Consensus 193 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-----~~~~ 263 (504)
T 3q5i_A 193 FGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV-----EKGK 263 (504)
T ss_dssp CTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HHCC
T ss_pred CCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----HcCC
Confidence 9999876332 2234567999999999986 46899999999999999999999999876544332221 1121
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 785 IKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 785 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.. .+... .......+.+++.+|++.+|++|||+.|+++
T Consensus 264 ~~--~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 264 YY--FDFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CC--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC--CCccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 10 00000 0122456889999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=330.54 Aligned_cols=257 Identities=21% Similarity=0.282 Sum_probs=201.2
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhc-cc-----cceeEEEEEecCCeEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAH-HK-----NLTILVGYCDEGANMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~-----nIv~l~g~~~~~~~~~LV~ 635 (870)
.+.+.||+|+||.||+|+.. ++.||||++.... ....++..|+.++..++ |+ +++++++++......++||
T Consensus 57 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 135 (382)
T 2vx3_A 57 EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVF 135 (382)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEE
T ss_pred EEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEE
Confidence 34579999999999999976 7899999997543 34567788999999885 44 4999999999999999999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEc--CCCcEEEEeccCCccccC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLN--EKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld--~~~~vkL~DFGla~~~~~ 713 (870)
||+. |+|.+++.......+++..+..++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+|||+++....
T Consensus 136 e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~ 213 (382)
T 2vx3_A 136 EMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213 (382)
T ss_dssp ECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred ecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc
Confidence 9997 5999999776656799999999999999999999953 33899999999999995 477899999999986532
Q ss_pred CCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc--------CCc
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR--------GDI 785 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~--------~~~ 785 (870)
......||+.|+|||++.+..++.++|||||||++|||++|++||........+.......-.. ...
T Consensus 214 -----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (382)
T 2vx3_A 214 -----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288 (382)
T ss_dssp -----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTH
T ss_pred -----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHH
Confidence 1234678999999999999999999999999999999999999998766544444433221100 000
Q ss_pred chhcccc----c-----------------------------------C--CCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 002887 786 KNIVDHR----L-----------------------------------Q--GDFDTNTVWKAVEIALACIHTISTRRPTMN 824 (870)
Q Consensus 786 ~~i~d~~----l-----------------------------------~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~ 824 (870)
.+.++.. + . ......+...+.+++.+||+.||++|||+.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~ 368 (382)
T 2vx3_A 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPY 368 (382)
T ss_dssp HHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHH
T ss_pred HHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHH
Confidence 0000000 0 0 001123446789999999999999999999
Q ss_pred HHHH
Q 002887 825 QVVI 828 (870)
Q Consensus 825 eVl~ 828 (870)
|+++
T Consensus 369 e~L~ 372 (382)
T 2vx3_A 369 YALQ 372 (382)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=327.89 Aligned_cols=258 Identities=21% Similarity=0.332 Sum_probs=200.2
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecC-----CeEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEG-----ANMGLI 634 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~LV 634 (870)
+.+.+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|++++.+++||||+++++++... ...++|
T Consensus 29 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv 108 (364)
T 3qyz_A 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIV 108 (364)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEE
Confidence 344579999999999999975 8889999997543 33446789999999999999999999999654 468999
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
|||+. |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 109 ~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 109 QDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 99998 589888853 4689999999999999999999998 9999999999999999999999999999866322
Q ss_pred CCc-cccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcch-----
Q 002887 715 GGT-HVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKN----- 787 (870)
Q Consensus 715 ~~~-~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~----- 787 (870)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|++||........+.......-. .....
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~ 260 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS-PSQEDLNCII 260 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCS-CCHHHHHTCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCC-CCHHHHHHhh
Confidence 111 11244579999999998764 45899999999999999999999999877665555443321111 00000
Q ss_pred ------hccccc-CCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 788 ------IVDHRL-QGDFD-----TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 788 ------i~d~~l-~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...... ..... ......+.+++.+|++.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 00000 122356889999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=338.66 Aligned_cols=195 Identities=27% Similarity=0.388 Sum_probs=162.5
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecC-----CeEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEG-----ANMGL 633 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~L 633 (870)
+.+.+.||+|+||.||+|+.. ++.||||++... .....+.+.+|++++++++|+||+++++++... ...++
T Consensus 28 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 107 (432)
T 3n9x_A 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI 107 (432)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred EEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEE
Confidence 345689999999999999986 789999999764 334457789999999999999999999999765 57899
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
||||+. |+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 108 v~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 108 VLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 999987 599998853 35699999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCc--------------------cccccccCCCCccCcccc-ccCCCCccchHHHHHHHHHHHHhCCCCC
Q 002887 714 EGGT--------------------HVSTTVVGTPGYLDPEYY-ISNRLTEKSDVYSFGVVLLELITGQPVI 763 (870)
Q Consensus 714 ~~~~--------------------~~~~~~~gt~~y~APE~~-~~~~~~~ksDVwS~GvvL~elltG~~p~ 763 (870)
.... .......||+.|+|||++ ....++.++||||+||++|||++|..||
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 2211 123556899999999986 4566999999999999999999855444
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=333.53 Aligned_cols=255 Identities=21% Similarity=0.271 Sum_probs=190.5
Q ss_pred ccccccccCcEEEEEEEEC-CeeEEEEEeeccchh-----------hhHHHHHHHHHHHHhccccceeEEEEEe-----c
Q 002887 565 FERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQ-----------GYKQFQAEVELLIRAHHKNLTILVGYCD-----E 627 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~-----------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~-----~ 627 (870)
+.+.||+|+||.||+|... ++.||||++...... ..+.+.+|++++++++||||+++++++. .
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (362)
T 3pg1_A 26 VQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPA 105 (362)
T ss_dssp EEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTT
T ss_pred EeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCC
Confidence 3579999999999999876 889999998653221 2367899999999999999999999984 3
Q ss_pred CCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccC
Q 002887 628 GANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGL 707 (870)
Q Consensus 628 ~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGl 707 (870)
....++||||++ |+|.+.+... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 106 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 180 (362)
T 3pg1_A 106 MHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNL 180 (362)
T ss_dssp CCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCTTC
T ss_pred cceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEecCc
Confidence 346899999998 6888877643 35799999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcc
Q 002887 708 SRIFPVEGGTHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIK 786 (870)
Q Consensus 708 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~ 786 (870)
++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........+.......- .....
T Consensus 181 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~ 256 (362)
T 3pg1_A 181 AREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG-TPKIE 256 (362)
T ss_dssp ------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-CCCHH
T ss_pred ccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC-CCChH
Confidence 9754222 22344578999999999987 6789999999999999999999999987664444333322111 11000
Q ss_pred -----------hhcccccCCC-------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 787 -----------NIVDHRLQGD-------FDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 787 -----------~i~d~~l~~~-------~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+.+...+... ........+.+++.+|++.+|++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 0010111000 01122456889999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=334.48 Aligned_cols=257 Identities=23% Similarity=0.313 Sum_probs=180.9
Q ss_pred cccccccCcEEEEEEEEC----CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEe--cCCeEEEEEEEcc
Q 002887 566 ERVLGKGGFGTVYHGYLD----DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCD--EGANMGLIYEFMA 639 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~----~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~~LV~Ey~~ 639 (870)
.++||+|+||.||+|+.. ++.||||++..... ...+.+|++++++++||||+++++++. .....++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 458999999999999964 67899999975532 356889999999999999999999994 4678999999997
Q ss_pred CCchhhhhhhcc-------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEE----cCCCcEEEEeccCC
Q 002887 640 NGNLQAHLLEDK-------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILL----NEKFQAKLADFGLS 708 (870)
Q Consensus 640 ~gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILl----d~~~~vkL~DFGla 708 (870)
+ +|.+.+.... ...+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 5 7777775332 12499999999999999999999998 99999999999999 77889999999999
Q ss_pred ccccCCCC-ccccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCcc---------chHHHHHH
Q 002887 709 RIFPVEGG-THVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQR---------TLIGQWVS 777 (870)
Q Consensus 709 ~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~---------~~l~~~~~ 777 (870)
+.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|++||...... ..+...+.
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 87643211 1223456799999999999874 5899999999999999999999999754421 22222221
Q ss_pred HHhhc--CCcchhc------------ccccCCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 778 SMLAR--GDIKNIV------------DHRLQGDFD---------TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 778 ~~~~~--~~~~~i~------------d~~l~~~~~---------~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..-.. ..+..+. ......... ......+.+|+.+||+.||++|||+.|+++
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11100 0000000 000000000 011346789999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=329.33 Aligned_cols=257 Identities=20% Similarity=0.279 Sum_probs=186.5
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCe-------EEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGAN-------MGLI 634 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-------~~LV 634 (870)
.+.+.||+|+||.||+|+.. ++.||||++.... .....+.+|++.+..++||||+++++++..... .++|
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv 104 (360)
T 3e3p_A 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVV 104 (360)
T ss_dssp EEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEE
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEE
Confidence 34579999999999999986 8899999986543 233456788889999999999999999965333 7899
Q ss_pred EEEccCCchhhhhhh--cccccccHHHHHHHHHHHHHHHHHHH--hCCCCCceeCCCCCCCEEEcC-CCcEEEEeccCCc
Q 002887 635 YEFMANGNLQAHLLE--DKADTLCWERRLQIASESAQGLEYLH--NGCKPPIVHRDVKSANILLNE-KFQAKLADFGLSR 709 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH--~~~~~~IvHrDLKp~NILld~-~~~vkL~DFGla~ 709 (870)
|||++++ |...+.. .....+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+||+|||+++
T Consensus 105 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 105 MEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180 (360)
T ss_dssp EECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred eeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence 9999974 4443332 23457889999999999999999999 76 9999999999999997 8999999999998
Q ss_pred cccCCCCccccccccCCCCccCccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC-----
Q 002887 710 IFPVEGGTHVSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG----- 783 (870)
Q Consensus 710 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~----- 783 (870)
..... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||........+..+....-...
T Consensus 181 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3e3p_A 181 KLSPS---EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLR 257 (360)
T ss_dssp CCCTT---SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ecCCC---CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHH
Confidence 76432 2223457899999999997654 89999999999999999999999988765555444433211100
Q ss_pred ------Ccchhcc------cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 784 ------DIKNIVD------HRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 784 ------~~~~i~d------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
......+ ..............+.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000 00011112234678999999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=332.94 Aligned_cols=254 Identities=25% Similarity=0.339 Sum_probs=182.4
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecC------CeEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEG------ANMGL 633 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~L 633 (870)
.+.+.||+|+||.||+|... ++.||||++... .....+.+.+|++++++++||||+++++++... ...++
T Consensus 32 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~l 111 (367)
T 2fst_X 32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 111 (367)
T ss_dssp EEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEE
Confidence 34578999999999999875 889999998754 233456788999999999999999999998654 56799
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
|+|++ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 112 v~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 112 VTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp EEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred Eeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 99999 6899988853 5699999999999999999999998 999999999999999999999999999986422
Q ss_pred CCCccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC-----C---
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG-----D--- 784 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~-----~--- 784 (870)
......||+.|+|||++.+ ..++.++|||||||+++||++|+.||.+......+.......-... .
T Consensus 185 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 185 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred -----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 1234679999999999987 6789999999999999999999999987665444433332111000 0
Q ss_pred --cchhcccccC-CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 785 --IKNIVDHRLQ-GDFD-----TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 785 --~~~i~d~~l~-~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
....+..... .... ......+.+++.+||+.||++|||+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000000 0001 1123568899999999999999999999863
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=323.23 Aligned_cols=256 Identities=20% Similarity=0.283 Sum_probs=201.1
Q ss_pred hhccccccccCcEEEEEEEEC--C-eeEEEEEeeccchhhhHHHHHHHHHHHHhcccc------ceeEEEEEecCCeEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--D-KQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKN------LTILVGYCDEGANMGL 633 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~-~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~l~g~~~~~~~~~L 633 (870)
+.+.+.||+|+||.||+|... + +.||+|++.... ...+.+.+|++++++++|++ ++.+.+++......++
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~l 99 (355)
T 2eu9_A 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCI 99 (355)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEE
T ss_pred EEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEE
Confidence 445689999999999999975 3 789999997543 34567889999999998877 8999999999999999
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEE-------------------
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILL------------------- 694 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILl------------------- 694 (870)
||||+ ++++.+.+.......+++..+..++.|++.||+|||+. +|+||||||+|||+
T Consensus 100 v~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 100 AFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccccc
Confidence 99999 56777777666556799999999999999999999998 99999999999999
Q ss_pred cCCCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHH
Q 002887 695 NEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQ 774 (870)
Q Consensus 695 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~ 774 (870)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........+..
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250 (355)
T ss_dssp ESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 67889999999999864221 2345799999999999999999999999999999999999999987654433322
Q ss_pred HHHHHh-------hcCCcchhc-ccc---------------------cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 002887 775 WVSSML-------ARGDIKNIV-DHR---------------------LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQ 825 (870)
Q Consensus 775 ~~~~~~-------~~~~~~~i~-d~~---------------------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~e 825 (870)
.....- ......... ... ............+.+++.+||+.||++|||+.|
T Consensus 251 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 330 (355)
T 2eu9_A 251 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330 (355)
T ss_dssp HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHH
Confidence 211110 000000000 000 000112344668899999999999999999999
Q ss_pred HHH
Q 002887 826 VVI 828 (870)
Q Consensus 826 Vl~ 828 (870)
+++
T Consensus 331 ~l~ 333 (355)
T 2eu9_A 331 ALL 333 (355)
T ss_dssp HTT
T ss_pred Hhc
Confidence 985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=331.02 Aligned_cols=254 Identities=25% Similarity=0.384 Sum_probs=197.9
Q ss_pred hccccccccCcEEEEEEEECCeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 564 NFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
.+.+.||+|+||.||+|...+ .+|+|++.... ....+.+.+|+.++++++|+||+++++++......++||||++++
T Consensus 36 ~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 114 (319)
T 2y4i_B 36 EIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGR 114 (319)
T ss_dssp ECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSE
T ss_pred EEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCC
Confidence 346799999999999999876 59999987543 233466889999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC---Ccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG---GTH 718 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~---~~~ 718 (870)
+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++ ++.+||+|||+++...... ...
T Consensus 115 ~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~ 189 (319)
T 2y4i_B 115 TLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRED 189 (319)
T ss_dssp EHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----------CC
T ss_pred cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccccccccc
Confidence 999998653 34689999999999999999999998 999999999999998 6799999999987543211 112
Q ss_pred ccccccCCCCccCcccccc---------CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhc
Q 002887 719 VSTTVVGTPGYLDPEYYIS---------NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIV 789 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~---------~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~ 789 (870)
......|++.|+|||.+.. ..++.++||||||+++|||++|+.||..........+ ...+......
T Consensus 190 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~ 264 (319)
T 2y4i_B 190 KLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ-----MGTGMKPNLS 264 (319)
T ss_dssp SCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH-----HHTTCCCCCC
T ss_pred ccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----hccCCCCCCC
Confidence 2234468899999999874 3578899999999999999999999986554332221 1111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 790 DHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 790 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
.......+.+++.+|++.+|++|||+.|++++|+++...
T Consensus 265 --------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 265 --------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp --------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred --------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 111234578999999999999999999999999987644
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=318.34 Aligned_cols=247 Identities=23% Similarity=0.336 Sum_probs=190.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEec-------------C
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDE-------------G 628 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-------------~ 628 (870)
.+.+.||+|+||.||+|+.. ++.||||++... ....+.+.+|++++++++||||+++++++.+ .
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (303)
T 1zy4_A 9 EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKK 87 (303)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CE
T ss_pred hhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccC
Confidence 45679999999999999975 889999999654 3445778999999999999999999998854 3
Q ss_pred CeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCC
Q 002887 629 ANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 708 (870)
Q Consensus 629 ~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla 708 (870)
...++||||+++|+|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 163 (303)
T 1zy4_A 88 STLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLA 163 (303)
T ss_dssp EEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred CceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcch
Confidence 5688999999999999998653 35678899999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCC------------ccccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002887 709 RIFPVEGG------------THVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQW 775 (870)
Q Consensus 709 ~~~~~~~~------------~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~ 775 (870)
........ ........|++.|+|||++.+. .++.++|||||||++|||++ ||...... ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~---~~~ 237 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER---VNI 237 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH---HHH
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH---HHH
Confidence 86532110 1122345689999999999864 68999999999999999998 44322111 111
Q ss_pred HHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 776 VSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 776 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..... .. ...+...........+.+++.+|++.||++|||+.|+++
T Consensus 238 ~~~~~-~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 238 LKKLR-SV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHH-ST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcc-cc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11111 11 111222333445567889999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=328.61 Aligned_cols=258 Identities=20% Similarity=0.292 Sum_probs=196.9
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecC-----CeEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEG-----ANMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~LV~ 635 (870)
.+.+.||+|+||.||+|... ++.||||++.... ......+.+|++++++++||||+++++++... ...++||
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 93 (353)
T 2b9h_A 14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQ 93 (353)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEE
T ss_pred EEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEE
Confidence 34578999999999999986 8899999997543 33456788999999999999999999998654 6789999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
||+. |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 94 e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 94 ELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp CCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred eccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 9998 589888854 4689999999999999999999998 99999999999999999999999999998764221
Q ss_pred Ccc--------ccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC---
Q 002887 716 GTH--------VSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG--- 783 (870)
Q Consensus 716 ~~~--------~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~--- 783 (870)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|++||........+.......-...
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence 111 1223578999999998765 6789999999999999999999999987664433332221111000
Q ss_pred Ccc--------hhcccccC-CCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 784 DIK--------NIVDHRLQ-GDF-----DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 784 ~~~--------~i~d~~l~-~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
... +.+..... ... .......+.+++.+|++.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 00000000 000 0123457789999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=325.63 Aligned_cols=253 Identities=24% Similarity=0.307 Sum_probs=195.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeE------EE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANM------GL 633 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~------~L 633 (870)
.+.+.||+|+||.||+|... ++.||||++.... ....+.+.+|+.++++++||||+++++++...... ++
T Consensus 45 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 124 (371)
T 4exu_A 45 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 124 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEE
T ss_pred EEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEE
Confidence 34578999999999999975 8999999997643 23356789999999999999999999999877654 99
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
||||+. ++|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 125 v~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 125 VMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp EEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred EEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 999998 57877663 3489999999999999999999998 999999999999999999999999999986522
Q ss_pred CCCccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCC-----c--
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGD-----I-- 785 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~-----~-- 785 (870)
......||+.|+|||++.+ ..++.++|||||||+++||++|+.||........+.+.....-.... +
T Consensus 197 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 197 -----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred -----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 2234578999999999987 67899999999999999999999999876654444333221110000 0
Q ss_pred ---chhcccccCCCC------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 786 ---KNIVDHRLQGDF------DTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 786 ---~~i~d~~l~~~~------~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
............ .......+.+++.+|++.||++|||+.|+++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000000000 01224678899999999999999999999863
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=325.68 Aligned_cols=245 Identities=22% Similarity=0.302 Sum_probs=169.8
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEec----CCeEEEEEEEcc
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDE----GANMGLIYEFMA 639 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~LV~Ey~~ 639 (870)
.+.||+|+||.||+|... ++.||||++.... ....+....+..++|+||+++++++.. +...++||||++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred ceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 357999999999999986 8899999997542 122223344566799999999999866 445899999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC---CCcEEEEeccCCccccCCCC
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE---KFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~---~~~vkL~DFGla~~~~~~~~ 716 (870)
+|+|.+++.+.....+++.++..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 110 gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~--- 183 (336)
T 3fhr_A 110 GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--- 183 (336)
T ss_dssp TEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceeccc---
Confidence 99999999876666899999999999999999999999 9999999999999986 45599999999986532
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||............... ...+. ......
T Consensus 184 -~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~------~~~~~~ 255 (336)
T 3fhr_A 184 -NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR-IRLGQ------YGFPNP 255 (336)
T ss_dssp ---------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------CCCTT
T ss_pred -cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh-hhccc------cccCch
Confidence 1223457899999999998888999999999999999999999999765432221111100 00000 001111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
........+.+++.+|++.+|++|||+.|+++
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11234567889999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=326.93 Aligned_cols=257 Identities=22% Similarity=0.334 Sum_probs=197.7
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhc-----------cccceeEEEEEecCC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAH-----------HKNLTILVGYCDEGA 629 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-----------H~nIv~l~g~~~~~~ 629 (870)
+.+.+.||+|+||.||+|+.. ++.||||++.... ...+.+.+|++++++++ |+||+++++++....
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~ 99 (373)
T 1q8y_A 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 99 (373)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred EEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccC
Confidence 445689999999999999974 8899999997543 34467889999999886 899999999987644
Q ss_pred ----eEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEc------CCCc
Q 002887 630 ----NMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLN------EKFQ 699 (870)
Q Consensus 630 ----~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld------~~~~ 699 (870)
..++||||+ +++|.+++.......+++..+..++.|++.||+|||+++ +|+||||||+|||++ ..+.
T Consensus 100 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 100 PNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp TTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred CCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcce
Confidence 789999999 899999998766667999999999999999999999853 899999999999994 4458
Q ss_pred EEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCcc------chHH
Q 002887 700 AKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQR------TLIG 773 (870)
Q Consensus 700 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~------~~l~ 773 (870)
+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.
T Consensus 177 ~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 251 (373)
T 1q8y_A 177 IKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251 (373)
T ss_dssp EEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred EEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence 999999999865321 23457899999999999999999999999999999999999999864421 1111
Q ss_pred HHHHHH-------hhcCCcc-hhccc-------------------ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 002887 774 QWVSSM-------LARGDIK-NIVDH-------------------RLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQV 826 (870)
Q Consensus 774 ~~~~~~-------~~~~~~~-~i~d~-------------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eV 826 (870)
+..... ...+... ..++. .-....+......+.+++.+||+.||++|||+.|+
T Consensus 252 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 331 (373)
T 1q8y_A 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 331 (373)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHH
Confidence 111100 0000000 00000 00112345677889999999999999999999999
Q ss_pred HH
Q 002887 827 VI 828 (870)
Q Consensus 827 l~ 828 (870)
++
T Consensus 332 l~ 333 (373)
T 1q8y_A 332 VN 333 (373)
T ss_dssp HT
T ss_pred hh
Confidence 86
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=315.90 Aligned_cols=247 Identities=27% Similarity=0.393 Sum_probs=199.3
Q ss_pred HhhccccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 562 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.+.+.||+|+||.||+|+.. ++.||+|++..... ...+.+.+|++++++++||||+++++++......++|+||
T Consensus 23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (287)
T 2wei_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102 (287)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEc
Confidence 4456789999999999999985 88999999976432 3456789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC---CcEEEEeccCCccccCC
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK---FQAKLADFGLSRIFPVE 714 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~---~~vkL~DFGla~~~~~~ 714 (870)
+++++|.+.+... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||++......
T Consensus 103 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 103 YTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 9999999988643 4689999999999999999999998 99999999999999764 46999999999865322
Q ss_pred CCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccC
Q 002887 715 GGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794 (870)
Q Consensus 715 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 794 (870)
. ......|++.|+|||.+.+ .++.++||||||+++++|++|+.||........... +..+...... +.
T Consensus 178 ~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~-~~-- 245 (287)
T 2wei_A 178 T---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR-----VETGKYAFDL-PQ-- 245 (287)
T ss_dssp S---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHHCCCCCCS-GG--
T ss_pred C---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHcCCCCCCc-hh--
Confidence 1 1233457889999999865 489999999999999999999999986554332222 1122111000 00
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 795 GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 795 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.......+.+++.+|++.+|++|||+.|+++
T Consensus 246 ---~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 246 ---WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ---GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0123456889999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=322.27 Aligned_cols=252 Identities=24% Similarity=0.315 Sum_probs=194.6
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCe------EEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGAN------MGL 633 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~------~~L 633 (870)
.+.+.||+|+||.||+|... ++.||||++.... ....+.+.+|+.++++++||||+++++++..... .++
T Consensus 27 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 106 (353)
T 3coi_A 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 106 (353)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred EEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEE
Confidence 34578999999999999985 8999999997642 2335678999999999999999999999977654 499
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
||||+. |+|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++....
T Consensus 107 v~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 107 VMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp EEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred Eecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 999998 58887763 3489999999999999999999998 999999999999999999999999999976421
Q ss_pred CCCccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC-----Cc--
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG-----DI-- 785 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~-----~~-- 785 (870)
......||+.|+|||++.+ ..++.++|||||||+++||++|+.||........+.......-... .+
T Consensus 179 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 179 -----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred -----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 1234578999999999987 6789999999999999999999999987654433333222110000 00
Q ss_pred ---chhc---ccccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 786 ---KNIV---DHRLQ---GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 786 ---~~i~---d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...+ ..... ..........+.+++.+|++.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 00000 0112234567899999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=318.49 Aligned_cols=238 Identities=24% Similarity=0.395 Sum_probs=190.3
Q ss_pred HHhhccccccccCcEEEEEEEEC--CeeEEEEEeeccch------hhhHHHHHHHHHHHHh----ccccceeEEEEEecC
Q 002887 561 ITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV------QGYKQFQAEVELLIRA----HHKNLTILVGYCDEG 628 (870)
Q Consensus 561 ~t~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~------~~~~~f~~Ei~~l~~l----~H~nIv~l~g~~~~~ 628 (870)
..+.+.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++.++ +|+||+++++++...
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~ 110 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence 34556789999999999999874 78999999976533 2234567899999999 899999999999999
Q ss_pred CeEEEEEEE-ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEc-CCCcEEEEecc
Q 002887 629 ANMGLIYEF-MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLN-EKFQAKLADFG 706 (870)
Q Consensus 629 ~~~~LV~Ey-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld-~~~~vkL~DFG 706 (870)
+..++|+|| +.+++|.+++.+. ..+++..++.++.|+++||+|||+. +|+||||||+||+++ +++.+||+|||
T Consensus 111 ~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 111 EGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp --CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred CeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 999999999 7899999998753 4689999999999999999999998 999999999999999 88999999999
Q ss_pred CCccccCCCCccccccccCCCCccCccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCc
Q 002887 707 LSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLT-EKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDI 785 (870)
Q Consensus 707 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~-~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~ 785 (870)
+++..... ......|+..|+|||++.+..+. .++||||||+++|||++|+.||.... +. .. .
T Consensus 186 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~----~~-~-- 248 (312)
T 2iwi_A 186 SGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EI----LE-A-- 248 (312)
T ss_dssp SCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HH----HH-T--
T ss_pred hhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HH----hh-h--
Confidence 99876322 22345689999999999876654 58999999999999999999996421 10 10 1
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 786 KNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 786 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
. ..........+.+++.+|++.+|++|||+.|+++
T Consensus 249 ------~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 249 ------E--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ------C--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------c--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0112233456789999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=315.16 Aligned_cols=246 Identities=22% Similarity=0.266 Sum_probs=176.1
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchh--hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ--GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
.+.+.||+|+||.||+|... ++.||||++...... ..+.+.++..+++.++||||+++++++.+....++||||+
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 106 (318)
T 2dyl_A 28 ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM- 106 (318)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred cccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-
Confidence 34578999999999999985 889999999765322 2233455556778889999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHh-CCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++.+ ..+.......+++..+..++.|+++||.|||+ . +|+||||||+||+++.++.+||+|||++...... .
T Consensus 107 ~~~~-~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~---~ 179 (318)
T 2dyl_A 107 GTCA-EKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD---K 179 (318)
T ss_dssp SEEH-HHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred CCcH-HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC---c
Confidence 3444 44444445679999999999999999999998 4 8999999999999999999999999999765322 2
Q ss_pred ccccccCCCCccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccccc
Q 002887 719 VSTTVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
......|++.|+|||++. ...++.++||||||+++|||++|+.||........ .......... . .+
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~-~-----~~ 250 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE---VLTKVLQEEP-P-----LL 250 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHHSCC-C-----CC
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH---HHHHHhccCC-C-----CC
Confidence 223457899999999994 45688999999999999999999999986432211 1122221111 0 01
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 794 QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
. ........+.+++.+|++.+|++||++.|+++
T Consensus 251 ~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 251 P--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp C--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 01123456889999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=318.21 Aligned_cols=249 Identities=22% Similarity=0.286 Sum_probs=174.7
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHH-HHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVE-LLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.||+|+||.||+|... ++.||||++.... .....++..|+. +++.++||||+++++++...+..++||||+++
T Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (327)
T 3aln_A 26 DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST 105 (327)
T ss_dssp C-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE
T ss_pred ehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC
Confidence 3478999999999999986 8999999997653 233445566665 66678999999999999999999999999985
Q ss_pred Cchhhhhhh---cccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 641 GNLQAHLLE---DKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 641 gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+|.+++.. .....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 106 -~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 179 (327)
T 3aln_A 106 -SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS--- 179 (327)
T ss_dssp -EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred -ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccc---
Confidence 77776653 2246789999999999999999999984 28999999999999999999999999999865322
Q ss_pred cccccccCCCCccCcccc----ccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccccc
Q 002887 718 HVSTTVVGTPGYLDPEYY----ISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~----~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
.......||+.|+|||++ .+..++.++||||||+++|||++|+.||........ ...... .+ ..+.+
T Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~-~~-----~~~~~ 250 (327)
T 3aln_A 180 IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---QLTQVV-KG-----DPPQL 250 (327)
T ss_dssp --------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------CCCC-CS-----CCCCC
T ss_pred cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---HHHHHh-cC-----CCCCC
Confidence 122334799999999998 456789999999999999999999999975432110 000000 01 01111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 794 QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...........+.+++.+|++.+|++||++.|+++
T Consensus 251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11112234567889999999999999999999976
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=320.43 Aligned_cols=236 Identities=24% Similarity=0.381 Sum_probs=194.9
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchh------hhHHHHHHHHHHHHhc--cccceeEEEEEecCCeEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ------GYKQFQAEVELLIRAH--HKNLTILVGYCDEGANMG 632 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~------~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~ 632 (870)
+.+.+.||+|+||.||+|+.. ++.||||++...... ..+.+.+|+.++++++ |+||+++++++......+
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~ 124 (320)
T 3a99_A 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 124 (320)
T ss_dssp EEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEE
Confidence 345689999999999999874 889999999765332 2356788999999996 599999999999999999
Q ss_pred EEEEEccC-CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEc-CCCcEEEEeccCCcc
Q 002887 633 LIYEFMAN-GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRI 710 (870)
Q Consensus 633 LV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld-~~~~vkL~DFGla~~ 710 (870)
+|+|++.+ ++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++ +++.+||+|||+++.
T Consensus 125 lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 125 LILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp EEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 99999986 8999988653 4689999999999999999999998 999999999999999 789999999999987
Q ss_pred ccCCCCccccccccCCCCccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhc
Q 002887 711 FPVEGGTHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIV 789 (870)
Q Consensus 711 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~ 789 (870)
.... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... .. .. +..
T Consensus 200 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~----~~-~~~---- 260 (320)
T 3a99_A 200 LKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EI----IR-GQV---- 260 (320)
T ss_dssp CCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HH----HH-CCC----
T ss_pred cccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hh----hc-ccc----
Confidence 6321 2234579999999999987665 688999999999999999999996421 10 11 100
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 790 DHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 790 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.........+.+++.+||+.+|++|||+.|+++
T Consensus 261 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 261 ------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011223456889999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=329.91 Aligned_cols=246 Identities=23% Similarity=0.327 Sum_probs=184.4
Q ss_pred cccccccCcEEEEEE-EECCeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEccCCch
Q 002887 566 ERVLGKGGFGTVYHG-YLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMANGNL 643 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~-~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 643 (870)
.+.||+|+||+||.+ ...++.||||++.... .+.+.+|++++.++ +||||+++++++.+....++||||+. |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 468999999999654 4559999999987542 34678999999987 89999999999999999999999996 699
Q ss_pred hhhhhhccccc-----ccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC-------------CcEEEEec
Q 002887 644 QAHLLEDKADT-----LCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK-------------FQAKLADF 705 (870)
Q Consensus 644 ~~~l~~~~~~~-----l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~-------------~~vkL~DF 705 (870)
.+++....... .++..++.++.|++.||+|||+. +|+||||||+|||++.+ +.+||+||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 99987543211 13345678999999999999998 99999999999999754 48999999
Q ss_pred cCCccccCCCCcc--ccccccCCCCccCcccccc-------CCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHH
Q 002887 706 GLSRIFPVEGGTH--VSTTVVGTPGYLDPEYYIS-------NRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQW 775 (870)
Q Consensus 706 Gla~~~~~~~~~~--~~~~~~gt~~y~APE~~~~-------~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~ 775 (870)
|+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||....... ..+
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i 250 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNI 250 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHH
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHH
Confidence 9998764332211 1234579999999999975 568999999999999999999 999997543321 111
Q ss_pred HHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 776 VSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 776 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
....... +.+...........+.+++.+|++.+|++|||+.||++
T Consensus 251 ~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 251 IRGIFSL--------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHTCCCC--------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hcCCCCc--------ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111100 11111223456778999999999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=326.12 Aligned_cols=245 Identities=27% Similarity=0.366 Sum_probs=184.4
Q ss_pred hccccccccCcEE-EEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 564 NFERVLGKGGFGT-VYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 564 ~f~~~LG~G~fG~-Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
...+.||+|+||. ||++..+++.||||++.... ...+.+|+++++++ +||||+++++++.+....++||||+. |
T Consensus 27 ~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g 102 (432)
T 3p23_A 27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A 102 (432)
T ss_dssp EEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred ecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence 3457899999998 55666679999999996543 23467899999999 89999999999999999999999997 5
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC-----CCcEEEEeccCCccccCCCC
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE-----KFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~-----~~~vkL~DFGla~~~~~~~~ 716 (870)
+|.+++.... ..+.+..+..++.|+++||+|||+. +|+||||||+|||++. ...+||+|||+++.......
T Consensus 103 ~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 103 TLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp EHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred CHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 9999886543 2344556678999999999999998 9999999999999953 33688999999987643221
Q ss_pred c-cccccccCCCCccCccccc---cCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhccc
Q 002887 717 T-HVSTTVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDH 791 (870)
Q Consensus 717 ~-~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 791 (870)
. .......||+.|+|||++. ...++.++|||||||++|||++ |+.||........ ......... ..
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-----~~~~~~~~~-~~--- 249 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-----NILLGACSL-DC--- 249 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-----HHHTTCCCC-TT---
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-----HHHhccCCc-cc---
Confidence 1 2234567999999999997 4567889999999999999999 9999965432211 111111110 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 792 RLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 792 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..........+.+++.+|++.||++|||+.||++
T Consensus 250 ---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 250 ---LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ---SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0112244556789999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=337.98 Aligned_cols=266 Identities=25% Similarity=0.301 Sum_probs=205.3
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeecc-chhhhHHHHHHHHHHHHhccccceeEEEEEec------CCeEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS-SVQGYKQFQAEVELLIRAHHKNLTILVGYCDE------GANMGL 633 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------~~~~~L 633 (870)
+.+.+.||+|+||.||+|... ++.||||++... .....+.+.+|++++++++||||+++++++.. ....++
T Consensus 16 Y~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~L 95 (676)
T 3qa8_A 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLL 95 (676)
T ss_dssp -CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEE
Confidence 456689999999999999974 889999998764 33456778999999999999999999999865 677899
Q ss_pred EEEEccCCchhhhhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCc---EEEEeccCCc
Q 002887 634 IYEFMANGNLQAHLLEDK-ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQ---AKLADFGLSR 709 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~---vkL~DFGla~ 709 (870)
||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++.
T Consensus 96 VmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 96 AMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp EEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 999999999999987543 23689999999999999999999998 9999999999999997765 9999999998
Q ss_pred cccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhc
Q 002887 710 IFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIV 789 (870)
Q Consensus 710 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~ 789 (870)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...|.......+......
T Consensus 173 ~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~---~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 173 ELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ---PVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp BTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH---HHHSSTTCC------CCS
T ss_pred ccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc---hhhhhhhhhcccchhhhh
Confidence 76332 223456799999999999999999999999999999999999999975432 112211111111000000
Q ss_pred c----------cc--cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH-----HHHHHHHhhhHh
Q 002887 790 D----------HR--LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQ-----VVIELNDCLAME 837 (870)
Q Consensus 790 d----------~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~e-----Vl~~L~~~~~~e 837 (870)
. .. ............+.+++.+|++.||++|||+.| ..+.+++++...
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 0 00 011233456788999999999999999999988 567777776654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=301.75 Aligned_cols=228 Identities=12% Similarity=0.096 Sum_probs=180.8
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
+.+.+.||+|+||.||+|+.. ++.||||++..... ...+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 33 y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 112 (286)
T 3uqc_A 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEW 112 (286)
T ss_dssp EEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEe
Confidence 445689999999999999986 89999999976532 3347789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++++|.+++... ....++.+|+.|++.||+|||++ +|+||||||+|||+++++.+||+++|
T Consensus 113 ~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 113 IRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp CCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred cCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 9999999998432 34557889999999999999999 99999999999999999999998543
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccC--C
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ--G 795 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~--~ 795 (870)
|++ .++.++|||||||++|||++|+.||........+.. .......... .
T Consensus 175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~----------~~~~~~~~~~~~~ 226 (286)
T 3uqc_A 175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP----------AERDTAGQPIEPA 226 (286)
T ss_dssp -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE----------CCBCTTSCBCCHH
T ss_pred -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH----------HHHHhccCCCChh
Confidence 233 268899999999999999999999986543221100 0000000000 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHh
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e 837 (870)
.........+.+++.+||+.||++| |+.|+++.|+++...+
T Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0112234568899999999999999 9999999999976543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=337.63 Aligned_cols=238 Identities=22% Similarity=0.280 Sum_probs=192.1
Q ss_pred hhccccccccCcEEEEEEEEC---CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCe-----EEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD---DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGAN-----MGL 633 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~---~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-----~~L 633 (870)
+.+.+.||+|+||.||+|... ++.||||++.... ......+.+|++++++++||||+++++++..... .++
T Consensus 82 y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~l 161 (681)
T 2pzi_A 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI 161 (681)
T ss_dssp EEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEE
Confidence 445679999999999999974 7899999987543 3445678999999999999999999999987655 799
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
||||+++++|.+++.. .+++.+++.++.||+.||.|||++ +|+||||||+|||++++ .+||+|||+++....
T Consensus 162 v~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 162 VMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred EEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 9999999999987642 699999999999999999999998 99999999999999986 999999999986532
Q ss_pred CCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccccc
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
. ....||+.|+|||++.++. +.++|||||||+++||++|.+|+........ .
T Consensus 234 ~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------------~------- 285 (681)
T 2pzi_A 234 F------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------------P------- 285 (681)
T ss_dssp C------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------------C-------
T ss_pred C------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc--------------c-------
Confidence 2 3457999999999987654 8899999999999999999988764221100 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhhhH
Q 002887 794 QGDFDTNTVWKAVEIALACIHTISTRRP-TMNQVVIELNDCLAM 836 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-sm~eVl~~L~~~~~~ 836 (870)
...........+.+++.+|++.+|++|| ++.++.+.|...+..
T Consensus 286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 0000112335688999999999999999 577777778776543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=300.01 Aligned_cols=219 Identities=22% Similarity=0.347 Sum_probs=175.5
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHH-HHhccccceeEEEEEec----CCeEEEEEEEcc
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELL-IRAHHKNLTILVGYCDE----GANMGLIYEFMA 639 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l-~~l~H~nIv~l~g~~~~----~~~~~LV~Ey~~ 639 (870)
+.||+|+||.||++... ++.||+|++... ..+.+|++++ +..+||||+++++++.. ....++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 67999999999999985 889999998653 4567889888 55699999999999876 677899999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC---CCcEEEEeccCCccccCCCC
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE---KFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~---~~~vkL~DFGla~~~~~~~~ 716 (870)
+|+|.+++.......+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||++....
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---- 171 (299)
T 3m2w_A 99 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---- 171 (299)
T ss_dssp SCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc----
Confidence 99999999876666899999999999999999999998 9999999999999998 7899999999986531
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
+..++.++|||||||++|||++|+.||......... ......+..... .
T Consensus 172 --------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~---------~~~~~~~~~~~~--~ 220 (299)
T 3m2w_A 172 --------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---------PGMKTRIRMGQY--E 220 (299)
T ss_dssp --------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------------CCSCCSSCTTCC--S
T ss_pred --------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh---------HHHHHHHhhccc--c
Confidence 234678999999999999999999999754322110 000000100000 1
Q ss_pred CC----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 797 FD----TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 797 ~~----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.. ......+.+++.+|++.+|++|||+.|+++
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11 123567889999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=312.96 Aligned_cols=234 Identities=17% Similarity=0.105 Sum_probs=176.2
Q ss_pred cccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhcc-ccc---------e-e---------
Q 002887 566 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHH-KNL---------T-I--------- 620 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H-~nI---------v-~--------- 620 (870)
.+.||+|+||.||+|.+. ++.||||++..... ...+.+.+|+.+++.++| +|. + .
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 468999999999999976 89999999884332 236778999999999977 221 1 1
Q ss_pred --EEEEEec-----CCeEEEEEEEccCCchhhhhh-----hcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCC
Q 002887 621 --LVGYCDE-----GANMGLIYEFMANGNLQAHLL-----EDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVK 688 (870)
Q Consensus 621 --l~g~~~~-----~~~~~LV~Ey~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLK 688 (870)
+..++.. ....+++|++ .+++|.+++. ......+++..++.++.|+++||+|||++ +|+|||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiK 238 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLR 238 (413)
T ss_dssp --------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCC
T ss_pred CccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcc
Confidence 1111111 1234566664 4689998884 22345789999999999999999999998 99999999
Q ss_pred CCCEEEcCCCcEEEEeccCCccccCCCCccccccccCCCCccCcccc----------ccCCCCccchHHHHHHHHHHHHh
Q 002887 689 SANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYY----------ISNRLTEKSDVYSFGVVLLELIT 758 (870)
Q Consensus 689 p~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~----------~~~~~~~ksDVwS~GvvL~ellt 758 (870)
|+|||++.++.+||+|||+++.... ......| +.|+|||++ .+..++.++|||||||++|||++
T Consensus 239 p~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 239 PVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred cceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 9999999999999999999876421 1345567 999999999 55568889999999999999999
Q ss_pred CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 759 GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 759 G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
|+.||........ ...++... . ..+..+.+++.+||+.+|++||++.|+++
T Consensus 313 g~~Pf~~~~~~~~-------------~~~~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 313 ADLPNTDDAALGG-------------SEWIFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp SSCCCCTTGGGSC-------------SGGGGSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCcchhhh-------------HHHHHhhc--c----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999976442211 11111110 1 12356889999999999999999888854
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=5.1e-33 Score=307.60 Aligned_cols=240 Identities=15% Similarity=0.149 Sum_probs=183.5
Q ss_pred HhhccccccccCcEEEEEEEECCeeEEEEEeeccch--------hhhHHHHHHHHHHHHhc---------cccceeEEEE
Q 002887 562 TNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSV--------QGYKQFQAEVELLIRAH---------HKNLTILVGY 624 (870)
Q Consensus 562 t~~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~--------~~~~~f~~Ei~~l~~l~---------H~nIv~l~g~ 624 (870)
.+.+.+.||+|+||.||+|+.+++.||||++..... ...+.+.+|+.++++++ |+||+++.+.
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~ 100 (336)
T 2vuw_A 21 KLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSV 100 (336)
T ss_dssp HHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEE
T ss_pred cchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcce
Confidence 345678999999999999999999999999986532 23377899999999986 7777777776
Q ss_pred Ee------------------------------cCCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHH
Q 002887 625 CD------------------------------EGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL 674 (870)
Q Consensus 625 ~~------------------------------~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yL 674 (870)
+. .....++||||+++|++.+.+.+ ..+++..+..++.|++.||+||
T Consensus 101 ~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 101 HCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHHH
T ss_pred eEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHHH
Confidence 42 26789999999999988777743 5689999999999999999999
Q ss_pred H-hCCCCCceeCCCCCCCEEEcCCC--------------------cEEEEeccCCccccCCCCccccccccCCCCccCcc
Q 002887 675 H-NGCKPPIVHRDVKSANILLNEKF--------------------QAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPE 733 (870)
Q Consensus 675 H-~~~~~~IvHrDLKp~NILld~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 733 (870)
| +. +|+||||||+|||++.++ .+||+|||+++.... ....||+.|+|||
T Consensus 178 H~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE 247 (336)
T 2vuw_A 178 EASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDED 247 (336)
T ss_dssp HHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSG
T ss_pred HHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChh
Confidence 9 88 999999999999999887 899999999987632 2347999999999
Q ss_pred ccccCCCCccchHHHHHHH-HHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHc
Q 002887 734 YYISNRLTEKSDVYSFGVV-LLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALAC 812 (870)
Q Consensus 734 ~~~~~~~~~ksDVwS~Gvv-L~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C 812 (870)
++.+.. +.++||||+|++ .+++++|..||..... .............. ...............+.+++.+|
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~~~~s~~~~dli~~~ 319 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW---LHYLTDKMLKQMTF----KTKCNTPAMKQIKRKIQEFHRTM 319 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH---HHHHHHHHHHTCCC----SSCCCSHHHHHHHHHHHHHHHHG
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcchhh---hhHHHHhhhhhhcc----CcccchhhhhhcCHHHHHHHHHH
Confidence 998766 899999998777 7778889998842100 00011111111000 00001111235677899999999
Q ss_pred cccCCCCCCCHHHHH
Q 002887 813 IHTISTRRPTMNQVV 827 (870)
Q Consensus 813 l~~dP~~RPsm~eVl 827 (870)
|+.+ |++|++
T Consensus 320 L~~d-----sa~e~l 329 (336)
T 2vuw_A 320 LNFS-----SATDLL 329 (336)
T ss_dssp GGSS-----SHHHHH
T ss_pred hccC-----CHHHHH
Confidence 9976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-27 Score=280.20 Aligned_cols=185 Identities=15% Similarity=0.097 Sum_probs=131.4
Q ss_pred ccccccCcEEEEEEEE--CCeeEEEEEeeccc----------hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEE
Q 002887 567 RVLGKGGFGTVYHGYL--DDKQVAVKMLSSSS----------VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGL 633 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~--~~~~vAVK~l~~~~----------~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~L 633 (870)
...+.|+.|.+..++. .|+.+++|.+.... ....++|.+|+++|+++ .|+||+++++++.++...||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 3467777777776553 48999999997541 23356799999999999 79999999999999999999
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
||||++|++|.+.|.+. ..++.. +|+.||+.||+|||++ +||||||||+|||+++++++||+|||+|+....
T Consensus 320 VMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999999754 355543 5899999999999999 999999999999999999999999999987633
Q ss_pred CCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCC
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPV 762 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p 762 (870)
. .......+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 392 ~--~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 D--CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred C--CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 2 223345689999999999875 467789999999998887665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6e-25 Score=258.13 Aligned_cols=184 Identities=15% Similarity=0.194 Sum_probs=147.5
Q ss_pred cccccccCcEEEEEEEECCeeEEEEEeeccch--------hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 566 ERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSV--------QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 566 ~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~--------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.||+|+||.||+|...++.+++|+...... ...+++.+|++++++++||||+++..++....+.++||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~ 420 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY 420 (540)
T ss_dssp -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence 46899999999999988899999998754321 1235589999999999999999666666677778999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++++|.+++.+ +..++.|+++||+|||++ +|+||||||+|||+++ ++||+|||+++........
T Consensus 421 ~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 421 INGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp CCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred CCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 999999999864 568999999999999998 9999999999999999 9999999999876322111
Q ss_pred c-----ccccccCCCCccCcccccc--CCCCccchHHHHHHHHHHHHhCCCCCC
Q 002887 718 H-----VSTTVVGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLELITGQPVIQ 764 (870)
Q Consensus 718 ~-----~~~~~~gt~~y~APE~~~~--~~~~~ksDVwS~GvvL~elltG~~p~~ 764 (870)
. ......||+.|||||++.. ..|+.++|+|+..+-.++.+.++.+|.
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 1 1235689999999999986 568888999999999988888776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1e-20 Score=203.86 Aligned_cols=140 Identities=15% Similarity=0.133 Sum_probs=113.4
Q ss_pred ccccccccCcEEEEEEEEC-CeeEEEEEeeccch------------------hhhHHHHHHHHHHHHhccccceeEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSV------------------QGYKQFQAEVELLIRAHHKNLTILVGYC 625 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~------------------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~ 625 (870)
+.+.||+|+||.||+|... ++.||||+++.... .....+.+|++++++++| +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeEE
Confidence 3479999999999999985 88999999965321 134568999999999994 5555544
Q ss_pred ecCCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEec
Q 002887 626 DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADF 705 (870)
Q Consensus 626 ~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DF 705 (870)
.. +..++||||+++|+|.+ +.. .....++.|+++||.|||+. +|+||||||+|||++ ++.+||+||
T Consensus 171 ~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 171 AW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp EE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCC
T ss_pred ec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 33 55699999999999998 421 12346999999999999998 999999999999999 999999999
Q ss_pred cCCccccCCCCccccccccCCCCccCccccc
Q 002887 706 GLSRIFPVEGGTHVSTTVVGTPGYLDPEYYI 736 (870)
Q Consensus 706 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~ 736 (870)
|+++.. ..++|||++.
T Consensus 237 G~a~~~---------------~~~~a~e~l~ 252 (282)
T 1zar_A 237 PQSVEV---------------GEEGWREILE 252 (282)
T ss_dssp TTCEET---------------TSTTHHHHHH
T ss_pred CCCeEC---------------CCCCHHHHHH
Confidence 998643 3468899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=2.1e-17 Score=175.56 Aligned_cols=133 Identities=20% Similarity=0.219 Sum_probs=103.3
Q ss_pred ccccccccCcEEEEEEEE--CCee--EEEEEeeccchh------------------------hhHHHHHHHHHHHHhccc
Q 002887 565 FERVLGKGGFGTVYHGYL--DDKQ--VAVKMLSSSSVQ------------------------GYKQFQAEVELLIRAHHK 616 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~--~~~~--vAVK~l~~~~~~------------------------~~~~f~~Ei~~l~~l~H~ 616 (870)
+.+.||+|+||.||+|.. .|+. ||||+++..... ....+.+|+..+.+++|+
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 130 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA 130 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence 457899999999999998 5888 999987543111 113578999999999988
Q ss_pred cc--eeEEEEEecCCeEEEEEEEccC-C----chhhhhhhcccccccHHHHHHHHHHHHHHHHHHH-hCCCCCceeCCCC
Q 002887 617 NL--TILVGYCDEGANMGLIYEFMAN-G----NLQAHLLEDKADTLCWERRLQIASESAQGLEYLH-NGCKPPIVHRDVK 688 (870)
Q Consensus 617 nI--v~l~g~~~~~~~~~LV~Ey~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~IvHrDLK 688 (870)
++ ..++++ ...++||||+.+ | +|.+... ..++..+..++.|++.||.||| +. +|+|||||
T Consensus 131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlk 198 (258)
T 1zth_A 131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR-----ELKELDVEGIFNDVVENVKRLYQEA---ELVHADLS 198 (258)
T ss_dssp TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG-----GGGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCS
T ss_pred CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh-----ccChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCC
Confidence 64 344443 356899999942 5 4444332 1234567889999999999999 77 99999999
Q ss_pred CCCEEEcCCCcEEEEeccCCccc
Q 002887 689 SANILLNEKFQAKLADFGLSRIF 711 (870)
Q Consensus 689 p~NILld~~~~vkL~DFGla~~~ 711 (870)
|+|||+++ .++|+|||++...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999999754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.58 E-value=1.9e-15 Score=165.05 Aligned_cols=126 Identities=29% Similarity=0.505 Sum_probs=110.2
Q ss_pred cCChhhHHHHHHHHhhcC---CCCCCCC--CCCCCCCCCccceecCCCCCCCCcEEEEEcCCCCCcc--cCcccccccCc
Q 002887 362 LTNQQDVDAIMKIKSKYE---VKRDWQG--DPCAPKVYMWQGINCSYDANQSPRIISINLSSSGIAG--DIVPYIFSLTS 434 (870)
Q Consensus 362 ~~~~~d~~al~~~k~~~~---~~~~w~~--~pC~~~~~~W~Gv~C~~~~~~~~~l~~l~L~~n~l~G--~ip~~~~~l~~ 434 (870)
.|.++|..||++||+++. .+.+|.. |||. +.|.||.|+... ...+|+.|+|++|+|+| .+|+.|+++++
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~---~~w~gv~C~~~~-~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~ 77 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN---RTWLGVLCDTDT-QTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTT---TCSTTEEECCSS-SCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCCc---CCCcceEeCCCC-CCceEEEEECCCCCccCCcccChhHhCCCC
Confidence 488999999999999984 3568863 4552 249999997421 23699999999999999 99999999999
Q ss_pred cccccccc-CcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccccccC
Q 002887 435 IESLDLSK-NSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 435 L~~L~Ls~-N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
|++|+|++ |+++|.+|..|+++++|++|+|++|+++|.+|..+..+++++.|+++.+
T Consensus 78 L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N 135 (313)
T 1ogq_A 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN 135 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSS
T ss_pred CCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCC
Confidence 99999995 9999999999999999999999999999999999999999999988743
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.50 E-value=8.2e-15 Score=162.65 Aligned_cols=132 Identities=11% Similarity=0.078 Sum_probs=96.5
Q ss_pred hccccccccCcEEEEEEEEC-CeeEEEEEeeccchh-----h---------h--------HHHHHHHHHHHHhccccce-
Q 002887 564 NFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQ-----G---------Y--------KQFQAEVELLIRAHHKNLT- 619 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~-----~---------~--------~~f~~Ei~~l~~l~H~nIv- 619 (870)
.+.+.||+|++|.||+|... |+.||||+++..... . . ....+|...|.++.+..+.
T Consensus 98 ~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~v 177 (397)
T 4gyi_A 98 SVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPV 177 (397)
T ss_dssp EEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSC
T ss_pred EecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 45678999999999999976 899999997642110 0 0 0123566677777555442
Q ss_pred -eEEEEEecCCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC
Q 002887 620 -ILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF 698 (870)
Q Consensus 620 -~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~ 698 (870)
..++. ...+|||||++++.|...... .....++.|++.+|.|||+. +||||||||.|||+++++
T Consensus 178 p~p~~~----~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 178 PEPIAQ----SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEK 242 (397)
T ss_dssp CCEEEE----ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEE
T ss_pred Ceeeec----cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCC
Confidence 22222 123799999999888765421 12356889999999999998 999999999999998877
Q ss_pred ----------cEEEEeccCCcc
Q 002887 699 ----------QAKLADFGLSRI 710 (870)
Q Consensus 699 ----------~vkL~DFGla~~ 710 (870)
.+.|+||+-+..
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEE
T ss_pred CcccccccccceEEEEeCCccc
Confidence 389999997753
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.6e-14 Score=177.64 Aligned_cols=126 Identities=16% Similarity=0.233 Sum_probs=107.3
Q ss_pred cCChhhHHHHHHHHhhcCCCCCCCCCC----CCCCCCCc------------cceecCCCCCCCCcEEEEEcCCCCCcccC
Q 002887 362 LTNQQDVDAIMKIKSKYEVKRDWQGDP----CAPKVYMW------------QGINCSYDANQSPRIISINLSSSGIAGDI 425 (870)
Q Consensus 362 ~~~~~d~~al~~~k~~~~~~~~w~~~p----C~~~~~~W------------~Gv~C~~~~~~~~~l~~l~L~~n~l~G~i 425 (870)
.+..+|+.||++||+++... +|+.+. +.|..|.| .||.|+. ..+|+.|+|++|+|+|.|
T Consensus 265 ~~~~~d~~ALl~~k~~l~~~-~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~----~~~V~~L~Ls~~~L~G~i 339 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDGK-NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN----NGRVTGLSLAGFGAKGRV 339 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTGG-GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT----TSCEEEEECTTTCCEEEE
T ss_pred ccchHHHHHHHHHHHHcCCC-CCCcCCCcccccCCccccccccccccccCcCceEecC----CCCEEEEECccCCCCCcC
Confidence 45567999999999998644 885322 11223489 9999975 469999999999999999
Q ss_pred cccccccCccccccc-ccCcCCCC--------------------------------------------------------
Q 002887 426 VPYIFSLTSIESLDL-SKNSLTGP-------------------------------------------------------- 448 (870)
Q Consensus 426 p~~~~~l~~L~~L~L-s~N~l~g~-------------------------------------------------------- 448 (870)
|++|++|++|++|+| ++|.|+|.
T Consensus 340 p~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~ 419 (876)
T 4ecn_A 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKK 419 (876)
T ss_dssp CGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCC
T ss_pred chHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccc
Confidence 999999999999999 88877666
Q ss_pred --------------------CCccccCcCCCCeEEecCCcCCC-----------------CCCCccc--ccccCCccccc
Q 002887 449 --------------------VPEFLAELQSLRVLNLSGNNLQG-----------------SLPSGLS--EKVKNGSLSLS 489 (870)
Q Consensus 449 --------------------iP~~~~~l~~L~~L~ls~N~l~g-----------------~ip~~l~--~~~~~~~l~~~ 489 (870)
||..|++|++|+.|+|++|+|+| .||+.++ ++++|+.|+++
T Consensus 420 ~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls 499 (876)
T 4ecn_A 420 DSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY 499 (876)
T ss_dssp CCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEE
T ss_pred ccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECc
Confidence 89999999999999999999999 4999998 99999999998
Q ss_pred cCC
Q 002887 490 VDG 492 (870)
Q Consensus 490 ~~~ 492 (870)
.+.
T Consensus 500 ~N~ 502 (876)
T 4ecn_A 500 NCP 502 (876)
T ss_dssp SCT
T ss_pred CCC
Confidence 543
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=3.2e-13 Score=134.16 Aligned_cols=145 Identities=15% Similarity=0.154 Sum_probs=98.9
Q ss_pred cEEeccCCCCCCccccCCCceEEecCCCccccCcceeeCC----CCcccccccccccccccCcCcccceecCCCCCCccE
Q 002887 29 FISIDCGIPENENYADKVTGINYVSDAPYVDTAVSHSISP----EYSKETVERQFSYLRSFPEGIRNCYTLRPPNGDVKF 104 (870)
Q Consensus 29 ~~~idCG~~~~~~~~~~~~~~~~~~D~~~~~~g~~~~~~~----~~~~~~~~~~~~t~R~Fp~g~~ncY~l~~~~~~~~y 104 (870)
.+.||||++.. +| ..|++|.+|..|...|....... ..........|+|.|+||. ..+|.+ |+.++|+|
T Consensus 7 ~~~INcGg~~~---~d-~~gr~w~~D~~~~~~g~~~~~~~~~~~~~~~~~~~~lY~TaR~~~~--~~tY~f-~v~~~G~Y 79 (174)
T 2jwp_A 7 IWAVNAGGESH---VD-VHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNED--SFGYDI-PIKEEGEY 79 (174)
T ss_dssp EEEEEETSSSE---EE-TTTEEECSSCSSTTCCCCCCCCTTSCCSSSCHHHHHTTTCCCCCCS--CEEEEE-ECCSCEEE
T ss_pred EEEEECCCCCc---cC-CCCCEEcCCcCcccCCcccccccceEecccCCCCchhhhhhccCCC--CeEEEE-EeCCCeEE
Confidence 47899996432 23 46999999988864443221110 1111233568999999985 789999 55778899
Q ss_pred EEEeeeeeccCCCCCCCCceEEEEccee-eEEEEcCC---CccceeEEEEEe-------------cCCCceEEEEeecCC
Q 002887 105 LIRARFMYGNYDGLDKAPSFDLMLGADA-WDSVQLQD---PRSIITKEIIHM-------------PNKDYIHVCLVNTDS 167 (870)
Q Consensus 105 lvR~~f~ygnyd~~~~~p~Fd~~~~~~~-w~~v~~~~---~~~~~~~e~~~~-------------~~~~~~~vcl~~t~~ 167 (870)
+||++|.--.|.. .....||++++|.. ...+++.. ...++..|+.+. +..+.+.|.|.+...
T Consensus 80 ~VrLhF~ei~~~~-~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~~ 158 (174)
T 2jwp_A 80 VLVLKFAEVYFAQ-SQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYY 158 (174)
T ss_dssp EEEEEEECCSCCC-SSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECSSS
T ss_pred EEEEEEeccccCC-CCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEEEeccCC
Confidence 9999997666654 44578999999976 45565421 222445566554 356789999997655
Q ss_pred CCceeeeeeeeecC
Q 002887 168 GIPFISALELRPLT 181 (870)
Q Consensus 168 ~~pfis~lEl~~l~ 181 (870)
+.||||+|||.+-.
T Consensus 159 ~~a~inaIEI~~~~ 172 (174)
T 2jwp_A 159 DNPKVCALFIMKGT 172 (174)
T ss_dssp CSSSEEEEEEESSC
T ss_pred CCcEEEEEEEEeCc
Confidence 66999999999753
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.42 E-value=9.2e-14 Score=166.63 Aligned_cols=121 Identities=19% Similarity=0.257 Sum_probs=103.7
Q ss_pred cCChhhHHHHHHHHhhcCC------------CCCCCC--CCCCCCCCCc---cceecCCCCCCCCcEEEEEcCCCCCccc
Q 002887 362 LTNQQDVDAIMKIKSKYEV------------KRDWQG--DPCAPKVYMW---QGINCSYDANQSPRIISINLSSSGIAGD 424 (870)
Q Consensus 362 ~~~~~d~~al~~~k~~~~~------------~~~w~~--~pC~~~~~~W---~Gv~C~~~~~~~~~l~~l~L~~n~l~G~ 424 (870)
....+|+.||.+|+++.+. ..+|+. ++| .| .||+|+.. .+|+.|+|++|+|+|.
T Consensus 26 ~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c-----~w~~~~GV~C~~~----~~V~~L~L~~~~l~g~ 96 (636)
T 4eco_A 26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELD-----MWGAQPGVSLNSN----GRVTGLSLEGFGASGR 96 (636)
T ss_dssp CHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGG-----GTTCCTTEEECTT----CCEEEEECTTSCCEEE
T ss_pred hhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcc-----cccCCCCeEEcCC----CCEEEEEecCcccCCc
Confidence 3445799999999998632 126753 334 79 99999752 6999999999999999
Q ss_pred CcccccccCcccccccccC-------------------------------------------------------------
Q 002887 425 IVPYIFSLTSIESLDLSKN------------------------------------------------------------- 443 (870)
Q Consensus 425 ip~~~~~l~~L~~L~Ls~N------------------------------------------------------------- 443 (870)
+|++|++|++|++|+|++|
T Consensus 97 lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~ 176 (636)
T 4eco_A 97 VPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIK 176 (636)
T ss_dssp ECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCC
T ss_pred CChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccc
Confidence 9999999999999999988
Q ss_pred -----------------cCCCCCCccccCcCCCCeEEecCCcCCCC-----------------CCCccc--ccccCCccc
Q 002887 444 -----------------SLTGPVPEFLAELQSLRVLNLSGNNLQGS-----------------LPSGLS--EKVKNGSLS 487 (870)
Q Consensus 444 -----------------~l~g~iP~~~~~l~~L~~L~ls~N~l~g~-----------------ip~~l~--~~~~~~~l~ 487 (870)
+|+| ||..|++|++|++|+|++|+|+|. +|..++ ++++|+.|+
T Consensus 177 ~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~ 255 (636)
T 4eco_A 177 KSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVE 255 (636)
T ss_dssp CCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEE
T ss_pred cccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEE
Confidence 4556 999999999999999999999997 999999 999999999
Q ss_pred cccCC
Q 002887 488 LSVDG 492 (870)
Q Consensus 488 ~~~~~ 492 (870)
++.+.
T Consensus 256 L~~n~ 260 (636)
T 4eco_A 256 VYNCP 260 (636)
T ss_dssp EECCT
T ss_pred ecCCc
Confidence 98543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=4.6e-13 Score=164.14 Aligned_cols=122 Identities=26% Similarity=0.370 Sum_probs=97.3
Q ss_pred ccCChhhHHHHHHHHhhcC---CCCCCC-CCCCCCCCCCccceecCCCCCCCCcEEEEEcCCCCCccc---Cc-------
Q 002887 361 LLTNQQDVDAIMKIKSKYE---VKRDWQ-GDPCAPKVYMWQGINCSYDANQSPRIISINLSSSGIAGD---IV------- 426 (870)
Q Consensus 361 ~~~~~~d~~al~~~k~~~~---~~~~w~-~~pC~~~~~~W~Gv~C~~~~~~~~~l~~l~L~~n~l~G~---ip------- 426 (870)
....++|.+||++||+.+. .+.+|. ++.|| .|.||+|+ ..+|+.|+|+++++.|. +|
T Consensus 7 ~~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C----~w~gv~C~-----~~~v~~L~L~~~~l~g~~~~l~~~l~~L~ 77 (768)
T 3rgz_A 7 SQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPC----TFDGVTCR-----DDKVTSIDLSSKPLNVGFSAVSSSLLSLT 77 (768)
T ss_dssp -CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGG----GSTTEEEE-----TTEEEEEECTTSCCCEEHHHHHHHTTTCT
T ss_pred ccCCHHHHHHHHHHHhhCCCcccccCCCCCCCCc----CCcceEEC-----CCcEEEEECCCCCcCCccCccChhHhccC
Confidence 3456789999999999874 477996 44443 89999997 35999999999999997 55
Q ss_pred ----------------ccccccCcccccccccCcCCCCCCc--cccCcCCCCeEEecCCcCCCCCCCcc-cccccCCccc
Q 002887 427 ----------------PYIFSLTSIESLDLSKNSLTGPVPE--FLAELQSLRVLNLSGNNLQGSLPSGL-SEKVKNGSLS 487 (870)
Q Consensus 427 ----------------~~~~~l~~L~~L~Ls~N~l~g~iP~--~~~~l~~L~~L~ls~N~l~g~ip~~l-~~~~~~~~l~ 487 (870)
..|++|++|++|+|++|+++|.+|. .+++|++|++|+|++|+++|.+|..+ ..+++|+.|+
T Consensus 78 ~L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 157 (768)
T 3rgz_A 78 GLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLD 157 (768)
T ss_dssp TCCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEE
T ss_pred cccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEE
Confidence 4677778888888888888888888 88888888888888888888888766 6777777777
Q ss_pred cccC
Q 002887 488 LSVD 491 (870)
Q Consensus 488 ~~~~ 491 (870)
++.+
T Consensus 158 Ls~n 161 (768)
T 3rgz_A 158 LSAN 161 (768)
T ss_dssp CCSS
T ss_pred CCCC
Confidence 6643
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.27 E-value=6.3e-12 Score=124.36 Aligned_cols=103 Identities=20% Similarity=0.174 Sum_probs=89.9
Q ss_pred CCccceecCCCC------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCC
Q 002887 394 YMWQGINCSYDA------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467 (870)
Q Consensus 394 ~~W~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N 467 (870)
|.|+.|.|+++. .....++.|+|++|+|++..|..|.+|++|++|+|++|+|++..|..|..+++|+.|+|++|
T Consensus 9 C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 9 CSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 589999998742 23467899999999999988999999999999999999999777777899999999999999
Q ss_pred cCCCCCCCcccccccCCccccccCCCCCCCC
Q 002887 468 NLQGSLPSGLSEKVKNGSLSLSVDGNRNLCP 498 (870)
Q Consensus 468 ~l~g~ip~~l~~~~~~~~l~~~~~~n~~lc~ 498 (870)
+|++..|..+..+++|+.|+++ +|+..|.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~--~N~~~c~ 117 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLL--NNPWDCA 117 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECC--SSCBCTT
T ss_pred ccCEeCHHHhcCCCCCCEEEeC--CCCCCCC
Confidence 9997777779999999988876 7777665
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=1.3e-12 Score=129.77 Aligned_cols=142 Identities=13% Similarity=0.127 Sum_probs=91.0
Q ss_pred eEEeeccCCCC--ccCCceeccCCCCC-ccccccc-cccCCCCCCCCChHHhhhhceecCCCCCceEEeec-ccCCcceE
Q 002887 203 LVLRWDVGTPL--DIYDRIWWPDNFKN-VERISTS-SNVNPATSLFQPPVTVMQSAIIPANGSSSFWFSWE-SVSTVFKY 277 (870)
Q Consensus 203 ~~~R~~~g~p~--D~~dR~W~~~~~~~-~~~~st~-~~~~~~~~~~~~P~~v~~tA~~~~~~~~~l~~~w~-~~~~~~~y 277 (870)
...|+|+|++. |..+|.|.+|.... ....+.. ..+.. ...+.+|..|||||.... . +++|. +++++-.|
T Consensus 6 ~~~~INcGg~~~~d~~gr~w~~D~~~~~~g~~~~~~~~~~~-~~~~~~~~~lY~TaR~~~---~--~~tY~f~v~~~G~Y 79 (174)
T 2jwp_A 6 VIWAVNAGGESHVDVHGIHYRKDPLEGRVGRASDYGMKLPI-LRSNPEDQVLYQTERYNE---D--SFGYDIPIKEEGEY 79 (174)
T ss_dssp EEEEEEETSSSEEETTTEEECSSCSSTTCCCCCCCCTTSCC-SSSCHHHHHTTTCCCCCC---S--CEEEEEECCSCEEE
T ss_pred EEEEEECCCCCccCCCCCEEcCCcCcccCCcccccccceEe-cccCCCCchhhhhhccCC---C--CeEEEEEeCCCeEE
Confidence 57899999974 67999999884311 1111110 11111 112345899999998743 2 45555 45667799
Q ss_pred EEEEeeeccchhcccccceEEEEEECCccccCCCCCCccc----ceee--eee------------eeccceEEEEEEecc
Q 002887 278 YTCMYFSEFESEQAETRSREMNIYLNGRFWSEIPPPQYLN----TTTH--RLT------------ATNAQQYVISIMQTK 339 (870)
Q Consensus 278 ~v~lhFae~~~~~~~~~~R~F~i~~ng~~~~~~~~p~~~~----~~~~--~~~------------~~~~~~~~~sl~~t~ 339 (870)
.|.|||||+.. .+.++|+|||++||+.+.+.+++.... +... .+. ....+.+++++.+.
T Consensus 80 ~VrLhF~ei~~--~~~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~- 156 (174)
T 2jwp_A 80 VLVLKFAEVYF--AQSQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKG- 156 (174)
T ss_dssp EEEEEEECCSC--CCSSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECS-
T ss_pred EEEEEEecccc--CCCCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEEEecc-
Confidence 99999999975 567899999999999876544432111 1000 111 13567788888864
Q ss_pred CcchhhHHHHHHHhh
Q 002887 340 NSSLAPILNALEIYQ 354 (870)
Q Consensus 340 ~s~lppilna~ei~~ 354 (870)
..-.|+|||+||+.
T Consensus 157 -~~~~a~inaIEI~~ 170 (174)
T 2jwp_A 157 -YYDNPKVCALFIMK 170 (174)
T ss_dssp -SSCSSSEEEEEEES
T ss_pred -CCCCcEEEEEEEEe
Confidence 24469999999863
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=5.6e-12 Score=154.48 Aligned_cols=97 Identities=27% Similarity=0.473 Sum_probs=84.5
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
...++.|+|++|+|+|.||.+|++|++|+.|+|++|+|+|.||..|++|++|+.|||++|+|+|.||..+..++.|+.|+
T Consensus 631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 35688999999999999999999999999999999999999999999999999999999999999999999988888777
Q ss_pred cc---------------------cCCCCCCCCC--Ccccc
Q 002887 488 LS---------------------VDGNRNLCPS--ASCKK 504 (870)
Q Consensus 488 ~~---------------------~~~n~~lc~~--~sc~~ 504 (870)
++ |.||+++||. ..|..
T Consensus 711 ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~ 750 (768)
T 3rgz_A 711 LSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP 750 (768)
T ss_dssp CCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCS
T ss_pred CcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCCC
Confidence 54 4478888876 35653
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.21 E-value=3.2e-12 Score=140.36 Aligned_cols=129 Identities=16% Similarity=0.322 Sum_probs=105.9
Q ss_pred ccCChhhHHHHHHHHhhcC-----CCCCCC-CCCCCCCCCCccceecCCC-----CCCCCcEEEEEcCCCCCcccCcccc
Q 002887 361 LLTNQQDVDAIMKIKSKYE-----VKRDWQ-GDPCAPKVYMWQGINCSYD-----ANQSPRIISINLSSSGIAGDIVPYI 429 (870)
Q Consensus 361 ~~~~~~d~~al~~~k~~~~-----~~~~w~-~~pC~~~~~~W~Gv~C~~~-----~~~~~~l~~l~L~~n~l~G~ip~~~ 429 (870)
.....+|..||+++|..+. ...+|. +..|.+..+.|.|+.|... .....+|+.|+|++|+|+ .||+.+
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l 100 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA 100 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence 4567889999999999762 234562 1122333348999999521 123468999999999999 999999
Q ss_pred cccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccccccCC
Q 002887 430 FSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSVDG 492 (870)
Q Consensus 430 ~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~~~~ 492 (870)
++|++|++|+|++|+++ .||..++++++|++|+|++|+|+ .+|..++.+++|+.|+++.+.
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~ 161 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACP 161 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEET
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCC
Confidence 99999999999999999 99999999999999999999999 999999999999999998543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.18 E-value=2e-11 Score=123.24 Aligned_cols=98 Identities=15% Similarity=0.168 Sum_probs=80.6
Q ss_pred CCccceecCCCC------CCCCcEEEEEcCCCCCcccCcc-cccccCcccccccccCcCCCCCCccccCcCCCCeEEecC
Q 002887 394 YMWQGINCSYDA------NQSPRIISINLSSSGIAGDIVP-YIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG 466 (870)
Q Consensus 394 ~~W~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~-~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~ 466 (870)
|.|..|.|++.+ .....++.|+|++|+|++..+. .|+++++|++|+|++|+|++.+|..|+.+++|+.|+|++
T Consensus 8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 689999998643 2334788899999999866554 388999999999999999988888899999999999999
Q ss_pred CcCCCCCCCcccccccCCccccccC
Q 002887 467 NNLQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 467 N~l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
|+|++..|..+..+++|+.|+++.+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N 112 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDN 112 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCC
Confidence 9999888888888888888887743
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.16 E-value=6e-11 Score=117.77 Aligned_cols=103 Identities=17% Similarity=0.139 Sum_probs=86.7
Q ss_pred CCccceecCCCC------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCC
Q 002887 394 YMWQGINCSYDA------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467 (870)
Q Consensus 394 ~~W~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N 467 (870)
+...-+.|++.. .....++.|+|++|+|++..|..|++|++|++|+|++|+|++..|..|.+|++|+.|+|++|
T Consensus 12 C~~~~l~~~~n~l~~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 12 CDQTLVNCQNIRLASVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp ECSSEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred ECCcEEEeCCCCCCccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 456778998642 23467899999999999988999999999999999999999755566799999999999999
Q ss_pred cCCCCCCCcccccccCCccccccCCCCCCCC
Q 002887 468 NLQGSLPSGLSEKVKNGSLSLSVDGNRNLCP 498 (870)
Q Consensus 468 ~l~g~ip~~l~~~~~~~~l~~~~~~n~~lc~ 498 (870)
+|++..|..+..+++|+.|+++ +|+..|.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~--~N~~~c~ 120 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLY--NNPWDCE 120 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECC--SSCBCTT
T ss_pred ccceeCHHHhccccCCCEEEeC--CCCcccc
Confidence 9996666668999999988776 7776654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.15 E-value=6.1e-11 Score=119.83 Aligned_cols=104 Identities=17% Similarity=0.212 Sum_probs=88.4
Q ss_pred CCCCCCC-CCccceecCCCC------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCC
Q 002887 387 DPCAPKV-YMWQGINCSYDA------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSL 459 (870)
Q Consensus 387 ~pC~~~~-~~W~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L 459 (870)
.+|...+ |.|..|.|++.. ..+..++.|+|++|+|+ .||..|.++++|+.|+|++|+|++..|..|.+|++|
T Consensus 2 ~~CP~~C~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L 80 (193)
T 2wfh_A 2 SRCPTECTCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80 (193)
T ss_dssp --CCTTCEEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CCCCCCCEeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCC
Confidence 3453332 679999998742 24467999999999998 899999999999999999999998888889999999
Q ss_pred CeEEecCCcCCCCCCCcccccccCCccccccC
Q 002887 460 RVLNLSGNNLQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 460 ~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
+.|+|++|+|++..|..+..+++|+.|+++.|
T Consensus 81 ~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N 112 (193)
T 2wfh_A 81 LTLILSYNRLRCIPPRTFDGLKSLRLLSLHGN 112 (193)
T ss_dssp CEEECCSSCCCBCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCccCEeCHHHhCCCCCCCEEECCCC
Confidence 99999999999888888999999999888743
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=1.5e-10 Score=122.32 Aligned_cols=139 Identities=12% Similarity=0.079 Sum_probs=110.3
Q ss_pred ccccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhc-cccceeEEEEEecCCeEEEEEEEccCCch
Q 002887 565 FERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAH-HKNLTILVGYCDEGANMGLIYEFMANGNL 643 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 643 (870)
+...++.|+.+.||+....++.+++|+...........+.+|+++++.+. |..+.++++++......++||||++|.+|
T Consensus 18 ~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 97 (263)
T 3tm0_A 18 CVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLC 97 (263)
T ss_dssp EEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEH
T ss_pred eEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeeh
Confidence 45677888889999998878899999987643233456899999999994 66788899999888899999999999998
Q ss_pred hhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 002887 644 QAHLLEDKADTLCWERRLQIASESAQGLEYLHNGC--------------------------------------------- 678 (870)
Q Consensus 644 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--------------------------------------------- 678 (870)
.+.+.. ......++.+++++|..||+..
T Consensus 98 ~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (263)
T 3tm0_A 98 SEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL 170 (263)
T ss_dssp HHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHH
T ss_pred hhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHH
Confidence 775321 1123478889999999999810
Q ss_pred -----------CCCceeCCCCCCCEEEcCCCcEEEEeccCCcc
Q 002887 679 -----------KPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 679 -----------~~~IvHrDLKp~NILld~~~~vkL~DFGla~~ 710 (870)
...++|+|+++.||+++++..+.|+||+.+..
T Consensus 171 ~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13589999999999998866677999997753
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.11 E-value=8.3e-11 Score=129.78 Aligned_cols=102 Identities=23% Similarity=0.255 Sum_probs=83.3
Q ss_pred CCccceecCCC-C-------CCCCcEEEEEcCC-CCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEe
Q 002887 394 YMWQGINCSYD-A-------NQSPRIISINLSS-SGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNL 464 (870)
Q Consensus 394 ~~W~Gv~C~~~-~-------~~~~~l~~l~L~~-n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~l 464 (870)
|.|..|.|++. . ....+|+.|+|++ |.|++..|..|++|++|+.|+|++|+|+|..|..|++|++|+.|+|
T Consensus 8 C~~~~v~~~~~n~l~~ip~l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 87 (347)
T 2ifg_A 8 HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (347)
T ss_dssp SSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred ccCCEEEcCCCCCCCccCCCCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeC
Confidence 58999999875 1 1234589999996 9999888889999999999999999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccCCccccccCCCCCCCC
Q 002887 465 SGNNLQGSLPSGLSEKVKNGSLSLSVDGNRNLCP 498 (870)
Q Consensus 465 s~N~l~g~ip~~l~~~~~~~~l~~~~~~n~~lc~ 498 (870)
++|+|++ +|..+.....|..|++. +|+..|.
T Consensus 88 ~~N~l~~-~~~~~~~~~~L~~l~l~--~N~~~c~ 118 (347)
T 2ifg_A 88 SFNALES-LSWKTVQGLSLQELVLS--GNPLHCS 118 (347)
T ss_dssp CSSCCSC-CCSTTTCSCCCCEEECC--SSCCCCC
T ss_pred CCCccce-eCHHHcccCCceEEEee--CCCccCC
Confidence 9999995 45444443347777665 6766664
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.11 E-value=9e-11 Score=121.84 Aligned_cols=97 Identities=19% Similarity=0.151 Sum_probs=83.9
Q ss_pred CccceecCCCC------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCc
Q 002887 395 MWQGINCSYDA------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468 (870)
Q Consensus 395 ~W~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~ 468 (870)
+|.+|+|+... ..++.++.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus 20 s~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 99 (229)
T 3e6j_A 20 SGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99 (229)
T ss_dssp ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred eCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence 89999998642 345679999999999999889999999999999999999985555667999999999999999
Q ss_pred CCCCCCCcccccccCCccccccC
Q 002887 469 LQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 469 l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
|++..|..+..+++|+.|+++.+
T Consensus 100 l~~l~~~~~~~l~~L~~L~Ls~N 122 (229)
T 3e6j_A 100 LTVLPSAVFDRLVHLKELFMCCN 122 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCccChhHhCcchhhCeEeccCC
Confidence 99777777888999998888743
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.09 E-value=1.3e-10 Score=115.21 Aligned_cols=98 Identities=19% Similarity=0.213 Sum_probs=84.3
Q ss_pred CCccceecCCCC------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCC
Q 002887 394 YMWQGINCSYDA------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467 (870)
Q Consensus 394 ~~W~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N 467 (870)
|.|.+|.|+..+ .....++.|+|++|+|++..+..++++++|++|+|++|+|++..|..++.+++|+.|+|++|
T Consensus 7 C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp EETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 589999998643 23468899999999999766667899999999999999999776777899999999999999
Q ss_pred cCCCCCCCcccccccCCccccccC
Q 002887 468 NLQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 468 ~l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
+|++..|..+..+++++.|+++.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N 110 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTN 110 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CccccCHHHhhCCcccCEEECcCC
Confidence 999877777889999999888743
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.02 E-value=3.9e-10 Score=114.86 Aligned_cols=98 Identities=21% Similarity=0.212 Sum_probs=83.3
Q ss_pred CCccceecCCCC------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCC
Q 002887 394 YMWQGINCSYDA------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467 (870)
Q Consensus 394 ~~W~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N 467 (870)
|.|.+|.|+..+ ...++++.|+|++|+|++..+..++++++|++|+|++|+|++..|..|..+++|++|+|++|
T Consensus 7 C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 7 CSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred ECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 589999998643 23457999999999999766666899999999999999999766667899999999999999
Q ss_pred cCCCCCCCcccccccCCccccccC
Q 002887 468 NLQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 468 ~l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
+|++..+..+..+++|+.|+++.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N 110 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTN 110 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cCCccCHhHhcCccCCCEEEcCCC
Confidence 999776677889999999888743
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.00 E-value=3.9e-10 Score=116.29 Aligned_cols=98 Identities=21% Similarity=0.208 Sum_probs=83.4
Q ss_pred CCccceecCCCC------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCC
Q 002887 394 YMWQGINCSYDA------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467 (870)
Q Consensus 394 ~~W~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N 467 (870)
|.|..|.|++.+ ..+..++.|+|++|+|++..+..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 689999998643 23457899999999999777778999999999999999999888999999999999999999
Q ss_pred cCCCCCCCcccccccCCccccccC
Q 002887 468 NLQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 468 ~l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
+|++..+..+..+++|+.|+++.+
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N 114 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNAN 114 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cCCccCHhHccCCCCCCEEECCCC
Confidence 999554455688899998888744
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.97 E-value=1.8e-09 Score=113.32 Aligned_cols=128 Identities=16% Similarity=0.094 Sum_probs=97.5
Q ss_pred cccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccc--eeEEEEEecCCeEEEEEEEccCCchhhh
Q 002887 570 GKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNL--TILVGYCDEGANMGLIYEFMANGNLQAH 646 (870)
Q Consensus 570 G~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI--v~l~g~~~~~~~~~LV~Ey~~~gsL~~~ 646 (870)
+.|..+.||+.... ++.+++|+.... ....+.+|+.+++.+++.++ .+++++...++..++||||++|.++.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 45666999999765 677999997654 23567899999999976554 45888888878899999999998884
Q ss_pred hhhcccccccHHHHHHHHHHHHHHHHHHHhCC------------------------------------------------
Q 002887 647 LLEDKADTLCWERRLQIASESAQGLEYLHNGC------------------------------------------------ 678 (870)
Q Consensus 647 l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------------------------------------------------ 678 (870)
... .+ ...++.++++.|..||+..
T Consensus 104 ~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 211 11 2356778888888888642
Q ss_pred -------CCCceeCCCCCCCEEEcCCCcEEEEeccCCcc
Q 002887 679 -------KPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 679 -------~~~IvHrDLKp~NILld~~~~vkL~DFGla~~ 710 (870)
...++|+|++|.||+++++..+.|+|||.+..
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998876677999998753
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.94 E-value=7.9e-10 Score=113.98 Aligned_cols=98 Identities=12% Similarity=0.124 Sum_probs=81.5
Q ss_pred CCccceecCCCC------CCCCcEEEEEcCCCCCcccCcc-cccccCcccccccccCcCCCCCCccccCcCCCCeEEecC
Q 002887 394 YMWQGINCSYDA------NQSPRIISINLSSSGIAGDIVP-YIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG 466 (870)
Q Consensus 394 ~~W~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~-~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~ 466 (870)
|.|..+.|++.. ..+..++.|+|++|+|++..|. .|.++++|+.|+|++|+|++..|..|+++++|+.|+|++
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 689999998743 2334678899999999977664 478999999999999999987777899999999999999
Q ss_pred CcCCCCCCCcccccccCCccccccC
Q 002887 467 NNLQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 467 N~l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
|+|++..|..+..+++|+.|+++.+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N 115 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSN 115 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTS
T ss_pred CccCccCHhHhcCCcCCCEEECCCC
Confidence 9999887778888888888888744
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.92 E-value=1e-09 Score=113.04 Aligned_cols=89 Identities=22% Similarity=0.254 Sum_probs=78.7
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.++++.|+|++|.|++..|..|.+|++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+..++++..|+
T Consensus 80 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 159 (220)
T 2v70_A 80 ASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLN 159 (220)
T ss_dssp CTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEE
Confidence 45789999999999988777899999999999999999988899999999999999999999988899999999988877
Q ss_pred cccCCCCCCCC
Q 002887 488 LSVDGNRNLCP 498 (870)
Q Consensus 488 ~~~~~n~~lc~ 498 (870)
++ +|+..|.
T Consensus 160 L~--~N~l~c~ 168 (220)
T 2v70_A 160 LL--ANPFNCN 168 (220)
T ss_dssp CC--SCCEECS
T ss_pred ec--CcCCcCC
Confidence 76 7776664
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.88 E-value=4.5e-10 Score=130.12 Aligned_cols=79 Identities=20% Similarity=0.190 Sum_probs=46.8
Q ss_pred CcEEEEEcCCCCCcccCccccc-ccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIF-SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~-~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
+.++.|+|++|.|+|.+|..+. +|++|+.|+|++|+|++. |. +..+++|+.|+|++|+|+| +|..+..+++|..|+
T Consensus 144 ~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~ 220 (487)
T 3oja_A 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWIS 220 (487)
T ss_dssp SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEE
T ss_pred CCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEE
Confidence 4566666666666666665554 566666666666666544 22 2346666666666666664 344466666666666
Q ss_pred ccc
Q 002887 488 LSV 490 (870)
Q Consensus 488 ~~~ 490 (870)
++.
T Consensus 221 Ls~ 223 (487)
T 3oja_A 221 LRN 223 (487)
T ss_dssp CTT
T ss_pred ecC
Confidence 653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.88 E-value=5.7e-09 Score=115.73 Aligned_cols=140 Identities=14% Similarity=0.184 Sum_probs=107.7
Q ss_pred ccccccCcEEEEEEEECCeeEEEEEee--ccc-hhhhHHHHHHHHHHHHhc--cccceeEEEEEecC---CeEEEEEEEc
Q 002887 567 RVLGKGGFGTVYHGYLDDKQVAVKMLS--SSS-VQGYKQFQAEVELLIRAH--HKNLTILVGYCDEG---ANMGLIYEFM 638 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~~~vAVK~l~--~~~-~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~---~~~~LV~Ey~ 638 (870)
+.|+.|.++.||+....+..+++|+.. ... ......+.+|+.+++.++ +..+.++++++.+. ...++||||+
T Consensus 44 ~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v 123 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFV 123 (359)
T ss_dssp EECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECC
T ss_pred EEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEec
Confidence 468999999999999888889999876 332 123457889999999997 45578899998776 4588999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGC---------------------------------------- 678 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~---------------------------------------- 678 (870)
++..+.+.. ...++..++..++.+++++|+.||+..
T Consensus 124 ~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (359)
T 3dxp_A 124 SGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS 199 (359)
T ss_dssp CCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred CCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence 998775422 134677888899999999999999731
Q ss_pred ---------------CCCceeCCCCCCCEEEcCCCc--EEEEeccCCcc
Q 002887 679 ---------------KPPIVHRDVKSANILLNEKFQ--AKLADFGLSRI 710 (870)
Q Consensus 679 ---------------~~~IvHrDLKp~NILld~~~~--vkL~DFGla~~ 710 (870)
...++|||+++.|||+++++. +.|+||+.+..
T Consensus 200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999998864
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.88 E-value=1.6e-09 Score=109.28 Aligned_cols=89 Identities=25% Similarity=0.296 Sum_probs=79.4
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
..+++.|+|++|.|++..+..|.+|++|+.|+|++|+|++..|..|..|++|+.|+|++|+|++..+..+..++++..|+
T Consensus 53 l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 132 (193)
T 2wfh_A 53 YKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLA 132 (193)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred ccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEE
Confidence 35899999999999988788899999999999999999998888999999999999999999966666788899998877
Q ss_pred cccCCCCCCCC
Q 002887 488 LSVDGNRNLCP 498 (870)
Q Consensus 488 ~~~~~n~~lc~ 498 (870)
++ +|+..|.
T Consensus 133 L~--~N~~~C~ 141 (193)
T 2wfh_A 133 IG--ANPLYCD 141 (193)
T ss_dssp CC--SSCEECS
T ss_pred eC--CCCeecC
Confidence 76 8887764
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=98.87 E-value=7.7e-10 Score=120.44 Aligned_cols=108 Identities=24% Similarity=0.460 Sum_probs=90.1
Q ss_pred CCCCCCCCCCC--CCccceecCCCC-----------CCCCcEEEEEcCC-CCCcccCcccccccCcccccccccCcCCCC
Q 002887 383 DWQGDPCAPKV--YMWQGINCSYDA-----------NQSPRIISINLSS-SGIAGDIVPYIFSLTSIESLDLSKNSLTGP 448 (870)
Q Consensus 383 ~w~~~pC~~~~--~~W~Gv~C~~~~-----------~~~~~l~~l~L~~-n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~ 448 (870)
.|.|-.|.... ..-..+..+... ...+.++.|+|++ |++.|.+|..|++|++|++|+|++|+++|.
T Consensus 37 ~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~ 116 (313)
T 1ogq_A 37 TWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116 (313)
T ss_dssp CSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEE
T ss_pred CCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCc
Confidence 39998885421 233334433211 1235789999995 999999999999999999999999999999
Q ss_pred CCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccccc
Q 002887 449 VPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSV 490 (870)
Q Consensus 449 iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~~ 490 (870)
+|..|+++++|++|+|++|+++|.+|..+..+++|+.|+++.
T Consensus 117 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 158 (313)
T 1ogq_A 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158 (313)
T ss_dssp CCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred CCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcC
Confidence 999999999999999999999999999999999999998874
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=98.85 E-value=1.6e-09 Score=123.72 Aligned_cols=104 Identities=17% Similarity=0.143 Sum_probs=86.7
Q ss_pred CCCCCCCCCccc--eecCCCC-----CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCC-ccccCcCC
Q 002887 387 DPCAPKVYMWQG--INCSYDA-----NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVP-EFLAELQS 458 (870)
Q Consensus 387 ~pC~~~~~~W~G--v~C~~~~-----~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP-~~~~~l~~ 458 (870)
|||. ..|.|.+ |.|++.+ ..+++++.|+|++|++++..|..|++|++|++|+|++|.+++.+| ..|.++++
T Consensus 2 ~p~~-~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~ 80 (455)
T 3v47_A 2 DPGT-SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80 (455)
T ss_dssp ------CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTT
T ss_pred CCcc-ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECccccccccc
Confidence 5664 3456666 9998642 234679999999999999889999999999999999999998885 57899999
Q ss_pred CCeEEecCCcCCCCCCCcccccccCCccccccC
Q 002887 459 LRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 459 L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
|++|+|++|++++.+|..+..+++|+.|+++.+
T Consensus 81 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 113 (455)
T 3v47_A 81 LIILKLDYNQFLQLETGAFNGLANLEVLTLTQC 113 (455)
T ss_dssp CCEEECTTCTTCEECTTTTTTCTTCCEEECTTS
T ss_pred CCEEeCCCCccCccChhhccCcccCCEEeCCCC
Confidence 999999999999999999999999999988744
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=98.82 E-value=3e-09 Score=111.69 Aligned_cols=97 Identities=20% Similarity=0.204 Sum_probs=83.1
Q ss_pred CccceecCCCC------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCc
Q 002887 395 MWQGINCSYDA------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468 (870)
Q Consensus 395 ~W~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~ 468 (870)
.|..|+|++.. ..+..++.|+|++|+|++..|..|+++++|++|+|++|+|++..|..|..+++|+.|+|++|+
T Consensus 15 ~~~~l~~~~~~l~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 94 (251)
T 3m19_A 15 GKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94 (251)
T ss_dssp GGTEEECTTCCCSSCCSCCCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred CCeEEecCCCCccccCCCCCCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCc
Confidence 35556665421 244678999999999999888899999999999999999999888889999999999999999
Q ss_pred CCCCCCCcccccccCCccccccC
Q 002887 469 LQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 469 l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
|++..|..+..+++|+.|+++.+
T Consensus 95 l~~~~~~~~~~l~~L~~L~L~~N 117 (251)
T 3m19_A 95 LASLPLGVFDHLTQLDKLYLGGN 117 (251)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSS
T ss_pred ccccChhHhcccCCCCEEEcCCC
Confidence 99877788899999999988744
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=98.79 E-value=4.4e-09 Score=105.87 Aligned_cols=89 Identities=21% Similarity=0.333 Sum_probs=82.5
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.+.++.|+|++|+|++.+|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++.+|..+..+++++.|+
T Consensus 53 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 132 (192)
T 1w8a_A 53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132 (192)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEE
T ss_pred CCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEE
Confidence 46899999999999999999999999999999999999999999899999999999999999999999999999999888
Q ss_pred cccCCCCCCCC
Q 002887 488 LSVDGNRNLCP 498 (870)
Q Consensus 488 ~~~~~n~~lc~ 498 (870)
++ +|+..|.
T Consensus 133 L~--~N~l~c~ 141 (192)
T 1w8a_A 133 LA--SNPFNCN 141 (192)
T ss_dssp CT--TCCBCCS
T ss_pred eC--CCCccCc
Confidence 76 7776654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=98.77 E-value=7e-09 Score=106.80 Aligned_cols=88 Identities=22% Similarity=0.208 Sum_probs=61.0
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
++++.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+..+++++.|++
T Consensus 80 ~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 159 (220)
T 2v9t_B 80 RSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHL 159 (220)
T ss_dssp SSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEe
Confidence 46777777777777333333567777777777777777777777777777777777777777666666777777776655
Q ss_pred ccCCCCCCCC
Q 002887 489 SVDGNRNLCP 498 (870)
Q Consensus 489 ~~~~n~~lc~ 498 (870)
+ +|+..|.
T Consensus 160 ~--~N~~~c~ 167 (220)
T 2v9t_B 160 A--QNPFICD 167 (220)
T ss_dssp C--SSCEECS
T ss_pred C--CCCcCCC
Confidence 4 6665553
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.76 E-value=9e-09 Score=101.89 Aligned_cols=89 Identities=20% Similarity=0.168 Sum_probs=75.8
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.+.++.|+|++|+|++..+..++++++|+.|+|++|+|++..|..+..+++|+.|+|++|+|++..+..+..+++++.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 130 (177)
T 2o6r_A 51 LTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIW 130 (177)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred cccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEE
Confidence 46899999999999966666689999999999999999987777789999999999999999966555568888898887
Q ss_pred cccCCCCCCCC
Q 002887 488 LSVDGNRNLCP 498 (870)
Q Consensus 488 ~~~~~n~~lc~ 498 (870)
++ +|+..|.
T Consensus 131 l~--~N~~~~~ 139 (177)
T 2o6r_A 131 LH--TNPWDCS 139 (177)
T ss_dssp CC--SSCBCCC
T ss_pred ec--CCCeecc
Confidence 76 6765553
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.76 E-value=6.6e-09 Score=115.38 Aligned_cols=108 Identities=22% Similarity=0.183 Sum_probs=87.2
Q ss_pred CCCCCCCCCC-CCccceecCCCC------CCCCcEEEEEcCCCCCcccCccccc-ccCcccccccccCcCCCCCCccccC
Q 002887 384 WQGDPCAPKV-YMWQGINCSYDA------NQSPRIISINLSSSGIAGDIVPYIF-SLTSIESLDLSKNSLTGPVPEFLAE 455 (870)
Q Consensus 384 w~~~pC~~~~-~~W~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~-~l~~L~~L~Ls~N~l~g~iP~~~~~ 455 (870)
+....|...| |.|.-|.|++.. ..+..++.|+|++|+|++..+..+. ++++|+.|+|++|+|++..|..|.+
T Consensus 7 ~~~~~Cp~~C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~ 86 (361)
T 2xot_A 7 RSVVSCPANCLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVP 86 (361)
T ss_dssp CCCTTCCTTCEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTT
T ss_pred CcCCCCCCCCEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccC
Confidence 4445674444 678999998642 2344678899999999977777777 8999999999999999877788999
Q ss_pred cCCCCeEEecCCcCCCCCCCcccccccCCccccccC
Q 002887 456 LQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 456 l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
|++|+.|+|++|+|++..|..+..+.+|+.|+++.+
T Consensus 87 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 122 (361)
T 2xot_A 87 VPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNN 122 (361)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCC
Confidence 999999999999999777778888899988888743
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=6.7e-09 Score=123.32 Aligned_cols=90 Identities=23% Similarity=0.196 Sum_probs=80.3
Q ss_pred CCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCccccc-ccCCc
Q 002887 407 QSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEK-VKNGS 485 (870)
Q Consensus 407 ~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~-~~~~~ 485 (870)
..+.++.|+|++|+|++.+|..|.+|++|+.|+|++|+|++..|..|..|++|+.|||++|+|++.+|..+..+ .+|+.
T Consensus 492 ~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~ 571 (635)
T 4g8a_A 492 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF 571 (635)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCE
T ss_pred hccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCE
Confidence 34678999999999999999999999999999999999999888899999999999999999999999998887 56787
Q ss_pred cccccCCCCCCCC
Q 002887 486 LSLSVDGNRNLCP 498 (870)
Q Consensus 486 l~~~~~~n~~lc~ 498 (870)
|+++ +|+..|.
T Consensus 572 L~L~--~Np~~C~ 582 (635)
T 4g8a_A 572 LNLT--QNDFACT 582 (635)
T ss_dssp EECT--TCCBCCS
T ss_pred EEee--CCCCccc
Confidence 7766 8888886
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=98.75 E-value=1e-08 Score=106.26 Aligned_cols=88 Identities=19% Similarity=0.192 Sum_probs=67.8
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.++++.|+|++|+|++..+..|..+++|+.|+|++|+|+ .||..+..+++|+.|+|++|+|++..+..+..+++++.|+
T Consensus 87 l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 165 (229)
T 3e6j_A 87 LTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAY 165 (229)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEE
Confidence 457888888888888655556788888888888888888 7888888888888888888888866666677777777766
Q ss_pred cccCCCCCCCC
Q 002887 488 LSVDGNRNLCP 498 (870)
Q Consensus 488 ~~~~~n~~lc~ 498 (870)
++ +|+..|.
T Consensus 166 l~--~N~~~c~ 174 (229)
T 3e6j_A 166 LF--GNPWDCE 174 (229)
T ss_dssp CT--TSCBCTT
T ss_pred ee--CCCccCC
Confidence 65 7766654
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=98.73 E-value=8.2e-09 Score=113.10 Aligned_cols=79 Identities=19% Similarity=0.183 Sum_probs=41.9
Q ss_pred cEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 410 RIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 410 ~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
+++.|+|++|++.|.+|..++++++|+.|+|++|++.|.+|..++++++|+.|+|++|++.|.+|+.++.++++..+.+
T Consensus 230 ~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l 308 (328)
T 4fcg_A 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILV 308 (328)
T ss_dssp TCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEEC
T ss_pred CCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeC
Confidence 4555555555555555555555555555555555555555555555555555555555555555555555555444433
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.72 E-value=1.1e-08 Score=110.82 Aligned_cols=182 Identities=20% Similarity=0.192 Sum_probs=121.5
Q ss_pred ccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhc-ccc--ceeEEEEEecCC---eEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAH-HKN--LTILVGYCDEGA---NMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~n--Iv~l~g~~~~~~---~~~LV~Ey~~~ 640 (870)
+.++.|....||+.. ..+++|+.... .....+.+|+++++.+. +.. +.+.+....... ..++||++++|
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 458999999999863 56888886533 34567899999999883 333 334555544333 34789999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNG------------------------------------------- 677 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------------------------------------------- 677 (870)
.++..... ..++..++..++.++++.++.||+.
T Consensus 101 ~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 101 VPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp EECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred eECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 88865332 2466777788888888888888861
Q ss_pred ------------CCCCceeCCCCCCCEEEcC--CCcEEEEeccCCccccCCCCccccccccCCCCc---cCcccccc---
Q 002887 678 ------------CKPPIVHRDVKSANILLNE--KFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGY---LDPEYYIS--- 737 (870)
Q Consensus 678 ------------~~~~IvHrDLKp~NILld~--~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y---~APE~~~~--- 737 (870)
..+.++|+|+++.||++++ +..+.|+||+.+...... . .......+ ..|+....
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~--~----Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD--N----DFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT--H----HHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH--H----HHHHHHhhccccCHHHHHHHHH
Confidence 1235899999999999998 556789999998653211 0 00000011 12222110
Q ss_pred --CC---------CCccchHHHHHHHHHHHHhCCCCC
Q 002887 738 --NR---------LTEKSDVYSFGVVLLELITGQPVI 763 (870)
Q Consensus 738 --~~---------~~~ksDVwS~GvvL~elltG~~p~ 763 (870)
+. .....+.|+++.+++++.+|+.+|
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 01 112368999999999999998765
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=98.72 E-value=6.8e-09 Score=123.28 Aligned_cols=94 Identities=20% Similarity=0.140 Sum_probs=78.7
Q ss_pred ceecCCCC------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCC
Q 002887 398 GINCSYDA------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQG 471 (870)
Q Consensus 398 Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g 471 (870)
-|+|++.+ +.+..++.|+|++|+|++..|..|++|++|++|||++|+|++..|..|.+|++|++|+|++|+|++
T Consensus 35 ~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~ 114 (635)
T 4g8a_A 35 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 114 (635)
T ss_dssp EEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred EEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCC
Confidence 47898532 345679999999999997666789999999999999999997777789999999999999999997
Q ss_pred CCCCcccccccCCccccccC
Q 002887 472 SLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 472 ~ip~~l~~~~~~~~l~~~~~ 491 (870)
..|..+..+.+|+.|+++.+
T Consensus 115 l~~~~f~~L~~L~~L~Ls~N 134 (635)
T 4g8a_A 115 LALGAFSGLSSLQKLVAVET 134 (635)
T ss_dssp ECGGGGTTCTTCCEEECTTS
T ss_pred CCHHHhcCCCCCCEEECCCC
Confidence 66667888888888887644
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=98.72 E-value=1.5e-08 Score=116.08 Aligned_cols=97 Identities=21% Similarity=0.153 Sum_probs=86.1
Q ss_pred CccceecCCCC------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCc
Q 002887 395 MWQGINCSYDA------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468 (870)
Q Consensus 395 ~W~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~ 468 (870)
.|..|.|+..+ ..++.++.|+|++|+|++..|..|.+|++|+.|+|++|++++..|..|.++++|+.|+|++|+
T Consensus 55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 47889998643 345689999999999999889999999999999999999999888999999999999999999
Q ss_pred CCCCCCCcccccccCCccccccC
Q 002887 469 LQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 469 l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
|++..+..+..+++|+.|+++.+
T Consensus 135 l~~~~~~~~~~l~~L~~L~L~~N 157 (452)
T 3zyi_A 135 LTVIPSGAFEYLSKLRELWLRNN 157 (452)
T ss_dssp CSBCCTTTSSSCTTCCEEECCSC
T ss_pred CCccChhhhcccCCCCEEECCCC
Confidence 99777777899999999988744
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=98.71 E-value=5.8e-09 Score=100.09 Aligned_cols=79 Identities=24% Similarity=0.238 Sum_probs=45.2
Q ss_pred CcEEEEEcCCCCCc-ccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 409 PRIISINLSSSGIA-GDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 409 ~~l~~l~L~~n~l~-G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
++++.|+|++|+++ |.+|..+..+++|+.|+|++|++++. ..++++++|+.|+|++|++++.+|..+..++++..|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 35555666666655 55555555566666666666655543 4455556666666666666555555555555555555
Q ss_pred cc
Q 002887 488 LS 489 (870)
Q Consensus 488 ~~ 489 (870)
++
T Consensus 95 ls 96 (149)
T 2je0_A 95 LS 96 (149)
T ss_dssp CT
T ss_pred CC
Confidence 54
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.70 E-value=1.4e-08 Score=107.75 Aligned_cols=108 Identities=21% Similarity=0.244 Sum_probs=84.0
Q ss_pred CCCCCCCCCCCCCccceecCCCC------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCc
Q 002887 383 DWQGDPCAPKVYMWQGINCSYDA------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAEL 456 (870)
Q Consensus 383 ~w~~~pC~~~~~~W~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l 456 (870)
.|.|..|.. ...|..|.|+... ..+..++.|+|++|+|++..+..|+++++|++|+|++|++++..+..|.++
T Consensus 6 ~~~~~~C~c-~~~~~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l 84 (270)
T 2o6q_A 6 KKDGGVCSC-NNNKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKEL 84 (270)
T ss_dssp GGGTCSBEE-ETTTTEEECTTSCCSSCCSCCCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSC
T ss_pred CCCCCCCEe-CCCCCEEEccCCCCCccCCCCCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCC
Confidence 466666621 1256777887532 234568999999999997666689999999999999999995545556889
Q ss_pred CCCCeEEecCCcCCCCCCCcccccccCCccccccC
Q 002887 457 QSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 457 ~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
++|+.|+|++|++++..+..+..+++|+.|+++.+
T Consensus 85 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 119 (270)
T 2o6q_A 85 KNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRN 119 (270)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSS
T ss_pred CCCCEEECCCCcCCcCCHhHcccccCCCEEECCCC
Confidence 99999999999999776677788899998888743
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=98.70 E-value=1.8e-08 Score=105.79 Aligned_cols=89 Identities=22% Similarity=0.249 Sum_probs=71.7
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.++++.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|+.+++|+.|+|++|+|++..|..+..+++++.|+
T Consensus 106 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 185 (251)
T 3m19_A 106 LTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTIT 185 (251)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred cCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEE
Confidence 45788899999998865555678889999999999999876666788889999999999999877777888888888777
Q ss_pred cccCCCCCCCC
Q 002887 488 LSVDGNRNLCP 498 (870)
Q Consensus 488 ~~~~~n~~lc~ 498 (870)
++ +|+..|.
T Consensus 186 l~--~N~~~c~ 194 (251)
T 3m19_A 186 LF--GNQFDCS 194 (251)
T ss_dssp CC--SCCBCTT
T ss_pred ee--CCceeCC
Confidence 65 7766654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=98.70 E-value=9.4e-09 Score=100.74 Aligned_cols=83 Identities=23% Similarity=0.228 Sum_probs=65.2
Q ss_pred CCCcEEEEEcCCCCCc-ccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCc
Q 002887 407 QSPRIISINLSSSGIA-GDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGS 485 (870)
Q Consensus 407 ~~~~l~~l~L~~n~l~-G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~ 485 (870)
.++.++.|+|++|+++ |.+|..+..+++|+.|+|++|.+++. ..++.+++|+.|+|++|++++.+|..+..+++|+.
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 3457888888888887 78888888888888888888888865 66788888888888888888777777777888887
Q ss_pred cccccC
Q 002887 486 LSLSVD 491 (870)
Q Consensus 486 l~~~~~ 491 (870)
|+++.+
T Consensus 100 L~Ls~N 105 (168)
T 2ell_A 100 LNLSGN 105 (168)
T ss_dssp EECBSS
T ss_pred EeccCC
Confidence 777643
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=7.1e-09 Score=121.44 Aligned_cols=96 Identities=20% Similarity=0.134 Sum_probs=82.7
Q ss_pred CccceecCCCC--------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecC
Q 002887 395 MWQGINCSYDA--------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG 466 (870)
Q Consensus 395 ~W~Gv~C~~~~--------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~ 466 (870)
.|.|+ |+... ...+.++.|+|++|++++..|..|++|++|++|+|++|++++..|..|+++++|++|+|++
T Consensus 5 ~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~ 83 (549)
T 2z81_A 5 DASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSD 83 (549)
T ss_dssp CTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTT
T ss_pred CCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCC
Confidence 78888 75321 2345899999999999988889999999999999999999988889999999999999999
Q ss_pred CcCCCCCCCcccccccCCccccccC
Q 002887 467 NNLQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 467 N~l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
|++++..|..++.+++|+.|+++.+
T Consensus 84 n~l~~~~~~~~~~l~~L~~L~Ls~n 108 (549)
T 2z81_A 84 NHLSSLSSSWFGPLSSLKYLNLMGN 108 (549)
T ss_dssp SCCCSCCHHHHTTCTTCCEEECTTC
T ss_pred CccCccCHHHhccCCCCcEEECCCC
Confidence 9999887777999999998888744
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.67 E-value=2.7e-08 Score=101.06 Aligned_cols=89 Identities=20% Similarity=0.182 Sum_probs=70.8
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.++++.|+|++|+|++..+..+.++++|++|+|++|+|++..|..+..+++|+.|+|++|++++..+..+..+++++.|+
T Consensus 75 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 154 (208)
T 2o6s_A 75 LTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW 154 (208)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred CCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEE
Confidence 45788899999999865555678899999999999999876666788889999999999999876666678888888777
Q ss_pred cccCCCCCCCC
Q 002887 488 LSVDGNRNLCP 498 (870)
Q Consensus 488 ~~~~~n~~lc~ 498 (870)
++ +|+..|.
T Consensus 155 l~--~N~~~~~ 163 (208)
T 2o6s_A 155 LH--DNPWDCT 163 (208)
T ss_dssp CC--SCCBCCC
T ss_pred ec--CCCeecC
Confidence 76 5655543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.66 E-value=2.5e-08 Score=114.78 Aligned_cols=97 Identities=19% Similarity=0.184 Sum_probs=84.5
Q ss_pred CccceecCCCC------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCc
Q 002887 395 MWQGINCSYDA------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468 (870)
Q Consensus 395 ~W~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~ 468 (870)
.|..|.|+... ..+..++.|+|++|+|++..|..|.++++|++|+|++|++++..|..|++|++|+.|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 58899998632 345678999999999998888899999999999999999999889999999999999999999
Q ss_pred CCCCCCCcccccccCCccccccC
Q 002887 469 LQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 469 l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
+++..+..+..+++|+.|+++.+
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n 114 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISEN 114 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTS
T ss_pred CCccCcccccCCCCCCEEECCCC
Confidence 99665566888999999888744
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=1.7e-08 Score=118.81 Aligned_cols=79 Identities=28% Similarity=0.278 Sum_probs=72.5
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCC-CCcccccccCCcc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSL-PSGLSEKVKNGSL 486 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~i-p~~l~~~~~~~~l 486 (870)
.+.++.|+|++|+|+ .||..|++|++|+.|+|++|+|++ || .+++|++|+.|+|++|+|++.+ |..++.+++|..|
T Consensus 462 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L 538 (567)
T 1dce_A 462 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 538 (567)
T ss_dssp GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred cccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEE
Confidence 357899999999999 999999999999999999999997 88 7999999999999999999887 9999999999988
Q ss_pred ccc
Q 002887 487 SLS 489 (870)
Q Consensus 487 ~~~ 489 (870)
+++
T Consensus 539 ~L~ 541 (567)
T 1dce_A 539 NLQ 541 (567)
T ss_dssp ECT
T ss_pred Eec
Confidence 887
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=98.65 E-value=3.2e-08 Score=105.14 Aligned_cols=89 Identities=21% Similarity=0.189 Sum_probs=72.2
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.++++.|+|++|+|++..+..++++++|+.|+|++|++++..|..++.+++|+.|+|++|++++..|..+..+++++.|+
T Consensus 132 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 211 (272)
T 3rfs_A 132 LTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW 211 (272)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEE
Confidence 45788889999988866666678889999999999999877777778889999999999999887777788888888777
Q ss_pred cccCCCCCCCC
Q 002887 488 LSVDGNRNLCP 498 (870)
Q Consensus 488 ~~~~~n~~lc~ 498 (870)
++ +|+..|.
T Consensus 212 l~--~N~~~~~ 220 (272)
T 3rfs_A 212 LH--DNPWDCT 220 (272)
T ss_dssp CC--SSCBCCC
T ss_pred cc--CCCcccc
Confidence 76 6665554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=98.63 E-value=8.8e-09 Score=98.82 Aligned_cols=80 Identities=24% Similarity=0.286 Sum_probs=69.9
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCC-CCCCcccccccCCcc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQG-SLPSGLSEKVKNGSL 486 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g-~ip~~l~~~~~~~~l 486 (870)
.++++.|+|++|+|++. ..++++++|++|+|++|++++.+|..++.+++|+.|+|++|++++ ..|..+..+++++.|
T Consensus 41 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L 118 (149)
T 2je0_A 41 FEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSL 118 (149)
T ss_dssp CTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEE
T ss_pred cCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEE
Confidence 46889999999999876 789999999999999999998899888889999999999999987 345788889999888
Q ss_pred ccc
Q 002887 487 SLS 489 (870)
Q Consensus 487 ~~~ 489 (870)
+++
T Consensus 119 ~l~ 121 (149)
T 2je0_A 119 DLF 121 (149)
T ss_dssp ECT
T ss_pred eCc
Confidence 876
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=3.7e-08 Score=105.23 Aligned_cols=95 Identities=19% Similarity=0.127 Sum_probs=80.5
Q ss_pred cceecCCCC------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCc-C
Q 002887 397 QGINCSYDA------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN-L 469 (870)
Q Consensus 397 ~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~-l 469 (870)
..|.|+..+ ..++.++.|+|++|++++..+..|+++++|++|+|++|++++..|..|+++++|+.|+|++|+ +
T Consensus 14 ~~~~c~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l 93 (285)
T 1ozn_A 14 VTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93 (285)
T ss_dssp CEEECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTC
T ss_pred eEEEcCcCCcccCCcCCCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCc
Confidence 457887532 345688999999999998777789999999999999999998889999999999999999997 7
Q ss_pred CCCCCCcccccccCCccccccC
Q 002887 470 QGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 470 ~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
++..|..+..+++|+.|+++.+
T Consensus 94 ~~~~~~~~~~l~~L~~L~l~~n 115 (285)
T 1ozn_A 94 RSVDPATFHGLGRLHTLHLDRC 115 (285)
T ss_dssp CCCCTTTTTTCTTCCEEECTTS
T ss_pred cccCHHHhcCCcCCCEEECCCC
Confidence 7666888999999998888743
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=5.1e-08 Score=106.50 Aligned_cols=93 Identities=23% Similarity=0.261 Sum_probs=81.0
Q ss_pred CCccceecCCCC------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCC
Q 002887 394 YMWQGINCSYDA------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467 (870)
Q Consensus 394 ~~W~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N 467 (870)
+.|..+.|+..+ ..++.++.|+|++|++++..+..|+++++|++|+|++|++++..|..|+++++|+.|+|++|
T Consensus 31 c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 110 (330)
T 1xku_A 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110 (330)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCC
Confidence 589999998632 23468899999999999877778999999999999999999888999999999999999999
Q ss_pred cCCCCCCCcccccccCCccccc
Q 002887 468 NLQGSLPSGLSEKVKNGSLSLS 489 (870)
Q Consensus 468 ~l~g~ip~~l~~~~~~~~l~~~ 489 (870)
+++ .+|..+. ++++.|+++
T Consensus 111 ~l~-~l~~~~~--~~L~~L~l~ 129 (330)
T 1xku_A 111 QLK-ELPEKMP--KTLQELRVH 129 (330)
T ss_dssp CCS-BCCSSCC--TTCCEEECC
T ss_pred cCC-ccChhhc--ccccEEECC
Confidence 998 7887765 567777776
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=2.9e-08 Score=117.76 Aligned_cols=95 Identities=19% Similarity=0.147 Sum_probs=80.4
Q ss_pred cceecCCCC------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCC
Q 002887 397 QGINCSYDA------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQ 470 (870)
Q Consensus 397 ~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~ 470 (870)
..|.|+..+ ..+.+++.|+|++|++++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|+++
T Consensus 14 ~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~ 93 (606)
T 3vq2_A 14 ITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93 (606)
T ss_dssp TEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred CceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCccc
Confidence 458887632 34567899999999999888888999999999999999999888888999999999999999999
Q ss_pred CCCCCcccccccCCccccccC
Q 002887 471 GSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 471 g~ip~~l~~~~~~~~l~~~~~ 491 (870)
+..|..++.+++|+.|+++.+
T Consensus 94 ~~~p~~~~~l~~L~~L~L~~n 114 (606)
T 3vq2_A 94 SFSPGSFSGLTSLENLVAVET 114 (606)
T ss_dssp CCCTTSSTTCTTCCEEECTTS
T ss_pred ccChhhcCCcccCCEEEccCC
Confidence 888989999988888887744
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=3e-08 Score=105.47 Aligned_cols=94 Identities=20% Similarity=0.140 Sum_probs=82.2
Q ss_pred ceecCCCC------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCC
Q 002887 398 GINCSYDA------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQG 471 (870)
Q Consensus 398 Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g 471 (870)
.+.|.... ..++.++.|+|++|+|++..+..|+++++|++|+|++|++++..|..+.++++|+.|+|++|++++
T Consensus 11 ~~~c~~~~l~~ip~~l~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 90 (276)
T 2z62_A 11 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 90 (276)
T ss_dssp EEECTTSCCSSCCSSSCTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred eEEecCCCccccCCCCCCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCc
Confidence 57887632 234569999999999998777799999999999999999998777889999999999999999998
Q ss_pred CCCCcccccccCCccccccC
Q 002887 472 SLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 472 ~ip~~l~~~~~~~~l~~~~~ 491 (870)
..|..+..+++++.|+++.+
T Consensus 91 ~~~~~~~~l~~L~~L~l~~n 110 (276)
T 2z62_A 91 LALGAFSGLSSLQKLVAVET 110 (276)
T ss_dssp ECTTTTTTCTTCCEEECTTS
T ss_pred cChhhhcCCccccEEECCCC
Confidence 88899999999999888743
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.60 E-value=5.2e-08 Score=111.03 Aligned_cols=97 Identities=22% Similarity=0.152 Sum_probs=84.0
Q ss_pred CccceecCCCC------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCc
Q 002887 395 MWQGINCSYDA------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468 (870)
Q Consensus 395 ~W~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~ 468 (870)
.|..|.|+..+ ..+..++.|+|++|+|++..+..|.+|++|++|+|++|++++..|..|.++++|+.|+|++|+
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 47789998632 344678999999999998888999999999999999999998888899999999999999999
Q ss_pred CCCCCCCcccccccCCccccccC
Q 002887 469 LQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 469 l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
|++..+..+..+++|+.|+++.+
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N 146 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNN 146 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSC
T ss_pred CCeeCHhHhhccccCceeeCCCC
Confidence 99766668899999998888743
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.58 E-value=5.2e-08 Score=106.56 Aligned_cols=94 Identities=20% Similarity=0.226 Sum_probs=81.9
Q ss_pred CCccceecCCCC------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCC
Q 002887 394 YMWQGINCSYDA------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467 (870)
Q Consensus 394 ~~W~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N 467 (870)
+.|..+.|+... ...+.++.|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|+.|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 579999998632 23458899999999999877889999999999999999999988999999999999999999
Q ss_pred cCCCCCCCcccccccCCcccccc
Q 002887 468 NLQGSLPSGLSEKVKNGSLSLSV 490 (870)
Q Consensus 468 ~l~g~ip~~l~~~~~~~~l~~~~ 490 (870)
+++ .+|..+. ++++.|+++.
T Consensus 113 ~l~-~l~~~~~--~~L~~L~l~~ 132 (332)
T 2ft3_A 113 HLV-EIPPNLP--SSLVELRIHD 132 (332)
T ss_dssp CCC-SCCSSCC--TTCCEEECCS
T ss_pred cCC-ccCcccc--ccCCEEECCC
Confidence 999 7888776 6777777763
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.58 E-value=2.5e-08 Score=110.07 Aligned_cols=97 Identities=22% Similarity=0.149 Sum_probs=80.4
Q ss_pred Cccce-ecCCCC------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCC
Q 002887 395 MWQGI-NCSYDA------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467 (870)
Q Consensus 395 ~W~Gv-~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N 467 (870)
.|.|+ .|++.. ...+.++.|+|++|++++..+..|.++++|++|+|++|++++..|..|+++++|+.|+|++|
T Consensus 31 ~~~~~c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 110 (353)
T 2z80_A 31 DRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYN 110 (353)
T ss_dssp CTTSEEECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCeEeeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCC
Confidence 78887 333321 23458999999999999766668999999999999999999988899999999999999999
Q ss_pred cCCCCCCCcccccccCCccccccC
Q 002887 468 NLQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 468 ~l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
++++..+..+..+++++.|+++.+
T Consensus 111 ~l~~~~~~~~~~l~~L~~L~L~~n 134 (353)
T 2z80_A 111 YLSNLSSSWFKPLSSLTFLNLLGN 134 (353)
T ss_dssp CCSSCCHHHHTTCTTCSEEECTTC
T ss_pred cCCcCCHhHhCCCccCCEEECCCC
Confidence 999644445888999999888743
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=3.1e-08 Score=117.46 Aligned_cols=107 Identities=15% Similarity=0.068 Sum_probs=87.7
Q ss_pred CCCCCCCCCCCCccceecCCCC------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcC
Q 002887 384 WQGDPCAPKVYMWQGINCSYDA------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQ 457 (870)
Q Consensus 384 w~~~pC~~~~~~W~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~ 457 (870)
|.+.+|.. ...+.-|+|++.+ ..+..++.|+|++|+|++..|..|++|++|++|+|++|++++..|..|++++
T Consensus 3 ~~~~~C~~-~~~~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~ 81 (606)
T 3t6q_A 3 SSDQKCIE-KEVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQH 81 (606)
T ss_dssp ---CCCEE-EETTTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCT
T ss_pred cccCceec-ccCCceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCcc
Confidence 45556631 1235568898632 3456889999999999988889999999999999999999998899999999
Q ss_pred CCCeEEecCCcCCCCCCCcccccccCCccccccC
Q 002887 458 SLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 458 ~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
+|+.|+|++|++++..|..++.+++|+.|+++.+
T Consensus 82 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 115 (606)
T 3t6q_A 82 RLDTLVLTANPLIFMAETALSGPKALKHLFFIQT 115 (606)
T ss_dssp TCCEEECTTCCCSEECTTTTSSCTTCCEEECTTS
T ss_pred ccCeeeCCCCcccccChhhhcccccccEeecccc
Confidence 9999999999999999999999999998888754
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.58 E-value=3.2e-08 Score=102.87 Aligned_cols=93 Identities=15% Similarity=0.125 Sum_probs=77.6
Q ss_pred eecCCCC---CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCc-CCCCCCccccCcCCCCeEEecC-CcCCCCC
Q 002887 399 INCSYDA---NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNS-LTGPVPEFLAELQSLRVLNLSG-NNLQGSL 473 (870)
Q Consensus 399 v~C~~~~---~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~-l~g~iP~~~~~l~~L~~L~ls~-N~l~g~i 473 (870)
|.|..-. ..+..++.|+|++|+|++..+..|+++++|++|+|++|+ +++..|..|.++++|+.|+|++ |++++..
T Consensus 18 v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~ 97 (239)
T 2xwt_C 18 VTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYID 97 (239)
T ss_dssp EEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEEC
T ss_pred eEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcC
Confidence 4496411 134579999999999997777789999999999999997 8865566899999999999999 9999777
Q ss_pred CCcccccccCCccccccC
Q 002887 474 PSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 474 p~~l~~~~~~~~l~~~~~ 491 (870)
|..+..+++++.|+++.+
T Consensus 98 ~~~f~~l~~L~~L~l~~n 115 (239)
T 2xwt_C 98 PDALKELPLLKFLGIFNT 115 (239)
T ss_dssp TTSEECCTTCCEEEEEEE
T ss_pred HHHhCCCCCCCEEeCCCC
Confidence 778899999999988744
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=98.57 E-value=6.9e-08 Score=95.52 Aligned_cols=77 Identities=21% Similarity=0.209 Sum_probs=68.8
Q ss_pred EEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccccccC
Q 002887 412 ISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 412 ~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
+.|++++|+|+ .||..+. ++|+.|+|++|+|++..|..|+++++|+.|+|++|+|++..+..+..+++|+.|+++.|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 57999999995 8999875 89999999999999999999999999999999999999755556789999999988743
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=98.57 E-value=2.9e-08 Score=120.44 Aligned_cols=78 Identities=22% Similarity=0.313 Sum_probs=56.6
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
..|+.|+|++|.|+ .||..|++|++|++|+|++|+|+ .||..|++|++|+.|+|++|+|+ .||..++.+++|..|++
T Consensus 247 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L 323 (727)
T 4b8c_D 247 DFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGV 323 (727)
T ss_dssp CSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEEC
T ss_pred CCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeC
Confidence 45667777777777 77777777777777777777777 67777777777777777777775 67777777777776666
Q ss_pred c
Q 002887 489 S 489 (870)
Q Consensus 489 ~ 489 (870)
+
T Consensus 324 ~ 324 (727)
T 4b8c_D 324 E 324 (727)
T ss_dssp T
T ss_pred C
Confidence 5
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=98.56 E-value=7.9e-08 Score=94.66 Aligned_cols=78 Identities=23% Similarity=0.226 Sum_probs=69.7
Q ss_pred EEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccccc
Q 002887 411 IISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSV 490 (870)
Q Consensus 411 l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~~ 490 (870)
.+.|++++|+|+ .||..+. ++|++|+|++|+|++..|..|+++++|+.|+|++|+|++..|..+..+++|+.|+++.
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 357999999999 6898774 8999999999999999899999999999999999999977776778999999998874
Q ss_pred C
Q 002887 491 D 491 (870)
Q Consensus 491 ~ 491 (870)
|
T Consensus 88 N 88 (170)
T 3g39_A 88 N 88 (170)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.55 E-value=6.2e-08 Score=104.54 Aligned_cols=89 Identities=24% Similarity=0.189 Sum_probs=70.9
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccc-cCCcc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKV-KNGSL 486 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~-~~~~l 486 (870)
.++++.|+|++|+|++..|..|.++++|+.|+|++|++++..+..+..+++|+.|+|++|++++.+|..+..++ ++..|
T Consensus 174 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L 253 (306)
T 2z66_A 174 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL 253 (306)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEE
T ss_pred CcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEE
Confidence 45788888888888887788888888888888888888877676788888888888888888888888888774 67776
Q ss_pred ccccCCCCCCCC
Q 002887 487 SLSVDGNRNLCP 498 (870)
Q Consensus 487 ~~~~~~n~~lc~ 498 (870)
+++ +|+..|.
T Consensus 254 ~L~--~N~~~~~ 263 (306)
T 2z66_A 254 NLT--QNDFACT 263 (306)
T ss_dssp ECT--TCCEECS
T ss_pred Ecc--CCCeecc
Confidence 665 6665553
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=98.54 E-value=1.6e-08 Score=120.94 Aligned_cols=84 Identities=13% Similarity=0.256 Sum_probs=75.5
Q ss_pred CCcEEEEEcCCCCCccc-----------------Cccccc--ccCcccccccccCcCCCCCCccccCcCCCCeEEecCCc
Q 002887 408 SPRIISINLSSSGIAGD-----------------IVPYIF--SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~-----------------ip~~~~--~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~ 468 (870)
.++++.|+|++|.|+|. ||.+++ +|++|++|+|++|+++|.+|..|++|++|+.|+|++|+
T Consensus 205 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred ccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 46889999999999996 999999 99999999999999999999999999999999999998
Q ss_pred -CCC-CCCCccccc------ccCCccccccC
Q 002887 469 -LQG-SLPSGLSEK------VKNGSLSLSVD 491 (870)
Q Consensus 469 -l~g-~ip~~l~~~------~~~~~l~~~~~ 491 (870)
|+| .+|..++.+ ++++.|+++.+
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n 315 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYN 315 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSS
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCC
Confidence 999 899988876 88888887743
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.54 E-value=3.7e-08 Score=99.34 Aligned_cols=80 Identities=19% Similarity=0.272 Sum_probs=54.6
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
+.++.|+|++|++++..|..|++|++|++|+|++|++++.+|..++.+++|+.|+|++|++.+.+| .+..+++|+.|++
T Consensus 88 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l 166 (197)
T 4ezg_A 88 SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNI 166 (197)
T ss_dssp TTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEEC
T ss_pred CCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEEC
Confidence 466677777777776666677777777777777777776666667777777777777776444555 5666666666666
Q ss_pred c
Q 002887 489 S 489 (870)
Q Consensus 489 ~ 489 (870)
+
T Consensus 167 ~ 167 (197)
T 4ezg_A 167 Q 167 (197)
T ss_dssp T
T ss_pred C
Confidence 5
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=98.53 E-value=7.6e-08 Score=116.80 Aligned_cols=81 Identities=32% Similarity=0.384 Sum_probs=76.6
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
...++.|+|++|.|. .||..+++|++|++|+|++|+|+ .||..|++|++|+.|+|++|+|+ .||..++.+.+|..|+
T Consensus 223 l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 299 (727)
T 4b8c_D 223 DQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFY 299 (727)
T ss_dssp CCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEE
T ss_pred CCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEE
Confidence 467899999999999 99999999999999999999999 99999999999999999999999 8999999999999999
Q ss_pred cccC
Q 002887 488 LSVD 491 (870)
Q Consensus 488 ~~~~ 491 (870)
++.|
T Consensus 300 L~~N 303 (727)
T 4b8c_D 300 FFDN 303 (727)
T ss_dssp CCSS
T ss_pred CCCC
Confidence 8744
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=7.8e-08 Score=109.71 Aligned_cols=87 Identities=22% Similarity=0.207 Sum_probs=52.2
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
++++.|+|++|.|++..|..++++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..+..+++++.|++
T Consensus 323 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 402 (455)
T 3v47_A 323 THLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWL 402 (455)
T ss_dssp TTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred ccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEc
Confidence 45666666666666555566666666666666666666666666666666666666666666544444555666665555
Q ss_pred ccCCCCCCC
Q 002887 489 SVDGNRNLC 497 (870)
Q Consensus 489 ~~~~n~~lc 497 (870)
+ +|+..|
T Consensus 403 ~--~N~l~~ 409 (455)
T 3v47_A 403 H--TNPWDC 409 (455)
T ss_dssp C--SSCBCC
T ss_pred c--CCCccc
Confidence 4 454444
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=98.52 E-value=1.1e-07 Score=101.08 Aligned_cols=79 Identities=22% Similarity=0.190 Sum_probs=33.2
Q ss_pred cEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 410 RIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 410 ~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
.++.|+|++|++++..|..++++++|++|+|++|+|++..|..++.+++|+.|+|++|++++..|..+..+++|+.|++
T Consensus 110 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 188 (272)
T 3rfs_A 110 NLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRL 188 (272)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEEC
Confidence 3444444444444333333444444444444444444333333344444444444444444333333344444444433
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.51 E-value=6.2e-08 Score=110.41 Aligned_cols=89 Identities=18% Similarity=0.115 Sum_probs=81.3
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
..+++.|+|++|.|++..|..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..+..+++++.|+
T Consensus 206 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 285 (440)
T 3zyj_A 206 LIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIH 285 (440)
T ss_dssp CSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEE
T ss_pred CcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEE
Confidence 45899999999999999999999999999999999999999999999999999999999999977777788899998877
Q ss_pred cccCCCCCCCC
Q 002887 488 LSVDGNRNLCP 498 (870)
Q Consensus 488 ~~~~~n~~lc~ 498 (870)
++ +|+..|.
T Consensus 286 L~--~Np~~Cd 294 (440)
T 3zyj_A 286 LH--HNPWNCN 294 (440)
T ss_dssp CC--SSCEECS
T ss_pred cC--CCCccCC
Confidence 76 8888775
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=98.51 E-value=6.7e-08 Score=110.55 Aligned_cols=89 Identities=19% Similarity=0.094 Sum_probs=81.1
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.++++.|+|++|.|++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..+..+++++.|+
T Consensus 217 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 296 (452)
T 3zyi_A 217 LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELH 296 (452)
T ss_dssp CTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEE
T ss_pred cccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEE
Confidence 45899999999999999999999999999999999999999999999999999999999999977777788899888877
Q ss_pred cccCCCCCCCC
Q 002887 488 LSVDGNRNLCP 498 (870)
Q Consensus 488 ~~~~~n~~lc~ 498 (870)
++ +|+..|.
T Consensus 297 L~--~Np~~Cd 305 (452)
T 3zyi_A 297 LH--HNPWNCD 305 (452)
T ss_dssp CC--SSCEECS
T ss_pred cc--CCCcCCC
Confidence 76 8887775
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.51 E-value=7.4e-08 Score=114.33 Aligned_cols=83 Identities=20% Similarity=0.153 Sum_probs=62.2
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
+.++.|+|++|+|++..|..|++|++|++|+|++|.|++..|..|++|++|+.|+|++|+|++..|..++.+++|..|++
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 45677788888888777777888888888888888888777777788888888888888887444444577777777777
Q ss_pred ccC
Q 002887 489 SVD 491 (870)
Q Consensus 489 ~~~ 491 (870)
+.+
T Consensus 155 s~N 157 (597)
T 3oja_B 155 SNN 157 (597)
T ss_dssp CSS
T ss_pred eCC
Confidence 644
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=6.3e-08 Score=114.00 Aligned_cols=77 Identities=27% Similarity=0.392 Sum_probs=71.5
Q ss_pred cEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccccc
Q 002887 410 RIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLS 489 (870)
Q Consensus 410 ~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~ 489 (870)
.++.|+|++|+|++ ||. |++|++|+.|+|++|+|+ .||..|++|++|+.|+|++|+|++ +| .++.+++|..|+++
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 47889999999996 786 999999999999999999 999999999999999999999997 78 89999999999887
Q ss_pred cC
Q 002887 490 VD 491 (870)
Q Consensus 490 ~~ 491 (870)
.|
T Consensus 517 ~N 518 (567)
T 1dce_A 517 NN 518 (567)
T ss_dssp SS
T ss_pred CC
Confidence 44
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.51 E-value=1.3e-07 Score=100.29 Aligned_cols=89 Identities=21% Similarity=0.211 Sum_probs=74.4
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.++++.|+|++|.|++..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++++.|+
T Consensus 132 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 211 (270)
T 2o6q_A 132 LTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQ 211 (270)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred CcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEE
Confidence 46899999999999965555689999999999999999977677789999999999999999976666688888888777
Q ss_pred cccCCCCCCCC
Q 002887 488 LSVDGNRNLCP 498 (870)
Q Consensus 488 ~~~~~n~~lc~ 498 (870)
++ +|+..|.
T Consensus 212 l~--~N~~~c~ 220 (270)
T 2o6q_A 212 LQ--ENPWDCT 220 (270)
T ss_dssp CC--SSCBCCS
T ss_pred ec--CCCeeCC
Confidence 65 7877665
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.51 E-value=3.6e-08 Score=107.03 Aligned_cols=81 Identities=20% Similarity=0.215 Sum_probs=68.1
Q ss_pred CcEEEEEcCCCCCcccCcccc--cccCcccccccccCcCCCCCCccccCc-----CCCCeEEecCCcCCCCCCCcccccc
Q 002887 409 PRIISINLSSSGIAGDIVPYI--FSLTSIESLDLSKNSLTGPVPEFLAEL-----QSLRVLNLSGNNLQGSLPSGLSEKV 481 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~--~~l~~L~~L~Ls~N~l~g~iP~~~~~l-----~~L~~L~ls~N~l~g~ip~~l~~~~ 481 (870)
.+++.|+|++|+++|.+|..+ +++++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..++.++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 478888888888888888886 8888888888888888877 8877777 8888888888888887778888888
Q ss_pred cCCcccccc
Q 002887 482 KNGSLSLSV 490 (870)
Q Consensus 482 ~~~~l~~~~ 490 (870)
+++.|+++.
T Consensus 174 ~L~~L~Ls~ 182 (312)
T 1wwl_A 174 ALSTLDLSD 182 (312)
T ss_dssp SCCEEECCS
T ss_pred CCCEEECCC
Confidence 888888773
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=4.7e-08 Score=104.38 Aligned_cols=89 Identities=22% Similarity=0.210 Sum_probs=72.1
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.++++.|+|++|+|++..+..+.++++|+.|+|++|++++..|..++++++|+.|+|++|++++..|..+..+++++.|+
T Consensus 152 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 231 (285)
T 1ozn_A 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLR 231 (285)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEE
T ss_pred CCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEe
Confidence 45788899999988865555688889999999999999888888888889999999999999876666688888888777
Q ss_pred cccCCCCCCCC
Q 002887 488 LSVDGNRNLCP 498 (870)
Q Consensus 488 ~~~~~n~~lc~ 498 (870)
++ +|+..|.
T Consensus 232 l~--~N~~~c~ 240 (285)
T 1ozn_A 232 LN--DNPWVCD 240 (285)
T ss_dssp CC--SSCEECS
T ss_pred cc--CCCccCC
Confidence 65 6766554
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=98.50 E-value=1.3e-07 Score=101.67 Aligned_cols=88 Identities=24% Similarity=0.268 Sum_probs=66.7
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.++++.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+|+ .+|..+..+.++..|.
T Consensus 123 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~ 201 (290)
T 1p9a_G 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAF 201 (290)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEE
T ss_pred CCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEE
Confidence 357888888888888655556778888888888888888544455677888888888888888 7888887777777665
Q ss_pred cccCCCCCCCC
Q 002887 488 LSVDGNRNLCP 498 (870)
Q Consensus 488 ~~~~~n~~lc~ 498 (870)
++ +|+..|.
T Consensus 202 L~--~Np~~C~ 210 (290)
T 1p9a_G 202 LH--GNPWLCN 210 (290)
T ss_dssp CC--SCCBCCS
T ss_pred eC--CCCccCc
Confidence 54 7877775
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=98.50 E-value=6.2e-08 Score=94.84 Aligned_cols=81 Identities=23% Similarity=0.215 Sum_probs=46.9
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCC-CCccccCcCCCCeEEecCCcCCCCCC---CcccccccCC
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGP-VPEFLAELQSLRVLNLSGNNLQGSLP---SGLSEKVKNG 484 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~-iP~~~~~l~~L~~L~ls~N~l~g~ip---~~l~~~~~~~ 484 (870)
++++.|+|++|.+++.+|..+.++++|++|+|++|++++. .+..+..+++|+.|+|++|++++..+ ..+..+++++
T Consensus 71 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~ 150 (168)
T 2ell_A 71 PKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLT 150 (168)
T ss_dssp SSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCC
T ss_pred CCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCc
Confidence 4566666666666655555555566666666666666542 12455666666666666666664333 2555566666
Q ss_pred ccccc
Q 002887 485 SLSLS 489 (870)
Q Consensus 485 ~l~~~ 489 (870)
.|+++
T Consensus 151 ~L~l~ 155 (168)
T 2ell_A 151 YLDGY 155 (168)
T ss_dssp EETTE
T ss_pred EecCC
Confidence 55554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=98.49 E-value=6.9e-08 Score=106.24 Aligned_cols=77 Identities=16% Similarity=0.181 Sum_probs=70.8
Q ss_pred EEEcCCC-CCcccCcccccccCccccccccc-CcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccccc
Q 002887 413 SINLSSS-GIAGDIVPYIFSLTSIESLDLSK-NSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSV 490 (870)
Q Consensus 413 ~l~L~~n-~l~G~ip~~~~~l~~L~~L~Ls~-N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~~ 490 (870)
.++++++ +|+ .||. |..+++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|+|..|..+..+++|..|+++.
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 3589998 898 5999 99999999999996 999988888999999999999999999999999999999999999885
Q ss_pred C
Q 002887 491 D 491 (870)
Q Consensus 491 ~ 491 (870)
|
T Consensus 90 N 90 (347)
T 2ifg_A 90 N 90 (347)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.47 E-value=2.8e-08 Score=122.22 Aligned_cols=84 Identities=17% Similarity=0.235 Sum_probs=74.3
Q ss_pred CCcEEEEEcCCCCCcc-----------------cCccccc--ccCcccccccccCcCCCCCCccccCcCCCCeEEecCCc
Q 002887 408 SPRIISINLSSSGIAG-----------------DIVPYIF--SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G-----------------~ip~~~~--~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~ 468 (870)
.++++.|+|++|.|+| .||++++ +|++|++|+|++|+++|.+|..|++|++|+.|+|++|+
T Consensus 447 L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 4688999999999999 4999988 99999999999999999999999999999999999998
Q ss_pred -CCC-CCCCcccccc-------cCCccccccC
Q 002887 469 -LQG-SLPSGLSEKV-------KNGSLSLSVD 491 (870)
Q Consensus 469 -l~g-~ip~~l~~~~-------~~~~l~~~~~ 491 (870)
|+| .+|..++.+. +|+.|+++.+
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N 558 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYN 558 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSS
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCC
Confidence 999 8998887776 7888777643
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.46 E-value=9.8e-08 Score=105.88 Aligned_cols=83 Identities=23% Similarity=0.183 Sum_probs=60.4
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
..+++.|+|++|+|++..|..|.+|++|++|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..+..+++|+.|+
T Consensus 63 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 142 (361)
T 2xot_A 63 LTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLY 142 (361)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred ccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEE
Confidence 34677777777777766666677777777777777777766666677777777777777777766677777777777776
Q ss_pred ccc
Q 002887 488 LSV 490 (870)
Q Consensus 488 ~~~ 490 (870)
++.
T Consensus 143 L~~ 145 (361)
T 2xot_A 143 LSQ 145 (361)
T ss_dssp CCS
T ss_pred CCC
Confidence 663
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.5e-07 Score=113.16 Aligned_cols=97 Identities=22% Similarity=0.241 Sum_probs=75.2
Q ss_pred CccceecCCCC------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCc
Q 002887 395 MWQGINCSYDA------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNN 468 (870)
Q Consensus 395 ~W~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~ 468 (870)
.++-|.|+..+ ..+.+++.|+|++|++++..+..|+++++|++|+|++|++++..|..+++|++|+.|+|++|+
T Consensus 5 ~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 84 (680)
T 1ziw_A 5 SHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84 (680)
T ss_dssp BSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSC
T ss_pred ECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCc
Confidence 56778887532 234678899999999987777778888888888888888888888888888888888888888
Q ss_pred CCCCCCCcccccccCCccccccC
Q 002887 469 LQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 469 l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
+++..+..++.+++|+.|+++.+
T Consensus 85 l~~l~~~~~~~l~~L~~L~L~~n 107 (680)
T 1ziw_A 85 LSQLSDKTFAFCTNLTELHLMSN 107 (680)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSS
T ss_pred cCccChhhhccCCCCCEEECCCC
Confidence 88544446777777777777644
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.1e-07 Score=112.79 Aligned_cols=81 Identities=22% Similarity=0.223 Sum_probs=42.8
Q ss_pred CcEEEEEcCCCCCccc-CcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 409 PRIISINLSSSGIAGD-IVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~-ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
++++.|+|++|.+++. +|..++++++|+.|+|++|++++.+|..++++++|+.|+|++|++++.+|..+..+++++.|+
T Consensus 448 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 527 (606)
T 3vq2_A 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLD 527 (606)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEE
Confidence 3455555555555552 444455555555555555555555555555555555555555555555555555555555544
Q ss_pred cc
Q 002887 488 LS 489 (870)
Q Consensus 488 ~~ 489 (870)
++
T Consensus 528 l~ 529 (606)
T 3vq2_A 528 CS 529 (606)
T ss_dssp CT
T ss_pred CC
Confidence 44
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.43 E-value=1.3e-07 Score=111.02 Aligned_cols=89 Identities=20% Similarity=0.241 Sum_probs=61.7
Q ss_pred CCcEEEEEcCCCCCc-ccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcc
Q 002887 408 SPRIISINLSSSGIA-GDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSL 486 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~-G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l 486 (870)
.++++.|+|++|.++ |.+|..+..+++|+.|+|++|++++..|..++++++|+.|+|++|++++.+|..+..+++++.|
T Consensus 444 l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 523 (570)
T 2z63_A 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKI 523 (570)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred CCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEE
Confidence 346677777777776 5677777777777777777777777667777777777777777777776666667777777666
Q ss_pred ccccCCCCCCCC
Q 002887 487 SLSVDGNRNLCP 498 (870)
Q Consensus 487 ~~~~~~n~~lc~ 498 (870)
+++ +|+..|.
T Consensus 524 ~l~--~N~~~~~ 533 (570)
T 2z63_A 524 WLH--TNPWDCS 533 (570)
T ss_dssp ECC--SSCBCCC
T ss_pred Eec--CCcccCC
Confidence 655 5555443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=98.43 E-value=8.2e-08 Score=94.89 Aligned_cols=78 Identities=19% Similarity=0.127 Sum_probs=54.2
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCC--cccccccCCcc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPS--GLSEKVKNGSL 486 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~--~l~~~~~~~~l 486 (870)
+.++.|+|++|+|++. +.|++|++|++|+|++|+|++..|..++.+++|+.|+|++|+++ .+|. .+..++++..|
T Consensus 42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 118 (176)
T ss_dssp TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence 3677777777777754 56777777777777777777543343477777777777777774 5665 66677777766
Q ss_pred ccc
Q 002887 487 SLS 489 (870)
Q Consensus 487 ~~~ 489 (870)
+++
T Consensus 119 ~l~ 121 (176)
T 1a9n_A 119 CIL 121 (176)
T ss_dssp ECC
T ss_pred Eec
Confidence 665
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.41 E-value=1.8e-07 Score=110.03 Aligned_cols=92 Identities=25% Similarity=0.267 Sum_probs=78.9
Q ss_pred cceecCCCC------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCC
Q 002887 397 QGINCSYDA------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQ 470 (870)
Q Consensus 397 ~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~ 470 (870)
.-++|++.. ..++.++.|+|++|+|++..|..|+++++|++|+|++|++++..|..|+++++|++|||++|+|+
T Consensus 34 ~~l~ls~~~L~~ip~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 113 (562)
T 3a79_B 34 SMVDYSNRNLTHVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ 113 (562)
T ss_dssp CEEECTTSCCCSCCTTSCTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred cEEEcCCCCCccCCCCCCCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC
Confidence 567887532 23468999999999999888889999999999999999999888999999999999999999998
Q ss_pred CCCCCcccccccCCccccccC
Q 002887 471 GSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 471 g~ip~~l~~~~~~~~l~~~~~ 491 (870)
.+|.. .+++|+.|+++.+
T Consensus 114 -~lp~~--~l~~L~~L~Ls~N 131 (562)
T 3a79_B 114 -NISCC--PMASLRHLDLSFN 131 (562)
T ss_dssp -EECSC--CCTTCSEEECCSS
T ss_pred -ccCcc--ccccCCEEECCCC
Confidence 78877 7888888888744
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=2.7e-07 Score=97.94 Aligned_cols=81 Identities=22% Similarity=0.251 Sum_probs=59.3
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCC-CCCCcccccccCCccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQG-SLPSGLSEKVKNGSLS 487 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g-~ip~~l~~~~~~~~l~ 487 (870)
++++.|+|++|.|++..|..|.++++|++|+|++|++++..+..++++++|+.|+|++|++++ .+|..+..+++++.|+
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~ 155 (276)
T 2z62_A 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD 155 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEE
T ss_pred cCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEE
Confidence 467777777777776666677777777777777777776666567777777777777777775 3677777777777776
Q ss_pred cc
Q 002887 488 LS 489 (870)
Q Consensus 488 ~~ 489 (870)
++
T Consensus 156 Ls 157 (276)
T 2z62_A 156 LS 157 (276)
T ss_dssp CC
T ss_pred CC
Confidence 65
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.41 E-value=1.6e-07 Score=116.15 Aligned_cols=82 Identities=18% Similarity=0.124 Sum_probs=43.1
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCC-CccccCcCCCCeEEecCCcCCCCCCCcccccccCCcc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPV-PEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSL 486 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~i-P~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l 486 (870)
+++++.|+|++|.|++..|..|++|++|++|+|++|.+.+.| |..|++|++|++|+|++|++++..|..+..+++|+.|
T Consensus 23 p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 102 (844)
T 3j0a_A 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFEL 102 (844)
T ss_dssp CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCE
T ss_pred CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEe
Confidence 345666666666666555555555555555555555444444 3444555555555555555554445555555544444
Q ss_pred ccc
Q 002887 487 SLS 489 (870)
Q Consensus 487 ~~~ 489 (870)
+++
T Consensus 103 ~Ls 105 (844)
T 3j0a_A 103 RLY 105 (844)
T ss_dssp ECT
T ss_pred eCc
Confidence 444
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=98.40 E-value=3e-07 Score=98.69 Aligned_cols=82 Identities=22% Similarity=0.226 Sum_probs=62.3
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.++++.|+|++|+|++..|..|.+|++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+..+++|+.|+
T Consensus 99 l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~ 178 (290)
T 1p9a_G 99 LPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178 (290)
T ss_dssp CTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEE
Confidence 35678888888888866666788888888888888888866666677888888888888888844444556677777777
Q ss_pred cc
Q 002887 488 LS 489 (870)
Q Consensus 488 ~~ 489 (870)
++
T Consensus 179 L~ 180 (290)
T 1p9a_G 179 LQ 180 (290)
T ss_dssp CC
T ss_pred CC
Confidence 76
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.39 E-value=1.8e-07 Score=100.83 Aligned_cols=84 Identities=21% Similarity=0.196 Sum_probs=73.8
Q ss_pred CCcEEEEEcCCCCCcc-cCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcc
Q 002887 408 SPRIISINLSSSGIAG-DIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSL 486 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G-~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l 486 (870)
.+.++.|+|++|.+++ .+|..+.++++|++|+|++|++++..|..+.++++|+.|+|++|++++..+..+..+++++.|
T Consensus 149 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 228 (306)
T 2z66_A 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 228 (306)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEE
T ss_pred CcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEe
Confidence 4578999999999988 678889999999999999999998888899999999999999999997777788888899988
Q ss_pred ccccC
Q 002887 487 SLSVD 491 (870)
Q Consensus 487 ~~~~~ 491 (870)
+++.+
T Consensus 229 ~L~~N 233 (306)
T 2z66_A 229 DYSLN 233 (306)
T ss_dssp ECTTS
T ss_pred ECCCC
Confidence 88744
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=1.1e-07 Score=112.71 Aligned_cols=86 Identities=29% Similarity=0.308 Sum_probs=51.6
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
++++.|+|++|++++..|..|+++++|+.|+|++|++++.+|..+.++++| .|+|++|++++.+|..+..+++++.|++
T Consensus 476 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l 554 (606)
T 3t6q_A 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINL 554 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEEC
T ss_pred CCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeC
Confidence 455566666666665556666666666666666666666666666666666 6666666666555555555555555544
Q ss_pred ccCCCCCCC
Q 002887 489 SVDGNRNLC 497 (870)
Q Consensus 489 ~~~~n~~lc 497 (870)
+ +|+..|
T Consensus 555 ~--~N~~~c 561 (606)
T 3t6q_A 555 R--QNPLDC 561 (606)
T ss_dssp T--TCCEEC
T ss_pred C--CCCccc
Confidence 4 555544
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.37 E-value=9.8e-08 Score=96.21 Aligned_cols=82 Identities=21% Similarity=0.235 Sum_probs=71.5
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.+.++.|+|++|.++ .++.+.++++|++|+|++|++++..|..++.|++|+.|+|++|++++..|..++.+++|+.|+
T Consensus 65 l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~ 142 (197)
T 4ezg_A 65 AHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142 (197)
T ss_dssp CTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred CCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence 357899999999664 445899999999999999999988888999999999999999999988888899999999888
Q ss_pred cccC
Q 002887 488 LSVD 491 (870)
Q Consensus 488 ~~~~ 491 (870)
++.+
T Consensus 143 L~~n 146 (197)
T 4ezg_A 143 LSYN 146 (197)
T ss_dssp CCSC
T ss_pred ccCC
Confidence 8744
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.37 E-value=2.6e-07 Score=99.99 Aligned_cols=81 Identities=20% Similarity=0.109 Sum_probs=59.3
Q ss_pred cEEEEEcCCCCCcccCcccc--cccCcccccccccCcCCCCCC----ccccCcCCCCeEEecCCcCCCCCCCcccccccC
Q 002887 410 RIISINLSSSGIAGDIVPYI--FSLTSIESLDLSKNSLTGPVP----EFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKN 483 (870)
Q Consensus 410 ~l~~l~L~~n~l~G~ip~~~--~~l~~L~~L~Ls~N~l~g~iP----~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~ 483 (870)
+++.|+|++|+++|.+|..+ +++++|++|+|++|++++.+| ..+..+++|+.|+|++|++++..|..+..+++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 47777777777777777777 777777777777777777666 334567777777777777777777777777777
Q ss_pred Ccccccc
Q 002887 484 GSLSLSV 490 (870)
Q Consensus 484 ~~l~~~~ 490 (870)
+.|+++.
T Consensus 172 ~~L~Ls~ 178 (310)
T 4glp_A 172 TSLDLSD 178 (310)
T ss_dssp CEEECCS
T ss_pred CEEECCC
Confidence 7777763
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.36 E-value=1.9e-07 Score=103.11 Aligned_cols=97 Identities=14% Similarity=0.140 Sum_probs=81.6
Q ss_pred CCccceecCCCC------CCCCcEEEEEcCCCCCcccCcc-cccccCcccccccccCcCCCCCCc-cccCcCCCCe-EEe
Q 002887 394 YMWQGINCSYDA------NQSPRIISINLSSSGIAGDIVP-YIFSLTSIESLDLSKNSLTGPVPE-FLAELQSLRV-LNL 464 (870)
Q Consensus 394 ~~W~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~-~~~~l~~L~~L~Ls~N~l~g~iP~-~~~~l~~L~~-L~l 464 (870)
|.|..|.|++.+ ..+..++.|+|++|+|+ .||+ .|.+|++|++|+|++|++.+.||. .|.+|++|+. +++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 689999998632 23457899999999999 6665 689999999999999999988885 5788988775 777
Q ss_pred cCCcCCCCCCCcccccccCCccccccC
Q 002887 465 SGNNLQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 465 s~N~l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
++|+|++..|..+..+++|+.|+++.+
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n 114 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNT 114 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEE
T ss_pred cCCcccccCchhhhhcccccccccccc
Confidence 889999877888999999999988754
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=3e-07 Score=100.36 Aligned_cols=81 Identities=26% Similarity=0.324 Sum_probs=72.3
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
+.++.|+|++|.+++..|..|.++++|+.|+|++|++++..|..+..+++|+.|+|++|+++ .+|..+..+++++.|++
T Consensus 192 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 270 (330)
T 1xku_A 192 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270 (330)
T ss_dssp TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEEC
Confidence 57889999999999888888999999999999999999888888899999999999999998 88988988888888887
Q ss_pred cc
Q 002887 489 SV 490 (870)
Q Consensus 489 ~~ 490 (870)
+.
T Consensus 271 ~~ 272 (330)
T 1xku_A 271 HN 272 (330)
T ss_dssp CS
T ss_pred CC
Confidence 73
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.34 E-value=3e-07 Score=105.73 Aligned_cols=89 Identities=26% Similarity=0.226 Sum_probs=75.6
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.+.++.|+|++|.|++..+..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..+..+++|+.|+
T Consensus 247 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 326 (477)
T 2id5_A 247 LVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLI 326 (477)
T ss_dssp CTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEE
T ss_pred ccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEE
Confidence 35788999999999987777899999999999999999988899999999999999999999976666778888888777
Q ss_pred cccCCCCCCCC
Q 002887 488 LSVDGNRNLCP 498 (870)
Q Consensus 488 ~~~~~n~~lc~ 498 (870)
++ +|+..|.
T Consensus 327 l~--~N~l~c~ 335 (477)
T 2id5_A 327 LD--SNPLACD 335 (477)
T ss_dssp CC--SSCEECS
T ss_pred cc--CCCccCc
Confidence 65 7776664
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.33 E-value=3.5e-07 Score=107.39 Aligned_cols=85 Identities=20% Similarity=0.131 Sum_probs=68.6
Q ss_pred CCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcc
Q 002887 407 QSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSL 486 (870)
Q Consensus 407 ~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l 486 (870)
.+..++.|+|++|++++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..+..+.+|+.|
T Consensus 26 l~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (570)
T 2z63_A 26 LPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKL 105 (570)
T ss_dssp SCSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEE
T ss_pred ccccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccc
Confidence 34578888888888887777788888888888888888887777778888888888888888887777788888888877
Q ss_pred ccccC
Q 002887 487 SLSVD 491 (870)
Q Consensus 487 ~~~~~ 491 (870)
+++.+
T Consensus 106 ~L~~n 110 (570)
T 2z63_A 106 VAVET 110 (570)
T ss_dssp ECTTS
T ss_pred ccccc
Confidence 77644
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.32 E-value=3.1e-07 Score=100.36 Aligned_cols=81 Identities=21% Similarity=0.258 Sum_probs=70.9
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
+.++.|+|++|.+++..|..+.++++|+.|+|++|++++..|..++.+++|+.|+|++|+++ .+|..+..+++++.|++
T Consensus 193 ~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 271 (332)
T 2ft3_A 193 ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYL 271 (332)
T ss_dssp SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEEC
T ss_pred CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEEC
Confidence 47888999999999888888999999999999999999887878889999999999999998 88888888888888887
Q ss_pred cc
Q 002887 489 SV 490 (870)
Q Consensus 489 ~~ 490 (870)
+.
T Consensus 272 ~~ 273 (332)
T 2ft3_A 272 HT 273 (332)
T ss_dssp CS
T ss_pred CC
Confidence 73
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.32 E-value=5e-07 Score=107.20 Aligned_cols=84 Identities=18% Similarity=0.162 Sum_probs=67.4
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.+.++.|+|++|.|++..|..|++|++|++|+|++|.|++..|..|+++++|+.|+|++|+|++..|..++.+++|..|+
T Consensus 98 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 177 (597)
T 3oja_B 98 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ 177 (597)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEE
Confidence 45788888888888887777788888888888888888854445568888888888888888888888888888888887
Q ss_pred cccC
Q 002887 488 LSVD 491 (870)
Q Consensus 488 ~~~~ 491 (870)
++.+
T Consensus 178 L~~N 181 (597)
T 3oja_B 178 LSSN 181 (597)
T ss_dssp CTTS
T ss_pred CcCC
Confidence 7643
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=3.2e-07 Score=107.29 Aligned_cols=84 Identities=30% Similarity=0.320 Sum_probs=63.2
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCC-CCCCcccccccCCcc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQG-SLPSGLSEKVKNGSL 486 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g-~ip~~l~~~~~~~~l 486 (870)
.++++.|+|++|++++..|..|++|++|++|+|++|++++..|..|+++++|++|+|++|++++ .+|..+..+++++.|
T Consensus 49 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L 128 (549)
T 2z81_A 49 CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128 (549)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence 3567778888888887777778888888888888888887666667778888888888888776 466777777777777
Q ss_pred ccccC
Q 002887 487 SLSVD 491 (870)
Q Consensus 487 ~~~~~ 491 (870)
+++.+
T Consensus 129 ~L~~n 133 (549)
T 2z81_A 129 RIGNV 133 (549)
T ss_dssp EEEES
T ss_pred ECCCC
Confidence 77643
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.31 E-value=1.3e-07 Score=102.63 Aligned_cols=81 Identities=22% Similarity=0.228 Sum_probs=70.4
Q ss_pred CCcEEEEEcCCCCCcccCccccccc-----CcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCC--CCCcc--c
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSL-----TSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGS--LPSGL--S 478 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l-----~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~--ip~~l--~ 478 (870)
.++++.|+|++|+|++. |..++++ ++|++|+|++|++++..|..|+.+++|+.|+|++|+++|. +|..+ .
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 46899999999999987 8888888 9999999999999988889999999999999999999876 34455 7
Q ss_pred ccccCCccccc
Q 002887 479 EKVKNGSLSLS 489 (870)
Q Consensus 479 ~~~~~~~l~~~ 489 (870)
.+++++.|+++
T Consensus 199 ~l~~L~~L~L~ 209 (312)
T 1wwl_A 199 KFPTLQVLALR 209 (312)
T ss_dssp SCTTCCEEECT
T ss_pred cCCCCCEEECC
Confidence 78888888876
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.31 E-value=2.3e-07 Score=107.90 Aligned_cols=78 Identities=22% Similarity=0.183 Sum_probs=41.9
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCC-CCCCcccccccCCccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQG-SLPSGLSEKVKNGSLS 487 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g-~ip~~l~~~~~~~~l~ 487 (870)
++++.|+|++|+|++..|..|++|++|++|+|++|+|+ .||.. .+++|++|+|++|++++ .+|..++.+++|+.|+
T Consensus 45 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~ 121 (520)
T 2z7x_B 45 SKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121 (520)
T ss_dssp TTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEE
T ss_pred ccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEE
Confidence 34555555555555544555555555555555555555 34544 45555555555555554 3555555555555555
Q ss_pred cc
Q 002887 488 LS 489 (870)
Q Consensus 488 ~~ 489 (870)
++
T Consensus 122 L~ 123 (520)
T 2z7x_B 122 LS 123 (520)
T ss_dssp EE
T ss_pred ec
Confidence 54
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.30 E-value=3.4e-07 Score=106.42 Aligned_cols=78 Identities=26% Similarity=0.221 Sum_probs=43.3
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
++++.|+|++|++++..|..|.+|++|++|+|++|++++..|..|++|++|++|||++|+++ .||.. .+++|+.|++
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 35555555555555555555555555555555555555555555555555555555555555 45544 4555555555
Q ss_pred c
Q 002887 489 S 489 (870)
Q Consensus 489 ~ 489 (870)
+
T Consensus 98 ~ 98 (520)
T 2z7x_B 98 S 98 (520)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.28 E-value=4e-07 Score=105.29 Aligned_cols=85 Identities=21% Similarity=0.194 Sum_probs=73.0
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.+.++.|+|++|.|+|. +.+..+++|+.|+|++|+|+| +|..++.+++|+.|+|++|+|++ +|..+..++++..|+
T Consensus 168 l~~L~~L~Ls~N~l~~~--~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~ 243 (487)
T 3oja_A 168 SDTLEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFD 243 (487)
T ss_dssp TTTCCEEECTTSCCCEE--ECCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEE
T ss_pred CCcccEEecCCCccccc--cccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEE
Confidence 46899999999999976 345579999999999999997 55559999999999999999995 898899999988877
Q ss_pred cccCCCCCCCC
Q 002887 488 LSVDGNRNLCP 498 (870)
Q Consensus 488 ~~~~~n~~lc~ 498 (870)
++ +|+..|+
T Consensus 244 l~--~N~l~c~ 252 (487)
T 3oja_A 244 LR--GNGFHCG 252 (487)
T ss_dssp CT--TCCBCHH
T ss_pred cC--CCCCcCc
Confidence 75 7777664
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=98.28 E-value=3.5e-07 Score=90.31 Aligned_cols=79 Identities=22% Similarity=0.189 Sum_probs=69.5
Q ss_pred CCcEEEEEcCCCCCcccCccc-ccccCcccccccccCcCCCCCCc--cccCcCCCCeEEecCCcCCCCCCCc----cccc
Q 002887 408 SPRIISINLSSSGIAGDIVPY-IFSLTSIESLDLSKNSLTGPVPE--FLAELQSLRVLNLSGNNLQGSLPSG----LSEK 480 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~-~~~l~~L~~L~Ls~N~l~g~iP~--~~~~l~~L~~L~ls~N~l~g~ip~~----l~~~ 480 (870)
.++++.|+|++|.|++ +|+. ++.+++|++|+|++|+|+ .+|. .+..+++|+.|+|++|.++ .+|.. +..+
T Consensus 63 l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l 139 (176)
T 1a9n_A 63 LRRLKTLLVNNNRICR-IGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKV 139 (176)
T ss_dssp CSSCCEEECCSSCCCE-ECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHC
T ss_pred CCCCCEEECCCCcccc-cCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHC
Confidence 4689999999999995 5555 599999999999999995 7887 8999999999999999998 67775 8889
Q ss_pred ccCCccccc
Q 002887 481 VKNGSLSLS 489 (870)
Q Consensus 481 ~~~~~l~~~ 489 (870)
++++.|+++
T Consensus 140 ~~L~~Ld~~ 148 (176)
T 1a9n_A 140 PQVRVLDFQ 148 (176)
T ss_dssp TTCSEETTE
T ss_pred CccceeCCC
Confidence 999988876
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.27 E-value=3.1e-07 Score=107.90 Aligned_cols=88 Identities=19% Similarity=0.296 Sum_probs=59.7
Q ss_pred CCCCCCCCCCccce-ecCCCCCCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEe
Q 002887 386 GDPCAPKVYMWQGI-NCSYDANQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNL 464 (870)
Q Consensus 386 ~~pC~~~~~~W~Gv-~C~~~~~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~l 464 (870)
++||.-....|.|+ .|.. .+++.|+|++|+|+| ||..+. ++|++|+|++|+|+ .|| +.+++|+.|+|
T Consensus 40 ~~~~~~~~~~~~~l~~C~~-----~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~L 107 (571)
T 3cvr_A 40 ALPGENRNEAVSLLKECLI-----NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDA 107 (571)
T ss_dssp CCTTCCHHHHHHHHHHHHH-----TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEEC
T ss_pred CCccccccchhhhcccccc-----CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEc
Confidence 56774322369998 6753 267778888888876 777663 67777777777777 677 34677777777
Q ss_pred cCCcCCCCCCCcccccccCCccccc
Q 002887 465 SGNNLQGSLPSGLSEKVKNGSLSLS 489 (870)
Q Consensus 465 s~N~l~g~ip~~l~~~~~~~~l~~~ 489 (870)
++|+|++ ||. +.. +|..|+++
T Consensus 108 s~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 108 CDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp CSSCCSC-CCC-CCT--TCCEEECC
T ss_pred cCCCCCC-cch-hhc--CCCEEECC
Confidence 7777776 666 544 55666655
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.26 E-value=9.6e-07 Score=109.13 Aligned_cols=80 Identities=21% Similarity=0.145 Sum_probs=39.8
Q ss_pred cEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCcc--ccCcCCCCeEEecCCcCCCCCC-CcccccccCCcc
Q 002887 410 RIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEF--LAELQSLRVLNLSGNNLQGSLP-SGLSEKVKNGSL 486 (870)
Q Consensus 410 ~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~--~~~l~~L~~L~ls~N~l~g~ip-~~l~~~~~~~~l 486 (870)
+++.|+|++|+|++..|..|++|++|++|+|++|++++.+|.. +++|++|+.|||++|++++..| ..++++++|+.|
T Consensus 74 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L 153 (844)
T 3j0a_A 74 NLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSI 153 (844)
T ss_dssp TCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEE
T ss_pred CCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEE
Confidence 4555555555555544555555555555555555555544433 4555555555555555544433 244445555444
Q ss_pred ccc
Q 002887 487 SLS 489 (870)
Q Consensus 487 ~~~ 489 (870)
+++
T Consensus 154 ~Ls 156 (844)
T 3j0a_A 154 DFS 156 (844)
T ss_dssp EEE
T ss_pred ECC
Confidence 443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.24 E-value=1.1e-06 Score=98.19 Aligned_cols=82 Identities=20% Similarity=0.195 Sum_probs=66.0
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCcc-ccCcCCCCeEEecCCcCCCCCCCcccccccCCcc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEF-LAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSL 486 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~-~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l 486 (870)
.+.++.|+|++|++++..|..|+++++|++|+|++|+++ .+|.. |+++++|+.|+|++|++++..|..+..+++++.|
T Consensus 92 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 170 (390)
T 3o6n_A 92 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNL 170 (390)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEE
T ss_pred CCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEE
Confidence 457888888888888777777888888888888888888 45544 5888888888888888887777778888888888
Q ss_pred cccc
Q 002887 487 SLSV 490 (870)
Q Consensus 487 ~~~~ 490 (870)
+++.
T Consensus 171 ~l~~ 174 (390)
T 3o6n_A 171 QLSS 174 (390)
T ss_dssp ECCS
T ss_pred ECCC
Confidence 7763
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.22 E-value=1e-06 Score=95.37 Aligned_cols=76 Identities=32% Similarity=0.416 Sum_probs=43.1
Q ss_pred CcEEEEEcCCCCCcccCccccccc---CcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSL---TSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGS 485 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l---~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~ 485 (870)
+.++.|+|++|.|++.+|+.++.+ ++|++|+|++|+|+ .||..+. ++|+.|||++|+|+|. |. +..+++++.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~ 298 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDN 298 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence 355566666666666656655555 46666666666666 5565553 5666666666666642 22 344455555
Q ss_pred cccc
Q 002887 486 LSLS 489 (870)
Q Consensus 486 l~~~ 489 (870)
|+++
T Consensus 299 L~L~ 302 (310)
T 4glp_A 299 LTLD 302 (310)
T ss_dssp EECS
T ss_pred EECc
Confidence 5444
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.22 E-value=7.6e-07 Score=104.67 Aligned_cols=80 Identities=25% Similarity=0.224 Sum_probs=66.4
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCC-CCCCcccccccCCcc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQG-SLPSGLSEKVKNGSL 486 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g-~ip~~l~~~~~~~~l 486 (870)
.++++.|+|++|+|++..|..|++|++|++|+|++|+|+ .||.. .+++|+.|+|++|++++ ++|..++.+++|+.|
T Consensus 75 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L 151 (562)
T 3a79_B 75 LSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFL 151 (562)
T ss_dssp CTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEE
T ss_pred CCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEE
Confidence 457888888888888877888888888888888888888 68876 78888888888888887 567888888888888
Q ss_pred cccc
Q 002887 487 SLSV 490 (870)
Q Consensus 487 ~~~~ 490 (870)
+++.
T Consensus 152 ~L~~ 155 (562)
T 3a79_B 152 GLSA 155 (562)
T ss_dssp EEEC
T ss_pred ecCC
Confidence 8774
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.22 E-value=1.1e-06 Score=98.25 Aligned_cols=79 Identities=27% Similarity=0.288 Sum_probs=42.0
Q ss_pred cEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCc-ccccccCCcccc
Q 002887 410 RIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSG-LSEKVKNGSLSL 488 (870)
Q Consensus 410 ~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~-l~~~~~~~~l~~ 488 (870)
+++.|+|++|++++..+..|+++++|++|+|++|++++..|..|+++++|+.|+|++|+++ .+|.. +..+++|+.|++
T Consensus 70 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 70 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEEC
T ss_pred cCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEEC
Confidence 4455555555555444445555555555555555555555555555555555555555555 33333 345555555555
Q ss_pred c
Q 002887 489 S 489 (870)
Q Consensus 489 ~ 489 (870)
+
T Consensus 149 ~ 149 (390)
T 3o6n_A 149 S 149 (390)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.20 E-value=5.6e-07 Score=95.01 Aligned_cols=78 Identities=26% Similarity=0.314 Sum_probs=66.0
Q ss_pred CCcEEEEEcCCCCCcc--cCcccccccCcccccccccCcCCCCCCccccCcC--CCCeEEecCCcCCCCCCC-------c
Q 002887 408 SPRIISINLSSSGIAG--DIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQ--SLRVLNLSGNNLQGSLPS-------G 476 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G--~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~--~L~~L~ls~N~l~g~ip~-------~ 476 (870)
.+.|+.|+|++|+|++ .+|..+..|++|+.|+|++|+|++. ..+..++ +|+.|+|++|.+++.+|. .
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~i 246 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAI 246 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHH
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHH
Confidence 4689999999999998 7888899999999999999999975 4456666 999999999999998884 2
Q ss_pred ccccccCCccc
Q 002887 477 LSEKVKNGSLS 487 (870)
Q Consensus 477 l~~~~~~~~l~ 487 (870)
+..+++|..|+
T Consensus 247 l~~~P~L~~LD 257 (267)
T 3rw6_A 247 RERFPKLLRLD 257 (267)
T ss_dssp HHHCTTCCEES
T ss_pred HHHCcccCeEC
Confidence 56677777664
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.19 E-value=1e-06 Score=97.18 Aligned_cols=83 Identities=31% Similarity=0.297 Sum_probs=71.3
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCC--cccccccCCc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPS--GLSEKVKNGS 485 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~--~l~~~~~~~~ 485 (870)
.++++.|+|++|++++..|..|+++++|++|+|++|++++..+..++++++|+.|+|++|+++ .+|. .+..+++++.
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~ 153 (353)
T 2z80_A 75 CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQI 153 (353)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCE
T ss_pred CCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcE
Confidence 468999999999999888888999999999999999999644445899999999999999999 4665 7888999999
Q ss_pred cccccC
Q 002887 486 LSLSVD 491 (870)
Q Consensus 486 l~~~~~ 491 (870)
|+++.+
T Consensus 154 L~l~~n 159 (353)
T 2z80_A 154 LRVGNM 159 (353)
T ss_dssp EEEEES
T ss_pred EECCCC
Confidence 888744
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.19 E-value=6.7e-08 Score=97.52 Aligned_cols=76 Identities=22% Similarity=0.291 Sum_probs=48.4
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
+.++.|+|++|+|++ +| .+.++++|++|+|++|+++ .+|..+..+++|+.|+|++|++++ +| .+..+++++.|++
T Consensus 48 ~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l 122 (198)
T 1ds9_A 48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEE
T ss_pred CCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEEC
Confidence 356666666666665 55 6666666666666666666 566666666666666666666664 44 4566666666655
Q ss_pred c
Q 002887 489 S 489 (870)
Q Consensus 489 ~ 489 (870)
+
T Consensus 123 ~ 123 (198)
T 1ds9_A 123 S 123 (198)
T ss_dssp S
T ss_pred C
Confidence 5
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=1.5e-05 Score=86.21 Aligned_cols=135 Identities=20% Similarity=0.173 Sum_probs=93.3
Q ss_pred ccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhccc---cceeEEEEEe-cCCeEEEEEEEccCCc
Q 002887 567 RVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHK---NLTILVGYCD-EGANMGLIYEFMANGN 642 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~---nIv~l~g~~~-~~~~~~LV~Ey~~~gs 642 (870)
+.++.|....||+. +..+++|+-.. ......+.+|+++|..+.+. .+.+.+.++. ..+..++||||++|..
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE---CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 45788999999987 67788888432 23456789999999999753 2556666664 4456789999999988
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNG--------------------------------------------- 677 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~--------------------------------------------- 677 (870)
+..... ..++..++..++.++++.|+.||+.
T Consensus 100 l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 100 LGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp CHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred Cchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 765321 1223344444555555555555532
Q ss_pred ------------CCCCceeCCCCCCCEEEcC---CCc-EEEEeccCCcc
Q 002887 678 ------------CKPPIVHRDVKSANILLNE---KFQ-AKLADFGLSRI 710 (870)
Q Consensus 678 ------------~~~~IvHrDLKp~NILld~---~~~-vkL~DFGla~~ 710 (870)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2335799999999999998 455 48999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=7.9e-06 Score=90.04 Aligned_cols=79 Identities=5% Similarity=-0.003 Sum_probs=57.3
Q ss_pred ccc-cccCcEEEEEEEEC--------CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhcc---ccceeEEEEEecC---
Q 002887 567 RVL-GKGGFGTVYHGYLD--------DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHH---KNLTILVGYCDEG--- 628 (870)
Q Consensus 567 ~~L-G~G~fG~Vy~~~~~--------~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H---~nIv~l~g~~~~~--- 628 (870)
+.| +.|....+|+.... ++.+++|+..... ......+.+|+.+++.+.. -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 88999999998765 6778888865432 1123567899999998853 2466788887665
Q ss_pred CeEEEEEEEccCCchhh
Q 002887 629 ANMGLIYEFMANGNLQA 645 (870)
Q Consensus 629 ~~~~LV~Ey~~~gsL~~ 645 (870)
...++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877653
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.15 E-value=1.1e-06 Score=91.28 Aligned_cols=80 Identities=21% Similarity=0.318 Sum_probs=58.5
Q ss_pred CCcEEEEEcCCCC-CcccCcccccccCccccccccc-CcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCC-
Q 002887 408 SPRIISINLSSSG-IAGDIVPYIFSLTSIESLDLSK-NSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNG- 484 (870)
Q Consensus 408 ~~~l~~l~L~~n~-l~G~ip~~~~~l~~L~~L~Ls~-N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~- 484 (870)
.++++.|+|++|. +++..+..|.++++|++|+|++ |+|++..|..|.++++|+.|+|++|++++ +|. +..+.++.
T Consensus 54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDI 131 (239)
T ss_dssp CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccc
Confidence 3577888888886 6644444678888888888887 88886556677788888888888888875 676 66666666
Q ss_pred --ccccc
Q 002887 485 --SLSLS 489 (870)
Q Consensus 485 --~l~~~ 489 (870)
.|+++
T Consensus 132 L~~L~l~ 138 (239)
T 2xwt_C 132 FFILEIT 138 (239)
T ss_dssp EEEEEEE
T ss_pred ccEEECC
Confidence 66665
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=2e-06 Score=103.46 Aligned_cols=81 Identities=25% Similarity=0.246 Sum_probs=49.7
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCccc--ccccCCcc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLS--EKVKNGSL 486 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~--~~~~~~~l 486 (870)
.+++.|+|++|++++..|..|++|++|++|+|++|++++..|..++++++|+.|+|++|++++..|..+. .+++++.|
T Consensus 97 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L 176 (680)
T 1ziw_A 97 TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKL 176 (680)
T ss_dssp TTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEE
T ss_pred CCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEE
Confidence 4566666666666655555566666666666666666666666666666666666666666655554433 23555555
Q ss_pred ccc
Q 002887 487 SLS 489 (870)
Q Consensus 487 ~~~ 489 (870)
+++
T Consensus 177 ~L~ 179 (680)
T 1ziw_A 177 ELS 179 (680)
T ss_dssp ECT
T ss_pred ECC
Confidence 554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.13 E-value=7.7e-08 Score=97.04 Aligned_cols=79 Identities=20% Similarity=0.300 Sum_probs=59.0
Q ss_pred cEEEEEcCCCCCcccCcc------cccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccC
Q 002887 410 RIISINLSSSGIAGDIVP------YIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKN 483 (870)
Q Consensus 410 ~l~~l~L~~n~l~G~ip~------~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~ 483 (870)
.++.++|+.+.|+|.+|. .++++++|++|+|++|++++ +| .+..+++|+.|+|++|+++ .+|..+..++++
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 455566666677777666 78888888888888888876 77 6778888888888888887 677777777777
Q ss_pred CccccccC
Q 002887 484 GSLSLSVD 491 (870)
Q Consensus 484 ~~l~~~~~ 491 (870)
+.|+++.+
T Consensus 96 ~~L~L~~N 103 (198)
T 1ds9_A 96 EELWISYN 103 (198)
T ss_dssp SEEEEEEE
T ss_pred CEEECcCC
Confidence 77777644
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=1.3e-05 Score=84.44 Aligned_cols=134 Identities=19% Similarity=0.114 Sum_probs=95.2
Q ss_pred cccccCcE-EEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhc-cccceeEEEEEecCCeEEEEEEEccCCch
Q 002887 568 VLGKGGFG-TVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAH-HKNLTILVGYCDEGANMGLIYEFMANGNL 643 (870)
Q Consensus 568 ~LG~G~fG-~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 643 (870)
.+..|..| .||+.... +..+.+|+-... ....+.+|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445554 68987654 567889986543 3456788999999884 33466788999888999999999999887
Q ss_pred hhhhhhcccccccHHHHHHHHHHHHHHHHHHHhC----------------------------------------------
Q 002887 644 QAHLLEDKADTLCWERRLQIASESAQGLEYLHNG---------------------------------------------- 677 (870)
Q Consensus 644 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~---------------------------------------------- 677 (870)
.+...... .....++.++++.|..||+.
T Consensus 108 ~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 108 FQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 66543211 12234556666666666642
Q ss_pred ---------CCCCceeCCCCCCCEEEcCCCcEEEEeccCCcc
Q 002887 678 ---------CKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 678 ---------~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~ 710 (870)
..+.++|+|+++.|||+++++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012378999999999999887778999998754
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.11 E-value=1.2e-06 Score=95.00 Aligned_cols=82 Identities=20% Similarity=0.156 Sum_probs=46.5
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
+.++.|+|++|.|++. | ....+++|+.|+|++|++++ +|..+..+++|+.|+|++|+|+ .+|..+..+++++.|++
T Consensus 169 ~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l 244 (317)
T 3o53_A 169 DTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDL 244 (317)
T ss_dssp TTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEEC
T ss_pred CcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEc
Confidence 3556666666666533 2 23346666666666666663 4444666666666666666666 45666666666665555
Q ss_pred ccCCCCCC
Q 002887 489 SVDGNRNL 496 (870)
Q Consensus 489 ~~~~n~~l 496 (870)
+ +|+..
T Consensus 245 ~--~N~~~ 250 (317)
T 3o53_A 245 R--GNGFH 250 (317)
T ss_dssp T--TCCCB
T ss_pred c--CCCcc
Confidence 4 44433
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.02 E-value=2.3e-06 Score=93.77 Aligned_cols=78 Identities=26% Similarity=0.304 Sum_probs=63.2
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.++++.|+|++|.+++. +.+..+++|+.|+|++|++++..|..++.+++|+.|+|++|++++..| +..+++++.|+
T Consensus 264 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 339 (347)
T 4fmz_A 264 LTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSAD 339 (347)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEES
T ss_pred CCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceee
Confidence 45788888888888864 458888888888888888888888888888888888888888887666 77778888777
Q ss_pred cc
Q 002887 488 LS 489 (870)
Q Consensus 488 ~~ 489 (870)
++
T Consensus 340 l~ 341 (347)
T 4fmz_A 340 FA 341 (347)
T ss_dssp SS
T ss_pred hh
Confidence 65
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.02 E-value=4.7e-06 Score=89.38 Aligned_cols=74 Identities=30% Similarity=0.383 Sum_probs=35.9
Q ss_pred cEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccccc
Q 002887 410 RIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLS 489 (870)
Q Consensus 410 ~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~ 489 (870)
.++.|+|++|++++. +.++++++|+.|+|++|++++..| +..+++|+.|+|++|++++ +| .+..+++|..|+++
T Consensus 135 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~ 208 (291)
T 1h6t_A 135 QLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (291)
T ss_dssp TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred CCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECc
Confidence 455555555555532 345555555555555555554322 4555555555555555543 33 24444444444443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.00 E-value=4.4e-06 Score=88.20 Aligned_cols=75 Identities=24% Similarity=0.393 Sum_probs=64.1
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
..++.|+|++|+|++ ++ .++++++|+.|+|++|++++ +| .++.+++|+.|+|++|++++. ..+..+++++.|++
T Consensus 106 ~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l 179 (263)
T 1xeu_A 106 ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDL 179 (263)
T ss_dssp SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEE
T ss_pred CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeC
Confidence 578899999999986 44 69999999999999999996 45 688999999999999999976 67888888888877
Q ss_pred c
Q 002887 489 S 489 (870)
Q Consensus 489 ~ 489 (870)
+
T Consensus 180 ~ 180 (263)
T 1xeu_A 180 T 180 (263)
T ss_dssp E
T ss_pred C
Confidence 6
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=97.98 E-value=4.3e-06 Score=89.67 Aligned_cols=78 Identities=31% Similarity=0.428 Sum_probs=68.4
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.+.++.|+|++|++++ + +.+.+|++|+.|+|++|++++. ..++.+++|+.|+|++|++++..| +..+++|+.|+
T Consensus 111 l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~ 184 (291)
T 1h6t_A 111 LKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 184 (291)
T ss_dssp CTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEE
Confidence 4689999999999996 3 5799999999999999999975 578999999999999999997655 88899999988
Q ss_pred cccC
Q 002887 488 LSVD 491 (870)
Q Consensus 488 ~~~~ 491 (870)
++.+
T Consensus 185 L~~N 188 (291)
T 1h6t_A 185 LSKN 188 (291)
T ss_dssp CCSS
T ss_pred CCCC
Confidence 8744
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=97.97 E-value=6.2e-06 Score=87.08 Aligned_cols=76 Identities=24% Similarity=0.279 Sum_probs=57.4
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.+.++.|+|++|+|++. |+ +++|++|+.|+|++|++++ +|... . ++|+.|+|++|++++ +| .+..+++|+.|+
T Consensus 62 l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L~~N~l~~-l~~~~-~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~ 134 (263)
T 1xeu_A 62 FTNLKELHLSHNQISDL-SP-LKDLTKLEELSVNRNRLKN-LNGIP-S-ACLSRLFLDNNELRD-TD-SLIHLKNLEILS 134 (263)
T ss_dssp CTTCCEEECCSSCCCCC-GG-GTTCSSCCEEECCSSCCSC-CTTCC-C-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCCC-hh-hccCCCCCEEECCCCccCC-cCccc-c-CcccEEEccCCccCC-Ch-hhcCcccccEEE
Confidence 35788888888888854 44 8888888888888888885 55533 3 888888888888886 33 577888888877
Q ss_pred ccc
Q 002887 488 LSV 490 (870)
Q Consensus 488 ~~~ 490 (870)
++.
T Consensus 135 Ls~ 137 (263)
T 1xeu_A 135 IRN 137 (263)
T ss_dssp CTT
T ss_pred CCC
Confidence 763
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=97.96 E-value=6.3e-06 Score=97.59 Aligned_cols=75 Identities=31% Similarity=0.412 Sum_probs=40.8
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
++|+.|+|++|.|++. +.|++|++|+.|+|++|+|++..| +..|++|+.|+|++|+|++ +| .+..+++|..|++
T Consensus 131 ~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~L 204 (605)
T 1m9s_A 131 PQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLEL 204 (605)
T ss_dssp TTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEC
T ss_pred CccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEc
Confidence 3455555555555543 445555555555555555555444 5555555555555555554 22 3555555555554
Q ss_pred c
Q 002887 489 S 489 (870)
Q Consensus 489 ~ 489 (870)
+
T Consensus 205 ~ 205 (605)
T 1m9s_A 205 F 205 (605)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=97.95 E-value=5.7e-06 Score=89.72 Aligned_cols=81 Identities=20% Similarity=0.193 Sum_probs=66.9
Q ss_pred CCcEEEEEcCCCCCcccCccccc-ccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIF-SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSL 486 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~-~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l 486 (870)
.+.++.|+|++|.+++..|..+. ++++|++|+|++|++++. |. ...+++|+.|+|++|++++ +|..+..+++++.|
T Consensus 143 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L 219 (317)
T 3o53_A 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWI 219 (317)
T ss_dssp GSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEE
T ss_pred cCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCc-chhhhcccCcccEE
Confidence 35899999999999988887774 789999999999999855 43 3468999999999999995 56668889999988
Q ss_pred ccccC
Q 002887 487 SLSVD 491 (870)
Q Consensus 487 ~~~~~ 491 (870)
+++.+
T Consensus 220 ~L~~N 224 (317)
T 3o53_A 220 SLRNN 224 (317)
T ss_dssp ECTTS
T ss_pred ECcCC
Confidence 88744
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=97.94 E-value=5e-06 Score=98.49 Aligned_cols=78 Identities=31% Similarity=0.428 Sum_probs=66.9
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.++|+.|+|++|.|++ + +.+.+|++|+.|+|++|+|++. ..|+.|++|+.|+|++|+|++.+| +..+++|..|+
T Consensus 108 l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 181 (605)
T 1m9s_A 108 LKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 181 (605)
T ss_dssp CTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred CCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEE
Confidence 4688999999999986 3 5699999999999999999975 568899999999999999997766 88889999888
Q ss_pred cccC
Q 002887 488 LSVD 491 (870)
Q Consensus 488 ~~~~ 491 (870)
++.+
T Consensus 182 Ls~N 185 (605)
T 1m9s_A 182 LSKN 185 (605)
T ss_dssp CCSS
T ss_pred CcCC
Confidence 8744
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=97.94 E-value=7.6e-06 Score=93.65 Aligned_cols=75 Identities=21% Similarity=0.219 Sum_probs=58.2
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.++++.|+|++|+|+| +| ++++++|++|+|++|+|++ +| ++++++|+.|+|++|+|++ +| ++.+++++.|+
T Consensus 63 l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~ 133 (457)
T 3bz5_A 63 LTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLN 133 (457)
T ss_dssp CTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEE
T ss_pred cCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEE
Confidence 3578888888888886 44 8888888888888888886 44 7888888888888888886 55 77778888777
Q ss_pred cccC
Q 002887 488 LSVD 491 (870)
Q Consensus 488 ~~~~ 491 (870)
++.+
T Consensus 134 l~~N 137 (457)
T 3bz5_A 134 CARN 137 (457)
T ss_dssp CTTS
T ss_pred CCCC
Confidence 7643
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=97.93 E-value=7.1e-06 Score=88.69 Aligned_cols=76 Identities=20% Similarity=0.286 Sum_probs=44.9
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.++++.|+|++|.+++.. + ++++++|+.|+|++|++++ +|. +..+++|+.|+|++|++++..| +..+++++.|+
T Consensus 128 l~~L~~L~l~~n~l~~~~-~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~ 201 (308)
T 1h6u_A 128 LSNLQVLYLDLNQITNIS-P-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVH 201 (308)
T ss_dssp CTTCCEEECCSSCCCCCG-G-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEE
T ss_pred CCCCCEEECCCCccCcCc-c-ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEE
Confidence 345666666666666432 2 6666666666666666664 333 5666666666666666664322 55566666655
Q ss_pred cc
Q 002887 488 LS 489 (870)
Q Consensus 488 ~~ 489 (870)
++
T Consensus 202 L~ 203 (308)
T 1h6u_A 202 LK 203 (308)
T ss_dssp CT
T ss_pred cc
Confidence 55
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=97.92 E-value=7.8e-06 Score=93.56 Aligned_cols=75 Identities=19% Similarity=0.242 Sum_probs=59.6
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.++++.|+|++|+|+|. | +++|++|++|+|++|+|++ +| ++.+++|+.|+|++|+|++ +| ++.+++++.|+
T Consensus 84 l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~ 154 (457)
T 3bz5_A 84 NTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELD 154 (457)
T ss_dssp CTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEE
T ss_pred CCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEE
Confidence 46788888888888873 3 8888888888888888886 55 7888888888888888887 43 77778888777
Q ss_pred cccC
Q 002887 488 LSVD 491 (870)
Q Consensus 488 ~~~~ 491 (870)
++.+
T Consensus 155 l~~n 158 (457)
T 3bz5_A 155 CHLN 158 (457)
T ss_dssp CTTC
T ss_pred CCCC
Confidence 7643
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=97.91 E-value=1.3e-06 Score=100.01 Aligned_cols=63 Identities=13% Similarity=0.012 Sum_probs=33.2
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCC-------------CeEEecCCcCCC
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSL-------------RVLNLSGNNLQG 471 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L-------------~~L~ls~N~l~g 471 (870)
..+++.|+|++|+| |.||++|++|++|++|+|++|+++|.+|..++++++| +.|+|++|+|+|
T Consensus 10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~ 85 (454)
T 1jl5_A 10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS 85 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC
T ss_pred cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc
Confidence 45889999999999 8999999999999999999999999999999887764 677777777664
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=97.90 E-value=9.3e-06 Score=92.85 Aligned_cols=74 Identities=19% Similarity=0.293 Sum_probs=56.9
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
+.++.|+|++|++++ +| +|+++++|++|+|++|++++ +|..+ .+|+.|+|++|++++ +| .++.+++++.|++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 477888888888886 77 58888888888888888885 77643 478888888888886 66 5777787777776
Q ss_pred cc
Q 002887 489 SV 490 (870)
Q Consensus 489 ~~ 490 (870)
+.
T Consensus 203 ~~ 204 (454)
T 1jl5_A 203 DN 204 (454)
T ss_dssp CS
T ss_pred CC
Confidence 63
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=97.90 E-value=8.9e-06 Score=87.91 Aligned_cols=76 Identities=17% Similarity=0.336 Sum_probs=56.2
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.++++.|+|++|++++ +++ +.++++|+.|+|++|++++. |. +..+++|+.|+|++|++++..| +..+++++.|+
T Consensus 150 l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~ 223 (308)
T 1h6u_A 150 LTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDI-SP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223 (308)
T ss_dssp CTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEE
T ss_pred CCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcC-hh-hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEE
Confidence 3577888888888875 444 78888888888888888754 33 7778888888888888875543 67777777777
Q ss_pred cc
Q 002887 488 LS 489 (870)
Q Consensus 488 ~~ 489 (870)
++
T Consensus 224 l~ 225 (308)
T 1h6u_A 224 LT 225 (308)
T ss_dssp EE
T ss_pred cc
Confidence 65
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=97.87 E-value=8.1e-06 Score=95.79 Aligned_cols=72 Identities=15% Similarity=0.248 Sum_probs=47.9
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCC-------CeEEecCCcCCCCCCCcccccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSL-------RVLNLSGNNLQGSLPSGLSEKV 481 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L-------~~L~ls~N~l~g~ip~~l~~~~ 481 (870)
+.++.|+|++|.|++ ||. |. ++|+.|+|++|+|+ .||. +.. +| +.|+|++|+|+ .||..+..++
T Consensus 160 ~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~ 230 (571)
T 3cvr_A 160 TSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLD 230 (571)
T ss_dssp TTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSC
T ss_pred CCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCC
Confidence 466777777777775 666 55 77777777777777 6666 543 55 77777777777 5777777777
Q ss_pred cCCccccc
Q 002887 482 KNGSLSLS 489 (870)
Q Consensus 482 ~~~~l~~~ 489 (870)
++..|+++
T Consensus 231 ~L~~L~L~ 238 (571)
T 3cvr_A 231 PTCTIILE 238 (571)
T ss_dssp TTEEEECC
T ss_pred CCCEEEee
Confidence 76666655
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=97.86 E-value=7.9e-07 Score=96.96 Aligned_cols=80 Identities=21% Similarity=0.284 Sum_probs=59.7
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCC-CCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGP-VPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~-iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
..++.|+|++|.+.+.++. +.++++|++|+|++|++++. +|..+..+++|+.|+|++|++++.+|..++.+++|+.|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 4677777888777766554 56777788888888777765 777777777888888888877777777777777777777
Q ss_pred cc
Q 002887 488 LS 489 (870)
Q Consensus 488 ~~ 489 (870)
++
T Consensus 149 L~ 150 (336)
T 2ast_B 149 LS 150 (336)
T ss_dssp CT
T ss_pred CC
Confidence 66
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=97.82 E-value=1.1e-05 Score=92.53 Aligned_cols=75 Identities=21% Similarity=0.259 Sum_probs=53.3
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
++++.|+|++|+++|..| ++.+++|+.|+|++|++++. ..++++++|+.|+|++|+++|.+| +..+++++.|++
T Consensus 309 ~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l 382 (466)
T 1o6v_A 309 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 382 (466)
T ss_dssp TTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEEC
T ss_pred CCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEec
Confidence 467777777777776555 67777777777777777764 356777777777777777777666 666777776665
Q ss_pred c
Q 002887 489 S 489 (870)
Q Consensus 489 ~ 489 (870)
+
T Consensus 383 ~ 383 (466)
T 1o6v_A 383 N 383 (466)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=97.82 E-value=1.6e-06 Score=94.45 Aligned_cols=81 Identities=28% Similarity=0.321 Sum_probs=49.9
Q ss_pred CcEEEEEcCCCCCccc-CcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCC-cCCC-CCCCcccccccCCc
Q 002887 409 PRIISINLSSSGIAGD-IVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN-NLQG-SLPSGLSEKVKNGS 485 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~-ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N-~l~g-~ip~~l~~~~~~~~ 485 (870)
++++.|+|++|.+++. +|..+.++++|++|+|++|++++.+|..++++++|+.|+|++| .+++ .+|..+..+++|+.
T Consensus 93 ~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~ 172 (336)
T 2ast_B 93 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 172 (336)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCE
Confidence 4566666666666654 6666666666666666666666666666666666666666666 4554 25555555666666
Q ss_pred cccc
Q 002887 486 LSLS 489 (870)
Q Consensus 486 l~~~ 489 (870)
|+++
T Consensus 173 L~l~ 176 (336)
T 2ast_B 173 LNLS 176 (336)
T ss_dssp EECC
T ss_pred EcCC
Confidence 5554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=97.79 E-value=1.7e-05 Score=94.05 Aligned_cols=71 Identities=21% Similarity=0.287 Sum_probs=35.4
Q ss_pred cEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccccc
Q 002887 410 RIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLS 489 (870)
Q Consensus 410 ~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~ 489 (870)
.++.|+|++|+|++ || ..+++|+.|+|++|+|+ .||. .+++|+.|+|++|+|+ .||..+..+++|..|+++
T Consensus 222 ~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~ 292 (622)
T 3g06_A 222 GLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292 (622)
T ss_dssp TCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECC
T ss_pred CCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEec
Confidence 45555555555553 44 33445555555555555 3444 3445555555555555 455555555555544443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=97.79 E-value=1.5e-06 Score=96.88 Aligned_cols=81 Identities=17% Similarity=0.189 Sum_probs=63.7
Q ss_pred CcEEEEEcCCCCCc----ccCcccccccCcccccccccCcCCCC----CCccc--cCcCCCCeEEecCCcCCC----CCC
Q 002887 409 PRIISINLSSSGIA----GDIVPYIFSLTSIESLDLSKNSLTGP----VPEFL--AELQSLRVLNLSGNNLQG----SLP 474 (870)
Q Consensus 409 ~~l~~l~L~~n~l~----G~ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~~--~~l~~L~~L~ls~N~l~g----~ip 474 (870)
++++.|+|++|.|+ +.+|..+.++++|+.|+|++|.+++. +|..+ +.+++|+.|+|++|++++ .+|
T Consensus 216 ~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~ 295 (386)
T 2ca6_A 216 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 295 (386)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHH
T ss_pred CCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHH
Confidence 47888888888886 67888888888888888888888876 66666 348888888888888887 477
Q ss_pred Ccc-cccccCCccccc
Q 002887 475 SGL-SEKVKNGSLSLS 489 (870)
Q Consensus 475 ~~l-~~~~~~~~l~~~ 489 (870)
..+ .+++++..|+++
T Consensus 296 ~~l~~~l~~L~~L~l~ 311 (386)
T 2ca6_A 296 TVIDEKMPDLLFLELN 311 (386)
T ss_dssp HHHHHHCTTCCEEECT
T ss_pred HHHHhcCCCceEEEcc
Confidence 777 556788877776
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=97.75 E-value=3.3e-06 Score=94.19 Aligned_cols=81 Identities=25% Similarity=0.263 Sum_probs=62.3
Q ss_pred CcEEEEEcCCCCCcccCc----ccccccCccccccccc---CcCCCCCCccc-------cCcCCCCeEEecCCcCCC---
Q 002887 409 PRIISINLSSSGIAGDIV----PYIFSLTSIESLDLSK---NSLTGPVPEFL-------AELQSLRVLNLSGNNLQG--- 471 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip----~~~~~l~~L~~L~Ls~---N~l~g~iP~~~-------~~l~~L~~L~ls~N~l~g--- 471 (870)
+.++.|+|++|+|++..+ ..|.++++|+.|+|++ |+++|.+|..+ ..+++|+.|+|++|++++
T Consensus 32 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~ 111 (386)
T 2ca6_A 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 111 (386)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHH
Confidence 467888888888887633 4466788888888887 46677777665 678888888888888887
Q ss_pred -CCCCcccccccCCccccc
Q 002887 472 -SLPSGLSEKVKNGSLSLS 489 (870)
Q Consensus 472 -~ip~~l~~~~~~~~l~~~ 489 (870)
.+|..+..+++++.|+++
T Consensus 112 ~~l~~~l~~~~~L~~L~L~ 130 (386)
T 2ca6_A 112 EPLIDFLSKHTPLEHLYLH 130 (386)
T ss_dssp HHHHHHHHHCTTCCEEECC
T ss_pred HHHHHHHHhCCCCCEEECc
Confidence 477778888888887776
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=97.73 E-value=1.6e-05 Score=87.06 Aligned_cols=78 Identities=21% Similarity=0.284 Sum_probs=65.6
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.++++.|+|++|.+++ + +.+..+++|+.|+|++|++++ +| .+..+++|+.|+|++|++++..|..+..+++++.|+
T Consensus 242 l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 317 (347)
T 4fmz_A 242 LSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLF 317 (347)
T ss_dssp CTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEE
T ss_pred CCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEE
Confidence 4578899999999886 3 568889999999999999986 44 478889999999999999988888888888888888
Q ss_pred cc
Q 002887 488 LS 489 (870)
Q Consensus 488 ~~ 489 (870)
++
T Consensus 318 L~ 319 (347)
T 4fmz_A 318 LS 319 (347)
T ss_dssp CC
T ss_pred cc
Confidence 77
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=97.73 E-value=5.5e-06 Score=91.67 Aligned_cols=80 Identities=28% Similarity=0.261 Sum_probs=46.8
Q ss_pred cEEEEEcCCCCCcccCc----ccccccC-cccccccccCcCCCCCCccccCc-----CCCCeEEecCCcCCCCCCCcccc
Q 002887 410 RIISINLSSSGIAGDIV----PYIFSLT-SIESLDLSKNSLTGPVPEFLAEL-----QSLRVLNLSGNNLQGSLPSGLSE 479 (870)
Q Consensus 410 ~l~~l~L~~n~l~G~ip----~~~~~l~-~L~~L~Ls~N~l~g~iP~~~~~l-----~~L~~L~ls~N~l~g~ip~~l~~ 479 (870)
.++.|+|++|+|++.-+ ..+.+++ +|++|+|++|++++..|..++.+ ++|+.|+|++|++++..+..++.
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~ 102 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence 46666666666665444 4455565 66666666666666555555554 66666666666666555554433
Q ss_pred c-----ccCCccccc
Q 002887 480 K-----VKNGSLSLS 489 (870)
Q Consensus 480 ~-----~~~~~l~~~ 489 (870)
. ++++.|+++
T Consensus 103 ~l~~~~~~L~~L~Ls 117 (362)
T 3goz_A 103 TLAAIPFTITVLDLG 117 (362)
T ss_dssp HHHTSCTTCCEEECC
T ss_pred HHHhCCCCccEEECc
Confidence 3 455555554
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00012 Score=79.72 Aligned_cols=138 Identities=16% Similarity=0.196 Sum_probs=81.3
Q ss_pred cccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhccc--cceeEEEE------EecCCeEEEEEEEcc
Q 002887 568 VLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHK--NLTILVGY------CDEGANMGLIYEFMA 639 (870)
Q Consensus 568 ~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~------~~~~~~~~LV~Ey~~ 639 (870)
.|+.|..+.||+....+..+++|+..... ..+..|+.++..+... .+.+++.. ....+..+++|+|++
T Consensus 39 ~l~gG~~n~~~~v~~~~~~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~ 114 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSGAVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE 114 (346)
T ss_dssp ECC----CEEEEEEETTEEEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred eccccccCcEEEEEeCCCCEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence 46667789999998887779999987531 3344566666665322 22333321 123556789999999
Q ss_pred CCchh--------------hhhhhcc-----c-------ccccHHHH-------------------------------HH
Q 002887 640 NGNLQ--------------AHLLEDK-----A-------DTLCWERR-------------------------------LQ 662 (870)
Q Consensus 640 ~gsL~--------------~~l~~~~-----~-------~~l~~~~~-------------------------------~~ 662 (870)
|..+. ..++... . ..-.|... ..
T Consensus 115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (346)
T 2q83_A 115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG 194 (346)
T ss_dssp CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence 86542 1111110 0 00123211 01
Q ss_pred HHHHHHHHHHHHHh----------CCCCCceeCCCCCCCEEEcCCCcEEEEeccCCc
Q 002887 663 IASESAQGLEYLHN----------GCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 709 (870)
Q Consensus 663 i~~~ia~aL~yLH~----------~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~ 709 (870)
+...+.+++++|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11224446667763 124589999999999999888899999999775
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=97.70 E-value=1.9e-05 Score=90.38 Aligned_cols=77 Identities=25% Similarity=0.359 Sum_probs=57.5
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
++++.|+|++|.+++. |+ +++|++|++|+|++|++++..| ++++++|+.|+|++|++++. |. +..+++|+.|++
T Consensus 68 ~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~l 141 (466)
T 1o6v_A 68 NNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDI-DP-LKNLTNLNRLEL 141 (466)
T ss_dssp TTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-GG-GTTCTTCSEEEE
T ss_pred cCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCC-hH-HcCCCCCCEEEC
Confidence 4778888888888854 33 8888888888888888886544 78888888888888888754 33 777777777777
Q ss_pred ccC
Q 002887 489 SVD 491 (870)
Q Consensus 489 ~~~ 491 (870)
+.+
T Consensus 142 ~~n 144 (466)
T 1o6v_A 142 SSN 144 (466)
T ss_dssp EEE
T ss_pred CCC
Confidence 643
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=97.66 E-value=6.9e-06 Score=86.63 Aligned_cols=68 Identities=29% Similarity=0.381 Sum_probs=53.1
Q ss_pred ccCcccccccCcccccccccCcCCC--CCCccccCcCCCCeEEecCCcCCCCCCCcccccc--cCCccccccCCCC
Q 002887 423 GDIVPYIFSLTSIESLDLSKNSLTG--PVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKV--KNGSLSLSVDGNR 494 (870)
Q Consensus 423 G~ip~~~~~l~~L~~L~Ls~N~l~g--~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~--~~~~l~~~~~~n~ 494 (870)
+.++....+|++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|..|.++ +|+
T Consensus 160 ~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~--~Np 231 (267)
T 3rw6_A 160 ATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLD--GNS 231 (267)
T ss_dssp HHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECT--TST
T ss_pred HHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEcc--CCc
Confidence 3333334678999999999999999 7788889999999999999999975 4455555 56655554 776
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00015 Score=81.19 Aligned_cols=73 Identities=18% Similarity=0.183 Sum_probs=49.4
Q ss_pred ccccccCcEEEEEEEE--CCeeEEEEEeeccch-------hhhHHHHHHHHHHHHhcc--ccce-eEEEEEecCCeEEEE
Q 002887 567 RVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSV-------QGYKQFQAEVELLIRAHH--KNLT-ILVGYCDEGANMGLI 634 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~-------~~~~~f~~Ei~~l~~l~H--~nIv-~l~g~~~~~~~~~LV 634 (870)
+.||.|..+.||++.. .++.++||....... .....+..|.+++..+.+ +..+ +++.+. ....++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEEE
Confidence 5799999999999965 367899998653211 123456789999988843 3444 555443 3456899
Q ss_pred EEEccCC
Q 002887 635 YEFMANG 641 (870)
Q Consensus 635 ~Ey~~~g 641 (870)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00033 Score=75.71 Aligned_cols=136 Identities=18% Similarity=0.206 Sum_probs=92.7
Q ss_pred ccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhcc---ccceeEEEEEecCCeEEEEEEEccCCch
Q 002887 567 RVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHH---KNLTILVGYCDEGANMGLIYEFMANGNL 643 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H---~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 643 (870)
+.|+.|....+|+....+..+++|+.... ....+..|...|+.+.. ..+.++++++...+..++||||+++..+
T Consensus 42 ~~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 46899999999999887888999987643 24568899999998842 5677888888888889999999998765
Q ss_pred hh-----------hhhhccc-c-------------------cccHHHHH---HHH----------------HHHHHH-HH
Q 002887 644 QA-----------HLLEDKA-D-------------------TLCWERRL---QIA----------------SESAQG-LE 672 (870)
Q Consensus 644 ~~-----------~l~~~~~-~-------------------~l~~~~~~---~i~----------------~~ia~a-L~ 672 (870)
.. .|+.... . .-+|.... ++. ..+... ..
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 21 1222111 0 12454322 111 111111 22
Q ss_pred HHHh-CCCCCceeCCCCCCCEEEcCCCcEEEEecc
Q 002887 673 YLHN-GCKPPIVHRDVKSANILLNEKFQAKLADFG 706 (870)
Q Consensus 673 yLH~-~~~~~IvHrDLKp~NILld~~~~vkL~DFG 706 (870)
.|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3421 2356899999999999999887 8899974
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=97.57 E-value=1.9e-05 Score=93.72 Aligned_cols=71 Identities=25% Similarity=0.320 Sum_probs=64.3
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccC
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKN 483 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~ 483 (870)
.+.++.|+|++|+|+ .||. .+++|+.|+|++|+|+ .||..|.++++|+.|+|++|+|+|.+|..+..+...
T Consensus 240 l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~~~ 310 (622)
T 3g06_A 240 PSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSA 310 (622)
T ss_dssp CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHHHS
T ss_pred CCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcccc
Confidence 358999999999999 6887 7899999999999999 899999999999999999999999999988776643
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=97.53 E-value=1.8e-05 Score=87.52 Aligned_cols=78 Identities=28% Similarity=0.239 Sum_probs=69.6
Q ss_pred EEEcCCCCCcccCcccccccCcccccccccCcCCCCCC----ccccCcC-CCCeEEecCCcCCCCCCCccccc-----cc
Q 002887 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVP----EFLAELQ-SLRVLNLSGNNLQGSLPSGLSEK-----VK 482 (870)
Q Consensus 413 ~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP----~~~~~l~-~L~~L~ls~N~l~g~ip~~l~~~-----~~ 482 (870)
.+.|+.|+++|.+|..+...++|++|+|++|++++.-+ ..|..++ +|+.|+|++|++++..+..++.+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46899999999999999999999999999999997777 7788888 99999999999999888888776 88
Q ss_pred CCcccccc
Q 002887 483 NGSLSLSV 490 (870)
Q Consensus 483 ~~~l~~~~ 490 (870)
++.|+++.
T Consensus 82 L~~L~Ls~ 89 (362)
T 3goz_A 82 VTSLNLSG 89 (362)
T ss_dssp CCEEECCS
T ss_pred ccEEECcC
Confidence 88888873
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=97.41 E-value=9.1e-05 Score=81.39 Aligned_cols=76 Identities=26% Similarity=0.364 Sum_probs=61.7
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCc-cccCcCCCCeEEecCCcCCCCCCC-cccccccCCcc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPE-FLAELQSLRVLNLSGNNLQGSLPS-GLSEKVKNGSL 486 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~-~~~~l~~L~~L~ls~N~l~g~ip~-~l~~~~~~~~l 486 (870)
..++.|+|++|+|+ .||+.+...++|+.|+|++|+.-+.||. .|..+++|+.|||++|+|+ .+|. .+.++.+|..+
T Consensus 154 ~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~-~lp~~~~~~L~~L~~l 231 (350)
T 4ay9_X 154 FESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRAR 231 (350)
T ss_dssp SSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC-CCCSSSCTTCCEEECT
T ss_pred hhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC-ccChhhhccchHhhhc
Confidence 46889999999999 7888888999999999997665558885 5799999999999999999 5555 45555555443
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=97.35 E-value=1.2e-05 Score=91.47 Aligned_cols=81 Identities=22% Similarity=0.191 Sum_probs=65.0
Q ss_pred CcEEEEEcCCCCCccc----CcccccccCcccccccccCcCCCCCCccccC-----cCCCCeEEecCCcCCC----CCCC
Q 002887 409 PRIISINLSSSGIAGD----IVPYIFSLTSIESLDLSKNSLTGPVPEFLAE-----LQSLRVLNLSGNNLQG----SLPS 475 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~----ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~-----l~~L~~L~ls~N~l~g----~ip~ 475 (870)
++++.|+|++|++++. ++..+.++++|+.|+|++|.+++..+..++. +++|+.|+|++|++++ .+|.
T Consensus 313 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~ 392 (461)
T 1z7x_W 313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 392 (461)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred ccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHH
Confidence 4788888888888875 6777788889999999999888765555543 6788999999998886 7888
Q ss_pred cccccccCCccccc
Q 002887 476 GLSEKVKNGSLSLS 489 (870)
Q Consensus 476 ~l~~~~~~~~l~~~ 489 (870)
.+..+++++.|+++
T Consensus 393 ~l~~~~~L~~L~l~ 406 (461)
T 1z7x_W 393 TLLANHSLRELDLS 406 (461)
T ss_dssp HHHHCCCCCEEECC
T ss_pred HHHhCCCccEEECC
Confidence 88888888888776
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00074 Score=76.08 Aligned_cols=77 Identities=10% Similarity=0.098 Sum_probs=47.0
Q ss_pred CCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccccc--CCCCccCccccccC---CCCccchHHHHHHHH
Q 002887 679 KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVV--GTPGYLDPEYYISN---RLTEKSDVYSFGVVL 753 (870)
Q Consensus 679 ~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~--gt~~y~APE~~~~~---~~~~ksDVwS~GvvL 753 (870)
.+.++|+|+++.|||+++++ ++++||+.+..-... ....... -...|++|+..... +.....++......+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~---~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG---FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH---HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH---HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 45899999999999999876 999999988753110 0000000 01245666554311 112235566778888
Q ss_pred HHHHhC
Q 002887 754 LELITG 759 (870)
Q Consensus 754 ~elltG 759 (870)
|+..++
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 877765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00075 Score=71.78 Aligned_cols=73 Identities=18% Similarity=0.103 Sum_probs=53.9
Q ss_pred ccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccc---cceeEEEEEecCCeEEEEEEEccCCc
Q 002887 567 RVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHK---NLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~---nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
+.+|.|..+.||+.... |+.+.+|+-..........|..|+..|+.+... -+.+++++. ..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 46899999999999986 789999987655444445688999999998432 244555543 2478999998764
Q ss_pred h
Q 002887 643 L 643 (870)
Q Consensus 643 L 643 (870)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=97.06 E-value=3.5e-05 Score=87.69 Aligned_cols=81 Identities=20% Similarity=0.238 Sum_probs=51.8
Q ss_pred CcEEEEEcCCCCCccc----CcccccccCcccccccccCcCCCCCCccccCc-----CCCCeEEecCCcCCCC----CCC
Q 002887 409 PRIISINLSSSGIAGD----IVPYIFSLTSIESLDLSKNSLTGPVPEFLAEL-----QSLRVLNLSGNNLQGS----LPS 475 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~----ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l-----~~L~~L~ls~N~l~g~----ip~ 475 (870)
++++.|+|++|++++. ++..+.++++|+.|+|++|.+++.-+..+... ++|+.|+|++|++++. +|.
T Consensus 256 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 335 (461)
T 1z7x_W 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHH
Confidence 4667777777777654 66666667777777777777665444444332 5777777777777654 455
Q ss_pred cccccccCCccccc
Q 002887 476 GLSEKVKNGSLSLS 489 (870)
Q Consensus 476 ~l~~~~~~~~l~~~ 489 (870)
.+..+++++.|+++
T Consensus 336 ~l~~~~~L~~L~Ls 349 (461)
T 1z7x_W 336 VLAQNRFLLELQIS 349 (461)
T ss_dssp HHHHCSSCCEEECC
T ss_pred HHhhCCCccEEEcc
Confidence 55566666666665
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.04 E-value=4.7e-05 Score=84.63 Aligned_cols=81 Identities=21% Similarity=0.213 Sum_probs=53.6
Q ss_pred CcEEEEEcCCCCCcc----cCcccccccCcccccccccCcCCCC----CCccccCcCCCCeEEecCCcCCCC----CCCc
Q 002887 409 PRIISINLSSSGIAG----DIVPYIFSLTSIESLDLSKNSLTGP----VPEFLAELQSLRVLNLSGNNLQGS----LPSG 476 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G----~ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~~~~l~~L~~L~ls~N~l~g~----ip~~ 476 (870)
+.++.|+|++|+|+. .++..+..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+.. ++..
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 234 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence 367777888887764 3455556777788888888877642 355566667788888888877642 3334
Q ss_pred ccccccCCccccc
Q 002887 477 LSEKVKNGSLSLS 489 (870)
Q Consensus 477 l~~~~~~~~l~~~ 489 (870)
+..++.+..|+++
T Consensus 235 L~~~~~L~~L~Ls 247 (372)
T 3un9_A 235 AREHPSLELLHLY 247 (372)
T ss_dssp HHHCSSCCEEECT
T ss_pred HHhCCCCCEEecc
Confidence 4455667777666
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.97 E-value=0.002 Score=69.34 Aligned_cols=141 Identities=11% Similarity=0.142 Sum_probs=82.4
Q ss_pred ccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhccccc--eeEEEEE------ecCCeEEEEEEEc
Q 002887 567 RVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNL--TILVGYC------DEGANMGLIYEFM 638 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI--v~l~g~~------~~~~~~~LV~Ey~ 638 (870)
+.|+.|....+|+....+..+++|+.... .....+..|+.++..+....+ .+++... ...+..+++++|+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eccCCCcccceEEEEeCCccEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 35777888999999887668889988653 123456678888887753332 2333211 1234578999999
Q ss_pred cCCchhh--------------hhhhcc-----c-----ccccHHHHHH------------HHHHHHHHHHHHHhC----C
Q 002887 639 ANGNLQA--------------HLLEDK-----A-----DTLCWERRLQ------------IASESAQGLEYLHNG----C 678 (870)
Q Consensus 639 ~~gsL~~--------------~l~~~~-----~-----~~l~~~~~~~------------i~~~ia~aL~yLH~~----~ 678 (870)
+|..+.. .++... . ....|..... +...+.+.++.+++. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 9865421 011100 0 0122433111 011244556666532 2
Q ss_pred CCCceeCCCCCCCEEEcCCCcEEEEeccCCc
Q 002887 679 KPPIVHRDVKSANILLNEKFQAKLADFGLSR 709 (870)
Q Consensus 679 ~~~IvHrDLKp~NILld~~~~vkL~DFGla~ 709 (870)
...++|+|+++.|||++++..+.|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3479999999999999987666899998775
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0029 Score=67.61 Aligned_cols=127 Identities=12% Similarity=0.130 Sum_probs=76.3
Q ss_pred ccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhccccc-eeEEEEEecCCeEEEEEEEc-cCCchh
Q 002887 567 RVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNL-TILVGYCDEGANMGLIYEFM-ANGNLQ 644 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~LV~Ey~-~~gsL~ 644 (870)
+.|+.|....+|+. +.+++|+-...... .....+|+.+++.+....+ .++++++. +.-++++||+ ++.++.
T Consensus 24 ~~l~gG~tN~~~~~----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~~l~ 96 (301)
T 3dxq_A 24 LERLGGLTNLVFRA----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQTMS 96 (301)
T ss_dssp EEEESCSSEEEEEE----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCEECC
T ss_pred eEcCCcccccccee----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCccCC
Confidence 56888999999998 66888887653221 2234678888888754444 35555543 3346899999 554443
Q ss_pred hhhhhcccccccHHHHHHHHHHHHHHHHHHHh------------------------------------------------
Q 002887 645 AHLLEDKADTLCWERRLQIASESAQGLEYLHN------------------------------------------------ 676 (870)
Q Consensus 645 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~------------------------------------------------ 676 (870)
...... +..++.++++.|+-||+
T Consensus 97 ~~~~~~---------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~ 167 (301)
T 3dxq_A 97 PEKFKT---------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALA 167 (301)
T ss_dssp HHHHHH---------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHH
T ss_pred HhhHhh---------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHH
Confidence 210000 00112222222222222
Q ss_pred --CCCCCceeCCCCCCCEEEcCCCcEEEEeccCCcc
Q 002887 677 --GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 677 --~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~ 710 (870)
.....++|+|+.+.||+ .+++.+.++||..+..
T Consensus 168 ~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 168 AHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp SSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred hcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 12235899999999999 5667889999988764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0036 Score=67.91 Aligned_cols=139 Identities=14% Similarity=0.037 Sum_probs=73.7
Q ss_pred ccccccCcEE-EEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhcccc--ceeEEEEEecCCeEEEEEEEccCCc
Q 002887 567 RVLGKGGFGT-VYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKN--LTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 567 ~~LG~G~fG~-Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
+.|+.|.... +|+.... ++.+++|...... ...+..|+.++..+.... +.+++.+..+.. +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 3466565554 6677664 6777777654321 134567788887774333 456666644333 68999997766
Q ss_pred hhhhhhhccc------------------------ccccHHHHH--------------------HHHHHHHHHHHHHH---
Q 002887 643 LQAHLLEDKA------------------------DTLCWERRL--------------------QIASESAQGLEYLH--- 675 (870)
Q Consensus 643 L~~~l~~~~~------------------------~~l~~~~~~--------------------~i~~~ia~aL~yLH--- 675 (870)
+.+++..... ..++..... .....+.+.++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 5443321100 001110000 00011122223331
Q ss_pred hCCCCCceeCCCCCCCEEEcCC----CcEEEEeccCCcc
Q 002887 676 NGCKPPIVHRDVKSANILLNEK----FQAKLADFGLSRI 710 (870)
Q Consensus 676 ~~~~~~IvHrDLKp~NILld~~----~~vkL~DFGla~~ 710 (870)
......++|||+.+.||+++.+ ..+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123479999999999999875 6899999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0034 Score=70.95 Aligned_cols=71 Identities=15% Similarity=0.225 Sum_probs=49.9
Q ss_pred ccccccCcEEEEEEEEC---------CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccc-eeEEEEEecCCeEEEEEE
Q 002887 567 RVLGKGGFGTVYHGYLD---------DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNL-TILVGYCDEGANMGLIYE 636 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~---------~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~LV~E 636 (870)
+.|+.|....+|+.... ++.+++|+..... ....+.+|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 46888989999999875 3678888874421 11455679999998854444 567776653 38999
Q ss_pred EccCCch
Q 002887 637 FMANGNL 643 (870)
Q Consensus 637 y~~~gsL 643 (870)
|+++.++
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.68 E-value=0.00018 Score=79.91 Aligned_cols=80 Identities=25% Similarity=0.243 Sum_probs=38.0
Q ss_pred cEEEEEcCCCCCcccCccccc-ccCcccccccccCcCCCCCCccc-----cCcCCCCeEEecCCcCCC----CCCCcccc
Q 002887 410 RIISINLSSSGIAGDIVPYIF-SLTSIESLDLSKNSLTGPVPEFL-----AELQSLRVLNLSGNNLQG----SLPSGLSE 479 (870)
Q Consensus 410 ~l~~l~L~~n~l~G~ip~~~~-~l~~L~~L~Ls~N~l~g~iP~~~-----~~l~~L~~L~ls~N~l~g----~ip~~l~~ 479 (870)
.++.|+|++|+|+..-...+. .|++|+.|+|++|+|+..-...+ ...++|+.|+|++|+|+. .++..+..
T Consensus 102 ~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~ 181 (372)
T 3un9_A 102 ALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAG 181 (372)
T ss_dssp CEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHT
T ss_pred CceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhc
Confidence 566666666665543222222 34555666666665543322222 123455556666555542 12333344
Q ss_pred cccCCccccc
Q 002887 480 KVKNGSLSLS 489 (870)
Q Consensus 480 ~~~~~~l~~~ 489 (870)
++++..|+++
T Consensus 182 ~~~L~~L~Ls 191 (372)
T 3un9_A 182 NTSVTHLSLL 191 (372)
T ss_dssp CSSCCEEECT
T ss_pred CCCcCEEeCC
Confidence 4455555544
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.64 E-value=0.01 Score=67.53 Aligned_cols=72 Identities=14% Similarity=0.132 Sum_probs=49.0
Q ss_pred ccccccCcEEEEEEEECC--eeEEEEEeeccchhhhHHHHHHHHHHHHhccccc-eeEEEEEecCCeEEEEEEEccCCch
Q 002887 567 RVLGKGGFGTVYHGYLDD--KQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNL-TILVGYCDEGANMGLIYEFMANGNL 643 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~--~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~LV~Ey~~~gsL 643 (870)
+.|+.|-...+|+....+ ..+++|+...... ..-...+|..++..+...++ .++++.+.. .+||||+++.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 468889999999999876 7888888744321 11123689999999965555 467777642 259999997655
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.61 E-value=0.00021 Score=71.02 Aligned_cols=79 Identities=20% Similarity=0.276 Sum_probs=38.3
Q ss_pred cEEEEEcCCC-CCcc----cCcccccccCcccccccccCcCCCC----CCccccCcCCCCeEEecCCcCCCC----CCCc
Q 002887 410 RIISINLSSS-GIAG----DIVPYIFSLTSIESLDLSKNSLTGP----VPEFLAELQSLRVLNLSGNNLQGS----LPSG 476 (870)
Q Consensus 410 ~l~~l~L~~n-~l~G----~ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~~~~l~~L~~L~ls~N~l~g~----ip~~ 476 (870)
.++.|+|++| +|.. .+...+...++|++|+|++|+|+.. |...+...++|+.|+|++|+++.. +...
T Consensus 37 ~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~ 116 (185)
T 1io0_A 37 DLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEA 116 (185)
T ss_dssp TCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHG
T ss_pred CCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHH
Confidence 4555555555 5543 1333344455556666666555421 223333445555666666655432 2333
Q ss_pred ccccccCCcccc
Q 002887 477 LSEKVKNGSLSL 488 (870)
Q Consensus 477 l~~~~~~~~l~~ 488 (870)
+.....+..|++
T Consensus 117 L~~n~~L~~L~L 128 (185)
T 1io0_A 117 LQSNTSLIELRI 128 (185)
T ss_dssp GGGCSSCCEEEC
T ss_pred HHhCCCceEEEe
Confidence 444444555555
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0071 Score=67.01 Aligned_cols=139 Identities=17% Similarity=0.220 Sum_probs=82.5
Q ss_pred ccccccCcEEEEEEEEC---------CeeEEEEEeeccchhhhHHHHHHHHHHHHhcccc-ceeEEEEEecCCeEEEEEE
Q 002887 567 RVLGKGGFGTVYHGYLD---------DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKN-LTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~---------~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~LV~E 636 (870)
+.|..|-...+|+.... ++.+.+|+-... ......+.+|..+++.+.... ..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 35777888889998863 367888885332 223455678999998885333 3566776654 29999
Q ss_pred EccCCchhhh-h----------------hhcc---cccc--cHHHHHHHHHHHHH-------------------HHHHHH
Q 002887 637 FMANGNLQAH-L----------------LEDK---ADTL--CWERRLQIASESAQ-------------------GLEYLH 675 (870)
Q Consensus 637 y~~~gsL~~~-l----------------~~~~---~~~l--~~~~~~~i~~~ia~-------------------aL~yLH 675 (870)
|++|..|... + +... .+.. -|.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665421 1 1000 0112 24454444443321 233332
Q ss_pred ----hC-CCCCceeCCCCCCCEEEcCC----CcEEEEeccCCcc
Q 002887 676 ----NG-CKPPIVHRDVKSANILLNEK----FQAKLADFGLSRI 710 (870)
Q Consensus 676 ----~~-~~~~IvHrDLKp~NILld~~----~~vkL~DFGla~~ 710 (870)
.. ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 23468999999999999887 7899999988753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.44 E-value=0.011 Score=65.19 Aligned_cols=72 Identities=14% Similarity=0.155 Sum_probs=45.3
Q ss_pred ccccccCcEEEEEEEECC----------eeEEEEEeeccchhhhHHHHHHHHHHHHhccccc-eeEEEEEecCCeEEEEE
Q 002887 567 RVLGKGGFGTVYHGYLDD----------KQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNL-TILVGYCDEGANMGLIY 635 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~~----------~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~LV~ 635 (870)
+.|+.|....+|+....+ +.+++|+...... .......|.++++.+...++ .++++... -.+||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 457788888999998764 6788887654322 12234688888888854444 36665542 26899
Q ss_pred EEccCCch
Q 002887 636 EFMANGNL 643 (870)
Q Consensus 636 Ey~~~gsL 643 (870)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99997654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.43 E-value=0.00028 Score=70.12 Aligned_cols=81 Identities=14% Similarity=0.191 Sum_probs=62.9
Q ss_pred CcEEEEEcCCCCCcc----cCcccccccCcccccccccCcCCCC----CCccccCcCCCCeEEe--cCCcCCCC----CC
Q 002887 409 PRIISINLSSSGIAG----DIVPYIFSLTSIESLDLSKNSLTGP----VPEFLAELQSLRVLNL--SGNNLQGS----LP 474 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G----~ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~~~~l~~L~~L~l--s~N~l~g~----ip 474 (870)
..++.|+|++|+|.. .|...+...++|++|+|++|+|+.. +...+...++|+.|+| ++|.++.. +.
T Consensus 65 ~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~ 144 (185)
T 1io0_A 65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 144 (185)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHH
Confidence 478999999999975 3555667778999999999999864 5677888899999999 88998754 23
Q ss_pred CcccccccCCccccc
Q 002887 475 SGLSEKVKNGSLSLS 489 (870)
Q Consensus 475 ~~l~~~~~~~~l~~~ 489 (870)
..+...+.+..|+++
T Consensus 145 ~~L~~n~~L~~L~L~ 159 (185)
T 1io0_A 145 NMLEKNTTLLKFGYH 159 (185)
T ss_dssp HHHHHCSSCCEEECC
T ss_pred HHHHhCCCcCEEecc
Confidence 344455677777775
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=96.36 E-value=0.00025 Score=83.27 Aligned_cols=79 Identities=11% Similarity=0.111 Sum_probs=43.0
Q ss_pred cEEEEEcCCCCCccc----CcccccccCcccccccccCcCC----CCCCccccCcCCCCeEEecCCcCCCCCCCcccccc
Q 002887 410 RIISINLSSSGIAGD----IVPYIFSLTSIESLDLSKNSLT----GPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKV 481 (870)
Q Consensus 410 ~l~~l~L~~n~l~G~----ip~~~~~l~~L~~L~Ls~N~l~----g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~ 481 (870)
.++.|+|++|.+++. ++..+.++++|+.|+|++|.++ +.++..+.++++|+.|+|++|.+++ +|..+..++
T Consensus 165 ~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~ 243 (592)
T 3ogk_B 165 KIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAA 243 (592)
T ss_dssp TCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCT
T ss_pred CCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhh
Confidence 455566666655544 4444455566666666666655 2333334455666666666666554 455555555
Q ss_pred cCCccccc
Q 002887 482 KNGSLSLS 489 (870)
Q Consensus 482 ~~~~l~~~ 489 (870)
++..|.++
T Consensus 244 ~L~~L~l~ 251 (592)
T 3ogk_B 244 NLEEFCGG 251 (592)
T ss_dssp TCCEEEEC
T ss_pred HHHhhccc
Confidence 55555544
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.31 E-value=0.0043 Score=57.75 Aligned_cols=56 Identities=23% Similarity=0.338 Sum_probs=38.6
Q ss_pred EEEcCCCCCc-ccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCC
Q 002887 413 SINLSSSGIA-GDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQ 470 (870)
Q Consensus 413 ~l~L~~n~l~-G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~ 470 (870)
.++.++++|+ ..+|..|. ++|+.|+|++|+|+..-+..|..|++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4566677775 45665432 46788888888888443455677888888888888764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.16 E-value=0.011 Score=63.68 Aligned_cols=139 Identities=12% Similarity=0.137 Sum_probs=80.0
Q ss_pred cccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhcccc--ceeEEEE-----EecCCeEEEEEEEcc
Q 002887 568 VLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKN--LTILVGY-----CDEGANMGLIYEFMA 639 (870)
Q Consensus 568 ~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~-----~~~~~~~~LV~Ey~~ 639 (870)
.++ |....||+.... |+.+++|+..... .....+..|..++..+.... +.+++.. ....+..+++|+|++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 466 777899988765 5679999986432 12356677888888875333 3334433 112345678999999
Q ss_pred CCchhh----h----------hhhcc-------cccccHHHH----HHH---------------HHHHHHHHHHHHhC--
Q 002887 640 NGNLQA----H----------LLEDK-------ADTLCWERR----LQI---------------ASESAQGLEYLHNG-- 677 (870)
Q Consensus 640 ~gsL~~----~----------l~~~~-------~~~l~~~~~----~~i---------------~~~ia~aL~yLH~~-- 677 (870)
|..+.. . ++... ....++... ..+ ...+.+.++.+...
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 865421 0 11100 011222211 001 11111223333321
Q ss_pred --CCCCceeCCCCCCCEEEcCCCcEEEEeccCCcc
Q 002887 678 --CKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 678 --~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~ 710 (870)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234688999999999999 4 899999987753
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=95.89 E-value=0.002 Score=75.54 Aligned_cols=58 Identities=12% Similarity=0.111 Sum_probs=44.8
Q ss_pred CcEEEEEcCCCCCc----ccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCC
Q 002887 409 PRIISINLSSSGIA----GDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467 (870)
Q Consensus 409 ~~l~~l~L~~n~l~----G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N 467 (870)
+.++.|+|++|+++ +.++..+.++++|+.|+|++|.++| +|..+.++++|+.|+++.+
T Consensus 192 ~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~ 253 (592)
T 3ogk_B 192 TSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSL 253 (592)
T ss_dssp CCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBC
T ss_pred CCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhccccc
Confidence 47888888888887 5666667788888888888888875 6777777777777777753
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=95.89 E-value=0.00062 Score=79.88 Aligned_cols=80 Identities=18% Similarity=0.137 Sum_probs=59.3
Q ss_pred CcEEEEEcCCCCCcccCcccccc-cCcccccccccCcCCCCCCccc-cCcCCCCeEEecCCcCCCCCCC-cccccccCCc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEFL-AELQSLRVLNLSGNNLQGSLPS-GLSEKVKNGS 485 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~-l~~L~~L~Ls~N~l~g~iP~~~-~~l~~L~~L~ls~N~l~g~ip~-~l~~~~~~~~ 485 (870)
++++.|+|++ ++++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++..+. .+..+++|+.
T Consensus 432 ~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~ 510 (594)
T 2p1m_B 432 KDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRS 510 (594)
T ss_dssp TTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSE
T ss_pred CCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCE
Confidence 4688888876 777777777776 8888888888888877655555 5688888888888888654443 3344777887
Q ss_pred cccc
Q 002887 486 LSLS 489 (870)
Q Consensus 486 l~~~ 489 (870)
|+++
T Consensus 511 L~l~ 514 (594)
T 2p1m_B 511 LWMS 514 (594)
T ss_dssp EEEE
T ss_pred Eeee
Confidence 7776
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=95.83 E-value=0.00094 Score=78.35 Aligned_cols=82 Identities=21% Similarity=0.216 Sum_probs=51.2
Q ss_pred CcEEEEEcCCCCCcccCccccc-ccCcccccccccC-cCCCC-CCccccCcCCCCeEEecCCcCCCCCCCccc----ccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIF-SLTSIESLDLSKN-SLTGP-VPEFLAELQSLRVLNLSGNNLQGSLPSGLS----EKV 481 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~-~l~~L~~L~Ls~N-~l~g~-iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~----~~~ 481 (870)
++++.|+|++|.+++..+..+. ++++|+.|+|++| .++.. ++..+.++++|+.|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 3567777777777776666665 5777777777777 44432 444445677777777777776665544443 344
Q ss_pred cCCcccccc
Q 002887 482 KNGSLSLSV 490 (870)
Q Consensus 482 ~~~~l~~~~ 490 (870)
+|+.|+++.
T Consensus 185 ~L~~L~l~~ 193 (594)
T 2p1m_B 185 SLVSLNISC 193 (594)
T ss_dssp CCCEEECTT
T ss_pred cCcEEEecc
Confidence 566666653
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=95.64 E-value=0.011 Score=54.82 Aligned_cols=59 Identities=25% Similarity=0.302 Sum_probs=46.5
Q ss_pred cccccccCcCC-CCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccccccCCCCCCCC
Q 002887 436 ESLDLSKNSLT-GPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSVDGNRNLCP 498 (870)
Q Consensus 436 ~~L~Ls~N~l~-g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~~~~n~~lc~ 498 (870)
..++.++++|+ ..||..+. ++|+.|+|++|+|+..-+..+..+++|+.|+++ +|+..|.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~--~NP~~Cd 70 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLG--ANPWRCD 70 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECC--SSCCBCS
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEec--CCCeecc
Confidence 47899999997 67887543 479999999999995444556778888877665 8998886
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.33 E-value=0.04 Score=59.94 Aligned_cols=68 Identities=12% Similarity=0.102 Sum_probs=44.0
Q ss_pred cccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhcccc---ceeEEEE------EecCCeEEEEEEEccC
Q 002887 570 GKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKN---LTILVGY------CDEGANMGLIYEFMAN 640 (870)
Q Consensus 570 G~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n---Iv~l~g~------~~~~~~~~LV~Ey~~~ 640 (870)
|.|....||+....+..+++|+...... ..|+.++..+.... +.+.+.. .......+++|+|++|
T Consensus 32 G~g~~N~vy~v~~~~g~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 32 GADTNAFAYQADSESKSYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp TSCSSCEEEEEECSSCEEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred cCccccceEEEEeCCCCEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 4444689999987655899998765431 45666776663222 3444432 1234667899999998
Q ss_pred Cch
Q 002887 641 GNL 643 (870)
Q Consensus 641 gsL 643 (870)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 765
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=95.32 E-value=0.0023 Score=70.51 Aligned_cols=64 Identities=19% Similarity=0.353 Sum_probs=48.7
Q ss_pred CCcEEEEEcCCCCCcccCccccc---ccCcccccccccCcCCCC----CCccccCcCCCCeEEecCCcCCC
Q 002887 408 SPRIISINLSSSGIAGDIVPYIF---SLTSIESLDLSKNSLTGP----VPEFLAELQSLRVLNLSGNNLQG 471 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~---~l~~L~~L~Ls~N~l~g~----iP~~~~~l~~L~~L~ls~N~l~g 471 (870)
.++++.|+|.+|.+.+..+..+. .+++|+.|+|+.|.|++. ++..+..+++|+.|+|++|.++.
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 46888888888888866555554 478888888988888763 55556677888888888887763
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=94.74 E-value=0.018 Score=62.29 Aligned_cols=76 Identities=12% Similarity=0.099 Sum_probs=48.3
Q ss_pred cEEEEEcCCCCCcccCcc-cccccCcccccccccCcCCCCCCccccCcCCCC-eEEecCCcCCCCCCCcccccccCCccc
Q 002887 410 RIISINLSSSGIAGDIVP-YIFSLTSIESLDLSKNSLTGPVPEFLAELQSLR-VLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 410 ~l~~l~L~~n~l~G~ip~-~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~-~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.++.|+|++|+++ .||. .|.+|++|+.|+|++| ++..=+..|.++++|+ .|+|.+ +++.--+..+..+.+|+.++
T Consensus 227 ~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~ 303 (329)
T 3sb4_A 227 NLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL 303 (329)
T ss_dssp TCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred CCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence 5677777777776 4554 3777777777777776 5532234567777777 777776 55533335666666666665
Q ss_pred c
Q 002887 488 L 488 (870)
Q Consensus 488 ~ 488 (870)
+
T Consensus 304 l 304 (329)
T 3sb4_A 304 A 304 (329)
T ss_dssp E
T ss_pred e
Confidence 4
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.50 E-value=0.15 Score=51.33 Aligned_cols=166 Identities=13% Similarity=0.069 Sum_probs=89.0
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
-+|.+.|. ..+.++++.+++.++.|.+.+|.-+-.+.. + ..+=+.|..|++..+|.+...+ +.+.
T Consensus 33 vSL~eIL~-~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILR-LYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHH-HcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 36777764 356799999999999999999877622111 1 1344456899999999988764 1110
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCC-CCccchHHHHHHHHhhcCCcchhcccccCC--CC
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK-TPQRTLIGQWVSSMLARGDIKNIVDHRLQG--DF 797 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~-~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~--~~ 797 (870)
.....+.|||... ...+++.=|||+|+++|.-+-=..|-+. ..-...+.+.+..+.....-....|..+.. +.
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg 173 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEG 173 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTEEECCCHHHHHHHHHHTTCCC---------------
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcccchhhCHHHHHHHHHHHhcccccccccccccccccc
Confidence 1123466888763 4557889999999999998864333221 111223334333333221111112221110 00
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
+.++. . ...+..|++.++|++.=...+.
T Consensus 174 ~~d~~-~---------~~~~~~~~sl~~Vi~~C~~hl~ 201 (229)
T 2yle_A 174 LGDED-E---------KRKISAIRSYRDVMKLCAAHLP 201 (229)
T ss_dssp ------C---------CSCCCCCCSHHHHHHHHHTTSS
T ss_pred ccccc-c---------cccccCcCCHHHHHHHHHhhcc
Confidence 00000 0 2456789999999877666543
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=94.22 E-value=0.0065 Score=59.49 Aligned_cols=81 Identities=20% Similarity=0.123 Sum_probs=59.7
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCc-CCCCCCccccCc----CCCCeEEecCCc-CCCCCCCccccccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNS-LTGPVPEFLAEL----QSLRVLNLSGNN-LQGSLPSGLSEKVK 482 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~-l~g~iP~~~~~l----~~L~~L~ls~N~-l~g~ip~~l~~~~~ 482 (870)
.+|+.|||+++.++..=-..+.+|++|+.|+|+++. ++..==..++.+ ++|+.|+|+++. +|..==..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 479999999999886545668899999999999985 653211224443 479999999975 66322235677888
Q ss_pred CCccccc
Q 002887 483 NGSLSLS 489 (870)
Q Consensus 483 ~~~l~~~ 489 (870)
|+.|+++
T Consensus 141 L~~L~L~ 147 (176)
T 3e4g_A 141 LKYLFLS 147 (176)
T ss_dssp CCEEEEE
T ss_pred CCEEECC
Confidence 8888876
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=94.05 E-value=0.03 Score=60.41 Aligned_cols=76 Identities=14% Similarity=0.146 Sum_probs=62.0
Q ss_pred CcEEEEEcCCCCCcccCcc-cccccCccc-ccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcc
Q 002887 409 PRIISINLSSSGIAGDIVP-YIFSLTSIE-SLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSL 486 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~-~~~~l~~L~-~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l 486 (870)
..++.|+|.+| ++ .|++ .|.+|++|+ .|+|.+ +++-.-+..|.+|++|+.|+|++|+++.--+..+.++++|+.+
T Consensus 250 ~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~l 326 (329)
T 3sb4_A 250 KYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLI 326 (329)
T ss_dssp TTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEE
T ss_pred CCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhh
Confidence 47899999998 77 5655 599999999 999999 7774445789999999999999999995555577888877765
Q ss_pred c
Q 002887 487 S 487 (870)
Q Consensus 487 ~ 487 (870)
.
T Consensus 327 y 327 (329)
T 3sb4_A 327 Y 327 (329)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.72 E-value=0.29 Score=54.84 Aligned_cols=72 Identities=11% Similarity=0.177 Sum_probs=48.6
Q ss_pred ccccccCcEEEEEEEEC---------CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccc-eeEEEEEecCCeEEEEEE
Q 002887 567 RVLGKGGFGTVYHGYLD---------DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNL-TILVGYCDEGANMGLIYE 636 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~---------~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~LV~E 636 (870)
+.+..|-...+|+.... ++.+++|+-.... ...-...+|..+++.+...++ .++++.+. -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 45777888899998876 5778888864432 222234688999988854344 45555443 268999
Q ss_pred EccCCch
Q 002887 637 FMANGNL 643 (870)
Q Consensus 637 y~~~gsL 643 (870)
|++|..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998765
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=93.20 E-value=0.01 Score=65.31 Aligned_cols=58 Identities=14% Similarity=0.191 Sum_probs=30.1
Q ss_pred cCcccccccccCcCCCCCCcccc---CcCCCCeEEecCCcCCCC----CCCcccccccCCccccc
Q 002887 432 LTSIESLDLSKNSLTGPVPEFLA---ELQSLRVLNLSGNNLQGS----LPSGLSEKVKNGSLSLS 489 (870)
Q Consensus 432 l~~L~~L~Ls~N~l~g~iP~~~~---~l~~L~~L~ls~N~l~g~----ip~~l~~~~~~~~l~~~ 489 (870)
+++|+.|+|++|.+++..+..+. .+++|+.|+|+.|+|++. ++..+..+++|..|+++
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~ 315 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMK 315 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECC
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECC
Confidence 55666666666665543333232 355666666666666542 33334445555555554
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.28 E-value=3.2 Score=45.77 Aligned_cols=29 Identities=41% Similarity=0.568 Sum_probs=24.4
Q ss_pred ceeCCCCCCCEEE------cCCCcEEEEeccCCcc
Q 002887 682 IVHRDVKSANILL------NEKFQAKLADFGLSRI 710 (870)
Q Consensus 682 IvHrDLKp~NILl------d~~~~vkL~DFGla~~ 710 (870)
++|+|+.+.|||+ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5699999999999 4566799999988753
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=84.64 E-value=0.1 Score=51.98 Aligned_cols=58 Identities=19% Similarity=0.226 Sum_probs=27.2
Q ss_pred cEEEEEcCCCCCccc----CcccccccCcccccccccCcCCCC----CCccccCcCCCCeEEecCC
Q 002887 410 RIISINLSSSGIAGD----IVPYIFSLTSIESLDLSKNSLTGP----VPEFLAELQSLRVLNLSGN 467 (870)
Q Consensus 410 ~l~~l~L~~n~l~G~----ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~~~~l~~L~~L~ls~N 467 (870)
.|+.|+|++|+|... |...+..=+.|+.|+|++|+|+.. |-+.|..-+.|+.|+|++|
T Consensus 71 ~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 71 HIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp CCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCC
T ss_pred CcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCC
Confidence 455566666655532 222233345556666666655432 1222333344555666543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=83.69 E-value=0.23 Score=49.35 Aligned_cols=81 Identities=17% Similarity=0.249 Sum_probs=56.2
Q ss_pred CcEEEEEcCCC-CCcc----cCcccccccCcccccccccCcCCCC----CCccccCcCCCCeEEecCCcCCCCCC----C
Q 002887 409 PRIISINLSSS-GIAG----DIVPYIFSLTSIESLDLSKNSLTGP----VPEFLAELQSLRVLNLSGNNLQGSLP----S 475 (870)
Q Consensus 409 ~~l~~l~L~~n-~l~G----~ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~~~~l~~L~~L~ls~N~l~g~ip----~ 475 (870)
..++.|+|++| +|.. .|-..+..=+.|+.|+|++|++.-. |-+.|..-+.|+.|+|++|+|+..-- +
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 47889999986 7653 2455566678999999999999732 33445456899999999999974311 2
Q ss_pred cccccccCCccccc
Q 002887 476 GLSEKVKNGSLSLS 489 (870)
Q Consensus 476 ~l~~~~~~~~l~~~ 489 (870)
.|.....|..|+++
T Consensus 121 aL~~N~tL~~L~L~ 134 (197)
T 1pgv_A 121 STLVTQSIVEFKAD 134 (197)
T ss_dssp HTTTTCCCSEEECC
T ss_pred HHhhCCceeEEECC
Confidence 23334446666665
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=81.23 E-value=1.1 Score=49.62 Aligned_cols=77 Identities=13% Similarity=0.135 Sum_probs=47.0
Q ss_pred cEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccccc
Q 002887 410 RIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLS 489 (870)
Q Consensus 410 ~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~ 489 (870)
.|+.|.|.+ ++.-.-+..|.+|++|+.|+|++|+++ .||...-...+|+.|.|.+| ++---...+..+.+|+.+.+.
T Consensus 158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~ 234 (401)
T 4fdw_A 158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP 234 (401)
T ss_dssp CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECC
T ss_pred CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecC
Confidence 466677764 555222345777888888888888777 45544333577788877744 552223355566666666553
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 870 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-69 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 9e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 3e-69
Identities = 77/271 (28%), Positives = 124/271 (45%), Gaps = 20/271 (7%)
Query: 565 FERVLGKGGFGTVYHGYLDDKQVAVKML--SSSSVQGYKQFQAEVELLIRAHHKNLTILV 622
+ +G G FGTVY G VAVKML ++ + Q + F+ EV +L + H N+ + +
Sbjct: 12 VGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 623 GYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPI 682
GY + ++ ++ +L H L + + IA ++AQG++YLH I
Sbjct: 71 GYSTAP-QLAIVTQWCEGSSLY-HHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSI 125
Query: 683 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYY---ISNR 739
+HRD+KS NI L+E K+ DFGL+ + G+H + G+ ++ PE N
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 740 LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799
+ +SDVY+FG+VL EL+TGQ R I V D+ +
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS--------- 236
Query: 800 NTVWKAVEIALACIHTISTRRPTMNQVVIEL 830
N + C+ RP Q++ +
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 1e-62
Identities = 63/297 (21%), Positives = 121/297 (40%), Gaps = 28/297 (9%)
Query: 565 FERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGY 624
+ +GKG FG V+ G ++VAVK+ SS + +AE+ + H+N+ +
Sbjct: 7 LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65
Query: 625 CDEGAN----MGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGC-- 678
++ + L+ ++ +G+L +L T+ E +++A +A GL +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 679 ---KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT--HVSTTVVGTPGYLDPE 733
KP I HRD+KS NIL+ + +AD GL+ T VGT Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 734 YYISN------RLTEKSDVYSFGVVLLELITGQPV------IQKTPQRTLIGQWVSSMLA 781
+ +++D+Y+ G+V E+ + Q + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 782 RGDIKNIVDHRLQGDFDTNTVWKAV-EIALACIHTISTRRPTMNQVVIELNDCLAME 837
+ + + + + + + + +I C + R T ++ L+ E
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 6e-61
Identities = 68/269 (25%), Positives = 117/269 (43%), Gaps = 20/269 (7%)
Query: 565 FERVLGKGGFGTVYHGYLDD-KQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVG 623
LG G FG V+ GY + +VAVK L S F AE L+ + H+ L L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIV 683
+ + +I E+M NG+L L L + L +A++ A+G+ ++ + +
Sbjct: 76 VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYI 131
Query: 684 HRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEK 743
HRD+++ANIL+++ K+ADFGL+R+ + + PE T K
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 744 SDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVW 803
SDV+SFG++L E++T G+ + ++ ++ + N
Sbjct: 191 SDVWSFGILLTEIVTH-------------GRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237
Query: 804 KAVEIALACIHTISTRRPTMNQVVIELND 832
+ ++ C RPT + + L D
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 6e-59
Identities = 68/275 (24%), Positives = 121/275 (44%), Gaps = 24/275 (8%)
Query: 565 FERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGY 624
+ +GKG FG V G +VAVK + + + + F AE ++ + H NL L+G
Sbjct: 11 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 68
Query: 625 C-DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIV 683
+E + ++ E+MA G+L +L L + L+ + + + +EYL V
Sbjct: 69 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFV 125
Query: 684 HRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEK 743
HRD+ + N+L++E AK++DFGL++ T + PE + + K
Sbjct: 126 HRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFSTK 180
Query: 744 SDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVW 803
SDV+SFG++L E+ + + P + + V + +G + D
Sbjct: 181 SDVWSFGILLWEIYSF----GRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP--------- 227
Query: 804 KAVEIALACIHTISTRRPTMNQVVIELNDCLAMEI 838
E+ C H + RP+ Q+ +L E+
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 200 bits (509), Expect = 8e-59
Identities = 69/273 (25%), Positives = 112/273 (41%), Gaps = 20/273 (7%)
Query: 564 NFERVLGKGGFGTVYHGYLDD--KQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTIL 621
+ LG G +G VY G VAVK L +++ ++F E ++ H NL L
Sbjct: 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQL 78
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPP 681
+G C +I EFM GNL +L E + L +A++ + +EYL K
Sbjct: 79 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKN 135
Query: 682 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLT 741
+HRD+ + N L+ E K+ADFGLSR+ + PE N+ +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 742 EKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801
KSDV++FGV+L E+ T G + + +++ + +
Sbjct: 195 IKSDVWAFGVLLWEIATY-------------GMSPYPGIDLSQVYELLEKDYRMERPEGC 241
Query: 802 VWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834
K E+ AC + RP+ ++
Sbjct: 242 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-58
Identities = 64/272 (23%), Positives = 119/272 (43%), Gaps = 20/272 (7%)
Query: 564 NFERVLGKGGFGTVYHGYL-DDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILV 622
F + +G G FG V+ GY + +VA+K + + + F E E++++ H L L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 623 GYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPI 682
G C E A + L++EFM +G L L + E L + + +G+ YL + +
Sbjct: 67 GVCLEQAPICLVFEFMEHGCLS-DYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACV 122
Query: 683 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTE 742
+HRD+ + N L+ E K++DFG++R + ST + PE + +R +
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 743 KSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTV 802
KSDV+SFGV++ E+ + G+ + ++ + +
Sbjct: 182 KSDVWSFGVLMWEVFSE-------------GKIPYENRSNSEVVEDISTGFRLYKPRLAS 228
Query: 803 WKAVEIALACIHTISTRRPTMNQVVIELNDCL 834
+I C RP ++++ +L +
Sbjct: 229 THVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 4e-58
Identities = 65/270 (24%), Positives = 119/270 (44%), Gaps = 20/270 (7%)
Query: 564 NFERVLGKGGFGTVYHGYL-DDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILV 622
F + LG G FG V +G VA+KM+ S +F E ++++ H+ L L
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 623 GYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPI 682
G C + + +I E+MANG L + L + ++ L++ + + +EYL +
Sbjct: 66 GVCTKQRPIFIITEYMANGCLL-NYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 121
Query: 683 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTE 742
+HRD+ + N L+N++ K++DFGLSR + S + PE + ++ +
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 743 KSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTV 802
KSD+++FGV++ E+ + G+ + + L+
Sbjct: 181 KSDIWAFGVLMWEIYSL-------------GKMPYERFTNSETAEHIAQGLRLYRPHLAS 227
Query: 803 WKAVEIALACIHTISTRRPTMNQVVIELND 832
K I +C H + RPT ++ + D
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 6e-58
Identities = 67/272 (24%), Positives = 116/272 (42%), Gaps = 20/272 (7%)
Query: 565 FERVLGKGGFGTVYHGYLDD-KQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVG 623
E LG+G FG V+ G + +VA+K L + + F E +++ + H+ L L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 79
Query: 624 YCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIV 683
E + ++ E+M+ G+L L + L + + +A++ A G+ Y+ V
Sbjct: 80 VVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 135
Query: 684 HRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEK 743
HRD+++ANIL+ E K+ADFGL+R+ + + PE + R T K
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 194
Query: 744 SDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVW 803
SDV+SFG++L EL T G+ + ++ + V+ +
Sbjct: 195 SDVWSFGILLTELTTK-------------GRVPYPGMVNREVLDQVERGYRMPCPPECPE 241
Query: 804 KAVEIALACIHTISTRRPTMNQVVIELNDCLA 835
++ C RPT + L D
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (503), Expect = 9e-58
Identities = 72/302 (23%), Positives = 127/302 (42%), Gaps = 37/302 (12%)
Query: 553 FSYFDVLKITNNF-----------ERVLGKGGFGTVYHGYL-----DDKQVAVKMLSSS- 595
F++ D + F E+V+G G FG V G+L + VA+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 596 SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTL 655
+ + + F +E ++ + H N+ L G + + +I EFM NG+L L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD-SFLRQNDGQF 125
Query: 656 CWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715
+ + + A G++YL + VHRD+ + NIL+N K++DFGLSR +
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 716 GTHVSTTVVG---TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLI 772
T+ +G + PE + T SDV+S+G+V+ E+++
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY------------- 229
Query: 773 GQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832
G+ + D+ N ++ + + ++ L C RP Q+V L+
Sbjct: 230 GERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289
Query: 833 CL 834
+
Sbjct: 290 MI 291
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-57
Identities = 63/272 (23%), Positives = 110/272 (40%), Gaps = 29/272 (10%)
Query: 565 FERVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTI 620
F+ +G+G F TVY G +VA L + ++F+ E E+L H N+
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 621 LVGYCDEGANMG----LIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN 676
+ L+ E M +G L+ +L + + + + +GL++LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 677 GCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYY 735
PPI+HRD+K NI + K+ D GL+ + + V+GTP ++ PE
Sbjct: 131 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAPEM- 184
Query: 736 ISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795
+ E DVY+FG+ +LE+ T + + I + +
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------------YRRVTSGVKPA 232
Query: 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVV 827
FD + + EI CI R ++ ++
Sbjct: 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-57
Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 562 TNNFE--RVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQGY-KQFQAEVELLIRAHHK 616
++FE LG G G V+ +A K++ Q E+++L +
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 617 NLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN 676
+ G + + E M G+L L KA + + +++ +GL YL
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYI 736
K I+HRDVK +NIL+N + + KL DFG+S ++ + VGT Y+ PE
Sbjct: 123 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQ 176
Query: 737 SNRLTEKSDVYSFGVVLLELITGQP 761
+ +SD++S G+ L+E+ G+
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 6e-57
Identities = 68/279 (24%), Positives = 119/279 (42%), Gaps = 25/279 (8%)
Query: 564 NFERVLGKGGFGTVYHGYLDD------KQVAVKMLSSSSVQGYK-QFQAEVELLIRAHHK 616
++V+G G FG VY G L VA+K L + + + F E ++ + H
Sbjct: 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 69
Query: 617 NLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN 676
N+ L G + M +I E+M NG L +K + + + A G++YL N
Sbjct: 70 NIIRLEGVISKYKPMMIITEYMENG-ALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG-GTHVSTTVVGTPGYLDPEYY 735
VHRD+ + NIL+N K++DFGLSR+ + T+ ++ + PE
Sbjct: 129 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 736 ISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795
+ T SDV+SFG+V+ E++T G+ L+ ++ ++ +
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTY-------------GERPYWELSNHEVMKAINDGFRL 232
Query: 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834
+ ++ + C RRP +V L+ +
Sbjct: 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (497), Expect = 7e-57
Identities = 78/300 (26%), Positives = 115/300 (38%), Gaps = 48/300 (16%)
Query: 563 NNFE--RVLGKGGFGTVYHGYL-------DDKQVAVKMLS-SSSVQGYKQFQAEVELLIR 612
NN E R +G+G FG V+ VAVKML +S FQ E L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 613 AHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHL----------------------LED 650
+ N+ L+G C G M L++E+MA G+L L
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 651 KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710
L +L IA + A G+ YL VHRD+ + N L+ E K+ADFGLSR
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 711 FPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRT 770
++ PE NR T +SDV+++GVVL E+ + P
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY----GLQPYYG 245
Query: 771 LIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIEL 830
+ + V + G+I + N + + C + RP+ + L
Sbjct: 246 MAHEEVIYYVRDGNILACPE---------NCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 4e-55
Identities = 54/285 (18%), Positives = 115/285 (40%), Gaps = 24/285 (8%)
Query: 566 ERVLGKGGFGTVYHGYLDDKQ----VAVKMLSSSSVQG-YKQFQAEVELLIRAHHKNLTI 620
+ LG G FG+V G ++ VA+K+L + + ++ E +++ + + +
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 621 LVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKP 680
L+G C + + L+ E G L L+ + + + ++ + + G++YL
Sbjct: 74 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE---K 128
Query: 681 PIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT-HVSTTVVGTPGYLDPEYYISNR 739
VHRD+ + N+LL + AK++DFGLS+ + + + PE +
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188
Query: 740 LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799
+ +SDV+S+GV + E ++ GQ + ++ ++ + +
Sbjct: 189 FSSRSDVWSYGVTMWEALSY-------------GQKPYKKMKGPEVMAFIEQGKRMECPP 235
Query: 800 NTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAMEIARTKAH 844
+ + C RP V + C ++ + H
Sbjct: 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 280
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 4e-55
Identities = 72/297 (24%), Positives = 130/297 (43%), Gaps = 26/297 (8%)
Query: 548 LENRKFSYFDVLKITNNFERVLGKGGFGTVYHGYLDDK-----QVAVKMLSSSSVQG-YK 601
++ + + +F V+G+G FG VYHG L D AVK L+ + G
Sbjct: 14 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS 73
Query: 602 QFQAEVELLIRAHHKNLTILVGYC-DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERR 660
QF E ++ H N+ L+G C + ++ +M +G+L+ + + ++ +
Sbjct: 74 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR-NFIRNETHNPTVKDL 132
Query: 661 LQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG--TH 718
+ + A+G+ VHRD+ + N +L+EKF K+ADFGL+R + H
Sbjct: 133 IGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189
Query: 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSS 778
T ++ E + + T KSDV+SFGV+L EL+T P + ++
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR----GAPPYPDVNTFDITV 245
Query: 779 MLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835
L +G ++ E+ L C H + RP+ +++V ++ +
Sbjct: 246 YLLQGRRLLQPEY---------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 6e-55
Identities = 66/274 (24%), Positives = 125/274 (45%), Gaps = 26/274 (9%)
Query: 566 ERVLGKGGFGTVYHGYLDDKQ----VAVKMLSSSSVQGY--KQFQAEVELLIRAHHKNLT 619
++ LG G FGTV GY K+ VAVK+L + + + AE ++ + + +
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCK 679
++G C+ + M L+ E G L +L +++ + + +++ + + G++YL
Sbjct: 72 RMIGICEAESWM-LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE--- 125
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT-VVGTPGYLDPEYYISN 738
VHRD+ + N+LL + AK++DFGLS+ + + + T + PE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 739 RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798
+ + KSDV+SFGV++ E + + P R + G V++ML +G+ +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSY----GQKPYRGMKGSEVTAMLEKGE---------RMGCP 232
Query: 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832
+ ++ C RP V + L +
Sbjct: 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 6e-55
Identities = 67/276 (24%), Positives = 116/276 (42%), Gaps = 28/276 (10%)
Query: 564 NFE--RVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKN 617
++E +G G +G D K + K L S+ + +EV LL H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 618 LTILVGYCDEGAN--MGLIYEFMANGNLQAHLLEDKAD--TLCWERRLQIASESAQGLEY 673
+ + N + ++ E+ G+L + + + + L E L++ ++ L+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 674 LH--NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLD 731
H + ++HRD+K AN+ L+ K KL DFGL+RI T + VGTP Y+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTPYYMS 182
Query: 732 PEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDH 791
PE EKSD++S G +L EL P Q+ L G+ I+
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK----------IREGKFR 232
Query: 792 RLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVV 827
R+ + + EI ++ RP++ +++
Sbjct: 233 RIPYRYSD----ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 9e-55
Identities = 68/297 (22%), Positives = 119/297 (40%), Gaps = 45/297 (15%)
Query: 565 FERVLGKGGFGTVYHGYLDD-------KQVAVKMLSSSSVQGY-KQFQAEVELLIR-AHH 615
F +VLG G FG V + QVAVKML + + +E++++ + H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNLQAHL---------------------LEDKADT 654
+N+ L+G C + LI+E+ G+L +L E+ +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 655 LCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714
L +E L A + A+G+E+L VHRD+ + N+L+ K+ DFGL+R +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 715 GGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQ 774
V ++ PE T KSDV+S+G++L E+ + P
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL----GVNP------- 266
Query: 775 WVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELN 831
+ + ++ + + D + I +C S +RP+ + L
Sbjct: 267 -YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 1e-54
Identities = 68/296 (22%), Positives = 114/296 (38%), Gaps = 40/296 (13%)
Query: 565 FERVLGKGGFGTVYHGYL-------DDKQVAVKMLSSSSVQGYKQ-FQAEVELLIR-AHH 615
F + LG G FG V VAVKML S+ ++ +E+++L +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNLQAHL----------------LEDKADTLCWER 659
N+ L+G C G +I E+ G+L L +ED L E
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 660 RLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719
L + + A+G+ +L + +HRD+ + NILL K+ DFGL+R + V
Sbjct: 147 LLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSM 779
++ PE + T +SDV+S+G+ L EL + M
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS------------SPYPGM 251
Query: 780 LARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835
++ + + + +I C +RPT Q+V + ++
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-53
Identities = 59/271 (21%), Positives = 108/271 (39%), Gaps = 25/271 (9%)
Query: 563 NNFE--RVLGKGGFGTVYHGYL--DDKQVAVKMLS-SSSVQGYKQFQAEVELLIRAHHKN 617
+++ + LG+G +G V ++ VAVK++ +V + + E+ + +H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNG 677
+ G+ EG L E+ + G L + D + + + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH-- 120
Query: 678 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYIS 737
I HRD+K N+LL+E+ K++DFGL+ +F + + GT Y+ PE
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 738 NRL-TEKSDVYSFGVVLLELITGQPVI-QKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795
E DV+S G+VL ++ G+ Q + W K I
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA---- 235
Query: 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQV 826
+ + + + R T+ +
Sbjct: 236 ---------PLALLHKILVENPSARITIPDI 257
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 4e-53
Identities = 72/268 (26%), Positives = 111/268 (41%), Gaps = 29/268 (10%)
Query: 565 FERVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLT 619
R LGKG FG VY +A+K+L + + Q + EVE+ H N+
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCK 679
L GY + + LI E+ G + L K +R +E A L Y H
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCH---S 124
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNR 739
++HRD+K N+LL + K+ADFG S P + TT+ GT YL PE
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIEGRM 180
Query: 740 LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799
EK D++S GV+ E + G+P + + K I R++ F
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-------------YKRIS--RVEFTFPD 225
Query: 800 NTVWKAVEIALACIHTISTRRPTMNQVV 827
A ++ + ++RP + +V+
Sbjct: 226 FVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 5e-53
Identities = 58/269 (21%), Positives = 105/269 (39%), Gaps = 25/269 (9%)
Query: 565 FERVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILV 622
LG G FG VY A K++ + S + + + E+++L H N+ L+
Sbjct: 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 623 GYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPI 682
N+ ++ EF A G + ++ + L + + ++ L YLH I
Sbjct: 76 DAFYYENNLWILIEFCAGGAVD-AVMLELERPLTESQIQVVCKQTLDALNYLH---DNKI 131
Query: 683 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRL-- 740
+HRD+K+ NIL KLADFG+S + +GTP ++ PE +
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMCETSKD 189
Query: 741 ---TEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797
K+DV+S G+ L+E+ +P + ++ + S + +
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK--- 246
Query: 798 DTNTVWKAVEIALACIHTISTRRPTMNQV 826
+ C+ R T +Q+
Sbjct: 247 ---------DFLKKCLEKNVDARWTTSQL 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-52
Identities = 68/285 (23%), Positives = 123/285 (43%), Gaps = 26/285 (9%)
Query: 558 VLKITN-NFERVLGKGGFGTVYHGYLDDK------QVAVKMLS-SSSVQGYKQFQAEVEL 609
+LK T +VLG G FGTVY G + VA+K L ++S + K+ E +
Sbjct: 5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 64
Query: 610 LIRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQ 669
+ + ++ L+G C + LI + M G L ++ E K D + + L + A+
Sbjct: 65 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 122
Query: 670 GLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGY 729
G+ YL + +VHRD+ + N+L+ K+ DFGL+++ E + + +
Sbjct: 123 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 730 LDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIV 789
+ E + T +SDV+S+GV + EL+T G + +I +I+
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTF-------------GSKPYDGIPASEISSIL 226
Query: 790 DHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834
+ + I + C + RP +++IE +
Sbjct: 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-52
Identities = 74/302 (24%), Positives = 131/302 (43%), Gaps = 40/302 (13%)
Query: 554 SYFDVLKITN-NFERVLGKGGFGTVYHGYLDD----KQVAVKMLS-SSSVQGYKQFQAEV 607
+ + VL + F+ V+G+G FG V + A+K + +S ++ F E+
Sbjct: 2 TIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGEL 61
Query: 608 ELLIR-AHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHL--------------LEDKA 652
E+L + HH N+ L+G C+ + L E+ +GNL L A
Sbjct: 62 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 653 DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 712
TL ++ L A++ A+G++YL + +HRD+ + NIL+ E + AK+ADFGLSR
Sbjct: 122 STLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE 178
Query: 713 VEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLI 772
V T ++ E + T SDV+S+GV+L E+++
Sbjct: 179 VY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL------------- 222
Query: 773 GQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELND 832
G + ++ + + + N + ++ C RP+ Q+++ LN
Sbjct: 223 GGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282
Query: 833 CL 834
L
Sbjct: 283 ML 284
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (464), Expect = 3e-52
Identities = 65/269 (24%), Positives = 104/269 (38%), Gaps = 32/269 (11%)
Query: 567 RVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQG---YKQFQAEVELLIRAHHKNLTIL 621
R +G G FG VY + + VA+K +S S Q ++ EV L + H N
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 622 VGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPP 681
G L+ E+ + K L + + QGL YLH
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLH---SHN 135
Query: 682 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYIS---N 738
++HRDVK+ NILL+E KL DFG + I + + VGTP ++ PE ++
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVILAMDEG 189
Query: 739 RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798
+ K DV+S G+ +EL +P + + + +I +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------------LYHIAQNESPALQS 236
Query: 799 TNTVWKAVEIALACIHTISTRRPTMNQVV 827
+ +C+ I RPT ++
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 3e-51
Identities = 66/286 (23%), Positives = 121/286 (42%), Gaps = 32/286 (11%)
Query: 565 FERVLGKGGFGTVYHGYL-------DDKQVAVKMLS-SSSVQGYKQFQAEVELLIRAHHK 616
R LG+G FG VY G + +VA+K ++ ++S++ +F E ++ +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 617 NLTILVGYCDEGANMGLIYEFMANGNLQAHL--------LEDKADTLCWERRLQIASESA 668
++ L+G +G +I E M G+L+++L + +Q+A E A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 669 QGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPG 728
G+ YL+ VHRD+ + N ++ E F K+ DFG++R +
Sbjct: 144 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 729 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNI 788
++ PE T SDV+SFGVVL E+ T + P + L + V + G + +
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATL----AEQPYQGLSNEQVLRFVMEGGLLDK 256
Query: 789 VDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834
D+ E+ C RP+ +++ + + +
Sbjct: 257 PDNCPD---------MLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-50
Identities = 63/282 (22%), Positives = 112/282 (39%), Gaps = 25/282 (8%)
Query: 565 FERVLGKGGFGTVYHGYLDDKQ-----VAVKMLSSSSVQGYKQ-FQAEVELLIRAHHKNL 618
R +G+G FG V+ G + VA+K + + ++ F E + + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 619 TILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGC 678
L+G E + +I E G L+ L+ + +L + A + + L YL
Sbjct: 71 VKLIGVITEN-PVWIIMELCTLGELR-SFLQVRKYSLDLASLILYAYQLSTALAYLE--- 125
Query: 679 KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISN 738
VHRD+ + N+L++ KL DFGLSR + + ++ ++ PE
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFR 184
Query: 739 RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798
R T SDV+ FGV + E++ P + + V + G+
Sbjct: 185 RFTSASDVWMFGVCMWEILMH----GVKPFQGVKNNDVIGRIENGERL---------PMP 231
Query: 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAMEIAR 840
N + C +RRP ++ +L+ L E A+
Sbjct: 232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 273
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-50
Identities = 55/262 (20%), Positives = 105/262 (40%), Gaps = 22/262 (8%)
Query: 567 RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGY 624
+G+G GTVY ++VA++ ++ + E+ ++ + N+ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 625 CDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVH 684
G + ++ E++A G+L + E D + + E Q LE+LH ++H
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEFLH---SNQVIH 139
Query: 685 RDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKS 744
RD+KS NILL KL DFG E +T+VGTP ++ PE K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 197
Query: 745 DVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWK 804
D++S G++ +E+I G+P + ++ + +
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR---------- 247
Query: 805 AVEIALACIHTISTRRPTMNQV 826
+ C+ +R + ++
Sbjct: 248 --DFLNRCLDMDVEKRGSAKEL 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 5e-50
Identities = 64/278 (23%), Positives = 97/278 (34%), Gaps = 26/278 (9%)
Query: 565 FERVLGKGGFGTVYHGYLDDK-----QVAVKMLSSSSV---QGYKQFQAEVELLIRAHHK 616
LG G FG V G D VAVK L + + F EV + H+
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 617 NLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN 676
NL L G M ++ E G+L L + A + A+G+ YL +
Sbjct: 72 NLIRLYGVVLTP-PMKMVTELAPLGSLL-DRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT-VVGTPGYLDPEYY 735
+HRD+ + N+LL + K+ DFGL R P +V + PE
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 736 ISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795
+ + SD + FGV L E+ T + P L G + + I +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTY----GQEPWIGLNGSQI--------LHKIDKEGERL 234
Query: 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833
+ + + C RPT + L +
Sbjct: 235 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 7e-50
Identities = 73/297 (24%), Positives = 129/297 (43%), Gaps = 41/297 (13%)
Query: 565 FERVLGKGGFGTVYHGYL---------DDKQVAVKMLSSSSVQ-GYKQFQAEVELLIR-A 613
+ LG+G FG V +VAVKML S + + +E+E++
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 614 HHKNLTILVGYCDEGANMGLIYEFMANGNLQAHL--------------LEDKADTLCWER 659
HKN+ L+G C + + +I E+ + GNL+ +L + + L +
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 660 RLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719
+ A + A+G+EYL +HRD+ + N+L+ E K+ADFGL+R
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSM 779
+T ++ PE T +SDV+SFGV+L E+ T G
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL-------------GGSPYPG 240
Query: 780 LARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836
+ ++ ++ + D +N + + C H + ++RPT Q+V +L+ +A+
Sbjct: 241 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-48
Identities = 76/294 (25%), Positives = 124/294 (42%), Gaps = 39/294 (13%)
Query: 565 FERVLGKGGFGTVYHGYL-------DDKQVAVKMLSSSSVQG-YKQFQAEVELLIR-AHH 615
+ LG+G FG V + VAVKML + ++ +E+++LI HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 616 KNLTILVGYC-DEGANMGLIYEFMANGNLQAHLLEDK--------------ADTLCWERR 660
N+ L+G C G + +I EF GNL +L + D L E
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 661 LQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720
+ + + A+G+E+L + +HRD+ + NILL+EK K+ DFGL+R +
Sbjct: 137 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSML 780
++ PE T +SDV+SFGV+L E+ + + I + L
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK---IDEEFCRRL 250
Query: 781 ARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834
G D+ + + L C H ++RPT +++V L + L
Sbjct: 251 KEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-48
Identities = 54/267 (20%), Positives = 106/267 (39%), Gaps = 25/267 (9%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLT 619
F ++LG+G F TV ++ A+K+L + E +++ R H
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCK 679
L + + + NG L ++ + + A+ + L
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYT---AEIVSALEYLHG 126
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNR 739
I+HRD+K NILLNE ++ DFG +++ E + + VGT Y+ PE
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186
Query: 740 LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799
+ SD+++ G ++ +L+ G P + + + + I+ +L+ DF
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-------------FQKII--KLEYDFPE 231
Query: 800 NTVWKAVEIALACIHTISTRRPTMNQV 826
KA ++ + +T+R ++
Sbjct: 232 KFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (421), Expect = 5e-46
Identities = 52/272 (19%), Positives = 99/272 (36%), Gaps = 24/272 (8%)
Query: 561 ITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHK 616
+ ++++ LG G FG V+ A K + + + + E++ + H
Sbjct: 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 83
Query: 617 NLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN 676
L L ++ M +IYEFM+ G L + D+ + + + ++ + +GL ++H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELF-EKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 677 GCKPPIVHRDVKSANILLNEKF--QAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEY 734
VH D+K NI+ K + KL DFGL+ GT + PE
Sbjct: 143 NN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEV 196
Query: 735 YISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794
+ +D++S GV+ L++G + S D +
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS-----------CDWNMD 245
Query: 795 GDFDTNTVWKAVEIALACIHTISTRRPTMNQV 826
+ + + R T++Q
Sbjct: 246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (407), Expect = 5e-44
Identities = 47/273 (17%), Positives = 100/273 (36%), Gaps = 24/273 (8%)
Query: 560 KITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHH 615
+ + ++ LG G FG V+ + K +++ + E+ ++ + HH
Sbjct: 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 85
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH 675
L L ++ M LI EF++ G L + + + + ++ +GL+++H
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGEL-FDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 676 NGCKPPIVHRDVKSANILL--NEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPE 733
+ IVH D+K NI+ + K+ DFGL+ + T + PE
Sbjct: 145 ---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPE 198
Query: 734 YYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL 793
+ +D+++ GV+ L++G + D
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR-----------CDWEF 247
Query: 794 QGDFDTNTVWKAVEIALACIHTISTRRPTMNQV 826
D ++ +A + + +R T++
Sbjct: 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 5e-44
Identities = 56/271 (20%), Positives = 107/271 (39%), Gaps = 21/271 (7%)
Query: 561 ITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGY-KQFQAEVELLIRAHH 615
I + ++ VLG G F V K VA+K ++ +++G + E+ +L + H
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKH 66
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH 675
N+ L + G ++ LI + ++ G L ++E ++ + ++YLH
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLH 124
Query: 676 NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYY 735
+ + L+E + ++DFGLS++ E V +T GTPGY+ PE
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVL 181
Query: 736 ISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795
++ D +S GV+ L+ G P L Q + + ++
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA-----------EYEFDS 230
Query: 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQV 826
+ + A + + +R T Q
Sbjct: 231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 157 bits (398), Expect = 1e-43
Identities = 58/229 (25%), Positives = 109/229 (47%), Gaps = 17/229 (7%)
Query: 560 KITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQG---YKQFQAEVELLIR 612
+++ +E +LG GG V+ + VAVK+L + + Y +F+ E +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 613 AHHKNLTILVGYCDEGANMG----LIYEFMANGNLQAHLLEDKADTLCWERRLQIASESA 668
+H + + + G ++ E++ L+ + + + +R +++ +++
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADAC 121
Query: 669 QGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST-TVVGTP 727
Q L + + I+HRDVK ANI+++ K+ DFG++R G + T V+GT
Sbjct: 122 QALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 728 GYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWV 776
YL PE + + +SDVYS G VL E++TG+P ++ Q V
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 227
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-42
Identities = 47/268 (17%), Positives = 100/268 (37%), Gaps = 27/268 (10%)
Query: 565 FERVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILV 622
LG+G FG V+ K K + + E+ +L A H+N+ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLH 67
Query: 623 GYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPI 682
+ + +I+EF++ ++ + A L + + + L++LH I
Sbjct: 68 ESFESMEELVMIFEFISGLDI-FERINTSAFELNEREIVSYVHQVCEALQFLH---SHNI 123
Query: 683 VHRDVKSANILLNEK--FQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRL 740
H D++ NI+ + K+ +FG +R + P Y PE + + +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 741 TEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800
+ +D++S G ++ L++G + + I+NI++ D +
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQI-------------IENIMNAEYTFDEEAF 227
Query: 801 TVW--KAVEIALACIHTISTRRPTMNQV 826
+A++ + R T ++
Sbjct: 228 KEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (386), Expect = 7e-42
Identities = 47/288 (16%), Positives = 99/288 (34%), Gaps = 25/288 (8%)
Query: 559 LKITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAH 614
L++ N + R +G G FG +Y G ++VA+K+ + Q E ++
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQ 60
Query: 615 HKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL 674
+ +C + ++ + +L+ L + + L +A + +EY+
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLE-DLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 675 HNGCKPPIVHRDVKSANILLNEK---FQAKLADFGLSRIFPVEGGT-----HVSTTVVGT 726
H+ +HRDVK N L+ + DFGL++ + + + GT
Sbjct: 120 HSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 727 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIK 786
Y ++ + + D+ S G VL+ G Q T ++ +
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK---M 233
Query: 787 NIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834
+ L + + + C +P + + +
Sbjct: 234 STPIEVLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 153 bits (387), Expect = 9e-42
Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 563 NNFE--RVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQGYKQ---FQAEVELLIRAHH 615
+F+ R LG G FG V+ + + A+K+L V KQ E +L H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH 675
+ + G + + +I +++ G L + L + + + +A+ L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY-----AAEVCLALE 118
Query: 676 NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYY 735
I++RD+K NILL++ K+ DFG ++ P V+ T+ GTP Y+ PE
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPEVV 173
Query: 736 ISNRLTEKSDVYSFGVVLLELITGQP 761
+ + D +SFG+++ E++ G
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 151 bits (383), Expect = 1e-41
Identities = 44/289 (15%), Positives = 98/289 (33%), Gaps = 29/289 (10%)
Query: 561 ITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIR-AHH 615
+ +++ R +G+G FG ++ G L+++QVA+K S Q + E A
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGC 60
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH 675
+ + + EG + L+ + + G LL+ + A + ++ +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 676 NGCKPPIVHRDVKSANILLNEKFQ-----AKLADFGLSRIFPVEGGT-----HVSTTVVG 725
+ +V+RD+K N L+ + DFG+ + + + G
Sbjct: 119 ---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 726 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDI 785
T Y+ ++ + + D+ + G V + + G Q T ++ I
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER-------I 228
Query: 786 KNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834
+ + + + P + + + L
Sbjct: 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 150 bits (381), Expect = 2e-41
Identities = 62/282 (21%), Positives = 105/282 (37%), Gaps = 41/282 (14%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGY---------KQFQAEVELLIRA 613
+ +LG+G V K+ AVK++ + + + EV++L +
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 614 H-HKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLE 672
H N+ L + L+++ M G L +L E TL + +I + +
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVIC 124
Query: 673 YLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDP 732
LH K IVHRD+K NILL++ KL DFG S V GTP YL P
Sbjct: 125 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD---PGEKLREVCGTPSYLAP 178
Query: 733 EYYISNRL------TEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIK 786
E + ++ D++S GV++ L+ G P Q + ++
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-------------LR 225
Query: 787 NIVDHRLQGDFDTNTVW--KAVEIALACIHTISTRRPTMNQV 826
I+ Q + ++ + +R T +
Sbjct: 226 MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 9e-41
Identities = 58/293 (19%), Positives = 105/293 (35%), Gaps = 32/293 (10%)
Query: 560 KITNNFE--RVLGKGGFGTVYHGY---LDDKQVAVKMLSSSSVQGYKQFQAEVEL----- 609
+ +E +G+G +G V+ + VA+K + + + E+
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 610 LIRAHHKNLTILVGYCDEGANMGLIYEFM----ANGNLQAHLLEDKADTLCWERRLQIAS 665
L H N+ L C + + +L +L + + E +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 666 ESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVG 725
+ +GL++LH+ +VHRD+K NIL+ Q KLADFGL+RI+ T+VV
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVV 177
Query: 726 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP------------VIQKTPQRTLIG 773
T Y PE + + D++S G + E+ +P I
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 774 QWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQV 826
W + + + F T+ ++ L C+ +R +
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-40
Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 13/203 (6%)
Query: 565 FERVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSV---QGYKQFQAEVELLIRA-HHKNL 618
++LGKG FG V+ ++ A+K L V + E +L A H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 619 TILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGC 678
T + N+ + E++ G+L H+ R A+E GL++L
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFL---H 120
Query: 679 KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISN 738
IV+RD+K NILL++ K+ADFG+ + + T GTP Y+ PE +
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEILLGQ 178
Query: 739 RLTEKSDVYSFGVVLLELITGQP 761
+ D +SFGV+L E++ GQ
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQS 201
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-40
Identities = 70/282 (24%), Positives = 110/282 (39%), Gaps = 30/282 (10%)
Query: 567 RVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQG-----YKQFQAEVELLIRAHHKNLT 619
LG+G F TVY ++ VA+K + + E++LL H N+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 620 ILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCK 679
L+ +N+ L+++FM +++D + L + QGLEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV--IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 680 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNR 739
I+HRD+K N+LL+E KLADFGL++ F + T V T Y PE R
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGAR 176
Query: 740 L-TEKSDVYSFGVVLLELITGQPV------------IQKTPQRTLIGQW--VSSMLARGD 784
+ D+++ G +L EL+ P I +T QW + S+
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 785 IKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQV 826
K+ L F +++ R T Q
Sbjct: 237 FKSFPGIPLHHIFS-AAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 148 bits (375), Expect = 1e-39
Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 20/209 (9%)
Query: 563 NNFE--RVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSV---QGYKQFQAEVE---LLIR 612
N+F R++G+GGFG VY K A+K L + QG E L+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 613 AHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLE 672
+ + + I + M G+L HL + A+E GLE
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLE 121
Query: 673 YLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDP 732
++H +V+RD+K ANILL+E +++D GL+ F VGT GY+ P
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAP 174
Query: 733 EYYISNR-LTEKSDVYSFGVVLLELITGQ 760
E +D +S G +L +L+ G
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-39
Identities = 61/295 (20%), Positives = 120/295 (40%), Gaps = 31/295 (10%)
Query: 558 VLKITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGY-KQFQAEVELLIR 612
V + + +G+G +G V Y ++ +VA+K +S Q Y ++ E+++L+R
Sbjct: 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 62
Query: 613 AHHKNLTILVGYCDEGANMGLIYEFMAN---GNLQAHLLEDKADTLCWERRLQIASESAQ 669
H+N+ + + ++ G LL+ + L + + +
Sbjct: 63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILR 120
Query: 670 GLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH-VSTTVVGTPG 728
GL+Y+H ++HRD+K +N+LLN K+ DFGL+R+ + T V T
Sbjct: 121 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 729 YLDPEYYISNRL-TEKSDVYSFGVVLLELITGQ-PVIQKTPQRTL------IGQWVSSML 780
Y PE ++++ T+ D++S G +L E+++ + K L +G L
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 781 ARGDIKNIVDHRLQGDFDTNTVW---------KAVEIALACIHTISTRRPTMNQV 826
++ L W KA+++ + +R + Q
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 48/209 (22%), Positives = 87/209 (41%), Gaps = 20/209 (9%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGY------KQFQAEVELL--IRAH 614
+LG GGFG+VY G D+ VA+K + + + + EV LL + +
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 615 HKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYL 674
+ L+ + + + LI E + ++ L E + + + +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHC 126
Query: 675 HNGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPE 733
++HRD+K NIL++ + + KL DFG + V T GT Y PE
Sbjct: 127 ---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPE 179
Query: 734 YYISNRL-TEKSDVYSFGVVLLELITGQP 761
+ +R + V+S G++L +++ G
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDI 208
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-39
Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 15/210 (7%)
Query: 560 KIT-NNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSV---QGYKQFQAEVELLI 611
K+T N+F+ ++LGKG FG V + A+K+L + E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 612 RAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGL 671
H LT L + + E+ G L HL + ER A+ +
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYG---AEIV 115
Query: 672 EYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLD 731
L +V+RD+K N++L++ K+ DFGL + +G T T GTP YL
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLA 173
Query: 732 PEYYISNRLTEKSDVYSFGVVLLELITGQP 761
PE N D + GVV+ E++ G+
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-38
Identities = 56/280 (20%), Positives = 105/280 (37%), Gaps = 31/280 (11%)
Query: 560 KITNNFE---RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRA- 613
I ++++ +VLG G G V + ++ A+KML + + EVEL RA
Sbjct: 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRAS 62
Query: 614 HHKNLTILVGYCD----EGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQ 669
++ +V + + ++ E + G L + + + +I +
Sbjct: 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122
Query: 670 GLEYLHNGCKPPIVHRDVKSANILLNEKFQ---AKLADFGLSRIFPVEGGTHVSTTVVGT 726
++YLH I HRDVK N+L K KL DFG ++ T T
Sbjct: 123 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYT 176
Query: 727 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIK 786
P Y+ PE + + D++S GV++ L+ G P + + +
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR------ 230
Query: 787 NIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQV 826
+ + + + + + T T+R T+ +
Sbjct: 231 -MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 4e-38
Identities = 58/285 (20%), Positives = 106/285 (37%), Gaps = 29/285 (10%)
Query: 564 NFE--RVLGKGGFGTVYHGY--LDDKQVAVKML--SSSSVQGYKQFQAEVELLIRAHHKN 617
NF+ +G+G +G VY L + VA+K + + + E+ LL +H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNG 677
+ L+ + L++EF+ + +L+ + + + QGL +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC--- 118
Query: 678 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYIS 737
++HRD+K N+L+N + KLADFGL+R F V T+ T V T Y PE +
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLG 176
Query: 738 NR-LTEKSDVYSFGVVLLELITGQPV---------------IQKTPQRTLIGQWVSSMLA 781
+ + D++S G + E++T + + TP + S
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 782 RGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQV 826
+ + +H +R +
Sbjct: 237 KPSFPKWARQDFSKVVPPLDE-DGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-37
Identities = 57/280 (20%), Positives = 107/280 (38%), Gaps = 33/280 (11%)
Query: 561 ITNNFE--RVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQG------YKQFQAEVELL 610
+ + ++ LG G F V Q A K + + + + EV +L
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 611 IRAHHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQG 670
H N+ L + ++ LI E +A G L L E + +L E + Q
Sbjct: 68 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFL---KQI 122
Query: 671 LEYLHNGCKPPIVHRDVKSANILLNE----KFQAKLADFGLSRIFPVEGGTHVSTTVVGT 726
L ++ I H D+K NI+L + K + K+ DFGL+ + + GT
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGT 179
Query: 727 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIK 786
P ++ PE L ++D++S GV+ L++G ++ + +
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA--------- 230
Query: 787 NIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQV 826
V++ + ++ +NT A + + +R T+
Sbjct: 231 --VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 4e-37
Identities = 52/216 (24%), Positives = 94/216 (43%), Gaps = 22/216 (10%)
Query: 563 NNFE--RVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQG--YKQFQAEVELLIRAHHK 616
+ +E +G+G FG V+ ++VA+K + + + E+++L H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 617 NLTILVGYCDEGA--------NMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESA 668
N+ L+ C A ++ L+++F + TL +R+
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-----MQ 124
Query: 669 QGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS--TTVVGT 726
L L+ + I+HRD+K+AN+L+ KLADFGL+R F + + + T V T
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 727 PGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQP 761
Y PE + R D++ G ++ E+ T P
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 137 bits (346), Expect = 1e-36
Identities = 53/285 (18%), Positives = 105/285 (36%), Gaps = 29/285 (10%)
Query: 563 NNFE--RVLGKGGFGTVYHGYL-DDKQVAVKML--SSSSVQGYKQFQAEVELLIRAHHKN 617
+ +G+G +G VY + A+K + E+ +L H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 618 LTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNG 677
+ L + L++E + LL+ L + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLK--KLLDVCEGGLESVTAKSFLLQLLNGIAYCH-- 117
Query: 678 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYIS 737
++HRD+K N+L+N + + K+ADFGL+R F + + T + T Y P+ +
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDVLMG 174
Query: 738 N-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796
+ + + D++S G + E++ G P+ + + + +L + KN +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL-MRIFRILGTPNSKNWPNVTELPK 233
Query: 797 FDTNTVWK---------------AVEIALACIHTISTRRPTMNQV 826
+D N +++ + +R T Q
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 6e-36
Identities = 59/288 (20%), Positives = 103/288 (35%), Gaps = 35/288 (12%)
Query: 564 NFERVLGKGGFGTVYHGYL--DDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTIL 621
+V+G G FG VY L + VA+K + + E++++ + H N+ L
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRL 78
Query: 622 VGYCDEGAN------MGLIYEFMANGNLQAHL-LEDKADTLCWERRLQIASESAQGLEYL 674
+ + L+ +++ + TL + + L Y+
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 675 HNGCKPPIVHRDVKSANILLNEK-FQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPE 733
H+ I HRD+K N+LL+ KL DFG ++ G + +
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPEL 193
Query: 734 YYISNRLTEKSDVYSFGVVLLELITGQPV---------------IQKTPQRTLIGQWVSS 778
+ + T DV+S G VL EL+ GQP+ + TP R I + ++
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI-REMNP 252
Query: 779 MLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQV 826
I H F T +A+ + + T R T +
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (342), Expect = 2e-35
Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 17/206 (8%)
Query: 563 NNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQ---FQAEVELLIRAHH 615
+ F+ + LG G FG V A+K+L V KQ E +L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH 675
L L + +N+ ++ E++A G + +HL + A++ EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 676 NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYY 735
+++RD+K N+L++++ ++ DFG ++ + T+ GTP L PE
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWTLCGTPEALAPEII 210
Query: 736 ISNRLTEKSDVYSFGVVLLELITGQP 761
+S + D ++ GV++ E+ G P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 4e-34
Identities = 51/286 (17%), Positives = 99/286 (34%), Gaps = 29/286 (10%)
Query: 563 NNFE--RVLGKGGFGTVYHGYL--DDKQVAVKML--SSSSVQGYKQFQAEVELLIRAHHK 616
+E +G+G +GTV+ + VA+K + E+ LL HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 617 NLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHN 676
N+ L + L++EF + + E Q L+ L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL--DPEIVKSFL---FQLLKGLGF 116
Query: 677 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYI 736
++HRD+K N+L+N + KLA+FGL+R F + + + V T Y P+
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLF 174
Query: 737 SNR-LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795
+ + D++S G + EL + + + +L +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 796 DFDTNTVWKAVEIALACIHTIS---------------TRRPTMNQV 826
D+ ++ A + + ++ +R + +
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 3e-31
Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 560 KITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKML--SSSSVQGYKQFQAEVELLIRA 613
++ + + +G G +G V +VA+K L S K+ E+ LL
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 614 HHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLED--KADTLCWERRLQIASESAQGL 671
H+N+ L+ + +F L K + L +R + + +GL
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134
Query: 672 EYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLD 731
Y+H I+HRD+K N+ +NE + K+ DFGL+R E T V T Y
Sbjct: 135 RYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRA 186
Query: 732 PEYYISN-RLTEKSDVYSFGVVLLELITGQP 761
PE ++ R T+ D++S G ++ E+ITG+
Sbjct: 187 PEVILNWMRYTQTVDIWSVGCIMAEMITGKT 217
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-30
Identities = 49/212 (23%), Positives = 84/212 (39%), Gaps = 18/212 (8%)
Query: 563 NNFE--RVLGKGGFGTVYHGYL-----DDKQVAVKMLSSSSV----QGYKQFQAEVELLI 611
NFE +VLG G +G V+ K A+K+L +++ + + + E ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 612 RA-HHKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQG 670
L L + LI +++ G L HL + + T + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEI 138
Query: 671 LEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYL 730
+ L + K I++RD+K NILL+ L DFGLS+ F +
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 731 DPEYYISNR-LTEKSDVYSFGVVLLELITGQP 761
+ + D +S GV++ EL+TG
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 119 bits (300), Expect = 4e-30
Identities = 45/228 (19%), Positives = 93/228 (40%), Gaps = 29/228 (12%)
Query: 549 ENRKFSYFDVLKITNNFE--------RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQ 598
+R Y+D + R LG+G + V+ ++++V VK+L
Sbjct: 15 THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK- 73
Query: 599 GYKQFQAEVELLIR-AHHKNLTILVGYCDEGAN--MGLIYEFMANGNLQAHLLEDKADTL 655
K+ + E+++L N+ L + + L++E + N + + TL
Sbjct: 74 --KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTL 126
Query: 656 CWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF-QAKLADFGLSRIFPVE 714
E + L+Y H+ I+HRDVK N++++ + + +L D+GL+ +
Sbjct: 127 TDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--- 180
Query: 715 GGTHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQP 761
V + + PE + ++ D++S G +L +I +
Sbjct: 181 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (300), Expect = 5e-30
Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 561 ITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSV--QGYKQFQAEVELLIRAH 614
+ ++ + +G G G V Y + D+ VA+K LS K+ E+ L+ +
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 615 HKNLTILVGYC------DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESA 668
HKN+ L+ +E ++ L+ E M Q +E ER + +
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQML 129
Query: 669 QGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPG 728
G+++LH+ I+HRD+K +NI++ K+ DFGL+R G + + T V T
Sbjct: 130 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRY 183
Query: 729 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
Y PE + E D++S G ++ E++ +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 3e-28
Identities = 50/216 (23%), Positives = 97/216 (44%), Gaps = 21/216 (9%)
Query: 557 DVLKITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSSS--SVQGYKQFQAEVELL 610
+ ++ ++ +G G +G+V + +VAVK LS S+ K+ E+ LL
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 611 IRAHHKNLTILVGYCDEGANMG----LIYEFMANGNLQAHLLEDKADTLCWERRLQIASE 666
H+N+ L+ ++ + G ++++ + L + + +
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQ 129
Query: 667 SAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGT 726
+GL+Y+H+ HRD+K +N+ +NE + K+ DFGL+R T V T
Sbjct: 130 ILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHT-----DDEMTGYVAT 181
Query: 727 PGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQP 761
Y PE ++ + D++S G ++ EL+TG+
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 109 bits (273), Expect = 2e-26
Identities = 44/215 (20%), Positives = 86/215 (40%), Gaps = 22/215 (10%)
Query: 565 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILV 622
R LG G F TV+ +++ VA+K++ V + + E++LL R + + T
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKED 75
Query: 623 GYC---------------DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASES 667
G ++ +++E + L + + + + QI+ +
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLA-LIKKYEHRGIPLIYVKQISKQL 134
Query: 668 AQGLEYLHNGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIFPVEGGTHVSTTVVGT 726
GL+Y+H + I+H D+K N+L+ L ++ + T + T
Sbjct: 135 LLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 727 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 761
Y PE + +D++S ++ ELITG
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 227
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.1 bits (207), Expect = 4e-19
Identities = 26/154 (16%), Positives = 52/154 (33%), Gaps = 20/154 (12%)
Query: 567 RVLGKGGFGTVYHGYL-DDKQVAVKMLSSSSV----------QGYKQFQAEVELLIRAHH 615
+++G+G V++ Y + VK G F R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 616 KNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLH 675
+ L L +G + +Y + N L + + + E ++ + + +
Sbjct: 66 RALQKL-----QGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 676 NGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 709
+ IVH D+ N+L++E + DF S
Sbjct: 121 H---RGIVHGDLSQYNVLVSE-EGIWIIDFPQSV 150
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 62.1 bits (149), Expect = 7e-11
Identities = 25/76 (32%), Positives = 38/76 (50%), Gaps = 13/76 (17%)
Query: 433 TSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS----L 488
++ LDL N + G +P+ L +L+ L LN+S NNL G +P G G+L
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-------GNLQRFDVS 296
Query: 489 SVDGNRNLC--PSASC 502
+ N+ LC P +C
Sbjct: 297 AYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 61.3 bits (147), Expect = 1e-10
Identities = 17/91 (18%), Positives = 33/91 (36%), Gaps = 1/91 (1%)
Query: 384 WQGDPCAPKVYMWQGINCSYDANQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKN 443
+ + S + ++L ++ I G + + L + SL++S N
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278
Query: 444 SLTGPVPEFLAELQSLRVLNLSGNNLQGSLP 474
+L G +P+ LQ V + N P
Sbjct: 279 NLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 48.2 bits (113), Expect = 2e-06
Identities = 29/114 (25%), Positives = 39/114 (34%), Gaps = 35/114 (30%)
Query: 362 LTNQQDVDAIMKIKSKYE---VKRDWQ--GDPCAPKVYMWQGINCSYDANQSPRIISINL 416
L N QD A+++IK W D C W G+ C Q+ R+ +
Sbjct: 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRT---WLGVLCD-TDTQTYRVNN--- 54
Query: 417 SSSGIAGDIVPYIFSLTSIESLDLSKNSLTG--PVPEFLAELQSLRVLNLSGNN 468
LDLS +L P+P LA L L L + G N
Sbjct: 55 ---------------------LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGIN 87
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 54.2 bits (129), Expect = 3e-08
Identities = 13/81 (16%), Positives = 30/81 (37%), Gaps = 4/81 (4%)
Query: 394 YMWQGINCSYDANQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFL 453
+ + + + L + I+ + + SLT ++ L + N ++ L
Sbjct: 292 LNENQLEDISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSDV--SSL 347
Query: 454 AELQSLRVLNLSGNNLQGSLP 474
A L ++ L+ N + P
Sbjct: 348 ANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 49.2 bits (116), Expect = 1e-06
Identities = 12/59 (20%), Positives = 27/59 (45%), Gaps = 4/59 (6%)
Query: 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN 467
++ + +++ ++ V + +LT+I L N ++ P LA L + L L+
Sbjct: 329 TKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 4e-04
Identities = 10/63 (15%), Positives = 22/63 (34%), Gaps = 4/63 (6%)
Query: 412 ISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQG 471
+ L + + + L + +L + + + + L +L +N S N L
Sbjct: 25 MKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTD 80
Query: 472 SLP 474
P
Sbjct: 81 ITP 83
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (128), Expect = 4e-08
Identities = 15/86 (17%), Positives = 30/86 (34%), Gaps = 5/86 (5%)
Query: 408 SPRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTG----PVPEFLAELQSLRVL 462
S I S+++ ++ + L + + L LT + L +L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 463 NLSGNNLQGSLPSGLSEKVKNGSLSL 488
NL N L + + ++ S +
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 4e-05
Identities = 16/62 (25%), Positives = 24/62 (38%), Gaps = 4/62 (6%)
Query: 433 TSIESLDLSKNSLTGPVPEFLAE----LQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488
+ + L L+ ++ LA SLR L+LS N L + L E V+ L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 489 SV 490
Sbjct: 429 EQ 430
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 9e-05
Identities = 17/101 (16%), Positives = 28/101 (27%), Gaps = 11/101 (10%)
Query: 394 YMWQGINCSYDANQSP--RIISINLSSSGIAGDIVPYIFS----LTSIESLDLSKNSLTG 447
G+ P + + L+ ++ + + S+ LDLS N L
Sbjct: 352 LEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411
Query: 448 PVPEFLAE-----LQSLRVLNLSGNNLQGSLPSGLSEKVKN 483
L E L L L + L K+
Sbjct: 412 AGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKD 452
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 10/69 (14%), Positives = 22/69 (31%), Gaps = 9/69 (13%)
Query: 409 PRIISINLSSSGI----AGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAEL-----QSL 459
+ + L G+ DI + ++ L+L N L + + +
Sbjct: 27 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKI 86
Query: 460 RVLNLSGNN 468
+ L+L
Sbjct: 87 QKLSLQNCC 95
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 47.7 bits (112), Expect = 3e-06
Identities = 28/175 (16%), Positives = 57/175 (32%), Gaps = 11/175 (6%)
Query: 396 WQGINCSY------DANQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPV 449
+ + CS + P ++L ++ I +L ++ +L L N ++
Sbjct: 12 LRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71
Query: 450 PEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSVDGNRNLCPSASCKKKSNKF 509
P A L L L LS N L+ LP + + ++ L + + + S
Sbjct: 72 PGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQE--LRVHENEITKVRKSVFNGLNQMIV 128
Query: 510 IFPVLASVVSFCILLALLAILQNLRRRKQAGKKKGSLELENRKFSYFDVLKITNN 564
+ + S I ++ L + A ++ L + N
Sbjct: 129 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGN 181
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 9e-06
Identities = 16/83 (19%), Positives = 31/83 (37%), Gaps = 4/83 (4%)
Query: 394 YMWQGINCSYDANQSPRIISINLSSSGIAGDIVPYIFS-LTSIESLDLSKNSLTGPVPEF 452
A ++ +NLS + ++ +F + LD+S+ +
Sbjct: 161 NKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG 220
Query: 453 LAELQSLRVLNLSGNNLQGSLPS 475
L L+ LR + NL+ LP+
Sbjct: 221 LENLKKLRARST--YNLK-KLPT 240
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 3e-05
Identities = 20/112 (17%), Positives = 34/112 (30%), Gaps = 12/112 (10%)
Query: 384 WQGDPCAPKVYMWQGINCSYDANQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKN 443
+ D + + + + + +I S+E L++S N
Sbjct: 235 YLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNN 294
Query: 444 SLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSL-SLSVDGNR 494
L E A L L S N+L +P +L L V+ N
Sbjct: 295 KLI----ELPALPPRLERLIASFNHLA-EVPELP------QNLKQLHVEYNP 335
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.4 bits (103), Expect = 4e-05
Identities = 19/98 (19%), Positives = 36/98 (36%), Gaps = 10/98 (10%)
Query: 384 WQGDPCAPKVYMWQGINCSYDANQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKN 443
P + P + +N+S++ + +P +E L S N
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE--LPA--LPPRLERLIASFN 314
Query: 444 SLTGPVPEFLAELQSLRVLNLSGNNLQG--SLPSGLSE 479
L VPE Q+L+ L++ N L+ +P + +
Sbjct: 315 HLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.002
Identities = 16/79 (20%), Positives = 26/79 (32%), Gaps = 5/79 (6%)
Query: 433 TSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSVDG 492
L+L+ L+ +PE L L S N+L LP + ++
Sbjct: 38 RQAHELELNNLGLSS-LPE---LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 493 NRNLCPSASCKKKSNKFIF 511
+L P SN +
Sbjct: 93 LSDLPPLLEYLGVSNNQLE 111
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.3 bits (100), Expect = 8e-05
Identities = 14/92 (15%), Positives = 26/92 (28%), Gaps = 6/92 (6%)
Query: 384 WQGDPCAPKVYMWQGINCSYDANQSPRIISINLSSSGIAGDIVPYIF-SLTSIESLDLSK 442
S+ + + LS+ G A + + +++L L
Sbjct: 223 QDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQY 282
Query: 443 NSLTGPVPEFLAE-----LQSLRVLNLSGNNL 469
N + L + L L L+GN
Sbjct: 283 NEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 314
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 6e-04
Identities = 8/63 (12%), Positives = 24/63 (38%), Gaps = 4/63 (6%)
Query: 412 ISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGP----VPEFLAELQSLRVLNLSGN 467
+ ++ ++ + + S++ + LS N++ + E +A + L + S
Sbjct: 10 LKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI 69
Query: 468 NLQ 470
Sbjct: 70 FTG 72
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.5 bits (90), Expect = 0.002
Identities = 16/54 (29%), Positives = 25/54 (46%), Gaps = 4/54 (7%)
Query: 434 SIESLDLSKNSLTG----PVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKN 483
SIE L +++T V L E S++ + LSGN + LSE + +
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIAS 57
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 2e-04
Identities = 10/71 (14%), Positives = 33/71 (46%), Gaps = 2/71 (2%)
Query: 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGS 472
+++L+ + D+ + S I + ++ + P+ E + + ++ ++LS + ++ S
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQGVI-AFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVS 61
Query: 473 LPSGLSEKVKN 483
G+ +
Sbjct: 62 TLHGILSQCSK 72
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.3 bits (91), Expect = 2e-04
Identities = 14/51 (27%), Positives = 22/51 (43%), Gaps = 3/51 (5%)
Query: 436 ESLDLSKNSLTG-PVPEFLAELQSLRVLNLSGNNLQG--SLPSGLSEKVKN 483
+ L L N L + L L +LNL GN+L + L+E + +
Sbjct: 68 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 7e-04
Identities = 9/40 (22%), Positives = 20/40 (50%), Gaps = 2/40 (5%)
Query: 426 VPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLS 465
+ + SL ++ + L N ++ P LA +L ++ L+
Sbjct: 188 ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 8/40 (20%), Positives = 18/40 (45%), Gaps = 2/40 (5%)
Query: 431 SLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQ 470
+L + + K+++T V A+L + L+ G +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT 54
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 0.001
Identities = 12/63 (19%), Positives = 20/63 (31%), Gaps = 3/63 (4%)
Query: 406 NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLS 465
++ + +N + + P + L LS+N L L L LNL
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 466 GNN 468
Sbjct: 64 RAE 66
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 14/41 (34%), Positives = 23/41 (56%), Gaps = 2/41 (4%)
Query: 426 VPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG 466
+ + LT +++L LSKN ++ LA L++L VL L
Sbjct: 171 IVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.003
Identities = 7/45 (15%), Positives = 14/45 (31%), Gaps = 1/45 (2%)
Query: 426 VPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQ 470
+ LDL + + A L ++ S N ++
Sbjct: 11 AAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR 54
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 870 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.82 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.71 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.04 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.04 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.98 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 98.79 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 98.66 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 98.64 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.55 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.5 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.46 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.45 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.39 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.2 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.18 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.16 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.12 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.09 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 97.95 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 97.95 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 97.84 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 97.75 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 97.71 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 97.66 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 97.64 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.6 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 97.59 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 97.45 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 97.42 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.33 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.28 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 97.24 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.18 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.92 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 96.76 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 96.59 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 96.14 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.06 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 95.48 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 95.42 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.31 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.09 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 94.53 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 94.44 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 93.39 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 93.2 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 91.1 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 88.78 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 81.25 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=414.45 Aligned_cols=256 Identities=30% Similarity=0.509 Sum_probs=203.4
Q ss_pred hccccccccCcEEEEEEEECCeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 564 NFERVLGKGGFGTVYHGYLDDKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
.+.+.||+|+||+||+|++++ .||||+++.. .....+.|++|++++++++|||||++++++.+ ...++||||+++|
T Consensus 11 ~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g 88 (276)
T d1uwha_ 11 TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGS 88 (276)
T ss_dssp CCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEE
T ss_pred EEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCC
Confidence 346789999999999998765 5999998754 34456789999999999999999999999865 5689999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++.... ..+++..++.|+.||++||+|||++ +|+||||||+|||+++++.+||+|||+++............
T Consensus 89 ~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~ 164 (276)
T d1uwha_ 89 SLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 164 (276)
T ss_dssp EHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-----------
T ss_pred CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCccccc
Confidence 9999986533 4699999999999999999999998 99999999999999999999999999998765444444455
Q ss_pred cccCCCCccCccccccC---CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 722 TVVGTPGYLDPEYYISN---RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~---~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
...||+.|||||++.+. .++.++|||||||++|||+||+.||........+...+. .+.. .+.+ ....
T Consensus 165 ~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~----~~~~----~p~~-~~~~ 235 (276)
T d1uwha_ 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG----RGYL----SPDL-SKVR 235 (276)
T ss_dssp -CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH----HTSC----CCCG-GGSC
T ss_pred ccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHh----cCCC----CCcc-hhcc
Confidence 67899999999999643 489999999999999999999999987654433332222 2211 1111 1112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
...+..+.+++.+||+.+|++||||+||++.|+.+.
T Consensus 236 ~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 234567889999999999999999999999998754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9e-48 Score=416.54 Aligned_cols=266 Identities=26% Similarity=0.418 Sum_probs=206.6
Q ss_pred ccCHHHHHHHHhhc-----------cccccccCcEEEEEEEEC--C---eeEEEEEeecc-chhhhHHHHHHHHHHHHhc
Q 002887 552 KFSYFDVLKITNNF-----------ERVLGKGGFGTVYHGYLD--D---KQVAVKMLSSS-SVQGYKQFQAEVELLIRAH 614 (870)
Q Consensus 552 ~~~~~dl~~~t~~f-----------~~~LG~G~fG~Vy~~~~~--~---~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~ 614 (870)
.++|+|+.+++.+| .+.||+|+||+||+|++. + ..||||++... .....++|.+|+++|++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 34566666666655 368999999999999985 2 25899988764 3345678999999999999
Q ss_pred cccceeEEEEEecCCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEE
Q 002887 615 HKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILL 694 (870)
Q Consensus 615 H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILl 694 (870)
|||||+++|+|.+++..++|||||++|+|.+++... ...++|.+++.++.|||+||+|||++ +|+||||||+||||
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl 161 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILV 161 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEE
Confidence 999999999999999999999999999999987643 34699999999999999999999998 99999999999999
Q ss_pred cCCCcEEEEeccCCccccCCCCccc---cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccc
Q 002887 695 NEKFQAKLADFGLSRIFPVEGGTHV---STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRT 770 (870)
Q Consensus 695 d~~~~vkL~DFGla~~~~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~ 770 (870)
++++.+||+|||+++.+........ .....||+.|+|||.+.++.++.++|||||||++|||+| |++||.......
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~ 241 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241 (299)
T ss_dssp CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999987643322221 122457899999999999999999999999999999998 899998665433
Q ss_pred hHHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 771 LIGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 771 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
... . +..+ .....+.+.+..+.+++.+||+.+|++||||.||++.|+++++
T Consensus 242 ~~~----~-i~~~---------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 242 VIN----A-IEQD---------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HHH----H-HHTT---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHH----H-HHcC---------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 221 1 1111 1112233455678899999999999999999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=407.40 Aligned_cols=251 Identities=25% Similarity=0.426 Sum_probs=198.0
Q ss_pred hccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 564 NFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
.+.+.||+|+||.||+|++. ++.||||+++... ...++|.+|++++++++|||||+++|+|...+..++||||+++|+
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~ 86 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86 (263)
T ss_dssp EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence 35678999999999999986 7789999997643 345789999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.+++... ...++|..++.|+.|+|+||+|||+. +|+||||||+|||+++++.+||+|||+++..... .......
T Consensus 87 L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~-~~~~~~~ 161 (263)
T d1sm2a_ 87 LSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTG 161 (263)
T ss_dssp HHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred HHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCC-Cceeecc
Confidence 99988643 35789999999999999999999998 9999999999999999999999999999876432 2222344
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHhC-CCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITG-QPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG-~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
..||+.|+|||++.+..++.++|||||||++|||+|+ ++|+.......... . +..+. ....+...
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~----~-i~~~~---------~~~~p~~~ 227 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----D-ISTGF---------RLYKPRLA 227 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHH----H-HHHTC---------CCCCCTTS
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHH----H-HHhcC---------CCCCcccc
Confidence 6789999999999999999999999999999999995 55555433322221 1 11121 11122233
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
..++.+++.+||+.+|++||||+||++.|+++.
T Consensus 228 ~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 467889999999999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=407.42 Aligned_cols=253 Identities=28% Similarity=0.405 Sum_probs=207.8
Q ss_pred hhccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
..+.+.||+|+||.||+|.++ ++.||||+++... ...++|.+|++++++++|||||+++|++.+ +..++||||+++|
T Consensus 15 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g 92 (272)
T d1qpca_ 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENG 92 (272)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTC
T ss_pred eEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCC
Confidence 345678999999999999997 6789999997653 345679999999999999999999998865 5678999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++.......++|..+++|+.||++||+|||++ +|+||||||+||||++++.+||+|||+|+.+.. .......
T Consensus 93 ~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~-~~~~~~~ 168 (272)
T d1qpca_ 93 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTARE 168 (272)
T ss_dssp BHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS-SCEECCT
T ss_pred cHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccC-Ccccccc
Confidence 999988766666799999999999999999999998 999999999999999999999999999987643 2233344
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
...||+.|+|||++.++.++.++|||||||++|||+||..|+........+.+. +..+. ....+...
T Consensus 169 ~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~----i~~~~---------~~~~p~~~ 235 (272)
T d1qpca_ 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN----LERGY---------RMVRPDNC 235 (272)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HHTTC---------CCCCCTTC
T ss_pred ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH----HHhcC---------CCCCcccC
Confidence 567999999999999999999999999999999999965554433322222111 11111 11122334
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
+..+.+++.+||+.+|++||||.||+++|++..
T Consensus 236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 457889999999999999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-47 Score=411.45 Aligned_cols=254 Identities=27% Similarity=0.384 Sum_probs=213.3
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
..+.+.||+|+||+||+|++. ++.||||+++... ...++|.+|++++++++|||||+++++|.+++..++||||+++
T Consensus 19 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~ 97 (287)
T d1opja_ 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 97 (287)
T ss_dssp EEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred eEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccC
Confidence 345689999999999999985 8899999987653 3457899999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|.+++.+.....+++..++.|+.|+++||+|||++ +|+||||||+||||++++.+||+|||+++..... .....
T Consensus 98 g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-~~~~~ 173 (287)
T d1opja_ 98 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAH 173 (287)
T ss_dssp CBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-SSEEE
T ss_pred cchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCC-Cceee
Confidence 9999999877777899999999999999999999998 9999999999999999999999999999876432 22333
Q ss_pred ccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 721 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
....|++.|+|||++.++.++.++|||||||++|||++|+.|+........+.+. +..+ .....+..
T Consensus 174 ~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~----i~~~---------~~~~~~~~ 240 (287)
T d1opja_ 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL----LEKD---------YRMERPEG 240 (287)
T ss_dssp TTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH----HHTT---------CCCCCCTT
T ss_pred ccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHH----HhcC---------CCCCCCcc
Confidence 4456899999999999999999999999999999999977766544332222221 2211 11223334
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
.+..+.+++.+||+.||++||||.||++.|+.+.
T Consensus 241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 4567899999999999999999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-47 Score=402.32 Aligned_cols=248 Identities=21% Similarity=0.304 Sum_probs=202.5
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
++.+.||+|+||+||+|+.. ++.||||++..... ...+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 87 (271)
T d1nvra_ 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 87 (271)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCC
Confidence 45689999999999999985 88999999976533 3456789999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
|+|.+++.. ...+++.++..++.|+++||+|||++ +|+||||||+|||+++++++||+|||+|+.+.........
T Consensus 88 g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 88 GELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp EEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 999999863 35799999999999999999999998 9999999999999999999999999999977544433445
Q ss_pred ccccCCCCccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 721 TTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~~-~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
...+||+.|||||++.+..+ +.++||||+||++|||++|++||........... ....... ......
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~---~~~~~~~---------~~~~~~ 230 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKT---------YLNPWK 230 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH---HHHTTCT---------TSTTGG
T ss_pred cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH---HHhcCCC---------CCCccc
Confidence 56789999999999988775 5789999999999999999999976554322211 1111110 011112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.....+.+++.+||+.||++|||++|+++
T Consensus 231 ~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 231 KIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 33456789999999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=400.53 Aligned_cols=248 Identities=25% Similarity=0.412 Sum_probs=202.4
Q ss_pred ccccccCcEEEEEEEEC----CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 567 RVLGKGGFGTVYHGYLD----DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~----~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.||+|+||.||+|.+. ++.||||+++... ....++|.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999864 4679999997542 2345679999999999999999999999965 567899999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc-c
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH-V 719 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~-~ 719 (870)
|+|.+++.+ ...+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.+....... .
T Consensus 92 g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 999998864 35699999999999999999999998 99999999999999999999999999998764332222 2
Q ss_pred cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......... ..+..+.. ...+
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~-----~~i~~~~~---------~~~p 232 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-----AMLEKGER---------MGCP 232 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-----HHHHTTCC---------CCCC
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHH-----HHHHcCCC---------CCCC
Confidence 334578999999999999999999999999999999998 89999875543221 12222211 1223
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
...+..+.+++.+||+.||++|||++||+++|++..
T Consensus 233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 344567889999999999999999999999998864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=399.04 Aligned_cols=249 Identities=22% Similarity=0.394 Sum_probs=206.4
Q ss_pred cccccCcEEEEEEEEC----CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 568 VLGKGGFGTVYHGYLD----DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 568 ~LG~G~fG~Vy~~~~~----~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
.||+|+||.||+|.+. +..||||+++... ....++|.+|++++++++|||||+++|+|.. +..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 4999999999999864 4479999997653 3456789999999999999999999999965 56899999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc-ccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH-VST 721 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~-~~~ 721 (870)
|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.+....... ...
T Consensus 95 L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 170 (285)
T d1u59a_ 95 LHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170 (285)
T ss_dssp HHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred HHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccccccccc
Confidence 99987543 35799999999999999999999998 99999999999999999999999999998764433222 223
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTN 800 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 800 (870)
...||+.|+|||++.++.++.++|||||||++|||+| |+.||......+... .+..+.. ...+..
T Consensus 171 ~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~-----~i~~~~~---------~~~p~~ 236 (285)
T d1u59a_ 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-----FIEQGKR---------MECPPE 236 (285)
T ss_dssp SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH-----HHHTTCC---------CCCCTT
T ss_pred ccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHH-----HHHcCCC---------CCCCCc
Confidence 4568999999999999999999999999999999998 999998765433221 2222221 122334
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 801 TVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 801 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
.+..+.+++.+||+.+|++||||.+|++.|+.+..
T Consensus 237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 45678899999999999999999999999998653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-46 Score=393.46 Aligned_cols=250 Identities=27% Similarity=0.424 Sum_probs=210.5
Q ss_pred hccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCCc
Q 002887 564 NFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANGN 642 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 642 (870)
.|.+.||+|+||+||+|+++ ++.||||+++.... ..++|.+|++++++++||||++++|+|.+....++||||+++|+
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence 35689999999999999997 67899999987543 45689999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.+++... ...+++..+++++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++..... .......
T Consensus 86 l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~ 160 (258)
T d1k2pa_ 86 LLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVG 160 (258)
T ss_dssp HHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCCCCCC
T ss_pred HHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCC-Cceeecc
Confidence 99987543 35688999999999999999999998 9999999999999999999999999999876433 2223344
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
..||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+.... +..+. ....+...
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~-----i~~~~---------~~~~p~~~ 226 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-----IAQGL---------RLYRPHLA 226 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH-----HHTTC---------CCCCCTTC
T ss_pred cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH-----HHhCC---------CCCCcccc
Confidence 678999999999999999999999999999999998 8999987654433222 22221 11122234
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
...+.+++.+||+.+|++|||++|+++.|.++
T Consensus 227 ~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 227 SEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred cHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 46788999999999999999999999998763
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-46 Score=400.38 Aligned_cols=245 Identities=22% Similarity=0.339 Sum_probs=206.8
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
.+.+.||+|+||+||+|+.. ++.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 23 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg 102 (293)
T d1yhwa1 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 102 (293)
T ss_dssp CSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred EEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCC
Confidence 34578999999999999975 8999999998776666678999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++.+ ..+++.++..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++.+... .....
T Consensus 103 ~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~--~~~~~ 174 (293)
T d1yhwa1 103 SLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRS 174 (293)
T ss_dssp BHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST--TCCBC
T ss_pred cHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccc--ccccc
Confidence 99987743 4699999999999999999999998 9999999999999999999999999999876432 22335
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
...||+.|+|||++.++.++.++|||||||++|||++|+.||........+... ...+.. . ...+...
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~~~~~------~--~~~~~~~ 242 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI----ATNGTP------E--LQNPEKL 242 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----HHHCSC------C--CSSGGGS
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH----HhCCCC------C--CCCcccC
Confidence 568999999999999999999999999999999999999999865543333222 111110 0 1112334
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...+.+++.+||+.||++|||+.|+++
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 567889999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=408.40 Aligned_cols=253 Identities=27% Similarity=0.415 Sum_probs=209.1
Q ss_pred hhccccccccCcEEEEEEEECC-------eeEEEEEeeccc-hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLDD-------KQVAVKMLSSSS-VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGL 633 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~~-------~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~L 633 (870)
..+.+.||+|+||+||+|++.+ ..||||++.... ......+.+|+.++.++ +|||||+++++|.+.+..++
T Consensus 39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (325)
T d1rjba_ 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 118 (325)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEE
Confidence 3456899999999999998742 369999986543 34456789999999998 89999999999999999999
Q ss_pred EEEEccCCchhhhhhhccc---------------------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCE
Q 002887 634 IYEFMANGNLQAHLLEDKA---------------------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANI 692 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NI 692 (870)
||||+++|+|.+++...+. ..+++..++.++.||++||+|||++ +|+||||||+||
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Ni 195 (325)
T d1rjba_ 119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNV 195 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGE
T ss_pred EEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhcc
Confidence 9999999999999975432 3589999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccch
Q 002887 693 LLNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTL 771 (870)
Q Consensus 693 Lld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~ 771 (870)
|++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |++||.+......
T Consensus 196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~ 275 (325)
T d1rjba_ 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275 (325)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987755444444456678999999999999999999999999999999998 8999987665444
Q ss_pred HHHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002887 772 IGQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELN 831 (870)
Q Consensus 772 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 831 (870)
+.+.+ ..+ ...+.+...+..+.+|+.+||+.+|++||||+||++.|.
T Consensus 276 ~~~~~----~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 276 FYKLI----QNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHH----HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHH----hcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 43332 222 111223344567889999999999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-46 Score=398.17 Aligned_cols=254 Identities=27% Similarity=0.391 Sum_probs=200.2
Q ss_pred ccccccccCcEEEEEEEECC------eeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLDD------KQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~~------~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
+.++||+|+||.||+|.+.+ ..||||++.... .....+|.+|++++++++|||||+++|+|.+....++||||
T Consensus 11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~ 90 (283)
T d1mqba_ 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 90 (283)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence 45789999999999998752 369999997643 33456799999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC-
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG- 716 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~- 716 (870)
+.+|++.+.+... ...++|.+++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 91 ~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 91 MENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp CTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred cccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 9999998877543 35799999999999999999999998 999999999999999999999999999987643322
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
........||+.|+|||++.++.++.++|||||||++|||++|..|+........+.+ . +..+ ....
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~---~-i~~~---------~~~~ 233 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK---A-INDG---------FRLP 233 (283)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---H-HHTT---------CCCC
T ss_pred ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHH---H-Hhcc---------CCCC
Confidence 2223345689999999999999999999999999999999997655543332222221 1 2222 1122
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
.+...+..+.+|+.+||+.+|++||||.||+++|+++++
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 234 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 333455678999999999999999999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=395.99 Aligned_cols=242 Identities=29% Similarity=0.407 Sum_probs=204.6
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
+.+.+.||+|+||.||+|+.. ++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 455689999999999999986 7899999997543 23456789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++|+|.+++.+. ..+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 88 ~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--- 159 (263)
T d2j4za1 88 APLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 159 (263)
T ss_dssp CTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred cCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence 9999999998643 4699999999999999999999998 9999999999999999999999999999865322
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........... .. .+. ...
T Consensus 160 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~----i~-~~~----------~~~ 223 (263)
T d2j4za1 160 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR----IS-RVE----------FTF 223 (263)
T ss_dssp -CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HH-TTC----------CCC
T ss_pred -cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHH----HH-cCC----------CCC
Confidence 23456799999999999999999999999999999999999999976554333222 11 111 112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+......+.+++.+||+.||++|||++|+++
T Consensus 224 p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 2233457889999999999999999999976
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-46 Score=398.76 Aligned_cols=247 Identities=24% Similarity=0.367 Sum_probs=207.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
++.+.||+|+||.||+|+.. ++.||||++........+.+.+|++++++++|||||++++++.+.+..++||||+++|
T Consensus 15 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g 94 (288)
T d2jfla1 15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCC
Confidence 44578999999999999985 7889999998877777788999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++.+. ...+++.++..++.||++||+|||++ +|+||||||+|||++.++++||+|||+++..... .....
T Consensus 95 ~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~~~ 168 (288)
T d2jfla1 95 AVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRD 168 (288)
T ss_dssp EHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHHHT
T ss_pred cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC--ccccc
Confidence 999987643 35699999999999999999999998 9999999999999999999999999999764221 12234
Q ss_pred cccCCCCccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 722 TVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 722 ~~~gt~~y~APE~~~-----~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
...||+.|+|||++. +..++.++|||||||++|||++|+.||........+.+... +... . ..
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~-----~~~~-----~--~~ 236 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK-----SEPP-----T--LA 236 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHH-----SCCC-----C--CS
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHc-----CCCC-----C--CC
Confidence 568999999999984 45588999999999999999999999987665554433221 1111 0 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.+......+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12234567889999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=397.99 Aligned_cols=249 Identities=25% Similarity=0.377 Sum_probs=192.5
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEec--CCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDE--GANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~LV~Ey 637 (870)
++.+.||+|+||+||+|+.. ++.||||++.... ....+.+.+|++++++++|||||++++++.+ ....++||||
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy 86 (269)
T d2java1 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 86 (269)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEEC
T ss_pred EEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEec
Confidence 45689999999999999985 8899999997653 3345678999999999999999999999865 4568999999
Q ss_pred ccCCchhhhhhhc--ccccccHHHHHHHHHHHHHHHHHHHhCC--CCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 638 MANGNLQAHLLED--KADTLCWERRLQIASESAQGLEYLHNGC--KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 638 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
+++|+|.+++.+. ....+++..++.++.|++.||+|||++. ..+|+||||||+|||+++++.+||+|||+++.+..
T Consensus 87 ~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 166 (269)
T d2java1 87 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166 (269)
T ss_dssp CTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC--
T ss_pred CCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeeccc
Confidence 9999999998653 3457999999999999999999999862 12599999999999999999999999999987643
Q ss_pred CCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccccc
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
. ........||+.|+|||++.+..++.++|||||||++|||+||++||........... +..+...
T Consensus 167 ~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~-----i~~~~~~------- 232 (269)
T d2java1 167 D--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK-----IREGKFR------- 232 (269)
T ss_dssp -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-----HHHTCCC-------
T ss_pred C--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHH-----HHcCCCC-------
Confidence 2 2233457899999999999999999999999999999999999999986554332222 2222221
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 794 QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..+......+.+++.+||+.||++|||+.|+++
T Consensus 233 --~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 --RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 112223456889999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-46 Score=393.05 Aligned_cols=249 Identities=27% Similarity=0.414 Sum_probs=202.3
Q ss_pred hccccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEec-CCeEEEEEEEccCCc
Q 002887 564 NFERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDE-GANMGLIYEFMANGN 642 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~LV~Ey~~~gs 642 (870)
.+.+.||+|+||.||+|+++++.||||+++... ..++|.+|++++++++||||++++|+|.+ ....++||||+++|+
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~ 87 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 87 (262)
T ss_dssp EEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred EEeEEEecCCCeEEEEEEECCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence 356889999999999999999999999997643 45779999999999999999999999865 456899999999999
Q ss_pred hhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccccc
Q 002887 643 LQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVSTT 722 (870)
Q Consensus 643 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 722 (870)
|.+++.......++|..+++|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.... ....
T Consensus 88 L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-----~~~~ 159 (262)
T d1byga_ 88 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDT 159 (262)
T ss_dssp HHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC-----CCcc
Confidence 99999776656799999999999999999999998 999999999999999999999999999986522 2234
Q ss_pred ccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 723 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 723 ~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
..+++.|+|||++.++.++.++|||||||++|||+| |++||........ ..++ ..+. ..+.+...
T Consensus 160 ~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~-~~~i----~~~~---------~~~~~~~~ 225 (262)
T d1byga_ 160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-VPRV----EKGY---------KMDAPDGC 225 (262)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-HHHH----TTTC---------CCCCCTTC
T ss_pred ccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH-HHHH----HcCC---------CCCCCccC
Confidence 568899999999999999999999999999999998 6888876554432 2222 1121 12223334
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
...+.+++.+||+.||++||||.||+++|+++..-
T Consensus 226 ~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 226 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 46788999999999999999999999999987543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=397.22 Aligned_cols=253 Identities=27% Similarity=0.398 Sum_probs=202.9
Q ss_pred hhccccccccCcEEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
..+.+.||+|+||.||+|++. ++.||||+++... ...+.|.+|+.++++++|||||+++|+|.+ ++.++||||+++|
T Consensus 19 ~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g 96 (285)
T d1fmka3 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 96 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTC
T ss_pred EEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCC
Confidence 456789999999999999997 6789999997553 345789999999999999999999999965 5688999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|...+.......++|.+++.|+.||++||+|||++ +|+||||||+||||++++++||+|||+++..... ......
T Consensus 97 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~-~~~~~~ 172 (285)
T d1fmka3 97 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQ 172 (285)
T ss_dssp BHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred chhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCC-Cceeec
Confidence 999988776667799999999999999999999998 9999999999999999999999999999876322 223334
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCHHH
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDTNT 801 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 801 (870)
...||+.|+|||++..+.++.++|||||||++|||++|..|+........+...+ ..+ ...+.+...
T Consensus 173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i----~~~---------~~~~~~~~~ 239 (285)
T d1fmka3 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV----ERG---------YRMPCPPEC 239 (285)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH----HTT---------CCCCCCTTS
T ss_pred cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH----Hhc---------CCCCCCccc
Confidence 5679999999999999999999999999999999999766654433322222221 111 111223344
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 802 VWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 802 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
..++.+++.+||+.+|++||+|.+|+++|++..
T Consensus 240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 567889999999999999999999999999865
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=391.68 Aligned_cols=245 Identities=27% Similarity=0.447 Sum_probs=197.3
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEec----CCeEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDE----GANMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~LV~ 635 (870)
.|.+.||+|+||+||+|+.. ++.||+|++.... ....+.|.+|++++++++|||||++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45678999999999999986 7789999987653 3345679999999999999999999999854 34678999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEc-CCCcEEEEeccCCccccCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld-~~~~vkL~DFGla~~~~~~ 714 (870)
||+++|+|.+++.+. ..+++..+..++.||++||+|||++ .++|+||||||+|||++ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~- 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 167 (270)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-
Confidence 999999999998643 4789999999999999999999987 22399999999999996 578999999999986421
Q ss_pred CCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccC
Q 002887 715 GGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794 (870)
Q Consensus 715 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 794 (870)
.......||+.|+|||++.+ .++.++|||||||++|||++|+.||........+.+ . +..+.....
T Consensus 168 ---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~---~-i~~~~~~~~------ 233 (270)
T d1t4ha_ 168 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR---R-VTSGVKPAS------ 233 (270)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH---H-HTTTCCCGG------
T ss_pred ---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHH---H-HHcCCCCcc------
Confidence 22345689999999998865 699999999999999999999999976543332222 1 112211111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 795 GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 795 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.+.....++.+++.+||+.||++|||+.|+++
T Consensus 234 --~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 --FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11122346789999999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-46 Score=398.11 Aligned_cols=246 Identities=23% Similarity=0.357 Sum_probs=203.1
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
+.+.+.||+|+||+||+|+.. ++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 456789999999999999985 8899999997643 23346789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.+......
T Consensus 90 ~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 90 AKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 9999999988643 5799999999999999999999998 9999999999999999999999999999987544444
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..........+. . .+.. .+
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i----~-~~~~----------~~ 229 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI----I-KLEY----------DF 229 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----H-TTCC----------CC
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH----H-cCCC----------CC
Confidence 4455678999999999999999999999999999999999999999865543332221 1 1111 12
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
+......+.+++.+||+.||++|||++|+++
T Consensus 230 p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 230 PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 2233456889999999999999999999754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-45 Score=398.00 Aligned_cols=254 Identities=29% Similarity=0.432 Sum_probs=209.5
Q ss_pred hccccccccCcEEEEEEEEC-------CeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 635 (870)
++.+.||+|+||+||+|++. ++.||||++..... ...++|.+|++++++++||||++++++|......++||
T Consensus 16 ~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~ 95 (301)
T d1lufa_ 16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF 95 (301)
T ss_dssp EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEE
Confidence 34578999999999999874 36899999976533 34567999999999999999999999999999999999
Q ss_pred EEccCCchhhhhhhcc----------------------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEE
Q 002887 636 EFMANGNLQAHLLEDK----------------------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANIL 693 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NIL 693 (870)
||+++|+|.+++.... ...+++..++.|+.|++.||+|||+. +|+||||||+|||
T Consensus 96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NIL 172 (301)
T d1lufa_ 96 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL 172 (301)
T ss_dssp ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred EecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccceE
Confidence 9999999999986432 13589999999999999999999998 9999999999999
Q ss_pred EcCCCcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCC-CCCCCCCccchH
Q 002887 694 LNEKFQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ-PVIQKTPQRTLI 772 (870)
Q Consensus 694 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~-~p~~~~~~~~~l 772 (870)
+|.++.+||+|||+++.+.............|++.|+|||.+.+..++.++|||||||++|||++|. +||......+..
T Consensus 173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~ 252 (301)
T d1lufa_ 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI 252 (301)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHH
Confidence 9999999999999998764444444445677899999999999999999999999999999999996 577765543332
Q ss_pred HHHHHHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 002887 773 GQWVSSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCL 834 (870)
Q Consensus 773 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 834 (870)
.. +.++... ..+...+..+.+|+.+||+.+|++||||.||+++|+++.
T Consensus 253 ~~-----v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 253 YY-----VRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HH-----HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HH-----HHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 21 2223211 122334557889999999999999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-45 Score=388.69 Aligned_cols=257 Identities=25% Similarity=0.344 Sum_probs=201.1
Q ss_pred hhccccccccCcEEEEEEEEC-----CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-----DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-----~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
+++.+.||+|+||.||+|++. +..||||.++... ....+.|.+|++++++++||||+++++++.+ +..++|||
T Consensus 9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~E 87 (273)
T d1mp8a_ 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIME 87 (273)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred eEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEEE
Confidence 445689999999999999874 3458899886543 3445679999999999999999999999964 67899999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
|+++|+|.+++... ...+++..++.++.||++||+|||++ +|+||||||+||++++++.+||+|||+++.+... .
T Consensus 88 ~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~-~ 162 (273)
T d1mp8a_ 88 LCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-T 162 (273)
T ss_dssp CCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred eccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCC-c
Confidence 99999999887543 35789999999999999999999998 9999999999999999999999999999876322 2
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
........||+.|+|||++.++.++.++|||||||++|||++ |++||............ ..+.. .
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i-----~~~~~---------~ 228 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-----ENGER---------L 228 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-----HTTCC---------C
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH-----HcCCC---------C
Confidence 223345678999999999999999999999999999999998 89999876655443321 12211 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHhHh
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAMEIA 839 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e~~ 839 (870)
..+...+..+.+++.+||+.||++|||+.||++.|+.+++.+.+
T Consensus 229 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k~ 272 (273)
T d1mp8a_ 229 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272 (273)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhC
Confidence 12334456788999999999999999999999999998766543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=401.64 Aligned_cols=256 Identities=22% Similarity=0.302 Sum_probs=200.1
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
+.+.||+|+||+||+|+.. ++.||+|+++... ....+++.+|+.+|++++|||||+++++|.+..+.++||||+++|
T Consensus 10 ~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg 89 (322)
T d1s9ja_ 10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 89 (322)
T ss_dssp EEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 4578999999999999985 8899999997653 334567899999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
+|.+++.+. ..+++..+..++.|+++||.|||+++ +|+||||||+|||+++++++||+|||+|+.+.. ....
T Consensus 90 ~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~----~~~~ 161 (322)
T d1s9ja_ 90 SLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMAN 161 (322)
T ss_dssp EHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----HTC-
T ss_pred cHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCC----Cccc
Confidence 999998643 46999999999999999999999731 799999999999999999999999999986532 1234
Q ss_pred cccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc-------------------
Q 002887 722 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR------------------- 782 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~------------------- 782 (870)
..+||+.|+|||++.+..++.++||||+||++|||++|+.||...........+.......
T Consensus 162 ~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241 (322)
T ss_dssp --CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------------
T ss_pred cccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccc
Confidence 5689999999999999999999999999999999999999997654322111100000000
Q ss_pred ------CCcchhccccc---CCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 783 ------GDIKNIVDHRL---QGDFD-TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 783 ------~~~~~i~d~~l---~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
....+..+... ..... .....++.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00000000000 00000 112356889999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=393.36 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=203.6
Q ss_pred hccccccccCcEEEEEEEEC--Ce----eEEEEEeecc-chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DK----QVAVKMLSSS-SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~----~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
++.+.||+|+||+||+|.+. ++ .||+|+++.. .....++|.+|++++++++|||||+++|+|.++ ..++++|
T Consensus 12 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e 90 (317)
T d1xkka_ 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQ 90 (317)
T ss_dssp EEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEE
T ss_pred EEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEE
Confidence 45589999999999999975 33 5899988654 334567899999999999999999999999875 5678899
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
|+.+|+|.+.+... ...+++..++.++.|||+||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 91 ~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 91 LMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp CCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred eccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 99999999987653 46799999999999999999999998 999999999999999999999999999998754444
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
........||+.|+|||++.++.++.++|||||||++|||+| |++||......... .. +..+. ..
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-~~----i~~~~---------~~ 232 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI----LEKGE---------RL 232 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-HH----HHHTC---------CC
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-HH----HHcCC---------CC
Confidence 444455679999999999999999999999999999999999 78998866544322 21 22221 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
..+...+..+.+++.+||+.+|++|||+.||++.|+.+..
T Consensus 233 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 2233445678899999999999999999999999988653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=390.28 Aligned_cols=257 Identities=29% Similarity=0.397 Sum_probs=201.1
Q ss_pred hhccccccccCcEEEEEEEEC-------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHh-ccccceeEEEEEecC-CeEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEG-ANMG 632 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~-~~~~ 632 (870)
+.+.+.||+|+||.||+|++. ++.||||+++... ....+.+.+|...+.++ +|+||+.+++++.+. ...+
T Consensus 15 y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~ 94 (299)
T d1ywna1 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 94 (299)
T ss_dssp EEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred EEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEE
Confidence 445689999999999999863 3679999997543 34456788888888887 789999999998664 4689
Q ss_pred EEEEEccCCchhhhhhhccc--------------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC
Q 002887 633 LIYEFMANGNLQAHLLEDKA--------------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF 698 (870)
Q Consensus 633 LV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~ 698 (870)
+|||||++|+|.+++...+. ..+++.+++.++.||++||+|||++ +|+||||||+||||++++
T Consensus 95 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~ 171 (299)
T d1ywna1 95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKN 171 (299)
T ss_dssp EEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCCC
Confidence 99999999999999975432 3589999999999999999999998 999999999999999999
Q ss_pred cEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCC-CCCCCCCccchHHHHHH
Q 002887 699 QAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ-PVIQKTPQRTLIGQWVS 777 (870)
Q Consensus 699 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~-~p~~~~~~~~~l~~~~~ 777 (870)
++||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+||. +||........+.+
T Consensus 172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~--- 248 (299)
T d1ywna1 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR--- 248 (299)
T ss_dssp CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH---
T ss_pred cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH---
Confidence 99999999998765444444455678999999999999999999999999999999999974 67765544333322
Q ss_pred HHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 778 SMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 778 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
.+..+.. ...+......+.+++.+||+.||++|||+.||+++|+++++
T Consensus 249 -~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 249 -RLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp -HHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHhcCCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 2222211 12223345578899999999999999999999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.9e-44 Score=398.34 Aligned_cols=248 Identities=20% Similarity=0.299 Sum_probs=207.5
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+.+.+.||+|+||.||+|+.. |+.||||++........+.+.+|+++|++++|||||++++++.+++..++|||||++
T Consensus 28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 107 (350)
T d1koaa2 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 107 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 456689999999999999985 899999999877666678899999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC--CCcEEEEeccCCccccCCCCcc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE--KFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~--~~~vkL~DFGla~~~~~~~~~~ 718 (870)
|+|.+++.+. ...+++..+..|+.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++.+... .
T Consensus 108 g~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~---~ 180 (350)
T d1koaa2 108 GELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---Q 180 (350)
T ss_dssp CBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT---S
T ss_pred CCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc---c
Confidence 9999988543 34699999999999999999999998 9999999999999964 678999999999876322 2
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
......||+.|||||++.+..++.++|||||||++|||++|+.||........+... .. +.. .+.....
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i----~~-~~~------~~~~~~~ 249 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV----KS-CDW------NMDDSAF 249 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HH-TCC------CSCCGGG
T ss_pred ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH----Hh-CCC------CCCcccc
Confidence 334568999999999999999999999999999999999999999866544333222 11 110 0001111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
......+.+++.+||+.||++|||++|+++
T Consensus 250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 250 SGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 223457889999999999999999999987
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.1e-45 Score=394.04 Aligned_cols=247 Identities=25% Similarity=0.400 Sum_probs=189.5
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccch-hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV-QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
+++.+.||+|+||+||+|+.. ++.||||++..... ...+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 456789999999999999986 78899999976543 234568899999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEc---CCCcEEEEeccCCccccCCCC
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLN---EKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld---~~~~vkL~DFGla~~~~~~~~ 716 (870)
+|+|.+++.+ ...+++..+..++.|++.||+|||++ +|+||||||+|||+. +++.+||+|||+++.....
T Consensus 91 gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-- 163 (307)
T d1a06a_ 91 GGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-- 163 (307)
T ss_dssp SCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred CCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCC--
Confidence 9999999964 35799999999999999999999998 999999999999994 5789999999999865322
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
.......||+.|+|||++.+..++.++|||||||++|||++|++||........... ... +.. .....
T Consensus 164 -~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~----i~~-~~~------~~~~~ 231 (307)
T d1a06a_ 164 -SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ----ILK-AEY------EFDSP 231 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHT-TCC------CCCTT
T ss_pred -CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHH----Hhc-cCC------CCCCc
Confidence 223456799999999999999999999999999999999999999986554332222 111 111 11111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.....+..+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 232 YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 22234567889999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-44 Score=389.35 Aligned_cols=241 Identities=26% Similarity=0.372 Sum_probs=199.3
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
...+.||+|+||.||+|+.. ++.||||++..... ...+.+.+|++++++++|||||++++++.++...++|||||
T Consensus 18 ~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 97 (309)
T d1u5ra_ 18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 97 (309)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEec
Confidence 34578999999999999975 88999999976532 34467899999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
++|+|..++.. ...+++.++..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 98 ~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----- 167 (309)
T d1u5ra_ 98 LGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (309)
T ss_dssp SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred CCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-----
Confidence 99999766543 35799999999999999999999998 999999999999999999999999999986532
Q ss_pred ccccccCCCCccCcccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCC
Q 002887 719 VSTTVVGTPGYLDPEYYIS---NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQG 795 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~---~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 795 (870)
.....||+.|||||++.+ +.++.++|||||||++|||++|+.||........+.. ..... ... +
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~----i~~~~-~~~-----~-- 234 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNE-SPA-----L-- 234 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSC-CCC-----C--
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhCC-CCC-----C--
Confidence 234679999999999864 4589999999999999999999999976544332222 11111 111 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 796 DFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 796 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.+......+.+++.+||+.||++|||+.|+++
T Consensus 235 -~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 -QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11223457889999999999999999999975
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=389.93 Aligned_cols=255 Identities=28% Similarity=0.412 Sum_probs=205.4
Q ss_pred hccccccccCcEEEEEEEECC-----eeEEEEEeecc-chhhhHHHHHHHHHHHHhccccceeEEEEEec-CCeEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLDD-----KQVAVKMLSSS-SVQGYKQFQAEVELLIRAHHKNLTILVGYCDE-GANMGLIYE 636 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~~-----~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~LV~E 636 (870)
+|.++||+|+||+||+|++.. ..||||+++.. .....++|.+|++++++++||||++++|+|.+ +...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 457899999999999999742 35899999753 44556789999999999999999999999865 568899999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
||++|+|.+++.. ....+++..+++++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 110 ~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 110 YMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp CCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EeecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999998754 345688999999999999999999998 999999999999999999999999999987643322
Q ss_pred c--cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccC
Q 002887 717 T--HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794 (870)
Q Consensus 717 ~--~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 794 (870)
. .......||+.|+|||.+.++.++.++||||||+++|||+||+.||........+..++ ..+..
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i----~~g~~--------- 252 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQGRR--------- 252 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH----HTTCC---------
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH----HcCCC---------
Confidence 2 12234578999999999999999999999999999999999888876543322222221 12211
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 795 GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 795 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
...+......+.+++.+||+.||++||+|.||++.|++++.
T Consensus 253 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11122334578899999999999999999999999998864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.6e-44 Score=394.90 Aligned_cols=248 Identities=19% Similarity=0.295 Sum_probs=208.1
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
+++.+.||+|+||.||+|+.. ++.||||++........+.+++|+++|++++|||||++++++.++...++||||+++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 456689999999999999985 889999999877666667889999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEc--CCCcEEEEeccCCccccCCCCcc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLN--EKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld--~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
|+|.+.+.. ....+++.++..|+.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+.+... .
T Consensus 111 g~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~---~ 183 (352)
T d1koba_ 111 GELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---E 183 (352)
T ss_dssp CBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT---S
T ss_pred ChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC---C
Confidence 999887753 334699999999999999999999998 999999999999998 6789999999999876432 2
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.+......+... . .+.. .......
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i----~-~~~~------~~~~~~~ 252 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV----K-RCDW------EFDEDAF 252 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH----H-HCCC------CCCSSTT
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----H-hCCC------CCCcccc
Confidence 334567999999999999999999999999999999999999999866544333222 1 1111 1111112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
......+.+++.+||+.||++|||+.|+++
T Consensus 253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 234457889999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=386.97 Aligned_cols=257 Identities=26% Similarity=0.394 Sum_probs=213.9
Q ss_pred hhccccccccCcEEEEEEEEC-------CeeEEEEEeeccc-hhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSSS-VQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGL 633 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~L 633 (870)
..+.+.||+|+||.||+|++. ++.||||+++... .....+|.+|+.+++++ +|||||+++++|.+....++
T Consensus 25 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~l 104 (311)
T d1t46a_ 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 104 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEE
Confidence 446789999999999999862 4689999997653 34456789999999999 69999999999999999999
Q ss_pred EEEEccCCchhhhhhhccc----------------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC
Q 002887 634 IYEFMANGNLQAHLLEDKA----------------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK 697 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~ 697 (870)
||||+++|+|.+++.+... ..+++..++.++.||++||+|||++ +++||||||+|||++.+
T Consensus 105 vmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~ 181 (311)
T d1t46a_ 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG 181 (311)
T ss_dssp EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETT
T ss_pred EEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccccc
Confidence 9999999999999875432 3689999999999999999999999 99999999999999999
Q ss_pred CcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHH
Q 002887 698 FQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWV 776 (870)
Q Consensus 698 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~ 776 (870)
+.+|++|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |++|+........+.+.+
T Consensus 182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i 261 (311)
T d1t46a_ 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261 (311)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999999997754444444556789999999999999999999999999999999999 556665554444333332
Q ss_pred HHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 777 SSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 777 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
.. + .....+...+..+.+|+.+||+.||++||||.||+++|++++.
T Consensus 262 ~~----~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 262 KE----G---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HH----T---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hc----C---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 22 1 1122223345678999999999999999999999999998764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=387.21 Aligned_cols=257 Identities=30% Similarity=0.461 Sum_probs=209.2
Q ss_pred hhccccccccCcEEEEEEEEC---------CeeEEEEEeeccch-hhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD---------DKQVAVKMLSSSSV-QGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANM 631 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~---------~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 631 (870)
+.+.+.||+|+||.||+|+.. +..||||+++.... ....++.+|...+.++ +|||||+++++|.++...
T Consensus 15 ~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~ 94 (299)
T d1fgka_ 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 94 (299)
T ss_dssp EEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred eEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeE
Confidence 345689999999999999863 24699999976543 4457789999999998 899999999999999999
Q ss_pred EEEEEEccCCchhhhhhhcc--------------cccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC
Q 002887 632 GLIYEFMANGNLQAHLLEDK--------------ADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK 697 (870)
Q Consensus 632 ~LV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~ 697 (870)
++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 95 ~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~ 171 (299)
T d1fgka_ 95 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTED 171 (299)
T ss_dssp EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCC
Confidence 99999999999999997543 24689999999999999999999999 99999999999999999
Q ss_pred CcEEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHH
Q 002887 698 FQAKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWV 776 (870)
Q Consensus 698 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~ 776 (870)
+.+||+|||+++...............|++.|+|||.+.++.++.++|||||||++|||++ |++||.........
T Consensus 172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~---- 247 (299)
T d1fgka_ 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF---- 247 (299)
T ss_dssp CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH----
T ss_pred CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH----
Confidence 9999999999997755544444556779999999999999999999999999999999998 68888765543221
Q ss_pred HHHhhcCCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhH
Q 002887 777 SSMLARGDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAM 836 (870)
Q Consensus 777 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 836 (870)
..+..+. ....+...+..+.+++.+||+.+|++|||+.||+++|+++++.
T Consensus 248 -~~i~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 248 -KLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp -HHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHcCC---------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 1222221 1122223445788999999999999999999999999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-44 Score=384.91 Aligned_cols=247 Identities=23% Similarity=0.337 Sum_probs=203.6
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccch------hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV------QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLI 634 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 634 (870)
+++.+.||+|+||+||+|+.. ++.||||++..... ...+.+.+|+++|++++|||||++++++.+....++|
T Consensus 12 Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (293)
T d1jksa_ 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 91 (293)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 455689999999999999985 88999999975422 2356799999999999999999999999999999999
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC----cEEEEeccCCcc
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF----QAKLADFGLSRI 710 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~----~vkL~DFGla~~ 710 (870)
||||++|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+|++|||+++.
T Consensus 92 ~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 92 LELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 9999999999998653 4799999999999999999999998 999999999999998876 599999999987
Q ss_pred ccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcc
Q 002887 711 FPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVD 790 (870)
Q Consensus 711 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d 790 (870)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+ . .+...
T Consensus 167 ~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i----~-~~~~~---- 234 (293)
T d1jksa_ 167 IDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----S-AVNYE---- 234 (293)
T ss_dssp CTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----H-TTCCC----
T ss_pred cCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH----H-hcCCC----
Confidence 6322 2334567999999999999999999999999999999999999999876544333221 1 11100
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 791 HRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 791 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.........+..+.+++.+||+.||++|||++|+++
T Consensus 235 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 --FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000001123456789999999999999999999975
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-44 Score=385.96 Aligned_cols=265 Identities=23% Similarity=0.322 Sum_probs=201.4
Q ss_pred ccccccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCC----eEEEEEEEccC
Q 002887 565 FERVLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGA----NMGLIYEFMAN 640 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~LV~Ey~~~ 640 (870)
+.+.||+|+||.||+|+++|+.||||+++..... ...++.|+..+.+++||||++++++|.+.. ..++|||||++
T Consensus 7 l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~ 85 (303)
T d1vjya_ 7 LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEECCSSSEEEEEEETTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEEeeCCCeEEEEEEECCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccC
Confidence 4678999999999999999999999999755322 122344555566789999999999997643 57899999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCC-----CCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGC-----KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
|+|.+++.+ ..++|..+++++.|+|.||+|||+.. .++|+||||||+||||++++.+||+|||+++......
T Consensus 86 g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~ 162 (303)
T d1vjya_ 86 GSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162 (303)
T ss_dssp CBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred CCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCC
Confidence 999999964 46999999999999999999999731 3599999999999999999999999999998775433
Q ss_pred Ccc--ccccccCCCCccCccccccCC------CCccchHHHHHHHHHHHHhCCCCCCCCCccc----------hHHHHHH
Q 002887 716 GTH--VSTTVVGTPGYLDPEYYISNR------LTEKSDVYSFGVVLLELITGQPVIQKTPQRT----------LIGQWVS 777 (870)
Q Consensus 716 ~~~--~~~~~~gt~~y~APE~~~~~~------~~~ksDVwS~GvvL~elltG~~p~~~~~~~~----------~l~~~~~ 777 (870)
... ......||+.|+|||++.+.. ++.++|||||||+||||+||..|+....... .......
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T d1vjya_ 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242 (303)
T ss_dssp TEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHH
T ss_pred cceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHH
Confidence 222 234568999999999987643 5678999999999999999998875432111 0111111
Q ss_pred HHhhcCCcchhcccccCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhHh
Q 002887 778 SMLARGDIKNIVDHRLQGDF-DTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLAME 837 (870)
Q Consensus 778 ~~~~~~~~~~i~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~e 837 (870)
.....+. .++.+.... ..+....+.+++.+||+.||++||||.||++.|+++...+
T Consensus 243 ~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 243 KVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 2221111 111111111 2346677999999999999999999999999999877554
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-44 Score=381.18 Aligned_cols=252 Identities=25% Similarity=0.355 Sum_probs=197.0
Q ss_pred hccccccccCcEEEEEEEEC-----CeeEEEEEeecc---chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD-----DKQVAVKMLSSS---SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-----~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 635 (870)
++.+.||+|+||.||+|++. ...||||++... .....++|.+|++++++++||||++++|+|.+ ...++||
T Consensus 11 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~ 89 (273)
T d1u46a_ 11 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVT 89 (273)
T ss_dssp EEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred EEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheee
Confidence 45678999999999999864 236899998754 23445789999999999999999999999976 4678999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
||+++|++.+.+... ...+++..++.++.|+|+||.|||++ +|+||||||+|||++.++++||+|||+++......
T Consensus 90 e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 90 ELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp ECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 999999999887653 35699999999999999999999998 99999999999999999999999999999764433
Q ss_pred Cccc-cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhcCCcchhccccc
Q 002887 716 GTHV-STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRL 793 (870)
Q Consensus 716 ~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 793 (870)
.... .....|+..|+|||++.+..++.++|||||||++|||+| |+.||.......... ...+.+.
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~----~i~~~~~--------- 232 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH----KIDKEGE--------- 232 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHTSCC---------
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH----HHHhCCC---------
Confidence 3222 234567889999999999999999999999999999998 899998665443322 2222221
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002887 794 QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDC 833 (870)
Q Consensus 794 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 833 (870)
..+.....+..+.+++.+||+.||++||||.||++.|++.
T Consensus 233 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1112233445788999999999999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-44 Score=387.88 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=210.6
Q ss_pred hccccccccCcEEEEEEEEC-------CeeEEEEEeecc-chhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSSS-SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~-------~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 635 (870)
.+.+.||+|+||.||+|.+. ++.||||+++.. .......|.+|++++++++||||+++++.|......++||
T Consensus 23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 102 (308)
T d1p4oa_ 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 102 (308)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEE
Confidence 45688999999999999874 468999999754 3344567899999999999999999999999999999999
Q ss_pred EEccCCchhhhhhhccc--------ccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccC
Q 002887 636 EFMANGNLQAHLLEDKA--------DTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGL 707 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGl 707 (870)
||+++|+|.+++...+. ..+++..+.+++.|+|+||.|||++ +|+||||||+|||+++++++||+|||+
T Consensus 103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeeccc
Confidence 99999999998865432 3478999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCC-CCCCCCCccchHHHHHHHHhhcCCcc
Q 002887 708 SRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ-PVIQKTPQRTLIGQWVSSMLARGDIK 786 (870)
Q Consensus 708 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~-~p~~~~~~~~~l~~~~~~~~~~~~~~ 786 (870)
++.+.............||+.|+|||.+.++.++.++|||||||++|||+||+ +||........ ..... ++..
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~----~~~i~-~~~~- 253 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV----LRFVM-EGGL- 253 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH----HHHHH-TTCC-
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH----HHHHH-hCCC-
Confidence 98775444444445567899999999999999999999999999999999985 67765443322 22222 2221
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 787 NIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 787 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
...+...+..+.+++.+||+.+|++||||.||+++|++.++
T Consensus 254 --------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 254 --------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11122344678999999999999999999999999987644
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=385.78 Aligned_cols=252 Identities=29% Similarity=0.448 Sum_probs=202.9
Q ss_pred hccccccccCcEEEEEEEEC--Ce--eEEEEEeecc-chhhhHHHHHHHHHHHHh-ccccceeEEEEEecCCeEEEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DK--QVAVKMLSSS-SVQGYKQFQAEVELLIRA-HHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~--~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
.+.+.||+|+||.||+|++. +. .||||+++.. .....+.|.+|+++|.++ +|||||+++|+|.+++..++||||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey 92 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 92 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence 35689999999999999985 43 5788888654 334567899999999998 799999999999999999999999
Q ss_pred ccCCchhhhhhhc--------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEE
Q 002887 638 MANGNLQAHLLED--------------KADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLA 703 (870)
Q Consensus 638 ~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~ 703 (870)
+++|+|.+++... ....++|..++.++.|||+||.|||+. +|+||||||+|||++.++.+||+
T Consensus 93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEc
Confidence 9999999998653 236799999999999999999999998 99999999999999999999999
Q ss_pred eccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCC-CCCCCCCccchHHHHHHHHhhc
Q 002887 704 DFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ-PVIQKTPQRTLIGQWVSSMLAR 782 (870)
Q Consensus 704 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~-~p~~~~~~~~~l~~~~~~~~~~ 782 (870)
|||+++..... .......||..|+|||.+.++.++.++|||||||++|||++|. +||......... . .+.+
T Consensus 170 DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~----~-~i~~ 241 (309)
T d1fvra_ 170 DFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY----E-KLPQ 241 (309)
T ss_dssp CTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----H-HGGG
T ss_pred ccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHH----H-HHHh
Confidence 99999764321 2223456899999999999999999999999999999999976 466554432221 1 1222
Q ss_pred CCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 783 GDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 783 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
+. ....+...+..+.+++.+||+.||++||||+||++.|+++++
T Consensus 242 ~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 242 GY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp TC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 21 112233445678899999999999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=385.91 Aligned_cols=244 Identities=25% Similarity=0.349 Sum_probs=205.0
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
+++.+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 345689999999999999975 8899999998653 23456789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
|++|+|.+++.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+..... .
T Consensus 87 ~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~--~ 159 (337)
T d1o6la_ 87 ANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--G 159 (337)
T ss_dssp CTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--T
T ss_pred cCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC--C
Confidence 9999999988643 4689999999999999999999999 9999999999999999999999999999865322 2
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
......+||+.|+|||++.+..++.++||||+||++|||++|++||...........+ . .+.. .+
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i----~-~~~~----------~~ 224 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI----L-MEEI----------RF 224 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----H-HCCC----------CC
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH----h-cCCC----------CC
Confidence 2345578999999999999999999999999999999999999999876544332221 1 1111 12
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRPT-----MNQVVI 828 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~ 828 (870)
+......+.+++.+||+.||++||+ +.|+++
T Consensus 225 p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 2234456789999999999999995 777765
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.5e-43 Score=377.52 Aligned_cols=256 Identities=23% Similarity=0.358 Sum_probs=200.4
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCC----eEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGA----NMGL 633 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~L 633 (870)
+.+.+.||+|+||.||+|+.. ++.||||+++... ....+.|.+|++++++++||||+++++++.... ..++
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence 345689999999999999975 8999999997643 234567999999999999999999999986543 3789
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
||||+++|+|.+++... ..+++.++..++.|+++||+|||++ +|+||||||+|||++.++..+++|||.++....
T Consensus 89 vmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhcc
Confidence 99999999999987643 4799999999999999999999998 999999999999999999999999999876533
Q ss_pred CCC-ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccc
Q 002887 714 EGG-THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHR 792 (870)
Q Consensus 714 ~~~-~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 792 (870)
... ........||+.|+|||++.+..++.++|||||||++|||+||++||.......... .....+... +
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~----~~~~~~~~~----~- 234 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY----QHVREDPIP----P- 234 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----HHHHCCCCC----G-
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH----HHHhcCCCC----C-
Confidence 222 223345689999999999999999999999999999999999999998655433322 222222111 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhh
Q 002887 793 LQGDFDTNTVWKAVEIALACIHTISTRRP-TMNQVVIELNDCL 834 (870)
Q Consensus 793 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-sm~eVl~~L~~~~ 834 (870)
.......+..+.+++.+|++.||++|| |++++++.|..+.
T Consensus 235 --~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 235 --SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp --GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 011122345788999999999999999 8999999887753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5e-43 Score=381.80 Aligned_cols=241 Identities=24% Similarity=0.343 Sum_probs=202.8
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEF 637 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 637 (870)
+++.+.||+|+||+||+|+.. ++.||||+++... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 345689999999999999985 8899999997642 23456789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+++|+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---- 156 (316)
T d1fota_ 86 IEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 156 (316)
T ss_dssp CCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred cCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc----
Confidence 9999999888643 4678889999999999999999998 999999999999999999999999999987632
Q ss_pred cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCC
Q 002887 718 HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDF 797 (870)
Q Consensus 718 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 797 (870)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..........+. .. +.. ..
T Consensus 157 -~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i----~~-~~~----------~~ 220 (316)
T d1fota_ 157 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI----LN-AEL----------RF 220 (316)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----HH-CCC----------CC
T ss_pred -ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH----Hc-CCC----------CC
Confidence 223568999999999999999999999999999999999999999876543333222 11 111 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002887 798 DTNTVWKAVEIALACIHTISTRRP-----TMNQVVI 828 (870)
Q Consensus 798 ~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 828 (870)
+......+.+++.+|++.+|++|| |++|+++
T Consensus 221 p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 221 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 222345688999999999999996 8999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.6e-42 Score=370.71 Aligned_cols=246 Identities=24% Similarity=0.324 Sum_probs=202.4
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchh---------hhHHHHHHHHHHHHhc-cccceeEEEEEecCCeE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ---------GYKQFQAEVELLIRAH-HKNLTILVGYCDEGANM 631 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~---------~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~ 631 (870)
.+.+.||+|+||+||+|+.. ++.||||+++..... ..+.+.+|+.++++++ ||||+++++++.+.+..
T Consensus 6 ~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 85 (277)
T d1phka_ 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 85 (277)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcce
Confidence 45689999999999999984 899999999764321 2346889999999997 99999999999999999
Q ss_pred EEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccc
Q 002887 632 GLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 711 (870)
Q Consensus 632 ~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~ 711 (870)
++||||+++|+|.+++... ..+++.++..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.+
T Consensus 86 ~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 86 FLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeEc
Confidence 9999999999999999653 4799999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCccccccccCCCCccCcccccc------CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCc
Q 002887 712 PVEGGTHVSTTVVGTPGYLDPEYYIS------NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDI 785 (870)
Q Consensus 712 ~~~~~~~~~~~~~gt~~y~APE~~~~------~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~ 785 (870)
... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||............. .+..
T Consensus 161 ~~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~-----~~~~ 232 (277)
T d1phka_ 161 DPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM-----SGNY 232 (277)
T ss_dssp CTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HTCC
T ss_pred cCC---CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHH-----hCCC
Confidence 432 22345689999999999863 346889999999999999999999998765433322221 1111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 786 KNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 786 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
. +........+.++.+++.+||+.+|++|||+.||++
T Consensus 233 ~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 233 Q------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp C------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred C------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 111112234567889999999999999999999865
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=381.43 Aligned_cols=244 Identities=23% Similarity=0.326 Sum_probs=195.1
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHh-ccccceeEEEEEec----CCeEEEEEEEcc
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRA-HHKNLTILVGYCDE----GANMGLIYEFMA 639 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~~~LV~Ey~~ 639 (870)
+.||+|+||.||+|+.. ++.||||+++.. +.+.+|++++.++ +|||||++++++.+ ....++|||||+
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~ 92 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence 57999999999999975 889999998653 4578899987665 89999999999864 456899999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC---CCcEEEEeccCCccccCCCC
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE---KFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~---~~~vkL~DFGla~~~~~~~~ 716 (870)
+|+|.+++.+.....+++.++..|+.|++.||+|||+. +|+||||||+|||+++ ++.+||+|||+++.....
T Consensus 93 gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~-- 167 (335)
T d2ozaa1 93 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-- 167 (335)
T ss_dssp SEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC--
T ss_pred CCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCC--
Confidence 99999999765556899999999999999999999998 9999999999999986 457999999999876432
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
.......||+.|+|||++.+..++.++|||||||++|||+||++||............. .....+.. .+...
T Consensus 168 -~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~-~~i~~~~~------~~~~~ 239 (335)
T d2ozaa1 168 -NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-TRIRMGQY------EFPNP 239 (335)
T ss_dssp -CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------CCCSCSS------SCCTT
T ss_pred -CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH-HHHhcCCC------CCCCc
Confidence 22345689999999999999999999999999999999999999997654332221111 11111100 00001
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
........+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11234567899999999999999999999976
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=372.90 Aligned_cols=255 Identities=24% Similarity=0.283 Sum_probs=197.7
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccchh-----hhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEcc
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQ-----GYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
++||+|+||+||+|+.. ++.||||+++..... ..+.+.+|++++++++|||||++++++..++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 57999999999999975 889999998754322 23568899999999999999999999999999999999999
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccc
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 719 (870)
++++..... ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++..... ...
T Consensus 84 ~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~--~~~ 156 (299)
T d1ua2a_ 84 TDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRA 156 (299)
T ss_dssp EEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--CCC
T ss_pred chHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCC--ccc
Confidence 988776553 345688999999999999999999998 9999999999999999999999999999865432 222
Q ss_pred cccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC--Ccch---hcccc-
Q 002887 720 STTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG--DIKN---IVDHR- 792 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~--~~~~---i~d~~- 792 (870)
.....||+.|+|||++... .++.++|||||||++|||++|++||......+.+.......-... .... .....
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 3456799999999998755 579999999999999999999999987665555444433221110 0000 00000
Q ss_pred c--CCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 793 L--QGDFD-----TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 793 l--~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
. ..... ......+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0 00011 122357889999999999999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-42 Score=380.31 Aligned_cols=240 Identities=21% Similarity=0.324 Sum_probs=202.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEc
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFM 638 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 638 (870)
++.+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|+++|++++||||+++++++......++||||+
T Consensus 44 ~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~ 123 (350)
T d1rdqe_ 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123 (350)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccc
Confidence 34579999999999999985 8899999997543 233467899999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcc
Q 002887 639 ANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTH 718 (870)
Q Consensus 639 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 718 (870)
.+|+|..++.+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 124 ~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~----- 193 (350)
T d1rdqe_ 124 AGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----- 193 (350)
T ss_dssp TTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS-----
T ss_pred cccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc-----
Confidence 999999998654 4699999999999999999999998 999999999999999999999999999987632
Q ss_pred ccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCC
Q 002887 719 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFD 798 (870)
Q Consensus 719 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 798 (870)
......||+.|||||++.+..++.++|||||||++|||+||+.||..........+. . .+.. ..+
T Consensus 194 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i----~-~~~~----------~~p 258 (350)
T d1rdqe_ 194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----V-SGKV----------RFP 258 (350)
T ss_dssp CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----H-HCCC----------CCC
T ss_pred ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH----h-cCCC----------CCC
Confidence 123567999999999999999999999999999999999999999865433322221 1 1111 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002887 799 TNTVWKAVEIALACIHTISTRRP-----TMNQVVI 828 (870)
Q Consensus 799 ~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 828 (870)
......+.+++.+||+.||++|+ |++|+++
T Consensus 259 ~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 23345688999999999999994 8899875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=376.72 Aligned_cols=244 Identities=25% Similarity=0.370 Sum_probs=201.2
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccc---hhhhHHHHHHHHHHH-HhccccceeEEEEEecCCeEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS---VQGYKQFQAEVELLI-RAHHKNLTILVGYCDEGANMGLIYE 636 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~-~l~H~nIv~l~g~~~~~~~~~LV~E 636 (870)
+.+.+.||+|+||+||+|+.. ++.||||+++... ....+.+..|..++. .++||||+++++++.+++..++|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 346789999999999999985 8999999997642 233455677777765 6899999999999999999999999
Q ss_pred EccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCC
Q 002887 637 FMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 637 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 716 (870)
|+++|+|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+++.....
T Consensus 84 y~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-- 156 (320)
T d1xjda_ 84 YLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-- 156 (320)
T ss_dssp CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--
T ss_pred ecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc--
Confidence 99999999998643 4688999999999999999999999 9999999999999999999999999999865322
Q ss_pred ccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCC
Q 002887 717 THVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGD 796 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 796 (870)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+......... +..+. ..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~-----i~~~~----------~~ 221 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS-----IRMDN----------PF 221 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHHCC----------CC
T ss_pred cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH-----HHcCC----------CC
Confidence 2233456899999999999999999999999999999999999999987654333222 11111 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 002887 797 FDTNTVWKAVEIALACIHTISTRRPTMN-QVVI 828 (870)
Q Consensus 797 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~-eVl~ 828 (870)
++......+.+++.+||+.||++||++. |+++
T Consensus 222 ~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 2223345688999999999999999996 6753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-42 Score=374.88 Aligned_cols=246 Identities=18% Similarity=0.289 Sum_probs=202.3
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
.+.+.||+|+||+||+|... ++.||||+++.... ....+.+|+++|++++||||+++++++.+....++|||||++|
T Consensus 8 ~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg 86 (321)
T d1tkia_ 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCC
Confidence 45689999999999999985 88999999976543 3456889999999999999999999999999999999999999
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCC--CcEEEEeccCCccccCCCCccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEK--FQAKLADFGLSRIFPVEGGTHV 719 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~--~~vkL~DFGla~~~~~~~~~~~ 719 (870)
+|.+++.+. ...+++.++..++.||++||+|||+. +|+||||||+|||++.+ ..+||+|||+++.... ...
T Consensus 87 ~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~---~~~ 159 (321)
T d1tkia_ 87 DIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDN 159 (321)
T ss_dssp BHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT---TCE
T ss_pred cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc---CCc
Confidence 999988643 34689999999999999999999998 99999999999999854 5899999999986532 223
Q ss_pred cccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccCCCCCH
Q 002887 720 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQGDFDT 799 (870)
Q Consensus 720 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 799 (870)
.....+|+.|+|||.+.+..++.++||||+||++|||++|+.||............ .. +... ++.... .
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i----~~-~~~~--~~~~~~----~ 228 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI----MN-AEYT--FDEEAF----K 228 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----HH-TCCC--CCHHHH----T
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH----Hh-CCCC--CChhhc----c
Confidence 34567999999999999999999999999999999999999999876544333222 11 1100 000000 0
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 800 NTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 800 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.....+.+++.+|++.||++|||+.|+++
T Consensus 229 ~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 229 EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12346789999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-41 Score=377.33 Aligned_cols=244 Identities=25% Similarity=0.346 Sum_probs=195.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccch---hhhHHHHHH---HHHHHHhccccceeEEEEEecCCeEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV---QGYKQFQAE---VELLIRAHHKNLTILVGYCDEGANMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~E---i~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 635 (870)
.+.+.||+|+||.||+|+.. ++.||||++..... .....+.+| +++++.++|||||++++++.+.+..++||
T Consensus 7 ~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivm 86 (364)
T d1omwa3 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 86 (364)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEE
Confidence 45689999999999999985 88999999975422 222334444 55666678999999999999999999999
Q ss_pred EEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCC
Q 002887 636 EFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 715 (870)
Q Consensus 636 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 715 (870)
||+++|+|.+++.+. ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 87 E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~- 160 (364)
T d1omwa3 87 DLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 160 (364)
T ss_dssp CCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred EecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence 999999999998643 4688999999999999999999998 9999999999999999999999999999876432
Q ss_pred CccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcccccC
Q 002887 716 GTHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDHRLQ 794 (870)
Q Consensus 716 ~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 794 (870)
......||+.|+|||++.. ..++.++|||||||++|||+||+.||......... ....... .. .
T Consensus 161 ---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~~~~~~-~~----------~ 225 (364)
T d1omwa3 161 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL-TM----------A 225 (364)
T ss_dssp ---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH-HHHHHSS-SC----------C
T ss_pred ---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcc-cC----------C
Confidence 2345679999999999975 56899999999999999999999999865433221 1111111 00 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002887 795 GDFDTNTVWKAVEIALACIHTISTRRPT-----MNQVVI 828 (870)
Q Consensus 795 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~ 828 (870)
...+......+.+++.+||+.||++||| ++|+++
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1112234457889999999999999999 577764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=365.66 Aligned_cols=258 Identities=21% Similarity=0.295 Sum_probs=200.1
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
..+.||+|+||+||+|+.. ++.||||+++.... ...+++.+|++++++++||||+++++++.++.+.++||||+.+
T Consensus 6 ~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~ 85 (298)
T d1gz8a_ 6 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 85 (298)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC
Confidence 3478999999999999985 88999999965432 2357889999999999999999999999999999999999986
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
+ +.+.+.......+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 86 ~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--~~~~ 159 (298)
T d1gz8a_ 86 D-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTY 159 (298)
T ss_dssp E-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--SBCT
T ss_pred c-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC--cccc
Confidence 5 44555555556799999999999999999999998 9999999999999999999999999999876322 2334
Q ss_pred ccccCCCCccCccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCc--chhc-ccccCCC
Q 002887 721 TTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDI--KNIV-DHRLQGD 796 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~-~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~--~~i~-d~~l~~~ 796 (870)
....||+.|+|||.+.... ++.++||||+||++|||++|+.||........+.+........... .... .+.....
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence 4568999999999987665 5789999999999999999999998766544444333222111100 0000 0000000
Q ss_pred ------CC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 797 ------FD-----TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 797 ------~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.. ......+.+++.+|++.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00 122356789999999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=361.65 Aligned_cols=236 Identities=25% Similarity=0.388 Sum_probs=193.1
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccch------hhhHHHHHHHHHHHHhc--cccceeEEEEEecCCeEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSV------QGYKQFQAEVELLIRAH--HKNLTILVGYCDEGANMG 632 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~------~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~ 632 (870)
+.+.+.||+|+||.||+|+.. ++.||||++..... ....++.+|+.++++++ ||||+++++++.+.+..+
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~ 85 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 85 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence 345689999999999999985 88999999975432 12345789999999996 899999999999999999
Q ss_pred EEEEEccC-CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC-CCcEEEEeccCCcc
Q 002887 633 LIYEFMAN-GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE-KFQAKLADFGLSRI 710 (870)
Q Consensus 633 LV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~-~~~vkL~DFGla~~ 710 (870)
+||||+.+ +++.+++.. ...+++.++..++.|+++||+|||++ +|+||||||+|||++. ++.+||+|||+++.
T Consensus 86 lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccccee
Confidence 99999986 567777653 35799999999999999999999998 9999999999999985 47999999999986
Q ss_pred ccCCCCccccccccCCCCccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhc
Q 002887 711 FPVEGGTHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIV 789 (870)
Q Consensus 711 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~ 789 (870)
... .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... + .. .+..
T Consensus 161 ~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~----i~-~~~~---- 221 (273)
T d1xwsa_ 161 LKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------E----II-RGQV---- 221 (273)
T ss_dssp CCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H----HH-HCCC----
T ss_pred ccc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------H----Hh-hccc----
Confidence 532 22345689999999999987765 577999999999999999999997421 1 11 1110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 790 DHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 790 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
.++...+..+.+++.+|++.||++|||++|+++
T Consensus 222 ------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 ------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111223456889999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.7e-41 Score=359.36 Aligned_cols=257 Identities=19% Similarity=0.286 Sum_probs=198.5
Q ss_pred ccccccccCcEEEEEEEEC-CeeEEEEEeeccch--hhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccCC
Q 002887 565 FERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSV--QGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMANG 641 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 641 (870)
..+.||+|+||+||+|+.. ++.||||++..... ...+.+.+|+.+|++++||||+++++++...+..++++||+.++
T Consensus 6 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~ 85 (286)
T d1ob3a_ 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD 85 (286)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEE
T ss_pred eccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhh
Confidence 3478999999999999987 88999999976532 23568999999999999999999999999999999999999987
Q ss_pred chhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCccccc
Q 002887 642 NLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVST 721 (870)
Q Consensus 642 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 721 (870)
.+..... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||++...... .....
T Consensus 86 ~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~ 158 (286)
T d1ob3a_ 86 LKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYT 158 (286)
T ss_dssp HHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred hHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccC--ccccc
Confidence 7766653 346799999999999999999999998 9999999999999999999999999999876322 22234
Q ss_pred cccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC--Cc---chhc--cccc
Q 002887 722 TVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG--DI---KNIV--DHRL 793 (870)
Q Consensus 722 ~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~--~~---~~i~--d~~l 793 (870)
...|++.|+|||.+.+. .++.++||||+||+++||++|+.||......+.+.+.....-... .. .... +...
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 45689999999999764 578999999999999999999999987665444444332211110 00 0000 0000
Q ss_pred C-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 794 Q-------GDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 794 ~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
. ..........+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0011123457889999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=360.19 Aligned_cols=258 Identities=22% Similarity=0.319 Sum_probs=198.1
Q ss_pred hccccccccCcEEEEEEEEC---CeeEEEEEeeccch--hhhHHHHHHHHHHHHh---ccccceeEEEEEec-----CCe
Q 002887 564 NFERVLGKGGFGTVYHGYLD---DKQVAVKMLSSSSV--QGYKQFQAEVELLIRA---HHKNLTILVGYCDE-----GAN 630 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~---~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~-----~~~ 630 (870)
++.+.||+|+||+||+|+.. ++.||||+++.... .....+.+|+.+++.+ +||||++++++|.. ...
T Consensus 10 ~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~ 89 (305)
T d1blxa_ 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 89 (305)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred EEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCce
Confidence 34578999999999999973 56799999876432 2344567888887776 79999999999843 346
Q ss_pred EEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCcc
Q 002887 631 MGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 631 ~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~ 710 (870)
.+++|||+.++.+.... ......+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 90 ~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 90 LTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred EEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 88999999988765443 33456789999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCc-----
Q 002887 711 FPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDI----- 785 (870)
Q Consensus 711 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~----- 785 (870)
.. .........||+.|+|||++.+..++.++||||+||++|||++|++||........+.............
T Consensus 166 ~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 166 YS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence 42 2233456789999999999999999999999999999999999999998776555444433322111100
Q ss_pred ---c-hhccccc---CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 786 ---K-NIVDHRL---QGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 786 ---~-~i~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
. ....... ...........+.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 0000000 00111223456789999999999999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=360.18 Aligned_cols=255 Identities=22% Similarity=0.288 Sum_probs=194.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeEEEEEec------CCeEEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTILVGYCDE------GANMGLIY 635 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------~~~~~LV~ 635 (870)
...++||+|+||+||+|+.. ++.||||++.... ..+.+|+++|++++|+||+++++++.. ....++||
T Consensus 23 ~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred EeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 34578999999999999985 8899999997653 233579999999999999999999843 23478999
Q ss_pred EEccCCchhhhhhh-cccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC-cEEEEeccCCccccC
Q 002887 636 EFMANGNLQAHLLE-DKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF-QAKLADFGLSRIFPV 713 (870)
Q Consensus 636 Ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~-~vkL~DFGla~~~~~ 713 (870)
||++++.+...... .....+++.++..++.||++||+|||++ +|+||||||+|||++.++ .+||+|||+++....
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 99987654443322 2345799999999999999999999998 999999999999999775 899999999987633
Q ss_pred CCCccccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc----------
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR---------- 782 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~---------- 782 (870)
. .......|++.|+|||.+.+ ..++.++||||+||++|||++|++||........+.++++..-..
T Consensus 176 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 176 G---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp T---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred C---cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence 2 22345679999999999875 468999999999999999999999998766544444433211000
Q ss_pred ----CCcchhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 783 ----GDIKNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 783 ----~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
..........+...........+.+|+.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000000111233456889999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-39 Score=347.45 Aligned_cols=259 Identities=18% Similarity=0.205 Sum_probs=195.9
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccceeE-EEEEecCCeEEEEEEEcc
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLTIL-VGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l-~g~~~~~~~~~LV~Ey~~ 639 (870)
+.+.+.||+|+||.||+|+.. ++.||||++.... ..+++..|++++++++|+|++.. .++..+....++||||+.
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence 345689999999999999975 8899999987653 23568899999999987775554 555577788899999985
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC---CCcEEEEeccCCccccCCCC
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE---KFQAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~---~~~vkL~DFGla~~~~~~~~ 716 (870)
+ ++...+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++. +..+||+|||+|+.+.....
T Consensus 87 ~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 87 P-SLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp C-BHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred C-chhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 4 55555433 345799999999999999999999998 9999999999999864 55799999999997743322
Q ss_pred c-----cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhccc
Q 002887 717 T-----HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVDH 791 (870)
Q Consensus 717 ~-----~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 791 (870)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||................... . ....+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~-~~~~~ 238 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK--M-STPIE 238 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH--H-HSCHH
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc--C-CCChh
Confidence 1 12345679999999999999999999999999999999999999998755433222111110000 0 00001
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 792 RLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 792 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
.+. ...+.++.+++..|++.+|++||++.++.+.|+.+..
T Consensus 239 ~~~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 239 VLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHT----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred Hhc----cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 111 1233568899999999999999999999999988653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-39 Score=349.49 Aligned_cols=260 Identities=20% Similarity=0.260 Sum_probs=194.0
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEec--------CCeE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDE--------GANM 631 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--------~~~~ 631 (870)
.+.+.||+|+||+||+|+.. ++.||||++.... ....+++.+|+++|++++|+|++++++.+.. ....
T Consensus 13 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~ 92 (318)
T d3blha1 13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI 92 (318)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CE
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceE
Confidence 34578999999999999985 8899999986542 2345678999999999999999999999855 3458
Q ss_pred EEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccc
Q 002887 632 GLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 711 (870)
Q Consensus 632 ~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~ 711 (870)
++||||++++.+..... ....++...+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++.+
T Consensus 93 ~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 93 YLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp EEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeeec
Confidence 89999999887765443 345788899999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCc--cccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcC--Ccc
Q 002887 712 PVEGGT--HVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARG--DIK 786 (870)
Q Consensus 712 ~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~--~~~ 786 (870)
...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||........+........... ...
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 432211 222345799999999999865 689999999999999999999999987665444333322221110 000
Q ss_pred hhccccc--------CCCCCHH-------HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 787 NIVDHRL--------QGDFDTN-------TVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 787 ~i~d~~l--------~~~~~~~-------~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
....... ....... ....+++|+.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0000000 0001111 1235678999999999999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-39 Score=352.19 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=203.0
Q ss_pred hhccccccccCcEEEEEEEE-----CCeeEEEEEeeccc----hhhhHHHHHHHHHHHHhcc-ccceeEEEEEecCCeEE
Q 002887 563 NNFERVLGKGGFGTVYHGYL-----DDKQVAVKMLSSSS----VQGYKQFQAEVELLIRAHH-KNLTILVGYCDEGANMG 632 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~-----~~~~vAVK~l~~~~----~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~ 632 (870)
+++.+.||+|+||+||+|+. +++.||||+++... ....+.+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 45678999999999999986 26889999986542 2345678899999999977 79999999999999999
Q ss_pred EEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCcccc
Q 002887 633 LIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 712 (870)
Q Consensus 633 LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~ 712 (870)
++|||+.+|+|.+++... ..+.......++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 106 ~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 999999999999998654 3567888899999999999999998 99999999999999999999999999998663
Q ss_pred CCCCccccccccCCCCccCccccccC--CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcchhcc
Q 002887 713 VEGGTHVSTTVVGTPGYLDPEYYISN--RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIKNIVD 790 (870)
Q Consensus 713 ~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d 790 (870)
.. .........|++.|+|||.+.+. .++.++|||||||+||||++|+.||..........+.........
T Consensus 181 ~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~------- 252 (322)
T d1vzoa_ 181 AD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE------- 252 (322)
T ss_dssp GG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC-------
T ss_pred cc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC-------
Confidence 22 22233456799999999999764 478899999999999999999999987766555544443333211
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002887 791 HRLQGDFDTNTVWKAVEIALACIHTISTRRPT-----MNQVVI 828 (870)
Q Consensus 791 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~ 828 (870)
...+.....++.+++.+|++.+|++||| ++|+++
T Consensus 253 ----~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 ----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1122345567889999999999999994 788865
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.3e-39 Score=345.41 Aligned_cols=257 Identities=16% Similarity=0.209 Sum_probs=204.8
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhcc-ccceeEEEEEecCCeEEEEEEEcc
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHH-KNLTILVGYCDEGANMGLIYEFMA 639 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~LV~Ey~~ 639 (870)
+.+.+.||+|+||.||+|+.. ++.||||++.... ....+.+|++.++.++| +|++.+++++.++...++||||+
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 345689999999999999975 8899999986543 33567899999999965 89999999999999999999998
Q ss_pred CCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcC-----CCcEEEEeccCCccccCC
Q 002887 640 NGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNE-----KFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 640 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~-----~~~vkL~DFGla~~~~~~ 714 (870)
+++|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++.+...
T Consensus 84 ~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 84 GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 6799887754 345799999999999999999999998 9999999999999974 578999999999976433
Q ss_pred CCc-----cccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHH--HHHhhcCCcch
Q 002887 715 GGT-----HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWV--SSMLARGDIKN 787 (870)
Q Consensus 715 ~~~-----~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~--~~~~~~~~~~~ 787 (870)
... .......||+.|||||++.+..++.++|||||||++|||++|+.||...........+. ..........
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~- 238 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR- 238 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH-
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH-
Confidence 221 12335679999999999999999999999999999999999999998665433322211 1111111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 002887 788 IVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIELNDCLA 835 (870)
Q Consensus 788 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 835 (870)
.+.. ..+.++.+++..|+..+|++||+++.+.+.|++++.
T Consensus 239 ----~l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 239 ----ELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp ----HHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred ----HhcC----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 1111 123568889999999999999999999999988753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-39 Score=354.55 Aligned_cols=257 Identities=24% Similarity=0.309 Sum_probs=192.9
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeecc--chhhhHHHHHHHHHHHHhccccceeEEEEEecCC------eEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSS--SVQGYKQFQAEVELLIRAHHKNLTILVGYCDEGA------NMGL 633 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~~L 633 (870)
...+.||+|+||+||+|... ++.||||+++.. .....+.+.+|+++|++++|||||+++++|...+ +.++
T Consensus 21 ~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 100 (346)
T d1cm8a_ 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL 100 (346)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEE
Confidence 34578999999999999975 889999999754 2334567899999999999999999999997654 5799
Q ss_pred EEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccC
Q 002887 634 IYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 713 (870)
Q Consensus 634 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~ 713 (870)
||||+ +.+|..... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||+++....
T Consensus 101 v~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 101 VMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp EEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccCC
Confidence 99999 456666553 34699999999999999999999998 999999999999999999999999999986532
Q ss_pred CCCccccccccCCCCccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhc-------CCc
Q 002887 714 EGGTHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLAR-------GDI 785 (870)
Q Consensus 714 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~-------~~~ 785 (870)
..+...||+.|+|||++.+. .++.++||||+||+++||++|++||........+.......... ...
T Consensus 174 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 174 -----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp -----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred -----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 23456799999999998764 57899999999999999999999998766544443332211100 000
Q ss_pred ----------chhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHh
Q 002887 786 ----------KNIVDHRLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVIE--LNDC 833 (870)
Q Consensus 786 ----------~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~--L~~~ 833 (870)
.+.....+. .........+.+|+.+||+.||++|||+.|+++. ++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 000000000 0111223567899999999999999999999874 5443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-39 Score=356.56 Aligned_cols=258 Identities=21% Similarity=0.318 Sum_probs=193.9
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc-hhhhHHHHHHHHHHHHhccccceeEEEEEecCC----eEEEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGA----NMGLIYEF 637 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~LV~Ey 637 (870)
..+.||+|+||+||+|+.. ++.||||++.... ....+++++|+++|++++||||+++++++.... ..+++++|
T Consensus 12 ~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~ 91 (345)
T d1pmea_ 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTH 91 (345)
T ss_dssp EEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEe
Confidence 4579999999999999975 8899999997543 334567899999999999999999999996543 34566677
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCc
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGT 717 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 717 (870)
+.+|+|.+++.. ..+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 92 ~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~ 165 (345)
T d1pmea_ 92 LMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165 (345)
T ss_dssp CCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred ecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence 889999999853 4699999999999999999999998 9999999999999999999999999999865332221
Q ss_pred -cccccccCCCCccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCCcc---------
Q 002887 718 -HVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGDIK--------- 786 (870)
Q Consensus 718 -~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~--------- 786 (870)
.......||+.|+|||++.. ..++.++||||+||+++||++|+.||................. .....
T Consensus 166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG-SPSQEDLNCIINLK 244 (345)
T ss_dssp CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-SCCHHHHHTCCCHH
T ss_pred ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhcc-CCChhhhhhhhhhh
Confidence 22345679999999999854 5678999999999999999999999987654333222211111 00000
Q ss_pred --hhcccccC-CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 787 --NIVDHRLQ-GDFD-----TNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 787 --~i~d~~l~-~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
........ ...+ .....++.+++.+|++.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000 0001 0122468899999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.3e-38 Score=344.97 Aligned_cols=252 Identities=19% Similarity=0.288 Sum_probs=194.1
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhc-cccceeEEEEEec--CCeEEEEEEE
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAH-HKNLTILVGYCDE--GANMGLIYEF 637 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~--~~~~~LV~Ey 637 (870)
+.+.+.||+|+||+||+|+.. ++.||||+++... .+++.+|+++|++++ ||||+++++++.. ....++||||
T Consensus 37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 345689999999999999985 8999999997543 467889999999995 9999999999874 4568999999
Q ss_pred ccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCC-cEEEEeccCCccccCCCC
Q 002887 638 MANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKF-QAKLADFGLSRIFPVEGG 716 (870)
Q Consensus 638 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~-~vkL~DFGla~~~~~~~~ 716 (870)
+.+++|.... +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.....
T Consensus 114 ~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-- 183 (328)
T d3bqca1 114 VNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-- 183 (328)
T ss_dssp CCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT--
T ss_pred cCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC--
Confidence 9999997764 3689999999999999999999999 999999999999998655 6999999999876432
Q ss_pred ccccccccCCCCccCccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHh---------hcCCc-
Q 002887 717 THVSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSML---------ARGDI- 785 (870)
Q Consensus 717 ~~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~---------~~~~~- 785 (870)
.......+|+.|+|||.+.+.. ++.++||||+||+++||++|+.||............+...+ .....
T Consensus 184 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 184 -QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp -CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred -CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 2234567899999999988654 79999999999999999999999976553221111111100 00000
Q ss_pred -----chhccc--------ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 786 -----KNIVDH--------RLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 786 -----~~i~d~--------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
...... .............+.+|+.+||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 0011111223456889999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-38 Score=340.61 Aligned_cols=257 Identities=19% Similarity=0.222 Sum_probs=199.9
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEecCCeEEEEEEEccC
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDEGANMGLIYEFMAN 640 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 640 (870)
..+.||+|+||+||+|+.. ++.||||+++... ....+++++|+.++++++||||+++++++.+....++|+|++.+
T Consensus 6 ~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~ 85 (292)
T d1unla_ 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSE
T ss_pred eeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccc
Confidence 4578999999999999985 7889999997553 23457889999999999999999999999999999999999999
Q ss_pred CchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCCCCcccc
Q 002887 641 GNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGTHVS 720 (870)
Q Consensus 641 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 720 (870)
+++..++. ..+.+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||.++...... ...
T Consensus 86 ~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~--~~~ 158 (292)
T d1unla_ 86 DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCY 158 (292)
T ss_dssp EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC--SCC
T ss_pred cccccccc--cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC--ccc
Confidence 99887765 345788999999999999999999998 99999999999999999999999999998764322 223
Q ss_pred ccccCCCCccCccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCC---c---chhcccc-
Q 002887 721 TTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGD---I---KNIVDHR- 792 (870)
Q Consensus 721 ~~~~gt~~y~APE~~~~~~-~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~---~---~~i~d~~- 792 (870)
....+++.|+|||.+.... ++.++||||+||+++||++|+.||..........+-+........ . ....+..
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 3456788999999988665 689999999999999999999997654432222221221111110 0 0000000
Q ss_pred --------cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 793 --------LQGDFDTNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 793 --------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
-...........+.+++.+|++.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000111223456789999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-37 Score=343.24 Aligned_cols=254 Identities=22% Similarity=0.270 Sum_probs=188.7
Q ss_pred ccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEec------CCeEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDE------GANMGLI 634 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------~~~~~LV 634 (870)
..++||+|+||+||+|+.. ++.||||++.... ....+++.+|+.++++++||||+++++++.. ....++|
T Consensus 21 i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv 100 (355)
T d2b1pa1 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 100 (355)
T ss_dssp EEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEE
Confidence 3479999999999999986 8999999997643 3344678999999999999999999999953 4688999
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
|||+.++.+.. +. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||+++....
T Consensus 101 ~Ey~~~~l~~~-~~----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~- 171 (355)
T d2b1pa1 101 MELMDANLCQV-IQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT- 171 (355)
T ss_dssp EECCSEEHHHH-HT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EeccchHHHHh-hh----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcccc-
Confidence 99998765543 32 4588999999999999999999999 999999999999999999999999999876532
Q ss_pred CCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHh--------------
Q 002887 715 GGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSML-------------- 780 (870)
Q Consensus 715 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~-------------- 780 (870)
........||+.|+|||++.+..++.++||||+||+++||++|+.||..........+......
T Consensus 172 --~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 172 --SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred --ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 2333456799999999999999999999999999999999999999986654333332221111
Q ss_pred ----hcC-C-----cchhcccccCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002887 781 ----ARG-D-----IKNIVDHRLQGDF---DTNTVWKAVEIALACIHTISTRRPTMNQVVIE 829 (870)
Q Consensus 781 ----~~~-~-----~~~i~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 829 (870)
... . ....+........ .......+.+|+.+|++.||++|||++|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 0 0111111111111 12346678999999999999999999999853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-37 Score=339.31 Aligned_cols=254 Identities=24% Similarity=0.310 Sum_probs=193.2
Q ss_pred hccccccccCcEEEEEEEEC--CeeEEEEEeeccc--hhhhHHHHHHHHHHHHhccccceeEEEEEec-----CCeEEEE
Q 002887 564 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS--VQGYKQFQAEVELLIRAHHKNLTILVGYCDE-----GANMGLI 634 (870)
Q Consensus 564 ~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-----~~~~~LV 634 (870)
...+.||+|+||+||+|+.. ++.||||++.... ....+++.+|+++|++++|||++++++++.. ....+++
T Consensus 21 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i 100 (348)
T d2gfsa1 21 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 100 (348)
T ss_dssp EEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEE
Confidence 34578999999999999975 8999999997543 3345678899999999999999999999853 3345777
Q ss_pred EEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEeccCCccccCC
Q 002887 635 YEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 714 (870)
Q Consensus 635 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 714 (870)
++|+.+|+|.+++.. +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++....
T Consensus 101 ~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~-- 172 (348)
T d2gfsa1 101 VTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD-- 172 (348)
T ss_dssp EEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT--
T ss_pred EEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC--
Confidence 888999999998843 4699999999999999999999998 99999999999999999999999999987542
Q ss_pred CCccccccccCCCCccCccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhcCC------c--
Q 002887 715 GGTHVSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTPQRTLIGQWVSSMLARGD------I-- 785 (870)
Q Consensus 715 ~~~~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwS~GvvL~elltG~~p~~~~~~~~~l~~~~~~~~~~~~------~-- 785 (870)
.......|++.|+|||...+.. ++.++||||+||++|||++|++||..................... .
T Consensus 173 ---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 173 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp ---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred ---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence 2334567889999999877654 689999999999999999999999876644433333222111000 0
Q ss_pred --chhcccccC-CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002887 786 --KNIVDHRLQ-GDFD-----TNTVWKAVEIALACIHTISTRRPTMNQVVI 828 (870)
Q Consensus 786 --~~i~d~~l~-~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 828 (870)
......... .... ......+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000000000 0000 112356789999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-33 Score=312.59 Aligned_cols=263 Identities=22% Similarity=0.303 Sum_probs=191.3
Q ss_pred hhccccccccCcEEEEEEEEC--CeeEEEEEeeccchhhhHHHHHHHHHHHHhc-----------cccceeEEEEEec--
Q 002887 563 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSSSSVQGYKQFQAEVELLIRAH-----------HKNLTILVGYCDE-- 627 (870)
Q Consensus 563 ~~f~~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-----------H~nIv~l~g~~~~-- 627 (870)
+.+.+.||+|+||+||+|+.. ++.||||+++.... ..+.+++|++++++++ |+||+++++++..
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 456789999999999999975 89999999986543 3457788999988875 5789999988754
Q ss_pred CCeEEEEEEEccCCch-hhhhhhcccccccHHHHHHHHHHHHHHHHHHHh-CCCCCceeCCCCCCCEEEcCCC------c
Q 002887 628 GANMGLIYEFMANGNL-QAHLLEDKADTLCWERRLQIASESAQGLEYLHN-GCKPPIVHRDVKSANILLNEKF------Q 699 (870)
Q Consensus 628 ~~~~~LV~Ey~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~IvHrDLKp~NILld~~~------~ 699 (870)
....+++++++..+.. ...........+++..+..++.|++.||+|||+ . +|+||||||+|||++.++ .
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccce
Confidence 3566677777655443 333333445678899999999999999999998 5 899999999999998765 4
Q ss_pred EEEEeccCCccccCCCCccccccccCCCCccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCcc------chHH
Q 002887 700 AKLADFGLSRIFPVEGGTHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPQR------TLIG 773 (870)
Q Consensus 700 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~GvvL~elltG~~p~~~~~~~------~~l~ 773 (870)
+|++|||.+..... ......||+.|+|||++....++.++||||+||+++||++|+.||...... ..+.
T Consensus 171 ~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 171 IKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 99999999976532 224567999999999999999999999999999999999999999754321 1111
Q ss_pred HHHHHH-------hhcCC-cchhccc-------------------ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 002887 774 QWVSSM-------LARGD-IKNIVDH-------------------RLQGDFDTNTVWKAVEIALACIHTISTRRPTMNQV 826 (870)
Q Consensus 774 ~~~~~~-------~~~~~-~~~i~d~-------------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eV 826 (870)
+.+... ...+. .....+. .............+.+++.+|++.||++|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 111110 00000 0000000 00122345667789999999999999999999999
Q ss_pred HHH--HHHhh
Q 002887 827 VIE--LNDCL 834 (870)
Q Consensus 827 l~~--L~~~~ 834 (870)
++. +++..
T Consensus 326 L~Hp~f~~~~ 335 (362)
T d1q8ya_ 326 VNHPWLKDTL 335 (362)
T ss_dssp HTCGGGTTCT
T ss_pred hcCcccCCCC
Confidence 863 44433
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.82 E-value=8.9e-21 Score=189.73 Aligned_cols=161 Identities=17% Similarity=0.214 Sum_probs=118.2
Q ss_pred ccccccccCcEEEEEEEEC-CeeEEEEEeeccch------------------hhhHHHHHHHHHHHHhccccceeEEEEE
Q 002887 565 FERVLGKGGFGTVYHGYLD-DKQVAVKMLSSSSV------------------QGYKQFQAEVELLIRAHHKNLTILVGYC 625 (870)
Q Consensus 565 f~~~LG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~------------------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~ 625 (870)
+.+.||+|+||.||+|+.. |+.||||+++.... .....+..|+..+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 4689999999999999975 89999998753211 1123356788899999999999888764
Q ss_pred ecCCeEEEEEEEccCCchhhhhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCCCceeCCCCCCCEEEcCCCcEEEEec
Q 002887 626 DEGANMGLIYEFMANGNLQAHLLEDKADTLCWERRLQIASESAQGLEYLHNGCKPPIVHRDVKSANILLNEKFQAKLADF 705 (870)
Q Consensus 626 ~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvHrDLKp~NILld~~~~vkL~DF 705 (870)
. .+++|||++++.+.+ ++......++.|+++||+|||+. +|+||||||+|||++++ .++|+||
T Consensus 84 ~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 84 G----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp T----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCC
T ss_pred C----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEEC
Confidence 3 379999999865543 23344567899999999999998 99999999999999975 5899999
Q ss_pred cCCccccCCCCccccccccCCCCccC------ccccccCCCCccchHHHHHHHH
Q 002887 706 GLSRIFPVEGGTHVSTTVVGTPGYLD------PEYYISNRLTEKSDVYSFGVVL 753 (870)
Q Consensus 706 Gla~~~~~~~~~~~~~~~~gt~~y~A------PE~~~~~~~~~ksDVwS~GvvL 753 (870)
|+|......... .|.. .| +..+++..++|+||..--+
T Consensus 147 G~a~~~~~~~~~----------~~l~rd~~~~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWR----------EILERDVRNIIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHH----------HHHHHHHHHHHH-HHHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcH----------HHHHHHHHHHHH-HHcCCCCCcccHHHHHHHH
Confidence 999764221110 0111 01 1245678889999975433
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.71 E-value=5.5e-18 Score=182.37 Aligned_cols=125 Identities=30% Similarity=0.504 Sum_probs=109.4
Q ss_pred cCChhhHHHHHHHHhhcC---CCCCCC--CCCCCCCCCCccceecCCCCCCCCcEEEEEcCCCCCcc--cCcccccccCc
Q 002887 362 LTNQQDVDAIMKIKSKYE---VKRDWQ--GDPCAPKVYMWQGINCSYDANQSPRIISINLSSSGIAG--DIVPYIFSLTS 434 (870)
Q Consensus 362 ~~~~~d~~al~~~k~~~~---~~~~w~--~~pC~~~~~~W~Gv~C~~~~~~~~~l~~l~L~~n~l~G--~ip~~~~~l~~ 434 (870)
-|.++|.+||++||+.+. .+.+|. +|+|. +.|.||+|+.+ +...||+.|+|++|+++| .||++|++|++
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~---~~w~gv~C~~~-~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~ 77 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN---RTWLGVLCDTD-TQTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTT---TCSTTEEECCS-SSCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred CCCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCC---CcCCCeEEeCC-CCcEEEEEEECCCCCCCCCCCCChHHhcCcc
Confidence 388999999999999873 467884 35552 36999999853 344689999999999999 68999999999
Q ss_pred cccccccc-CcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccccc
Q 002887 435 IESLDLSK-NSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSV 490 (870)
Q Consensus 435 L~~L~Ls~-N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~~ 490 (870)
|++|+|++ |+|+|.||.+|++|++|++|+|++|+|+|.+|..+..+.++..++++.
T Consensus 78 L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~ 134 (313)
T d1ogqa_ 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSY 134 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCS
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccccccchhhhccccccc
Confidence 99999996 899999999999999999999999999999999999999888887764
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.04 E-value=1.1e-10 Score=115.32 Aligned_cols=98 Identities=15% Similarity=0.168 Sum_probs=85.3
Q ss_pred CCccceecCCCC------CCCCcEEEEEcCCCCCcccCcc-cccccCcccccccccCcCCCCCCccccCcCCCCeEEecC
Q 002887 394 YMWQGINCSYDA------NQSPRIISINLSSSGIAGDIVP-YIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG 466 (870)
Q Consensus 394 ~~W~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~-~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~ 466 (870)
|.|..|.|++.+ ..+..++.|+|++|.|++.++. .|.++++|+.|+|++|++++..|..+..+++|+.|+|++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 579999998643 3446789999999999987754 578999999999999999999999999999999999999
Q ss_pred CcCCCCCCCcccccccCCccccccC
Q 002887 467 NNLQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 467 N~l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
|+|++..|..+..+++|+.|+++.+
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N 112 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDN 112 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSS
T ss_pred ccccccCHHHHhCCCcccccccCCc
Confidence 9999777788899999999988743
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.04 E-value=3.5e-11 Score=128.29 Aligned_cols=91 Identities=29% Similarity=0.409 Sum_probs=80.2
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
...++.|++++|+++|.+| +++.+++|+.|+|++|+|+|.||+.|++|++|++|||++|+|+|.||+ ++++.++..++
T Consensus 220 ~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~ 297 (313)
T d1ogqa_ 220 DKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSA 297 (313)
T ss_dssp TSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGG
T ss_pred ccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHH
Confidence 4578899999999998865 799999999999999999999999999999999999999999999995 57777777655
Q ss_pred cccCCCCCCCCC--Ccc
Q 002887 488 LSVDGNRNLCPS--ASC 502 (870)
Q Consensus 488 ~~~~~n~~lc~~--~sc 502 (870)
+ .||+.+|+. ++|
T Consensus 298 l--~~N~~l~g~plp~c 312 (313)
T d1ogqa_ 298 Y--ANNKCLCGSPLPAC 312 (313)
T ss_dssp T--CSSSEEESTTSSCC
T ss_pred h--CCCccccCCCCCCC
Confidence 5 489989976 455
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.98 E-value=4.4e-10 Score=107.09 Aligned_cols=107 Identities=24% Similarity=0.321 Sum_probs=84.7
Q ss_pred CCCCCCCCCccceecCCCC--------CCCCcEEEEEcCCCC-CcccCcccccccCcccccccccCcCCCCCCccccCcC
Q 002887 387 DPCAPKVYMWQGINCSYDA--------NQSPRIISINLSSSG-IAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQ 457 (870)
Q Consensus 387 ~pC~~~~~~W~Gv~C~~~~--------~~~~~l~~l~L~~n~-l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~ 457 (870)
+.|.+ ..+.+|+|+..+ ....+++.|+|.+|+ |+..-+..|.+|++|+.|+|++|+|++.-|..|..++
T Consensus 3 ~~C~c--~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~ 80 (156)
T d2ifga3 3 DACCP--HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTP 80 (156)
T ss_dssp SSSCC--SSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCS
T ss_pred CCCCc--CCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccc
Confidence 34543 368899998633 233578999998775 7744445699999999999999999977788899999
Q ss_pred CCCeEEecCCcCCCCCCCcccccccCCccccccCCCCCCCC
Q 002887 458 SLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSVDGNRNLCP 498 (870)
Q Consensus 458 ~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~~~~n~~lc~ 498 (870)
+|+.|+|++|+|+ .+|.......++..|+++ +|+..|.
T Consensus 81 ~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~--~Np~~C~ 118 (156)
T d2ifga3 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLS--GNPLHCS 118 (156)
T ss_dssp CCCEEECCSSCCS-CCCSTTTCSCCCCEEECC--SSCCCCC
T ss_pred cccceeccCCCCc-ccChhhhccccccccccC--CCcccCC
Confidence 9999999999999 788777666677766665 8888775
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=98.79 E-value=1.7e-09 Score=106.48 Aligned_cols=89 Identities=21% Similarity=0.333 Sum_probs=80.7
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.++++.|+|++|++.+..+..+..+++|++|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..+..+++++.|+
T Consensus 53 l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~ 132 (192)
T d1w8aa_ 53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132 (192)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEE
T ss_pred CceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccc
Confidence 46899999999999999999999999999999999999987788899999999999999999988888899999999887
Q ss_pred cccCCCCCCCC
Q 002887 488 LSVDGNRNLCP 498 (870)
Q Consensus 488 ~~~~~n~~lc~ 498 (870)
++ +|+..|.
T Consensus 133 L~--~N~~~~~ 141 (192)
T d1w8aa_ 133 LA--SNPFNCN 141 (192)
T ss_dssp CT--TCCBCCS
T ss_pred cc--ccccccc
Confidence 76 7776664
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.66 E-value=9.2e-09 Score=93.70 Aligned_cols=78 Identities=28% Similarity=0.304 Sum_probs=53.6
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCC-CCcccccccCCccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSL-PSGLSEKVKNGSLS 487 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~i-p~~l~~~~~~~~l~ 487 (870)
..++.|+|++|.|+ .+|+.++.+++|+.|+|++|.|+ .+|. ++++++|+.|++++|+++... +..+..++++..|+
T Consensus 20 ~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~-~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~ 96 (124)
T d1dcea3 20 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 96 (124)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred CCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccCc-cccccccCeEECCCCccCCCCCchhhcCCCCCCEEE
Confidence 46777777777776 57777777777777777777777 3553 677777777777777776332 23566667776666
Q ss_pred cc
Q 002887 488 LS 489 (870)
Q Consensus 488 ~~ 489 (870)
++
T Consensus 97 l~ 98 (124)
T d1dcea3 97 LQ 98 (124)
T ss_dssp CT
T ss_pred CC
Confidence 54
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.64 E-value=1.4e-08 Score=92.40 Aligned_cols=74 Identities=28% Similarity=0.405 Sum_probs=66.2
Q ss_pred EEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccccccC
Q 002887 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 413 ~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
.|+|++|+|+ .++ .+.+|++|++|+|++|+|+ .+|+.++.+++|+.|+|++|+|+ .+| .+..+++++.|+++.+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 6899999998 665 5999999999999999998 78999999999999999999999 455 5889999999888744
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.55 E-value=4e-08 Score=101.58 Aligned_cols=88 Identities=24% Similarity=0.268 Sum_probs=79.6
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
..++..|++++|.+++..+..+..+++|+.|+|++|+|++..|..|..+++|+.|||++|+|+ .||+++..+.+++.|+
T Consensus 123 l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~ 201 (266)
T d1p9ag_ 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAF 201 (266)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEE
T ss_pred ccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEE
Confidence 457899999999999666667888999999999999999888888999999999999999999 9999999999998877
Q ss_pred cccCCCCCCCC
Q 002887 488 LSVDGNRNLCP 498 (870)
Q Consensus 488 ~~~~~n~~lc~ 498 (870)
++ ||+..|.
T Consensus 202 L~--~Np~~Cd 210 (266)
T d1p9ag_ 202 LH--GNPWLCN 210 (266)
T ss_dssp CC--SCCBCCS
T ss_pred ec--CCCCCCC
Confidence 76 9998886
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.50 E-value=5.5e-08 Score=100.54 Aligned_cols=94 Identities=22% Similarity=0.236 Sum_probs=78.0
Q ss_pred eecCCCC------CCCCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCC
Q 002887 399 INCSYDA------NQSPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGS 472 (870)
Q Consensus 399 v~C~~~~------~~~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ 472 (870)
|.|++.+ ..++.++.|+|++|.|++.-+..|.+|++|++|+|++|+|+ .||. ++.+++|+.|+|++|+|++
T Consensus 15 v~C~~~~L~~iP~~lp~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l~~- 91 (266)
T d1p9ag_ 15 VNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQS- 91 (266)
T ss_dssp EECTTSCCSSCCSCCCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSCCSS-
T ss_pred EEccCCCCCeeCcCcCcCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-ccccccccccccccccccc-
Confidence 7897632 24457999999999999665677999999999999999998 5775 5889999999999999994
Q ss_pred CCCcccccccCCccccccCCCCC
Q 002887 473 LPSGLSEKVKNGSLSLSVDGNRN 495 (870)
Q Consensus 473 ip~~l~~~~~~~~l~~~~~~n~~ 495 (870)
+|..+..+++++.|+++.+....
T Consensus 92 ~~~~~~~l~~L~~L~l~~~~~~~ 114 (266)
T d1p9ag_ 92 LPLLGQTLPALTVLDVSFNRLTS 114 (266)
T ss_dssp CCCCTTTCTTCCEEECCSSCCCC
T ss_pred cccccccccccccccccccccce
Confidence 57788899999999887654433
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.46 E-value=3.4e-08 Score=103.06 Aligned_cols=89 Identities=22% Similarity=0.210 Sum_probs=77.5
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
..+++.|+|++|+|++..+..|.++++|+.|+|++|++++..|..|..+++|+.||+++|++++..|..+..+.+++.|+
T Consensus 152 ~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~ 231 (284)
T d1ozna_ 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLR 231 (284)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEE
T ss_pred ccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEE
Confidence 35788999999999977778889999999999999999998899999999999999999999988888888888888776
Q ss_pred cccCCCCCCCC
Q 002887 488 LSVDGNRNLCP 498 (870)
Q Consensus 488 ~~~~~n~~lc~ 498 (870)
++ +|+..|.
T Consensus 232 l~--~N~l~C~ 240 (284)
T d1ozna_ 232 LN--DNPWVCD 240 (284)
T ss_dssp CC--SSCEECS
T ss_pred ec--CCCCCCC
Confidence 65 8887764
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.45 E-value=1.3e-07 Score=99.46 Aligned_cols=92 Identities=24% Similarity=0.317 Sum_probs=75.0
Q ss_pred CCccceecCCCC------CCCCcEEEEEcCCCCCcccCc-ccccccCcccccccccCcCCCCCCccccCcCCCCeEEecC
Q 002887 394 YMWQGINCSYDA------NQSPRIISINLSSSGIAGDIV-PYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSG 466 (870)
Q Consensus 394 ~~W~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip-~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~ 466 (870)
|.|.+|+|++.+ ..++.++.|+|++|+|+ .|| ..|.+|++|++|++++|.++...|..|.+|++|+.|+|++
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence 689999998632 23467999999999999 555 4799999999999999999987788999999999999999
Q ss_pred CcCCCCCCCcccccccCCccccc
Q 002887 467 NNLQGSLPSGLSEKVKNGSLSLS 489 (870)
Q Consensus 467 N~l~g~ip~~l~~~~~~~~l~~~ 489 (870)
|+++ .+|.... ..+..|..+
T Consensus 89 n~l~-~l~~~~~--~~l~~L~~~ 108 (305)
T d1xkua_ 89 NQLK-ELPEKMP--KTLQELRVH 108 (305)
T ss_dssp SCCS-BCCSSCC--TTCCEEECC
T ss_pred CccC-cCccchh--hhhhhhhcc
Confidence 9999 6776543 234444443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.39 E-value=9.1e-08 Score=91.21 Aligned_cols=78 Identities=18% Similarity=0.124 Sum_probs=61.8
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
.+++.|+|++|+|+ .||..+..+++|+.|||++|+|+ .++ .++.|++|+.|+|++|+++...+..+..++++..|++
T Consensus 18 ~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 18 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp TSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 46888999999998 67776778899999999999988 565 4788899999999999998443334456788888777
Q ss_pred c
Q 002887 489 S 489 (870)
Q Consensus 489 ~ 489 (870)
+
T Consensus 95 ~ 95 (162)
T d1a9na_ 95 T 95 (162)
T ss_dssp C
T ss_pred c
Confidence 6
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.20 E-value=2.6e-07 Score=87.97 Aligned_cols=82 Identities=20% Similarity=0.146 Sum_probs=66.9
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCC--CcccccccCCc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLP--SGLSEKVKNGS 485 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip--~~l~~~~~~~~ 485 (870)
...++.|+|++|.|+ .++ .|..|++|+.|+|++|+++..-|..+..+++|+.|+|++|+++ .++ ..+..+++|..
T Consensus 40 l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~~ 116 (162)
T d1a9na_ 40 LDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTY 116 (162)
T ss_dssp TTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCE
T ss_pred cccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccccc-ccccccccccccccch
Confidence 357999999999999 664 5899999999999999999544444578999999999999998 444 36777888887
Q ss_pred cccccCCCC
Q 002887 486 LSLSVDGNR 494 (870)
Q Consensus 486 l~~~~~~n~ 494 (870)
|+++ +|+
T Consensus 117 L~l~--~N~ 123 (162)
T d1a9na_ 117 LCIL--RNP 123 (162)
T ss_dssp EECC--SSG
T ss_pred hhcC--CCc
Confidence 7766 553
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.18 E-value=6.6e-06 Score=83.78 Aligned_cols=132 Identities=13% Similarity=0.116 Sum_probs=95.5
Q ss_pred cCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhc-cccceeEEEEEecCCeEEEEEEEccCCchhhhhhhc
Q 002887 572 GGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAH-HKNLTILVGYCDEGANMGLIYEFMANGNLQAHLLED 650 (870)
Q Consensus 572 G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~ 650 (870)
++.+.||+...+++.+.+|+...........+.+|...+..+. +--+.+++.++..++..++||+++++..+.+.....
T Consensus 25 ~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~ 104 (263)
T d1j7la_ 25 MSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE 104 (263)
T ss_dssp CSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC
T ss_pred CCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc
Confidence 3446899988888889999987765555667889999988874 333567888888888899999999998876543211
Q ss_pred ccccccHHHHHHHHHHHHHHHHHHHhC-----------------------------------------------------
Q 002887 651 KADTLCWERRLQIASESAQGLEYLHNG----------------------------------------------------- 677 (870)
Q Consensus 651 ~~~~l~~~~~~~i~~~ia~aL~yLH~~----------------------------------------------------- 677 (870)
. ....++.++++.+..||+.
T Consensus 105 ~-------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 177 (263)
T d1j7la_ 105 Q-------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE 177 (263)
T ss_dssp S-------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHS
T ss_pred c-------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhc
Confidence 1 1223455555556666642
Q ss_pred C---CCCceeCCCCCCCEEEcCCCcEEEEeccCCcc
Q 002887 678 C---KPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 678 ~---~~~IvHrDLKp~NILld~~~~vkL~DFGla~~ 710 (870)
. ...++|+|+.+.|||+++++..-|+||+.+..
T Consensus 178 ~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 178 KPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 0 12378999999999999877778999998753
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.16 E-value=6.8e-07 Score=93.70 Aligned_cols=79 Identities=25% Similarity=0.310 Sum_probs=38.1
Q ss_pred cEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccccc
Q 002887 410 RIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLS 489 (870)
Q Consensus 410 ~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~ 489 (870)
+++.|+|++|.+++.++..+.+++.+++|++++|.+++..|..+.++++|++|+|++|+|+ .||.++..+++|+.|+++
T Consensus 172 ~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls 250 (305)
T d1xkua_ 172 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 250 (305)
T ss_dssp TCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECC
T ss_pred ccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECC
Confidence 4444445444444444444444444455555544444444444444444555555555444 344444444444444443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.12 E-value=8.7e-07 Score=92.01 Aligned_cols=83 Identities=17% Similarity=0.111 Sum_probs=75.8
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
...++.|++++|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..|..+..++++..|+
T Consensus 128 ~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~ 207 (284)
T d1ozna_ 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207 (284)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred hcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccc
Confidence 45789999999999966667789999999999999999988888999999999999999999999999999999999988
Q ss_pred ccc
Q 002887 488 LSV 490 (870)
Q Consensus 488 ~~~ 490 (870)
++.
T Consensus 208 l~~ 210 (284)
T d1ozna_ 208 LFA 210 (284)
T ss_dssp CCS
T ss_pred ccc
Confidence 873
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.09 E-value=8.6e-07 Score=95.48 Aligned_cols=76 Identities=22% Similarity=0.280 Sum_probs=66.3
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.+.++.|+|++|+|++. + .+..+++|+.|+|++|+|++ +| .|++|++|+.|+|++|+|++.+| +.++++|+.|+
T Consensus 306 ~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~ 379 (384)
T d2omza2 306 LKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLG 379 (384)
T ss_dssp CTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEE
T ss_pred hcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEee
Confidence 35788999999999975 3 38999999999999999995 56 58999999999999999997655 88899999988
Q ss_pred cc
Q 002887 488 LS 489 (870)
Q Consensus 488 ~~ 489 (870)
++
T Consensus 380 L~ 381 (384)
T d2omza2 380 LN 381 (384)
T ss_dssp CC
T ss_pred CC
Confidence 87
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=97.95 E-value=2.6e-06 Score=85.22 Aligned_cols=76 Identities=14% Similarity=0.265 Sum_probs=64.4
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
.++++.|++++|.+.+.. .+++|++|+.|+|++|++++ +|. +++|++|+.|+|++|++++ +| .+.++++|..|+
T Consensus 150 ~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~-i~-~l~~l~~L~~L~ 223 (227)
T d1h6ua2 150 LTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISD-VS-PLANTSNLFIVT 223 (227)
T ss_dssp CTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCB-CG-GGTTCTTCCEEE
T ss_pred ccccccccccccccccch--hhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCC-Cc-ccccCCCCCEEE
Confidence 357899999999998543 38999999999999999995 655 8999999999999999994 55 378888888887
Q ss_pred cc
Q 002887 488 LS 489 (870)
Q Consensus 488 ~~ 489 (870)
++
T Consensus 224 ls 225 (227)
T d1h6ua2 224 LT 225 (227)
T ss_dssp EE
T ss_pred ee
Confidence 75
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.95 E-value=3e-06 Score=79.78 Aligned_cols=79 Identities=18% Similarity=0.192 Sum_probs=67.9
Q ss_pred EEEcCCCCCcccCcccccccCcccccccccCc-CCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccccccC
Q 002887 413 SINLSSSGIAGDIVPYIFSLTSIESLDLSKNS-LTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 413 ~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~-l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
.++..++++. .+|..+..+++|+.|+|++|+ |+..-+..|.+|++|+.|+|++|+|++.-|..+..+++++.|+++.|
T Consensus 12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence 4788999988 788899999999999998765 88544567999999999999999999777888999999999999854
Q ss_pred C
Q 002887 492 G 492 (870)
Q Consensus 492 ~ 492 (870)
.
T Consensus 91 ~ 91 (156)
T d2ifga3 91 A 91 (156)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.84 E-value=5.4e-06 Score=83.38 Aligned_cols=97 Identities=14% Similarity=0.182 Sum_probs=78.8
Q ss_pred CCccceecCCCC------CCCCcEEEEEcCCCCCcccCcc-cccccCcccccccccCcCCCCCCc-cccCcCCCCeEEec
Q 002887 394 YMWQGINCSYDA------NQSPRIISINLSSSGIAGDIVP-YIFSLTSIESLDLSKNSLTGPVPE-FLAELQSLRVLNLS 465 (870)
Q Consensus 394 ~~W~Gv~C~~~~------~~~~~l~~l~L~~n~l~G~ip~-~~~~l~~L~~L~Ls~N~l~g~iP~-~~~~l~~L~~L~ls 465 (870)
|.+..|.|++.+ ..+..++.|+|++|.|+ .||+ .|.+|++|++|+|++|.+...+|. .|..+++|+.|++.
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 577889998632 22347899999999998 5555 689999999999999999877764 57889999999986
Q ss_pred C-CcCCCCCCCcccccccCCccccccC
Q 002887 466 G-NNLQGSLPSGLSEKVKNGSLSLSVD 491 (870)
Q Consensus 466 ~-N~l~g~ip~~l~~~~~~~~l~~~~~ 491 (870)
. |+++...|..+..+++++.+.++.+
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~ 113 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNT 113 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESC
T ss_pred ccccccccccccccccccccccccchh
Confidence 4 7888788888899999998888643
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=97.75 E-value=1.2e-05 Score=78.54 Aligned_cols=73 Identities=23% Similarity=0.350 Sum_probs=32.1
Q ss_pred cEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 410 RIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 410 ~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
.++.|+|++|+|++. ++ +++|++|++|++++|.+. .+|. ++++++|+.|++++|.+... ..+..++++..|++
T Consensus 63 nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l 135 (199)
T d2omxa2 63 NLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLEL 135 (199)
T ss_dssp TCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEEC
T ss_pred CcCcCccccccccCc-cc-ccCCcccccccccccccc-cccc-cccccccccccccccccccc--cccchhhhhHHhhh
Confidence 444455555554432 21 444555555555555444 2332 44445555555554444421 12334444444444
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=97.71 E-value=1.2e-05 Score=79.22 Aligned_cols=75 Identities=28% Similarity=0.410 Sum_probs=62.7
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
+.+..++++.|.+++ +..+++|++|+.|++++|++++ +++ +++|++|+.|+|++|+++ .+| .+..+++|+.|++
T Consensus 134 ~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~L 207 (210)
T d1h6ta2 134 PQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLEL 207 (210)
T ss_dssp TTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEE
T ss_pred ccccccccccccccc--cccccccccccccccccccccc-ccc-ccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEc
Confidence 467889999999875 3468889999999999999985 554 889999999999999998 566 5888888888877
Q ss_pred c
Q 002887 489 S 489 (870)
Q Consensus 489 ~ 489 (870)
+
T Consensus 208 s 208 (210)
T d1h6ta2 208 F 208 (210)
T ss_dssp E
T ss_pred c
Confidence 5
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=97.66 E-value=1.6e-05 Score=85.18 Aligned_cols=75 Identities=20% Similarity=0.301 Sum_probs=61.1
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
..|+.|+|++++++ .| ..|..|++|++|+|++|+|++ +|. +++|++|++|+|++|++++. + .++.+++++.|++
T Consensus 44 ~~l~~L~l~~~~I~-~l-~gl~~L~nL~~L~Ls~N~l~~-l~~-l~~L~~L~~L~L~~n~i~~i-~-~l~~l~~L~~L~~ 117 (384)
T d2omza2 44 DQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLTL 117 (384)
T ss_dssp TTCCEEECCSSCCC-CC-TTGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCC-Cc-cccccCCCCCEEeCcCCcCCC-Ccc-ccCCcccccccccccccccc-c-ccccccccccccc
Confidence 46889999999988 45 468889999999999999995 554 88999999999999999854 3 3778888887776
Q ss_pred c
Q 002887 489 S 489 (870)
Q Consensus 489 ~ 489 (870)
+
T Consensus 118 ~ 118 (384)
T d2omza2 118 F 118 (384)
T ss_dssp C
T ss_pred c
Confidence 5
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=97.64 E-value=2.1e-05 Score=77.54 Aligned_cols=74 Identities=23% Similarity=0.340 Sum_probs=36.9
Q ss_pred cEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccccc
Q 002887 410 RIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSLS 489 (870)
Q Consensus 410 ~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~~ 489 (870)
+++.|+|++|.|++ ++ .+++|++|+.|+|++|++++ +| .+..+++|+.|++++|.++ .+ ..+..++.+..+.++
T Consensus 69 ~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~ 142 (210)
T d1h6ta2 69 NVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLG 142 (210)
T ss_dssp TCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECC
T ss_pred CCCEEeCCCccccC-cc-ccccCccccccccccccccc-cc-ccccccccccccccccccc-cc-ccccccccccccccc
Confidence 45555555555553 22 24555555555555555552 44 2455555555555555554 22 234444444444433
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.60 E-value=0.00015 Score=73.01 Aligned_cols=130 Identities=16% Similarity=0.106 Sum_probs=84.4
Q ss_pred cccccCc-EEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhcccc--ceeEEEEEecCCeEEEEEEEccCCch
Q 002887 568 VLGKGGF-GTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKN--LTILVGYCDEGANMGLIYEFMANGNL 643 (870)
Q Consensus 568 ~LG~G~f-G~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~~~~~~~~~LV~Ey~~~gsL 643 (870)
.+..|.. +.||+...+ +..+.+|.-.... ...+..|+..++.+.... +.++++++.+....++||+++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444543 679998877 5567888765442 345678888888875433 45678888888889999999998766
Q ss_pred hhhhhhcccccccHHHHHHHHHHHHHH---------------------------------------------------HH
Q 002887 644 QAHLLEDKADTLCWERRLQIASESAQG---------------------------------------------------LE 672 (870)
Q Consensus 644 ~~~l~~~~~~~l~~~~~~~i~~~ia~a---------------------------------------------------L~ 672 (870)
.+.... ....+.++++. +.
T Consensus 94 ~~~~~~----------~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 94 LSSHLA----------PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTSCCC----------HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cccccc----------HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 442100 00111222222 23
Q ss_pred HHHhCC----CCCceeCCCCCCCEEEcCCCcEEEEeccCCcc
Q 002887 673 YLHNGC----KPPIVHRDVKSANILLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 673 yLH~~~----~~~IvHrDLKp~NILld~~~~vkL~DFGla~~ 710 (870)
.+.... .+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 332221 22379999999999999887778999997753
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=97.59 E-value=1.4e-06 Score=85.71 Aligned_cols=78 Identities=22% Similarity=0.272 Sum_probs=62.2
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
...++.|+|++|+|+ .|+ .|.+|++|+.|+|++|.|+ .||.....+++|+.|+|++|+++. ++ .+..+++++.|+
T Consensus 47 L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~ 121 (198)
T d1m9la_ 47 LKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEE
T ss_pred ccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccccccccc
Confidence 357888999999988 665 5889999999999999987 678766667789999999999884 43 477778888887
Q ss_pred ccc
Q 002887 488 LSV 490 (870)
Q Consensus 488 ~~~ 490 (870)
++.
T Consensus 122 L~~ 124 (198)
T d1m9la_ 122 MSN 124 (198)
T ss_dssp ESE
T ss_pred ccc
Confidence 763
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=97.45 E-value=1.9e-06 Score=84.59 Aligned_cols=80 Identities=25% Similarity=0.267 Sum_probs=66.0
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCC--CcccccccCCcc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLP--SGLSEKVKNGSL 486 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip--~~l~~~~~~~~l 486 (870)
.+++.|+|++|.|+ .||..+..+.+|+.|+|++|+++. ++ .+..+++|+.|+|++|+++ .++ ..+..+++|+.|
T Consensus 70 ~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L 145 (198)
T d1m9la_ 70 ENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDL 145 (198)
T ss_dssp TTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEE
T ss_pred ccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccccccccccccchhc-cccccccccCCCcccee
Confidence 47899999999997 788777778899999999999994 54 4789999999999999998 444 367888888887
Q ss_pred ccccCCCC
Q 002887 487 SLSVDGNR 494 (870)
Q Consensus 487 ~~~~~~n~ 494 (870)
+++ ||+
T Consensus 146 ~L~--~N~ 151 (198)
T d1m9la_ 146 LLA--GNP 151 (198)
T ss_dssp EEC--SSH
T ss_pred ecC--CCc
Confidence 776 553
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=97.42 E-value=5.9e-05 Score=73.41 Aligned_cols=76 Identities=20% Similarity=0.275 Sum_probs=60.6
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
.+++.|+|++|+++ .++ .+..|++|++|+|++|++++. |. +++|++|+.|++++|.+. .+| .+..++.++.|++
T Consensus 40 ~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l 113 (199)
T d2omxa2 40 DQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTL 113 (199)
T ss_dssp TTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEEC
T ss_pred cCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCc-cc-ccCCcccccccccccccc-ccc-ccccccccccccc
Confidence 47888999999988 453 588899999999999999864 43 889999999999999887 444 4777888887777
Q ss_pred cc
Q 002887 489 SV 490 (870)
Q Consensus 489 ~~ 490 (870)
+.
T Consensus 114 ~~ 115 (199)
T d2omxa2 114 FN 115 (199)
T ss_dssp CS
T ss_pred cc
Confidence 53
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.33 E-value=1.9e-05 Score=74.63 Aligned_cols=41 Identities=34% Similarity=0.521 Sum_probs=19.1
Q ss_pred cccCcccccccccCcCCCC--CCccccCcCCCCeEEecCCcCC
Q 002887 430 FSLTSIESLDLSKNSLTGP--VPEFLAELQSLRVLNLSGNNLQ 470 (870)
Q Consensus 430 ~~l~~L~~L~Ls~N~l~g~--iP~~~~~l~~L~~L~ls~N~l~ 470 (870)
.++++|++|+|++|+|+.. ++..+..+++|+.|||++|+++
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~ 104 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 104 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc
Confidence 3445555555555555421 1223344455555555555554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.28 E-value=0.00014 Score=76.17 Aligned_cols=74 Identities=22% Similarity=0.342 Sum_probs=50.9
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLS 487 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~ 487 (870)
++.++.|+|++|+|+ .||..+ .+|+.|++++|+++ .|++. .++|++|+|++|+++ .+|. .+.+.+++.|+
T Consensus 57 ~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~ 126 (353)
T d1jl5a_ 57 PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIID 126 (353)
T ss_dssp CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEE
T ss_pred CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccccccccc-cccc-hhhhccceeec
Confidence 456778888888887 777654 45677777777776 45432 145888888888887 5664 56677777777
Q ss_pred cccC
Q 002887 488 LSVD 491 (870)
Q Consensus 488 ~~~~ 491 (870)
++.+
T Consensus 127 l~~~ 130 (353)
T d1jl5a_ 127 VDNN 130 (353)
T ss_dssp CCSS
T ss_pred cccc
Confidence 6543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=97.24 E-value=0.00013 Score=72.44 Aligned_cols=76 Identities=25% Similarity=0.392 Sum_probs=61.8
Q ss_pred CcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCcccccccCCcccc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
..++.|+|.+|+|+ .++ .|.+|++|+.|+|++|++++..| +..+++|+.|++++|.++ .++ .+..++.+..+.+
T Consensus 41 ~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l 114 (227)
T d1h6ua2 41 DGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDL 114 (227)
T ss_dssp HTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEEC
T ss_pred CCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-ccccccccccccc
Confidence 36889999999998 564 68999999999999999986544 789999999999999987 554 5777777777766
Q ss_pred cc
Q 002887 489 SV 490 (870)
Q Consensus 489 ~~ 490 (870)
+.
T Consensus 115 ~~ 116 (227)
T d1h6ua2 115 TS 116 (227)
T ss_dssp TT
T ss_pred cc
Confidence 53
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.18 E-value=0.00013 Score=76.40 Aligned_cols=64 Identities=27% Similarity=0.375 Sum_probs=51.4
Q ss_pred CCcEEEEEcCCCCCcccCcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCCcCCCCCCCccccc
Q 002887 408 SPRIISINLSSSGIAGDIVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGNNLQGSLPSGLSEK 480 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~ip~~l~~~ 480 (870)
.+.++.|+|++|+|+ .||.. +++|+.|+|++|+|+ .||.. +++|+.|+|++|+|+ .+|.....+
T Consensus 283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~~~L 346 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIPESV 346 (353)
T ss_dssp CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCCTTC
T ss_pred CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCcccccc
Confidence 467899999999998 78864 567889999999998 78864 468999999999998 777644333
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.92 E-value=0.0011 Score=71.21 Aligned_cols=75 Identities=17% Similarity=0.198 Sum_probs=48.3
Q ss_pred ccccccCcEEEEEEEEC--CeeEEEEEeeccc-------hhhhHHHHHHHHHHHHhc-c--ccceeEEEEEecCCeEEEE
Q 002887 567 RVLGKGGFGTVYHGYLD--DKQVAVKMLSSSS-------VQGYKQFQAEVELLIRAH-H--KNLTILVGYCDEGANMGLI 634 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-------~~~~~~f~~Ei~~l~~l~-H--~nIv~l~g~~~~~~~~~LV 634 (870)
+.||.|....||+.... ++.++||.-...- .....+...|.+.|+.+. + ..+.+++.+. ....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 46899999999999864 5678999754311 112334566888887763 2 3345555543 3456789
Q ss_pred EEEccCCch
Q 002887 635 YEFMANGNL 643 (870)
Q Consensus 635 ~Ey~~~gsL 643 (870)
||++.+..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999987543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.76 E-value=0.00064 Score=67.54 Aligned_cols=77 Identities=26% Similarity=0.349 Sum_probs=60.7
Q ss_pred CcEEEEEcCCCCCcccCcccccccCccccc-ccccCcCCCCCCc-cccCcCCCCeEEecCCcCCCCCCC-cccccccCCc
Q 002887 409 PRIISINLSSSGIAGDIVPYIFSLTSIESL-DLSKNSLTGPVPE-FLAELQSLRVLNLSGNNLQGSLPS-GLSEKVKNGS 485 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~ip~~~~~l~~L~~L-~Ls~N~l~g~iP~-~~~~l~~L~~L~ls~N~l~g~ip~-~l~~~~~~~~ 485 (870)
..++.|++.+|+++ .++..+.+.++++.+ ++++|+|+ .||. .|..+++|+.|+|++|+|+ .+|. .+.++++|+.
T Consensus 153 ~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~~ 229 (242)
T d1xwdc1 153 FESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRA 229 (242)
T ss_dssp SSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCC-CCCSSSCTTCCEEES
T ss_pred ccceeeeccccccc-ccccccccchhhhccccccccccc-cccHHHhcCCCCCCEEECCCCcCC-ccCHHHHcCCccccc
Confidence 47889999999999 677777777776655 67888898 5665 5789999999999999999 5554 5777777776
Q ss_pred ccc
Q 002887 486 LSL 488 (870)
Q Consensus 486 l~~ 488 (870)
+++
T Consensus 230 l~~ 232 (242)
T d1xwdc1 230 RST 232 (242)
T ss_dssp SSE
T ss_pred CcC
Confidence 654
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.59 E-value=0.00017 Score=67.67 Aligned_cols=79 Identities=24% Similarity=0.230 Sum_probs=61.0
Q ss_pred CCcEEEEEcCCCCCccc--CcccccccCcccccccccCcCCCCCCc-cccCcCCCCeEEecCCcCCCCCCCc-------c
Q 002887 408 SPRIISINLSSSGIAGD--IVPYIFSLTSIESLDLSKNSLTGPVPE-FLAELQSLRVLNLSGNNLQGSLPSG-------L 477 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~--ip~~~~~l~~L~~L~Ls~N~l~g~iP~-~~~~l~~L~~L~ls~N~l~g~ip~~-------l 477 (870)
.+.++.|+|++|+|+.. ++..+..|++|+.|+|++|.++ .+++ ......+|+.|+|++|.+++..... +
T Consensus 64 ~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~ 142 (162)
T d1koha1 64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIR 142 (162)
T ss_dssp CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHH
T ss_pred CCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccchhHHHHHH
Confidence 45799999999999853 4556888999999999999999 5554 2334467999999999998766543 4
Q ss_pred cccccCCccc
Q 002887 478 SEKVKNGSLS 487 (870)
Q Consensus 478 ~~~~~~~~l~ 487 (870)
..++++..|+
T Consensus 143 ~~~P~L~~LD 152 (162)
T d1koha1 143 ERFPKLLRLD 152 (162)
T ss_dssp TTSTTCCEET
T ss_pred HHCCCCCEEC
Confidence 4567776654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.14 E-value=0.0002 Score=73.76 Aligned_cols=83 Identities=28% Similarity=0.289 Sum_probs=65.9
Q ss_pred CCcEEEEEcCCCCCccc-CcccccccCcccccccccCcCCCCCCccccCcCCCCeEEecCC-cCCCC-CCCcccccccCC
Q 002887 408 SPRIISINLSSSGIAGD-IVPYIFSLTSIESLDLSKNSLTGPVPEFLAELQSLRVLNLSGN-NLQGS-LPSGLSEKVKNG 484 (870)
Q Consensus 408 ~~~l~~l~L~~n~l~G~-ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N-~l~g~-ip~~l~~~~~~~ 484 (870)
..+++.|+|+++.+++. ++.-+.++++|++|+|+++++++..+..++++++|+.|+|+++ .++.. +..-...+++|+
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~ 124 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 124 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcc
Confidence 45899999999998865 4556788999999999999999999999999999999999995 56521 122234567888
Q ss_pred cccccc
Q 002887 485 SLSLSV 490 (870)
Q Consensus 485 ~l~~~~ 490 (870)
.|++++
T Consensus 125 ~L~ls~ 130 (284)
T d2astb2 125 ELNLSW 130 (284)
T ss_dssp EEECCC
T ss_pred cccccc
Confidence 888763
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.06 E-value=0.006 Score=63.45 Aligned_cols=133 Identities=12% Similarity=0.153 Sum_probs=76.6
Q ss_pred EEEEEEEEC-CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccce--eEEE-----EEecCCeEEEEEEEccCCchhhh
Q 002887 575 GTVYHGYLD-DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLT--ILVG-----YCDEGANMGLIYEFMANGNLQAH 646 (870)
Q Consensus 575 G~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv--~l~g-----~~~~~~~~~LV~Ey~~~gsL~~~ 646 (870)
-.||+...+ |+.+++|+.+.. ....+++..|...+..|....+. ..+. ....+...+.++++++|..+...
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 479999886 778999997654 23456788899998888544332 1111 12334567889999987543210
Q ss_pred --------------hhhc-------ccccccHHH-------------------HHHHHHHHHHHHHHHHh----CCCCCc
Q 002887 647 --------------LLED-------KADTLCWER-------------------RLQIASESAQGLEYLHN----GCKPPI 682 (870)
Q Consensus 647 --------------l~~~-------~~~~l~~~~-------------------~~~i~~~ia~aL~yLH~----~~~~~I 682 (870)
++.. ....+++.. +..+...+.+.++.+.. ....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0100 001111110 11122222233333322 224478
Q ss_pred eeCCCCCCCEEEcCCCcEEEEeccCCcc
Q 002887 683 VHRDVKSANILLNEKFQAKLADFGLSRI 710 (870)
Q Consensus 683 vHrDLKp~NILld~~~~vkL~DFGla~~ 710 (870)
+|+|+.+.|||++++ ..++||+-++.
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899998764
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.48 E-value=0.00074 Score=73.01 Aligned_cols=17 Identities=24% Similarity=0.352 Sum_probs=7.9
Q ss_pred ccccCcccccccccCcC
Q 002887 429 IFSLTSIESLDLSKNSL 445 (870)
Q Consensus 429 ~~~l~~L~~L~Ls~N~l 445 (870)
+..+++|+.|||++|+|
T Consensus 51 L~~~~~L~~LdLs~N~i 67 (460)
T d1z7xw1 51 LRVNPALAELNLRSNEL 67 (460)
T ss_dssp HHTCTTCCEEECTTCCC
T ss_pred HhcCCCCCEEECcCCcC
Confidence 34444444444444444
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.42 E-value=0.0023 Score=65.39 Aligned_cols=59 Identities=22% Similarity=0.164 Sum_probs=28.5
Q ss_pred cccCcccccccccC-cCCCCCCccccCcCCCCeEEecC-CcCCCCCCCcccccccCCcccc
Q 002887 430 FSLTSIESLDLSKN-SLTGPVPEFLAELQSLRVLNLSG-NNLQGSLPSGLSEKVKNGSLSL 488 (870)
Q Consensus 430 ~~l~~L~~L~Ls~N-~l~g~iP~~~~~l~~L~~L~ls~-N~l~g~ip~~l~~~~~~~~l~~ 488 (870)
.++++|+.|+|++| .+++..+..++++++|+.|+|++ +++++.....++++++|+.|++
T Consensus 172 ~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l 232 (284)
T d2astb2 172 RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQV 232 (284)
T ss_dssp HHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEEC
T ss_pred cccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEee
Confidence 34455555555543 34444444455555555555555 3444444444444455554444
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.31 E-value=0.027 Score=59.93 Aligned_cols=72 Identities=15% Similarity=0.229 Sum_probs=49.2
Q ss_pred ccccccCcEEEEEEEEC---------CeeEEEEEeeccchhhhHHHHHHHHHHHHhccccc-eeEEEEEecCCeEEEEEE
Q 002887 567 RVLGKGGFGTVYHGYLD---------DKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNL-TILVGYCDEGANMGLIYE 636 (870)
Q Consensus 567 ~~LG~G~fG~Vy~~~~~---------~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~LV~E 636 (870)
+.|+.|-.-.+|+.... .+.|.+++.... .......+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 46888999999999864 234666665432 223345689999988854454 477787754 58999
Q ss_pred EccCCchh
Q 002887 637 FMANGNLQ 644 (870)
Q Consensus 637 y~~~gsL~ 644 (870)
|+++..+.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99876553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.09 E-value=0.042 Score=56.20 Aligned_cols=140 Identities=9% Similarity=0.038 Sum_probs=74.4
Q ss_pred cccccCcEEEEEEEECCeeEEEEEeeccchhhhHHHHHHHHHHHHhccccce--eEEE------EEecCCeEEEEEEEcc
Q 002887 568 VLGKGGFGTVYHGYLDDKQVAVKMLSSSSVQGYKQFQAEVELLIRAHHKNLT--ILVG------YCDEGANMGLIYEFMA 639 (870)
Q Consensus 568 ~LG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv--~l~g------~~~~~~~~~LV~Ey~~ 639 (870)
.|..|---+.|+...++..+++|+..... ..++...|++++..+.+.++. ..+. ..........++.++.
T Consensus 25 ~i~~G~~N~ny~v~t~~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~ 102 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 102 (316)
T ss_dssp EECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred cCCCCcccCeEEEEECCCcEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence 35567778889998887779999876532 234556677777777544332 1111 0112344566677766
Q ss_pred CCchhhhh--------------hhc-------cc--ccccH----------------HHHHHHHHHHHHHHHHHHh-CCC
Q 002887 640 NGNLQAHL--------------LED-------KA--DTLCW----------------ERRLQIASESAQGLEYLHN-GCK 679 (870)
Q Consensus 640 ~gsL~~~l--------------~~~-------~~--~~l~~----------------~~~~~i~~~ia~aL~yLH~-~~~ 679 (870)
+......- +.. .. ....| ......+......+.-.+. ...
T Consensus 103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 182 (316)
T d2ppqa1 103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 182 (316)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence 54332110 000 00 00000 0011122222222232222 224
Q ss_pred CCceeCCCCCCCEEEcCCCcEEEEeccCCc
Q 002887 680 PPIVHRDVKSANILLNEKFQAKLADFGLSR 709 (870)
Q Consensus 680 ~~IvHrDLKp~NILld~~~~vkL~DFGla~ 709 (870)
.++||+|+.+.||+++++...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999998777899999875
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=94.53 E-value=0.0021 Score=67.41 Aligned_cols=63 Identities=21% Similarity=0.290 Sum_probs=44.7
Q ss_pred cEEEEEcCCCCCccc-----CcccccccCcccccccccCcCCCC----CCccccCcCCCCeEEecCCcCCCC
Q 002887 410 RIISINLSSSGIAGD-----IVPYIFSLTSIESLDLSKNSLTGP----VPEFLAELQSLRVLNLSGNNLQGS 472 (870)
Q Consensus 410 ~l~~l~L~~n~l~G~-----ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~~~~l~~L~~L~ls~N~l~g~ 472 (870)
.++.|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+..+++|+.|+|++|++++.
T Consensus 187 ~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~ 258 (344)
T d2ca6a1 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 258 (344)
T ss_dssp TCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred hhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCch
Confidence 577788888887632 344567778888888888887532 445566778888888888887643
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.44 E-value=0.0024 Score=68.82 Aligned_cols=81 Identities=23% Similarity=0.260 Sum_probs=59.4
Q ss_pred CcEEEEEcCCCCCccc-CcccccccCcccccccccCcCC----CCCCccccCcCCCCeEEecCCcCCCC----CCCcccc
Q 002887 409 PRIISINLSSSGIAGD-IVPYIFSLTSIESLDLSKNSLT----GPVPEFLAELQSLRVLNLSGNNLQGS----LPSGLSE 479 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~-ip~~~~~l~~L~~L~Ls~N~l~----g~iP~~~~~l~~L~~L~ls~N~l~g~----ip~~l~~ 479 (870)
..|+.|||++|++++. +..-+..|++|+.|+|++|+++ ..|+..+..+++|+.|||++|+++.. +...+..
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 4789999999999974 2444677899999999999987 24566678899999999999998621 1122221
Q ss_pred -cccCCccccc
Q 002887 480 -KVKNGSLSLS 489 (870)
Q Consensus 480 -~~~~~~l~~~ 489 (870)
..+++.|+++
T Consensus 82 ~~~~L~~L~L~ 92 (460)
T d1z7xw1 82 PSCKIQKLSLQ 92 (460)
T ss_dssp TTCCCCEEECT
T ss_pred CCCCCCEEECC
Confidence 2356666665
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=93.39 E-value=0.0047 Score=64.59 Aligned_cols=81 Identities=22% Similarity=0.236 Sum_probs=62.1
Q ss_pred CcEEEEEcCCCCCcc----cCcccccccCcccccccccCcCCCC-----CCccccCcCCCCeEEecCCcCCCC----CCC
Q 002887 409 PRIISINLSSSGIAG----DIVPYIFSLTSIESLDLSKNSLTGP-----VPEFLAELQSLRVLNLSGNNLQGS----LPS 475 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G----~ip~~~~~l~~L~~L~Ls~N~l~g~-----iP~~~~~l~~L~~L~ls~N~l~g~----ip~ 475 (870)
+.++.|++++|.++- .+...+..++.|+.|+|++|+++.. +...+..+++|+.|+|++|+++.. +..
T Consensus 158 ~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~ 237 (344)
T d2ca6a1 158 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 237 (344)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred cccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccc
Confidence 467889999998863 3455577889999999999998742 345577889999999999998633 444
Q ss_pred cccccccCCccccc
Q 002887 476 GLSEKVKNGSLSLS 489 (870)
Q Consensus 476 ~l~~~~~~~~l~~~ 489 (870)
.+..+++++.|+++
T Consensus 238 ~l~~~~~L~~L~Ls 251 (344)
T d2ca6a1 238 ALKSWPNLRELGLN 251 (344)
T ss_dssp HGGGCTTCCEEECT
T ss_pred cccccccchhhhhh
Confidence 56677788877775
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=93.20 E-value=0.0061 Score=56.86 Aligned_cols=42 Identities=29% Similarity=0.430 Sum_probs=18.5
Q ss_pred ccccCcccccccccCcCCCC----CCccccCcCCCCeEEecCCcCC
Q 002887 429 IFSLTSIESLDLSKNSLTGP----VPEFLAELQSLRVLNLSGNNLQ 470 (870)
Q Consensus 429 ~~~l~~L~~L~Ls~N~l~g~----iP~~~~~l~~L~~L~ls~N~l~ 470 (870)
+...+.|+.|+|++|.++.. +-+.+...+.|+.|+|++|+++
T Consensus 40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 33444455555555544321 1122333344555555555544
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=91.10 E-value=0.031 Score=51.81 Aligned_cols=62 Identities=18% Similarity=0.203 Sum_probs=47.9
Q ss_pred CcEEEEEcCCCCCccc----CcccccccCcccccccccCcCCCC----CCccccCcCCCCeEEecCCcCC
Q 002887 409 PRIISINLSSSGIAGD----IVPYIFSLTSIESLDLSKNSLTGP----VPEFLAELQSLRVLNLSGNNLQ 470 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~----ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~~~~l~~L~~L~ls~N~l~ 470 (870)
..|+.|+|++|++... +...+...+.|+.|+|++|.++.. +=..+...++|+.|+|++|.+.
T Consensus 44 ~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 44 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred CccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence 4789999999999743 334456678999999999998853 2234566688999999999765
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=88.78 E-value=0.027 Score=51.96 Aligned_cols=85 Identities=19% Similarity=0.255 Sum_probs=53.9
Q ss_pred CcEEEEEcCC-CCCccc----CcccccccCcccccccccCcCCCC----CCccccCcCCCCeEEecCCcCCCCC----CC
Q 002887 409 PRIISINLSS-SGIAGD----IVPYIFSLTSIESLDLSKNSLTGP----VPEFLAELQSLRVLNLSGNNLQGSL----PS 475 (870)
Q Consensus 409 ~~l~~l~L~~-n~l~G~----ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~~~~l~~L~~L~ls~N~l~g~i----p~ 475 (870)
+.++.|+|++ +.++.. +-..+...++|+.|+|++|.++.. |-..+...++|+.|++++|.++..- -.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 5788888887 456532 334456778899999999887654 2233455688899999988876331 12
Q ss_pred cccccccCCccccccCCC
Q 002887 476 GLSEKVKNGSLSLSVDGN 493 (870)
Q Consensus 476 ~l~~~~~~~~l~~~~~~n 493 (870)
.+...+.++.+++..++|
T Consensus 97 ~l~~~~~L~~l~L~l~~n 114 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQ 114 (166)
T ss_dssp GGGGCSSCCEEECCCCSS
T ss_pred HHHhCccccEEeeccCCC
Confidence 344455555555543333
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=81.25 E-value=0.058 Score=49.62 Aligned_cols=82 Identities=13% Similarity=0.184 Sum_probs=57.5
Q ss_pred CcEEEEEcCCCCCccc----CcccccccCcccccccccCcCCCC----CCccccCcCCCCeEEe--cCCcCCC----CCC
Q 002887 409 PRIISINLSSSGIAGD----IVPYIFSLTSIESLDLSKNSLTGP----VPEFLAELQSLRVLNL--SGNNLQG----SLP 474 (870)
Q Consensus 409 ~~l~~l~L~~n~l~G~----ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~~~~l~~L~~L~l--s~N~l~g----~ip 474 (870)
+.++.|+|++|+++.. |-..+...++|+.|++++|.++.. +-..+...++|+.++| ++|++.. .|-
T Consensus 46 ~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La 125 (166)
T d1io0a_ 46 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 125 (166)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHH
Confidence 4789999999998754 334566789999999999998754 3355677889998666 5666642 233
Q ss_pred CcccccccCCcccccc
Q 002887 475 SGLSEKVKNGSLSLSV 490 (870)
Q Consensus 475 ~~l~~~~~~~~l~~~~ 490 (870)
..+...+.+..|++++
T Consensus 126 ~~L~~n~~L~~L~l~~ 141 (166)
T d1io0a_ 126 NMLEKNTTLLKFGYHF 141 (166)
T ss_dssp HHHHHCSSCCEEECCC
T ss_pred HHHHhCCCcCEEeCcC
Confidence 3445666677766654
|